,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
11674,GO:0044456,4.37556712425591e-19,1,33,704,synapse part,CC,SYT13;GABRA1;PTPRN;LZTS1;SYT1;CAMK2A;RPH3A;RIMS4;SYTL4;SLC17A7;DNM1;NEURL1;GABRA4;CRYAB;GABRG2;SLC30A3;CNR1;IQSEC3;HPCA;PACSIN1;SNAP25;SYT4;CHRM3;GABRB2;TENM2;NRGN;GNG3;KCNC2;KCNK9;DDN;SV2B;SLC6A17;GRIN2B
17793,GO:0097458,3.29151399702365e-17,1,42,1425,neuron part,CC,CAMK1G;SYT13;GABRA1;PTPRN;LZTS1;SYT1;CAMK2A;RPH3A;KIF4A;RIMS4;EEF1A2;SYTL4;STMN2;NEFM;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;CRYAB;GABRG2;SLC30A3;CNR1;HPCA;PACSIN1;SNAP25;SYT4;CHRM3;SLC4A10;GABRB2;TENM2;NRGN;GNG3;FABP7;KCNC2;KCNK9;NPTX1;ENC1;DDN;SV2B;SLC6A17;GRIN2B
11929,GO:0045202,9.57447677727892e-17,1,33,835,synapse,CC,SYT13;GABRA1;PTPRN;LZTS1;SYT1;CAMK2A;RPH3A;RIMS4;SYTL4;SLC17A7;DNM1;NEURL1;GABRA4;CRYAB;GABRG2;SLC30A3;CNR1;IQSEC3;HPCA;PACSIN1;SNAP25;SYT4;CHRM3;GABRB2;TENM2;NRGN;GNG3;KCNC2;KCNK9;DDN;SV2B;SLC6A17;GRIN2B
3705,GO:0007268,1.91807504714125e-14,1,26,603,chemical synaptic transmission,BP,SYT13;GABRA1;SYT1;CAMK2A;RPH3A;RIMS4;CELF4;SYTL4;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;GABRG2;CNR1;PRLHR;VGF;SNAP25;SYT4;CHRM3;GABRB2;NRGN;NPTX1;NEUROD2;SV2B;GRIN2B
18128,GO:0098916,1.91807504714125e-14,1,26,603,anterograde trans-synaptic signaling,BP,SYT13;GABRA1;SYT1;CAMK2A;RPH3A;RIMS4;CELF4;SYTL4;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;GABRG2;CNR1;PRLHR;VGF;SNAP25;SYT4;CHRM3;GABRB2;NRGN;NPTX1;NEUROD2;SV2B;GRIN2B
18264,GO:0099537,2.21008020288724e-14,1,26,606,trans-synaptic signaling,BP,SYT13;GABRA1;SYT1;CAMK2A;RPH3A;RIMS4;CELF4;SYTL4;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;GABRG2;CNR1;PRLHR;VGF;SNAP25;SYT4;CHRM3;GABRB2;NRGN;NPTX1;NEUROD2;SV2B;GRIN2B
18263,GO:0099536,2.33881507950156e-14,1,26,607,synaptic signaling,BP,SYT13;GABRA1;SYT1;CAMK2A;RPH3A;RIMS4;CELF4;SYTL4;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;GABRG2;CNR1;PRLHR;VGF;SNAP25;SYT4;CHRM3;GABRB2;NRGN;NPTX1;NEUROD2;SV2B;GRIN2B
11004,GO:0043005,7.86589127452824e-14,1,34,1140,neuron projection,CC,CAMK1G;GABRA1;PTPRN;LZTS1;SYT1;CAMK2A;RPH3A;KIF4A;STMN2;NEFM;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;CRYAB;GABRG2;SLC30A3;CNR1;HPCA;PACSIN1;SNAP25;SYT4;CHRM3;SLC4A10;GABRB2;TENM2;NRGN;GNG3;KCNC2;NPTX1;DDN;SV2B;GRIN2B
3704,GO:0007267,6.0353682717641e-13,1,36,1447,cell-cell signaling,BP,SYT13;GABRA1;PTPRN;ASPM;SYT1;CAMK2A;RPH3A;RIMS4;CELF4;SYTL4;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;GABRG2;IGFBP2;CNR1;PRLHR;VGF;SNAP25;SYT4;CHRM3;SFRP2;CXCL14;GABRB2;DAAM2;NRGN;VSNL1;KCNC2;NPTX1;NEUROD2;PCSK1;SV2B;NMB;GRIN2B
17582,GO:0097060,6.76776804556901e-13,1,19,303,synaptic membrane,CC,GABRA1;LZTS1;SYT1;CAMK2A;RIMS4;DNM1;NEURL1;GABRA4;CRYAB;GABRG2;CNR1;IQSEC3;SNAP25;CHRM3;GABRB2;TENM2;KCNC2;DDN;GRIN2B
18051,GO:0098793,2.11154911299347e-12,1,19,357,presynapse,CC,SYT13;PTPRN;SYT1;CAMK2A;RPH3A;RIMS4;SYTL4;SLC17A7;DNM1;SLC30A3;CNR1;PACSIN1;SNAP25;SYT4;CHRM3;KCNC2;KCNK9;SV2B;SLC6A17
7177,GO:0030133,7.47046207544916e-12,1,18,356,transport vesicle,CC,SYT13;PTPRN;SYT1;RPH3A;CHGA;SYTL4;SLC17A7;DNM1;SLC30A3;VGF;SNAP25;SYT4;NRGN;KCNK9;NPTX1;PCSK1;SV2B;SLC6A17
18052,GO:0098794,3.29539239392469e-11,1,20,435,postsynapse,CC,GABRA1;LZTS1;CAMK2A;SLC17A7;DNM1;NEURL1;GABRA4;CRYAB;GABRG2;IQSEC3;HPCA;SNAP25;CHRM3;GABRB2;TENM2;NRGN;GNG3;KCNC2;DDN;GRIN2B
10300,GO:0036477,7.31596400903402e-10,0.999999999881516,23,725,somatodendritic compartment,CC,GABRA1;PTPRN;LZTS1;EEF1A2;STMN2;NPTX2;DNM1;NEURL1;GABRA4;CRYAB;GABRG2;HPCA;SNAP25;SYT4;CHRM3;SLC4A10;TENM2;NRGN;GNG3;FABP7;KCNC2;ENC1;DDN
10995,GO:0042995,1.23519409122553e-09,0.999999999712012,37,1877,cell projection,CC,CAMK1G;GABRA1;PTPRN;LZTS1;SYT1;CAMK2A;RPH3A;KIF4A;STMN2;NEFM;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;CRYAB;GABRG2;SLC30A3;CENPF;CNR1;HPCA;PACSIN1;SNAP25;SYT4;CHRM3;SLC4A10;GABRB2;TENM2;NRGN;GNG3;FABP7;KCNC2;NPTX1;DDN;SV2B;SPRY4;GRIN2B
18467,GO:0120025,1.72864082162774e-09,0.999999999597441,36,1807,plasma membrane bounded cell projection,CC,CAMK1G;GABRA1;PTPRN;LZTS1;SYT1;CAMK2A;RPH3A;KIF4A;STMN2;NEFM;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;CRYAB;GABRG2;SLC30A3;CENPF;CNR1;HPCA;PACSIN1;SNAP25;SYT4;CHRM3;SLC4A10;GABRB2;TENM2;NRGN;GNG3;KCNC2;NPTX1;DDN;SV2B;SPRY4;GRIN2B
17961,GO:0098590,2.8389232747234e-09,0.999999999452737,26,977,plasma membrane region,CC,GABRA1;LZTS1;ASPM;SYT1;CAMK2A;RIMS4;DNM1;NEURL1;GABRA4;CRYAB;GABRG2;IGFBP2;CNR1;IQSEC3;HPCA;PACSIN1;SNAP25;CHRM3;SLC14A1;SLC4A10;GABRB2;TENM2;KCNC2;DDN;SPRY4;GRIN2B
7362,GO:0030424,4.03834962917596e-09,0.999999999404034,19,516,axon,CC,PTPRN;SYT1;KIF4A;STMN2;NEFM;SLC17A7;NPTX2;DNM1;CRYAB;GABRG2;CNR1;HPCA;PACSIN1;SNAP25;SYT4;CHRM3;TENM2;NRGN;KCNC2
15773,GO:0070382,2.01168635013142e-08,0.999999998374165,11,181,exocytic vesicle,CC,SYT1;RPH3A;SYTL4;SLC17A7;DNM1;SLC30A3;SNAP25;SYT4;KCNK9;SV2B;SLC6A17
18242,GO:0099504,2.88699219474647e-08,0.999999997958801,10,128,synaptic vesicle cycle,BP,SYT13;SYT1;RPH3A;RIMS4;SYTL4;SLC17A7;DNM1;PACSIN1;SNAP25;SYT4
7458,GO:0030658,2.97947117036594e-08,0.999999997493451,11,186,transport vesicle membrane,CC,PTPRN;SYT1;RPH3A;CHGA;SYTL4;SLC17A7;SLC30A3;SYT4;NRGN;SV2B;SLC6A17
11676,GO:0044459,4.02163238423621e-08,0.999999988427625,39,2421,plasma membrane part,CC,SYT13;GABRA1;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;RIMS4;NPTX2;DNM1;NEURL1;GABRA4;CRYAB;GABRG2;SLC30A3;IGFBP2;CNR1;PRLHR;IQSEC3;HPCA;KCNS1;PACSIN1;CALY;SNAP25;CHRM3;SLC14A1;SLC4A10;GABRB2;TENM2;GNG3;ADCY1;KCNC2;TMEM130;KCNK9;DDN;SPRY4;SELL;SLC6A17;GRIN2B
3852,GO:0008021,1.01818048815801e-07,0.999999991661166,10,167,synaptic vesicle,CC,SYT1;RPH3A;SLC17A7;DNM1;SLC30A3;SNAP25;SYT4;KCNK9;SV2B;SLC6A17
11934,GO:0045211,1.42830613092096e-07,0.999999983992647,12,233,postsynaptic membrane,CC,GABRA1;LZTS1;DNM1;NEURL1;GABRA4;GABRG2;IQSEC3;CHRM3;GABRB2;TENM2;KCNC2;GRIN2B
8518,GO:0032590,1.87236409522019e-07,0.99999999457536,6,37,dendrite membrane,CC,GABRA1;GABRA4;GABRG2;HPCA;KCNC2;DDN
7459,GO:0030659,2.0563084741995e-07,0.999999959893934,19,714,cytoplasmic vesicle membrane,CC,GABRA1;PTPRN;SYT1;CAMK2A;RPH3A;CHGA;SYTL4;SLC17A7;GABRG2;SLC30A3;PACSIN1;CALY;SNAP25;SYT4;GABRB2;NRGN;SV2B;SELL;SLC6A17
13239,GO:0048791,2.0814113724211e-07,0.999999993858119,6,37,calcium ion-regulated exocytosis of neurotransmitter,BP,SYT13;SYT1;RPH3A;RIMS4;SYTL4;SYT4
7363,GO:0030425,2.61911179908488e-07,0.999999953252195,17,543,dendrite,CC,GABRA1;LZTS1;NPTX2;DNM1;NEURL1;GABRA4;CRYAB;GABRG2;HPCA;SYT4;CHRM3;SLC4A10;TENM2;NRGN;GNG3;KCNC2;DDN
17785,GO:0097447,2.65656948567201e-07,0.999999952532731,17,544,dendritic tree,CC,GABRA1;LZTS1;NPTX2;DNM1;NEURL1;GABRA4;CRYAB;GABRG2;HPCA;SYT4;CHRM3;SLC4A10;TENM2;NRGN;GNG3;KCNC2;DDN
5119,GO:0012506,3.16942438143096e-07,0.999999936315642,19,733,vesicle membrane,CC,GABRA1;PTPRN;SYT1;CAMK2A;RPH3A;CHGA;SYTL4;SLC17A7;GABRG2;SLC30A3;PACSIN1;CALY;SNAP25;SYT4;GABRB2;NRGN;SV2B;SELL;SLC6A17
7139,GO:0030054,3.72215962082354e-07,0.999999906574334,25,1176,cell junction,CC,GABRA1;PTPRN;LZTS1;SYT1;CAMK2A;RPH3A;RIMS4;SLC17A7;NEURL1;GABRA4;GABRG2;SLC30A3;TJP2;PACSIN1;SNAP25;SYT4;CHRM3;GABRB2;TENM2;FABP7;KCNC2;SV2B;SPRY4;SLC6A17;GRIN2B
11677,GO:0044463,4.30141995760282e-07,0.999999888301261,26,1261,cell projection part,CC,GABRA1;PTPRN;LZTS1;SYT1;KIF4A;STMN2;NPTX2;DNM1;NEURL1;GABRA4;CRYAB;GABRG2;CENPF;CNR1;HPCA;PACSIN1;SNAP25;SYT4;CHRM3;SLC4A10;TENM2;NRGN;GNG3;KCNC2;DDN;SPRY4
18474,GO:0120038,4.30141995760282e-07,0.999999888301261,26,1261,plasma membrane bounded cell projection part,CC,GABRA1;PTPRN;LZTS1;SYT1;KIF4A;STMN2;NPTX2;DNM1;NEURL1;GABRA4;CRYAB;GABRG2;CENPF;CNR1;HPCA;PACSIN1;SNAP25;SYT4;CHRM3;SLC4A10;TENM2;NRGN;GNG3;KCNC2;DDN;SPRY4
3448,GO:0006836,4.62333315593021e-07,0.999999948280335,11,230,neurotransmitter transport,BP,SYT13;SYT1;CAMK2A;RPH3A;RIMS4;SYTL4;SLC17A7;SNAP25;SYT4;SV2B;SLC6A17
18172,GO:0099003,5.14439928930226e-07,0.99999995747043,9,135,vesicle-mediated transport in synapse,BP,SYT13;SYT1;RPH3A;RIMS4;SYTL4;DNM1;PACSIN1;SNAP25;SYT4
16633,GO:0071944,5.44211407549403e-07,0.999999810134007,53,4376,cell periphery,CC,CAMK1G;SYT13;GABRA1;PTPRN;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;RPH3A;RIMS4;SYTL4;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;CRYAB;GABRG2;SLC30A3;IGFBP2;RGS4;CNR1;TJP2;PRLHR;IQSEC3;HPCA;KCNS1;PACSIN1;CALY;SNAP25;SYT4;CHRM3;MRAP2;SLC14A1;STAC2;SLC4A10;GABRB2;TENM2;FREM2;GNG3;FABP7;ADCY1;KCNC2;TMEM130;KCNK9;NPTX1;DDN;SV2B;SPRY4;SELL;SLC6A17;GRIN2B
14158,GO:0051932,6.20172811644996e-07,0.999999977533076,6,43,synaptic transmission, GABAergic,BP,GABRA1;DNM1;GABRA4;GABRG2;CNR1;GABRB2
2827,GO:0005886,6.81946519315916e-07,0.999999760448052,52,4280,plasma membrane,CC,CAMK1G;SYT13;GABRA1;PTPRN;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;RPH3A;RIMS4;SYTL4;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;CRYAB;GABRG2;SLC30A3;IGFBP2;RGS4;CNR1;TJP2;PRLHR;IQSEC3;HPCA;KCNS1;PACSIN1;CALY;SNAP25;SYT4;CHRM3;MRAP2;SLC14A1;STAC2;SLC4A10;GABRB2;TENM2;FREM2;GNG3;ADCY1;KCNC2;TMEM130;KCNK9;NPTX1;DDN;SV2B;SPRY4;SELL;SLC6A17;GRIN2B
11575,GO:0044297,1.02289515811599e-06,0.999999820567398,15,490,cell body,CC,PTPRN;EEF1A2;STMN2;NPTX2;NEURL1;CRYAB;HPCA;SYT4;SLC4A10;NRGN;GNG3;FABP7;KCNC2;ENC1;DDN
11020,GO:0043025,1.38872809636567e-06,0.99999976732541,14,428,neuronal cell body,CC,PTPRN;EEF1A2;STMN2;NPTX2;NEURL1;CRYAB;HPCA;SYT4;SLC4A10;NRGN;FABP7;KCNC2;ENC1;DDN
13076,GO:0048489,1.49401206733698e-06,0.999999883927586,8,116,synaptic vesicle transport,BP,SYT13;SYT1;RPH3A;RIMS4;SYTL4;DNM1;SNAP25;SYT4
17804,GO:0097480,1.49401206733698e-06,0.999999883927586,8,116,establishment of synaptic vesicle localization,BP,SYT13;SYT1;RPH3A;RIMS4;SYTL4;DNM1;SNAP25;SYT4
7468,GO:0030672,1.98679778364095e-06,0.999999874222245,7,91,synaptic vesicle membrane,CC,SYT1;RPH3A;SLC17A7;SLC30A3;SYT4;SV2B;SLC6A17
18240,GO:0099501,1.98679778364095e-06,0.999999874222245,7,91,exocytic vesicle membrane,CC,SYT1;RPH3A;SLC17A7;SLC30A3;SYT4;SV2B;SLC6A17
13504,GO:0050804,1.99125597842958e-06,0.99999971002166,12,317,modulation of chemical synaptic transmission,BP,SYT1;CAMK2A;RIMS4;CELF4;NEURL1;CNR1;VGF;SNAP25;SYT4;NRGN;NEUROD2;GRIN2B
18230,GO:0099177,1.99125597842958e-06,0.99999971002166,12,317,regulation of trans-synaptic signaling,BP,SYT1;CAMK2A;RIMS4;CELF4;NEURL1;CNR1;VGF;SNAP25;SYT4;NRGN;NEUROD2;GRIN2B
17803,GO:0097479,2.51527532280154e-06,0.999999789686388,8,123,synaptic vesicle localization,BP,SYT13;SYT1;RPH3A;RIMS4;SYTL4;DNM1;SNAP25;SYT4
5697,GO:0016079,2.64229599196651e-06,0.999999825704979,7,86,synaptic vesicle exocytosis,BP,SYT13;SYT1;RPH3A;RIMS4;SYTL4;SNAP25;SYT4
7104,GO:0023061,2.80338906144462e-06,0.999999537253469,13,401,signal release,BP,SYT13;PTPRN;SYT1;CAMK2A;RPH3A;RIMS4;SYTL4;CNR1;VGF;SNAP25;SYT4;VSNL1;KCNC2
12947,GO:0048167,2.88984693386227e-06,0.999999702496564,9,164,regulation of synaptic plasticity,BP,CAMK2A;RIMS4;NEURL1;VGF;SNAP25;SYT4;NRGN;NEUROD2;GRIN2B
8517,GO:0032589,3.00518326718777e-06,0.999999854056157,6,53,neuron projection membrane,CC,GABRA1;GABRA4;GABRG2;HPCA;KCNC2;DDN
2504,GO:0005237,3.13105865376648e-06,0.99999995265546,4,15,inhibitory extracellular ligand-gated ion channel activity,MF,GABRA1;GABRA4;GABRG2;GABRB2
2301,GO:0004890,4.97342983262011e-06,0.999999913001006,4,17,GABA-A receptor activity,MF,GABRA1;GABRA4;GABRG2;GABRB2
19397,GO:1902711,4.97342983262011e-06,0.999999913001006,4,17,GABA-A receptor complex,CC,GABRA1;GABRA4;GABRG2;GABRB2
8939,GO:0033267,5.93529724200307e-06,0.999999034943716,12,340,axon part,CC,PTPRN;SYT1;KIF4A;STMN2;NPTX2;DNM1;CNR1;PACSIN1;SNAP25;CHRM3;TENM2;KCNC2
3706,GO:0007269,6.05933343862304e-06,0.999999425668995,8,139,neurotransmitter secretion,BP,SYT13;SYT1;CAMK2A;RPH3A;RIMS4;SYTL4;SNAP25;SYT4
18314,GO:0099643,6.05933343862304e-06,0.999999425668995,8,139,signal release from synapse,BP,SYT13;SYT1;CAMK2A;RPH3A;RIMS4;SYTL4;SNAP25;SYT4
18208,GO:0099095,6.45397100759869e-06,0.999999877982379,4,18,ligand-gated anion channel activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2
2501,GO:0005230,6.75794855445907e-06,0.999999615285874,6,68,extracellular ligand-gated ion channel activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;GABRB2;GRIN2B
19396,GO:1902710,6.76272088421527e-06,0.999999870607911,4,18,GABA receptor complex,CC,GABRA1;GABRA4;GABRG2;GABRB2
7280,GO:0030276,8.93932827863431e-06,0.999999464779717,6,69,clathrin binding,MF,SYT13;SYT1;RPH3A;SYTL4;CALY;SYT4
18261,GO:0099531,9.05761366056293e-06,0.999999090201827,8,149,presynaptic process involved in chemical synaptic transmission,BP,SYT13;SYT1;CAMK2A;RPH3A;RIMS4;SYTL4;SNAP25;SYT4
3762,GO:0007417,1.0030361623381e-05,0.999997418863962,19,878,central nervous system development,BP,ASPM;SYT1;SLC17A7;NEURL1;GABRA4;CENPF;HPCA;SYT4;SLC4A10;SFRP2;DAAM2;NRGN;FABP7;ADCY1;KCNC2;NPTX1;NEUROD2;SLC6A17;GRIN2B
11649,GO:0044425,1.02021600928443e-05,0.999995959854821,56,5383,membrane part,CC,SYT13;GABRA1;PTPRN;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;RPH3A;RIMS4;EEF1A2;ST8SIA5;SYTL4;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;CRYAB;PTPN5;GABRG2;SLC30A3;IGFBP2;CNR1;PRLHR;IQSEC3;HPCA;KCNS1;PACSIN1;PRRG3;CALY;SNAP25;SYT4;CHRM3;FAM189A2;MRAP2;SLC14A1;SLC4A10;SFRP2;GABRB2;TENM2;FREM2;CHST9;GNG3;ADCY1;KCNC2;TMEM130;KCNK9;DDN;ZDHHC23;SV2B;C11ORF87;SPRY4;SELL;SLC6A17;GRIN2B
6133,GO:0016917,1.08027112051784e-05,0.999999762666594,4,20,GABA receptor activity,MF,GABRA1;GABRA4;GABRG2;GABRB2
3751,GO:0007399,1.15079308991739e-05,0.999995999891152,32,2100,nervous system development,BP,ASPM;SYT1;CAMK2A;RBFOX1;STMN2;NEFM;SLC17A7;NPTX2;NEURL1;GABRA4;CENPF;CNR1;HPCA;PACSIN1;SNAP25;SYT4;CHRM3;SLC4A10;SFRP2;GABRB2;TENM2;DAAM2;NRGN;FABP7;ADCY1;KCNC2;NPTX1;NEUROD2;ENC1;MYT1L;SLC6A17;GRIN2B
6245,GO:0017158,1.21945402544729e-05,0.999999226123441,6,73,regulation of calcium ion-dependent exocytosis,BP,SYT13;SYT1;RPH3A;RIMS4;SYTL4;SYT4
11119,GO:0043197,1.22692798381459e-05,0.99999871419645,8,149,dendritic spine,CC,LZTS1;DNM1;NEURL1;CRYAB;HPCA;TENM2;NRGN;DDN
18561,GO:0150034,1.23467737149631e-05,0.999998240952486,10,255,distal axon,CC,PTPRN;SYT1;STMN2;NPTX2;CNR1;PACSIN1;SNAP25;CHRM3;TENM2;KCNC2
6243,GO:0017156,1.29016376013085e-05,0.999998900477111,7,110,calcium ion regulated exocytosis,BP,SYT13;SYT1;RPH3A;RIMS4;SYTL4;SNAP25;SYT4
11586,GO:0044309,1.39257688405559e-05,0.999998513873647,8,151,neuron spine,CC,LZTS1;DNM1;NEURL1;CRYAB;HPCA;TENM2;NRGN;DDN
3624,GO:0007154,1.44874215312758e-05,0.999994172749028,57,5474,cell communication,BP,CAMK1G;SYT13;GABRA1;PTPRN;ASPM;SYT1;PTPN3;CAMK2A;RPH3A;BIRC5;CHGA;RIMS4;CELF4;SYTL4;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;CRYAB;FOXM1;GABRG2;IGFBP2;RGS4;CNR1;TJP2;PRLHR;IQSEC3;HPCA;VGF;CALY;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;STAC2;SFRP2;CXCL14;GABRB2;TENM2;DAAM2;FREM2;ZNF385D;NRGN;GNG3;VSNL1;ADCY1;KCNC2;NPTX1;NEUROD2;ZCCHC12;PCSK1;SV2B;SPRY4;NMB;GRIN2B
11599,GO:0044327,1.57079816841499e-05,0.999999872567186,3,8,dendritic spine head,CC,DNM1;HPCA;NRGN
2629,GO:0005544,1.59491244356004e-05,0.999999278030398,5,48,calcium-dependent phospholipid binding,MF,SYT13;SYT1;RPH3A;SYTL4;SYT4
16323,GO:0071420,1.67542945417448e-05,0.999999869958482,3,7,cellular response to histamine,BP,GABRA1;GABRG2;GABRB2
3824,GO:0007610,1.69858730253898e-05,0.999996426663501,14,529,behavior,BP,SLC17A7;NPTX2;DNM1;GABRG2;CNR1;PRLHR;SNAP25;SYT4;MRAP2;SLC4A10;NRGN;ADCY1;NEUROD2;GRIN2B
3764,GO:0007420,1.70538153932973e-05,0.99999598155138,16,656,brain development,BP,ASPM;SYT1;SLC17A7;NEURL1;CENPF;HPCA;SYT4;SLC4A10;SFRP2;NRGN;FABP7;ADCY1;KCNC2;NEUROD2;SLC6A17;GRIN2B
3652,GO:0007186,1.71002811112701e-05,0.999995963736095,16,771,G-protein coupled receptor signaling pathway,BP,GABRA1;CAMK2A;CHGA;GABRA4;GABRG2;RGS4;CNR1;PRLHR;CALY;CHRM3;MRAP2;SFRP2;GABRB2;GNG3;ADCY1;NMB
3675,GO:0007214,1.99557686851415e-05,0.999999476001178,4,23,gamma-aminobutyric acid signaling pathway,BP,GABRA1;GABRA4;GABRG2;GABRB2
7761,GO:0031256,2.28444078744205e-05,0.999997382568927,8,158,leading edge membrane,CC,GABRA1;GABRA4;GABRG2;HPCA;PACSIN1;KCNC2;DDN;SPRY4
16207,GO:0071242,2.40699830397573e-05,0.999998804336004,5,53,cellular response to ammonium ion,BP,GABRA1;GABRG2;CHRM3;GABRB2;KCNC2
9051,GO:0033604,2.68133500587856e-05,0.999999717231698,3,10,negative regulation of catecholamine secretion,BP,CHGA;CNR1;SYT4
9546,GO:0034776,3.07761230751679e-05,0.999999671625473,3,9,response to histamine,BP,GABRA1;GABRG2;GABRB2
10887,GO:0042734,3.07938262768499e-05,0.999997686618298,6,77,presynaptic membrane,CC,SYT1;CAMK2A;RIMS4;CNR1;SNAP25;KCNC2
7100,GO:0023052,3.320481823182e-05,0.999986130324294,56,5462,signaling,BP,CAMK1G;SYT13;GABRA1;PTPRN;ASPM;SYT1;PTPN3;CAMK2A;RPH3A;BIRC5;CHGA;RIMS4;CELF4;SYTL4;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;CRYAB;FOXM1;GABRG2;IGFBP2;RGS4;CNR1;TJP2;PRLHR;IQSEC3;HPCA;VGF;CALY;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;STAC2;SFRP2;CXCL14;GABRB2;TENM2;DAAM2;ZNF385D;NRGN;GNG3;VSNL1;ADCY1;KCNC2;NPTX1;NEUROD2;ZCCHC12;PCSK1;SV2B;SPRY4;NMB;GRIN2B
14696,GO:0060322,3.32083419280284e-05,0.999991713989024,16,695,head development,BP,ASPM;SYT1;SLC17A7;NEURL1;CENPF;HPCA;SYT4;SLC4A10;SFRP2;NRGN;FABP7;ADCY1;KCNC2;NEUROD2;SLC6A17;GRIN2B
6704,GO:0019905,3.35571010839263e-05,0.999997424703848,6,88,syntaxin binding,MF,SYT13;SYT1;RPH3A;SYTL4;SNAP25;SYT4
3825,GO:0007611,3.72230450926213e-05,0.999994654024255,9,225,learning or memory,BP,SLC17A7;NPTX2;CNR1;SNAP25;SYT4;NRGN;ADCY1;NEUROD2;GRIN2B
15543,GO:0065008,3.86808209846824e-05,0.999984525562112,40,3342,regulation of biological quality,BP,SYT13;GABRA1;PTPRN;ASPM;SYT1;PTPN3;CAMK2A;RPH3A;CHGA;RIMS4;CELF4;SYTL4;SLC17A7;DNM1;NEURL1;GABRA4;CRYAB;GABRG2;SLC30A3;CNR1;TJP2;PRLHR;VGF;SNAP25;SYT4;CHRM3;MRAP2;SLC4A10;GABRB2;CHST9;NRGN;GNG3;VSNL1;ADCY1;KCNC2;KCNK9;NEUROD2;PCSK1;NELL2;GRIN2B
4146,GO:0008503,4.0054110172289e-05,0.999999516170237,3,10,benzodiazepine receptor activity,MF,GABRA1;GABRA4;GABRG2
3440,GO:0006821,5.22231459015427e-05,0.999995641656596,6,97,chloride transport,BP,GABRA1;SLC17A7;GABRA4;GABRG2;SLC4A10;GABRB2
13350,GO:0050433,5.9431997794899e-05,0.99999783311238,4,36,regulation of catecholamine secretion,BP,SYT1;CHGA;CNR1;SYT4
8299,GO:0032279,6.19590511457084e-05,0.999990486054317,9,226,asymmetric synapse,CC,LZTS1;CAMK2A;DNM1;NEURL1;CRYAB;CHRM3;NRGN;GNG3;GRIN2B
7075,GO:0022851,6.27575725981698e-05,0.999999093057634,3,11,GABA-gated chloride ion channel activity,MF,GABRA1;GABRA4;GABRG2
14727,GO:0060359,6.66108110870471e-05,0.999994171297618,6,106,response to ammonium ion,BP,GABRA1;GABRG2;CNR1;CHRM3;GABRB2;KCNC2
18165,GO:0098984,6.74301800461744e-05,0.999989526985763,9,229,neuron to neuron synapse,CC,LZTS1;CAMK2A;DNM1;NEURL1;CRYAB;CHRM3;NRGN;GNG3;GRIN2B
18241,GO:0099503,8.57287584293073e-05,0.999976722460652,16,879,secretory vesicle,CC,PTPRN;SYT1;RPH3A;CHGA;SYTL4;SLC17A7;DNM1;SLC30A3;SNAP25;SYT4;CHI3L1;KCNK9;PCSK1;SV2B;SELL;SLC6A17
13163,GO:0048666,8.73684785457269e-05,0.999973434789856,19,1004,neuron development,BP,SYT1;CAMK2A;STMN2;NEFM;NPTX2;NEURL1;CNR1;PACSIN1;SNAP25;SYT4;SLC4A10;SFRP2;GABRB2;TENM2;ADCY1;NPTX1;NEUROD2;ENC1;MYT1L
13564,GO:0050890,9.34798001239561e-05,0.99998480856519,9,255,cognition,BP,SLC17A7;NPTX2;CNR1;SNAP25;SYT4;NRGN;ADCY1;NEUROD2;GRIN2B
13349,GO:0050432,9.37319514740357e-05,0.999996129701922,4,39,catecholamine secretion,BP,SYT1;CHGA;CNR1;SYT4
13554,GO:0050877,9.7116074245959e-05,0.999973353035862,16,810,nervous system process,BP,GABRA1;BIRC5;SLC17A7;NPTX2;DNM1;GABRA4;GABRG2;CNR1;SNAP25;SYT4;GABRB2;NRGN;FABP7;ADCY1;NEUROD2;GRIN2B
2828,GO:0005887,0.000103754973553311,0.999965253000566,22,1405,integral component of plasma membrane,CC,SYT13;GABRA1;GABRA4;GABRG2;SLC30A3;CNR1;PRLHR;KCNS1;CALY;SNAP25;CHRM3;SLC14A1;SLC4A10;GABRB2;TENM2;ADCY1;KCNC2;TMEM130;KCNK9;SELL;SLC6A17;GRIN2B
7858,GO:0031410,0.000104019557892625,0.999960996412722,28,2091,cytoplasmic vesicle,CC,SYT13;GABRA1;PTPRN;SYT1;CAMK2A;RPH3A;CHGA;SYTL4;STMN2;SLC17A7;DNM1;GABRG2;SLC30A3;IGFBP2;PACSIN1;VGF;CALY;SNAP25;SYT4;CHI3L1;GABRB2;NRGN;KCNK9;NPTX1;PCSK1;SV2B;SELL;SLC6A17
17897,GO:0097708,0.000106985962984089,0.999959811612285,28,2094,intracellular vesicle,CC,SYT13;GABRA1;PTPRN;SYT1;CAMK2A;RPH3A;CHGA;SYTL4;STMN2;SLC17A7;DNM1;GABRG2;SLC30A3;IGFBP2;PACSIN1;VGF;CALY;SNAP25;SYT4;CHI3L1;GABRB2;NRGN;KCNK9;NPTX1;PCSK1;SV2B;SELL;SLC6A17
11126,GO:0043204,0.000111034457584382,0.99998930593012,6,114,perikaryon,CC,PTPRN;NEURL1;CRYAB;HPCA;KCNC2;DDN
10711,GO:0042391,0.000111789785400376,0.999977091270282,11,401,regulation of membrane potential,BP,GABRA1;PTPN3;RIMS4;CELF4;SLC17A7;GABRA4;GABRG2;CNR1;GABRB2;KCNK9;GRIN2B
10769,GO:0042493,0.000120651962958972,0.999966229015891,16,876,response to drug,BP,SYT1;SLC17A7;GABRA4;CRYAB;IGFBP2;CENPF;CNR1;HPCA;SYT4;CHRM3;SFRP2;ADCY1;KCNC2;SELL;SLC6A17;GRIN2B
5662,GO:0016020,0.00012443220499346,0.999946147376541,68,7647,membrane,CC,CAMK1G;SYT13;GABRA1;PTPRN;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;RPH3A;KIF4A;CHGA;RIMS4;EEF1A2;ST8SIA5;SYTL4;STMN2;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;CRYAB;PTPN5;GABRG2;SLC30A3;IGFBP2;RGS4;CNR1;TJP2;PRLHR;IQSEC3;HPCA;KCNS1;PACSIN1;PRRG3;CALY;SNAP25;SYT4;CHRM3;FAM189A2;MRAP2;SLC14A1;STAC2;SLC4A10;SFRP2;GABRB2;TENM2;MKI67;FREM2;CHST9;NRGN;GNG3;VSNL1;ADCY1;KCNC2;TMEM130;KCNK9;NPTX1;DDN;ZDHHC23;SV2B;C11ORF87;SPRY4;SELL;SLC6A17;PPP1R14C;GRIN2B
19665,GO:1903305,0.000129916537996635,0.999987109862424,6,117,regulation of regulated secretory pathway,BP,SYT13;SYT1;RPH3A;RIMS4;SYTL4;SYT4
2517,GO:0005254,0.000130807101075387,0.999990531757432,5,73,chloride channel activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;GABRB2
7335,GO:0030348,0.000133137245401663,0.999999706899262,2,3,syntaxin-3 binding,MF,SYT1;SYT4
11656,GO:0044433,0.000134192625982431,0.999955293334655,21,1376,cytoplasmic vesicle part,CC,GABRA1;PTPRN;SYT1;CAMK2A;RPH3A;CHGA;SYTL4;SLC17A7;GABRG2;SLC30A3;PACSIN1;CALY;SNAP25;SYT4;CHI3L1;GABRB2;NRGN;PCSK1;SV2B;SELL;SLC6A17
473,GO:0001505,0.000136120801254152,0.99997669694402,9,285,regulation of neurotransmitter levels,BP,SYT13;SYT1;CAMK2A;RPH3A;RIMS4;SYTL4;SLC17A7;SNAP25;SYT4
6244,GO:0017157,0.00016504170808062,0.999978583201956,7,175,regulation of exocytosis,BP,SYT13;SYT1;RPH3A;RIMS4;SYTL4;SYT4;VSNL1
7288,GO:0030285,0.000167586681924081,0.999996312260756,3,17,integral component of synaptic vesicle membrane,CC,SYT1;SLC17A7;SYT4
72,GO:0000149,0.00017323570840729,0.999981849643862,6,122,SNARE binding,MF,SYT13;SYT1;RPH3A;SYTL4;SNAP25;SYT4
15474,GO:0061792,0.000179282583581762,0.99999954148819,2,3,secretory granule maturation,BP,PTPRN;SYT4
9506,GO:0034707,0.000180906695990335,0.999991069860282,4,43,chloride channel complex,CC,GABRA1;GABRA4;GABRG2;GABRB2
7745,GO:0031226,0.000182616182445658,0.999936217521062,22,1460,intrinsic component of plasma membrane,CC,SYT13;GABRA1;GABRA4;GABRG2;SLC30A3;CNR1;PRLHR;KCNS1;CALY;SNAP25;CHRM3;SLC14A1;SLC4A10;GABRB2;TENM2;ADCY1;KCNC2;TMEM130;KCNK9;SELL;SLC6A17;GRIN2B
19312,GO:1902476,0.000191379770830158,0.999984928481934,5,77,chloride transmembrane transport,BP,GABRA1;SLC17A7;GABRA4;GABRG2;GABRB2
5153,GO:0014047,0.000194603991268048,0.999990237667338,4,41,glutamate secretion,BP,SYT1;SLC17A7;SNAP25;SYT4
14614,GO:0060199,0.000207343050336865,0.9999991938353,2,4,clathrin-sculpted glutamate transport vesicle,CC,SYT1;SLC17A7
14617,GO:0060203,0.000207343050336865,0.9999991938353,2,4,clathrin-sculpted glutamate transport vesicle membrane,CC,SYT1;SLC17A7
14171,GO:0051953,0.000224456693028167,0.999994423803579,3,20,negative regulation of amine transport,BP,CHGA;CNR1;SYT4
18281,GO:0099565,0.000226636003594837,0.999975047762433,6,120,chemical synaptic transmission, postsynaptic,BP,GABRA1;CELF4;SLC17A7;GABRA4;GABRG2;GRIN2B
11583,GO:0044306,0.000250385661876485,0.999971843541186,6,132,neuron projection terminus,CC,PTPRN;SYT1;PACSIN1;SYT4;CHRM3;KCNC2
14011,GO:0051650,0.000269080615292896,0.999955493279491,8,239,establishment of vesicle localization,BP,SYT13;SYT1;RPH3A;RIMS4;SYTL4;DNM1;SNAP25;SYT4
2516,GO:0005253,0.000269322773121208,0.999977062830079,5,86,anion channel activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;GABRB2
7149,GO:0030073,0.000274335228683205,0.999961241902155,7,186,insulin secretion,BP,PTPRN;SYTL4;CNR1;VGF;SNAP25;VSNL1;KCNC2
3853,GO:0008022,0.000275653125082981,0.999961037191657,7,183,protein C-terminus binding,MF,SYT1;RBFOX1;DNM1;CENPF;TJP2;TOP2A;MKI67
14162,GO:0051937,0.000276216716062165,0.999984593092958,4,52,catecholamine transport,BP,SYT1;CHGA;CNR1;SYT4
5319,GO:0015108,0.000290139425472921,0.99997490626217,5,84,chloride transmembrane transporter activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;GABRB2
14540,GO:0060078,0.000291020484049129,0.999966385588781,6,125,regulation of postsynaptic membrane potential,BP,GABRA1;CELF4;SLC17A7;GABRA4;GABRG2;GRIN2B
7433,GO:0030594,0.000304411802312028,0.999973341439527,5,89,neurotransmitter receptor activity,MF,GABRA1;GABRA4;GABRG2;CHRM3;GRIN2B
5174,GO:0014069,0.000309648809117821,0.999947763212726,8,221,postsynaptic density,CC,LZTS1;CAMK2A;DNM1;NEURL1;CRYAB;NRGN;GNG3;GRIN2B
18286,GO:0099572,0.000324515855429324,0.999944858926475,8,223,postsynaptic specialization,CC,LZTS1;CAMK2A;DNM1;NEURL1;CRYAB;NRGN;GNG3;GRIN2B
5152,GO:0014046,0.000329508380196853,0.999990562670493,3,22,dopamine secretion,BP,SYT1;CNR1;SYT4
5164,GO:0014059,0.000329508380196853,0.999990562670493,3,22,regulation of dopamine secretion,BP,SYT1;CNR1;SYT4
7067,GO:0022839,0.000351383830204926,0.999931464519892,9,311,ion gated channel activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;KCNS1;GABRB2;KCNC2;KCNK9;GRIN2B
7214,GO:0030182,0.000365284350698757,0.999871670691783,20,1230,neuron differentiation,BP,ASPM;SYT1;CAMK2A;STMN2;NEFM;NPTX2;NEURL1;CNR1;PACSIN1;SNAP25;SYT4;SLC4A10;SFRP2;GABRB2;TENM2;ADCY1;NPTX1;NEUROD2;ENC1;MYT1L
7518,GO:0030816,0.000368180737052657,0.999988868214598,3,26,positive regulation of cAMP metabolic process,BP,CHGA;HPCA;MRAP2
7065,GO:0022836,0.000371483426214902,0.999926975269736,9,314,gated channel activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;KCNS1;GABRB2;KCNC2;KCNK9;GRIN2B
14009,GO:0051648,0.000384212127980428,0.999932900207201,8,251,vesicle localization,BP,SYT13;SYT1;RPH3A;RIMS4;SYTL4;DNM1;SNAP25;SYT4
5400,GO:0015276,0.000392428938586933,0.999951968858602,6,133,ligand-gated ion channel activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;GABRB2;GRIN2B
7063,GO:0022834,0.000392428938586933,0.999951968858602,6,133,ligand-gated channel activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;GABRB2;GRIN2B
7011,GO:0022008,0.000444688302727975,0.999833764104354,22,1446,neurogenesis,BP,ASPM;SYT1;CAMK2A;STMN2;NEFM;NPTX2;NEURL1;CNR1;PACSIN1;SNAP25;SYT4;SLC4A10;SFRP2;GABRB2;TENM2;DAAM2;FABP7;ADCY1;NPTX1;NEUROD2;ENC1;MYT1L
3494,GO:0006906,0.000457813403996341,0.999942153670576,6,149,vesicle fusion,BP,SYT13;SYT1;RPH3A;SYTL4;SNAP25;SYT4
7066,GO:0022838,0.000469118874911892,0.999894877702414,10,395,substrate-specific channel activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;KCNS1;SLC14A1;GABRB2;KCNC2;KCNK9;GRIN2B
7060,GO:0022824,0.000472508870421868,0.999969641028323,4,51,transmitter-gated ion channel activity,MF,GABRA1;GABRA4;GABRG2;GRIN2B
7064,GO:0022835,0.000472508870421868,0.999969641028323,4,51,transmitter-gated channel activity,MF,GABRA1;GABRA4;GABRG2;GRIN2B
13192,GO:0048699,0.000484760487727066,0.999821475682312,21,1353,generation of neurons,BP,ASPM;SYT1;CAMK2A;STMN2;NEFM;NPTX2;NEURL1;CNR1;PACSIN1;SNAP25;SYT4;SLC4A10;SFRP2;GABRB2;TENM2;DAAM2;ADCY1;NPTX1;NEUROD2;ENC1;MYT1L
15135,GO:0061025,0.000489234300503427,0.999923658480872,7,216,membrane fusion,BP,SYT13;SYT1;RPH3A;SYTL4;DNM1;SNAP25;SYT4
17999,GO:0098661,0.000495959390747955,0.999951586764953,5,93,inorganic anion transmembrane transport,BP,GABRA1;SLC17A7;GABRA4;GABRG2;GABRB2
17949,GO:0098563,0.000500125934381551,0.999983198831486,3,26,intrinsic component of synaptic vesicle membrane,CC,SYT1;SLC17A7;SYT4
5316,GO:0015103,0.000508259698604689,0.999934520194977,6,146,inorganic anion transmembrane transporter activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;SLC4A10;GABRB2
4968,GO:0010817,0.000513365807252548,0.99988347188237,10,443,regulation of hormone levels,BP,PTPRN;SYTL4;CNR1;PRLHR;VGF;SNAP25;CHST9;VSNL1;KCNC2;PCSK1
17291,GO:0090174,0.000547464827241522,0.999928381444578,6,154,organelle membrane fusion,BP,SYT13;SYT1;RPH3A;SYTL4;SNAP25;SYT4
5577,GO:0015844,0.00057085892501908,0.999961051159135,4,63,monoamine transport,BP,SYT1;CHGA;CNR1;SYT4
13209,GO:0048731,0.000583699331500745,0.99972492706809,43,4025,system development,BP,PTPRN;ASPM;SYT1;PTPN3;CAMK2A;RBFOX1;CELF4;STMN2;NEFM;SLC17A7;NPTX2;NEURL1;GABRA4;CRYAB;CENPF;CNR1;TJP2;HPCA;PACSIN1;VGF;TOP2A;SNAP25;SYT4;CHRM3;CHI3L1;SLC4A10;SFRP2;CXCL14;GABRB2;TENM2;DAAM2;FREM2;NRGN;FABP7;ADCY1;KCNC2;NPTX1;NEUROD2;ENC1;MYT1L;SPRY4;SLC6A17;GRIN2B
19777,GO:1903530,0.000587372018282285,0.99984281241092,12,611,regulation of secretion by cell,BP,SYT13;SYT1;CAMK2A;RPH3A;CHGA;RIMS4;SYTL4;CNR1;SNAP25;SYT4;VSNL1;KCNC2
6196,GO:0017075,0.000587584176109974,0.99997946335604,3,22,syntaxin-1 binding,MF,SYT1;SNAP25;SYT4
14170,GO:0051952,0.000605717866447974,0.999957986370699,4,64,regulation of amine transport,BP,SYT1;CHGA;CNR1;SYT4
5395,GO:0015267,0.000612703307136913,0.999857785319086,10,413,channel activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;KCNS1;SLC14A1;GABRB2;KCNC2;KCNK9;GRIN2B
7057,GO:0022803,0.000612703307136913,0.999857785319086,10,413,passive transmembrane transporter activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;KCNS1;SLC14A1;GABRB2;KCNC2;KCNK9;GRIN2B
14015,GO:0051656,0.000622500319294297,0.999855175611036,10,423,establishment of organelle localization,BP,SYT13;SYT1;RPH3A;CHGA;RIMS4;SYTL4;DNM1;CENPF;SNAP25;SYT4
7148,GO:0030072,0.000694568614259854,0.999884938073712,7,222,peptide hormone secretion,BP,PTPRN;SYTL4;CNR1;VGF;SNAP25;VSNL1;KCNC2
2611,GO:0005516,0.000750853795641189,0.999874334985649,7,186,calmodulin binding,MF,CAMK1G;ASPM;SYT1;CAMK2A;RGS4;NRGN;ADCY1
5548,GO:0015800,0.000809189257662304,0.999939544308109,4,59,acidic amino acid transport,BP,SYT1;SLC17A7;SNAP25;SYT4
16227,GO:0071277,0.00085317089805125,0.999935344007407,4,59,cellular response to calcium ion,BP,SYT1;HPCA;ADCY1;NEUROD2
5573,GO:0015837,0.000855867331428574,0.999934613363661,4,71,amine transport,BP,SYT1;CHGA;CNR1;SYT4
5504,GO:0015698,0.000858557494306915,0.99987746178513,6,160,inorganic anion transport,BP,GABRA1;SLC17A7;GABRA4;GABRG2;SLC4A10;GABRB2
9501,GO:0034702,0.000906047827586102,0.999819274359337,8,276,ion channel complex,CC,GABRA1;GABRA4;GABRG2;KCNS1;SNAP25;GABRB2;KCNC2;GRIN2B
5679,GO:0016050,0.000913390085295957,0.999795835013834,9,371,vesicle organization,BP,SYT13;PTPRN;SYT1;RPH3A;SYTL4;SLC17A7;DNM1;SNAP25;SYT4
13005,GO:0048284,0.000961255864584205,0.999859534910046,6,175,organelle fusion,BP,SYT13;SYT1;RPH3A;SYTL4;SNAP25;SYT4
11403,GO:0043679,0.00106124589900663,0.999876515449992,5,117,axon terminus,CC,PTPRN;SYT1;PACSIN1;CHRM3;KCNC2
13661,GO:0051046,0.00108714099398169,0.999687261600013,12,657,regulation of secretion,BP,SYT13;SYT1;CAMK2A;RPH3A;CHGA;RIMS4;SYTL4;CNR1;SNAP25;SYT4;VSNL1;KCNC2
17998,GO:0098660,0.00115816568404074,0.99964586016014,13,719,inorganic ion transmembrane transport,BP,GABRA1;PTPN3;SLC17A7;GABRA4;GABRG2;SLC30A3;HPCA;KCNS1;SLC4A10;GABRB2;KCNC2;KCNK9;GRIN2B
21740,GO:2001023,0.00116200612150789,0.999903447682364,4,74,regulation of response to drug,BP,SYT1;GABRA4;CNR1;SYT4
5595,GO:0015872,0.00123487027524875,0.999942014255985,3,35,dopamine transport,BP,SYT1;CNR1;SYT4
10624,GO:0042221,0.00126391971512289,0.99939016482846,38,3764,response to chemical,BP,GABRA1;PTPRN;SYT1;CAMK2A;BIRC5;CHGA;MYBL2;EEF1A2;STMN2;SLC17A7;NEURL1;GABRA4;CRYAB;PTPN5;GABRG2;SLC30A3;IGFBP2;CENPF;CNR1;TJP2;HPCA;VGF;SYT4;CHRM3;CHI3L1;SFRP2;CXCL14;GABRB2;GNG3;VSNL1;ADCY1;KCNC2;NEUROD2;ZCCHC12;SPRY4;SELL;SLC6A17;GRIN2B
15566,GO:0070050,0.00126857943443127,0.999982046116139,2,10,neuron cellular homeostasis,BP,SLC17A7;NELL2
4025,GO:0008306,0.00131863718253573,0.99988700685438,4,67,associative learning,BP,NPTX2;SNAP25;NRGN;NEUROD2
17995,GO:0098656,0.00132274870889128,0.99975495235308,7,236,anion transmembrane transport,BP,GABRA1;SLC17A7;GABRA4;GABRG2;SLC4A10;GABRB2;SLC6A17
10812,GO:0042583,0.00138359033689883,0.99998053165041,2,8,chromaffin granule,CC,SYT1;CHGA
19318,GO:1902495,0.00143373324046316,0.999692347850591,8,299,transmembrane transporter complex,CC,GABRA1;GABRA4;GABRG2;KCNS1;SNAP25;GABRB2;KCNC2;GRIN2B
7759,GO:0031253,0.00143836156125284,0.999691209933145,8,298,cell projection membrane,CC,GABRA1;GABRA4;GABRG2;HPCA;PACSIN1;KCNC2;DDN;SPRY4
1370,GO:0003008,0.00154260860773155,0.999387323550283,20,1463,system process,BP,GABRA1;BIRC5;CHGA;SLC17A7;NPTX2;DNM1;GABRA4;CRYAB;GABRG2;CNR1;TJP2;SNAP25;SYT4;CHRM3;GABRB2;NRGN;FABP7;ADCY1;NEUROD2;GRIN2B
12258,GO:0045921,0.00156299900892577,0.999859108471691,4,76,positive regulation of exocytosis,BP,SYT1;SYTL4;SYT4;VSNL1
20965,GO:1990351,0.00161173756855907,0.99964755693313,8,307,transporter complex,CC,GABRA1;GABRA4;GABRG2;KCNS1;SNAP25;GABRB2;KCNC2;GRIN2B
5419,GO:0015318,0.00163134817386552,0.999481272249363,13,750,inorganic molecular entity transmembrane transporter activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;SLC30A3;KCNS1;SLC14A1;SLC4A10;GABRB2;KCNC2;KCNK9;SLC6A17;GRIN2B
3464,GO:0006865,0.00164110858172379,0.99978891348102,5,126,amino acid transport,BP,SYT1;SLC17A7;SNAP25;SYT4;SLC6A17
2490,GO:0005216,0.00167004972128473,0.999592487596379,9,386,ion channel activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;KCNS1;GABRB2;KCNC2;KCNK9;GRIN2B
7503,GO:0030801,0.00171549639176004,0.999908619805951,3,43,positive regulation of cyclic nucleotide metabolic process,BP,CHGA;HPCA;MRAP2
8098,GO:0031915,0.00172907253219247,0.999971971574673,2,9,positive regulation of synaptic plasticity,BP,SNAP25;NEUROD2
17262,GO:0090129,0.00173457816998693,0.999972617858856,2,8,positive regulation of synapse maturation,BP,NEURL1;NEUROD2
7758,GO:0031252,0.00176590067711526,0.999565783853099,9,367,cell leading edge,CC,GABRA1;STMN2;GABRA4;GABRG2;HPCA;PACSIN1;KCNC2;DDN;SPRY4
12167,GO:0045744,0.00177654666674225,0.999904550089861,3,40,negative regulation of G-protein coupled receptor protein signaling pathway,BP,DNM1;RGS4;MRAP2
12700,GO:0046903,0.0018024598971055,0.999290331359057,19,1439,secretion,BP,SYT13;PTPRN;SYT1;CAMK2A;RPH3A;CHGA;RIMS4;SYTL4;SLC17A7;NEURL1;CNR1;VGF;SNAP25;SYT4;CHRM3;CHI3L1;VSNL1;KCNC2;SELL
13988,GO:0051602,0.00182475485841381,0.999901168413099,3,39,response to electrical stimulus,BP,EEF1A2;HPCA;NEUROD2
18259,GO:0099529,0.00188072398826194,0.999897687743663,3,35,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,GABRA1;GABRA4;GABRG2
20159,GO:1904315,0.00188072398826194,0.999897687743663,3,35,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,GABRA1;GABRA4;GABRG2
18292,GO:0099590,0.00196231934259611,0.999964728766897,2,11,neurotransmitter receptor internalization,BP,DNM1;SNAP25
14613,GO:0060198,0.0020567257892862,0.999961602728671,2,12,clathrin-sculpted vesicle,CC,SYT1;SLC17A7
12128,GO:0045666,0.00215400602108475,0.999506349710996,8,321,positive regulation of neuron differentiation,BP,SYT1;STMN2;NEURL1;CNR1;PACSIN1;SYT4;NEUROD2;ENC1
20556,GO:1905114,0.00218848198169521,0.999353727489162,11,584,cell surface receptor signaling pathway involved in cell-cell signaling,BP,GABRA1;ASPM;CAMK2A;CELF4;SLC17A7;GABRA4;GABRG2;IGFBP2;SFRP2;DAAM2;GRIN2B
5098,GO:0010976,0.00221453685258157,0.999550633880406,7,244,positive regulation of neuron projection development,BP,SYT1;STMN2;NEURL1;CNR1;PACSIN1;SYT4;ENC1
2608,GO:0005509,0.00228242493619707,0.999322517999978,11,560,calcium ion binding,MF,SYT13;SYT1;RPH3A;SYTL4;HPCA;PRRG3;SYT4;TENM2;VSNL1;NELL2;SELL
3433,GO:0006811,0.00229185949737152,0.999077533070974,19,1419,ion transport,BP,GABRA1;SYT1;PTPN3;CAMK2A;SLC17A7;GABRA4;GABRG2;SLC30A3;CNR1;HPCA;KCNS1;SNAP25;SYT4;SLC4A10;GABRB2;KCNC2;KCNK9;SLC6A17;GRIN2B
18472,GO:0120035,0.00231868287185335,0.999310327741651,11,562,regulation of plasma membrane bounded cell projection organization,BP,SYT1;STMN2;NEURL1;CNR1;PACSIN1;SNAP25;SYT4;SFRP2;TENM2;ENC1;GRIN2B
12683,GO:0046879,0.00236532507408181,0.999513592621481,7,277,hormone secretion,BP,PTPRN;SYTL4;CNR1;VGF;SNAP25;VSNL1;KCNC2
18149,GO:0098960,0.00238114499317124,0.999858793366661,3,37,postsynaptic neurotransmitter receptor activity,MF,GABRA1;GABRA4;GABRG2
13477,GO:0050769,0.00243704405019241,0.999370869239957,9,406,positive regulation of neurogenesis,BP,ASPM;SYT1;STMN2;NEURL1;CNR1;PACSIN1;SYT4;NEUROD2;ENC1
12126,GO:0045664,0.00244105847272213,0.999268998324256,11,568,regulation of neuron differentiation,BP,ASPM;SYT1;STMN2;NEURL1;CNR1;PACSIN1;SNAP25;SYT4;SFRP2;NEUROD2;ENC1
12330,GO:0046058,0.00259499137318195,0.999730159175916,4,86,cAMP metabolic process,BP,CHGA;HPCA;MRAP2;ADCY1
7826,GO:0031344,0.0026083855801304,0.999212076734177,11,571,regulation of cell projection organization,BP,SYT1;STMN2;NEURL1;CNR1;PACSIN1;SNAP25;SYT4;SFRP2;TENM2;ENC1;GRIN2B
16215,GO:0071257,0.00267526017391637,0.999942885218985,2,12,cellular response to electrical stimulus,BP,HPCA;NEUROD2
7828,GO:0031346,0.00267814208023683,0.999364106152474,8,326,positive regulation of cell projection organization,BP,SYT1;STMN2;NEURL1;CNR1;PACSIN1;SYT4;TENM2;ENC1
3447,GO:0006835,0.00272271748811729,0.99971338159394,4,83,dicarboxylic acid transport,BP,SYT1;SLC17A7;SNAP25;SYT4
3439,GO:0006820,0.00272342861346222,0.999225386849295,10,529,anion transport,BP,GABRA1;SYT1;SLC17A7;GABRA4;GABRG2;SNAP25;SYT4;SLC4A10;GABRB2;SLC6A17
17261,GO:0090128,0.00274195555647513,0.999942535870962,2,10,regulation of synapse maturation,BP,NEURL1;NEUROD2
4673,GO:0010035,0.00277845638859211,0.99926765126364,9,466,response to inorganic substance,BP,SYT1;EEF1A2;CRYAB;SLC30A3;IGFBP2;HPCA;ADCY1;KCNC2;NEUROD2
11129,GO:0043209,0.00278579558370353,0.999593672386792,5,158,myelin sheath,CC,EEF1A2;DNM1;CRYAB;PACSIN1;SNAP25
4635,GO:0009914,0.00282964711286189,0.999398922361229,7,287,hormone transport,BP,PTPRN;SYTL4;CNR1;VGF;SNAP25;VSNL1;KCNC2
14002,GO:0051640,0.00306638080496772,0.999053370053817,11,614,organelle localization,BP,SYT13;ASPM;SYT1;RPH3A;CHGA;RIMS4;SYTL4;DNM1;CENPF;SNAP25;SYT4
19778,GO:1903531,0.00319011386441238,0.999519799788922,5,159,negative regulation of secretion by cell,BP,CHGA;SYTL4;CNR1;SYT4;VSNL1
13506,GO:0050806,0.00323884401361423,0.999511802560167,5,141,positive regulation of synaptic transmission,BP,SYT1;RIMS4;SNAP25;NRGN;GRIN2B
14914,GO:0060627,0.00326949510570403,0.999117063921638,9,452,regulation of vesicle-mediated transport,BP,SYT13;SYT1;RPH3A;RIMS4;SYTL4;PACSIN1;CALY;SYT4;VSNL1
13075,GO:0048488,0.00334646753683492,0.999775203074972,3,40,synaptic vesicle endocytosis,BP,SYT1;DNM1;PACSIN1
4675,GO:0010038,0.00336691042722126,0.999261533759832,7,306,response to metal ion,BP,SYT1;SLC30A3;IGFBP2;HPCA;ADCY1;KCNC2;NEUROD2
3432,GO:0006810,0.00348301018192801,0.998173580078993,42,4455,transport,BP,SYT13;GABRA1;PTPRN;SYT1;PTPN3;CAMK2A;RBFOX1;RPH3A;KIF4A;CHGA;RIMS4;SYTL4;SLC17A7;DNM1;NEURL1;GABRA4;CRYAB;GABRG2;SLC30A3;CENPF;CNR1;TJP2;HPCA;KCNS1;PACSIN1;VGF;CALY;SNAP25;SYT4;CHRM3;CHI3L1;SLC14A1;SLC4A10;GABRB2;VSNL1;KCNC2;KCNK9;ZDHHC23;SV2B;SELL;SLC6A17;GRIN2B
13020,GO:0048306,0.00352132891047142,0.999755757251863,3,55,calcium-dependent protein binding,MF,SYT1;STMN2;SNAP25
7078,GO:0022857,0.00358970059286525,0.998695519339031,14,931,transmembrane transporter activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;SLC30A3;KCNS1;SLC14A1;SLC4A10;GABRB2;KCNC2;KCNK9;SV2B;SLC6A17;GRIN2B
7651,GO:0031045,0.00359625990355822,0.999909633845803,2,13,dense core granule,CC,SYT1;SYT4
3711,GO:0007275,0.0037197498215497,0.99802898932681,44,4533,multicellular organism development,BP,PTPRN;ASPM;SYT1;PTPN3;CAMK2A;RBFOX1;CELF4;STMN2;NEFM;SLC17A7;NPTX2;NEURL1;GABRA4;CRYAB;GABRG2;CENPF;CNR1;TJP2;HPCA;PACSIN1;VGF;TOP2A;SNAP25;SYT4;CHRM3;CHI3L1;SLC4A10;SFRP2;CXCL14;GABRB2;TENM2;DAAM2;FREM2;NRGN;FABP7;ADCY1;KCNC2;NPTX1;NEUROD2;ENC1;MYT1L;SPRY4;SLC6A17;GRIN2B
12629,GO:0046717,0.00374769834488304,0.999566833008532,4,99,acid secretion,BP,SYT1;SLC17A7;SNAP25;SYT4
14666,GO:0060284,0.00377335590250761,0.998676108037116,13,785,regulation of cell development,BP,ASPM;SYT1;STMN2;NEURL1;CNR1;TJP2;PACSIN1;SNAP25;SYT4;SFRP2;DAAM2;NEUROD2;ENC1
4480,GO:0009306,0.00379965371279004,0.998949761679301,9,477,protein secretion,BP,PTPRN;SYTL4;CNR1;VGF;SNAP25;SYT4;CHI3L1;VSNL1;KCNC2
13475,GO:0050767,0.00387061883291082,0.998699611274558,12,689,regulation of neurogenesis,BP,ASPM;SYT1;STMN2;NEURL1;CNR1;PACSIN1;SNAP25;SYT4;SFRP2;DAAM2;NEUROD2;ENC1
7521,GO:0030819,0.00393780116736767,0.999893021046191,2,17,positive regulation of cAMP biosynthetic process,BP,HPCA;MRAP2
4151,GO:0008509,0.00398766599418006,0.999098236743679,7,302,anion transmembrane transporter activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;SLC4A10;GABRB2;SLC6A17
5097,GO:0010975,0.00410593473175489,0.99885260931527,9,428,regulation of neuron projection development,BP,SYT1;STMN2;NEURL1;CNR1;PACSIN1;SNAP25;SYT4;SFRP2;ENC1
6712,GO:0019932,0.00417726748685235,0.999047390378744,7,300,second-messenger-mediated signaling,BP,CHGA;HPCA;MRAP2;ADCY1;KCNC2;NEUROD2;GRIN2B
13063,GO:0048468,0.00422721331081654,0.998063369704739,23,1852,cell development,BP,ASPM;SYT1;CAMK2A;CELF4;STMN2;NEFM;NPTX2;NEURL1;CNR1;TJP2;PACSIN1;SNAP25;SYT4;SLC4A10;SFRP2;GABRB2;TENM2;DAAM2;ADCY1;NPTX1;NEUROD2;ENC1;MYT1L
7526,GO:0030824,0.00424692635999938,1,1,1,negative regulation of cGMP metabolic process,BP,HPCA
7529,GO:0030827,0.00424692635999938,1,1,1,negative regulation of cGMP biosynthetic process,BP,HPCA
7780,GO:0031283,0.00424692635999938,1,1,1,negative regulation of guanylate cyclase activity,BP,HPCA
19121,GO:1901986,0.00424692635999938,1,1,1,response to ketamine,BP,HPCA
20027,GO:1904008,0.00424692635999938,1,1,1,response to monosodium glutamate,BP,HPCA
20028,GO:1904009,0.00424692635999938,1,1,1,cellular response to monosodium glutamate,BP,HPCA
20029,GO:1904010,0.00424692635999938,1,1,1,response to Aroclor 1254,BP,HPCA
16206,GO:0071241,0.00429734822055962,0.999306137098416,5,164,cellular response to inorganic substance,BP,SYT1;HPCA;ADCY1;KCNC2;NEUROD2
13499,GO:0050796,0.00434678101160675,0.999296624755577,5,159,regulation of insulin secretion,BP,SYTL4;CNR1;SNAP25;VSNL1;KCNC2
8750,GO:0032940,0.00448639962261119,0.998163413776772,17,1334,secretion by cell,BP,SYT13;PTPRN;SYT1;CAMK2A;RPH3A;CHGA;RIMS4;SYTL4;SLC17A7;CNR1;VGF;SNAP25;SYT4;CHI3L1;VSNL1;KCNC2;SELL
7730,GO:0031175,0.0046393040070012,0.998264042931154,14,886,neuron projection development,BP,SYT1;CAMK2A;STMN2;NEFM;NPTX2;NEURL1;CNR1;PACSIN1;SNAP25;SYT4;SFRP2;ADCY1;NPTX1;ENC1
7364,GO:0030426,0.00465495350175357,0.999235649360027,5,146,growth cone,CC,STMN2;NPTX2;CNR1;SNAP25;TENM2
3654,GO:0007188,0.00468876663186393,0.999226729983638,5,171,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,CHGA;CNR1;CHRM3;MRAP2;ADCY1
19035,GO:1901698,0.00488977120293601,0.998158319432402,14,965,response to nitrogen compound,BP,GABRA1;PTPRN;CAMK2A;NEURL1;GABRG2;CNR1;HPCA;VGF;CHRM3;GABRB2;GNG3;ADCY1;KCNC2;SELL
4716,GO:0010243,0.00490886926175432,0.998221159021305,13,863,response to organonitrogen compound,BP,GABRA1;PTPRN;CAMK2A;NEURL1;GABRG2;CNR1;HPCA;VGF;GABRB2;GNG3;ADCY1;KCNC2;SELL
4862,GO:0010646,0.00492218293699398,0.997488942385122,32,3117,regulation of cell communication,BP,ASPM;SYT1;PTPN3;CAMK2A;BIRC5;CHGA;RIMS4;CELF4;SYTL4;DNM1;NEURL1;FOXM1;IGFBP2;RGS4;CNR1;IQSEC3;VGF;SNAP25;SYT4;CHI3L1;MRAP2;SFRP2;CXCL14;DAAM2;NRGN;GNG3;VSNL1;KCNC2;NEUROD2;SPRY4;NMB;GRIN2B
13664,GO:0051049,0.0049765123253166,0.997799683236377,20,1637,regulation of transport,BP,SYT13;SYT1;PTPN3;CAMK2A;RPH3A;CHGA;RIMS4;SYTL4;DNM1;CRYAB;SLC30A3;CNR1;HPCA;KCNS1;PACSIN1;CALY;SNAP25;SYT4;VSNL1;KCNC2
3434,GO:0006812,0.00497904989677131,0.998120636158837,14,976,cation transport,BP,SYT1;PTPN3;CAMK2A;SLC17A7;SLC30A3;CNR1;HPCA;KCNS1;SYT4;SLC4A10;KCNC2;KCNK9;SLC6A17;GRIN2B
15230,GO:0061185,0.00498461052700159,1,1,1,negative regulation of dermatome development,BP,SFRP2
17141,GO:0086030,0.00505557010092282,1,1,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation,BP,CHGA
5609,GO:0015893,0.00506918918630835,0.999147928069795,5,178,drug transport,BP,SYT1;SLC17A7;CNR1;SYT4;SLC6A17
2772,GO:0005794,0.00508218025749877,0.99784091734922,18,1391,Golgi apparatus,CC,CAMK1G;PTPRN;SYT1;RBFOX1;RPH3A;ST8SIA5;STMN2;DNM1;CRYAB;VGF;SNAP25;SYT4;CXCL14;TENM2;CHST9;TMEM130;CREG2;ZDHHC23
5477,GO:0015633,0.00512005480094674,1,1,1,zinc-transporting ATPase activity,MF,SLC30A3
13784,GO:0051234,0.0052616877825494,0.99716316180411,42,4549,establishment of localization,BP,SYT13;GABRA1;PTPRN;SYT1;PTPN3;CAMK2A;RBFOX1;RPH3A;KIF4A;CHGA;RIMS4;SYTL4;SLC17A7;DNM1;NEURL1;GABRA4;CRYAB;GABRG2;SLC30A3;CENPF;CNR1;TJP2;HPCA;KCNS1;PACSIN1;VGF;CALY;SNAP25;SYT4;CHRM3;CHI3L1;SLC14A1;SLC4A10;GABRB2;VSNL1;KCNC2;KCNK9;ZDHHC23;SV2B;SELL;SLC6A17;GRIN2B
13663,GO:0051048,0.0052649439917819,0.999106976341548,5,179,negative regulation of secretion,BP,CHGA;SYTL4;CNR1;SYT4;VSNL1
4902,GO:0010720,0.005385432245973,0.998429736972595,9,463,positive regulation of cell development,BP,ASPM;SYT1;STMN2;NEURL1;CNR1;PACSIN1;SYT4;NEUROD2;ENC1
14180,GO:0051962,0.00539034004072791,0.9984281641177,9,460,positive regulation of nervous system development,BP,ASPM;SYT1;STMN2;NEURL1;CNR1;PACSIN1;SYT4;NEUROD2;ENC1
1273,GO:0002790,0.0055077169674792,0.998387343664062,9,508,peptide secretion,BP,PTPRN;SYTL4;CNR1;VGF;SNAP25;SYT4;CHI3L1;VSNL1;KCNC2
2997,GO:0006171,0.00551053081769705,0.999551489863226,3,55,cAMP biosynthetic process,BP,HPCA;MRAP2;ADCY1
10291,GO:0036465,0.00555544880847803,0.999548530683414,3,49,synaptic vesicle recycling,BP,SYT1;DNM1;PACSIN1
2865,GO:0005954,0.00559430659422833,1,1,1,calcium- and calmodulin-dependent protein kinase complex,CC,CAMK1G
7365,GO:0030427,0.00568956689182421,0.999019695420313,5,151,site of polarized growth,CC,STMN2;NPTX2;CNR1;SNAP25;TENM2
7184,GO:0030141,0.00589405959276061,0.998011176195883,11,750,secretory granule,CC,PTPRN;SYT1;RPH3A;CHGA;SYTL4;SNAP25;SYT4;CHI3L1;PCSK1;SV2B;SELL
11916,GO:0045183,0.00594525924325653,1,1,1,translation factor activity, non-nucleic acid binding,MF,NEURL1
7516,GO:0030814,0.00603866960985479,0.999490249886827,3,61,regulation of cAMP metabolic process,BP,CHGA;HPCA;MRAP2
3877,GO:0008068,0.00617441489798702,1,1,1,extracellularly glutamate-gated chloride channel activity,MF,SLC17A7
17764,GO:0097401,0.00617441489798702,1,1,1,synaptic vesicle lumen acidification,BP,SLC17A7
17780,GO:0097440,0.0062649593643453,0.999786734686557,2,15,apical dendrite,CC,NEURL1;SLC4A10
13006,GO:0048285,0.00627235324092036,0.998280972576185,8,407,organelle fission,BP,ASPM;BIRC5;KIF4A;MYBL2;DNM1;CENPF;TOP2A;MKI67
13503,GO:0050803,0.00627636497971092,0.998891909872339,5,160,regulation of synapse structure or activity,BP,SLC17A7;DNM1;NEURL1;NEUROD2;GRIN2B
12712,GO:0046928,0.00630648540428667,0.999462289208292,3,52,regulation of neurotransmitter secretion,BP,CAMK2A;RIMS4;SYT4
7099,GO:0023051,0.00634312705971233,0.996700862279151,32,3168,regulation of signaling,BP,ASPM;SYT1;PTPN3;CAMK2A;BIRC5;CHGA;RIMS4;CELF4;SYTL4;DNM1;NEURL1;FOXM1;IGFBP2;RGS4;CNR1;IQSEC3;VGF;SNAP25;SYT4;CHI3L1;MRAP2;SFRP2;CXCL14;DAAM2;NRGN;GNG3;VSNL1;KCNC2;NEUROD2;SPRY4;NMB;GRIN2B
10375,GO:0038060,0.00654902432927467,1,1,1,nitric oxide-cGMP-mediated signaling pathway,BP,KCNC2
12948,GO:0048168,0.00656676974052325,0.999431864314072,3,52,regulation of neuronal synaptic plasticity,BP,CAMK2A;NEURL1;SYT4
18193,GO:0099072,0.00667637498904837,0.999758446255778,2,20,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,DNM1;SNAP25
13778,GO:0051225,0.0068335807414974,0.999062817828107,4,106,spindle assembly,BP,ASPM;BIRC5;KIF4A;MYBL2
20342,GO:1904692,0.00684686099286157,1,1,1,positive regulation of type B pancreatic cell proliferation,BP,PTPRN
9258,GO:0034220,0.00715165144536099,0.997182547816868,14,990,ion transmembrane transport,BP,GABRA1;PTPN3;SLC17A7;GABRA4;GABRG2;SLC30A3;HPCA;KCNS1;SLC4A10;GABRB2;KCNC2;KCNK9;SLC6A17;GRIN2B
5302,GO:0015075,0.0071532560737396,0.997396977045069,12,793,ion transmembrane transporter activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;SLC30A3;KCNS1;SLC4A10;GABRB2;KCNC2;KCNK9;SLC6A17;GRIN2B
12952,GO:0048174,0.00727402584111021,1,1,1,negative regulation of short-term neuronal synaptic plasticity,BP,SYT4
15471,GO:0061782,0.00727402584111021,1,1,1,vesicle fusion with vesicle,BP,SYT4
20690,GO:1905432,0.00727402584111021,1,1,1,regulation of retrograde trans-synaptic signaling by neuropeptide,BP,SYT4
20691,GO:1905433,0.00727402584111021,1,1,1,negative regulation of retrograde trans-synaptic signaling by neuropeptide,BP,SYT4
3807,GO:0007584,0.00734991977631474,0.998648492631963,5,194,response to nutrient,BP,IGFBP2;CNR1;HPCA;SFRP2;SELL
17367,GO:0090276,0.00742916866536781,0.998631381640704,5,184,regulation of peptide hormone secretion,BP,SYTL4;CNR1;SNAP25;VSNL1;KCNC2
4409,GO:0009187,0.00744433478410787,0.998951824467235,4,116,cyclic nucleotide metabolic process,BP,CHGA;HPCA;MRAP2;ADCY1
3653,GO:0007187,0.00749637572999282,0.998614724087359,5,197,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,CHGA;CNR1;CHRM3;MRAP2;ADCY1
19950,GO:1903861,0.00763947361680507,0.999707961341452,2,17,positive regulation of dendrite extension,BP,SYT1;SYT4
4003,GO:0008277,0.00776990440164534,0.998891249922371,4,123,regulation of G-protein coupled receptor protein signaling pathway,BP,CHGA;DNM1;RGS4;MRAP2
3827,GO:0007613,0.00792124777897296,0.998866995152159,4,105,memory,BP,SLC17A7;CNR1;SYT4;ADCY1
18028,GO:0098746,0.00798276279973686,1,1,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,SYT1
14536,GO:0060074,0.00807430647633995,0.999682350563824,2,17,synapse maturation,BP,NEURL1;NEUROD2
5118,GO:0012505,0.00809163380879434,0.995588117468035,37,3974,endomembrane system,CC,CAMK1G;SYT13;PTPRN;SYT1;RBFOX1;RPH3A;CHGA;ST8SIA5;SYTL4;STMN2;SLC17A7;DNM1;CRYAB;PTPN5;SLC30A3;CENPF;PACSIN1;VGF;CALY;SNAP25;SYT4;CHI3L1;MRAP2;CXCL14;TENM2;CHST9;NRGN;TMEM130;KCNK9;NPTX1;PCSK1;CREG2;DDN;ZDHHC23;SV2B;SELL;SLC6A17
3890,GO:0008092,0.00819793307493766,0.996834577455758,13,846,cytoskeletal protein binding,MF,PTPRN;LZTS1;PTPN3;BIRC5;KIF4A;STMN2;NEFM;DNM1;CRYAB;HPCA;PACSIN1;DAAM2;ENC1
4714,GO:0010226,0.00841522595461707,0.999654208083043,2,22,response to lithium ion,BP,IGFBP2;ADCY1
13979,GO:0051592,0.00847550275258802,0.998761804820238,4,114,response to calcium ion,BP,SYT1;HPCA;ADCY1;NEUROD2
11253,GO:0043407,0.0086151076304802,0.99917056470789,3,67,negative regulation of MAP kinase activity,BP,RGS4;SFRP2;SPRY4
17948,GO:0098562,0.00874493835796008,0.998323411342383,5,191,cytoplasmic side of membrane,CC,PTPN3;EEF1A2;NPTX2;SNAP25;GNG3
8059,GO:0031780,0.00875490499404199,0.999980948360347,1,2,corticotropin hormone receptor binding,MF,MRAP2
8062,GO:0031783,0.00875490499404199,0.999980948360347,1,2,type 5 melanocortin receptor binding,MF,MRAP2
14178,GO:0051960,0.00888198739856293,0.99667454072158,12,768,regulation of nervous system development,BP,ASPM;SYT1;STMN2;NEURL1;CNR1;PACSIN1;SNAP25;SYT4;SFRP2;DAAM2;NEUROD2;ENC1
6400,GO:0019035,0.00889088281186198,1,1,1,viral integration complex,CC,TOP2A
12230,GO:0045870,0.00889088281186198,1,1,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,TOP2A
20709,GO:1905463,0.00889088281186198,1,1,1,negative regulation of DNA duplex unwinding,BP,TOP2A
17395,GO:0090307,0.00913832256440248,0.999103191024885,3,62,mitotic spindle assembly,BP,BIRC5;KIF4A;MYBL2
5435,GO:0015370,0.00946647779327962,0.999059432593328,3,61,solute:sodium symporter activity,MF,SLC17A7;SLC4A10;SLC6A17
19948,GO:1903859,0.00953700192460426,0.999584875474914,2,20,regulation of dendrite extension,BP,SYT1;SYT4
12295,GO:0045981,0.00954584330463036,0.999044020896846,3,72,positive regulation of nucleotide metabolic process,BP,CHGA;HPCA;MRAP2
18756,GO:1900544,0.00954584330463036,0.999044020896846,3,72,positive regulation of purine nucleotide metabolic process,BP,CHGA;HPCA;MRAP2
8133,GO:0031982,0.00955656129521862,0.99477490317357,35,3837,vesicle,CC,SYT13;GABRA1;PTPRN;SYT1;CAMK2A;RPH3A;CHGA;SYTL4;STMN2;SLC17A7;DNM1;CRYAB;GABRG2;SLC30A3;IGFBP2;PACSIN1;VGF;CALY;SNAP25;SYT4;CHI3L1;GABRB2;DAAM2;FREM2;NRGN;PI16;ADCY1;KCNC2;KCNK9;NPTX1;PCSK1;SV2B;SELL;CPNE4;SLC6A17
5175,GO:0014070,0.00991367101696261,0.996231395237182,12,847,response to organic cyclic compound,BP,GABRA1;PTPRN;CRYAB;GABRG2;IGFBP2;CNR1;HPCA;VGF;GABRB2;ADCY1;KCNC2;SELL
8670,GO:0032809,0.0103198335478882,0.999526988978184,2,23,neuronal cell body membrane,CC,HPCA;KCNC2
11576,GO:0044298,0.0103198335478882,0.999526988978184,2,23,cell body membrane,CC,HPCA;KCNC2
12285,GO:0045956,0.0103517124608833,0.999526276052005,2,22,positive regulation of calcium ion-dependent exocytosis,BP,SYT1;SYT4
13269,GO:0048856,0.0104616045257879,0.994035424517171,45,4939,anatomical structure development,BP,PTPRN;ASPM;SYT1;PTPN3;CAMK2A;RBFOX1;CELF4;STMN2;NEFM;SLC17A7;NPTX2;NEURL1;GABRA4;CRYAB;FOXM1;GABRG2;CENPF;CNR1;TJP2;HPCA;PACSIN1;VGF;TOP2A;SNAP25;SYT4;CHRM3;CHI3L1;SLC4A10;SFRP2;CXCL14;GABRB2;TENM2;DAAM2;FREM2;NRGN;FABP7;ADCY1;KCNC2;NPTX1;NEUROD2;ENC1;MYT1L;SPRY4;SLC6A17;GRIN2B
19098,GO:1901899,0.0105076987668318,0.999972531687315,1,2,positive regulation of relaxation of cardiac muscle,BP,CHGA
5476,GO:0015631,0.0108149254856078,0.997050568949307,7,322,tubulin binding,MF,LZTS1;BIRC5;KIF4A;STMN2;NEFM;DNM1;CRYAB
10593,GO:0042137,0.0110238581759582,0.999969758862,1,2,sequestering of neurotransmitter,BP,SLC17A7
12678,GO:0046873,0.0110269898583854,0.996667705105605,8,418,metal ion transmembrane transporter activity,MF,SLC17A7;SLC30A3;KCNS1;SLC4A10;KCNC2;KCNK9;SLC6A17;GRIN2B
20820,GO:1905809,0.0110788852778196,0.999474729588311,2,22,negative regulation of synapse organization,BP,NEUROD2;GRIN2B
2503,GO:0005234,0.0110960520245905,0.999479609690473,2,19,extracellularly glutamate-gated ion channel activity,MF,SLC17A7;GRIN2B
21194,GO:2000050,0.0115349942717544,0.999441463585146,2,22,regulation of non-canonical Wnt signaling pathway,BP,SFRP2;DAAM2
13666,GO:0051051,0.0116123934258465,0.996783933914131,7,392,negative regulation of transport,BP,CHGA;SYTL4;CRYAB;CNR1;PACSIN1;SYT4;VSNL1
136,GO:0000280,0.0119920664244416,0.996659785931733,7,367,nuclear division,BP,ASPM;BIRC5;KIF4A;MYBL2;CENPF;TOP2A;MKI67
15163,GO:0061054,0.0120411682110061,0.999963901160905,1,2,dermatome development,BP,SFRP2
15228,GO:0061183,0.0120411682110061,0.999963901160905,1,2,regulation of dermatome development,BP,SFRP2
6715,GO:0019935,0.0121304982695059,0.998027654488013,4,135,cyclic-nucleotide-mediated signaling,BP,CHGA;MRAP2;ADCY1;KCNC2
21472,GO:2000503,0.0124266575019959,0.999948762959499,1,3,positive regulation of natural killer cell chemotaxis,BP,CXCL14
18770,GO:1900738,0.0124269810343366,0.999948760284006,1,3,positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,CHGA
21186,GO:2000040,0.012583493357159,0.999960565303301,1,2,regulation of planar cell polarity pathway involved in axis elongation,BP,SFRP2
21187,GO:2000041,0.012583493357159,0.999960565303301,1,2,negative regulation of planar cell polarity pathway involved in axis elongation,BP,SFRP2
4412,GO:0009190,0.0126307682085567,0.99859577047403,3,77,cyclic nucleotide biosynthetic process,BP,HPCA;MRAP2;ADCY1
14301,GO:0052652,0.0126307682085567,0.99859577047403,3,77,cyclic purine nucleotide metabolic process,BP,HPCA;MRAP2;ADCY1
2514,GO:0005251,0.0127613661163793,0.999341252498494,2,26,delayed rectifier potassium channel activity,MF,KCNS1;KCNC2
16110,GO:0070996,0.0127971140627066,0.999945653402839,1,3,type 1 melanocortin receptor binding,MF,MRAP2
8469,GO:0032502,0.0128622251279343,0.992530458787099,47,5296,developmental process,BP,PTPRN;ASPM;SYT1;PTPN3;CAMK2A;RBFOX1;MYBL2;CELF4;STMN2;NEFM;SLC17A7;NPTX2;NEURL1;GABRA4;CRYAB;FOXM1;GABRG2;IGFBP2;CENPF;CNR1;TJP2;HPCA;PACSIN1;VGF;TOP2A;SNAP25;SYT4;CHRM3;CHI3L1;SLC4A10;SFRP2;CXCL14;GABRB2;TENM2;DAAM2;FREM2;NRGN;FABP7;ADCY1;KCNC2;NPTX1;NEUROD2;ENC1;MYT1L;SPRY4;SLC6A17;GRIN2B
3850,GO:0008017,0.0129012549487344,0.996784380930226,6,246,microtubule binding,MF,LZTS1;BIRC5;KIF4A;NEFM;DNM1;CRYAB
12168,GO:0045745,0.0129084087295586,0.999328147393688,2,27,positive regulation of G-protein coupled receptor protein signaling pathway,BP,CHGA;MRAP2
9100,GO:0033693,0.0129443653457445,0.999958263358099,1,2,neurofilament bundle assembly,BP,NEFM
8468,GO:0032501,0.0131773384907206,0.992303237008302,51,5937,multicellular organismal process,BP,GABRA1;PTPRN;ASPM;SYT1;PTPN3;CAMK2A;RBFOX1;BIRC5;CHGA;CELF4;STMN2;NEFM;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;CRYAB;GABRG2;IGFBP2;CENPF;CNR1;TJP2;PRLHR;HPCA;PACSIN1;VGF;TOP2A;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;SLC4A10;SFRP2;CXCL14;GABRB2;TENM2;DAAM2;FREM2;NRGN;FABP7;ADCY1;KCNC2;NPTX1;NEUROD2;ENC1;MYT1L;SPRY4;SLC6A17;GRIN2B
16211,GO:0071248,0.0133342402601482,0.99776920055879,4,142,cellular response to metal ion,BP,SYT1;HPCA;ADCY1;NEUROD2
7506,GO:0030804,0.0134491454541415,0.999278309158528,2,32,positive regulation of cyclic nucleotide biosynthetic process,BP,HPCA;MRAP2
7501,GO:0030799,0.0134958611275955,0.99846056476489,3,81,regulation of cyclic nucleotide metabolic process,BP,CHGA;HPCA;MRAP2
3635,GO:0007165,0.0135796920693613,0.9921254296874,44,5032,signal transduction,BP,CAMK1G;GABRA1;PTPRN;ASPM;PTPN3;CAMK2A;BIRC5;CHGA;CELF4;SLC17A7;DNM1;NEURL1;GABRA4;CRYAB;FOXM1;GABRG2;IGFBP2;RGS4;CNR1;TJP2;PRLHR;IQSEC3;HPCA;VGF;CALY;CHRM3;CHI3L1;MRAP2;STAC2;SFRP2;CXCL14;GABRB2;TENM2;DAAM2;ZNF385D;NRGN;GNG3;ADCY1;KCNC2;NEUROD2;ZCCHC12;SPRY4;NMB;GRIN2B
8218,GO:0032127,0.0135800730739173,0.999954048357843,1,2,dense core granule membrane,CC,SYT4
12180,GO:0045769,0.0137000580407064,1,1,1,negative regulation of asymmetric cell division,BP,ASPM
14010,GO:0051649,0.0138657976698616,0.993106967165992,21,1941,establishment of localization in cell,BP,SYT13;PTPRN;SYT1;CAMK2A;RPH3A;KIF4A;CHGA;RIMS4;SYTL4;SLC17A7;DNM1;CRYAB;CENPF;HPCA;PACSIN1;CALY;SNAP25;SYT4;VSNL1;ZDHHC23;GRIN2B
16574,GO:0071847,0.0139499767486153,0.999951501782723,1,2,TNFSF11-mediated signaling pathway,BP,TJP2
4877,GO:0010665,0.014059535439313,0.999233148792737,2,28,regulation of cardiac muscle cell apoptotic process,BP,CAMK2A;SFRP2
5663,GO:0016021,0.0141405317283281,0.991953968579078,37,4139,integral component of membrane,CC,SYT13;GABRA1;PTPRN;SYT1;ST8SIA5;SLC17A7;GABRA4;PTPN5;GABRG2;SLC30A3;CNR1;PRLHR;KCNS1;PRRG3;CALY;SNAP25;SYT4;CHRM3;FAM189A2;MRAP2;SLC14A1;SLC4A10;SFRP2;GABRB2;TENM2;FREM2;CHST9;ADCY1;KCNC2;TMEM130;KCNK9;ZDHHC23;SV2B;C11ORF87;SELL;SLC6A17;GRIN2B
8975,GO:0033363,0.0144066020536196,0.999209448582499,2,25,secretory granule organization,BP,PTPRN;SYT4
3480,GO:0006887,0.0145228380025183,0.994431297657939,11,817,exocytosis,BP,SYT13;SYT1;RPH3A;CHGA;RIMS4;SYTL4;SNAP25;SYT4;CHI3L1;VSNL1;SELL
11833,GO:0045055,0.0146154454952495,0.994671692561364,10,715,regulated exocytosis,BP,SYT13;SYT1;RPH3A;CHGA;RIMS4;SYTL4;SNAP25;SYT4;CHI3L1;SELL
2489,GO:0005215,0.0147798681194314,0.993631097504641,14,1100,transporter activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;SLC30A3;KCNS1;SLC14A1;SLC4A10;GABRB2;KCNC2;KCNK9;SV2B;SLC6A17;GRIN2B
7686,GO:0031090,0.0148386110479006,0.992113672093716,26,2684,organelle membrane,CC,CAMK1G;GABRA1;PTPRN;SYT1;CAMK2A;RPH3A;CHGA;EEF1A2;ST8SIA5;SYTL4;SLC17A7;DNM1;GABRG2;SLC30A3;CNR1;PACSIN1;CALY;SNAP25;SYT4;GABRB2;CHST9;NRGN;TMEM130;SV2B;SELL;SLC6A17
3841,GO:0007631,0.0148906558791275,0.998236509988091,3,85,feeding behavior,BP,CNR1;PRLHR;MRAP2
5502,GO:0015696,0.0149684856063675,0.998223402137757,3,86,ammonium transport,BP,SYT1;CNR1;SYT4
11255,GO:0043409,0.0149795553495546,0.997406311562584,4,143,negative regulation of MAPK cascade,BP,FOXM1;RGS4;SFRP2;SPRY4
10947,GO:0042835,0.0150608702772786,0.999943437929535,1,2,BRE binding,MF,CELF4
14670,GO:0060291,0.0153008010798842,0.998178252854082,3,70,long-term synaptic potentiation,BP,SNAP25;NRGN;GRIN2B
7708,GO:0031117,0.0154760275566153,0.999920421639584,1,3,positive regulation of microtubule depolymerization,BP,STMN2
3826,GO:0007612,0.0155315530409247,0.997286331746075,4,129,learning,BP,NPTX2;SNAP25;NRGN;NEUROD2
2149,GO:0004683,0.0156424766434679,0.999097638109443,2,28,calmodulin-dependent protein kinase activity,MF,CAMK1G;CAMK2A
4489,GO:0009330,0.0157718792581324,0.999937948849952,1,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,TOP2A
13085,GO:0048513,0.0157794122853888,0.991348083883022,29,2913,animal organ development,BP,PTPRN;ASPM;SYT1;PTPN3;CELF4;SLC17A7;NEURL1;CRYAB;CENPF;TJP2;HPCA;VGF;TOP2A;SYT4;CHI3L1;SLC4A10;SFRP2;CXCL14;GABRB2;DAAM2;FREM2;NRGN;FABP7;ADCY1;KCNC2;NEUROD2;SPRY4;SLC6A17;GRIN2B
1805,GO:0004084,0.0158064299399144,0.999937675586727,1,2,branched-chain-amino-acid transaminase activity,MF,BCAT1
4324,GO:0009082,0.0158064299399144,0.999937675586727,1,2,branched-chain amino acid biosynthetic process,BP,BCAT1
4333,GO:0009098,0.0158064299399144,0.999937675586727,1,2,leucine biosynthetic process,BP,BCAT1
4334,GO:0009099,0.0158064299399144,0.999937675586727,1,2,valine biosynthetic process,BP,BCAT1
14302,GO:0052654,0.0158064299399144,0.999937675586727,1,2,L-leucine transaminase activity,MF,BCAT1
14303,GO:0052655,0.0158064299399144,0.999937675586727,1,2,L-valine transaminase activity,MF,BCAT1
14304,GO:0052656,0.0158064299399144,0.999937675586727,1,2,L-isoleucine transaminase activity,MF,BCAT1
11092,GO:0043154,0.0159316546684231,0.99806474089071,3,86,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,BIRC5;CRYAB;SFRP2
7071,GO:0022843,0.015937801567577,0.997192192583165,4,134,voltage-gated cation channel activity,MF,KCNS1;KCNC2;KCNK9;GRIN2B
8058,GO:0031779,0.0159834374226062,0.9999045287209,1,4,melanocortin receptor binding,MF,MRAP2
8060,GO:0031781,0.0159834374226062,0.9999045287209,1,4,type 3 melanocortin receptor binding,MF,MRAP2
8061,GO:0031782,0.0159834374226062,0.9999045287209,1,4,type 4 melanocortin receptor binding,MF,MRAP2
21015,GO:1990502,0.0160296910217536,0.999935895209661,1,2,dense core granule maturation,BP,PTPRN
4874,GO:0010662,0.0160399714709774,0.999058931971794,2,30,regulation of striated muscle cell apoptotic process,BP,CAMK2A;SFRP2
3655,GO:0007189,0.0160503777848216,0.998047002848598,3,82,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,CHGA;MRAP2;ADCY1
20708,GO:1905462,0.0161027962485739,0.999935306744177,1,2,regulation of DNA duplex unwinding,BP,TOP2A
4576,GO:0009719,0.016118331083846,0.992418675486639,17,1450,response to endogenous stimulus,BP,GABRA1;PTPRN;CAMK2A;STMN2;NEURL1;CRYAB;GABRG2;IGFBP2;VGF;CHRM3;SFRP2;GABRB2;GNG3;ADCY1;KCNC2;ZCCHC12;SPRY4
14747,GO:0060384,0.0162920757830796,0.999046255952136,2,25,innervation,BP,GABRB2;NPTX1
13930,GO:0051491,0.0166073887660934,0.999011309777903,2,28,positive regulation of filopodium assembly,BP,NEURL1;TENM2
4871,GO:0010659,0.0166095578102472,0.999007446744632,2,30,cardiac muscle cell apoptotic process,BP,CAMK2A;SFRP2
2628,GO:0005543,0.0166910136362497,0.995038466610619,7,380,phospholipid binding,MF,SYT13;SYT1;RPH3A;SYTL4;PACSIN1;SYT4;NRGN
21615,GO:2000707,0.0168065598450398,0.999929503043819,1,2,positive regulation of dense core granule biogenesis,BP,CHGA
13569,GO:0050896,0.017148255970594,0.989822941340278,59,7420,response to stimulus,BP,CAMK1G;GABRA1;PTPRN;ASPM;SYT1;PTPN3;CAMK2A;BIRC5;CHGA;MYBL2;EEF1A2;CELF4;STMN2;SLC17A7;DNM1;NEURL1;GABRA4;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;IGFBP2;RGS4;CENPF;CNR1;TJP2;PRLHR;IQSEC3;HPCA;VGF;CALY;TOP2A;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;STAC2;SLC4A10;SFRP2;CXCL14;GABRB2;TENM2;DAAM2;ZNF385D;NRGN;GNG3;VSNL1;FABP7;ADCY1;KCNC2;NEUROD2;ZCCHC12;SPRY4;SELL;SLC6A17;NMB;GRIN2B
1689,GO:0003918,0.0172038068067438,0.999926116052701,1,2,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,TOP2A
15335,GO:0061505,0.0172038068067438,0.999926116052701,1,2,DNA topoisomerase II activity,MF,TOP2A
14444,GO:0055085,0.0173559459672708,0.99194846383653,16,1359,transmembrane transport,BP,GABRA1;PTPN3;SLC17A7;GABRA4;GABRG2;SLC30A3;HPCA;KCNS1;SLC14A1;SLC4A10;GABRB2;KCNC2;KCNK9;SV2B;SLC6A17;GRIN2B
7920,GO:0031523,0.0174053561856656,0.999924366952837,1,2,Myb complex,CC,MYBL2
20853,GO:1905907,0.0177278256970614,0.999895472315153,1,3,negative regulation of amyloid fibril formation,BP,CRYAB
14615,GO:0060200,0.017768324877077,0.999894992248995,1,3,clathrin-sculpted acetylcholine transport vesicle,CC,SYT1
14616,GO:0060201,0.017768324877077,0.999894992248995,1,3,clathrin-sculpted acetylcholine transport vesicle membrane,CC,SYT1
8043,GO:0031749,0.0177741244039871,0.999894923412238,1,3,D2 dopamine receptor binding,MF,DNM1
3004,GO:0006182,0.0179702506757515,0.998878749140919,2,31,cGMP biosynthetic process,BP,HPCA;ADCY1
18201,GO:0099082,0.0181058620709649,0.999890948039579,1,3,retrograde trans-synaptic signaling by neuropeptide,BP,SYT4
5394,GO:0015265,0.0181233258025691,0.999890736701294,1,3,urea channel activity,MF,SLC14A1
21078,GO:1990742,0.0181572936042513,0.99989032504732,1,3,microvesicle,CC,SYT4
21146,GO:1990926,0.0183638900896228,0.999887804506319,1,3,short-term synaptic potentiation,BP,SNAP25
17805,GO:0097484,0.0185693610601293,0.998825170446511,2,29,dendrite extension,BP,SYT1;SYT4
18811,GO:1901079,0.0186006241322115,0.999884880773832,1,3,positive regulation of relaxation of muscle,BP,CHGA
4870,GO:0010658,0.0187330093402065,0.998803355622138,2,32,striated muscle cell apoptotic process,BP,CAMK2A;SFRP2
12687,GO:0046883,0.0187411807575167,0.995650143449462,5,235,regulation of hormone secretion,BP,SYTL4;CNR1;SNAP25;VSNL1;KCNC2
10857,GO:0042662,0.0189724572590067,0.999865310800871,1,4,negative regulation of mesodermal cell fate specification,BP,SFRP2
20808,GO:1905771,0.0189724572590067,0.999865310800871,1,4,negative regulation of mesodermal cell differentiation,BP,SFRP2
20851,GO:1905903,0.0189724572590067,0.999865310800871,1,4,negative regulation of mesoderm formation,BP,SFRP2
18768,GO:1900736,0.0189899933408309,0.999865060692063,1,4,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,CHGA
2804,GO:0005853,0.0192568665031282,0.999861225539801,1,4,eukaryotic translation elongation factor 1 complex,CC,EEF1A2
13975,GO:0051588,0.0193050898223198,0.997481724296544,3,84,regulation of neurotransmitter transport,BP,CAMK2A;RIMS4;SYT4
5420,GO:0015319,0.0194002279036129,0.999874724954426,1,3,sodium:inorganic phosphate symporter activity,MF,SLC17A7
2512,GO:0005249,0.0195961217330531,0.997428032363208,3,86,voltage-gated potassium channel activity,MF,KCNS1;KCNC2;KCNK9
18062,GO:0098805,0.0196797789580859,0.990526382700819,17,1523,whole membrane,CC,PTPRN;SYT1;CAMK2A;RPH3A;CHGA;EEF1A2;SYTL4;SLC17A7;SLC30A3;CNR1;SNAP25;SYT4;NRGN;ADCY1;SV2B;SELL;SLC6A17
21235,GO:2000117,0.019864904215347,0.99737402120781,3,95,negative regulation of cysteine-type endopeptidase activity,BP,BIRC5;CRYAB;SFRP2
19494,GO:1902951,0.019976713356291,0.99986713426082,1,3,negative regulation of dendritic spine maintenance,BP,GRIN2B
17959,GO:0098588,0.0199917871020956,0.989830495313563,20,1891,bounding membrane of organelle,CC,CAMK1G;PTPRN;SYT1;CAMK2A;RPH3A;CHGA;EEF1A2;ST8SIA5;SYTL4;SLC17A7;SLC30A3;CNR1;SNAP25;SYT4;CHST9;NRGN;TMEM130;SV2B;SELL;SLC6A17
21470,GO:2000501,0.0202057484313319,0.999837016465845,1,5,regulation of natural killer cell chemotaxis,BP,CXCL14
15558,GO:0070032,0.0204193005482969,0.999843888265262,1,4,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,SNAP25
15165,GO:0061056,0.0205035072174034,0.999842592378407,1,4,sclerotome development,BP,SFRP2
2336,GO:0004949,0.0205668383216944,0.999859130564521,1,3,cannabinoid receptor activity,MF,CNR1
3880,GO:0008076,0.0211045057607441,0.997150966939725,3,87,voltage-gated potassium channel complex,CC,KCNS1;SNAP25;KCNC2
7743,GO:0031224,0.0211459503637016,0.987572470503369,37,4249,intrinsic component of membrane,CC,SYT13;GABRA1;PTPRN;SYT1;ST8SIA5;SLC17A7;GABRA4;PTPN5;GABRG2;SLC30A3;CNR1;PRLHR;KCNS1;PRRG3;CALY;SNAP25;SYT4;CHRM3;FAM189A2;MRAP2;SLC14A1;SLC4A10;SFRP2;GABRB2;TENM2;FREM2;CHST9;ADCY1;KCNC2;TMEM130;KCNK9;ZDHHC23;SV2B;C11ORF87;SELL;SLC6A17;GRIN2B
14538,GO:0060076,0.0215302911606132,0.998526803992257,2,29,excitatory synapse,CC,SYT1;SLC17A7
19036,GO:1901699,0.0217132454221202,0.992043065433308,9,589,cellular response to nitrogen compound,BP,GABRA1;CAMK2A;NEURL1;GABRG2;CHRM3;GABRB2;GNG3;ADCY1;KCNC2
4671,GO:0010033,0.0218049244560753,0.987882911246555,27,2868,response to organic substance,BP,GABRA1;PTPRN;CAMK2A;BIRC5;MYBL2;STMN2;NEURL1;CRYAB;PTPN5;GABRG2;IGFBP2;CNR1;TJP2;HPCA;VGF;CHRM3;CHI3L1;SFRP2;GABRB2;GNG3;VSNL1;ADCY1;KCNC2;ZCCHC12;SPRY4;SELL;GRIN2B
21329,GO:2000297,0.0218884457197911,0.999840348406381,1,3,negative regulation of synapse maturation,BP,NEUROD2
6867,GO:0021700,0.0221866096801146,0.994625130681308,5,232,developmental maturation,BP,PTPRN;SLC17A7;NEURL1;SYT4;NEUROD2
4016,GO:0008294,0.0222324600098619,0.999876292615201,1,2,calcium- and calmodulin-responsive adenylate cyclase activity,MF,ADCY1
5564,GO:0015820,0.0222651800978027,0.999834777007919,1,3,leucine transport,BP,SLC6A17
9049,GO:0033602,0.0227029992667219,0.999828180953241,1,3,negative regulation of dopamine secretion,BP,CNR1
5409,GO:0015294,0.0230900809158222,0.996776002865635,3,86,solute:cation symporter activity,MF,SLC17A7;SLC4A10;SLC6A17
12605,GO:0046676,0.0232218513342472,0.998328866546584,2,36,negative regulation of insulin secretion,BP,SYTL4;VSNL1
4012,GO:0008289,0.0232899448741587,0.991358931831861,9,626,lipid binding,MF,SYT13;SYT1;RPH3A;SYTL4;PACSIN1;SYT4;NRGN;FABP7;SELL
16293,GO:0071377,0.0233710058736873,0.998312394683977,2,36,cellular response to glucagon stimulus,BP,GNG3;ADCY1
15197,GO:0061110,0.0235518249295246,0.99981502106125,1,3,dense core granule biogenesis,BP,CHGA
21613,GO:2000705,0.0235518249295246,0.99981502106125,1,3,regulation of dense core granule biogenesis,BP,CHGA
10930,GO:0042802,0.0236726978933627,0.988595060727952,16,1494,identical protein binding,MF,BCAT1;SYT1;CAMK2A;BIRC5;DNM1;CRYAB;CENPF;HPCA;PACSIN1;SULT4A1;TOP2A;SYT4;MRAP2;TENM2;KCNK9;PCSK1
12860,GO:0047756,0.0237627482064672,0.999788276991786,1,4,chondroitin 4-sulfotransferase activity,MF,CHST9
5742,GO:0016185,0.0238710377320884,0.999809945096295,1,3,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,DNM1
18086,GO:0098844,0.0238710377320884,0.999809945096295,1,3,postsynaptic endocytic zone membrane,CC,DNM1
18106,GO:0098884,0.0238710377320884,0.999809945096295,1,3,postsynaptic neurotransmitter receptor internalization,BP,DNM1
5303,GO:0015077,0.0241388097432487,0.993067724165267,6,335,monovalent inorganic cation transmembrane transporter activity,MF,SLC17A7;KCNS1;SLC4A10;KCNC2;KCNK9;SLC6A17
8220,GO:0032133,0.0241532329340501,0.999766735820739,1,5,chromosome passenger complex,CC,BIRC5
18104,GO:0098881,0.0241664325668821,0.999780984484923,1,4,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,SNAP25
18153,GO:0098967,0.0241664325668821,0.999780984484923,1,4,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,SNAP25
111,GO:0000226,0.0242348883781434,0.991544402023334,8,491,microtubule cytoskeleton organization,BP,ASPM;BIRC5;KIF4A;MYBL2;STMN2;NEURL1;CRYAB;MAP7D2
7382,GO:0030496,0.0245732746504506,0.995057555001441,4,160,midbody,CC,ASPM;BIRC5;KIF4A;CENPF
644,GO:0001786,0.0251334080882994,0.998111331828389,2,37,phosphatidylserine binding,MF,SYT1;SYT4
16618,GO:0071918,0.025338062022736,0.999759112325546,1,4,urea transmembrane transport,BP,SLC14A1
13825,GO:0051291,0.0253418736537915,0.996323451909177,3,100,protein heterooligomerization,BP,SYT1;KCNC2;GRIN2B
17782,GO:0097442,0.025563856057357,0.999781865035538,1,3,CA3 pyramidal cell dendrite,CC,SLC4A10
13065,GO:0048471,0.0255685602201275,0.99035854545487,9,630,perinuclear region of cytoplasm,CC,CHGA;STMN2;NEURL1;CENPF;KCNS1;PACSIN1;SNAP25;SYT4;CHI3L1
6880,GO:0021759,0.025801362883028,0.999750173020318,1,4,globus pallidus development,BP,KCNC2
4662,GO:0009996,0.0258781959772146,0.999732037748383,1,5,negative regulation of cell fate specification,BP,SFRP2
13437,GO:0050709,0.0259956905409564,0.99619049811457,3,102,negative regulation of protein secretion,BP,SYTL4;SYT4;VSNL1
9504,GO:0034705,0.0261398110486703,0.996167129218821,3,94,potassium channel complex,CC,KCNS1;SNAP25;KCNC2
4099,GO:0008430,0.0263858902072641,0.999738659684704,1,4,selenium binding,MF,RPH3A
18275,GO:0099552,0.0267290206861139,0.999761400123013,1,3,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,CNR1
18276,GO:0099553,0.0267290206861139,0.999761400123013,1,3,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,CNR1
7463,GO:0030665,0.0268870052300678,0.99601107465578,3,99,clathrin-coated vesicle membrane,CC,SYT1;SLC17A7;NRGN
7519,GO:0030817,0.0272771106523058,0.997846540575647,2,43,regulation of cAMP biosynthetic process,BP,HPCA;MRAP2
15202,GO:0061133,0.0273592481903633,0.999687915246736,1,6,endopeptidase activator activity,MF,SFRP2
642,GO:0001784,0.0276652634613322,0.997816769178834,2,35,phosphotyrosine residue binding,MF,PTPN3;PTPN5
8701,GO:0032873,0.027694075788763,0.997803635701573,2,39,negative regulation of stress-activated MAPK cascade,BP,FOXM1;SFRP2
15727,GO:0070303,0.027694075788763,0.997803635701573,2,39,negative regulation of stress-activated protein kinase signaling cascade,BP,FOXM1;SFRP2
4632,GO:0009898,0.0277290091235013,0.994209021135205,4,170,cytoplasmic side of plasma membrane,CC,PTPN3;NPTX2;SNAP25;GNG3
3829,GO:0007616,0.0277733310853575,0.997806444206373,2,34,long-term memory,BP,SLC17A7;ADCY1
20487,GO:1904956,0.0279628764821563,0.999686857377879,1,5,regulation of midbrain dopaminergic neuron differentiation,BP,SFRP2
5551,GO:0015803,0.0280849479875352,0.999703703269414,1,4,branched-chain amino acid transport,BP,SLC6A17
15588,GO:0070081,0.0281433065843949,0.999682779652003,1,5,clathrin-sculpted monoamine transport vesicle,CC,SYT1
15589,GO:0070083,0.0281433065843949,0.999682779652003,1,5,clathrin-sculpted monoamine transport vesicle membrane,CC,SYT1
18265,GO:0099538,0.0281745837590313,0.999701797453516,1,4,synaptic signaling via neuropeptide,BP,SYT4
18266,GO:0099540,0.0281745837590313,0.999701797453516,1,4,trans-synaptic signaling by neuropeptide,BP,SYT4
17951,GO:0098574,0.0283856643934696,0.999677260358824,1,5,cytoplasmic side of lysosomal membrane,CC,EEF1A2
16035,GO:0070887,0.0286436537761039,0.983798583654293,26,2805,cellular response to chemical stimulus,BP,GABRA1;PTPRN;SYT1;CAMK2A;BIRC5;CHGA;MYBL2;STMN2;NEURL1;PTPN5;GABRG2;IGFBP2;TJP2;HPCA;CHRM3;CHI3L1;SFRP2;CXCL14;GABRB2;GNG3;VSNL1;ADCY1;KCNC2;NEUROD2;ZCCHC12;SPRY4
6235,GO:0017145,0.0286687356665108,0.997688632111327,2,37,stem cell division,BP,ASPM;SFRP2
17369,GO:0090278,0.0287264492169206,0.997672329850414,2,41,negative regulation of peptide hormone secretion,BP,SYTL4;VSNL1
7273,GO:0030263,0.0287475520662391,0.99968946899788,1,4,apoptotic chromosome condensation,BP,TOP2A
12268,GO:0045933,0.028798218144136,0.99765761205696,2,44,positive regulation of muscle contraction,BP,CHGA;CHRM3
7082,GO:0022890,0.0288680946398707,0.989586790283909,8,523,inorganic cation transmembrane transporter activity,MF,SLC17A7;SLC30A3;KCNS1;SLC4A10;KCNC2;KCNK9;SLC6A17;GRIN2B
494,GO:0001537,0.0290794316332426,0.999661194647534,1,5,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,CHST9
9655,GO:0035249,0.0290851599204117,0.995563495979735,3,88,synaptic transmission, glutamatergic,BP,SYT1;SLC17A7;CNR1
12227,GO:0045861,0.0291248591585492,0.992418119708426,5,275,negative regulation of proteolysis,BP,PTPN3;BIRC5;CRYAB;SFRP2;PI16
3585,GO:0007051,0.0293279403214342,0.993772159192821,4,163,spindle organization,BP,ASPM;BIRC5;KIF4A;MYBL2
1275,GO:0002792,0.0295527765355876,0.995447213732798,3,108,negative regulation of peptide secretion,BP,SYTL4;SYT4;VSNL1
7948,GO:0031584,0.0295864075686919,0.999649204718869,1,5,activation of phospholipase D activity,BP,HPCA
13750,GO:0051179,0.0300203585342666,0.981402025578469,47,5679,localization,BP,SYT13;GABRA1;PTPRN;ASPM;SYT1;PTPN3;CAMK2A;RBFOX1;RPH3A;BIRC5;KIF4A;CHGA;RIMS4;SYTL4;SLC17A7;DNM1;NEURL1;GABRA4;CRYAB;GABRG2;SLC30A3;CENPF;CNR1;TJP2;HPCA;KCNS1;PACSIN1;VGF;CALY;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;SLC14A1;SLC4A10;SFRP2;CXCL14;GABRB2;VSNL1;KCNC2;KCNK9;ZDHHC23;SV2B;SELL;SLC6A17;GRIN2B
17345,GO:0090244,0.0300451127026608,0.999660614607656,1,4,Wnt signaling pathway involved in somitogenesis,BP,SFRP2
15542,GO:0065007,0.0300487367512742,0.982548762043011,76,10285,biological regulation,BP,CAMK1G;SYT13;GABRA1;PTPRN;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;RBFOX1;RPH3A;BIRC5;CHGA;MYBL2;RIMS4;EEF1A2;CELF4;SYTL4;STMN2;SLC17A7;DNM1;NEURL1;GABRA4;CRYAB;FOXM1;GABRG2;SLC30A3;IGFBP2;RGS4;CENPF;CNR1;TJP2;PRLHR;IQSEC3;HPCA;KCNS1;PACSIN1;VGF;CALY;TOP2A;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;STAC2;SLC4A10;SFRP2;CXCL14;GABRB2;TENM2;DAAM2;MKI67;ZNF385D;CHST9;NRGN;ABI3BP;GNG3;VSNL1;FABP7;PI16;ADCY1;KCNC2;KCNK9;NEUROD2;ENC1;ZCCHC12;PCSK1;DDN;NELL2;MYT1L;SPRY4;SELL;NMB;PPP1R14C;GRIN2B
18505,GO:0140014,0.0300631457659682,0.992114862849566,5,252,mitotic nuclear division,BP,BIRC5;KIF4A;MYBL2;CENPF;MKI67
18473,GO:0120036,0.0301104406340258,0.985057408723314,16,1355,plasma membrane bounded cell projection organization,BP,SYT1;CAMK2A;STMN2;NEFM;NPTX2;NEURL1;CNR1;PACSIN1;SNAP25;SYT4;SFRP2;TENM2;ADCY1;NPTX1;ENC1;GRIN2B
13256,GO:0048839,0.0302680213300758,0.99350735567499,4,168,inner ear development,BP,HPCA;CXCL14;GABRB2;FREM2
2540,GO:0005315,0.0304687038433587,0.999650913896651,1,4,inorganic phosphate transmembrane transporter activity,MF,SLC17A7
18000,GO:0098662,0.0305791001926842,0.988100105693766,9,644,inorganic cation transmembrane transport,BP,PTPN3;SLC17A7;SLC30A3;HPCA;KCNS1;SLC4A10;KCNC2;KCNK9;GRIN2B
11052,GO:0043086,0.0312724098381226,0.987778086158566,9,688,negative regulation of catalytic activity,BP,BIRC5;CRYAB;RGS4;CNR1;HPCA;SFRP2;PI16;SPRY4;PPP1R14C
13804,GO:0051259,0.0313184375488823,0.989405780093216,7,470,protein complex oligomerization,BP,SYT1;LNX1;DNM1;CRYAB;KCNS1;KCNC2;GRIN2B
17394,GO:0090306,0.0313215056067664,0.999630963564174,1,4,spindle assembly involved in meiosis,BP,ASPM
14048,GO:0051716,0.0313970877547452,0.980428228379284,50,6193,cellular response to stimulus,BP,CAMK1G;GABRA1;PTPRN;ASPM;SYT1;PTPN3;CAMK2A;BIRC5;CHGA;MYBL2;CELF4;STMN2;SLC17A7;DNM1;NEURL1;GABRA4;CRYAB;PTPN5;FOXM1;GABRG2;IGFBP2;RGS4;CNR1;TJP2;PRLHR;IQSEC3;HPCA;VGF;CALY;TOP2A;CHRM3;CHI3L1;MRAP2;STAC2;SFRP2;CXCL14;GABRB2;TENM2;DAAM2;ZNF385D;NRGN;GNG3;VSNL1;ADCY1;KCNC2;NEUROD2;ZCCHC12;SPRY4;NMB;GRIN2B
5421,GO:0015321,0.0316259084134914,0.999598836836059,1,5,sodium-dependent phosphate transmembrane transporter activity,MF,SLC17A7
4595,GO:0009786,0.0319470389237911,0.999615972627078,1,4,regulation of asymmetric cell division,BP,ASPM
4762,GO:0010466,0.0321094906651178,0.992973274622359,4,196,negative regulation of peptidase activity,BP,BIRC5;CRYAB;SFRP2;PI16
177,GO:0000381,0.0322023205032568,0.997223241342616,2,42,regulation of alternative mRNA splicing, via spliceosome,BP,RBFOX1;CELF4
3565,GO:0007021,0.032210812894421,0.999554309315164,1,7,tubulin complex assembly,BP,CRYAB
2063,GO:0004568,0.0323151147943474,0.999563746317773,1,6,chitinase activity,MF,CHI3L1
2915,GO:0006030,0.0323151147943474,0.999563746317773,1,6,chitin metabolic process,BP,CHI3L1
2916,GO:0006032,0.0323151147943474,0.999563746317773,1,6,chitin catabolic process,BP,CHI3L1
13928,GO:0051489,0.0324080242527114,0.99720351810675,2,39,regulation of filopodium assembly,BP,NEURL1;TENM2
8145,GO:0031999,0.032467433953284,0.999603270729262,1,4,negative regulation of fatty acid beta-oxidation,BP,CNR1
3670,GO:0007207,0.0328001192465363,0.999550465309172,1,6,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,CHRM3
17825,GO:0097512,0.0328291799836595,0.999549663123974,1,6,cardiac myofibril,CC,CRYAB
13234,GO:0048786,0.0328404952224509,0.99716192215721,2,34,presynaptic active zone,CC,RIMS4;SLC17A7
5580,GO:0015849,0.032987214100875,0.991128947675106,5,270,organic acid transport,BP,SYT1;SLC17A7;SNAP25;SYT4;SLC6A17
12721,GO:0046942,0.032987214100875,0.991128947675106,5,270,carboxylic acid transport,BP,SYT1;SLC17A7;SNAP25;SYT4;SLC6A17
7733,GO:0031201,0.0331836176206487,0.997077395985187,2,49,SNARE complex,CC,SYT1;SNAP25
11875,GO:0045110,0.03322274669524,0.99955701109595,1,5,intermediate filament bundle assembly,BP,NEFM
18116,GO:0098902,0.0333529584500521,0.999581174821877,1,4,regulation of membrane depolarization during action potential,BP,PTPN3
5575,GO:0015840,0.0334594091235992,0.999532088153378,1,6,urea transport,BP,SLC14A1
17033,GO:0072687,0.0336365621133013,0.999545829057339,1,5,meiotic spindle,CC,ASPM
13093,GO:0048523,0.0337803907131397,0.979421303057819,36,4134,negative regulation of cellular process,BP,LZTS1;ASPM;PTPN3;BIRC5;CHGA;CELF4;SYTL4;STMN2;DNM1;NEURL1;CRYAB;FOXM1;IGFBP2;RGS4;CENPF;CNR1;TJP2;HPCA;PACSIN1;TOP2A;SYT4;MRAP2;SFRP2;CXCL14;GABRB2;TENM2;DAAM2;VSNL1;FABP7;PI16;NEUROD2;ENC1;MYT1L;SPRY4;PPP1R14C;GRIN2B
5371,GO:0015204,0.0339347234852269,0.999518607655916,1,6,urea transmembrane transporter activity,MF,SLC14A1
14748,GO:0060385,0.0341900113570622,0.999530652916763,1,5,axonogenesis involved in innervation,BP,NPTX1
14765,GO:0060405,0.0342185752847176,0.999529862800627,1,5,regulation of penile erection,BP,CNR1
10856,GO:0042661,0.0342514136411967,0.999509518200666,1,6,regulation of mesodermal cell fate specification,BP,SFRP2
20807,GO:1905770,0.0342514136411967,0.999509518200666,1,6,regulation of mesodermal cell differentiation,BP,SFRP2
20850,GO:1905902,0.0342514136411967,0.999509518200666,1,6,regulation of mesoderm formation,BP,SFRP2
17771,GO:0097418,0.0344599554941582,0.99952315899056,1,5,neurofibrillary tangle,CC,NEFM
11171,GO:0043269,0.0345581336801018,0.987093168900672,8,559,regulation of ion transport,BP,SYT1;PTPN3;CAMK2A;CNR1;HPCA;KCNS1;SYT4;KCNC2
6697,GO:0019898,0.034670437224869,0.990554140738568,5,266,extrinsic component of membrane,CC,RPH3A;SYTL4;HPCA;SNAP25;GNG3
5834,GO:0016363,0.0347418571286541,0.994308176724487,3,103,nuclear matrix,CC,KIF4A;CENPF;ENC1
565,GO:0001664,0.0348808558136043,0.992162130712639,4,212,G-protein coupled receptor binding,MF,DNM1;MRAP2;CXCL14;GNG3
10607,GO:0042165,0.0349124129000984,0.996839766580316,2,49,neurotransmitter binding,MF,CHRM3;GRIN2B
12335,GO:0046068,0.0350303827014407,0.996839142275167,2,42,cGMP metabolic process,BP,HPCA;ADCY1
5581,GO:0015850,0.0350889494133321,0.992109628539187,4,190,organic hydroxy compound transport,BP,SYT1;CHGA;CNR1;SYT4
3662,GO:0007197,0.035103229449943,0.999484642063842,1,6,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,CHRM3
6131,GO:0016907,0.035103229449943,0.999484642063842,1,6,G-protein coupled acetylcholine receptor activity,MF,CHRM3
12175,GO:0045762,0.0351201855378457,0.999504576572838,1,5,positive regulation of adenylate cyclase activity,BP,HPCA
13436,GO:0050708,0.0352930010344429,0.988930520747647,6,374,regulation of protein secretion,BP,SYTL4;CNR1;SNAP25;SYT4;VSNL1;KCNC2
12606,GO:0046677,0.0353498803614265,0.990312458522713,5,290,response to antibiotic,BP,CRYAB;CNR1;ADCY1;KCNC2;GRIN2B
7123,GO:0030030,0.0353739024896412,0.982080943458617,16,1386,cell projection organization,BP,SYT1;CAMK2A;STMN2;NEFM;NPTX2;NEURL1;CNR1;PACSIN1;SNAP25;SYT4;SFRP2;TENM2;ADCY1;NPTX1;ENC1;GRIN2B
12032,GO:0045471,0.0354793569132128,0.994128486115969,3,116,response to ethanol,BP,CNR1;KCNC2;GRIN2B
19667,GO:1903307,0.0355576572910061,0.996755701329925,2,46,positive regulation of regulated secretory pathway,BP,SYT1;SYT4
18430,GO:0106071,0.0356116941704796,0.999490508837407,1,5,positive regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,MRAP2
19156,GO:1902075,0.0358677041793727,0.999446569254751,1,7,cellular response to salt,BP,HPCA
3922,GO:0008146,0.0359576712234388,0.996697071245094,2,47,sulfotransferase activity,MF,SULT4A1;CHST9
19451,GO:1902866,0.0359991517215866,0.999457804268461,1,6,regulation of retina development in camera-type eye,BP,CELF4
2584,GO:0005436,0.0360963153332359,0.999454852144522,1,6,sodium:phosphate symporter activity,MF,SLC17A7
4083,GO:0008406,0.0360986544220901,0.991813415642417,4,184,gonad development,BP,PTPRN;ASPM;VGF;SFRP2
7963,GO:0031622,0.0363680796654682,0.999446551938516,1,6,positive regulation of fever generation,BP,CNR1
15627,GO:0070142,0.0364927792481608,0.999464790394567,1,5,synaptic vesicle budding,BP,DNM1
9950,GO:0035747,0.0369319082566867,0.999412994618529,1,7,natural killer cell chemotaxis,BP,CXCL14
12172,GO:0045759,0.0373972477344765,0.999414542149577,1,6,negative regulation of action potential,BP,CNR1
12950,GO:0048170,0.0374239807608262,0.999436910085681,1,5,positive regulation of long-term neuronal synaptic plasticity,BP,NEURL1
11578,GO:0044300,0.0377303421265818,0.999427580404864,1,5,cerebellar mossy fiber,CC,SLC17A7
19037,GO:1901700,0.0381608720114966,0.980887131406198,15,1422,response to oxygen-containing compound,BP,PTPRN;CAMK2A;NEURL1;CRYAB;IGFBP2;CNR1;HPCA;VGF;CHRM3;GNG3;VSNL1;ADCY1;KCNC2;SELL;GRIN2B
11118,GO:0043196,0.0382632381417967,0.999369579268717,1,7,varicosity,CC,DNM1
3872,GO:0008061,0.0385031274978356,0.99936158916621,1,7,chitin binding,MF,CHI3L1
13497,GO:0050794,0.038618203728925,0.976201722786524,69,9170,regulation of cellular process,BP,CAMK1G;SYT13;GABRA1;PTPRN;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;RBFOX1;RPH3A;BIRC5;CHGA;MYBL2;RIMS4;EEF1A2;CELF4;SYTL4;STMN2;SLC17A7;DNM1;NEURL1;GABRA4;CRYAB;FOXM1;GABRG2;SLC30A3;IGFBP2;RGS4;CENPF;CNR1;TJP2;PRLHR;IQSEC3;HPCA;KCNS1;PACSIN1;VGF;CALY;TOP2A;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;STAC2;SFRP2;CXCL14;GABRB2;TENM2;DAAM2;MKI67;ZNF385D;NRGN;GNG3;VSNL1;FABP7;PI16;ADCY1;KCNC2;NEUROD2;ENC1;ZCCHC12;DDN;MYT1L;SPRY4;NMB;PPP1R14C;GRIN2B
7465,GO:0030667,0.0387159799558974,0.989132541651855,5,282,secretory granule membrane,CC,SYT1;SYTL4;SNAP25;SYT4;SELL
1316,GO:0002866,0.0387574053177312,0.99935306404356,1,7,positive regulation of acute inflammatory response to antigenic stimulus,BP,CNR1
11893,GO:0045137,0.0387595049693325,0.991009676622355,4,189,development of primary sexual characteristics,BP,PTPRN;ASPM;VGF;SFRP2
9404,GO:0034481,0.0388406694619975,0.999368108154698,1,6,chondroitin sulfotransferase activity,MF,CHST9
9112,GO:0033762,0.0388528820509301,0.996278303664206,2,47,response to glucagon,BP,GNG3;ADCY1
13627,GO:0051001,0.0388917769950077,0.999366431067632,1,6,negative regulation of nitric-oxide synthase activity,BP,CNR1
19554,GO:1903047,0.0390725331261166,0.983285386476424,10,802,mitotic cell cycle process,BP,BCAT1;LZTS1;CAMK2A;BIRC5;KIF4A;MYBL2;FOXM1;CENPF;TOP2A;MKI67
14541,GO:0060079,0.0391245319998655,0.993285061784107,3,105,excitatory postsynaptic potential,BP,CELF4;SLC17A7;GRIN2B
3586,GO:0007052,0.0391548266338068,0.993276762889346,3,106,mitotic spindle organization,BP,BIRC5;KIF4A;MYBL2
7105,GO:0030001,0.0394816308563617,0.983082248240213,10,781,metal ion transport,BP,PTPN3;CAMK2A;SLC17A7;SLC30A3;HPCA;KCNS1;SLC4A10;KCNC2;KCNK9;GRIN2B
12056,GO:0045576,0.0397092562300167,0.996139533505773,2,52,mast cell activation,BP,CHGA;CNR1
8707,GO:0032879,0.0397149769905095,0.977413140220795,23,2369,regulation of localization,BP,SYT13;SYT1;PTPN3;CAMK2A;RPH3A;CHGA;RIMS4;SYTL4;DNM1;CRYAB;SLC30A3;CNR1;HPCA;KCNS1;PACSIN1;CALY;SNAP25;SYT4;MRAP2;SFRP2;CXCL14;VSNL1;KCNC2
2544,GO:0005326,0.0397244157120217,0.99614873463772,2,47,neurotransmitter transporter activity,MF,SLC17A7;SLC6A17
13805,GO:0051260,0.0398202966428797,0.988734181138504,5,295,protein homooligomerization,BP,SYT1;LNX1;CRYAB;KCNS1;KCNC2
21824,GO:2001205,0.039914033149295,0.99935882263401,1,5,negative regulation of osteoclast development,BP,TJP2
17781,GO:0097441,0.040053863399022,0.999354284773061,1,5,basal dendrite,CC,SLC4A10
2502,GO:0005231,0.0401073746974028,0.996093929840241,2,46,excitatory extracellular ligand-gated ion channel activity,MF,SLC17A7;GRIN2B
18085,GO:0098843,0.0401987107058976,0.999322776769924,1,6,postsynaptic endocytic zone,CC,DNM1
291,GO:0000793,0.0402717986130632,0.990543341408567,4,194,condensed chromosome,CC,BIRC5;CENPF;TOP2A;MKI67
11128,GO:0043208,0.0403293608422071,0.999299086048519,1,7,glycosphingolipid binding,MF,SELL
11975,GO:0045309,0.0403923057661791,0.996056716050362,2,44,protein phosphorylated amino acid binding,MF,PTPN3;PTPN5
9005,GO:0033500,0.0408643369673959,0.990358468852991,4,197,carbohydrate homeostasis,BP,PTPRN;CNR1;VGF;VSNL1
10821,GO:0042593,0.0408643369673959,0.990358468852991,4,197,glucose homeostasis,BP,PTPRN;CNR1;VGF;VSNL1
18005,GO:0098693,0.0410342704974697,0.995965948698134,2,42,regulation of synaptic vesicle cycle,BP,RIMS4;DNM1
18267,GO:0099541,0.0411052151007974,0.999319644397526,1,5,trans-synaptic signaling by lipid,BP,CNR1
18268,GO:0099542,0.0411052151007974,0.999319644397526,1,5,trans-synaptic signaling by endocannabinoid,BP,CNR1
14179,GO:0051961,0.0411807981782703,0.988254478029828,5,264,negative regulation of nervous system development,BP,ASPM;STMN2;SYT4;DAAM2;NEUROD2
12749,GO:0046982,0.0412566151820582,0.986569244338836,6,404,protein heterodimerization activity,MF,SYT1;TOP2A;SYT4;TENM2;KCNK9;NEUROD2
2521,GO:0005267,0.041330340924276,0.992738479466422,3,119,potassium channel activity,MF,KCNS1;KCNC2;KCNK9
8175,GO:0032051,0.0413757711511892,0.999310581055924,1,5,clathrin light chain binding,MF,CALY
10509,GO:0040016,0.0414861703038865,0.999278327122056,1,6,embryonic cleavage,BP,TOP2A
1789,GO:0004062,0.0416197345041505,0.999225823332143,1,9,aryl sulfotransferase activity,MF,SULT4A1
2300,GO:0004888,0.0416960732827442,0.982834564707239,9,729,transmembrane signaling receptor activity,MF,GABRA1;GABRA4;GABRG2;CNR1;PRLHR;CHRM3;SFRP2;GABRB2;GRIN2B
7821,GO:0031339,0.0417629029070489,0.999268585317247,1,6,negative regulation of vesicle fusion,BP,SYT4
8628,GO:0032762,0.0418383284963963,0.999245202825376,1,7,mast cell cytokine production,BP,CHGA
1687,GO:0003916,0.0419994737289315,0.999260204661874,1,6,DNA topoisomerase activity,MF,TOP2A
20852,GO:1905906,0.0421647132538744,0.999233281217515,1,7,regulation of amyloid fibril formation,BP,CRYAB
7822,GO:0031340,0.0432631771418527,0.999192460433757,1,7,positive regulation of vesicle fusion,BP,SYT1
13641,GO:0051020,0.04332571583586,0.982050734707915,9,623,GTPase binding,MF,PTPRN;CAMK2A;RPH3A;BIRC5;RIMS4;SYTL4;IQSEC3;DAAM2;GRIN2B
2507,GO:0005244,0.0435464712204157,0.989525045918172,4,184,voltage-gated ion channel activity,MF,KCNS1;KCNC2;KCNK9;GRIN2B
7062,GO:0022832,0.0435464712204157,0.989525045918172,4,184,voltage-gated channel activity,MF,KCNS1;KCNC2;KCNK9;GRIN2B
7962,GO:0031620,0.0435597406419777,0.999181254993037,1,7,regulation of fever generation,BP,CNR1
17699,GO:0097264,0.0436386120319362,0.999178261670684,1,7,self proteolysis,BP,TENM2
18431,GO:0106072,0.0437573457471528,0.999173745016359,1,7,negative regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,MRAP2
4035,GO:0008324,0.0440538054723111,0.982744960561854,8,578,cation transmembrane transporter activity,MF,SLC17A7;SLC30A3;KCNS1;SLC4A10;KCNC2;KCNK9;SLC6A17;GRIN2B
1575,GO:0003402,0.0442629150159727,0.999177564094438,1,6,planar cell polarity pathway involved in axis elongation,BP,SFRP2
11915,GO:0045182,0.0445186208555803,0.995399234569261,2,50,translation regulator activity,MF,CELF4;NEURL1
11609,GO:0044341,0.044645014983915,0.999139578714324,1,7,sodium-dependent phosphate transport,BP,SLC17A7
4872,GO:0010660,0.0447282775730152,0.995360546990736,2,52,regulation of muscle cell apoptotic process,BP,CAMK2A;SFRP2
1274,GO:0002791,0.0450742110436765,0.985015067125337,6,400,regulation of peptide secretion,BP,SYTL4;CNR1;SNAP25;SYT4;VSNL1;KCNC2
15239,GO:0061200,0.0450852401455377,0.999104336969468,1,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,SYT1
15240,GO:0061202,0.0450852401455377,0.999104336969468,1,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,SYT1
11358,GO:0043583,0.0453190903178098,0.988953676897781,4,194,ear development,BP,HPCA;CXCL14;GABRB2;FREM2
5073,GO:0010942,0.0453468531482495,0.9821310477861,8,616,positive regulation of cell death,BP,CAMK2A;MYBL2;EEF1A2;NEURL1;CNR1;TOP2A;SFRP2;GRIN2B
10813,GO:0042584,0.0453624714739242,0.999135810261224,1,6,chromaffin granule membrane,CC,SYT1
20354,GO:1904714,0.0454079397657346,0.9990913549341,1,8,regulation of chaperone-mediated autophagy,BP,EEF1A2
21398,GO:2000381,0.0459375411528308,0.999069843261733,1,8,negative regulation of mesoderm development,BP,SFRP2
18007,GO:0098700,0.0459770475736558,0.999068228296853,1,8,neurotransmitter loading into synaptic vesicle,BP,SLC17A7
14497,GO:0060028,0.0460211583496873,0.999085217698259,1,7,convergent extension involved in axis elongation,BP,SFRP2
2481,GO:0005179,0.0463668085965682,0.99506173570231,2,69,hormone activity,MF,VGF;NMB
16611,GO:0071901,0.0463810501831816,0.991467472357326,3,125,negative regulation of protein serine/threonine kinase activity,BP,RGS4;SFRP2;SPRY4
17356,GO:0090263,0.0466604747244335,0.991394752657932,3,126,positive regulation of canonical Wnt signaling pathway,BP,ASPM;SFRP2;DAAM2
18805,GO:1901072,0.0468199268693934,0.999018309850925,1,9,glucosamine-containing compound catabolic process,BP,CHI3L1
21499,GO:2000542,0.0468757262929347,0.999050606482527,1,7,negative regulation of gastrulation,BP,SFRP2
19096,GO:1901897,0.0470979790881681,0.999041497644447,1,7,regulation of relaxation of cardiac muscle,BP,CHGA
7504,GO:0030802,0.0471739158565044,0.994945876979573,2,59,regulation of cyclic nucleotide biosynthetic process,BP,HPCA;MRAP2
434,GO:0001135,0.047260514745128,0.999034808211497,1,7,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,MYBL2
2284,GO:0004865,0.0473965486469192,0.998981362531125,1,10,protein serine/threonine phosphatase inhibitor activity,MF,PPP1R14C
7512,GO:0030810,0.0474512559389945,0.994906452941169,2,56,positive regulation of nucleotide biosynthetic process,BP,HPCA;MRAP2
18731,GO:1900373,0.0474512559389945,0.994906452941169,2,56,positive regulation of purine nucleotide biosynthetic process,BP,HPCA;MRAP2
10433,GO:0038171,0.0476095054529218,0.999020364813047,1,7,cannabinoid signaling pathway,BP,CNR1
21184,GO:2000035,0.0477029151015234,0.998996284497687,1,8,regulation of stem cell division,BP,SFRP2
4903,GO:0010721,0.04778797430363,0.985804773460298,5,277,negative regulation of cell development,BP,ASPM;STMN2;TJP2;SYT4;DAAM2
7073,GO:0022849,0.0479725504755376,0.999070666048298,1,5,glutamate-gated calcium ion channel activity,MF,GRIN2B
6291,GO:0018107,0.0480781623655522,0.991042077596566,3,113,peptidyl-threonine phosphorylation,BP,CAMK1G;CAMK2A;CHI3L1
13801,GO:0051256,0.0480838923041018,0.99898003598922,1,8,mitotic spindle midzone assembly,BP,KIF4A
6624,GO:0019755,0.0481501354687128,0.998961201176773,1,9,one-carbon compound transport,BP,SLC14A1
2362,GO:0004983,0.0481974088527937,0.998959141366806,1,9,neuropeptide Y receptor activity,MF,PRLHR
9967,GO:0035773,0.0483110110059989,0.994765348268274,2,55,insulin secretion involved in cellular response to glucose stimulus,BP,PTPRN;VSNL1
5408,GO:0015293,0.0483488400905957,0.990964603922272,3,119,symporter activity,MF,SLC17A7;SLC4A10;SLC6A17
14019,GO:0051661,0.0488920021795678,0.999034329706258,1,5,maintenance of centrosome location,BP,ASPM
5818,GO:0016323,0.0492845460018497,0.987661795649434,4,194,basolateral plasma membrane,CC,CHRM3;SLC14A1;SLC4A10;KCNC2
11050,GO:0043084,0.0493718937063541,0.998945755336194,1,7,penile erection,BP,CNR1
18786,GO:1901016,0.0494548163370169,0.994589537219163,2,49,regulation of potassium ion transmembrane transporter activity,BP,KCNS1;KCNC2
21195,GO:2000051,0.0496110745610681,0.998964565433253,1,6,negative regulation of non-canonical Wnt signaling pathway,BP,SFRP2
3246,GO:0006551,0.0496287456790818,0.998912785455072,1,8,leucine metabolic process,BP,BCAT1
1389,GO:0003056,0.0498796874713572,0.998923740040787,1,7,regulation of vascular smooth muscle contraction,BP,CHRM3
176,GO:0000380,0.0499472339113604,0.994490944490793,2,54,alternative mRNA splicing, via spliceosome,BP,RBFOX1;CELF4
18114,GO:0098900,0.0500887723177217,0.994500161215176,2,44,regulation of action potential,BP,PTPN3;CNR1
21234,GO:2000116,0.050220769376568,0.987332611846616,4,227,regulation of cysteine-type endopeptidase activity,BP,BIRC5;CRYAB;SFRP2;GRIN2B
7779,GO:0031282,0.0502304754064204,0.998868587723447,1,9,regulation of guanylate cyclase activity,BP,HPCA
5511,GO:0015711,0.0502453213341453,0.982853464566678,6,403,organic anion transport,BP,SYT1;SLC17A7;SNAP25;SYT4;SLC4A10;SLC6A17
4869,GO:0010657,0.0502558962979452,0.994435438690614,2,55,muscle cell apoptotic process,BP,CAMK2A;SFRP2
18129,GO:0098917,0.0503048481802359,0.998905128785105,1,7,retrograde trans-synaptic signaling,BP,SYT4
12692,GO:0046888,0.0503138841945827,0.994420405193234,2,57,negative regulation of hormone secretion,BP,SYTL4;VSNL1
6713,GO:0019933,0.0504304960387576,0.990409091585544,3,126,cAMP-mediated signaling,BP,CHGA;MRAP2;ADCY1
4753,GO:0010454,0.0504762166447655,0.998843322080127,1,10,negative regulation of cell fate commitment,BP,SFRP2
1641,GO:0003828,0.0506946424442476,0.998918364094117,1,6,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,ST8SIA5
15325,GO:0061469,0.0509139251127573,0.998855170364993,1,8,regulation of type B pancreatic cell proliferation,BP,PTPRN
3766,GO:0007423,0.0514179684494183,0.980662173073457,7,480,sensory organ development,BP,CELF4;SLC17A7;CRYAB;HPCA;CXCL14;GABRB2;FREM2
7995,GO:0031667,0.0514540118531429,0.982334948932221,6,422,response to nutrient levels,BP,IGFBP2;CNR1;HPCA;VGF;SFRP2;SELL
13714,GO:0051129,0.0514805278108822,0.979196012749073,8,600,negative regulation of cellular component organization,BP,STMN2;CRYAB;CENPF;PACSIN1;TOP2A;SYT4;NEUROD2;GRIN2B
19531,GO:1903011,0.0516155893283237,0.998846726716483,1,7,negative regulation of bone development,BP,TJP2
5155,GO:0014049,0.051865652719661,0.998811525837322,1,8,positive regulation of glutamate secretion,BP,SYT4
2488,GO:0005212,0.0521303168741511,0.998734358206273,1,13,structural constituent of eye lens,MF,CRYAB
12422,GO:0046322,0.0521338690494642,0.998799075417382,1,8,negative regulation of fatty acid oxidation,BP,CNR1
12608,GO:0046683,0.0521383433658987,0.989953314571264,3,125,response to organophosphorus,BP,PTPRN;VGF;SELL
15836,GO:0070492,0.0521833491740944,0.998762949555957,1,10,oligosaccharide binding,MF,SELL
12535,GO:0046541,0.052494359718056,0.998748010477226,1,10,saliva secretion,BP,CHRM3
1568,GO:0003373,0.0526602372674916,0.99879907130166,1,7,dynamin family protein polymerization involved in membrane fission,BP,DNM1
1569,GO:0003374,0.0526602372674916,0.99879907130166,1,7,dynamin family protein polymerization involved in mitochondrial fission,BP,DNM1
10428,GO:0038166,0.0526712258445749,0.998754785031742,1,9,angiotensin-activated signaling pathway,BP,CAMK2A
5567,GO:0015824,0.0533480881050512,0.998767154447578,1,7,proline transport,BP,SLC6A17
13660,GO:0051045,0.0534703224896657,0.998736050763946,1,8,negative regulation of membrane protein ectodomain proteolysis,BP,PTPN3
1313,GO:0002863,0.053914954480012,0.998678609769437,1,10,positive regulation of inflammatory response to antigenic stimulus,BP,CNR1
5561,GO:0015816,0.0540997972059266,0.998705795634855,1,8,glycine transport,BP,SLC6A17
6944,GO:0021873,0.054192431499674,0.9987273915092,1,7,forebrain neuroblast division,BP,ASPM
18155,GO:0098969,0.0544351573209695,0.998669073573694,1,9,neurotransmitter receptor transport to postsynaptic membrane,BP,SNAP25
19784,GO:1903540,0.0544351573209695,0.998669073573694,1,9,establishment of protein localization to postsynaptic membrane,BP,SNAP25
8324,GO:0032328,0.0547650864443705,0.99867342174196,1,8,alanine transport,BP,SLC6A17
18273,GO:0099550,0.054892779306004,0.998693920418847,1,7,trans-synaptic signaling, modulating synaptic transmission,BP,CNR1
20903,GO:1990089,0.0549065895072425,0.993626530169002,2,52,response to nerve growth factor,BP,STMN2;KCNC2
6938,GO:0021860,0.0549744064465272,0.998689990392581,1,7,pyramidal neuron development,BP,SLC4A10
19493,GO:1902950,0.0552412838037265,0.998628932798803,1,9,regulation of dendritic spine maintenance,BP,GRIN2B
17942,GO:0098552,0.0552996114625498,0.980678054348791,6,426,side of membrane,CC,PTPN3;EEF1A2;NPTX2;SNAP25;GNG3;SELL
2824,GO:0005883,0.0554268542011254,0.998668097371544,1,7,neurofilament,CC,NEFM
20168,GO:1904338,0.0556948546350261,0.998606079531116,1,9,regulation of dopaminergic neuron differentiation,BP,SFRP2
8289,GO:0032269,0.0557270095400378,0.97363417511609,11,978,negative regulation of cellular protein metabolic process,BP,PTPN3;BIRC5;CELF4;CRYAB;FOXM1;RGS4;SFRP2;PI16;ENC1;SPRY4;PPP1R14C
8141,GO:0031995,0.055815896129106,0.998621455227596,1,8,insulin-like growth factor II binding,MF,IGFBP2
8435,GO:0032463,0.0558580179833506,0.998580587991129,1,10,negative regulation of protein homooligomerization,BP,CRYAB
17994,GO:0098655,0.0564670927699019,0.975406921689639,9,727,cation transmembrane transport,BP,PTPN3;SLC17A7;SLC30A3;HPCA;KCNS1;SLC4A10;KCNC2;KCNK9;GRIN2B
12072,GO:0045597,0.05664911458847,0.974147976808574,10,834,positive regulation of cell differentiation,BP,ASPM;SYT1;STMN2;NEURL1;CNR1;PACSIN1;SYT4;SFRP2;NEUROD2;ENC1
135,GO:0000278,0.0569389523759328,0.972963777240865,11,974,mitotic cell cycle,BP,BCAT1;LZTS1;PTPN3;CAMK2A;BIRC5;KIF4A;MYBL2;FOXM1;CENPF;TOP2A;MKI67
2635,GO:0005575,0.0569523210662082,1,99,15065,cellular_component,CC,CAMK1G;SYT13;GABRA1;PTPRN;BCAT1;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;LNX1;RBFOX1;RPH3A;BIRC5;KIF4A;CHGA;MYBL2;RIMS4;EEF1A2;CELF4;ST8SIA5;SYTL4;STMN2;NEFM;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;IGFBP2;RGS4;CENPF;CNR1;TJP2;PRLHR;IQSEC3;HPCA;KCNS1;PACSIN1;VGF;PRRG3;SULT4A1;CALY;TOP2A;SNAP25;SYT4;CHRM3;CHI3L1;FAM189A2;MRAP2;SLC14A1;STAC2;SLC4A10;SFRP2;LIX1;CXCL14;GABRB2;TENM2;DAAM2;MKI67;FREM2;ZNF385D;CHST9;NRGN;ABI3BP;GNG3;VSNL1;IGFN1;FABP7;PI16;ADCY1;KCNC2;TMEM130;KCNK9;NPTX1;NEUROD2;ENC1;ZCCHC12;PCSK1;CREG2;DDN;ZDHHC23;MAP7D2;NELL2;SV2B;C11ORF87;MYT1L;SPRY4;SELL;CPNE4;SLC6A17;NMB;PPP1R14C;GRIN2B
19727,GO:1903423,0.0571164478036342,0.998584700794156,1,7,positive regulation of synaptic vesicle recycling,BP,DNM1
17135,GO:0086023,0.0573785975530794,0.998610553258313,1,6,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,CHGA
15181,GO:0061088,0.0575159152120634,0.998512380596919,1,9,regulation of sequestering of zinc ion,BP,SLC30A3
3267,GO:0006573,0.0580147037319022,0.998486172704274,1,9,valine metabolic process,BP,BCAT1
3044,GO:0006265,0.0580912425621188,0.998482130404576,1,9,DNA topological change,BP,TOP2A
13665,GO:0051050,0.0582385607498953,0.973288372059643,10,862,positive regulation of transport,BP,SYT1;CAMK2A;SYTL4;DNM1;SLC30A3;HPCA;CALY;SYT4;VSNL1;KCNC2
1314,GO:0002864,0.0585331169149184,0.99842429959159,1,11,regulation of acute inflammatory response to antigenic stimulus,BP,CNR1
1130,GO:0002551,0.0586110344355082,0.99843556612358,1,10,mast cell chemotaxis,BP,CHGA
6048,GO:0016782,0.0587273699439501,0.992883740789637,2,66,transferase activity, transferring sulfur-containing groups,MF,SULT4A1;CHST9
4377,GO:0009150,0.0588119135862186,0.97913147979531,6,454,purine ribonucleotide metabolic process,BP,CHGA;TJP2;HPCA;SULT4A1;MRAP2;ADCY1
2631,GO:0005546,0.0588737420536238,0.992871404166594,2,60,phosphatidylinositol-4,5-bisphosphate binding,MF,SYT1;RPH3A
7820,GO:0031338,0.0590808995782574,0.992841270045049,2,57,regulation of vesicle fusion,BP,SYT1;SYT4
19445,GO:1902850,0.05909589109989,0.988027954792101,3,125,microtubule cytoskeleton organization involved in mitosis,BP,BIRC5;KIF4A;MYBL2
8794,GO:0033004,0.0591086462710399,0.998392806929447,1,11,negative regulation of mast cell activation,BP,CNR1
2570,GO:0005372,0.059536772027247,0.998369173372389,1,11,water transmembrane transporter activity,MF,SLC14A1
13800,GO:0051255,0.0596599733164282,0.99837841230717,1,10,spindle midzone assembly,BP,KIF4A
17786,GO:0097449,0.0597147310441502,0.998375399895362,1,10,astrocyte projection,CC,SYT4
13777,GO:0051224,0.0598787829743164,0.987783083452751,3,144,negative regulation of protein transport,BP,SYTL4;SYT4;VSNL1
7987,GO:0031652,0.0600404680082334,0.998357420857473,1,10,positive regulation of heat generation,BP,CNR1
14803,GO:0060452,0.0601536375559338,0.998334810582859,1,11,positive regulation of cardiac muscle contraction,BP,CHGA
12665,GO:0046847,0.0605419591796236,0.992574443029496,2,54,filopodium assembly,BP,NEURL1;TENM2
18102,GO:0098877,0.0605846622647686,0.998327158171257,1,10,neurotransmitter receptor transport to plasma membrane,BP,SNAP25
4875,GO:0010663,0.0607074254818639,0.998340642284449,1,9,positive regulation of striated muscle cell apoptotic process,BP,CAMK2A
4878,GO:0010666,0.0607074254818639,0.998340642284449,1,9,positive regulation of cardiac muscle cell apoptotic process,BP,CAMK2A
562,GO:0001660,0.0608313798767419,0.998313345029101,1,10,fever generation,BP,CNR1
16321,GO:0071417,0.0608489838023472,0.976242422051452,7,499,cellular response to organonitrogen compound,BP,GABRA1;CAMK2A;NEURL1;GABRG2;GABRB2;GNG3;ADCY1
11865,GO:0045091,0.0616135227760025,0.998252025891303,1,11,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,TOP2A
9353,GO:0034399,0.0617153034883731,0.987273115131476,3,128,nuclear periphery,CC,KIF4A;CENPF;ENC1
5554,GO:0015807,0.0617958696132747,0.992313813196456,2,60,L-amino acid transport,BP,SLC17A7;SLC6A17
8390,GO:0032412,0.0620613883716689,0.983247150748791,4,213,regulation of ion transmembrane transporter activity,BP,PTPN3;HPCA;KCNS1;KCNC2
13088,GO:0048518,0.0624341141320319,0.959213373096994,41,5067,positive regulation of biological process,BP,PTPRN;ASPM;SYT1;CAMK2A;BIRC5;CHGA;MYBL2;RIMS4;EEF1A2;CELF4;SYTL4;STMN2;DNM1;NEURL1;FOXM1;SLC30A3;IGFBP2;CNR1;HPCA;PACSIN1;CALY;TOP2A;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;SFRP2;CXCL14;TENM2;DAAM2;NRGN;ABI3BP;GNG3;VSNL1;ADCY1;KCNC2;NEUROD2;ENC1;DDN;GRIN2B
506,GO:0001553,0.0627841628087929,0.998223729665075,1,9,luteinization,BP,PTPRN
8634,GO:0032769,0.0628262896825828,0.998199517487212,1,10,negative regulation of monooxygenase activity,BP,CNR1
15534,GO:0062013,0.0633012107523805,0.986793415407839,3,143,positive regulation of small molecule metabolic process,BP,CHGA;HPCA;MRAP2
12164,GO:0045741,0.0633479002687306,0.998169126883027,1,10,positive regulation of epidermal growth factor-activated receptor activity,BP,NEURL1
8217,GO:0032119,0.0633790027954815,0.99814916372764,1,11,sequestering of zinc ion,BP,SLC30A3
16515,GO:0071705,0.0634198045256881,0.963624609057184,19,2063,nitrogen compound transport,BP,PTPRN;SYT1;RBFOX1;RPH3A;CHGA;SYTL4;SLC17A7;CENPF;CNR1;HPCA;VGF;SNAP25;SYT4;CHI3L1;SLC14A1;VSNL1;KCNC2;ZDHHC23;SLC6A17
12284,GO:0045955,0.0636164951728985,0.998175727395394,1,9,negative regulation of calcium ion-dependent exocytosis,BP,SYT4
4864,GO:0010648,0.0636211246666167,0.967319182694609,13,1238,negative regulation of cell communication,BP,PTPN3;CELF4;SYTL4;DNM1;NEURL1;FOXM1;IGFBP2;RGS4;SYT4;MRAP2;SFRP2;VSNL1;SPRY4
11,GO:0000022,0.063838349963931,0.998140314039867,1,10,mitotic spindle elongation,BP,KIF4A
310,GO:0000819,0.0639871402895708,0.982546790994997,4,223,sister chromatid segregation,BP,BIRC5;KIF4A;CENPF;TOP2A
17483,GO:0090557,0.0640055526765519,0.998181363052482,1,8,establishment of endothelial intestinal barrier,BP,TJP2
10664,GO:0042301,0.064049178688195,0.998109328239785,1,11,phosphate ion binding,MF,RPH3A
6714,GO:0019934,0.0641375893661908,0.998122621128724,1,10,cGMP-mediated signaling,BP,KCNC2
20482,GO:1904950,0.0641993611061664,0.986524194035352,3,148,negative regulation of establishment of protein localization,BP,SYTL4;SYT4;VSNL1
7706,GO:0031115,0.0642112135530633,0.998099631582344,1,11,negative regulation of microtubule polymerization,BP,STMN2
16874,GO:0072347,0.0642479950209706,0.991822045414849,2,64,response to anesthetic,BP,CNR1;HPCA
18540,GO:0140131,0.0647269637233909,0.998052834062423,1,12,positive regulation of lymphocyte chemotaxis,BP,CXCL14
7102,GO:0023057,0.0647861592442704,0.96662663624771,13,1242,negative regulation of signaling,BP,PTPN3;CELF4;SYTL4;DNM1;NEURL1;FOXM1;IGFBP2;RGS4;SYT4;MRAP2;SFRP2;VSNL1;SPRY4
6937,GO:0021859,0.0648332884873331,0.998133408247476,1,8,pyramidal neuron differentiation,BP,SLC4A10
12439,GO:0046348,0.0651426912561954,0.998013921349456,1,13,amino sugar catabolic process,BP,CHI3L1
5085,GO:0010959,0.0652791240664166,0.978838724651313,5,325,regulation of metal ion transport,BP,PTPN3;CAMK2A;HPCA;KCNS1;KCNC2
10281,GO:0036449,0.0652872914973042,0.998144720049306,1,7,microtubule minus-end,CC,ASPM
7084,GO:0022898,0.0653930549295103,0.982039416208592,4,218,regulation of transmembrane transporter activity,BP,PTPN3;HPCA;KCNS1;KCNC2
2356,GO:0004972,0.0654197397742643,0.998137085332981,1,7,NMDA glutamate receptor activity,MF,GRIN2B
4659,GO:0009991,0.0655461511989767,0.976111508770147,6,450,response to extracellular stimulus,BP,IGFBP2;CNR1;HPCA;VGF;SFRP2;SELL
3717,GO:0007288,0.0655615320286069,0.998037251696828,1,10,sperm axoneme assembly,BP,NEURL1
16870,GO:0072341,0.065612654865676,0.991539115696512,2,68,modified amino acid binding,MF,SYT1;SYT4
10492,GO:0039692,0.0659421233107872,0.997978098985146,1,12,single stranded viral RNA replication via double stranded DNA intermediate,BP,TOP2A
4463,GO:0009259,0.0662358878970548,0.975792074998403,6,469,ribonucleotide metabolic process,BP,CHGA;TJP2;HPCA;SULT4A1;MRAP2;ADCY1
17834,GO:0097531,0.0664046621775507,0.997965866006408,1,11,mast cell migration,BP,CHGA
2990,GO:0006163,0.0665702390812847,0.975638836314289,6,471,purine nucleotide metabolic process,BP,CHGA;TJP2;HPCA;SULT4A1;MRAP2;ADCY1
18809,GO:1901077,0.0666463191790162,0.997950843393019,1,11,regulation of relaxation of muscle,BP,CHGA
10886,GO:0042733,0.0668065230787371,0.99132190836362,2,60,embryonic digit morphogenesis,BP,SFRP2;FREM2
8019,GO:0031702,0.0668418035596619,0.997958833054787,1,10,type 1 angiotensin receptor binding,MF,GNG3
4639,GO:0009931,0.0668519646430834,0.997958204368492,1,10,calcium-dependent protein serine/threonine kinase activity,MF,CAMK2A
13493,GO:0050789,0.0670048346718253,0.956996684366763,71,9735,regulation of biological process,BP,CAMK1G;SYT13;GABRA1;PTPRN;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;RBFOX1;RPH3A;BIRC5;CHGA;MYBL2;RIMS4;EEF1A2;CELF4;SYTL4;STMN2;SLC17A7;DNM1;NEURL1;GABRA4;CRYAB;FOXM1;GABRG2;SLC30A3;IGFBP2;RGS4;CENPF;CNR1;TJP2;PRLHR;IQSEC3;HPCA;KCNS1;PACSIN1;VGF;CALY;TOP2A;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;STAC2;SFRP2;CXCL14;GABRB2;TENM2;DAAM2;MKI67;ZNF385D;NRGN;ABI3BP;GNG3;VSNL1;FABP7;PI16;ADCY1;KCNC2;NEUROD2;ENC1;ZCCHC12;DDN;MYT1L;SPRY4;SELL;NMB;PPP1R14C;GRIN2B
11384,GO:0043627,0.0675839235770279,0.991137161959931,2,69,response to estrogen,BP,PTPRN;IGFBP2
6322,GO:0018210,0.0678301873777055,0.98546113757763,3,132,peptidyl-threonine modification,BP,CAMK1G;CAMK2A;CHI3L1
9502,GO:0034703,0.0678736416093015,0.981138344428383,4,206,cation channel complex,CC,KCNS1;SNAP25;KCNC2;GRIN2B
18161,GO:0098976,0.0681566207861056,0.997934417785351,1,8,excitatory chemical synaptic transmission,BP,GRIN2B
14506,GO:0060041,0.0683043825580551,0.985323839172466,3,128,retina development in camera-type eye,BP,CELF4;SLC17A7;HPCA
825,GO:0002031,0.0683429154991782,0.9978113304675,1,13,G-protein coupled receptor internalization,BP,DNM1
19155,GO:1902074,0.068359219447429,0.997810272498733,1,13,response to salt,BP,HPCA
14280,GO:0052547,0.0684449811637748,0.977500299457425,5,360,regulation of peptidase activity,BP,BIRC5;CRYAB;SFRP2;PI16;GRIN2B
5952,GO:0016595,0.0687227312546679,0.997840762489844,1,10,glutamate binding,MF,GRIN2B
3589,GO:0007059,0.0689289969643401,0.977309219697646,5,328,chromosome segregation,BP,BIRC5;KIF4A;CENPF;TOP2A;MKI67
13781,GO:0051231,0.0689622921673448,0.997803992993276,1,11,spindle elongation,BP,KIF4A
15421,GO:0061684,0.0692100646066998,0.997769945707259,1,12,chaperone-mediated autophagy,BP,EEF1A2
5699,GO:0016081,0.0695627710116087,0.997813664740899,1,9,synaptic vesicle docking,BP,SNAP25
4560,GO:0009642,0.0695964346402811,0.997762873442462,1,11,response to light intensity,BP,KCNC2
18429,GO:0106070,0.0696750494371033,0.997779682797794,1,10,regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,MRAP2
3821,GO:0007605,0.0699151821484286,0.98482706159535,3,133,sensory perception of sound,BP,BIRC5;DNM1;GABRB2
10854,GO:0042659,0.0699526319738841,0.997739604796654,1,11,regulation of cell fate specification,BP,SFRP2
4765,GO:0010469,0.0704944965674653,0.976619658243311,5,397,regulation of signaling receptor activity,BP,NEURL1;VGF;SFRP2;CXCL14;NMB
16367,GO:0071479,0.0705519794663883,0.990531549549112,2,66,cellular response to ionizing radiation,BP,CRYAB;SFRP2
19117,GO:1901981,0.0709685147766691,0.98449722312246,3,138,phosphatidylinositol phosphate binding,MF,SYT1;RPH3A;NRGN
16378,GO:0071495,0.0709823676298134,0.962911007684547,13,1217,cellular response to endogenous stimulus,BP,GABRA1;CAMK2A;STMN2;NEURL1;GABRG2;IGFBP2;CHRM3;SFRP2;GABRB2;GNG3;ADCY1;ZCCHC12;SPRY4
13236,GO:0048788,0.0710340089696769,0.997858520208156,1,6,cytoskeleton of presynaptic active zone,CC,RIMS4
7679,GO:0031083,0.0715646147581536,0.997583199078864,1,14,BLOC-1 complex,CC,SNAP25
19152,GO:1902065,0.0716128681842343,0.997629517224146,1,11,response to L-glutamate,BP,HPCA
6943,GO:0021872,0.0716544694636945,0.990309401772271,2,63,forebrain generation of neurons,BP,ASPM;SLC4A10
8018,GO:0031701,0.0717492868784805,0.997620351908974,1,11,angiotensin receptor binding,MF,GNG3
11043,GO:0043065,0.0720854291528855,0.970742571853792,7,563,positive regulation of apoptotic process,BP,CAMK2A;MYBL2;EEF1A2;NEURL1;CNR1;TOP2A;SFRP2
14003,GO:0051641,0.0722714856320368,0.956020468532885,23,2548,cellular localization,BP,SYT13;PTPRN;ASPM;SYT1;CAMK2A;RPH3A;KIF4A;CHGA;RIMS4;SYTL4;SLC17A7;DNM1;CRYAB;CENPF;HPCA;PACSIN1;CALY;SNAP25;SYT4;MRAP2;VSNL1;ZDHHC23;GRIN2B
5002,GO:0010857,0.0722818209221119,0.997584399497969,1,11,calcium-dependent protein kinase activity,MF,CAMK2A
5489,GO:0015672,0.0722915741544971,0.973001917300587,6,443,monovalent inorganic cation transport,BP,PTPN3;SLC17A7;KCNS1;SLC4A10;KCNC2;KCNK9
1595,GO:0003674,0.0723342720577926,0.975132836414329,96,14390,molecular_function,MF,CAMK1G;SYT13;GABRA1;PTPRN;BCAT1;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;LNX1;RBFOX1;RPH3A;BIRC5;KIF4A;MYBL2;RIMS4;EEF1A2;CELF4;ST8SIA5;SYTL4;STMN2;NEFM;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;IGFBP2;RGS4;CENPF;CNR1;TJP2;PRLHR;IQSEC3;HPCA;KCNS1;PACSIN1;VGF;PRRG3;SULT4A1;CALY;TOP2A;SNAP25;SYT4;CHRM3;CHI3L1;FAM189A2;MRAP2;SLC14A1;STAC2;SLC4A10;SFRP2;CXCL14;GABRB2;TENM2;DAAM2;MKI67;FREM2;ZNF385D;CHST9;NRGN;ABI3BP;GNG3;VSNL1;IGFN1;FABP7;PI16;ADCY1;KCNC2;KCNK9;NPTX1;NEUROD2;ENC1;ZCCHC12;PCSK1;CREG2;DDN;ZDHHC23;MAP7D2;NELL2;SV2B;C11ORF87;MYT1L;SPRY4;SELL;CPNE4;SLC6A17;NMB;PPP1R14C;GRIN2B
13003,GO:0048278,0.0723407917936609,0.990145263810601,2,69,vesicle docking,BP,SYT1;SNAP25
3781,GO:0007501,0.0727990901061221,0.997512388563634,1,13,mesodermal cell fate specification,BP,SFRP2
17441,GO:0090394,0.0729048974506181,0.997566001776527,1,10,negative regulation of excitatory postsynaptic potential,BP,CELF4
4152,GO:0008510,0.0732122217345975,0.997574764425216,1,9,sodium:bicarbonate symporter activity,MF,SLC4A10
6606,GO:0019693,0.0734546333682695,0.972445193858339,6,483,ribose phosphate metabolic process,BP,CHGA;TJP2;HPCA;SULT4A1;MRAP2;ADCY1
18054,GO:0098796,0.0734807595735587,0.96354746650763,11,1052,membrane protein complex,CC,GABRA1;SYT1;DNM1;GABRA4;GABRG2;KCNS1;SNAP25;GABRB2;GNG3;KCNC2;GRIN2B
21859,GO:2001257,0.0737086937338045,0.983643280658831,3,141,regulation of cation channel activity,BP,HPCA;KCNS1;KCNC2
7985,GO:0031650,0.0739122980701956,0.997452033186125,1,12,regulation of heat generation,BP,CNR1
13092,GO:0048522,0.0741253467569205,0.951266330640056,37,4532,positive regulation of cellular process,BP,PTPRN;ASPM;SYT1;CAMK2A;BIRC5;CHGA;MYBL2;RIMS4;EEF1A2;CELF4;SYTL4;STMN2;NEURL1;FOXM1;IGFBP2;CNR1;HPCA;PACSIN1;CALY;TOP2A;SNAP25;SYT4;CHI3L1;MRAP2;SFRP2;CXCL14;TENM2;DAAM2;NRGN;GNG3;VSNL1;ADCY1;KCNC2;NEUROD2;ENC1;DDN;GRIN2B
3798,GO:0007548,0.0741964383266759,0.978742639616778,4,232,sex differentiation,BP,PTPRN;ASPM;VGF;SFRP2
17485,GO:0090559,0.0745804723601085,0.98964564864409,2,76,regulation of membrane permeability,BP,CAMK2A;TJP2
13206,GO:0048715,0.0747948328678212,0.997410997941511,1,11,negative regulation of oligodendrocyte differentiation,BP,DAAM2
7304,GO:0030307,0.0748435507639201,0.983285807248468,3,142,positive regulation of cell growth,BP,SYT1;SYT4;SFRP2
15203,GO:0061134,0.0750250423182461,0.983205452153354,3,161,peptidase regulator activity,MF,BIRC5;SFRP2;PI16
13793,GO:0051248,0.0750340739504524,0.962643351021819,11,1031,negative regulation of protein metabolic process,BP,PTPN3;BIRC5;CELF4;CRYAB;FOXM1;RGS4;SFRP2;PI16;ENC1;SPRY4;PPP1R14C
13787,GO:0051238,0.075149732892656,0.997331356775696,1,14,sequestering of metal ion,BP,SLC30A3
20876,GO:1990001,0.0754410664214277,0.9973911299919,1,10,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,BIRC5
9821,GO:0035567,0.075709407987942,0.983001906650109,3,150,non-canonical Wnt signaling pathway,BP,CAMK2A;SFRP2;DAAM2
11046,GO:0043068,0.0758637561133639,0.968846080521128,7,569,positive regulation of programmed cell death,BP,CAMK2A;MYBL2;EEF1A2;NEURL1;CNR1;TOP2A;SFRP2
7069,GO:0022841,0.0759399247707518,0.997274121320575,1,14,potassium ion leak channel activity,MF,KCNK9
8387,GO:0032409,0.0761237456387614,0.978004389075101,4,231,regulation of transporter activity,BP,PTPN3;HPCA;KCNS1;KCNC2
12299,GO:0045989,0.0762041575877845,0.997254842878121,1,14,positive regulation of striated muscle contraction,BP,CHGA
11305,GO:0043508,0.076288805224552,0.997264533168582,1,13,negative regulation of JUN kinase activity,BP,SFRP2
5177,GO:0014074,0.0764840964114301,0.982768269720363,3,141,response to purine-containing compound,BP,PTPRN;VGF;SELL
7316,GO:0030322,0.0764873889057308,0.997234100660597,1,14,stabilization of membrane potential,BP,KCNK9
6167,GO:0017016,0.0765949079880974,0.968499607443703,7,487,Ras GTPase binding,MF,CAMK2A;RPH3A;BIRC5;RIMS4;SYTL4;DAAM2;GRIN2B
21823,GO:2001204,0.0766176640159062,0.997281346911024,1,11,regulation of osteoclast development,BP,TJP2
12713,GO:0046929,0.0766199695368892,0.997307715927955,1,10,negative regulation of neurotransmitter secretion,BP,SYT4
15034,GO:0060828,0.0769719621621091,0.97766722496334,4,244,regulation of canonical Wnt signaling pathway,BP,ASPM;IGFBP2;SFRP2;DAAM2
18284,GO:0099569,0.0773254348153385,0.997384746028539,1,7,presynaptic cytoskeleton,CC,RIMS4
7792,GO:0031301,0.0773677391888608,0.982454664441759,3,167,integral component of organelle membrane,CC,SYT1;SLC17A7;SYT4
17840,GO:0097539,0.0774057961471768,0.997251362969818,1,10,ciliary transition fiber,CC,CENPF
17187,GO:0086103,0.0774162776420016,0.997250607259431,1,10,G-protein coupled receptor signaling pathway involved in heart process,BP,CHGA
5322,GO:0015114,0.0776144946215717,0.997209065884343,1,11,phosphate ion transmembrane transporter activity,MF,SLC17A7
11117,GO:0043195,0.0783051024642553,0.988853332961711,2,67,terminal bouton,CC,SYT1;KCNC2
102,GO:0000212,0.0783962471559751,0.997179478949711,1,10,meiotic spindle organization,BP,ASPM
18500,GO:0120111,0.0785885153120025,0.988790165786755,2,67,neuron projection cytoplasm,CC,KIF4A;HPCA
556,GO:0001654,0.078603766911692,0.973143827315923,5,319,eye development,BP,CELF4;SLC17A7;CRYAB;HPCA;FREM2
7038,GO:0022600,0.0789270519565018,0.98868977756453,2,75,digestive system process,BP,TJP2;CHRM3
5305,GO:0015079,0.0799098553778651,0.981652059842477,3,153,potassium ion transmembrane transporter activity,MF,KCNS1;KCNC2;KCNK9
2610,GO:0005515,0.080055505146005,0.948216495055777,73,10245,protein binding,MF,CAMK1G;SYT13;PTPRN;BCAT1;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;LNX1;RBFOX1;RPH3A;BIRC5;KIF4A;MYBL2;RIMS4;EEF1A2;ST8SIA5;SYTL4;STMN2;NEFM;DNM1;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;IGFBP2;RGS4;CENPF;CNR1;TJP2;PRLHR;IQSEC3;HPCA;KCNS1;PACSIN1;VGF;SULT4A1;CALY;TOP2A;SNAP25;SYT4;CHRM3;MRAP2;STAC2;SFRP2;CXCL14;GABRB2;TENM2;DAAM2;MKI67;ZNF385D;NRGN;GNG3;VSNL1;IGFN1;ADCY1;KCNC2;KCNK9;NEUROD2;ENC1;ZCCHC12;PCSK1;DDN;NELL2;SV2B;C11ORF87;SPRY4;SELL;CPNE4;NMB;GRIN2B
3679,GO:0007218,0.0802950309103591,0.988348184330433,2,89,neuropeptide signaling pathway,BP,PRLHR;NMB
2483,GO:0005184,0.0804264677824879,0.996868487255657,1,20,neuropeptide hormone activity,MF,VGF
13833,GO:0051301,0.0806277425868722,0.966424402315438,7,561,cell division,BP,ASPM;BIRC5;KIF4A;CENPF;PACSIN1;TOP2A;SFRP2
5743,GO:0016188,0.0807777128385311,0.996973220781042,1,11,synaptic vesicle maturation,BP,SLC17A7
17920,GO:0097756,0.0808364258458983,0.988267687524375,2,72,negative regulation of blood vessel diameter,BP,CHGA;CHRM3
13505,GO:0050805,0.0810790845131991,0.988232961752486,2,66,negative regulation of synaptic transmission,BP,CELF4;SYT4
5349,GO:0015171,0.0818129428810012,0.98804505548043,2,72,amino acid transmembrane transporter activity,MF,SLC17A7;SLC6A17
13488,GO:0050780,0.0821956516631527,0.996817332756236,1,13,dopamine receptor binding,MF,DNM1
13689,GO:0051093,0.082251504173209,0.961460066906445,9,778,negative regulation of developmental process,BP,ASPM;STMN2;FOXM1;TJP2;SYT4;SFRP2;CXCL14;DAAM2;NEUROD2
14184,GO:0051966,0.0828025140910073,0.987851008610647,2,63,regulation of synaptic transmission, glutamatergic,BP,SYT1;CNR1
16938,GO:0072521,0.0828557766966351,0.967948709378303,6,499,purine-containing compound metabolic process,BP,CHGA;TJP2;HPCA;SULT4A1;MRAP2;ADCY1
21217,GO:2000095,0.0829942595535284,0.996754190819914,1,13,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,SFRP2
21659,GO:2000781,0.0831989064211902,0.996759957270416,1,12,positive regulation of double-strand break repair,BP,FOXM1
14016,GO:0051657,0.0832830059190365,0.996810782834298,1,10,maintenance of organelle location,BP,ASPM
823,GO:0002029,0.0833458472173932,0.99667643198112,1,16,desensitization of G-protein coupled receptor protein signaling pathway,BP,DNM1
7025,GO:0022401,0.0833458472173932,0.99667643198112,1,16,negative adaptation of signaling pathway,BP,DNM1
4863,GO:0010647,0.0833583465006377,0.953372736127369,15,1567,positive regulation of cell communication,BP,ASPM;SYT1;CHGA;RIMS4;NEURL1;SNAP25;CHI3L1;MRAP2;SFRP2;DAAM2;NRGN;GNG3;VSNL1;NEUROD2;GRIN2B
1544,GO:0003333,0.0838206680970007,0.987585694001304,2,71,amino acid transmembrane transport,BP,SLC17A7;SLC6A17
19783,GO:1903539,0.0839548664614019,0.996699845190033,1,12,protein localization to postsynaptic membrane,BP,SNAP25
12908,GO:0048024,0.0841287918747308,0.987501273776163,2,75,regulation of mRNA splicing, via spliceosome,BP,RBFOX1;CELF4
17273,GO:0090148,0.0842169733021962,0.996678869874352,1,12,membrane fission,BP,DNM1
3446,GO:0006833,0.0844750210289033,0.996599065236145,1,15,water transport,BP,SLC14A1
14570,GO:0060134,0.0846627152698632,0.99664304138736,1,12,prepulse inhibition,BP,FABP7
252,GO:0000712,0.0846950992330719,0.996617579085902,1,13,resolution of meiotic recombination intermediates,BP,TOP2A
10352,GO:0038023,0.0848099068347146,0.960009606032155,9,829,signaling receptor activity,MF,GABRA1;GABRA4;GABRG2;CNR1;PRLHR;CHRM3;SFRP2;GABRB2;GRIN2B
14549,GO:0060089,0.0848099068347146,0.960009606032155,9,829,molecular transducer activity,MF,GABRA1;GABRA4;GABRG2;CNR1;PRLHR;CHRM3;SFRP2;GABRB2;GRIN2B
5154,GO:0014048,0.084964693216897,0.996575953038144,1,14,regulation of glutamate secretion,BP,SYT4
18921,GO:1901379,0.0849749059181536,0.987323849307635,2,69,regulation of potassium ion transmembrane transport,BP,KCNS1;KCNC2
2609,GO:0005513,0.0853485425100087,0.996564320900261,1,13,detection of calcium ion,BP,SYT1
11581,GO:0044304,0.085619823779166,0.987201486508651,2,62,main axon,CC,DNM1;KCNC2
7101,GO:0023056,0.0856737181534413,0.951880485258364,15,1574,positive regulation of signaling,BP,ASPM;SYT1;CHGA;RIMS4;NEURL1;SNAP25;CHI3L1;MRAP2;SFRP2;DAAM2;NRGN;GNG3;VSNL1;NEUROD2;GRIN2B
20875,GO:1990000,0.0858204882339269,0.996505483356753,1,14,amyloid fibril formation,BP,CRYAB
5121,GO:0012510,0.0859367123947846,0.996495855785261,1,14,trans-Golgi network transport vesicle membrane,CC,NRGN
14163,GO:0051938,0.0859469795420075,0.996538702162261,1,12,L-glutamate import,BP,SLC17A7
11881,GO:0045120,0.086185583491059,0.99651913513075,1,12,pronucleus,CC,CENPF
2666,GO:0005614,0.0862596743912544,0.99651304760945,1,12,interstitial matrix,CC,ABI3BP
10521,GO:0040037,0.086676508629669,0.996454761528389,1,13,negative regulation of fibroblast growth factor receptor signaling pathway,BP,SPRY4
14175,GO:0051957,0.0868001066937207,0.996423906930527,1,14,positive regulation of amino acid transport,BP,SYT4
13605,GO:0050954,0.086816821700995,0.979379356272262,3,147,sensory perception of mechanical stimulus,BP,BIRC5;DNM1;GABRB2
343,GO:0000940,0.0868838084208318,0.996437498561786,1,13,condensed chromosome outer kinetochore,CC,CENPF
592,GO:0001708,0.086909807265641,0.986844418663445,2,76,cell fate specification,BP,SFRP2;MYT1L
7461,GO:0030662,0.0869563821297244,0.979311097010838,3,162,coated vesicle membrane,CC,SYT1;SLC17A7;NRGN
3800,GO:0007565,0.0877401383282471,0.979049242279039,3,160,female pregnancy,BP,IGFBP2;CNR1;PRLHR
16530,GO:0071732,0.0879426036757161,0.996309245499774,1,15,cellular response to nitric oxide,BP,KCNC2
18996,GO:1901623,0.0882109282846677,0.996256007526131,1,17,regulation of lymphocyte chemotaxis,BP,CXCL14
7212,GO:0030177,0.0884398911156391,0.978812232244975,3,160,positive regulation of Wnt signaling pathway,BP,ASPM;SFRP2;DAAM2
13855,GO:0051346,0.0885562365335802,0.968656831172641,5,367,negative regulation of hydrolase activity,BP,BIRC5;CRYAB;SFRP2;PI16;PPP1R14C
7103,GO:0023058,0.0885766069043371,0.996224377845371,1,17,adaptation of signaling pathway,BP,DNM1
10548,GO:0042058,0.0888394047354213,0.986380170360878,2,77,regulation of epidermal growth factor receptor signaling pathway,BP,PTPN3;NEURL1
12574,GO:0046625,0.0891632527250844,0.996187858354777,1,16,sphingolipid binding,MF,SELL
21397,GO:2000380,0.0892291203241776,0.996198601613734,1,15,regulation of mesoderm development,BP,SFRP2
7970,GO:0031629,0.0894532470491989,0.996162596799886,1,16,synaptic vesicle fusion to presynaptic active zone membrane,BP,SNAP25
18239,GO:0099500,0.0894532470491989,0.996162596799886,1,16,vesicle fusion to plasma membrane,BP,SNAP25
13624,GO:0050998,0.0896408501279713,0.996229382649226,1,12,nitric-oxide synthase binding,MF,DNM1
13121,GO:0048583,0.089747943603771,0.941387434808065,30,3641,regulation of response to stimulus,BP,ASPM;SYT1;PTPN3;CAMK2A;BIRC5;CHGA;CELF4;DNM1;NEURL1;GABRA4;CRYAB;FOXM1;IGFBP2;RGS4;CNR1;IQSEC3;VGF;SYT4;CHI3L1;MRAP2;SFRP2;CXCL14;DAAM2;GNG3;VSNL1;FABP7;NEUROD2;SPRY4;SELL;NMB
20162,GO:1904321,0.0899922967996323,0.996229749784356,1,11,response to forskolin,BP,ADCY1
20163,GO:1904322,0.0899922967996323,0.996229749784356,1,11,cellular response to forskolin,BP,ADCY1
7528,GO:0030826,0.0900375174144419,0.996096641955093,1,17,regulation of cGMP biosynthetic process,BP,HPCA
19089,GO:1901881,0.0900587609588161,0.99612635355742,1,15,positive regulation of protein depolymerization,BP,STMN2
9881,GO:0035641,0.0902366397747532,0.99615226287842,1,13,locomotory exploration behavior,BP,SLC4A10
10743,GO:0042445,0.0902629660828204,0.978166175334158,3,180,hormone metabolic process,BP,PRLHR;CHST9;PCSK1
15134,GO:0061024,0.0906147554201668,0.956705629196163,9,806,membrane organization,BP,SYT13;SYT1;CAMK2A;RPH3A;SYTL4;DNM1;PACSIN1;SNAP25;SYT4
7068,GO:0022840,0.0907156650708266,0.996051621007231,1,16,leak channel activity,MF,KCNK9
7070,GO:0022842,0.0907156650708266,0.996051621007231,1,16,narrow pore channel activity,MF,KCNK9
5306,GO:0015081,0.0911568665539086,0.977910817754244,3,143,sodium ion transmembrane transporter activity,MF,SLC17A7;SLC4A10;SLC6A17
8432,GO:0032460,0.0911611625392908,0.99604892097305,1,14,negative regulation of protein oligomerization,BP,CRYAB
5951,GO:0016594,0.0911902470166687,0.996026684882409,1,15,glycine binding,MF,GRIN2B
12910,GO:0048026,0.0912508647192669,0.996004078819866,1,16,positive regulation of mRNA splicing, via spliceosome,BP,CELF4
325,GO:0000900,0.0913073755086242,0.996058775973628,1,13,translation repressor activity, mRNA regulatory element binding,MF,CELF4
8434,GO:0032462,0.0915515309814707,0.995961942121345,1,17,regulation of protein homooligomerization,BP,CRYAB
10608,GO:0042166,0.0918459290531482,0.995950872981512,1,16,acetylcholine binding,MF,CHRM3
10541,GO:0042043,0.0918736807505265,0.996008861427621,1,13,neurexin family protein binding,MF,SYTL4
13836,GO:0051304,0.0922277154655547,0.985562580482657,2,75,chromosome separation,BP,CENPF;TOP2A
18566,GO:1900006,0.092241080391516,0.985599551331463,2,65,positive regulation of dendrite development,BP,NEURL1;PACSIN1
3674,GO:0007213,0.0924501111847461,0.995896479094229,1,16,G-protein coupled acetylcholine receptor signaling pathway,BP,CHRM3
13858,GO:0051349,0.0925157144135772,0.995908261388555,1,15,positive regulation of lyase activity,BP,HPCA
14113,GO:0051861,0.0926493325686249,0.995862792346742,1,17,glycolipid binding,MF,SELL
594,GO:0001710,0.0926710856029585,0.995860815103407,1,17,mesodermal cell fate commitment,BP,SFRP2
18854,GO:1901216,0.0928332552893715,0.985409907178713,2,76,positive regulation of neuron death,BP,MYBL2;GRIN2B
18754,GO:1900542,0.0928477003668507,0.977294516584859,3,164,regulation of purine nucleotide metabolic process,BP,CHGA;HPCA;MRAP2
9068,GO:0033630,0.093226321551707,0.995826045949459,1,16,positive regulation of cell adhesion mediated by integrin,BP,SFRP2
17729,GO:0097340,0.0932454351380516,0.99588660480443,1,13,inhibition of cysteine-type endopeptidase activity,BP,BIRC5
17730,GO:0097341,0.0932454351380516,0.99588660480443,1,13,zymogen inhibition,BP,BIRC5
12902,GO:0048018,0.0933876351600297,0.971025787875952,4,324,receptor ligand activity,MF,VGF;SFRP2;CXCL14;NMB
13872,GO:0051382,0.0935587158264212,0.995834514950431,1,14,kinetochore assembly,BP,CENPF
7791,GO:0031300,0.0937551780176986,0.976956584527211,3,182,intrinsic component of organelle membrane,CC,SYT1;SLC17A7;SYT4
20480,GO:1904948,0.0939893812801231,0.99577448140538,1,15,midbrain dopaminergic neuron differentiation,BP,SFRP2
4775,GO:0010499,0.0940737975746875,0.995683072949286,1,21,proteasomal ubiquitin-independent protein catabolic process,BP,ENC1
15329,GO:0061478,0.09432568009093,0.995817338245248,1,12,response to platelet aggregation inhibitor,BP,ADCY1
6846,GO:0021675,0.0943564238973595,0.985050728433669,2,71,nerve development,BP,GABRB2;NPTX1
11610,GO:0044342,0.0943850239023221,0.995719749948644,1,16,type B pancreatic cell proliferation,BP,PTPRN
6236,GO:0017146,0.0946653274382126,0.995820372858477,1,11,NMDA selective glutamate receptor complex,CC,GRIN2B
82,GO:0000165,0.0946795368746513,0.954356687098782,9,827,MAPK cascade,BP,CAMK2A;CRYAB;FOXM1;RGS4;CHI3L1;SFRP2;GNG3;SPRY4;GRIN2B
10279,GO:0036445,0.0946855919093063,0.995756193910937,1,13,neuronal stem cell division,BP,ASPM
14425,GO:0055057,0.0946855919093063,0.995756193910937,1,13,neuroblast division,BP,ASPM
17296,GO:0090179,0.0947411824607759,0.995751117701033,1,13,planar cell polarity pathway involved in neural tube closure,BP,SFRP2
1311,GO:0002861,0.0948564777785272,0.995632024456974,1,19,regulation of inflammatory response to antigenic stimulus,BP,CNR1
7778,GO:0031281,0.094906316837023,0.995671476193146,1,16,positive regulation of cyclase activity,BP,HPCA
3658,GO:0007193,0.0949601664575289,0.984877599316081,2,77,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,CHRM3;ADCY1
7179,GO:0030135,0.094988692768342,0.970399194777068,4,260,coated vesicle,CC,SYT1;SLC17A7;PACSIN1;NRGN
3811,GO:0007589,0.0949924771655882,0.984866100796821,2,78,body fluid secretion,BP,NEURL1;CHRM3
3833,GO:0007620,0.095144466754489,0.995649329198171,1,16,copulation,BP,CNR1
6612,GO:0019722,0.095355151312482,0.976433066525032,3,155,calcium-mediated signaling,BP,HPCA;NEUROD2;GRIN2B
8519,GO:0032591,0.0953907035641159,0.995691573954549,1,13,dendritic spine membrane,CC,DDN
14078,GO:0051782,0.095484943984019,0.995658002067651,1,14,negative regulation of cell division,BP,ASPM
19929,GO:1903818,0.0964226596859574,0.995596086925501,1,13,positive regulation of voltage-gated potassium channel activity,BP,KCNC2
19234,GO:1902259,0.0964969334963081,0.995541713976374,1,15,regulation of delayed rectifier potassium channel activity,BP,KCNS1
12071,GO:0045596,0.0966885746469245,0.957983322799572,7,576,negative regulation of cell differentiation,BP,ASPM;STMN2;TJP2;SYT4;SFRP2;CXCL14;DAAM2
1479,GO:0003214,0.0967749459512416,0.995563241142082,1,13,cardiac left ventricle morphogenesis,BP,SFRP2
18580,GO:1900034,0.0967832156230894,0.984425812534214,2,75,regulation of cellular response to heat,BP,CAMK2A;CRYAB
510,GO:0001558,0.0968008998575036,0.964836006133519,5,365,regulation of cell growth,BP,SYT1;CRYAB;IGFBP2;SYT4;SFRP2
1946,GO:0004385,0.0968376800659461,0.995557378774889,1,13,guanylate kinase activity,MF,TJP2
12624,GO:0046710,0.0968376800659461,0.995557378774889,1,13,GDP metabolic process,BP,TJP2
11662,GO:0044444,0.097232521423521,0.93364545862243,62,8623,cytoplasmic part,CC,CAMK1G;SYT13;GABRA1;PTPRN;BCAT1;SYT1;CAMK2A;RBFOX1;RPH3A;BIRC5;KIF4A;CHGA;RIMS4;EEF1A2;ST8SIA5;SYTL4;STMN2;NEFM;SLC17A7;DNM1;NEURL1;CRYAB;PTPN5;GABRG2;SLC30A3;IGFBP2;RGS4;CENPF;CNR1;TJP2;HPCA;KCNS1;PACSIN1;VGF;SULT4A1;CALY;TOP2A;SNAP25;SYT4;CHI3L1;MRAP2;STAC2;CXCL14;GABRB2;TENM2;CHST9;NRGN;VSNL1;IGFN1;FABP7;ADCY1;TMEM130;KCNK9;NPTX1;PCSK1;CREG2;DDN;ZDHHC23;SV2B;SPRY4;SELL;SLC6A17
3803,GO:0007568,0.0973133444669478,0.969417325504229,4,267,aging,BP,CRYAB;FOXM1;IGFBP2;CNR1
13507,GO:0050807,0.0974825023717543,0.975691402408392,3,150,regulation of synapse organization,BP,NEURL1;NEUROD2;GRIN2B
21100,GO:1990778,0.0975156675812047,0.969345399901267,4,251,protein localization to cell periphery,BP,PACSIN1;SNAP25;MRAP2;ZDHHC23
16369,GO:0071481,0.0976011469742371,0.995485712422772,1,13,cellular response to X-ray,BP,SFRP2
1061,GO:0002438,0.0977219188092884,0.995359098627004,1,19,acute inflammatory response to antigenic stimulus,BP,CNR1
8140,GO:0031994,0.097774208214535,0.995469384452973,1,13,insulin-like growth factor I binding,MF,IGFBP2
2538,GO:0005313,0.0978354364427904,0.995437460440995,1,14,L-glutamate transmembrane transporter activity,MF,SLC17A7
5350,GO:0015172,0.0978354364427904,0.995437460440995,1,14,acidic amino acid transmembrane transporter activity,MF,SLC17A7
14495,GO:0060026,0.0981407361214106,0.995385610297827,1,15,convergent extension,BP,SFRP2
1945,GO:0004383,0.0982949524814908,0.995450865696617,1,12,guanylate cyclase activity,MF,ADCY1
3879,GO:0008074,0.0982949524814908,0.995450865696617,1,12,guanylate cyclase complex, soluble,CC,ADCY1
2982,GO:0006140,0.0990375766521028,0.975107088453646,3,170,regulation of nucleotide metabolic process,BP,CHGA;HPCA;MRAP2
14539,GO:0060077,0.0991613064030177,0.995287288291447,1,15,inhibitory synapse,CC,IQSEC3
13476,GO:0050768,0.0996569180532363,0.968443636774876,4,245,negative regulation of neurogenesis,BP,ASPM;STMN2;SYT4;DAAM2
13773,GO:0051219,0.0997375848798257,0.983675022127435,2,74,phosphoprotein binding,MF,PTPN3;PTPN5
17715,GO:0097305,0.101214476566353,0.974324199494405,3,171,response to alcohol,BP,CNR1;KCNC2;GRIN2B
10245,GO:0036342,0.101524287378427,0.995055502854794,1,15,post-anal tail morphogenesis,BP,SFRP2
11442,GO:0043950,0.101744199693739,0.994961489618066,1,19,positive regulation of cAMP-mediated signaling,BP,MRAP2
17295,GO:0090178,0.101791601714872,0.995053435944131,1,14,regulation of establishment of planar polarity involved in neural tube closure,BP,SFRP2
18077,GO:0098831,0.101922223796895,0.995245655361977,1,9,presynaptic active zone cytoplasmic component,CC,RIMS4
18852,GO:1901214,0.101948832977284,0.967445212819528,4,266,regulation of neuron death,BP,CHGA;MYBL2;GABRB2;GRIN2B
16577,GO:0071855,0.102087930550356,0.994879391798003,1,23,neuropeptide receptor binding,MF,MRAP2
4135,GO:0008483,0.102204663430228,0.99494699864981,1,17,transaminase activity,MF,BCAT1
4554,GO:0009628,0.102267242587012,0.946184014576035,11,1099,response to abiotic stimulus,BP,CAMK2A;EEF1A2;CRYAB;IGFBP2;HPCA;VGF;CHI3L1;SLC4A10;SFRP2;KCNC2;NEUROD2
17758,GO:0097386,0.102321207594648,0.994954357545229,1,16,glial cell projection,CC,SYT4
10571,GO:0042104,0.102482421234887,0.994886670721135,1,19,positive regulation of activated T cell proliferation,BP,IGFBP2
1627,GO:0003746,0.102550572527776,0.994894998780037,1,18,translation elongation factor activity,MF,EEF1A2
7678,GO:0031082,0.103322234368822,0.99480085839452,1,19,BLOC complex,CC,SNAP25
13286,GO:0048878,0.103690692803378,0.947054999254408,10,971,chemical homeostasis,BP,PTPRN;PTPN3;SLC30A3;CNR1;VGF;SLC4A10;GNG3;VSNL1;ADCY1;GRIN2B
13523,GO:0050832,0.104234318268445,0.99463044472307,1,26,defense response to fungus,BP,CHGA
18307,GO:0099632,0.104388475139642,0.994706656212619,1,18,protein transport within plasma membrane,BP,SNAP25
18309,GO:0099637,0.104388475139642,0.994706656212619,1,18,neurotransmitter receptor transport,BP,SNAP25
14648,GO:0060259,0.104417602422369,0.994721334229013,1,17,regulation of feeding behavior,BP,CNR1
7964,GO:0031623,0.104565191381877,0.982371369075204,2,85,receptor internalization,BP,DNM1;SNAP25
13839,GO:0051307,0.104682382409297,0.994713998966612,1,16,meiotic chromosome separation,BP,TOP2A
3691,GO:0007250,0.104973371383218,0.994645973226909,1,18,activation of NF-kappaB-inducing kinase activity,BP,CHI3L1
16529,GO:0071731,0.105004747388046,0.994642707796001,1,18,response to nitric oxide,BP,KCNC2
7769,GO:0031267,0.105236006399209,0.953352712668043,7,529,small GTPase binding,MF,CAMK2A;RPH3A;BIRC5;RIMS4;SYTL4;DAAM2;GRIN2B
17294,GO:0090177,0.105400318992042,0.994662758043005,1,15,establishment of planar polarity involved in neural tube closure,BP,SFRP2
3665,GO:0007200,0.105441275553993,0.982103178708297,2,97,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,CHGA;CHRM3
4023,GO:0008301,0.105709912157874,0.994569045047813,1,18,DNA binding, bending,MF,TOP2A
11443,GO:0043951,0.1058298653223,0.994574636254811,1,17,negative regulation of cAMP-mediated signaling,BP,MRAP2
1754,GO:0004016,0.105865184358972,0.994671744177345,1,13,adenylate cyclase activity,MF,ADCY1
7984,GO:0031649,0.105914655257761,0.994547559148239,1,18,heat generation,BP,CNR1
13776,GO:0051223,0.106143982640248,0.952824130786727,7,614,regulation of protein transport,BP,SYTL4;CNR1;HPCA;SNAP25;SYT4;VSNL1;KCNC2
13089,GO:0048519,0.106408910527539,0.927622589062355,36,4564,negative regulation of biological process,BP,LZTS1;ASPM;PTPN3;BIRC5;CHGA;CELF4;SYTL4;STMN2;DNM1;NEURL1;CRYAB;FOXM1;IGFBP2;RGS4;CENPF;CNR1;TJP2;HPCA;PACSIN1;TOP2A;SYT4;MRAP2;SFRP2;CXCL14;GABRB2;TENM2;DAAM2;VSNL1;FABP7;PI16;NEUROD2;ENC1;MYT1L;SPRY4;PPP1R14C;GRIN2B
5078,GO:0010951,0.106548098829591,0.972352563922553,3,189,negative regulation of endopeptidase activity,BP,BIRC5;CRYAB;SFRP2
13621,GO:0050995,0.106970273511426,0.994454648867232,1,17,negative regulation of lipid catabolic process,BP,CNR1
7180,GO:0030136,0.107411980072602,0.972060523642556,3,169,clathrin-coated vesicle,CC,SYT1;SLC17A7;NRGN
6757,GO:0021516,0.107810668135382,0.994329618948895,1,19,dorsal spinal cord development,BP,DAAM2
3809,GO:0007586,0.108502904319537,0.981287487870101,2,93,digestion,BP,TJP2;CHRM3
12909,GO:0048025,0.108523954105584,0.994252770193214,1,19,negative regulation of mRNA splicing, via spliceosome,BP,CELF4
5459,GO:0015464,0.108540337930782,0.994250998683695,1,19,acetylcholine receptor activity,MF,CHRM3
2630,GO:0005545,0.109220626492579,0.994260346553379,1,15,1-phosphatidylinositol binding,MF,SYT1
11874,GO:0045109,0.109297343946306,0.994205563424574,1,17,intermediate filament organization,BP,NEFM
7688,GO:0031092,0.109723802796652,0.994181283092865,1,16,platelet alpha granule membrane,CC,SYTL4
15942,GO:0070679,0.109845246509485,0.994254625510519,1,13,inositol 1,4,5 trisphosphate binding,MF,RPH3A
18471,GO:0120034,0.110023909304077,0.980912154564973,2,81,positive regulation of plasma membrane bounded cell projection assembly,BP,NEURL1;TENM2
12951,GO:0048172,0.110058905535796,0.994170005716444,1,15,regulation of short-term neuronal synaptic plasticity,BP,SYT4
19187,GO:1902170,0.110619586934183,0.99404163192477,1,18,cellular response to reactive nitrogen species,BP,KCNC2
5700,GO:0016082,0.110655661857331,0.994105245157044,1,15,synaptic vesicle priming,BP,SNAP25
6038,GO:0016769,0.111047176961899,0.993976590990182,1,19,transferase activity, transferring nitrogenous groups,MF,BCAT1
12999,GO:0048268,0.111490130920327,0.993988326867927,1,16,clathrin coat assembly,BP,CALY
7585,GO:0030900,0.111505030506075,0.957766170283252,5,351,forebrain development,BP,ASPM;SLC4A10;NRGN;FABP7;KCNC2
17719,GO:0097320,0.111661108050079,0.993946704791606,1,17,plasma membrane tubulation,BP,PACSIN1
19725,GO:1903421,0.111832946494902,0.993976390177536,1,15,regulation of synaptic vesicle recycling,BP,DNM1
2574,GO:0005385,0.112181128706848,0.993850271914903,1,19,zinc ion transmembrane transporter activity,MF,SLC30A3
4879,GO:0010667,0.112491010209201,0.9938155139819,1,19,negative regulation of cardiac muscle cell apoptotic process,BP,SFRP2
12897,GO:0048013,0.112720063720932,0.980145392072743,2,87,ephrin receptor signaling pathway,BP,DNM1;GRIN2B
11351,GO:0043567,0.113778026649557,0.99368885450751,1,18,regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP2
7087,GO:0023014,0.113850459018849,0.942986687569939,9,855,signal transduction by protein phosphorylation,BP,CAMK2A;CRYAB;FOXM1;RGS4;CHI3L1;SFRP2;GNG3;SPRY4;GRIN2B
13863,GO:0051354,0.113882853021375,0.993641194782475,1,20,negative regulation of oxidoreductase activity,BP,CNR1
11168,GO:0043266,0.114021608985336,0.979796601267729,2,83,regulation of potassium ion transport,BP,KCNS1;KCNC2
17548,GO:0097009,0.114250982992258,0.993635116170578,1,18,energy homeostasis,BP,MRAP2
14467,GO:0055119,0.114381922235344,0.993641430144044,1,17,relaxation of cardiac muscle,BP,CHGA
7412,GO:0030545,0.114403393063288,0.961917680369837,4,347,receptor regulator activity,MF,VGF;SFRP2;CXCL14;NMB
11269,GO:0043434,0.11568100443039,0.955675131191313,5,385,response to peptide hormone,BP,PTPRN;CAMK2A;VGF;GNG3;ADCY1
18066,GO:0098813,0.115990289390084,0.961251705411327,4,279,nuclear chromosome segregation,BP,BIRC5;KIF4A;CENPF;TOP2A
816,GO:0002021,0.116097023585136,0.993403518204625,1,19,response to dietary excess,BP,VGF
20060,GO:1904062,0.1161936285358,0.961164510091611,4,274,regulation of cation transmembrane transport,BP,PTPN3;HPCA;KCNS1;KCNC2
12259,GO:0045922,0.116236023177432,0.99338735925557,1,19,negative regulation of fatty acid metabolic process,BP,CNR1
10114,GO:0036035,0.116574612345612,0.993389697394504,1,17,osteoclast development,BP,TJP2
778,GO:0001965,0.116807052580667,0.993286813058948,1,21,G-protein alpha-subunit binding,MF,RGS4
16187,GO:0071214,0.117177183493671,0.960707426833391,4,288,cellular response to abiotic stimulus,BP,CRYAB;HPCA;SFRP2;NEUROD2
18403,GO:0104004,0.117177183493671,0.960707426833391,4,288,cellular response to environmental stimulus,BP,CRYAB;HPCA;SFRP2;NEUROD2
11147,GO:0043235,0.117193142306026,0.954939696152164,5,354,receptor complex,CC,GABRA1;GABRA4;GABRG2;GABRB2;GRIN2B
20196,GO:1904385,0.117319370634506,0.99324272950135,1,20,cellular response to angiotensin,BP,CAMK2A
9248,GO:0034199,0.117363918133517,0.993322988212428,1,16,activation of protein kinase A activity,BP,ADCY1
10634,GO:0042249,0.117912448442291,0.993233595408558,1,17,establishment of planar polarity of embryonic epithelium,BP,SFRP2
16328,GO:0071425,0.118484539820942,0.993123092309296,1,19,hematopoietic stem cell proliferation,BP,SFRP2
17584,GO:0097062,0.118603273952453,0.993152241846686,1,17,dendritic spine maintenance,BP,GRIN2B
4055,GO:0008356,0.118607669071749,0.993128889147044,1,18,asymmetric cell division,BP,ASPM
4873,GO:0010661,0.118711953572426,0.993096062853802,1,19,positive regulation of muscle cell apoptotic process,BP,CAMK2A
4191,GO:0008585,0.119042664833581,0.978358749753994,2,86,female gonad development,BP,PTPRN;VGF
6137,GO:0016925,0.119244033929378,0.978293175481562,2,88,protein sumoylation,BP,BIRC5;TOP2A
15724,GO:0070300,0.119474473785042,0.993025752475093,1,18,phosphatidic acid binding,MF,NRGN
3438,GO:0006817,0.11967534495806,0.993001737058699,1,18,phosphate ion transport,BP,SLC17A7
4654,GO:0009975,0.11967801445809,0.993050827306616,1,16,cyclase activity,MF,ADCY1
21182,GO:2000026,0.120104653256217,0.927804108594191,16,1712,regulation of multicellular organismal development,BP,ASPM;SYT1;CELF4;STMN2;NEURL1;CENPF;CNR1;TJP2;PACSIN1;SNAP25;SYT4;CHI3L1;SFRP2;DAAM2;NEUROD2;ENC1
6091,GO:0016849,0.120157442456097,0.992993729791568,1,16,phosphorus-oxygen lyase activity,MF,ADCY1
16424,GO:0071577,0.120241164963674,0.992893977799958,1,20,zinc ion transmembrane transport,BP,SLC30A3
18837,GO:1901184,0.121492343741207,0.977633804234304,2,90,regulation of ERBB signaling pathway,BP,PTPN3;NEURL1
8160,GO:0032026,0.121569979084912,0.992824080492637,1,16,response to magnesium ion,BP,KCNC2
3045,GO:0006266,0.122083614010586,0.992621096686701,1,23,DNA ligation,BP,TOP2A
3700,GO:0007263,0.122382420943493,0.992614855759032,1,21,nitric oxide mediated signal transduction,BP,KCNC2
11727,GO:0044706,0.122396975011053,0.966301324550192,3,187,multi-multicellular organism process,BP,IGFBP2;CNR1;PRLHR
17544,GO:0095500,0.122908364124751,0.992549734687129,1,21,acetylcholine receptor signaling pathway,BP,CHRM3
19938,GO:1903831,0.122908364124751,0.992549734687129,1,21,signal transduction involved in cellular response to ammonium ion,BP,CHRM3
20561,GO:1905144,0.122908364124751,0.992549734687129,1,21,response to acetylcholine,BP,CHRM3
20562,GO:1905145,0.122908364124751,0.992549734687129,1,21,cellular response to acetylcholine,BP,CHRM3
4657,GO:0009987,0.123102120108558,0.93167882573925,90,13331,cellular process,BP,CAMK1G;SYT13;GABRA1;PTPRN;BCAT1;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;LNX1;RBFOX1;RPH3A;BIRC5;KIF4A;CHGA;MYBL2;RIMS4;EEF1A2;CELF4;ST8SIA5;SYTL4;STMN2;NEFM;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;IGFBP2;RGS4;CENPF;CNR1;TJP2;PRLHR;IQSEC3;HPCA;KCNS1;PACSIN1;VGF;SULT4A1;CALY;TOP2A;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;STAC2;SLC4A10;SFRP2;LIX1;CXCL14;GABRB2;TENM2;DAAM2;MKI67;FREM2;ZNF385D;CHST9;NRGN;ABI3BP;GNG3;VSNL1;FABP7;PI16;ADCY1;KCNC2;KCNK9;NPTX1;NEUROD2;ENC1;ZCCHC12;PCSK1;DDN;ZDHHC23;MAP7D2;NELL2;SV2B;MYT1L;SPRY4;SELL;NMB;PPP1R14C;GRIN2B
19666,GO:1903306,0.123228729256534,0.992527866658933,1,20,negative regulation of regulated secretory pathway,BP,SYT4
8144,GO:0031998,0.123253267760119,0.992619134089968,1,16,regulation of fatty acid beta-oxidation,BP,CNR1
7191,GO:0030154,0.123370689746328,0.916863752683498,29,3484,cell differentiation,BP,ASPM;SYT1;CAMK2A;MYBL2;CELF4;STMN2;NEFM;NPTX2;NEURL1;FOXM1;CENPF;CNR1;TJP2;PACSIN1;TOP2A;SNAP25;SYT4;SLC4A10;SFRP2;CXCL14;GABRB2;TENM2;DAAM2;FABP7;ADCY1;NPTX1;NEUROD2;ENC1;MYT1L
17238,GO:0090087,0.123467756752974,0.94306099948046,7,642,regulation of peptide transport,BP,SYTL4;CNR1;HPCA;SNAP25;SYT4;VSNL1;KCNC2
13873,GO:0051383,0.123575669569306,0.992504677213978,1,19,kinetochore organization,BP,CENPF
19483,GO:1902936,0.123602496796296,0.977014884510804,2,90,phosphatidylinositol bisphosphate binding,MF,SYT1;RPH3A
13463,GO:0050750,0.123829052819192,0.992495434264054,1,18,low-density lipoprotein particle receptor binding,MF,SYT1
5227,GO:0014829,0.123866656253017,0.99246848808514,1,19,vascular smooth muscle contraction,BP,CHRM3
19530,GO:1903010,0.123906759533556,0.99246349339744,1,19,regulation of bone development,BP,TJP2
20621,GO:1905276,0.1239156403477,0.992484682688691,1,18,regulation of epithelial tube formation,BP,SFRP2
4325,GO:0009083,0.124195024514645,0.992389160045232,1,21,branched-chain amino acid catabolic process,BP,BCAT1
276,GO:0000777,0.124565364112035,0.976709064333054,2,96,condensed chromosome kinetochore,CC,BIRC5;CENPF
10542,GO:0042044,0.124935613100705,0.992295920822372,1,21,fluid transport,BP,SLC14A1
3536,GO:0006978,0.125026401202188,0.992323345859414,1,19,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,FOXM1
10841,GO:0042629,0.125057371835049,0.992280534558705,1,21,mast cell granule,CC,CHGA
4752,GO:0010453,0.125251201043466,0.99222377375549,1,23,regulation of cell fate commitment,BP,SFRP2
7525,GO:0030823,0.125594426899428,0.992195532850866,1,22,regulation of cGMP metabolic process,BP,HPCA
8717,GO:0032892,0.125787770298027,0.992170902542186,1,22,positive regulation of organic acid transport,BP,SYT4
9160,GO:0034035,0.12593503548576,0.992136563460018,1,23,purine ribonucleoside bisphosphate metabolic process,BP,SULT4A1
13345,GO:0050427,0.12593503548576,0.992136563460018,1,23,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,SULT4A1
8691,GO:0032838,0.125962239370744,0.964917793886339,3,169,plasma membrane bounded cell projection cytoplasm,CC,KIF4A;CENPF;HPCA
19362,GO:1902600,0.126158340001667,0.97619103269175,2,111,proton transmembrane transport,BP,SLC17A7;SLC4A10
8515,GO:0032587,0.126557264197539,0.976157586508212,2,85,ruffle membrane,CC,PACSIN1;SPRY4
18804,GO:1901071,0.126586877908654,0.992068671092081,1,22,glucosamine-containing compound metabolic process,BP,CHI3L1
13658,GO:0051043,0.126615793393567,0.992082179349442,1,21,regulation of membrane protein ectodomain proteolysis,BP,PTPN3
12538,GO:0046545,0.126679187870631,0.976100636942113,2,90,development of primary female sexual characteristics,BP,PTPRN;VGF
16594,GO:0071880,0.126877054946622,0.99211209982565,1,18,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,CHGA
16245,GO:0071310,0.126914384357119,0.919279033952444,20,2366,cellular response to organic substance,BP,GABRA1;PTPRN;CAMK2A;BIRC5;MYBL2;STMN2;NEURL1;PTPN5;GABRG2;IGFBP2;TJP2;CHRM3;CHI3L1;SFRP2;GABRB2;GNG3;VSNL1;ADCY1;ZCCHC12;SPRY4
11181,GO:0043281,0.127180902078191,0.96437400115083,3,204,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,BIRC5;CRYAB;SFRP2
13976,GO:0051589,0.127231403917279,0.992043378316575,1,19,negative regulation of neurotransmitter transport,BP,SYT4
12139,GO:0045686,0.127325009834837,0.991991036085437,1,21,negative regulation of glial cell differentiation,BP,DAAM2
150,GO:0000302,0.127351545079902,0.964302820575104,3,206,response to reactive oxygen species,BP,PTPRN;CRYAB;KCNC2
7026,GO:0022402,0.127587044015047,0.928184102561367,12,1259,cell cycle process,BP,BCAT1;LZTS1;ASPM;CAMK2A;BIRC5;KIF4A;MYBL2;FOXM1;CENPF;PACSIN1;TOP2A;MKI67
6328,GO:0018230,0.128170311114392,0.991864042542596,1,22,peptidyl-L-cysteine S-palmitoylation,BP,ZDHHC23
6329,GO:0018231,0.128170311114392,0.991864042542596,1,22,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,ZDHHC23
3846,GO:0008009,0.128311192994299,0.991729733285305,1,32,chemokine activity,MF,CXCL14
10913,GO:0042772,0.128457078559623,0.991863917925592,1,20,DNA damage response, signal transduction resulting in transcription,BP,FOXM1
12124,GO:0045662,0.128775111322741,0.991768900104476,1,23,negative regulation of myoblast differentiation,BP,CXCL14
7777,GO:0031280,0.129392559847564,0.991704217925339,1,22,negative regulation of cyclase activity,BP,HPCA
15175,GO:0061082,0.129527751811491,0.991686439537686,1,22,myeloid leukocyte cytokine production,BP,CHGA
6232,GO:0017137,0.129728353807781,0.963401991828147,3,170,Rab GTPase binding,MF,RPH3A;RIMS4;SYTL4
4060,GO:0008373,0.12982472475365,0.991685340749119,1,20,sialyltransferase activity,MF,ST8SIA5
17820,GO:0097503,0.12982472475365,0.991685340749119,1,20,sialylation,BP,ST8SIA5
1188,GO:0002675,0.129988099147554,0.991580028443046,1,25,positive regulation of acute inflammatory response,BP,CNR1
10898,GO:0042752,0.13011699383595,0.975054688341656,2,92,regulation of circadian rhythm,BP,TOP2A;ADCY1
3713,GO:0007281,0.130209043197732,0.96317029411464,3,191,germ cell development,BP,ASPM;CELF4;NEURL1
14532,GO:0060070,0.130431722808926,0.954570620950173,4,293,canonical Wnt signaling pathway,BP,ASPM;IGFBP2;SFRP2;DAAM2
18717,GO:1900273,0.130592549168365,0.991690085239876,1,16,positive regulation of long-term synaptic potentiation,BP,NRGN
4876,GO:0010664,0.130675255445799,0.991534731952952,1,22,negative regulation of striated muscle cell apoptotic process,BP,SFRP2
8852,GO:0033119,0.130987945867652,0.991460896859296,1,24,negative regulation of RNA splicing,BP,CELF4
7469,GO:0030673,0.131269919185213,0.991601419948971,1,16,axolemma,CC,KCNC2
13978,GO:0051591,0.131743259555906,0.974561394180976,2,91,response to cAMP,BP,PTPRN;VGF
19571,GO:1903077,0.13193146434347,0.991366998880062,1,22,negative regulation of protein localization to plasma membrane,BP,MRAP2
15535,GO:0062014,0.132025948116013,0.974441662446195,2,100,negative regulation of small molecule metabolic process,BP,CNR1;HPCA
11008,GO:0043010,0.133091559417951,0.953327715395583,4,275,camera-type eye development,BP,CELF4;SLC17A7;CRYAB;HPCA
16551,GO:0071804,0.133257546359745,0.961932809403887,3,187,cellular potassium ion transport,BP,KCNS1;KCNC2;KCNK9
16552,GO:0071805,0.133257546359745,0.961932809403887,3,187,potassium ion transmembrane transport,BP,KCNS1;KCNC2;KCNK9
9968,GO:0035774,0.133327738045518,0.991130428332149,1,25,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,VSNL1
3356,GO:0006688,0.133830897205495,0.99111009162665,1,22,glycosphingolipid biosynthetic process,BP,ST8SIA5
99,GO:0000188,0.133863314246114,0.991071995478118,1,24,inactivation of MAPK activity,BP,RGS4
15664,GO:0070201,0.134390805634617,0.936703394426993,7,656,regulation of establishment of protein localization,BP,SYTL4;CNR1;HPCA;SNAP25;SYT4;VSNL1;KCNC2
14195,GO:0051983,0.134414887671123,0.973740398113737,2,90,regulation of chromosome segregation,BP,CENPF;MKI67
7505,GO:0030803,0.134614283660523,0.990985209835061,1,23,negative regulation of cyclic nucleotide biosynthetic process,BP,HPCA
13789,GO:0051240,0.134796505990905,0.921648666596238,13,1393,positive regulation of multicellular organismal process,BP,ASPM;SYT1;CHGA;STMN2;NEURL1;CNR1;PACSIN1;SYT4;CHRM3;CHI3L1;SFRP2;NEUROD2;ENC1
4558,GO:0009636,0.135427522385278,0.945517990441643,5,442,response to toxic substance,BP,CRYAB;CNR1;HPCA;KCNC2;GRIN2B
839,GO:0002052,0.135891635331249,0.990868543922256,1,20,positive regulation of neuroblast proliferation,BP,ASPM
15544,GO:0065009,0.136241221858991,0.9096296582636,24,2938,regulation of molecular function,BP,PTPN3;CAMK2A;BIRC5;EEF1A2;NEURL1;CRYAB;RGS4;CNR1;IQSEC3;HPCA;KCNS1;VGF;CHI3L1;SFRP2;CXCL14;GNG3;PI16;ADCY1;KCNC2;NEUROD2;SPRY4;NMB;PPP1R14C;GRIN2B
3445,GO:0006829,0.136243414474338,0.990759863521817,1,23,zinc ion transport,BP,SLC30A3
21414,GO:2000403,0.136760978955934,0.99064111566236,1,26,positive regulation of lymphocyte migration,BP,CXCL14
16513,GO:0071702,0.13681624697094,0.912057450609331,20,2410,organic substance transport,BP,PTPRN;SYT1;RBFOX1;RPH3A;CHGA;SYTL4;SLC17A7;CENPF;CNR1;HPCA;VGF;SNAP25;SYT4;CHI3L1;SLC14A1;SLC4A10;VSNL1;KCNC2;ZDHHC23;SLC6A17
12320,GO:0046037,0.137003687709784,0.990692267761014,1,21,GMP metabolic process,BP,TJP2
7181,GO:0030137,0.137022476159192,0.990618669252952,1,25,COPI-coated vesicle,CC,PACSIN1
2725,GO:0005737,0.137138370387096,0.905381027913626,71,10204,cytoplasm,CC,CAMK1G;SYT13;GABRA1;PTPRN;BCAT1;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;LNX1;RBFOX1;RPH3A;BIRC5;KIF4A;CHGA;RIMS4;EEF1A2;CELF4;ST8SIA5;SYTL4;STMN2;NEFM;SLC17A7;DNM1;NEURL1;CRYAB;PTPN5;GABRG2;SLC30A3;IGFBP2;RGS4;CENPF;CNR1;TJP2;IQSEC3;HPCA;KCNS1;PACSIN1;VGF;SULT4A1;CALY;TOP2A;SNAP25;SYT4;CHI3L1;MRAP2;STAC2;LIX1;CXCL14;GABRB2;TENM2;CHST9;NRGN;VSNL1;IGFN1;FABP7;ADCY1;TMEM130;KCNK9;NPTX1;ENC1;PCSK1;CREG2;DDN;ZDHHC23;SV2B;SPRY4;SELL;SLC6A17;PPP1R14C
16111,GO:0070997,0.137208686949693,0.951333634077596,4,297,neuron death,BP,CHGA;MYBL2;GABRB2;GRIN2B
13572,GO:0050901,0.137344444292172,0.9905889517654,1,24,leukocyte tethering or rolling,BP,SELL
16930,GO:0072509,0.137412992816703,0.990596275982944,1,23,divalent inorganic cation transmembrane transporter activity,MF,SLC30A3
13859,GO:0051350,0.138537161114572,0.990420363846979,1,24,negative regulation of lyase activity,BP,HPCA
3839,GO:0007626,0.138982937453128,0.95957874389332,3,177,locomotory behavior,BP,DNM1;SNAP25;SLC4A10
4901,GO:0010719,0.139625155416327,0.99023420944006,1,26,negative regulation of epithelial to mesenchymal transition,BP,SFRP2
21098,GO:1990776,0.139703197076992,0.990271562373614,1,23,response to angiotensin,BP,CAMK2A
14713,GO:0060341,0.139772627021172,0.929922465517818,8,761,regulation of cellular localization,BP,CAMK2A;RIMS4;DNM1;CRYAB;HPCA;SYT4;MRAP2;VSNL1
6551,GO:0019433,0.140344287256496,0.990130609642252,1,26,triglyceride catabolic process,BP,FABP7
19218,GO:1902230,0.140502925824281,0.990080786671706,1,28,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,SFRP2
3561,GO:0007017,0.140848804347066,0.929273426461916,8,708,microtubule-based process,BP,ASPM;BIRC5;KIF4A;MYBL2;STMN2;NEURL1;CRYAB;MAP7D2
16590,GO:0071875,0.141446792739375,0.990061562206401,1,21,adrenergic receptor signaling pathway,BP,CHGA
17421,GO:0090344,0.141630159496001,0.990035063939772,1,21,negative regulation of cell aging,BP,FOXM1
18258,GO:0099528,0.141849895664391,0.989911839591369,1,26,G-protein coupled neurotransmitter receptor activity,MF,CHRM3
13416,GO:0050685,0.141851846348084,0.989926907672922,1,25,positive regulation of mRNA processing,BP,CELF4
16997,GO:0072606,0.142112846470163,0.989873372245354,1,26,interleukin-8 secretion,BP,CHI3L1
20188,GO:1904376,0.14280998724085,0.989803434808502,1,24,negative regulation of protein localization to cell periphery,BP,MRAP2
9704,GO:0035335,0.143005908251349,0.971003657062881,2,93,peptidyl-tyrosine dephosphorylation,BP,PTPN3;PTPN5
4347,GO:0009117,0.143284477071743,0.93583814175838,6,591,nucleotide metabolic process,BP,CHGA;TJP2;HPCA;SULT4A1;MRAP2;ADCY1
4155,GO:0008514,0.14334287594284,0.957697145100059,3,201,organic anion transmembrane transporter activity,MF,SLC17A7;SLC4A10;SLC6A17
4599,GO:0009791,0.143600751806244,0.970854533632254,2,84,post-embryonic development,BP,GABRG2;SLC4A10
2323,GO:0004930,0.143754025027188,0.948100593870315,4,355,G-protein coupled receptor activity,MF,CNR1;PRLHR;CHRM3;SFRP2
11818,GO:0045026,0.144027392311742,0.989562702329605,1,28,plasma membrane fusion,BP,SNAP25
4323,GO:0009081,0.144470841843058,0.989558142388409,1,24,branched-chain amino acid metabolic process,BP,BCAT1
8522,GO:0032594,0.144627815572172,0.989501546581848,1,26,protein transport within lipid bilayer,BP,SNAP25
2180,GO:0004725,0.144978165342952,0.970358791674394,2,94,protein tyrosine phosphatase activity,MF,PTPN3;PTPN5
11054,GO:0043090,0.145366406472134,0.989464312809153,1,22,amino acid import,BP,SLC17A7
3557,GO:0007010,0.14539194141341,0.916190369896507,12,1189,cytoskeleton organization,BP,ASPM;BIRC5;KIF4A;MYBL2;STMN2;NEFM;NEURL1;CRYAB;IQSEC3;PACSIN1;DAAM2;MAP7D2
5674,GO:0016043,0.146097002014926,0.895777730136383,43,5585,cellular component organization,BP,SYT13;PTPRN;ASPM;SYT1;CAMK2A;LNX1;RPH3A;BIRC5;KIF4A;CHGA;MYBL2;CELF4;SYTL4;STMN2;NEFM;SLC17A7;NPTX2;DNM1;NEURL1;CRYAB;IGFBP2;CENPF;CNR1;IQSEC3;KCNS1;PACSIN1;CALY;TOP2A;SNAP25;SYT4;SFRP2;LIX1;TENM2;DAAM2;MKI67;ABI3BP;ADCY1;KCNC2;NPTX1;NEUROD2;ENC1;MAP7D2;GRIN2B
14872,GO:0060561,0.146149533017949,0.989326280156169,1,23,apoptotic process involved in morphogenesis,BP,CRYAB
14281,GO:0052548,0.14702375799402,0.946500547647143,4,337,regulation of endopeptidase activity,BP,BIRC5;CRYAB;SFRP2;GRIN2B
7752,GO:0031234,0.147481438816568,0.969494043903146,2,105,extrinsic component of cytoplasmic side of plasma membrane,CC,SNAP25;GNG3
12271,GO:0045936,0.147971096799343,0.933165440700697,6,540,negative regulation of phosphate metabolic process,BP,FOXM1;RGS4;HPCA;SFRP2;SPRY4;PPP1R14C
3400,GO:0006753,0.148265280725803,0.932970786650281,6,598,nucleoside phosphate metabolic process,BP,CHGA;TJP2;HPCA;SULT4A1;MRAP2;ADCY1
4806,GO:0010563,0.148686239640446,0.932751506447576,6,541,negative regulation of phosphorus metabolic process,BP,FOXM1;RGS4;HPCA;SFRP2;SPRY4;PPP1R14C
10935,GO:0042813,0.148751739884797,0.988953250265584,1,22,Wnt-activated receptor activity,MF,SFRP2
7975,GO:0031640,0.148759046514844,0.988749954933713,1,37,killing of cells of other organism,BP,CHGA
11623,GO:0044364,0.148759046514844,0.988749954933713,1,37,disruption of cells of other organism,BP,CHGA
278,GO:0000779,0.149630422262046,0.9687739621476,2,107,condensed chromosome, centromeric region,CC,BIRC5;CENPF
21741,GO:2001024,0.149837821735734,0.988725815478145,1,25,negative regulation of response to drug,BP,CNR1
5318,GO:0015106,0.150201047879642,0.988754774420575,1,21,bicarbonate transmembrane transporter activity,MF,SLC4A10
17230,GO:0090079,0.150601841188299,0.988625902273735,1,24,translation regulator activity, nucleic acid binding,MF,CELF4
2354,GO:0004970,0.150749799649592,0.988726574000815,1,19,ionotropic glutamate receptor activity,MF,GRIN2B
9880,GO:0035640,0.150959719309813,0.988590663524918,1,23,exploration behavior,BP,SLC4A10
16004,GO:0070840,0.151052052493553,0.988650150455811,1,20,dynein complex binding,MF,CENPF
2545,GO:0005328,0.151342023263748,0.988531083567269,1,23,neurotransmitter:sodium symporter activity,MF,SLC6A17
7700,GO:0031109,0.151423218586133,0.968208952997654,2,98,microtubule polymerization or depolymerization,BP,STMN2;CRYAB
2414,GO:0005086,0.1521302970474,0.98848263618253,1,20,ARF guanyl-nucleotide exchange factor activity,MF,IQSEC3
13824,GO:0051290,0.152144628470626,0.988316330088018,1,28,protein heterotetramerization,BP,GRIN2B
10493,GO:0039694,0.152299960925121,0.988323349130382,1,26,viral RNA genome replication,BP,TOP2A
6614,GO:0019725,0.152605891720429,0.921885385797355,8,813,cellular homeostasis,BP,PTPRN;SLC17A7;SLC30A3;SLC4A10;GNG3;VSNL1;NELL2;GRIN2B
12750,GO:0046983,0.152632978348297,0.915770631361107,10,1108,protein dimerization activity,MF,SYT1;CAMK2A;DNM1;CRYAB;CENPF;TOP2A;SYT4;TENM2;KCNK9;NEUROD2
13566,GO:0050892,0.152820796613577,0.988240957453707,1,26,intestinal absorption,BP,TJP2
19779,GO:1903532,0.153133121802141,0.943458355532155,4,324,positive regulation of secretion by cell,BP,SYT1;SYTL4;SYT4;VSNL1
18788,GO:1901018,0.153242374770224,0.988255511919788,1,22,positive regulation of potassium ion transmembrane transporter activity,BP,KCNC2
3567,GO:0007026,0.153585750411561,0.98820122633671,1,22,negative regulation of microtubule depolymerization,BP,STMN2
5560,GO:0015813,0.153649193978743,0.98816802884315,1,23,L-glutamate transmembrane transport,BP,SLC17A7
7263,GO:0030246,0.153870780966793,0.953108557753321,3,223,carbohydrate binding,MF,NPTX2;CHI3L1;SELL
12932,GO:0048103,0.153874417994152,0.988155486975602,1,22,somatic stem cell division,BP,ASPM
17402,GO:0090314,0.153970511933481,0.988041248753807,1,27,positive regulation of protein targeting to membrane,BP,HPCA
15740,GO:0070325,0.154158571980753,0.988135903421901,1,21,lipoprotein particle receptor binding,MF,SYT1
3760,GO:0007413,0.154712368974002,0.988076192807239,1,20,axonal fasciculation,BP,CNR1
18418,GO:0106030,0.154712368974002,0.988076192807239,1,20,neuron projection fasciculation,BP,CNR1
7210,GO:0030175,0.155185399178238,0.966969546280896,2,91,filopodium,CC,NPTX2;TENM2
15458,GO:0061756,0.155265801737611,0.987833040442052,1,27,leukocyte adhesion to vascular endothelial cell,BP,SELL
6609,GO:0019706,0.155641315226161,0.987772322720678,1,27,protein-cysteine S-palmitoyltransferase activity,MF,ZDHHC23
6610,GO:0019707,0.155641315226161,0.987772322720678,1,27,protein-cysteine S-acyltransferase activity,MF,ZDHHC23
2785,GO:0005819,0.156324216203968,0.941862704095787,4,305,spindle,CC,ASPM;BIRC5;KIF4A;CENPF
2288,GO:0004871,0.156363911660995,0.910795214819385,11,1194,signal transducer activity,MF,GABRA1;SLC17A7;GABRA4;GABRG2;CNR1;PRLHR;CHRM3;SFRP2;GABRB2;GNG3;GRIN2B
7502,GO:0030800,0.156446140257256,0.987641647915985,1,27,negative regulation of cyclic nucleotide metabolic process,BP,HPCA
5886,GO:0016486,0.156500104169959,0.987632859719,1,27,peptide hormone processing,BP,PCSK1
11122,GO:0043200,0.156521099788767,0.966450641109963,2,105,response to amino acid,BP,NEURL1;HPCA
2519,GO:0005261,0.156674138841806,0.941704091470458,4,288,cation channel activity,MF,KCNS1;KCNC2;KCNK9;GRIN2B
8342,GO:0032355,0.156710275111529,0.96635026833531,2,115,response to estradiol,BP,CRYAB;IGFBP2
12302,GO:0045992,0.157086353234039,0.987573431393016,1,25,negative regulation of embryonic development,BP,SFRP2
9685,GO:0035296,0.157431278940175,0.966108727650499,2,113,regulation of tube diameter,BP,CHGA;CHRM3
17914,GO:0097746,0.157431278940175,0.966108727650499,2,113,regulation of blood vessel diameter,BP,CHGA;CHRM3
12257,GO:0045920,0.158043332097406,0.98738013524906,1,27,negative regulation of exocytosis,BP,SYT4
14172,GO:0051954,0.158236480837109,0.987331892857923,1,28,positive regulation of amine transport,BP,SYT4
3475,GO:0006882,0.158421244378961,0.987245844599491,1,32,cellular zinc ion homeostasis,BP,SLC30A3
7341,GO:0030371,0.15859453227996,0.987346961796569,1,24,translation repressor activity,MF,CELF4
6456,GO:0019201,0.158953409816286,0.987266948694605,1,25,nucleotide kinase activity,MF,TJP2
13690,GO:0051094,0.159470176288736,0.908673926319888,11,1161,positive regulation of developmental process,BP,ASPM;SYT1;STMN2;NEURL1;CNR1;PACSIN1;SYT4;CHI3L1;SFRP2;NEUROD2;ENC1
21295,GO:2000241,0.159763468656865,0.965294329109731,2,115,regulation of reproductive process,BP,ASPM;CNR1
4552,GO:0009620,0.160231351603858,0.986899354256032,1,36,response to fungus,BP,CHGA
5406,GO:0015291,0.160636038234864,0.950133064184753,3,202,secondary active transmembrane transporter activity,MF,SLC17A7;SLC4A10;SLC6A17
6814,GO:0021591,0.160668900914834,0.987003185368183,1,24,ventricular system development,BP,CENPF
11251,GO:0043405,0.161179200116961,0.939370164103161,4,315,regulation of MAP kinase activity,BP,RGS4;SFRP2;GNG3;SPRY4
12600,GO:0046660,0.161439067980728,0.964754544554648,2,103,female sex differentiation,BP,PTPRN;VGF
12133,GO:0045671,0.161492606539716,0.98686531545383,1,24,negative regulation of osteoclast differentiation,BP,TJP2
2586,GO:0005452,0.162047193256422,0.98673030895372,1,26,inorganic anion exchanger activity,MF,SLC4A10
17227,GO:0090075,0.16221025596722,0.986684151293655,1,27,relaxation of muscle,BP,CHGA
16261,GO:0071333,0.162248936710734,0.96444282775812,2,110,cellular response to glucose stimulus,BP,PTPRN;VSNL1
3116,GO:0006376,0.162544313926211,0.986627493799078,1,27,mRNA splice site selection,BP,CELF4
10520,GO:0040036,0.162569391877154,0.986641903116267,1,26,regulation of fibroblast growth factor receptor signaling pathway,BP,SPRY4
848,GO:0002063,0.162634565385025,0.986696668781401,1,23,chondrocyte development,BP,SFRP2
13415,GO:0050684,0.163140870734906,0.964121524292238,2,112,regulation of mRNA processing,BP,RBFOX1;CELF4
12702,GO:0046907,0.163729823110646,0.899666625318374,14,1616,intracellular transport,BP,SYT13;SYT1;RPH3A;KIF4A;CHGA;RIMS4;SYTL4;DNM1;CRYAB;HPCA;CALY;SNAP25;SYT4;ZDHHC23
1968,GO:0004435,0.163807488939923,0.98647370567774,1,24,phosphatidylinositol phospholipase C activity,MF,CHRM3
3645,GO:0007176,0.164369057060706,0.986315748286305,1,27,regulation of epidermal growth factor-activated receptor activity,BP,NEURL1
781,GO:0001968,0.164465408377617,0.986338924225401,1,25,fibronectin binding,MF,SFRP2
3973,GO:0008227,0.164564288796309,0.986204491700059,1,32,G-protein coupled amine receptor activity,MF,CHRM3
7272,GO:0030262,0.164733777467942,0.986235183258272,1,28,apoptotic nuclear changes,BP,TOP2A
820,GO:0002026,0.164818763200752,0.986278245122758,1,25,regulation of the force of heart contraction,BP,CHGA
14431,GO:0055069,0.164830193342794,0.986145686829263,1,33,zinc ion homeostasis,BP,SLC30A3
13417,GO:0050686,0.165217476781037,0.986134933427114,1,29,negative regulation of mRNA processing,BP,CELF4
12070,GO:0045595,0.165938398185139,0.898082033110302,14,1545,regulation of cell differentiation,BP,ASPM;SYT1;STMN2;NEURL1;CNR1;TJP2;PACSIN1;SNAP25;SYT4;SFRP2;CXCL14;DAAM2;NEUROD2;ENC1
14173,GO:0051955,0.165955918433005,0.986023468807823,1,28,regulation of amino acid transport,BP,SYT4
777,GO:0001964,0.165963665665101,0.986103425179439,1,24,startle response,BP,FABP7
16368,GO:0071480,0.166154131848082,0.986007073320817,1,27,cellular response to gamma radiation,BP,CRYAB
16259,GO:0071331,0.166206839916825,0.963033680130616,2,112,cellular response to hexose stimulus,BP,PTPRN;VSNL1
7813,GO:0031330,0.166492102534403,0.947466661511132,3,208,negative regulation of cellular catabolic process,BP,LZTS1;PTPN3;CNR1
7161,GO:0030111,0.166668393170133,0.936521036884277,4,320,regulation of Wnt signaling pathway,BP,ASPM;IGFBP2;SFRP2;DAAM2
20715,GO:1905476,0.167178589800281,0.985792876632063,1,29,negative regulation of protein localization to membrane,BP,MRAP2
16645,GO:0071985,0.167266520788079,0.985794514543061,1,28,multivesicular body sorting pathway,BP,SYTL4
16257,GO:0071326,0.168554771514659,0.96218793800372,2,113,cellular response to monosaccharide stimulus,BP,PTPRN;VSNL1
11495,GO:0044092,0.168843422960906,0.907892748762288,9,967,negative regulation of molecular function,BP,BIRC5;CRYAB;RGS4;CNR1;HPCA;SFRP2;PI16;SPRY4;PPP1R14C
12183,GO:0045777,0.169004454108289,0.985438920477611,1,31,positive regulation of blood pressure,BP,CNR1
7232,GO:0030206,0.169481892024129,0.985464025753445,1,25,chondroitin sulfate biosynthetic process,BP,CHST9
19217,GO:1902229,0.169706678273843,0.985261012199153,1,35,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,SFRP2
11339,GO:0043549,0.169814464431194,0.910839366812706,8,803,regulation of kinase activity,BP,EEF1A2;NEURL1;RGS4;CHI3L1;SFRP2;GNG3;ADCY1;SPRY4
3435,GO:0006813,0.169901603233154,0.945893343605055,3,211,potassium ion transport,BP,KCNS1;KCNC2;KCNK9
16705,GO:0072089,0.1699072256387,0.961736329936885,2,104,stem cell proliferation,BP,ASPM;SFRP2
5176,GO:0014072,0.17010389079536,0.985257890852726,1,30,response to isoquinoline alkaloid,BP,CNR1
11178,GO:0043278,0.17010389079536,0.985257890852726,1,30,response to morphine,BP,CNR1
4470,GO:0009266,0.170273119362373,0.945712697156667,3,216,response to temperature stimulus,BP,CAMK2A;CRYAB;VGF
15019,GO:0060795,0.170319745595635,0.985203739584935,1,31,cell fate commitment involved in formation of primary germ layer,BP,SFRP2
12297,GO:0045987,0.170585861694513,0.985171416601667,1,30,positive regulation of smooth muscle contraction,BP,CHRM3
12307,GO:0046006,0.170756459336327,0.985110645040907,1,32,regulation of activated T cell proliferation,BP,IGFBP2
17628,GO:0097150,0.170780825601978,0.985311685680055,1,22,neuronal stem cell population maintenance,BP,ASPM
3924,GO:0008150,0.170963133224685,0.921423437562964,95,14380,biological_process,BP,CAMK1G;SYT13;GABRA1;PTPRN;BCAT1;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;LNX1;RBFOX1;RPH3A;BIRC5;KIF4A;CHGA;MYBL2;RIMS4;EEF1A2;CELF4;ST8SIA5;SYTL4;STMN2;NEFM;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;IGFBP2;RGS4;CENPF;CNR1;TJP2;PRLHR;IQSEC3;HPCA;KCNS1;PACSIN1;VGF;PRRG3;SULT4A1;CALY;TOP2A;SNAP25;SYT4;CHRM3;CHI3L1;FAM189A2;MRAP2;SLC14A1;STAC2;SLC4A10;SFRP2;LIX1;CXCL14;GABRB2;TENM2;DAAM2;MKI67;FREM2;ZNF385D;CHST9;NRGN;ABI3BP;GNG3;VSNL1;IGFN1;FABP7;PI16;ADCY1;KCNC2;KCNK9;NPTX1;NEUROD2;ENC1;ZCCHC12;PCSK1;DDN;ZDHHC23;MAP7D2;NELL2;SV2B;MYT1L;SPRY4;SELL;SLC6A17;NMB;PPP1R14C;GRIN2B
10931,GO:0042803,0.171153059664256,0.914231547360143,7,731,protein homodimerization activity,MF,CAMK2A;CRYAB;CENPF;TOP2A;SYT4;TENM2;KCNK9
7154,GO:0030100,0.171210732120391,0.945279944293887,3,215,regulation of endocytosis,BP,PACSIN1;CALY;SYT4
21332,GO:2000300,0.171447653217132,0.985113271876279,1,25,regulation of synaptic vesicle exocytosis,BP,RIMS4
12949,GO:0048169,0.17154527057173,0.985073285350301,1,26,regulation of long-term neuronal synaptic plasticity,BP,NEURL1
13557,GO:0050880,0.171594582724057,0.96105770819917,2,121,regulation of blood vessel size,BP,CHGA;CHRM3
8692,GO:0032839,0.171901249127218,0.984988284646364,1,27,dendrite cytoplasm,CC,HPCA
19932,GO:1903825,0.172045332820036,0.960946230049302,2,107,organic acid transmembrane transport,BP,SLC17A7;SLC6A17
20526,GO:1905039,0.172045332820036,0.960946230049302,2,107,carboxylic acid transmembrane transport,BP,SLC17A7;SLC6A17
17772,GO:0097421,0.172692160033514,0.98475955204433,1,32,liver regeneration,BP,PTPN3
4955,GO:0010800,0.172875086091293,0.984792262823562,1,28,positive regulation of peptidyl-threonine phosphorylation,BP,CHI3L1
9626,GO:0035150,0.173133767954776,0.960491262879591,2,122,regulation of tube size,BP,CHGA;CHRM3
13162,GO:0048665,0.173346473825323,0.984654892187922,1,31,neuron fate specification,BP,MYT1L
3503,GO:0006921,0.173417107742132,0.984657979404622,1,30,cellular component disassembly involved in execution phase of apoptosis,BP,TOP2A
14004,GO:0051642,0.173417997339783,0.984838596145259,1,22,centrosome localization,BP,ASPM
18926,GO:1901385,0.173437063278777,0.98463830053164,1,31,regulation of voltage-gated calcium channel activity,BP,HPCA
1368,GO:0003006,0.17343912514219,0.918049503129165,6,559,developmental process involved in reproduction,BP,PTPRN;ASPM;CELF4;NEURL1;VGF;SFRP2
11172,GO:0043270,0.173512437537475,0.944204751604584,3,217,positive regulation of ion transport,BP,CAMK2A;SYT4;KCNC2
15204,GO:0061135,0.174128766442395,0.960106294643547,2,128,endopeptidase regulator activity,MF,BIRC5;SFRP2
2792,GO:0005834,0.174290878035355,0.984452030036554,1,33,heterotrimeric G-protein complex,CC,GNG3
20661,GO:1905360,0.174290878035355,0.984452030036554,1,33,GTPase complex,CC,GNG3
5772,GO:0016242,0.174476838286148,0.984519279967553,1,27,negative regulation of macroautophagy,BP,LZTS1
17401,GO:0090313,0.174483286060829,0.984445987463089,1,31,regulation of protein targeting to membrane,BP,HPCA
8910,GO:0033198,0.174829756395737,0.984398303295114,1,30,response to ATP,BP,SELL
11286,GO:0043484,0.174876049591168,0.959886628627113,2,112,regulation of RNA splicing,BP,RBFOX1;CELF4
12174,GO:0045761,0.175639347641427,0.984248430857793,1,30,regulation of adenylate cyclase activity,BP,HPCA
2614,GO:0005520,0.175846595126766,0.984227555176,1,29,insulin-like growth factor binding,MF,IGFBP2
5678,GO:0016049,0.176109153176504,0.923032628871979,5,437,cell growth,BP,SYT1;CRYAB;IGFBP2;SYT4;SFRP2
3436,GO:0006814,0.176134146913772,0.943004108195285,3,202,sodium ion transport,BP,PTPN3;SLC17A7;SLC4A10
17777,GO:0097431,0.176625474031827,0.984167943243553,1,25,mitotic spindle pole,CC,ASPM
12483,GO:0046461,0.176678460746119,0.984022724518748,1,32,neutral lipid catabolic process,BP,FABP7
12486,GO:0046464,0.176678460746119,0.984022724518748,1,32,acylglycerol catabolic process,BP,FABP7
3708,GO:0007271,0.176993737872635,0.983963653763838,1,32,synaptic transmission, cholinergic,BP,CHRM3
13662,GO:0051047,0.177155631117087,0.930952888922334,4,345,positive regulation of secretion,BP,SYT1;SYTL4;SYT4;VSNL1
5415,GO:0015301,0.177451263646252,0.983947382087631,1,28,anion:anion antiporter activity,MF,SLC4A10
19008,GO:1901652,0.178274035125916,0.921771475820017,5,446,response to peptide,BP,PTPRN;CAMK2A;VGF;GNG3;ADCY1
2108,GO:0004629,0.178430054968218,0.983784369190504,1,27,phospholipase C activity,MF,CHRM3
10708,GO:0042379,0.178792486469607,0.983506638819262,1,42,chemokine receptor binding,MF,CXCL14
7703,GO:0031112,0.178799156925849,0.983714819680158,1,27,positive regulation of microtubule polymerization or depolymerization,BP,STMN2
5775,GO:0016247,0.17965988133162,0.958063514465849,2,123,channel regulator activity,MF,PTPN3;KCNS1
19429,GO:1902803,0.17970443274915,0.983543563486431,1,27,regulation of synaptic vesicle transport,BP,RIMS4
13032,GO:0048333,0.180082091571578,0.983412306744215,1,30,mesodermal cell differentiation,BP,SFRP2
6351,GO:0018345,0.180453807718076,0.98330768813766,1,32,protein palmitoylation,BP,ZDHHC23
19147,GO:1902042,0.180734008747945,0.983224209585164,1,34,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,SFRP2
5850,GO:0016417,0.180776671293502,0.983262079571989,1,31,S-acyltransferase activity,MF,ZDHHC23
7358,GO:0030414,0.18080274187606,0.95761935914992,2,127,peptidase inhibitor activity,MF,BIRC5;PI16
3831,GO:0007618,0.180880319031465,0.983225852842063,1,32,mating,BP,CNR1
8751,GO:0032941,0.181071654095977,0.983173692515029,1,33,secretion by tissue,BP,CHRM3
6949,GO:0021884,0.181984056614802,0.983086338666212,1,28,forebrain neuron development,BP,SLC4A10
15490,GO:0061842,0.182437079389814,0.983097189198235,1,24,microtubule organizing center localization,BP,ASPM
8853,GO:0033120,0.182666118012663,0.982915314274992,1,30,positive regulation of RNA splicing,BP,CELF4
3522,GO:0006953,0.183456689020084,0.982669078701101,1,36,acute-phase response,BP,CNR1
16400,GO:0071542,0.183639731448731,0.982691206841122,1,32,dopaminergic neuron differentiation,BP,SFRP2
12429,GO:0046329,0.183730987682455,0.982708212052257,1,30,negative regulation of JNK cascade,BP,SFRP2
14023,GO:0051668,0.183813122067184,0.956524570621493,2,114,localization within membrane,BP,DNM1;SNAP25
2283,GO:0004864,0.183931590347636,0.982634131232619,1,32,protein phosphatase inhibitor activity,MF,PPP1R14C
433,GO:0001134,0.183961836638527,0.982703068077478,1,28,transcription factor activity, transcription factor recruiting,MF,MYBL2
4379,GO:0009152,0.183962892615637,0.93921620194527,3,236,purine ribonucleotide biosynthetic process,BP,HPCA;MRAP2;ADCY1
7390,GO:0030507,0.184111903778554,0.982745822058348,1,25,spectrin binding,MF,PTPRN
19395,GO:1902692,0.184703698443605,0.982580481449618,1,27,regulation of neuroblast proliferation,BP,ASPM
21312,GO:2000273,0.184764363666681,0.982525395863092,1,29,positive regulation of signaling receptor activity,BP,NEURL1
4190,GO:0008584,0.184920581934072,0.95609298747926,2,116,male gonad development,BP,ASPM;SFRP2
472,GO:0001504,0.184962302724905,0.982467066516125,1,30,neurotransmitter uptake,BP,SNAP25
19334,GO:1902532,0.185314603433184,0.917643441989456,5,458,negative regulation of intracellular signal transduction,BP,FOXM1;RGS4;MRAP2;SFRP2;SPRY4
4855,GO:0010639,0.185404970808002,0.926512609985528,4,327,negative regulation of organelle organization,BP,STMN2;CENPF;TOP2A;SYT4
16036,GO:0070888,0.186005959336887,0.98224283579691,1,31,E-box binding,MF,NEUROD2
8793,GO:0033003,0.18603357166318,0.982174178607919,1,35,regulation of mast cell activation,BP,CNR1
10820,GO:0042592,0.186472063134058,0.88503396525242,13,1514,homeostatic process,BP,PTPRN;PTPN3;SLC17A7;SLC30A3;CNR1;VGF;MRAP2;SLC4A10;GNG3;VSNL1;ADCY1;NELL2;GRIN2B
19412,GO:1902742,0.186560964115481,0.982171121067227,1,29,apoptotic process involved in development,BP,CRYAB
6930,GO:0021846,0.186681402180134,0.98221596454226,1,26,cell proliferation in forebrain,BP,FABP7
16255,GO:0071322,0.186956667842112,0.955290396223149,2,121,cellular response to carbohydrate stimulus,BP,PTPRN;VSNL1
10956,GO:0042887,0.187054146595716,0.981957002371721,1,36,amide transmembrane transporter activity,MF,SLC14A1
13530,GO:0050850,0.187288452395594,0.981953948905222,1,33,positive regulation of calcium-mediated signaling,BP,NEUROD2
4868,GO:0010656,0.187354275409509,0.981957251604233,1,32,negative regulation of muscle cell apoptotic process,BP,SFRP2
7705,GO:0031114,0.187513101822235,0.982051158875869,1,26,regulation of microtubule depolymerization,BP,STMN2
12983,GO:0048247,0.187610128932502,0.981786562560384,1,41,lymphocyte chemotaxis,BP,CXCL14
6199,GO:0017080,0.187655216734711,0.981880554898509,1,33,sodium channel regulator activity,MF,PTPN3
13807,GO:0051262,0.187718787659459,0.954981044318399,2,125,protein tetramerization,BP,DNM1;GRIN2B
516,GO:0001569,0.187733088575441,0.981899078834024,1,31,branching involved in blood vessel morphogenesis,BP,SFRP2
12539,GO:0046546,0.187879825094848,0.954949209325689,2,117,development of primary male sexual characteristics,BP,ASPM;SFRP2
3656,GO:0007190,0.188340076856974,0.981777425248905,1,31,activation of adenylate cyclase activity,BP,ADCY1
2597,GO:0005484,0.188386933707823,0.981689275785676,1,36,SNAP receptor activity,MF,SNAP25
12165,GO:0045742,0.188733674299995,0.981680519308962,1,32,positive regulation of epidermal growth factor receptor signaling pathway,BP,NEURL1
1574,GO:0003401,0.189049841507994,0.981674008976841,1,29,axis elongation,BP,SFRP2
2991,GO:0006164,0.189432475871821,0.936556705795283,3,240,purine nucleotide biosynthetic process,BP,HPCA;MRAP2;ADCY1
7816,GO:0031333,0.189470006074786,0.954323649369729,2,119,negative regulation of protein complex assembly,BP,STMN2;CRYAB
7183,GO:0030140,0.189652980200786,0.981531949437194,1,30,trans-Golgi network transport vesicle,CC,NRGN
3605,GO:0007094,0.189667854752259,0.981509779889565,1,31,mitotic spindle assembly checkpoint,BP,CENPF
16177,GO:0071173,0.189667854752259,0.981509779889565,1,31,spindle assembly checkpoint,BP,CENPF
16178,GO:0071174,0.189667854752259,0.981509779889565,1,31,mitotic spindle checkpoint,BP,CENPF
18041,GO:0098772,0.189723382620497,0.882644718956577,13,1545,molecular function regulator,MF,PTPN3;CAMK2A;BIRC5;RGS4;IQSEC3;KCNS1;VGF;SFRP2;CXCL14;PI16;NMB;PPP1R14C;GRIN2B
12420,GO:0046320,0.190389029074837,0.981425602072843,1,28,regulation of fatty acid oxidation,BP,CNR1
13383,GO:0050650,0.190627988041132,0.981334288997521,1,30,chondroitin sulfate proteoglycan biosynthetic process,BP,CHST9
16610,GO:0071900,0.191058121819119,0.914233285479362,5,466,regulation of protein serine/threonine kinase activity,BP,RGS4;CHI3L1;SFRP2;GNG3;SPRY4
13204,GO:0048713,0.191105086115656,0.981182338833579,1,33,regulation of oligodendrocyte differentiation,BP,DAAM2
6237,GO:0017147,0.191568444735682,0.981123010357012,1,31,Wnt-protein binding,MF,SFRP2
4766,GO:0010470,0.191659847495029,0.981085960226031,1,32,regulation of gastrulation,BP,SFRP2
6466,GO:0019212,0.192337173082813,0.980913202879128,1,34,phosphatase inhibitor activity,MF,PPP1R14C
5552,GO:0015804,0.192377038957843,0.980921318512165,1,33,neutral amino acid transport,BP,SLC6A17
17737,GO:0097352,0.192402175556564,0.980899803597871,1,34,autophagosome maturation,BP,LIX1
5901,GO:0016504,0.192766319140258,0.980809187308022,1,35,peptidase activator activity,MF,SFRP2
9645,GO:0035235,0.193192483062483,0.980903833597106,1,26,ionotropic glutamate receptor signaling pathway,BP,GRIN2B
4805,GO:0010562,0.193244476392498,0.891287280256564,9,974,positive regulation of phosphorus metabolic process,BP,CHGA;EEF1A2;NEURL1;HPCA;CHI3L1;MRAP2;SFRP2;GNG3;ADCY1
12272,GO:0045937,0.193244476392498,0.891287280256564,9,974,positive regulation of phosphate metabolic process,BP,CHGA;EEF1A2;NEURL1;HPCA;CHI3L1;MRAP2;SFRP2;GNG3;ADCY1
7271,GO:0030261,0.193271301066969,0.980861263782378,1,27,chromosome condensation,BP,TOP2A
3180,GO:0006469,0.193892877979108,0.934370455862454,3,236,negative regulation of protein kinase activity,BP,RGS4;SFRP2;SPRY4
1405,GO:0003091,0.194011302017655,0.980661028521669,1,29,renal water homeostasis,BP,ADCY1
13279,GO:0048869,0.194095459417368,0.861639776628532,29,3667,cellular developmental process,BP,ASPM;SYT1;CAMK2A;MYBL2;CELF4;STMN2;NEFM;NPTX2;NEURL1;FOXM1;CENPF;CNR1;TJP2;PACSIN1;TOP2A;SNAP25;SYT4;SLC4A10;SFRP2;CXCL14;GABRB2;TENM2;DAAM2;FABP7;ADCY1;NPTX1;NEUROD2;ENC1;MYT1L
13500,GO:0050798,0.194209171743426,0.980494778003812,1,36,activated T cell proliferation,BP,IGFBP2
12218,GO:0045841,0.195313748624296,0.980329144477078,1,32,negative regulation of mitotic metaphase/anaphase transition,BP,CENPF
19165,GO:1902100,0.195313748624296,0.980329144477078,1,32,negative regulation of metaphase/anaphase transition of cell cycle,BP,CENPF
12205,GO:0045823,0.195492420349045,0.980256939392175,1,34,positive regulation of heart contraction,BP,CHGA
17617,GO:0097120,0.195816965805236,0.980223659361463,1,32,receptor localization to synapse,BP,SNAP25
8267,GO:0032228,0.195938006658581,0.980237856887825,1,30,regulation of synaptic transmission, GABAergic,BP,CNR1
576,GO:0001678,0.196115693041864,0.951689016129373,2,123,cellular glucose homeostasis,BP,PTPRN;VSNL1
19470,GO:1902904,0.196177162701209,0.951693691033438,2,116,negative regulation of supramolecular fiber organization,BP,STMN2;CRYAB
17011,GO:0072659,0.196621934110746,0.933045736402298,3,220,protein localization to plasma membrane,BP,PACSIN1;MRAP2;ZDHHC23
9132,GO:0033865,0.197166548188717,0.979844297463431,1,38,nucleoside bisphosphate metabolic process,BP,SULT4A1
9138,GO:0033875,0.197166548188717,0.979844297463431,1,38,ribonucleoside bisphosphate metabolic process,BP,SULT4A1
9157,GO:0034032,0.197166548188717,0.979844297463431,1,38,purine nucleoside bisphosphate metabolic process,BP,SULT4A1
3642,GO:0007173,0.197484940932421,0.951158263362611,2,119,epidermal growth factor receptor signaling pathway,BP,PTPN3;NEURL1
19916,GO:1903793,0.197608460644459,0.979810106759035,1,34,positive regulation of anion transport,BP,SYT4
18839,GO:1901186,0.19765396199975,0.979800439141568,1,34,positive regulation of ERBB signaling pathway,BP,NEURL1
1060,GO:0002437,0.198045200837381,0.979644011450732,1,39,inflammatory response to antigenic stimulus,BP,CNR1
20822,GO:1905819,0.198045582699746,0.979734436085864,1,33,negative regulation of chromosome separation,BP,CENPF
21679,GO:2000816,0.198045582699746,0.979734436085864,1,33,negative regulation of mitotic sister chromatid separation,BP,CENPF
17328,GO:0090218,0.198378952604311,0.979681883121712,1,32,positive regulation of lipid kinase activity,BP,EEF1A2
19130,GO:1901998,0.198712176291421,0.979542957976157,1,36,toxin transport,BP,DNM1
12225,GO:0045859,0.199245669077493,0.896054601239636,7,720,regulation of protein kinase activity,BP,NEURL1;RGS4;CHI3L1;SFRP2;GNG3;ADCY1;SPRY4
275,GO:0000776,0.199797988253158,0.950203765643527,2,125,kinetochore,CC,BIRC5;CENPF
8431,GO:0032459,0.20002658919041,0.979260500387505,1,36,regulation of protein oligomerization,BP,CRYAB
2917,GO:0006040,0.200336404743219,0.979193618192957,1,36,amino sugar metabolic process,BP,CHI3L1
12182,GO:0045776,0.201361938763733,0.978971397179133,1,36,negative regulation of blood pressure,BP,CNR1
11597,GO:0044325,0.201402830030926,0.949592391620145,2,116,ion channel binding,MF,RIMS4;KCNC2
3591,GO:0007062,0.201590818290271,0.949485734537325,2,123,sister chromatid cohesion,BP,BIRC5;CENPF
10890,GO:0042742,0.201614292151119,0.949377648621764,2,153,defense response to bacterium,BP,CHGA;VGF
10089,GO:0036002,0.201746376896186,0.978903752673629,1,35,pre-mRNA binding,MF,CELF4
17275,GO:0090150,0.201976826064967,0.930257057380243,3,285,establishment of protein localization to membrane,BP,HPCA;SNAP25;ZDHHC23
9438,GO:0034605,0.202410131234338,0.949160873259404,2,121,cellular response to heat,BP,CAMK2A;CRYAB
11845,GO:0045070,0.20245242421717,0.978804150716651,1,32,positive regulation of viral genome replication,BP,TOP2A
4187,GO:0008574,0.202685452750567,0.978795716577693,1,30,ATP-dependent microtubule motor activity, plus-end-directed,MF,KIF4A
564,GO:0001662,0.202941998748894,0.97864269214435,1,35,behavioral fear response,BP,NEUROD2
933,GO:0002209,0.202941998748894,0.97864269214435,1,35,behavioral defense response,BP,NEUROD2
11152,GO:0043243,0.202973160386927,0.978711061059925,1,31,positive regulation of protein complex disassembly,BP,STMN2
7943,GO:0031577,0.202980062217245,0.978651490281302,1,34,spindle checkpoint,BP,CENPF
7911,GO:0031503,0.203073422830015,0.929780640336771,3,233,protein-containing complex localization,BP,BIRC5;DNM1;SNAP25
4464,GO:0009260,0.203291040237127,0.929642588302641,3,249,ribonucleotide biosynthetic process,BP,HPCA;MRAP2;ADCY1
561,GO:0001659,0.203376335663859,0.978531178550283,1,36,temperature homeostasis,BP,CNR1
16572,GO:0071840,0.203454529993815,0.849335766979318,43,5788,cellular component organization or biogenesis,BP,SYT13;PTPRN;ASPM;SYT1;CAMK2A;LNX1;RPH3A;BIRC5;KIF4A;CHGA;MYBL2;CELF4;SYTL4;STMN2;NEFM;SLC17A7;NPTX2;DNM1;NEURL1;CRYAB;IGFBP2;CENPF;CNR1;IQSEC3;KCNS1;PACSIN1;CALY;TOP2A;SNAP25;SYT4;SFRP2;LIX1;TENM2;DAAM2;MKI67;ABI3BP;ADCY1;KCNC2;NPTX1;NEUROD2;ENC1;MAP7D2;GRIN2B
1355,GO:0002931,0.20356576556564,0.978541324225767,1,33,response to ischemia,BP,CAMK2A
14871,GO:0060560,0.203931896858684,0.9293999605454,3,207,developmental growth involved in morphogenesis,BP,SYT1;SYT4;SFRP2
3876,GO:0008066,0.204392273008833,0.978498848436961,1,27,glutamate receptor activity,MF,GRIN2B
7510,GO:0030808,0.204523723537652,0.948268582125408,2,128,regulation of nucleotide biosynthetic process,BP,HPCA;MRAP2
18729,GO:1900371,0.204523723537652,0.948268582125408,2,128,regulation of purine nucleotide biosynthetic process,BP,HPCA;MRAP2
13521,GO:0050829,0.204731024875898,0.978097566638091,1,47,defense response to Gram-negative bacterium,BP,CHGA
5827,GO:0016339,0.204891958441313,0.978249173690468,1,33,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,SELL
2424,GO:0005102,0.204966032131021,0.876428439230464,11,1311,signaling receptor binding,MF,SYT1;CAMK2A;SYTL4;DNM1;IGFBP2;VGF;MRAP2;SFRP2;CXCL14;GNG3;NMB
21855,GO:2001251,0.205050691761884,0.948103456003516,2,116,negative regulation of chromosome organization,BP,CENPF;TOP2A
21084,GO:1990752,0.205115365001373,0.978401872496471,1,25,microtubule end,CC,ASPM
7702,GO:0031111,0.205331376520068,0.978171667450861,1,32,negative regulation of microtubule polymerization or depolymerization,BP,STMN2
16939,GO:0072522,0.205809194827236,0.92835860127096,3,251,purine-containing compound biosynthetic process,BP,HPCA;MRAP2;ADCY1
9066,GO:0033628,0.206861101330215,0.977742051489643,1,37,regulation of cell adhesion mediated by integrin,BP,SFRP2
7198,GO:0030162,0.206927465270854,0.897002478205736,6,636,regulation of proteolysis,BP,PTPN3;BIRC5;CRYAB;SFRP2;PI16;GRIN2B
12457,GO:0046390,0.207571411280065,0.927455792721706,3,252,ribose phosphate biosynthetic process,BP,HPCA;MRAP2;ADCY1
21412,GO:2000401,0.207764550832321,0.977495737898164,1,40,regulation of lymphocyte migration,BP,CXCL14
12264,GO:0045927,0.209255835005793,0.92664249948284,3,224,positive regulation of growth,BP,SYT1;SYT4;SFRP2
11870,GO:0045104,0.210801043487739,0.976921345621109,1,33,intermediate filament cytoskeleton organization,BP,NEFM
3673,GO:0007212,0.210907475134998,0.976809272553155,1,38,dopamine receptor signaling pathway,BP,CALY
7511,GO:0030809,0.210952505795176,0.976831133882371,1,36,negative regulation of nucleotide biosynthetic process,BP,HPCA
18730,GO:1900372,0.210952505795176,0.976831133882371,1,36,negative regulation of purine nucleotide biosynthetic process,BP,HPCA
15968,GO:0070741,0.211225092011954,0.97678617643715,1,35,response to interleukin-6,BP,CHI3L1
12706,GO:0046915,0.211480336372022,0.976693455651848,1,37,transition metal ion transmembrane transporter activity,MF,SLC30A3
5831,GO:0016358,0.211614654159386,0.925464465031228,3,207,dendrite development,BP,CAMK2A;NEURL1;PACSIN1
18923,GO:1901381,0.211858913888075,0.97670015678793,1,32,positive regulation of potassium ion transmembrane transport,BP,KCNC2
9415,GO:0034508,0.211979789798741,0.976533449513533,1,40,centromere complex assembly,BP,CENPF
5131,GO:0014014,0.212075721852032,0.976573095480249,1,36,negative regulation of gliogenesis,BP,DAAM2
3956,GO:0008201,0.212456399935242,0.944940294077939,2,136,heparin binding,MF,ABI3BP;SELL
10824,GO:0042596,0.212479193174466,0.976463256673489,1,37,fear response,BP,NEUROD2
18031,GO:0098751,0.21253221962876,0.976545401494733,1,32,bone cell development,BP,TJP2
12169,GO:0045746,0.212608291408208,0.976402423963625,1,39,negative regulation of Notch signaling pathway,BP,NEURL1
8708,GO:0032880,0.213465090210175,0.881390455767736,8,867,regulation of protein localization,BP,SYTL4;CNR1;HPCA;SNAP25;SYT4;MRAP2;VSNL1;KCNC2
2287,GO:0004869,0.214248432137314,0.975979448562311,1,42,cysteine-type endopeptidase inhibitor activity,MF,BIRC5
2537,GO:0005310,0.215235604442476,0.975857013329558,1,35,dicarboxylic acid transmembrane transporter activity,MF,SLC17A7
9603,GO:0035091,0.215320525751818,0.923499119819097,3,224,phosphatidylinositol binding,MF,SYT1;RPH3A;NRGN
7036,GO:0022414,0.215649226453547,0.871802068020823,10,1156,reproductive process,BP,PTPRN;ASPM;CELF4;NEURL1;IGFBP2;CNR1;PRLHR;VGF;TOP2A;SFRP2
13906,GO:0051445,0.215706012933034,0.975694805883851,1,38,regulation of meiotic cell cycle,BP,ASPM
5746,GO:0016192,0.21580509992245,0.858990205908283,15,1818,vesicle-mediated transport,BP,SYT13;SYT1;RPH3A;KIF4A;CHGA;RIMS4;SYTL4;DNM1;PACSIN1;CALY;SNAP25;SYT4;CHI3L1;VSNL1;SELL
11869,GO:0045103,0.216066934180444,0.975681335941159,1,34,intermediate filament-based process,BP,NEFM
5843,GO:0016409,0.216338971008358,0.97554567317969,1,38,palmitoyltransferase activity,MF,ZDHHC23
13625,GO:0050999,0.21662094194577,0.975463417620282,1,39,regulation of nitric-oxide synthase activity,BP,CNR1
5684,GO:0016055,0.217100849697981,0.89830977475948,5,472,Wnt signaling pathway,BP,ASPM;CAMK2A;IGFBP2;SFRP2;DAAM2
9081,GO:0033673,0.217214489135532,0.922456882164152,3,250,negative regulation of kinase activity,BP,RGS4;SFRP2;SPRY4
2,GO:0000003,0.217239944602916,0.870643135857769,10,1159,reproduction,BP,PTPRN;ASPM;CELF4;NEURL1;IGFBP2;CNR1;PRLHR;VGF;TOP2A;SFRP2
18715,GO:1900271,0.217515520278873,0.975406262672897,1,31,regulation of long-term synaptic potentiation,BP,NRGN
14445,GO:0055086,0.217592012197732,0.890033652991393,6,674,nucleobase-containing small molecule metabolic process,BP,CHGA;TJP2;HPCA;SULT4A1;MRAP2;ADCY1
12893,GO:0048009,0.217923281262277,0.975309850501329,1,31,insulin-like growth factor receptor signaling pathway,BP,IGFBP2
7870,GO:0031430,0.218145449585897,0.975309654914093,1,29,M band,CC,CRYAB
1695,GO:0003924,0.218530783895824,0.921729112384488,3,272,GTPase activity,MF,EEF1A2;DNM1;GNG3
3887,GO:0008089,0.218790645838307,0.974980171855676,1,37,anterograde axonal transport,BP,KIF4A
130,GO:0000266,0.218884762925039,0.975014206198528,1,34,mitochondrial fission,BP,DNM1
5081,GO:0010955,0.219198409654116,0.974919362450656,1,35,negative regulation of protein processing,BP,BIRC5
19673,GO:1903318,0.219198409654116,0.974919362450656,1,35,negative regulation of protein maturation,BP,BIRC5
18562,GO:0198738,0.219499898553067,0.896802727470484,5,474,cell-cell signaling by wnt,BP,ASPM;CAMK2A;IGFBP2;SFRP2;DAAM2
2632,GO:0005547,0.220031087896078,0.974761342377038,1,33,phosphatidylinositol-3,4,5-trisphosphate binding,MF,NRGN
3946,GO:0008188,0.220032741368434,0.974555907474677,1,46,neuropeptide receptor activity,MF,PRLHR
11444,GO:0043954,0.220456957680443,0.974617493155709,1,35,cellular component maintenance,BP,GRIN2B
7320,GO:0030326,0.220867776957771,0.941408170993271,2,122,embryonic limb morphogenesis,BP,SFRP2;FREM2
9616,GO:0035113,0.220867776957771,0.941408170993271,2,122,embryonic appendage morphogenesis,BP,SFRP2;FREM2
4702,GO:0010165,0.221009320783821,0.97448438325634,1,35,response to X-ray,BP,SFRP2
13885,GO:0051403,0.22121470495602,0.920359715012973,3,243,stress-activated MAPK cascade,BP,CRYAB;FOXM1;SFRP2
8827,GO:0033048,0.222005475376329,0.974224015924025,1,36,negative regulation of mitotic sister chromatid segregation,BP,CENPF
4652,GO:0009968,0.222468789140344,0.866822914588532,10,1145,negative regulation of signal transduction,BP,PTPN3;CELF4;DNM1;NEURL1;FOXM1;IGFBP2;RGS4;MRAP2;SFRP2;SPRY4
2554,GO:0005342,0.222474369314246,0.940647770010404,2,137,organic acid transmembrane transporter activity,MF,SLC17A7;SLC6A17
12722,GO:0046943,0.222474369314246,0.940647770010404,2,137,carboxylic acid transmembrane transporter activity,MF,SLC17A7;SLC6A17
21573,GO:2000648,0.222910248043237,0.974023384739116,1,35,positive regulation of stem cell proliferation,BP,ASPM
4171,GO:0008536,0.223208226076775,0.973993396510071,1,33,Ran GTPase binding,MF,BIRC5
5178,GO:0014075,0.223481836043424,0.973864277831096,1,36,response to amine,BP,KCNC2
3297,GO:0006612,0.223572816738973,0.940050794106685,2,177,protein targeting to membrane,BP,HPCA;ZDHHC23
18295,GO:0099604,0.223925241339292,0.973985525703783,1,27,ligand-gated calcium channel activity,MF,GRIN2B
11441,GO:0043949,0.224500402930444,0.973545269686871,1,40,regulation of cAMP-mediated signaling,BP,MRAP2
4578,GO:0009725,0.225181848790363,0.873158931796317,8,888,response to hormone,BP,PTPRN;CAMK2A;CRYAB;IGFBP2;VGF;CHRM3;GNG3;ADCY1
13522,GO:0050830,0.225189650143454,0.973221442064275,1,53,defense response to Gram-positive bacterium,BP,CHGA
7807,GO:0031324,0.226361354205766,0.845758960325403,18,2250,negative regulation of cellular metabolic process,BP,LZTS1;PTPN3;BIRC5;CELF4;CRYAB;FOXM1;RGS4;CENPF;CNR1;HPCA;SFRP2;TENM2;PI16;NEUROD2;ENC1;MYT1L;SPRY4;PPP1R14C
17379,GO:0090288,0.226588714628199,0.938893658321437,2,126,negative regulation of cellular response to growth factor stimulus,BP,SFRP2;SPRY4
21394,GO:2000377,0.226988581675471,0.938641101894923,2,145,regulation of reactive oxygen species metabolic process,BP,CRYAB;FOXM1
18082,GO:0098839,0.227738855252936,0.972900789818148,1,32,postsynaptic density membrane,CC,GRIN2B
6043,GO:0016776,0.227801487094415,0.972709130963902,1,41,phosphotransferase activity, phosphate group as acceptor,MF,TJP2
740,GO:0001917,0.228076029055076,0.972727358186096,1,36,photoreceptor inner segment,CC,DNM1
4629,GO:0009895,0.228710840999724,0.916351131091371,3,243,negative regulation of catabolic process,BP,LZTS1;PTPN3;CNR1
1380,GO:0003018,0.228853829343545,0.937819340575553,2,144,vascular process in circulatory system,BP,CHGA;CHRM3
8825,GO:0033046,0.229648424192759,0.972312564857657,1,37,negative regulation of sister chromatid segregation,BP,CENPF
14197,GO:0051985,0.229648424192759,0.972312564857657,1,37,negative regulation of chromosome segregation,BP,CENPF
967,GO:0002279,0.230061905123623,0.97212386970811,1,42,mast cell activation involved in immune response,BP,CHGA
11192,GO:0043303,0.230061905123623,0.97212386970811,1,42,mast cell degranulation,BP,CHGA
15186,GO:0061098,0.230095926745292,0.972180823088784,1,38,positive regulation of protein tyrosine kinase activity,BP,NEURL1
6473,GO:0019220,0.23024760176462,0.852159644076947,13,1554,regulation of phosphate metabolic process,BP,CHGA;EEF1A2;NEURL1;FOXM1;RGS4;HPCA;CHI3L1;MRAP2;SFRP2;GNG3;ADCY1;SPRY4;PPP1R14C
7208,GO:0030173,0.230308793303116,0.97206118130535,1,42,integral component of Golgi membrane,CC,SYT4
5506,GO:0015701,0.230500348277419,0.972027737326927,1,41,bicarbonate transport,BP,SLC4A10
17009,GO:0072657,0.230709564443486,0.889640842936817,5,530,protein localization to membrane,BP,HPCA;PACSIN1;SNAP25;MRAP2;ZDHHC23
14559,GO:0060119,0.231423130640967,0.971882331114227,1,36,inner ear receptor cell development,BP,GABRB2
4680,GO:0010043,0.231447543987722,0.971681027945727,1,49,response to zinc ion,BP,SLC30A3
3424,GO:0006796,0.231736329745623,0.836486407800509,22,2861,phosphate-containing compound metabolic process,BP,CAMK1G;PTPN3;CAMK2A;BIRC5;CHGA;EEF1A2;NEURL1;CRYAB;PTPN5;FOXM1;RGS4;TJP2;HPCA;SULT4A1;CHI3L1;MRAP2;SFRP2;GNG3;ADCY1;SPRY4;PPP1R14C;GRIN2B
7776,GO:0031279,0.232515371961426,0.971497468014923,1,42,regulation of cyclase activity,BP,HPCA
4954,GO:0010799,0.23276216984019,0.971483073319017,1,39,regulation of peptidyl-threonine phosphorylation,BP,CHI3L1
17419,GO:0090342,0.232845398311396,0.971461698878302,1,39,regulation of cell aging,BP,FOXM1
13848,GO:0051339,0.232904314419107,0.971397464389877,1,42,regulation of lyase activity,BP,HPCA
13123,GO:0048585,0.232930964864903,0.852716614973372,12,1437,negative regulation of response to stimulus,BP,PTPN3;CELF4;DNM1;NEURL1;FOXM1;IGFBP2;RGS4;CNR1;MRAP2;SFRP2;FABP7;SPRY4
3209,GO:0006509,0.233086638711313,0.971382481566168,1,40,membrane protein ectodomain proteolysis,BP,PTPN3
18859,GO:1901224,0.233313077577697,0.971277264801039,1,43,positive regulation of NIK/NF-kappaB signaling,BP,CHI3L1
18504,GO:0140013,0.234848388628694,0.935138959179231,2,143,meiotic nuclear division,BP,ASPM;TOP2A
12162,GO:0045739,0.235064509024087,0.970838539614351,1,42,positive regulation of DNA repair,BP,FOXM1
12196,GO:0045806,0.235398183881527,0.970708224386452,1,45,negative regulation of endocytosis,BP,PACSIN1
10549,GO:0042059,0.235958655634136,0.970621425219726,1,41,negative regulation of epidermal growth factor receptor signaling pathway,BP,PTPN3
11749,GO:0044772,0.236123888737009,0.886161403881958,5,515,mitotic cell cycle phase transition,BP,BCAT1;LZTS1;CAMK2A;FOXM1;CENPF
3861,GO:0008038,0.236360783391429,0.970705795261658,1,32,neuron recognition,BP,CNR1
13267,GO:0048854,0.236821459299364,0.970511566306383,1,35,brain morphogenesis,BP,SLC4A10
18308,GO:0099634,0.237016582614096,0.970483911624255,1,34,postsynaptic specialization membrane,CC,GRIN2B
15138,GO:0061028,0.237240270083964,0.970339279521327,1,38,establishment of endothelial barrier,BP,TJP2
15281,GO:0061351,0.237397115373358,0.934047378090651,2,128,neural precursor cell proliferation,BP,ASPM;FABP7
13715,GO:0051130,0.237662725286962,0.855580657787842,10,1122,positive regulation of cellular component organization,BP,SYT1;STMN2;NEURL1;CNR1;PACSIN1;CALY;SYT4;TENM2;NEUROD2;ENC1
3970,GO:0008217,0.23769214428157,0.933826622072961,2,149,regulation of blood pressure,BP,CHGA;CNR1
6615,GO:0019730,0.238981886809419,0.969586019843508,1,63,antimicrobial humoral response,BP,CHGA
1071,GO:0002448,0.239370624997191,0.969675986864846,1,44,mast cell mediated immunity,BP,CHGA
21395,GO:2000378,0.239963973353309,0.969503642214767,1,45,negative regulation of reactive oxygen species metabolic process,BP,CRYAB
4710,GO:0010212,0.240009078555238,0.932793382555,2,142,response to ionizing radiation,BP,CRYAB;SFRP2
9606,GO:0035094,0.240048633108772,0.969526230615749,1,42,response to nicotine,BP,CNR1
13834,GO:0051302,0.240192421483448,0.932725535134422,2,138,regulation of cell division,BP,ASPM;SFRP2
7407,GO:0030534,0.240527336730644,0.932607428790528,2,130,adult behavior,BP,DNM1;GABRG2
13747,GO:0051174,0.240543774734908,0.84419729320974,13,1568,regulation of phosphorus metabolic process,BP,CHGA;EEF1A2;NEURL1;FOXM1;RGS4;HPCA;CHI3L1;MRAP2;SFRP2;GNG3;ADCY1;SPRY4;PPP1R14C
4512,GO:0009409,0.240565435890356,0.969372508546955,1,43,response to cold,BP,VGF
1502,GO:0003254,0.241072613159562,0.969305264808362,1,39,regulation of membrane depolarization,BP,PTPN3
12601,GO:0046661,0.242318766981746,0.931742547607052,2,139,male sex differentiation,BP,ASPM;SFRP2
7039,GO:0022602,0.24233401579334,0.968966981912955,1,39,ovulation cycle process,BP,PTPRN
8715,GO:0032890,0.242966587412609,0.968743156438206,1,42,regulation of organic acid transport,BP,SYT4
13496,GO:0050793,0.243274029467281,0.832207202672931,18,2208,regulation of developmental process,BP,ASPM;SYT1;CELF4;STMN2;NEURL1;FOXM1;CENPF;CNR1;TJP2;PACSIN1;SNAP25;SYT4;CHI3L1;SFRP2;CXCL14;DAAM2;NEUROD2;ENC1
17744,GO:0097366,0.243351051848308,0.968639162899313,1,42,response to bronchodilator,BP,KCNC2
13458,GO:0050732,0.243717826045496,0.968508029027646,1,44,negative regulation of peptidyl-tyrosine phosphorylation,BP,SFRP2
13847,GO:0051338,0.243875771962663,0.859760476429264,8,898,regulation of transferase activity,BP,EEF1A2;NEURL1;RGS4;CHI3L1;SFRP2;GNG3;ADCY1;SPRY4
3488,GO:0006897,0.244000143924857,0.872323505250779,6,632,endocytosis,BP,SYT1;DNM1;PACSIN1;CALY;SNAP25;SYT4
18316,GO:0099738,0.244091542739751,0.968603278094327,1,34,cell cortex region,CC,RIMS4
20070,GO:1904115,0.244363026408551,0.968399637606845,1,40,axon cytoplasm,CC,KIF4A
5077,GO:0010950,0.244501889447837,0.930673921162758,2,154,positive regulation of endopeptidase activity,BP,SFRP2;GRIN2B
10810,GO:0042581,0.244942840290143,0.930468725799589,2,154,specific granule,CC,SNAP25;CHI3L1
6313,GO:0018198,0.245337464964939,0.96805164228812,1,45,peptidyl-cysteine modification,BP,ZDHHC23
11726,GO:0044703,0.24544192099727,0.864341260984708,7,787,multi-organism reproductive process,BP,ASPM;CELF4;NEURL1;IGFBP2;CNR1;PRLHR;VGF
10623,GO:0042220,0.246021761388704,0.967928859156365,1,41,response to cocaine,BP,CNR1
1257,GO:0002762,0.246556180643272,0.96778221881255,1,41,negative regulation of myeloid leukocyte differentiation,BP,TJP2
7747,GO:0031228,0.248418122186725,0.967187647750143,1,46,intrinsic component of Golgi membrane,CC,SYT4
750,GO:0001933,0.248839237470904,0.88936618960023,4,387,negative regulation of protein phosphorylation,BP,FOXM1;RGS4;SFRP2;SPRY4
9747,GO:0035418,0.249104958353858,0.967205951908571,1,35,protein localization to synapse,BP,SNAP25
3616,GO:0007131,0.249152471286554,0.967013577806345,1,44,reciprocal meiotic recombination,BP,TOP2A
9994,GO:0035825,0.249152471286554,0.967013577806345,1,44,homologous recombination,BP,TOP2A
3683,GO:0007223,0.249282461649947,0.96708749491736,1,38,Wnt signaling pathway, calcium modulating pathway,BP,CAMK2A
3563,GO:0007019,0.249700658000912,0.96697120591877,1,38,microtubule depolymerization,BP,STMN2
11170,GO:0043268,0.249741489661913,0.966939049214681,1,39,positive regulation of potassium ion transport,BP,KCNC2
3513,GO:0006937,0.249921485596513,0.928175904389674,2,143,regulation of muscle contraction,BP,CHGA;CHRM3
7434,GO:0030595,0.250274464028524,0.927912359890132,2,171,leukocyte chemotaxis,BP,CHGA;CXCL14
7035,GO:0022412,0.250619788330555,0.904184846077893,3,264,cellular process involved in reproduction in multicellular organism,BP,ASPM;CELF4;NEURL1
13620,GO:0050994,0.250741963160826,0.966585647741202,1,43,regulation of lipid catabolic process,BP,CNR1
13083,GO:0048511,0.251328075000902,0.903794272618345,3,258,rhythmic process,BP,PTPRN;TOP2A;ADCY1
3812,GO:0007595,0.251481486186371,0.966452383177395,1,39,lactation,BP,NEURL1
13713,GO:0051128,0.251728770128225,0.825353884007632,18,2217,regulation of cellular component organization,BP,SYT1;STMN2;NEURL1;CRYAB;IGFBP2;CENPF;CNR1;PACSIN1;CALY;TOP2A;SNAP25;SYT4;SFRP2;TENM2;MKI67;NEUROD2;ENC1;GRIN2B
335,GO:0000922,0.251950102960793,0.927219603906237,2,142,spindle pole,CC,ASPM;CENPF
18068,GO:0098815,0.252358958860702,0.966226691209795,1,38,modulation of excitatory postsynaptic potential,BP,CELF4
12179,GO:0045766,0.252524680486525,0.926938174721232,2,144,positive regulation of angiogenesis,BP,CHI3L1;SFRP2
18049,GO:0098791,0.253112926152512,0.858881524906638,7,769,Golgi subcompartment,CC,CAMK1G;RBFOX1;ST8SIA5;SNAP25;SYT4;CHST9;TMEM130
16981,GO:0072583,0.25316053937001,0.966000386032254,1,38,clathrin-dependent endocytosis,BP,DNM1
7704,GO:0031113,0.253315115008076,0.96589562711201,1,41,regulation of microtubule polymerization,BP,STMN2
21264,GO:2000179,0.25349638101549,0.965863560511689,1,40,positive regulation of neural precursor cell proliferation,BP,ASPM
2412,GO:0005080,0.253513715100551,0.96580329654438,1,43,protein kinase C binding,MF,TOP2A
13857,GO:0051348,0.253648008655134,0.90244096340645,3,275,negative regulation of transferase activity,BP,RGS4;SFRP2;SPRY4
7230,GO:0030204,0.253886122731008,0.965733517874321,1,41,chondroitin sulfate metabolic process,BP,CHST9
2711,GO:0005694,0.254024467034641,0.852350014880364,8,900,chromosome,CC,BIRC5;KIF4A;MYBL2;CENPF;TOP2A;MKI67;ENC1;MYT1L
12265,GO:0045930,0.254192161657771,0.902117925990745,3,282,negative regulation of mitotic cell cycle,BP,PTPN3;CENPF;TOP2A
14013,GO:0051653,0.255214919080447,0.965416557192708,1,38,spindle localization,BP,ASPM
8477,GO:0032515,0.255459251961599,0.965199302279309,1,46,negative regulation of phosphoprotein phosphatase activity,BP,PPP1R14C
18469,GO:0120032,0.255501804183135,0.925529036170536,2,141,regulation of plasma membrane bounded cell projection assembly,BP,NEURL1;TENM2
18755,GO:1900543,0.25643175592341,0.96491957508663,1,46,negative regulation of purine nucleotide metabolic process,BP,HPCA
35,GO:0000070,0.256768756459791,0.924911636229062,2,143,mitotic sister chromatid segregation,BP,KIF4A;CENPF
7117,GO:0030018,0.257447846884789,0.924702723804037,2,120,Z disc,CC,CRYAB;IGFN1
5458,GO:0015459,0.257493932520164,0.964612634109586,1,46,potassium channel regulator activity,MF,KCNS1
12123,GO:0045661,0.258185540099009,0.964411979438018,1,46,regulation of myoblast differentiation,BP,CXCL14
9934,GO:0035725,0.258931097516967,0.923914422831213,2,133,sodium ion transmembrane transport,BP,PTPN3;SLC17A7
12294,GO:0045980,0.259183067160763,0.964106129279273,1,47,negative regulation of nucleotide metabolic process,BP,HPCA
10412,GO:0038127,0.259363795865742,0.923666848007706,2,141,ERBB signaling pathway,BP,PTPN3;NEURL1
20714,GO:1905475,0.259795818684355,0.923407618589607,2,153,regulation of protein localization to membrane,BP,HPCA;MRAP2
7305,GO:0030308,0.260020019403715,0.923294911010874,2,154,negative regulation of cell growth,BP,CRYAB;SFRP2
13481,GO:0050773,0.260141838387964,0.923353757276827,2,128,regulation of dendrite development,BP,NEURL1;PACSIN1
12516,GO:0046503,0.260727776115889,0.963624353015089,1,49,glycerolipid catabolic process,BP,FABP7
8633,GO:0032768,0.260783371240259,0.963607990434543,1,49,regulation of monooxygenase activity,BP,CNR1
14831,GO:0060491,0.260836243274905,0.922942657140686,2,143,regulation of cell projection assembly,BP,NEURL1;TENM2
3627,GO:0007157,0.260843094519096,0.963685996162999,1,43,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,TENM2
17249,GO:0090102,0.260960795613452,0.963651417682227,1,43,cochlea development,BP,GABRB2
13387,GO:0050654,0.261117202908642,0.963605439680645,1,43,chondroitin sulfate proteoglycan metabolic process,BP,CHST9
9815,GO:0035556,0.261267032534998,0.814626962473024,20,2556,intracellular signal transduction,BP,CAMK1G;CAMK2A;CHGA;CRYAB;FOXM1;RGS4;TJP2;IQSEC3;HPCA;CHI3L1;MRAP2;STAC2;SFRP2;ZNF385D;GNG3;ADCY1;KCNC2;NEUROD2;SPRY4;GRIN2B
11883,GO:0045123,0.261300128464318,0.963470022248592,1,48,cellular extravasation,BP,SELL
11319,GO:0043525,0.261331107252568,0.963491399950357,1,46,positive regulation of neuron apoptotic process,BP,MYBL2
3493,GO:0006904,0.261866997673447,0.963302623137128,1,48,vesicle docking involved in exocytosis,BP,SNAP25
4786,GO:0010518,0.262320341241423,0.963215586601642,1,45,positive regulation of phospholipase activity,BP,HPCA
6459,GO:0019205,0.26248395397059,0.963105501829401,1,49,nucleobase-containing compound kinase activity,MF,TJP2
13132,GO:0048608,0.263200618276539,0.880316071006186,4,381,reproductive structure development,BP,PTPRN;ASPM;VGF;SFRP2
11254,GO:0043408,0.263526823930349,0.858735711046315,6,654,regulation of MAPK cascade,BP,FOXM1;RGS4;CHI3L1;SFRP2;GNG3;SPRY4
10955,GO:0042886,0.263718795907176,0.823411464397335,14,1809,amide transport,BP,PTPRN;RPH3A;SYTL4;CENPF;CNR1;HPCA;VGF;SNAP25;SYT4;CHI3L1;SLC14A1;VSNL1;KCNC2;ZDHHC23
19311,GO:1902475,0.264238154105545,0.962663017121235,1,44,L-alpha-amino acid transmembrane transport,BP,SLC17A7
18823,GO:1901135,0.264405878168939,0.839576115363792,9,1121,carbohydrate derivative metabolic process,BP,CHGA;ST8SIA5;TJP2;HPCA;SULT4A1;CHI3L1;MRAP2;CHST9;ADCY1
17241,GO:0090090,0.264746837469973,0.920956903041225,2,161,negative regulation of canonical Wnt signaling pathway,BP,IGFBP2;SFRP2
12216,GO:0045839,0.264777176816317,0.962467839564293,1,46,negative regulation of mitotic nuclear division,BP,CENPF
2598,GO:0005488,0.265138332969318,0.818249275869766,85,12745,binding,MF,CAMK1G;SYT13;GABRA1;PTPRN;BCAT1;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;LNX1;RBFOX1;RPH3A;BIRC5;KIF4A;MYBL2;RIMS4;EEF1A2;CELF4;ST8SIA5;SYTL4;STMN2;NEFM;NPTX2;DNM1;NEURL1;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;IGFBP2;RGS4;CENPF;CNR1;TJP2;PRLHR;IQSEC3;HPCA;KCNS1;PACSIN1;VGF;PRRG3;SULT4A1;CALY;TOP2A;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;STAC2;SFRP2;CXCL14;GABRB2;TENM2;DAAM2;MKI67;FREM2;ZNF385D;NRGN;ABI3BP;GNG3;VSNL1;IGFN1;FABP7;ADCY1;KCNC2;KCNK9;NPTX1;NEUROD2;ENC1;ZCCHC12;PCSK1;CREG2;DDN;NELL2;SV2B;C11ORF87;MYT1L;SPRY4;SELL;CPNE4;NMB;GRIN2B
12547,GO:0046578,0.265235686984245,0.895827640306507,3,234,regulation of Ras protein signal transduction,BP,FOXM1;IQSEC3;SPRY4
9660,GO:0035254,0.265689751842162,0.962286472215513,1,41,glutamate receptor binding,MF,CAMK2A
15322,GO:0061458,0.26698639105958,0.877885182091867,4,384,reproductive system development,BP,PTPRN;ASPM;VGF;SFRP2
475,GO:0001508,0.267013025983295,0.919980542364186,2,129,action potential,BP,PTPN3;CNR1
15224,GO:0061178,0.267058555326637,0.961734723960947,1,49,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,VSNL1
3604,GO:0007093,0.267364695423688,0.91967776622237,2,157,mitotic cell cycle checkpoint,BP,CENPF;TOP2A
6289,GO:0018105,0.268569143393152,0.893819603111098,3,255,peptidyl-serine phosphorylation,BP,CAMK1G;CAMK2A;SFRP2
19553,GO:1903046,0.269832491422962,0.918453665638196,2,156,meiotic cell cycle process,BP,ASPM;TOP2A
7692,GO:0031098,0.269919928937351,0.892992730723142,3,269,stress-activated protein kinase signaling cascade,BP,CRYAB;FOXM1;SFRP2
5072,GO:0010941,0.270298426216216,0.82362265004246,12,1524,regulation of cell death,BP,CAMK2A;BIRC5;CHGA;MYBL2;EEF1A2;NEURL1;CRYAB;CNR1;TOP2A;SFRP2;GABRB2;GRIN2B
18801,GO:1901068,0.270878331546117,0.960553960689913,1,50,guanosine-containing compound metabolic process,BP,TJP2
4487,GO:0009314,0.271261868956398,0.875102488307491,4,402,response to radiation,BP,CRYAB;SLC4A10;SFRP2;KCNC2
15119,GO:0060999,0.271600529150638,0.960536456646797,1,39,positive regulation of dendritic spine development,BP,NEURL1
497,GO:0001541,0.271699489483904,0.960315507030511,1,49,ovarian follicle development,BP,VGF
18138,GO:0098930,0.27190236114298,0.96031893076745,1,45,axonal transport,BP,KIF4A
11747,GO:0044770,0.272970387314568,0.861538426949566,5,545,cell cycle phase transition,BP,BCAT1;LZTS1;CAMK2A;FOXM1;CENPF
7391,GO:0030509,0.273453145376787,0.916698019101027,2,142,BMP signaling pathway,BP,SFRP2;ZCCHC12
9699,GO:0035329,0.273665574218783,0.95992375824107,1,38,hippo signaling,BP,TJP2
3423,GO:0006793,0.275846713188133,0.799932055130679,22,2947,phosphorus metabolic process,BP,CAMK1G;PTPN3;CAMK2A;BIRC5;CHGA;EEF1A2;NEURL1;CRYAB;PTPN5;FOXM1;RGS4;TJP2;HPCA;SULT4A1;CHI3L1;MRAP2;SFRP2;GNG3;ADCY1;SPRY4;PPP1R14C;GRIN2B
9692,GO:0035308,0.276468235061086,0.958811665972532,1,50,negative regulation of protein dephosphorylation,BP,PPP1R14C
6862,GO:0021695,0.276693507477486,0.958843484191039,1,44,cerebellar cortex development,BP,NEUROD2
3601,GO:0007088,0.277114588318668,0.914803239248656,2,151,regulation of mitotic nuclear division,BP,CENPF;MKI67
7147,GO:0030071,0.27711523294046,0.958638816009608,1,48,regulation of mitotic metaphase/anaphase transition,BP,CENPF
19164,GO:1902099,0.27711523294046,0.958638816009608,1,48,regulation of metaphase/anaphase transition of cell cycle,BP,CENPF
7850,GO:0031400,0.278467054780554,0.857749411424394,5,537,negative regulation of protein modification process,BP,FOXM1;RGS4;SFRP2;SPRY4;PPP1R14C
7225,GO:0030199,0.278508351096198,0.958289744483968,1,43,collagen fibril organization,BP,SFRP2
9831,GO:0035580,0.278526396950994,0.958042955827464,1,59,specific granule lumen,CC,CHI3L1
21574,GO:2000649,0.278773020154657,0.958147601781647,1,46,regulation of sodium ion transmembrane transporter activity,BP,PTPN3
11340,GO:0043550,0.279195496090285,0.95799531664801,1,47,regulation of lipid kinase activity,BP,EEF1A2
7396,GO:0030514,0.279318889228106,0.957992329808879,1,45,negative regulation of BMP signaling pathway,BP,SFRP2
13106,GO:0048546,0.279947096182781,0.957791839455744,1,45,digestive tract morphogenesis,BP,SFRP2
7999,GO:0031672,0.280009525730426,0.957904060637657,1,39,A band,CC,CRYAB
9613,GO:0035107,0.281966205528905,0.912360304201715,2,142,appendage morphogenesis,BP,SFRP2;FREM2
9614,GO:0035108,0.281966205528905,0.912360304201715,2,142,limb morphogenesis,BP,SFRP2;FREM2
13281,GO:0048871,0.282031339910886,0.885714803698447,3,281,multicellular organismal homeostasis,BP,CNR1;MRAP2;ADCY1
8001,GO:0031674,0.282196675860673,0.912301022848128,2,131,I band,CC,CRYAB;IGFN1
2776,GO:0005798,0.282295792370516,0.912099155400781,2,163,Golgi-associated vesicle,CC,PACSIN1;NRGN
11064,GO:0043112,0.282530520158082,0.911993485704623,2,159,receptor metabolic process,BP,DNM1;SNAP25
5079,GO:0010952,0.282796415948848,0.911811659110797,2,171,positive regulation of peptidase activity,BP,SFRP2;GRIN2B
4511,GO:0009408,0.285669076401712,0.910366000145419,2,159,response to heat,BP,CAMK2A;CRYAB
19172,GO:1902108,0.285718907119791,0.955712643844659,1,59,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,CAMK2A
3639,GO:0007169,0.285799419102732,0.842784220866369,6,648,transmembrane receptor protein tyrosine kinase signaling pathway,BP,PTPN3;DNM1;NEURL1;IGFBP2;SPRY4;GRIN2B
962,GO:0002274,0.286296135927782,0.852249604310316,5,589,myeloid leukocyte activation,BP,CHGA;CNR1;SNAP25;CHI3L1;SELL
13246,GO:0048812,0.286478376334177,0.842325017598245,6,598,neuron projection morphogenesis,BP,SYT1;CAMK2A;PACSIN1;SYT4;ADCY1;NPTX1
14442,GO:0055082,0.28698736865114,0.841898448838565,6,682,cellular chemical homeostasis,BP,PTPRN;SLC30A3;SLC4A10;GNG3;VSNL1;GRIN2B
2909,GO:0006022,0.287029552816039,0.909660493356337,2,158,aminoglycan metabolic process,BP,CHI3L1;CHST9
15533,GO:0062012,0.288034357417317,0.864041439953989,4,425,regulation of small molecule metabolic process,BP,CHGA;CNR1;HPCA;MRAP2
8370,GO:0032387,0.288407364692245,0.954860552841819,1,56,negative regulation of intracellular transport,BP,CRYAB
6696,GO:0019897,0.288828977623034,0.908709916061681,2,160,extrinsic component of plasma membrane,CC,SNAP25;GNG3
11908,GO:0045171,0.289685773458096,0.954461840831081,1,54,intercellular bridge,CC,KIF4A
8153,GO:0032011,0.290289024870516,0.954434784325745,1,44,ARF protein signal transduction,BP,IQSEC3
8154,GO:0032012,0.290289024870516,0.954434784325745,1,44,regulation of ARF protein signal transduction,BP,IQSEC3
16366,GO:0071478,0.290520680174216,0.907803945453579,2,164,cellular response to radiation,BP,CRYAB;SFRP2
5819,GO:0016324,0.290645943191863,0.880473259132709,3,267,apical plasma membrane,CC,ASPM;IGFBP2;KCNC2
12549,GO:0046580,0.290682009379216,0.954262454155576,1,46,negative regulation of Ras protein signal transduction,BP,SPRY4
4391,GO:0009165,0.292442744117549,0.879285363494716,3,307,nucleotide biosynthetic process,BP,HPCA;MRAP2;ADCY1
3515,GO:0006940,0.292488061764219,0.953506425761403,1,55,regulation of smooth muscle contraction,BP,CHRM3
18857,GO:1901222,0.292501983883653,0.953501721073676,1,55,regulation of NIK/NF-kappaB signaling,BP,CHI3L1
6479,GO:0019229,0.292582917507675,0.953503270261004,1,53,regulation of vasoconstriction,BP,CHRM3
12075,GO:0045600,0.292721726162988,0.953441625457675,1,54,positive regulation of fat cell differentiation,BP,SFRP2
118,GO:0000245,0.293343112877655,0.953189969869803,1,57,spliceosomal complex assembly,BP,CELF4
21657,GO:2000779,0.294491099081256,0.952904374879459,1,50,regulation of double-strand break repair,BP,FOXM1
3603,GO:0007091,0.294564276352297,0.952862729489567,1,51,metaphase/anaphase transition of mitotic cell cycle,BP,CENPF
11756,GO:0044784,0.294564276352297,0.952862729489567,1,51,metaphase/anaphase transition of cell cycle,BP,CENPF
19146,GO:1902041,0.294941471700259,0.952673191224929,1,55,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,SFRP2
15783,GO:0070405,0.295224785192675,0.9525235814417,1,59,ammonium ion binding,MF,CHRM3
14611,GO:0060193,0.295694691312157,0.952430184992365,1,54,positive regulation of lipase activity,BP,HPCA
18838,GO:1901185,0.296112731872039,0.952302050183915,1,53,negative regulation of ERBB signaling pathway,BP,PTPN3
10680,GO:0042326,0.296254683520136,0.858521586394244,4,420,negative regulation of phosphorylation,BP,FOXM1;RGS4;SFRP2;SPRY4
13841,GO:0051310,0.296601172767744,0.952104768517572,1,55,metaphase plate congression,BP,CENPF
20032,GO:1904018,0.296704722596037,0.904529330673553,2,161,positive regulation of vasculature development,BP,CHI3L1;SFRP2
5090,GO:0010965,0.296962353571372,0.952026072676389,1,52,regulation of mitotic sister chromatid separation,BP,CENPF
3546,GO:0006996,0.297035338830874,0.777730274652903,26,3478,organelle organization,BP,SYT13;PTPRN;ASPM;SYT1;CAMK2A;RPH3A;BIRC5;KIF4A;CHGA;MYBL2;SYTL4;STMN2;NEFM;SLC17A7;DNM1;NEURL1;CRYAB;CENPF;IQSEC3;PACSIN1;TOP2A;SNAP25;SYT4;DAAM2;MKI67;MAP7D2
14557,GO:0060113,0.297183233276949,0.952019747649375,1,48,inner ear receptor cell differentiation,BP,GABRB2
9065,GO:0033627,0.297685642712736,0.951777009824406,1,52,cell adhesion mediated by integrin,BP,SFRP2
4587,GO:0009749,0.297706574519933,0.90397569525827,2,165,response to glucose,BP,PTPRN;VSNL1
18883,GO:1901293,0.297747219487823,0.875974673713347,3,311,nucleoside phosphate biosynthetic process,BP,HPCA;MRAP2;ADCY1
5354,GO:0015179,0.298915689247911,0.951335817615598,1,53,L-amino acid transmembrane transporter activity,MF,SLC17A7
16534,GO:0071772,0.299353560586982,0.903141264453804,2,153,response to BMP,BP,SFRP2;ZCCHC12
16535,GO:0071773,0.299353560586982,0.903141264453804,2,153,cellular response to BMP stimulus,BP,SFRP2;ZCCHC12
19971,GO:1903902,0.299749696638684,0.951015875256006,1,55,positive regulation of viral life cycle,BP,TOP2A
328,GO:0000910,0.300421661160666,0.902546422956197,2,157,cytokinesis,BP,KIF4A;PACSIN1
14080,GO:0051784,0.300477990867203,0.950776975302162,1,54,negative regulation of nuclear division,BP,CENPF
18244,GO:0099512,0.301244402885256,0.823299055109847,7,752,supramolecular fiber,CC,ASPM;BIRC5;KIF4A;NEFM;DNM1;CRYAB;IGFN1
6698,GO:0019899,0.30164447143768,0.785731403962056,17,2133,enzyme binding,MF,PTPRN;ASPM;PTPN3;CAMK2A;RPH3A;BIRC5;RIMS4;EEF1A2;SYTL4;DNM1;FOXM1;IQSEC3;HPCA;TOP2A;DAAM2;SELL;GRIN2B
21737,GO:2001020,0.3020233727803,0.901621099138434,2,171,regulation of response to DNA damage stimulus,BP,FOXM1;SFRP2
4719,GO:0010256,0.302030757671653,0.854629050643728,4,392,endomembrane system organization,BP,PTPRN;DNM1;PACSIN1;SYT4
2817,GO:0005874,0.302032103186022,0.854645062150762,4,380,microtubule,CC,ASPM;BIRC5;KIF4A;DNM1
19038,GO:1901701,0.302118513642505,0.815932075342835,8,959,cellular response to oxygen-containing compound,BP,PTPRN;CAMK2A;NEURL1;CHRM3;GNG3;VSNL1;ADCY1;KCNC2
7827,GO:0031345,0.302412780989416,0.901462876844973,2,158,negative regulation of cell projection organization,BP,STMN2;GRIN2B
4785,GO:0010517,0.302437531958689,0.950122502105619,1,52,regulation of phospholipase activity,BP,HPCA
16291,GO:0071375,0.302812223498098,0.872839878512945,3,283,cellular response to peptide hormone stimulus,BP,CAMK2A;GNG3;ADCY1
20904,GO:1990090,0.30307656101423,0.94995079077389,1,49,cellular response to nerve growth factor stimulus,BP,STMN2
19010,GO:1901654,0.30341253239175,0.900857896214269,2,173,response to ketone,BP,HPCA;ADCY1
18984,GO:1901607,0.303658015929145,0.949588989918366,1,59,alpha-amino acid biosynthetic process,BP,BCAT1
18475,GO:0120039,0.304123942975536,0.829313246919569,6,612,plasma membrane bounded cell projection morphogenesis,BP,SYT1;CAMK2A;PACSIN1;SYT4;ADCY1;NPTX1
2818,GO:0005875,0.304557854219568,0.900379843571396,2,141,microtubule associated complex,CC,BIRC5;KIF4A
13271,GO:0048858,0.305029349119721,0.828637084908167,6,613,cell projection morphogenesis,BP,SYT1;CAMK2A;PACSIN1;SYT4;ADCY1;NPTX1
5954,GO:0016597,0.305449418065314,0.948966137658257,1,58,amino acid binding,MF,GRIN2B
13838,GO:0051306,0.305536721918549,0.948993634702245,1,54,mitotic sister chromatid separation,BP,CENPF
13498,GO:0050795,0.305606336192019,0.948953380716471,1,55,regulation of behavior,BP,CNR1
20917,GO:1990138,0.306474202395479,0.899303872109442,2,146,neuron projection extension,BP,SYT1;SYT4
4586,GO:0009746,0.306623381483406,0.899116578098013,2,169,response to hexose,BP,PTPRN;VSNL1
3181,GO:0006470,0.306657372092166,0.870399930353069,3,283,protein dephosphorylation,BP,PTPN3;PTPN5;PPP1R14C
496,GO:0001540,0.306752675547432,0.948544018741769,1,55,amyloid-beta binding,MF,CRYAB
8549,GO:0032637,0.306780707212075,0.948451258991066,1,61,interleukin-8 production,BP,CHI3L1
4650,GO:0009966,0.306814334816384,0.774835986571325,21,2831,regulation of signal transduction,BP,ASPM;PTPN3;BIRC5;CHGA;CELF4;DNM1;NEURL1;FOXM1;IGFBP2;RGS4;IQSEC3;VGF;CHI3L1;MRAP2;SFRP2;CXCL14;DAAM2;GNG3;NEUROD2;SPRY4;NMB
13270,GO:0048857,0.306877328210153,0.948469859529189,1,57,neural nucleus development,BP,KCNC2
18055,GO:0098797,0.307044587685035,0.8375039375727,5,536,plasma membrane protein complex,CC,KCNS1;SNAP25;GNG3;KCNC2;GRIN2B
4732,GO:0010332,0.307089071483468,0.948472173153101,1,52,response to gamma radiation,BP,CRYAB
4037,GO:0008328,0.307199332747695,0.948487327391298,1,49,ionotropic glutamate receptor complex,CC,GRIN2B
13565,GO:0050891,0.307292812922811,0.948399188343323,1,52,multicellular organismal water homeostasis,BP,ADCY1
6946,GO:0021879,0.307618655125221,0.948265459440581,1,53,forebrain neuron differentiation,BP,SLC4A10
13148,GO:0048639,0.307920603184741,0.898483192500993,2,151,positive regulation of developmental growth,BP,SYT1;SYT4
11547,GO:0044242,0.308155201387693,0.898212096262123,2,186,cellular lipid catabolic process,BP,CNR1;FABP7
12132,GO:0045670,0.308480414657983,0.947955615108415,1,53,regulation of osteoclast differentiation,BP,TJP2
8158,GO:0032024,0.308837935864205,0.947710762418666,1,61,positive regulation of insulin secretion,BP,VSNL1
9538,GO:0034765,0.308933695366589,0.849869569161113,4,404,regulation of ion transmembrane transport,BP,PTPN3;HPCA;KCNS1;KCNC2
2278,GO:0004857,0.310725081603071,0.867734443752685,3,317,enzyme inhibitor activity,MF,BIRC5;PI16;PPP1R14C
9274,GO:0034248,0.310774881261462,0.84856284300273,4,430,regulation of cellular amide metabolic process,BP,EEF1A2;CELF4;NEURL1;ENC1
20821,GO:1905818,0.311538916135762,0.946814686976781,1,55,regulation of chromosome separation,BP,CENPF
3637,GO:0007167,0.311659721193874,0.808476998743662,8,929,enzyme linked receptor protein signaling pathway,BP,PTPN3;DNM1;NEURL1;IGFBP2;SFRP2;ZCCHC12;SPRY4;GRIN2B
9598,GO:0035082,0.312236478223111,0.946610186909904,1,52,axoneme assembly,BP,NEURL1
18200,GO:0099081,0.312293807381274,0.814817281968686,7,759,supramolecular polymer,CC,ASPM;BIRC5;KIF4A;NEFM;DNM1;CRYAB;IGFN1
9082,GO:0033674,0.312339984177435,0.833651883565431,5,543,positive regulation of kinase activity,BP,EEF1A2;NEURL1;CHI3L1;GNG3;ADCY1
717,GO:0001885,0.313229712226208,0.946229061037995,1,53,endothelial cell development,BP,TJP2
18103,GO:0098878,0.314185864434281,0.945913468107013,1,51,neurotransmitter receptor complex,CC,GRIN2B
18199,GO:0099080,0.314279604763563,0.813281063713397,7,760,supramolecular complex,CC,ASPM;BIRC5;KIF4A;NEFM;DNM1;CRYAB;IGFN1
4455,GO:0009247,0.314387198321659,0.945645938681855,1,64,glycolipid biosynthetic process,BP,ST8SIA5
13772,GO:0051216,0.314574414684648,0.89471902518977,2,166,cartilage development,BP,CHI3L1;SFRP2
19773,GO:1903524,0.314732360621901,0.945555669981535,1,61,positive regulation of blood circulation,BP,CHGA
15767,GO:0070373,0.31647462282256,0.944950851273919,1,58,negative regulation of ERK1 and ERK2 cascade,BP,SPRY4
16002,GO:0070838,0.316883826044461,0.844329194174144,4,412,divalent metal ion transport,BP,CAMK2A;SLC30A3;HPCA;GRIN2B
13745,GO:0051172,0.317197557415974,0.77460186847036,16,2109,negative regulation of nitrogen compound metabolic process,BP,PTPN3;BIRC5;CELF4;CRYAB;FOXM1;RGS4;CENPF;HPCA;SFRP2;TENM2;PI16;NEUROD2;ENC1;MYT1L;SPRY4;PPP1R14C
9284,GO:0034284,0.318799721865461,0.892307549143361,2,174,response to monosaccharide,BP,PTPRN;VSNL1
1578,GO:0003407,0.319138561799825,0.944035919759016,1,53,neural retina development,BP,SLC17A7
10766,GO:0042490,0.319228914916723,0.944001994308388,1,53,mechanoreceptor differentiation,BP,GABRB2
420,GO:0001101,0.319281292586305,0.862209110844685,3,309,response to acid chemical,BP,NEURL1;IGFBP2;HPCA
18518,GO:0140056,0.319830321309973,0.891739809401899,2,170,organelle localization by membrane tethering,BP,SYT1;SNAP25
13160,GO:0048663,0.320153711343745,0.943543277620775,1,60,neuron fate commitment,BP,MYT1L
601,GO:0001726,0.320322584367242,0.89151899790692,2,157,ruffle,CC,PACSIN1;SPRY4
16932,GO:0072511,0.320899754617944,0.841504771070624,4,415,divalent inorganic cation transport,BP,CAMK2A;SLC30A3;HPCA;GRIN2B
8396,GO:0032418,0.320970567779793,0.943207193733799,1,62,lysosome localization,BP,CHGA
6321,GO:0018209,0.321029538481067,0.861112284051035,3,286,peptidyl-serine modification,BP,CAMK1G;CAMK2A;SFRP2
3886,GO:0008088,0.321647285125918,0.943071818232975,1,54,axo-dendritic transport,BP,KIF4A
6989,GO:0021953,0.321917929992619,0.890574211257326,2,165,central nervous system neuron differentiation,BP,SLC4A10;SFRP2
2625,GO:0005539,0.32246304063407,0.89020198933145,2,180,glycosaminoglycan binding,MF,ABI3BP;SELL
2177,GO:0004721,0.323005418058478,0.889944685905879,2,167,phosphoprotein phosphatase activity,MF,PTPN3;PTPN5
13673,GO:0051058,0.323017490206498,0.942587448305275,1,52,negative regulation of small GTPase mediated signal transduction,BP,SPRY4
12131,GO:0045669,0.323277485099456,0.942417870308648,1,56,positive regulation of osteoblast differentiation,BP,SFRP2
8785,GO:0032990,0.323404668883486,0.814742044180441,6,631,cell part morphogenesis,BP,SYT1;CAMK2A;PACSIN1;SYT4;ADCY1;NPTX1
21861,GO:2001259,0.323794165818969,0.942254496478316,1,54,positive regulation of cation channel activity,BP,KCNC2
7312,GO:0030317,0.324424350172199,0.941903520924737,1,61,flagellated sperm motility,BP,NEURL1
18853,GO:1901215,0.324623349546605,0.888980666357338,2,176,negative regulation of neuron death,BP,CHGA;GABRB2
14079,GO:0051783,0.324889075823173,0.888848490407374,2,171,regulation of nuclear division,BP,CENPF;MKI67
18248,GO:0099516,0.325411422258372,0.941599999929407,1,56,ion antiporter activity,MF,SLC4A10
19256,GO:1902305,0.325882958212083,0.941435307010384,1,55,regulation of sodium ion transmembrane transport,BP,PTPN3
14571,GO:0060135,0.325896367624256,0.941413211228566,1,56,maternal process involved in female pregnancy,BP,CNR1
7157,GO:0030104,0.325970202592359,0.941384741789188,1,56,water homeostasis,BP,ADCY1
12138,GO:0045685,0.326116371572381,0.941251961843316,1,61,regulation of glial cell differentiation,BP,DAAM2
11663,GO:0044445,0.326329728194199,0.887841999088801,2,227,cytosolic part,CC,SNAP25;ADCY1
3755,GO:0007405,0.326751287650295,0.941136059476614,1,53,neuroblast proliferation,BP,ASPM
17023,GO:0072676,0.327323550990232,0.940663216943884,1,71,lymphocyte migration,BP,CXCL14
2815,GO:0005871,0.327958478517458,0.94072825493149,1,50,kinesin complex,CC,KIF4A
13147,GO:0048638,0.328994292465536,0.855872848527484,3,280,regulation of developmental growth,BP,SYT1;SYT4;SFRP2
13508,GO:0050808,0.330258202343117,0.855069175277985,3,265,synapse organization,BP,NEURL1;NEUROD2;GRIN2B
10867,GO:0042698,0.330359203200541,0.939614363877534,1,60,ovulation cycle,BP,PTPRN
5288,GO:0015031,0.330681212458903,0.77099731881699,13,1754,protein transport,BP,PTPRN;RPH3A;SYTL4;CENPF;CNR1;HPCA;VGF;SNAP25;SYT4;CHI3L1;VSNL1;KCNC2;ZDHHC23
5475,GO:0015630,0.331517598053567,0.786757128535339,9,1074,microtubule cytoskeleton,CC,ASPM;BIRC5;KIF4A;SYTL4;DNM1;CRYAB;CENPF;TOP2A;MAP7D2
12210,GO:0045833,0.332029431783167,0.93887494103928,1,66,negative regulation of lipid metabolic process,BP,CNR1
10744,GO:0042446,0.332077594144632,0.938843670988717,1,67,hormone biosynthetic process,BP,CHST9
16706,GO:0072091,0.333037466116241,0.938605752861191,1,57,regulation of stem cell proliferation,BP,ASPM
2912,GO:0006026,0.333261550797842,0.938469171781116,1,60,aminoglycan catabolic process,BP,CHI3L1
18229,GO:0099175,0.333298336369984,0.938574536567828,1,53,regulation of postsynapse organization,BP,GRIN2B
2819,GO:0005876,0.333399977022837,0.938462065482115,1,57,spindle microtubule,CC,KIF4A
11078,GO:0043130,0.334316334568683,0.937979649863302,1,65,ubiquitin binding,MF,TOP2A
12699,GO:0046902,0.334423545020559,0.937876662093083,1,70,regulation of mitochondrial membrane permeability,BP,CAMK2A
13785,GO:0051235,0.335598817030955,0.851441679012134,3,287,maintenance of location,BP,ASPM;SLC17A7;SLC30A3
8229,GO:0032147,0.336275892381954,0.850951577962725,3,303,activation of protein kinase activity,BP,CHI3L1;GNG3;ADCY1
21738,GO:2001021,0.336874921837864,0.936954730031306,1,65,negative regulation of response to DNA damage stimulus,BP,SFRP2
17903,GO:0097722,0.337300997930237,0.936810342375715,1,63,sperm motility,BP,NEURL1
17996,GO:0098657,0.337503273481116,0.803812730786831,6,709,import into cell,BP,SYT1;DNM1;PACSIN1;CALY;SNAP25;SYT4
9059,GO:0033619,0.337857669841254,0.936600123617339,1,62,membrane protein proteolysis,BP,PTPN3
1202,GO:0002690,0.339930409791504,0.935563720781047,1,79,positive regulation of leukocyte chemotaxis,BP,CXCL14
13212,GO:0048736,0.340341470927806,0.879839951057833,2,165,appendage development,BP,SFRP2;FREM2
14599,GO:0060173,0.340341470927806,0.879839951057833,2,165,limb development,BP,SFRP2;FREM2
7029,GO:0022406,0.340432595849096,0.879723603953004,2,179,membrane docking,BP,SYT1;SNAP25
8409,GO:0032432,0.340703910172731,0.935543399330389,1,56,actin filament bundle,CC,CRYAB
8823,GO:0033044,0.340839027635299,0.847882250893774,3,295,regulation of chromosome organization,BP,CENPF;TOP2A;MKI67
14719,GO:0060348,0.341154797694774,0.879336470114392,2,169,bone development,BP,TJP2;SFRP2
9906,GO:0035690,0.341213926473998,0.84758853368897,3,314,cellular response to drug,BP,CHRM3;ADCY1;KCNC2
4541,GO:0009593,0.34159903820996,0.934899750951496,1,77,detection of chemical stimulus,BP,SYT1
18245,GO:0099513,0.341652113070916,0.811832524028957,5,545,polymeric cytoskeletal fiber,CC,ASPM;BIRC5;KIF4A;NEFM;DNM1
3583,GO:0007049,0.341834039129954,0.761531988110153,13,1712,cell cycle,BP,BCAT1;LZTS1;ASPM;PTPN3;CAMK2A;BIRC5;KIF4A;MYBL2;FOXM1;CENPF;PACSIN1;TOP2A;MKI67
11317,GO:0043523,0.342427407044933,0.878508673074837,2,185,regulation of neuron apoptotic process,BP,MYBL2;GABRB2
17123,GO:0086010,0.343033216674414,0.934842389891054,1,45,membrane depolarization during action potential,BP,PTPN3
618,GO:0001756,0.343303764766537,0.934461153927804,1,57,somitogenesis,BP,SFRP2
13494,GO:0050790,0.343392795475624,0.754509147588178,15,2016,regulation of catalytic activity,BP,BIRC5;EEF1A2;NEURL1;CRYAB;RGS4;CNR1;HPCA;CHI3L1;SFRP2;GNG3;PI16;ADCY1;SPRY4;PPP1R14C;GRIN2B
3817,GO:0007600,0.344372031253243,0.824603231855426,4,457,sensory perception,BP,BIRC5;DNM1;CNR1;GABRB2
274,GO:0000775,0.344714516825701,0.877152072434885,2,181,chromosome, centromeric region,CC,BIRC5;CENPF
2612,GO:0005518,0.345295469348137,0.933604130175554,1,59,collagen binding,MF,ABI3BP
591,GO:0001707,0.345342433815482,0.933536744761209,1,62,mesoderm formation,BP,SFRP2
3836,GO:0007623,0.345795046349906,0.876497130000825,2,182,circadian rhythm,BP,TOP2A;ADCY1
3636,GO:0007166,0.345982687635172,0.743861606216548,19,2604,cell surface receptor signaling pathway,BP,GABRA1;PTPRN;ASPM;PTPN3;CAMK2A;BIRC5;CELF4;SLC17A7;DNM1;NEURL1;GABRA4;GABRG2;IGFBP2;TJP2;SFRP2;DAAM2;ZCCHC12;SPRY4;GRIN2B
7213,GO:0030178,0.345986925680604,0.876335872140861,2,194,negative regulation of Wnt signaling pathway,BP,IGFBP2;SFRP2
8292,GO:0032272,0.346460304950745,0.933056960252777,1,63,negative regulation of protein polymerization,BP,STMN2
15341,GO:0061515,0.346998995063257,0.932832291722682,1,63,myeloid cell development,BP,TJP2
19088,GO:1901880,0.347781423916283,0.932622737696955,1,56,negative regulation of protein depolymerization,BP,STMN2
11033,GO:0043043,0.349190759646823,0.805977196653063,5,672,peptide biosynthetic process,BP,EEF1A2;CELF4;NEURL1;ENC1;PCSK1
1623,GO:0003729,0.349429801370382,0.874264333390765,2,190,mRNA binding,MF,RBFOX1;CELF4
11438,GO:0043933,0.349631182283834,0.7518090425949,14,1936,protein-containing complex subunit organization,BP,SYT1;LNX1;CELF4;STMN2;DNM1;CRYAB;CENPF;KCNS1;CALY;SNAP25;SFRP2;LIX1;KCNC2;GRIN2B
3313,GO:0006635,0.350192084625846,0.93139629089882,1,70,fatty acid beta-oxidation,BP,CNR1
11654,GO:0044431,0.350780270619317,0.784353585139975,7,858,Golgi apparatus part,CC,CAMK1G;RBFOX1;ST8SIA5;SNAP25;SYT4;CHST9;TMEM130
870,GO:0002088,0.35112281580871,0.931162820862994,1,59,lens development in camera-type eye,BP,CRYAB
1186,GO:0002673,0.351599505391181,0.930764173620862,1,73,regulation of acute inflammatory response,BP,CNR1
16202,GO:0071230,0.352519759783739,0.930536136939279,1,61,cellular response to amino acid stimulus,BP,NEURL1
6393,GO:0018995,0.352639069083546,0.930423937489476,1,65,host,CC,TOP2A
11401,GO:0043657,0.352639069083546,0.930423937489476,1,65,host cell,CC,TOP2A
13068,GO:0048477,0.352830600875944,0.930314305908893,1,67,oogenesis,BP,ASPM
12371,GO:0046128,0.353000095375956,0.930202975285111,1,70,purine ribonucleoside metabolic process,BP,TJP2
8826,GO:0033047,0.353238511981286,0.930229801002625,1,61,regulation of mitotic sister chromatid segregation,BP,CENPF
3355,GO:0006687,0.353350576537941,0.930078854423414,1,68,glycosphingolipid metabolic process,BP,ST8SIA5
7638,GO:0031012,0.354328967569799,0.817300701835304,4,431,extracellular matrix,CC,CHI3L1;SFRP2;FREM2;ABI3BP
5572,GO:0015833,0.355314492359996,0.749950247178023,13,1788,peptide transport,BP,PTPRN;RPH3A;SYTL4;CENPF;CNR1;HPCA;VGF;SNAP25;SYT4;CHI3L1;VSNL1;KCNC2;ZDHHC23
18025,GO:0098742,0.355812689415874,0.870459409724871,2,166,cell-cell adhesion via plasma-membrane adhesion molecules,BP,TENM2;SELL
13031,GO:0048332,0.358054266770784,0.928108765290178,1,64,mesoderm morphogenesis,BP,SFRP2
9020,GO:0033555,0.358084121656577,0.928066100199126,1,66,multicellular organismal response to stress,BP,NEUROD2
19670,GO:1903313,0.35829939708157,0.928017814817939,1,63,positive regulation of mRNA metabolic process,BP,CELF4
10501,GO:0040008,0.358729912005229,0.798666847059683,5,592,regulation of growth,BP,SYT1;CRYAB;IGFBP2;SYT4;SFRP2
10671,GO:0042310,0.359309540956684,0.927504260371931,1,68,vasoconstriction,BP,CHRM3
3211,GO:0006513,0.359486502502039,0.927500732763842,1,63,protein monoubiquitination,BP,NEURL1
16268,GO:0071345,0.3595856064465,0.777162050308487,7,952,cellular response to cytokine stimulus,BP,PTPRN;CAMK2A;BIRC5;MYBL2;PTPN5;TJP2;CHI3L1
7694,GO:0031100,0.36026684085026,0.92704614548476,1,71,animal organ regeneration,BP,PTPN3
6693,GO:0019888,0.361427697790181,0.926536284622985,1,71,protein phosphatase regulator activity,MF,PPP1R14C
3572,GO:0007032,0.361697389553831,0.926443640844092,1,69,endosome organization,BP,DNM1
7201,GO:0030166,0.361855901971944,0.926513002280656,1,60,proteoglycan biosynthetic process,BP,CHST9
2778,GO:0005802,0.361938808489964,0.866550492737075,2,189,trans-Golgi network,CC,RBFOX1;SNAP25
6699,GO:0019900,0.36324722220216,0.783461411942195,6,700,kinase binding,MF,ASPM;EEF1A2;DNM1;FOXM1;HPCA;TOP2A
11188,GO:0043299,0.363283858581516,0.810522442522696,4,505,leukocyte degranulation,BP,CHGA;SNAP25;CHI3L1;SELL
15185,GO:0061097,0.363551447239213,0.925652435270152,1,67,regulation of protein tyrosine kinase activity,BP,NEURL1
13125,GO:0048589,0.363827953479163,0.794734071922179,5,545,developmental growth,BP,ASPM;SYT1;SYT4;SLC4A10;SFRP2
10653,GO:0042278,0.364524107223466,0.925141062302079,1,73,purine nucleoside metabolic process,BP,TJP2
1024,GO:0002367,0.365208896333421,0.924800710718606,1,76,cytokine production involved in immune response,BP,CHGA
7058,GO:0022804,0.365485179549594,0.83073976016299,3,308,active transmembrane transporter activity,MF,SLC17A7;SLC4A10;SLC6A17
11890,GO:0045132,0.366407812585253,0.924338487656066,1,70,meiotic chromosome segregation,BP,TOP2A
4008,GO:0008284,0.367210042248662,0.780231777977608,6,761,positive regulation of cell proliferation,BP,PTPRN;ASPM;BIRC5;FOXM1;IGFBP2;SFRP2
137,GO:0000281,0.367826578610688,0.92379018121529,1,64,mitotic cytokinesis,BP,KIF4A
13835,GO:0051303,0.367865482713322,0.92368414328133,1,70,establishment of chromosome localization,BP,CENPF
11496,GO:0044093,0.368127801907385,0.742363408522268,12,1584,positive regulation of molecular function,BP,CAMK2A;EEF1A2;NEURL1;RGS4;HPCA;CHI3L1;SFRP2;GNG3;ADCY1;KCNC2;NEUROD2;GRIN2B
4584,GO:0009743,0.368384362511264,0.862464843550431,2,195,response to carbohydrate,BP,PTPRN;VSNL1
7895,GO:0031463,0.369046487617534,0.923209162130957,1,66,Cul3-RING ubiquitin ligase complex,CC,ENC1
21739,GO:2001022,0.369188656395118,0.923060887346182,1,72,positive regulation of response to DNA damage stimulus,BP,FOXM1
6774,GO:0021536,0.369403007115399,0.922990358126403,1,70,diencephalon development,BP,KCNC2
17368,GO:0090277,0.370117231762113,0.922557967933104,1,79,positive regulation of peptide hormone secretion,BP,VSNL1
13456,GO:0050730,0.370211717337655,0.861276398787177,2,202,regulation of peptidyl-tyrosine phosphorylation,BP,NEURL1;SFRP2
3179,GO:0006468,0.370221381322966,0.737017309754582,13,1717,protein phosphorylation,BP,CAMK1G;CAMK2A;BIRC5;NEURL1;CRYAB;FOXM1;RGS4;CHI3L1;SFRP2;GNG3;ADCY1;SPRY4;GRIN2B
14609,GO:0060191,0.370293442258217,0.922586871464539,1,70,regulation of lipase activity,BP,HPCA
15538,GO:0065003,0.370857939681754,0.739979260085526,12,1656,protein-containing complex assembly,BP,SYT1;LNX1;CELF4;STMN2;DNM1;CRYAB;CENPF;KCNS1;CALY;SNAP25;KCNC2;GRIN2B
3972,GO:0008219,0.370942314694473,0.733238748613925,14,1956,cell death,BP,CAMK2A;BIRC5;CHGA;MYBL2;EEF1A2;NEURL1;CRYAB;CNR1;TOP2A;CHI3L1;SFRP2;GABRB2;ZNF385D;GRIN2B
19669,GO:1903312,0.370977987518752,0.922289750218819,1,69,negative regulation of mRNA metabolic process,BP,CELF4
4778,GO:0010507,0.371200677075012,0.922217537030676,1,67,negative regulation of autophagy,BP,LZTS1
2823,GO:0005882,0.371727957563811,0.921920654190676,1,71,intermediate filament,CC,NEFM
21153,GO:1990939,0.37186903377327,0.922312428252763,1,48,ATP-dependent microtubule motor activity,MF,KIF4A
12643,GO:0046785,0.37192253353585,0.921903941102316,1,66,microtubule polymerization,BP,STMN2
12104,GO:0045638,0.372242244509696,0.921659749604727,1,73,negative regulation of myeloid cell differentiation,BP,TJP2
11533,GO:0044215,0.37237381775556,0.921639336219143,1,70,other organism,CC,TOP2A
11534,GO:0044216,0.37237381775556,0.921639336219143,1,70,other organism cell,CC,TOP2A
11535,GO:0044217,0.37237381775556,0.921639336219143,1,70,other organism part,CC,TOP2A
13295,GO:0050000,0.373204540218542,0.921245391318548,1,71,chromosome localization,BP,CENPF
4225,GO:0008652,0.373514720827898,0.921051953701333,1,75,cellular amino acid biosynthetic process,BP,BCAT1
963,GO:0002275,0.37379621956768,0.802541535069437,4,513,myeloid cell activation involved in immune response,BP,CHGA;SNAP25;CHI3L1;SELL
13703,GO:0051117,0.373799524466966,0.920946009104694,1,73,ATPase binding,MF,PTPN3
11151,GO:0043242,0.374264945176741,0.920898167854637,1,62,negative regulation of protein complex disassembly,BP,STMN2
18101,GO:0098876,0.375385105648136,0.920284643494325,1,68,vesicle-mediated transport to the plasma membrane,BP,SNAP25
3318,GO:0006641,0.37548534778458,0.920143912573139,1,75,triglyceride metabolic process,BP,FABP7
10500,GO:0040007,0.375515994722223,0.764091198788587,7,858,growth,BP,ASPM;SYT1;CRYAB;IGFBP2;SYT4;SLC4A10;SFRP2
13571,GO:0050900,0.376561409391404,0.822701049160021,3,361,leukocyte migration,BP,CHGA;CXCL14;SELL
13850,GO:0051341,0.376603692241595,0.919601900837207,1,77,regulation of oxidoreductase activity,BP,CNR1
1067,GO:0002444,0.37675308414338,0.800273518038792,4,516,myeloid leukocyte mediated immunity,BP,CHGA;SNAP25;CHI3L1;SELL
11107,GO:0043178,0.376976981516642,0.91953289966419,1,69,alcohol binding,MF,RPH3A
3512,GO:0006936,0.377028249775056,0.822436750640743,3,321,muscle contraction,BP,CHGA;CRYAB;CHRM3
15992,GO:0070821,0.377689429184497,0.91918730452003,1,70,tertiary granule membrane,CC,SNAP25
18094,GO:0098858,0.378112421564738,0.856302132313846,2,177,actin-based cell projection,CC,NPTX2;TENM2
2052,GO:0004553,0.378393882360616,0.918780216754032,1,76,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,CHI3L1
8700,GO:0032872,0.378457181430468,0.856007544196513,2,193,regulation of stress-activated MAPK cascade,BP,FOXM1;SFRP2
10570,GO:0042102,0.379313098952288,0.91826234230309,1,84,positive regulation of T cell proliferation,BP,IGFBP2
13405,GO:0050673,0.380127994572026,0.820177841378767,3,325,epithelial cell proliferation,BP,PTPRN;SFRP2;FABP7
19009,GO:1901653,0.380261384459557,0.820082767960884,3,324,cellular response to peptide,BP,CAMK2A;GNG3;ADCY1
4212,GO:0008625,0.380366878850608,0.917843640526033,1,77,extrinsic apoptotic signaling pathway via death domain receptors,BP,SFRP2
15726,GO:0070302,0.380692258132294,0.854549531500991,2,194,regulation of stress-activated protein kinase signaling cascade,BP,FOXM1;SFRP2
10808,GO:0042578,0.380879607864076,0.819634411478449,3,323,phosphoric ester hydrolase activity,MF,PTPN3;PTPN5;CHRM3
13845,GO:0051321,0.380931414554102,0.854362316056362,2,202,meiotic cell cycle,BP,ASPM;TOP2A
3735,GO:0007346,0.381627662628189,0.780575694018274,5,615,regulation of mitotic cell cycle,BP,PTPN3;BIRC5;CENPF;TOP2A;MKI67
14153,GO:0051924,0.382211335727098,0.853529725986306,2,201,regulation of calcium ion transport,BP,CAMK2A;HPCA
8473,GO:0032508,0.382690454120645,0.916839475495085,1,70,DNA duplex unwinding,BP,TOP2A
13528,GO:0050848,0.38273528690769,0.916803873992925,1,71,regulation of calcium-mediated signaling,BP,NEUROD2
18506,GO:0140029,0.383230839206928,0.916502633423775,1,76,exocytic process,BP,SNAP25
13442,GO:0050714,0.383574101637661,0.852607292302993,2,209,positive regulation of protein secretion,BP,SYTL4;VSNL1
7701,GO:0031110,0.383724726193486,0.916394867825273,1,67,regulation of microtubule polymerization or depolymerization,BP,STMN2
7043,GO:0022607,0.383885022091038,0.710105297355602,19,2631,cellular component assembly,BP,ASPM;SYT1;LNX1;BIRC5;KIF4A;MYBL2;CELF4;STMN2;NEFM;DNM1;NEURL1;CRYAB;CENPF;KCNS1;CALY;SNAP25;TENM2;KCNC2;GRIN2B
832,GO:0002039,0.384989239460518,0.915777231383486,1,68,p53 binding,MF,ZNF385D
18968,GO:1901566,0.386591394601066,0.72619387210177,12,1765,organonitrogen compound biosynthetic process,BP,BCAT1;EEF1A2;CELF4;ST8SIA5;NEURL1;HPCA;MRAP2;CHST9;ADCY1;ENC1;PCSK1;ZDHHC23
14700,GO:0060326,0.387319869212263,0.850079356683918,2,227,cell chemotaxis,BP,CHGA;CXCL14
13525,GO:0050839,0.387547175418212,0.791985736336454,4,460,cell adhesion molecule binding,MF,TJP2;SFRP2;TENM2;SELL
8866,GO:0033138,0.388124744036552,0.914147553071494,1,77,positive regulation of peptidyl-serine phosphorylation,BP,SFRP2
8824,GO:0033045,0.388885104833756,0.913875777270844,1,70,regulation of sister chromatid segregation,BP,CENPF
14705,GO:0060333,0.389729616690203,0.913290798428767,1,84,interferon-gamma-mediated signaling pathway,BP,CAMK2A
12187,GO:0045785,0.389746597175999,0.813063262083424,3,353,positive regulation of cell adhesion,BP,IGFBP2;SFRP2;ABI3BP
12027,GO:0045445,0.389817792145738,0.913340702985612,1,76,myoblast differentiation,BP,CXCL14
16990,GO:0072593,0.389929789116316,0.848382366564447,2,216,reactive oxygen species metabolic process,BP,CRYAB;FOXM1
17660,GO:0097194,0.390549084494458,0.912972647540106,1,77,execution phase of apoptosis,BP,TOP2A
16865,GO:0072332,0.391615939286722,0.91242804836459,1,79,intrinsic apoptotic signaling pathway by p53 class mediator,BP,ZNF385D
1433,GO:0003151,0.392435479910684,0.912134167807071,1,71,outflow tract morphogenesis,BP,SFRP2
6990,GO:0021954,0.393142264440094,0.911834751387552,1,68,central nervous system neuron development,BP,SLC4A10
11488,GO:0044070,0.393231191003434,0.911715294878305,1,73,regulation of anion transport,BP,SYT4
19170,GO:1902106,0.393509204615094,0.91153804364908,1,76,negative regulation of leukocyte differentiation,BP,TJP2
19031,GO:1901681,0.393657780362044,0.845912621633753,2,210,sulfur compound binding,MF,ABI3BP;SELL
7343,GO:0030374,0.393790156067948,0.911516836816386,1,68,ligand-dependent nuclear receptor transcription coactivator activity,MF,ZCCHC12
4549,GO:0009612,0.394401565518921,0.845463725836808,2,197,response to mechanical stimulus,BP,IGFBP2;CHI3L1
15118,GO:0060998,0.396227311961182,0.910404064296968,1,63,regulation of dendritic spine development,BP,NEURL1
1474,GO:0003208,0.396362046244868,0.910248081250177,1,68,cardiac ventricle morphogenesis,BP,SFRP2
4626,GO:0009892,0.396786605839953,0.700340500859213,18,2559,negative regulation of metabolic process,BP,LZTS1;PTPN3;BIRC5;CELF4;CRYAB;FOXM1;RGS4;CENPF;CNR1;HPCA;SFRP2;TENM2;PI16;NEUROD2;ENC1;MYT1L;SPRY4;PPP1R14C
6718,GO:0019953,0.397875195676398,0.767400845425779,5,641,sexual reproduction,BP,ASPM;CELF4;NEURL1;CNR1;VGF
6470,GO:0019217,0.398681871084984,0.909016464538021,1,73,regulation of fatty acid metabolic process,BP,CNR1
13884,GO:0051402,0.399003512897122,0.842314006976425,2,208,neuron apoptotic process,BP,MYBL2;GABRB2
13856,GO:0051347,0.39900859264442,0.766495422340291,5,614,positive regulation of transferase activity,BP,EEF1A2;NEURL1;CHI3L1;GNG3;ADCY1
569,GO:0001669,0.399051475248767,0.908703837560808,1,83,acrosomal vesicle,CC,SV2B
17351,GO:0090257,0.399706796663321,0.841867966966476,2,200,regulation of muscle system process,BP,CHGA;CHRM3
14465,GO:0055117,0.399865254650057,0.908485884703293,1,69,regulation of cardiac muscle contraction,BP,CHGA
12226,GO:0045860,0.40078789066701,0.781538583649957,4,479,positive regulation of protein kinase activity,BP,NEURL1;CHI3L1;GNG3;ADCY1
3458,GO:0006855,0.401962750606134,0.907353920876648,1,74,drug transmembrane transport,BP,SLC17A7
36,GO:0000075,0.40217817555638,0.840141907250935,2,211,cell cycle checkpoint,BP,CENPF;TOP2A
11844,GO:0045069,0.402566249233562,0.906956771354307,1,81,regulation of viral genome replication,BP,TOP2A
21262,GO:2000177,0.402996940281113,0.906875794803806,1,71,regulation of neural precursor cell proliferation,BP,ASPM
11911,GO:0045177,0.403352129471791,0.802934559210532,3,324,apical part of cell,CC,ASPM;IGFBP2;KCNC2
5810,GO:0016310,0.403353840801979,0.701485430463417,15,2081,phosphorylation,BP,CAMK1G;CAMK2A;BIRC5;EEF1A2;NEURL1;CRYAB;FOXM1;RGS4;CHI3L1;SFRP2;GNG3;ADCY1;SPRY4;PPP1R14C;GRIN2B
10679,GO:0042325,0.403597218577857,0.720156419340132,10,1343,regulation of phosphorylation,BP,EEF1A2;NEURL1;FOXM1;RGS4;CHI3L1;SFRP2;GNG3;ADCY1;SPRY4;PPP1R14C
10797,GO:0042562,0.40361556757938,0.906400798766756,1,83,hormone binding,MF,CHRM3
17583,GO:0097061,0.406021077634349,0.905421819591327,1,66,dendritic spine organization,BP,GRIN2B
11917,GO:0045184,0.406573844976397,0.70476142988076,13,1847,establishment of protein localization,BP,PTPRN;RPH3A;SYTL4;CENPF;CNR1;HPCA;VGF;SNAP25;SYT4;CHI3L1;VSNL1;KCNC2;ZDHHC23
3482,GO:0006890,0.407225430460383,0.904603959665093,1,79,retrograde vesicle-mediated transport, Golgi to ER,BP,KIF4A
12127,GO:0045665,0.407342017048661,0.836656709486398,2,196,negative regulation of neuron differentiation,BP,ASPM;STMN2
5412,GO:0015297,0.407527273514518,0.904489019661945,1,76,antiporter activity,MF,SLC4A10
21848,GO:2001243,0.407805475105206,0.904180464716321,1,90,negative regulation of intrinsic apoptotic signaling pathway,BP,SFRP2
7116,GO:0030017,0.408021191586576,0.836238577803667,2,185,sarcomere,CC,CRYAB;IGFN1
9446,GO:0034622,0.408048594660423,0.7365394617631,7,969,cellular protein-containing complex assembly,BP,CELF4;STMN2;DNM1;CRYAB;CENPF;CALY;SNAP25
3914,GO:0008135,0.408621773233688,0.903823291231206,1,84,translation factor activity, RNA binding,MF,EEF1A2
18789,GO:1901019,0.40942382698301,0.903496400829085,1,77,regulation of calcium ion transmembrane transporter activity,BP,HPCA
17779,GO:0097435,0.40969990934346,0.757698140497198,5,592,supramolecular fiber organization,BP,STMN2;NEFM;CRYAB;PACSIN1;SFRP2
12263,GO:0045926,0.410011404717828,0.834718536308493,2,219,negative regulation of growth,BP,CRYAB;SFRP2
18283,GO:0099568,0.410027662425957,0.774198972448467,4,441,cytoplasmic region,CC,KIF4A;RIMS4;CENPF;HPCA
10985,GO:0042981,0.411676277152503,0.712987659543206,10,1399,regulation of apoptotic process,BP,CAMK2A;BIRC5;MYBL2;EEF1A2;NEURL1;CRYAB;CNR1;TOP2A;SFRP2;GABRB2
11099,GO:0043169,0.411822733704496,0.673750597005152,27,3756,cation binding,MF,SYT13;SYT1;CAMK2A;LNX1;RPH3A;BIRC5;SYTL4;NPTX2;NEURL1;CRYAB;HPCA;PRRG3;TOP2A;SYT4;CHRM3;STAC2;TENM2;FREM2;ZNF385D;VSNL1;ADCY1;NPTX1;ZCCHC12;NELL2;MYT1L;SELL;GRIN2B
16279,GO:0071356,0.411903726726206,0.833305757649643,2,250,cellular response to tumor necrosis factor,BP,TJP2;CHI3L1
5885,GO:0016485,0.412547894808466,0.832928505345599,2,226,protein processing,BP,BIRC5;PCSK1
4047,GO:0008344,0.413034780693278,0.901630247638734,1,76,adult locomotory behavior,BP,DNM1
13124,GO:0048588,0.413607388915306,0.832331414052038,2,190,developmental cell growth,BP,SYT1;SYT4
7687,GO:0031091,0.413897369173966,0.901073666292795,1,84,platelet alpha granule,CC,SYTL4
16059,GO:0070925,0.414567010304169,0.740929865800237,6,753,organelle assembly,BP,ASPM;BIRC5;KIF4A;MYBL2;NEURL1;CENPF
7586,GO:0030901,0.414747128972568,0.900638364909232,1,83,midbrain development,BP,SFRP2
1200,GO:0002688,0.415331251368831,0.900158833122454,1,100,regulation of leukocyte chemotaxis,BP,CXCL14
2413,GO:0005085,0.415725768440345,0.793512427487315,3,306,guanyl-nucleotide exchange factor activity,MF,CAMK2A;IQSEC3;GRIN2B
1276,GO:0002793,0.415800494856934,0.830646717320834,2,227,positive regulation of peptide secretion,BP,SYTL4;VSNL1
12184,GO:0045778,0.416226999475996,0.899921529361488,1,78,positive regulation of ossification,BP,SFRP2
15402,GO:0061640,0.416702251872173,0.899683857309972,1,77,cytoskeleton-dependent cytokinesis,BP,KIF4A
15162,GO:0061053,0.417034182748162,0.899567930630385,1,73,somite development,BP,SFRP2
8699,GO:0032870,0.417065249356295,0.751519960435459,5,630,cellular response to hormone stimulus,BP,CAMK2A;IGFBP2;CHRM3;GNG3;ADCY1
4899,GO:0010717,0.417487000664114,0.899253365171453,1,78,regulation of epithelial to mesenchymal transition,BP,SFRP2
19570,GO:1903076,0.417763240246232,0.899079374437116,1,80,regulation of protein localization to plasma membrane,BP,MRAP2
7311,GO:0030316,0.418465290484814,0.898746878033744,1,77,osteoclast differentiation,BP,TJP2
18416,GO:0106027,0.419474931034726,0.898336504189447,1,69,neuron projection organization,BP,GRIN2B
2104,GO:0004620,0.420293853302435,0.897676760643618,1,84,phospholipase activity,MF,CHRM3
8374,GO:0032392,0.420615044450201,0.897555425209152,1,80,DNA geometric change,BP,TOP2A
11303,GO:0043506,0.42095534586112,0.897414508089186,1,77,regulation of JUN kinase activity,BP,SFRP2
6238,GO:0017148,0.421150564771897,0.826944102665306,2,206,negative regulation of translation,BP,CELF4;ENC1
9535,GO:0034762,0.421941608794436,0.764476533556148,4,476,regulation of transmembrane transport,BP,PTPN3;HPCA;KCNS1;KCNC2
11045,GO:0043067,0.422250315896762,0.703543430167947,10,1411,regulation of programmed cell death,BP,CAMK2A;BIRC5;MYBL2;EEF1A2;NEURL1;CRYAB;CNR1;TOP2A;SFRP2;GABRB2
14720,GO:0060349,0.424959069418659,0.89520734135015,1,80,bone morphogenesis,BP,SFRP2
8238,GO:0032182,0.425213473861755,0.895029231001415,1,83,ubiquitin-like protein binding,MF,TOP2A
11489,GO:0044085,0.425482360155834,0.67021011741082,20,2889,cellular component biogenesis,BP,ASPM;SYT1;LNX1;BIRC5;KIF4A;CHGA;MYBL2;CELF4;STMN2;NEFM;DNM1;NEURL1;CRYAB;CENPF;KCNS1;CALY;SNAP25;TENM2;KCNC2;GRIN2B
19087,GO:1901879,0.425486928740264,0.895025008776893,1,73,regulation of protein depolymerization,BP,STMN2
13133,GO:0048609,0.426113403138474,0.743871851748578,5,657,multicellular organismal reproductive process,BP,PTPRN;ASPM;CELF4;NEURL1;CNR1
13912,GO:0051453,0.427186297311955,0.89392586166352,1,85,regulation of intracellular pH,BP,SLC4A10
16012,GO:0070848,0.427650261815807,0.742594251987308,5,626,response to growth factor,BP,STMN2;SFRP2;KCNC2;ZCCHC12;SPRY4
6462,GO:0019208,0.427671851753358,0.893671790143372,1,84,phosphatase regulator activity,MF,PPP1R14C
13790,GO:0051241,0.428301933263339,0.718940628724836,7,950,negative regulation of multicellular organismal process,BP,ASPM;STMN2;TJP2;SYT4;SFRP2;DAAM2;NEUROD2
3537,GO:0006979,0.42841792076105,0.783428950685018,3,390,response to oxidative stress,BP,PTPRN;CRYAB;KCNC2
18212,GO:0099106,0.429081768877613,0.892871084102922,1,86,ion channel regulator activity,MF,KCNS1
3556,GO:0007009,0.429473637978241,0.892839768081121,1,73,plasma membrane organization,BP,PACSIN1
8209,GO:0032103,0.42949873799095,0.820817331341522,2,247,positive regulation of response to external stimulus,BP,CNR1;CXCL14
5765,GO:0016234,0.429682149856567,0.892661058049389,1,77,inclusion body,CC,NEFM
6481,GO:0019233,0.429759974076997,0.892521256982893,1,84,sensory perception of pain,BP,CNR1
460,GO:0001227,0.43026171593351,0.820350970703774,2,221,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,FOXM1;MYT1L
2971,GO:0006112,0.431147620972892,0.891806070930693,1,80,energy reserve metabolic process,BP,MRAP2
15905,GO:0070613,0.431461314791392,0.891541243772798,1,87,regulation of protein processing,BP,BIRC5
2487,GO:0005201,0.431692224692123,0.891702722006742,1,68,extracellular matrix structural constituent,MF,CHI3L1
3892,GO:0008094,0.431714452496014,0.891520143982456,1,78,DNA-dependent ATPase activity,MF,TOP2A
19011,GO:1901655,0.431845127198333,0.891377753807764,1,83,cellular response to ketone,BP,ADCY1
4348,GO:0009119,0.432137827127761,0.891087399237619,1,94,ribonucleoside metabolic process,BP,TJP2
822,GO:0002028,0.432231333019389,0.891189658222215,1,81,regulation of sodium ion transport,BP,PTPN3
2806,GO:0005856,0.432980993520552,0.67741155235445,14,1863,cytoskeleton,CC,ASPM;PTPN3;BIRC5;KIF4A;RIMS4;SYTL4;NEFM;DNM1;CRYAB;CENPF;TOP2A;SNAP25;ENC1;MAP7D2
730,GO:0001906,0.433423007021128,0.89024424094342,1,108,cell killing,BP,CHGA
8470,GO:0032504,0.433970016285434,0.737174071751385,5,665,multicellular organism reproduction,BP,PTPRN;ASPM;CELF4;NEURL1;CNR1
3317,GO:0006639,0.435986967813385,0.888983679249953,1,89,acylglycerol metabolic process,BP,FABP7
523,GO:0001578,0.4359984177059,0.88912296200816,1,78,microtubule bundle formation,BP,NEURL1
13200,GO:0048709,0.436057397160098,0.888967713503011,1,87,oligodendrocyte differentiation,BP,DAAM2
14055,GO:0051726,0.4360752864144,0.703785986849346,8,1091,regulation of cell cycle,BP,ASPM;PTPN3;BIRC5;MYBL2;FOXM1;CENPF;TOP2A;MKI67
8288,GO:0032268,0.436327893195802,0.668586590062325,16,2295,regulation of cellular protein metabolic process,BP,PTPN3;BIRC5;CELF4;NEURL1;CRYAB;FOXM1;RGS4;CHI3L1;SFRP2;GNG3;PI16;ADCY1;ENC1;SPRY4;PPP1R14C;GRIN2B
13683,GO:0051087,0.437182556104794,0.888296634810255,1,90,chaperone binding,MF,BIRC5
5683,GO:0016054,0.437183070217064,0.815204947636516,2,251,organic acid catabolic process,BP,BCAT1;CNR1
12460,GO:0046395,0.437183070217064,0.815204947636516,2,251,carboxylic acid catabolic process,BP,BCAT1;CNR1
4513,GO:0009410,0.437984678450852,0.814662344184251,2,236,response to xenobiotic stimulus,BP,CNR1;HPCA
3517,GO:0006942,0.43948862148061,0.887116195869819,1,80,regulation of striated muscle contraction,BP,CHGA
19672,GO:1903317,0.439510242107712,0.886985811029967,1,89,regulation of protein maturation,BP,BIRC5
3316,GO:0006638,0.439601026916915,0.886922379557193,1,90,neutral lipid metabolic process,BP,FABP7
13687,GO:0051091,0.439963019694507,0.813231749502883,2,228,positive regulation of DNA binding transcription factor activity,BP,CAMK2A;NEUROD2
13455,GO:0050729,0.440103846324304,0.886540815215775,1,99,positive regulation of inflammatory response,BP,CNR1
15320,GO:0061448,0.4405730536511,0.812810646737283,2,220,connective tissue development,BP,CHI3L1;SFRP2
13791,GO:0051246,0.440608743152565,0.662155255955885,17,2458,regulation of protein metabolic process,BP,PTPN3;BIRC5;EEF1A2;CELF4;NEURL1;CRYAB;FOXM1;RGS4;CHI3L1;SFRP2;GNG3;PI16;ADCY1;ENC1;SPRY4;PPP1R14C;GRIN2B
7452,GO:0030641,0.441692003351771,0.885737651860968,1,89,regulation of cellular pH,BP,SLC4A10
3884,GO:0008081,0.44189696180717,0.885696622268272,1,83,phosphoric diester hydrolase activity,MF,CHRM3
6691,GO:0019886,0.441904298144636,0.885570150018676,1,93,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,KIF4A
11369,GO:0043604,0.44208693299059,0.730131763793118,5,750,amide biosynthetic process,BP,EEF1A2;CELF4;NEURL1;ENC1;PCSK1
9680,GO:0035282,0.442127851726915,0.885564032401281,1,83,segmentation,BP,SFRP2
9185,GO:0034097,0.442272263573084,0.706540687941269,7,1031,response to cytokine,BP,PTPRN;CAMK2A;BIRC5;MYBL2;PTPN5;TJP2;CHI3L1
7187,GO:0030148,0.442382931063181,0.885305975668937,1,92,sphingolipid biosynthetic process,BP,ST8SIA5
6700,GO:0019901,0.442838186515672,0.729577532360301,5,625,protein kinase binding,MF,ASPM;EEF1A2;DNM1;FOXM1;TOP2A
9830,GO:0035579,0.444738609778112,0.883992779234044,1,88,specific granule membrane,CC,SNAP25
3553,GO:0007006,0.445142280655801,0.883600412701004,1,103,mitochondrial membrane organization,BP,CAMK2A
6537,GO:0019395,0.446560237783908,0.882853759109837,1,95,fatty acid oxidation,BP,CNR1
11905,GO:0045165,0.447011994849419,0.808000289291448,2,225,cell fate commitment,BP,SFRP2;MYT1L
12707,GO:0046916,0.4477771451119,0.882092051740201,1,100,cellular transition metal ion homeostasis,BP,SLC30A3
3056,GO:0006282,0.447842412199126,0.882173484329599,1,89,regulation of DNA repair,BP,FOXM1
11667,GO:0044449,0.447905981805868,0.807435777818843,2,200,contractile fiber part,CC,CRYAB;IGFN1
8369,GO:0032386,0.449038139874882,0.766913214559069,3,371,regulation of intracellular transport,BP,RIMS4;CRYAB;HPCA
42,GO:0000086,0.449535969146578,0.806062129462975,2,237,G2/M transition of mitotic cell cycle,BP,FOXM1;CENPF
7392,GO:0030510,0.44979334431532,0.881137145601054,1,81,regulation of BMP signaling pathway,BP,SFRP2
2750,GO:0005768,0.449848097804373,0.71019089027531,6,813,endosome,CC,PTPRN;SYTL4;STMN2;SLC30A3;PACSIN1;CALY
20187,GO:1904375,0.450188956272933,0.880808292683799,1,88,regulation of protein localization to cell periphery,BP,MRAP2
1094,GO:0002495,0.450861265032709,0.880318908599189,1,96,antigen processing and presentation of peptide antigen via MHC class II,BP,KIF4A
9372,GO:0034440,0.451366106394032,0.8800098765384,1,97,lipid oxidation,BP,CNR1
9439,GO:0034612,0.451476799577347,0.804504378369869,2,268,response to tumor necrosis factor,BP,TJP2;CHI3L1
3786,GO:0007517,0.451681707318583,0.764800615061157,3,347,muscle organ development,BP,NEURL1;CRYAB;CENPF
6059,GO:0016798,0.451721729910709,0.879759150526963,1,101,hydrolase activity, acting on glycosyl bonds,MF,CHI3L1
13671,GO:0051056,0.452306628428377,0.764337048811421,3,326,regulation of small GTPase mediated signal transduction,BP,FOXM1;IQSEC3;SPRY4
5387,GO:0015238,0.452599035554831,0.87932273674286,1,93,drug transmembrane transporter activity,MF,SLC17A7
13775,GO:0051222,0.45379392317993,0.762994523915335,3,384,positive regulation of protein transport,BP,SYTL4;HPCA;VSNL1
7200,GO:0030165,0.454594852993992,0.878277807402764,1,82,PDZ domain binding,MF,LNX1
3712,GO:0007276,0.455254997955799,0.736494546452997,4,528,gamete generation,BP,ASPM;CELF4;NEURL1;CNR1
2638,GO:0005578,0.455266333588903,0.761871431553374,3,340,proteinaceous extracellular matrix,CC,CHI3L1;FREM2;ABI3BP
3501,GO:0006915,0.455718082141369,0.6635581738672,12,1756,apoptotic process,BP,CAMK2A;BIRC5;MYBL2;EEF1A2;NEURL1;CRYAB;CNR1;TOP2A;CHI3L1;SFRP2;GABRB2;ZNF385D
1098,GO:0002504,0.455817572398005,0.877357825174809,1,97,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,KIF4A
13149,GO:0048640,0.456091532007335,0.877339380709805,1,85,negative regulation of developmental growth,BP,SFRP2
4195,GO:0008593,0.456251091287173,0.877178072624895,1,90,regulation of Notch signaling pathway,BP,NEURL1
8392,GO:0032414,0.457272013658479,0.876644293425533,1,84,positive regulation of ion transmembrane transporter activity,BP,KCNC2
9275,GO:0034249,0.457375667803798,0.800168940563989,2,222,negative regulation of cellular amide metabolic process,BP,CELF4;ENC1
18825,GO:1901137,0.45805237996722,0.716238851170676,5,688,carbohydrate derivative biosynthetic process,BP,ST8SIA5;HPCA;MRAP2;CHST9;ADCY1
13788,GO:0051239,0.458104924882892,0.643475987168051,18,2566,regulation of multicellular organismal process,BP,ASPM;SYT1;CHGA;CELF4;STMN2;NEURL1;CENPF;CNR1;TJP2;PACSIN1;SNAP25;SYT4;CHRM3;CHI3L1;SFRP2;DAAM2;NEUROD2;ENC1
3613,GO:0007127,0.45836574668101,0.875834330889028,1,96,meiosis I,BP,TOP2A
2914,GO:0006029,0.458586817076425,0.875851470588642,1,84,proteoglycan metabolic process,BP,CHST9
15360,GO:0061564,0.458935071769449,0.73340512008163,4,471,axon development,BP,NEFM;CNR1;ADCY1;NPTX1
2636,GO:0005576,0.459228740439376,0.632429899343881,24,3793,extracellular region,CC,KIF4A;CHGA;NPTX2;DNM1;CRYAB;IGFBP2;VGF;PRRG3;SYT4;CHI3L1;SFRP2;CXCL14;GABRB2;DAAM2;FREM2;CHST9;ABI3BP;PI16;ADCY1;PCSK1;CREG2;NELL2;CPNE4;NMB
12677,GO:0046872,0.459858084981383,0.629492261854921,26,3677,metal ion binding,MF,SYT13;SYT1;CAMK2A;LNX1;RPH3A;BIRC5;SYTL4;NPTX2;NEURL1;CRYAB;HPCA;PRRG3;TOP2A;SYT4;STAC2;TENM2;FREM2;ZNF385D;VSNL1;ADCY1;NPTX1;ZCCHC12;NELL2;MYT1L;SELL;GRIN2B
19935,GO:1903828,0.459895206943395,0.874918909951529,1,95,negative regulation of cellular protein localization,BP,MRAP2
4216,GO:0008630,0.459928087360128,0.874855616577241,1,99,intrinsic apoptotic signaling pathway in response to DNA damage,BP,SFRP2
14155,GO:0051928,0.460187417363353,0.874741405689234,1,95,positive regulation of calcium ion transport,BP,CAMK2A
21842,GO:2001237,0.460596697224168,0.874492523350264,1,95,negative regulation of extrinsic apoptotic signaling pathway,BP,SFRP2
21111,GO:1990823,0.460794838140597,0.874407024235092,1,92,response to leukemia inhibitory factor,BP,MYBL2
21115,GO:1990830,0.460794838140597,0.874407024235092,1,92,cellular response to leukemia inhibitory factor,BP,MYBL2
7115,GO:0030016,0.461064834614008,0.797411686607504,2,205,myofibril,CC,CRYAB;IGFN1
6787,GO:0021549,0.461504834216957,0.874066222733573,1,85,cerebellum development,BP,NEUROD2
40,GO:0000082,0.462360243467618,0.796271941450749,2,240,G1/S transition of mitotic cell cycle,BP,BCAT1;CAMK2A
22,GO:0000041,0.462934650886093,0.873010613094572,1,100,transition metal ion transport,BP,SLC30A3
3514,GO:0006939,0.463871636584566,0.872501521294258,1,94,smooth muscle contraction,BP,CHRM3
17032,GO:0072686,0.464306339591732,0.872351135900573,1,85,mitotic spindle,CC,ASPM
3478,GO:0006885,0.464695925745412,0.871971361065931,1,96,regulation of pH,BP,SLC4A10
13846,GO:0051336,0.464903605929999,0.67761993863066,8,1111,regulation of hydrolase activity,BP,BIRC5;CRYAB;RGS4;HPCA;SFRP2;PI16;PPP1R14C;GRIN2B
8480,GO:0032526,0.465217109356232,0.87163883042944,1,97,response to retinoic acid,BP,IGFBP2
13678,GO:0051082,0.465732493369401,0.871210990428843,1,108,unfolded protein binding,MF,CRYAB
10888,GO:0042737,0.4659670951717,0.871006998275608,1,115,drug catabolic process,BP,CHI3L1
15528,GO:0061982,0.465979000424069,0.871157138255609,1,98,meiosis I cell cycle process,BP,TOP2A
1199,GO:0002687,0.466033423402452,0.870981994415375,1,113,positive regulation of leukocyte migration,BP,CXCL14
691,GO:0001843,0.466070644688665,0.871263573578347,1,85,neural tube closure,BP,SFRP2
13501,GO:0050801,0.466471871557825,0.70878440899466,5,683,ion homeostasis,BP,PTPN3;SLC30A3;SLC4A10;GNG3;GRIN2B
13094,GO:0048524,0.466726947310099,0.870672584517074,1,100,positive regulation of viral process,BP,TOP2A
3490,GO:0006900,0.466935873522372,0.870621938397873,1,93,vesicle budding from membrane,BP,DNM1
2486,GO:0005200,0.467457391058887,0.870310574866008,1,92,structural constituent of cytoskeleton,MF,NEFM
14907,GO:0060606,0.467833177062979,0.870156923118993,1,86,tube closure,BP,SFRP2
7810,GO:0031327,0.468483446160146,0.661223483876388,10,1410,negative regulation of cellular biosynthetic process,BP,BIRC5;CELF4;FOXM1;CENPF;HPCA;SFRP2;TENM2;NEUROD2;ENC1;MYT1L
5059,GO:0010923,0.46963573556586,0.868992200225678,1,89,negative regulation of phosphatase activity,BP,PPP1R14C
3143,GO:0006414,0.47006020866839,0.868376413691764,1,126,translational elongation,BP,EEF1A2
3145,GO:0006417,0.470092102319346,0.749416091734688,3,387,regulation of translation,BP,CELF4;NEURL1;ENC1
4551,GO:0009617,0.470170810912786,0.749276396686521,3,432,response to bacterium,BP,CHGA;CNR1;VGF
14012,GO:0051651,0.470509595879266,0.868458971950131,1,88,maintenance of location in cell,BP,ASPM
1376,GO:0003014,0.470741043650735,0.868213026527762,1,96,renal system process,BP,ADCY1
4309,GO:0009062,0.47112544631087,0.867886260259817,1,104,fatty acid catabolic process,BP,CNR1
13575,GO:0050905,0.471409754700058,0.867894248249661,1,88,neuromuscular process,BP,FABP7
7162,GO:0030117,0.472738283838859,0.866956293100796,1,96,membrane coat,CC,DNM1
13066,GO:0048475,0.472738283838859,0.866956293100796,1,96,coated membrane,CC,DNM1
847,GO:0002062,0.472873265199533,0.86695912901052,1,89,chondrocyte differentiation,BP,SFRP2
6751,GO:0021510,0.473546162606455,0.866482019767691,1,93,spinal cord development,BP,DAAM2
4310,GO:0009063,0.474707478594726,0.865566398219993,1,110,cellular amino acid catabolic process,BP,BCAT1
4166,GO:0008528,0.474890294185835,0.865391331840213,1,117,G-protein coupled peptide receptor activity,MF,PRLHR
3804,GO:0007569,0.475637191444237,0.865118831978144,1,96,cell aging,BP,FOXM1
3716,GO:0007286,0.475778058872288,0.864983849139285,1,100,spermatid development,BP,NEURL1
3437,GO:0006816,0.476955093506656,0.743626516733383,3,371,calcium ion transport,BP,CAMK2A;HPCA;GRIN2B
1256,GO:0002761,0.477145969192957,0.864144472566255,1,97,regulation of myeloid leukocyte differentiation,BP,TJP2
12028,GO:0045446,0.477842434090425,0.863786526761762,1,90,endothelial cell differentiation,BP,TJP2
555,GO:0001653,0.478405095231107,0.863136307109072,1,118,peptide receptor activity,MF,PRLHR
3714,GO:0007283,0.478548149884841,0.742214118147508,3,399,spermatogenesis,BP,ASPM;NEURL1;CNR1
8697,GO:0032868,0.479361816721179,0.782925564595358,2,238,response to insulin,BP,PTPRN;VGF
11781,GO:0044839,0.479373046044945,0.782868153179385,2,252,cell cycle G2/M phase transition,BP,FOXM1;CENPF
68,GO:0000139,0.479508058816286,0.697084757366048,5,685,Golgi membrane,CC,CAMK1G;ST8SIA5;SYT4;CHST9;TMEM130
6055,GO:0016791,0.479514811588487,0.782807050812,2,237,phosphatase activity,MF,PTPN3;PTPN5
3676,GO:0007215,0.479894345427076,0.862540603770784,1,85,glutamate receptor signaling pathway,BP,GRIN2B
11179,GO:0043279,0.479907658822448,0.862383007566504,1,96,response to alkaloid,BP,CNR1
4007,GO:0008283,0.479965035766386,0.640749464098748,12,1774,cell proliferation,BP,PTPRN;BCAT1;ASPM;BIRC5;NEURL1;FOXM1;IGFBP2;CENPF;CHRM3;SFRP2;MKI67;FABP7
16926,GO:0072503,0.480333598761449,0.740689276332315,3,397,cellular divalent inorganic cation homeostasis,BP,SLC30A3;GNG3;GRIN2B
16168,GO:0071156,0.480357704099557,0.861974139821662,1,107,regulation of cell cycle arrest,BP,FOXM1
11183,GO:0043292,0.48058486193555,0.782036873742692,2,216,contractile fiber,CC,CRYAB;IGFN1
5130,GO:0014013,0.482095593735144,0.860944167202971,1,98,regulation of gliogenesis,BP,DAAM2
4624,GO:0009890,0.483088142110294,0.647494880084197,10,1430,negative regulation of biosynthetic process,BP,BIRC5;CELF4;FOXM1;CENPF;HPCA;SFRP2;TENM2;NEUROD2;ENC1;MYT1L
4219,GO:0008637,0.483244233754068,0.860037146706563,1,114,apoptotic mitochondrial changes,BP,CAMK2A
5961,GO:0016605,0.483967901897607,0.859774471330969,1,94,PML body,CC,TENM2
8389,GO:0032411,0.484381301267266,0.859517479377323,1,93,positive regulation of transporter activity,BP,KCNC2
4176,GO:0008543,0.485121381620912,0.858960064550281,1,99,fibroblast growth factor receptor signaling pathway,BP,SPRY4
15116,GO:0060996,0.485430981304076,0.858961017319769,1,84,dendritic spine development,BP,NEURL1
10376,GO:0038061,0.485489036569766,0.858543701635937,1,117,NIK/NF-kappaB signaling,BP,CHI3L1
7460,GO:0030660,0.485732629576114,0.858484021561561,1,106,Golgi-associated vesicle membrane,CC,NRGN
14533,GO:0060071,0.486714968828965,0.857838358649137,1,106,Wnt signaling pathway, planar cell polarity pathway,BP,SFRP2
7107,GO:0030003,0.486877559477607,0.708763698107978,4,554,cellular cation homeostasis,BP,SLC30A3;SLC4A10;GNG3;GRIN2B
17378,GO:0090287,0.487004218282836,0.776799947103443,2,232,regulation of cellular response to growth factor stimulus,BP,SFRP2;SPRY4
4346,GO:0009116,0.487437967834334,0.857295470575794,1,113,nucleoside metabolic process,BP,TJP2
11051,GO:0043085,0.488065383865302,0.648861526634812,9,1279,positive regulation of catalytic activity,BP,EEF1A2;NEURL1;RGS4;HPCA;CHI3L1;SFRP2;GNG3;ADCY1;GRIN2B
8419,GO:0032446,0.488982812652457,0.674681256400327,6,845,protein modification by small protein conjugation,BP,LNX1;BIRC5;NEURL1;TOP2A;NEUROD2;ENC1
7022,GO:0022037,0.489255807746933,0.85631083320331,1,93,metencephalon development,BP,NEUROD2
11782,GO:0044843,0.489495304233629,0.774703173900153,2,252,cell cycle G1/S phase transition,BP,BCAT1;CAMK2A
6775,GO:0021537,0.489658640619483,0.774663318146437,2,227,telencephalon development,BP,ASPM;NRGN
5135,GO:0014020,0.489660182683878,0.856056173090382,1,92,primary neural tube formation,BP,SFRP2
11098,GO:0043168,0.490006694336833,0.612957409694905,18,2541,anion binding,MF,CAMK1G;SYT13;SYT1;CAMK2A;RPH3A;KIF4A;EEF1A2;SYTL4;DNM1;PACSIN1;TOP2A;SYT4;MKI67;NRGN;ABI3BP;ADCY1;SELL;GRIN2B
367,GO:0000982,0.490385152999367,0.732018303190627,3,390,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,MYBL2;DDN;MYT1L
13403,GO:0050671,0.490517742209102,0.855219146562107,1,117,positive regulation of lymphocyte proliferation,BP,IGFBP2
11139,GO:0043226,0.490527359433258,0.604508773539912,77,11884,organelle,CC,CAMK1G;SYT13;GABRA1;PTPRN;BCAT1;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;RBFOX1;RPH3A;BIRC5;KIF4A;CHGA;MYBL2;RIMS4;EEF1A2;CELF4;ST8SIA5;SYTL4;STMN2;NEFM;SLC17A7;DNM1;NEURL1;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;IGFBP2;RGS4;CENPF;CNR1;TJP2;PACSIN1;VGF;CALY;TOP2A;SNAP25;SYT4;CHI3L1;MRAP2;SLC14A1;CXCL14;GABRB2;TENM2;DAAM2;MKI67;FREM2;ZNF385D;CHST9;NRGN;GNG3;IGFN1;FABP7;PI16;ADCY1;KCNC2;TMEM130;KCNK9;NPTX1;NEUROD2;ENC1;ZCCHC12;PCSK1;CREG2;DDN;ZDHHC23;MAP7D2;SV2B;MYT1L;SELL;CPNE4;SLC6A17;GRIN2B
12691,GO:0046887,0.490846514517154,0.855044058883269,1,112,positive regulation of hormone secretion,BP,VSNL1
8091,GO:0031902,0.491849123722756,0.854356736364764,1,114,late endosome membrane,CC,SLC30A3
13087,GO:0048515,0.492607082318694,0.853936749858392,1,105,spermatid differentiation,BP,NEURL1
9689,GO:0035305,0.493330428923603,0.85356858453215,1,95,negative regulation of dephosphorylation,BP,PPP1R14C
8755,GO:0032946,0.493357430253722,0.853311593868238,1,118,positive regulation of mononuclear cell proliferation,BP,IGFBP2
17292,GO:0090175,0.493783822187742,0.853116536959952,1,108,regulation of establishment of planar polarity,BP,SFRP2
12269,GO:0045934,0.493950809267964,0.643278667342868,9,1290,negative regulation of nucleobase-containing compound metabolic process,BP,BIRC5;CELF4;FOXM1;CENPF;HPCA;SFRP2;TENM2;NEUROD2;MYT1L
13803,GO:0051258,0.49437118409729,0.770719396872988,2,250,protein polymerization,BP,STMN2;DNM1
6421,GO:0019079,0.494608945160728,0.852581759058632,1,106,viral genome replication,BP,TOP2A
5803,GO:0016298,0.494852703157754,0.85241750038618,1,106,lipase activity,MF,CHRM3
11402,GO:0043666,0.496219978986084,0.851548959796961,1,101,regulation of phosphoprotein phosphatase activity,BP,PPP1R14C
5673,GO:0016042,0.497225264732957,0.768292807130448,2,273,lipid catabolic process,BP,CNR1;FABP7
17659,GO:0097193,0.497646564331679,0.767956091287183,2,269,intrinsic apoptotic signaling pathway,BP,SFRP2;ZNF385D
16864,GO:0072331,0.498323148279861,0.767427024808043,2,259,signal transduction by p53 class mediator,BP,FOXM1;ZNF385D
6308,GO:0018193,0.498489726879339,0.646208605690466,8,1147,peptidyl-amino acid modification,BP,CAMK1G;CAMK2A;BIRC5;NEURL1;TOP2A;CHI3L1;SFRP2;ZDHHC23
11751,GO:0044774,0.498847235909076,0.849709051459845,1,106,mitotic DNA integrity checkpoint,BP,TOP2A
12178,GO:0045765,0.499363377501848,0.766608764349211,2,246,regulation of angiogenesis,BP,CHI3L1;SFRP2
12188,GO:0045786,0.500403817070563,0.696532612796706,4,571,negative regulation of cell cycle,BP,PTPN3;FOXM1;CENPF;TOP2A
2668,GO:0005622,0.502167868950863,0.605117308734619,83,12823,intracellular,CC,CAMK1G;SYT13;GABRA1;PTPRN;BCAT1;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;LNX1;RBFOX1;RPH3A;BIRC5;KIF4A;CHGA;MYBL2;RIMS4;EEF1A2;CELF4;ST8SIA5;SYTL4;STMN2;NEFM;SLC17A7;DNM1;NEURL1;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;IGFBP2;RGS4;CENPF;CNR1;TJP2;IQSEC3;HPCA;KCNS1;PACSIN1;VGF;SULT4A1;CALY;TOP2A;SNAP25;SYT4;CHI3L1;MRAP2;SLC14A1;STAC2;LIX1;CXCL14;GABRB2;TENM2;MKI67;ZNF385D;CHST9;NRGN;GNG3;VSNL1;IGFN1;FABP7;ADCY1;KCNC2;TMEM130;KCNK9;NPTX1;NEUROD2;ENC1;ZCCHC12;PCSK1;CREG2;DDN;ZDHHC23;MAP7D2;SV2B;MYT1L;SPRY4;SELL;SLC6A17;PPP1R14C;GRIN2B
15931,GO:0070665,0.502797922301139,0.846858112613057,1,121,positive regulation of leukocyte proliferation,BP,IGFBP2
14139,GO:0051899,0.503085125718523,0.847018787751896,1,89,membrane depolarization,BP,PTPN3
3468,GO:0006873,0.504294521538836,0.692985365855296,4,565,cellular ion homeostasis,BP,SLC30A3;SLC4A10;GNG3;GRIN2B
10615,GO:0042177,0.504329083096292,0.845951486400676,1,105,negative regulation of protein catabolic process,BP,PTPN3
8864,GO:0033135,0.504376710640842,0.845907576556567,1,106,regulation of peptidyl-serine phosphorylation,BP,SFRP2
9544,GO:0034774,0.504678033779498,0.762014368190858,2,299,secretory granule lumen,CC,CHI3L1;PCSK1
8135,GO:0031984,0.505005324773552,0.626559538466032,10,1497,organelle subcompartment,CC,CAMK1G;RBFOX1;ST8SIA5;PTPN5;SNAP25;SYT4;MRAP2;CHST9;TMEM130;DDN
10130,GO:0036064,0.505061700680344,0.845489242972364,1,101,ciliary basal body,CC,CENPF
16316,GO:0071407,0.505367110243473,0.692036016266138,4,536,cellular response to organic cyclic compound,BP,GABRA1;GABRG2;GABRB2;ADCY1
3489,GO:0006898,0.505436398287693,0.761508941994405,2,254,receptor-mediated endocytosis,BP,DNM1;SNAP25
9992,GO:0035821,0.505623034618185,0.844916629312323,1,119,modification of morphology or physiology of other organism,BP,CHGA
20483,GO:1904951,0.505711241702222,0.71846300825373,3,419,positive regulation of establishment of protein localization,BP,SYTL4;HPCA;VSNL1
3721,GO:0007292,0.506650758992459,0.844337427482651,1,105,female gamete generation,BP,ASPM
19780,GO:1903533,0.507168076576705,0.843884085563536,1,114,regulation of protein targeting,BP,HPCA
3215,GO:0006518,0.50738571165242,0.671362993889374,5,805,peptide metabolic process,BP,EEF1A2;CELF4;NEURL1;ENC1;PCSK1
1374,GO:0003012,0.508229250162115,0.716258222745094,3,394,muscle system process,BP,CHGA;CRYAB;CHRM3
7324,GO:0030330,0.508714698466887,0.842871469358315,1,107,DNA damage response, signal transduction by p53 class mediator,BP,FOXM1
7108,GO:0030004,0.509732708948254,0.842155982462606,1,107,cellular monovalent inorganic cation homeostasis,BP,SLC4A10
3667,GO:0007204,0.509836873282751,0.757786503513866,2,257,positive regulation of cytosolic calcium ion concentration,BP,GNG3;GRIN2B
13122,GO:0048584,0.510057590398746,0.607814858370488,13,1979,positive regulation of response to stimulus,BP,ASPM;CHGA;NEURL1;FOXM1;CNR1;CHI3L1;MRAP2;SFRP2;CXCL14;DAAM2;GNG3;VSNL1;NEUROD2
16929,GO:0072507,0.510163876534953,0.714489606872112,3,413,divalent inorganic cation homeostasis,BP,SLC30A3;GNG3;GRIN2B
3336,GO:0006664,0.510227991629384,0.841699063093805,1,118,glycolipid metabolic process,BP,ST8SIA5
19761,GO:1903509,0.510227991629384,0.841699063093805,1,118,liposaccharide metabolic process,BP,ST8SIA5
20716,GO:1905477,0.510409036248843,0.841647838115435,1,110,positive regulation of protein localization to membrane,BP,HPCA
15766,GO:0070372,0.510723776689759,0.757017825855237,2,262,regulation of ERK1 and ERK2 cascade,BP,CHI3L1;SPRY4
4962,GO:0010811,0.510864896845201,0.841426828849149,1,101,positive regulation of cell-substrate adhesion,BP,ABI3BP
13806,GO:0051261,0.510911822282294,0.841457863980932,1,96,protein depolymerization,BP,STMN2
363,GO:0000978,0.511187127923763,0.713588115054034,3,403,RNA polymerase II proximal promoter sequence-specific DNA binding,MF,MYBL2;NEUROD2;DDN
12270,GO:0045935,0.511587465972728,0.614932285248444,11,1600,positive regulation of nucleobase-containing compound metabolic process,BP,PTPRN;CHGA;MYBL2;CELF4;FOXM1;HPCA;TOP2A;MRAP2;SFRP2;NEUROD2;DDN
19869,GO:1903707,0.511887514155356,0.840562964682051,1,114,negative regulation of hemopoiesis,BP,TJP2
13590,GO:0050921,0.512210590141751,0.840270565663912,1,121,positive regulation of chemotaxis,BP,CXCL14
12973,GO:0048232,0.512364228788136,0.712502358328704,3,418,male gamete generation,BP,ASPM;NEURL1;CNR1
10943,GO:0042826,0.512679861123048,0.840106524248603,1,104,histone deacetylase binding,MF,TOP2A
13798,GO:0051253,0.512779667996213,0.632538663037837,8,1163,negative regulation of RNA metabolic process,BP,BIRC5;CELF4;FOXM1;CENPF;SFRP2;TENM2;NEUROD2;MYT1L
18207,GO:0099094,0.513364068717109,0.839694344316997,1,98,ligand-gated cation channel activity,MF,GRIN2B
5117,GO:0012501,0.513682162617305,0.608295284714172,12,1832,programmed cell death,BP,CAMK2A;BIRC5;MYBL2;EEF1A2;NEURL1;CRYAB;CNR1;TOP2A;CHI3L1;SFRP2;GABRB2;ZNF385D
12129,GO:0045667,0.516543320968362,0.837337605264654,1,105,regulation of osteoblast differentiation,BP,SFRP2
2911,GO:0006024,0.517351325928454,0.836780588097152,1,103,glycosaminoglycan biosynthetic process,BP,CHST9
12211,GO:0045834,0.518015019937967,0.83621344284448,1,111,positive regulation of lipid metabolic process,BP,EEF1A2
2285,GO:0004866,0.518593177150333,0.835692406552785,1,122,endopeptidase inhibitor activity,MF,BIRC5
3208,GO:0006508,0.520477326001565,0.611548889265348,10,1529,proteolysis,BP,PTPN3;LNX1;BIRC5;CRYAB;SFRP2;TENM2;PI16;ENC1;PCSK1;GRIN2B
1116,GO:0002526,0.520724693161465,0.834114100478699,1,126,acute inflammatory response,BP,CNR1
689,GO:0001841,0.520767061169148,0.834349269001297,1,100,neural tube formation,BP,SFRP2
11876,GO:0045111,0.522366560384379,0.833111652293064,1,106,intermediate filament cytoskeleton,CC,NEFM
13990,GO:0051604,0.522429142495333,0.746898365939289,2,286,protein maturation,BP,BIRC5;PCSK1
12073,GO:0045598,0.522665916369344,0.832837936924199,1,111,regulation of fat cell differentiation,BP,SFRP2
2484,GO:0005198,0.523208360582752,0.67541363802454,4,596,structural molecule activity,MF,NEFM;CRYAB;CHI3L1;MAP7D2
18227,GO:0099173,0.523265656229015,0.832568555931428,1,97,postsynapse organization,BP,GRIN2B
3885,GO:0008083,0.523394458429393,0.832111274616483,1,133,growth factor activity,MF,VGF
3141,GO:0006412,0.523546208320648,0.675044392023322,4,652,translation,BP,EEF1A2;CELF4;NEURL1;ENC1
16862,GO:0072329,0.523774705356983,0.831912070967752,1,123,monocarboxylic acid catabolic process,BP,CNR1
17248,GO:0090101,0.524200605968356,0.831805552550031,1,103,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,SFRP2
609,GO:0001736,0.52433406679789,0.831555961668609,1,117,establishment of planar polarity,BP,SFRP2
3634,GO:0007164,0.52433406679789,0.831555961668609,1,117,establishment of tissue polarity,BP,SFRP2
19668,GO:1903311,0.524652228189332,0.745003375273208,2,273,regulation of mRNA metabolic process,BP,RBFOX1;CELF4
3778,GO:0007498,0.525893989642894,0.830458040590635,1,112,mesoderm development,BP,SFRP2
6092,GO:0016853,0.526549931131251,0.829795952119611,1,132,isomerase activity,MF,TOP2A
3742,GO:0007368,0.527654139337189,0.829189322836252,1,109,determination of left/right symmetry,BP,DAAM2
1436,GO:0003158,0.527708939857472,0.829183026923898,1,106,endothelium development,BP,TJP2
19762,GO:1903510,0.527902162714629,0.829005477109849,1,109,mucopolysaccharide metabolic process,BP,CHST9
11201,GO:0043312,0.528071953106404,0.698112019358482,3,462,neutrophil degranulation,BP,SNAP25;CHI3L1;SELL
11153,GO:0043244,0.528089863361667,0.829002556315033,1,98,regulation of protein complex disassembly,BP,STMN2
2910,GO:0006023,0.52824427697306,0.828774378636671,1,107,aminoglycan biosynthetic process,BP,CHST9
3629,GO:0007159,0.528310423466193,0.741753660851559,2,290,leukocyte cell-cell adhesion,BP,IGFBP2;SELL
10787,GO:0042542,0.528380112965673,0.828512554534861,1,123,response to hydrogen peroxide,BP,CRYAB
14437,GO:0055076,0.530238980024837,0.827119025154792,1,124,transition metal ion homeostasis,BP,SLC30A3
815,GO:0002020,0.531622415698583,0.826210119333324,1,111,protease binding,MF,SELL
970,GO:0002283,0.53179677370078,0.694660643836963,3,465,neutrophil activation involved in immune response,BP,SNAP25;CHI3L1;SELL
14618,GO:0060205,0.532083586887513,0.738365288392259,2,315,cytoplasmic vesicle lumen,CC,CHI3L1;PCSK1
13555,GO:0050878,0.532934530561382,0.693664573552116,3,426,regulation of body fluid levels,BP,NEURL1;CHRM3;ADCY1
8134,GO:0031983,0.533816415167007,0.736828237695611,2,316,vesicle lumen,CC,CHI3L1;PCSK1
326,GO:0000902,0.533838749263331,0.621040488948001,7,941,cell morphogenesis,BP,SYT1;CAMK2A;PACSIN1;SYT4;TENM2;ADCY1;NPTX1
2436,GO:0005125,0.53487708254126,0.823448473619121,1,149,cytokine activity,MF,CXCL14
2660,GO:0005604,0.534932078986652,0.824037314703131,1,88,basement membrane,CC,FREM2
369,GO:0000987,0.535702985960324,0.691103168203213,3,416,proximal promoter sequence-specific DNA binding,MF,MYBL2;NEUROD2;DDN
5767,GO:0016236,0.536372626078006,0.734655201638036,2,279,macroautophagy,BP,LZTS1;LIX1
2855,GO:0005930,0.537102836860121,0.822192574327542,1,101,axoneme,CC,CENPF
1140,GO:0002576,0.537557222336379,0.82164183915965,1,119,platelet degranulation,BP,SYTL4
19771,GO:1903522,0.537768590376424,0.733472212602268,2,260,regulation of blood circulation,BP,CHGA;CHRM3
11173,GO:0043271,0.539492910636574,0.820161961292906,1,119,negative regulation of ion transport,BP,CNR1
17553,GO:0097014,0.540327421765872,0.819714856969138,1,102,ciliary plasm,CC,CENPF
13411,GO:0050680,0.540720615187744,0.819314206384616,1,110,negative regulation of epithelial cell proliferation,BP,SFRP2
3996,GO:0008270,0.540726329786911,0.639632635423282,5,719,zinc ion binding,MF,RPH3A;ZNF385D;ZCCHC12;MYT1L;GRIN2B
3860,GO:0008037,0.540851785137913,0.819148286800563,1,116,cell recognition,BP,CNR1
7004,GO:0021987,0.541373189500726,0.818897583910888,1,103,cerebral cortex development,BP,ASPM
19013,GO:1901657,0.541630501769713,0.81838791637249,1,134,glycosyl compound metabolic process,BP,TJP2
1023,GO:0002366,0.541638202606388,0.657863868261132,4,630,leukocyte activation involved in immune response,BP,CHGA;SNAP25;CHI3L1;SELL
10585,GO:0042129,0.541763176285003,0.818293292836082,1,133,regulation of T cell proliferation,BP,IGFBP2
19969,GO:1903900,0.541856581956578,0.818287926299812,1,125,regulation of viral life cycle,BP,TOP2A
12305,GO:0045995,0.542621631728685,0.817871937967391,1,108,regulation of embryonic development,BP,SFRP2
10581,GO:0042119,0.543051921034612,0.68411362900841,3,473,neutrophil activation,BP,SNAP25;CHI3L1;SELL
2416,GO:0005088,0.543467366642203,0.728452751790503,2,235,Ras guanyl-nucleotide exchange factor activity,MF,CAMK2A;GRIN2B
1873,GO:0004252,0.543809047080841,0.816671386655249,1,138,serine-type endopeptidase activity,MF,PCSK1
4362,GO:0009135,0.543958530228883,0.816779296212288,1,113,purine nucleoside diphosphate metabolic process,BP,TJP2
4402,GO:0009179,0.543958530228883,0.816779296212288,1,113,purine ribonucleoside diphosphate metabolic process,BP,TJP2
1069,GO:0002446,0.545652679283437,0.681650523204236,3,475,neutrophil mediated immunity,BP,SNAP25;CHI3L1;SELL
15765,GO:0070371,0.545899099649113,0.726091731988439,2,278,ERK1 and ERK2 cascade,BP,CHI3L1;SPRY4
588,GO:0001704,0.546018848702474,0.81520961027155,1,110,formation of primary germ layer,BP,SFRP2
5811,GO:0016311,0.546147448317893,0.681279346573108,3,414,dephosphorylation,BP,PTPN3;PTPN5;PPP1R14C
18907,GO:1901342,0.546358884960857,0.725703729401315,2,269,regulation of vasculature development,BP,CHI3L1;SFRP2
4517,GO:0009416,0.547405923285941,0.724732177980349,2,275,response to light stimulus,BP,SLC4A10;KCNC2
958,GO:0002263,0.548505429566503,0.651224761823127,4,633,cell activation involved in immune response,BP,CHGA;SNAP25;CHI3L1;SELL
2480,GO:0005178,0.548520232447707,0.813227359114713,1,112,integrin binding,MF,SFRP2
4407,GO:0009185,0.548600183796872,0.813131428607689,1,115,ribonucleoside diphosphate metabolic process,BP,TJP2
9688,GO:0035304,0.548929810277226,0.812830554909102,1,119,regulation of protein dephosphorylation,BP,PPP1R14C
20062,GO:1904064,0.549527648374962,0.812379979864195,1,117,positive regulation of cation transmembrane transport,BP,KCNC2
10201,GO:0036230,0.549635831095515,0.677859383738973,3,478,granulocyte activation,BP,SNAP25;CHI3L1;SELL
4616,GO:0009855,0.549792736274463,0.81217088388502,1,117,determination of bilateral symmetry,BP,DAAM2
10681,GO:0042327,0.550150843823,0.616070027315204,6,894,positive regulation of phosphorylation,BP,EEF1A2;NEURL1;CHI3L1;SFRP2;GNG3;ADCY1
7555,GO:0030863,0.551533522027583,0.810988136435333,1,101,cortical cytoskeleton,CC,RIMS4
8781,GO:0032984,0.551907795645134,0.720557646175002,2,295,protein-containing complex disassembly,BP,STMN2;LIX1
4603,GO:0009799,0.551936894451175,0.810463492342648,1,118,specification of symmetry,BP,DAAM2
4801,GO:0010558,0.551963075415347,0.586673505732957,9,1346,negative regulation of macromolecule biosynthetic process,BP,BIRC5;CELF4;FOXM1;CENPF;SFRP2;TENM2;NEUROD2;ENC1;MYT1L
2850,GO:0005923,0.552270377950627,0.810299224464654,1,109,bicellular tight junction,CC,TJP2
13874,GO:0051384,0.554774589635943,0.808088421919615,1,130,response to glucocorticoid,BP,IGFBP2
1472,GO:0003206,0.5553775323194,0.807773363661292,1,113,cardiac chamber morphogenesis,BP,SFRP2
17832,GO:0097529,0.558554106319134,0.804944059840731,1,143,myeloid leukocyte migration,BP,CHGA
5750,GO:0016202,0.558719830192912,0.805059817271323,1,115,regulation of striated muscle tissue development,BP,CENPF
12489,GO:0046467,0.559080953880581,0.804586314732675,1,134,membrane lipid biosynthetic process,BP,ST8SIA5
12277,GO:0045944,0.559303026317925,0.595771920509246,7,1037,positive regulation of transcription by RNA polymerase II,BP,PTPRN;MYBL2;FOXM1;TOP2A;SFRP2;NEUROD2;DDN
21847,GO:2001242,0.560979766962995,0.802966889651036,1,144,regulation of intrinsic apoptotic signaling pathway,BP,SFRP2
15166,GO:0061061,0.561040113792436,0.639036063917626,4,559,muscle structure development,BP,NEURL1;CRYAB;CENPF;CXCL14
12197,GO:0045807,0.56186602946228,0.802419571714723,1,123,positive regulation of endocytosis,BP,CALY
15632,GO:0070160,0.562211674813544,0.802255865703203,1,112,occluding junction,CC,TJP2
3528,GO:0006959,0.562776138619694,0.801396101160772,1,160,humoral immune response,BP,CHGA
174,GO:0000377,0.562813327255832,0.710398834833446,2,312,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,RBFOX1;CELF4
186,GO:0000398,0.562813327255832,0.710398834833446,2,312,mRNA splicing, via spliceosome,BP,RBFOX1;CELF4
11612,GO:0044344,0.562875633808633,0.801574852451389,1,125,cellular response to fibroblast growth factor stimulus,BP,SPRY4
13144,GO:0048634,0.563560074148741,0.801095544568268,1,117,regulation of muscle organ development,BP,CENPF
2268,GO:0004842,0.564205799001826,0.663900689128427,3,422,ubiquitin-protein transferase activity,MF,LNX1;BIRC5;NEURL1
13925,GO:0051480,0.565237132828908,0.708203031022218,2,284,regulation of cytosolic calcium ion concentration,BP,GNG3;GRIN2B
1491,GO:0003231,0.565573566246699,0.799509189065242,1,111,cardiac ventricle development,BP,SFRP2
17101,GO:0080135,0.56685709322814,0.633225440760896,4,602,regulation of cellular response to stress,BP,CAMK2A;CRYAB;FOXM1;SFRP2
19080,GO:1901861,0.567080456034317,0.798194571098015,1,117,regulation of muscle tissue development,BP,CENPF
173,GO:0000375,0.567365426532808,0.706108023393908,2,315,RNA splicing, via transesterification reactions,BP,RBFOX1;CELF4
685,GO:0001837,0.56854076763608,0.796909701128634,1,124,epithelial to mesenchymal transition,BP,SFRP2
3200,GO:0006497,0.568543934272984,0.79679924007275,1,136,protein lipidation,BP,ZDHHC23
13409,GO:0050678,0.569804181101046,0.703906510814933,2,278,regulation of epithelial cell proliferation,BP,PTPRN;SFRP2
1633,GO:0003779,0.569930604182179,0.658368516844729,3,386,actin binding,MF,HPCA;DAAM2;ENC1
16270,GO:0071347,0.56997381356357,0.7955305055093,1,146,cellular response to interleukin-1,BP,CHI3L1
13688,GO:0051092,0.570270174468605,0.795367772516328,1,135,positive regulation of NF-kappaB transcription factor activity,BP,CAMK2A
686,GO:0001838,0.570476715723212,0.795357787780385,1,118,embryonic epithelial tube formation,BP,SFRP2
10911,GO:0042770,0.571567037581682,0.794353005556946,1,127,signal transduction in response to DNA damage,BP,FOXM1
17678,GO:0097223,0.571581142834023,0.794229310898313,1,140,sperm part,CC,SV2B
5930,GO:0016567,0.571608618712431,0.609020152319432,5,763,protein ubiquitination,BP,LNX1;BIRC5;NEURL1;NEUROD2;ENC1
21764,GO:2001056,0.572213554606936,0.793722101929128,1,137,positive regulation of cysteine-type endopeptidase activity,BP,GRIN2B
19602,GO:1903169,0.572520305713475,0.793571676482022,1,125,regulation of calcium ion transmembrane transport,BP,HPCA
2781,GO:0005814,0.572645313721066,0.793539415377698,1,118,centriole,CC,TOP2A
3500,GO:0006914,0.572934291035076,0.655275816431835,3,457,autophagy,BP,LZTS1;EEF1A2;LIX1
15516,GO:0061919,0.572934291035076,0.655275816431835,3,457,process utilizing autophagic mechanism,BP,LZTS1;EEF1A2;LIX1
1207,GO:0002695,0.57463661875339,0.791670263354241,1,138,negative regulation of leukocyte activation,BP,CNR1
749,GO:0001932,0.574714864697141,0.57112747270685,8,1230,regulation of protein phosphorylation,BP,NEURL1;FOXM1;RGS4;CHI3L1;SFRP2;GNG3;ADCY1;SPRY4
16269,GO:0071346,0.576268136976328,0.79022477061287,1,146,cellular response to interferon-gamma,BP,CAMK2A
11648,GO:0044424,0.576372506385176,0.527345085018013,81,12617,intracellular part,CC,CAMK1G;SYT13;GABRA1;PTPRN;BCAT1;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;LNX1;RBFOX1;RPH3A;BIRC5;KIF4A;CHGA;MYBL2;RIMS4;EEF1A2;CELF4;ST8SIA5;SYTL4;STMN2;NEFM;SLC17A7;DNM1;NEURL1;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;IGFBP2;RGS4;CENPF;CNR1;TJP2;IQSEC3;HPCA;KCNS1;PACSIN1;VGF;SULT4A1;CALY;TOP2A;SNAP25;SYT4;CHI3L1;MRAP2;SLC14A1;STAC2;LIX1;CXCL14;GABRB2;TENM2;MKI67;ZNF385D;CHST9;NRGN;GNG3;VSNL1;IGFN1;FABP7;ADCY1;TMEM130;KCNK9;NPTX1;NEUROD2;ENC1;ZCCHC12;PCSK1;CREG2;DDN;ZDHHC23;MAP7D2;SV2B;MYT1L;SPRY4;SELL;SLC6A17;PPP1R14C
610,GO:0001738,0.576748359625796,0.789929114119785,1,132,morphogenesis of a polarized epithelium,BP,SFRP2
16205,GO:0071236,0.577906960809667,0.788978415663558,1,128,cellular response to antibiotic,BP,ADCY1
8914,GO:0033209,0.578537868562166,0.788188976130654,1,161,tumor necrosis factor-mediated signaling pathway,BP,TJP2
4828,GO:0010605,0.5791443599876,0.531937522550126,15,2356,negative regulation of macromolecule metabolic process,BP,PTPN3;BIRC5;CELF4;CRYAB;FOXM1;RGS4;CENPF;SFRP2;TENM2;PI16;NEUROD2;ENC1;MYT1L;SPRY4;PPP1R14C
16536,GO:0071774,0.579393432743597,0.787687941740587,1,130,response to fibroblast growth factor,BP,SPRY4
11882,GO:0045121,0.57939577419516,0.694695064491276,2,286,membrane raft,CC,CNR1;ADCY1
11318,GO:0043524,0.579951010814462,0.787200345423025,1,131,negative regulation of neuron apoptotic process,BP,GABRB2
10601,GO:0042158,0.580677737198699,0.786498468965704,1,140,lipoprotein biosynthetic process,BP,ZDHHC23
13115,GO:0048565,0.580684621270565,0.786658485854909,1,122,digestive tract development,BP,SFRP2
14440,GO:0055080,0.58132899856217,0.618679535155033,4,620,cation homeostasis,BP,SLC30A3;SLC4A10;GNG3;GRIN2B
18093,GO:0098857,0.581446050260112,0.692706856749113,2,287,membrane microdomain,CC,CNR1;ADCY1
17846,GO:0097553,0.581828999921551,0.785739668771705,1,116,calcium ion transmembrane import into cytosol,BP,GRIN2B
14513,GO:0060048,0.582135404942367,0.785429771495756,1,120,cardiac muscle contraction,BP,CHGA
6474,GO:0019221,0.582319344766733,0.617613831286017,4,687,cytokine-mediated signaling pathway,BP,PTPRN;CAMK2A;BIRC5;TJP2
98,GO:0000187,0.584061199523088,0.783632798745424,1,133,activation of MAPK activity,BP,GNG3
9540,GO:0034767,0.58561690619186,0.782325715344075,1,128,positive regulation of ion transmembrane transport,BP,KCNC2
4777,GO:0010506,0.586361559893704,0.687897739364141,2,293,regulation of autophagy,BP,LZTS1;EEF1A2
721,GO:0001889,0.588490678199366,0.779780682227397,1,131,liver development,BP,PTPN3
362,GO:0000977,0.588860861400524,0.611015179689736,4,614,RNA polymerase II regulatory region sequence-specific DNA binding,MF,MYBL2;FOXM1;NEUROD2;DDN
4359,GO:0009132,0.589134189139062,0.779186832202417,1,134,nucleoside diphosphate metabolic process,BP,TJP2
19759,GO:1903507,0.59001242091458,0.564468374388197,7,1087,negative regulation of nucleic acid-templated transcription,BP,BIRC5;FOXM1;CENPF;SFRP2;TENM2;NEUROD2;MYT1L
13933,GO:0051494,0.590468532296719,0.778086301322649,1,126,negative regulation of cytoskeleton organization,BP,STMN2
16763,GO:0072175,0.591043456735747,0.777577787079265,1,126,epithelial tube formation,BP,SFRP2
19388,GO:1902679,0.591309650073598,0.563124815861651,7,1089,negative regulation of RNA biosynthetic process,BP,BIRC5;FOXM1;CENPF;SFRP2;TENM2;NEUROD2;MYT1L
405,GO:0001078,0.592404055191155,0.776284772305479,1,135,transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,MYT1L
3084,GO:0006323,0.592426933679027,0.776204846093544,1,142,DNA packaging,BP,TOP2A
14137,GO:0051897,0.592645680407985,0.776106892770262,1,131,positive regulation of protein kinase B signaling,BP,CHI3L1
1197,GO:0002685,0.593153057987295,0.775435561129816,1,159,regulation of leukocyte migration,BP,CXCL14
4651,GO:0009967,0.593227156111314,0.544585196277351,9,1428,positive regulation of signal transduction,BP,ASPM;CHGA;NEURL1;CHI3L1;MRAP2;SFRP2;DAAM2;GNG3;NEUROD2
383,GO:0001012,0.593339672391527,0.606414684567884,4,617,RNA polymerase II regulatory region DNA binding,MF,MYBL2;FOXM1;NEUROD2;DDN
16285,GO:0071363,0.593773697652187,0.605983725833329,4,602,cellular response to growth factor stimulus,BP,STMN2;SFRP2;ZCCHC12;SPRY4
4808,GO:0010565,0.594488649907023,0.774327410735491,1,147,regulation of cellular ketone metabolic process,BP,CNR1
9441,GO:0034614,0.595618523578132,0.773315511158986,1,147,cellular response to reactive oxygen species,BP,KCNC2
17939,GO:0098542,0.596110939491751,0.678131025148428,2,343,defense response to other organism,BP,CHGA;VGF
18040,GO:0098771,0.597005550789916,0.602617274918938,4,631,inorganic ion homeostasis,BP,SLC30A3;SLC4A10;GNG3;GRIN2B
6641,GO:0019787,0.597334966781448,0.630738122753196,3,446,ubiquitin-like protein transferase activity,MF,LNX1;BIRC5;NEURL1
1066,GO:0002443,0.598095306952545,0.601436923327045,4,688,leukocyte mediated immunity,BP,CHGA;SNAP25;CHI3L1;SELL
15126,GO:0061008,0.598377354951237,0.770941117549329,1,134,hepaticobiliary system development,BP,PTPN3
3921,GO:0008144,0.598408621610567,0.527568410074363,11,1592,drug binding,MF,CAMK1G;GABRA1;CAMK2A;KIF4A;CNR1;TOP2A;CHRM3;CHI3L1;MKI67;ADCY1;GRIN2B
8123,GO:0031960,0.598885866739916,0.770371556172884,1,147,response to corticosteroid,BP,IGFBP2
7565,GO:0030879,0.599019675396997,0.770449744135573,1,125,mammary gland development,BP,NEURL1
15897,GO:0070588,0.599031151784375,0.675398786194918,2,277,calcium ion transmembrane transport,BP,HPCA;GRIN2B
3422,GO:0006790,0.600462918705094,0.673796709773463,2,333,sulfur compound metabolic process,BP,SULT4A1;CHST9
17960,GO:0098589,0.600474652716427,0.673886827567736,2,296,membrane region,CC,CNR1;ADCY1
3177,GO:0006464,0.601261324854738,0.49108107521804,24,3694,cellular protein modification process,BP,CAMK1G;PTPN3;CAMK2A;LNX1;BIRC5;ST8SIA5;NEURL1;CRYAB;PTPN5;FOXM1;RGS4;VGF;TOP2A;CHRM3;CHI3L1;SFRP2;GNG3;ADCY1;NEUROD2;ENC1;ZDHHC23;SPRY4;PPP1R14C;GRIN2B
10193,GO:0036211,0.601261324854738,0.49108107521804,24,3694,protein modification process,BP,CAMK1G;PTPN3;CAMK2A;LNX1;BIRC5;ST8SIA5;NEURL1;CRYAB;PTPN5;FOXM1;RGS4;VGF;TOP2A;CHRM3;CHI3L1;SFRP2;GNG3;ADCY1;NEUROD2;ENC1;ZDHHC23;SPRY4;PPP1R14C;GRIN2B
6077,GO:0016829,0.601623387050801,0.767791857808536,1,160,lyase activity,MF,ADCY1
14469,GO:0055123,0.601990390027857,0.767699078694515,1,130,digestive system development,BP,SFRP2
2520,GO:0005262,0.603084143044197,0.766908060836449,1,112,calcium channel activity,MF,GRIN2B
6664,GO:0019838,0.60323622921886,0.76658069520675,1,128,growth factor binding,MF,IGFBP2
3470,GO:0006875,0.603912690078742,0.623908359702525,3,479,cellular metal ion homeostasis,BP,SLC30A3;GNG3;GRIN2B
11186,GO:0043296,0.603997687601707,0.765925466277097,1,124,apical junction complex,CC,TJP2
3702,GO:0007265,0.60568480891873,0.622133036432021,3,441,Ras protein signal transduction,BP,FOXM1;IQSEC3;SPRY4
12228,GO:0045862,0.606285285263325,0.667944089548277,2,320,positive regulation of proteolysis,BP,SFRP2;GRIN2B
1087,GO:0002478,0.606332794254546,0.763448514805815,1,163,antigen processing and presentation of exogenous peptide antigen,BP,KIF4A
2619,GO:0005525,0.607367885567841,0.666799296764931,2,337,GTP binding,MF,EEF1A2;DNM1
7587,GO:0030902,0.60803008327417,0.762132448183196,1,131,hindbrain development,BP,NEUROD2
3848,GO:0008015,0.608948245121087,0.618697628271194,3,464,blood circulation,BP,CHGA;CNR1;CHRM3
1063,GO:0002440,0.609345782600951,0.760721350503625,1,153,production of molecular mediator of immune response,BP,CHGA
21841,GO:2001236,0.609921710397392,0.760238231318749,1,146,regulation of extrinsic apoptotic signaling pathway,BP,SFRP2
3337,GO:0006665,0.610079293988908,0.760059790263948,1,150,sphingolipid metabolic process,BP,ST8SIA5
10567,GO:0042098,0.610104214133008,0.759978510402072,1,158,T cell proliferation,BP,IGFBP2
8493,GO:0032550,0.611978144419017,0.662075945424303,2,340,purine ribonucleoside binding,MF,EEF1A2;DNM1
469,GO:0001501,0.612107731499962,0.615416448005322,3,450,skeletal system development,BP,TJP2;CHI3L1;SFRP2
9303,GO:0034341,0.61327999676804,0.756960344144763,1,164,response to interferon-gamma,BP,CAMK2A
14430,GO:0055067,0.613863639046297,0.756565741366798,1,143,monovalent inorganic cation homeostasis,BP,SLC4A10
3978,GO:0008236,0.613877033527739,0.756404014472535,1,163,serine-type peptidase activity,MF,PCSK1
15991,GO:0070820,0.615197155440618,0.755211499710177,1,155,tertiary granule,CC,SNAP25
13518,GO:0050821,0.6155084412008,0.754977971054141,1,147,protein stabilization,BP,CRYAB
715,GO:0001883,0.616324701233569,0.657584886099371,2,343,purine nucleoside binding,MF,EEF1A2;DNM1
1375,GO:0003013,0.616859565735293,0.610386638953542,3,468,circulatory system process,BP,CHGA;CNR1;CHRM3
18004,GO:0098687,0.616971248521623,0.657001486487039,2,310,chromosomal region,CC,BIRC5;CENPF
947,GO:0002244,0.617060916677476,0.753414066040127,1,159,hematopoietic progenitor cell differentiation,BP,TOP2A
11425,GO:0043900,0.61725945394312,0.656622992410786,2,340,regulation of multi-organism process,BP,CNR1;TOP2A
13457,GO:0050731,0.617311137140679,0.753257884231575,1,148,positive regulation of peptidyl-tyrosine phosphorylation,BP,NEURL1
14763,GO:0060402,0.6185765987677,0.752195268033066,1,132,calcium ion transport into cytosol,BP,GRIN2B
6689,GO:0019884,0.619280825497677,0.751235607523742,1,168,antigen processing and presentation of exogenous antigen,BP,KIF4A
5099,GO:0010977,0.619291922152487,0.751491516655193,1,134,negative regulation of neuron projection development,BP,STMN2
9668,GO:0035264,0.619465610395966,0.75134524894508,1,132,multicellular organism growth,BP,SLC4A10
8492,GO:0032549,0.620349085415553,0.653398203309828,2,344,ribonucleoside binding,MF,EEF1A2;DNM1
18966,GO:1901564,0.620695420373944,0.460382126167903,37,5974,organonitrogen compound metabolic process,BP,CAMK1G;BCAT1;PTPN3;CAMK2A;LNX1;BIRC5;CHGA;EEF1A2;CELF4;ST8SIA5;NEURL1;CRYAB;PTPN5;FOXM1;IGFBP2;RGS4;TJP2;HPCA;VGF;SULT4A1;TOP2A;CHRM3;CHI3L1;MRAP2;SFRP2;TENM2;CHST9;GNG3;PI16;ADCY1;NEUROD2;ENC1;PCSK1;ZDHHC23;SPRY4;PPP1R14C;GRIN2B
11492,GO:0044089,0.620902705010232,0.606110143835243,3,464,positive regulation of cellular component biogenesis,BP,CHGA;NEURL1;TENM2
13546,GO:0050866,0.621747215851876,0.748947052716979,1,156,negative regulation of cell activation,BP,CNR1
3646,GO:0007178,0.623275536048537,0.650455941621876,2,300,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,SFRP2;ZCCHC12
15873,GO:0070555,0.623845651746969,0.746849544331733,1,166,response to interleukin-1,BP,CHI3L1
6253,GO:0017171,0.624119603358011,0.746577357531919,1,167,serine hydrolase activity,MF,PCSK1
7464,GO:0030666,0.625268030335863,0.74556718795963,1,152,endocytic vesicle membrane,CC,CAMK2A
11645,GO:0044420,0.625976937853032,0.745271223471164,1,114,extracellular matrix component,CC,FREM2
5094,GO:0010970,0.626629208545526,0.744369847107259,1,137,transport along microtubule,BP,KIF4A
18213,GO:0099111,0.626629208545526,0.744369847107259,1,137,microtubule-based transport,BP,KIF4A
4336,GO:0009101,0.628321988328264,0.645099360380448,2,312,glycoprotein biosynthetic process,BP,ST8SIA5;CHST9
9625,GO:0035148,0.630412643053754,0.740627844211324,1,140,tube formation,BP,SFRP2
714,GO:0001882,0.631066271931011,0.642083023862532,2,351,nucleoside binding,MF,EEF1A2;DNM1
19469,GO:1902903,0.63213873626927,0.641053694432665,2,308,regulation of supramolecular fiber organization,BP,STMN2;CRYAB
2669,GO:0005623,0.632743066404573,0.504933182108517,90,14077,cell,CC,CAMK1G;SYT13;GABRA1;PTPRN;BCAT1;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;LNX1;RBFOX1;RPH3A;BIRC5;KIF4A;CHGA;MYBL2;RIMS4;EEF1A2;CELF4;ST8SIA5;SYTL4;STMN2;NEFM;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;IGFBP2;RGS4;CENPF;CNR1;TJP2;PRLHR;IQSEC3;HPCA;KCNS1;PACSIN1;VGF;SULT4A1;CALY;TOP2A;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;SLC14A1;STAC2;SLC4A10;LIX1;CXCL14;GABRB2;TENM2;MKI67;FREM2;ZNF385D;CHST9;NRGN;GNG3;VSNL1;IGFN1;FABP7;ADCY1;KCNC2;TMEM130;KCNK9;NPTX1;NEUROD2;ENC1;ZCCHC12;PCSK1;CREG2;DDN;ZDHHC23;MAP7D2;NELL2;SV2B;MYT1L;SPRY4;SELL;SLC6A17;PPP1R14C;GRIN2B
11427,GO:0043902,0.633990803479874,0.736930319535216,1,158,positive regulation of multi-organism process,BP,TOP2A
12888,GO:0048002,0.634172294158324,0.736636343371457,1,175,antigen processing and presentation of peptide antigen,BP,KIF4A
623,GO:0001764,0.634367201037256,0.736805804240465,1,130,neuron migration,BP,ASPM
4831,GO:0010608,0.634791519865963,0.591126068878986,3,509,posttranscriptional regulation of gene expression,BP,CELF4;NEURL1;ENC1
7229,GO:0030203,0.635090713655736,0.735919544859218,1,147,glycosaminoglycan metabolic process,BP,CHST9
13247,GO:0048813,0.63574726814626,0.735438039854898,1,129,dendrite morphogenesis,BP,CAMK2A
8784,GO:0032989,0.636034319565719,0.515766668615362,7,1033,cellular component morphogenesis,BP,SYT1;CAMK2A;PACSIN1;SYT4;TENM2;ADCY1;NPTX1
3788,GO:0007519,0.636594281069698,0.734388280015323,1,150,skeletal muscle tissue development,BP,NEURL1
8504,GO:0032561,0.637494661630405,0.635188610448136,2,354,guanyl ribonucleotide binding,MF,EEF1A2;DNM1
6597,GO:0019637,0.638258292167755,0.524520748977547,6,1043,organophosphate metabolic process,BP,CHGA;TJP2;HPCA;SULT4A1;MRAP2;ADCY1
5822,GO:0016331,0.639102347833869,0.731922820032544,1,143,morphogenesis of embryonic epithelium,BP,SFRP2
6394,GO:0019001,0.639112452769084,0.633439786961703,2,355,guanyl nucleotide binding,MF,EEF1A2;DNM1
6469,GO:0019216,0.640301525874461,0.632230863715995,2,324,regulation of lipid metabolic process,BP,EEF1A2;CNR1
6216,GO:0017111,0.640904590444848,0.536211227029541,5,769,nucleoside-triphosphatase activity,MF,KIF4A;EEF1A2;DNM1;TOP2A;GNG3
21232,GO:2000113,0.641022445303591,0.501290036215293,8,1285,negative regulation of cellular macromolecule biosynthetic process,BP,BIRC5;CELF4;FOXM1;CENPF;SFRP2;TENM2;ENC1;MYT1L
7693,GO:0031099,0.642069807300481,0.728764909247787,1,161,regeneration,BP,PTPN3
16612,GO:0071902,0.642596293265566,0.62972805384279,2,328,positive regulation of protein serine/threonine kinase activity,BP,CHI3L1;GNG3
14762,GO:0060401,0.644290142919535,0.726652028496081,1,142,cytosolic calcium ion transport,BP,GRIN2B
1632,GO:0003777,0.64508203017295,0.726196944028927,1,112,microtubule motor activity,MF,KIF4A
11653,GO:0044430,0.646129517802888,0.488335272277696,9,1393,cytoskeletal part,CC,ASPM;BIRC5;KIF4A;SYTL4;NEFM;DNM1;CRYAB;CENPF;TOP2A
3894,GO:0008104,0.64672287923406,0.460878913378623,15,2423,protein localization,BP,PTPRN;RPH3A;SYTL4;CENPF;CNR1;HPCA;PACSIN1;VGF;SNAP25;SYT4;CHI3L1;MRAP2;VSNL1;KCNC2;ZDHHC23
7939,GO:0031570,0.647677359155889,0.723035577629997,1,157,DNA integrity checkpoint,BP,TOP2A
2728,GO:0005741,0.648065197269774,0.722589246937279,1,163,mitochondrial outer membrane,CC,CNR1
14642,GO:0060249,0.648174622980179,0.62360395622077,2,336,anatomical structure homeostasis,BP,SLC17A7;NELL2
5771,GO:0016241,0.648350828050755,0.722345731112895,1,156,regulation of macroautophagy,BP,LZTS1
18824,GO:1901136,0.648448672445264,0.722163639818266,1,167,carbohydrate derivative catabolic process,BP,CHI3L1
14858,GO:0060538,0.649668631390071,0.720976917253912,1,156,skeletal muscle organ development,BP,NEURL1
13223,GO:0048754,0.650165579506127,0.720561947427097,1,144,branching morphogenesis of an epithelial tube,BP,SFRP2
13396,GO:0050663,0.650714326194038,0.719792500067275,1,169,cytokine secretion,BP,CHI3L1
10614,GO:0042176,0.652114832278937,0.61926207726401,2,333,regulation of protein catabolic process,BP,PTPN3;EEF1A2
2747,GO:0005765,0.654271106390095,0.616852143003043,2,339,lysosomal membrane,CC,EEF1A2;SLC30A3
18090,GO:0098852,0.654271106390095,0.616852143003043,2,339,lytic vacuole membrane,CC,EEF1A2;SLC30A3
7856,GO:0031406,0.654924005833841,0.715359401027878,1,171,carboxylic acid binding,MF,GRIN2B
6658,GO:0019827,0.656484260202594,0.713885436372735,1,148,stem cell population maintenance,BP,ASPM
6292,GO:0018108,0.659598373958241,0.610905239248416,2,335,peptidyl-tyrosine phosphorylation,BP,NEURL1;SFRP2
10600,GO:0042157,0.660126005786009,0.70984027517742,1,169,lipoprotein metabolic process,BP,ZDHHC23
11562,GO:0044272,0.660483329937357,0.709471286784381,1,167,sulfur compound biosynthetic process,BP,CHST9
13410,GO:0050679,0.660547300013268,0.709469878117172,1,158,positive regulation of epithelial cell proliferation,BP,PTPRN
11976,GO:0045321,0.660600685021796,0.499877208705932,6,1074,leukocyte activation,BP,CHGA;IGFBP2;CNR1;SNAP25;CHI3L1;SELL
13402,GO:0050670,0.662020437333191,0.707722194393832,1,182,regulation of lymphocyte proliferation,BP,IGFBP2
18018,GO:0098727,0.662078046511102,0.70789190495318,1,150,maintenance of cell number,BP,ASPM
1471,GO:0003205,0.662144961211372,0.707855998260207,1,146,cardiac chamber development,BP,SFRP2
11106,GO:0043177,0.663532253080955,0.706147321131736,1,173,organic acid binding,MF,GRIN2B
3292,GO:0006605,0.663707122114438,0.606135026539728,2,394,protein targeting,BP,HPCA;ZDHHC23
8753,GO:0032944,0.663912033519335,0.705673724067915,1,183,regulation of mononuclear cell proliferation,BP,IGFBP2
6324,GO:0018212,0.663992598186092,0.605937668846701,2,338,peptidyl-tyrosine modification,BP,NEURL1;SFRP2
8126,GO:0031966,0.665225812700172,0.557172969081277,3,619,mitochondrial membrane,CC,DNM1;CNR1;NRGN
12428,GO:0046328,0.665336982759056,0.704308396968277,1,157,regulation of JNK cascade,BP,SFRP2
11801,GO:0044877,0.666704531509989,0.507495455022428,5,810,protein-containing complex binding,MF,RPH3A;CRYAB;CENPF;SFRP2;ABI3BP
7224,GO:0030198,0.666941658424618,0.602666308171445,2,310,extracellular matrix organization,BP,SFRP2;ABI3BP
5307,GO:0015085,0.666946200341269,0.702786414643636,1,133,calcium ion transmembrane transporter activity,MF,GRIN2B
13495,GO:0050792,0.666982640916366,0.702366078798375,1,178,regulation of viral process,BP,TOP2A
11490,GO:0044087,0.667346463470629,0.506770881488589,5,809,regulation of cellular component biogenesis,BP,CHGA;STMN2;NEURL1;CRYAB;TENM2
2782,GO:0005815,0.66832383081341,0.525206587207143,4,659,microtubule organizing center,CC,ASPM;SYTL4;CENPF;TOP2A
112,GO:0000228,0.669287469438797,0.552659447482639,3,513,nuclear chromosome,CC,BIRC5;TOP2A;ENC1
20646,GO:1905330,0.669727999400251,0.699403869687284,1,171,regulation of morphogenesis of an epithelium,BP,SFRP2
6970,GO:0021915,0.670781135498555,0.698409264220057,1,150,neural tube development,BP,SFRP2
13550,GO:0050870,0.672529378743196,0.696209216393165,1,187,positive regulation of T cell activation,BP,IGFBP2
11568,GO:0044282,0.67307027744383,0.595439305740235,2,390,small molecule catabolic process,BP,BCAT1;CNR1
5057,GO:0010921,0.673359935344804,0.695503340233584,1,156,regulation of phosphatase activity,BP,PPP1R14C
1195,GO:0002683,0.673834845675219,0.594603367030217,2,368,negative regulation of immune system process,BP,CNR1;TJP2
7034,GO:0022411,0.674141302053164,0.547056879780794,3,530,cellular component disassembly,BP,STMN2;TOP2A;LIX1
751,GO:0001934,0.674288722269511,0.498859550542832,5,855,positive regulation of protein phosphorylation,BP,NEURL1;CHI3L1;SFRP2;GNG3;ADCY1
15929,GO:0070663,0.675640278184109,0.692733812152504,1,189,regulation of leukocyte proliferation,BP,IGFBP2
11368,GO:0043603,0.675787181945031,0.497087625082652,5,965,cellular amide metabolic process,BP,EEF1A2;CELF4;NEURL1;ENC1;PCSK1
1139,GO:0002573,0.676218043298126,0.692201161258811,1,171,myeloid leukocyte differentiation,BP,TJP2
7470,GO:0030674,0.676913680796398,0.691480295917781,1,163,protein binding, bridging,MF,TJP2
7318,GO:0030324,0.67877569894194,0.689417892647895,1,159,lung development,BP,CHI3L1
3516,GO:0006941,0.678863307946072,0.689311001499452,1,160,striated muscle contraction,BP,CHGA
7808,GO:0031325,0.679095170267978,0.420346174773875,17,2766,positive regulation of cellular metabolic process,BP,PTPRN;CHGA;MYBL2;EEF1A2;CELF4;NEURL1;FOXM1;HPCA;TOP2A;CHI3L1;MRAP2;SFRP2;GNG3;ADCY1;NEUROD2;DDN;GRIN2B
15922,GO:0070647,0.679419482801168,0.478677519831787,6,1011,protein modification by small protein conjugation or removal,BP,LNX1;BIRC5;NEURL1;TOP2A;NEUROD2;ENC1
1631,GO:0003774,0.679565860436517,0.688840548888251,1,128,motor activity,MF,KIF4A
13589,GO:0050920,0.679701512733731,0.688214916106721,1,181,regulation of chemotaxis,BP,CXCL14
5877,GO:0016462,0.679951942404642,0.492410530883856,5,811,pyrophosphatase activity,MF,KIF4A;EEF1A2;DNM1;TOP2A;GNG3
6072,GO:0016817,0.68105814961549,0.491138322225156,5,813,hydrolase activity, acting on acid anhydrides,MF,KIF4A;EEF1A2;DNM1;TOP2A;GNG3
6073,GO:0016818,0.68105814961549,0.491138322225156,5,813,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,KIF4A;EEF1A2;DNM1;TOP2A;GNG3
19243,GO:1902275,0.681169074421142,0.686726969585556,1,157,regulation of chromatin organization,BP,MKI67
13854,GO:0051345,0.681319992110367,0.510265137052924,4,682,positive regulation of hydrolase activity,BP,RGS4;HPCA;SFRP2;GRIN2B
7282,GO:0030278,0.68194437869936,0.685759529245784,1,168,regulation of ossification,BP,SFRP2
2876,GO:0005975,0.682579073571111,0.53723757324037,3,544,carbohydrate metabolic process,BP,ST8SIA5;CHI3L1;CHST9
11257,GO:0043412,0.682910963925486,0.4041534819208,24,3860,macromolecule modification,BP,CAMK1G;PTPN3;CAMK2A;LNX1;BIRC5;ST8SIA5;NEURL1;CRYAB;PTPN5;FOXM1;RGS4;VGF;TOP2A;CHRM3;CHI3L1;SFRP2;GNG3;ADCY1;NEUROD2;ENC1;ZDHHC23;SPRY4;PPP1R14C;GRIN2B
15539,GO:0065004,0.683016405628416,0.684383437048728,1,192,protein-DNA complex assembly,BP,CENPF
3680,GO:0007219,0.683734088956138,0.683689631314082,1,172,Notch signaling pathway,BP,NEURL1
6781,GO:0021543,0.684442198415746,0.683012334575029,1,155,pallium development,BP,ASPM
11668,GO:0044450,0.684513807503549,0.682888214811452,1,160,microtubule organizing center part,CC,TOP2A
361,GO:0000976,0.685044521178006,0.505937210369104,4,685,transcription regulatory region sequence-specific DNA binding,MF,MYBL2;FOXM1;NEUROD2;DDN
14866,GO:0060548,0.686604583978758,0.484686959023206,5,896,negative regulation of cell death,BP,BIRC5;CHGA;CRYAB;SFRP2;GABRB2
7317,GO:0030323,0.687505013092111,0.679423047165459,1,163,respiratory tube development,BP,CHI3L1
2437,GO:0005126,0.688046265303895,0.678537903908226,1,204,cytokine receptor binding,MF,CXCL14
5182,GO:0014706,0.690411475288319,0.575238818673775,2,332,striated muscle tissue development,BP,NEURL1;CENPF
3743,GO:0007369,0.69110586017223,0.675226683954414,1,165,gastrulation,BP,SFRP2
19471,GO:1902905,0.692059602212466,0.674018307759158,1,178,positive regulation of supramolecular fiber organization,BP,STMN2
19550,GO:1903039,0.692722666668697,0.6731319839765,1,196,positive regulation of leukocyte cell-cell adhesion,BP,IGFBP2
6579,GO:0019538,0.692787745914095,0.386771466035623,31,5080,protein metabolic process,BP,CAMK1G;PTPN3;CAMK2A;LNX1;BIRC5;EEF1A2;CELF4;ST8SIA5;NEURL1;CRYAB;PTPN5;FOXM1;IGFBP2;RGS4;VGF;TOP2A;CHRM3;CHI3L1;SFRP2;TENM2;CHST9;GNG3;PI16;ADCY1;NEUROD2;ENC1;PCSK1;ZDHHC23;SPRY4;PPP1R14C;GRIN2B
14429,GO:0055065,0.693261909112547,0.524640371840677,3,543,metal ion homeostasis,BP,SLC30A3;GNG3;GRIN2B
11666,GO:0044448,0.693587546454326,0.67238671480628,1,157,cell cortex part,CC,RIMS4
7489,GO:0030705,0.693887363793261,0.67201724688307,1,159,cytoskeleton-dependent intracellular transport,BP,KIF4A
18531,GO:0140097,0.693895593751591,0.67184451655079,1,181,catalytic activity, acting on DNA,MF,TOP2A
8128,GO:0031968,0.694935907200118,0.670619105044484,1,181,organelle outer membrane,CC,CNR1
10583,GO:0042127,0.695209082607074,0.440769685452729,8,1410,regulation of cell proliferation,BP,PTPRN;ASPM;BIRC5;NEURL1;FOXM1;IGFBP2;SFRP2;FABP7
4742,GO:0010389,0.695365808165682,0.670079904219891,1,186,regulation of G2/M transition of mitotic cell cycle,BP,CENPF
10617,GO:0042180,0.696557768341335,0.668594396298694,1,199,cellular ketone metabolic process,BP,CNR1
7893,GO:0031461,0.697422129814278,0.667682682829115,1,180,cullin-RING ubiquitin ligase complex,CC,ENC1
15842,GO:0070507,0.69772749536926,0.667444457535375,1,163,regulation of microtubule cytoskeleton organization,BP,STMN2
6687,GO:0019882,0.698014772203552,0.666822238631845,1,207,antigen processing and presentation,BP,KIF4A
18982,GO:1901605,0.69821353511309,0.66661664930357,1,201,alpha-amino acid metabolic process,BP,BCAT1
14136,GO:0051896,0.698246801092059,0.666743242926289,1,174,regulation of protein kinase B signaling,BP,CHI3L1
2727,GO:0005740,0.699040879933004,0.517616385428866,3,655,mitochondrial envelope,CC,DNM1;CNR1;NRGN
3469,GO:0006874,0.699567132931327,0.564134989795665,2,366,cellular calcium ion homeostasis,BP,GNG3;GRIN2B
7051,GO:0022618,0.699915278923858,0.664618579450725,1,195,ribonucleoprotein complex assembly,BP,CELF4
6318,GO:0018205,0.700100790465123,0.563508353916247,2,357,peptidyl-lysine modification,BP,BIRC5;TOP2A
9537,GO:0034764,0.700378075705486,0.664220272687727,1,171,positive regulation of transmembrane transport,BP,KCNC2
18060,GO:0098802,0.700757952979593,0.663743278617999,1,174,plasma membrane receptor complex,CC,GRIN2B
17404,GO:0090316,0.700999214618527,0.663419160790723,1,179,positive regulation of intracellular protein transport,BP,HPCA
6682,GO:0019867,0.701147932386007,0.663214237853268,1,183,outer membrane,CC,CNR1
11381,GO:0043624,0.701179167597416,0.66308154702437,1,199,cellular protein complex disassembly,BP,STMN2
11140,GO:0043227,0.701920992499422,0.378489189907119,69,11108,membrane-bounded organelle,CC,CAMK1G;SYT13;GABRA1;PTPRN;BCAT1;ASPM;SYT1;CAMK2A;RBFOX1;RPH3A;BIRC5;KIF4A;CHGA;MYBL2;EEF1A2;CELF4;ST8SIA5;SYTL4;STMN2;SLC17A7;DNM1;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;IGFBP2;RGS4;CENPF;CNR1;TJP2;PACSIN1;VGF;CALY;TOP2A;SNAP25;SYT4;CHI3L1;MRAP2;SLC14A1;CXCL14;GABRB2;TENM2;DAAM2;MKI67;FREM2;ZNF385D;CHST9;NRGN;IGFN1;FABP7;PI16;ADCY1;KCNC2;TMEM130;KCNK9;NPTX1;NEUROD2;ENC1;ZCCHC12;PCSK1;CREG2;DDN;ZDHHC23;SV2B;MYT1L;SELL;CPNE4;SLC6A17
21839,GO:2001234,0.702411075955631,0.661611033995339,1,197,negative regulation of apoptotic signaling pathway,BP,SFRP2
13390,GO:0050657,0.703518011858125,0.660379823876005,1,180,nucleic acid transport,BP,RBFOX1
13391,GO:0050658,0.703518011858125,0.660379823876005,1,180,RNA transport,BP,RBFOX1
11559,GO:0044267,0.706130692011928,0.374464092181346,28,4620,cellular protein metabolic process,BP,CAMK1G;PTPN3;CAMK2A;LNX1;BIRC5;EEF1A2;CELF4;ST8SIA5;NEURL1;CRYAB;PTPN5;FOXM1;IGFBP2;RGS4;VGF;TOP2A;CHRM3;CHI3L1;SFRP2;GNG3;PI16;ADCY1;NEUROD2;ENC1;ZDHHC23;SPRY4;PPP1R14C;GRIN2B
7255,GO:0030234,0.706967338732458,0.460807927715842,5,903,enzyme regulator activity,MF,BIRC5;RGS4;SFRP2;PI16;PPP1R14C
12237,GO:0045892,0.707824312916813,0.44573870143032,6,1050,negative regulation of transcription, DNA-templated,BP,BIRC5;FOXM1;CENPF;SFRP2;TENM2;MYT1L
11428,GO:0043903,0.708860874520673,0.653742441413312,1,202,regulation of symbiosis, encompassing mutualism through parasitism,BP,TOP2A
13686,GO:0051090,0.711502967963768,0.549443034121521,2,379,regulation of DNA binding transcription factor activity,BP,CAMK2A;NEUROD2
3320,GO:0006643,0.711943411637609,0.649933663405864,1,204,membrane lipid metabolic process,BP,ST8SIA5
13746,GO:0051173,0.712096284484124,0.385982724034091,16,2668,positive regulation of nitrogen compound metabolic process,BP,PTPRN;CHGA;MYBL2;CELF4;NEURL1;FOXM1;HPCA;TOP2A;CHI3L1;MRAP2;SFRP2;GNG3;ADCY1;NEUROD2;DDN;GRIN2B
17688,GO:0097237,0.712801255365957,0.648870814879057,1,204,cellular response to toxic substance,BP,KCNC2
13786,GO:0051236,0.712833445496943,0.648955865926228,1,183,establishment of RNA localization,BP,RBFOX1
14435,GO:0055074,0.713592173180962,0.546847562668702,2,376,calcium ion homeostasis,BP,GNG3;GRIN2B
6028,GO:0016747,0.713651946569472,0.647876463501709,1,193,transferase activity, transferring acyl groups other than amino-acyl groups,MF,ZDHHC23
14857,GO:0060537,0.713973033600119,0.546445407028212,2,346,muscle tissue development,BP,NEURL1;CENPF
4066,GO:0008380,0.715325255305555,0.544618203760197,2,406,RNA splicing,BP,RBFOX1;CELF4
4644,GO:0009952,0.716823199138723,0.643972675082307,1,184,anterior/posterior pattern specification,BP,SFRP2
15206,GO:0061138,0.716836779280526,0.644025648690135,1,174,morphogenesis of a branching epithelium,BP,SFRP2
139,GO:0000287,0.717608631017136,0.642973231435595,1,186,magnesium ion binding,MF,TOP2A
5747,GO:0016197,0.718586715522395,0.641761706462265,1,183,endosomal transport,BP,CALY
16607,GO:0071897,0.718849404199347,0.641378923326411,1,191,DNA biosynthetic process,BP,CENPF
13226,GO:0048762,0.719737034213479,0.640289333038977,1,186,mesenchymal cell differentiation,BP,SFRP2
19126,GO:1901991,0.71984584244167,0.640034017353765,1,206,negative regulation of mitotic cell cycle phase transition,BP,CENPF
4335,GO:0009100,0.720052952983474,0.538736426691732,2,374,glycoprotein metabolic process,BP,ST8SIA5;CHST9
14550,GO:0060090,0.720209851796015,0.639717581235796,1,182,molecular adaptor activity,MF,TJP2
16566,GO:0071826,0.720306503083709,0.639445414331619,1,207,ribonucleoprotein complex subunit organization,BP,CELF4
4961,GO:0010810,0.720692939820605,0.639162438635454,1,174,regulation of cell-substrate adhesion,BP,ABI3BP
3072,GO:0006302,0.720989417995155,0.638683222795816,1,189,double-strand break repair,BP,FOXM1
16201,GO:0071229,0.723153480841012,0.63593424859239,1,188,cellular response to acid chemical,BP,NEURL1
19419,GO:1902749,0.723900500206721,0.634895388423611,1,202,regulation of cell cycle G2/M phase transition,BP,CENPF
12026,GO:0045444,0.723921517914044,0.634920959264676,1,193,fat cell differentiation,BP,SFRP2
21119,GO:1990837,0.723995056611711,0.459296732558338,4,721,sequence-specific double-stranded DNA binding,MF,MYBL2;FOXM1;NEUROD2;DDN
3694,GO:0007254,0.72412944561737,0.634692547010623,1,187,JNK cascade,BP,SFRP2
2755,GO:0005774,0.724833091077395,0.532624769000026,2,392,vacuolar membrane,CC,EEF1A2;SLC30A3
5680,GO:0016051,0.72508173176339,0.633375290281798,1,203,carbohydrate biosynthetic process,BP,CHST9
15768,GO:0070374,0.725432977447702,0.632952307183567,1,198,positive regulation of ERK1 and ERK2 cascade,BP,CHI3L1
8291,GO:0032271,0.726004397743497,0.632246979249427,1,193,regulation of protein polymerization,BP,STMN2
8817,GO:0033036,0.726711916776246,0.369365785359367,16,2703,macromolecule localization,BP,PTPRN;RBFOX1;RPH3A;SYTL4;CENPF;CNR1;HPCA;PACSIN1;VGF;SNAP25;SYT4;CHI3L1;MRAP2;VSNL1;KCNC2;ZDHHC23
2954,GO:0006091,0.727333277500133,0.52934771518029,2,433,generation of precursor metabolites and energy,BP,VGF;MRAP2
461,GO:0001228,0.729198004965883,0.527048096446871,2,383,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,MYBL2;NEUROD2
6180,GO:0017048,0.730083221980889,0.62717539299177,1,164,Rho GTPase binding,MF,DAAM2
3174,GO:0006457,0.730142744157441,0.626717347694651,1,225,protein folding,BP,CRYAB
11041,GO:0043062,0.730690815778805,0.525186909570929,2,356,extracellular structure organization,BP,SFRP2;ABI3BP
4663,GO:0010001,0.731327889710357,0.62535904658243,1,190,glial cell differentiation,BP,DAAM2
9687,GO:0035303,0.731593036092783,0.625051918004721,1,184,regulation of dephosphorylation,BP,PPP1R14C
403,GO:0001076,0.731769723921903,0.624820718965325,1,184,transcription factor activity, RNA polymerase II transcription factor binding,MF,MYBL2
13669,GO:0051054,0.732403038707946,0.6238847844452,1,201,positive regulation of DNA metabolic process,BP,FOXM1
14860,GO:0060541,0.732615051608451,0.623712973642052,1,184,respiratory system development,BP,CHI3L1
7849,GO:0031399,0.73294344465502,0.389712002515142,9,1579,regulation of protein modification process,BP,NEURL1;FOXM1;RGS4;CHI3L1;SFRP2;GNG3;ADCY1;SPRY4;PPP1R14C
551,GO:0001649,0.733134478472686,0.622984847634414,1,191,osteoblast differentiation,BP,SFRP2
849,GO:0002064,0.733431133962269,0.622654843150753,1,182,epithelial cell development,BP,TJP2
17657,GO:0097191,0.734319078258148,0.621337109706734,1,206,extrinsic apoptotic signaling pathway,BP,SFRP2
13934,GO:0051495,0.734975455906797,0.620510390815935,1,199,positive regulation of cytoskeleton organization,BP,STMN2
11097,GO:0043167,0.735207320546013,0.337601438696824,35,5527,ion binding,MF,CAMK1G;SYT13;SYT1;CAMK2A;LNX1;RPH3A;BIRC5;KIF4A;EEF1A2;SYTL4;NPTX2;DNM1;NEURL1;CRYAB;HPCA;PACSIN1;PRRG3;TOP2A;SYT4;CHRM3;STAC2;TENM2;MKI67;FREM2;ZNF385D;NRGN;ABI3BP;VSNL1;ADCY1;NPTX1;ZCCHC12;NELL2;MYT1L;SELL;GRIN2B
12594,GO:0046651,0.73672750412266,0.618068583330943,1,222,lymphocyte proliferation,BP,IGFBP2
7121,GO:0030027,0.737451510551055,0.617373409255779,1,177,lamellipodium,CC,STMN2
12103,GO:0045637,0.738020086431882,0.61645876117513,1,201,regulation of myeloid cell differentiation,BP,TJP2
16564,GO:0071824,0.738563985667785,0.615637690572631,1,219,protein-DNA complex subunit organization,BP,CENPF
8752,GO:0032943,0.739947656324081,0.613762888705159,1,224,mononuclear cell proliferation,BP,IGFBP2
13197,GO:0048705,0.740422957572979,0.613287366387719,1,194,skeletal system morphogenesis,BP,SFRP2
11678,GO:0044464,0.741328043717435,0.379303458701209,89,14059,cell part,CC,CAMK1G;SYT13;GABRA1;PTPRN;BCAT1;LZTS1;ASPM;SYT1;PTPN3;CAMK2A;LNX1;RBFOX1;RPH3A;BIRC5;KIF4A;CHGA;MYBL2;RIMS4;EEF1A2;CELF4;ST8SIA5;SYTL4;STMN2;NEFM;SLC17A7;NPTX2;DNM1;NEURL1;GABRA4;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;IGFBP2;RGS4;CENPF;CNR1;TJP2;PRLHR;IQSEC3;HPCA;KCNS1;PACSIN1;VGF;SULT4A1;CALY;TOP2A;SNAP25;SYT4;CHRM3;CHI3L1;MRAP2;SLC14A1;STAC2;SLC4A10;LIX1;CXCL14;GABRB2;TENM2;MKI67;FREM2;ZNF385D;CHST9;NRGN;GNG3;VSNL1;IGFN1;FABP7;ADCY1;KCNC2;TMEM130;KCNK9;NPTX1;NEUROD2;ENC1;ZCCHC12;PCSK1;CREG2;DDN;ZDHHC23;MAP7D2;SV2B;MYT1L;SPRY4;SELL;SLC6A17;PPP1R14C;GRIN2B
19123,GO:1901988,0.741551285867522,0.611632373004248,1,219,negative regulation of cell cycle phase transition,BP,CENPF
18967,GO:1901565,0.743598015365075,0.402642125126849,6,1130,organonitrogen compound catabolic process,BP,BCAT1;PTPN3;LNX1;EEF1A2;CHI3L1;ENC1
10835,GO:0042623,0.743636042333935,0.508264749501661,2,349,ATPase activity, coupled,MF,KIF4A;TOP2A
12705,GO:0046914,0.744176150703177,0.415517502657886,5,931,transition metal ion binding,MF,RPH3A;ZNF385D;ZCCHC12;MYT1L;GRIN2B
622,GO:0001763,0.744530841417608,0.607787664922279,1,187,morphogenesis of a branching structure,BP,SFRP2
1206,GO:0002694,0.746528257197077,0.504240145599286,2,431,regulation of leukocyte activation,BP,IGFBP2;CNR1
7032,GO:0022409,0.748216673253843,0.602540842278374,1,225,positive regulation of cell-cell adhesion,BP,IGFBP2
4631,GO:0009897,0.748300611378435,0.60247479552307,1,215,external side of plasma membrane,CC,SELL
3749,GO:0007389,0.749006855891737,0.500994284391191,2,395,pattern specification process,BP,SFRP2;DAAM2
17447,GO:0090407,0.749746934634112,0.454188899674738,3,611,organophosphate biosynthetic process,BP,HPCA;MRAP2;ADCY1
13799,GO:0051254,0.749956614334491,0.376164312687993,8,1409,positive regulation of RNA metabolic process,BP,PTPRN;MYBL2;CELF4;FOXM1;TOP2A;SFRP2;NEUROD2;DDN
8711,GO:0032886,0.750398058415837,0.599732186824654,1,190,regulation of microtubule-based process,BP,STMN2
4846,GO:0010629,0.751347676936209,0.367691660120297,9,1637,negative regulation of gene expression,BP,BIRC5;CELF4;CRYAB;FOXM1;CENPF;SFRP2;TENM2;ENC1;MYT1L
17092,GO:0080090,0.752844730532231,0.318746454394715,33,5437,regulation of primary metabolic process,BP,PTPRN;LZTS1;PTPN3;CAMK2A;RBFOX1;BIRC5;CHGA;MYBL2;EEF1A2;CELF4;NEURL1;CRYAB;FOXM1;RGS4;CENPF;CNR1;HPCA;TOP2A;CHI3L1;MRAP2;SFRP2;TENM2;GNG3;PI16;ADCY1;NEUROD2;ENC1;ZCCHC12;DDN;MYT1L;SPRY4;PPP1R14C;GRIN2B
2752,GO:0005770,0.752966031963849,0.596004401436038,1,219,late endosome,CC,SLC30A3
13991,GO:0051606,0.753115104425534,0.595772380878507,1,224,detection of stimulus,BP,SYT1
7812,GO:0031329,0.753479601920139,0.422201203461562,4,763,regulation of cellular catabolic process,BP,LZTS1;PTPN3;EEF1A2;CNR1
11160,GO:0043254,0.755038912745913,0.492836902508168,2,404,regulation of protein complex assembly,BP,STMN2;CRYAB
11646,GO:0044421,0.755537617970617,0.33172017962807,18,3312,extracellular region part,CC,KIF4A;CHGA;DNM1;CRYAB;IGFBP2;VGF;SYT4;CHI3L1;SFRP2;CXCL14;GABRB2;DAAM2;FREM2;ABI3BP;PI16;ADCY1;PCSK1;CPNE4
17243,GO:0090092,0.755703752662937,0.592265025927709,1,203,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,SFRP2
6027,GO:0016746,0.756305647257174,0.59132788285505,1,220,transferase activity, transferring acyl groups,MF,ZDHHC23
15927,GO:0070661,0.757092620275482,0.590150241040414,1,235,leukocyte proliferation,BP,IGFBP2
7192,GO:0030155,0.757333482509231,0.444249919464021,3,583,regulation of cell adhesion,BP,IGFBP2;SFRP2;ABI3BP
1615,GO:0003714,0.758601621376441,0.588142012433123,1,210,transcription corepressor activity,MF,NEUROD2
3479,GO:0006886,0.759654749262646,0.395978055163532,5,1002,intracellular protein transport,BP,RPH3A;SYTL4;HPCA;SNAP25;ZDHHC23
4009,GO:0008285,0.759835430512781,0.440904192768327,3,610,negative regulation of cell proliferation,BP,NEURL1;SFRP2;FABP7
5647,GO:0015980,0.759996459315876,0.586002910517746,1,244,energy derivation by oxidation of organic compounds,BP,MRAP2
11293,GO:0043491,0.76069019901805,0.585194094419139,1,207,protein kinase B signaling,BP,CHI3L1
11333,GO:0043543,0.760756950722321,0.585055308770793,1,215,protein acylation,BP,ZDHHC23
13744,GO:0051171,0.761356537957173,0.309626802806232,32,5304,regulation of nitrogen compound metabolic process,BP,PTPRN;LZTS1;PTPN3;CAMK2A;RBFOX1;BIRC5;CHGA;MYBL2;EEF1A2;CELF4;NEURL1;CRYAB;FOXM1;RGS4;CENPF;HPCA;TOP2A;CHI3L1;MRAP2;SFRP2;TENM2;GNG3;PI16;ADCY1;NEUROD2;ENC1;ZCCHC12;DDN;MYT1L;SPRY4;PPP1R14C;GRIN2B
3134,GO:0006403,0.762456284713731,0.582623791941,1,216,RNA localization,BP,RBFOX1
16153,GO:0071103,0.762462532628868,0.582589297521531,1,221,DNA conformation change,BP,TOP2A
13210,GO:0048732,0.763650957516697,0.481049834439685,2,398,gland development,BP,PTPN3;NEURL1
3701,GO:0007264,0.764475462991187,0.434780176238559,3,553,small GTPase mediated signal transduction,BP,FOXM1;IQSEC3;SPRY4
19169,GO:1902105,0.767038264244386,0.575979866319592,1,224,regulation of leukocyte differentiation,BP,TJP2
11650,GO:0044427,0.767939491346334,0.403401071996966,4,786,chromosomal part,CC,BIRC5;MYBL2;CENPF;ENC1
5630,GO:0015931,0.767995946007825,0.574603160067649,1,221,nucleobase-containing compound transport,BP,RBFOX1
13796,GO:0051251,0.770307503922728,0.571126642759127,1,243,positive regulation of lymphocyte activation,BP,IGFBP2
11044,GO:0043066,0.771010517527846,0.399340264982394,4,812,negative regulation of apoptotic process,BP,BIRC5;CRYAB;SFRP2;GABRB2
7996,GO:0031668,0.771747111187006,0.569098888445722,1,224,cellular response to extracellular stimulus,BP,SFRP2
21183,GO:2000027,0.772742282289618,0.56759866104866,1,231,regulation of organ morphogenesis,BP,SFRP2
162,GO:0000323,0.772983223941441,0.423212072259513,3,633,lytic vacuole,CC,CHGA;EEF1A2;SLC30A3
2746,GO:0005764,0.772983223941441,0.423212072259513,3,633,lysosome,CC,CHGA;EEF1A2;SLC30A3
13164,GO:0048667,0.773086982497292,0.42317834971075,3,538,cell morphogenesis involved in neuron differentiation,BP,CAMK2A;ADCY1;NPTX1
8207,GO:0032101,0.774942245535652,0.420531759005059,3,646,regulation of response to external stimulus,BP,CNR1;CXCL14;FABP7
633,GO:0001775,0.775816033045315,0.362165492371403,6,1208,cell activation,BP,CHGA;IGFBP2;CNR1;SNAP25;CHI3L1;SELL
9153,GO:0033993,0.776969476596502,0.391428830719041,4,828,response to lipid,BP,CRYAB;IGFBP2;CNR1;ADCY1
15399,GO:0061630,0.777015844162614,0.561346780959523,1,212,ubiquitin protein ligase activity,MF,NEURL1
10652,GO:0042277,0.778278309939564,0.559313816424138,1,241,peptide binding,MF,CRYAB
3128,GO:0006397,0.778626183681049,0.459903664600189,2,457,mRNA processing,BP,RBFOX1;CELF4
11047,GO:0043069,0.77958875877989,0.387935384110324,4,823,negative regulation of programmed cell death,BP,BIRC5;CRYAB;SFRP2;GABRB2
371,GO:0000989,0.780046777646517,0.413577855053168,3,603,transcription factor activity, transcription factor binding,MF,MYBL2;NEUROD2;ZCCHC12
7329,GO:0030336,0.780962717047186,0.555388767670112,1,216,negative regulation of cell migration,BP,SFRP2
8371,GO:0032388,0.781815459757898,0.554055281900495,1,224,positive regulation of intracellular transport,BP,HPCA
4544,GO:0009605,0.78217519147033,0.324463479956252,10,1879,response to external stimulus,BP,CHGA;IGFBP2;CNR1;HPCA;VGF;CHI3L1;SFRP2;CXCL14;FABP7;SELL
6033,GO:0016757,0.782603341549106,0.552783708952614,1,240,transferase activity, transferring glycosyl groups,MF,ST8SIA5
14041,GO:0051707,0.783249942352184,0.409075895484565,3,688,response to other organism,BP,CHGA;CNR1;VGF
7199,GO:0030163,0.783536386170993,0.382648869803051,4,806,protein catabolic process,BP,PTPN3;LNX1;EEF1A2;ENC1
15412,GO:0061659,0.783645032868082,0.551308292110662,1,217,ubiquitin-like protein ligase activity,MF,NEURL1
370,GO:0000988,0.783786197055073,0.408407263972899,3,607,transcription factor activity, protein binding,MF,MYBL2;NEUROD2;ZCCHC12
11127,GO:0043207,0.784561554801085,0.407255618787234,3,690,response to external biotic stimulus,BP,CHGA;CNR1;VGF
3584,GO:0007050,0.78498387871476,0.549172601313227,1,235,cell cycle arrest,BP,FOXM1
13545,GO:0050865,0.7852096645944,0.45042570813578,2,464,regulation of cell activation,BP,IGFBP2;CNR1
3849,GO:0008016,0.785502410661237,0.548456214478618,1,219,regulation of heart contraction,BP,CHGA
2842,GO:0005911,0.786144182775429,0.449181234240699,2,402,cell-cell junction,CC,TJP2;FABP7
7982,GO:0031647,0.786936262424641,0.546168304906094,1,236,regulation of protein stability,BP,CRYAB
7811,GO:0031328,0.78769162208333,0.322937864016601,9,1662,positive regulation of cellular biosynthetic process,BP,PTPRN;MYBL2;FOXM1;HPCA;TOP2A;MRAP2;SFRP2;NEUROD2;DDN
4627,GO:0009893,0.788377873207781,0.294906309902248,17,2964,positive regulation of metabolic process,BP,PTPRN;CHGA;MYBL2;EEF1A2;CELF4;NEURL1;FOXM1;HPCA;TOP2A;CHI3L1;MRAP2;SFRP2;GNG3;ADCY1;NEUROD2;DDN;GRIN2B
3080,GO:0006310,0.788470121261396,0.543817500127808,1,232,DNA recombination,BP,TOP2A
1604,GO:0003690,0.793048384727537,0.369750222298948,4,799,double-stranded DNA binding,MF,MYBL2;FOXM1;NEUROD2;DDN
14825,GO:0060485,0.794476634088076,0.534430751596493,1,232,mesenchyme development,BP,SFRP2
21248,GO:2000146,0.795368393121473,0.533041542366147,1,228,negative regulation of cell motility,BP,SFRP2
3193,GO:0006486,0.795451467758928,0.532872052240083,1,236,protein glycosylation,BP,ST8SIA5
11258,GO:0043413,0.795451467758928,0.532872052240083,1,236,macromolecule glycosylation,BP,ST8SIA5
19548,GO:1903037,0.797205612054274,0.52998495521617,1,261,regulation of leukocyte cell-cell adhesion,BP,IGFBP2
4625,GO:0009891,0.798823177890502,0.308860439887632,9,1684,positive regulation of biosynthetic process,BP,PTPRN;MYBL2;FOXM1;HPCA;TOP2A;MRAP2;SFRP2;NEUROD2;DDN
7806,GO:0031323,0.79990740517542,0.264548153506837,33,5557,regulation of cellular metabolic process,BP,PTPRN;LZTS1;PTPN3;CAMK2A;RBFOX1;BIRC5;CHGA;MYBL2;EEF1A2;CELF4;NEURL1;CRYAB;FOXM1;RGS4;CENPF;CNR1;HPCA;TOP2A;CHI3L1;MRAP2;SFRP2;TENM2;GNG3;PI16;ADCY1;NEUROD2;ENC1;ZCCHC12;DDN;MYT1L;SPRY4;PPP1R14C;GRIN2B
9434,GO:0034599,0.800634810189332,0.52451121478125,1,258,cellular response to oxidative stress,BP,KCNC2
8882,GO:0033157,0.801577566669776,0.523067834450915,1,240,regulation of intracellular protein transport,BP,HPCA
19333,GO:1902531,0.802511247741444,0.304159934265748,9,1671,regulation of intracellular signal transduction,BP,FOXM1;RGS4;IQSEC3;CHI3L1;MRAP2;SFRP2;GNG3;NEUROD2;SPRY4
11647,GO:0044422,0.802744273408281,0.257903201557585,50,8352,organelle part,CC,CAMK1G;GABRA1;PTPRN;ASPM;SYT1;CAMK2A;RBFOX1;RPH3A;BIRC5;KIF4A;CHGA;MYBL2;EEF1A2;ST8SIA5;SYTL4;NEFM;SLC17A7;DNM1;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;CENPF;CNR1;TJP2;PACSIN1;VGF;CALY;TOP2A;SNAP25;SYT4;CHI3L1;MRAP2;SLC14A1;GABRB2;TENM2;MKI67;CHST9;NRGN;IGFN1;TMEM130;ENC1;ZCCHC12;PCSK1;DDN;SV2B;SELL;SLC6A17;GRIN2B
4656,GO:0009986,0.803022965352246,0.381229182046037,3,638,cell surface,CC,CRYAB;SELL;GRIN2B
15590,GO:0070085,0.803940710745586,0.519228846625525,1,243,glycosylation,BP,ST8SIA5
3450,GO:0006839,0.804844847498524,0.517626773491638,1,277,mitochondrial transport,BP,CAMK2A
7268,GO:0030258,0.805849685563606,0.516117421022824,1,243,lipid modification,BP,CNR1
284,GO:0000785,0.806593492901849,0.418721676964089,2,452,chromatin,CC,CENPF;ENC1
487,GO:0001525,0.806830007486012,0.418392666277573,2,434,angiogenesis,BP,CHI3L1;SFRP2
6053,GO:0016788,0.808055438539661,0.373941972851111,3,662,hydrolase activity, acting on ester bonds,MF,PTPN3;PTPN5;CHRM3
3552,GO:0007005,0.809445412918993,0.414285692573912,2,513,mitochondrion organization,BP,CAMK2A;DNM1
1369,GO:0003007,0.809747555334483,0.509796203448661,1,224,heart morphogenesis,BP,SFRP2
3957,GO:0008202,0.810136776125567,0.508979085958073,1,263,steroid metabolic process,BP,SULT4A1
366,GO:0000981,0.810344834041117,0.329024218192738,5,1013,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,MYBL2;FOXM1;NEUROD2;DDN;MYT1L
7128,GO:0030036,0.810505531948469,0.370440416042,3,598,actin cytoskeleton organization,BP,IQSEC3;PACSIN1;DAAM2
8208,GO:0032102,0.811702141606443,0.506393342189403,1,259,negative regulation of response to external stimulus,BP,FABP7
12238,GO:0045893,0.812004291525398,0.305363399428773,7,1339,positive regulation of transcription, DNA-templated,BP,PTPRN;MYBL2;FOXM1;TOP2A;SFRP2;NEUROD2;DDN
19760,GO:1903508,0.812004291525398,0.305363399428773,7,1339,positive regulation of nucleic acid-templated transcription,BP,PTPRN;MYBL2;FOXM1;TOP2A;SFRP2;NEUROD2;DDN
19389,GO:1902680,0.812538763179187,0.304654586352775,7,1340,positive regulation of RNA biosynthetic process,BP,PTPRN;MYBL2;FOXM1;TOP2A;SFRP2;NEUROD2;DDN
1208,GO:0002696,0.812822073731775,0.504465724445194,1,275,positive regulation of leukocyte activation,BP,IGFBP2
3521,GO:0006952,0.812875922797872,0.313421866193092,6,1317,defense response,BP,CAMK2A;CHGA;CNR1;VGF;CHI3L1;NEUROD2
17219,GO:0090066,0.81297864004995,0.408950609660277,2,449,regulation of anatomical structure size,BP,CHGA;CHRM3
11530,GO:0044212,0.813092140768245,0.34187693171712,4,817,transcription regulatory region DNA binding,MF,MYBL2;FOXM1;NEUROD2;DDN
8822,GO:0033043,0.813723135169138,0.312326995359728,6,1159,regulation of organelle organization,BP,SYT1;STMN2;CENPF;TOP2A;SYT4;MKI67
2667,GO:0005615,0.813775942317361,0.266035515630934,16,3125,extracellular space,CC,CHGA;DNM1;CRYAB;IGFBP2;VGF;CHI3L1;SFRP2;CXCL14;GABRB2;DAAM2;FREM2;ABI3BP;PI16;ADCY1;PCSK1;CPNE4
2721,GO:0005730,0.813979802595862,0.340586450327616,4,877,nucleolus,CC,TOP2A;SLC14A1;MKI67;ENC1
399,GO:0001067,0.814029966441407,0.340549408579892,4,818,regulatory region nucleic acid binding,MF,MYBL2;FOXM1;NEUROD2;DDN
4393,GO:0009167,0.814430232356675,0.50175644314258,1,279,purine ribonucleoside monophosphate metabolic process,BP,TJP2
4545,GO:0009607,0.814570844446128,0.364379730991144,3,726,response to biotic stimulus,BP,CHGA;CNR1;VGF
11142,GO:0043229,0.814879969950905,0.249381031432146,68,11114,intracellular organelle,CC,CAMK1G;SYT13;GABRA1;PTPRN;BCAT1;ASPM;SYT1;PTPN3;CAMK2A;RBFOX1;RPH3A;BIRC5;KIF4A;CHGA;MYBL2;RIMS4;EEF1A2;CELF4;ST8SIA5;SYTL4;STMN2;NEFM;SLC17A7;DNM1;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;IGFBP2;RGS4;CENPF;CNR1;TJP2;PACSIN1;VGF;CALY;TOP2A;SNAP25;SYT4;CHI3L1;MRAP2;SLC14A1;CXCL14;GABRB2;TENM2;MKI67;ZNF385D;CHST9;NRGN;IGFN1;FABP7;ADCY1;TMEM130;KCNK9;NPTX1;NEUROD2;ENC1;ZCCHC12;PCSK1;CREG2;DDN;ZDHHC23;MAP7D2;SV2B;MYT1L;SELL;SLC6A17
4353,GO:0009126,0.815162165467772,0.500521542538043,1,280,purine nucleoside monophosphate metabolic process,BP,TJP2
12639,GO:0046777,0.815173385314155,0.500726109934184,1,226,protein autophosphorylation,BP,CAMK2A
10551,GO:0042063,0.815397255160404,0.500263351394151,1,244,gliogenesis,BP,DAAM2
8920,GO:0033218,0.81663369758454,0.49806067708878,1,273,amide binding,MF,CRYAB
11567,GO:0044281,0.817430861430017,0.284886656436995,9,1880,small molecule metabolic process,BP,BCAT1;CHGA;CNR1;TJP2;HPCA;SULT4A1;MRAP2;CHST9;ADCY1
11252,GO:0043406,0.818172087372951,0.4955429109153,1,249,positive regulation of MAP kinase activity,BP,GNG3
17970,GO:0098609,0.819580345036931,0.357044046127777,3,650,cell-cell adhesion,BP,IGFBP2;TENM2;SELL
13543,GO:0050863,0.822478249890731,0.488038752929713,1,283,regulation of T cell activation,BP,IGFBP2
6116,GO:0016887,0.824313899274824,0.391300318271673,2,410,ATPase activity,MF,KIF4A;TOP2A
13547,GO:0050867,0.82467681895443,0.484225021182564,1,285,positive regulation of cell activation,BP,IGFBP2
13453,GO:0050727,0.824685965105155,0.484212387488808,1,284,regulation of inflammatory response,BP,CNR1
7851,GO:0031401,0.82487537107296,0.308860876632832,5,1039,positive regulation of protein modification process,BP,NEURL1;CHI3L1;SFRP2;GNG3;ADCY1
11482,GO:0044057,0.826166821592706,0.38826205850353,2,465,regulation of system process,BP,CHGA;CHRM3
4387,GO:0009161,0.826913418538012,0.48030425237901,1,291,ribonucleoside monophosphate metabolic process,BP,TJP2
4807,GO:0010564,0.827803210378155,0.344724538314392,3,670,regulation of cell cycle process,BP,FOXM1;CENPF;MKI67
4628,GO:0009894,0.828530565351014,0.319732103992064,4,855,regulation of catabolic process,BP,LZTS1;PTPN3;EEF1A2;CNR1
3625,GO:0007155,0.829738591021477,0.290442315167061,6,1161,cell adhesion,BP,IGFBP2;SFRP2;TENM2;FREM2;ABI3BP;SELL
14512,GO:0060047,0.829957724111517,0.475096078525781,1,250,heart contraction,BP,CHGA
404,GO:0001077,0.830387101003594,0.474299165095251,1,259,transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,MYBL2
19934,GO:1903827,0.832884381653118,0.377465403123716,2,476,regulation of cellular protein localization,BP,HPCA;MRAP2
2780,GO:0005813,0.833110623249219,0.37711410155083,2,466,centrosome,CC,ASPM;CENPF
7044,GO:0022610,0.8335785675551,0.285114227291638,6,1168,biological adhesion,BP,IGFBP2;SFRP2;TENM2;FREM2;ABI3BP;SELL
13812,GO:0051271,0.834548226643823,0.466892414364902,1,255,negative regulation of cellular component movement,BP,SFRP2
1377,GO:0003015,0.83461447081199,0.466781649935549,1,253,heart process,BP,CHGA
11256,GO:0043410,0.835005089372645,0.374013501686664,2,484,positive regulation of MAPK cascade,BP,CHI3L1;GNG3
2762,GO:0005783,0.835505128382209,0.266757159693915,8,1648,endoplasmic reticulum,CC,PTPN5;VGF;CHI3L1;MRAP2;TENM2;CREG2;DDN;ZDHHC23
3865,GO:0008047,0.835762368093,0.372802324191618,2,469,enzyme activator activity,MF,RGS4;SFRP2
11664,GO:0044446,0.836063922539127,0.218614477798966,48,8154,intracellular organelle part,CC,CAMK1G;GABRA1;PTPRN;ASPM;SYT1;CAMK2A;RBFOX1;RPH3A;BIRC5;KIF4A;CHGA;MYBL2;EEF1A2;ST8SIA5;SYTL4;NEFM;SLC17A7;DNM1;CRYAB;PTPN5;FOXM1;GABRG2;SLC30A3;CENPF;CNR1;TJP2;PACSIN1;VGF;CALY;TOP2A;SNAP25;SYT4;CHI3L1;MRAP2;SLC14A1;GABRB2;TENM2;MKI67;CHST9;NRGN;TMEM130;ENC1;ZCCHC12;PCSK1;DDN;SV2B;SELL;SLC6A17
671,GO:0001822,0.83786554804705,0.460937406071042,1,246,kidney development,BP,CENPF
8463,GO:0032496,0.838035361260557,0.460427700434884,1,302,response to lipopolysaccharide,BP,CNR1
7041,GO:0022604,0.838444973602275,0.368458693274076,2,442,regulation of cell morphogenesis,BP,SYT1;SYT4
7182,GO:0030139,0.838525917533598,0.459618275864093,1,276,endocytic vesicle,CC,CAMK2A
17745,GO:0097367,0.838548929633258,0.248442584565447,11,1994,carbohydrate derivative binding,MF,CAMK1G;CAMK2A;KIF4A;EEF1A2;DNM1;TOP2A;CHI3L1;MKI67;ABI3BP;ADCY1;SELL
2767,GO:0005788,0.838608263684998,0.459500883200245,1,267,endoplasmic reticulum lumen,CC,VGF
3757,GO:0007409,0.83906380451102,0.36745456491742,2,435,axonogenesis,BP,ADCY1;NPTX1
4350,GO:0009123,0.839839832741546,0.457125228447305,1,306,nucleoside monophosphate metabolic process,BP,TJP2
19335,GO:1902533,0.841953512909082,0.299968388245887,4,901,positive regulation of intracellular signal transduction,BP,CHI3L1;MRAP2;GNG3;NEUROD2
2754,GO:0005773,0.845848981232505,0.31694498517427,3,723,vacuole,CC,CHGA;EEF1A2;SLC30A3
10506,GO:0040013,0.846280597877456,0.445337350363193,1,267,negative regulation of locomotion,BP,SFRP2
6410,GO:0019058,0.851720992436896,0.434977384793895,1,291,viral life cycle,BP,TOP2A
16379,GO:0071496,0.853000434022213,0.432528212522767,1,292,cellular response to external stimulus,BP,SFRP2
11550,GO:0044248,0.853436576710486,0.232501146117677,10,2061,cellular catabolic process,BP,BCAT1;LZTS1;PTPN3;LNX1;EEF1A2;CNR1;CHI3L1;LIX1;FABP7;ENC1
5075,GO:0010948,0.854852858668867,0.428930456625212,1,304,negative regulation of cell cycle process,BP,CENPF
945,GO:0002237,0.855414801040993,0.427806447953226,1,318,response to molecule of bacterial origin,BP,CNR1
74,GO:0000151,0.855942194538411,0.426870835428194,1,289,ubiquitin ligase complex,CC,ENC1
1618,GO:0003723,0.857149444036356,0.243539834736694,7,1533,RNA binding,MF,RBFOX1;EEF1A2;CELF4;DNM1;TOP2A;MKI67;ZNF385D
16650,GO:0072001,0.857277577656904,0.424374286728671,1,262,renal system development,BP,CENPF
11657,GO:0044437,0.857978069865103,0.335467159954405,2,533,vacuolar part,CC,EEF1A2;SLC30A3
4568,GO:0009653,0.85798973194705,0.216731447458992,13,2350,anatomical structure morphogenesis,BP,SYT1;CAMK2A;CRYAB;FOXM1;PACSIN1;SYT4;CHI3L1;SLC4A10;SFRP2;TENM2;FREM2;ADCY1;NPTX1
17656,GO:0097190,0.858849315231941,0.333940711736633,2,552,apoptotic signaling pathway,BP,SFRP2;ZNF385D
5960,GO:0016604,0.85981806006399,0.294733365407623,3,704,nuclear body,CC,TENM2;MKI67;ZCCHC12
2423,GO:0005096,0.859962276933379,0.419120064254422,1,263,GTPase activator activity,MF,RGS4
11630,GO:0044389,0.862019505379652,0.414920718629796,1,305,ubiquitin-like protein ligase binding,MF,PTPRN
1031,GO:0002376,0.863431365772744,0.212207180907918,12,2481,immune system process,BP,CAMK2A;KIF4A;CHGA;IGFBP2;CNR1;TJP2;TOP2A;SNAP25;CHI3L1;SFRP2;CXCL14;SELL
1600,GO:0003682,0.863625780681138,0.325689689661132,2,495,chromatin binding,MF,CENPF;TOP2A
3216,GO:0006520,0.864396938796607,0.410098702960309,1,341,cellular amino acid metabolic process,BP,BCAT1
809,GO:0002009,0.866045594201827,0.321429814551954,2,498,morphogenesis of an epithelium,BP,SFRP2;FREM2
13814,GO:0051276,0.866606267068875,0.248169132675251,5,1087,chromosome organization,BP,BIRC5;KIF4A;CENPF;TOP2A;MKI67
3311,GO:0006631,0.866859772258339,0.405189113270972,1,327,fatty acid metabolic process,BP,CNR1
7151,GO:0030097,0.867482708405772,0.282208069392001,3,747,hemopoiesis,BP,TJP2;TOP2A;SFRP2
3533,GO:0006974,0.868660702056327,0.280268874496186,3,745,cellular response to DNA damage stimulus,BP,FOXM1;TOP2A;SFRP2
3523,GO:0006954,0.872137816867079,0.310486310495131,2,591,inflammatory response,BP,CNR1;CHI3L1
2843,GO:0005912,0.872372365105255,0.310151354170679,2,509,adherens junction,CC,TJP2;SPRY4
953,GO:0002252,0.872566538206344,0.252948848253224,4,1003,immune effector process,BP,CHGA;SNAP25;CHI3L1;SELL
3511,GO:0006935,0.872999460482892,0.308999168711542,2,530,chemotaxis,BP,CHGA;CXCL14
327,GO:0000904,0.873074400354509,0.273009048497379,3,661,cell morphogenesis involved in differentiation,BP,CAMK2A;ADCY1;NPTX1
10683,GO:0042330,0.873429487580775,0.308223663066394,2,531,taxis,BP,CHGA;CXCL14
1367,GO:0003002,0.874146362375527,0.390340516823749,1,308,regionalization,BP,SFRP2
288,GO:0000790,0.874195078196509,0.390245193625099,1,306,nuclear chromatin,CC,ENC1
11271,GO:0043436,0.874646002474432,0.249643583529849,4,1020,oxoacid metabolic process,BP,BCAT1;CNR1;SULT4A1;CHST9
18468,GO:0120031,0.875075421237207,0.30527647636886,2,509,plasma membrane bounded cell projection assembly,BP,NEURL1;TENM2
1863,GO:0004175,0.875293653716355,0.387885936728652,1,335,endopeptidase activity,MF,PCSK1
2144,GO:0004674,0.875329614902079,0.304860395935346,2,475,protein serine/threonine kinase activity,MF,CAMK1G;CAMK2A
1613,GO:0003712,0.8759584874653,0.303650022238857,2,531,transcription cofactor activity,MF,NEUROD2;ZCCHC12
7122,GO:0030029,0.876500205231673,0.267259106651554,3,680,actin filament-based process,BP,IQSEC3;PACSIN1;DAAM2
567,GO:0001666,0.877857516497113,0.382546102441383,1,324,response to hypoxia,BP,CRYAB
4598,GO:0009790,0.878115988667965,0.244156814617505,4,892,embryo development,BP,CELF4;TOP2A;SFRP2;FREM2
2856,GO:0005938,0.87983123048031,0.378507377307187,1,280,cell cortex,CC,RIMS4
11972,GO:0045296,0.880007977223876,0.378042555457506,1,309,cadherin binding,MF,TJP2
2947,GO:0006082,0.88008846401252,0.240934073262006,4,1032,organic acid metabolic process,BP,BCAT1;CNR1;SULT4A1;CHST9
8127,GO:0031967,0.880380450232659,0.240456731688745,4,1054,organelle envelope,CC,DNM1;CENPF;CNR1;NRGN
8131,GO:0031975,0.880380450232659,0.240456731688745,4,1054,envelope,CC,DNM1;CENPF;CNR1;NRGN
7030,GO:0022407,0.880936851226275,0.375995814484759,1,337,regulation of cell-cell adhesion,BP,IGFBP2
1614,GO:0003713,0.880994712019337,0.375953117377268,1,306,transcription coactivator activity,MF,ZCCHC12
13086,GO:0048514,0.882177104147551,0.292277053453162,2,515,blood vessel morphogenesis,BP,CHI3L1;SFRP2
3783,GO:0007507,0.882461475249449,0.291778031150822,2,493,heart development,BP,SFRP2;FREM2
3104,GO:0006357,0.883885733341996,0.190565383075679,10,2033,regulation of transcription by RNA polymerase II,BP,PTPRN;MYBL2;FOXM1;TOP2A;SFRP2;TENM2;NEUROD2;ZCCHC12;DDN;MYT1L
7124,GO:0030031,0.883911643594795,0.289052720697072,2,523,cell projection assembly,BP,NEURL1;TENM2
15633,GO:0070161,0.884051482666422,0.288791655314805,2,524,anchoring junction,CC,TJP2;SPRY4
7485,GO:0030695,0.88490711581155,0.367591101867185,1,293,GTPase regulator activity,MF,RGS4
7952,GO:0031589,0.8860379502666,0.365131775857409,1,295,cell-substrate adhesion,BP,ABI3BP
21838,GO:2001233,0.886225690967469,0.364570363501037,1,355,regulation of apoptotic signaling pathway,BP,SFRP2
10217,GO:0036293,0.886380655140049,0.364285173946256,1,332,response to decreased oxygen levels,BP,CRYAB
59,GO:0000122,0.886774455994102,0.249715447606399,3,752,negative regulation of transcription by RNA polymerase II,BP,FOXM1;TENM2;MYT1L
11652,GO:0044429,0.887218975019616,0.248870941781922,3,910,mitochondrial part,CC,DNM1;CNR1;NRGN
557,GO:0001655,0.887247469692354,0.362495327062353,1,295,urogenital system development,BP,CENPF
6022,GO:0016740,0.887654367431909,0.18201171511478,11,2206,transferase activity,MF,CAMK1G;BCAT1;CAMK2A;LNX1;BIRC5;ST8SIA5;NEURL1;TJP2;SULT4A1;CHST9;ZDHHC23
13098,GO:0048534,0.887753287931926,0.248005966774088,3,785,hematopoietic or lymphoid organ development,BP,TJP2;TOP2A;SFRP2
14873,GO:0060562,0.888139797627928,0.360523800779911,1,301,epithelial tube morphogenesis,BP,SFRP2
19936,GO:1903829,0.892377452855633,0.351079261741265,1,326,positive regulation of cellular protein localization,BP,HPCA
4845,GO:0010628,0.892448798660686,0.186600203429637,8,1691,positive regulation of gene expression,BP,PTPRN;MYBL2;CELF4;FOXM1;TOP2A;SFRP2;NEUROD2;DDN
8290,GO:0032270,0.892689941382559,0.198647906946539,6,1366,positive regulation of cellular protein metabolic process,BP,NEURL1;CHI3L1;SFRP2;GNG3;ADCY1;GRIN2B
2726,GO:0005739,0.894262537447453,0.196184859572356,6,1557,mitochondrion,CC,BCAT1;CAMK2A;DNM1;CRYAB;CNR1;NRGN
3562,GO:0007018,0.895312848822431,0.34457983312744,1,292,microtubule-based movement,BP,KIF4A
13130,GO:0048598,0.895451885369876,0.267199498789133,2,542,embryonic morphogenesis,BP,SFRP2;FREM2
13794,GO:0051249,0.897979422329912,0.338326100416921,1,370,regulation of lymphocyte activation,BP,IGFBP2
4600,GO:0009792,0.898111359537612,0.262049999839467,2,546,embryo development ending in birth or egg hatching,BP,CELF4;SFRP2
7040,GO:0022603,0.899004650775151,0.209855067808976,4,945,regulation of anatomical structure morphogenesis,BP,SYT1;SYT4;CHI3L1;SFRP2
7153,GO:0030099,0.899663280097425,0.334510900449906,1,346,myeloid cell differentiation,BP,TJP2
13280,GO:0048870,0.899903949760816,0.187450320590191,6,1317,cell motility,BP,ASPM;CHGA;NEURL1;SFRP2;CXCL14;SELL
14025,GO:0051674,0.899903949760816,0.187450320590191,6,1317,localization of cell,BP,ASPM;CHGA;NEURL1;SFRP2;CXCL14;SELL
15829,GO:0070482,0.901458859522775,0.330340928127748,1,354,response to oxygen levels,BP,CRYAB
6475,GO:0019222,0.902176807853811,0.139377598183831,33,5923,regulation of metabolic process,BP,PTPRN;LZTS1;PTPN3;CAMK2A;RBFOX1;BIRC5;CHGA;MYBL2;EEF1A2;CELF4;NEURL1;CRYAB;FOXM1;RGS4;CENPF;CNR1;HPCA;TOP2A;CHI3L1;MRAP2;SFRP2;TENM2;GNG3;PI16;ADCY1;NEUROD2;ENC1;ZCCHC12;DDN;MYT1L;SPRY4;PPP1R14C;GRIN2B
3310,GO:0006629,0.903014899027037,0.191121990905949,5,1245,lipid metabolic process,BP,EEF1A2;ST8SIA5;CNR1;SULT4A1;FABP7
19797,GO:1903561,0.903569958978032,0.159426175091102,11,2458,extracellular vesicle,CC,DNM1;CRYAB;IGFBP2;SYT4;CHI3L1;GABRB2;DAAM2;FREM2;PI16;ADCY1;CPNE4
665,GO:0001816,0.903829459591355,0.250768113657853,2,621,cytokine production,BP,CHGA;CHI3L1
11143,GO:0043230,0.90394805727181,0.158882722307963,11,2460,extracellular organelle,CC,DNM1;CRYAB;IGFBP2;SYT4;CHI3L1;GABRB2;DAAM2;FREM2;PI16;ADCY1;CPNE4
3524,GO:0006955,0.904117353031155,0.174310841338197,7,1710,immune response,BP,CAMK2A;CHGA;CNR1;SNAP25;CHI3L1;CXCL14;SELL
1194,GO:0002682,0.905041194421572,0.187806846537913,5,1285,regulation of immune system process,BP,IGFBP2;CNR1;TJP2;CXCL14;SELL
12960,GO:0048193,0.90558971314934,0.320701711408555,1,335,Golgi vesicle transport,BP,KIF4A
14039,GO:0051704,0.906387284456977,0.161667457199539,9,2043,multi-organism process,BP,ASPM;CHGA;CELF4;NEURL1;IGFBP2;CNR1;PRLHR;VGF;TOP2A
4304,GO:0009057,0.90689380245363,0.184781806396352,5,1231,macromolecule catabolic process,BP,PTPN3;LNX1;EEF1A2;CHI3L1;ENC1
4854,GO:0010638,0.907315936914432,0.243849002694691,2,588,positive regulation of organelle organization,BP,SYT1;STMN2
1110,GO:0002520,0.907923950030444,0.212130149948841,3,824,immune system development,BP,TJP2;TOP2A;SFRP2
17100,GO:0080134,0.907961399854268,0.183024285887623,5,1237,regulation of response to stress,BP,CAMK2A;CRYAB;FOXM1;CNR1;SFRP2
12459,GO:0046394,0.90817153634816,0.314474998775352,1,375,carboxylic acid biosynthetic process,BP,BCAT1
13105,GO:0048545,0.9085041354716,0.31370313953833,1,362,response to steroid hormone,BP,IGFBP2
5682,GO:0016053,0.908723319710793,0.313150662364053,1,376,organic acid biosynthetic process,BP,BCAT1
471,GO:0001503,0.90908444364658,0.312347559403139,1,344,ossification,BP,SFRP2
14893,GO:0060589,0.909832144872731,0.310569544093315,1,334,nucleoside-triphosphatase regulator activity,MF,RGS4
14658,GO:0060271,0.91012476218058,0.309847201433851,1,341,cilium assembly,BP,NEURL1
5962,GO:0016607,0.911219841811808,0.307152943131351,1,361,nuclear speck,CC,ZCCHC12
4800,GO:0010557,0.911475462342964,0.162920517269062,7,1569,positive regulation of macromolecule biosynthetic process,BP,PTPRN;MYBL2;FOXM1;TOP2A;SFRP2;NEUROD2;DDN
19125,GO:1901990,0.912482183553853,0.304050130453135,1,376,regulation of mitotic cell cycle phase transition,BP,CENPF
13667,GO:0051052,0.914265071007453,0.299708919604757,1,359,regulation of DNA metabolic process,BP,FOXM1
19868,GO:1903706,0.914575431484028,0.29889023683009,1,388,regulation of hemopoiesis,BP,TJP2
1196,GO:0002684,0.915622550005201,0.197860340148251,3,888,positive regulation of immune system process,BP,IGFBP2;CNR1;CXCL14
11754,GO:0044782,0.916305069771616,0.29467226471179,1,352,cilium organization,BP,NEURL1
11406,GO:0043687,0.916360983766582,0.29445563333308,1,394,post-translational protein modification,BP,VGF
3913,GO:0008134,0.916717281248833,0.224682506545106,2,597,transcription factor binding,MF,PTPRN;CENPF
7831,GO:0031349,0.917944848013292,0.290493516350601,1,397,positive regulation of defense response,BP,CNR1
11141,GO:0043228,0.918626641171417,0.125422618906627,19,3670,non-membrane-bounded organelle,CC,ASPM;PTPN3;BIRC5;KIF4A;MYBL2;RIMS4;SYTL4;NEFM;DNM1;CRYAB;CENPF;TOP2A;SNAP25;SLC14A1;MKI67;IGFN1;ENC1;MAP7D2;MYT1L
11145,GO:0043232,0.918626641171417,0.125422618906627,19,3670,intracellular non-membrane-bounded organelle,CC,ASPM;PTPN3;BIRC5;KIF4A;MYBL2;RIMS4;SYTL4;NEFM;DNM1;CRYAB;CENPF;TOP2A;SNAP25;SLC14A1;MKI67;IGFN1;ENC1;MAP7D2;MYT1L
1609,GO:0003700,0.919174131654125,0.156615602626863,6,1412,DNA binding transcription factor activity,MF,LZTS1;MYBL2;FOXM1;NEUROD2;DDN;MYT1L
11350,GO:0043565,0.919235869555046,0.174888159327578,4,1030,sequence-specific DNA binding,MF,MYBL2;FOXM1;NEUROD2;DDN
9879,GO:0035639,0.921548577939065,0.142490626490609,8,1684,purine ribonucleoside triphosphate binding,MF,CAMK1G;CAMK2A;KIF4A;EEF1A2;DNM1;TOP2A;MKI67;ADCY1
13989,GO:0051603,0.92202890422169,0.21353947712784,2,627,proteolysis involved in cellular protein catabolic process,BP,LNX1;ENC1
5881,GO:0016477,0.923023747571384,0.157750249385112,5,1198,cell migration,BP,ASPM;CHGA;SFRP2;CXCL14;SELL
10576,GO:0042110,0.923116960610165,0.277341503022522,1,403,T cell activation,BP,IGFBP2
7046,GO:0022613,0.92321825229494,0.277025649233094,1,442,ribonucleoprotein complex biogenesis,BP,CELF4
3559,GO:0007015,0.923348825338808,0.2768186670728,1,360,actin filament organization,BP,PACSIN1
13792,GO:0051247,0.923540798105876,0.149429449378318,6,1455,positive regulation of protein metabolic process,BP,NEURL1;CHI3L1;SFRP2;GNG3;ADCY1;GRIN2B
18974,GO:1901575,0.923766760658915,0.138994851710059,8,1894,organic substance catabolic process,BP,BCAT1;PTPN3;LNX1;EEF1A2;CNR1;CHI3L1;FABP7;ENC1
515,GO:0001568,0.924259025755234,0.208832719062647,2,586,blood vessel development,BP,CHI3L1;SFRP2
5805,GO:0016301,0.924538250255476,0.180972156923281,3,785,kinase activity,MF,CAMK1G;CAMK2A;TJP2
13207,GO:0048729,0.925106388523009,0.207016294448243,2,593,tissue morphogenesis,BP,SFRP2;FREM2
19122,GO:1901987,0.925546014490185,0.271052813361161,1,400,regulation of cell cycle phase transition,BP,CENPF
12916,GO:0048037,0.925676135727852,0.270665907006131,1,433,cofactor binding,MF,CREG2
9440,GO:0034613,0.925892793871432,0.140009224735887,7,1648,cellular protein localization,BP,RPH3A;SYTL4;HPCA;PACSIN1;SNAP25;MRAP2;ZDHHC23
2680,GO:0005654,0.927187782672198,0.116579988742552,16,3247,nucleoplasm,CC,CAMK2A;BIRC5;KIF4A;MYBL2;SYTL4;DNM1;CRYAB;PTPN5;FOXM1;CENPF;TJP2;TOP2A;TENM2;MKI67;ENC1;ZCCHC12
2852,GO:0005925,0.927442399870309,0.266114378889222,1,381,focal adhesion,CC,SPRY4
15960,GO:0070727,0.928499564967147,0.13578345713505,7,1658,cellular macromolecule localization,BP,RPH3A;SYTL4;HPCA;PACSIN1;SNAP25;MRAP2;ZDHHC23
2851,GO:0005924,0.92867907924545,0.262841369707169,1,384,cell-substrate adherens junction,CC,SPRY4
11661,GO:0044441,0.928976915023763,0.262068273820982,1,374,ciliary part,CC,CENPF
11337,GO:0043547,0.929713319810527,0.260128700958159,1,363,positive regulation of GTPase activity,BP,RGS4
3111,GO:0006366,0.930630344001144,0.121946289658527,10,2202,transcription by RNA polymerase II,BP,PTPRN;MYBL2;FOXM1;TOP2A;SFRP2;TENM2;NEUROD2;ZCCHC12;DDN;MYT1L
12502,GO:0046486,0.930656319130392,0.257549943931895,1,397,glycerolipid metabolic process,BP,FABP7
7140,GO:0030055,0.930727797791202,0.257374316524946,1,387,cell-substrate junction,CC,SPRY4
8498,GO:0032555,0.932793317645063,0.124692054148103,8,1724,purine ribonucleotide binding,MF,CAMK1G;CAMK2A;KIF4A;EEF1A2;DNM1;TOP2A;MKI67;ADCY1
760,GO:0001944,0.933001734674576,0.189827131979365,2,610,vasculature development,BP,CHI3L1;SFRP2
6052,GO:0016787,0.933703152451625,0.117207787889878,10,2236,hydrolase activity,MF,PTPN3;KIF4A;EEF1A2;DNM1;PTPN5;TOP2A;CHRM3;CHI3L1;GNG3;PCSK1
3040,GO:0006259,0.935355509858656,0.159683773658813,3,898,DNA metabolic process,BP,FOXM1;CENPF;TOP2A
2142,GO:0004672,0.935434624237556,0.184427297505549,2,597,protein kinase activity,MF,CAMK1G;CAMK2A
8496,GO:0032553,0.935604594928633,0.120165756622264,8,1736,ribonucleotide binding,MF,CAMK1G;CAMK2A;KIF4A;EEF1A2;DNM1;TOP2A;MKI67;ADCY1
6197,GO:0017076,0.935753384423307,0.119925153629667,8,1738,purine nucleotide binding,MF,CAMK1G;CAMK2A;KIF4A;EEF1A2;DNM1;TOP2A;MKI67;ADCY1
16882,GO:0072358,0.935957457487448,0.183242821418529,2,618,cardiovascular system development,BP,CHI3L1;SFRP2
4303,GO:0009056,0.936579555187644,0.112738894209976,10,2313,catabolic process,BP,BCAT1;LZTS1;PTPN3;LNX1;EEF1A2;CNR1;CHI3L1;LIX1;FABP7;ENC1
2768,GO:0005789,0.936899327947793,0.156572638383687,3,932,endoplasmic reticulum membrane,CC,PTPN5;MRAP2;DDN
18073,GO:0098827,0.93805551173276,0.154237652818837,3,936,endoplasmic reticulum subcompartment,CC,PTPN5;MRAP2;DDN
4665,GO:0010008,0.939909673004021,0.232048836808447,1,427,endosome membrane,CC,SLC30A3
7328,GO:0030335,0.940596373746954,0.230126948545242,1,410,positive regulation of cell migration,BP,CXCL14
11553,GO:0044257,0.940703954390934,0.172461088683015,2,676,cellular protein catabolic process,BP,LNX1;ENC1
1111,GO:0002521,0.940704140729816,0.2298020682541,1,424,leukocyte differentiation,BP,TJP2
4774,GO:0010498,0.941090221544598,0.228689169354549,1,436,proteasomal protein catabolic process,BP,ENC1
10613,GO:0042175,0.943246626628161,0.14362408318061,3,949,nuclear outer membrane-endoplasmic reticulum membrane network,CC,PTPN5;MRAP2;DDN
2671,GO:0005635,0.943489030430402,0.22183086597472,1,420,nuclear envelope,CC,CENPF
15575,GO:0070062,0.943521905611588,0.101828090904052,10,2442,extracellular exosome,CC,DNM1;CRYAB;IGFBP2;CHI3L1;GABRB2;DAAM2;FREM2;PI16;ADCY1;CPNE4
21249,GO:2000147,0.944107542282391,0.220037892414493,1,422,positive regulation of cell motility,BP,CXCL14
11862,GO:0045087,0.944156995605686,0.164458085551958,2,750,innate immune response,BP,CAMK2A;CHGA
4827,GO:0010604,0.94439765903346,0.0951486282144026,13,2772,positive regulation of macromolecule metabolic process,BP,PTPRN;MYBL2;CELF4;NEURL1;FOXM1;TOP2A;CHI3L1;SFRP2;GNG3;ADCY1;NEUROD2;DDN;GRIN2B
11552,GO:0044255,0.944780269308478,0.140445551459101,3,953,cellular lipid metabolic process,BP,ST8SIA5;CNR1;FABP7
14647,GO:0060255,0.945343932188973,0.083095866133119,29,5491,regulation of macromolecule metabolic process,BP,PTPRN;LZTS1;PTPN3;CAMK2A;RBFOX1;BIRC5;MYBL2;EEF1A2;CELF4;NEURL1;CRYAB;FOXM1;RGS4;CENPF;TOP2A;CHI3L1;SFRP2;TENM2;GNG3;PI16;ADCY1;NEUROD2;ENC1;ZCCHC12;DDN;MYT1L;SPRY4;PPP1R14C;GRIN2B
6703,GO:0019904,0.945480683624188,0.161413767238182,2,657,protein domain specific binding,MF,LNX1;TJP2
2618,GO:0005524,0.946645005168951,0.110003217366797,6,1377,ATP binding,MF,CAMK1G;CAMK2A;KIF4A;TOP2A;MKI67;ADCY1
11655,GO:0044432,0.947023919166767,0.123314569606539,4,1174,endoplasmic reticulum part,CC,PTPN5;VGF;MRAP2;DDN
13813,GO:0051272,0.948372375353199,0.207484149485925,1,433,positive regulation of cellular component movement,BP,CXCL14
5690,GO:0016071,0.949862376836932,0.150985737502501,2,774,mRNA metabolic process,BP,RBFOX1;CELF4
6472,GO:0019219,0.951438571901451,0.0788482832745927,19,3857,regulation of nucleobase-containing compound metabolic process,BP,PTPRN;LZTS1;CAMK2A;RBFOX1;BIRC5;CHGA;MYBL2;CELF4;FOXM1;CENPF;HPCA;TOP2A;MRAP2;SFRP2;TENM2;NEUROD2;ZCCHC12;DDN;MYT1L
18530,GO:0140096,0.951730942016672,0.0908745187374464,9,2058,catalytic activity, acting on a protein,MF,CAMK1G;PTPN3;CAMK2A;LNX1;BIRC5;NEURL1;PTPN5;PCSK1;ZDHHC23
11660,GO:0044440,0.953213989412306,0.192775031518849,1,464,endosomal part,CC,SLC30A3
8502,GO:0032559,0.954354607182655,0.0961942828113785,6,1413,adenyl ribonucleotide binding,MF,CAMK1G;CAMK2A;KIF4A;TOP2A;MKI67;ADCY1
10510,GO:0040017,0.954569080228447,0.188590409616172,1,452,positive regulation of locomotion,BP,CXCL14
7421,GO:0030554,0.95629806804565,0.0926521920388756,6,1425,adenyl nucleotide binding,MF,CAMK1G;CAMK2A;KIF4A;TOP2A;MKI67;ADCY1
3055,GO:0006281,0.956576457465834,0.182273661938864,1,475,DNA repair,BP,FOXM1
10144,GO:0036094,0.956615724332714,0.0807071244829756,10,2253,small molecule binding,MF,CAMK1G;CAMK2A;RPH3A;KIF4A;EEF1A2;DNM1;TOP2A;MKI67;ADCY1;GRIN2B
18537,GO:0140110,0.956944691748026,0.0876261569758635,7,1754,transcription regulator activity,MF,LZTS1;MYBL2;FOXM1;NEUROD2;ZCCHC12;DDN;MYT1L
7327,GO:0030334,0.957771038890592,0.131667856899768,2,698,regulation of cell migration,BP,SFRP2;CXCL14
15551,GO:0070011,0.958416620781071,0.176403774896532,1,494,peptidase activity, acting on L-amino acid peptides,MF,PCSK1
10504,GO:0040011,0.958979422274032,0.0877127793624431,6,1527,locomotion,BP,ASPM;CHGA;NEURL1;SFRP2;CXCL14;SELL
11053,GO:0043087,0.960094967367102,0.171048300786714,1,436,regulation of GTPase activity,BP,RGS4
11672,GO:0044454,0.960469811575934,0.169785843247268,1,481,nuclear chromosome part,CC,ENC1
11644,GO:0044419,0.962322070514556,0.120080958488586,2,814,interspecies interaction between organisms,BP,CHGA;TOP2A
6039,GO:0016772,0.963157724763077,0.100595492677618,3,936,transferase activity, transferring phosphorus-containing groups,MF,CAMK1G;CAMK2A;TJP2
11561,GO:0044271,0.96458033124228,0.0578968354624694,22,4604,cellular nitrogen compound biosynthetic process,BP,PTPRN;LZTS1;CAMK2A;BIRC5;MYBL2;EEF1A2;CELF4;NEURL1;FOXM1;CENPF;HPCA;TOP2A;MRAP2;SFRP2;TENM2;ADCY1;NEUROD2;ENC1;ZCCHC12;PCSK1;DDN;MYT1L
3975,GO:0008233,0.964651668308574,0.155908775248318,1,518,peptidase activity,MF,PCSK1
7809,GO:0031326,0.96469985260571,0.0590544835164764,19,3977,regulation of cellular biosynthetic process,BP,PTPRN;LZTS1;CAMK2A;BIRC5;MYBL2;CELF4;NEURL1;FOXM1;CENPF;HPCA;TOP2A;MRAP2;SFRP2;TENM2;NEUROD2;ENC1;ZCCHC12;DDN;MYT1L
16883,GO:0072359,0.964871346575257,0.0966878148548961,3,921,circulatory system development,BP,CHI3L1;SFRP2;FREM2
8649,GO:0032787,0.965024399850078,0.154640845568997,1,532,monocarboxylic acid metabolic process,BP,CNR1
13484,GO:0050776,0.966014014401359,0.110459979599675,2,836,regulation of immune response,BP,CNR1;SELL
5474,GO:0015629,0.966077235043263,0.151122987738449,1,459,actin cytoskeleton,CC,CRYAB
2854,GO:0005929,0.966153795275737,0.150839111018269,1,485,cilium,CC,CENPF
21247,GO:2000145,0.966515096141393,0.109165472462486,2,741,regulation of cell motility,BP,SFRP2;CXCL14
13932,GO:0051493,0.966959248170679,0.148087111930874,1,475,regulation of cytoskeleton organization,BP,STMN2
14464,GO:0055114,0.967241093803486,0.107200735210412,2,874,oxidation-reduction process,BP,CNR1;MRAP2
6040,GO:0016773,0.969689394807217,0.100674924117077,2,721,phosphotransferase activity, alcohol group as acceptor,MF,CAMK1G;CAMK2A
4622,GO:0009888,0.970115697478022,0.0666230906138601,6,1618,tissue development,BP,NEURL1;CENPF;TJP2;CHI3L1;SFRP2;FREM2
83,GO:0000166,0.970318224845622,0.0610026707059084,8,1956,nucleotide binding,MF,CAMK1G;CAMK2A;KIF4A;EEF1A2;DNM1;TOP2A;MKI67;ADCY1
18878,GO:1901265,0.970387351228384,0.0608770834075379,8,1957,nucleoside phosphate binding,MF,CAMK1G;CAMK2A;KIF4A;EEF1A2;DNM1;TOP2A;MKI67;ADCY1
16308,GO:0071396,0.970467190838717,0.135787172766919,1,523,cellular response to lipid,BP,ADCY1
4623,GO:0009889,0.970813181198855,0.0496698513513975,19,4038,regulation of biosynthetic process,BP,PTPRN;LZTS1;CAMK2A;BIRC5;MYBL2;CELF4;NEURL1;FOXM1;CENPF;HPCA;TOP2A;MRAP2;SFRP2;TENM2;NEUROD2;ENC1;ZCCHC12;DDN;MYT1L
3506,GO:0006928,0.970856606908967,0.0622931118241334,7,1753,movement of cell or subcellular component,BP,ASPM;KIF4A;CHGA;NEURL1;SFRP2;CXCL14;SELL
9647,GO:0035239,0.971135106447901,0.0967325921778156,2,736,tube morphogenesis,BP,CHI3L1;SFRP2
14783,GO:0060429,0.971352121905619,0.0815063552179991,3,1008,epithelium development,BP,TJP2;SFRP2;FREM2
11555,GO:0044260,0.972516777831616,0.0431628053162536,39,7383,cellular macromolecule metabolic process,BP,CAMK1G;PTPRN;LZTS1;PTPN3;CAMK2A;LNX1;BIRC5;MYBL2;EEF1A2;CELF4;ST8SIA5;DNM1;NEURL1;CRYAB;PTPN5;FOXM1;IGFBP2;RGS4;CENPF;VGF;TOP2A;SNAP25;CHRM3;CHI3L1;SFRP2;TENM2;CHST9;GNG3;PI16;ADCY1;NEUROD2;ENC1;ZCCHC12;DDN;ZDHHC23;MYT1L;SPRY4;PPP1R14C;GRIN2B
3127,GO:0006396,0.972666811863185,0.0924714168618946,2,893,RNA processing,BP,RBFOX1;CELF4
11669,GO:0044451,0.973469291234226,0.076407004671187,3,1032,nucleoplasm part,CC,TENM2;MKI67;ZCCHC12
1597,GO:0003677,0.973662995434568,0.0531763244958969,9,2247,DNA binding,MF,LZTS1;KIF4A;MYBL2;FOXM1;TOP2A;MKI67;NEUROD2;DDN;MYT1L
3210,GO:0006511,0.973941724137488,0.123206925822711,1,539,ubiquitin-dependent protein catabolic process,BP,LNX1
12593,GO:0046649,0.97429634910576,0.121881910858117,1,568,lymphocyte activation,BP,IGFBP2
7548,GO:0030855,0.974704877455154,0.120385861943624,1,536,epithelial cell differentiation,BP,TJP2
8132,GO:0031981,0.974773592558239,0.044361466385165,17,3776,nuclear lumen,CC,CAMK2A;BIRC5;KIF4A;MYBL2;SYTL4;DNM1;CRYAB;PTPN5;FOXM1;CENPF;TJP2;TOP2A;SLC14A1;TENM2;MKI67;ENC1;ZCCHC12
6716,GO:0019941,0.975415896311407,0.117727065493347,1,549,modification-dependent protein catabolic process,BP,LNX1
11007,GO:0043009,0.976636571438145,0.113137308228543,1,528,chordate embryonic development,BP,SFRP2
11389,GO:0043632,0.976747835309414,0.112697984031182,1,558,modification-dependent macromolecule catabolic process,BP,LNX1
13797,GO:0051252,0.976963403064104,0.0413201436292614,16,3566,regulation of RNA metabolic process,BP,PTPRN;LZTS1;CAMK2A;RBFOX1;BIRC5;MYBL2;CELF4;FOXM1;CENPF;TOP2A;SFRP2;TENM2;NEUROD2;ZCCHC12;DDN;MYT1L
10505,GO:0040012,0.977167203502327,0.079774262057647,2,805,regulation of locomotion,BP,SFRP2;CXCL14
21231,GO:2000112,0.978081380232326,0.0390283487162055,17,3756,regulation of cellular macromolecule biosynthetic process,BP,PTPRN;LZTS1;CAMK2A;BIRC5;MYBL2;CELF4;NEURL1;FOXM1;CENPF;TOP2A;SFRP2;TENM2;NEUROD2;ENC1;ZCCHC12;DDN;MYT1L
6623,GO:0019752,0.978854901636411,0.0748438523724913,2,932,carboxylic acid metabolic process,BP,BCAT1;CNR1
9019,GO:0033554,0.979223524021483,0.0484557062604172,6,1785,cellular response to stress,BP,CAMK2A;CRYAB;FOXM1;TOP2A;SFRP2;KCNC2
13811,GO:0051270,0.9794888294592,0.0730034847594761,2,813,regulation of cellular component movement,BP,SFRP2;CXCL14
8786,GO:0032991,0.979595236475034,0.035205889828582,21,4556,protein-containing complex,CC,CAMK1G;GABRA1;SYT1;RPH3A;BIRC5;KIF4A;MYBL2;EEF1A2;DNM1;GABRA4;GABRG2;CENPF;KCNS1;TOP2A;SNAP25;GABRB2;GNG3;ADCY1;KCNC2;ENC1;GRIN2B
4764,GO:0010468,0.980112491623013,0.0349828944062448,19,4149,regulation of gene expression,BP,PTPRN;LZTS1;CAMK2A;RBFOX1;BIRC5;MYBL2;CELF4;NEURL1;CRYAB;FOXM1;CENPF;TOP2A;SFRP2;TENM2;NEUROD2;ENC1;ZCCHC12;DDN;MYT1L
7829,GO:0031347,0.981277230500493,0.0949635229953538,1,626,regulation of defense response,BP,CNR1
13486,GO:0050778,0.98199414847077,0.0920599040311615,1,637,positive regulation of immune response,BP,CNR1
4203,GO:0008610,0.982747975921477,0.0889833941707704,1,625,lipid biosynthetic process,BP,ST8SIA5
4799,GO:0010556,0.983213515580178,0.030584648055477,17,3837,regulation of macromolecule biosynthetic process,BP,PTPRN;LZTS1;CAMK2A;BIRC5;MYBL2;CELF4;NEURL1;FOXM1;CENPF;TOP2A;SFRP2;TENM2;NEUROD2;ENC1;ZCCHC12;DDN;MYT1L
2789,GO:0005829,0.983766228303133,0.0285319556400899,21,4614,cytosol,CC,BCAT1;SYT1;CAMK2A;RPH3A;BIRC5;KIF4A;SYTL4;CRYAB;RGS4;CENPF;TJP2;HPCA;PACSIN1;SULT4A1;SNAP25;STAC2;GABRB2;VSNL1;FABP7;ADCY1;SPRY4
6234,GO:0017144,0.984727527156696,0.0807063763973536,1,690,drug metabolic process,BP,CHI3L1
3102,GO:0006355,0.98547435043997,0.0279178472972256,14,3344,regulation of transcription, DNA-templated,BP,PTPRN;LZTS1;CAMK2A;BIRC5;MYBL2;FOXM1;CENPF;TOP2A;SFRP2;TENM2;NEUROD2;ZCCHC12;DDN;MYT1L
11544,GO:0044237,0.985710199301401,0.0234696757655559,50,9434,cellular metabolic process,BP,CAMK1G;PTPRN;BCAT1;LZTS1;PTPN3;CAMK2A;LNX1;RBFOX1;BIRC5;CHGA;MYBL2;EEF1A2;CELF4;ST8SIA5;DNM1;NEURL1;CRYAB;PTPN5;FOXM1;IGFBP2;RGS4;CENPF;CNR1;TJP2;HPCA;VGF;SULT4A1;TOP2A;SNAP25;CHRM3;CHI3L1;MRAP2;SFRP2;LIX1;TENM2;CHST9;GNG3;FABP7;PI16;ADCY1;NEUROD2;ENC1;ZCCHC12;PCSK1;DDN;ZDHHC23;MYT1L;SPRY4;PPP1R14C;GRIN2B
11569,GO:0044283,0.985715187887156,0.076494167026425,1,674,small molecule biosynthetic process,BP,BCAT1
19758,GO:1903506,0.986418459532614,0.0262569322931632,14,3363,regulation of nucleic acid-templated transcription,BP,PTPRN;LZTS1;CAMK2A;BIRC5;MYBL2;FOXM1;CENPF;TOP2A;SFRP2;TENM2;NEUROD2;ZCCHC12;DDN;MYT1L
21782,GO:2001141,0.986622026734163,0.0258973179431175,14,3368,regulation of RNA biosynthetic process,BP,PTPRN;LZTS1;CAMK2A;BIRC5;MYBL2;FOXM1;CENPF;TOP2A;SFRP2;TENM2;NEUROD2;ZCCHC12;DDN;MYT1L
9462,GO:0034645,0.98664845788348,0.0238297066481767,21,4682,cellular macromolecule biosynthetic process,BP,PTPRN;LZTS1;CAMK2A;BIRC5;MYBL2;EEF1A2;CELF4;ST8SIA5;NEURL1;FOXM1;CENPF;TOP2A;SFRP2;TENM2;CHST9;NEUROD2;ENC1;ZCCHC12;DDN;ZDHHC23;MYT1L
9469,GO:0034654,0.988393248981647,0.0218012425296968,17,3989,nucleobase-containing compound biosynthetic process,BP,PTPRN;LZTS1;CAMK2A;BIRC5;MYBL2;FOXM1;CENPF;HPCA;TOP2A;MRAP2;SFRP2;TENM2;ADCY1;NEUROD2;ZCCHC12;DDN;MYT1L
1596,GO:0003676,0.988409317500706,0.0223633439178852,15,3641,nucleic acid binding,MF,LZTS1;RBFOX1;KIF4A;MYBL2;EEF1A2;CELF4;DNM1;FOXM1;TOP2A;MKI67;ZNF385D;NEUROD2;ZCCHC12;DDN;MYT1L
4621,GO:0009887,0.9890333557085,0.0431976446741519,2,913,animal organ morphogenesis,BP,SLC4A10;SFRP2
9684,GO:0035295,0.989110944132603,0.042940644359216,2,899,tube development,BP,CHI3L1;SFRP2
11144,GO:0043231,0.989129540667777,0.0182191127719777,51,9668,intracellular membrane-bounded organelle,CC,CAMK1G;SYT13;PTPRN;BCAT1;ASPM;SYT1;CAMK2A;RBFOX1;RPH3A;BIRC5;KIF4A;CHGA;MYBL2;EEF1A2;CELF4;ST8SIA5;SYTL4;STMN2;DNM1;CRYAB;PTPN5;FOXM1;SLC30A3;RGS4;CENPF;CNR1;TJP2;VGF;TOP2A;SNAP25;SYT4;CHI3L1;MRAP2;SLC14A1;CXCL14;TENM2;MKI67;ZNF385D;CHST9;NRGN;IGFN1;FABP7;ADCY1;TMEM130;NEUROD2;ENC1;ZCCHC12;CREG2;DDN;ZDHHC23;MYT1L
6298,GO:0018130,0.990424751225964,0.0182634335005812,17,4046,heterocycle biosynthetic process,BP,PTPRN;LZTS1;CAMK2A;BIRC5;MYBL2;FOXM1;CENPF;HPCA;TOP2A;MRAP2;SFRP2;TENM2;ADCY1;NEUROD2;ZCCHC12;DDN;MYT1L
5667,GO:0016032,0.990572273289443,0.0545969978906822,1,736,viral process,BP,TOP2A
11551,GO:0044249,0.99066921832751,0.0165274612910409,26,5703,cellular biosynthetic process,BP,PTPRN;BCAT1;LZTS1;CAMK2A;BIRC5;MYBL2;EEF1A2;CELF4;ST8SIA5;NEURL1;FOXM1;CENPF;HPCA;TOP2A;MRAP2;SFRP2;TENM2;CHST9;ADCY1;NEUROD2;ENC1;ZCCHC12;PCSK1;DDN;ZDHHC23;MYT1L
6552,GO:0019438,0.990722073683338,0.0177403069122142,17,4053,aromatic compound biosynthetic process,BP,PTPRN;LZTS1;CAMK2A;BIRC5;MYBL2;FOXM1;CENPF;HPCA;TOP2A;MRAP2;SFRP2;TENM2;ADCY1;NEUROD2;ZCCHC12;DDN;MYT1L
4306,GO:0009059,0.990952172184845,0.0166324995787356,21,4792,macromolecule biosynthetic process,BP,PTPRN;LZTS1;CAMK2A;BIRC5;MYBL2;EEF1A2;CELF4;ST8SIA5;NEURL1;FOXM1;CENPF;TOP2A;SFRP2;TENM2;CHST9;NEUROD2;ENC1;ZCCHC12;DDN;ZDHHC23;MYT1L
11558,GO:0044265,0.991032991669392,0.0364055058821086,2,1025,cellular macromolecule catabolic process,BP,LNX1;ENC1
3085,GO:0006325,0.991400885183063,0.0506449636056785,1,676,chromatin organization,BP,MKI67
3098,GO:0006351,0.99148888591904,0.0171165173892205,14,3495,transcription, DNA-templated,BP,PTPRN;LZTS1;CAMK2A;BIRC5;MYBL2;FOXM1;CENPF;TOP2A;SFRP2;TENM2;NEUROD2;ZCCHC12;DDN;MYT1L
13155,GO:0048646,0.991884925158111,0.0334445544247646,2,942,anatomical structure formation involved in morphogenesis,BP,CHI3L1;SFRP2
17881,GO:0097659,0.991908034870076,0.0163409272897287,14,3509,nucleic acid-templated transcription,BP,PTPRN;LZTS1;CAMK2A;BIRC5;MYBL2;FOXM1;CENPF;TOP2A;SFRP2;TENM2;NEUROD2;ZCCHC12;DDN;MYT1L
11651,GO:0044428,0.992127795703483,0.015246004562321,17,4097,nuclear part,CC,CAMK2A;BIRC5;KIF4A;MYBL2;SYTL4;DNM1;CRYAB;PTPN5;FOXM1;CENPF;TJP2;TOP2A;SLC14A1;TENM2;MKI67;ENC1;ZCCHC12
8638,GO:0032774,0.992262151555934,0.0156827885335522,14,3522,RNA biosynthetic process,BP,PTPRN;LZTS1;CAMK2A;BIRC5;MYBL2;FOXM1;CENPF;TOP2A;SFRP2;TENM2;NEUROD2;ZCCHC12;DDN;MYT1L
18975,GO:1901576,0.992931740871125,0.0127655626114439,26,5780,organic substance biosynthetic process,BP,PTPRN;BCAT1;LZTS1;CAMK2A;BIRC5;MYBL2;EEF1A2;CELF4;ST8SIA5;NEURL1;FOXM1;CENPF;HPCA;TOP2A;MRAP2;SFRP2;TENM2;CHST9;ADCY1;NEUROD2;ENC1;ZCCHC12;PCSK1;DDN;ZDHHC23;MYT1L
11635,GO:0044403,0.993226260849247,0.0415863733601125,1,790,symbiont process,BP,TOP2A
3429,GO:0006807,0.993324463521506,0.0115299591626453,45,8864,nitrogen compound metabolic process,BP,CAMK1G;PTPRN;BCAT1;LZTS1;PTPN3;CAMK2A;LNX1;RBFOX1;BIRC5;CHGA;MYBL2;EEF1A2;CELF4;ST8SIA5;NEURL1;CRYAB;PTPN5;FOXM1;IGFBP2;RGS4;CENPF;TJP2;HPCA;VGF;SULT4A1;TOP2A;CHRM3;CHI3L1;MRAP2;SFRP2;TENM2;CHST9;GNG3;PI16;ADCY1;NEUROD2;ENC1;ZCCHC12;PCSK1;DDN;ZDHHC23;MYT1L;SPRY4;PPP1R14C;GRIN2B
20942,GO:1990234,0.993539690858818,0.0399925043587042,1,744,transferase complex,CC,ENC1
8130,GO:0031974,0.993730694903553,0.0119464929239774,20,4779,membrane-enclosed lumen,CC,CAMK2A;BIRC5;KIF4A;MYBL2;SYTL4;DNM1;CRYAB;PTPN5;FOXM1;CENPF;TJP2;VGF;TOP2A;CHI3L1;SLC14A1;TENM2;MKI67;ENC1;ZCCHC12;PCSK1
11146,GO:0043233,0.993730694903553,0.0119464929239774,20,4779,organelle lumen,CC,CAMK2A;BIRC5;KIF4A;MYBL2;SYTL4;DNM1;CRYAB;PTPN5;FOXM1;CENPF;TJP2;VGF;TOP2A;CHI3L1;SLC14A1;TENM2;MKI67;ENC1;ZCCHC12;PCSK1
15553,GO:0070013,0.993730694903553,0.0119464929239774,20,4779,intracellular organelle lumen,CC,CAMK2A;BIRC5;KIF4A;MYBL2;SYTL4;DNM1;CRYAB;PTPN5;FOXM1;CENPF;TJP2;VGF;TOP2A;CHI3L1;SLC14A1;TENM2;MKI67;ENC1;ZCCHC12;PCSK1
18914,GO:1901362,0.993971009651921,0.0119150565674538,17,4175,organic cyclic compound biosynthetic process,BP,PTPRN;LZTS1;CAMK2A;BIRC5;MYBL2;FOXM1;CENPF;HPCA;TOP2A;MRAP2;SFRP2;TENM2;ADCY1;NEUROD2;ZCCHC12;DDN;MYT1L
3520,GO:0006950,0.994030099623216,0.01285161098897,12,3332,response to stress,BP,PTPRN;CAMK2A;CHGA;CRYAB;FOXM1;CNR1;VGF;TOP2A;CHI3L1;SFRP2;KCNC2;NEUROD2
4305,GO:0009058,0.994272830234119,0.0104929505289653,26,5840,biosynthetic process,BP,PTPRN;BCAT1;LZTS1;CAMK2A;BIRC5;MYBL2;EEF1A2;CELF4;ST8SIA5;NEURL1;FOXM1;CENPF;HPCA;TOP2A;MRAP2;SFRP2;TENM2;CHST9;ADCY1;NEUROD2;ENC1;ZCCHC12;PCSK1;DDN;ZDHHC23;MYT1L
4763,GO:0010467,0.994522572129652,0.010440422421809,21,4942,gene expression,BP,PTPRN;LZTS1;CAMK2A;RBFOX1;BIRC5;MYBL2;EEF1A2;CELF4;NEURL1;CRYAB;FOXM1;CENPF;TOP2A;SFRP2;TENM2;NEUROD2;ENC1;ZCCHC12;PCSK1;DDN;MYT1L
11100,GO:0043170,0.994561737544257,0.00953935255377516,41,8205,macromolecule metabolic process,BP,CAMK1G;PTPRN;LZTS1;PTPN3;CAMK2A;LNX1;RBFOX1;BIRC5;MYBL2;EEF1A2;CELF4;ST8SIA5;DNM1;NEURL1;CRYAB;PTPN5;FOXM1;IGFBP2;RGS4;CENPF;VGF;TOP2A;SNAP25;CHRM3;CHI3L1;SFRP2;TENM2;CHST9;GNG3;PI16;ADCY1;NEUROD2;ENC1;ZCCHC12;PCSK1;DDN;ZDHHC23;MYT1L;SPRY4;PPP1R14C;GRIN2B
16514,GO:0071704,0.994853790462837,0.00905227286020747,49,9561,organic substance metabolic process,BP,CAMK1G;PTPRN;BCAT1;LZTS1;PTPN3;CAMK2A;LNX1;RBFOX1;BIRC5;CHGA;MYBL2;EEF1A2;CELF4;ST8SIA5;DNM1;NEURL1;CRYAB;PTPN5;FOXM1;IGFBP2;RGS4;CENPF;CNR1;TJP2;HPCA;VGF;SULT4A1;TOP2A;SNAP25;CHRM3;CHI3L1;MRAP2;SFRP2;TENM2;CHST9;GNG3;FABP7;PI16;ADCY1;NEUROD2;ENC1;ZCCHC12;PCSK1;DDN;ZDHHC23;MYT1L;SPRY4;PPP1R14C;GRIN2B
2670,GO:0005634,0.994902290420925,0.00922633131002441,30,6483,nucleus,CC,PTPRN;ASPM;CAMK2A;RBFOX1;BIRC5;KIF4A;MYBL2;CELF4;SYTL4;DNM1;CRYAB;PTPN5;FOXM1;RGS4;CENPF;TJP2;TOP2A;SLC14A1;TENM2;MKI67;ZNF385D;NRGN;IGFN1;FABP7;ADCY1;NEUROD2;ENC1;ZCCHC12;DDN;MYT1L
11545,GO:0044238,0.995303632232618,0.00829980431931223,47,9272,primary metabolic process,BP,CAMK1G;PTPRN;BCAT1;LZTS1;PTPN3;CAMK2A;LNX1;RBFOX1;BIRC5;CHGA;MYBL2;EEF1A2;CELF4;ST8SIA5;NEURL1;CRYAB;PTPN5;FOXM1;IGFBP2;RGS4;CENPF;CNR1;TJP2;HPCA;VGF;SULT4A1;TOP2A;CHRM3;CHI3L1;MRAP2;SFRP2;TENM2;CHST9;GNG3;FABP7;PI16;ADCY1;NEUROD2;ENC1;ZCCHC12;PCSK1;DDN;ZDHHC23;MYT1L;SPRY4;PPP1R14C;GRIN2B
9459,GO:0034641,0.995415366991064,0.00852522375971635,26,5944,cellular nitrogen compound metabolic process,BP,PTPRN;LZTS1;CAMK2A;RBFOX1;BIRC5;CHGA;MYBL2;EEF1A2;CELF4;NEURL1;FOXM1;CENPF;TJP2;HPCA;SULT4A1;TOP2A;MRAP2;SFRP2;TENM2;ADCY1;NEUROD2;ENC1;ZCCHC12;PCSK1;DDN;MYT1L
1638,GO:0003824,0.996286245064359,0.00720639932765951,22,5217,catalytic activity,MF,CAMK1G;BCAT1;PTPN3;CAMK2A;LNX1;BIRC5;KIF4A;EEF1A2;ST8SIA5;DNM1;NEURL1;PTPN5;TJP2;SULT4A1;TOP2A;CHRM3;CHI3L1;CHST9;GNG3;ADCY1;PCSK1;ZDHHC23
3925,GO:0008152,0.996888203894799,0.00566358879604845,51,10000,metabolic process,BP,CAMK1G;PTPRN;BCAT1;LZTS1;PTPN3;CAMK2A;LNX1;RBFOX1;BIRC5;CHGA;MYBL2;EEF1A2;CELF4;ST8SIA5;DNM1;NEURL1;CRYAB;PTPN5;FOXM1;IGFBP2;RGS4;CENPF;CNR1;TJP2;PRLHR;HPCA;VGF;SULT4A1;TOP2A;SNAP25;CHRM3;CHI3L1;MRAP2;SFRP2;LIX1;TENM2;CHST9;GNG3;FABP7;PI16;ADCY1;NEUROD2;ENC1;ZCCHC12;PCSK1;DDN;ZDHHC23;MYT1L;SPRY4;PPP1R14C;GRIN2B
2981,GO:0006139,0.997048204964754,0.00581545874013421,22,5311,nucleobase-containing compound metabolic process,BP,PTPRN;LZTS1;CAMK2A;RBFOX1;BIRC5;CHGA;MYBL2;CELF4;FOXM1;CENPF;TJP2;HPCA;SULT4A1;TOP2A;MRAP2;SFRP2;TENM2;ADCY1;NEUROD2;ZCCHC12;DDN;MYT1L
12500,GO:0046483,0.998273984402066,0.00351904382811839,22,5453,heterocycle metabolic process,BP,PTPRN;LZTS1;CAMK2A;RBFOX1;BIRC5;CHGA;MYBL2;CELF4;FOXM1;CENPF;TJP2;HPCA;SULT4A1;TOP2A;MRAP2;SFRP2;TENM2;ADCY1;NEUROD2;ZCCHC12;DDN;MYT1L
5689,GO:0016070,0.998411396648159,0.00349870099658934,16,4325,RNA metabolic process,BP,PTPRN;LZTS1;CAMK2A;RBFOX1;BIRC5;MYBL2;CELF4;FOXM1;CENPF;TOP2A;SFRP2;TENM2;NEUROD2;ZCCHC12;DDN;MYT1L
3381,GO:0006725,0.998521806067242,0.00304286144200481,22,5492,cellular aromatic compound metabolic process,BP,PTPRN;LZTS1;CAMK2A;RBFOX1;BIRC5;CHGA;MYBL2;CELF4;FOXM1;CENPF;TJP2;HPCA;SULT4A1;TOP2A;MRAP2;SFRP2;TENM2;ADCY1;NEUROD2;ZCCHC12;DDN;MYT1L
19317,GO:1902494,0.998538025988858,0.00753389768703156,2,1318,catalytic complex,CC,GNG3;ENC1
18912,GO:1901360,0.999279360209071,0.00154856668054765,22,5667,organic cyclic compound metabolic process,BP,PTPRN;LZTS1;CAMK2A;RBFOX1;BIRC5;CHGA;MYBL2;CELF4;FOXM1;CENPF;TJP2;HPCA;SULT4A1;TOP2A;MRAP2;SFRP2;TENM2;ADCY1;NEUROD2;ZCCHC12;DDN;MYT1L
17392,GO:0090304,0.999801339080327,0.000497084364707583,16,4768,nucleic acid metabolic process,BP,PTPRN;LZTS1;CAMK2A;RBFOX1;BIRC5;MYBL2;CELF4;FOXM1;CENPF;TOP2A;SFRP2;TENM2;NEUROD2;ZCCHC12;DDN;MYT1L
18915,GO:1901363,0.999962984061305,9.79769702403561e-05,18,5362,heterocyclic compound binding,MF,CAMK1G;LZTS1;CAMK2A;RBFOX1;KIF4A;MYBL2;EEF1A2;CELF4;DNM1;FOXM1;TOP2A;MKI67;ZNF385D;ADCY1;NEUROD2;ZCCHC12;DDN;MYT1L
17637,GO:0097159,0.999973367961996,7.16507158556467e-05,18,5427,organic cyclic compound binding,MF,CAMK1G;LZTS1;CAMK2A;RBFOX1;KIF4A;MYBL2;EEF1A2;CELF4;DNM1;FOXM1;TOP2A;MKI67;ZNF385D;ADCY1;NEUROD2;ZCCHC12;DDN;MYT1L
16569,GO:0071837,0.99999999999999,0.891320746303289,0,17,HMG box domain binding,MF,
7956,GO:0031593,0.999999999999991,0.788403074712242,0,35,polyubiquitin modification-dependent protein binding,MF,
7240,GO:0030215,0.999999999999994,0.854091870688216,0,20,semaphorin receptor binding,MF,
15680,GO:0070233,0.999999999999998,0.90088771560842,0,17,negative regulation of T cell apoptotic process,BP,
12613,GO:0046688,0.999999999999998,0.861595503784772,0,30,response to copper ion,BP,
9251,GO:0034204,0.999999999999999,0.803574410898634,0,24,lipid translocation,BP,
14084,GO:0051788,0.999999999999999,0.855976369207275,0,23,response to misfolded protein,BP,
8116,GO:0031952,0.999999999999999,0.757746273604575,0,39,regulation of protein autophosphorylation,BP,
8565,GO:0032655,0.999999999999999,0.750763489996327,0,47,regulation of interleukin-12 production,BP,
9133,GO:0033866,1,0.910970599092458,0,16,nucleoside bisphosphate biosynthetic process,BP,
9155,GO:0034030,1,0.910970599092458,0,16,ribonucleoside bisphosphate biosynthetic process,BP,
9158,GO:0034033,1,0.910970599092458,0,16,purine nucleoside bisphosphate biosynthetic process,BP,
10825,GO:0042599,1,0.911182363848607,0,16,lamellar body,CC,
11019,GO:0043024,1,0.915059275393279,0,14,ribosomal small subunit binding,MF,
1,GO:0000002,1,0.843454891685278,0,26,mitochondrial genome maintenance,BP,
3,GO:0000009,1,0.994529055302705,0,1,alpha-1,6-mannosyltransferase activity,MF,
4,GO:0000010,1,0.988751334214559,0,2,trans-hexaprenyltranstransferase activity,MF,
5,GO:0000011,1,0.994054740756748,0,1,vacuole inheritance,BP,
6,GO:0000012,1,0.949535321984726,0,8,single strand break repair,BP,
7,GO:0000014,1,0.951817805767737,0,7,single-stranded DNA endodeoxyribonuclease activity,MF,
8,GO:0000015,1,0.979528100692882,0,4,phosphopyruvate hydratase complex,CC,
9,GO:0000018,1,0.638526273775849,0,66,regulation of DNA recombination,BP,
10,GO:0000019,1,0.974252709754342,0,4,regulation of mitotic recombination,BP,
12,GO:0000023,1,0.975933102010754,0,3,maltose metabolic process,BP,
13,GO:0000026,1,0.979164983313945,0,3,alpha-1,2-mannosyltransferase activity,MF,
14,GO:0000027,1,0.871556011123338,0,26,ribosomal large subunit assembly,BP,
15,GO:0000028,1,0.936646017270364,0,17,ribosomal small subunit assembly,BP,
16,GO:0000030,1,0.874507091450399,0,23,mannosyltransferase activity,MF,
17,GO:0000032,1,0.995286990116764,0,1,cell wall mannoprotein biosynthetic process,BP,
18,GO:0000033,1,0.984955108751872,0,3,alpha-1,3-mannosyltransferase activity,MF,
19,GO:0000035,1,0.98718646806342,0,3,acyl binding,MF,
20,GO:0000036,1,0.993377801209287,0,2,acyl carrier activity,MF,
21,GO:0000038,1,0.8353374932002,0,30,very long-chain fatty acid metabolic process,BP,
23,GO:0000045,1,0.551551287890077,0,88,autophagosome assembly,BP,
24,GO:0000048,1,0.988950228301912,0,2,peptidyltransferase activity,MF,
25,GO:0000049,1,0.715798780575457,0,55,tRNA binding,MF,
26,GO:0000050,1,0.932837267747548,0,12,urea cycle,BP,
27,GO:0000052,1,0.943019080468107,0,8,citrulline metabolic process,BP,
28,GO:0000053,1,0.99522039893135,0,1,argininosuccinate metabolic process,BP,
29,GO:0000054,1,0.934969601735993,0,13,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.959163440242076,0,8,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.964787713567754,0,7,ribosomal small subunit export from nucleus,BP,
32,GO:0000060,1,0.752134754864965,0,43,protein import into nucleus, translocation,BP,
33,GO:0000062,1,0.906728343013978,0,18,fatty-acyl-CoA binding,MF,
34,GO:0000064,1,0.957970128005593,0,6,L-ornithine transmembrane transporter activity,MF,
37,GO:0000076,1,0.908743548825022,0,16,DNA replication checkpoint,BP,
38,GO:0000077,1,0.376749378294148,0,147,DNA damage checkpoint,BP,
39,GO:0000079,1,0.598122408566777,0,83,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
41,GO:0000083,1,0.839942318754454,0,28,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
43,GO:0000095,1,0.994712732642883,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
44,GO:0000096,1,0.795001613758106,0,37,sulfur amino acid metabolic process,BP,
45,GO:0000097,1,0.907688101410542,0,16,sulfur amino acid biosynthetic process,BP,
46,GO:0000098,1,0.94232309909113,0,10,sulfur amino acid catabolic process,BP,
47,GO:0000099,1,0.955771033733326,0,6,sulfur amino acid transmembrane transporter activity,MF,
48,GO:0000101,1,0.967970735000626,0,5,sulfur amino acid transport,BP,
49,GO:0000103,1,0.983337994582603,0,3,sulfate assimilation,BP,
50,GO:0000104,1,0.980640989710721,0,4,succinate dehydrogenase activity,MF,
51,GO:0000105,1,0.987908075419499,0,2,histidine biosynthetic process,BP,
52,GO:0000109,1,0.939952238958147,0,10,nucleotide-excision repair complex,CC,
53,GO:0000110,1,0.979229736253655,0,3,nucleotide-excision repair factor 1 complex,CC,
54,GO:0000111,1,0.993182115711814,0,1,nucleotide-excision repair factor 2 complex,CC,
55,GO:0000117,1,0.985035907154903,0,2,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
56,GO:0000118,1,0.629670542589593,0,60,histone deacetylase complex,CC,
57,GO:0000120,1,0.972596277618124,0,5,RNA polymerase I transcription factor complex,CC,
58,GO:0000121,1,0.993665856694707,0,1,glycerol-1-phosphatase activity,MF,
60,GO:0000123,1,0.610758043914246,0,75,histone acetyltransferase complex,CC,
61,GO:0000124,1,0.941072388392993,0,11,SAGA complex,CC,
62,GO:0000125,1,0.97358191620037,0,3,PCAF complex,CC,
63,GO:0000126,1,0.979397592148157,0,2,transcription factor TFIIIB complex,CC,
64,GO:0000127,1,0.960866872595198,0,6,transcription factor TFIIIC complex,CC,
65,GO:0000132,1,0.869433718675483,0,20,establishment of mitotic spindle orientation,BP,
66,GO:0000137,1,0.897321731930219,0,17,Golgi cis cisterna,CC,
67,GO:0000138,1,0.962591925887093,0,7,Golgi trans cisterna,CC,
69,GO:0000145,1,0.883265219615361,0,18,exocyst,CC,
70,GO:0000146,1,0.823305204151245,0,19,microfilament motor activity,MF,
71,GO:0000147,1,0.965169299494034,0,5,actin cortical patch assembly,BP,
73,GO:0000150,1,0.957146414576188,0,8,recombinase activity,MF,
75,GO:0000152,1,0.792859962553652,0,38,nuclear ubiquitin ligase complex,CC,
76,GO:0000153,1,0.932295891231918,0,11,cytoplasmic ubiquitin ligase complex,CC,
77,GO:0000154,1,0.847704229587016,0,31,rRNA modification,BP,
78,GO:0000155,1,0.954595482252752,0,6,phosphorelay sensor kinase activity,MF,
79,GO:0000159,1,0.886081968033236,0,19,protein phosphatase type 2A complex,CC,
80,GO:0000160,1,0.947999425305032,0,7,phosphorelay signal transduction system,BP,
81,GO:0000164,1,0.931107308848235,0,11,protein phosphatase type 1 complex,CC,
84,GO:0000170,1,0.995754326013234,0,1,sphingosine hydroxylase activity,MF,
85,GO:0000171,1,0.986577786661008,0,2,ribonuclease MRP activity,MF,
86,GO:0000172,1,0.967966424602557,0,6,ribonuclease MRP complex,CC,
87,GO:0000173,1,0.995443194468522,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
88,GO:0000175,1,0.82505975872004,0,30,3'-5'-exoribonuclease activity,MF,
89,GO:0000176,1,0.939413439209559,0,13,nuclear exosome (RNase complex),CC,
90,GO:0000177,1,0.917450176349138,0,15,cytoplasmic exosome (RNase complex),CC,
91,GO:0000178,1,0.880877709764668,0,22,exosome (RNase complex),CC,
92,GO:0000179,1,0.979441927059217,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
93,GO:0000182,1,0.922121515474531,0,10,rDNA binding,MF,
94,GO:0000183,1,0.902440305314555,0,18,chromatin silencing at rDNA,BP,
95,GO:0000184,1,0.574811184489318,0,117,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
96,GO:0000185,1,0.885242791783952,0,18,activation of MAPKKK activity,BP,
97,GO:0000186,1,0.673218406047022,0,53,activation of MAPKK activity,BP,
100,GO:0000209,1,0.14633147515435,0,290,protein polyubiquitination,BP,
101,GO:0000210,1,0.993307600531823,0,1,NAD+ diphosphatase activity,MF,
103,GO:0000213,1,0.979776711121487,0,4,tRNA-intron endonuclease activity,MF,
104,GO:0000214,1,0.98003663959953,0,4,tRNA-intron endonuclease complex,CC,
105,GO:0000215,1,0.990325142753192,0,2,tRNA 2'-phosphotransferase activity,MF,
106,GO:0000217,1,0.857405065832861,0,24,DNA secondary structure binding,MF,
107,GO:0000220,1,0.963871432830045,0,6,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
108,GO:0000221,1,0.979748342615221,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
109,GO:0000224,1,0.994332139315405,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
110,GO:0000225,1,0.996066355307388,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
113,GO:0000229,1,0.991658898756053,0,2,cytoplasmic chromosome,CC,
114,GO:0000235,1,0.941333798428693,0,8,astral microtubule,CC,
115,GO:0000242,1,0.850253363274757,0,20,pericentriolar material,CC,
116,GO:0000243,1,0.960893589293601,0,8,commitment complex,CC,
117,GO:0000244,1,0.92370152275034,0,12,spliceosomal tri-snRNP complex assembly,BP,
119,GO:0000246,1,0.992534825731674,0,1,delta24(24-1) sterol reductase activity,MF,
120,GO:0000247,1,0.996063866935014,0,1,C-8 sterol isomerase activity,MF,
121,GO:0000248,1,0.986506084658379,0,2,C-5 sterol desaturase activity,MF,
122,GO:0000250,1,0.992565526096552,0,1,lanosterol synthase activity,MF,
123,GO:0000252,1,0.995506877175019,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
124,GO:0000253,1,0.987686995814676,0,3,3-keto sterol reductase activity,MF,
125,GO:0000254,1,0.983986978260097,0,3,C-4 methylsterol oxidase activity,MF,
126,GO:0000255,1,0.972674734162958,0,4,allantoin metabolic process,BP,
127,GO:0000256,1,0.995696679025439,0,1,allantoin catabolic process,BP,
128,GO:0000257,1,0.99580314065602,0,1,nitrilase activity,MF,
129,GO:0000262,1,0.995513176598044,0,1,mitochondrial chromosome,CC,
131,GO:0000268,1,0.975879153793269,0,4,peroxisome targeting sequence binding,MF,
132,GO:0000270,1,0.992599492885239,0,2,peptidoglycan metabolic process,BP,
133,GO:0000271,1,0.60990091568248,0,69,polysaccharide biosynthetic process,BP,
134,GO:0000272,1,0.828808529146697,0,26,polysaccharide catabolic process,BP,
138,GO:0000285,1,0.974123168612461,0,4,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,
140,GO:0000288,1,0.610519821179775,0,74,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
141,GO:0000289,1,0.765298717552372,0,36,nuclear-transcribed mRNA poly(A) tail shortening,BP,
142,GO:0000290,1,0.949589711780362,0,8,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
143,GO:0000291,1,0.822499745230301,0,34,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
144,GO:0000293,1,0.980668558400003,0,3,ferric-chelate reductase activity,MF,
145,GO:0000294,1,0.985643506073086,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
146,GO:0000295,1,0.938330354756262,0,11,adenine nucleotide transmembrane transporter activity,MF,
147,GO:0000296,1,0.994635421593008,0,1,spermine transport,BP,
148,GO:0000298,1,0.977560788177497,0,4,endopolyphosphatase activity,MF,
149,GO:0000301,1,0.97727560489392,0,4,retrograde transport, vesicle recycling within Golgi,BP,
151,GO:0000303,1,0.862906782939526,0,27,response to superoxide,BP,
152,GO:0000305,1,0.847422675592043,0,30,response to oxygen radical,BP,
153,GO:0000306,1,0.972445101540649,0,4,extrinsic component of vacuolar membrane,CC,
154,GO:0000307,1,0.785152320423215,0,39,cyclin-dependent protein kinase holoenzyme complex,CC,
155,GO:0000308,1,0.984792683291108,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
156,GO:0000309,1,0.979624255573908,0,3,nicotinamide-nucleotide adenylyltransferase activity,MF,
157,GO:0000313,1,0.703959436868839,0,82,organellar ribosome,CC,
158,GO:0000314,1,0.892905680860986,0,27,organellar small ribosomal subunit,CC,
159,GO:0000315,1,0.80583820401781,0,50,organellar large ribosomal subunit,CC,
160,GO:0000320,1,0.985118042752168,0,2,re-entry into mitotic cell cycle,BP,
161,GO:0000322,1,0.982104262035304,0,3,storage vacuole,CC,
163,GO:0000333,1,0.983551314935534,0,2,telomerase catalytic core complex,CC,
164,GO:0000334,1,0.995898114741313,0,1,3-hydroxyanthranilate 3,4-dioxygenase activity,MF,
165,GO:0000338,1,0.950499788635454,0,10,protein deneddylation,BP,
166,GO:0000339,1,0.905947669773998,0,15,RNA cap binding,MF,
167,GO:0000340,1,0.950783157005246,0,7,RNA 7-methylguanosine cap binding,MF,
168,GO:0000346,1,0.927312694031462,0,13,transcription export complex,CC,
169,GO:0000347,1,0.968011991134458,0,6,THO complex,CC,
170,GO:0000349,1,0.988770622370197,0,2,generation of catalytic spliceosome for first transesterification step,BP,
171,GO:0000350,1,0.985571384839582,0,3,generation of catalytic spliceosome for second transesterification step,BP,
172,GO:0000354,1,0.983207974188732,0,2,cis assembly of pre-catalytic spliceosome,BP,
175,GO:0000379,1,0.984644315331506,0,3,tRNA-type intron splice site recognition and cleavage,BP,
178,GO:0000384,1,0.990917638762227,0,2,first spliceosomal transesterification activity,MF,
179,GO:0000386,1,0.978290632802161,0,3,second spliceosomal transesterification activity,MF,
180,GO:0000387,1,0.811421417878911,0,38,spliceosomal snRNP assembly,BP,
181,GO:0000389,1,0.964107749205252,0,6,mRNA 3'-splice site recognition,BP,
182,GO:0000390,1,0.989950161260908,0,2,spliceosomal complex disassembly,BP,
183,GO:0000393,1,0.974502413455289,0,5,spliceosomal conformational changes to generate catalytic conformation,BP,
184,GO:0000394,1,0.915281670341105,0,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,
185,GO:0000395,1,0.966017262228567,0,6,mRNA 5'-splice site recognition,BP,
187,GO:0000400,1,0.906217426274623,0,16,four-way junction DNA binding,MF,
188,GO:0000403,1,0.955175246209538,0,6,Y-form DNA binding,MF,
189,GO:0000404,1,0.97916133411605,0,3,heteroduplex DNA loop binding,MF,
190,GO:0000405,1,0.951119620809103,0,7,bubble DNA binding,MF,
191,GO:0000406,1,0.985883938278276,0,2,double-strand/single-strand DNA junction binding,MF,
192,GO:0000407,1,0.796858060530564,0,33,phagophore assembly site,CC,
193,GO:0000408,1,0.975626985527244,0,5,EKC/KEOPS complex,CC,
194,GO:0000409,1,0.989950284262693,0,1,regulation of transcription by galactose,BP,
195,GO:0000411,1,0.989950284262693,0,1,positive regulation of transcription by galactose,BP,
196,GO:0000412,1,0.993928059137074,0,1,histone peptidyl-prolyl isomerization,BP,
197,GO:0000413,1,0.844081305731765,0,31,protein peptidyl-prolyl isomerization,BP,
198,GO:0000414,1,0.962719317330716,0,4,regulation of histone H3-K36 methylation,BP,
199,GO:0000415,1,0.990470232990292,0,1,negative regulation of histone H3-K36 methylation,BP,
200,GO:0000416,1,0.99307710140477,0,1,positive regulation of histone H3-K36 methylation,BP,
201,GO:0000417,1,0.992783763344201,0,1,HIR complex,CC,
202,GO:0000421,1,0.830559797224397,0,31,autophagosome membrane,CC,
203,GO:0000422,1,0.592071635243045,0,80,autophagy of mitochondrion,BP,
204,GO:0000423,1,0.87887998419159,0,18,mitophagy,BP,
205,GO:0000428,1,0.431330296962351,0,132,DNA-directed RNA polymerase complex,CC,
206,GO:0000429,1,0.975413108465005,0,4,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
207,GO:0000430,1,0.985316733490076,0,3,regulation of transcription from RNA polymerase II promoter by glucose,BP,
208,GO:0000431,1,0.989950284262693,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
209,GO:0000432,1,0.985316733490076,0,3,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
210,GO:0000435,1,0.989950284262693,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
211,GO:0000436,1,0.975413108465005,0,4,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
212,GO:0000438,1,0.986081901800787,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
213,GO:0000439,1,0.953473511284922,0,8,core TFIIH complex,CC,
214,GO:0000444,1,0.969926098848328,0,4,MIS12/MIND type complex,CC,
215,GO:0000445,1,0.968011991134458,0,6,THO complex part of transcription export complex,CC,
216,GO:0000447,1,0.949192537983612,0,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
217,GO:0000448,1,0.990134865609346,0,1,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
218,GO:0000451,1,0.991679212898038,0,1,rRNA 2'-O-methylation,BP,
219,GO:0000453,1,0.991679212898038,0,1,enzyme-directed rRNA 2'-O-methylation,BP,
220,GO:0000454,1,0.988254744669842,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
221,GO:0000455,1,0.990167930617168,0,2,enzyme-directed rRNA pseudouridine synthesis,BP,
222,GO:0000459,1,0.965236513775338,0,7,exonucleolytic trimming involved in rRNA processing,BP,
223,GO:0000460,1,0.830202503262336,0,32,maturation of 5.8S rRNA,BP,
224,GO:0000461,1,0.993120619063664,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
225,GO:0000462,1,0.811450064312849,0,37,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
226,GO:0000463,1,0.953571044855628,0,9,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
227,GO:0000466,1,0.882781665464825,0,21,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
228,GO:0000467,1,0.965236513775338,0,7,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
229,GO:0000469,1,0.86275984561961,0,25,cleavage involved in rRNA processing,BP,
230,GO:0000470,1,0.886568098150463,0,22,maturation of LSU-rRNA,BP,
231,GO:0000472,1,0.976664689417071,0,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
232,GO:0000478,1,0.9104149929596,0,14,endonucleolytic cleavage involved in rRNA processing,BP,
233,GO:0000479,1,0.915505539341527,0,13,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
234,GO:0000480,1,0.959560055725584,0,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
235,GO:0000481,1,0.993185017021863,0,1,maturation of 5S rRNA,BP,
236,GO:0000491,1,0.956893891437777,0,8,small nucleolar ribonucleoprotein complex assembly,BP,
237,GO:0000492,1,0.967260941743581,0,6,box C/D snoRNP assembly,BP,
238,GO:0000493,1,0.989285642057669,0,2,box H/ACA snoRNP assembly,BP,
239,GO:0000494,1,0.996047689627225,0,1,box C/D snoRNA 3'-end processing,BP,
240,GO:0000495,1,0.994283746643721,0,1,box H/ACA snoRNA 3'-end processing,BP,
241,GO:0000502,1,0.729692323403893,0,62,proteasome complex,CC,
242,GO:0000506,1,0.957471808753703,0,9,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,
243,GO:0000578,1,0.80768607350038,0,31,embryonic axis specification,BP,
244,GO:0000700,1,0.979155143862091,0,4,mismatch base pair DNA N-glycosylase activity,MF,
245,GO:0000701,1,0.991054889167709,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
246,GO:0000702,1,0.978661796089097,0,5,oxidized base lesion DNA N-glycosylase activity,MF,
247,GO:0000703,1,0.991734800068985,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
248,GO:0000706,1,0.980487506583647,0,3,meiotic DNA double-strand break processing,BP,
249,GO:0000707,1,0.956669011453511,0,8,meiotic DNA recombinase assembly,BP,
250,GO:0000710,1,0.97210925900569,0,4,meiotic mismatch repair,BP,
251,GO:0000711,1,0.995734910152389,0,1,meiotic DNA repair synthesis,BP,
253,GO:0000715,1,0.882279956632738,0,23,nucleotide-excision repair, DNA damage recognition,BP,
254,GO:0000717,1,0.879539290661255,0,22,nucleotide-excision repair, DNA duplex unwinding,BP,
255,GO:0000718,1,0.995346516039137,0,1,nucleotide-excision repair, DNA damage removal,BP,
256,GO:0000720,1,0.98243126163274,0,3,pyrimidine dimer repair by nucleotide-excision repair,BP,
257,GO:0000722,1,0.899706563241794,0,14,telomere maintenance via recombination,BP,
258,GO:0000723,1,0.380613912772205,0,144,telomere maintenance,BP,
259,GO:0000724,1,0.490250289050387,0,104,double-strand break repair via homologous recombination,BP,
260,GO:0000725,1,0.487314623383705,0,105,recombinational repair,BP,
261,GO:0000726,1,0.643175470871848,0,64,non-recombinational repair,BP,
262,GO:0000727,1,0.972460787878014,0,5,double-strand break repair via break-induced replication,BP,
263,GO:0000729,1,0.857611996591769,0,22,DNA double-strand break processing,BP,
264,GO:0000730,1,0.945426273720465,0,10,DNA recombinase assembly,BP,
265,GO:0000731,1,0.632507643953863,0,68,DNA synthesis involved in DNA repair,BP,
266,GO:0000732,1,0.831101193923458,0,25,strand displacement,BP,
267,GO:0000733,1,0.943255886107959,0,9,DNA strand renaturation,BP,
268,GO:0000737,1,0.852816838071952,0,26,DNA catabolic process, endonucleolytic,BP,
269,GO:0000738,1,0.976449295715522,0,4,DNA catabolic process, exonucleolytic,BP,
270,GO:0000741,1,0.995321197939531,0,1,karyogamy,BP,
271,GO:0000768,1,0.763476201825821,0,37,syncytium formation by plasma membrane fusion,BP,
272,GO:0000773,1,0.996265061457174,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
273,GO:0000774,1,0.938892727307049,0,11,adenyl-nucleotide exchange factor activity,MF,
277,GO:0000778,1,0.935402285293619,0,12,condensed nuclear chromosome kinetochore,CC,
279,GO:0000780,1,0.886733123438068,0,20,condensed nuclear chromosome, centromeric region,CC,
280,GO:0000781,1,0.403245794649797,0,135,chromosome, telomeric region,CC,
281,GO:0000782,1,0.93627024714271,0,11,telomere cap complex,CC,
282,GO:0000783,1,0.93627024714271,0,11,nuclear telomere cap complex,CC,
283,GO:0000784,1,0.497319253739867,0,105,nuclear chromosome, telomeric region,CC,
285,GO:0000786,1,0.81046623053508,0,47,nucleosome,CC,
286,GO:0000788,1,0.941208357997171,0,14,nuclear nucleosome,CC,
287,GO:0000789,1,0.996128526869432,0,1,cytoplasmic chromatin,CC,
289,GO:0000791,1,0.837495146391032,0,30,euchromatin,CC,
290,GO:0000792,1,0.629764301561153,0,68,heterochromatin,CC,
292,GO:0000794,1,0.573372299929321,0,82,condensed nuclear chromosome,CC,
293,GO:0000795,1,0.822514941708992,0,31,synaptonemal complex,CC,
294,GO:0000796,1,0.944344365083288,0,7,condensin complex,CC,
295,GO:0000797,1,0.991999338814842,0,1,condensin core heterodimer,CC,
296,GO:0000798,1,0.968547221106622,0,5,nuclear cohesin complex,CC,
297,GO:0000799,1,0.975716127732155,0,3,nuclear condensin complex,CC,
298,GO:0000800,1,0.911202617323367,0,13,lateral element,CC,
299,GO:0000801,1,0.967042426358761,0,6,central element,CC,
300,GO:0000803,1,0.841884659366362,0,25,sex chromosome,CC,
301,GO:0000805,1,0.946633896305454,0,7,X chromosome,CC,
302,GO:0000806,1,0.986427463717709,0,2,Y chromosome,CC,
303,GO:0000808,1,0.947417628636592,0,9,origin recognition complex,CC,
304,GO:0000811,1,0.98260318972791,0,3,GINS complex,CC,
305,GO:0000812,1,0.9318589467809,0,10,Swr1 complex,CC,
306,GO:0000813,1,0.945410729762963,0,10,ESCRT I complex,CC,
307,GO:0000814,1,0.984593770859273,0,3,ESCRT II complex,CC,
308,GO:0000815,1,0.93638448060373,0,12,ESCRT III complex,CC,
309,GO:0000818,1,0.989091335409556,0,2,nuclear MIS12/MIND complex,CC,
311,GO:0000820,1,0.965904441886318,0,5,regulation of glutamine family amino acid metabolic process,BP,
312,GO:0000821,1,0.982867935223231,0,2,regulation of arginine metabolic process,BP,
313,GO:0000822,1,0.970749928821579,0,3,inositol hexakisphosphate binding,MF,
314,GO:0000823,1,0.99526163217479,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
315,GO:0000824,1,0.99526163217479,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
316,GO:0000825,1,0.99526163217479,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
317,GO:0000827,1,0.965636118647957,0,5,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
318,GO:0000828,1,0.965636118647957,0,5,inositol hexakisphosphate kinase activity,MF,
319,GO:0000829,1,0.965636118647957,0,5,inositol heptakisphosphate kinase activity,MF,
320,GO:0000831,1,0.994071849960113,0,1,inositol hexakisphosphate 6-kinase activity,MF,
321,GO:0000832,1,0.965636118647957,0,5,inositol hexakisphosphate 5-kinase activity,MF,
322,GO:0000835,1,0.957772692942787,0,6,ER ubiquitin ligase complex,CC,
323,GO:0000836,1,0.965305977299076,0,5,Hrd1p ubiquitin ligase complex,CC,
324,GO:0000839,1,0.979625187621497,0,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,
329,GO:0000912,1,0.955819139965356,0,6,assembly of actomyosin apparatus involved in cytokinesis,BP,
330,GO:0000915,1,0.955819139965356,0,6,actomyosin contractile ring assembly,BP,
331,GO:0000916,1,0.994771634288492,0,1,actomyosin contractile ring contraction,BP,
332,GO:0000917,1,0.995191838765683,0,1,division septum assembly,BP,
333,GO:0000920,1,0.910925600851469,0,17,cell separation after cytokinesis,BP,
334,GO:0000921,1,0.917531533584858,0,13,septin ring assembly,BP,
336,GO:0000923,1,0.965540661555102,0,5,equatorial microtubule organizing center,CC,
337,GO:0000928,1,0.994054740756748,0,1,gamma-tubulin small complex, spindle pole body,CC,
338,GO:0000930,1,0.870948097889918,0,19,gamma-tubulin complex,CC,
339,GO:0000931,1,0.948277551728595,0,7,gamma-tubulin large complex,CC,
340,GO:0000932,1,0.586871634582258,0,79,P-body,CC,
341,GO:0000938,1,0.971367857519884,0,4,GARP complex,CC,
342,GO:0000939,1,0.98458765611059,0,3,condensed chromosome inner kinetochore,CC,
344,GO:0000941,1,0.994680254176584,0,1,condensed nuclear chromosome inner kinetochore,CC,
345,GO:0000942,1,0.977894714495234,0,4,condensed nuclear chromosome outer kinetochore,CC,
346,GO:0000956,1,0.325889402850099,0,200,nuclear-transcribed mRNA catabolic process,BP,
347,GO:0000957,1,0.964215882546371,0,5,mitochondrial RNA catabolic process,BP,
348,GO:0000958,1,0.979588472185268,0,3,mitochondrial mRNA catabolic process,BP,
349,GO:0000959,1,0.773489831979443,0,41,mitochondrial RNA metabolic process,BP,
350,GO:0000960,1,0.971186128411475,0,4,regulation of mitochondrial RNA catabolic process,BP,
351,GO:0000961,1,0.984310334653903,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
352,GO:0000962,1,0.986668711109556,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
353,GO:0000963,1,0.912519611377985,0,16,mitochondrial RNA processing,BP,
354,GO:0000964,1,0.977040208213766,0,4,mitochondrial RNA 5'-end processing,BP,
355,GO:0000965,1,0.971963223146603,0,5,mitochondrial RNA 3'-end processing,BP,
356,GO:0000966,1,0.886601622585398,0,21,RNA 5'-end processing,BP,
357,GO:0000967,1,0.976664689417071,0,3,rRNA 5'-end processing,BP,
358,GO:0000972,1,0.956534457441082,0,7,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
359,GO:0000973,1,0.980729656860057,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
360,GO:0000974,1,0.927797135098152,0,13,Prp19 complex,CC,
364,GO:0000979,1,0.786281490334504,0,36,RNA polymerase II core promoter sequence-specific DNA binding,MF,
365,GO:0000980,1,0.638071321506865,0,67,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,
368,GO:0000983,1,0.858108784074414,0,21,transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding,MF,
372,GO:0000990,1,0.93850572412481,0,8,transcription factor activity, core RNA polymerase binding,MF,
373,GO:0000991,1,0.986656539262814,0,2,transcription factor activity, core RNA polymerase II binding,MF,
374,GO:0000992,1,0.984242422335685,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
375,GO:0000993,1,0.83340342194982,0,28,RNA polymerase II core binding,MF,
376,GO:0000994,1,0.995281919699883,0,1,RNA polymerase III core binding,MF,
377,GO:0000995,1,0.963387192452277,0,4,transcription factor activity, core RNA polymerase III binding,MF,
378,GO:0001002,1,0.984242422335685,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
379,GO:0001003,1,0.984242422335685,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
380,GO:0001007,1,0.964519094059885,0,4,transcription factor activity, RNA polymerase III transcription factor binding,MF,
381,GO:0001010,1,0.871905833370497,0,19,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,
382,GO:0001011,1,0.988595964372473,0,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,
384,GO:0001013,1,0.945082497019919,0,8,RNA polymerase I regulatory region DNA binding,MF,
385,GO:0001016,1,0.950502139449934,0,7,RNA polymerase III regulatory region DNA binding,MF,
386,GO:0001018,1,0.988787168935591,0,2,mitochondrial promoter sequence-specific DNA binding,MF,
387,GO:0001025,1,0.964936801584914,0,3,RNA polymerase III transcription factor binding,MF,
388,GO:0001026,1,0.979397592148157,0,2,TFIIIB-type transcription factor activity,MF,
389,GO:0001030,1,0.958544699585962,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
390,GO:0001031,1,0.958544699585962,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
391,GO:0001032,1,0.969055270338599,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
392,GO:0001034,1,0.99524831386947,0,1,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
393,GO:0001042,1,0.961591394715725,0,5,RNA polymerase I core binding,MF,
394,GO:0001046,1,0.543707524875966,0,85,core promoter sequence-specific DNA binding,MF,
395,GO:0001047,1,0.372911414646449,0,139,core promoter binding,MF,
396,GO:0001054,1,0.941848988592285,0,11,RNA polymerase I activity,MF,
397,GO:0001055,1,0.944975333670417,0,11,RNA polymerase II activity,MF,
398,GO:0001056,1,0.923078970029353,0,15,RNA polymerase III activity,MF,
400,GO:0001069,1,0.983843963811246,0,2,regulatory region RNA binding,MF,
401,GO:0001074,1,0.99427126138325,0,1,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding involved in preinitiation complex assembly,MF,
402,GO:0001075,1,0.945792018268702,0,7,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,
406,GO:0001079,1,0.994811863082861,0,1,nitrogen catabolite regulation of transcription from RNA polymerase II promoter,BP,
407,GO:0001080,1,0.994811863082861,0,1,nitrogen catabolite activation of transcription from RNA polymerase II promoter,BP,
408,GO:0001083,1,0.95075178414936,0,6,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,
409,GO:0001084,1,0.99427126138325,0,1,transcription factor activity, TFIID-class binding,MF,
410,GO:0001085,1,0.387525203857043,0,138,RNA polymerase II transcription factor binding,MF,
411,GO:0001087,1,0.988595964372473,0,1,transcription factor activity, TFIIB-class binding,MF,
413,GO:0001093,1,0.974547519358921,0,3,TFIIB-class transcription factor binding,MF,
414,GO:0001094,1,0.942608016244142,0,9,TFIID-class transcription factor binding,MF,
415,GO:0001096,1,0.993126148768618,0,1,TFIIF-class transcription factor binding,MF,
416,GO:0001097,1,0.979517923819564,0,3,TFIIH-class transcription factor binding,MF,
417,GO:0001098,1,0.753762149326094,0,43,basal transcription machinery binding,MF,
418,GO:0001099,1,0.753762149326094,0,43,basal RNA polymerase II transcription machinery binding,MF,
419,GO:0001100,1,0.994054740756748,0,1,negative regulation of exit from mitosis,BP,
421,GO:0001102,1,0.723059999506044,0,47,RNA polymerase II activating transcription factor binding,MF,
422,GO:0001103,1,0.813643797229312,0,32,RNA polymerase II repressing transcription factor binding,MF,
423,GO:0001104,1,0.484610156564346,0,101,RNA polymerase II transcription cofactor activity,MF,
424,GO:0001105,1,0.721406874301318,0,43,RNA polymerase II transcription coactivator activity,MF,
425,GO:0001106,1,0.832103292729315,0,28,RNA polymerase II transcription corepressor activity,MF,
426,GO:0001112,1,0.993772065128086,0,1,DNA-templated transcriptional open complex formation,BP,
427,GO:0001113,1,0.993772065128086,0,1,transcriptional open complex formation at RNA polymerase II promoter,BP,
428,GO:0001120,1,0.993772065128086,0,1,protein-DNA complex remodeling,BP,
429,GO:0001128,1,0.995825652397013,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
430,GO:0001129,1,0.967266681087237,0,4,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,
431,GO:0001132,1,0.967266681087237,0,4,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,
432,GO:0001133,1,0.877281110769622,0,18,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,
435,GO:0001147,1,0.979618745336051,0,2,transcription termination site sequence-specific DNA binding,MF,
436,GO:0001156,1,0.964936801584914,0,3,TFIIIC-class transcription factor binding,MF,
437,GO:0001158,1,0.56346379347875,0,86,enhancer sequence-specific DNA binding,MF,
438,GO:0001160,1,0.979618745336051,0,2,transcription termination site DNA binding,MF,
439,GO:0001161,1,0.922171272892413,0,12,intronic transcription regulatory region sequence-specific DNA binding,MF,
440,GO:0001162,1,0.933399083234461,0,10,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,
441,GO:0001163,1,0.945082497019919,0,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,
442,GO:0001164,1,0.945082497019919,0,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,
443,GO:0001165,1,0.99224419731352,0,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,
444,GO:0001172,1,0.983123672693594,0,2,transcription, RNA-templated,BP,
445,GO:0001179,1,0.995176603525616,0,1,RNA polymerase I transcription factor binding,MF,
446,GO:0001181,1,0.993048305012086,0,1,transcription factor activity, core RNA polymerase I binding,MF,
447,GO:0001188,1,0.945082497019919,0,8,RNA polymerase I transcriptional preinitiation complex assembly,BP,
448,GO:0001190,1,0.619203472091539,0,64,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,
449,GO:0001191,1,0.740694674573825,0,46,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,
450,GO:0001192,1,0.996414898747953,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
451,GO:0001193,1,0.996414898747953,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
452,GO:0001205,1,0.819716913745923,0,30,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding,MF,
453,GO:0001206,1,0.919948878121129,0,10,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
454,GO:0001221,1,0.742566219536606,0,40,transcription cofactor binding,MF,
455,GO:0001222,1,0.908957398135574,0,14,transcription corepressor binding,MF,
456,GO:0001223,1,0.85131051217864,0,20,transcription coactivator binding,MF,
457,GO:0001224,1,0.973558900971354,0,3,RNA polymerase II transcription cofactor binding,MF,
458,GO:0001225,1,0.979924634673124,0,2,RNA polymerase II transcription coactivator binding,MF,
459,GO:0001226,1,0.99350517844687,0,1,RNA polymerase II transcription corepressor binding,MF,
462,GO:0001300,1,0.987337945895348,0,2,chronological cell aging,BP,
463,GO:0001302,1,0.962496214124312,0,6,replicative cell aging,BP,
464,GO:0001306,1,0.996227856480328,0,1,age-dependent response to oxidative stress,BP,
465,GO:0001315,1,0.996227856480328,0,1,age-dependent response to reactive oxygen species,BP,
466,GO:0001325,1,0.908471383177724,0,14,formation of extrachromosomal circular DNA,BP,
467,GO:0001401,1,0.988819769384975,0,2,mitochondrial sorting and assembly machinery complex,CC,
468,GO:0001405,1,0.972492950908187,0,5,presequence translocase-associated import motor,CC,
470,GO:0001502,1,0.891624917776079,0,17,cartilage condensation,BP,
474,GO:0001507,1,0.988106830533469,0,2,acetylcholine catabolic process in synaptic cleft,BP,
476,GO:0001510,1,0.713332608926611,0,57,RNA methylation,BP,
477,GO:0001512,1,0.996081283074209,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
478,GO:0001514,1,0.946775807279209,0,8,selenocysteine incorporation,BP,
479,GO:0001515,1,0.981410105055633,0,4,opioid peptide activity,MF,
480,GO:0001516,1,0.888554936210298,0,22,prostaglandin biosynthetic process,BP,
481,GO:0001517,1,0.956699860130061,0,6,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
482,GO:0001518,1,0.871235799626442,0,14,voltage-gated sodium channel complex,CC,
483,GO:0001519,1,0.993074700335626,0,1,peptide amidation,BP,
484,GO:0001520,1,0.980320996963272,0,3,outer dense fiber,CC,
485,GO:0001522,1,0.913842386938513,0,18,pseudouridine synthesis,BP,
486,GO:0001523,1,0.634730786545634,0,70,retinoid metabolic process,BP,
488,GO:0001527,1,0.921083041709616,0,10,microfibril,CC,
489,GO:0001530,1,0.883273440127791,0,23,lipopolysaccharide binding,MF,
490,GO:0001532,1,0.993528417899201,0,1,interleukin-21 receptor activity,MF,
491,GO:0001533,1,0.825621588909012,0,29,cornified envelope,CC,
492,GO:0001534,1,0.975430813902598,0,4,radial spoke,CC,
493,GO:0001536,1,0.981262994419181,0,3,radial spoke stalk,CC,
495,GO:0001539,1,0.787881487123682,0,31,cilium or flagellum-dependent cell motility,BP,
498,GO:0001542,1,0.927220882125235,0,9,ovulation from ovarian follicle,BP,
499,GO:0001543,1,0.989332167421001,0,1,ovarian follicle rupture,BP,
500,GO:0001544,1,0.989549687843132,0,1,initiation of primordial ovarian follicle growth,BP,
501,GO:0001545,1,0.992762116426303,0,1,primary ovarian follicle growth,BP,
502,GO:0001546,1,0.985090657252406,0,3,preantral ovarian follicle growth,BP,
503,GO:0001547,1,0.954745554011711,0,6,antral ovarian follicle growth,BP,
504,GO:0001550,1,0.983544589258489,0,2,ovarian cumulus expansion,BP,
505,GO:0001552,1,0.995075026513928,0,1,ovarian follicle atresia,BP,
507,GO:0001554,1,0.961147358000552,0,5,luteolysis,BP,
508,GO:0001555,1,0.983030604400516,0,3,oocyte growth,BP,
509,GO:0001556,1,0.8806898098664,0,20,oocyte maturation,BP,
511,GO:0001560,1,0.973133275488844,0,3,regulation of cell growth by extracellular stimulus,BP,
512,GO:0001561,1,0.956320889186437,0,8,fatty acid alpha-oxidation,BP,
513,GO:0001562,1,0.894693410056591,0,20,response to protozoan,BP,
514,GO:0001567,1,0.995793131798205,0,1,cholesterol 25-hydroxylase activity,MF,
517,GO:0001570,1,0.587179895408673,0,73,vasculogenesis,BP,
518,GO:0001572,1,0.992015248853713,0,1,lactosylceramide biosynthetic process,BP,
519,GO:0001573,1,0.894353445797538,0,17,ganglioside metabolic process,BP,
520,GO:0001574,1,0.935912984758343,0,10,ganglioside biosynthetic process,BP,
521,GO:0001575,1,0.990033581945558,0,2,globoside metabolic process,BP,
522,GO:0001576,1,0.994887523218437,0,1,globoside biosynthetic process,BP,
524,GO:0001579,1,0.987140035893796,0,2,medium-chain fatty acid transport,BP,
525,GO:0001580,1,0.910528858952824,0,21,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
526,GO:0001581,1,0.993740261094865,0,1,detection of chemical stimulus involved in sensory perception of sour taste,BP,
527,GO:0001582,1,0.994307000868295,0,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
528,GO:0001587,1,0.992079820991083,0,1,Gq/11-coupled serotonin receptor activity,MF,
529,GO:0001588,1,0.979982867522693,0,4,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
530,GO:0001591,1,0.984266001599692,0,3,dopamine neurotransmitter receptor activity, coupled via Gi/Go,MF,
531,GO:0001595,1,0.986775883549633,0,3,angiotensin receptor activity,MF,
532,GO:0001596,1,0.994590763027963,0,1,angiotensin type I receptor activity,MF,
533,GO:0001601,1,0.982558098343243,0,3,peptide YY receptor activity,MF,
534,GO:0001602,1,0.975674406518905,0,5,pancreatic polypeptide receptor activity,MF,
535,GO:0001604,1,0.991711174894366,0,2,urotensin II receptor activity,MF,
536,GO:0001605,1,0.984261824032797,0,3,adrenomedullin receptor activity,MF,
537,GO:0001607,1,0.988477320605621,0,2,neuromedin U receptor activity,MF,
538,GO:0001608,1,0.933950459525046,0,13,G-protein coupled nucleotide receptor activity,MF,
539,GO:0001609,1,0.968242359588553,0,6,G-protein coupled adenosine receptor activity,MF,
540,GO:0001614,1,0.899677733767652,0,20,purinergic nucleotide receptor activity,MF,
541,GO:0001618,1,0.652548864209107,0,64,virus receptor activity,MF,
542,GO:0001621,1,0.995650881288885,0,1,ADP receptor activity,MF,
543,GO:0001626,1,0.993517291526562,0,1,nociceptin receptor activity,MF,
544,GO:0001631,1,0.969410456626742,0,6,cysteinyl leukotriene receptor activity,MF,
545,GO:0001632,1,0.988951399638232,0,2,leukotriene B4 receptor activity,MF,
546,GO:0001635,1,0.9824415728478,0,3,calcitonin gene-related peptide receptor activity,MF,
547,GO:0001637,1,0.875833252411748,0,24,G-protein coupled chemoattractant receptor activity,MF,
548,GO:0001640,1,0.952005106903324,0,6,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
549,GO:0001641,1,0.986816507176328,0,2,group II metabotropic glutamate receptor activity,MF,
550,GO:0001642,1,0.976663383396855,0,3,group III metabotropic glutamate receptor activity,MF,
552,GO:0001650,1,0.434766495678342,0,127,fibrillar center,CC,
553,GO:0001651,1,0.996047689627225,0,1,dense fibrillar component,CC,
554,GO:0001652,1,0.973638092082476,0,5,granular component,CC,
558,GO:0001656,1,0.553865796757254,0,81,metanephros development,BP,
559,GO:0001657,1,0.522509200538415,0,92,ureteric bud development,BP,
560,GO:0001658,1,0.682274130526524,0,54,branching involved in ureteric bud morphogenesis,BP,
563,GO:0001661,1,0.965968388417223,0,5,conditioned taste aversion,BP,
566,GO:0001665,1,0.969238110479704,0,6,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,
568,GO:0001667,1,0.094458943748994,0,333,ameboidal-type cell migration,BP,
570,GO:0001671,1,0.864671053389839,0,26,ATPase activator activity,MF,
571,GO:0001672,1,0.930135491882737,0,9,regulation of chromatin assembly or disassembly,BP,
572,GO:0001673,1,0.933735891319344,0,11,male germ cell nucleus,CC,
573,GO:0001674,1,0.989260475676695,0,2,female germ cell nucleus,CC,
574,GO:0001675,1,0.939020594623151,0,8,acrosome assembly,BP,
575,GO:0001676,1,0.595543682514603,0,86,long-chain fatty acid metabolic process,BP,
577,GO:0001680,1,0.994652836670812,0,1,tRNA 3'-terminal CCA addition,BP,
578,GO:0001681,1,0.993978033807462,0,1,sialate O-acetylesterase activity,MF,
579,GO:0001682,1,0.941068246051369,0,12,tRNA 5'-leader removal,BP,
580,GO:0001692,1,0.985920216340287,0,3,histamine metabolic process,BP,
581,GO:0001694,1,0.994486100098361,0,1,histamine biosynthetic process,BP,
582,GO:0001695,1,0.99637530557595,0,1,histamine catabolic process,BP,
583,GO:0001696,1,0.912543102727455,0,16,gastric acid secretion,BP,
584,GO:0001697,1,0.994003256365647,0,1,histamine-induced gastric acid secretion,BP,
585,GO:0001698,1,0.99087965676575,0,2,gastrin-induced gastric acid secretion,BP,
586,GO:0001701,1,0.126456111881088,0,293,in utero embryonic development,BP,
587,GO:0001702,1,0.821326773669107,0,25,gastrulation with mouth forming second,BP,
589,GO:0001705,1,0.986138021041921,0,2,ectoderm formation,BP,
590,GO:0001706,1,0.683284839976532,0,53,endoderm formation,BP,
593,GO:0001709,1,0.782565423079259,0,37,cell fate determination,BP,
595,GO:0001711,1,0.91431979443262,0,15,endodermal cell fate commitment,BP,
596,GO:0001712,1,0.986138021041921,0,2,ectodermal cell fate commitment,BP,
597,GO:0001714,1,0.959968703630286,0,8,endodermal cell fate specification,BP,
598,GO:0001715,1,0.992962066760823,0,1,ectodermal cell fate specification,BP,
599,GO:0001716,1,0.994929875925431,0,1,L-amino-acid oxidase activity,MF,
600,GO:0001725,1,0.674570442916729,0,52,stress fiber,CC,
602,GO:0001727,1,0.965010520607941,0,5,lipid kinase activity,MF,
603,GO:0001729,1,0.986297853992372,0,2,ceramide kinase activity,MF,
604,GO:0001730,1,0.974632790035236,0,4,2'-5'-oligoadenylate synthetase activity,MF,
605,GO:0001731,1,0.947011959053779,0,8,formation of translation preinitiation complex,BP,
606,GO:0001732,1,0.986607311056453,0,2,formation of cytoplasmic translation initiation complex,BP,
607,GO:0001733,1,0.97894001257893,0,4,galactosylceramide sulfotransferase activity,MF,
608,GO:0001735,1,0.985819774932378,0,2,prenylcysteine oxidase activity,MF,
611,GO:0001739,1,0.971092570869351,0,5,sex chromatin,CC,
612,GO:0001740,1,0.978264613486571,0,3,Barr body,CC,
613,GO:0001741,1,0.929190746864569,0,12,XY body,CC,
614,GO:0001743,1,0.977288958668955,0,3,optic placode formation,BP,
615,GO:0001750,1,0.626232684522367,0,66,photoreceptor outer segment,CC,
616,GO:0001754,1,0.761858117663795,0,38,eye photoreceptor cell differentiation,BP,
617,GO:0001755,1,0.729019321536744,0,46,neural crest cell migration,BP,
619,GO:0001757,1,0.970793847604053,0,5,somite specification,BP,
620,GO:0001758,1,0.964159319385557,0,7,retinal dehydrogenase activity,MF,
621,GO:0001759,1,0.902301882516436,0,18,organ induction,BP,
624,GO:0001765,1,0.950268213013153,0,9,membrane raft assembly,BP,
625,GO:0001766,1,0.950853027759013,0,9,membrane raft polarization,BP,
626,GO:0001767,1,0.929921875296603,0,10,establishment of lymphocyte polarity,BP,
627,GO:0001768,1,0.939536171652865,0,9,establishment of T cell polarity,BP,
628,GO:0001770,1,0.989773378568246,0,1,establishment of natural killer cell polarity,BP,
629,GO:0001771,1,0.920565408701883,0,13,immunological synapse formation,BP,
630,GO:0001772,1,0.817967365022442,0,32,immunological synapse,CC,
631,GO:0001773,1,0.878061844564163,0,24,myeloid dendritic cell activation,BP,
632,GO:0001774,1,0.840771794509353,0,25,microglial cell activation,BP,
634,GO:0001776,1,0.600330131111351,0,80,leukocyte homeostasis,BP,
635,GO:0001777,1,0.986047977459084,0,3,T cell homeostatic proliferation,BP,
636,GO:0001778,1,0.959334144214082,0,5,plasma membrane repair,BP,
637,GO:0001779,1,0.896164513617534,0,17,natural killer cell differentiation,BP,
638,GO:0001780,1,0.911376918991315,0,14,neutrophil homeostasis,BP,
639,GO:0001781,1,0.956367310479166,0,7,neutrophil apoptotic process,BP,
640,GO:0001782,1,0.828093385759924,0,28,B cell homeostasis,BP,
641,GO:0001783,1,0.871995783458964,0,22,B cell apoptotic process,BP,
643,GO:0001785,1,0.98796403950403,0,2,prostaglandin J receptor activity,MF,
645,GO:0001787,1,0.959916488942427,0,7,natural killer cell proliferation,BP,
646,GO:0001788,1,0.995499946615139,0,1,antibody-dependent cellular cytotoxicity,BP,
647,GO:0001791,1,0.995342719470316,0,1,IgM binding,MF,
648,GO:0001792,1,0.992545552038055,0,1,polymeric immunoglobulin receptor activity,MF,
649,GO:0001794,1,0.984036763041629,0,3,type IIa hypersensitivity,BP,
650,GO:0001796,1,0.984036763041629,0,3,regulation of type IIa hypersensitivity,BP,
651,GO:0001797,1,0.995499946615139,0,1,negative regulation of type IIa hypersensitivity,BP,
652,GO:0001798,1,0.988485520752558,0,2,positive regulation of type IIa hypersensitivity,BP,
653,GO:0001802,1,0.991008862047412,0,2,type III hypersensitivity,BP,
654,GO:0001803,1,0.991008862047412,0,2,regulation of type III hypersensitivity,BP,
655,GO:0001805,1,0.991008862047412,0,2,positive regulation of type III hypersensitivity,BP,
656,GO:0001806,1,0.984529382480196,0,3,type IV hypersensitivity,BP,
657,GO:0001807,1,0.990737475576943,0,2,regulation of type IV hypersensitivity,BP,
658,GO:0001808,1,0.994946961735599,0,1,negative regulation of type IV hypersensitivity,BP,
659,GO:0001809,1,0.99576935168197,0,1,positive regulation of type IV hypersensitivity,BP,
660,GO:0001810,1,0.98654886222847,0,3,regulation of type I hypersensitivity,BP,
661,GO:0001811,1,0.995499946615139,0,1,negative regulation of type I hypersensitivity,BP,
662,GO:0001812,1,0.991008862047412,0,2,positive regulation of type I hypersensitivity,BP,
663,GO:0001813,1,0.995499946615139,0,1,regulation of antibody-dependent cellular cytotoxicity,BP,
664,GO:0001814,1,0.995499946615139,0,1,negative regulation of antibody-dependent cellular cytotoxicity,BP,
666,GO:0001817,1,0.0281068000709493,0,563,regulation of cytokine production,BP,
667,GO:0001818,1,0.273252176210407,0,213,negative regulation of cytokine production,BP,
668,GO:0001819,1,0.103041769128202,0,362,positive regulation of cytokine production,BP,
669,GO:0001820,1,0.946376159625063,0,10,serotonin secretion,BP,
670,GO:0001821,1,0.955036574441638,0,9,histamine secretion,BP,
672,GO:0001823,1,0.506953176756101,0,96,mesonephros development,BP,
673,GO:0001824,1,0.706600760624516,0,54,blastocyst development,BP,
674,GO:0001825,1,0.850436211835356,0,25,blastocyst formation,BP,
675,GO:0001826,1,0.953006869048211,0,6,inner cell mass cell differentiation,BP,
676,GO:0001827,1,0.983432720985165,0,2,inner cell mass cell fate commitment,BP,
677,GO:0001828,1,0.978087881440923,0,3,inner cell mass cellular morphogenesis,BP,
678,GO:0001829,1,0.926155541095803,0,12,trophectodermal cell differentiation,BP,
679,GO:0001831,1,0.985003460107642,0,2,trophectodermal cellular morphogenesis,BP,
680,GO:0001832,1,0.889961046298216,0,16,blastocyst growth,BP,
681,GO:0001833,1,0.925027199539244,0,11,inner cell mass cell proliferation,BP,
682,GO:0001834,1,0.983727089211652,0,2,trophectodermal cell proliferation,BP,
683,GO:0001835,1,0.993544641356897,0,1,blastocyst hatching,BP,
684,GO:0001836,1,0.746753944258221,0,54,release of cytochrome c from mitochondria,BP,
687,GO:0001839,1,0.961391656130447,0,6,neural plate morphogenesis,BP,
688,GO:0001840,1,0.935623562629679,0,9,neural plate development,BP,
690,GO:0001842,1,0.95609186400456,0,7,neural fold formation,BP,
692,GO:0001844,1,0.833851781126133,0,32,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
693,GO:0001845,1,0.925934175976893,0,12,phagolysosome assembly,BP,
694,GO:0001846,1,0.914689593119691,0,12,opsonin binding,MF,
695,GO:0001847,1,0.972119740392243,0,4,opsonin receptor activity,MF,
696,GO:0001848,1,0.896016854590986,0,15,complement binding,MF,
697,GO:0001849,1,0.95769656359783,0,6,complement component C1q binding,MF,
698,GO:0001850,1,0.995218495218442,0,1,complement component C3a binding,MF,
699,GO:0001851,1,0.969184840599111,0,4,complement component C3b binding,MF,
700,GO:0001855,1,0.983274962849342,0,2,complement component C4b binding,MF,
701,GO:0001856,1,0.994575918219464,0,1,complement component C5a binding,MF,
702,GO:0001861,1,0.987694060342987,0,1,complement component C4b receptor activity,MF,
703,GO:0001865,1,0.946926885142487,0,8,NK T cell differentiation,BP,
704,GO:0001866,1,0.974088755072502,0,5,NK T cell proliferation,BP,
705,GO:0001867,1,0.952964527601066,0,9,complement activation, lectin pathway,BP,
706,GO:0001868,1,0.987321668480103,0,2,regulation of complement activation, lectin pathway,BP,
707,GO:0001869,1,0.987321668480103,0,2,negative regulation of complement activation, lectin pathway,BP,
708,GO:0001871,1,0.888468306522668,0,19,pattern binding,MF,
709,GO:0001872,1,0.995082643175081,0,1,(1->3)-beta-D-glucan binding,MF,
710,GO:0001875,1,0.968575644284214,0,5,lipopolysaccharide receptor activity,MF,
711,GO:0001878,1,0.979774584422604,0,4,response to yeast,BP,
712,GO:0001880,1,0.978155536270709,0,3,Mullerian duct regression,BP,
713,GO:0001881,1,0.816821323719109,0,30,receptor recycling,BP,
716,GO:0001884,1,0.985583851178493,0,2,pyrimidine nucleoside binding,MF,
718,GO:0001886,1,0.926653104710431,0,10,endothelial cell morphogenesis,BP,
719,GO:0001887,1,0.970099283888268,0,5,selenium compound metabolic process,BP,
720,GO:0001888,1,0.98466990881886,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
722,GO:0001890,1,0.400690871820662,0,136,placenta development,BP,
723,GO:0001891,1,0.874459491400259,0,21,phagocytic cup,CC,
724,GO:0001892,1,0.571774824911402,0,81,embryonic placenta development,BP,
725,GO:0001893,1,0.81537787671351,0,30,maternal placenta development,BP,
726,GO:0001894,1,0.32225090359926,0,173,tissue homeostasis,BP,
727,GO:0001895,1,0.717675767299387,0,52,retina homeostasis,BP,
728,GO:0001897,1,0.988854263786942,0,2,cytolysis by symbiont of host cells,BP,
729,GO:0001905,1,0.974293914526312,0,3,activation of membrane attack complex,BP,
731,GO:0001907,1,0.973028979874562,0,5,killing by symbiont of host cells,BP,
732,GO:0001909,1,0.646297175907295,0,77,leukocyte mediated cytotoxicity,BP,
733,GO:0001910,1,0.745564114723962,0,52,regulation of leukocyte mediated cytotoxicity,BP,
734,GO:0001911,1,0.924624191337459,0,14,negative regulation of leukocyte mediated cytotoxicity,BP,
735,GO:0001912,1,0.832884243100995,0,32,positive regulation of leukocyte mediated cytotoxicity,BP,
736,GO:0001913,1,0.861158291642216,0,27,T cell mediated cytotoxicity,BP,
737,GO:0001914,1,0.897649472460329,0,20,regulation of T cell mediated cytotoxicity,BP,
738,GO:0001915,1,0.964001087901214,0,6,negative regulation of T cell mediated cytotoxicity,BP,
739,GO:0001916,1,0.939707272513414,0,12,positive regulation of T cell mediated cytotoxicity,BP,
741,GO:0001919,1,0.864926877045842,0,22,regulation of receptor recycling,BP,
742,GO:0001920,1,0.975950807364558,0,4,negative regulation of receptor recycling,BP,
743,GO:0001921,1,0.914267255732716,0,13,positive regulation of receptor recycling,BP,
744,GO:0001922,1,0.976585369207933,0,3,B-1 B cell homeostasis,BP,
745,GO:0001923,1,0.980577237093319,0,3,B-1 B cell differentiation,BP,
746,GO:0001927,1,0.97892671708734,0,3,exocyst assembly,BP,
747,GO:0001928,1,0.994675264672291,0,1,regulation of exocyst assembly,BP,
748,GO:0001931,1,0.919500219223605,0,13,uropod,CC,
752,GO:0001935,1,0.439879827534257,0,120,endothelial cell proliferation,BP,
753,GO:0001936,1,0.48040440898556,0,106,regulation of endothelial cell proliferation,BP,
754,GO:0001937,1,0.798981672246839,0,32,negative regulation of endothelial cell proliferation,BP,
755,GO:0001938,1,0.581552229014431,0,78,positive regulation of endothelial cell proliferation,BP,
756,GO:0001939,1,0.959466133048701,0,6,female pronucleus,CC,
757,GO:0001940,1,0.959271234805883,0,5,male pronucleus,CC,
758,GO:0001941,1,0.77345206225913,0,35,postsynaptic membrane organization,BP,
759,GO:0001942,1,0.568610822601984,0,81,hair follicle development,BP,
761,GO:0001945,1,0.828728706501793,0,24,lymph vessel development,BP,
762,GO:0001946,1,0.891194905419547,0,15,lymphangiogenesis,BP,
763,GO:0001947,1,0.686369938574337,0,55,heart looping,BP,
764,GO:0001949,1,0.99446653393058,0,1,sebaceous gland cell differentiation,BP,
765,GO:0001951,1,0.972999342467419,0,4,intestinal D-glucose absorption,BP,
766,GO:0001952,1,0.475493965479034,0,98,regulation of cell-matrix adhesion,BP,
767,GO:0001953,1,0.791814217452225,0,31,negative regulation of cell-matrix adhesion,BP,
768,GO:0001954,1,0.717328531638216,0,45,positive regulation of cell-matrix adhesion,BP,
769,GO:0001955,1,0.94607170940097,0,8,blood vessel maturation,BP,
770,GO:0001956,1,0.90985126061181,0,13,positive regulation of neurotransmitter secretion,BP,
771,GO:0001957,1,0.957851321903658,0,6,intramembranous ossification,BP,
772,GO:0001958,1,0.841813195440255,0,25,endochondral ossification,BP,
773,GO:0001959,1,0.402100393544467,0,143,regulation of cytokine-mediated signaling pathway,BP,
774,GO:0001960,1,0.760691941917788,0,44,negative regulation of cytokine-mediated signaling pathway,BP,
775,GO:0001961,1,0.75602132779182,0,44,positive regulation of cytokine-mediated signaling pathway,BP,
776,GO:0001963,1,0.862170991120158,0,26,synaptic transmission, dopaminergic,BP,
779,GO:0001966,1,0.995808144242034,0,1,thigmotaxis,BP,
780,GO:0001967,1,0.926790472671761,0,11,suckling behavior,BP,
782,GO:0001969,1,0.974293914526312,0,3,regulation of activation of membrane attack complex,BP,
783,GO:0001970,1,0.984908049971767,0,2,positive regulation of activation of membrane attack complex,BP,
784,GO:0001971,1,0.989224865396287,0,1,negative regulation of activation of membrane attack complex,BP,
785,GO:0001972,1,0.923555746382474,0,12,retinoic acid binding,MF,
786,GO:0001973,1,0.93236305436165,0,12,adenosine receptor signaling pathway,BP,
787,GO:0001974,1,0.754478061214888,0,39,blood vessel remodeling,BP,
788,GO:0001975,1,0.845581421339161,0,24,response to amphetamine,BP,
789,GO:0001976,1,0.931551794433818,0,11,neurological system process involved in regulation of systemic arterial blood pressure,BP,
790,GO:0001977,1,0.932665003817554,0,12,renal system process involved in regulation of blood volume,BP,
791,GO:0001978,1,0.994769750931191,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
792,GO:0001979,1,0.995381299247171,0,1,regulation of systemic arterial blood pressure by chemoreceptor signaling,BP,
793,GO:0001980,1,0.99645199690118,0,1,regulation of systemic arterial blood pressure by ischemic conditions,BP,
794,GO:0001983,1,0.994769750931191,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
795,GO:0001985,1,0.994769750931191,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
796,GO:0001990,1,0.836902270355508,0,30,regulation of systemic arterial blood pressure by hormone,BP,
797,GO:0001991,1,0.917970157404282,0,14,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,
798,GO:0001992,1,0.975378756453969,0,4,regulation of systemic arterial blood pressure by vasopressin,BP,
799,GO:0001993,1,0.946639171869589,0,9,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
800,GO:0001994,1,0.978349115361685,0,4,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
801,GO:0001996,1,0.973052523899248,0,4,positive regulation of heart rate by epinephrine-norepinephrine,BP,
802,GO:0001997,1,0.988764538713357,0,2,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
803,GO:0001998,1,0.995102956696936,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
804,GO:0001999,1,0.974656795151472,0,4,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,
805,GO:0002001,1,0.974656795151472,0,4,renin secretion into blood stream,BP,
806,GO:0002002,1,0.941854024865454,0,10,regulation of angiotensin levels in blood,BP,
807,GO:0002003,1,0.941854024865454,0,10,angiotensin maturation,BP,
808,GO:0002007,1,0.995381299247171,0,1,detection of hypoxic conditions in blood by chemoreceptor signaling,BP,
810,GO:0002011,1,0.677977273578388,0,50,morphogenesis of an epithelial sheet,BP,
811,GO:0002016,1,0.966241492112679,0,6,regulation of blood volume by renin-angiotensin,BP,
812,GO:0002017,1,0.995152478346503,0,1,regulation of blood volume by renal aldosterone,BP,
813,GO:0002018,1,0.988904527411017,0,2,renin-angiotensin regulation of aldosterone production,BP,
814,GO:0002019,1,0.984434708636611,0,3,regulation of renal output by angiotensin,BP,
817,GO:0002023,1,0.994920388122017,0,1,reduction of food intake in response to dietary excess,BP,
818,GO:0002024,1,0.952487360490114,0,8,diet induced thermogenesis,BP,
819,GO:0002025,1,0.983220158997822,0,3,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
821,GO:0002027,1,0.539951945105509,0,86,regulation of heart rate,BP,
824,GO:0002030,1,0.993910437466855,0,1,inhibitory G-protein coupled receptor phosphorylation,BP,
826,GO:0002032,1,0.990098401564583,0,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,
827,GO:0002034,1,0.978809516658908,0,4,regulation of blood vessel diameter by renin-angiotensin,BP,
828,GO:0002035,1,0.981218416934805,0,3,brain renin-angiotensin system,BP,
829,GO:0002036,1,0.965181297663688,0,5,regulation of L-glutamate import across plasma membrane,BP,
830,GO:0002037,1,0.994843354294139,0,1,negative regulation of L-glutamate import across plasma membrane,BP,
831,GO:0002038,1,0.994666537808309,0,1,positive regulation of L-glutamate import across plasma membrane,BP,
833,GO:0002040,1,0.51118306679924,0,94,sprouting angiogenesis,BP,
834,GO:0002041,1,0.994634178655006,0,1,intussusceptive angiogenesis,BP,
835,GO:0002042,1,0.730038808523297,0,45,cell migration involved in sprouting angiogenesis,BP,
836,GO:0002043,1,0.902591135362933,0,15,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
837,GO:0002046,1,0.996287373512551,0,1,opsin binding,MF,
838,GO:0002051,1,0.964556386827757,0,4,osteoblast fate commitment,BP,
840,GO:0002053,1,0.831342647077953,0,27,positive regulation of mesenchymal cell proliferation,BP,
841,GO:0002054,1,0.980066595879956,0,4,nucleobase binding,MF,
842,GO:0002055,1,0.996580460939613,0,1,adenine binding,MF,
843,GO:0002058,1,0.994839572655344,0,1,uracil binding,MF,
844,GO:0002059,1,0.994839572655344,0,1,thymine binding,MF,
845,GO:0002060,1,0.985151164469935,0,3,purine nucleobase binding,MF,
846,GO:0002061,1,0.994839572655344,0,1,pyrimidine nucleobase binding,MF,
850,GO:0002065,1,0.514786876428526,0,99,columnar/cuboidal epithelial cell differentiation,BP,
851,GO:0002066,1,0.702817822034335,0,51,columnar/cuboidal epithelial cell development,BP,
852,GO:0002067,1,0.751842537334393,0,43,glandular epithelial cell differentiation,BP,
853,GO:0002068,1,0.851728576905917,0,23,glandular epithelial cell development,BP,
854,GO:0002069,1,0.969111765186624,0,6,columnar/cuboidal epithelial cell maturation,BP,
855,GO:0002070,1,0.905107677946815,0,15,epithelial cell maturation,BP,
856,GO:0002071,1,0.989811291721259,0,2,glandular epithelial cell maturation,BP,
857,GO:0002072,1,0.933811114411226,0,8,optic cup morphogenesis involved in camera-type eye development,BP,
858,GO:0002074,1,0.961833611105088,0,5,extraocular skeletal muscle development,BP,
859,GO:0002076,1,0.886521595571884,0,17,osteoblast development,BP,
860,GO:0002077,1,0.995796885383885,0,1,acrosome matrix dispersal,BP,
861,GO:0002079,1,0.973432835318753,0,4,inner acrosomal membrane,CC,
862,GO:0002080,1,0.895708402670797,0,18,acrosomal membrane,CC,
863,GO:0002081,1,0.982936826557504,0,2,outer acrosomal membrane,CC,
864,GO:0002082,1,0.913954979350114,0,15,regulation of oxidative phosphorylation,BP,
865,GO:0002083,1,0.995455182597529,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
866,GO:0002084,1,0.949581491980244,0,9,protein depalmitoylation,BP,
867,GO:0002085,1,0.972041766177353,0,4,inhibition of neuroepithelial cell differentiation,BP,
868,GO:0002086,1,0.989849663105433,0,2,diaphragm contraction,BP,
869,GO:0002087,1,0.921532412434551,0,12,regulation of respiratory gaseous exchange by neurological system process,BP,
871,GO:0002089,1,0.879102968786407,0,16,lens morphogenesis in camera-type eye,BP,
872,GO:0002090,1,0.79518542618346,0,35,regulation of receptor internalization,BP,
873,GO:0002091,1,0.943703773471904,0,9,negative regulation of receptor internalization,BP,
874,GO:0002092,1,0.860153703094085,0,22,positive regulation of receptor internalization,BP,
875,GO:0002093,1,0.918633706401278,0,12,auditory receptor cell morphogenesis,BP,
876,GO:0002094,1,0.98898005347698,0,2,polyprenyltransferase activity,MF,
877,GO:0002097,1,0.911429084884801,0,16,tRNA wobble base modification,BP,
878,GO:0002098,1,0.936076149557204,0,12,tRNA wobble uridine modification,BP,
879,GO:0002100,1,0.990587302290689,0,1,tRNA wobble adenosine to inosine editing,BP,
880,GO:0002101,1,0.982940872098853,0,3,tRNA wobble cytosine modification,BP,
881,GO:0002102,1,0.796067419958941,0,32,podosome,CC,
882,GO:0002113,1,0.994640394684361,0,1,interleukin-33 binding,MF,
883,GO:0002114,1,0.987675525951149,0,2,interleukin-33 receptor activity,MF,
884,GO:0002115,1,0.899618214710932,0,16,store-operated calcium entry,BP,
885,GO:0002116,1,0.899977557036125,0,11,semaphorin receptor complex,CC,
886,GO:0002118,1,0.958612893317859,0,7,aggressive behavior,BP,
887,GO:0002121,1,0.987038617639666,0,2,inter-male aggressive behavior,BP,
888,GO:0002125,1,0.987909245632342,0,2,maternal aggressive behavior,BP,
889,GO:0002127,1,0.995712978464286,0,1,tRNA wobble base cytosine methylation,BP,
890,GO:0002133,1,0.975516730735154,0,2,polycystin complex,CC,
891,GO:0002134,1,0.985583851178493,0,2,UTP binding,MF,
892,GO:0002135,1,0.994323749019896,0,1,CTP binding,MF,
893,GO:0002138,1,0.957140333670552,0,8,retinoic acid biosynthetic process,BP,
894,GO:0002139,1,0.963844520094769,0,4,stereocilia coupling link,CC,
895,GO:0002140,1,0.989495416816709,0,1,stereocilia tip link,CC,
896,GO:0002141,1,0.974079514297404,0,3,stereocilia ankle link,CC,
897,GO:0002142,1,0.974079514297404,0,3,stereocilia ankle link complex,CC,
898,GO:0002143,1,0.979873026260293,0,4,tRNA wobble position uridine thiolation,BP,
899,GO:0002144,1,0.994868582831931,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
900,GO:0002148,1,0.993574169836367,0,1,hypochlorous acid metabolic process,BP,
901,GO:0002149,1,0.993574169836367,0,1,hypochlorous acid biosynthetic process,BP,
902,GO:0002151,1,0.947063632978186,0,6,G-quadruplex RNA binding,MF,
903,GO:0002152,1,0.993370035430556,0,1,bile acid conjugation,BP,
904,GO:0002153,1,0.994474477197674,0,1,steroid receptor RNA activator RNA binding,MF,
905,GO:0002154,1,0.958076837260232,0,5,thyroid hormone mediated signaling pathway,BP,
906,GO:0002155,1,0.979335413261886,0,3,regulation of thyroid hormone mediated signaling pathway,BP,
907,GO:0002158,1,0.97031293894764,0,5,osteoclast proliferation,BP,
908,GO:0002159,1,0.96843795063234,0,4,desmosome assembly,BP,
909,GO:0002161,1,0.930993052980634,0,11,aminoacyl-tRNA editing activity,MF,
910,GO:0002162,1,0.930059222002494,0,8,dystroglycan binding,MF,
911,GO:0002169,1,0.987479442583646,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
912,GO:0002174,1,0.993875418370528,0,1,mammary stem cell proliferation,BP,
913,GO:0002175,1,0.96513295386765,0,4,protein localization to paranode region of axon,BP,
914,GO:0002176,1,0.971504548215394,0,6,male germ cell proliferation,BP,
915,GO:0002177,1,0.964344115758718,0,7,manchette,CC,
916,GO:0002178,1,0.936227181054825,0,11,palmitoyltransferase complex,CC,
917,GO:0002181,1,0.649982884642223,0,84,cytoplasmic translation,BP,
918,GO:0002182,1,0.937207522414745,0,10,cytoplasmic translational elongation,BP,
919,GO:0002183,1,0.890161116218472,0,18,cytoplasmic translational initiation,BP,
920,GO:0002184,1,0.983749984390947,0,2,cytoplasmic translational termination,BP,
921,GO:0002188,1,0.972854741105794,0,3,translation reinitiation,BP,
922,GO:0002189,1,0.994332739031476,0,1,ribose phosphate diphosphokinase complex,CC,
923,GO:0002190,1,0.976271801783089,0,5,cap-independent translational initiation,BP,
924,GO:0002191,1,0.981870085509503,0,3,cap-dependent translational initiation,BP,
925,GO:0002192,1,0.991903394914749,0,2,IRES-dependent translational initiation of linear mRNA,BP,
926,GO:0002193,1,0.97358423394113,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
927,GO:0002194,1,0.993732872242499,0,1,hepatocyte cell migration,BP,
928,GO:0002196,1,0.995128986768719,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
929,GO:0002199,1,0.957811008966471,0,8,zona pellucida receptor complex,CC,
930,GO:0002200,1,0.670914690250853,0,57,somatic diversification of immune receptors,BP,
931,GO:0002204,1,0.775852756550749,0,39,somatic recombination of immunoglobulin genes involved in immune response,BP,
932,GO:0002208,1,0.775852756550749,0,39,somatic diversification of immunoglobulins involved in immune response,BP,
934,GO:0002215,1,0.989763703279535,0,2,defense response to nematode,BP,
935,GO:0002218,1,0.182251709848545,0,265,activation of innate immune response,BP,
936,GO:0002220,1,0.51705940335799,0,110,innate immune response activating cell surface receptor signaling pathway,BP,
937,GO:0002221,1,0.349459682520468,0,161,pattern recognition receptor signaling pathway,BP,
938,GO:0002223,1,0.524314817650367,0,107,stimulatory C-type lectin receptor signaling pathway,BP,
939,GO:0002224,1,0.450958622589855,0,125,toll-like receptor signaling pathway,BP,
940,GO:0002225,1,0.990836581822905,0,2,positive regulation of antimicrobial peptide production,BP,
941,GO:0002227,1,0.94246344580896,0,15,innate immune response in mucosa,BP,
942,GO:0002228,1,0.73749090445174,0,52,natural killer cell mediated immunity,BP,
943,GO:0002230,1,0.87374518107817,0,21,positive regulation of defense response to virus by host,BP,
944,GO:0002232,1,0.990176761253477,0,2,leukocyte chemotaxis involved in inflammatory response,BP,
946,GO:0002238,1,0.986074064725305,0,2,response to molecule of fungal origin,BP,
948,GO:0002246,1,0.966317003146206,0,6,wound healing involved in inflammatory response,BP,
949,GO:0002248,1,0.970618306451804,0,5,connective tissue replacement involved in inflammatory response wound healing,BP,
950,GO:0002249,1,0.968175792466643,0,5,lymphocyte anergy,BP,
951,GO:0002250,1,0.147768689876676,0,311,adaptive immune response,BP,
952,GO:0002251,1,0.902437534252526,0,23,organ or tissue specific immune response,BP,
954,GO:0002253,1,0.0396245247372542,0,509,activation of immune response,BP,
955,GO:0002254,1,0.984460232399154,0,3,kinin cascade,BP,
956,GO:0002260,1,0.684081267225775,0,60,lymphocyte homeostasis,BP,
957,GO:0002262,1,0.423083818773576,0,133,myeloid cell homeostasis,BP,
959,GO:0002265,1,0.967398445220073,0,3,astrocyte activation involved in immune response,BP,
960,GO:0002266,1,0.984484219551523,0,3,follicular dendritic cell activation,BP,
961,GO:0002268,1,0.988934979734212,0,2,follicular dendritic cell differentiation,BP,
964,GO:0002276,1,0.987530947336964,0,2,basophil activation involved in immune response,BP,
965,GO:0002277,1,0.982178772114954,0,3,myeloid dendritic cell activation involved in immune response,BP,
966,GO:0002278,1,0.979053507927434,0,4,eosinophil activation involved in immune response,BP,
968,GO:0002281,1,0.945091406704285,0,9,macrophage activation involved in immune response,BP,
969,GO:0002282,1,0.987857799511252,0,2,microglial cell activation involved in immune response,BP,
971,GO:0002285,1,0.423958290133151,0,132,lymphocyte activation involved in immune response,BP,
972,GO:0002286,1,0.629155729103597,0,73,T cell activation involved in immune response,BP,
974,GO:0002290,1,0.993954635307716,0,1,gamma-delta T cell activation involved in immune response,BP,
975,GO:0002291,1,0.955867541413117,0,8,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
976,GO:0002292,1,0.70169941110865,0,55,T cell differentiation involved in immune response,BP,
978,GO:0002294,1,0.72861184565217,0,49,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,
979,GO:0002295,1,0.923277998420908,0,13,T-helper cell lineage commitment,BP,
980,GO:0002296,1,0.98286876858552,0,2,T-helper 1 cell lineage commitment,BP,
981,GO:0002298,1,0.995416049171629,0,1,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
982,GO:0002299,1,0.995555356305338,0,1,alpha-beta intraepithelial T cell differentiation,BP,
983,GO:0002300,1,0.995555356305338,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
984,GO:0002302,1,0.994100510744414,0,1,CD8-positive, alpha-beta T cell differentiation involved in immune response,BP,
985,GO:0002304,1,0.995555356305338,0,1,gamma-delta intraepithelial T cell differentiation,BP,
986,GO:0002305,1,0.995555356305338,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
987,GO:0002309,1,0.980084735985372,0,4,T cell proliferation involved in immune response,BP,
988,GO:0002312,1,0.669845155213575,0,61,B cell activation involved in immune response,BP,
989,GO:0002313,1,0.895509106638029,0,17,mature B cell differentiation involved in immune response,BP,
990,GO:0002314,1,0.98330706039071,0,3,germinal center B cell differentiation,BP,
991,GO:0002315,1,0.931431266643102,0,9,marginal zone B cell differentiation,BP,
992,GO:0002316,1,0.988089379553177,0,2,follicular B cell differentiation,BP,
993,GO:0002317,1,0.987400285210661,0,3,plasma cell differentiation,BP,
994,GO:0002318,1,0.966713468299327,0,5,myeloid progenitor cell differentiation,BP,
995,GO:0002320,1,0.875884899357683,0,18,lymphoid progenitor cell differentiation,BP,
996,GO:0002322,1,0.964508499223779,0,5,B cell proliferation involved in immune response,BP,
997,GO:0002323,1,0.95331147186129,0,8,natural killer cell activation involved in immune response,BP,
998,GO:0002325,1,0.991775635780122,0,2,natural killer cell differentiation involved in immune response,BP,
999,GO:0002326,1,0.969910320546518,0,3,B cell lineage commitment,BP,
1000,GO:0002327,1,0.934614293452525,0,7,immature B cell differentiation,BP,
1001,GO:0002328,1,0.917207579098321,0,10,pro-B cell differentiation,BP,
1002,GO:0002329,1,0.960217874048703,0,4,pre-B cell differentiation,BP,
1003,GO:0002331,1,0.976537000036277,0,2,pre-B cell allelic exclusion,BP,
1004,GO:0002332,1,0.991196258237097,0,1,transitional stage B cell differentiation,BP,
1005,GO:0002333,1,0.991196258237097,0,1,transitional one stage B cell differentiation,BP,
1006,GO:0002335,1,0.871352809990997,0,21,mature B cell differentiation,BP,
1007,GO:0002337,1,0.988676382185005,0,2,B-1a B cell differentiation,BP,
1008,GO:0002339,1,0.985544883862253,0,3,B cell selection,BP,
1009,GO:0002343,1,0.994228653570667,0,1,peripheral B cell selection,BP,
1010,GO:0002344,1,0.994228653570667,0,1,B cell affinity maturation,BP,
1011,GO:0002347,1,0.909305908472245,0,17,response to tumor cell,BP,
1012,GO:0002349,1,0.970401542757949,0,6,histamine production involved in inflammatory response,BP,
1013,GO:0002351,1,0.982606199990249,0,3,serotonin production involved in inflammatory response,BP,
1014,GO:0002352,1,0.991266331652653,0,2,B cell negative selection,BP,
1015,GO:0002353,1,0.984460232399154,0,3,plasma kallikrein-kinin cascade,BP,
1016,GO:0002355,1,0.994468977205759,0,1,detection of tumor cell,BP,
1017,GO:0002357,1,0.98257815097537,0,3,defense response to tumor cell,BP,
1018,GO:0002358,1,0.996491547285932,0,1,B cell homeostatic proliferation,BP,
1019,GO:0002360,1,0.868689688774888,0,21,T cell lineage commitment,BP,
1020,GO:0002361,1,0.978883523661288,0,4,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
1021,GO:0002362,1,0.99457962741388,0,1,CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment,BP,
1022,GO:0002363,1,0.907332338641718,0,16,alpha-beta T cell lineage commitment,BP,
1025,GO:0002368,1,0.988862637326811,0,2,B cell cytokine production,BP,
1026,GO:0002369,1,0.840619570190982,0,30,T cell cytokine production,BP,
1027,GO:0002370,1,0.986621204565993,0,2,natural killer cell cytokine production,BP,
1028,GO:0002371,1,0.957411495040134,0,6,dendritic cell cytokine production,BP,
1029,GO:0002373,1,0.996333212205767,0,1,plasmacytoid dendritic cell cytokine production,BP,
1030,GO:0002374,1,0.90400106592111,0,16,cytokine secretion involved in immune response,BP,
1032,GO:0002377,1,0.586699807843031,0,86,immunoglobulin production,BP,
1033,GO:0002378,1,0.978358861759365,0,3,immunoglobulin biosynthetic process,BP,
1034,GO:0002380,1,0.992329984975921,0,1,immunoglobulin secretion involved in immune response,BP,
1035,GO:0002381,1,0.755261707014095,0,44,immunoglobulin production involved in immunoglobulin mediated immune response,BP,
1036,GO:0002384,1,0.988745850446191,0,2,hepatic immune response,BP,
1037,GO:0002385,1,0.912718853869711,0,21,mucosal immune response,BP,
1038,GO:0002386,1,0.987678975507972,0,2,immune response in mucosal-associated lymphoid tissue,BP,
1039,GO:0002396,1,0.979221924545194,0,5,MHC protein complex assembly,BP,
1040,GO:0002397,1,0.995108035511957,0,1,MHC class I protein complex assembly,BP,
1041,GO:0002399,1,0.984036579408116,0,4,MHC class II protein complex assembly,BP,
1042,GO:0002407,1,0.878264082244094,0,22,dendritic cell chemotaxis,BP,
1043,GO:0002408,1,0.979336570791013,0,4,myeloid dendritic cell chemotaxis,BP,
1044,GO:0002414,1,0.983037848513985,0,3,immunoglobulin transcytosis in epithelial cells,BP,
1045,GO:0002415,1,0.987678975507972,0,2,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
1046,GO:0002416,1,0.99530156398722,0,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,
1047,GO:0002418,1,0.92378083939423,0,14,immune response to tumor cell,BP,
1048,GO:0002420,1,0.950076942944067,0,9,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1049,GO:0002423,1,0.950076942944067,0,9,natural killer cell mediated immune response to tumor cell,BP,
1050,GO:0002424,1,0.988010079938717,0,2,T cell mediated immune response to tumor cell,BP,
1051,GO:0002426,1,0.995982929342318,0,1,immunoglobulin production in mucosal tissue,BP,
1052,GO:0002428,1,0.98454695195946,0,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
1053,GO:0002429,1,0.137953664358049,0,321,immune response-activating cell surface receptor signaling pathway,BP,
1054,GO:0002430,1,0.952297097096993,0,8,complement receptor mediated signaling pathway,BP,
1055,GO:0002431,1,0.614009809709424,0,75,Fc receptor mediated stimulatory signaling pathway,BP,
1056,GO:0002432,1,0.992411558380291,0,1,granuloma formation,BP,
1057,GO:0002433,1,0.63182517299832,0,70,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,
1058,GO:0002434,1,0.98990286145183,0,2,immune complex clearance,BP,
1059,GO:0002436,1,0.98990286145183,0,2,immune complex clearance by monocytes and macrophages,BP,
1062,GO:0002439,1,0.981387699872637,0,4,chronic inflammatory response to antigenic stimulus,BP,
1064,GO:0002441,1,0.970401542757949,0,6,histamine secretion involved in inflammatory response,BP,
1065,GO:0002442,1,0.982606199990249,0,3,serotonin secretion involved in inflammatory response,BP,
1068,GO:0002445,1,0.984036763041629,0,3,type II hypersensitivity,BP,
1070,GO:0002447,1,0.979053507927434,0,4,eosinophil mediated immunity,BP,
1072,GO:0002449,1,0.30998394828359,0,194,lymphocyte mediated immunity,BP,
1073,GO:0002450,1,0.995499946615139,0,1,B cell antigen processing and presentation,BP,
1074,GO:0002455,1,0.808564528651366,0,37,humoral immune response mediated by circulating immunoglobulin,BP,
1075,GO:0002456,1,0.645896976418632,0,74,T cell mediated immunity,BP,
1076,GO:0002457,1,0.96932591127669,0,5,T cell antigen processing and presentation,BP,
1077,GO:0002458,1,0.989462566946125,0,2,peripheral T cell tolerance induction,BP,
1078,GO:0002460,1,0.291613948554806,0,200,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1079,GO:0002461,1,0.984114658852911,0,3,tolerance induction dependent upon immune response,BP,
1080,GO:0002465,1,0.989462566946125,0,2,peripheral tolerance induction,BP,
1081,GO:0002467,1,0.903943573668946,0,15,germinal center formation,BP,
1082,GO:0002468,1,0.949019033326893,0,9,dendritic cell antigen processing and presentation,BP,
1083,GO:0002474,1,0.62770478223615,0,88,antigen processing and presentation of peptide antigen via MHC class I,BP,
1084,GO:0002475,1,0.95245808260035,0,8,antigen processing and presentation via MHC class Ib,BP,
1085,GO:0002476,1,0.988228564810821,0,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
1086,GO:0002477,1,0.996274978924817,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1088,GO:0002479,1,0.712224651969425,0,69,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,
1089,GO:0002480,1,0.962890402139275,0,8,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,
1090,GO:0002481,1,0.996274978924817,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
1091,GO:0002483,1,0.950605617405057,0,8,antigen processing and presentation of endogenous peptide antigen,BP,
1092,GO:0002488,1,0.992788570226548,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1093,GO:0002489,1,0.992788570226548,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
1095,GO:0002501,1,0.983072527106316,0,4,peptide antigen assembly with MHC protein complex,BP,
1096,GO:0002502,1,0.995108035511957,0,1,peptide antigen assembly with MHC class I protein complex,BP,
1097,GO:0002503,1,0.9879059220312,0,3,peptide antigen assembly with MHC class II protein complex,BP,
1099,GO:0002505,1,0.99204501794397,0,2,antigen processing and presentation of polysaccharide antigen via MHC class II,BP,
1100,GO:0002506,1,0.99204501794397,0,2,polysaccharide assembly with MHC class II protein complex,BP,
1101,GO:0002507,1,0.86740545544643,0,23,tolerance induction,BP,
1102,GO:0002508,1,0.98910049069112,0,2,central tolerance induction,BP,
1103,GO:0002509,1,0.994855334100235,0,1,central tolerance induction to self antigen,BP,
1104,GO:0002510,1,0.994215697574978,0,1,central B cell tolerance induction,BP,
1105,GO:0002513,1,0.970434059454081,0,5,tolerance induction to self antigen,BP,
1106,GO:0002514,1,0.986425646009945,0,2,B cell tolerance induction,BP,
1107,GO:0002517,1,0.92985973139051,0,12,T cell tolerance induction,BP,
1108,GO:0002518,1,0.996006601352857,0,1,lymphocyte chemotaxis across high endothelial venule,BP,
1109,GO:0002519,1,0.990036288707098,0,2,natural killer cell tolerance induction,BP,
1112,GO:0002522,1,0.989313769375925,0,2,leukocyte migration involved in immune response,BP,
1113,GO:0002523,1,0.942369580959695,0,11,leukocyte migration involved in inflammatory response,BP,
1114,GO:0002524,1,0.958194087155888,0,8,hypersensitivity,BP,
1115,GO:0002525,1,0.984073599525335,0,3,acute inflammatory response to non-antigenic stimulus,BP,
1117,GO:0002528,1,0.982806755526364,0,2,regulation of vascular permeability involved in acute inflammatory response,BP,
1118,GO:0002532,1,0.75015254734362,0,47,production of molecular mediator involved in inflammatory response,BP,
1120,GO:0002536,1,0.986412538835939,0,3,respiratory burst involved in inflammatory response,BP,
1121,GO:0002537,1,0.980597960913957,0,2,nitric oxide production involved in inflammatory response,BP,
1122,GO:0002538,1,0.987978665235368,0,2,arachidonic acid metabolite production involved in inflammatory response,BP,
1123,GO:0002540,1,0.987978665235368,0,2,leukotriene production involved in inflammatory response,BP,
1124,GO:0002541,1,0.984245682711258,0,3,activation of plasma proteins involved in acute inflammatory response,BP,
1125,GO:0002542,1,0.989631201676056,0,2,Factor XII activation,BP,
1126,GO:0002543,1,0.98664753050633,0,2,activation of blood coagulation via clotting cascade,BP,
1127,GO:0002544,1,0.907684328711027,0,17,chronic inflammatory response,BP,
1128,GO:0002545,1,0.995149938738083,0,1,chronic inflammatory response to non-antigenic stimulus,BP,
1129,GO:0002548,1,0.815060885143978,0,40,monocyte chemotaxis,BP,
1131,GO:0002553,1,0.970401542757949,0,6,histamine secretion by mast cell,BP,
1132,GO:0002554,1,0.982606199990249,0,3,serotonin secretion by platelet,BP,
1133,GO:0002560,1,0.992633084128786,0,1,basophil mediated immunity,BP,
1134,GO:0002561,1,0.992633084128786,0,1,basophil degranulation,BP,
1135,GO:0002562,1,0.70128687437427,0,51,somatic diversification of immune receptors via germline recombination within a single locus,BP,
1136,GO:0002566,1,0.922807106788218,0,12,somatic diversification of immune receptors via somatic mutation,BP,
1137,GO:0002568,1,0.954166822631863,0,5,somatic diversification of T cell receptor genes,BP,
1138,GO:0002572,1,0.986618325703877,0,2,pro-T cell differentiation,BP,
1141,GO:0002577,1,0.912675709092884,0,17,regulation of antigen processing and presentation,BP,
1142,GO:0002578,1,0.960486833178295,0,7,negative regulation of antigen processing and presentation,BP,
1143,GO:0002579,1,0.954817855597391,0,9,positive regulation of antigen processing and presentation,BP,
1144,GO:0002580,1,0.972999648144008,0,5,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1145,GO:0002581,1,0.980260521074877,0,3,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1146,GO:0002582,1,0.992594404322031,0,2,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1147,GO:0002583,1,0.972306902800672,0,6,regulation of antigen processing and presentation of peptide antigen,BP,
1148,GO:0002584,1,0.979562660051872,0,4,negative regulation of antigen processing and presentation of peptide antigen,BP,
1149,GO:0002585,1,0.992594404322031,0,2,positive regulation of antigen processing and presentation of peptide antigen,BP,
1150,GO:0002586,1,0.981809488155619,0,4,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1151,GO:0002587,1,0.989135432875502,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1152,GO:0002588,1,0.992594404322031,0,2,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1153,GO:0002589,1,0.99032314512091,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1154,GO:0002590,1,0.99032314512091,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1155,GO:0002604,1,0.949019033326893,0,9,regulation of dendritic cell antigen processing and presentation,BP,
1156,GO:0002605,1,0.986568505437881,0,2,negative regulation of dendritic cell antigen processing and presentation,BP,
1157,GO:0002606,1,0.961944416859286,0,7,positive regulation of dendritic cell antigen processing and presentation,BP,
1158,GO:0002622,1,0.995499946615139,0,1,regulation of B cell antigen processing and presentation,BP,
1159,GO:0002625,1,0.990301675379496,0,2,regulation of T cell antigen processing and presentation,BP,
1160,GO:0002626,1,0.995068679758576,0,1,negative regulation of T cell antigen processing and presentation,BP,
1161,GO:0002634,1,0.93997751696583,0,9,regulation of germinal center formation,BP,
1162,GO:0002635,1,0.980510271030429,0,2,negative regulation of germinal center formation,BP,
1163,GO:0002636,1,0.98801212826035,0,3,positive regulation of germinal center formation,BP,
1164,GO:0002637,1,0.730278923492816,0,52,regulation of immunoglobulin production,BP,
1165,GO:0002638,1,0.934906605027539,0,10,negative regulation of immunoglobulin production,BP,
1166,GO:0002639,1,0.819819643574597,0,34,positive regulation of immunoglobulin production,BP,
1167,GO:0002640,1,0.994054740756748,0,1,regulation of immunoglobulin biosynthetic process,BP,
1168,GO:0002642,1,0.994054740756748,0,1,positive regulation of immunoglobulin biosynthetic process,BP,
1169,GO:0002643,1,0.902228466747811,0,16,regulation of tolerance induction,BP,
1170,GO:0002644,1,0.994859749441091,0,1,negative regulation of tolerance induction,BP,
1171,GO:0002645,1,0.94215533611773,0,9,positive regulation of tolerance induction,BP,
1172,GO:0002646,1,0.994215697574978,0,1,regulation of central tolerance induction,BP,
1173,GO:0002648,1,0.994215697574978,0,1,positive regulation of central tolerance induction,BP,
1174,GO:0002649,1,0.992165083474084,0,1,regulation of tolerance induction to self antigen,BP,
1175,GO:0002651,1,0.992165083474084,0,1,positive regulation of tolerance induction to self antigen,BP,
1176,GO:0002652,1,0.989204342017514,0,2,regulation of tolerance induction dependent upon immune response,BP,
1177,GO:0002654,1,0.99457962741388,0,1,positive regulation of tolerance induction dependent upon immune response,BP,
1178,GO:0002658,1,0.99457962741388,0,1,regulation of peripheral tolerance induction,BP,
1179,GO:0002660,1,0.99457962741388,0,1,positive regulation of peripheral tolerance induction,BP,
1180,GO:0002661,1,0.986425646009945,0,2,regulation of B cell tolerance induction,BP,
1181,GO:0002663,1,0.986425646009945,0,2,positive regulation of B cell tolerance induction,BP,
1182,GO:0002664,1,0.940118425957501,0,10,regulation of T cell tolerance induction,BP,
1183,GO:0002666,1,0.958493246447026,0,7,positive regulation of T cell tolerance induction,BP,
1184,GO:0002667,1,0.968175792466643,0,5,regulation of T cell anergy,BP,
1185,GO:0002669,1,0.980752625711943,0,3,positive regulation of T cell anergy,BP,
1187,GO:0002674,1,0.944208332526676,0,9,negative regulation of acute inflammatory response,BP,
1189,GO:0002676,1,0.957455519298789,0,8,regulation of chronic inflammatory response,BP,
1190,GO:0002677,1,0.975041197153661,0,4,negative regulation of chronic inflammatory response,BP,
1191,GO:0002678,1,0.981968738242972,0,4,positive regulation of chronic inflammatory response,BP,
1192,GO:0002679,1,0.958330316191015,0,7,respiratory burst involved in defense response,BP,
1193,GO:0002681,1,0.954166822631863,0,5,somatic recombination of T cell receptor gene segments,BP,
1198,GO:0002686,1,0.824859352874587,0,33,negative regulation of leukocyte migration,BP,
1201,GO:0002689,1,0.923537880920321,0,14,negative regulation of leukocyte chemotaxis,BP,
1203,GO:0002691,1,0.872754677839454,0,22,regulation of cellular extravasation,BP,
1204,GO:0002692,1,0.950443378615465,0,8,negative regulation of cellular extravasation,BP,
1205,GO:0002693,1,0.92686183840124,0,12,positive regulation of cellular extravasation,BP,
1209,GO:0002697,1,0.154931800851474,0,301,regulation of immune effector process,BP,
1210,GO:0002698,1,0.560509483408614,0,93,negative regulation of immune effector process,BP,
1211,GO:0002699,1,0.38564714743579,0,158,positive regulation of immune effector process,BP,
1212,GO:0002700,1,0.530608864305672,0,104,regulation of production of molecular mediator of immune response,BP,
1213,GO:0002701,1,0.830351439080655,0,30,negative regulation of production of molecular mediator of immune response,BP,
1214,GO:0002702,1,0.667088156477461,0,68,positive regulation of production of molecular mediator of immune response,BP,
1215,GO:0002703,1,0.400137849074006,0,152,regulation of leukocyte mediated immunity,BP,
1216,GO:0002704,1,0.786231131708208,0,41,negative regulation of leukocyte mediated immunity,BP,
1217,GO:0002705,1,0.583446319805574,0,90,positive regulation of leukocyte mediated immunity,BP,
1218,GO:0002706,1,0.520328453827698,0,110,regulation of lymphocyte mediated immunity,BP,
1219,GO:0002707,1,0.836829838148681,0,31,negative regulation of lymphocyte mediated immunity,BP,
1220,GO:0002708,1,0.653762907689421,0,71,positive regulation of lymphocyte mediated immunity,BP,
1221,GO:0002709,1,0.763983336139396,0,48,regulation of T cell mediated immunity,BP,
1222,GO:0002710,1,0.922138222141643,0,15,negative regulation of T cell mediated immunity,BP,
1223,GO:0002711,1,0.846791729543947,0,29,positive regulation of T cell mediated immunity,BP,
1224,GO:0002712,1,0.774460800435337,0,41,regulation of B cell mediated immunity,BP,
1225,GO:0002713,1,0.944063127970691,0,9,negative regulation of B cell mediated immunity,BP,
1226,GO:0002714,1,0.843119229104931,0,28,positive regulation of B cell mediated immunity,BP,
1227,GO:0002715,1,0.823750381483128,0,33,regulation of natural killer cell mediated immunity,BP,
1228,GO:0002716,1,0.939761853595263,0,11,negative regulation of natural killer cell mediated immunity,BP,
1229,GO:0002717,1,0.881842775529214,0,21,positive regulation of natural killer cell mediated immunity,BP,
1230,GO:0002718,1,0.697168177560654,0,60,regulation of cytokine production involved in immune response,BP,
1231,GO:0002719,1,0.883531161706476,0,21,negative regulation of cytokine production involved in immune response,BP,
1232,GO:0002720,1,0.809378271502441,0,35,positive regulation of cytokine production involved in immune response,BP,
1233,GO:0002721,1,0.994228653570667,0,1,regulation of B cell cytokine production,BP,
1234,GO:0002724,1,0.884733001510735,0,21,regulation of T cell cytokine production,BP,
1235,GO:0002725,1,0.96971652259292,0,6,negative regulation of T cell cytokine production,BP,
1236,GO:0002726,1,0.91838513522543,0,14,positive regulation of T cell cytokine production,BP,
1237,GO:0002727,1,0.986621204565993,0,2,regulation of natural killer cell cytokine production,BP,
1238,GO:0002728,1,0.992362942528679,0,1,negative regulation of natural killer cell cytokine production,BP,
1239,GO:0002729,1,0.994214521253028,0,1,positive regulation of natural killer cell cytokine production,BP,
1240,GO:0002730,1,0.96547681174882,0,5,regulation of dendritic cell cytokine production,BP,
1241,GO:0002731,1,0.987746875101147,0,2,negative regulation of dendritic cell cytokine production,BP,
1242,GO:0002732,1,0.992336875245075,0,1,positive regulation of dendritic cell cytokine production,BP,
1243,GO:0002736,1,0.996333212205767,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1244,GO:0002737,1,0.996333212205767,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
1245,GO:0002739,1,0.923949198832501,0,13,regulation of cytokine secretion involved in immune response,BP,
1246,GO:0002740,1,0.973986314969058,0,5,negative regulation of cytokine secretion involved in immune response,BP,
1247,GO:0002741,1,0.954800425602903,0,7,positive regulation of cytokine secretion involved in immune response,BP,
1248,GO:0002752,1,0.990866743157571,0,2,cell surface pattern recognition receptor signaling pathway,BP,
1249,GO:0002753,1,0.700436011774254,0,52,cytoplasmic pattern recognition receptor signaling pathway,BP,
1250,GO:0002755,1,0.797191487315519,0,35,MyD88-dependent toll-like receptor signaling pathway,BP,
1251,GO:0002756,1,0.834681246337105,0,30,MyD88-independent toll-like receptor signaling pathway,BP,
1252,GO:0002757,1,0.0574700640160138,0,451,immune response-activating signal transduction,BP,
1253,GO:0002758,1,0.206387557477387,0,248,innate immune response-activating signal transduction,BP,
1254,GO:0002759,1,0.979311512092395,0,4,regulation of antimicrobial humoral response,BP,
1255,GO:0002760,1,0.990836581822905,0,2,positive regulation of antimicrobial humoral response,BP,
1258,GO:0002763,1,0.76415875259586,0,42,positive regulation of myeloid leukocyte differentiation,BP,
1259,GO:0002764,1,0.0473047491014889,0,481,immune response-regulating signaling pathway,BP,
1260,GO:0002765,1,0.962955622293097,0,7,immune response-inhibiting signal transduction,BP,
1261,GO:0002767,1,0.967847807156266,0,6,immune response-inhibiting cell surface receptor signaling pathway,BP,
1262,GO:0002768,1,0.113060332980341,0,351,immune response-regulating cell surface receptor signaling pathway,BP,
1263,GO:0002769,1,0.990334298940534,0,2,natural killer cell inhibitory signaling pathway,BP,
1264,GO:0002774,1,0.981684397764714,0,3,Fc receptor mediated inhibitory signaling pathway,BP,
1265,GO:0002775,1,0.980444346995999,0,4,antimicrobial peptide production,BP,
1266,GO:0002777,1,0.996353024203384,0,1,antimicrobial peptide biosynthetic process,BP,
1267,GO:0002778,1,0.980444346995999,0,4,antibacterial peptide production,BP,
1268,GO:0002780,1,0.996353024203384,0,1,antibacterial peptide biosynthetic process,BP,
1269,GO:0002784,1,0.984033678185543,0,3,regulation of antimicrobial peptide production,BP,
1270,GO:0002785,1,0.993134818868669,0,1,negative regulation of antimicrobial peptide production,BP,
1271,GO:0002786,1,0.984033678185543,0,3,regulation of antibacterial peptide production,BP,
1272,GO:0002787,1,0.993134818868669,0,1,negative regulation of antibacterial peptide production,BP,
1277,GO:0002803,1,0.990836581822905,0,2,positive regulation of antibacterial peptide production,BP,
1278,GO:0002812,1,0.996353024203384,0,1,biosynthetic process of antibacterial peptides active against Gram-negative bacteria,BP,
1279,GO:0002818,1,0.996422938334043,0,1,intracellular defense response,BP,
1280,GO:0002819,1,0.487279366580994,0,120,regulation of adaptive immune response,BP,
1281,GO:0002820,1,0.810333065290116,0,34,negative regulation of adaptive immune response,BP,
1282,GO:0002821,1,0.651085212814741,0,73,positive regulation of adaptive immune response,BP,
1283,GO:0002822,1,0.519550279751613,0,109,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1284,GO:0002823,1,0.824184415169323,0,31,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1285,GO:0002824,1,0.668207193386327,0,69,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1286,GO:0002825,1,0.899704039927585,0,19,regulation of T-helper 1 type immune response,BP,
1287,GO:0002826,1,0.959338481486388,0,7,negative regulation of T-helper 1 type immune response,BP,
1288,GO:0002827,1,0.937655871462956,0,12,positive regulation of T-helper 1 type immune response,BP,
1289,GO:0002828,1,0.856679079242569,0,27,regulation of type 2 immune response,BP,
1290,GO:0002829,1,0.93683914009175,0,11,negative regulation of type 2 immune response,BP,
1291,GO:0002830,1,0.919041866538276,0,15,positive regulation of type 2 immune response,BP,
1292,GO:0002831,1,0.500707621827659,0,109,regulation of response to biotic stimulus,BP,
1293,GO:0002832,1,0.789742374958992,0,38,negative regulation of response to biotic stimulus,BP,
1294,GO:0002833,1,0.805555246344048,0,34,positive regulation of response to biotic stimulus,BP,
1295,GO:0002834,1,0.938679733806029,0,11,regulation of response to tumor cell,BP,
1296,GO:0002835,1,0.987954721637621,0,2,negative regulation of response to tumor cell,BP,
1297,GO:0002836,1,0.956473007553492,0,8,positive regulation of response to tumor cell,BP,
1298,GO:0002837,1,0.938679733806029,0,11,regulation of immune response to tumor cell,BP,
1299,GO:0002838,1,0.987954721637621,0,2,negative regulation of immune response to tumor cell,BP,
1300,GO:0002839,1,0.956473007553492,0,8,positive regulation of immune response to tumor cell,BP,
1301,GO:0002840,1,0.988010079938717,0,2,regulation of T cell mediated immune response to tumor cell,BP,
1302,GO:0002842,1,0.99460314982677,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
1303,GO:0002849,1,0.99457962741388,0,1,regulation of peripheral T cell tolerance induction,BP,
1304,GO:0002851,1,0.99457962741388,0,1,positive regulation of peripheral T cell tolerance induction,BP,
1305,GO:0002855,1,0.950076942944067,0,9,regulation of natural killer cell mediated immune response to tumor cell,BP,
1306,GO:0002856,1,0.987954721637621,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1307,GO:0002857,1,0.961665015808971,0,7,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1308,GO:0002858,1,0.950076942944067,0,9,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1309,GO:0002859,1,0.987954721637621,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1310,GO:0002860,1,0.961665015808971,0,7,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1312,GO:0002862,1,0.956749052250925,0,9,negative regulation of inflammatory response to antigenic stimulus,BP,
1315,GO:0002865,1,0.979435067524774,0,4,negative regulation of acute inflammatory response to antigenic stimulus,BP,
1317,GO:0002870,1,0.968175792466643,0,5,T cell anergy,BP,
1318,GO:0002874,1,0.986684012878991,0,3,regulation of chronic inflammatory response to antigenic stimulus,BP,
1319,GO:0002875,1,0.995470320023357,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
1320,GO:0002876,1,0.991174116662106,0,2,positive regulation of chronic inflammatory response to antigenic stimulus,BP,
1321,GO:0002877,1,0.984073599525335,0,3,regulation of acute inflammatory response to non-antigenic stimulus,BP,
1322,GO:0002878,1,0.993627020860235,0,1,negative regulation of acute inflammatory response to non-antigenic stimulus,BP,
1323,GO:0002879,1,0.990385922976515,0,2,positive regulation of acute inflammatory response to non-antigenic stimulus,BP,
1324,GO:0002880,1,0.995149938738083,0,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1325,GO:0002882,1,0.995149938738083,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1326,GO:0002883,1,0.964237780395871,0,7,regulation of hypersensitivity,BP,
1327,GO:0002884,1,0.990469418199515,0,2,negative regulation of hypersensitivity,BP,
1328,GO:0002885,1,0.973518485863901,0,5,positive regulation of hypersensitivity,BP,
1329,GO:0002886,1,0.77370140872205,0,43,regulation of myeloid leukocyte mediated immunity,BP,
1330,GO:0002887,1,0.942676410740021,0,10,negative regulation of myeloid leukocyte mediated immunity,BP,
1331,GO:0002888,1,0.884270675023537,0,21,positive regulation of myeloid leukocyte mediated immunity,BP,
1332,GO:0002889,1,0.774460800435337,0,41,regulation of immunoglobulin mediated immune response,BP,
1333,GO:0002890,1,0.944063127970691,0,9,negative regulation of immunoglobulin mediated immune response,BP,
1334,GO:0002891,1,0.843119229104931,0,28,positive regulation of immunoglobulin mediated immune response,BP,
1335,GO:0002892,1,0.984036763041629,0,3,regulation of type II hypersensitivity,BP,
1336,GO:0002893,1,0.995499946615139,0,1,negative regulation of type II hypersensitivity,BP,
1337,GO:0002894,1,0.988485520752558,0,2,positive regulation of type II hypersensitivity,BP,
1338,GO:0002895,1,0.994215697574978,0,1,regulation of central B cell tolerance induction,BP,
1339,GO:0002897,1,0.994215697574978,0,1,positive regulation of central B cell tolerance induction,BP,
1340,GO:0002901,1,0.982070243452095,0,4,mature B cell apoptotic process,BP,
1341,GO:0002902,1,0.900668566786926,0,17,regulation of B cell apoptotic process,BP,
1342,GO:0002903,1,0.93620352439162,0,11,negative regulation of B cell apoptotic process,BP,
1343,GO:0002904,1,0.982318406807909,0,3,positive regulation of B cell apoptotic process,BP,
1344,GO:0002905,1,0.982070243452095,0,4,regulation of mature B cell apoptotic process,BP,
1345,GO:0002906,1,0.982070243452095,0,4,negative regulation of mature B cell apoptotic process,BP,
1346,GO:0002911,1,0.968175792466643,0,5,regulation of lymphocyte anergy,BP,
1347,GO:0002913,1,0.980752625711943,0,3,positive regulation of lymphocyte anergy,BP,
1348,GO:0002920,1,0.739301865642284,0,52,regulation of humoral immune response,BP,
1349,GO:0002921,1,0.932477896045222,0,10,negative regulation of humoral immune response,BP,
1350,GO:0002922,1,0.9406988360402,0,12,positive regulation of humoral immune response,BP,
1351,GO:0002923,1,0.949999436257739,0,9,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1352,GO:0002924,1,0.967196872918121,0,5,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1353,GO:0002925,1,0.982225244394252,0,4,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1354,GO:0002930,1,0.986753740330358,0,2,trabecular meshwork development,BP,
1356,GO:0002933,1,0.984780063483711,0,3,lipid hydroxylation,BP,
1357,GO:0002934,1,0.930179924899849,0,9,desmosome organization,BP,
1358,GO:0002940,1,0.988848411118836,0,2,tRNA N2-guanine methylation,BP,
1359,GO:0002943,1,0.979373710672435,0,4,tRNA dihydrouridine synthesis,BP,
1360,GO:0002944,1,0.983364356213048,0,2,cyclin K-CDK12 complex,CC,
1361,GO:0002945,1,0.984674745298952,0,2,cyclin K-CDK13 complex,CC,
1362,GO:0002946,1,0.995712978464286,0,1,tRNA C5-cytosine methylation,BP,
1363,GO:0002947,1,0.992694101387193,0,1,tumor necrosis factor receptor superfamily complex,CC,
1364,GO:0002949,1,0.985444085112239,0,3,tRNA threonylcarbamoyladenosine modification,BP,
1365,GO:0002950,1,0.979502851299741,0,3,ceramide phosphoethanolamine synthase activity,MF,
1366,GO:0002951,1,0.988950228301912,0,2,leukotriene-C(4) hydrolase,MF,
1371,GO:0003009,1,0.793440378446333,0,38,skeletal muscle contraction,BP,
1372,GO:0003010,1,0.966756245452266,0,5,voluntary skeletal muscle contraction,BP,
1373,GO:0003011,1,0.981728159582234,0,3,involuntary skeletal muscle contraction,BP,
1378,GO:0003016,1,0.82655319411313,0,29,respiratory system process,BP,
1379,GO:0003017,1,0.987839479146518,0,1,lymph circulation,BP,
1381,GO:0003025,1,0.9753455944159,0,3,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
1382,GO:0003026,1,0.994054740756748,0,1,regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback,BP,
1383,GO:0003027,1,0.995381299247171,0,1,regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling,BP,
1384,GO:0003029,1,0.995381299247171,0,1,detection of hypoxic conditions in blood by carotid body chemoreceptor signaling,BP,
1385,GO:0003032,1,0.988323500856723,0,2,detection of oxygen,BP,
1386,GO:0003044,1,0.78922011948924,0,40,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,
1387,GO:0003050,1,0.991875859029977,0,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
1388,GO:0003051,1,0.981218416934805,0,3,angiotensin-mediated drinking behavior,BP,
1390,GO:0003057,1,0.973565539130409,0,5,regulation of the force of heart contraction by chemical signal,BP,
1391,GO:0003058,1,0.995957999246021,0,1,hormonal regulation of the force of heart contraction,BP,
1392,GO:0003062,1,0.957824269788711,0,6,regulation of heart rate by chemical signal,BP,
1393,GO:0003064,1,0.988833715609124,0,2,regulation of heart rate by hormone,BP,
1394,GO:0003065,1,0.995266704891586,0,1,positive regulation of heart rate by epinephrine,BP,
1395,GO:0003068,1,0.996227856480328,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1396,GO:0003069,1,0.996227856480328,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1397,GO:0003070,1,0.996227856480328,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
1398,GO:0003071,1,0.901479330219184,0,18,renal system process involved in regulation of systemic arterial blood pressure,BP,
1399,GO:0003072,1,0.978809516658908,0,4,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
1400,GO:0003073,1,0.626718226567244,0,74,regulation of systemic arterial blood pressure,BP,
1401,GO:0003081,1,0.894812394501741,0,19,regulation of systemic arterial blood pressure by renin-angiotensin,BP,
1402,GO:0003083,1,0.996642149851149,0,1,negative regulation of renal output by angiotensin,BP,
1403,GO:0003084,1,0.944917838252351,0,9,positive regulation of systemic arterial blood pressure,BP,
1404,GO:0003085,1,0.924573972584296,0,13,negative regulation of systemic arterial blood pressure,BP,
1406,GO:0003093,1,0.941602677406485,0,10,regulation of glomerular filtration,BP,
1407,GO:0003094,1,0.905000552788501,0,15,glomerular filtration,BP,
1408,GO:0003095,1,0.995338922498099,0,1,pressure natriuresis,BP,
1409,GO:0003096,1,0.967327366786964,0,5,renal sodium ion transport,BP,
1410,GO:0003097,1,0.971468760440911,0,5,renal water transport,BP,
1411,GO:0003099,1,0.984767495425454,0,3,positive regulation of the force of heart contraction by chemical signal,BP,
1412,GO:0003100,1,0.966782863321154,0,6,regulation of systemic arterial blood pressure by endothelin,BP,
1413,GO:0003104,1,0.976133432796956,0,4,positive regulation of glomerular filtration,BP,
1414,GO:0003105,1,0.978646436098153,0,4,negative regulation of glomerular filtration,BP,
1415,GO:0003106,1,0.996642149851149,0,1,negative regulation of glomerular filtration by angiotensin,BP,
1416,GO:0003127,1,0.979809215597207,0,2,detection of nodal flow,BP,
1417,GO:0003128,1,0.932946502153275,0,10,heart field specification,BP,
1418,GO:0003129,1,0.980380471695873,0,4,heart induction,BP,
1419,GO:0003130,1,0.98895556333503,0,2,BMP signaling pathway involved in heart induction,BP,
1420,GO:0003131,1,0.993994270098414,0,1,mesodermal-endodermal cell signaling,BP,
1421,GO:0003133,1,0.98895556333503,0,2,endodermal-mesodermal cell signaling,BP,
1422,GO:0003134,1,0.98895556333503,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
1423,GO:0003137,1,0.996061378444575,0,1,Notch signaling pathway involved in heart induction,BP,
1424,GO:0003138,1,0.990540722899116,0,1,primary heart field specification,BP,
1425,GO:0003139,1,0.937401861412879,0,9,secondary heart field specification,BP,
1426,GO:0003140,1,0.952562401214744,0,8,determination of left/right asymmetry in lateral mesoderm,BP,
1427,GO:0003142,1,0.994566033676475,0,1,cardiogenic plate morphogenesis,BP,
1428,GO:0003143,1,0.648606736909783,0,61,embryonic heart tube morphogenesis,BP,
1429,GO:0003147,1,0.996199316858008,0,1,neural crest cell migration involved in heart formation,BP,
1430,GO:0003148,1,0.832258380975956,0,25,outflow tract septum morphogenesis,BP,
1431,GO:0003149,1,0.943201115296911,0,9,membranous septum morphogenesis,BP,
1432,GO:0003150,1,0.964098354600204,0,5,muscular septum morphogenesis,BP,
1434,GO:0003156,1,0.822853950320262,0,32,regulation of animal organ formation,BP,
1435,GO:0003157,1,0.925166674726833,0,11,endocardium development,BP,
1437,GO:0003159,1,0.912531220986763,0,15,morphogenesis of an endothelium,BP,
1438,GO:0003160,1,0.962078894463214,0,6,endocardium morphogenesis,BP,
1439,GO:0003161,1,0.919127383676129,0,12,cardiac conduction system development,BP,
1440,GO:0003162,1,0.97412256724076,0,3,atrioventricular node development,BP,
1441,GO:0003163,1,0.979631209525107,0,3,sinoatrial node development,BP,
1442,GO:0003164,1,0.967720977569141,0,5,His-Purkinje system development,BP,
1443,GO:0003165,1,0.986315082035143,0,2,Purkinje myocyte development,BP,
1444,GO:0003166,1,0.976342354022516,0,4,bundle of His development,BP,
1445,GO:0003167,1,0.992076346715573,0,1,atrioventricular bundle cell differentiation,BP,
1446,GO:0003168,1,0.995100417345176,0,1,Purkinje myocyte differentiation,BP,
1447,GO:0003169,1,0.981057251855587,0,2,coronary vein morphogenesis,BP,
1448,GO:0003170,1,0.744953065329636,0,38,heart valve development,BP,
1449,GO:0003171,1,0.840012203078644,0,23,atrioventricular valve development,BP,
1450,GO:0003172,1,0.990540722899116,0,1,sinoatrial valve development,BP,
1451,GO:0003174,1,0.919886192774735,0,10,mitral valve development,BP,
1452,GO:0003175,1,0.954723749122943,0,6,tricuspid valve development,BP,
1453,GO:0003176,1,0.963769987933293,0,6,aortic valve development,BP,
1454,GO:0003177,1,0.919248305651187,0,11,pulmonary valve development,BP,
1455,GO:0003179,1,0.764450638952823,0,34,heart valve morphogenesis,BP,
1456,GO:0003180,1,0.963769987933293,0,6,aortic valve morphogenesis,BP,
1457,GO:0003181,1,0.848309627190935,0,21,atrioventricular valve morphogenesis,BP,
1458,GO:0003183,1,0.919886192774735,0,10,mitral valve morphogenesis,BP,
1459,GO:0003184,1,0.919248305651187,0,11,pulmonary valve morphogenesis,BP,
1460,GO:0003185,1,0.990540722899116,0,1,sinoatrial valve morphogenesis,BP,
1461,GO:0003186,1,0.959034020364788,0,5,tricuspid valve morphogenesis,BP,
1462,GO:0003188,1,0.914359129806198,0,12,heart valve formation,BP,
1463,GO:0003190,1,0.941120790400368,0,7,atrioventricular valve formation,BP,
1464,GO:0003192,1,0.968003072784885,0,3,mitral valve formation,BP,
1465,GO:0003193,1,0.995507507163806,0,1,pulmonary valve formation,BP,
1466,GO:0003195,1,0.98776260694479,0,2,tricuspid valve formation,BP,
1467,GO:0003197,1,0.756830408013081,0,39,endocardial cushion development,BP,
1468,GO:0003198,1,0.896655868688967,0,16,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
1469,GO:0003199,1,0.97723146073569,0,4,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
1470,GO:0003203,1,0.818212029033843,0,29,endocardial cushion morphogenesis,BP,
1473,GO:0003207,1,0.924290665839505,0,11,cardiac chamber formation,BP,
1475,GO:0003209,1,0.809384180719545,0,28,cardiac atrium morphogenesis,BP,
1476,GO:0003210,1,0.996061378444575,0,1,cardiac atrium formation,BP,
1477,GO:0003211,1,0.934623500873751,0,9,cardiac ventricle formation,BP,
1478,GO:0003213,1,0.978806018196381,0,2,cardiac right atrium morphogenesis,BP,
1480,GO:0003215,1,0.877903660495931,0,18,cardiac right ventricle morphogenesis,BP,
1481,GO:0003218,1,0.993151209466218,0,1,cardiac left ventricle formation,BP,
1482,GO:0003219,1,0.977781622803639,0,3,cardiac right ventricle formation,BP,
1483,GO:0003220,1,0.970292693164833,0,2,left ventricular cardiac muscle tissue morphogenesis,BP,
1484,GO:0003221,1,0.97432733767654,0,3,right ventricular cardiac muscle tissue morphogenesis,BP,
1485,GO:0003222,1,0.878945016078056,0,16,ventricular trabecula myocardium morphogenesis,BP,
1486,GO:0003223,1,0.922094969013441,0,8,ventricular compact myocardium morphogenesis,BP,
1487,GO:0003226,1,0.98667703089857,0,1,right ventricular compact myocardium morphogenesis,BP,
1488,GO:0003228,1,0.962632083115525,0,6,atrial cardiac muscle tissue development,BP,
1489,GO:0003229,1,0.672714017939394,0,51,ventricular cardiac muscle tissue development,BP,
1490,GO:0003230,1,0.781426777164035,0,32,cardiac atrium development,BP,
1492,GO:0003235,1,0.996061378444575,0,1,sinus venosus development,BP,
1493,GO:0003236,1,0.996061378444575,0,1,sinus venosus morphogenesis,BP,
1494,GO:0003241,1,0.973223520721418,0,4,growth involved in heart morphogenesis,BP,
1495,GO:0003245,1,0.989243170847015,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
1496,GO:0003247,1,0.995458967525347,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1497,GO:0003249,1,0.973678441381136,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1498,GO:0003250,1,0.973678441381136,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1499,GO:0003251,1,0.988195392288915,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1500,GO:0003252,1,0.985311378508647,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1501,GO:0003253,1,0.961228183879723,0,7,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
1503,GO:0003256,1,0.951869857619447,0,6,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1504,GO:0003257,1,0.975436456601043,0,3,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1505,GO:0003259,1,0.996061378444575,0,1,cardioblast anterior-lateral migration,BP,
1506,GO:0003260,1,0.996061378444575,0,1,cardioblast migration,BP,
1507,GO:0003263,1,0.949701168922827,0,9,cardioblast proliferation,BP,
1508,GO:0003264,1,0.938012435784364,0,10,regulation of cardioblast proliferation,BP,
1509,GO:0003266,1,0.943552763063966,0,9,regulation of secondary heart field cardioblast proliferation,BP,
1510,GO:0003270,1,0.987698566533785,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1511,GO:0003272,1,0.863623896564203,0,21,endocardial cushion formation,BP,
1512,GO:0003273,1,0.963152090248375,0,4,cell migration involved in endocardial cushion formation,BP,
1513,GO:0003274,1,0.977812762835093,0,3,endocardial cushion fusion,BP,
1514,GO:0003275,1,0.980523752991712,0,3,apoptotic process involved in outflow tract morphogenesis,BP,
1515,GO:0003278,1,0.965183903287705,0,6,apoptotic process involved in heart morphogenesis,BP,
1516,GO:0003279,1,0.491135025063247,0,93,cardiac septum development,BP,
1517,GO:0003281,1,0.620368040371118,0,61,ventricular septum development,BP,
1518,GO:0003283,1,0.86906507796429,0,18,atrial septum development,BP,
1519,GO:0003284,1,0.971143119343602,0,4,septum primum development,BP,
1520,GO:0003285,1,0.988517855566962,0,2,septum secundum development,BP,
1521,GO:0003289,1,0.971143119343602,0,4,atrial septum primum morphogenesis,BP,
1522,GO:0003290,1,0.9933853549941,0,1,atrial septum secundum morphogenesis,BP,
1523,GO:0003292,1,0.986256620128967,0,2,cardiac septum cell differentiation,BP,
1524,GO:0003294,1,0.993673140428983,0,1,atrial ventricular junction remodeling,BP,
1525,GO:0003298,1,0.888849035603356,0,17,physiological muscle hypertrophy,BP,
1526,GO:0003299,1,0.845372758919675,0,22,muscle hypertrophy in response to stress,BP,
1527,GO:0003300,1,0.578461735484988,0,69,cardiac muscle hypertrophy,BP,
1528,GO:0003301,1,0.888849035603356,0,17,physiological cardiac muscle hypertrophy,BP,
1529,GO:0003306,1,0.950993344208966,0,8,Wnt signaling pathway involved in heart development,BP,
1530,GO:0003307,1,0.974341664301633,0,5,regulation of Wnt signaling pathway involved in heart development,BP,
1531,GO:0003308,1,0.979681437314183,0,4,negative regulation of Wnt signaling pathway involved in heart development,BP,
1532,GO:0003309,1,0.851975664389746,0,23,type B pancreatic cell differentiation,BP,
1533,GO:0003310,1,0.96267053596384,0,6,pancreatic A cell differentiation,BP,
1534,GO:0003312,1,0.989164316852009,0,2,pancreatic PP cell differentiation,BP,
1535,GO:0003318,1,0.996061378444575,0,1,cell migration to the midline involved in heart development,BP,
1536,GO:0003321,1,0.956986821486074,0,7,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
1537,GO:0003322,1,0.989961852611242,0,1,pancreatic A cell development,BP,
1538,GO:0003323,1,0.876636764873079,0,19,type B pancreatic cell development,BP,
1539,GO:0003326,1,0.989164316852009,0,2,pancreatic A cell fate commitment,BP,
1540,GO:0003327,1,0.994907742814175,0,1,type B pancreatic cell fate commitment,BP,
1541,GO:0003329,1,0.989164316852009,0,2,pancreatic PP cell fate commitment,BP,
1542,GO:0003330,1,0.988371538892863,0,2,regulation of extracellular matrix constituent secretion,BP,
1543,GO:0003331,1,0.988371538892863,0,2,positive regulation of extracellular matrix constituent secretion,BP,
1545,GO:0003334,1,0.926265718795956,0,10,keratinocyte development,BP,
1546,GO:0003335,1,0.995849402629573,0,1,corneocyte development,BP,
1547,GO:0003337,1,0.9240624439748,0,13,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1548,GO:0003338,1,0.80012703177837,0,31,metanephros morphogenesis,BP,
1549,GO:0003339,1,0.954735840018461,0,8,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1550,GO:0003340,1,0.9830498810251,0,3,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1551,GO:0003341,1,0.643093851625051,0,61,cilium movement,BP,
1552,GO:0003342,1,0.9889164751421,0,2,proepicardium development,BP,
1553,GO:0003343,1,0.9889164751421,0,2,septum transversum development,BP,
1554,GO:0003344,1,0.926200758252002,0,9,pericardium morphogenesis,BP,
1555,GO:0003345,1,0.992937652055048,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
1556,GO:0003348,1,0.9550397583489,0,6,cardiac endothelial cell differentiation,BP,
1557,GO:0003350,1,0.981561418252241,0,3,pulmonary myocardium development,BP,
1558,GO:0003351,1,0.891982970962799,0,19,epithelial cilium movement,BP,
1559,GO:0003352,1,0.913660481905087,0,13,regulation of cilium movement,BP,
1560,GO:0003353,1,0.993801419913101,0,1,positive regulation of cilium movement,BP,
1561,GO:0003356,1,0.92930072032577,0,10,regulation of cilium beat frequency,BP,
1562,GO:0003357,1,0.959237501568929,0,6,noradrenergic neuron differentiation,BP,
1563,GO:0003358,1,0.988444098501161,0,2,noradrenergic neuron development,BP,
1564,GO:0003359,1,0.994409330361848,0,1,noradrenergic neuron fate commitment,BP,
1565,GO:0003360,1,0.952005640850786,0,6,brainstem development,BP,
1566,GO:0003365,1,0.970240357786708,0,3,establishment of cell polarity involved in ameboidal cell migration,BP,
1567,GO:0003366,1,0.98484317818669,0,2,cell-matrix adhesion involved in ameboidal cell migration,BP,
1570,GO:0003376,1,0.932488981012022,0,12,sphingosine-1-phosphate signaling pathway,BP,
1571,GO:0003382,1,0.81496209612213,0,27,epithelial cell morphogenesis,BP,
1572,GO:0003383,1,0.972609602658184,0,3,apical constriction,BP,
1573,GO:0003400,1,0.994787965799874,0,1,regulation of COPII vesicle coating,BP,
1576,GO:0003404,1,0.987885420620201,0,2,optic vesicle morphogenesis,BP,
1577,GO:0003406,1,0.963932714347682,0,5,retinal pigment epithelium development,BP,
1579,GO:0003408,1,0.97369427254343,0,3,optic cup formation involved in camera-type eye development,BP,
1580,GO:0003409,1,0.993494097070391,0,1,optic cup structural organization,BP,
1581,GO:0003413,1,0.933188153859051,0,10,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,
1582,GO:0003414,1,0.992977387693188,0,1,chondrocyte morphogenesis involved in endochondral bone morphogenesis,BP,
1583,GO:0003415,1,0.972019554940932,0,4,chondrocyte hypertrophy,BP,
1584,GO:0003416,1,0.863914376658257,0,22,endochondral bone growth,BP,
1585,GO:0003417,1,0.912518700661833,0,15,growth plate cartilage development,BP,
1586,GO:0003418,1,0.962674094618378,0,6,growth plate cartilage chondrocyte differentiation,BP,
1587,GO:0003419,1,0.981355768923586,0,4,growth plate cartilage chondrocyte proliferation,BP,
1588,GO:0003420,1,0.988231313646456,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
1589,GO:0003421,1,0.992934301076455,0,1,growth plate cartilage axis specification,BP,
1590,GO:0003422,1,0.985960811019938,0,2,growth plate cartilage morphogenesis,BP,
1591,GO:0003429,1,0.992977387693188,0,1,growth plate cartilage chondrocyte morphogenesis,BP,
1592,GO:0003430,1,0.986199817564325,0,2,growth plate cartilage chondrocyte growth,BP,
1593,GO:0003431,1,0.972379349358176,0,4,growth plate cartilage chondrocyte development,BP,
1594,GO:0003433,1,0.960473307683233,0,6,chondrocyte development involved in endochondral bone morphogenesis,BP,
1598,GO:0003678,1,0.716700828794032,0,45,DNA helicase activity,MF,
1599,GO:0003680,1,0.942655846694649,0,10,AT DNA binding,MF,
1601,GO:0003684,1,0.642163173660967,0,66,damaged DNA binding,MF,
1602,GO:0003688,1,0.916847678797956,0,14,DNA replication origin binding,MF,
1603,GO:0003689,1,0.956063954651497,0,8,DNA clamp loader activity,MF,
1605,GO:0003691,1,0.94630750131546,0,9,double-stranded telomeric DNA binding,MF,
1606,GO:0003692,1,0.994767240131855,0,1,left-handed Z-DNA binding,MF,
1607,GO:0003696,1,0.954857214283902,0,7,satellite DNA binding,MF,
1608,GO:0003697,1,0.543012183893367,0,96,single-stranded DNA binding,MF,
1610,GO:0003705,1,0.54039626295641,0,92,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
1611,GO:0003707,1,0.670982269346719,0,56,steroid hormone receptor activity,MF,
1612,GO:0003708,1,0.954970368256153,0,7,retinoic acid receptor activity,MF,
1616,GO:0003720,1,0.946740313197902,0,8,telomerase activity,MF,
1617,GO:0003721,1,0.992809706686633,0,1,telomerase RNA reverse transcriptase activity,MF,
1619,GO:0003724,1,0.64500206886287,0,65,RNA helicase activity,MF,
1620,GO:0003725,1,0.635383176304719,0,66,double-stranded RNA binding,MF,
1621,GO:0003726,1,0.977127683095262,0,3,double-stranded RNA adenosine deaminase activity,MF,
1622,GO:0003727,1,0.609327498616133,0,77,single-stranded RNA binding,MF,
1624,GO:0003730,1,0.645032637341819,0,63,mRNA 3'-UTR binding,MF,
1625,GO:0003735,1,0.546122867918594,0,153,structural constituent of ribosome,MF,
1626,GO:0003743,1,0.743336625915504,0,50,translation initiation factor activity,MF,
1628,GO:0003747,1,0.960698766518152,0,6,translation release factor activity,MF,
1629,GO:0003755,1,0.844081305731765,0,31,peptidyl-prolyl cis-trans isomerase activity,MF,
1630,GO:0003756,1,0.897904111336772,0,17,protein disulfide isomerase activity,MF,
1634,GO:0003785,1,0.858938247909781,0,25,actin monomer binding,MF,
1635,GO:0003796,1,0.988520154877359,0,3,lysozyme activity,MF,
1636,GO:0003810,1,0.964165895536881,0,6,protein-glutamine gamma-glutamyltransferase activity,MF,
1637,GO:0003823,1,0.77653603494474,0,46,antigen binding,MF,
1639,GO:0003826,1,0.989527198939787,0,2,alpha-ketoacid dehydrogenase activity,MF,
1640,GO:0003827,1,0.987895706724568,0,2,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
1642,GO:0003829,1,0.9846627741973,0,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
1643,GO:0003830,1,0.9918100289378,0,1,beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
1644,GO:0003831,1,0.949930283896606,0,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,
1645,GO:0003834,1,0.994054740756748,0,1,beta-carotene 15,15'-monooxygenase activity,MF,
1646,GO:0003835,1,0.98268499130221,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
1647,GO:0003836,1,0.962468288953573,0,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,
1648,GO:0003837,1,0.99491027139586,0,1,beta-ureidopropionase activity,MF,
1649,GO:0003839,1,0.981793794661175,0,4,gamma-glutamylcyclotransferase activity,MF,
1650,GO:0003841,1,0.883605350867767,0,17,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,
1651,GO:0003842,1,0.993544641356897,0,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,
1652,GO:0003844,1,0.993689830708738,0,1,1,4-alpha-glucan branching enzyme activity,MF,
1653,GO:0003845,1,0.990917829264509,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
1654,GO:0003846,1,0.987557217379541,0,2,2-acylglycerol O-acyltransferase activity,MF,
1655,GO:0003847,1,0.976060299762999,0,5,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
1656,GO:0003854,1,0.984406132734313,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
1657,GO:0003857,1,0.954151771122918,0,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,
1658,GO:0003858,1,0.987328657841553,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
1659,GO:0003860,1,0.995089625587539,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
1660,GO:0003863,1,0.989527198939787,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
1661,GO:0003865,1,0.988888480222838,0,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,
1662,GO:0003867,1,0.991914726505661,0,1,4-aminobutyrate transaminase activity,MF,
1663,GO:0003868,1,0.990700428978069,0,2,4-hydroxyphenylpyruvate dioxygenase activity,MF,
1664,GO:0003870,1,0.989566415522704,0,2,5-aminolevulinate synthase activity,MF,
1665,GO:0003872,1,0.98154014817701,0,3,6-phosphofructokinase activity,MF,
1666,GO:0003873,1,0.972864364777898,0,4,6-phosphofructo-2-kinase activity,MF,
1667,GO:0003874,1,0.996339404102419,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
1668,GO:0003875,1,0.988656163209617,0,2,ADP-ribosylarginine hydrolase activity,MF,
1669,GO:0003876,1,0.985593557704322,0,2,AMP deaminase activity,MF,
1670,GO:0003877,1,0.994860380278518,0,1,ATP adenylyltransferase activity,MF,
1671,GO:0003878,1,0.992466922002185,0,1,ATP citrate synthase activity,MF,
1672,GO:0003880,1,0.981918613013563,0,3,protein C-terminal carboxyl O-methyltransferase activity,MF,
1673,GO:0003881,1,0.995160097074332,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
1674,GO:0003882,1,0.994437271645789,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
1675,GO:0003883,1,0.986962074568497,0,2,CTP synthase activity,MF,
1676,GO:0003884,1,0.991008643827727,0,2,D-amino-acid oxidase activity,MF,
1677,GO:0003886,1,0.976997054175694,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
1678,GO:0003887,1,0.827541819419266,0,27,DNA-directed DNA polymerase activity,MF,
1679,GO:0003896,1,0.984446626013009,0,3,DNA primase activity,MF,
1680,GO:0003899,1,0.795166176644561,0,41,DNA-directed 5'-3' RNA polymerase activity,MF,
1681,GO:0003905,1,0.996149649013535,0,1,alkylbase DNA N-glycosylase activity,MF,
1682,GO:0003906,1,0.936933695045486,0,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
1683,GO:0003908,1,0.995926818723458,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
1684,GO:0003909,1,0.957995571195411,0,7,DNA ligase activity,MF,
1685,GO:0003910,1,0.962950910608262,0,6,DNA ligase (ATP) activity,MF,
1686,GO:0003912,1,0.994946328757279,0,1,DNA nucleotidylexotransferase activity,MF,
1688,GO:0003917,1,0.974774648752598,0,4,DNA topoisomerase type I activity,MF,
1690,GO:0003919,1,0.995035050726997,0,1,FMN adenylyltransferase activity,MF,
1691,GO:0003920,1,0.990782325803101,0,2,GMP reductase activity,MF,
1692,GO:0003921,1,0.994420251781273,0,1,GMP synthase activity,MF,
1693,GO:0003922,1,0.994420251781273,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
1694,GO:0003923,1,0.971285418040061,0,5,GPI-anchor transamidase activity,MF,
1696,GO:0003933,1,0.995059160510793,0,1,GTP cyclohydrolase activity,MF,
1697,GO:0003934,1,0.995059160510793,0,1,GTP cyclohydrolase I activity,MF,
1698,GO:0003937,1,0.994876157112668,0,1,IMP cyclohydrolase activity,MF,
1699,GO:0003938,1,0.989774924219028,0,2,IMP dehydrogenase activity,MF,
1700,GO:0003939,1,0.99434294248527,0,1,L-iditol 2-dehydrogenase activity,MF,
1701,GO:0003940,1,0.994755319278953,0,1,L-iduronidase activity,MF,
1702,GO:0003941,1,0.985726700659358,0,3,L-serine ammonia-lyase activity,MF,
1703,GO:0003943,1,0.987271718627722,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
1704,GO:0003944,1,0.994739021509747,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
1705,GO:0003945,1,0.977368325995898,0,4,N-acetyllactosamine synthase activity,MF,
1706,GO:0003947,1,0.99378912044654,0,1,(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity,MF,
1707,GO:0003948,1,0.994887523218437,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
1708,GO:0003950,1,0.877780950431619,0,19,NAD+ ADP-ribosyltransferase activity,MF,
1709,GO:0003951,1,0.889294177073704,0,16,NAD+ kinase activity,MF,
1710,GO:0003952,1,0.994445795478841,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1711,GO:0003953,1,0.991312984954525,0,2,NAD+ nucleosidase activity,MF,
1712,GO:0003954,1,0.855305940726343,0,40,NADH dehydrogenase activity,MF,
1713,GO:0003955,1,0.983900982083481,0,3,NAD(P)H dehydrogenase (quinone) activity,MF,
1714,GO:0003956,1,0.986890319477354,0,3,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
1715,GO:0003957,1,0.992154189631561,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
1716,GO:0003958,1,0.957350776966697,0,6,NADPH-hemoprotein reductase activity,MF,
1717,GO:0003960,1,0.980960602557062,0,4,NADPH:quinone reductase activity,MF,
1718,GO:0003962,1,0.99532436368798,0,1,cystathionine gamma-synthase activity,MF,
1719,GO:0003963,1,0.988867135614137,0,2,RNA-3'-phosphate cyclase activity,MF,
1720,GO:0003964,1,0.946740313197902,0,8,RNA-directed DNA polymerase activity,MF,
1721,GO:0003968,1,0.983123672693594,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
1722,GO:0003972,1,0.994054740756748,0,1,RNA ligase (ATP) activity,MF,
1723,GO:0003973,1,0.986101297703634,0,2,(S)-2-hydroxy-acid oxidase activity,MF,
1724,GO:0003974,1,0.99549049382709,0,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,
1725,GO:0003975,1,0.99481689816392,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
1726,GO:0003976,1,0.982067225685908,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
1727,GO:0003977,1,0.988046850669607,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
1728,GO:0003978,1,0.99549049382709,0,1,UDP-glucose 4-epimerase activity,MF,
1729,GO:0003979,1,0.99360078408536,0,1,UDP-glucose 6-dehydrogenase activity,MF,
1730,GO:0003980,1,0.978299582133783,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
1731,GO:0003983,1,0.994818157148879,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
1732,GO:0003985,1,0.984224416355789,0,3,acetyl-CoA C-acetyltransferase activity,MF,
1733,GO:0003986,1,0.982767994443288,0,4,acetyl-CoA hydrolase activity,MF,
1734,GO:0003987,1,0.980053902337693,0,3,acetate-CoA ligase activity,MF,
1735,GO:0003988,1,0.969581739123175,0,6,acetyl-CoA C-acyltransferase activity,MF,
1736,GO:0003989,1,0.98772471497335,0,1,acetyl-CoA carboxylase activity,MF,
1737,GO:0003990,1,0.988759788553396,0,2,acetylcholinesterase activity,MF,
1738,GO:0003991,1,0.994907742814175,0,1,acetylglutamate kinase activity,MF,
1739,GO:0003993,1,0.970687009454312,0,6,acid phosphatase activity,MF,
1740,GO:0003994,1,0.987355891913834,0,2,aconitate hydratase activity,MF,
1741,GO:0003995,1,0.909784510605984,0,15,acyl-CoA dehydrogenase activity,MF,
1742,GO:0003996,1,0.973381042069561,0,5,acyl-CoA ligase activity,MF,
1743,GO:0003997,1,0.967943806347558,0,5,acyl-CoA oxidase activity,MF,
1744,GO:0003998,1,0.99269493645397,0,2,acylphosphatase activity,MF,
1745,GO:0003999,1,0.996580460939613,0,1,adenine phosphoribosyltransferase activity,MF,
1746,GO:0004000,1,0.941010456012597,0,9,adenosine deaminase activity,MF,
1747,GO:0004001,1,0.994930508558121,0,1,adenosine kinase activity,MF,
1748,GO:0004003,1,0.794497766579675,0,32,ATP-dependent DNA helicase activity,MF,
1749,GO:0004004,1,0.649074550335804,0,64,ATP-dependent RNA helicase activity,MF,
1750,GO:0004008,1,0.97905071252116,0,2,copper-exporting ATPase activity,MF,
1751,GO:0004012,1,0.826175359373386,0,20,phospholipid-translocating ATPase activity,MF,
1752,GO:0004013,1,0.979327849211577,0,3,adenosylhomocysteinase activity,MF,
1753,GO:0004014,1,0.993530949694249,0,1,adenosylmethionine decarboxylase activity,MF,
1755,GO:0004017,1,0.950915351879898,0,8,adenylate kinase activity,MF,
1756,GO:0004018,1,0.995657785552636,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
1757,GO:0004019,1,0.989362415033797,0,2,adenylosuccinate synthase activity,MF,
1758,GO:0004020,1,0.987313227578771,0,2,adenylylsulfate kinase activity,MF,
1759,GO:0004021,1,0.988062979401258,0,2,L-alanine:2-oxoglutarate aminotransferase activity,MF,
1760,GO:0004022,1,0.973996514081664,0,5,alcohol dehydrogenase (NAD) activity,MF,
1761,GO:0004024,1,0.98921140078955,0,2,alcohol dehydrogenase activity, zinc-dependent,MF,
1762,GO:0004027,1,0.995974205241353,0,1,alcohol sulfotransferase activity,MF,
1763,GO:0004028,1,0.959103713723677,0,7,3-chloroallyl aldehyde dehydrogenase activity,MF,
1764,GO:0004029,1,0.908511540104185,0,15,aldehyde dehydrogenase (NAD) activity,MF,
1765,GO:0004030,1,0.965629151398849,0,6,aldehyde dehydrogenase [NAD(P)+] activity,MF,
1766,GO:0004031,1,0.991871871186814,0,1,aldehyde oxidase activity,MF,
1767,GO:0004032,1,0.953143581776736,0,11,alditol:NADP+ 1-oxidoreductase activity,MF,
1768,GO:0004033,1,0.88760244468246,0,25,aldo-keto reductase (NADP) activity,MF,
1769,GO:0004034,1,0.994397214088083,0,1,aldose 1-epimerase activity,MF,
1770,GO:0004035,1,0.988259544266091,0,2,alkaline phosphatase activity,MF,
1771,GO:0004037,1,0.995696679025439,0,1,allantoicase activity,MF,
1772,GO:0004040,1,0.983450862405181,0,3,amidase activity,MF,
1773,GO:0004042,1,0.994907742814175,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
1774,GO:0004043,1,0.993234452258784,0,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,
1775,GO:0004044,1,0.993055980717331,0,1,amidophosphoribosyltransferase activity,MF,
1776,GO:0004045,1,0.98264652035007,0,4,aminoacyl-tRNA hydrolase activity,MF,
1777,GO:0004046,1,0.976797238500525,0,5,aminoacylase activity,MF,
1778,GO:0004047,1,0.990556816951984,0,2,aminomethyltransferase activity,MF,
1779,GO:0004051,1,0.994307000868295,0,1,arachidonate 5-lipoxygenase activity,MF,
1780,GO:0004052,1,0.983156416561482,0,3,arachidonate 12-lipoxygenase activity,MF,
1781,GO:0004053,1,0.990740895348684,0,2,arginase activity,MF,
1782,GO:0004055,1,0.99522039893135,0,1,argininosuccinate synthase activity,MF,
1783,GO:0004056,1,0.99500904875046,0,1,argininosuccinate lyase activity,MF,
1784,GO:0004057,1,0.994729001002452,0,1,arginyltransferase activity,MF,
1785,GO:0004058,1,0.994974191285603,0,1,aromatic-L-amino-acid decarboxylase activity,MF,
1786,GO:0004059,1,0.995671590620381,0,1,aralkylamine N-acetyltransferase activity,MF,
1787,GO:0004060,1,0.986575556118423,0,3,arylamine N-acetyltransferase activity,MF,
1788,GO:0004061,1,0.995384459698249,0,1,arylformamidase activity,MF,
1790,GO:0004063,1,0.991347382160158,0,2,aryldialkylphosphatase activity,MF,
1791,GO:0004064,1,0.972502717107046,0,6,arylesterase activity,MF,
1792,GO:0004065,1,0.929971767277374,0,11,arylsulfatase activity,MF,
1793,GO:0004066,1,0.989031187848003,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
1794,GO:0004067,1,0.989733850409957,0,2,asparaginase activity,MF,
1795,GO:0004069,1,0.989300290766131,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
1796,GO:0004070,1,0.980892664922349,0,2,aspartate carbamoyltransferase activity,MF,
1797,GO:0004074,1,0.992606589108026,0,2,biliverdin reductase activity,MF,
1798,GO:0004075,1,0.982115078686227,0,2,biotin carboxylase activity,MF,
1799,GO:0004077,1,0.990820609009119,0,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,
1800,GO:0004078,1,0.990820609009119,0,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,
1801,GO:0004079,1,0.990820609009119,0,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,
1802,GO:0004080,1,0.990820609009119,0,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,
1803,GO:0004081,1,0.990366130530287,0,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
1804,GO:0004082,1,0.982399267386844,0,4,bisphosphoglycerate mutase activity,MF,
1806,GO:0004085,1,0.995100417345176,0,1,butyryl-CoA dehydrogenase activity,MF,
1807,GO:0004087,1,0.980892664922349,0,2,carbamoyl-phosphate synthase (ammonia) activity,MF,
1808,GO:0004088,1,0.980892664922349,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1809,GO:0004089,1,0.934363236049227,0,13,carbonate dehydratase activity,MF,
1810,GO:0004090,1,0.980012832303561,0,5,carbonyl reductase (NADPH) activity,MF,
1811,GO:0004092,1,0.994000446002075,0,1,carnitine O-acetyltransferase activity,MF,
1812,GO:0004095,1,0.974999462197347,0,4,carnitine O-palmitoyltransferase activity,MF,
1813,GO:0004096,1,0.979633570846261,0,4,catalase activity,MF,
1814,GO:0004098,1,0.995122002862619,0,1,cerebroside-sulfatase activity,MF,
1815,GO:0004102,1,0.994416609558667,0,1,choline O-acetyltransferase activity,MF,
1816,GO:0004103,1,0.989636354992532,0,2,choline kinase activity,MF,
1817,GO:0004104,1,0.982972229746035,0,3,cholinesterase activity,MF,
1818,GO:0004105,1,0.986906062746311,0,2,choline-phosphate cytidylyltransferase activity,MF,
1819,GO:0004108,1,0.993825585102011,0,1,citrate (Si)-synthase activity,MF,
1820,GO:0004109,1,0.988537442759134,0,2,coproporphyrinogen oxidase activity,MF,
1821,GO:0004111,1,0.971929095529922,0,5,creatine kinase activity,MF,
1822,GO:0004112,1,0.840088300389922,0,23,cyclic-nucleotide phosphodiesterase activity,MF,
1823,GO:0004113,1,0.991612256455964,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1824,GO:0004114,1,0.847206296973502,0,22,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,
1825,GO:0004115,1,0.885143559838851,0,15,3',5'-cyclic-AMP phosphodiesterase activity,MF,
1826,GO:0004117,1,0.982436009549468,0,3,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
1827,GO:0004118,1,0.970429283284734,0,3,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
1828,GO:0004119,1,0.983491194490982,0,2,cGMP-inhibited cyclic-nucleotide phosphodiesterase activity,MF,
1829,GO:0004122,1,0.994255839328277,0,1,cystathionine beta-synthase activity,MF,
1830,GO:0004123,1,0.99532436368798,0,1,cystathionine gamma-lyase activity,MF,
1831,GO:0004126,1,0.952084768787764,0,10,cytidine deaminase activity,MF,
1832,GO:0004127,1,0.976237361261717,0,4,cytidylate kinase activity,MF,
1833,GO:0004128,1,0.962399741205773,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1834,GO:0004129,1,0.918771387467436,0,22,cytochrome-c oxidase activity,MF,
1835,GO:0004132,1,0.994961523664377,0,1,dCMP deaminase activity,MF,
1836,GO:0004133,1,0.989660397416249,0,1,glycogen debranching enzyme activity,MF,
1837,GO:0004134,1,0.989660397416249,0,1,4-alpha-glucanotransferase activity,MF,
1838,GO:0004135,1,0.989660397416249,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1839,GO:0004137,1,0.986079641055315,0,2,deoxycytidine kinase activity,MF,
1840,GO:0004138,1,0.996242741238324,0,1,deoxyguanosine kinase activity,MF,
1841,GO:0004139,1,0.995346516039137,0,1,deoxyribose-phosphate aldolase activity,MF,
1842,GO:0004140,1,0.989598068757692,0,2,dephospho-CoA kinase activity,MF,
1843,GO:0004142,1,0.982629725122087,0,3,diacylglycerol cholinephosphotransferase activity,MF,
1844,GO:0004143,1,0.923276175993556,0,10,diacylglycerol kinase activity,MF,
1845,GO:0004144,1,0.987557217379541,0,2,diacylglycerol O-acyltransferase activity,MF,
1846,GO:0004145,1,0.987272784417855,0,3,diamine N-acetyltransferase activity,MF,
1847,GO:0004146,1,0.989088083889221,0,2,dihydrofolate reductase activity,MF,
1848,GO:0004148,1,0.993212130508638,0,1,dihydrolipoyl dehydrogenase activity,MF,
1849,GO:0004149,1,0.993967989184179,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
1850,GO:0004151,1,0.980892664922349,0,2,dihydroorotase activity,MF,
1851,GO:0004152,1,0.994912800220172,0,1,dihydroorotate dehydrogenase activity,MF,
1852,GO:0004155,1,0.995442563407794,0,1,6,7-dihydropteridine reductase activity,MF,
1853,GO:0004157,1,0.987159722710986,0,2,dihydropyrimidinase activity,MF,
1854,GO:0004161,1,0.989688734730766,0,2,dimethylallyltranstransferase activity,MF,
1855,GO:0004163,1,0.995254022129267,0,1,diphosphomevalonate decarboxylase activity,MF,
1856,GO:0004164,1,0.995264168599676,0,1,diphthine synthase activity,MF,
1857,GO:0004165,1,0.981128109835356,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
1858,GO:0004167,1,0.988105864011349,0,3,dopachrome isomerase activity,MF,
1859,GO:0004168,1,0.994749048825574,0,1,dolichol kinase activity,MF,
1860,GO:0004169,1,0.974675490551359,0,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
1861,GO:0004170,1,0.995161366844555,0,1,dUTP diphosphatase activity,MF,
1862,GO:0004174,1,0.988142663657786,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
1864,GO:0004176,1,0.973817266764918,0,4,ATP-dependent peptidase activity,MF,
1865,GO:0004177,1,0.763054346541853,0,43,aminopeptidase activity,MF,
1866,GO:0004180,1,0.801727610877952,0,37,carboxypeptidase activity,MF,
1867,GO:0004181,1,0.863785592784742,0,24,metallocarboxypeptidase activity,MF,
1868,GO:0004185,1,0.942311966519736,0,9,serine-type carboxypeptidase activity,MF,
1869,GO:0004190,1,0.900432092946527,0,18,aspartic-type endopeptidase activity,MF,
1870,GO:0004197,1,0.585590835270548,0,82,cysteine-type endopeptidase activity,MF,
1871,GO:0004198,1,0.888519292473762,0,20,calcium-dependent cysteine-type endopeptidase activity,MF,
1872,GO:0004222,1,0.515554716382104,0,95,metalloendopeptidase activity,MF,
1874,GO:0004298,1,0.931622773983415,0,18,threonine-type endopeptidase activity,MF,
1875,GO:0004300,1,0.958470002891914,0,8,enoyl-CoA hydratase activity,MF,
1876,GO:0004301,1,0.965030649095282,0,7,epoxide hydrolase activity,MF,
1877,GO:0004303,1,0.959570579501471,0,9,estradiol 17-beta-dehydrogenase activity,MF,
1878,GO:0004304,1,0.990315544079316,0,2,estrone sulfotransferase activity,MF,
1879,GO:0004305,1,0.976864864553346,0,4,ethanolamine kinase activity,MF,
1880,GO:0004306,1,0.995180412493457,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
1881,GO:0004307,1,0.990878748830901,0,2,ethanolaminephosphotransferase activity,MF,
1882,GO:0004308,1,0.972910291912067,0,5,exo-alpha-sialidase activity,MF,
1883,GO:0004309,1,0.966064962899564,0,4,exopolyphosphatase activity,MF,
1884,GO:0004310,1,0.994863534742089,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
1885,GO:0004311,1,0.982782181606802,0,3,farnesyltranstransferase activity,MF,
1886,GO:0004312,1,0.938891828584364,0,10,fatty acid synthase activity,MF,
1887,GO:0004313,1,0.988453595791546,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1888,GO:0004314,1,0.983575507470044,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
1889,GO:0004315,1,0.984413404633367,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
1890,GO:0004316,1,0.988453595791546,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1891,GO:0004317,1,0.988453595791546,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1892,GO:0004319,1,0.988453595791546,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
1893,GO:0004320,1,0.983814502525686,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
1894,GO:0004321,1,0.978583106762224,0,4,fatty-acyl-CoA synthase activity,MF,
1895,GO:0004322,1,0.961664891958289,0,5,ferroxidase activity,MF,
1896,GO:0004324,1,0.995129621674049,0,1,ferredoxin-NADP+ reductase activity,MF,
1897,GO:0004325,1,0.98959927258738,0,1,ferrochelatase activity,MF,
1898,GO:0004326,1,0.994388744542027,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
1899,GO:0004329,1,0.986550465416363,0,2,formate-tetrahydrofolate ligase activity,MF,
1900,GO:0004331,1,0.972864364777898,0,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
1901,GO:0004332,1,0.985556839540142,0,3,fructose-bisphosphate aldolase activity,MF,
1902,GO:0004333,1,0.995264168599676,0,1,fumarate hydratase activity,MF,
1903,GO:0004334,1,0.995687899793896,0,1,fumarylacetoacetase activity,MF,
1904,GO:0004335,1,0.989458909262303,0,2,galactokinase activity,MF,
1905,GO:0004336,1,0.993903848785914,0,1,galactosylceramidase activity,MF,
1906,GO:0004337,1,0.989688734730766,0,2,geranyltranstransferase activity,MF,
1907,GO:0004339,1,0.990320412982422,0,1,glucan 1,4-alpha-glucosidase activity,MF,
1908,GO:0004340,1,0.964375656274267,0,5,glucokinase activity,MF,
1909,GO:0004341,1,0.995092164747453,0,1,gluconolactonase activity,MF,
1910,GO:0004342,1,0.989758201221805,0,2,glucosamine-6-phosphate deaminase activity,MF,
1911,GO:0004343,1,0.992884504969279,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
1912,GO:0004344,1,0.987888400990943,0,1,glucose dehydrogenase activity,MF,
1913,GO:0004345,1,0.982526303413845,0,2,glucose-6-phosphate dehydrogenase activity,MF,
1914,GO:0004346,1,0.983042766196642,0,3,glucose-6-phosphatase activity,MF,
1915,GO:0004347,1,0.994888786457122,0,1,glucose-6-phosphate isomerase activity,MF,
1916,GO:0004348,1,0.983166322852492,0,3,glucosylceramidase activity,MF,
1917,GO:0004349,1,0.993324266516756,0,1,glutamate 5-kinase activity,MF,
1918,GO:0004350,1,0.993324266516756,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
1919,GO:0004351,1,0.981332155863227,0,3,glutamate decarboxylase activity,MF,
1920,GO:0004352,1,0.987935384089541,0,2,glutamate dehydrogenase (NAD+) activity,MF,
1921,GO:0004353,1,0.987935384089541,0,2,glutamate dehydrogenase [NAD(P)+] activity,MF,
1922,GO:0004356,1,0.983936991387591,0,2,glutamate-ammonia ligase activity,MF,
1923,GO:0004357,1,0.986845598664973,0,2,glutamate-cysteine ligase activity,MF,
1924,GO:0004359,1,0.981253926413989,0,3,glutaminase activity,MF,
1925,GO:0004360,1,0.982157859059995,0,2,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1926,GO:0004361,1,0.995365492857349,0,1,glutaryl-CoA dehydrogenase activity,MF,
1927,GO:0004362,1,0.994660308103538,0,1,glutathione-disulfide reductase activity,MF,
1928,GO:0004363,1,0.995118193512694,0,1,glutathione synthase activity,MF,
1929,GO:0004364,1,0.902496749233521,0,24,glutathione transferase activity,MF,
1930,GO:0004365,1,0.995865645684935,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
1931,GO:0004366,1,0.97873564760249,0,3,glycerol-3-phosphate O-acyltransferase activity,MF,
1932,GO:0004367,1,0.986881690127976,0,2,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
1933,GO:0004368,1,0.984903368380188,0,2,glycerol-3-phosphate dehydrogenase activity,MF,
1934,GO:0004370,1,0.979990403024461,0,2,glycerol kinase activity,MF,
1935,GO:0004372,1,0.989153281269234,0,2,glycine hydroxymethyltransferase activity,MF,
1936,GO:0004373,1,0.987050103141114,0,2,glycogen (starch) synthase activity,MF,
1937,GO:0004375,1,0.992981218339583,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
1938,GO:0004376,1,0.977719582913033,0,4,glycolipid mannosyltransferase activity,MF,
1939,GO:0004377,1,0.994335738426201,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
1940,GO:0004378,1,0.993908240068689,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
1941,GO:0004379,1,0.983830838874912,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
1942,GO:0004380,1,0.995530809509173,0,1,glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity,MF,
1943,GO:0004381,1,0.995530809509173,0,1,fucosylgalactoside 3-alpha-galactosyltransferase activity,MF,
1944,GO:0004382,1,0.988278931716201,0,2,guanosine-diphosphatase activity,MF,
1947,GO:0004386,1,0.340239113215512,0,143,helicase activity,MF,
1948,GO:0004392,1,0.990917845753969,0,2,heme oxygenase (decyclizing) activity,MF,
1949,GO:0004394,1,0.992653447359898,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
1950,GO:0004395,1,0.995925571083506,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
1951,GO:0004396,1,0.964375656274267,0,5,hexokinase activity,MF,
1952,GO:0004397,1,0.993643035872852,0,1,histidine ammonia-lyase activity,MF,
1953,GO:0004398,1,0.994486100098361,0,1,histidine decarboxylase activity,MF,
1954,GO:0004402,1,0.69690328382066,0,50,histone acetyltransferase activity,MF,
1955,GO:0004407,1,0.738191577980817,0,43,histone deacetylase activity,MF,
1956,GO:0004408,1,0.994637907871476,0,1,holocytochrome-c synthase activity,MF,
1957,GO:0004411,1,0.995091529952727,0,1,homogentisate 1,2-dioxygenase activity,MF,
1958,GO:0004415,1,0.965574356721017,0,6,hyalurononglucosaminidase activity,MF,
1959,GO:0004416,1,0.989395786347222,0,2,hydroxyacylglutathione hydrolase activity,MF,
1960,GO:0004418,1,0.995671590620381,0,1,hydroxymethylbilane synthase activity,MF,
1961,GO:0004419,1,0.990008272928123,0,2,hydroxymethylglutaryl-CoA lyase activity,MF,
1962,GO:0004420,1,0.992314228762417,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
1963,GO:0004421,1,0.987839602814174,0,2,hydroxymethylglutaryl-CoA synthase activity,MF,
1964,GO:0004422,1,0.990846505908206,0,2,hypoxanthine phosphoribosyltransferase activity,MF,
1965,GO:0004423,1,0.991022633632201,0,1,iduronate-2-sulfatase activity,MF,
1966,GO:0004427,1,0.986905372665039,0,3,inorganic diphosphatase activity,MF,
1967,GO:0004430,1,0.971374629209718,0,4,1-phosphatidylinositol 4-kinase activity,MF,
1969,GO:0004438,1,0.884493511284262,0,15,phosphatidylinositol-3-phosphatase activity,MF,
1970,GO:0004439,1,0.941391116796443,0,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1971,GO:0004441,1,0.994884365414324,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
1972,GO:0004445,1,0.967945711680743,0,5,inositol-polyphosphate 5-phosphatase activity,MF,
1973,GO:0004446,1,0.993973566421534,0,1,inositol-hexakisphosphate phosphatase activity,MF,
1974,GO:0004447,1,0.993850428511364,0,1,iodide peroxidase activity,MF,
1975,GO:0004448,1,0.975440938336156,0,5,isocitrate dehydrogenase activity,MF,
1976,GO:0004449,1,0.985351594636668,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
1977,GO:0004450,1,0.989943504492188,0,2,isocitrate dehydrogenase (NADP+) activity,MF,
1978,GO:0004452,1,0.994830751629326,0,1,isopentenyl-diphosphate delta-isomerase activity,MF,
1979,GO:0004454,1,0.994477534309093,0,1,ketohexokinase activity,MF,
1980,GO:0004457,1,0.970757376987086,0,6,lactate dehydrogenase activity,MF,
1981,GO:0004458,1,0.989250181174096,0,2,D-lactate dehydrogenase (cytochrome) activity,MF,
1982,GO:0004459,1,0.981308266477515,0,4,L-lactate dehydrogenase activity,MF,
1983,GO:0004461,1,0.984167022980693,0,3,lactose synthase activity,MF,
1984,GO:0004462,1,0.994943164058008,0,1,lactoylglutathione lyase activity,MF,
1985,GO:0004463,1,0.994906478615167,0,1,leukotriene-A4 hydrolase activity,MF,
1986,GO:0004464,1,0.986335827529601,0,4,leukotriene-C4 synthase activity,MF,
1987,GO:0004465,1,0.965662382810153,0,6,lipoprotein lipase activity,MF,
1988,GO:0004466,1,0.972889520231323,0,5,long-chain-acyl-CoA dehydrogenase activity,MF,
1989,GO:0004467,1,0.925733328363595,0,12,long-chain fatty acid-CoA ligase activity,MF,
1990,GO:0004468,1,0.968047165082959,0,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
1991,GO:0004470,1,0.976525473644921,0,4,malic enzyme activity,MF,
1992,GO:0004471,1,0.980528703690497,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1993,GO:0004473,1,0.980528703690497,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
1994,GO:0004474,1,0.991061380407851,0,1,malate synthase activity,MF,
1995,GO:0004475,1,0.995500576717864,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
1996,GO:0004476,1,0.995286990116764,0,1,mannose-6-phosphate isomerase activity,MF,
1997,GO:0004477,1,0.975971440762103,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
1998,GO:0004478,1,0.987430272224567,0,2,methionine adenosyltransferase activity,MF,
1999,GO:0004479,1,0.994084438530368,0,1,methionyl-tRNA formyltransferase activity,MF,
2000,GO:0004482,1,0.990629520793018,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
2001,GO:0004483,1,0.988144472527205,0,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,
2002,GO:0004484,1,0.992354584338207,0,1,mRNA guanylyltransferase activity,MF,
2003,GO:0004485,1,0.987479442583646,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
2004,GO:0004486,1,0.993323285214078,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
2005,GO:0004487,1,0.982672366391647,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
2006,GO:0004488,1,0.975971440762103,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
2007,GO:0004489,1,0.989711097884374,0,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,
2008,GO:0004490,1,0.995518215394111,0,1,methylglutaconyl-CoA hydratase activity,MF,
2009,GO:0004491,1,0.994766612493681,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
2010,GO:0004492,1,0.994853442092789,0,1,methylmalonyl-CoA decarboxylase activity,MF,
2011,GO:0004493,1,0.996419846294915,0,1,methylmalonyl-CoA epimerase activity,MF,
2012,GO:0004494,1,0.993846097502652,0,1,methylmalonyl-CoA mutase activity,MF,
2013,GO:0004496,1,0.994907110706987,0,1,mevalonate kinase activity,MF,
2014,GO:0004497,1,0.630589982825499,0,76,monooxygenase activity,MF,
2015,GO:0004498,1,0.994388744542027,0,1,calcidiol 1-monooxygenase activity,MF,
2016,GO:0004499,1,0.970916863989871,0,5,N,N-dimethylaniline monooxygenase activity,MF,
2017,GO:0004500,1,0.98785765934728,0,2,dopamine beta-monooxygenase activity,MF,
2018,GO:0004502,1,0.991809031043913,0,1,kynurenine 3-monooxygenase activity,MF,
2019,GO:0004504,1,0.993074700335626,0,1,peptidylglycine monooxygenase activity,MF,
2020,GO:0004505,1,0.985006500127697,0,3,phenylalanine 4-monooxygenase activity,MF,
2021,GO:0004506,1,0.993813754158044,0,1,squalene monooxygenase activity,MF,
2022,GO:0004509,1,0.994964690141862,0,1,steroid 21-monooxygenase activity,MF,
2023,GO:0004510,1,0.98979579623483,0,2,tryptophan 5-monooxygenase activity,MF,
2024,GO:0004511,1,0.995119463290967,0,1,tyrosine 3-monooxygenase activity,MF,
2025,GO:0004512,1,0.994669030573683,0,1,inositol-3-phosphate synthase activity,MF,
2026,GO:0004513,1,0.994610588791943,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
2027,GO:0004514,1,0.981977760155945,0,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,
2028,GO:0004515,1,0.97099811283478,0,4,nicotinate-nucleotide adenylyltransferase activity,MF,
2029,GO:0004516,1,0.994054740756748,0,1,nicotinate phosphoribosyltransferase activity,MF,
2030,GO:0004517,1,0.976906877250128,0,3,nitric-oxide synthase activity,MF,
2031,GO:0004518,1,0.298515538789544,0,193,nuclease activity,MF,
2032,GO:0004519,1,0.495839353749087,0,118,endonuclease activity,MF,
2033,GO:0004520,1,0.755154462503648,0,47,endodeoxyribonuclease activity,MF,
2034,GO:0004521,1,0.751690615278705,0,51,endoribonuclease activity,MF,
2035,GO:0004522,1,0.988579404510654,0,3,ribonuclease A activity,MF,
2036,GO:0004523,1,0.971352321503905,0,6,RNA-DNA hybrid ribonuclease activity,MF,
2037,GO:0004525,1,0.96895711260441,0,4,ribonuclease III activity,MF,
2038,GO:0004526,1,0.945370802624748,0,11,ribonuclease P activity,MF,
2039,GO:0004527,1,0.615498110949202,0,73,exonuclease activity,MF,
2040,GO:0004528,1,0.961944379676462,0,6,phosphodiesterase I activity,MF,
2041,GO:0004529,1,0.891667507998974,0,19,exodeoxyribonuclease activity,MF,
2042,GO:0004530,1,0.980636299219568,0,2,deoxyribonuclease I activity,MF,
2043,GO:0004531,1,0.991098149801266,0,2,deoxyribonuclease II activity,MF,
2044,GO:0004532,1,0.796331453278689,0,34,exoribonuclease activity,MF,
2045,GO:0004534,1,0.968688186255098,0,3,5'-3' exoribonuclease activity,MF,
2046,GO:0004535,1,0.913870642964913,0,12,poly(A)-specific ribonuclease activity,MF,
2047,GO:0004536,1,0.678890071319774,0,65,deoxyribonuclease activity,MF,
2048,GO:0004540,1,0.571263558211183,0,94,ribonuclease activity,MF,
2049,GO:0004549,1,0.919742532691223,0,16,tRNA-specific ribonuclease activity,MF,
2050,GO:0004550,1,0.916486005410376,0,17,nucleoside diphosphate kinase activity,MF,
2051,GO:0004551,1,0.91300558942883,0,16,nucleotide diphosphatase activity,MF,
2053,GO:0004556,1,0.990260394305553,0,2,alpha-amylase activity,MF,
2054,GO:0004557,1,0.988837462051534,0,2,alpha-galactosidase activity,MF,
2055,GO:0004558,1,0.975933102010754,0,3,alpha-1,4-glucosidase activity,MF,
2056,GO:0004559,1,0.906208988199112,0,13,alpha-mannosidase activity,MF,
2057,GO:0004560,1,0.989755706774194,0,2,alpha-L-fucosidase activity,MF,
2058,GO:0004561,1,0.994047915725376,0,1,alpha-N-acetylglucosaminidase activity,MF,
2059,GO:0004563,1,0.969563136991992,0,5,beta-N-acetylhexosaminidase activity,MF,
2060,GO:0004565,1,0.96608608376015,0,6,beta-galactosidase activity,MF,
2061,GO:0004566,1,0.981852067781133,0,3,beta-glucuronidase activity,MF,
2062,GO:0004567,1,0.993472999393672,0,1,beta-mannosidase activity,MF,
2064,GO:0004569,1,0.992256046166012,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
2065,GO:0004571,1,0.948932690353168,0,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,
2066,GO:0004572,1,0.982321833743706,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
2067,GO:0004573,1,0.994105688663352,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
2068,GO:0004574,1,0.993194693117792,0,1,oligo-1,6-glucosidase activity,MF,
2069,GO:0004576,1,0.950493545237596,0,10,oligosaccharyl transferase activity,MF,
2070,GO:0004577,1,0.989965551580012,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
2071,GO:0004578,1,0.992873008238407,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
2072,GO:0004579,1,0.954269871604852,0,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
2073,GO:0004581,1,0.996044578029711,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
2074,GO:0004582,1,0.98875156866348,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
2075,GO:0004583,1,0.969810090942506,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
2076,GO:0004584,1,0.994545061767327,0,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,
2077,GO:0004585,1,0.995442563407794,0,1,ornithine carbamoyltransferase activity,MF,
2078,GO:0004586,1,0.981621819642333,0,3,ornithine decarboxylase activity,MF,
2079,GO:0004587,1,0.995022365211478,0,1,ornithine-oxo-acid transaminase activity,MF,
2080,GO:0004588,1,0.994191047919593,0,1,orotate phosphoribosyltransferase activity,MF,
2081,GO:0004590,1,0.994191047919593,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
2082,GO:0004591,1,0.97344876160619,0,4,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,
2083,GO:0004594,1,0.977255906209979,0,4,pantothenate kinase activity,MF,
2084,GO:0004595,1,0.994625481876938,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
2085,GO:0004596,1,0.934900712848964,0,11,peptide alpha-N-acetyltransferase activity,MF,
2086,GO:0004597,1,0.993168102241203,0,1,peptide-aspartate beta-dioxygenase activity,MF,
2087,GO:0004598,1,0.993074700335626,0,1,peptidylamidoglycolate lyase activity,MF,
2088,GO:0004601,1,0.819756279283395,0,38,peroxidase activity,MF,
2089,GO:0004602,1,0.935281410766931,0,16,glutathione peroxidase activity,MF,
2090,GO:0004603,1,0.996063866935014,0,1,phenylethanolamine N-methyltransferase activity,MF,
2091,GO:0004605,1,0.980593289703656,0,3,phosphatidate cytidylyltransferase activity,MF,
2092,GO:0004607,1,0.995814397937747,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
2093,GO:0004608,1,0.996265061457174,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
2094,GO:0004609,1,0.989026330858057,0,2,phosphatidylserine decarboxylase activity,MF,
2095,GO:0004610,1,0.995000173193968,0,1,phosphoacetylglucosamine mutase activity,MF,
2096,GO:0004611,1,0.989229586622609,0,2,phosphoenolpyruvate carboxykinase activity,MF,
2097,GO:0004613,1,0.989229586622609,0,2,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
2098,GO:0004614,1,0.965320235169278,0,5,phosphoglucomutase activity,MF,
2099,GO:0004615,1,0.99051455857279,0,2,phosphomannomutase activity,MF,
2100,GO:0004616,1,0.983252824850312,0,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
2101,GO:0004617,1,0.994973557798029,0,1,phosphoglycerate dehydrogenase activity,MF,
2102,GO:0004618,1,0.99446653393058,0,1,phosphoglycerate kinase activity,MF,
2103,GO:0004619,1,0.982399267386844,0,4,phosphoglycerate mutase activity,MF,
2105,GO:0004621,1,0.99463604311237,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2106,GO:0004622,1,0.894576796227486,0,18,lysophospholipase activity,MF,
2107,GO:0004623,1,0.864666045341089,0,26,phospholipase A2 activity,MF,
2109,GO:0004630,1,0.965001000952,0,6,phospholipase D activity,MF,
2110,GO:0004631,1,0.995885629313125,0,1,phosphomevalonate kinase activity,MF,
2111,GO:0004632,1,0.995928690122563,0,1,phosphopantothenate--cysteine ligase activity,MF,
2112,GO:0004633,1,0.994723993355779,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
2113,GO:0004634,1,0.979528100692882,0,4,phosphopyruvate hydratase activity,MF,
2114,GO:0004637,1,0.993349331339476,0,1,phosphoribosylamine-glycine ligase activity,MF,
2115,GO:0004638,1,0.993450975670729,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
2116,GO:0004639,1,0.993450975670729,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
2117,GO:0004641,1,0.993349331339476,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
2118,GO:0004642,1,0.99142634391198,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
2119,GO:0004643,1,0.994876157112668,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
2120,GO:0004644,1,0.993349331339476,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
2121,GO:0004645,1,0.961993890558767,0,6,phosphorylase activity,MF,
2122,GO:0004647,1,0.985371048929783,0,3,phosphoserine phosphatase activity,MF,
2123,GO:0004648,1,0.994847767098159,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
2124,GO:0004649,1,0.987986150839872,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
2125,GO:0004651,1,0.987842912652185,0,2,polynucleotide 5'-phosphatase activity,MF,
2126,GO:0004652,1,0.934566764434693,0,9,polynucleotide adenylyltransferase activity,MF,
2127,GO:0004653,1,0.882250498964799,0,19,polypeptide N-acetylgalactosaminyltransferase activity,MF,
2128,GO:0004654,1,0.992228391216673,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
2129,GO:0004655,1,0.993607972873277,0,1,porphobilinogen synthase activity,MF,
2130,GO:0004656,1,0.977774141611569,0,4,procollagen-proline 4-dioxygenase activity,MF,
2131,GO:0004657,1,0.994723993355779,0,1,proline dehydrogenase activity,MF,
2132,GO:0004658,1,0.989663561989444,0,2,propionyl-CoA carboxylase activity,MF,
2133,GO:0004659,1,0.910240137647647,0,15,prenyltransferase activity,MF,
2134,GO:0004660,1,0.989528014042836,0,2,protein farnesyltransferase activity,MF,
2135,GO:0004661,1,0.973102244893603,0,5,protein geranylgeranyltransferase activity,MF,
2136,GO:0004662,1,0.989635598164649,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2137,GO:0004663,1,0.978872703839603,0,4,Rab geranylgeranyltransferase activity,MF,
2138,GO:0004666,1,0.984183851219333,0,2,prostaglandin-endoperoxide synthase activity,MF,
2139,GO:0004667,1,0.991990243676777,0,2,prostaglandin-D synthase activity,MF,
2140,GO:0004668,1,0.973913012962342,0,4,protein-arginine deiminase activity,MF,
2141,GO:0004671,1,0.992019225454784,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
2143,GO:0004673,1,0.951339101769188,0,7,protein histidine kinase activity,MF,
2145,GO:0004675,1,0.876510736453926,0,15,transmembrane receptor protein serine/threonine kinase activity,MF,
2146,GO:0004676,1,0.989811760420519,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
2147,GO:0004677,1,0.964636671809557,0,3,DNA-dependent protein kinase activity,MF,
2148,GO:0004679,1,0.949820685310677,0,7,AMP-activated protein kinase activity,MF,
2150,GO:0004686,1,0.989456432416391,0,1,elongation factor-2 kinase activity,MF,
2151,GO:0004687,1,0.963801442104385,0,4,myosin light chain kinase activity,MF,
2152,GO:0004689,1,0.962584537853245,0,5,phosphorylase kinase activity,MF,
2153,GO:0004690,1,0.936939710323383,0,8,cyclic nucleotide-dependent protein kinase activity,MF,
2154,GO:0004691,1,0.949781318451059,0,6,cAMP-dependent protein kinase activity,MF,
2155,GO:0004692,1,0.986486386063216,0,2,cGMP-dependent protein kinase activity,MF,
2156,GO:0004693,1,0.806878911428891,0,34,cyclin-dependent protein serine/threonine kinase activity,MF,
2157,GO:0004694,1,0.970280762825621,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
2158,GO:0004697,1,0.893325631072959,0,15,protein kinase C activity,MF,
2159,GO:0004698,1,0.973535264062425,0,3,calcium-dependent protein kinase C activity,MF,
2160,GO:0004699,1,0.978775160576039,0,3,calcium-independent protein kinase C activity,MF,
2161,GO:0004702,1,0.400696564742566,0,118,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,
2162,GO:0004703,1,0.97791737656684,0,4,G-protein coupled receptor kinase activity,MF,
2163,GO:0004704,1,0.967612566965363,0,5,NF-kappaB-inducing kinase activity,MF,
2164,GO:0004705,1,0.981184082209509,0,3,JUN kinase activity,MF,
2165,GO:0004706,1,0.977965993659001,0,3,JUN kinase kinase kinase activity,MF,
2166,GO:0004707,1,0.917098682114943,0,14,MAP kinase activity,MF,
2167,GO:0004708,1,0.906659344494436,0,15,MAP kinase kinase activity,MF,
2168,GO:0004709,1,0.539567463649804,0,78,MAP kinase kinase kinase activity,MF,
2169,GO:0004711,1,0.94433563539109,0,7,ribosomal protein S6 kinase activity,MF,
2170,GO:0004712,1,0.757706274085263,0,41,protein serine/threonine/tyrosine kinase activity,MF,
2171,GO:0004713,1,0.295979033098488,0,170,protein tyrosine kinase activity,MF,
2172,GO:0004714,1,0.599830135551944,0,65,transmembrane receptor protein tyrosine kinase activity,MF,
2173,GO:0004715,1,0.72299668314192,0,49,non-membrane spanning protein tyrosine kinase activity,MF,
2174,GO:0004716,1,0.923258403298195,0,9,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,
2175,GO:0004719,1,0.981027589293755,0,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,
2176,GO:0004720,1,0.961909666127312,0,6,protein-lysine 6-oxidase activity,MF,
2178,GO:0004722,1,0.640805715501919,0,67,protein serine/threonine phosphatase activity,MF,
2179,GO:0004723,1,0.94911032836361,0,7,calcium-dependent protein serine/threonine phosphatase activity,MF,
2181,GO:0004726,1,0.950242398685418,0,8,non-membrane spanning protein tyrosine phosphatase activity,MF,
2182,GO:0004727,1,0.990841754876732,0,2,prenylated protein tyrosine phosphatase activity,MF,
2183,GO:0004728,1,0.994268886159727,0,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,
2184,GO:0004729,1,0.99532309742253,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
2185,GO:0004730,1,0.995422363806997,0,1,pseudouridylate synthase activity,MF,
2186,GO:0004731,1,0.986437354644902,0,2,purine-nucleoside phosphorylase activity,MF,
2187,GO:0004733,1,0.993330156877131,0,1,pyridoxamine-phosphate oxidase activity,MF,
2188,GO:0004735,1,0.990550220359505,0,2,pyrroline-5-carboxylate reductase activity,MF,
2189,GO:0004736,1,0.992795297843448,0,1,pyruvate carboxylase activity,MF,
2190,GO:0004738,1,0.969249293980597,0,5,pyruvate dehydrogenase activity,MF,
2191,GO:0004739,1,0.989031116260356,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
2192,GO:0004740,1,0.969895442939297,0,4,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
2193,GO:0004741,1,0.974685122980388,0,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
2194,GO:0004742,1,0.992473282198371,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
2195,GO:0004743,1,0.987857119376305,0,2,pyruvate kinase activity,MF,
2196,GO:0004744,1,0.994238094890298,0,1,retinal isomerase activity,MF,
2197,GO:0004745,1,0.94009113971565,0,12,retinol dehydrogenase activity,MF,
2198,GO:0004747,1,0.996009092494673,0,1,ribokinase activity,MF,
2199,GO:0004748,1,0.979091393063358,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2200,GO:0004749,1,0.978975205632008,0,4,ribose phosphate diphosphokinase activity,MF,
2201,GO:0004750,1,0.994624240025219,0,1,ribulose-phosphate 3-epimerase activity,MF,
2202,GO:0004751,1,0.995207071982963,0,1,ribose-5-phosphate isomerase activity,MF,
2203,GO:0004753,1,0.990947239315527,0,1,saccharopine dehydrogenase activity,MF,
2204,GO:0004756,1,0.988957602047516,0,2,selenide, water dikinase activity,MF,
2205,GO:0004757,1,0.995686645468036,0,1,sepiapterin reductase activity,MF,
2206,GO:0004758,1,0.966302453287211,0,5,serine C-palmitoyltransferase activity,MF,
2207,GO:0004760,1,0.995503097025035,0,1,serine-pyruvate transaminase activity,MF,
2208,GO:0004766,1,0.99591309289349,0,1,spermidine synthase activity,MF,
2209,GO:0004767,1,0.969346415158375,0,5,sphingomyelin phosphodiesterase activity,MF,
2210,GO:0004768,1,0.979415978018727,0,3,stearoyl-CoA 9-desaturase activity,MF,
2211,GO:0004769,1,0.996063866935014,0,1,steroid delta-isomerase activity,MF,
2212,GO:0004771,1,0.951215934024855,0,8,sterol esterase activity,MF,
2213,GO:0004772,1,0.993392284425244,0,1,sterol O-acyltransferase activity,MF,
2214,GO:0004773,1,0.990462898230888,0,1,steryl-sulfatase activity,MF,
2215,GO:0004774,1,0.985095585536086,0,3,succinate-CoA ligase activity,MF,
2216,GO:0004775,1,0.990490622847112,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
2217,GO:0004776,1,0.990258601864847,0,2,succinate-CoA ligase (GDP-forming) activity,MF,
2218,GO:0004777,1,0.991678213729253,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
2219,GO:0004778,1,0.995471581200991,0,1,succinyl-CoA hydrolase activity,MF,
2220,GO:0004779,1,0.987313227578771,0,2,sulfate adenylyltransferase activity,MF,
2221,GO:0004781,1,0.987313227578771,0,2,sulfate adenylyltransferase (ATP) activity,MF,
2222,GO:0004782,1,0.994133978983308,0,1,sulfinoalanine decarboxylase activity,MF,
2223,GO:0004784,1,0.978914926690751,0,5,superoxide dismutase activity,MF,
2224,GO:0004788,1,0.994548759404803,0,1,thiamine diphosphokinase activity,MF,
2225,GO:0004790,1,0.994309390787771,0,1,thioether S-methyltransferase activity,MF,
2226,GO:0004791,1,0.960320129056475,0,8,thioredoxin-disulfide reductase activity,MF,
2227,GO:0004792,1,0.986261503524884,0,3,thiosulfate sulfurtransferase activity,MF,
2228,GO:0004793,1,0.989153281269234,0,2,threonine aldolase activity,MF,
2229,GO:0004794,1,0.991276298374286,0,2,L-threonine ammonia-lyase activity,MF,
2230,GO:0004795,1,0.994854703412215,0,1,threonine synthase activity,MF,
2231,GO:0004796,1,0.994857857040155,0,1,thromboxane-A synthase activity,MF,
2232,GO:0004797,1,0.987327771952506,0,2,thymidine kinase activity,MF,
2233,GO:0004798,1,0.98993040397395,0,2,thymidylate kinase activity,MF,
2234,GO:0004799,1,0.995525772354966,0,1,thymidylate synthase activity,MF,
2235,GO:0004800,1,0.985383540653272,0,2,thyroxine 5'-deiodinase activity,MF,
2236,GO:0004801,1,0.995951764743922,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
2237,GO:0004802,1,0.989100286027618,0,2,transketolase activity,MF,
2238,GO:0004803,1,0.992778955217429,0,1,transposase activity,MF,
2239,GO:0004806,1,0.897588771842123,0,18,triglyceride lipase activity,MF,
2240,GO:0004807,1,0.995682882264999,0,1,triose-phosphate isomerase activity,MF,
2241,GO:0004809,1,0.983957724097845,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
2242,GO:0004810,1,0.994652836670812,0,1,tRNA adenylyltransferase activity,MF,
2243,GO:0004812,1,0.770339821549192,0,44,aminoacyl-tRNA ligase activity,MF,
2244,GO:0004813,1,0.980718739363232,0,3,alanine-tRNA ligase activity,MF,
2245,GO:0004814,1,0.984778577976615,0,3,arginine-tRNA ligase activity,MF,
2246,GO:0004815,1,0.988052319229923,0,2,aspartate-tRNA ligase activity,MF,
2247,GO:0004816,1,0.988626580822281,0,2,asparagine-tRNA ligase activity,MF,
2248,GO:0004817,1,0.989388499460258,0,2,cysteine-tRNA ligase activity,MF,
2249,GO:0004818,1,0.984741948232416,0,2,glutamate-tRNA ligase activity,MF,
2250,GO:0004819,1,0.986441742260113,0,2,glutamine-tRNA ligase activity,MF,
2251,GO:0004820,1,0.989612495296607,0,2,glycine-tRNA ligase activity,MF,
2252,GO:0004821,1,0.989446050942448,0,2,histidine-tRNA ligase activity,MF,
2253,GO:0004822,1,0.985631398140448,0,2,isoleucine-tRNA ligase activity,MF,
2254,GO:0004823,1,0.984618436070645,0,2,leucine-tRNA ligase activity,MF,
2255,GO:0004824,1,0.994860380278518,0,1,lysine-tRNA ligase activity,MF,
2256,GO:0004825,1,0.9878335743471,0,2,methionine-tRNA ligase activity,MF,
2257,GO:0004826,1,0.973320263464512,0,5,phenylalanine-tRNA ligase activity,MF,
2258,GO:0004827,1,0.982553676083417,0,3,proline-tRNA ligase activity,MF,
2259,GO:0004828,1,0.990057496706883,0,2,serine-tRNA ligase activity,MF,
2260,GO:0004829,1,0.982071006732854,0,3,threonine-tRNA ligase activity,MF,
2261,GO:0004830,1,0.98818989829456,0,2,tryptophan-tRNA ligase activity,MF,
2262,GO:0004831,1,0.988506031511682,0,2,tyrosine-tRNA ligase activity,MF,
2263,GO:0004832,1,0.977801755603153,0,3,valine-tRNA ligase activity,MF,
2264,GO:0004833,1,0.990943192576202,0,2,tryptophan 2,3-dioxygenase activity,MF,
2265,GO:0004835,1,0.99167221858092,0,1,tubulin-tyrosine ligase activity,MF,
2266,GO:0004838,1,0.994067281034976,0,1,L-tyrosine:2-oxoglutarate aminotransferase activity,MF,
2267,GO:0004839,1,0.963853337411042,0,5,ubiquitin activating enzyme activity,MF,
2269,GO:0004843,1,0.588528014692482,0,70,thiol-dependent ubiquitin-specific protease activity,MF,
2270,GO:0004844,1,0.975632465650335,0,5,uracil DNA N-glycosylase activity,MF,
2271,GO:0004849,1,0.974540505270879,0,5,uridine kinase activity,MF,
2272,GO:0004850,1,0.989750321689555,0,2,uridine phosphorylase activity,MF,
2273,GO:0004852,1,0.995810645825072,0,1,uroporphyrinogen-III synthase activity,MF,
2274,GO:0004853,1,0.995773107291764,0,1,uroporphyrinogen decarboxylase activity,MF,
2275,GO:0004854,1,0.983029835828362,0,2,xanthine dehydrogenase activity,MF,
2276,GO:0004855,1,0.99108623694053,0,1,xanthine oxidase activity,MF,
2277,GO:0004856,1,0.993105936622397,0,1,xylulokinase activity,MF,
2279,GO:0004859,1,0.964331253044567,0,8,phospholipase inhibitor activity,MF,
2280,GO:0004860,1,0.575323271300117,0,89,protein kinase inhibitor activity,MF,
2281,GO:0004861,1,0.936724173405707,0,12,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,
2282,GO:0004862,1,0.95117495418958,0,9,cAMP-dependent protein kinase inhibitor activity,MF,
2286,GO:0004867,1,0.696927054694054,0,61,serine-type endopeptidase inhibitor activity,MF,
2289,GO:0004873,1,0.991374151620798,0,2,asialoglycoprotein receptor activity,MF,
2290,GO:0004874,1,0.982698620718807,0,2,aryl hydrocarbon receptor activity,MF,
2291,GO:0004875,1,0.957434989600161,0,7,complement receptor activity,MF,
2292,GO:0004876,1,0.995061064269811,0,1,complement component C3a receptor activity,MF,
2293,GO:0004877,1,0.987694060342987,0,1,complement component C3b receptor activity,MF,
2294,GO:0004878,1,0.988662582393187,0,2,complement component C5a receptor activity,MF,
2295,GO:0004879,1,0.721463993801797,0,46,nuclear receptor activity,MF,
2296,GO:0004882,1,0.987319244173494,0,2,androgen receptor activity,MF,
2297,GO:0004883,1,0.990231890163882,0,1,glucocorticoid receptor activity,MF,
2298,GO:0004886,1,0.981322095973284,0,3,9-cis retinoic acid receptor activity,MF,
2299,GO:0004887,1,0.959704951970809,0,6,thyroid hormone receptor activity,MF,
2302,GO:0004896,1,0.599838462325881,0,82,cytokine receptor activity,MF,
2303,GO:0004897,1,0.968585067632738,0,4,ciliary neurotrophic factor receptor activity,MF,
2304,GO:0004900,1,0.995189299683767,0,1,erythropoietin receptor activity,MF,
2305,GO:0004904,1,0.970418085843371,0,5,interferon receptor activity,MF,
2306,GO:0004905,1,0.986519312671229,0,2,type I interferon receptor activity,MF,
2307,GO:0004906,1,0.989593053262675,0,2,interferon-gamma receptor activity,MF,
2308,GO:0004908,1,0.958161823342866,0,7,interleukin-1 receptor activity,MF,
2309,GO:0004909,1,0.986998611569652,0,2,interleukin-1, Type I, activating receptor activity,MF,
2310,GO:0004910,1,0.989560109062795,0,2,interleukin-1, Type II, blocking receptor activity,MF,
2311,GO:0004911,1,0.982038178405354,0,3,interleukin-2 receptor activity,MF,
2312,GO:0004912,1,0.991979443321047,0,1,interleukin-3 receptor activity,MF,
2313,GO:0004913,1,0.990123226262165,0,2,interleukin-4 receptor activity,MF,
2314,GO:0004914,1,0.986991654429457,0,2,interleukin-5 receptor activity,MF,
2315,GO:0004915,1,0.986332943431376,0,2,interleukin-6 receptor activity,MF,
2316,GO:0004917,1,0.990854619478344,0,2,interleukin-7 receptor activity,MF,
2317,GO:0004918,1,0.988501579974727,0,2,interleukin-8 receptor activity,MF,
2318,GO:0004920,1,0.968951554461672,0,5,interleukin-10 receptor activity,MF,
2319,GO:0004921,1,0.993599757936655,0,1,interleukin-11 receptor activity,MF,
2320,GO:0004923,1,0.980610116364822,0,2,leukemia inhibitory factor receptor activity,MF,
2321,GO:0004924,1,0.973896586163798,0,3,oncostatin-M receptor activity,MF,
2322,GO:0004925,1,0.985548881027674,0,1,prolactin receptor activity,MF,
2324,GO:0004931,1,0.963328373839,0,7,extracellularly ATP-gated cation channel activity,MF,
2325,GO:0004935,1,0.945911539754139,0,10,adrenergic receptor activity,MF,
2326,GO:0004936,1,0.971957071292856,0,5,alpha-adrenergic receptor activity,MF,
2327,GO:0004937,1,0.983725861766795,0,3,alpha1-adrenergic receptor activity,MF,
2328,GO:0004938,1,0.988038486411277,0,2,alpha2-adrenergic receptor activity,MF,
2329,GO:0004939,1,0.983220158997822,0,3,beta-adrenergic receptor activity,MF,
2330,GO:0004940,1,0.993963532966552,0,1,beta1-adrenergic receptor activity,MF,
2331,GO:0004941,1,0.99495329221185,0,1,beta2-adrenergic receptor activity,MF,
2332,GO:0004945,1,0.986775883549633,0,3,angiotensin type II receptor activity,MF,
2333,GO:0004946,1,0.995744306013715,0,1,bombesin receptor activity,MF,
2334,GO:0004947,1,0.988559032088689,0,2,bradykinin receptor activity,MF,
2335,GO:0004948,1,0.98506625310955,0,2,calcitonin receptor activity,MF,
2337,GO:0004950,1,0.875833252411748,0,24,chemokine receptor activity,MF,
2338,GO:0004951,1,0.990276510765678,0,2,cholecystokinin receptor activity,MF,
2339,GO:0004952,1,0.964560689024397,0,7,dopamine neurotransmitter receptor activity,MF,
2340,GO:0004953,1,0.909750916741072,0,17,icosanoid receptor activity,MF,
2341,GO:0004954,1,0.938476645233629,0,11,prostanoid receptor activity,MF,
2342,GO:0004955,1,0.943517102441496,0,10,prostaglandin receptor activity,MF,
2343,GO:0004956,1,0.98796403950403,0,2,prostaglandin D receptor activity,MF,
2344,GO:0004957,1,0.966936802696201,0,6,prostaglandin E receptor activity,MF,
2345,GO:0004958,1,0.985545454541081,0,2,prostaglandin F receptor activity,MF,
2346,GO:0004960,1,0.994660930931217,0,1,thromboxane receptor activity,MF,
2347,GO:0004961,1,0.994660930931217,0,1,thromboxane A2 receptor activity,MF,
2348,GO:0004962,1,0.98557560976996,0,2,endothelin receptor activity,MF,
2349,GO:0004965,1,0.97631213158595,0,3,G-protein coupled GABA receptor activity,MF,
2350,GO:0004966,1,0.953234794953037,0,10,galanin receptor activity,MF,
2351,GO:0004967,1,0.989116265440225,0,2,glucagon receptor activity,MF,
2352,GO:0004968,1,0.992577695112031,0,1,gonadotropin-releasing hormone receptor activity,MF,
2353,GO:0004969,1,0.969885091960935,0,5,histamine receptor activity,MF,
2355,GO:0004971,1,0.966625298667331,0,4,AMPA glutamate receptor activity,MF,
2357,GO:0004974,1,0.969410456626742,0,6,leukotriene receptor activity,MF,
2358,GO:0004977,1,0.981018093811254,0,4,melanocortin receptor activity,MF,
2359,GO:0004979,1,0.995171524763314,0,1,beta-endorphin receptor activity,MF,
2360,GO:0004980,1,0.989448758472213,0,2,melanocyte-stimulating hormone receptor activity,MF,
2361,GO:0004982,1,0.985353399047283,0,3,N-formyl peptide receptor activity,MF,
2363,GO:0004984,1,0.924653017071046,0,18,olfactory receptor activity,MF,
2364,GO:0004985,1,0.959099676240012,0,8,opioid receptor activity,MF,
2365,GO:0004990,1,0.992469368457749,0,1,oxytocin receptor activity,MF,
2366,GO:0004991,1,0.988983035092071,0,2,parathyroid hormone receptor activity,MF,
2367,GO:0004992,1,0.97954554435013,0,3,platelet activating factor receptor activity,MF,
2368,GO:0004993,1,0.932089838489807,0,13,G-protein coupled serotonin receptor activity,MF,
2369,GO:0004994,1,0.977661680752294,0,4,somatostatin receptor activity,MF,
2370,GO:0004995,1,0.9834258768451,0,3,tachykinin receptor activity,MF,
2371,GO:0004996,1,0.988917911303298,0,2,thyroid-stimulating hormone receptor activity,MF,
2372,GO:0004998,1,0.985630668775277,0,2,transferrin receptor activity,MF,
2373,GO:0004999,1,0.982431076336995,0,3,vasoactive intestinal polypeptide receptor activity,MF,
2374,GO:0005000,1,0.964525713998028,0,6,vasopressin receptor activity,MF,
2375,GO:0005001,1,0.868071684346517,0,16,transmembrane receptor protein tyrosine phosphatase activity,MF,
2376,GO:0005003,1,0.872525437939668,0,19,ephrin receptor activity,MF,
2377,GO:0005004,1,0.945143205489225,0,7,GPI-linked ephrin receptor activity,MF,
2378,GO:0005005,1,0.882975340928431,0,17,transmembrane-ephrin receptor activity,MF,
2379,GO:0005006,1,0.988444063834702,0,2,epidermal growth factor-activated receptor activity,MF,
2380,GO:0005007,1,0.964417222207309,0,5,fibroblast growth factor-activated receptor activity,MF,
2381,GO:0005008,1,0.99018625561594,0,1,hepatocyte growth factor-activated receptor activity,MF,
2382,GO:0005009,1,0.98793875927069,0,1,insulin-activated receptor activity,MF,
2383,GO:0005010,1,0.958414616911829,0,4,insulin-like growth factor-activated receptor activity,MF,
2384,GO:0005011,1,0.984915308179722,0,2,macrophage colony-stimulating factor receptor activity,MF,
2385,GO:0005017,1,0.977155318126187,0,3,platelet-derived growth factor-activated receptor activity,MF,
2386,GO:0005018,1,0.990257159973545,0,1,platelet-derived growth factor alpha-receptor activity,MF,
2387,GO:0005019,1,0.986770551305356,0,2,platelet-derived growth factor beta-receptor activity,MF,
2388,GO:0005020,1,0.991649235187485,0,1,stem cell factor receptor activity,MF,
2389,GO:0005021,1,0.944863144619465,0,7,vascular endothelial growth factor-activated receptor activity,MF,
2390,GO:0005024,1,0.936068098910594,0,8,transforming growth factor beta-activated receptor activity,MF,
2391,GO:0005025,1,0.96859970113263,0,4,transforming growth factor beta receptor activity, type I,MF,
2392,GO:0005026,1,0.992165083474084,0,1,transforming growth factor beta receptor activity, type II,MF,
2393,GO:0005030,1,0.96809842373078,0,4,neurotrophin receptor activity,MF,
2394,GO:0005031,1,0.876813553780501,0,24,tumor necrosis factor-activated receptor activity,MF,
2395,GO:0005034,1,0.993640449307716,0,1,osmosensor activity,MF,
2396,GO:0005035,1,0.876813553780501,0,24,death receptor activity,MF,
2397,GO:0005041,1,0.883507689472935,0,13,low-density lipoprotein particle receptor activity,MF,
2398,GO:0005042,1,0.949382404526304,0,6,netrin receptor activity,MF,
2399,GO:0005044,1,0.712480473917827,0,50,scavenger receptor activity,MF,
2400,GO:0005046,1,0.989690889772903,0,2,KDEL sequence binding,MF,
2401,GO:0005047,1,0.96587433899094,0,6,signal recognition particle binding,MF,
2402,GO:0005048,1,0.7675197534235,0,39,signal sequence binding,MF,
2403,GO:0005049,1,0.93547635445403,0,8,nuclear export signal receptor activity,MF,
2404,GO:0005052,1,0.986871229184005,0,2,peroxisome matrix targeting signal-1 binding,MF,
2405,GO:0005053,1,0.995650253571128,0,1,peroxisome matrix targeting signal-2 binding,MF,
2406,GO:0005055,1,0.990578236261124,0,2,laminin receptor activity,MF,
2407,GO:0005057,1,0.294016664471063,0,163,signal transducer activity, downstream of receptor,MF,
2408,GO:0005068,1,0.920771968929411,0,11,transmembrane receptor protein tyrosine kinase adaptor activity,MF,
2409,GO:0005070,1,0.688381395701629,0,57,SH3/SH2 adaptor activity,MF,
2410,GO:0005072,1,0.919618216944741,0,10,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,
2411,GO:0005078,1,0.937006489178193,0,7,MAP-kinase scaffold activity,MF,
2415,GO:0005087,1,0.980247934174496,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
2417,GO:0005089,1,0.517975759824196,0,77,Rho guanyl-nucleotide exchange factor activity,MF,
2418,GO:0005090,1,0.994787965799874,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
2419,GO:0005092,1,0.921359770048216,0,14,GDP-dissociation inhibitor activity,MF,
2420,GO:0005093,1,0.988988499303065,0,2,Rab GDP-dissociation inhibitor activity,MF,
2421,GO:0005094,1,0.987540254046294,0,3,Rho GDP-dissociation inhibitor activity,MF,
2422,GO:0005095,1,0.90975130556365,0,14,GTPase inhibitor activity,MF,
2425,GO:0005104,1,0.883630520238793,0,20,fibroblast growth factor receptor binding,MF,
2426,GO:0005105,1,0.986312054241367,0,3,type 1 fibroblast growth factor receptor binding,MF,
2427,GO:0005109,1,0.812144842741921,0,33,frizzled binding,MF,
2428,GO:0005111,1,0.988362495023686,0,3,type 2 fibroblast growth factor receptor binding,MF,
2429,GO:0005112,1,0.84149575750185,0,21,Notch binding,MF,
2430,GO:0005113,1,0.956060144998057,0,7,patched binding,MF,
2431,GO:0005114,1,0.9509486120541,0,7,type II transforming growth factor beta receptor binding,MF,
2432,GO:0005115,1,0.990997815957518,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
2433,GO:0005119,1,0.975442900726354,0,3,smoothened binding,MF,
2434,GO:0005123,1,0.908091934554705,0,16,death receptor binding,MF,
2435,GO:0005124,1,0.980418252922452,0,4,scavenger receptor binding,MF,
2438,GO:0005127,1,0.966598174520813,0,5,ciliary neurotrophic factor receptor binding,MF,
2439,GO:0005128,1,0.989400145257542,0,2,erythropoietin receptor binding,MF,
2440,GO:0005130,1,0.995611316222391,0,1,granulocyte colony-stimulating factor receptor binding,MF,
2441,GO:0005131,1,0.970900985655594,0,4,growth hormone receptor binding,MF,
2442,GO:0005134,1,0.983163687547609,0,3,interleukin-2 receptor binding,MF,
2443,GO:0005135,1,0.99352538125468,0,1,interleukin-3 receptor binding,MF,
2444,GO:0005136,1,0.989009352855154,0,2,interleukin-4 receptor binding,MF,
2445,GO:0005137,1,0.994789222732316,0,1,interleukin-5 receptor binding,MF,
2446,GO:0005138,1,0.959277969534807,0,7,interleukin-6 receptor binding,MF,
2447,GO:0005139,1,0.989294466633241,0,2,interleukin-7 receptor binding,MF,
2448,GO:0005141,1,0.995470320023357,0,1,interleukin-10 receptor binding,MF,
2449,GO:0005142,1,0.994556158930941,0,1,interleukin-11 receptor binding,MF,
2450,GO:0005143,1,0.982355790656167,0,3,interleukin-12 receptor binding,MF,
2451,GO:0005144,1,0.995906852572358,0,1,interleukin-13 receptor binding,MF,
2452,GO:0005146,1,0.988359005478291,0,2,leukemia inhibitory factor receptor binding,MF,
2453,GO:0005147,1,0.995177873192027,0,1,oncostatin-M receptor binding,MF,
2454,GO:0005148,1,0.996018433184944,0,1,prolactin receptor binding,MF,
2455,GO:0005149,1,0.933713292242957,0,11,interleukin-1 receptor binding,MF,
2456,GO:0005150,1,0.98850432469374,0,2,interleukin-1, Type I receptor binding,MF,
2457,GO:0005151,1,0.986802468364225,0,2,interleukin-1, Type II receptor binding,MF,
2458,GO:0005152,1,0.985341343186611,0,2,interleukin-1 receptor antagonist activity,MF,
2459,GO:0005153,1,0.987766153574864,0,2,interleukin-8 receptor binding,MF,
2460,GO:0005154,1,0.811376071885969,0,29,epidermal growth factor receptor binding,MF,
2461,GO:0005157,1,0.985428864069122,0,3,macrophage colony-stimulating factor receptor binding,MF,
2462,GO:0005158,1,0.831408114484105,0,21,insulin receptor binding,MF,
2463,GO:0005159,1,0.909454567948354,0,13,insulin-like growth factor receptor binding,MF,
2464,GO:0005160,1,0.751728282548658,0,45,transforming growth factor beta receptor binding,MF,
2465,GO:0005161,1,0.899722325998537,0,14,platelet-derived growth factor receptor binding,MF,
2466,GO:0005163,1,0.996198075687885,0,1,nerve growth factor receptor binding,MF,
2467,GO:0005164,1,0.859916482857444,0,29,tumor necrosis factor receptor binding,MF,
2468,GO:0005165,1,0.928909660411636,0,11,neurotrophin receptor binding,MF,
2469,GO:0005166,1,0.986475518895278,0,3,neurotrophin p75 receptor binding,MF,
2470,GO:0005167,1,0.941714896481637,0,8,neurotrophin TRK receptor binding,MF,
2471,GO:0005168,1,0.9521079006543,0,6,neurotrophin TRKA receptor binding,MF,
2472,GO:0005169,1,0.980680717677465,0,3,neurotrophin TRKB receptor binding,MF,
2473,GO:0005170,1,0.991499303479958,0,1,neurotrophin TRKC receptor binding,MF,
2474,GO:0005171,1,0.989956382278923,0,2,hepatocyte growth factor receptor binding,MF,
2475,GO:0005172,1,0.938456290888593,0,10,vascular endothelial growth factor receptor binding,MF,
2476,GO:0005173,1,0.973840925492947,0,3,stem cell factor receptor binding,MF,
2477,GO:0005174,1,0.989884160676787,0,2,CD40 receptor binding,MF,
2478,GO:0005175,1,0.996663114202392,0,1,CD27 receptor binding,MF,
2479,GO:0005176,1,0.983096010849256,0,3,ErbB-2 class receptor binding,MF,
2482,GO:0005183,1,0.99237479803136,0,2,gonadotropin hormone-releasing hormone activity,MF,
2485,GO:0005199,1,0.993426042293638,0,1,structural constituent of cell wall,MF,
2491,GO:0005217,1,0.762157303690334,0,31,intracellular ligand-gated ion channel activity,MF,
2492,GO:0005219,1,0.944387998523838,0,4,ryanodine-sensitive calcium-release channel activity,MF,
2493,GO:0005220,1,0.960277270329176,0,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,
2494,GO:0005221,1,0.939022581714592,0,9,intracellular cyclic nucleotide activated cation channel activity,MF,
2495,GO:0005222,1,0.944618065517137,0,8,intracellular cAMP activated cation channel activity,MF,
2496,GO:0005223,1,0.963405151891204,0,6,intracellular cGMP activated cation channel activity,MF,
2497,GO:0005225,1,0.928338730226587,0,10,volume-sensitive anion channel activity,MF,
2498,GO:0005227,1,0.839702301788452,0,27,calcium activated cation channel activity,MF,
2499,GO:0005228,1,0.983014454357692,0,2,intracellular sodium activated potassium channel activity,MF,
2500,GO:0005229,1,0.882919297045129,0,18,intracellular calcium activated chloride channel activity,MF,
2505,GO:0005242,1,0.881074671504462,0,20,inward rectifier potassium channel activity,MF,
2506,GO:0005243,1,0.940136150908835,0,10,gap junction channel activity,MF,
2508,GO:0005245,1,0.717979844431865,0,41,voltage-gated calcium channel activity,MF,
2509,GO:0005246,1,0.825424609717525,0,30,calcium channel regulator activity,MF,
2510,GO:0005247,1,0.929651627627384,0,10,voltage-gated chloride channel activity,MF,
2511,GO:0005248,1,0.80355512642466,0,23,voltage-gated sodium channel activity,MF,
2513,GO:0005250,1,0.972548982198511,0,4,A-type (transient outward) potassium channel activity,MF,
2515,GO:0005252,1,0.99283945646826,0,1,open rectifier potassium channel activity,MF,
2518,GO:0005260,1,0.990687528820758,0,1,intracellularly ATP-gated chloride channel activity,MF,
2522,GO:0005272,1,0.691006516010414,0,44,sodium channel activity,MF,
2523,GO:0005275,1,0.988847695384985,0,2,amine transmembrane transporter activity,MF,
2524,GO:0005277,1,0.984111586093965,0,3,acetylcholine transmembrane transporter activity,MF,
2525,GO:0005280,1,0.974544278577371,0,4,amino acid:proton symporter activity,MF,
2526,GO:0005283,1,0.88696060615316,0,17,amino acid:sodium symporter activity,MF,
2527,GO:0005287,1,0.983915839550454,0,2,high-affinity basic amino acid transmembrane transporter activity,MF,
2528,GO:0005289,1,0.983915839550454,0,2,high-affinity arginine transmembrane transporter activity,MF,
2529,GO:0005290,1,0.982607899518784,0,3,L-histidine transmembrane transporter activity,MF,
2530,GO:0005292,1,0.983915839550454,0,2,high-affinity lysine transmembrane transporter activity,MF,
2531,GO:0005294,1,0.987400732769895,0,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2532,GO:0005295,1,0.987560470216878,0,2,neutral amino acid:sodium symporter activity,MF,
2533,GO:0005298,1,0.985579022966387,0,2,proline:sodium symporter activity,MF,
2534,GO:0005302,1,0.993643035872852,0,1,L-tyrosine transmembrane transporter activity,MF,
2535,GO:0005308,1,0.985512577757081,0,2,creatine transmembrane transporter activity,MF,
2536,GO:0005309,1,0.993254875710568,0,1,creatine:sodium symporter activity,MF,
2539,GO:0005314,1,0.951070534391066,0,7,high-affinity glutamate transmembrane transporter activity,MF,
2541,GO:0005316,1,0.993507195519044,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
2542,GO:0005319,1,0.444667303883305,0,117,lipid transporter activity,MF,
2543,GO:0005324,1,0.972560559289278,0,5,long-chain fatty acid transporter activity,MF,
2546,GO:0005329,1,0.960014910207979,0,6,dopamine transmembrane transporter activity,MF,
2547,GO:0005330,1,0.978743336649729,0,3,dopamine:sodium symporter activity,MF,
2548,GO:0005332,1,0.975828969803321,0,4,gamma-aminobutyric acid:sodium symporter activity,MF,
2549,GO:0005333,1,0.98307618848362,0,3,norepinephrine transmembrane transporter activity,MF,
2550,GO:0005334,1,0.993435007118271,0,1,norepinephrine:sodium symporter activity,MF,
2551,GO:0005335,1,0.992288604496873,0,1,serotonin:sodium symporter activity,MF,
2552,GO:0005337,1,0.96768133986971,0,6,nucleoside transmembrane transporter activity,MF,
2553,GO:0005338,1,0.929872880200279,0,12,nucleotide-sugar transmembrane transporter activity,MF,
2555,GO:0005343,1,0.833894397833598,0,26,organic acid:sodium symporter activity,MF,
2556,GO:0005344,1,0.948228321431393,0,13,oxygen carrier activity,MF,
2557,GO:0005345,1,0.971993304200582,0,5,purine nucleobase transmembrane transporter activity,MF,
2558,GO:0005346,1,0.938330354756262,0,11,purine ribonucleotide transmembrane transporter activity,MF,
2559,GO:0005347,1,0.953333848389829,0,8,ATP transmembrane transporter activity,MF,
2560,GO:0005350,1,0.983537899913126,0,3,pyrimidine nucleobase transmembrane transporter activity,MF,
2561,GO:0005351,1,0.93508371409425,0,10,carbohydrate:proton symporter activity,MF,
2562,GO:0005353,1,0.994596954618774,0,1,fructose transmembrane transporter activity,MF,
2563,GO:0005355,1,0.887895527498554,0,19,glucose transmembrane transporter activity,MF,
2564,GO:0005362,1,0.988228046658812,0,2,low-affinity glucose:sodium symporter activity,MF,
2565,GO:0005365,1,0.975734277165345,0,2,myo-inositol transmembrane transporter activity,MF,
2566,GO:0005366,1,0.989855951657699,0,1,myo-inositol:proton symporter activity,MF,
2567,GO:0005367,1,0.985735061022293,0,1,myo-inositol:sodium symporter activity,MF,
2568,GO:0005368,1,0.990334051390634,0,1,taurine transmembrane transporter activity,MF,
2569,GO:0005369,1,0.990334051390634,0,1,taurine:sodium symporter activity,MF,
2571,GO:0005375,1,0.956599234184904,0,6,copper ion transmembrane transporter activity,MF,
2572,GO:0005381,1,0.940074719601425,0,10,iron ion transmembrane transporter activity,MF,
2573,GO:0005384,1,0.95985975254528,0,6,manganese ion transmembrane transporter activity,MF,
2575,GO:0005388,1,0.88469065116661,0,14,calcium-transporting ATPase activity,MF,
2576,GO:0005391,1,0.929262979058284,0,12,sodium:potassium-exchanging ATPase activity,MF,
2577,GO:0005395,1,0.989509690407549,0,1,eye pigment precursor transporter activity,MF,
2578,GO:0005402,1,0.893182090850554,0,17,carbohydrate:cation symporter activity,MF,
2579,GO:0005412,1,0.964973295502029,0,6,glucose:sodium symporter activity,MF,
2580,GO:0005415,1,0.989691736132576,0,2,nucleoside:sodium symporter activity,MF,
2581,GO:0005416,1,0.87399402289975,0,19,amino acid:cation symporter activity,MF,
2582,GO:0005427,1,0.993091994234998,0,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
2583,GO:0005432,1,0.958357842095089,0,6,calcium:sodium antiporter activity,MF,
2585,GO:0005451,1,0.913347053616031,0,13,monovalent cation:proton antiporter activity,MF,
2587,GO:0005456,1,0.995236261205466,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
2588,GO:0005457,1,0.983684860748946,0,2,GDP-fucose transmembrane transporter activity,MF,
2589,GO:0005459,1,0.991388930989588,0,2,UDP-galactose transmembrane transporter activity,MF,
2590,GO:0005461,1,0.990377924401688,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
2591,GO:0005462,1,0.984895473958835,0,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
2592,GO:0005464,1,0.990036173360473,0,1,UDP-xylose transmembrane transporter activity,MF,
2593,GO:0005471,1,0.988264132944211,0,2,ATP:ADP antiporter activity,MF,
2594,GO:0005476,1,0.983786394969199,0,3,carnitine:acyl carnitine antiporter activity,MF,
2595,GO:0005477,1,0.993257796847106,0,1,pyruvate secondary active transmembrane transporter activity,MF,
2596,GO:0005483,1,0.981327818088607,0,3,soluble NSF attachment protein activity,MF,
2599,GO:0005496,1,0.600054940290936,0,78,steroid binding,MF,
2600,GO:0005497,1,0.9813211399405,0,4,androgen binding,MF,
2601,GO:0005499,1,0.973463962867263,0,4,vitamin D binding,MF,
2602,GO:0005501,1,0.877157318935075,0,23,retinoid binding,MF,
2603,GO:0005502,1,0.976237455493195,0,4,11-cis retinal binding,MF,
2604,GO:0005503,1,0.987206260434338,0,2,all-trans retinal binding,MF,
2605,GO:0005504,1,0.881698776125286,0,24,fatty acid binding,MF,
2606,GO:0005506,1,0.455188620157201,0,130,iron ion binding,MF,
2607,GO:0005507,1,0.753646956094357,0,49,copper ion binding,MF,
2613,GO:0005519,1,0.992836578952904,0,1,cytoskeletal regulatory protein binding,MF,
2615,GO:0005521,1,0.894823278345802,0,15,lamin binding,MF,
2616,GO:0005522,1,0.917164236263007,0,10,profilin binding,MF,
2617,GO:0005523,1,0.92401769219593,0,13,tropomyosin binding,MF,
2620,GO:0005527,1,0.93307853550581,0,13,macrolide binding,MF,
2621,GO:0005528,1,0.93307853550581,0,13,FK506 binding,MF,
2622,GO:0005534,1,0.972474082766461,0,5,galactose binding,MF,
2623,GO:0005536,1,0.930607036113494,0,11,glucose binding,MF,
2624,GO:0005537,1,0.919812976559935,0,14,mannose binding,MF,
2626,GO:0005540,1,0.873503574367001,0,19,hyaluronic acid binding,MF,
2627,GO:0005542,1,0.950333350103842,0,10,folic acid binding,MF,
2633,GO:0005548,1,0.671641232837131,0,52,phospholipid transporter activity,MF,
2634,GO:0005549,1,0.984313684547971,0,4,odorant binding,MF,
2637,GO:0005577,1,0.953184531740049,0,7,fibrinogen complex,CC,
2639,GO:0005579,1,0.971727487899501,0,4,membrane attack complex,CC,
2640,GO:0005581,1,0.562850239577281,0,78,collagen trimer,CC,
2641,GO:0005582,1,0.99152329358162,0,1,collagen type XV trimer,CC,
2642,GO:0005583,1,0.89917113851273,0,12,fibrillar collagen trimer,CC,
2643,GO:0005584,1,0.982318464115268,0,2,collagen type I trimer,CC,
2644,GO:0005585,1,0.991802045428723,0,1,collagen type II trimer,CC,
2645,GO:0005586,1,0.99129750082479,0,1,collagen type III trimer,CC,
2646,GO:0005587,1,0.938795143163189,0,6,collagen type IV trimer,CC,
2647,GO:0005588,1,0.96925475895118,0,3,collagen type V trimer,CC,
2648,GO:0005589,1,0.976555328178329,0,3,collagen type VI trimer,CC,
2649,GO:0005590,1,0.987735541272552,0,1,collagen type VII trimer,CC,
2650,GO:0005591,1,0.994226885076045,0,1,collagen type VIII trimer,CC,
2651,GO:0005592,1,0.980354022168234,0,2,collagen type XI trimer,CC,
2652,GO:0005593,1,0.951392483367596,0,6,FACIT collagen trimer,CC,
2653,GO:0005594,1,0.981787028623017,0,3,collagen type IX trimer,CC,
2654,GO:0005595,1,0.987195593650324,0,1,collagen type XII trimer,CC,
2655,GO:0005596,1,0.990350619314812,0,1,collagen type XIV trimer,CC,
2656,GO:0005597,1,0.991183800886234,0,1,collagen type XVI trimer,CC,
2657,GO:0005598,1,0.994226885076045,0,1,short-chain collagen trimer,CC,
2658,GO:0005600,1,0.993742374400055,0,1,collagen type XIII trimer,CC,
2659,GO:0005602,1,0.992358494446987,0,2,complement component C1 complex,CC,
2661,GO:0005605,1,0.82745165486385,0,20,basal lamina,CC,
2662,GO:0005606,1,0.967779350042995,0,3,laminin-1 complex,CC,
2663,GO:0005607,1,0.98278112211118,0,2,laminin-2 complex,CC,
2664,GO:0005608,1,0.978589088742717,0,2,laminin-3 complex,CC,
2665,GO:0005610,1,0.967764349267562,0,3,laminin-5 complex,CC,
2672,GO:0005637,1,0.715643539153778,0,50,nuclear inner membrane,CC,
2673,GO:0005638,1,0.975388613026003,0,4,lamin filament,CC,
2674,GO:0005639,1,0.917734993965622,0,14,integral component of nuclear inner membrane,CC,
2675,GO:0005640,1,0.85790137791933,0,20,nuclear outer membrane,CC,
2676,GO:0005641,1,0.941224351996302,0,8,nuclear envelope lumen,CC,
2677,GO:0005642,1,0.958895237915296,0,5,annulate lamellae,CC,
2678,GO:0005643,1,0.576985838211257,0,76,nuclear pore,CC,
2679,GO:0005652,1,0.940669484314619,0,9,nuclear lamina,CC,
2681,GO:0005655,1,0.962364209489409,0,8,nucleolar ribonuclease P complex,CC,
2682,GO:0005656,1,0.984791274424711,0,3,nuclear pre-replicative complex,CC,
2683,GO:0005657,1,0.657163840395154,0,67,replication fork,CC,
2684,GO:0005658,1,0.963714992734926,0,6,alpha DNA polymerase:primase complex,CC,
2685,GO:0005662,1,0.917608437137776,0,14,DNA replication factor A complex,CC,
2686,GO:0005663,1,0.969170099077634,0,6,DNA replication factor C complex,CC,
2687,GO:0005664,1,0.947417628636592,0,9,nuclear origin of replication recognition complex,CC,
2688,GO:0005665,1,0.901716640718544,0,18,DNA-directed RNA polymerase II, core complex,CC,
2689,GO:0005666,1,0.913454860686561,0,17,DNA-directed RNA polymerase III complex,CC,
2690,GO:0005667,1,0.12017747323102,0,319,transcription factor complex,CC,
2691,GO:0005668,1,0.990555398312767,0,2,RNA polymerase transcription factor SL1 complex,CC,
2692,GO:0005669,1,0.807591936424684,0,36,transcription factor TFIID complex,CC,
2693,GO:0005671,1,0.91583848847566,0,13,Ada2/Gcn5/Ada3 transcription activator complex,CC,
2694,GO:0005672,1,0.977834086914655,0,5,transcription factor TFIIA complex,CC,
2695,GO:0005673,1,0.989384203255073,0,2,transcription factor TFIIE complex,CC,
2696,GO:0005674,1,0.990021696637031,0,2,transcription factor TFIIF complex,CC,
2697,GO:0005675,1,0.937910383669607,0,12,holo TFIIH complex,CC,
2698,GO:0005677,1,0.939043035666199,0,8,chromatin silencing complex,CC,
2699,GO:0005680,1,0.887657712105276,0,21,anaphase-promoting complex,CC,
2700,GO:0005681,1,0.339769572031237,0,180,spliceosomal complex,CC,
2701,GO:0005682,1,0.858695644767366,0,22,U5 snRNP,CC,
2702,GO:0005683,1,0.971898235043449,0,7,U7 snRNP,CC,
2703,GO:0005684,1,0.721166228728862,0,57,U2-type spliceosomal complex,CC,
2704,GO:0005685,1,0.895289957946317,0,20,U1 snRNP,CC,
2705,GO:0005686,1,0.899280691612606,0,20,U2 snRNP,CC,
2706,GO:0005687,1,0.9434826703118,0,11,U4 snRNP,CC,
2707,GO:0005688,1,0.965720102201068,0,8,U6 snRNP,CC,
2708,GO:0005689,1,0.878877480295982,0,26,U12-type spliceosomal complex,CC,
2709,GO:0005690,1,0.994757828176757,0,1,U4atac snRNP,CC,
2710,GO:0005691,1,0.992442931936121,0,1,U6atac snRNP,CC,
2712,GO:0005697,1,0.867447589763091,0,22,telomerase holoenzyme complex,CC,
2713,GO:0005712,1,0.983513547271133,0,2,chiasma,CC,
2714,GO:0005713,1,0.994415395872108,0,1,recombination nodule,CC,
2715,GO:0005715,1,0.994415395872108,0,1,late recombination nodule,CC,
2716,GO:0005719,1,0.874020990576396,0,23,nuclear euchromatin,CC,
2717,GO:0005720,1,0.811836046346421,0,31,nuclear heterochromatin,CC,
2718,GO:0005721,1,0.868205023963256,0,19,pericentric heterochromatin,CC,
2719,GO:0005724,1,0.995458967525347,0,1,nuclear telomeric heterochromatin,CC,
2720,GO:0005726,1,0.968949114125584,0,4,perichromatin fibrils,CC,
2722,GO:0005731,1,0.995357903332359,0,1,nucleolus organizer region,CC,
2723,GO:0005732,1,0.910810770557327,0,20,small nucleolar ribonucleoprotein complex,CC,
2724,GO:0005736,1,0.934703983456971,0,12,DNA-directed RNA polymerase I complex,CC,
2729,GO:0005742,1,0.963014571710568,0,8,mitochondrial outer membrane translocase complex,CC,
2730,GO:0005743,1,0.104706703426132,0,436,mitochondrial inner membrane,CC,
2731,GO:0005744,1,0.944342397048571,0,11,mitochondrial inner membrane presequence translocase complex,CC,
2732,GO:0005745,1,0.988010408858002,0,2,m-AAA complex,CC,
2733,GO:0005746,1,0.728389792866762,0,76,mitochondrial respiratory chain,CC,
2734,GO:0005747,1,0.844036321761002,0,43,mitochondrial respiratory chain complex I,CC,
2735,GO:0005749,1,0.980640989710721,0,4,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,
2736,GO:0005750,1,0.947731508902772,0,11,mitochondrial respiratory chain complex III,CC,
2737,GO:0005751,1,0.955490565352028,0,13,mitochondrial respiratory chain complex IV,CC,
2738,GO:0005753,1,0.994752810789212,0,1,mitochondrial proton-transporting ATP synthase complex,CC,
2739,GO:0005757,1,0.980764626361155,0,4,mitochondrial permeability transition pore complex,CC,
2740,GO:0005758,1,0.703629681088181,0,69,mitochondrial intermembrane space,CC,
2741,GO:0005759,1,0.0986913874449055,0,420,mitochondrial matrix,CC,
2742,GO:0005760,1,0.984823605335276,0,2,gamma DNA polymerase complex,CC,
2743,GO:0005761,1,0.703959436868839,0,82,mitochondrial ribosome,CC,
2744,GO:0005762,1,0.80583820401781,0,50,mitochondrial large ribosomal subunit,CC,
2745,GO:0005763,1,0.892905680860986,0,27,mitochondrial small ribosomal subunit,CC,
2748,GO:0005766,1,0.418070842427856,0,147,primary lysosome,CC,
2749,GO:0005767,1,0.928373883821115,0,13,secondary lysosome,CC,
2751,GO:0005769,1,0.119178593777452,0,308,early endosome,CC,
2753,GO:0005771,1,0.817844854287142,0,35,multivesicular body,CC,
2756,GO:0005775,1,0.377466630554169,0,158,vacuolar lumen,CC,
2757,GO:0005776,1,0.56348884815089,0,87,autophagosome,CC,
2758,GO:0005777,1,0.479135919331244,0,122,peroxisome,CC,
2759,GO:0005778,1,0.695506733767925,0,57,peroxisomal membrane,CC,
2760,GO:0005779,1,0.910760844587706,0,17,integral component of peroxisomal membrane,CC,
2761,GO:0005782,1,0.795767673284944,0,41,peroxisomal matrix,CC,
2763,GO:0005784,1,0.983861248422546,0,4,Sec61 translocon complex,CC,
2764,GO:0005785,1,0.958454481057982,0,8,signal recognition particle receptor complex,CC,
2765,GO:0005786,1,0.970390069118573,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2766,GO:0005787,1,0.975073974376838,0,5,signal peptidase complex,CC,
2769,GO:0005790,1,0.78534877049475,0,31,smooth endoplasmic reticulum,CC,
2770,GO:0005791,1,0.611771648961968,0,83,rough endoplasmic reticulum,CC,
2771,GO:0005793,1,0.479195443215152,0,113,endoplasmic reticulum-Golgi intermediate compartment,CC,
2773,GO:0005795,1,0.414132039035889,0,130,Golgi stack,CC,
2774,GO:0005796,1,0.593588786455426,0,77,Golgi lumen,CC,
2775,GO:0005797,1,0.954574826887611,0,8,Golgi medial cisterna,CC,
2777,GO:0005801,1,0.689327606948641,0,54,cis-Golgi network,CC,
2779,GO:0005811,1,0.635314152661608,0,71,lipid droplet,CC,
2783,GO:0005816,1,0.959798244420219,0,6,spindle pole body,CC,
2784,GO:0005818,1,0.941333798428693,0,8,aster,CC,
2786,GO:0005826,1,0.961759595114225,0,5,actomyosin contractile ring,CC,
2787,GO:0005827,1,0.96514279752627,0,5,polar microtubule,CC,
2788,GO:0005828,1,0.940010729564114,0,7,kinetochore microtubule,CC,
2790,GO:0005832,1,0.936047989529092,0,11,chaperonin-containing T-complex,CC,
2791,GO:0005833,1,0.962010892681771,0,11,hemoglobin complex,CC,
2793,GO:0005838,1,0.904133021505532,0,21,proteasome regulatory particle,CC,
2794,GO:0005839,1,0.918660693193505,0,19,proteasome core complex,CC,
2795,GO:0005840,1,0.349436770571213,0,228,ribosome,CC,
2796,GO:0005844,1,0.678305781115724,0,69,polysome,CC,
2797,GO:0005845,1,0.931401598701108,0,11,mRNA cap binding complex,CC,
2798,GO:0005846,1,0.986367570568868,0,2,nuclear cap binding complex,CC,
2799,GO:0005847,1,0.900346760253024,0,16,mRNA cleavage and polyadenylation specificity factor complex,CC,
2800,GO:0005849,1,0.887979035910166,0,18,mRNA cleavage factor complex,CC,
2801,GO:0005850,1,0.973435083920885,0,4,eukaryotic translation initiation factor 2 complex,CC,
2802,GO:0005851,1,0.968290324685569,0,6,eukaryotic translation initiation factor 2B complex,CC,
2803,GO:0005852,1,0.912199609583511,0,17,eukaryotic translation initiation factor 3 complex,CC,
2805,GO:0005854,1,0.988233988347816,0,2,nascent polypeptide-associated complex,CC,
2807,GO:0005858,1,0.830046633787835,0,17,axonemal dynein complex,CC,
2808,GO:0005859,1,0.827692593011281,0,23,muscle myosin complex,CC,
2809,GO:0005861,1,0.965860468978876,0,8,troponin complex,CC,
2810,GO:0005862,1,0.977968030686223,0,4,muscle thin filament tropomyosin,CC,
2811,GO:0005863,1,0.976944060479373,0,3,striated muscle myosin thick filament,CC,
2812,GO:0005865,1,0.809680679608385,0,30,striated muscle thin filament,CC,
2813,GO:0005868,1,0.860977491318913,0,22,cytoplasmic dynein complex,CC,
2814,GO:0005869,1,0.957237597507899,0,8,dynactin complex,CC,
2816,GO:0005873,1,0.982776948458174,0,2,plus-end kinesin complex,CC,
2820,GO:0005879,1,0.968909472974011,0,4,axonemal microtubule,CC,
2821,GO:0005880,1,0.995684763908813,0,1,nuclear microtubule,CC,
2822,GO:0005881,1,0.686397642595091,0,54,cytoplasmic microtubule,CC,
2825,GO:0005884,1,0.503781061191875,0,98,actin filament,CC,
2826,GO:0005885,1,0.949085836124531,0,11,Arp2/3 protein complex,CC,
2829,GO:0005889,1,0.986481433095541,0,2,potassium:proton exchanging ATPase complex,CC,
2830,GO:0005890,1,0.939017651217819,0,11,sodium:potassium-exchanging ATPase complex,CC,
2831,GO:0005891,1,0.723606604253378,0,40,voltage-gated calcium channel complex,CC,
2832,GO:0005892,1,0.906133839194455,0,16,acetylcholine-gated channel complex,CC,
2833,GO:0005895,1,0.994789222732316,0,1,interleukin-5 receptor complex,CC,
2834,GO:0005896,1,0.982416916169176,0,3,interleukin-6 receptor complex,CC,
2835,GO:0005898,1,0.992804904829047,0,1,interleukin-13 receptor complex,CC,
2836,GO:0005899,1,0.967383602204736,0,3,insulin receptor complex,CC,
2837,GO:0005900,1,0.986798196454286,0,2,oncostatin-M receptor complex,CC,
2838,GO:0005901,1,0.578617810469185,0,73,caveola,CC,
2839,GO:0005902,1,0.595323865702603,0,74,microvillus,CC,
2840,GO:0005903,1,0.550406505889167,0,82,brush border,CC,
2841,GO:0005905,1,0.604065290939271,0,66,clathrin-coated pit,CC,
2844,GO:0005913,1,0.473863232868461,0,105,cell-cell adherens junction,CC,
2845,GO:0005914,1,0.99345197504884,0,1,spot adherens junction,CC,
2846,GO:0005915,1,0.948889159301376,0,7,zonula adherens,CC,
2847,GO:0005916,1,0.927577728766208,0,10,fascia adherens,CC,
2848,GO:0005921,1,0.866573782578409,0,24,gap junction,CC,
2849,GO:0005922,1,0.923303962538858,0,14,connexin complex,CC,
2853,GO:0005927,1,0.983398048654385,0,3,muscle tendon junction,CC,
2857,GO:0005940,1,0.92489479007765,0,12,septin ring,CC,
2858,GO:0005942,1,0.867351192921608,0,18,phosphatidylinositol 3-kinase complex,CC,
2859,GO:0005943,1,0.984167042956007,0,2,phosphatidylinositol 3-kinase complex, class IA,CC,
2860,GO:0005944,1,0.983873608319983,0,2,phosphatidylinositol 3-kinase complex, class IB,CC,
2861,GO:0005945,1,0.987246772253267,0,2,6-phosphofructokinase complex,CC,
2862,GO:0005947,1,0.966971598088415,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2863,GO:0005952,1,0.959193959980721,0,7,cAMP-dependent protein kinase complex,CC,
2864,GO:0005953,1,0.989635598164649,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
2866,GO:0005955,1,0.966972709424762,0,4,calcineurin complex,CC,
2867,GO:0005956,1,0.990227453078549,0,2,protein kinase CK2 complex,CC,
2868,GO:0005958,1,0.972532117372562,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
2869,GO:0005960,1,0.98863737648173,0,2,glycine cleavage complex,CC,
2870,GO:0005964,1,0.962584537853245,0,5,phosphorylase kinase complex,CC,
2871,GO:0005965,1,0.989528014042836,0,2,protein farnesyltransferase complex,CC,
2872,GO:0005967,1,0.97949127982709,0,3,mitochondrial pyruvate dehydrogenase complex,CC,
2873,GO:0005968,1,0.973267944128023,0,4,Rab-protein geranylgeranyltransferase complex,CC,
2874,GO:0005969,1,0.988889081404865,0,1,serine-pyruvate aminotransferase complex,CC,
2875,GO:0005971,1,0.979091393063358,0,3,ribonucleoside-diphosphate reductase complex,CC,
2877,GO:0005976,1,0.498000354063439,0,99,polysaccharide metabolic process,BP,
2878,GO:0005977,1,0.613505848445878,0,68,glycogen metabolic process,BP,
2879,GO:0005978,1,0.721848995093181,0,44,glycogen biosynthetic process,BP,
2880,GO:0005979,1,0.825029258571909,0,23,regulation of glycogen biosynthetic process,BP,
2881,GO:0005980,1,0.847007824243339,0,23,glycogen catabolic process,BP,
2882,GO:0005981,1,0.973432312969375,0,4,regulation of glycogen catabolic process,BP,
2883,GO:0005982,1,0.990320412982422,0,1,starch metabolic process,BP,
2884,GO:0005983,1,0.990320412982422,0,1,starch catabolic process,BP,
2885,GO:0005984,1,0.943707959213001,0,9,disaccharide metabolic process,BP,
2886,GO:0005985,1,0.988806856824851,0,2,sucrose metabolic process,BP,
2887,GO:0005986,1,0.995582402948917,0,1,sucrose biosynthetic process,BP,
2888,GO:0005988,1,0.982442850449439,0,3,lactose metabolic process,BP,
2889,GO:0005989,1,0.982442850449439,0,3,lactose biosynthetic process,BP,
2890,GO:0005991,1,0.993852595675553,0,1,trehalose metabolic process,BP,
2891,GO:0005996,1,0.21747725646284,0,235,monosaccharide metabolic process,BP,
2892,GO:0005997,1,0.98052343928053,0,4,xylulose metabolic process,BP,
2893,GO:0005998,1,0.993105936622397,0,1,xylulose catabolic process,BP,
2894,GO:0005999,1,0.990833369988019,0,2,xylulose biosynthetic process,BP,
2895,GO:0006000,1,0.9290617940979,0,13,fructose metabolic process,BP,
2896,GO:0006001,1,0.977557097652614,0,4,fructose catabolic process,BP,
2897,GO:0006002,1,0.951369791533398,0,8,fructose 6-phosphate metabolic process,BP,
2898,GO:0006003,1,0.972864364777898,0,4,fructose 2,6-bisphosphate metabolic process,BP,
2899,GO:0006004,1,0.906620244053556,0,14,fucose metabolic process,BP,
2900,GO:0006006,1,0.320738985788551,0,172,glucose metabolic process,BP,
2901,GO:0006007,1,0.847243982244146,0,28,glucose catabolic process,BP,
2902,GO:0006011,1,0.957929662319553,0,6,UDP-glucose metabolic process,BP,
2903,GO:0006012,1,0.915427653632098,0,14,galactose metabolic process,BP,
2904,GO:0006013,1,0.948828425450008,0,8,mannose metabolic process,BP,
2905,GO:0006014,1,0.987267705974243,0,3,D-ribose metabolic process,BP,
2906,GO:0006015,1,0.983244658699639,0,3,5-phosphoribose 1-diphosphate biosynthetic process,BP,
2907,GO:0006020,1,0.917134422031579,0,11,inositol metabolic process,BP,
2908,GO:0006021,1,0.973592820402802,0,4,inositol biosynthetic process,BP,
2913,GO:0006027,1,0.689089021745499,0,54,glycosaminoglycan catabolic process,BP,
2918,GO:0006041,1,0.977800583161535,0,4,glucosamine metabolic process,BP,
2919,GO:0006043,1,0.989758201221805,0,2,glucosamine catabolic process,BP,
2920,GO:0006044,1,0.907150882188259,0,15,N-acetylglucosamine metabolic process,BP,
2921,GO:0006045,1,0.984603693700211,0,2,N-acetylglucosamine biosynthetic process,BP,
2922,GO:0006046,1,0.985015753042435,0,3,N-acetylglucosamine catabolic process,BP,
2923,GO:0006047,1,0.912862617816451,0,15,UDP-N-acetylglucosamine metabolic process,BP,
2924,GO:0006048,1,0.936020317524287,0,11,UDP-N-acetylglucosamine biosynthetic process,BP,
2925,GO:0006049,1,0.993891796771534,0,1,UDP-N-acetylglucosamine catabolic process,BP,
2926,GO:0006050,1,0.991217818742375,0,2,mannosamine metabolic process,BP,
2927,GO:0006051,1,0.991217818742375,0,2,N-acetylmannosamine metabolic process,BP,
2928,GO:0006054,1,0.935999006558128,0,11,N-acetylneuraminate metabolic process,BP,
2929,GO:0006055,1,0.995957999246021,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
2930,GO:0006056,1,0.995286990116764,0,1,mannoprotein metabolic process,BP,
2931,GO:0006057,1,0.995286990116764,0,1,mannoprotein biosynthetic process,BP,
2932,GO:0006059,1,0.98596646763841,0,3,hexitol metabolic process,BP,
2933,GO:0006060,1,0.990121044620983,0,2,sorbitol metabolic process,BP,
2934,GO:0006061,1,0.995754326013234,0,1,sorbitol biosynthetic process,BP,
2935,GO:0006062,1,0.99434294248527,0,1,sorbitol catabolic process,BP,
2936,GO:0006063,1,0.956464557124527,0,8,uronic acid metabolic process,BP,
2937,GO:0006064,1,0.975449316686297,0,5,glucuronate catabolic process,BP,
2938,GO:0006065,1,0.978939700262347,0,3,UDP-glucuronate biosynthetic process,BP,
2939,GO:0006066,1,0.159915861836232,0,283,alcohol metabolic process,BP,
2940,GO:0006067,1,0.919075022048587,0,16,ethanol metabolic process,BP,
2941,GO:0006068,1,0.952489230301116,0,10,ethanol catabolic process,BP,
2942,GO:0006069,1,0.9536538368591,0,8,ethanol oxidation,BP,
2943,GO:0006071,1,0.92595367327254,0,12,glycerol metabolic process,BP,
2944,GO:0006072,1,0.937949393185381,0,8,glycerol-3-phosphate metabolic process,BP,
2945,GO:0006073,1,0.607538169942331,0,69,cellular glucan metabolic process,BP,
2946,GO:0006081,1,0.672189055688899,0,69,cellular aldehyde metabolic process,BP,
2948,GO:0006083,1,0.978001214432968,0,3,acetate metabolic process,BP,
2949,GO:0006084,1,0.798177362587499,0,34,acetyl-CoA metabolic process,BP,
2950,GO:0006085,1,0.8769249849124,0,19,acetyl-CoA biosynthetic process,BP,
2951,GO:0006086,1,0.905377049119885,0,14,acetyl-CoA biosynthetic process from pyruvate,BP,
2952,GO:0006089,1,0.936647440963484,0,11,lactate metabolic process,BP,
2953,GO:0006090,1,0.428917120767646,0,126,pyruvate metabolic process,BP,
2955,GO:0006094,1,0.672817388263642,0,67,gluconeogenesis,BP,
2956,GO:0006096,1,0.53048320814611,0,92,glycolytic process,BP,
2957,GO:0006097,1,0.989943504492188,0,2,glyoxylate cycle,BP,
2958,GO:0006098,1,0.913862755658866,0,17,pentose-phosphate shunt,BP,
2959,GO:0006099,1,0.849624363750837,0,29,tricarboxylic acid cycle,BP,
2960,GO:0006101,1,0.823684880496932,0,33,citrate metabolic process,BP,
2961,GO:0006102,1,0.975346740641991,0,5,isocitrate metabolic process,BP,
2962,GO:0006103,1,0.894268440454713,0,18,2-oxoglutarate metabolic process,BP,
2963,GO:0006104,1,0.967423136080947,0,6,succinyl-CoA metabolic process,BP,
2964,GO:0006105,1,0.934723997765489,0,11,succinate metabolic process,BP,
2965,GO:0006106,1,0.984614622597328,0,3,fumarate metabolic process,BP,
2966,GO:0006107,1,0.932100295333194,0,12,oxaloacetate metabolic process,BP,
2967,GO:0006108,1,0.962639628062159,0,7,malate metabolic process,BP,
2968,GO:0006109,1,0.33127889960335,0,155,regulation of carbohydrate metabolic process,BP,
2969,GO:0006110,1,0.63822716909377,0,61,regulation of glycolytic process,BP,
2970,GO:0006111,1,0.83757773141242,0,26,regulation of gluconeogenesis,BP,
2972,GO:0006114,1,0.971401549366433,0,5,glycerol biosynthetic process,BP,
2973,GO:0006116,1,0.974591276943859,0,4,NADH oxidation,BP,
2974,GO:0006117,1,0.994283746643721,0,1,acetaldehyde metabolic process,BP,
2975,GO:0006119,1,0.632812564229087,0,98,oxidative phosphorylation,BP,
2976,GO:0006120,1,0.838412721261698,0,44,mitochondrial electron transport, NADH to ubiquinone,BP,
2977,GO:0006121,1,0.980567444739792,0,4,mitochondrial electron transport, succinate to ubiquinone,BP,
2978,GO:0006122,1,0.931194631889079,0,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
2979,GO:0006123,1,0.934471901036099,0,16,mitochondrial electron transport, cytochrome c to oxygen,BP,
2980,GO:0006127,1,0.984903368380188,0,2,glycerophosphate shuttle,BP,
2983,GO:0006144,1,0.878100497984909,0,22,purine nucleobase metabolic process,BP,
2984,GO:0006145,1,0.968402208661416,0,4,purine nucleobase catabolic process,BP,
2985,GO:0006147,1,0.991395369109287,0,1,guanine catabolic process,BP,
2986,GO:0006148,1,0.994482427989621,0,1,inosine catabolic process,BP,
2987,GO:0006152,1,0.967329231666264,0,6,purine nucleoside catabolic process,BP,
2988,GO:0006154,1,0.989903729787942,0,2,adenosine catabolic process,BP,
2989,GO:0006157,1,0.995584917977122,0,1,deoxyadenosine catabolic process,BP,
2992,GO:0006165,1,0.485907853817088,0,109,nucleoside diphosphate phosphorylation,BP,
2993,GO:0006166,1,0.974502684022668,0,5,purine ribonucleoside salvage,BP,
2994,GO:0006167,1,0.971182671505028,0,6,AMP biosynthetic process,BP,
2995,GO:0006168,1,0.987457952127031,0,3,adenine salvage,BP,
2996,GO:0006169,1,0.994930508558121,0,1,adenosine salvage,BP,
2998,GO:0006172,1,0.98787965423125,0,2,ADP biosynthetic process,BP,
2999,GO:0006173,1,0.993201955437161,0,1,dADP biosynthetic process,BP,
3000,GO:0006174,1,0.994054740756748,0,1,dADP phosphorylation,BP,
3001,GO:0006175,1,0.994930508558121,0,1,dATP biosynthetic process,BP,
3002,GO:0006177,1,0.975240874290047,0,5,GMP biosynthetic process,BP,
3003,GO:0006178,1,0.990846505908206,0,2,guanine salvage,BP,
3005,GO:0006183,1,0.957574474625643,0,10,GTP biosynthetic process,BP,
3006,GO:0006185,1,0.996268780695775,0,1,dGDP biosynthetic process,BP,
3007,GO:0006186,1,0.994054740756748,0,1,dGDP phosphorylation,BP,
3008,GO:0006188,1,0.93985044845032,0,10,IMP biosynthetic process,BP,
3009,GO:0006189,1,0.962407697763744,0,6,'de novo' IMP biosynthetic process,BP,
3010,GO:0006193,1,0.996131633573802,0,1,ITP catabolic process,BP,
3011,GO:0006195,1,0.746498873218807,0,44,purine nucleotide catabolic process,BP,
3012,GO:0006196,1,0.985294725814177,0,2,AMP catabolic process,BP,
3013,GO:0006198,1,0.87248090893027,0,17,cAMP catabolic process,BP,
3014,GO:0006203,1,0.985252901977411,0,3,dGTP catabolic process,BP,
3015,GO:0006206,1,0.895097131699329,0,18,pyrimidine nucleobase metabolic process,BP,
3016,GO:0006207,1,0.952983722152518,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
3017,GO:0006208,1,0.983370993824907,0,3,pyrimidine nucleobase catabolic process,BP,
3018,GO:0006210,1,0.983370993824907,0,3,thymine catabolic process,BP,
3019,GO:0006211,1,0.961773306294075,0,3,5-methylcytosine catabolic process,BP,
3020,GO:0006212,1,0.988545034214072,0,2,uracil catabolic process,BP,
3021,GO:0006213,1,0.799914546996415,0,43,pyrimidine nucleoside metabolic process,BP,
3022,GO:0006214,1,0.993673140428983,0,1,thymidine catabolic process,BP,
3023,GO:0006216,1,0.961723775594323,0,8,cytidine catabolic process,BP,
3024,GO:0006218,1,0.995240067575435,0,1,uridine catabolic process,BP,
3025,GO:0006220,1,0.795901256655571,0,45,pyrimidine nucleotide metabolic process,BP,
3026,GO:0006221,1,0.853884352279504,0,31,pyrimidine nucleotide biosynthetic process,BP,
3027,GO:0006222,1,0.944252868548572,0,10,UMP biosynthetic process,BP,
3028,GO:0006226,1,0.985677758727961,0,3,dUMP biosynthetic process,BP,
3029,GO:0006227,1,0.98993040397395,0,2,dUDP biosynthetic process,BP,
3030,GO:0006228,1,0.957522903392287,0,9,UTP biosynthetic process,BP,
3031,GO:0006231,1,0.984989507375686,0,3,dTMP biosynthetic process,BP,
3032,GO:0006233,1,0.98993040397395,0,2,dTDP biosynthetic process,BP,
3033,GO:0006235,1,0.981419609288433,0,4,dTTP biosynthetic process,BP,
3034,GO:0006238,1,0.995950517747861,0,1,CMP salvage,BP,
3035,GO:0006241,1,0.941529620453249,0,13,CTP biosynthetic process,BP,
3036,GO:0006244,1,0.938491140947707,0,13,pyrimidine nucleotide catabolic process,BP,
3037,GO:0006253,1,0.996112369163191,0,1,dCTP catabolic process,BP,
3038,GO:0006256,1,0.99387977965686,0,1,UDP catabolic process,BP,
3039,GO:0006258,1,0.99062384050156,0,2,UDP-glucose catabolic process,BP,
3041,GO:0006260,1,0.158824364657182,0,275,DNA replication,BP,
3042,GO:0006261,1,0.404750698410575,0,141,DNA-dependent DNA replication,BP,
3043,GO:0006264,1,0.93616159912095,0,10,mitochondrial DNA replication,BP,
3046,GO:0006267,1,0.984791274424711,0,3,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
3047,GO:0006268,1,0.958389901231299,0,7,DNA unwinding involved in DNA replication,BP,
3048,GO:0006269,1,0.969521755233545,0,5,DNA replication, synthesis of RNA primer,BP,
3049,GO:0006270,1,0.77586084314679,0,42,DNA replication initiation,BP,
3050,GO:0006271,1,0.887042464432232,0,20,DNA strand elongation involved in DNA replication,BP,
3051,GO:0006272,1,0.976397055599456,0,3,leading strand elongation,BP,
3052,GO:0006273,1,0.934378552035036,0,11,lagging strand elongation,BP,
3053,GO:0006275,1,0.476005572621376,0,108,regulation of DNA replication,BP,
3054,GO:0006278,1,0.632365739906194,0,67,RNA-dependent DNA biosynthetic process,BP,
3057,GO:0006283,1,0.660114977481803,0,73,transcription-coupled nucleotide-excision repair,BP,
3058,GO:0006284,1,0.773303120129894,0,41,base-excision repair,BP,
3059,GO:0006285,1,0.952087436475142,0,10,base-excision repair, AP site formation,BP,
3060,GO:0006286,1,0.991584631532678,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
3061,GO:0006287,1,0.965375981761526,0,5,base-excision repair, gap-filling,BP,
3062,GO:0006288,1,0.984261105979132,0,3,base-excision repair, DNA ligation,BP,
3063,GO:0006289,1,0.516594122175648,0,112,nucleotide-excision repair,BP,
3064,GO:0006290,1,0.952757394432889,0,7,pyrimidine dimer repair,BP,
3065,GO:0006293,1,0.876302573152655,0,21,nucleotide-excision repair, preincision complex stabilization,BP,
3066,GO:0006294,1,0.847645705564385,0,29,nucleotide-excision repair, preincision complex assembly,BP,
3067,GO:0006295,1,0.876302573152655,0,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,
3068,GO:0006296,1,0.806101281854618,0,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,
3069,GO:0006297,1,0.875701400745758,0,23,nucleotide-excision repair, DNA gap filling,BP,
3070,GO:0006298,1,0.825044831623197,0,30,mismatch repair,BP,
3071,GO:0006301,1,0.73945518575532,0,48,postreplication repair,BP,
3073,GO:0006303,1,0.666600017762149,0,58,double-strand break repair via nonhomologous end joining,BP,
3074,GO:0006304,1,0.541200411664203,0,93,DNA modification,BP,
3075,GO:0006305,1,0.68407405765745,0,54,DNA alkylation,BP,
3076,GO:0006306,1,0.68407405765745,0,54,DNA methylation,BP,
3077,GO:0006307,1,0.945679711813866,0,10,DNA dealkylation involved in DNA repair,BP,
3078,GO:0006308,1,0.802759587032397,0,35,DNA catabolic process,BP,
3079,GO:0006309,1,0.881991458606952,0,20,apoptotic DNA fragmentation,BP,
3081,GO:0006311,1,0.974946164184941,0,4,meiotic gene conversion,BP,
3082,GO:0006312,1,0.850539031124675,0,23,mitotic recombination,BP,
3083,GO:0006313,1,0.992778955217429,0,1,transposition, DNA-mediated,BP,
3086,GO:0006333,1,0.445966924538428,0,133,chromatin assembly or disassembly,BP,
3087,GO:0006334,1,0.603521596255203,0,91,nucleosome assembly,BP,
3088,GO:0006335,1,0.932545337920018,0,14,DNA replication-dependent nucleosome assembly,BP,
3089,GO:0006336,1,0.794416094304815,0,40,DNA replication-independent nucleosome assembly,BP,
3090,GO:0006337,1,0.887337036507011,0,17,nucleosome disassembly,BP,
3091,GO:0006338,1,0.346327827276292,0,159,chromatin remodeling,BP,
3092,GO:0006342,1,0.619736864985596,0,75,chromatin silencing,BP,
3093,GO:0006343,1,0.992965418025289,0,1,establishment of chromatin silencing,BP,
3094,GO:0006344,1,0.966457899335903,0,4,maintenance of chromatin silencing,BP,
3095,GO:0006346,1,0.906390110220662,0,14,methylation-dependent chromatin silencing,BP,
3096,GO:0006348,1,0.951750363308617,0,8,chromatin silencing at telomere,BP,
3097,GO:0006349,1,0.88729158588892,0,16,regulation of gene expression by genetic imprinting,BP,
3099,GO:0006352,1,0.226766702077109,0,225,DNA-templated transcription, initiation,BP,
3100,GO:0006353,1,0.533452839308747,0,107,DNA-templated transcription, termination,BP,
3101,GO:0006354,1,0.468840185489799,0,122,DNA-templated transcription, elongation,BP,
3103,GO:0006356,1,0.808447710260608,0,30,regulation of transcription by RNA polymerase I,BP,
3105,GO:0006359,1,0.827941716215886,0,27,regulation of transcription by RNA polymerase III,BP,
3106,GO:0006360,1,0.678912537850931,0,59,transcription by RNA polymerase I,BP,
3107,GO:0006361,1,0.815410554989966,0,35,transcription initiation from RNA polymerase I promoter,BP,
3108,GO:0006362,1,0.841192577005824,0,30,transcription elongation from RNA polymerase I promoter,BP,
3109,GO:0006363,1,0.844299827873404,0,30,termination of RNA polymerase I transcription,BP,
3110,GO:0006364,1,0.270980267967279,0,249,rRNA processing,BP,
3112,GO:0006367,1,0.310462112726779,0,177,transcription initiation from RNA polymerase II promoter,BP,
3113,GO:0006368,1,0.545140653200153,0,97,transcription elongation from RNA polymerase II promoter,BP,
3114,GO:0006369,1,0.667714972518522,0,68,termination of RNA polymerase II transcription,BP,
3115,GO:0006370,1,0.83939715349214,0,31,7-methylguanosine mRNA capping,BP,
3117,GO:0006378,1,0.764434649487366,0,40,mRNA polyadenylation,BP,
3118,GO:0006379,1,0.848217119246717,0,27,mRNA cleavage,BP,
3119,GO:0006382,1,0.959302826414435,0,5,adenosine to inosine editing,BP,
3120,GO:0006383,1,0.717797586015271,0,53,transcription by RNA polymerase III,BP,
3121,GO:0006384,1,0.946316740123801,0,7,transcription initiation from RNA polymerase III promoter,BP,
3122,GO:0006386,1,0.996511314624102,0,1,termination of RNA polymerase III transcription,BP,
3123,GO:0006388,1,0.932915179551634,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
3124,GO:0006390,1,0.916746711416727,0,13,mitochondrial transcription,BP,
3125,GO:0006391,1,0.983435947825897,0,3,transcription initiation from mitochondrial promoter,BP,
3126,GO:0006393,1,0.988144472527205,0,2,termination of mitochondrial transcription,BP,
3129,GO:0006398,1,0.96879164447367,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
3130,GO:0006399,1,0.357788361683695,0,181,tRNA metabolic process,BP,
3131,GO:0006400,1,0.658930480626297,0,73,tRNA modification,BP,
3132,GO:0006401,1,0.118226309923631,0,362,RNA catabolic process,BP,
3133,GO:0006402,1,0.14066666376884,0,333,mRNA catabolic process,BP,
3135,GO:0006404,1,0.978988392253383,0,3,RNA import into nucleus,BP,
3136,GO:0006405,1,0.41403332386534,0,135,RNA export from nucleus,BP,
3137,GO:0006406,1,0.501085138618102,0,104,mRNA export from nucleus,BP,
3138,GO:0006407,1,0.980345906598456,0,3,rRNA export from nucleus,BP,
3139,GO:0006408,1,0.990226731698718,0,2,snRNA export from nucleus,BP,
3140,GO:0006409,1,0.798923862136045,0,31,tRNA export from nucleus,BP,
3142,GO:0006413,1,0.370880920848906,0,191,translational initiation,BP,
3144,GO:0006415,1,0.627369311061258,0,99,translational termination,BP,
3146,GO:0006418,1,0.753572494708232,0,49,tRNA aminoacylation for protein translation,BP,
3147,GO:0006419,1,0.980718739363232,0,3,alanyl-tRNA aminoacylation,BP,
3148,GO:0006420,1,0.984778577976615,0,3,arginyl-tRNA aminoacylation,BP,
3149,GO:0006421,1,0.982135506639802,0,3,asparaginyl-tRNA aminoacylation,BP,
3150,GO:0006422,1,0.994582100957679,0,1,aspartyl-tRNA aminoacylation,BP,
3151,GO:0006423,1,0.989388499460258,0,2,cysteinyl-tRNA aminoacylation,BP,
3152,GO:0006424,1,0.984741948232416,0,2,glutamyl-tRNA aminoacylation,BP,
3153,GO:0006425,1,0.986441742260113,0,2,glutaminyl-tRNA aminoacylation,BP,
3154,GO:0006426,1,0.989612495296607,0,2,glycyl-tRNA aminoacylation,BP,
3155,GO:0006427,1,0.989446050942448,0,2,histidyl-tRNA aminoacylation,BP,
3156,GO:0006428,1,0.985631398140448,0,2,isoleucyl-tRNA aminoacylation,BP,
3157,GO:0006429,1,0.984618436070645,0,2,leucyl-tRNA aminoacylation,BP,
3158,GO:0006430,1,0.994860380278518,0,1,lysyl-tRNA aminoacylation,BP,
3159,GO:0006431,1,0.9878335743471,0,2,methionyl-tRNA aminoacylation,BP,
3160,GO:0006432,1,0.973320263464512,0,5,phenylalanyl-tRNA aminoacylation,BP,
3161,GO:0006433,1,0.982553676083417,0,3,prolyl-tRNA aminoacylation,BP,
3162,GO:0006434,1,0.990057496706883,0,2,seryl-tRNA aminoacylation,BP,
3163,GO:0006435,1,0.982071006732854,0,3,threonyl-tRNA aminoacylation,BP,
3164,GO:0006436,1,0.98818989829456,0,2,tryptophanyl-tRNA aminoacylation,BP,
3165,GO:0006437,1,0.988506031511682,0,2,tyrosyl-tRNA aminoacylation,BP,
3166,GO:0006438,1,0.977801755603153,0,3,valyl-tRNA aminoacylation,BP,
3167,GO:0006446,1,0.625466645558986,0,74,regulation of translational initiation,BP,
3168,GO:0006447,1,0.979226649548035,0,3,regulation of translational initiation by iron,BP,
3169,GO:0006448,1,0.889644447843831,0,18,regulation of translational elongation,BP,
3170,GO:0006449,1,0.948476924892164,0,8,regulation of translational termination,BP,
3171,GO:0006450,1,0.904807806224359,0,18,regulation of translational fidelity,BP,
3172,GO:0006451,1,0.946775807279209,0,8,translational readthrough,BP,
3173,GO:0006452,1,0.980269786215912,0,3,translational frameshifting,BP,
3175,GO:0006458,1,0.747372650886651,0,48,'de novo' protein folding,BP,
3176,GO:0006463,1,0.99306077920803,0,1,steroid hormone receptor complex assembly,BP,
3178,GO:0006465,1,0.897918243975758,0,20,signal peptide processing,BP,
3182,GO:0006471,1,0.846949724667852,0,26,protein ADP-ribosylation,BP,
3183,GO:0006473,1,0.312548472756347,0,174,protein acetylation,BP,
3184,GO:0006474,1,0.893313500112176,0,16,N-terminal protein amino acid acetylation,BP,
3185,GO:0006475,1,0.369695360977746,0,146,internal protein amino acid acetylation,BP,
3186,GO:0006476,1,0.506731997514769,0,95,protein deacetylation,BP,
3187,GO:0006477,1,0.959633027583138,0,6,protein sulfation,BP,
3188,GO:0006478,1,0.990026446893265,0,2,peptidyl-tyrosine sulfation,BP,
3189,GO:0006479,1,0.320728239005991,0,163,protein methylation,BP,
3190,GO:0006480,1,0.990410764385042,0,2,N-terminal protein amino acid methylation,BP,
3191,GO:0006481,1,0.981918613013563,0,3,C-terminal protein methylation,BP,
3192,GO:0006482,1,0.787110700855094,0,29,protein demethylation,BP,
3194,GO:0006487,1,0.583622594807321,0,89,protein N-linked glycosylation,BP,
3195,GO:0006488,1,0.883861832674781,0,20,dolichol-linked oligosaccharide biosynthetic process,BP,
3196,GO:0006489,1,0.960077110938945,0,7,dolichyl diphosphate biosynthetic process,BP,
3197,GO:0006490,1,0.878849175403367,0,21,oligosaccharide-lipid intermediate biosynthetic process,BP,
3198,GO:0006491,1,0.869822631609223,0,18,N-glycan processing,BP,
3199,GO:0006493,1,0.494489099417375,0,101,protein O-linked glycosylation,BP,
3201,GO:0006498,1,0.95765666348986,0,6,N-terminal protein lipidation,BP,
3202,GO:0006499,1,0.96724636618023,0,4,N-terminal protein myristoylation,BP,
3203,GO:0006500,1,0.990088882140908,0,2,N-terminal protein palmitoylation,BP,
3204,GO:0006501,1,0.704196370801326,0,57,C-terminal protein lipidation,BP,
3205,GO:0006505,1,0.831067548027384,0,33,GPI anchor metabolic process,BP,
3206,GO:0006506,1,0.839105407769636,0,31,GPI anchor biosynthetic process,BP,
3207,GO:0006507,1,0.99463604311237,0,1,GPI anchor release,BP,
3212,GO:0006515,1,0.844464963160076,0,25,protein quality control for misfolded or incompletely synthesized proteins,BP,
3213,GO:0006516,1,0.895525757389904,0,17,glycoprotein catabolic process,BP,
3214,GO:0006517,1,0.789502477409084,0,34,protein deglycosylation,BP,
3217,GO:0006521,1,0.764124607441789,0,55,regulation of cellular amino acid metabolic process,BP,
3218,GO:0006522,1,0.97919771879362,0,4,alanine metabolic process,BP,
3219,GO:0006524,1,0.97919771879362,0,4,alanine catabolic process,BP,
3220,GO:0006525,1,0.883111796345234,0,20,arginine metabolic process,BP,
3221,GO:0006526,1,0.961976651563335,0,6,arginine biosynthetic process,BP,
3222,GO:0006527,1,0.931773713981789,0,11,arginine catabolic process,BP,
3223,GO:0006528,1,0.974876300116661,0,5,asparagine metabolic process,BP,
3224,GO:0006529,1,0.989031187848003,0,2,asparagine biosynthetic process,BP,
3225,GO:0006530,1,0.989733850409957,0,2,asparagine catabolic process,BP,
3226,GO:0006531,1,0.945916879110687,0,10,aspartate metabolic process,BP,
3227,GO:0006532,1,0.989300290766131,0,2,aspartate biosynthetic process,BP,
3228,GO:0006533,1,0.985121885630939,0,3,aspartate catabolic process,BP,
3229,GO:0006534,1,0.926200457124885,0,13,cysteine metabolic process,BP,
3230,GO:0006535,1,0.994255839328277,0,1,cysteine biosynthetic process from serine,BP,
3231,GO:0006536,1,0.830680079086372,0,31,glutamate metabolic process,BP,
3232,GO:0006537,1,0.968146200105426,0,5,glutamate biosynthetic process,BP,
3233,GO:0006538,1,0.946489594170568,0,9,glutamate catabolic process,BP,
3234,GO:0006539,1,0.995124542452145,0,1,glutamate catabolic process via 2-oxoglutarate,BP,
3235,GO:0006540,1,0.980557526968812,0,3,glutamate decarboxylation to succinate,BP,
3236,GO:0006541,1,0.852459837501085,0,23,glutamine metabolic process,BP,
3237,GO:0006542,1,0.983936991387591,0,2,glutamine biosynthetic process,BP,
3238,GO:0006543,1,0.979882364043935,0,3,glutamine catabolic process,BP,
3239,GO:0006544,1,0.945533339708573,0,10,glycine metabolic process,BP,
3240,GO:0006545,1,0.984704665071551,0,3,glycine biosynthetic process,BP,
3241,GO:0006546,1,0.983603650358282,0,3,glycine catabolic process,BP,
3242,GO:0006547,1,0.949751954778689,0,9,histidine metabolic process,BP,
3243,GO:0006548,1,0.961381507956749,0,7,histidine catabolic process,BP,
3244,GO:0006549,1,0.967429580438431,0,5,isoleucine metabolic process,BP,
3245,GO:0006550,1,0.99032864454287,0,2,isoleucine catabolic process,BP,
3247,GO:0006552,1,0.965639921575164,0,6,leucine catabolic process,BP,
3248,GO:0006553,1,0.923089998289721,0,13,lysine metabolic process,BP,
3249,GO:0006554,1,0.92870648674848,0,12,lysine catabolic process,BP,
3250,GO:0006555,1,0.881237563682748,0,20,methionine metabolic process,BP,
3251,GO:0006556,1,0.982385780528851,0,3,S-adenosylmethionine biosynthetic process,BP,
3252,GO:0006557,1,0.993530949694249,0,1,S-adenosylmethioninamine biosynthetic process,BP,
3253,GO:0006558,1,0.952438632545791,0,10,L-phenylalanine metabolic process,BP,
3254,GO:0006559,1,0.952438632545791,0,10,L-phenylalanine catabolic process,BP,
3255,GO:0006560,1,0.963233433823697,0,7,proline metabolic process,BP,
3256,GO:0006561,1,0.979038459233705,0,4,proline biosynthetic process,BP,
3257,GO:0006562,1,0.983860014233869,0,3,proline catabolic process,BP,
3258,GO:0006563,1,0.944986598626401,0,11,L-serine metabolic process,BP,
3259,GO:0006564,1,0.969621375531809,0,6,L-serine biosynthetic process,BP,
3260,GO:0006565,1,0.980088826451688,0,4,L-serine catabolic process,BP,
3261,GO:0006566,1,0.981763684554351,0,4,threonine metabolic process,BP,
3262,GO:0006567,1,0.986841958246633,0,3,threonine catabolic process,BP,
3263,GO:0006568,1,0.949332716890768,0,9,tryptophan metabolic process,BP,
3264,GO:0006569,1,0.96490914332102,0,7,tryptophan catabolic process,BP,
3265,GO:0006570,1,0.961692402393387,0,8,tyrosine metabolic process,BP,
3266,GO:0006572,1,0.971696528697827,0,6,tyrosine catabolic process,BP,
3268,GO:0006574,1,0.979778129103117,0,4,valine catabolic process,BP,
3269,GO:0006575,1,0.392542274096786,0,159,cellular modified amino acid metabolic process,BP,
3270,GO:0006576,1,0.769528493402451,0,47,cellular biogenic amine metabolic process,BP,
3271,GO:0006577,1,0.902783607387424,0,17,amino-acid betaine metabolic process,BP,
3272,GO:0006578,1,0.959252539554499,0,7,amino-acid betaine biosynthetic process,BP,
3273,GO:0006579,1,0.982569284980154,0,3,amino-acid betaine catabolic process,BP,
3274,GO:0006580,1,0.994147315111515,0,1,ethanolamine metabolic process,BP,
3275,GO:0006581,1,0.988106830533469,0,2,acetylcholine catabolic process,BP,
3276,GO:0006582,1,0.89141253979261,0,16,melanin metabolic process,BP,
3277,GO:0006583,1,0.994561712259619,0,1,melanin biosynthetic process from tyrosine,BP,
3278,GO:0006584,1,0.745680174646911,0,47,catecholamine metabolic process,BP,
3279,GO:0006585,1,0.995119463290967,0,1,dopamine biosynthetic process from tyrosine,BP,
3280,GO:0006586,1,0.930865596671103,0,13,indolalkylamine metabolic process,BP,
3281,GO:0006589,1,0.98785765934728,0,2,octopamine biosynthetic process,BP,
3282,GO:0006590,1,0.910812868531013,0,13,thyroid hormone generation,BP,
3283,GO:0006591,1,0.952665223879686,0,9,ornithine metabolic process,BP,
3284,GO:0006592,1,0.993324266516756,0,1,ornithine biosynthetic process,BP,
3285,GO:0006593,1,0.995442563407794,0,1,ornithine catabolic process,BP,
3286,GO:0006595,1,0.924969033694529,0,16,polyamine metabolic process,BP,
3287,GO:0006596,1,0.936981212279097,0,13,polyamine biosynthetic process,BP,
3288,GO:0006597,1,0.988949991031187,0,2,spermine biosynthetic process,BP,
3289,GO:0006598,1,0.973821431144245,0,6,polyamine catabolic process,BP,
3290,GO:0006600,1,0.943839228389724,0,10,creatine metabolic process,BP,
3291,GO:0006601,1,0.990542659294594,0,2,creatine biosynthetic process,BP,
3293,GO:0006606,1,0.412227767052082,0,128,protein import into nucleus,BP,
3294,GO:0006607,1,0.846315495374052,0,20,NLS-bearing protein import into nucleus,BP,
3295,GO:0006610,1,0.940797097081318,0,8,ribosomal protein import into nucleus,BP,
3296,GO:0006611,1,0.318744680361205,0,173,protein export from nucleus,BP,
3298,GO:0006613,1,0.680283381674772,0,95,cotranslational protein targeting to membrane,BP,
3299,GO:0006614,1,0.706858728376866,0,90,SRP-dependent cotranslational protein targeting to membrane,BP,
3300,GO:0006616,1,0.972584086809488,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3301,GO:0006617,1,0.991111095060294,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
3302,GO:0006620,1,0.954810720386038,0,7,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3303,GO:0006621,1,0.943186388183605,0,10,protein retention in ER lumen,BP,
3304,GO:0006622,1,0.869174633507005,0,19,protein targeting to lysosome,BP,
3305,GO:0006623,1,0.780098631455716,0,31,protein targeting to vacuole,BP,
3306,GO:0006624,1,0.991419670952839,0,2,vacuolar protein processing,BP,
3307,GO:0006625,1,0.898784047237699,0,17,protein targeting to peroxisome,BP,
3308,GO:0006626,1,0.45610158038756,0,135,protein targeting to mitochondrion,BP,
3309,GO:0006627,1,0.954469444954121,0,8,protein processing involved in protein targeting to mitochondrion,BP,
3312,GO:0006633,1,0.482688586805685,0,120,fatty acid biosynthetic process,BP,
3314,GO:0006636,1,0.800775934192725,0,40,unsaturated fatty acid biosynthetic process,BP,
3315,GO:0006637,1,0.57242108918903,0,91,acyl-CoA metabolic process,BP,
3319,GO:0006642,1,0.963089196509326,0,4,triglyceride mobilization,BP,
3321,GO:0006644,1,0.0635374669857219,0,414,phospholipid metabolic process,BP,
3322,GO:0006646,1,0.915037662180322,0,14,phosphatidylethanolamine biosynthetic process,BP,
3323,GO:0006649,1,0.983231050987846,0,2,phospholipid transfer to membrane,BP,
3324,GO:0006650,1,0.107172162501831,0,331,glycerophospholipid metabolic process,BP,
3325,GO:0006651,1,0.985946671203175,0,2,diacylglycerol biosynthetic process,BP,
3326,GO:0006654,1,0.793741239095567,0,33,phosphatidic acid biosynthetic process,BP,
3327,GO:0006655,1,0.941161261505672,0,10,phosphatidylglycerol biosynthetic process,BP,
3328,GO:0006656,1,0.823669019399567,0,33,phosphatidylcholine biosynthetic process,BP,
3329,GO:0006657,1,0.959707607250984,0,7,CDP-choline pathway,BP,
3330,GO:0006658,1,0.868006197594422,0,24,phosphatidylserine metabolic process,BP,
3331,GO:0006659,1,0.976975180193189,0,4,phosphatidylserine biosynthetic process,BP,
3332,GO:0006660,1,0.995276848675697,0,1,phosphatidylserine catabolic process,BP,
3333,GO:0006661,1,0.383662023751195,0,136,phosphatidylinositol biosynthetic process,BP,
3334,GO:0006662,1,0.934708063304625,0,12,glycerol ether metabolic process,BP,
3335,GO:0006663,1,0.976204685322026,0,4,platelet activating factor biosynthetic process,BP,
3338,GO:0006666,1,0.991631246260237,0,1,3-keto-sphinganine metabolic process,BP,
3339,GO:0006667,1,0.980653610279977,0,3,sphinganine metabolic process,BP,
3340,GO:0006668,1,0.98737575411827,0,2,sphinganine-1-phosphate metabolic process,BP,
3341,GO:0006669,1,0.993845015440295,0,1,sphinganine-1-phosphate biosynthetic process,BP,
3342,GO:0006670,1,0.937263819782173,0,11,sphingosine metabolic process,BP,
3343,GO:0006671,1,0.992434112600359,0,1,phytosphingosine metabolic process,BP,
3344,GO:0006672,1,0.593618933000669,0,84,ceramide metabolic process,BP,
3345,GO:0006677,1,0.900296811532725,0,18,glycosylceramide metabolic process,BP,
3346,GO:0006678,1,0.956514471945506,0,7,glucosylceramide metabolic process,BP,
3347,GO:0006679,1,0.987224605885052,0,2,glucosylceramide biosynthetic process,BP,
3348,GO:0006680,1,0.981819782376944,0,3,glucosylceramide catabolic process,BP,
3349,GO:0006681,1,0.953930155905974,0,8,galactosylceramide metabolic process,BP,
3350,GO:0006682,1,0.972586594038321,0,5,galactosylceramide biosynthetic process,BP,
3351,GO:0006683,1,0.993903848785914,0,1,galactosylceramide catabolic process,BP,
3352,GO:0006684,1,0.921490934076675,0,13,sphingomyelin metabolic process,BP,
3353,GO:0006685,1,0.968017998727636,0,5,sphingomyelin catabolic process,BP,
3354,GO:0006686,1,0.961041938943134,0,6,sphingomyelin biosynthetic process,BP,
3357,GO:0006689,1,0.97220848308289,0,5,ganglioside catabolic process,BP,
3358,GO:0006690,1,0.617713367328863,0,86,icosanoid metabolic process,BP,
3359,GO:0006691,1,0.897303762810145,0,20,leukotriene metabolic process,BP,
3360,GO:0006692,1,0.824892270733191,0,34,prostanoid metabolic process,BP,
3361,GO:0006693,1,0.824892270733191,0,34,prostaglandin metabolic process,BP,
3362,GO:0006694,1,0.36485607644775,0,161,steroid biosynthetic process,BP,
3363,GO:0006695,1,0.660909084097147,0,62,cholesterol biosynthetic process,BP,
3364,GO:0006696,1,0.989714304546065,0,2,ergosterol biosynthetic process,BP,
3365,GO:0006699,1,0.82513984826758,0,32,bile acid biosynthetic process,BP,
3366,GO:0006700,1,0.885863428725119,0,20,C21-steroid hormone biosynthetic process,BP,
3367,GO:0006701,1,0.966481734619613,0,5,progesterone biosynthetic process,BP,
3368,GO:0006702,1,0.95717335013632,0,7,androgen biosynthetic process,BP,
3369,GO:0006703,1,0.950860536382566,0,10,estrogen biosynthetic process,BP,
3370,GO:0006704,1,0.922303696872733,0,13,glucocorticoid biosynthetic process,BP,
3371,GO:0006705,1,0.947275150707099,0,8,mineralocorticoid biosynthetic process,BP,
3372,GO:0006706,1,0.89370396452693,0,20,steroid catabolic process,BP,
3373,GO:0006707,1,0.949764744084981,0,9,cholesterol catabolic process,BP,
3374,GO:0006710,1,0.978833932752109,0,4,androgen catabolic process,BP,
3375,GO:0006711,1,0.995276848675697,0,1,estrogen catabolic process,BP,
3376,GO:0006713,1,0.995267972986845,0,1,glucocorticoid catabolic process,BP,
3377,GO:0006714,1,0.991500229136624,0,2,sesquiterpenoid metabolic process,BP,
3378,GO:0006720,1,0.529200323666359,0,103,isoprenoid metabolic process,BP,
3379,GO:0006721,1,0.584210701461639,0,85,terpenoid metabolic process,BP,
3380,GO:0006722,1,0.994491611210297,0,1,triterpenoid metabolic process,BP,
3382,GO:0006726,1,0.981145968760821,0,3,eye pigment biosynthetic process,BP,
3383,GO:0006729,1,0.966677844178117,0,7,tetrahydrobiopterin biosynthetic process,BP,
3384,GO:0006730,1,0.823472073732965,0,33,one-carbon metabolic process,BP,
3385,GO:0006732,1,0.115695705863304,0,348,coenzyme metabolic process,BP,
3386,GO:0006733,1,0.334017333323365,0,172,oxidoreduction coenzyme metabolic process,BP,
3387,GO:0006734,1,0.814277021139134,0,35,NADH metabolic process,BP,
3388,GO:0006735,1,0.870058443718303,0,24,NADH regeneration,BP,
3389,GO:0006738,1,0.994482427989621,0,1,nicotinamide riboside catabolic process,BP,
3390,GO:0006739,1,0.833009633224215,0,33,NADP metabolic process,BP,
3391,GO:0006740,1,0.981422237744078,0,3,NADPH regeneration,BP,
3392,GO:0006741,1,0.976587237877529,0,4,NADP biosynthetic process,BP,
3393,GO:0006742,1,0.985835734522228,0,3,NADP catabolic process,BP,
3394,GO:0006743,1,0.926328769723506,0,15,ubiquinone metabolic process,BP,
3395,GO:0006744,1,0.933508473535124,0,14,ubiquinone biosynthetic process,BP,
3396,GO:0006747,1,0.995035050726997,0,1,FAD biosynthetic process,BP,
3397,GO:0006749,1,0.796434814551973,0,46,glutathione metabolic process,BP,
3398,GO:0006750,1,0.926041314206957,0,14,glutathione biosynthetic process,BP,
3399,GO:0006751,1,0.974932465225541,0,5,glutathione catabolic process,BP,
3401,GO:0006754,1,0.467489930531766,0,115,ATP biosynthetic process,BP,
3402,GO:0006756,1,0.994054740756748,0,1,AMP phosphorylation,BP,
3403,GO:0006757,1,0.527309146568737,0,93,ATP generation from ADP,BP,
3404,GO:0006760,1,0.844619704187602,0,28,folic acid-containing compound metabolic process,BP,
3405,GO:0006766,1,0.465567093759889,0,123,vitamin metabolic process,BP,
3406,GO:0006767,1,0.58439159598102,0,84,water-soluble vitamin metabolic process,BP,
3407,GO:0006768,1,0.934730649017857,0,10,biotin metabolic process,BP,
3408,GO:0006771,1,0.957076069286601,0,7,riboflavin metabolic process,BP,
3409,GO:0006772,1,0.9785365352186,0,4,thiamine metabolic process,BP,
3410,GO:0006775,1,0.799190401232541,0,37,fat-soluble vitamin metabolic process,BP,
3411,GO:0006776,1,0.959445544499879,0,7,vitamin A metabolic process,BP,
3412,GO:0006777,1,0.964526815113495,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3413,GO:0006778,1,0.830985001253294,0,31,porphyrin-containing compound metabolic process,BP,
3414,GO:0006779,1,0.865522101628342,0,23,porphyrin-containing compound biosynthetic process,BP,
3415,GO:0006780,1,0.990618975006062,0,2,uroporphyrinogen III biosynthetic process,BP,
3416,GO:0006781,1,0.994786708960719,0,1,succinyl-CoA pathway,BP,
3417,GO:0006782,1,0.960545160042841,0,8,protoporphyrinogen IX biosynthetic process,BP,
3418,GO:0006783,1,0.890376546417801,0,19,heme biosynthetic process,BP,
3419,GO:0006784,1,0.983661872908738,0,2,heme a biosynthetic process,BP,
3420,GO:0006787,1,0.983590907831834,0,4,porphyrin-containing compound catabolic process,BP,
3421,GO:0006788,1,0.990917845753969,0,2,heme oxidation,BP,
3425,GO:0006797,1,0.96024101328664,0,5,polyphosphate metabolic process,BP,
3426,GO:0006798,1,0.966064962899564,0,4,polyphosphate catabolic process,BP,
3427,GO:0006801,1,0.717887449846647,0,56,superoxide metabolic process,BP,
3428,GO:0006805,1,0.591677536549019,0,93,xenobiotic metabolic process,BP,
3430,GO:0006808,1,0.984344436735952,0,3,regulation of nitrogen utilization,BP,
3431,GO:0006809,1,0.680204599129456,0,58,nitric oxide biosynthetic process,BP,
3441,GO:0006824,1,0.978223473864871,0,4,cobalt ion transport,BP,
3442,GO:0006825,1,0.877747714036975,0,20,copper ion transport,BP,
3443,GO:0006826,1,0.715410442444312,0,54,iron ion transport,BP,
3444,GO:0006828,1,0.931726864117914,0,10,manganese ion transport,BP,
3449,GO:0006837,1,0.916252906755256,0,15,serotonin transport,BP,
3451,GO:0006842,1,0.974746306460756,0,4,tricarboxylic acid transport,BP,
3452,GO:0006843,1,0.995503097025035,0,1,mitochondrial citrate transmembrane transport,BP,
3453,GO:0006844,1,0.989730178837486,0,2,acyl carnitine transport,BP,
3454,GO:0006848,1,0.976819943771779,0,4,pyruvate transport,BP,
3455,GO:0006850,1,0.988144472527205,0,2,mitochondrial pyruvate transmembrane transport,BP,
3456,GO:0006851,1,0.876139454108406,0,22,mitochondrial calcium ion transmembrane transport,BP,
3457,GO:0006853,1,0.933335965003536,0,9,carnitine shuttle,BP,
3459,GO:0006857,1,0.947974389097789,0,8,oligopeptide transport,BP,
3460,GO:0006858,1,0.984300265007222,0,3,extracellular transport,BP,
3461,GO:0006862,1,0.888688464132374,0,20,nucleotide transport,BP,
3462,GO:0006863,1,0.967826980539691,0,6,purine nucleobase transport,BP,
3463,GO:0006864,1,0.98788339701756,0,2,pyrimidine nucleotide transport,BP,
3465,GO:0006867,1,0.988504590143269,0,2,asparagine transport,BP,
3466,GO:0006868,1,0.962000576916554,0,6,glutamine transport,BP,
3467,GO:0006869,1,0.137592080939669,0,287,lipid transport,BP,
3471,GO:0006876,1,0.99294866239209,0,1,cellular cadmium ion homeostasis,BP,
3472,GO:0006878,1,0.923031299149404,0,13,cellular copper ion homeostasis,BP,
3473,GO:0006879,1,0.697617471833162,0,58,cellular iron ion homeostasis,BP,
3474,GO:0006880,1,0.987441044120523,0,3,intracellular sequestering of iron ion,BP,
3476,GO:0006883,1,0.889684149411944,0,17,cellular sodium ion homeostasis,BP,
3477,GO:0006884,1,0.852066909759048,0,22,cell volume homeostasis,BP,
3481,GO:0006888,1,0.284597007969344,0,186,ER to Golgi vesicle-mediated transport,BP,
3483,GO:0006891,1,0.809884903850216,0,33,intra-Golgi vesicle-mediated transport,BP,
3484,GO:0006892,1,0.505949487802598,0,92,post-Golgi vesicle-mediated transport,BP,
3485,GO:0006893,1,0.71683059776427,0,47,Golgi to plasma membrane transport,BP,
3486,GO:0006895,1,0.84753047959478,0,19,Golgi to endosome transport,BP,
3487,GO:0006896,1,0.9107245283303,0,14,Golgi to vacuole transport,BP,
3491,GO:0006901,1,0.644158783185803,0,66,vesicle coating,BP,
3492,GO:0006903,1,0.564216114837994,0,85,vesicle targeting,BP,
3495,GO:0006907,1,0.893039558644137,0,18,pinocytosis,BP,
3496,GO:0006909,1,0.246332150679106,0,219,phagocytosis,BP,
3497,GO:0006910,1,0.917941626075722,0,14,phagocytosis, recognition,BP,
3498,GO:0006911,1,0.755155430166044,0,44,phagocytosis, engulfment,BP,
3499,GO:0006913,1,0.11315559195654,0,324,nucleocytoplasmic transport,BP,
3502,GO:0006919,1,0.600328031017095,0,86,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
3504,GO:0006924,1,0.949667448147086,0,9,activation-induced cell death of T cells,BP,
3505,GO:0006925,1,0.899917046403048,0,17,inflammatory cell apoptotic process,BP,
3507,GO:0006929,1,0.830533705696435,0,25,substrate-dependent cell migration,BP,
3508,GO:0006930,1,0.946422967951562,0,8,substrate-dependent cell migration, cell extension,BP,
3509,GO:0006931,1,0.970022026029933,0,4,substrate-dependent cell migration, cell attachment to substrate,BP,
3510,GO:0006933,1,0.981969098229093,0,3,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
3518,GO:0006948,1,0.993691921123067,0,1,induction by virus of host cell-cell fusion,BP,
3519,GO:0006949,1,0.758485585885626,0,38,syncytium formation,BP,
3525,GO:0006956,1,0.750787651382098,0,49,complement activation,BP,
3526,GO:0006957,1,0.934521437825108,0,10,complement activation, alternative pathway,BP,
3527,GO:0006958,1,0.852760718706229,0,26,complement activation, classical pathway,BP,
3529,GO:0006968,1,0.760686592341298,0,49,cellular defense response,BP,
3530,GO:0006970,1,0.646769463524496,0,66,response to osmotic stress,BP,
3531,GO:0006971,1,0.929702496659198,0,9,hypotonic response,BP,
3532,GO:0006972,1,0.881092596685958,0,20,hyperosmotic response,BP,
3534,GO:0006975,1,0.947029741239357,0,8,DNA damage induced protein phosphorylation,BP,
3535,GO:0006977,1,0.686114812006245,0,60,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,
3538,GO:0006982,1,0.991683331945896,0,2,response to lipid hydroperoxide,BP,
3539,GO:0006983,1,0.932554305396728,0,10,ER overload response,BP,
3540,GO:0006984,1,0.765551380635011,0,42,ER-nucleus signaling pathway,BP,
3541,GO:0006986,1,0.343061952972104,0,171,response to unfolded protein,BP,
3542,GO:0006987,1,0.95122897149301,0,8,activation of signaling protein activity involved in unfolded protein response,BP,
3543,GO:0006990,1,0.978751815583449,0,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
3544,GO:0006991,1,0.935628316082261,0,10,response to sterol depletion,BP,
3545,GO:0006995,1,0.946849894445564,0,11,cellular response to nitrogen starvation,BP,
3547,GO:0006997,1,0.393294754480677,0,132,nucleus organization,BP,
3548,GO:0006998,1,0.578850719352632,0,81,nuclear envelope organization,BP,
3549,GO:0006999,1,0.892919102786561,0,15,nuclear pore organization,BP,
3550,GO:0007000,1,0.955290257006234,0,7,nucleolus organization,BP,
3551,GO:0007004,1,0.644556136190722,0,65,telomere maintenance via telomerase,BP,
3554,GO:0007007,1,0.890683659276268,0,22,inner mitochondrial membrane organization,BP,
3555,GO:0007008,1,0.993412121398656,0,1,outer mitochondrial membrane organization,BP,
3558,GO:0007014,1,0.993089110889709,0,1,actin ubiquitination,BP,
3560,GO:0007016,1,0.905053663307004,0,10,cytoskeletal anchoring at plasma membrane,BP,
3564,GO:0007020,1,0.828403653324009,0,25,microtubule nucleation,BP,
3566,GO:0007023,1,0.979686564098389,0,4,post-chaperonin tubulin folding pathway,BP,
3568,GO:0007028,1,0.925958495661421,0,9,cytoplasm organization,BP,
3569,GO:0007029,1,0.734244864378249,0,46,endoplasmic reticulum organization,BP,
3570,GO:0007030,1,0.391955635790187,0,128,Golgi organization,BP,
3571,GO:0007031,1,0.823814556936499,0,31,peroxisome organization,BP,
3573,GO:0007033,1,0.357582309526276,0,153,vacuole organization,BP,
3574,GO:0007034,1,0.41652756467443,0,123,vacuolar transport,BP,
3575,GO:0007035,1,0.87095694255106,0,22,vacuolar acidification,BP,
3576,GO:0007039,1,0.900853764321146,0,14,protein catabolic process in the vacuole,BP,
3577,GO:0007040,1,0.679824365732065,0,58,lysosome organization,BP,
3578,GO:0007041,1,0.508928495305062,0,93,lysosomal transport,BP,
3579,GO:0007042,1,0.962531264282274,0,8,lysosomal lumen acidification,BP,
3580,GO:0007043,1,0.459882438548592,0,109,cell-cell junction assembly,BP,
3581,GO:0007044,1,0.494147911137971,0,87,cell-substrate junction assembly,BP,
3582,GO:0007045,1,0.573444562506653,0,71,cell-substrate adherens junction assembly,BP,
3587,GO:0007056,1,0.9895142779005,0,2,spindle assembly involved in female meiosis,BP,
3588,GO:0007057,1,0.9895142779005,0,2,spindle assembly involved in female meiosis I,BP,
3590,GO:0007060,1,0.976430466188995,0,4,male meiosis chromosome segregation,BP,
3592,GO:0007063,1,0.866200186130828,0,19,regulation of sister chromatid cohesion,BP,
3593,GO:0007064,1,0.85899350900499,0,19,mitotic sister chromatid cohesion,BP,
3594,GO:0007066,1,0.996335689035427,0,1,female meiosis sister chromatid cohesion,BP,
3595,GO:0007072,1,0.995357903332359,0,1,positive regulation of transcription involved in exit from mitosis,BP,
3596,GO:0007076,1,0.864460156876753,0,16,mitotic chromosome condensation,BP,
3597,GO:0007077,1,0.743964041474774,0,42,mitotic nuclear envelope disassembly,BP,
3598,GO:0007079,1,0.974865405061671,0,3,mitotic chromosome movement towards spindle pole,BP,
3599,GO:0007080,1,0.768833057669278,0,44,mitotic metaphase plate congression,BP,
3600,GO:0007084,1,0.947866169877178,0,10,mitotic nuclear envelope reassembly,BP,
3602,GO:0007089,1,0.97258096809345,0,4,traversing start control point of mitotic cell cycle,BP,
3606,GO:0007095,1,0.87094144160466,0,19,mitotic G2 DNA damage checkpoint,BP,
3607,GO:0007096,1,0.908725937571323,0,16,regulation of exit from mitosis,BP,
3608,GO:0007097,1,0.844202599885994,0,19,nuclear migration,BP,
3609,GO:0007098,1,0.445222312885253,0,114,centrosome cycle,BP,
3610,GO:0007099,1,0.815077313054437,0,29,centriole replication,BP,
3611,GO:0007100,1,0.9011280157133,0,15,mitotic centrosome separation,BP,
3612,GO:0007113,1,0.985752091998974,0,3,endomitotic cell cycle,BP,
3614,GO:0007129,1,0.811634730422414,0,34,synapsis,BP,
3615,GO:0007130,1,0.90206829090891,0,16,synaptonemal complex assembly,BP,
3617,GO:0007135,1,0.955120041329727,0,8,meiosis II,BP,
3618,GO:0007140,1,0.767784376313397,0,39,male meiotic nuclear division,BP,
3619,GO:0007141,1,0.893973039137332,0,18,male meiosis I,BP,
3620,GO:0007143,1,0.855705244239342,0,23,female meiotic nuclear division,BP,
3621,GO:0007144,1,0.957867080846519,0,7,female meiosis I,BP,
3622,GO:0007146,1,0.994054740756748,0,1,meiotic recombination nodule assembly,BP,
3623,GO:0007147,1,0.993170517253164,0,1,female meiosis II,BP,
3626,GO:0007156,1,0.444123868666968,0,95,homophilic cell adhesion via plasma membrane adhesion molecules,BP,
3628,GO:0007158,1,0.882066158363448,0,16,neuron cell-cell adhesion,BP,
3630,GO:0007160,1,0.228843902558679,0,194,cell-matrix adhesion,BP,
3631,GO:0007161,1,0.959642546841603,0,4,calcium-independent cell-matrix adhesion,BP,
3632,GO:0007162,1,0.219289699901935,0,222,negative regulation of cell adhesion,BP,
3633,GO:0007163,1,0.235320393639452,0,196,establishment or maintenance of cell polarity,BP,
3638,GO:0007168,1,0.974357173753621,0,5,receptor guanylyl cyclase signaling pathway,BP,
3640,GO:0007171,1,0.909747904244579,0,13,activation of transmembrane receptor protein tyrosine kinase activity,BP,
3641,GO:0007172,1,0.950577292135461,0,8,signal complex assembly,BP,
3643,GO:0007174,1,0.994706480646018,0,1,epidermal growth factor catabolic process,BP,
3644,GO:0007175,1,0.909028363248414,0,14,negative regulation of epidermal growth factor-activated receptor activity,BP,
3647,GO:0007179,1,0.313379175636221,0,162,transforming growth factor beta receptor signaling pathway,BP,
3648,GO:0007181,1,0.980140366383376,0,3,transforming growth factor beta receptor complex assembly,BP,
3649,GO:0007182,1,0.951132223785339,0,6,common-partner SMAD protein phosphorylation,BP,
3650,GO:0007183,1,0.900463762166265,0,14,SMAD protein complex assembly,BP,
3651,GO:0007185,1,0.942834882424289,0,6,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,
3657,GO:0007191,1,0.947091510484996,0,9,adenylate cyclase-activating dopamine receptor signaling pathway,BP,
3659,GO:0007194,1,0.874325675031837,0,21,negative regulation of adenylate cyclase activity,BP,
3660,GO:0007195,1,0.960637183796597,0,6,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
3661,GO:0007196,1,0.925481692818611,0,9,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
3663,GO:0007198,1,0.980169970231947,0,4,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,
3664,GO:0007199,1,0.994283151526601,0,1,G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger,BP,
3666,GO:0007202,1,0.87717360801477,0,22,activation of phospholipase C activity,BP,
3668,GO:0007205,1,0.837031901543507,0,25,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,
3669,GO:0007206,1,0.981699002374258,0,2,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
3671,GO:0007208,1,0.985734344971615,0,2,phospholipase C-activating serotonin receptor signaling pathway,BP,
3672,GO:0007210,1,0.932089838489807,0,13,serotonin receptor signaling pathway,BP,
3677,GO:0007216,1,0.888908188699021,0,15,G-protein coupled glutamate receptor signaling pathway,BP,
3678,GO:0007217,1,0.967379815543147,0,7,tachykinin receptor signaling pathway,BP,
3681,GO:0007220,1,0.887602450775958,0,17,Notch receptor processing,BP,
3682,GO:0007221,1,0.850175579077602,0,18,positive regulation of transcription of Notch receptor target,BP,
3684,GO:0007224,1,0.418451589320457,0,124,smoothened signaling pathway,BP,
3685,GO:0007225,1,0.992085776148083,0,1,patched ligand maturation,BP,
3686,GO:0007227,1,0.973614431157955,0,4,signal transduction downstream of smoothened,BP,
3687,GO:0007228,1,0.980614035012451,0,3,positive regulation of hh target transcription factor activity,BP,
3688,GO:0007229,1,0.506450678268585,0,94,integrin-mediated signaling pathway,BP,
3689,GO:0007231,1,0.984303240897709,0,3,osmosensory signaling pathway,BP,
3690,GO:0007249,1,0.213862222733857,0,241,I-kappaB kinase/NF-kappaB signaling,BP,
3692,GO:0007252,1,0.908251241801528,0,14,I-kappaB phosphorylation,BP,
3693,GO:0007253,1,0.964776209811604,0,7,cytoplasmic sequestering of NF-kappaB,BP,
3695,GO:0007256,1,0.94876117683047,0,6,activation of JNKK activity,BP,
3696,GO:0007257,1,0.796551054120599,0,32,activation of JUN kinase activity,BP,
3697,GO:0007258,1,0.975047175717488,0,4,JUN phosphorylation,BP,
3698,GO:0007259,1,0.445088823710686,0,126,JAK-STAT cascade,BP,
3699,GO:0007260,1,0.704302855629341,0,58,tyrosine phosphorylation of STAT protein,BP,
3703,GO:0007266,1,0.244818284591891,0,189,Rho protein signal transduction,BP,
3707,GO:0007270,1,0.930130639500165,0,8,neuron-neuron synaptic transmission,BP,
3709,GO:0007272,1,0.43692135045149,0,113,ensheathment of neurons,BP,
3710,GO:0007274,1,0.844006002917603,0,26,neuromuscular synaptic transmission,BP,
3715,GO:0007284,1,0.985067341771056,0,2,spermatogonial cell division,BP,
3718,GO:0007289,1,0.901065289678882,0,14,spermatid nucleus differentiation,BP,
3719,GO:0007290,1,0.992056487690681,0,1,spermatid nucleus elongation,BP,
3720,GO:0007291,1,0.996282415975542,0,1,sperm individualization,BP,
3722,GO:0007296,1,0.964654705147382,0,4,vitellogenesis,BP,
3723,GO:0007308,1,0.987599014291715,0,2,oocyte construction,BP,
3724,GO:0007309,1,0.987599014291715,0,2,oocyte axis specification,BP,
3725,GO:0007314,1,0.987599014291715,0,2,oocyte anterior/posterior axis specification,BP,
3726,GO:0007315,1,0.987599014291715,0,2,pole plasm assembly,BP,
3727,GO:0007320,1,0.940462147819006,0,10,insemination,BP,
3728,GO:0007338,1,0.541246544310042,0,105,single fertilization,BP,
3729,GO:0007339,1,0.87468001498911,0,25,binding of sperm to zona pellucida,BP,
3730,GO:0007340,1,0.849396639346583,0,27,acrosome reaction,BP,
3731,GO:0007341,1,0.971716996762407,0,6,penetration of zona pellucida,BP,
3732,GO:0007342,1,0.95967015701859,0,9,fusion of sperm to egg plasma membrane involved in single fertilization,BP,
3733,GO:0007343,1,0.984722147714199,0,2,egg activation,BP,
3734,GO:0007344,1,0.995321197939531,0,1,pronuclear fusion,BP,
3736,GO:0007349,1,0.996282415975542,0,1,cellularization,BP,
3737,GO:0007350,1,0.903048176671435,0,15,blastoderm segmentation,BP,
3738,GO:0007351,1,0.922455456724117,0,12,tripartite regional subdivision,BP,
3739,GO:0007352,1,0.977362449112698,0,3,zygotic specification of dorsal/ventral axis,BP,
3740,GO:0007354,1,0.978658604749794,0,4,zygotic determination of anterior/posterior axis, embryo,BP,
3741,GO:0007356,1,0.985070330973862,0,3,thorax and anterior abdomen determination,BP,
3744,GO:0007371,1,0.993062698868,0,1,ventral midline determination,BP,
3745,GO:0007379,1,0.91551854082683,0,15,segment specification,BP,
3746,GO:0007386,1,0.965292185395707,0,5,compartment pattern specification,BP,
3747,GO:0007387,1,0.994127613608574,0,1,anterior compartment pattern formation,BP,
3748,GO:0007388,1,0.994127613608574,0,1,posterior compartment specification,BP,
3750,GO:0007398,1,0.882736301760373,0,18,ectoderm development,BP,
3752,GO:0007400,1,0.994409330361848,0,1,neuroblast fate determination,BP,
3753,GO:0007402,1,0.990936434823347,0,2,ganglion mother cell fate determination,BP,
3754,GO:0007403,1,0.993369541796353,0,1,glial cell fate determination,BP,
3756,GO:0007406,1,0.960727541273232,0,5,negative regulation of neuroblast proliferation,BP,
3758,GO:0007411,1,0.157450956503796,0,236,axon guidance,BP,
3759,GO:0007412,1,0.989019743434142,0,2,axon target recognition,BP,
3761,GO:0007416,1,0.376412834016079,0,123,synapse assembly,BP,
3763,GO:0007418,1,0.972276032966036,0,4,ventral midline development,BP,
3765,GO:0007422,1,0.573266958228294,0,74,peripheral nervous system development,BP,
3767,GO:0007431,1,0.764232767363929,0,38,salivary gland development,BP,
3768,GO:0007435,1,0.785199248512461,0,34,salivary gland morphogenesis,BP,
3769,GO:0007439,1,0.988186816464442,0,2,ectodermal digestive tract development,BP,
3770,GO:0007440,1,0.915952481585043,0,10,foregut morphogenesis,BP,
3771,GO:0007442,1,0.948062999246997,0,7,hindgut morphogenesis,BP,
3772,GO:0007468,1,0.989303357613017,0,2,regulation of rhodopsin gene expression,BP,
3773,GO:0007492,1,0.576347156585713,0,76,endoderm development,BP,
3774,GO:0007493,1,0.987902819390805,0,2,endodermal cell fate determination,BP,
3775,GO:0007494,1,0.927534201009729,0,11,midgut development,BP,
3776,GO:0007495,1,0.99361208529434,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
3777,GO:0007497,1,0.984531446253194,0,2,posterior midgut development,BP,
3779,GO:0007499,1,0.992192301935019,0,1,ectoderm and mesoderm interaction,BP,
3780,GO:0007500,1,0.989185070041953,0,2,mesodermal cell fate determination,BP,
3782,GO:0007506,1,0.987363106704001,0,2,gonadal mesoderm development,BP,
3784,GO:0007509,1,0.990288285900351,0,1,mesoderm migration involved in gastrulation,BP,
3785,GO:0007512,1,0.919392784280545,0,12,adult heart development,BP,
3787,GO:0007518,1,0.989812958431926,0,2,myoblast fate determination,BP,
3789,GO:0007520,1,0.817325050414896,0,29,myoblast fusion,BP,
3790,GO:0007521,1,0.984017489787169,0,2,muscle cell fate determination,BP,
3791,GO:0007522,1,0.990861122493657,0,1,visceral muscle development,BP,
3792,GO:0007525,1,0.970107571370192,0,2,somatic muscle development,BP,
3793,GO:0007528,1,0.685534707364023,0,46,neuromuscular junction development,BP,
3794,GO:0007529,1,0.985609179542141,0,2,establishment of synaptic specificity at neuromuscular junction,BP,
3795,GO:0007530,1,0.874821617345559,0,21,sex determination,BP,
3796,GO:0007538,1,0.984352719035787,0,2,primary sex determination,BP,
3797,GO:0007542,1,0.984352719035787,0,2,primary sex determination, germ-line,BP,
3799,GO:0007549,1,0.904514643847155,0,12,dosage compensation,BP,
3801,GO:0007566,1,0.760151703337559,0,43,embryo implantation,BP,
3802,GO:0007567,1,0.90189522801704,0,16,parturition,BP,
3805,GO:0007571,1,0.996227856480328,0,1,age-dependent general metabolic decline,BP,
3806,GO:0007576,1,0.994322551283136,0,1,nucleolar fragmentation,BP,
3808,GO:0007585,1,0.674783089472165,0,60,respiratory gaseous exchange,BP,
3810,GO:0007588,1,0.730670924049577,0,50,excretion,BP,
3813,GO:0007596,1,0.147337402877385,0,293,blood coagulation,BP,
3814,GO:0007597,1,0.916992920787498,0,15,blood coagulation, intrinsic pathway,BP,
3815,GO:0007598,1,0.978363482335395,0,4,blood coagulation, extrinsic pathway,BP,
3816,GO:0007599,1,0.143262830535247,0,298,hemostasis,BP,
3818,GO:0007601,1,0.336216773071402,0,164,visual perception,BP,
3819,GO:0007602,1,0.784787545796153,0,41,phototransduction,BP,
3820,GO:0007603,1,0.850577597187672,0,26,phototransduction, visible light,BP,
3822,GO:0007606,1,0.622013879258147,0,87,sensory perception of chemical stimulus,BP,
3823,GO:0007608,1,0.802250740393388,0,39,sensory perception of smell,BP,
3828,GO:0007614,1,0.946777965794038,0,9,short-term memory,BP,
3830,GO:0007617,1,0.893902880891123,0,18,mating behavior,BP,
3832,GO:0007619,1,0.979140614100984,0,3,courtship behavior,BP,
3834,GO:0007621,1,0.977659301441663,0,3,negative regulation of female receptivity,BP,
3835,GO:0007622,1,0.782976116332093,0,40,rhythmic behavior,BP,
3837,GO:0007624,1,0.992674754524924,0,1,ultradian rhythm,BP,
3838,GO:0007625,1,0.911958585530844,0,15,grooming behavior,BP,
3840,GO:0007628,1,0.820510072807173,0,26,adult walking behavior,BP,
3842,GO:0007632,1,0.690114191101932,0,49,visual behavior,BP,
3843,GO:0007634,1,0.994449451346764,0,1,optokinetic behavior,BP,
3844,GO:0007635,1,0.897776195582561,0,14,chemosensory behavior,BP,
3845,GO:0007638,1,0.889103902508861,0,13,mechanosensory behavior,BP,
3847,GO:0008013,1,0.536014864615337,0,79,beta-catenin binding,MF,
3851,GO:0008020,1,0.960413144844921,0,8,G-protein coupled photoreceptor activity,MF,
3854,GO:0008023,1,0.706773305759698,0,48,transcription elongation factor complex,CC,
3855,GO:0008024,1,0.942570871347563,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3856,GO:0008026,1,0.534302305111101,0,91,ATP-dependent helicase activity,MF,
3857,GO:0008028,1,0.739747585211295,0,49,monocarboxylic acid transmembrane transporter activity,MF,
3858,GO:0008033,1,0.515323736718615,0,118,tRNA processing,BP,
3859,GO:0008035,1,0.963192949907539,0,7,high-density lipoprotein particle binding,MF,
3862,GO:0008043,1,0.992408328884874,0,2,intracellular ferritin complex,CC,
3863,GO:0008045,1,0.849940997321175,0,21,motor neuron axon guidance,BP,
3864,GO:0008046,1,0.943737619423761,0,7,axon guidance receptor activity,MF,
3866,GO:0008048,1,0.985893229136606,0,3,calcium sensitive guanylate cyclase activator activity,MF,
3867,GO:0008049,1,0.995116923739894,0,1,male courtship behavior,BP,
3868,GO:0008050,1,0.983946081713423,0,2,female courtship behavior,BP,
3869,GO:0008052,1,0.996263821660609,0,1,sensory organ boundary specification,BP,
3870,GO:0008053,1,0.88891344921125,0,21,mitochondrial fusion,BP,
3871,GO:0008057,1,0.989431733414791,0,1,eye pigment granule organization,BP,
3873,GO:0008063,1,0.961536028439403,0,6,Toll signaling pathway,BP,
3874,GO:0008064,1,0.330501844355854,0,166,regulation of actin polymerization or depolymerization,BP,
3875,GO:0008065,1,0.981504441276804,0,3,establishment of blood-nerve barrier,BP,
3878,GO:0008073,1,0.987652493026954,0,3,ornithine decarboxylase inhibitor activity,MF,
3881,GO:0008078,1,0.98263990208672,0,3,mesodermal cell migration,BP,
3882,GO:0008079,1,0.960698766518152,0,6,translation termination factor activity,MF,
3883,GO:0008080,1,0.595857554526948,0,77,N-acetyltransferase activity,MF,
3888,GO:0008090,1,0.940721035571293,0,8,retrograde axonal transport,BP,
3889,GO:0008091,1,0.916102082609783,0,8,spectrin,CC,
3891,GO:0008093,1,0.917681410015861,0,12,cytoskeletal adaptor activity,MF,
3893,GO:0008097,1,0.952849616828429,0,10,5S rRNA binding,MF,
3895,GO:0008106,1,0.915241621874335,0,19,alcohol dehydrogenase (NADP+) activity,MF,
3896,GO:0008107,1,0.992580614502395,0,1,galactoside 2-alpha-L-fucosyltransferase activity,MF,
3897,GO:0008108,1,0.99583565400703,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
3898,GO:0008109,1,0.985724429592901,0,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
3899,GO:0008111,1,0.99503251339294,0,1,alpha-methylacyl-CoA racemase activity,MF,
3900,GO:0008112,1,0.99553710503278,0,1,nicotinamide N-methyltransferase activity,MF,
3901,GO:0008113,1,0.991511323190896,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
3902,GO:0008115,1,0.994481204304773,0,1,sarcosine oxidase activity,MF,
3903,GO:0008116,1,0.991227662191157,0,1,prostaglandin-I synthase activity,MF,
3904,GO:0008117,1,0.991057404697004,0,1,sphinganine-1-phosphate aldolase activity,MF,
3905,GO:0008118,1,0.994717110730619,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
3906,GO:0008119,1,0.993545656907173,0,1,thiopurine S-methyltransferase activity,MF,
3907,GO:0008120,1,0.995465274891211,0,1,ceramide glucosyltransferase activity,MF,
3908,GO:0008121,1,0.968829923556203,0,7,ubiquinol-cytochrome-c reductase activity,MF,
3909,GO:0008124,1,0.99079954573211,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
3910,GO:0008126,1,0.993978033807462,0,1,acetylesterase activity,MF,
3911,GO:0008127,1,0.995884380587454,0,1,quercetin 2,3-dioxygenase activity,MF,
3912,GO:0008131,1,0.968265922745991,0,5,primary amine oxidase activity,MF,
3915,GO:0008137,1,0.863704091858012,0,38,NADH dehydrogenase (ubiquinone) activity,MF,
3916,GO:0008138,1,0.780834732973817,0,40,protein tyrosine/serine/threonine phosphatase activity,MF,
3917,GO:0008139,1,0.845261177149164,0,22,nuclear localization sequence binding,MF,
3918,GO:0008140,1,0.950126935614697,0,8,cAMP response element binding protein binding,MF,
3919,GO:0008142,1,0.960774829419367,0,5,oxysterol binding,MF,
3920,GO:0008143,1,0.896435815034508,0,16,poly(A) binding,MF,
3923,GO:0008147,1,0.993520224143559,0,2,structural constituent of bone,MF,
3926,GO:0008154,1,0.286717128236613,0,187,actin polymerization or depolymerization,BP,
3927,GO:0008156,1,0.798192883241311,0,32,negative regulation of DNA replication,BP,
3928,GO:0008157,1,0.879239521169116,0,19,protein phosphatase 1 binding,MF,
3929,GO:0008158,1,0.978321648190532,0,3,hedgehog receptor activity,MF,
3930,GO:0008160,1,0.99423927615699,0,1,protein tyrosine phosphatase activator activity,MF,
3931,GO:0008168,1,0.316865676261935,0,182,methyltransferase activity,MF,
3932,GO:0008169,1,0.982548857352893,0,3,C-methyltransferase activity,MF,
3933,GO:0008170,1,0.586748750670021,0,81,N-methyltransferase activity,MF,
3934,GO:0008171,1,0.898270894836966,0,18,O-methyltransferase activity,MF,
3935,GO:0008172,1,0.960381223112846,0,6,S-methyltransferase activity,MF,
3936,GO:0008173,1,0.735020138798692,0,51,RNA methyltransferase activity,MF,
3937,GO:0008174,1,0.946797555971833,0,9,mRNA methyltransferase activity,MF,
3938,GO:0008175,1,0.84451973697411,0,27,tRNA methyltransferase activity,MF,
3939,GO:0008176,1,0.991229143766722,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
3940,GO:0008177,1,0.980640989710721,0,4,succinate dehydrogenase (ubiquinone) activity,MF,
3941,GO:0008179,1,0.907880407991738,0,13,adenylate cyclase binding,MF,
3942,GO:0008180,1,0.811783774338678,0,33,COP9 signalosome,CC,
3943,GO:0008184,1,0.980123632208085,0,3,glycogen phosphorylase activity,MF,
3944,GO:0008186,1,0.644425944770909,0,65,RNA-dependent ATPase activity,MF,
3945,GO:0008187,1,0.859481385346718,0,23,poly-pyrimidine tract binding,MF,
3947,GO:0008190,1,0.934572840726791,0,10,eukaryotic initiation factor 4E binding,MF,
3948,GO:0008191,1,0.913263087174881,0,15,metalloendopeptidase inhibitor activity,MF,
3949,GO:0008192,1,0.981053135558143,0,3,RNA guanylyltransferase activity,MF,
3950,GO:0008193,1,0.988612358970958,0,2,tRNA guanylyltransferase activity,MF,
3951,GO:0008194,1,0.471795653302872,0,118,UDP-glycosyltransferase activity,MF,
3952,GO:0008195,1,0.974724180424371,0,3,phosphatidate phosphatase activity,MF,
3953,GO:0008198,1,0.879269051523401,0,21,ferrous iron binding,MF,
3954,GO:0008199,1,0.967205179859859,0,6,ferric iron binding,MF,
3955,GO:0008200,1,0.815555912560056,0,31,ion channel inhibitor activity,MF,
3958,GO:0008203,1,0.454619215116699,0,119,cholesterol metabolic process,BP,
3959,GO:0008204,1,0.989714304546065,0,2,ergosterol metabolic process,BP,
3960,GO:0008206,1,0.769110822375762,0,43,bile acid metabolic process,BP,
3961,GO:0008207,1,0.847039765719412,0,29,C21-steroid hormone metabolic process,BP,
3962,GO:0008209,1,0.87802358842162,0,21,androgen metabolic process,BP,
3963,GO:0008210,1,0.903226875511807,0,18,estrogen metabolic process,BP,
3964,GO:0008211,1,0.889904882580931,0,20,glucocorticoid metabolic process,BP,
3965,GO:0008212,1,0.947275150707099,0,8,mineralocorticoid metabolic process,BP,
3966,GO:0008213,1,0.320728239005991,0,163,protein alkylation,BP,
3967,GO:0008214,1,0.787110700855094,0,29,protein dealkylation,BP,
3968,GO:0008215,1,0.966903503474334,0,7,spermine metabolic process,BP,
3969,GO:0008216,1,0.963412644335725,0,8,spermidine metabolic process,BP,
3971,GO:0008218,1,0.993311518882161,0,1,bioluminescence,BP,
3974,GO:0008228,1,0.953335246110971,0,7,opsonization,BP,
3976,GO:0008234,1,0.334200168264065,0,158,cysteine-type peptidase activity,MF,
3977,GO:0008235,1,0.706039915685291,0,55,metalloexopeptidase activity,MF,
3979,GO:0008237,1,0.33985466301593,0,162,metallopeptidase activity,MF,
3980,GO:0008238,1,0.549529168055166,0,95,exopeptidase activity,MF,
3981,GO:0008239,1,0.939372253515546,0,11,dipeptidyl-peptidase activity,MF,
3982,GO:0008240,1,0.978935631457756,0,3,tripeptidyl-peptidase activity,MF,
3983,GO:0008241,1,0.993431519320577,0,1,peptidyl-dipeptidase activity,MF,
3984,GO:0008242,1,0.945652528860076,0,9,omega peptidase activity,MF,
3985,GO:0008250,1,0.94263728551113,0,12,oligosaccharyltransferase complex,CC,
3986,GO:0008251,1,0.98474506606479,0,2,tRNA-specific adenosine deaminase activity,MF,
3987,GO:0008252,1,0.914695842310669,0,14,nucleotidase activity,MF,
3988,GO:0008253,1,0.92946010513665,0,12,5'-nucleotidase activity,MF,
3989,GO:0008254,1,0.989647017166485,0,1,3'-nucleotidase activity,MF,
3990,GO:0008260,1,0.988490222697198,0,2,3-oxoacid CoA-transferase activity,MF,
3991,GO:0008263,1,0.987993934293264,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
3992,GO:0008265,1,0.994099360874657,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
3993,GO:0008266,1,0.884758339821998,0,19,poly(U) RNA binding,MF,
3994,GO:0008267,1,0.988890016027559,0,1,poly-glutamine tract binding,MF,
3995,GO:0008269,1,0.989896550892733,0,2,JAK pathway signal transduction adaptor activity,MF,
3997,GO:0008271,1,0.931361345973782,0,10,secondary active sulfate transmembrane transporter activity,MF,
3998,GO:0008272,1,0.920770912649159,0,12,sulfate transport,BP,
3999,GO:0008273,1,0.971394211696898,0,4,calcium, potassium:sodium antiporter activity,MF,
4000,GO:0008274,1,0.948277551728595,0,7,gamma-tubulin ring complex,CC,
4001,GO:0008275,1,0.972479117691128,0,4,gamma-tubulin small complex,CC,
4002,GO:0008276,1,0.595859194680508,0,77,protein methyltransferase activity,MF,
4004,GO:0008278,1,0.92713175320784,0,10,cohesin complex,CC,
4005,GO:0008281,1,0.984014158498589,0,2,sulfonylurea receptor activity,MF,
4006,GO:0008282,1,0.972483577797938,0,4,inward rectifying potassium channel,CC,
4010,GO:0008286,1,0.440180734464221,0,118,insulin receptor signaling pathway,BP,
4011,GO:0008287,1,0.747446229394057,0,44,protein serine/threonine phosphatase complex,CC,
4013,GO:0008290,1,0.959188001710888,0,7,F-actin capping protein complex,CC,
4014,GO:0008291,1,0.982377859125742,0,3,acetylcholine metabolic process,BP,
4015,GO:0008292,1,0.994202771880615,0,1,acetylcholine biosynthetic process,BP,
4017,GO:0008295,1,0.979731551904219,0,4,spermidine biosynthetic process,BP,
4018,GO:0008296,1,0.944236887273903,0,10,3'-5'-exodeoxyribonuclease activity,MF,
4019,GO:0008297,1,0.955916399924989,0,7,single-stranded DNA exodeoxyribonuclease activity,MF,
4020,GO:0008298,1,0.935109744916712,0,12,intracellular mRNA localization,BP,
4021,GO:0008299,1,0.856267143731683,0,27,isoprenoid biosynthetic process,BP,
4022,GO:0008300,1,0.963801733646297,0,7,isoprenoid catabolic process,BP,
4024,GO:0008305,1,0.781321864320016,0,32,integrin complex,CC,
4026,GO:0008307,1,0.704132129332968,0,43,structural constituent of muscle,MF,
4027,GO:0008308,1,0.903751478230364,0,16,voltage-gated anion channel activity,MF,
4028,GO:0008309,1,0.979125599704413,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
4029,GO:0008310,1,0.967836224760997,0,5,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4030,GO:0008311,1,0.990694751840177,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4031,GO:0008312,1,0.965294269730536,0,7,7S RNA binding,MF,
4032,GO:0008318,1,0.954727521073439,0,7,protein prenyltransferase activity,MF,
4033,GO:0008320,1,0.940718036184488,0,13,protein transmembrane transporter activity,MF,
4034,GO:0008321,1,0.976676168404972,0,3,Ral guanyl-nucleotide exchange factor activity,MF,
4036,GO:0008327,1,0.904891036355516,0,15,methyl-CpG binding,MF,
4038,GO:0008329,1,0.919837061866857,0,14,signaling pattern recognition receptor activity,MF,
4039,GO:0008330,1,0.979107351627991,0,4,protein tyrosine/threonine phosphatase activity,MF,
4040,GO:0008331,1,0.888587929767381,0,12,high voltage-gated calcium channel activity,MF,
4041,GO:0008332,1,0.960883065243543,0,4,low voltage-gated calcium channel activity,MF,
4042,GO:0008333,1,0.697492004707902,0,52,endosome to lysosome transport,BP,
4043,GO:0008334,1,0.851858148855963,0,24,histone mRNA metabolic process,BP,
4044,GO:0008336,1,0.995139780213873,0,1,gamma-butyrobetaine dioxygenase activity,MF,
4045,GO:0008340,1,0.909290675131247,0,11,determination of adult lifespan,BP,
4046,GO:0008343,1,0.959229780638035,0,8,adult feeding behavior,BP,
4048,GO:0008347,1,0.769132656447672,0,38,glial cell migration,BP,
4049,GO:0008348,1,0.993134818868669,0,1,negative regulation of antimicrobial humoral response,BP,
4050,GO:0008349,1,0.918806315515988,0,11,MAP kinase kinase kinase kinase activity,MF,
4051,GO:0008352,1,0.99418636552551,0,1,katanin complex,CC,
4052,GO:0008353,1,0.910708331589859,0,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,
4053,GO:0008354,1,0.953348925617444,0,7,germ cell migration,BP,
4054,GO:0008355,1,0.985019921436258,0,2,olfactory learning,BP,
4056,GO:0008358,1,0.987599014291715,0,2,maternal determination of anterior/posterior axis, embryo,BP,
4057,GO:0008360,1,0.327294548368607,0,154,regulation of cell shape,BP,
4058,GO:0008361,1,0.310557705075336,0,157,regulation of cell size,BP,
4059,GO:0008366,1,0.43692135045149,0,113,axon ensheathment,BP,
4061,GO:0008374,1,0.777863982173428,0,37,O-acyltransferase activity,MF,
4062,GO:0008375,1,0.713300253386258,0,53,acetylglucosaminyltransferase activity,MF,
4063,GO:0008376,1,0.755152371909138,0,44,acetylgalactosaminyltransferase activity,MF,
4064,GO:0008378,1,0.832377821172737,0,31,galactosyltransferase activity,MF,
4065,GO:0008379,1,0.981042089700235,0,5,thioredoxin peroxidase activity,MF,
4067,GO:0008381,1,0.946378709585647,0,9,mechanosensitive ion channel activity,MF,
4068,GO:0008384,1,0.986186003966369,0,2,IkappaB kinase activity,MF,
4069,GO:0008385,1,0.943999120382528,0,9,IkappaB kinase complex,CC,
4070,GO:0008386,1,0.995036319435478,0,1,cholesterol monooxygenase (side-chain-cleaving) activity,MF,
4071,GO:0008387,1,0.994649102699105,0,1,steroid 7-alpha-hydroxylase activity,MF,
4072,GO:0008389,1,0.990635066119812,0,2,coumarin 7-hydroxylase activity,MF,
4073,GO:0008391,1,0.961274041904673,0,8,arachidonic acid monooxygenase activity,MF,
4074,GO:0008392,1,0.961274041904673,0,8,arachidonic acid epoxygenase activity,MF,
4075,GO:0008395,1,0.88810230452207,0,22,steroid hydroxylase activity,MF,
4076,GO:0008396,1,0.989182696949072,0,2,oxysterol 7-alpha-hydroxylase activity,MF,
4077,GO:0008397,1,0.992868217048133,0,1,sterol 12-alpha-hydroxylase activity,MF,
4078,GO:0008398,1,0.993726548433934,0,1,sterol 14-demethylase activity,MF,
4079,GO:0008401,1,0.981411658902933,0,3,retinoic acid 4-hydroxylase activity,MF,
4080,GO:0008403,1,0.993623927109821,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
4081,GO:0008404,1,0.995177873192027,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
4082,GO:0008405,1,0.995177873192027,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
4084,GO:0008408,1,0.734591610860244,0,48,3'-5' exonuclease activity,MF,
4085,GO:0008409,1,0.889034224345983,0,16,5'-3' exonuclease activity,MF,
4086,GO:0008410,1,0.977917249278989,0,4,CoA-transferase activity,MF,
4087,GO:0008413,1,0.991602992556259,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
4088,GO:0008417,1,0.918081887394778,0,12,fucosyltransferase activity,MF,
4089,GO:0008418,1,0.99611485527593,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
4090,GO:0008419,1,0.994196906702707,0,1,RNA lariat debranching enzyme activity,MF,
4091,GO:0008420,1,0.952407947380475,0,8,CTD phosphatase activity,MF,
4092,GO:0008422,1,0.975461338858061,0,4,beta-glucosidase activity,MF,
4093,GO:0008424,1,0.99350517844687,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
4094,GO:0008425,1,0.995925571083506,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
4095,GO:0008426,1,0.985385712348736,0,3,protein kinase C inhibitor activity,MF,
4096,GO:0008427,1,0.986718205163901,0,3,calcium-dependent protein kinase inhibitor activity,MF,
4097,GO:0008428,1,0.9815879681909,0,3,ribonuclease inhibitor activity,MF,
4098,GO:0008429,1,0.945417932484192,0,9,phosphatidylethanolamine binding,MF,
4100,GO:0008431,1,0.98800752412244,0,2,vitamin E binding,MF,
4101,GO:0008432,1,0.945283202088234,0,8,JUN kinase binding,MF,
4102,GO:0008434,1,0.992114050009461,0,1,calcitriol receptor activity,MF,
4103,GO:0008437,1,0.994993834607299,0,1,thyrotropin-releasing hormone activity,MF,
4104,GO:0008440,1,0.967630928387763,0,5,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
4105,GO:0008441,1,0.984126861743756,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
4106,GO:0008442,1,0.995026804807797,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
4107,GO:0008443,1,0.954900488056753,0,7,phosphofructokinase activity,MF,
4108,GO:0008444,1,0.994755319278953,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
4109,GO:0008445,1,0.995482929907883,0,1,D-aspartate oxidase activity,MF,
4110,GO:0008446,1,0.995409733454259,0,1,GDP-mannose 4,6-dehydratase activity,MF,
4111,GO:0008448,1,0.995208975963917,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
4112,GO:0008449,1,0.975659810660862,0,3,N-acetylglucosamine-6-sulfatase activity,MF,
4113,GO:0008452,1,0.994054740756748,0,1,RNA ligase activity,MF,
4114,GO:0008453,1,0.983700347724796,0,3,alanine-glyoxylate transaminase activity,MF,
4115,GO:0008454,1,0.980145395523092,0,3,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
4116,GO:0008455,1,0.994133978983308,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
4117,GO:0008456,1,0.993075180528113,0,1,alpha-N-acetylgalactosaminidase activity,MF,
4118,GO:0008457,1,0.992700867474221,0,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
4119,GO:0008458,1,0.993543625994518,0,1,carnitine O-octanoyltransferase activity,MF,
4120,GO:0008459,1,0.984558786000984,0,2,chondroitin 6-sulfotransferase activity,MF,
4121,GO:0008460,1,0.995116923739894,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
4122,GO:0008465,1,0.99595924605099,0,1,glycerate dehydrogenase activity,MF,
4123,GO:0008466,1,0.98871601361843,0,2,glycogenin glucosyltransferase activity,MF,
4124,GO:0008467,1,0.967563703504939,0,6,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,
4125,GO:0008469,1,0.951419788358967,0,9,histone-arginine N-methyltransferase activity,MF,
4126,GO:0008470,1,0.992204171659833,0,1,isovaleryl-CoA dehydrogenase activity,MF,
4127,GO:0008474,1,0.945123030648136,0,10,palmitoyl-(protein) hydrolase activity,MF,
4128,GO:0008475,1,0.980506545683797,0,3,procollagen-lysine 5-dioxygenase activity,MF,
4129,GO:0008476,1,0.990026446893265,0,2,protein-tyrosine sulfotransferase activity,MF,
4130,GO:0008478,1,0.989492562806172,0,1,pyridoxal kinase activity,MF,
4131,GO:0008479,1,0.981810560411841,0,4,queuine tRNA-ribosyltransferase activity,MF,
4132,GO:0008480,1,0.993483538889398,0,1,sarcosine dehydrogenase activity,MF,
4133,GO:0008481,1,0.989045960494139,0,2,sphinganine kinase activity,MF,
4134,GO:0008482,1,0.994580864111259,0,1,sulfite oxidase activity,MF,
4136,GO:0008484,1,0.894931403555421,0,16,sulfuric ester hydrolase activity,MF,
4137,GO:0008486,1,0.977560788177497,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
4138,GO:0008488,1,0.993626505102641,0,1,gamma-glutamyl carboxylase activity,MF,
4139,GO:0008489,1,0.993912086286088,0,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
4140,GO:0008493,1,0.995173429316568,0,1,tetracycline transmembrane transporter activity,MF,
4141,GO:0008494,1,0.934808480443785,0,11,translation activator activity,MF,
4142,GO:0008495,1,0.993806242189318,0,1,protoheme IX farnesyltransferase activity,MF,
4143,GO:0008496,1,0.992567960527844,0,1,mannan endo-1,6-alpha-mannosidase activity,MF,
4144,GO:0008499,1,0.931256037893524,0,12,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
4145,GO:0008502,1,0.979883275250385,0,4,melatonin receptor activity,MF,
4147,GO:0008504,1,0.943789143190704,0,9,monoamine transmembrane transporter activity,MF,
4148,GO:0008506,1,0.981643102359566,0,3,sucrose:proton symporter activity,MF,
4149,GO:0008507,1,0.993214069677797,0,1,sodium:iodide symporter activity,MF,
4150,GO:0008508,1,0.981617991696313,0,4,bile acid:sodium symporter activity,MF,
4153,GO:0008511,1,0.982157331777347,0,2,sodium:potassium:chloride symporter activity,MF,
4154,GO:0008513,1,0.984381630132822,0,3,secondary active organic cation transmembrane transporter activity,MF,
4156,GO:0008515,1,0.981643102359566,0,3,sucrose transmembrane transporter activity,MF,
4157,GO:0008517,1,0.964121867110281,0,6,folic acid transmembrane transporter activity,MF,
4158,GO:0008518,1,0.99398250618881,0,1,reduced folate carrier activity,MF,
4159,GO:0008519,1,0.844777619095757,0,28,ammonium transmembrane transporter activity,MF,
4160,GO:0008520,1,0.989895386513853,0,1,L-ascorbate:sodium symporter activity,MF,
4161,GO:0008521,1,0.994187535736652,0,1,acetyl-CoA transmembrane transporter activity,MF,
4162,GO:0008523,1,0.993490575578835,0,1,sodium-dependent multivitamin transmembrane transporter activity,MF,
4163,GO:0008525,1,0.940277516095193,0,8,phosphatidylcholine transporter activity,MF,
4164,GO:0008526,1,0.943926645153634,0,8,phosphatidylinositol transporter activity,MF,
4165,GO:0008527,1,0.939230184938744,0,14,taste receptor activity,MF,
4167,GO:0008531,1,0.994133978983308,0,1,riboflavin kinase activity,MF,
4168,GO:0008532,1,0.955252767405128,0,8,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,
4169,GO:0008534,1,0.983041099788595,0,4,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
4170,GO:0008535,1,0.87538869337539,0,24,respiratory chain complex IV assembly,BP,
4172,GO:0008537,1,0.986270784961023,0,3,proteasome activator complex,CC,
4173,GO:0008540,1,0.942190334388286,0,12,proteasome regulatory particle, base subcomplex,CC,
4174,GO:0008541,1,0.968039939848162,0,7,proteasome regulatory particle, lid subcomplex,CC,
4175,GO:0008542,1,0.716753719323791,0,44,visual learning,BP,
4177,GO:0008544,1,0.150531272793022,0,280,epidermis development,BP,
4178,GO:0008545,1,0.986520264532022,0,2,JUN kinase kinase activity,MF,
4179,GO:0008553,1,0.920366126596395,0,13,proton-exporting ATPase activity, phosphorylative mechanism,MF,
4180,GO:0008554,1,0.992034134391128,0,1,sodium-exporting ATPase activity, phosphorylative mechanism,MF,
4181,GO:0008555,1,0.991456324718384,0,1,chloride-transporting ATPase activity,MF,
4182,GO:0008556,1,0.929262979058284,0,12,potassium-transporting ATPase activity,MF,
4183,GO:0008559,1,0.952864588359396,0,6,xenobiotic transmembrane transporting ATPase activity,MF,
4184,GO:0008565,1,0.607000631274004,0,77,protein transporter activity,MF,
4185,GO:0008568,1,0.934314148304496,0,10,microtubule-severing ATPase activity,MF,
4186,GO:0008569,1,0.78823735576716,0,18,ATP-dependent microtubule motor activity, minus-end-directed,MF,
4188,GO:0008579,1,0.991548283852008,0,1,JUN kinase phosphatase activity,MF,
4189,GO:0008582,1,0.963019913235868,0,5,regulation of synaptic growth at neuromuscular junction,BP,
4192,GO:0008589,1,0.5868641237792,0,73,regulation of smoothened signaling pathway,BP,
4193,GO:0008591,1,0.995250216689571,0,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,
4194,GO:0008592,1,0.993556840448378,0,1,regulation of Toll signaling pathway,BP,
4196,GO:0008594,1,0.985598994090419,0,2,photoreceptor cell morphogenesis,BP,
4197,GO:0008595,1,0.922455456724117,0,12,anterior/posterior axis specification, embryo,BP,
4198,GO:0008597,1,0.983448700360599,0,3,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
4199,GO:0008603,1,0.960877591182266,0,7,cAMP-dependent protein kinase regulator activity,MF,
4200,GO:0008607,1,0.982861653857919,0,3,phosphorylase kinase regulator activity,MF,
4201,GO:0008608,1,0.82571939360994,0,30,attachment of spindle microtubules to kinetochore,BP,
4202,GO:0008609,1,0.989214012147117,0,1,alkylglycerone-phosphate synthase activity,MF,
4204,GO:0008611,1,0.966787810603996,0,5,ether lipid biosynthetic process,BP,
4205,GO:0008612,1,0.978501503818759,0,4,peptidyl-lysine modification to peptidyl-hypusine,BP,
4206,GO:0008614,1,0.988211943262445,0,2,pyridoxine metabolic process,BP,
4207,GO:0008615,1,0.988211943262445,0,2,pyridoxine biosynthetic process,BP,
4208,GO:0008616,1,0.98591684796691,0,3,queuosine biosynthetic process,BP,
4209,GO:0008617,1,0.996242741238324,0,1,guanosine metabolic process,BP,
4210,GO:0008622,1,0.97041860194139,0,5,epsilon DNA polymerase complex,CC,
4211,GO:0008623,1,0.985365430491662,0,2,CHRAC,CC,
4213,GO:0008626,1,0.970054654881918,0,6,granzyme-mediated apoptotic signaling pathway,BP,
4214,GO:0008627,1,0.947280811738794,0,8,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
4215,GO:0008628,1,0.986741761763234,0,3,hormone-mediated apoptotic signaling pathway,BP,
4217,GO:0008631,1,0.777993484278045,0,42,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
4218,GO:0008635,1,0.946501434247708,0,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,
4220,GO:0008641,1,0.937667899129221,0,10,ubiquitin-like modifier activating enzyme activity,MF,
4221,GO:0008643,1,0.417185245688743,0,129,carbohydrate transport,BP,
4222,GO:0008645,1,0.507016714186221,0,98,hexose transmembrane transport,BP,
4223,GO:0008649,1,0.919921536306581,0,15,rRNA methyltransferase activity,MF,
4224,GO:0008650,1,0.993225712026503,0,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,
4226,GO:0008654,1,0.173184103977154,0,263,phospholipid biosynthetic process,BP,
4227,GO:0008655,1,0.940476599916227,0,12,pyrimidine-containing compound salvage,BP,
4228,GO:0008656,1,0.914028115482502,0,14,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
4229,GO:0008670,1,0.991480554782372,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
4230,GO:0008689,1,0.995925571083506,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4231,GO:0008700,1,0.994054740756748,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
4232,GO:0008705,1,0.986581230283702,0,1,methionine synthase activity,MF,
4233,GO:0008709,1,0.996317729861585,0,1,cholate 7-alpha-dehydrogenase activity,MF,
4234,GO:0008721,1,0.994402058223341,0,1,D-serine ammonia-lyase activity,MF,
4235,GO:0008725,1,0.996149649013535,0,1,DNA-3-methyladenine glycosylase activity,MF,
4236,GO:0008732,1,0.989153281269234,0,2,L-allo-threonine aldolase activity,MF,
4237,GO:0008745,1,0.996318349227192,0,1,N-acetylmuramoyl-L-alanine amidase activity,MF,
4238,GO:0008746,1,0.988337441598686,0,2,NAD(P)+ transhydrogenase activity,MF,
4239,GO:0008747,1,0.995558502216948,0,1,N-acetylneuraminate lyase activity,MF,
4240,GO:0008750,1,0.992154189631561,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
4241,GO:0008753,1,0.99334293453817,0,1,NADPH dehydrogenase (quinone) activity,MF,
4242,GO:0008757,1,0.429268981936712,0,132,S-adenosylmethionine-dependent methyltransferase activity,MF,
4243,GO:0008761,1,0.991532290048965,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
4244,GO:0008768,1,0.996424793492119,0,1,UDP-sugar diphosphatase activity,MF,
4245,GO:0008775,1,0.995222302595604,0,1,acetate CoA-transferase activity,MF,
4246,GO:0008781,1,0.991302962930055,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
4247,GO:0008783,1,0.994750302710204,0,1,agmatinase activity,MF,
4248,GO:0008785,1,0.995550951605402,0,1,alkyl hydroperoxide reductase activity,MF,
4249,GO:0008792,1,0.994054740756748,0,1,arginine decarboxylase activity,MF,
4250,GO:0008794,1,0.996367879281004,0,1,arsenate reductase (glutaredoxin) activity,MF,
4251,GO:0008796,1,0.990366130530287,0,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
4252,GO:0008798,1,0.9856734190271,0,2,beta-aspartyl-peptidase activity,MF,
4253,GO:0008802,1,0.993234452258784,0,1,betaine-aldehyde dehydrogenase activity,MF,
4254,GO:0008803,1,0.996271260062548,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
4255,GO:0008808,1,0.993005644329228,0,1,cardiolipin synthase activity,MF,
4256,GO:0008812,1,0.993156033822864,0,1,choline dehydrogenase activity,MF,
4257,GO:0008817,1,0.992680560931435,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
4258,GO:0008821,1,0.95502383084545,0,8,crossover junction endodeoxyribonuclease activity,MF,
4259,GO:0008823,1,0.965799071190292,0,5,cupric reductase activity,MF,
4260,GO:0008829,1,0.995227378787111,0,1,dCTP deaminase activity,MF,
4261,GO:0008832,1,0.993596680715339,0,1,dGTPase activity,MF,
4262,GO:0008841,1,0.994388744542027,0,1,dihydrofolate synthase activity,MF,
4263,GO:0008843,1,0.99460686867035,0,1,endochitinase activity,MF,
4264,GO:0008852,1,0.993989224169943,0,1,exodeoxyribonuclease I activity,MF,
4265,GO:0008853,1,0.978621399892666,0,4,exodeoxyribonuclease III activity,MF,
4266,GO:0008859,1,0.996312155300031,0,1,exoribonuclease II activity,MF,
4267,GO:0008865,1,0.964375656274267,0,5,fructokinase activity,MF,
4268,GO:0008887,1,0.993557858277152,0,1,glycerate kinase activity,MF,
4269,GO:0008889,1,0.966862897621435,0,5,glycerophosphodiester phosphodiesterase activity,MF,
4270,GO:0008890,1,0.995527031704895,0,1,glycine C-acetyltransferase activity,MF,
4271,GO:0008891,1,0.995318665137046,0,1,glycolate oxidase activity,MF,
4272,GO:0008892,1,0.991395369109287,0,1,guanine deaminase activity,MF,
4273,GO:0008893,1,0.996204281272632,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
4274,GO:0008894,1,0.994098211288859,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
4275,GO:0008897,1,0.993956857881466,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
4276,GO:0008900,1,0.982193738009282,0,3,potassium:proton exchanging ATPase activity,MF,
4277,GO:0008903,1,0.996121070060819,0,1,hydroxypyruvate isomerase activity,MF,
4278,GO:0008905,1,0.995500576717864,0,1,mannose-phosphate guanylyltransferase activity,MF,
4279,GO:0008934,1,0.972597476595278,0,4,inositol monophosphate 1-phosphatase activity,MF,
4280,GO:0008940,1,0.980788111570563,0,3,nitrate reductase activity,MF,
4281,GO:0008941,1,0.989458140959411,0,2,nitric oxide dioxygenase activity,MF,
4282,GO:0008948,1,0.976023205639593,0,4,oxaloacetate decarboxylase activity,MF,
4283,GO:0008955,1,0.992858632899633,0,1,peptidoglycan glycosyltransferase activity,MF,
4284,GO:0008962,1,0.989300223610951,0,2,phosphatidylglycerophosphatase activity,MF,
4285,GO:0008963,1,0.99481689816392,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
4286,GO:0008967,1,0.988670932628709,0,2,phosphoglycolate phosphatase activity,MF,
4287,GO:0008970,1,0.95113151616346,0,9,phosphatidylcholine 1-acylhydrolase activity,MF,
4288,GO:0008973,1,0.993548704688427,0,1,phosphopentomutase activity,MF,
4289,GO:0008988,1,0.988144472527205,0,2,rRNA (adenine-N6-)-methyltransferase activity,MF,
4290,GO:0008995,1,0.994268886159727,0,1,ribonuclease E activity,MF,
4291,GO:0009000,1,0.994419037513581,0,1,selenocysteine lyase activity,MF,
4292,GO:0009007,1,0.993125185721406,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
4293,GO:0009008,1,0.966325483156337,0,5,DNA-methyltransferase activity,MF,
4294,GO:0009013,1,0.991678213729253,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
4295,GO:0009019,1,0.973971531905396,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4296,GO:0009020,1,0.995052180476412,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
4297,GO:0009032,1,0.995429939945863,0,1,thymidine phosphorylase activity,MF,
4298,GO:0009041,1,0.983954112016651,0,3,uridylate kinase activity,MF,
4299,GO:0009048,1,0.91375662049991,0,10,dosage compensation by inactivation of X chromosome,BP,
4300,GO:0009051,1,0.98592590372679,0,3,pentose-phosphate shunt, oxidative branch,BP,
4301,GO:0009052,1,0.973884780798753,0,5,pentose-phosphate shunt, non-oxidative branch,BP,
4302,GO:0009055,1,0.608501044756828,0,101,electron transfer activity,MF,
4307,GO:0009060,1,0.676798079469399,0,74,aerobic respiration,BP,
4308,GO:0009061,1,0.994503257274021,0,1,anaerobic respiration,BP,
4311,GO:0009064,1,0.654611373403763,0,69,glutamine family amino acid metabolic process,BP,
4312,GO:0009065,1,0.841406567473762,0,28,glutamine family amino acid catabolic process,BP,
4313,GO:0009066,1,0.721810061442595,0,55,aspartate family amino acid metabolic process,BP,
4314,GO:0009067,1,0.871488672040858,0,22,aspartate family amino acid biosynthetic process,BP,
4315,GO:0009068,1,0.887637339428644,0,21,aspartate family amino acid catabolic process,BP,
4316,GO:0009069,1,0.816494419414049,0,36,serine family amino acid metabolic process,BP,
4317,GO:0009070,1,0.922832368411472,0,15,serine family amino acid biosynthetic process,BP,
4318,GO:0009071,1,0.946159114797715,0,11,serine family amino acid catabolic process,BP,
4319,GO:0009072,1,0.881496896620171,0,24,aromatic amino acid family metabolic process,BP,
4320,GO:0009074,1,0.914639938947244,0,18,aromatic amino acid family catabolic process,BP,
4321,GO:0009078,1,0.97919771879362,0,4,pyruvate family amino acid metabolic process,BP,
4322,GO:0009080,1,0.97919771879362,0,4,pyruvate family amino acid catabolic process,BP,
4326,GO:0009084,1,0.89712680039066,0,17,glutamine family amino acid biosynthetic process,BP,
4327,GO:0009085,1,0.98495825626829,0,2,lysine biosynthetic process,BP,
4328,GO:0009086,1,0.927091565482857,0,12,methionine biosynthetic process,BP,
4329,GO:0009087,1,0.993388323907162,0,1,methionine catabolic process,BP,
4330,GO:0009088,1,0.994854703412215,0,1,threonine biosynthetic process,BP,
4331,GO:0009092,1,0.978736428914127,0,4,homoserine metabolic process,BP,
4332,GO:0009093,1,0.985321852774854,0,3,cysteine catabolic process,BP,
4337,GO:0009106,1,0.988654590906305,0,2,lipoate metabolic process,BP,
4338,GO:0009107,1,0.995411628283286,0,1,lipoate biosynthetic process,BP,
4339,GO:0009108,1,0.243867933250327,0,221,coenzyme biosynthetic process,BP,
4340,GO:0009109,1,0.924369737454336,0,14,coenzyme catabolic process,BP,
4341,GO:0009110,1,0.880211681745609,0,21,vitamin biosynthetic process,BP,
4342,GO:0009111,1,0.946194817437934,0,10,vitamin catabolic process,BP,
4343,GO:0009112,1,0.790886349433058,0,39,nucleobase metabolic process,BP,
4344,GO:0009113,1,0.929656513661189,0,13,purine nucleobase biosynthetic process,BP,
4345,GO:0009115,1,0.983029835828362,0,2,xanthine catabolic process,BP,
4349,GO:0009120,1,0.968547686462582,0,6,deoxyribonucleoside metabolic process,BP,
4351,GO:0009124,1,0.365328448616033,0,159,nucleoside monophosphate biosynthetic process,BP,
4352,GO:0009125,1,0.941246646859137,0,11,nucleoside monophosphate catabolic process,BP,
4354,GO:0009127,1,0.412567194940083,0,137,purine nucleoside monophosphate biosynthetic process,BP,
4355,GO:0009128,1,0.95113814717129,0,9,purine nucleoside monophosphate catabolic process,BP,
4356,GO:0009129,1,0.917259757138186,0,16,pyrimidine nucleoside monophosphate metabolic process,BP,
4357,GO:0009130,1,0.921386822579076,0,15,pyrimidine nucleoside monophosphate biosynthetic process,BP,
4358,GO:0009131,1,0.995524512964062,0,1,pyrimidine nucleoside monophosphate catabolic process,BP,
4360,GO:0009133,1,0.969199415290176,0,6,nucleoside diphosphate biosynthetic process,BP,
4361,GO:0009134,1,0.965703936506617,0,6,nucleoside diphosphate catabolic process,BP,
4363,GO:0009136,1,0.984193204289645,0,3,purine nucleoside diphosphate biosynthetic process,BP,
4364,GO:0009137,1,0.981419177680916,0,3,purine nucleoside diphosphate catabolic process,BP,
4365,GO:0009138,1,0.983871193663671,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
4366,GO:0009139,1,0.98993040397395,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4367,GO:0009140,1,0.99387977965686,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4368,GO:0009141,1,0.179309894169342,0,291,nucleoside triphosphate metabolic process,BP,
4369,GO:0009142,1,0.40390030173846,0,143,nucleoside triphosphate biosynthetic process,BP,
4370,GO:0009143,1,0.932908361436205,0,12,nucleoside triphosphate catabolic process,BP,
4371,GO:0009144,1,0.201134139328292,0,271,purine nucleoside triphosphate metabolic process,BP,
4372,GO:0009145,1,0.445219474619728,0,126,purine nucleoside triphosphate biosynthetic process,BP,
4373,GO:0009146,1,0.968124612176929,0,6,purine nucleoside triphosphate catabolic process,BP,
4374,GO:0009147,1,0.901294200382304,0,21,pyrimidine nucleoside triphosphate metabolic process,BP,
4375,GO:0009148,1,0.914520040090119,0,18,pyrimidine nucleoside triphosphate biosynthetic process,BP,
4376,GO:0009149,1,0.991292357064011,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4378,GO:0009151,1,0.947530127756726,0,10,purine deoxyribonucleotide metabolic process,BP,
4380,GO:0009153,1,0.984479070475542,0,3,purine deoxyribonucleotide biosynthetic process,BP,
4381,GO:0009154,1,0.804167067076177,0,31,purine ribonucleotide catabolic process,BP,
4382,GO:0009155,1,0.971885304358373,0,5,purine deoxyribonucleotide catabolic process,BP,
4383,GO:0009156,1,0.385029730664634,0,149,ribonucleoside monophosphate biosynthetic process,BP,
4384,GO:0009157,1,0.954289077653697,0,9,deoxyribonucleoside monophosphate biosynthetic process,BP,
4385,GO:0009158,1,0.954842456826605,0,8,ribonucleoside monophosphate catabolic process,BP,
4386,GO:0009159,1,0.989605593848487,0,2,deoxyribonucleoside monophosphate catabolic process,BP,
4388,GO:0009162,1,0.940839464091465,0,12,deoxyribonucleoside monophosphate metabolic process,BP,
4389,GO:0009163,1,0.807284948253349,0,41,nucleoside biosynthetic process,BP,
4390,GO:0009164,1,0.869431893997419,0,27,nucleoside catabolic process,BP,
4392,GO:0009166,1,0.355661882429574,0,156,nucleotide catabolic process,BP,
4394,GO:0009168,1,0.412567194940083,0,137,purine ribonucleoside monophosphate biosynthetic process,BP,
4395,GO:0009169,1,0.954842456826605,0,8,purine ribonucleoside monophosphate catabolic process,BP,
4396,GO:0009170,1,0.996268780695775,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,
4397,GO:0009173,1,0.944252868548572,0,10,pyrimidine ribonucleoside monophosphate metabolic process,BP,
4398,GO:0009174,1,0.944252868548572,0,10,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,
4399,GO:0009176,1,0.971429604729762,0,6,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4400,GO:0009177,1,0.975797856379477,0,5,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4401,GO:0009178,1,0.995524512964062,0,1,pyrimidine deoxyribonucleoside monophosphate catabolic process,BP,
4403,GO:0009180,1,0.984193204289645,0,3,purine ribonucleoside diphosphate biosynthetic process,BP,
4404,GO:0009181,1,0.981419177680916,0,3,purine ribonucleoside diphosphate catabolic process,BP,
4405,GO:0009182,1,0.983612410174105,0,3,purine deoxyribonucleoside diphosphate metabolic process,BP,
4406,GO:0009183,1,0.989495845727945,0,2,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
4408,GO:0009186,1,0.973706183367101,0,5,deoxyribonucleoside diphosphate metabolic process,BP,
4410,GO:0009188,1,0.984193204289645,0,3,ribonucleoside diphosphate biosynthetic process,BP,
4411,GO:0009189,1,0.97953096317618,0,4,deoxyribonucleoside diphosphate biosynthetic process,BP,
4413,GO:0009191,1,0.971506846764431,0,5,ribonucleoside diphosphate catabolic process,BP,
4414,GO:0009193,1,0.99387977965686,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4415,GO:0009195,1,0.99387977965686,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4416,GO:0009196,1,0.98993040397395,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4417,GO:0009197,1,0.98993040397395,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
4418,GO:0009199,1,0.201106175712759,0,270,ribonucleoside triphosphate metabolic process,BP,
4419,GO:0009200,1,0.920617154034424,0,16,deoxyribonucleoside triphosphate metabolic process,BP,
4420,GO:0009201,1,0.430902207950019,0,131,ribonucleoside triphosphate biosynthetic process,BP,
4421,GO:0009202,1,0.970636764151427,0,6,deoxyribonucleoside triphosphate biosynthetic process,BP,
4422,GO:0009203,1,0.996131633573802,0,1,ribonucleoside triphosphate catabolic process,BP,
4423,GO:0009204,1,0.963420042079681,0,7,deoxyribonucleoside triphosphate catabolic process,BP,
4424,GO:0009205,1,0.208916650096941,0,264,purine ribonucleoside triphosphate metabolic process,BP,
4425,GO:0009206,1,0.447506574216596,0,125,purine ribonucleoside triphosphate biosynthetic process,BP,
4426,GO:0009207,1,0.996131633573802,0,1,purine ribonucleoside triphosphate catabolic process,BP,
4427,GO:0009208,1,0.926445872072007,0,15,pyrimidine ribonucleoside triphosphate metabolic process,BP,
4428,GO:0009209,1,0.931846369343439,0,14,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,
4429,GO:0009211,1,0.972872141400936,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4430,GO:0009212,1,0.981419609288433,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
4431,GO:0009213,1,0.991292357064011,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
4432,GO:0009214,1,0.852418130302678,0,20,cyclic nucleotide catabolic process,BP,
4433,GO:0009215,1,0.95401866473565,0,9,purine deoxyribonucleoside triphosphate metabolic process,BP,
4434,GO:0009216,1,0.989015085658953,0,2,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
4435,GO:0009217,1,0.971885304358373,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
4436,GO:0009218,1,0.884815514956299,0,23,pyrimidine ribonucleotide metabolic process,BP,
4437,GO:0009219,1,0.912761592848545,0,19,pyrimidine deoxyribonucleotide metabolic process,BP,
4438,GO:0009220,1,0.895462270962848,0,21,pyrimidine ribonucleotide biosynthetic process,BP,
4439,GO:0009221,1,0.961968447722189,0,8,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4440,GO:0009222,1,0.99387977965686,0,1,pyrimidine ribonucleotide catabolic process,BP,
4441,GO:0009223,1,0.944273645768452,0,12,pyrimidine deoxyribonucleotide catabolic process,BP,
4442,GO:0009224,1,0.995950517747861,0,1,CMP biosynthetic process,BP,
4443,GO:0009225,1,0.803438087768071,0,36,nucleotide-sugar metabolic process,BP,
4444,GO:0009226,1,0.876906727926953,0,23,nucleotide-sugar biosynthetic process,BP,
4445,GO:0009227,1,0.984572333966028,0,3,nucleotide-sugar catabolic process,BP,
4446,GO:0009229,1,0.994548759404803,0,1,thiamine diphosphate biosynthetic process,BP,
4447,GO:0009231,1,0.994133978983308,0,1,riboflavin biosynthetic process,BP,
4448,GO:0009233,1,0.986799969627911,0,2,menaquinone metabolic process,BP,
4449,GO:0009234,1,0.993151209466218,0,1,menaquinone biosynthetic process,BP,
4450,GO:0009235,1,0.880816943495288,0,19,cobalamin metabolic process,BP,
4451,GO:0009236,1,0.97770952991399,0,3,cobalamin biosynthetic process,BP,
4452,GO:0009237,1,0.993888515932573,0,1,siderophore metabolic process,BP,
4453,GO:0009240,1,0.981012494891309,0,4,isopentenyl diphosphate biosynthetic process,BP,
4454,GO:0009245,1,0.993377801209287,0,2,lipid A biosynthetic process,BP,
4456,GO:0009249,1,0.968775821363916,0,8,protein lipoylation,BP,
4457,GO:0009250,1,0.721848995093181,0,44,glucan biosynthetic process,BP,
4458,GO:0009251,1,0.838795461702137,0,24,glucan catabolic process,BP,
4459,GO:0009253,1,0.992599492885239,0,2,peptidoglycan catabolic process,BP,
4460,GO:0009256,1,0.964564506533798,0,5,10-formyltetrahydrofolate metabolic process,BP,
4461,GO:0009257,1,0.986550465416363,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
4462,GO:0009258,1,0.983077232840061,0,2,10-formyltetrahydrofolate catabolic process,BP,
4465,GO:0009261,1,0.799234575013743,0,32,ribonucleotide catabolic process,BP,
4466,GO:0009262,1,0.842770626047322,0,33,deoxyribonucleotide metabolic process,BP,
4467,GO:0009263,1,0.927220088484075,0,14,deoxyribonucleotide biosynthetic process,BP,
4468,GO:0009264,1,0.913436237088848,0,18,deoxyribonucleotide catabolic process,BP,
4469,GO:0009265,1,0.947031989578245,0,11,2'-deoxyribonucleotide biosynthetic process,BP,
4471,GO:0009267,1,0.426443229872853,0,130,cellular response to starvation,BP,
4472,GO:0009268,1,0.806677974201606,0,36,response to pH,BP,
4473,GO:0009295,1,0.774091244453062,0,41,nucleoid,CC,
4474,GO:0009298,1,0.981409427844407,0,4,GDP-mannose biosynthetic process,BP,
4475,GO:0009299,1,0.845206573298609,0,25,mRNA transcription,BP,
4476,GO:0009301,1,0.670019985161694,0,66,snRNA transcription,BP,
4477,GO:0009303,1,0.844663117902705,0,27,rRNA transcription,BP,
4478,GO:0009304,1,0.954306191787039,0,7,tRNA transcription,BP,
4479,GO:0009305,1,0.990820609009119,0,1,protein biotinylation,BP,
4481,GO:0009308,1,0.519357545580738,0,121,amine metabolic process,BP,
4482,GO:0009309,1,0.89898339939369,0,21,amine biosynthetic process,BP,
4483,GO:0009310,1,0.888908733068269,0,21,amine catabolic process,BP,
4484,GO:0009311,1,0.63170861137346,0,73,oligosaccharide metabolic process,BP,
4485,GO:0009312,1,0.794904975269363,0,38,oligosaccharide biosynthetic process,BP,
4486,GO:0009313,1,0.936029328985211,0,11,oligosaccharide catabolic process,BP,
4488,GO:0009328,1,0.978016327610821,0,4,phenylalanine-tRNA ligase complex,CC,
4490,GO:0009331,1,0.977908373748564,0,3,glycerol-3-phosphate dehydrogenase complex,CC,
4491,GO:0009346,1,0.992466922002185,0,1,citrate lyase complex,CC,
4492,GO:0009353,1,0.995850652299223,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
4493,GO:0009360,1,0.994140932476139,0,1,DNA polymerase III complex,CC,
4494,GO:0009368,1,0.990638807312192,0,2,endopeptidase Clp complex,CC,
4495,GO:0009372,1,0.993514260851553,0,1,quorum sensing,BP,
4496,GO:0009374,1,0.960686584034477,0,5,biotin binding,MF,
4497,GO:0009378,1,0.963089286215402,0,5,four-way junction helicase activity,MF,
4498,GO:0009383,1,0.986569111921383,0,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,
4499,GO:0009384,1,0.991532290048965,0,1,N-acylmannosamine kinase activity,MF,
4500,GO:0009386,1,0.990160196158359,0,2,translational attenuation,BP,
4501,GO:0009394,1,0.864826028401787,0,29,2'-deoxyribonucleotide metabolic process,BP,
4502,GO:0009395,1,0.824028713627892,0,31,phospholipid catabolic process,BP,
4503,GO:0009396,1,0.950737441490936,0,9,folic acid-containing compound biosynthetic process,BP,
4504,GO:0009397,1,0.971822078987877,0,4,folic acid-containing compound catabolic process,BP,
4505,GO:0009398,1,0.994133978983308,0,1,FMN biosynthetic process,BP,
4506,GO:0009400,1,0.993974682800764,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
4507,GO:0009403,1,0.974738546229837,0,4,toxin biosynthetic process,BP,
4508,GO:0009404,1,0.891965962728247,0,20,toxin metabolic process,BP,
4509,GO:0009405,1,0.982373360589047,0,2,pathogenesis,BP,
4510,GO:0009407,1,0.977697794040489,0,5,toxin catabolic process,BP,
4514,GO:0009411,1,0.429178534042241,0,129,response to UV,BP,
4515,GO:0009414,1,0.961404600928651,0,7,response to water deprivation,BP,
4516,GO:0009415,1,0.923779008127635,0,12,response to water,BP,
4518,GO:0009435,1,0.756266898885797,0,47,NAD biosynthetic process,BP,
4519,GO:0009436,1,0.989584303959949,0,2,glyoxylate catabolic process,BP,
4520,GO:0009437,1,0.926221970137193,0,13,carnitine metabolic process,BP,
4521,GO:0009438,1,0.975774002567831,0,5,methylglyoxal metabolic process,BP,
4522,GO:0009439,1,0.991782600867498,0,2,cyanate metabolic process,BP,
4523,GO:0009440,1,0.991782600867498,0,2,cyanate catabolic process,BP,
4524,GO:0009441,1,0.981371855809957,0,3,glycolate metabolic process,BP,
4525,GO:0009443,1,0.989492562806172,0,1,pyridoxal 5'-phosphate salvage,BP,
4526,GO:0009444,1,0.991522793779851,0,1,pyruvate oxidation,BP,
4527,GO:0009445,1,0.964594448191624,0,7,putrescine metabolic process,BP,
4528,GO:0009446,1,0.971959629298238,0,5,putrescine biosynthetic process,BP,
4529,GO:0009447,1,0.987843584872026,0,3,putrescine catabolic process,BP,
4530,GO:0009448,1,0.971578111837244,0,4,gamma-aminobutyric acid metabolic process,BP,
4531,GO:0009449,1,0.979732917652644,0,3,gamma-aminobutyric acid biosynthetic process,BP,
4532,GO:0009450,1,0.983659550990496,0,2,gamma-aminobutyric acid catabolic process,BP,
4533,GO:0009451,1,0.47258623166017,0,130,RNA modification,BP,
4534,GO:0009452,1,0.833599278141395,0,32,7-methylguanosine RNA capping,BP,
4535,GO:0009566,1,0.443237789106248,0,133,fertilization,BP,
4536,GO:0009581,1,0.48278152526585,0,105,detection of external stimulus,BP,
4537,GO:0009582,1,0.474040949767835,0,108,detection of abiotic stimulus,BP,
4538,GO:0009583,1,0.720293426183118,0,53,detection of light stimulus,BP,
4539,GO:0009584,1,0.763198453658396,0,43,detection of visible light,BP,
4540,GO:0009590,1,0.994934304642976,0,1,detection of gravity,BP,
4542,GO:0009595,1,0.879214731442522,0,19,detection of biotic stimulus,BP,
4543,GO:0009597,1,0.96943325914343,0,5,detection of virus,BP,
4546,GO:0009608,1,0.988915827213485,0,2,response to symbiont,BP,
4547,GO:0009609,1,0.988915827213485,0,2,response to symbiotic bacterium,BP,
4548,GO:0009611,1,0.0219574805407181,0,563,response to wounding,BP,
4550,GO:0009615,1,0.188751349564716,0,267,response to virus,BP,
4553,GO:0009624,1,0.994247551829149,0,1,response to nematode,BP,
4555,GO:0009629,1,0.94784237914703,0,10,response to gravity,BP,
4556,GO:0009631,1,0.991722170285736,0,1,cold acclimation,BP,
4557,GO:0009635,1,0.942412095533944,0,11,response to herbicide,BP,
4559,GO:0009637,1,0.986257402171809,0,2,response to blue light,BP,
4561,GO:0009644,1,0.986496264700068,0,2,response to high light intensity,BP,
4562,GO:0009645,1,0.993311518882161,0,1,response to low light intensity stimulus,BP,
4563,GO:0009646,1,0.993502154158033,0,1,response to absence of light,BP,
4564,GO:0009648,1,0.856977180288135,0,24,photoperiodism,BP,
4565,GO:0009649,1,0.846972310269929,0,26,entrainment of circadian clock,BP,
4566,GO:0009650,1,0.926762501102427,0,13,UV protection,BP,
4567,GO:0009651,1,0.884269306550219,0,20,response to salt stress,BP,
4569,GO:0009669,1,0.981643102359566,0,3,sucrose:cation symporter activity,MF,
4570,GO:0009673,1,0.993136746224841,0,1,low-affinity phosphate transmembrane transporter activity,MF,
4571,GO:0009674,1,0.982157331777347,0,2,potassium:sodium symporter activity,MF,
4572,GO:0009692,1,0.994247551829149,0,1,ethylene metabolic process,BP,
4573,GO:0009698,1,0.971482584213764,0,6,phenylpropanoid metabolic process,BP,
4574,GO:0009712,1,0.745680174646911,0,47,catechol-containing compound metabolic process,BP,
4575,GO:0009713,1,0.895988443978909,0,19,catechol-containing compound biosynthetic process,BP,
4577,GO:0009720,1,0.993821817188543,0,1,detection of hormone stimulus,BP,
4579,GO:0009726,1,0.973754532955889,0,3,detection of endogenous stimulus,BP,
4580,GO:0009730,1,0.979352430434235,0,4,detection of carbohydrate stimulus,BP,
4581,GO:0009732,1,0.979352430434235,0,4,detection of hexose stimulus,BP,
4582,GO:0009737,1,0.992471325418713,0,1,response to abscisic acid,BP,
4583,GO:0009738,1,0.992471325418713,0,1,abscisic acid-activated signaling pathway,BP,
4585,GO:0009744,1,0.972397945194991,0,4,response to sucrose,BP,
4588,GO:0009750,1,0.951318995281966,0,8,response to fructose,BP,
4589,GO:0009753,1,0.983510965420382,0,4,response to jasmonic acid,BP,
4590,GO:0009755,1,0.246600693902599,0,203,hormone-mediated signaling pathway,BP,
4591,GO:0009756,1,0.960974329824768,0,7,carbohydrate mediated signaling,BP,
4592,GO:0009757,1,0.972486385684856,0,5,hexose mediated signaling,BP,
4593,GO:0009758,1,0.988194477035737,0,1,carbohydrate utilization,BP,
4594,GO:0009785,1,0.986257402171809,0,2,blue light signaling pathway,BP,
4596,GO:0009787,1,0.992471325418713,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4597,GO:0009789,1,0.992471325418713,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
4601,GO:0009794,1,0.976448608068322,0,4,regulation of mitotic cell cycle, embryonic,BP,
4602,GO:0009798,1,0.577515739691492,0,81,axis specification,BP,
4604,GO:0009804,1,0.971482584213764,0,6,coumarin metabolic process,BP,
4605,GO:0009810,1,0.994737768570471,0,1,stilbene metabolic process,BP,
4606,GO:0009812,1,0.967012014312166,0,6,flavonoid metabolic process,BP,
4607,GO:0009814,1,0.994746541367731,0,1,defense response, incompatible interaction,BP,
4608,GO:0009817,1,0.994746541367731,0,1,defense response to fungus, incompatible interaction,BP,
4609,GO:0009820,1,0.975665776114719,0,5,alkaloid metabolic process,BP,
4610,GO:0009822,1,0.990909273554136,0,2,alkaloid catabolic process,BP,
4611,GO:0009826,1,0.985526351899315,0,2,unidimensional cell growth,BP,
4612,GO:0009838,1,0.974886719149869,0,5,abscission,BP,
4613,GO:0009841,1,0.994549992266649,0,1,mitochondrial endopeptidase Clp complex,CC,
4614,GO:0009850,1,0.99125770745241,0,2,auxin metabolic process,BP,
4615,GO:0009852,1,0.99125770745241,0,2,auxin catabolic process,BP,
4617,GO:0009880,1,0.672557496492499,0,56,embryonic pattern specification,BP,
4618,GO:0009881,1,0.947209220719496,0,10,photoreceptor activity,MF,
4619,GO:0009882,1,0.986257402171809,0,2,blue light photoreceptor activity,MF,
4620,GO:0009886,1,0.91840835252039,0,11,post-embryonic animal morphogenesis,BP,
4630,GO:0009896,1,0.0744486201235537,0,367,positive regulation of catabolic process,BP,
4633,GO:0009912,1,0.966057040208345,0,5,auditory receptor cell fate commitment,BP,
4634,GO:0009913,1,0.303530928274066,0,180,epidermal cell differentiation,BP,
4636,GO:0009918,1,0.99419280488058,0,1,sterol delta7 reductase activity,MF,
4637,GO:0009922,1,0.963017449392389,0,6,fatty acid elongase activity,MF,
4638,GO:0009925,1,0.768385310350866,0,33,basal plasma membrane,CC,
4640,GO:0009946,1,0.986031976734719,0,3,proximal/distal axis specification,BP,
4641,GO:0009948,1,0.758227294663502,0,43,anterior/posterior axis specification,BP,
4642,GO:0009949,1,0.995539622956947,0,1,polarity specification of anterior/posterior axis,BP,
4643,GO:0009950,1,0.878707676369833,0,17,dorsal/ventral axis specification,BP,
4645,GO:0009953,1,0.564142263508422,0,89,dorsal/ventral pattern formation,BP,
4646,GO:0009954,1,0.814603885278665,0,32,proximal/distal pattern formation,BP,
4647,GO:0009955,1,0.994742780964552,0,1,adaxial/abaxial pattern specification,BP,
4648,GO:0009956,1,0.992900308871104,0,1,radial pattern formation,BP,
4649,GO:0009957,1,0.97656002340123,0,3,epidermal cell fate specification,BP,
4653,GO:0009972,1,0.961723775594323,0,8,cytidine deamination,BP,
4655,GO:0009982,1,0.931870593071172,0,13,pseudouridine synthase activity,MF,
4658,GO:0009988,1,0.742469468655284,0,53,cell-cell recognition,BP,
4660,GO:0009992,1,0.994773517865485,0,1,cellular water homeostasis,BP,
4661,GO:0009994,1,0.759152568582227,0,43,oocyte differentiation,BP,
4664,GO:0010002,1,0.891756419627311,0,16,cardioblast differentiation,BP,
4666,GO:0010009,1,0.971331777187074,0,5,cytoplasmic side of endosome membrane,CC,
4667,GO:0010015,1,0.996531076871997,0,1,root morphogenesis,BP,
4668,GO:0010021,1,0.993644070878608,0,1,amylopectin biosynthetic process,BP,
4669,GO:0010025,1,0.986468528664904,0,2,wax biosynthetic process,BP,
4670,GO:0010032,1,0.958664922792447,0,5,meiotic chromosome condensation,BP,
4672,GO:0010034,1,0.993258770758829,0,1,response to acetate,BP,
4674,GO:0010037,1,0.99370605575639,0,1,response to carbon dioxide,BP,
4676,GO:0010039,1,0.816631296961776,0,32,response to iron ion,BP,
4677,GO:0010040,1,0.978174993274726,0,4,response to iron(II) ion,BP,
4678,GO:0010041,1,0.968799211588004,0,5,response to iron(III) ion,BP,
4679,GO:0010042,1,0.895896643593928,0,16,response to manganese ion,BP,
4681,GO:0010044,1,0.972103063806428,0,5,response to aluminum ion,BP,
4682,GO:0010045,1,0.989311342502996,0,1,response to nickel cation,BP,
4683,GO:0010046,1,0.964997978802792,0,6,response to mycotoxin,BP,
4684,GO:0010053,1,0.996531076871997,0,1,root epidermal cell differentiation,BP,
4685,GO:0010054,1,0.996531076871997,0,1,trichoblast differentiation,BP,
4686,GO:0010070,1,0.994481204304773,0,1,zygote asymmetric cell division,BP,
4687,GO:0010085,1,0.994893840072259,0,1,polarity specification of proximal/distal axis,BP,
4688,GO:0010092,1,0.825318027214359,0,29,specification of animal organ identity,BP,
4689,GO:0010106,1,0.995068679758576,0,1,cellular response to iron ion starvation,BP,
4690,GO:0010107,1,0.759271610484437,0,40,potassium ion import,BP,
4691,GO:0010121,1,0.995022365211478,0,1,arginine catabolic process to proline via ornithine,BP,
4692,GO:0010124,1,0.99125770745241,0,2,phenylacetate catabolic process,BP,
4693,GO:0010133,1,0.988302350986661,0,2,proline catabolic process to glutamate,BP,
4694,GO:0010138,1,0.975945780343566,0,5,pyrimidine ribonucleotide salvage,BP,
4695,GO:0010139,1,0.995486712055545,0,1,pyrimidine deoxyribonucleotide salvage,BP,
4696,GO:0010142,1,0.987839602814174,0,2,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,
4697,GO:0010155,1,0.925109715198156,0,15,regulation of proton transport,BP,
4698,GO:0010157,1,0.98906900515484,0,1,response to chlorate,BP,
4699,GO:0010159,1,0.981011214202029,0,3,specification of animal organ position,BP,
4700,GO:0010160,1,0.996263821660609,0,1,formation of animal organ boundary,BP,
4701,GO:0010164,1,0.995486712055545,0,1,response to cesium ion,BP,
4703,GO:0010166,1,0.986468528664904,0,2,wax metabolic process,BP,
4704,GO:0010171,1,0.708385675696626,0,47,body morphogenesis,BP,
4705,GO:0010172,1,0.912640799486714,0,11,embryonic body morphogenesis,BP,
4706,GO:0010181,1,0.931291835013288,0,11,FMN binding,MF,
4707,GO:0010182,1,0.972486385684856,0,5,sugar mediated signaling pathway,BP,
4708,GO:0010189,1,0.995409101822884,0,1,vitamin E biosynthetic process,BP,
4709,GO:0010193,1,0.978620886435311,0,4,response to ozone,BP,
4711,GO:0010216,1,0.963232260642082,0,5,maintenance of DNA methylation,BP,
4712,GO:0010224,1,0.905419940766234,0,17,response to UV-B,BP,
4713,GO:0010225,1,0.90691336704786,0,13,response to UV-C,BP,
4715,GO:0010232,1,0.993673140428983,0,1,vascular transport,BP,
4717,GO:0010248,1,0.928084676002181,0,13,establishment or maintenance of transmembrane electrochemical gradient,BP,
4718,GO:0010255,1,0.972486385684856,0,5,glucose mediated signaling pathway,BP,
4720,GO:0010257,1,0.791919179233702,0,55,NADH dehydrogenase complex assembly,BP,
4721,GO:0010259,1,0.825129359139136,0,25,multicellular organism aging,BP,
4722,GO:0010265,1,0.96119114907581,0,6,SCF complex assembly,BP,
4723,GO:0010266,1,0.979796214700052,0,3,response to vitamin B1,BP,
4724,GO:0010269,1,0.963882044864981,0,5,response to selenium ion,BP,
4725,GO:0010273,1,0.958099292183819,0,11,detoxification of copper ion,BP,
4726,GO:0010286,1,0.97574255651168,0,5,heat acclimation,BP,
4727,GO:0010288,1,0.873865157794061,0,21,response to lead ion,BP,
4728,GO:0010309,1,0.995413523014708,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
4729,GO:0010310,1,0.926709840435737,0,14,regulation of hydrogen peroxide metabolic process,BP,
4730,GO:0010314,1,0.928522542564854,0,10,phosphatidylinositol-5-phosphate binding,MF,
4731,GO:0010324,1,0.677760550248001,0,61,membrane invagination,BP,
4733,GO:0010335,1,0.992331953816647,0,1,response to non-ionic osmotic stress,BP,
4734,GO:0010340,1,0.963285847750949,0,6,carboxyl-O-methyltransferase activity,MF,
4735,GO:0010348,1,0.994054740756748,0,1,lithium:proton antiporter activity,MF,
4736,GO:0010359,1,0.934638646306751,0,9,regulation of anion channel activity,BP,
4737,GO:0010360,1,0.980342946248395,0,3,negative regulation of anion channel activity,BP,
4738,GO:0010369,1,0.906308654938825,0,14,chromocenter,CC,
4739,GO:0010370,1,0.987991362743631,0,2,perinucleolar chromocenter,CC,
4740,GO:0010385,1,0.967556475258752,0,5,double-stranded methylated DNA binding,MF,
4741,GO:0010387,1,0.988719264426438,0,2,COP9 signalosome assembly,BP,
4743,GO:0010390,1,0.827482862058345,0,27,histone monoubiquitination,BP,
4744,GO:0010412,1,0.993472999393672,0,1,mannan metabolic process,BP,
4745,GO:0010420,1,0.995925571083506,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4746,GO:0010421,1,0.929848394789735,0,12,hydrogen peroxide-mediated programmed cell death,BP,
4747,GO:0010428,1,0.990933367736822,0,1,methyl-CpNpG binding,MF,
4748,GO:0010430,1,0.992122478254213,0,1,fatty acid omega-oxidation,BP,
4749,GO:0010446,1,0.987932954729272,0,2,response to alkaline pH,BP,
4750,GO:0010447,1,0.892087111649775,0,19,response to acidic pH,BP,
4751,GO:0010452,1,0.923861443662994,0,9,histone H3-K36 methylation,BP,
4754,GO:0010455,1,0.967652269246615,0,6,positive regulation of cell fate commitment,BP,
4755,GO:0010457,1,0.911477023922112,0,11,centriole-centriole cohesion,BP,
4756,GO:0010458,1,0.845147687611964,0,27,exit from mitosis,BP,
4757,GO:0010459,1,0.9551184409868,0,9,negative regulation of heart rate,BP,
4758,GO:0010460,1,0.864290582438395,0,22,positive regulation of heart rate,BP,
4759,GO:0010463,1,0.721915120838371,0,46,mesenchymal cell proliferation,BP,
4760,GO:0010464,1,0.787394306202687,0,35,regulation of mesenchymal cell proliferation,BP,
4761,GO:0010465,1,0.984089984175841,0,2,nerve growth factor receptor activity,MF,
4767,GO:0010477,1,0.993547688572631,0,1,response to sulfur dioxide,BP,
4768,GO:0010481,1,0.988093621527374,0,2,epidermal cell division,BP,
4769,GO:0010482,1,0.988093621527374,0,2,regulation of epidermal cell division,BP,
4770,GO:0010484,1,0.9656493969587,0,4,H3 histone acetyltransferase activity,MF,
4771,GO:0010485,1,0.878312577854124,0,18,H4 histone acetyltransferase activity,MF,
4772,GO:0010494,1,0.732364315181933,0,42,cytoplasmic stress granule,CC,
4773,GO:0010496,1,0.994997637646617,0,1,intercellular transport,BP,
4776,GO:0010501,1,0.755605456735127,0,44,RNA secondary structure unwinding,BP,
4779,GO:0010508,1,0.491443433488299,0,98,positive regulation of autophagy,BP,
4780,GO:0010509,1,0.99129750082479,0,1,polyamine homeostasis,BP,
4781,GO:0010510,1,0.916249210136612,0,12,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,
4782,GO:0010511,1,0.959911431770096,0,7,regulation of phosphatidylinositol biosynthetic process,BP,
4783,GO:0010512,1,0.988032369718007,0,2,negative regulation of phosphatidylinositol biosynthetic process,BP,
4784,GO:0010513,1,0.971541858433572,0,5,positive regulation of phosphatidylinositol biosynthetic process,BP,
4787,GO:0010519,1,0.968310815755923,0,5,negative regulation of phospholipase activity,BP,
4788,GO:0010520,1,0.981090375558139,0,3,regulation of reciprocal meiotic recombination,BP,
4789,GO:0010521,1,0.983193548228703,0,3,telomerase inhibitor activity,MF,
4790,GO:0010522,1,0.545720544331206,0,88,regulation of calcium ion transport into cytosol,BP,
4791,GO:0010523,1,0.903457691261342,0,17,negative regulation of calcium ion transport into cytosol,BP,
4792,GO:0010524,1,0.737870054948211,0,49,positive regulation of calcium ion transport into cytosol,BP,
4793,GO:0010528,1,0.900777132283764,0,17,regulation of transposition,BP,
4794,GO:0010529,1,0.900777132283764,0,17,negative regulation of transposition,BP,
4795,GO:0010533,1,0.981746476575961,0,4,regulation of activation of Janus kinase activity,BP,
4796,GO:0010536,1,0.990511381642465,0,2,positive regulation of activation of Janus kinase activity,BP,
4797,GO:0010543,1,0.819201247377323,0,30,regulation of platelet activation,BP,
4798,GO:0010544,1,0.894787578147363,0,17,negative regulation of platelet activation,BP,
4802,GO:0010559,1,0.792687155493475,0,36,regulation of glycoprotein biosynthetic process,BP,
4803,GO:0010560,1,0.878408796161502,0,19,positive regulation of glycoprotein biosynthetic process,BP,
4804,GO:0010561,1,0.942318169790824,0,10,negative regulation of glycoprotein biosynthetic process,BP,
4809,GO:0010566,1,0.923213044239018,0,13,regulation of ketone biosynthetic process,BP,
4810,GO:0010569,1,0.824401141114124,0,27,regulation of double-strand break repair via homologous recombination,BP,
4811,GO:0010571,1,0.949182376102085,0,6,positive regulation of nuclear cell cycle DNA replication,BP,
4812,GO:0010572,1,0.967367155215211,0,5,positive regulation of platelet activation,BP,
4813,GO:0010573,1,0.809471989437763,0,31,vascular endothelial growth factor production,BP,
4814,GO:0010574,1,0.816841114385716,0,30,regulation of vascular endothelial growth factor production,BP,
4815,GO:0010575,1,0.836055179711699,0,25,positive regulation of vascular endothelial growth factor production,BP,
4816,GO:0010578,1,0.994302223727147,0,1,regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,BP,
4817,GO:0010585,1,0.995092799545279,0,1,glutamine secretion,BP,
4818,GO:0010586,1,0.862165310005721,0,22,miRNA metabolic process,BP,
4819,GO:0010587,1,0.962510439382591,0,5,miRNA catabolic process,BP,
4820,GO:0010591,1,0.826311764395624,0,27,regulation of lamellipodium assembly,BP,
4821,GO:0010592,1,0.896544074450214,0,15,positive regulation of lamellipodium assembly,BP,
4822,GO:0010593,1,0.982443673879984,0,2,negative regulation of lamellipodium assembly,BP,
4823,GO:0010594,1,0.399495756415407,0,130,regulation of endothelial cell migration,BP,
4824,GO:0010595,1,0.559495302409064,0,83,positive regulation of endothelial cell migration,BP,
4825,GO:0010596,1,0.744251322387589,0,42,negative regulation of endothelial cell migration,BP,
4826,GO:0010603,1,0.935644016080192,0,8,regulation of cytoplasmic mRNA processing body assembly,BP,
4829,GO:0010606,1,0.954464504683691,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4830,GO:0010607,1,0.995049642451507,0,1,negative regulation of cytoplasmic mRNA processing body assembly,BP,
4832,GO:0010609,1,0.988686334721139,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
4833,GO:0010610,1,0.988386783164001,0,1,regulation of mRNA stability involved in response to stress,BP,
4834,GO:0010611,1,0.724840080267953,0,44,regulation of cardiac muscle hypertrophy,BP,
4835,GO:0010612,1,0.938757470842071,0,8,regulation of cardiac muscle adaptation,BP,
4836,GO:0010613,1,0.827651712469401,0,26,positive regulation of cardiac muscle hypertrophy,BP,
4837,GO:0010614,1,0.894169748344315,0,16,negative regulation of cardiac muscle hypertrophy,BP,
4838,GO:0010615,1,0.985578778832116,0,2,positive regulation of cardiac muscle adaptation,BP,
4839,GO:0010616,1,0.952500388025713,0,6,negative regulation of cardiac muscle adaptation,BP,
4840,GO:0010621,1,0.985685166997038,0,3,negative regulation of transcription by transcription factor localization,BP,
4841,GO:0010623,1,0.922013827695705,0,12,programmed cell death involved in cell development,BP,
4842,GO:0010624,1,0.954248122346117,0,6,regulation of Schwann cell proliferation,BP,
4843,GO:0010625,1,0.994435446306893,0,1,positive regulation of Schwann cell proliferation,BP,
4844,GO:0010626,1,0.959590031202355,0,5,negative regulation of Schwann cell proliferation,BP,
4847,GO:0010631,1,0.181431072430075,0,239,epithelial cell migration,BP,
4848,GO:0010632,1,0.267437829319464,0,184,regulation of epithelial cell migration,BP,
4849,GO:0010633,1,0.672446039262717,0,57,negative regulation of epithelial cell migration,BP,
4850,GO:0010634,1,0.426894452507329,0,120,positive regulation of epithelial cell migration,BP,
4851,GO:0010635,1,0.951411648850472,0,8,regulation of mitochondrial fusion,BP,
4852,GO:0010636,1,0.984808283893548,0,2,positive regulation of mitochondrial fusion,BP,
4853,GO:0010637,1,0.971804607047502,0,5,negative regulation of mitochondrial fusion,BP,
4856,GO:0010640,1,0.85007711842048,0,22,regulation of platelet-derived growth factor receptor signaling pathway,BP,
4857,GO:0010641,1,0.963496073129161,0,5,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
4858,GO:0010642,1,0.888742145618812,0,16,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,
4859,GO:0010643,1,0.987508065843472,0,2,cell communication by chemical coupling,BP,
4860,GO:0010644,1,0.808229516423556,0,27,cell communication by electrical coupling,BP,
4861,GO:0010645,1,0.993673140428983,0,1,regulation of cell communication by chemical coupling,BP,
4865,GO:0010649,1,0.916032382280886,0,12,regulation of cell communication by electrical coupling,BP,
4866,GO:0010650,1,0.979556171067937,0,2,positive regulation of cell communication by electrical coupling,BP,
4867,GO:0010652,1,0.993673140428983,0,1,positive regulation of cell communication by chemical coupling,BP,
4880,GO:0010668,1,0.957265288106687,0,6,ectodermal cell differentiation,BP,
4881,GO:0010669,1,0.877721096565074,0,20,epithelial structure maintenance,BP,
4882,GO:0010675,1,0.480129037919541,0,104,regulation of cellular carbohydrate metabolic process,BP,
4883,GO:0010676,1,0.721698312827796,0,44,positive regulation of cellular carbohydrate metabolic process,BP,
4884,GO:0010677,1,0.820706978048037,0,29,negative regulation of cellular carbohydrate metabolic process,BP,
4885,GO:0010692,1,0.925842558279041,0,9,regulation of alkaline phosphatase activity,BP,
4886,GO:0010693,1,0.979496537321903,0,3,negative regulation of alkaline phosphatase activity,BP,
4887,GO:0010694,1,0.945234031757004,0,6,positive regulation of alkaline phosphatase activity,BP,
4888,GO:0010698,1,0.99001736152919,0,2,acetyltransferase activator activity,MF,
4889,GO:0010700,1,0.973544469270496,0,5,negative regulation of norepinephrine secretion,BP,
4890,GO:0010701,1,0.980511447769959,0,3,positive regulation of norepinephrine secretion,BP,
4891,GO:0010705,1,0.986352439169014,0,2,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
4892,GO:0010710,1,0.983689605727805,0,3,regulation of collagen catabolic process,BP,
4893,GO:0010711,1,0.99653725154784,0,1,negative regulation of collagen catabolic process,BP,
4894,GO:0010712,1,0.831161557894221,0,31,regulation of collagen metabolic process,BP,
4895,GO:0010713,1,0.957885830073347,0,8,negative regulation of collagen metabolic process,BP,
4896,GO:0010714,1,0.883316653677036,0,20,positive regulation of collagen metabolic process,BP,
4897,GO:0010715,1,0.904323705828626,0,13,regulation of extracellular matrix disassembly,BP,
4898,GO:0010716,1,0.978375605263683,0,4,negative regulation of extracellular matrix disassembly,BP,
4900,GO:0010718,1,0.723989548673266,0,44,positive regulation of epithelial to mesenchymal transition,BP,
4904,GO:0010722,1,0.989700569072569,0,1,regulation of ferrochelatase activity,BP,
4905,GO:0010724,1,0.975580805368686,0,4,regulation of definitive erythrocyte differentiation,BP,
4906,GO:0010725,1,0.989108636168157,0,2,regulation of primitive erythrocyte differentiation,BP,
4907,GO:0010726,1,0.988628049029453,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
4908,GO:0010727,1,0.960291640571838,0,7,negative regulation of hydrogen peroxide metabolic process,BP,
4909,GO:0010728,1,0.97431664102413,0,4,regulation of hydrogen peroxide biosynthetic process,BP,
4910,GO:0010729,1,0.994967223531982,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
4911,GO:0010730,1,0.979246009435953,0,3,negative regulation of hydrogen peroxide biosynthetic process,BP,
4912,GO:0010731,1,0.991424195704817,0,2,protein glutathionylation,BP,
4913,GO:0010732,1,0.991424195704817,0,2,regulation of protein glutathionylation,BP,
4914,GO:0010734,1,0.991424195704817,0,2,negative regulation of protein glutathionylation,BP,
4915,GO:0010735,1,0.973092933777014,0,4,positive regulation of transcription via serum response element binding,BP,
4916,GO:0010736,1,0.987643282848609,0,2,serum response element binding,MF,
4917,GO:0010737,1,0.800247269799944,0,26,protein kinase A signaling,BP,
4918,GO:0010738,1,0.864495899987548,0,18,regulation of protein kinase A signaling,BP,
4919,GO:0010739,1,0.963618338597949,0,6,positive regulation of protein kinase A signaling,BP,
4920,GO:0010742,1,0.812900026627431,0,29,macrophage derived foam cell differentiation,BP,
4921,GO:0010743,1,0.838188895711885,0,25,regulation of macrophage derived foam cell differentiation,BP,
4922,GO:0010744,1,0.913741871065705,0,14,positive regulation of macrophage derived foam cell differentiation,BP,
4923,GO:0010745,1,0.917386844841942,0,11,negative regulation of macrophage derived foam cell differentiation,BP,
4924,GO:0010746,1,0.96682504477579,0,4,regulation of plasma membrane long-chain fatty acid transport,BP,
4925,GO:0010748,1,0.96682504477579,0,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,
4926,GO:0010749,1,0.963305916086058,0,5,regulation of nitric oxide mediated signal transduction,BP,
4927,GO:0010750,1,0.986706006995948,0,2,positive regulation of nitric oxide mediated signal transduction,BP,
4928,GO:0010751,1,0.976287802564349,0,3,negative regulation of nitric oxide mediated signal transduction,BP,
4929,GO:0010752,1,0.983571632909924,0,2,regulation of cGMP-mediated signaling,BP,
4930,GO:0010754,1,0.991028592248749,0,1,negative regulation of cGMP-mediated signaling,BP,
4931,GO:0010755,1,0.946493096825646,0,10,regulation of plasminogen activation,BP,
4932,GO:0010756,1,0.975785804515698,0,5,positive regulation of plasminogen activation,BP,
4933,GO:0010757,1,0.969987720229713,0,5,negative regulation of plasminogen activation,BP,
4934,GO:0010758,1,0.897270718954829,0,18,regulation of macrophage chemotaxis,BP,
4935,GO:0010759,1,0.940952021616537,0,10,positive regulation of macrophage chemotaxis,BP,
4936,GO:0010760,1,0.973089712908699,0,5,negative regulation of macrophage chemotaxis,BP,
4937,GO:0010761,1,0.760231802925949,0,38,fibroblast migration,BP,
4938,GO:0010762,1,0.829969364265956,0,28,regulation of fibroblast migration,BP,
4939,GO:0010763,1,0.926094823818427,0,11,positive regulation of fibroblast migration,BP,
4940,GO:0010764,1,0.952097887369449,0,8,negative regulation of fibroblast migration,BP,
4941,GO:0010765,1,0.803879782454223,0,31,positive regulation of sodium ion transport,BP,
4942,GO:0010766,1,0.899836156448842,0,14,negative regulation of sodium ion transport,BP,
4943,GO:0010767,1,0.97402417472357,0,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4944,GO:0010768,1,0.979748693405231,0,2,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4945,GO:0010769,1,0.140026399564562,0,260,regulation of cell morphogenesis involved in differentiation,BP,
4946,GO:0010770,1,0.363748703292914,0,133,positive regulation of cell morphogenesis involved in differentiation,BP,
4947,GO:0010771,1,0.536276916746183,0,86,negative regulation of cell morphogenesis involved in differentiation,BP,
4948,GO:0010789,1,0.994054740756748,0,1,meiotic sister chromatid cohesion involved in meiosis I,BP,
4949,GO:0010792,1,0.969745623525125,0,5,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4950,GO:0010793,1,0.962145144090498,0,5,regulation of mRNA export from nucleus,BP,
4951,GO:0010795,1,0.995925571083506,0,1,regulation of ubiquinone biosynthetic process,BP,
4952,GO:0010796,1,0.985830197675043,0,3,regulation of multivesicular body size,BP,
4953,GO:0010797,1,0.995990405924109,0,1,regulation of multivesicular body size involved in endosome transport,BP,
4956,GO:0010801,1,0.912155230662719,0,14,negative regulation of peptidyl-threonine phosphorylation,BP,
4957,GO:0010803,1,0.729864518176549,0,54,regulation of tumor necrosis factor-mediated signaling pathway,BP,
4958,GO:0010804,1,0.918137593882288,0,17,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,
4959,GO:0010807,1,0.959299978078079,0,6,regulation of synaptic vesicle priming,BP,
4960,GO:0010808,1,0.990440414304639,0,1,positive regulation of synaptic vesicle priming,BP,
4963,GO:0010812,1,0.684607073647092,0,51,negative regulation of cell-substrate adhesion,BP,
4964,GO:0010813,1,0.987403487447078,0,2,neuropeptide catabolic process,BP,
4965,GO:0010814,1,0.991703190862279,0,1,substance P catabolic process,BP,
4966,GO:0010815,1,0.973653415983377,0,4,bradykinin catabolic process,BP,
4967,GO:0010816,1,0.991703190862279,0,1,calcitonin catabolic process,BP,
4969,GO:0010818,1,0.899542426257265,0,20,T cell chemotaxis,BP,
4970,GO:0010819,1,0.946632978549954,0,10,regulation of T cell chemotaxis,BP,
4971,GO:0010820,1,0.950395903879369,0,9,positive regulation of T cell chemotaxis,BP,
4972,GO:0010821,1,0.265870510593523,0,209,regulation of mitochondrion organization,BP,
4973,GO:0010822,1,0.371581526529136,0,156,positive regulation of mitochondrion organization,BP,
4974,GO:0010823,1,0.755096811952206,0,45,negative regulation of mitochondrion organization,BP,
4975,GO:0010824,1,0.762594578779576,0,39,regulation of centrosome duplication,BP,
4976,GO:0010825,1,0.957926540802907,0,6,positive regulation of centrosome duplication,BP,
4977,GO:0010826,1,0.920320351148129,0,12,negative regulation of centrosome duplication,BP,
4978,GO:0010827,1,0.620306620145161,0,67,regulation of glucose transmembrane transport,BP,
4979,GO:0010828,1,0.738444632698539,0,40,positive regulation of glucose transmembrane transport,BP,
4980,GO:0010829,1,0.906582951327533,0,16,negative regulation of glucose transmembrane transport,BP,
4981,GO:0010830,1,0.744353888373362,0,46,regulation of myotube differentiation,BP,
4982,GO:0010831,1,0.855106516002534,0,25,positive regulation of myotube differentiation,BP,
4983,GO:0010832,1,0.909839225554176,0,14,negative regulation of myotube differentiation,BP,
4984,GO:0010833,1,0.602747947103876,0,75,telomere maintenance via telomere lengthening,BP,
4985,GO:0010835,1,0.964077556028955,0,6,regulation of protein ADP-ribosylation,BP,
4986,GO:0010836,1,0.985257153280852,0,3,negative regulation of protein ADP-ribosylation,BP,
4987,GO:0010837,1,0.83083598156239,0,25,regulation of keratinocyte proliferation,BP,
4988,GO:0010838,1,0.953601582622897,0,7,positive regulation of keratinocyte proliferation,BP,
4989,GO:0010839,1,0.913846069378882,0,11,negative regulation of keratinocyte proliferation,BP,
4990,GO:0010840,1,0.979266851050511,0,4,regulation of circadian sleep/wake cycle, wakefulness,BP,
4991,GO:0010841,1,0.983957429883854,0,3,positive regulation of circadian sleep/wake cycle, wakefulness,BP,
4992,GO:0010842,1,0.852470698770662,0,19,retina layer formation,BP,
4993,GO:0010845,1,0.987368869349382,0,2,positive regulation of reciprocal meiotic recombination,BP,
4994,GO:0010847,1,0.96753038825651,0,4,regulation of chromatin assembly,BP,
4995,GO:0010848,1,0.986019427791458,0,2,regulation of chromatin disassembly,BP,
4996,GO:0010849,1,0.994752810789212,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
4997,GO:0010851,1,0.973896318337667,0,5,cyclase regulator activity,MF,
4998,GO:0010853,1,0.981134689015136,0,4,cyclase activator activity,MF,
4999,GO:0010854,1,0.992623864429062,0,1,adenylate cyclase regulator activity,MF,
5000,GO:0010855,1,0.992623864429062,0,1,adenylate cyclase inhibitor activity,MF,
5001,GO:0010856,1,0.993510222452804,0,1,adenylate cyclase activator activity,MF,
5003,GO:0010858,1,0.986718205163901,0,3,calcium-dependent protein kinase regulator activity,MF,
5004,GO:0010859,1,0.992448809519178,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
5005,GO:0010862,1,0.753065947067714,0,44,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,
5006,GO:0010863,1,0.805249403090723,0,31,positive regulation of phospholipase C activity,BP,
5007,GO:0010866,1,0.911760832313971,0,15,regulation of triglyceride biosynthetic process,BP,
5008,GO:0010867,1,0.936642397542131,0,11,positive regulation of triglyceride biosynthetic process,BP,
5009,GO:0010868,1,0.985238229196826,0,2,negative regulation of triglyceride biosynthetic process,BP,
5010,GO:0010869,1,0.875871084850662,0,19,regulation of receptor biosynthetic process,BP,
5011,GO:0010870,1,0.937476808658985,0,11,positive regulation of receptor biosynthetic process,BP,
5012,GO:0010871,1,0.958837692181714,0,5,negative regulation of receptor biosynthetic process,BP,
5013,GO:0010872,1,0.961416244589714,0,8,regulation of cholesterol esterification,BP,
5014,GO:0010873,1,0.973182393777874,0,6,positive regulation of cholesterol esterification,BP,
5015,GO:0010874,1,0.874002018208192,0,18,regulation of cholesterol efflux,BP,
5016,GO:0010875,1,0.901295726444632,0,13,positive regulation of cholesterol efflux,BP,
5017,GO:0010876,1,0.113908133603077,0,317,lipid localization,BP,
5018,GO:0010877,1,0.990722712653195,0,2,lipid transport involved in lipid storage,BP,
5019,GO:0010878,1,0.89186143117348,0,15,cholesterol storage,BP,
5020,GO:0010879,1,0.994666537808309,0,1,cholesterol transport involved in cholesterol storage,BP,
5021,GO:0010880,1,0.819403359089419,0,25,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
5022,GO:0010881,1,0.87162513831317,0,18,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,
5023,GO:0010882,1,0.83769068138465,0,23,regulation of cardiac muscle contraction by calcium ion signaling,BP,
5024,GO:0010883,1,0.761569089860485,0,40,regulation of lipid storage,BP,
5025,GO:0010884,1,0.875773734354488,0,20,positive regulation of lipid storage,BP,
5026,GO:0010885,1,0.902619336109907,0,13,regulation of cholesterol storage,BP,
5027,GO:0010886,1,0.946067026107719,0,7,positive regulation of cholesterol storage,BP,
5028,GO:0010887,1,0.95410055147589,0,6,negative regulation of cholesterol storage,BP,
5029,GO:0010888,1,0.892546794998218,0,16,negative regulation of lipid storage,BP,
5030,GO:0010889,1,0.925905025450284,0,12,regulation of sequestering of triglyceride,BP,
5031,GO:0010890,1,0.965560215575027,0,7,positive regulation of sequestering of triglyceride,BP,
5032,GO:0010891,1,0.958944619801513,0,5,negative regulation of sequestering of triglyceride,BP,
5033,GO:0010893,1,0.918994068087637,0,13,positive regulation of steroid biosynthetic process,BP,
5034,GO:0010894,1,0.881250623099951,0,22,negative regulation of steroid biosynthetic process,BP,
5035,GO:0010896,1,0.957116601790884,0,8,regulation of triglyceride catabolic process,BP,
5036,GO:0010897,1,0.980661170005897,0,3,negative regulation of triglyceride catabolic process,BP,
5037,GO:0010898,1,0.975995811434463,0,5,positive regulation of triglyceride catabolic process,BP,
5038,GO:0010899,1,0.982732930035978,0,3,regulation of phosphatidylcholine catabolic process,BP,
5039,GO:0010900,1,0.996922961125442,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
5040,GO:0010901,1,0.993001265943391,0,2,regulation of very-low-density lipoprotein particle remodeling,BP,
5041,GO:0010902,1,0.99660390796036,0,1,positive regulation of very-low-density lipoprotein particle remodeling,BP,
5042,GO:0010903,1,0.996385206025579,0,1,negative regulation of very-low-density lipoprotein particle remodeling,BP,
5043,GO:0010904,1,0.994766612493681,0,1,regulation of UDP-glucose catabolic process,BP,
5044,GO:0010905,1,0.994766612493681,0,1,negative regulation of UDP-glucose catabolic process,BP,
5045,GO:0010906,1,0.553841864420412,0,81,regulation of glucose metabolic process,BP,
5046,GO:0010907,1,0.801516724883313,0,28,positive regulation of glucose metabolic process,BP,
5047,GO:0010908,1,0.980383108678533,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5048,GO:0010909,1,0.980383108678533,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5049,GO:0010911,1,0.949597692165657,0,7,regulation of isomerase activity,BP,
5050,GO:0010912,1,0.949597692165657,0,7,positive regulation of isomerase activity,BP,
5051,GO:0010915,1,0.989106622505957,0,3,regulation of very-low-density lipoprotein particle clearance,BP,
5052,GO:0010916,1,0.989106622505957,0,3,negative regulation of very-low-density lipoprotein particle clearance,BP,
5053,GO:0010917,1,0.956488438516144,0,8,negative regulation of mitochondrial membrane potential,BP,
5054,GO:0010918,1,0.954514886808337,0,8,positive regulation of mitochondrial membrane potential,BP,
5055,GO:0010919,1,0.928784665151814,0,12,regulation of inositol phosphate biosynthetic process,BP,
5056,GO:0010920,1,0.993964646557823,0,1,negative regulation of inositol phosphate biosynthetic process,BP,
5058,GO:0010922,1,0.80292662505026,0,28,positive regulation of phosphatase activity,BP,
5060,GO:0010924,1,0.993964646557823,0,1,regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5061,GO:0010925,1,0.993964646557823,0,1,positive regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5062,GO:0010927,1,0.465979968250333,0,96,cellular component assembly involved in morphogenesis,BP,
5063,GO:0010931,1,0.988681307770705,0,1,macrophage tolerance induction,BP,
5064,GO:0010932,1,0.988681307770705,0,1,regulation of macrophage tolerance induction,BP,
5065,GO:0010933,1,0.988681307770705,0,1,positive regulation of macrophage tolerance induction,BP,
5066,GO:0010934,1,0.911437576885003,0,14,macrophage cytokine production,BP,
5067,GO:0010935,1,0.923101978125783,0,12,regulation of macrophage cytokine production,BP,
5068,GO:0010936,1,0.965158026161734,0,5,negative regulation of macrophage cytokine production,BP,
5069,GO:0010938,1,0.993144458152951,0,1,cytoplasmic microtubule depolymerization,BP,
5070,GO:0010939,1,0.867320687855275,0,27,regulation of necrotic cell death,BP,
5071,GO:0010940,1,0.973163270662597,0,6,positive regulation of necrotic cell death,BP,
5074,GO:0010944,1,0.951452054839679,0,8,negative regulation of transcription by competitive promoter binding,BP,
5076,GO:0010949,1,0.99417351035814,0,1,negative regulation of intestinal phytosterol absorption,BP,
5080,GO:0010954,1,0.888687098255517,0,18,positive regulation of protein processing,BP,
5082,GO:0010956,1,0.981360163382596,0,3,negative regulation of calcidiol 1-monooxygenase activity,BP,
5083,GO:0010957,1,0.971837066121162,0,5,negative regulation of vitamin D biosynthetic process,BP,
5084,GO:0010958,1,0.959661532341494,0,6,regulation of amino acid import across plasma membrane,BP,
5086,GO:0010960,1,0.917129008858851,0,10,magnesium ion homeostasis,BP,
5087,GO:0010961,1,0.96800581891406,0,4,cellular magnesium ion homeostasis,BP,
5088,GO:0010962,1,0.825029258571909,0,23,regulation of glucan biosynthetic process,BP,
5089,GO:0010963,1,0.990002937284098,0,2,regulation of L-arginine import,BP,
5091,GO:0010966,1,0.967573205026167,0,4,regulation of phosphate transport,BP,
5092,GO:0010967,1,0.995384459698249,0,1,regulation of polyamine biosynthetic process,BP,
5093,GO:0010968,1,0.963895147928653,0,6,regulation of microtubule nucleation,BP,
5095,GO:0010971,1,0.873117737641928,0,21,positive regulation of G2/M transition of mitotic cell cycle,BP,
5096,GO:0010972,1,0.62151140819489,0,86,negative regulation of G2/M transition of mitotic cell cycle,BP,
5100,GO:0010979,1,0.986546600725009,0,2,regulation of vitamin D 24-hydroxylase activity,BP,
5101,GO:0010980,1,0.986546600725009,0,2,positive regulation of vitamin D 24-hydroxylase activity,BP,
5102,GO:0010982,1,0.987351620876938,0,2,regulation of high-density lipoprotein particle clearance,BP,
5103,GO:0010983,1,0.987351620876938,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
5104,GO:0010984,1,0.920613370302424,0,15,regulation of lipoprotein particle clearance,BP,
5105,GO:0010985,1,0.962761418623874,0,7,negative regulation of lipoprotein particle clearance,BP,
5106,GO:0010986,1,0.974569533216054,0,4,positive regulation of lipoprotein particle clearance,BP,
5107,GO:0010988,1,0.95072018485899,0,9,regulation of low-density lipoprotein particle clearance,BP,
5108,GO:0010989,1,0.973367561136128,0,4,negative regulation of low-density lipoprotein particle clearance,BP,
5109,GO:0010990,1,0.958180042370787,0,6,regulation of SMAD protein complex assembly,BP,
5110,GO:0010991,1,0.965118296552067,0,5,negative regulation of SMAD protein complex assembly,BP,
5111,GO:0010992,1,0.95625486852623,0,7,ubiquitin recycling,BP,
5112,GO:0010994,1,0.972234668727623,0,5,free ubiquitin chain polymerization,BP,
5113,GO:0010996,1,0.852529950676028,0,21,response to auditory stimulus,BP,
5114,GO:0010997,1,0.967661198649405,0,5,anaphase-promoting complex binding,MF,
5115,GO:0010998,1,0.933388115169749,0,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,
5116,GO:0010999,1,0.992357042927468,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
5120,GO:0012507,1,0.703430369825805,0,57,ER to Golgi transport vesicle membrane,CC,
5122,GO:0014002,1,0.793213004143785,0,31,astrocyte development,BP,
5123,GO:0014003,1,0.793323276663885,0,38,oligodendrocyte development,BP,
5124,GO:0014004,1,0.980428707831604,0,3,microglia differentiation,BP,
5125,GO:0014005,1,0.980428707831604,0,3,microglia development,BP,
5126,GO:0014009,1,0.780711723339142,0,34,glial cell proliferation,BP,
5127,GO:0014010,1,0.945544036107435,0,7,Schwann cell proliferation,BP,
5128,GO:0014011,1,0.994054740756748,0,1,Schwann cell proliferation involved in axon regeneration,BP,
5129,GO:0014012,1,0.972642803913447,0,5,peripheral nervous system axon regeneration,BP,
5132,GO:0014015,1,0.702058922224448,0,54,positive regulation of gliogenesis,BP,
5133,GO:0014016,1,0.983302942375021,0,3,neuroblast differentiation,BP,
5134,GO:0014017,1,0.994409330361848,0,1,neuroblast fate commitment,BP,
5136,GO:0014022,1,0.979283881362659,0,3,neural plate elongation,BP,
5137,GO:0014028,1,0.986817592078072,0,2,notochord formation,BP,
5138,GO:0014029,1,0.928058710321184,0,11,neural crest formation,BP,
5139,GO:0014031,1,0.610299261606918,0,72,mesenchymal cell development,BP,
5140,GO:0014032,1,0.630622797091754,0,68,neural crest cell development,BP,
5141,GO:0014033,1,0.595726890825619,0,75,neural crest cell differentiation,BP,
5142,GO:0014034,1,0.981388638212804,0,3,neural crest cell fate commitment,BP,
5143,GO:0014036,1,0.988941600996489,0,2,neural crest cell fate specification,BP,
5144,GO:0014037,1,0.744227775895764,0,36,Schwann cell differentiation,BP,
5145,GO:0014038,1,0.976621414063213,0,3,regulation of Schwann cell differentiation,BP,
5146,GO:0014040,1,0.981213194014515,0,2,positive regulation of Schwann cell differentiation,BP,
5147,GO:0014041,1,0.930328991425695,0,9,regulation of neuron maturation,BP,
5148,GO:0014042,1,0.964036101371334,0,4,positive regulation of neuron maturation,BP,
5149,GO:0014043,1,0.980766562664563,0,3,negative regulation of neuron maturation,BP,
5150,GO:0014044,1,0.787392910555252,0,28,Schwann cell development,BP,
5151,GO:0014045,1,0.975520719798939,0,4,establishment of endothelial blood-brain barrier,BP,
5156,GO:0014050,1,0.971298674497441,0,5,negative regulation of glutamate secretion,BP,
5157,GO:0014051,1,0.929247158390718,0,9,gamma-aminobutyric acid secretion,BP,
5158,GO:0014052,1,0.95870719333064,0,6,regulation of gamma-aminobutyric acid secretion,BP,
5159,GO:0014053,1,0.991914726505661,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
5160,GO:0014054,1,0.973918885860542,0,4,positive regulation of gamma-aminobutyric acid secretion,BP,
5161,GO:0014055,1,0.983049645024307,0,3,acetylcholine secretion, neurotransmission,BP,
5162,GO:0014056,1,0.983049645024307,0,3,regulation of acetylcholine secretion, neurotransmission,BP,
5163,GO:0014057,1,0.988813340151122,0,2,positive regulation of acetylcholine secretion, neurotransmission,BP,
5165,GO:0014060,1,0.98042172970397,0,4,regulation of epinephrine secretion,BP,
5166,GO:0014061,1,0.933890384158204,0,12,regulation of norepinephrine secretion,BP,
5167,GO:0014062,1,0.963135045964821,0,7,regulation of serotonin secretion,BP,
5168,GO:0014063,1,0.978591937989947,0,4,negative regulation of serotonin secretion,BP,
5169,GO:0014064,1,0.992288604496873,0,1,positive regulation of serotonin secretion,BP,
5170,GO:0014065,1,0.430890284559538,0,116,phosphatidylinositol 3-kinase signaling,BP,
5171,GO:0014066,1,0.536493866684343,0,88,regulation of phosphatidylinositol 3-kinase signaling,BP,
5172,GO:0014067,1,0.935526548697664,0,10,negative regulation of phosphatidylinositol 3-kinase signaling,BP,
5173,GO:0014068,1,0.649673768603399,0,60,positive regulation of phosphatidylinositol 3-kinase signaling,BP,
5179,GO:0014701,1,0.91216586104151,0,9,junctional sarcoplasmic reticulum membrane,CC,
5180,GO:0014704,1,0.6993494354254,0,47,intercalated disc,CC,
5181,GO:0014705,1,0.99257866829283,0,1,C zone,CC,
5183,GO:0014707,1,0.989482124841825,0,2,branchiomeric skeletal muscle development,BP,
5184,GO:0014717,1,0.989347099154831,0,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5185,GO:0014718,1,0.989347099154831,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5186,GO:0014719,1,0.966463177044538,0,5,skeletal muscle satellite cell activation,BP,
5187,GO:0014721,1,0.966756245452266,0,5,twitch skeletal muscle contraction,BP,
5188,GO:0014722,1,0.96546977742302,0,6,regulation of skeletal muscle contraction by calcium ion signaling,BP,
5189,GO:0014724,1,0.984099858696714,0,2,regulation of twitch skeletal muscle contraction,BP,
5190,GO:0014728,1,0.990773235766312,0,1,regulation of the force of skeletal muscle contraction,BP,
5191,GO:0014731,1,0.928174200601617,0,7,spectrin-associated cytoskeleton,CC,
5192,GO:0014732,1,0.957839222260868,0,7,skeletal muscle atrophy,BP,
5193,GO:0014733,1,0.916583936437437,0,11,regulation of skeletal muscle adaptation,BP,
5194,GO:0014734,1,0.973961034457299,0,3,skeletal muscle hypertrophy,BP,
5195,GO:0014735,1,0.979429558714055,0,3,regulation of muscle atrophy,BP,
5196,GO:0014736,1,0.984025644318991,0,2,negative regulation of muscle atrophy,BP,
5197,GO:0014737,1,0.995330061323471,0,1,positive regulation of muscle atrophy,BP,
5198,GO:0014738,1,0.985076782430855,0,3,regulation of muscle hyperplasia,BP,
5199,GO:0014739,1,0.996703796131955,0,1,positive regulation of muscle hyperplasia,BP,
5200,GO:0014740,1,0.98833492258735,0,2,negative regulation of muscle hyperplasia,BP,
5201,GO:0014741,1,0.880444133100577,0,18,negative regulation of muscle hypertrophy,BP,
5202,GO:0014742,1,0.827651712469401,0,26,positive regulation of muscle hypertrophy,BP,
5203,GO:0014743,1,0.713690280240441,0,46,regulation of muscle hypertrophy,BP,
5204,GO:0014744,1,0.966196033326809,0,5,positive regulation of muscle adaptation,BP,
5205,GO:0014745,1,0.917625399635636,0,11,negative regulation of muscle adaptation,BP,
5206,GO:0014802,1,0.968810814368599,0,4,terminal cisterna,CC,
5207,GO:0014804,1,0.995048373474354,0,1,terminal cisterna lumen,CC,
5208,GO:0014805,1,0.982380108854717,0,4,smooth muscle adaptation,BP,
5209,GO:0014806,1,0.990014547545779,0,2,smooth muscle hyperplasia,BP,
5210,GO:0014807,1,0.955429867810922,0,7,regulation of somitogenesis,BP,
5211,GO:0014808,1,0.796311568531061,0,28,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
5212,GO:0014809,1,0.971347423414325,0,5,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5213,GO:0014810,1,0.996526136781253,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5214,GO:0014812,1,0.575262549896171,0,74,muscle cell migration,BP,
5215,GO:0014813,1,0.994670277144347,0,1,skeletal muscle satellite cell commitment,BP,
5216,GO:0014816,1,0.944845219785902,0,7,skeletal muscle satellite cell differentiation,BP,
5217,GO:0014819,1,0.931080848558766,0,11,regulation of skeletal muscle contraction,BP,
5218,GO:0014820,1,0.947020400519473,0,9,tonic smooth muscle contraction,BP,
5219,GO:0014821,1,0.905560464661175,0,18,phasic smooth muscle contraction,BP,
5220,GO:0014822,1,0.994308195715901,0,1,detection of wounding,BP,
5221,GO:0014823,1,0.678739396190347,0,56,response to activity,BP,
5222,GO:0014824,1,0.960634052039194,0,7,artery smooth muscle contraction,BP,
5223,GO:0014825,1,0.996486604643215,0,1,stomach fundus smooth muscle contraction,BP,
5224,GO:0014826,1,0.977818823873594,0,4,vein smooth muscle contraction,BP,
5225,GO:0014827,1,0.96690194647658,0,6,intestine smooth muscle contraction,BP,
5226,GO:0014828,1,0.991649235187485,0,1,distal stomach smooth muscle contraction,BP,
5228,GO:0014831,1,0.93537567798198,0,11,gastro-intestinal system smooth muscle contraction,BP,
5229,GO:0014832,1,0.95606905538282,0,7,urinary bladder smooth muscle contraction,BP,
5230,GO:0014834,1,0.972433578764587,0,4,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,
5231,GO:0014835,1,0.987206438657572,0,2,myoblast differentiation involved in skeletal muscle regeneration,BP,
5232,GO:0014839,1,0.990961386983702,0,2,myoblast migration involved in skeletal muscle regeneration,BP,
5233,GO:0014841,1,0.91051522376565,0,13,skeletal muscle satellite cell proliferation,BP,
5234,GO:0014842,1,0.920472542029716,0,12,regulation of skeletal muscle satellite cell proliferation,BP,
5235,GO:0014843,1,0.990081615002755,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
5236,GO:0014846,1,0.983828701628941,0,2,esophagus smooth muscle contraction,BP,
5237,GO:0014847,1,0.996486604643215,0,1,proximal stomach smooth muscle contraction,BP,
5238,GO:0014848,1,0.95606905538282,0,7,urinary tract smooth muscle contraction,BP,
5239,GO:0014850,1,0.860749773765962,0,21,response to muscle activity,BP,
5240,GO:0014852,1,0.993950748745565,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
5241,GO:0014853,1,0.993950748745565,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
5242,GO:0014854,1,0.908030914257632,0,13,response to inactivity,BP,
5243,GO:0014855,1,0.65846088584787,0,59,striated muscle cell proliferation,BP,
5244,GO:0014856,1,0.906450139721431,0,14,skeletal muscle cell proliferation,BP,
5245,GO:0014857,1,0.916363453062895,0,13,regulation of skeletal muscle cell proliferation,BP,
5246,GO:0014858,1,0.979076037327848,0,3,positive regulation of skeletal muscle cell proliferation,BP,
5247,GO:0014859,1,0.979758380115896,0,3,negative regulation of skeletal muscle cell proliferation,BP,
5248,GO:0014861,1,0.991452327030306,0,1,regulation of skeletal muscle contraction via regulation of action potential,BP,
5249,GO:0014862,1,0.990773235766312,0,1,regulation of skeletal muscle contraction by chemo-mechanical energy conversion,BP,
5250,GO:0014866,1,0.893894487099439,0,12,skeletal myofibril assembly,BP,
5251,GO:0014870,1,0.922473105694327,0,10,response to muscle inactivity,BP,
5252,GO:0014873,1,0.989639641488509,0,2,response to muscle activity involved in regulation of muscle adaptation,BP,
5253,GO:0014874,1,0.89808299476908,0,14,response to stimulus involved in regulation of muscle adaptation,BP,
5254,GO:0014876,1,0.995781869132212,0,1,response to injury involved in regulation of muscle adaptation,BP,
5255,GO:0014877,1,0.927994424961207,0,9,response to muscle inactivity involved in regulation of muscle adaptation,BP,
5256,GO:0014878,1,0.972915889355247,0,4,response to electrical stimulus involved in regulation of muscle adaptation,BP,
5257,GO:0014883,1,0.95600106150917,0,6,transition between fast and slow fiber,BP,
5258,GO:0014886,1,0.993531456190943,0,1,transition between slow and fast fiber,BP,
5259,GO:0014887,1,0.845372758919675,0,22,cardiac muscle adaptation,BP,
5260,GO:0014888,1,0.748265985039372,0,41,striated muscle adaptation,BP,
5261,GO:0014889,1,0.927000101930122,0,12,muscle atrophy,BP,
5262,GO:0014891,1,0.952185456138186,0,8,striated muscle atrophy,BP,
5263,GO:0014894,1,0.927994424961207,0,9,response to denervation involved in regulation of muscle adaptation,BP,
5264,GO:0014895,1,0.996642149851149,0,1,smooth muscle hypertrophy,BP,
5265,GO:0014896,1,0.564736223519592,0,73,muscle hypertrophy,BP,
5266,GO:0014897,1,0.570085049777862,0,71,striated muscle hypertrophy,BP,
5267,GO:0014898,1,0.845372758919675,0,22,cardiac muscle hypertrophy in response to stress,BP,
5268,GO:0014900,1,0.98071205741494,0,4,muscle hyperplasia,BP,
5269,GO:0014901,1,0.989347099154831,0,2,satellite cell activation involved in skeletal muscle regeneration,BP,
5270,GO:0014902,1,0.536210999404595,0,89,myotube differentiation,BP,
5271,GO:0014904,1,0.81053393879317,0,31,myotube cell development,BP,
5272,GO:0014908,1,0.985856395184769,0,2,myotube differentiation involved in skeletal muscle regeneration,BP,
5273,GO:0014909,1,0.619941513136696,0,63,smooth muscle cell migration,BP,
5274,GO:0014910,1,0.653634094859975,0,55,regulation of smooth muscle cell migration,BP,
5275,GO:0014911,1,0.7902486971221,0,30,positive regulation of smooth muscle cell migration,BP,
5276,GO:0014912,1,0.859839156747777,0,21,negative regulation of smooth muscle cell migration,BP,
5277,GO:0014916,1,0.971545001280037,0,3,regulation of lung blood pressure,BP,
5278,GO:0015002,1,0.918771387467436,0,22,heme-copper terminal oxidase activity,MF,
5279,GO:0015012,1,0.828672914530192,0,25,heparan sulfate proteoglycan biosynthetic process,BP,
5280,GO:0015014,1,0.952723890397634,0,6,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
5281,GO:0015015,1,0.956784947942982,0,6,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
5282,GO:0015016,1,0.966436656574774,0,4,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
5283,GO:0015018,1,0.98409680246248,0,3,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
5284,GO:0015019,1,0.991607258924997,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
5285,GO:0015020,1,0.91653323738225,0,14,glucuronosyltransferase activity,MF,
5286,GO:0015026,1,0.786956320588249,0,36,coreceptor activity,MF,
5287,GO:0015030,1,0.727632059246575,0,53,Cajal body,CC,
5289,GO:0015035,1,0.903929232256459,0,20,protein disulfide oxidoreductase activity,MF,
5290,GO:0015036,1,0.831147064060436,0,36,disulfide oxidoreductase activity,MF,
5291,GO:0015037,1,0.940124033176508,0,13,peptide disulfide oxidoreductase activity,MF,
5292,GO:0015038,1,0.979174237144831,0,5,glutathione disulfide oxidoreductase activity,MF,
5293,GO:0015039,1,0.995129621674049,0,1,NADPH-adrenodoxin reductase activity,MF,
5294,GO:0015052,1,0.994209818476156,0,1,beta3-adrenergic receptor activity,MF,
5295,GO:0015054,1,0.994849658590611,0,1,gastrin receptor activity,MF,
5296,GO:0015056,1,0.989708945856507,0,2,corticotrophin-releasing factor receptor activity,MF,
5297,GO:0015057,1,0.969203009761436,0,5,thrombin-activated receptor activity,MF,
5298,GO:0015065,1,0.985123378396994,0,3,uridine nucleotide receptor activity,MF,
5299,GO:0015067,1,0.994272449347166,0,1,amidinotransferase activity,MF,
5300,GO:0015068,1,0.994272449347166,0,1,glycine amidinotransferase activity,MF,
5301,GO:0015074,1,0.932529956562549,0,10,DNA integration,BP,
5304,GO:0015078,1,0.568202059899986,0,98,proton transmembrane transporter activity,MF,
5308,GO:0015086,1,0.992648601131098,0,1,cadmium ion transmembrane transporter activity,MF,
5309,GO:0015087,1,0.992648601131098,0,1,cobalt ion transmembrane transporter activity,MF,
5310,GO:0015091,1,0.979739793152995,0,3,ferric iron transmembrane transporter activity,MF,
5311,GO:0015093,1,0.978380616866413,0,3,ferrous iron transmembrane transporter activity,MF,
5312,GO:0015094,1,0.992648601131098,0,1,lead ion transmembrane transporter activity,MF,
5313,GO:0015095,1,0.896235932725894,0,16,magnesium ion transmembrane transporter activity,MF,
5314,GO:0015098,1,0.995128986768719,0,1,molybdate ion transmembrane transporter activity,MF,
5315,GO:0015101,1,0.865226476215381,0,25,organic cation transmembrane transporter activity,MF,
5317,GO:0015105,1,0.995904356213965,0,1,arsenite transmembrane transporter activity,MF,
5320,GO:0015111,1,0.97787197756828,0,3,iodide transmembrane transporter activity,MF,
5321,GO:0015112,1,0.994195734433162,0,1,nitrate transmembrane transporter activity,MF,
5323,GO:0015116,1,0.926831478308772,0,11,sulfate transmembrane transporter activity,MF,
5324,GO:0015117,1,0.995139780213873,0,1,thiosulfate transmembrane transporter activity,MF,
5325,GO:0015119,1,0.981312692773125,0,3,hexose phosphate transmembrane transporter activity,MF,
5326,GO:0015125,1,0.922832987025761,0,13,bile acid transmembrane transporter activity,MF,
5327,GO:0015126,1,0.992034134391128,0,1,canalicular bile acid transmembrane transporter activity,MF,
5328,GO:0015127,1,0.991755126917671,0,1,bilirubin transmembrane transporter activity,MF,
5329,GO:0015129,1,0.967036905559855,0,5,lactate transmembrane transporter activity,MF,
5330,GO:0015130,1,0.992679109517626,0,1,mevalonate transmembrane transporter activity,MF,
5331,GO:0015131,1,0.995139780213873,0,1,oxaloacetate transmembrane transporter activity,MF,
5332,GO:0015132,1,0.992593259897461,0,1,prostaglandin transmembrane transporter activity,MF,
5333,GO:0015136,1,0.993476008792054,0,1,sialic acid transmembrane transporter activity,MF,
5334,GO:0015137,1,0.974746306460756,0,4,citrate transmembrane transporter activity,MF,
5335,GO:0015139,1,0.993954635307716,0,1,alpha-ketoglutarate transmembrane transporter activity,MF,
5336,GO:0015140,1,0.990441876569884,0,2,malate transmembrane transporter activity,MF,
5337,GO:0015141,1,0.981584079329087,0,3,succinate transmembrane transporter activity,MF,
5338,GO:0015142,1,0.974746306460756,0,4,tricarboxylic acid transmembrane transporter activity,MF,
5339,GO:0015143,1,0.974570988490225,0,5,urate transmembrane transporter activity,MF,
5340,GO:0015144,1,0.815804982819327,0,33,carbohydrate transmembrane transporter activity,MF,
5341,GO:0015145,1,0.874013169985852,0,21,monosaccharide transmembrane transporter activity,MF,
5342,GO:0015149,1,0.882946157302251,0,20,hexose transmembrane transporter activity,MF,
5343,GO:0015152,1,0.99486479665574,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
5344,GO:0015154,1,0.981643102359566,0,3,disaccharide transmembrane transporter activity,MF,
5345,GO:0015157,1,0.981643102359566,0,3,oligosaccharide transmembrane transporter activity,MF,
5346,GO:0015165,1,0.941480922483142,0,10,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
5347,GO:0015166,1,0.945709349098638,0,8,polyol transmembrane transporter activity,MF,
5348,GO:0015168,1,0.974549774196769,0,5,glycerol transmembrane transporter activity,MF,
5351,GO:0015173,1,0.982091025601366,0,3,aromatic amino acid transmembrane transporter activity,MF,
5352,GO:0015174,1,0.93171099015922,0,11,basic amino acid transmembrane transporter activity,MF,
5353,GO:0015175,1,0.827549587836139,0,29,neutral amino acid transmembrane transporter activity,MF,
5355,GO:0015180,1,0.966902419896406,0,5,L-alanine transmembrane transporter activity,MF,
5356,GO:0015181,1,0.958472959938578,0,6,arginine transmembrane transporter activity,MF,
5357,GO:0015182,1,0.988504590143269,0,2,L-asparagine transmembrane transporter activity,MF,
5358,GO:0015183,1,0.976017878017907,0,4,L-aspartate transmembrane transporter activity,MF,
5359,GO:0015184,1,0.980558657175225,0,3,L-cystine transmembrane transporter activity,MF,
5360,GO:0015185,1,0.970257065071017,0,5,gamma-aminobutyric acid transmembrane transporter activity,MF,
5361,GO:0015186,1,0.968422781600116,0,5,L-glutamine transmembrane transporter activity,MF,
5362,GO:0015187,1,0.963274777804373,0,6,glycine transmembrane transporter activity,MF,
5363,GO:0015189,1,0.958472959938578,0,6,L-lysine transmembrane transporter activity,MF,
5364,GO:0015190,1,0.994049052484948,0,1,L-leucine transmembrane transporter activity,MF,
5365,GO:0015191,1,0.994049052484948,0,1,L-methionine transmembrane transporter activity,MF,
5366,GO:0015193,1,0.963051953491023,0,5,L-proline transmembrane transporter activity,MF,
5367,GO:0015194,1,0.951936536034011,0,9,L-serine transmembrane transporter activity,MF,
5368,GO:0015195,1,0.992520677556813,0,1,L-threonine transmembrane transporter activity,MF,
5369,GO:0015196,1,0.994415395872108,0,1,L-tryptophan transmembrane transporter activity,MF,
5370,GO:0015203,1,0.990495042643607,0,2,polyamine transmembrane transporter activity,MF,
5372,GO:0015205,1,0.962168885304523,0,6,nucleobase transmembrane transporter activity,MF,
5373,GO:0015207,1,0.988264132944211,0,2,adenine transmembrane transporter activity,MF,
5374,GO:0015215,1,0.90985783737789,0,16,nucleotide transmembrane transporter activity,MF,
5375,GO:0015216,1,0.931034275095832,0,12,purine nucleotide transmembrane transporter activity,MF,
5376,GO:0015217,1,0.947918736701191,0,9,ADP transmembrane transporter activity,MF,
5377,GO:0015218,1,0.98788339701756,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
5378,GO:0015220,1,0.962903179189255,0,6,choline transmembrane transporter activity,MF,
5379,GO:0015222,1,0.981489539195804,0,3,serotonin transmembrane transporter activity,MF,
5380,GO:0015226,1,0.967446890000509,0,6,carnitine transmembrane transporter activity,MF,
5381,GO:0015227,1,0.989730178837486,0,2,acyl carnitine transmembrane transporter activity,MF,
5382,GO:0015228,1,0.982751723197433,0,3,coenzyme A transmembrane transporter activity,MF,
5383,GO:0015229,1,0.989895386513853,0,1,L-ascorbic acid transmembrane transporter activity,MF,
5384,GO:0015230,1,0.988478899811264,0,2,FAD transmembrane transporter activity,MF,
5385,GO:0015232,1,0.948018632091372,0,8,heme transporter activity,MF,
5386,GO:0015234,1,0.981764806812992,0,3,thiamine transmembrane transporter activity,MF,
5388,GO:0015245,1,0.953279568502452,0,8,fatty acid transmembrane transporter activity,MF,
5389,GO:0015247,1,0.975920410519079,0,3,aminophospholipid transmembrane transporter activity,MF,
5390,GO:0015248,1,0.847001954561223,0,25,sterol transporter activity,MF,
5391,GO:0015250,1,0.947363155190872,0,10,water channel activity,MF,
5392,GO:0015252,1,0.983387242084897,0,3,proton channel activity,MF,
5393,GO:0015254,1,0.980354776059166,0,4,glycerol channel activity,MF,
5396,GO:0015269,1,0.901158308135761,0,17,calcium-activated potassium channel activity,MF,
5397,GO:0015271,1,0.898161893659019,0,15,outward rectifier potassium channel activity,MF,
5398,GO:0015272,1,0.967180706444065,0,5,ATP-activated inward rectifier potassium channel activity,MF,
5399,GO:0015275,1,0.979534553911313,0,3,stretch-activated, cation-selective, calcium channel activity,MF,
5401,GO:0015277,1,0.961140231681727,0,5,kainate selective glutamate receptor activity,MF,
5402,GO:0015278,1,0.819403124606992,0,21,calcium-release channel activity,MF,
5403,GO:0015279,1,0.93205065480814,0,9,store-operated calcium channel activity,MF,
5404,GO:0015280,1,0.948052748651464,0,8,ligand-gated sodium channel activity,MF,
5405,GO:0015288,1,0.970272279068376,0,6,porin activity,MF,
5407,GO:0015292,1,0.994054740756748,0,1,uniporter activity,MF,
5410,GO:0015295,1,0.873864888122712,0,21,solute:proton symporter activity,MF,
5411,GO:0015296,1,0.922587163066269,0,10,anion:cation symporter activity,MF,
5413,GO:0015298,1,0.807268562778959,0,31,solute:cation antiporter activity,MF,
5414,GO:0015299,1,0.884640392302586,0,18,solute:proton antiporter activity,MF,
5416,GO:0015307,1,0.983774355125967,0,3,drug:proton antiporter activity,MF,
5417,GO:0015315,1,0.981312692773125,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5418,GO:0015317,1,0.99540215316049,0,1,phosphate:proton symporter activity,MF,
5422,GO:0015322,1,0.993091994234998,0,1,secondary active oligopeptide transmembrane transporter activity,MF,
5423,GO:0015327,1,0.987400732769895,0,1,cystine:glutamate antiporter activity,MF,
5424,GO:0015328,1,0.987400732769895,0,1,cystine secondary active transmembrane transporter activity,MF,
5425,GO:0015333,1,0.980456841799844,0,3,peptide:proton symporter activity,MF,
5426,GO:0015343,1,0.994054740756748,0,1,siderophore transmembrane transporter activity,MF,
5427,GO:0015347,1,0.856417942888362,0,24,sodium-independent organic anion transmembrane transporter activity,MF,
5428,GO:0015349,1,0.974177874831902,0,4,thyroid hormone transmembrane transporter activity,MF,
5429,GO:0015350,1,0.984397392804215,0,2,methotrexate transmembrane transporter activity,MF,
5430,GO:0015355,1,0.937073264069232,0,11,secondary active monocarboxylate transmembrane transporter activity,MF,
5431,GO:0015362,1,0.992753931430705,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
5432,GO:0015367,1,0.995279384262361,0,1,oxoglutarate:malate antiporter activity,MF,
5433,GO:0015368,1,0.922886721660029,0,11,calcium:cation antiporter activity,MF,
5434,GO:0015369,1,0.991364401183615,0,1,calcium:proton antiporter activity,MF,
5436,GO:0015373,1,0.969554840136833,0,4,anion:sodium symporter activity,MF,
5437,GO:0015375,1,0.987560470216878,0,2,glycine:sodium symporter activity,MF,
5438,GO:0015377,1,0.934585208649362,0,8,cation:chloride symporter activity,MF,
5439,GO:0015378,1,0.982157331777347,0,2,sodium:chloride symporter activity,MF,
5440,GO:0015379,1,0.934585208649362,0,8,potassium:chloride symporter activity,MF,
5441,GO:0015382,1,0.993915936105817,0,1,sodium:sulfate symporter activity,MF,
5442,GO:0015385,1,0.919323883231985,0,12,sodium:proton antiporter activity,MF,
5443,GO:0015386,1,0.93036180973949,0,10,potassium:proton antiporter activity,MF,
5444,GO:0015389,1,0.989691736132576,0,2,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5445,GO:0015390,1,0.994718987475769,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5446,GO:0015391,1,0.989691736132576,0,2,nucleobase:cation symporter activity,MF,
5447,GO:0015399,1,0.467462780819479,0,103,primary active transmembrane transporter activity,MF,
5448,GO:0015405,1,0.467462780819479,0,103,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,
5449,GO:0015410,1,0.979750528014573,0,3,manganese-transporting ATPase activity,MF,
5450,GO:0015420,1,0.99043455124782,0,1,cobalamin-transporting ATPase activity,MF,
5451,GO:0015421,1,0.993261693096881,0,1,oligopeptide-transporting ATPase activity,MF,
5452,GO:0015431,1,0.99043455124782,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
5453,GO:0015432,1,0.985344617528228,0,2,bile acid-exporting ATPase activity,MF,
5454,GO:0015433,1,0.986129375915119,0,2,peptide antigen-transporting ATPase activity,MF,
5455,GO:0015439,1,0.993821279184255,0,1,heme-transporting ATPase activity,MF,
5456,GO:0015440,1,0.973461060831402,0,4,peptide-transporting ATPase activity,MF,
5457,GO:0015450,1,0.973141666509955,0,6,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5460,GO:0015467,1,0.935213366228857,0,10,G-protein activated inward rectifier potassium channel activity,MF,
5461,GO:0015485,1,0.785244450506594,0,37,cholesterol binding,MF,
5462,GO:0015489,1,0.990495042643607,0,2,putrescine transmembrane transporter activity,MF,
5463,GO:0015491,1,0.820440686745389,0,28,cation:cation antiporter activity,MF,
5464,GO:0015495,1,0.994291488409353,0,1,gamma-aminobutyric acid:proton symporter activity,MF,
5465,GO:0015499,1,0.99419280488058,0,1,formate transmembrane transporter activity,MF,
5466,GO:0015501,1,0.951070534391066,0,7,glutamate:sodium symporter activity,MF,
5467,GO:0015526,1,0.981312692773125,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
5468,GO:0015538,1,0.993476008792054,0,1,sialic acid:proton symporter activity,MF,
5469,GO:0015556,1,0.953514750014767,0,8,C4-dicarboxylate transmembrane transporter activity,MF,
5470,GO:0015562,1,0.972212490646862,0,4,efflux transmembrane transporter activity,MF,
5471,GO:0015578,1,0.994432405020209,0,1,mannose transmembrane transporter activity,MF,
5472,GO:0015605,1,0.86625721027321,0,23,organophosphate ester transmembrane transporter activity,MF,
5473,GO:0015616,1,0.962315656419062,0,4,DNA translocase activity,MF,
5478,GO:0015636,1,0.994609348609969,0,1,short-chain fatty acid transmembrane transporter activity,MF,
5479,GO:0015643,1,0.949529368215686,0,9,toxic substance binding,MF,
5480,GO:0015645,1,0.901028248278151,0,17,fatty acid ligase activity,MF,
5481,GO:0015651,1,0.943748685303316,0,10,quaternary ammonium group transmembrane transporter activity,MF,
5482,GO:0015658,1,0.994049052484948,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5483,GO:0015660,1,0.99419280488058,0,1,formate efflux transmembrane transporter activity,MF,
5484,GO:0015662,1,0.758466538656022,0,38,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,
5485,GO:0015665,1,0.990338620047879,0,2,alcohol transmembrane transporter activity,MF,
5486,GO:0015669,1,0.928716886646434,0,17,gas transport,BP,
5487,GO:0015670,1,0.984805905302545,0,3,carbon dioxide transport,BP,
5488,GO:0015671,1,0.943054186546587,0,14,oxygen transport,BP,
5490,GO:0015677,1,0.938042543241631,0,8,copper ion import,BP,
5491,GO:0015679,1,0.980590263027623,0,2,plasma membrane copper ion transport,BP,
5492,GO:0015680,1,0.983677998353759,0,3,intracellular copper ion transport,BP,
5493,GO:0015682,1,0.793128849538654,0,38,ferric iron transport,BP,
5494,GO:0015684,1,0.978380616866413,0,3,ferrous iron transport,BP,
5495,GO:0015688,1,0.985374639148224,0,3,iron chelate transport,BP,
5496,GO:0015689,1,0.995128986768719,0,1,molybdate ion transport,BP,
5497,GO:0015691,1,0.97438548912721,0,4,cadmium ion transport,BP,
5498,GO:0015692,1,0.992648601131098,0,1,lead ion transport,BP,
5499,GO:0015693,1,0.888566763710182,0,17,magnesium ion transport,BP,
5500,GO:0015694,1,0.991755126917671,0,1,mercury ion transport,BP,
5501,GO:0015695,1,0.789080767880562,0,39,organic cation transport,BP,
5503,GO:0015697,1,0.923353672637436,0,13,quaternary ammonium group transport,BP,
5505,GO:0015700,1,0.995904356213965,0,1,arsenite transport,BP,
5507,GO:0015705,1,0.955164579076666,0,5,iodide transport,BP,
5508,GO:0015706,1,0.994195734433162,0,1,nitrate transport,BP,
5509,GO:0015707,1,0.99294866239209,0,1,nitrite transport,BP,
5510,GO:0015709,1,0.995139780213873,0,1,thiosulfate transport,BP,
5512,GO:0015712,1,0.966224578067238,0,6,hexose phosphate transport,BP,
5513,GO:0015718,1,0.420109705870128,0,134,monocarboxylic acid transport,BP,
5514,GO:0015721,1,0.852240409095597,0,25,bile acid and bile salt transport,BP,
5515,GO:0015722,1,0.971142312125693,0,4,canalicular bile acid transport,BP,
5516,GO:0015723,1,0.991755126917671,0,1,bilirubin transport,BP,
5517,GO:0015724,1,0.99419280488058,0,1,formate transport,BP,
5518,GO:0015727,1,0.959795547634556,0,6,lactate transport,BP,
5519,GO:0015728,1,0.992679109517626,0,1,mevalonate transport,BP,
5520,GO:0015729,1,0.995139780213873,0,1,oxaloacetate transport,BP,
5521,GO:0015732,1,0.923091639604214,0,13,prostaglandin transport,BP,
5522,GO:0015734,1,0.990334051390634,0,1,taurine transport,BP,
5523,GO:0015739,1,0.993476008792054,0,1,sialic acid transport,BP,
5524,GO:0015740,1,0.916754295678542,0,12,C4-dicarboxylate transport,BP,
5525,GO:0015742,1,0.984172292096339,0,3,alpha-ketoglutarate transport,BP,
5526,GO:0015743,1,0.995139780213873,0,1,malate transport,BP,
5527,GO:0015744,1,0.981584079329087,0,3,succinate transport,BP,
5528,GO:0015746,1,0.974746306460756,0,4,citrate transport,BP,
5529,GO:0015747,1,0.969014331410358,0,6,urate transport,BP,
5530,GO:0015748,1,0.5613600111686,0,84,organophosphate ester transport,BP,
5531,GO:0015749,1,0.501858464230766,0,99,monosaccharide transmembrane transport,BP,
5532,GO:0015755,1,0.994596954618774,0,1,fructose transmembrane transport,BP,
5533,GO:0015760,1,0.966224578067238,0,6,glucose-6-phosphate transport,BP,
5534,GO:0015761,1,0.994432405020209,0,1,mannose transmembrane transport,BP,
5535,GO:0015766,1,0.981643102359566,0,3,disaccharide transport,BP,
5536,GO:0015770,1,0.981643102359566,0,3,sucrose transport,BP,
5537,GO:0015772,1,0.981643102359566,0,3,oligosaccharide transport,BP,
5538,GO:0015780,1,0.924904004380711,0,13,nucleotide-sugar transmembrane transport,BP,
5539,GO:0015782,1,0.995236261205466,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
5540,GO:0015783,1,0.983684860748946,0,2,GDP-fucose transmembrane transport,BP,
5541,GO:0015786,1,0.994660308103538,0,1,UDP-glucose transmembrane transport,BP,
5542,GO:0015787,1,0.990377924401688,0,1,UDP-glucuronic acid transmembrane transport,BP,
5543,GO:0015790,1,0.990036173360473,0,1,UDP-xylose transmembrane transport,BP,
5544,GO:0015791,1,0.92714443801577,0,10,polyol transport,BP,
5545,GO:0015793,1,0.974549774196769,0,5,glycerol transport,BP,
5546,GO:0015797,1,0.99419280488058,0,1,mannitol transport,BP,
5547,GO:0015798,1,0.956928564066105,0,4,myo-inositol transport,BP,
5549,GO:0015801,1,0.970283750417032,0,5,aromatic amino acid transport,BP,
5550,GO:0015802,1,0.928460532924329,0,12,basic amino acid transport,BP,
5553,GO:0015805,1,0.994712732642883,0,1,S-adenosyl-L-methionine transport,BP,
5555,GO:0015808,1,0.966902419896406,0,5,L-alanine transport,BP,
5556,GO:0015809,1,0.949443537893234,0,8,arginine transport,BP,
5557,GO:0015810,1,0.981861964700897,0,3,aspartate transmembrane transport,BP,
5558,GO:0015811,1,0.980558657175225,0,3,L-cystine transport,BP,
5559,GO:0015812,1,0.908568372384124,0,13,gamma-aminobutyric acid transport,BP,
5562,GO:0015817,1,0.988491044051226,0,2,histidine transport,BP,
5563,GO:0015819,1,0.995142319853114,0,1,lysine transport,BP,
5565,GO:0015821,1,0.994049052484948,0,1,methionine transport,BP,
5566,GO:0015822,1,0.957369438494666,0,6,ornithine transport,BP,
5568,GO:0015825,1,0.951936536034011,0,9,L-serine transport,BP,
5569,GO:0015826,1,0.992520677556813,0,1,threonine transport,BP,
5570,GO:0015827,1,0.98246144720783,0,3,tryptophan transport,BP,
5571,GO:0015828,1,0.993643035872852,0,1,tyrosine transport,BP,
5574,GO:0015838,1,0.946544922947731,0,9,amino-acid betaine transport,BP,
5576,GO:0015842,1,0.979342255635635,0,4,aminergic neurotransmitter loading into synaptic vesicle,BP,
5578,GO:0015846,1,0.96225831170045,0,7,polyamine transport,BP,
5579,GO:0015847,1,0.990495042643607,0,2,putrescine transport,BP,
5582,GO:0015851,1,0.958044250254075,0,7,nucleobase transport,BP,
5583,GO:0015853,1,0.984028776698158,0,3,adenine transport,BP,
5584,GO:0015855,1,0.983537899913126,0,3,pyrimidine nucleobase transport,BP,
5585,GO:0015858,1,0.961855312348552,0,7,nucleoside transport,BP,
5586,GO:0015860,1,0.994718987475769,0,1,purine nucleoside transmembrane transport,BP,
5587,GO:0015862,1,0.994584575096351,0,1,uridine transport,BP,
5588,GO:0015864,1,0.989331873798861,0,2,pyrimidine nucleoside transport,BP,
5589,GO:0015865,1,0.915188802721951,0,15,purine nucleotide transport,BP,
5590,GO:0015866,1,0.947918736701191,0,9,ADP transport,BP,
5591,GO:0015867,1,0.941375274998038,0,10,ATP transport,BP,
5592,GO:0015868,1,0.922361957061856,0,14,purine ribonucleotide transport,BP,
5593,GO:0015870,1,0.977349699912448,0,4,acetylcholine transport,BP,
5594,GO:0015871,1,0.951084986292904,0,7,choline transport,BP,
5596,GO:0015874,1,0.904531885426033,0,17,norepinephrine transport,BP,
5597,GO:0015876,1,0.994187535736652,0,1,acetyl-CoA transport,BP,
5598,GO:0015878,1,0.993490575578835,0,1,biotin transport,BP,
5599,GO:0015879,1,0.962471089078682,0,7,carnitine transport,BP,
5600,GO:0015880,1,0.982751723197433,0,3,coenzyme A transport,BP,
5601,GO:0015881,1,0.985512577757081,0,2,creatine transmembrane transport,BP,
5602,GO:0015882,1,0.989895386513853,0,1,L-ascorbic acid transmembrane transport,BP,
5603,GO:0015884,1,0.943752460850913,0,8,folic acid transport,BP,
5604,GO:0015886,1,0.948018632091372,0,8,heme transport,BP,
5605,GO:0015887,1,0.993490575578835,0,1,pantothenate transmembrane transport,BP,
5606,GO:0015888,1,0.980255677050618,0,3,thiamine transport,BP,
5607,GO:0015889,1,0.958633317607165,0,6,cobalamin transport,BP,
5608,GO:0015891,1,0.985374639148224,0,3,siderophore transport,BP,
5610,GO:0015904,1,0.995173429316568,0,1,tetracycline transport,BP,
5611,GO:0015908,1,0.628814667156466,0,72,fatty acid transport,BP,
5612,GO:0015909,1,0.726687611514271,0,51,long-chain fatty acid transport,BP,
5613,GO:0015910,1,0.987790594020474,0,2,peroxisomal long-chain fatty acid import,BP,
5614,GO:0015911,1,0.961540942524473,0,5,plasma membrane long-chain fatty acid transport,BP,
5615,GO:0015912,1,0.994609348609969,0,1,short-chain fatty acid transport,BP,
5616,GO:0015913,1,0.994609348609969,0,1,short-chain fatty acid import,BP,
5617,GO:0015914,1,0.653846813884954,0,58,phospholipid transport,BP,
5618,GO:0015916,1,0.994187535736652,0,1,fatty-acyl-CoA transport,BP,
5619,GO:0015917,1,0.965703435244398,0,4,aminophospholipid transport,BP,
5620,GO:0015918,1,0.603841062894053,0,74,sterol transport,BP,
5621,GO:0015919,1,0.903536246918621,0,16,peroxisomal membrane transport,BP,
5622,GO:0015920,1,0.989399353935152,0,2,lipopolysaccharide transport,BP,
5623,GO:0015922,1,0.995482929907883,0,1,aspartate oxidase activity,MF,
5624,GO:0015923,1,0.900288296952166,0,14,mannosidase activity,MF,
5625,GO:0015924,1,0.93214850623922,0,9,mannosyl-oligosaccharide mannosidase activity,MF,
5626,GO:0015925,1,0.955298370081865,0,8,galactosidase activity,MF,
5627,GO:0015926,1,0.929925855996853,0,10,glucosidase activity,MF,
5628,GO:0015928,1,0.989755706774194,0,2,fucosidase activity,MF,
5629,GO:0015929,1,0.926984112483748,0,13,hexosaminidase activity,MF,
5631,GO:0015932,1,0.806091753984983,0,36,nucleobase-containing compound transmembrane transporter activity,MF,
5632,GO:0015934,1,0.623471867296552,0,113,large ribosomal subunit,CC,
5633,GO:0015935,1,0.747669486122503,0,69,small ribosomal subunit,CC,
5634,GO:0015936,1,0.918611683736762,0,15,coenzyme A metabolic process,BP,
5635,GO:0015937,1,0.948904301684974,0,10,coenzyme A biosynthetic process,BP,
5636,GO:0015938,1,0.996242741238324,0,1,coenzyme A catabolic process,BP,
5637,GO:0015939,1,0.951504358871121,0,8,pantothenate metabolic process,BP,
5638,GO:0015942,1,0.967057970116671,0,6,formate metabolic process,BP,
5639,GO:0015949,1,0.846277512265696,0,32,nucleobase-containing small molecule interconversion,BP,
5640,GO:0015950,1,0.990782325803101,0,2,purine nucleotide interconversion,BP,
5641,GO:0015951,1,0.990782325803101,0,2,purine ribonucleotide interconversion,BP,
5642,GO:0015959,1,0.960092036807979,0,7,diadenosine polyphosphate metabolic process,BP,
5643,GO:0015960,1,0.982134327921964,0,3,diadenosine polyphosphate biosynthetic process,BP,
5644,GO:0015961,1,0.977560788177497,0,4,diadenosine polyphosphate catabolic process,BP,
5645,GO:0015965,1,0.982134327921964,0,3,diadenosine tetraphosphate metabolic process,BP,
5646,GO:0015966,1,0.982134327921964,0,3,diadenosine tetraphosphate biosynthetic process,BP,
5648,GO:0015985,1,0.95061711039032,0,9,energy coupled proton transport, down electrochemical gradient,BP,
5649,GO:0015986,1,0.95061711039032,0,9,ATP synthesis coupled proton transport,BP,
5650,GO:0015988,1,0.85046397124477,0,28,energy coupled proton transmembrane transport, against electrochemical gradient,BP,
5651,GO:0015990,1,0.996518726057705,0,1,electron transport coupled proton transport,BP,
5652,GO:0015991,1,0.853439794598935,0,27,ATP hydrolysis coupled proton transport,BP,
5653,GO:0016004,1,0.947017578820128,0,9,phospholipase activator activity,MF,
5654,GO:0016005,1,0.986187060014893,0,2,phospholipase A2 activator activity,MF,
5655,GO:0016010,1,0.863671431686147,0,20,dystrophin-associated glycoprotein complex,CC,
5656,GO:0016011,1,0.953432922456408,0,7,dystroglycan complex,CC,
5657,GO:0016012,1,0.96196502827467,0,6,sarcoglycan complex,CC,
5658,GO:0016013,1,0.974547446982524,0,4,syntrophin complex,CC,
5659,GO:0016015,1,0.969808169669501,0,6,morphogen activity,MF,
5660,GO:0016018,1,0.944054405678705,0,10,cyclosporin A binding,MF,
5661,GO:0016019,1,0.991855408350982,0,2,peptidoglycan receptor activity,MF,
5664,GO:0016024,1,0.920896218167761,0,11,CDP-diacylglycerol biosynthetic process,BP,
5665,GO:0016028,1,0.993160859880905,0,1,rhabdomere,CC,
5666,GO:0016031,1,0.993412121398656,0,1,tRNA import into mitochondrion,BP,
5668,GO:0016034,1,0.99583565400703,0,1,maleylacetoacetate isomerase activity,MF,
5669,GO:0016035,1,0.982594892540134,0,2,zeta DNA polymerase complex,CC,
5670,GO:0016036,1,0.994660930931217,0,1,cellular response to phosphate starvation,BP,
5671,GO:0016037,1,0.994063857420126,0,1,light absorption,BP,
5672,GO:0016038,1,0.994063857420126,0,1,absorption of visible light,BP,
5675,GO:0016045,1,0.929190257441867,0,10,detection of bacterium,BP,
5676,GO:0016046,1,0.991186790406003,0,1,detection of fungus,BP,
5677,GO:0016048,1,0.889946730649959,0,18,detection of temperature stimulus,BP,
5681,GO:0016052,1,0.334619085054561,0,163,carbohydrate catabolic process,BP,
5685,GO:0016056,1,0.868017348397171,0,23,rhodopsin mediated signaling pathway,BP,
5686,GO:0016062,1,0.994298643242403,0,1,adaptation of rhodopsin mediated signaling,BP,
5687,GO:0016064,1,0.58076657691202,0,90,immunoglobulin mediated immune response,BP,
5688,GO:0016068,1,0.98654886222847,0,3,type I hypersensitivity,BP,
5691,GO:0016072,1,0.221111234842118,0,279,rRNA metabolic process,BP,
5692,GO:0016073,1,0.614456316868736,0,84,snRNA metabolic process,BP,
5693,GO:0016074,1,0.945497591497815,0,12,snoRNA metabolic process,BP,
5694,GO:0016075,1,0.910478653856325,0,16,rRNA catabolic process,BP,
5695,GO:0016077,1,0.990809253553117,0,1,snoRNA catabolic process,BP,
5696,GO:0016078,1,0.970614669309392,0,6,tRNA catabolic process,BP,
5698,GO:0016080,1,0.967934509553944,0,4,synaptic vesicle targeting,BP,
5701,GO:0016093,1,0.958536104271492,0,8,polyprenol metabolic process,BP,
5702,GO:0016094,1,0.979844670357749,0,3,polyprenol biosynthetic process,BP,
5703,GO:0016095,1,0.985736673052664,0,3,polyprenol catabolic process,BP,
5704,GO:0016098,1,0.990963381811312,0,2,monoterpenoid metabolic process,BP,
5705,GO:0016101,1,0.609617673360812,0,77,diterpenoid metabolic process,BP,
5706,GO:0016102,1,0.951447373305162,0,9,diterpenoid biosynthetic process,BP,
5707,GO:0016103,1,0.983692065189592,0,3,diterpenoid catabolic process,BP,
5708,GO:0016107,1,0.991500229136624,0,2,sesquiterpenoid catabolic process,BP,
5709,GO:0016108,1,0.982357839245915,0,3,tetraterpenoid metabolic process,BP,
5710,GO:0016109,1,0.994238094890298,0,1,tetraterpenoid biosynthetic process,BP,
5711,GO:0016114,1,0.924810806819417,0,14,terpenoid biosynthetic process,BP,
5712,GO:0016115,1,0.975329522201176,0,5,terpenoid catabolic process,BP,
5713,GO:0016116,1,0.982357839245915,0,3,carotenoid metabolic process,BP,
5714,GO:0016117,1,0.994238094890298,0,1,carotenoid biosynthetic process,BP,
5715,GO:0016119,1,0.98805158842378,0,2,carotene metabolic process,BP,
5716,GO:0016121,1,0.993961306708447,0,1,carotene catabolic process,BP,
5717,GO:0016122,1,0.988233846390404,0,2,xanthophyll metabolic process,BP,
5718,GO:0016123,1,0.994238094890298,0,1,xanthophyll biosynthetic process,BP,
5719,GO:0016125,1,0.415996886228894,0,134,sterol metabolic process,BP,
5720,GO:0016126,1,0.640978338597287,0,68,sterol biosynthetic process,BP,
5721,GO:0016127,1,0.949764744084981,0,9,sterol catabolic process,BP,
5722,GO:0016128,1,0.983966241296189,0,3,phytosteroid metabolic process,BP,
5723,GO:0016129,1,0.983966241296189,0,3,phytosteroid biosynthetic process,BP,
5724,GO:0016131,1,0.99419280488058,0,1,brassinosteroid metabolic process,BP,
5725,GO:0016132,1,0.99419280488058,0,1,brassinosteroid biosynthetic process,BP,
5726,GO:0016137,1,0.918051588928532,0,17,glycoside metabolic process,BP,
5727,GO:0016139,1,0.956652827414917,0,8,glycoside catabolic process,BP,
5728,GO:0016149,1,0.993111709046837,0,1,translation release factor activity, codon specific,MF,
5729,GO:0016150,1,0.995482929907883,0,1,translation release factor activity, codon nonspecific,MF,
5730,GO:0016151,1,0.990055870288832,0,2,nickel cation binding,MF,
5731,GO:0016153,1,0.993424549359064,0,1,urocanate hydratase activity,MF,
5732,GO:0016154,1,0.995429939945863,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
5733,GO:0016155,1,0.983077232840061,0,2,formyltetrahydrofolate dehydrogenase activity,MF,
5734,GO:0016160,1,0.980674139634998,0,3,amylase activity,MF,
5735,GO:0016165,1,0.988798860948403,0,2,linoleate 13S-lipoxygenase activity,MF,
5736,GO:0016167,1,0.981652715369907,0,2,glial cell-derived neurotrophic factor receptor activity,MF,
5737,GO:0016174,1,0.956159373797824,0,6,NAD(P)H oxidase activity,MF,
5738,GO:0016175,1,0.954727911833486,0,8,superoxide-generating NADPH oxidase activity,MF,
5739,GO:0016176,1,0.947697237235848,0,8,superoxide-generating NADPH oxidase activator activity,MF,
5740,GO:0016180,1,0.87159653757342,0,23,snRNA processing,BP,
5741,GO:0016182,1,0.992005305754115,0,1,synaptic vesicle budding from endosome,BP,
5744,GO:0016189,1,0.988889081404865,0,1,synaptic vesicle to endosome fusion,BP,
5745,GO:0016191,1,0.962236867904262,0,5,synaptic vesicle uncoating,BP,
5748,GO:0016198,1,0.95548059228691,0,6,axon choice point recognition,BP,
5749,GO:0016199,1,0.966373765877905,0,4,axon midline choice point recognition,BP,
5751,GO:0016206,1,0.988441639088164,0,2,catechol O-methyltransferase activity,MF,
5752,GO:0016208,1,0.947298843918669,0,10,AMP binding,MF,
5753,GO:0016209,1,0.693229815369665,0,71,antioxidant activity,MF,
5754,GO:0016211,1,0.983936991387591,0,2,ammonia ligase activity,MF,
5755,GO:0016212,1,0.98918226350021,0,2,kynurenine-oxoglutarate transaminase activity,MF,
5756,GO:0016213,1,0.993642001084221,0,1,linoleoyl-CoA desaturase activity,MF,
5757,GO:0016215,1,0.979415978018727,0,3,acyl-CoA desaturase activity,MF,
5758,GO:0016222,1,0.988277149751096,0,2,procollagen-proline 4-dioxygenase complex,CC,
5759,GO:0016226,1,0.902673523195801,0,20,iron-sulfur cluster assembly,BP,
5760,GO:0016229,1,0.888971276594874,0,25,steroid dehydrogenase activity,MF,
5761,GO:0016230,1,0.989033106166228,0,2,sphingomyelin phosphodiesterase activator activity,MF,
5762,GO:0016231,1,0.991700193847049,0,1,beta-N-acetylglucosaminidase activity,MF,
5763,GO:0016232,1,0.994008319935128,0,1,HNK-1 sulfotransferase activity,MF,
5764,GO:0016233,1,0.752849803037338,0,42,telomere capping,BP,
5766,GO:0016235,1,0.749749006945961,0,41,aggresome,CC,
5768,GO:0016237,1,0.991856914529987,0,1,lysosomal microautophagy,BP,
5769,GO:0016239,1,0.651111921682193,0,58,positive regulation of macroautophagy,BP,
5770,GO:0016240,1,0.973402596068108,0,4,autophagosome membrane docking,BP,
5773,GO:0016243,1,0.992810666932176,0,1,regulation of autophagosome size,BP,
5774,GO:0016246,1,0.90177488743767,0,15,RNA interference,BP,
5776,GO:0016248,1,0.80980468855241,0,32,channel inhibitor activity,MF,
5777,GO:0016250,1,0.994061576481446,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5778,GO:0016254,1,0.917327633151905,0,16,preassembly of GPI anchor in ER membrane,BP,
5779,GO:0016255,1,0.953676539174238,0,7,attachment of GPI anchor to protein,BP,
5780,GO:0016256,1,0.98718456926942,0,2,N-glycan processing to lysosome,BP,
5781,GO:0016259,1,0.97545895673795,0,4,selenocysteine metabolic process,BP,
5782,GO:0016260,1,0.988957602047516,0,2,selenocysteine biosynthetic process,BP,
5783,GO:0016262,1,0.980688617746804,0,3,protein N-acetylglucosaminyltransferase activity,MF,
5784,GO:0016263,1,0.990349037616492,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5785,GO:0016264,1,0.935867445085799,0,10,gap junction assembly,BP,
5786,GO:0016266,1,0.701592024227739,0,50,O-glycan processing,BP,
5787,GO:0016267,1,0.990349037616492,0,2,O-glycan processing, core 1,BP,
5788,GO:0016272,1,0.973440295476717,0,7,prefoldin complex,CC,
5789,GO:0016273,1,0.935162453736685,0,12,arginine N-methyltransferase activity,MF,
5790,GO:0016274,1,0.935162453736685,0,12,protein-arginine N-methyltransferase activity,MF,
5791,GO:0016277,1,0.994494674458398,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
5792,GO:0016278,1,0.691972727355524,0,51,lysine N-methyltransferase activity,MF,
5793,GO:0016279,1,0.696126503328187,0,50,protein-lysine N-methyltransferase activity,MF,
5794,GO:0016281,1,0.942782698813167,0,9,eukaryotic translation initiation factor 4F complex,CC,
5795,GO:0016282,1,0.992334906789397,0,1,eukaryotic 43S preinitiation complex,CC,
5796,GO:0016286,1,0.978439259065122,0,4,small conductance calcium-activated potassium channel activity,MF,
5797,GO:0016287,1,0.994152543346253,0,1,glycerone-phosphate O-acyltransferase activity,MF,
5798,GO:0016289,1,0.916876979760612,0,17,CoA hydrolase activity,MF,
5799,GO:0016290,1,0.95564059771895,0,9,palmitoyl-CoA hydrolase activity,MF,
5800,GO:0016295,1,0.983814502525686,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5801,GO:0016296,1,0.983814502525686,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5802,GO:0016297,1,0.983814502525686,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
5804,GO:0016300,1,0.980560884784408,0,3,tRNA (uracil) methyltransferase activity,MF,
5806,GO:0016303,1,0.751122255722963,0,37,1-phosphatidylinositol-3-kinase activity,MF,
5807,GO:0016307,1,0.893135416886911,0,15,phosphatidylinositol phosphate kinase activity,MF,
5808,GO:0016308,1,0.959382640708949,0,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
5809,GO:0016309,1,0.986691389742134,0,2,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
5812,GO:0016312,1,0.971630374764635,0,4,inositol bisphosphate phosphatase activity,MF,
5813,GO:0016314,1,0.978623561607359,0,3,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
5814,GO:0016316,1,0.982942945491416,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5815,GO:0016320,1,0.984718289437424,0,2,endoplasmic reticulum membrane fusion,BP,
5816,GO:0016321,1,0.977218130221337,0,4,female meiosis chromosome segregation,BP,
5817,GO:0016322,1,0.937089954207552,0,10,neuron remodeling,BP,
5820,GO:0016327,1,0.90837108215883,0,16,apicolateral plasma membrane,CC,
5821,GO:0016328,1,0.668662758132326,0,56,lateral plasma membrane,CC,
5823,GO:0016332,1,0.99290078771553,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
5824,GO:0016333,1,0.993870517351146,0,1,morphogenesis of follicular epithelium,BP,
5825,GO:0016334,1,0.993870517351146,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
5826,GO:0016338,1,0.907474284032631,0,18,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,
5828,GO:0016340,1,0.980818889774904,0,2,calcium-dependent cell-matrix adhesion,BP,
5829,GO:0016342,1,0.818012349786845,0,28,catenin complex,CC,
5830,GO:0016344,1,0.977575138073401,0,3,meiotic chromosome movement towards spindle pole,BP,
5832,GO:0016361,1,0.970329152680796,0,4,activin receptor activity, type I,MF,
5833,GO:0016362,1,0.971416760213808,0,2,activin receptor activity, type II,MF,
5835,GO:0016401,1,0.973818919420967,0,4,palmitoyl-CoA oxidase activity,MF,
5836,GO:0016402,1,0.988601456337053,0,2,pristanoyl-CoA oxidase activity,MF,
5837,GO:0016403,1,0.98868579563523,0,2,dimethylargininase activity,MF,
5838,GO:0016404,1,0.98647292602917,0,2,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
5839,GO:0016405,1,0.872586630701525,0,22,CoA-ligase activity,MF,
5840,GO:0016406,1,0.962889248940572,0,6,carnitine O-acyltransferase activity,MF,
5841,GO:0016407,1,0.53295707015198,0,94,acetyltransferase activity,MF,
5842,GO:0016408,1,0.908816852042711,0,17,C-acyltransferase activity,MF,
5844,GO:0016410,1,0.54443023268517,0,92,N-acyltransferase activity,MF,
5845,GO:0016411,1,0.86294207253761,0,21,acylglycerol O-acyltransferase activity,MF,
5846,GO:0016413,1,0.95574492418885,0,7,O-acetyltransferase activity,MF,
5847,GO:0016414,1,0.993543625994518,0,1,O-octanoyltransferase activity,MF,
5848,GO:0016415,1,0.989878120616984,0,2,octanoyltransferase activity,MF,
5849,GO:0016416,1,0.967145399948381,0,5,O-palmitoyltransferase activity,MF,
5851,GO:0016418,1,0.981012916623113,0,2,S-acetyltransferase activity,MF,
5852,GO:0016419,1,0.983575507470044,0,2,S-malonyltransferase activity,MF,
5853,GO:0016420,1,0.983575507470044,0,2,malonyltransferase activity,MF,
5854,GO:0016421,1,0.965272081380501,0,5,CoA carboxylase activity,MF,
5855,GO:0016422,1,0.984049818875684,0,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
5856,GO:0016423,1,0.925733473244367,0,13,tRNA (guanine) methyltransferase activity,MF,
5857,GO:0016426,1,0.982908660161923,0,3,tRNA (adenine) methyltransferase activity,MF,
5858,GO:0016427,1,0.947720446548286,0,8,tRNA (cytosine) methyltransferase activity,MF,
5859,GO:0016428,1,0.973814134402424,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
5860,GO:0016429,1,0.982908660161923,0,3,tRNA (adenine-N1-)-methyltransferase activity,MF,
5861,GO:0016433,1,0.968942515060615,0,6,rRNA (adenine) methyltransferase activity,MF,
5862,GO:0016434,1,0.980702903920736,0,3,rRNA (cytosine) methyltransferase activity,MF,
5863,GO:0016435,1,0.98178763553593,0,3,rRNA (guanine) methyltransferase activity,MF,
5864,GO:0016436,1,0.987035318539245,0,2,rRNA (uridine) methyltransferase activity,MF,
5865,GO:0016441,1,0.434598372479242,0,121,posttranscriptional gene silencing,BP,
5866,GO:0016442,1,0.916585468634403,0,11,RISC complex,CC,
5867,GO:0016444,1,0.70128687437427,0,51,somatic cell DNA recombination,BP,
5868,GO:0016445,1,0.72341898555699,0,48,somatic diversification of immunoglobulins,BP,
5869,GO:0016446,1,0.931849767425907,0,11,somatic hypermutation of immunoglobulin genes,BP,
5870,GO:0016447,1,0.748789585599125,0,43,somatic recombination of immunoglobulin gene segments,BP,
5871,GO:0016453,1,0.979821304727205,0,4,C-acetyltransferase activity,MF,
5872,GO:0016454,1,0.966302453287211,0,5,C-palmitoyltransferase activity,MF,
5873,GO:0016458,1,0.23404193279748,0,212,gene silencing,BP,
5874,GO:0016459,1,0.576151047613508,0,64,myosin complex,CC,
5875,GO:0016460,1,0.784753500469647,0,29,myosin II complex,CC,
5876,GO:0016461,1,0.916427652059666,0,10,unconventional myosin complex,CC,
5878,GO:0016469,1,0.861733344868234,0,28,proton-transporting two-sector ATPase complex,CC,
5879,GO:0016471,1,0.917743350921035,0,15,vacuolar proton-transporting V-type ATPase complex,CC,
5880,GO:0016476,1,0.979671852599269,0,3,regulation of embryonic cell shape,BP,
5882,GO:0016479,1,0.971570510892839,0,4,negative regulation of transcription by RNA polymerase I,BP,
5883,GO:0016480,1,0.986036726719975,0,3,negative regulation of transcription by RNA polymerase III,BP,
5884,GO:0016482,1,0.369108863711248,0,136,cytosolic transport,BP,
5887,GO:0016487,1,0.991500229136624,0,2,farnesol metabolic process,BP,
5888,GO:0016488,1,0.991500229136624,0,2,farnesol catabolic process,BP,
5889,GO:0016491,1,0.0236176506558326,0,646,oxidoreductase activity,MF,
5890,GO:0016492,1,0.988222118581948,0,2,G-protein coupled neurotensin receptor activity,MF,
5891,GO:0016493,1,0.946938552984303,0,10,C-C chemokine receptor activity,MF,
5892,GO:0016494,1,0.958112696110371,0,8,C-X-C chemokine receptor activity,MF,
5893,GO:0016495,1,0.993617230502728,0,1,C-X3-C chemokine receptor activity,MF,
5894,GO:0016496,1,0.993541595832212,0,1,substance P receptor activity,MF,
5895,GO:0016497,1,0.994479980796172,0,1,substance K receptor activity,MF,
5896,GO:0016499,1,0.99025117855355,0,2,orexin receptor activity,MF,
5897,GO:0016500,1,0.932594155525345,0,10,protein-hormone receptor activity,MF,
5898,GO:0016501,1,0.988799305091932,0,2,prostacyclin receptor activity,MF,
5899,GO:0016502,1,0.899677733767652,0,20,nucleotide receptor activity,MF,
5900,GO:0016503,1,0.995871891491824,0,1,pheromone receptor activity,MF,
5902,GO:0016505,1,0.898262052097782,0,17,peptidase activator activity involved in apoptotic process,MF,
5903,GO:0016507,1,0.993751896488685,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
5904,GO:0016508,1,0.980924531728606,0,3,long-chain-enoyl-CoA hydratase activity,MF,
5905,GO:0016509,1,0.9829264007334,0,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
5906,GO:0016514,1,0.899154886299656,0,15,SWI/SNF complex,CC,
5907,GO:0016517,1,0.995017291851267,0,1,interleukin-12 receptor activity,MF,
5908,GO:0016519,1,0.99495835748087,0,1,gastric inhibitory peptide receptor activity,MF,
5909,GO:0016520,1,0.988060049878314,0,2,growth hormone-releasing hormone receptor activity,MF,
5910,GO:0016521,1,0.993627020860235,0,1,pituitary adenylate cyclase activating polypeptide activity,MF,
5911,GO:0016525,1,0.543286623880236,0,86,negative regulation of angiogenesis,BP,
5912,GO:0016528,1,0.587099770058908,0,68,sarcoplasm,CC,
5913,GO:0016529,1,0.633145878720587,0,59,sarcoplasmic reticulum,CC,
5914,GO:0016530,1,0.959267102101064,0,7,metallochaperone activity,MF,
5915,GO:0016531,1,0.975081447036989,0,5,copper chaperone activity,MF,
5916,GO:0016532,1,0.981096732326571,0,3,superoxide dismutase copper chaperone activity,MF,
5917,GO:0016533,1,0.983525985538024,0,3,cyclin-dependent protein kinase 5 holoenzyme complex,CC,
5918,GO:0016534,1,0.987406288255042,0,2,cyclin-dependent protein kinase 5 activator activity,MF,
5919,GO:0016538,1,0.854147999337345,0,29,cyclin-dependent protein serine/threonine kinase regulator activity,MF,
5920,GO:0016539,1,0.995539622956947,0,1,intein-mediated protein splicing,BP,
5921,GO:0016540,1,0.921558774311623,0,13,protein autoprocessing,BP,
5922,GO:0016553,1,0.915435455726521,0,14,base conversion or substitution editing,BP,
5923,GO:0016554,1,0.95429035973069,0,9,cytidine to uridine editing,BP,
5924,GO:0016556,1,0.920934292846707,0,15,mRNA modification,BP,
5925,GO:0016557,1,0.985381448074651,0,3,peroxisome membrane biogenesis,BP,
5926,GO:0016558,1,0.929002691063809,0,12,protein import into peroxisome matrix,BP,
5927,GO:0016559,1,0.954523897910161,0,9,peroxisome fission,BP,
5928,GO:0016560,1,0.974479482098154,0,4,protein import into peroxisome matrix, docking,BP,
5929,GO:0016561,1,0.988413152816184,0,2,protein import into peroxisome matrix, translocation,BP,
5931,GO:0016569,1,0.0459520243471402,0,427,covalent chromatin modification,BP,
5932,GO:0016570,1,0.0485590303222127,0,419,histone modification,BP,
5933,GO:0016571,1,0.410357121571071,0,122,histone methylation,BP,
5934,GO:0016572,1,0.800561999022141,0,34,histone phosphorylation,BP,
5935,GO:0016573,1,0.389494845274029,0,137,histone acetylation,BP,
5936,GO:0016574,1,0.730627829201553,0,43,histone ubiquitination,BP,
5937,GO:0016575,1,0.555427254090406,0,83,histone deacetylation,BP,
5938,GO:0016576,1,0.960452149688329,0,6,histone dephosphorylation,BP,
5939,GO:0016577,1,0.795577300513919,0,27,histone demethylation,BP,
5940,GO:0016578,1,0.857227886839916,0,22,histone deubiquitination,BP,
5941,GO:0016579,1,0.181761736873675,0,249,protein deubiquitination,BP,
5942,GO:0016580,1,0.913146962911325,0,12,Sin3 complex,CC,
5943,GO:0016581,1,0.870218280959724,0,17,NuRD complex,CC,
5944,GO:0016584,1,0.962720524719628,0,7,nucleosome positioning,BP,
5945,GO:0016586,1,0.981753869698743,0,2,RSC-type complex,CC,
5946,GO:0016589,1,0.946460876503739,0,7,NURF complex,CC,
5947,GO:0016590,1,0.990848766051476,0,1,ACF complex,CC,
5948,GO:0016591,1,0.503680748764231,0,107,DNA-directed RNA polymerase II, holoenzyme,CC,
5949,GO:0016592,1,0.782552323710193,0,36,mediator complex,CC,
5950,GO:0016593,1,0.944668464766104,0,8,Cdc73/Paf1 complex,CC,
5953,GO:0016596,1,0.994054740756748,0,1,thienylcyclohexylpiperidine binding,MF,
5955,GO:0016598,1,0.989964870201914,0,2,protein arginylation,BP,
5956,GO:0016600,1,0.93078480252218,0,9,flotillin complex,CC,
5957,GO:0016601,1,0.771783102497094,0,37,Rac protein signal transduction,BP,
5958,GO:0016602,1,0.975194811984514,0,4,CCAAT-binding factor complex,CC,
5959,GO:0016603,1,0.990193066311805,0,2,glutaminyl-peptide cyclotransferase activity,MF,
5963,GO:0016608,1,0.993556853215441,0,2,growth hormone-releasing hormone activity,MF,
5964,GO:0016614,1,0.520777205141408,0,118,oxidoreductase activity, acting on CH-OH group of donors,MF,
5965,GO:0016615,1,0.962358449040874,0,7,malate dehydrogenase activity,MF,
5966,GO:0016616,1,0.574193900458873,0,104,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
5967,GO:0016618,1,0.983905459714775,0,3,hydroxypyruvate reductase activity,MF,
5968,GO:0016620,1,0.822004068423254,0,32,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,
5969,GO:0016623,1,0.987228204728047,0,2,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
5970,GO:0016624,1,0.952681499465579,0,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,
5971,GO:0016627,1,0.732869044637476,0,54,oxidoreductase activity, acting on the CH-CH group of donors,MF,
5972,GO:0016628,1,0.877614225965393,0,24,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,
5973,GO:0016634,1,0.952367999339078,0,8,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,
5974,GO:0016635,1,0.975651288628942,0,5,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,
5975,GO:0016638,1,0.883003058479005,0,21,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,
5976,GO:0016639,1,0.983776906189421,0,3,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
5977,GO:0016641,1,0.90727036434055,0,16,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,
5978,GO:0016642,1,0.992981218339583,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
5979,GO:0016645,1,0.864539257145984,0,24,oxidoreductase activity, acting on the CH-NH group of donors,MF,
5980,GO:0016646,1,0.904684063240919,0,16,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,
5981,GO:0016647,1,0.984848958155656,0,3,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
5982,GO:0016649,1,0.988142663657786,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
5983,GO:0016651,1,0.617009648925109,0,98,oxidoreductase activity, acting on NAD(P)H,MF,
5984,GO:0016652,1,0.988337441598686,0,2,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
5985,GO:0016653,1,0.91709729074331,0,13,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,
5986,GO:0016655,1,0.810252953008677,0,52,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,
5987,GO:0016657,1,0.990782325803101,0,2,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
5988,GO:0016661,1,0.9713308850417,0,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,
5989,GO:0016662,1,0.994255839328277,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
5990,GO:0016667,1,0.750964856098027,0,53,oxidoreductase activity, acting on a sulfur group of donors,MF,
5991,GO:0016668,1,0.934465249199793,0,13,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,
5992,GO:0016670,1,0.949571096359703,0,8,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
5993,GO:0016671,1,0.945650930050434,0,11,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,
5994,GO:0016672,1,0.992180086409795,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
5995,GO:0016675,1,0.913591529245522,0,23,oxidoreductase activity, acting on a heme group of donors,MF,
5996,GO:0016676,1,0.918771387467436,0,22,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,
5997,GO:0016679,1,0.963254998857396,0,8,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
5998,GO:0016681,1,0.968829923556203,0,7,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
5999,GO:0016684,1,0.802418242230096,0,42,oxidoreductase activity, acting on peroxide as acceptor,MF,
6000,GO:0016701,1,0.873916816052626,0,25,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,
6001,GO:0016702,1,0.873916816052626,0,25,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,
6002,GO:0016705,1,0.436236956900682,0,130,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,
6003,GO:0016706,1,0.750771579125695,0,41,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,
6004,GO:0016708,1,0.989458140959411,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
6005,GO:0016709,1,0.802575478925375,0,36,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,
6006,GO:0016711,1,0.994247551829149,0,1,flavonoid 3'-monooxygenase activity,MF,
6007,GO:0016712,1,0.900490699433219,0,19,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,
6008,GO:0016713,1,0.990398144966553,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,MF,
6009,GO:0016714,1,0.964424432002375,0,7,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
6010,GO:0016715,1,0.973927452652586,0,4,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
6011,GO:0016717,1,0.966197064671828,0,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
6012,GO:0016721,1,0.978914926690751,0,5,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,
6013,GO:0016722,1,0.89451081849293,0,16,oxidoreductase activity, oxidizing metal ions,MF,
6014,GO:0016723,1,0.935290525922111,0,10,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,
6015,GO:0016724,1,0.961664891958289,0,5,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,
6016,GO:0016725,1,0.952574226832482,0,7,oxidoreductase activity, acting on CH or CH2 groups,MF,
6017,GO:0016726,1,0.983029835828362,0,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,
6018,GO:0016727,1,0.99108623694053,0,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,
6019,GO:0016728,1,0.979091393063358,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
6020,GO:0016730,1,0.995129621674049,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
6021,GO:0016731,1,0.995129621674049,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
6023,GO:0016741,1,0.292162143279761,0,194,transferase activity, transferring one-carbon groups,MF,
6024,GO:0016742,1,0.950649015419079,0,8,hydroxymethyl-, formyl- and related transferase activity,MF,
6025,GO:0016743,1,0.976421439360771,0,3,carboxyl- or carbamoyltransferase activity,MF,
6026,GO:0016744,1,0.98509573193415,0,3,transferase activity, transferring aldehyde or ketonic groups,MF,
6029,GO:0016748,1,0.983596709120631,0,3,succinyltransferase activity,MF,
6030,GO:0016749,1,0.989566415522704,0,2,N-succinyltransferase activity,MF,
6031,GO:0016751,1,0.993967989184179,0,1,S-succinyltransferase activity,MF,
6032,GO:0016755,1,0.933722936565965,0,12,transferase activity, transferring amino-acyl groups,MF,
6034,GO:0016758,1,0.329178864651754,0,175,transferase activity, transferring hexosyl groups,MF,
6035,GO:0016763,1,0.757682489603591,0,44,transferase activity, transferring pentosyl groups,MF,
6036,GO:0016765,1,0.755379682438122,0,54,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,
6037,GO:0016768,1,0.995389515848887,0,1,spermine synthase activity,MF,
6041,GO:0016774,1,0.982796477018871,0,3,phosphotransferase activity, carboxyl group as acceptor,MF,
6042,GO:0016775,1,0.924620881033482,0,12,phosphotransferase activity, nitrogenous group as acceptor,MF,
6044,GO:0016778,1,0.973637432432429,0,5,diphosphotransferase activity,MF,
6045,GO:0016779,1,0.435137845894889,0,132,nucleotidyltransferase activity,MF,
6046,GO:0016780,1,0.895818000755655,0,18,phosphotransferase activity, for other substituted phosphate groups,MF,
6047,GO:0016781,1,0.988957602047516,0,2,phosphotransferase activity, paired acceptors,MF,
6049,GO:0016783,1,0.945560539353051,0,12,sulfurtransferase activity,MF,
6050,GO:0016784,1,0.995664688661669,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6051,GO:0016785,1,0.991183800886234,0,1,transferase activity, transferring selenium-containing groups,MF,
6054,GO:0016790,1,0.840028010741384,0,32,thiolester hydrolase activity,MF,
6056,GO:0016793,1,0.993596680715339,0,1,triphosphoric monoester hydrolase activity,MF,
6057,GO:0016794,1,0.996204281272632,0,1,diphosphoric monoester hydrolase activity,MF,
6058,GO:0016796,1,0.719873270785823,0,50,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6060,GO:0016799,1,0.891381441364782,0,22,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,
6061,GO:0016801,1,0.923729949999721,0,14,hydrolase activity, acting on ether bonds,MF,
6062,GO:0016802,1,0.979327849211577,0,3,trialkylsulfonium hydrolase activity,MF,
6063,GO:0016803,1,0.943240150921154,0,11,ether hydrolase activity,MF,
6064,GO:0016805,1,0.909787531286663,0,16,dipeptidase activity,MF,
6065,GO:0016807,1,0.994054740756748,0,1,cysteine-type carboxypeptidase activity,MF,
6066,GO:0016810,1,0.42615300336095,0,137,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,
6067,GO:0016811,1,0.590799369755715,0,84,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,
6068,GO:0016812,1,0.949867421496511,0,7,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
6069,GO:0016813,1,0.944875838928802,0,10,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,
6070,GO:0016814,1,0.836441417367784,0,30,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,
6071,GO:0016815,1,0.99580314065602,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
6074,GO:0016822,1,0.986801350158388,0,3,hydrolase activity, acting on acid carbon-carbon bonds,MF,
6075,GO:0016823,1,0.986801350158388,0,3,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
6076,GO:0016826,1,0.994061576481446,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
6078,GO:0016830,1,0.763964053404672,0,47,carbon-carbon lyase activity,MF,
6079,GO:0016831,1,0.83085052225642,0,32,carboxy-lyase activity,MF,
6080,GO:0016832,1,0.955928157245095,0,8,aldehyde-lyase activity,MF,
6081,GO:0016833,1,0.964634651850179,0,6,oxo-acid-lyase activity,MF,
6082,GO:0016835,1,0.696139230047149,0,66,carbon-oxygen lyase activity,MF,
6083,GO:0016836,1,0.769872713337964,0,48,hydro-lyase activity,MF,
6084,GO:0016838,1,0.985319210858045,0,3,carbon-oxygen lyase activity, acting on phosphates,MF,
6085,GO:0016840,1,0.935852929195784,0,13,carbon-nitrogen lyase activity,MF,
6086,GO:0016841,1,0.974686981197702,0,5,ammonia-lyase activity,MF,
6087,GO:0016842,1,0.965912145580967,0,7,amidine-lyase activity,MF,
6088,GO:0016843,1,0.994054740756748,0,1,amine-lyase activity,MF,
6089,GO:0016844,1,0.994054740756748,0,1,strictosidine synthase activity,MF,
6090,GO:0016846,1,0.962282162592195,0,9,carbon-sulfur lyase activity,MF,
6093,GO:0016854,1,0.911197674605103,0,16,racemase and epimerase activity,MF,
6094,GO:0016855,1,0.994402058223341,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
6095,GO:0016857,1,0.932144307716867,0,11,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,
6096,GO:0016859,1,0.835708518390384,0,33,cis-trans isomerase activity,MF,
6097,GO:0016860,1,0.790470564714682,0,43,intramolecular oxidoreductase activity,MF,
6098,GO:0016861,1,0.961276139986779,0,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
6099,GO:0016862,1,0.993509208685174,0,2,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
6100,GO:0016863,1,0.953175277820304,0,10,intramolecular oxidoreductase activity, transposing C=C bonds,MF,
6101,GO:0016864,1,0.897904111336772,0,17,intramolecular oxidoreductase activity, transposing S-S bonds,MF,
6102,GO:0016866,1,0.858999481021348,0,27,intramolecular transferase activity,MF,
6103,GO:0016868,1,0.939323803121702,0,11,intramolecular transferase activity, phosphotransferases,MF,
6104,GO:0016872,1,0.994669030573683,0,1,intramolecular lyase activity,MF,
6105,GO:0016874,1,0.385731097528978,0,150,ligase activity,MF,
6106,GO:0016875,1,0.770339821549192,0,44,ligase activity, forming carbon-oxygen bonds,MF,
6107,GO:0016877,1,0.800437481073249,0,36,ligase activity, forming carbon-sulfur bonds,MF,
6108,GO:0016878,1,0.853734971781902,0,26,acid-thiol ligase activity,MF,
6109,GO:0016879,1,0.725994491666776,0,48,ligase activity, forming carbon-nitrogen bonds,MF,
6110,GO:0016880,1,0.978086277204387,0,3,acid-ammonia (or amide) ligase activity,MF,
6111,GO:0016881,1,0.888025499120095,0,19,acid-amino acid ligase activity,MF,
6112,GO:0016882,1,0.989775544265827,0,2,cyclo-ligase activity,MF,
6113,GO:0016884,1,0.935731573386124,0,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
6114,GO:0016885,1,0.953353177085821,0,7,ligase activity, forming carbon-carbon bonds,MF,
6115,GO:0016886,1,0.941690566737913,0,10,ligase activity, forming phosphoric ester bonds,MF,
6117,GO:0016888,1,0.933988329446465,0,10,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6118,GO:0016889,1,0.900292521375513,0,20,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,
6119,GO:0016890,1,0.9880735995435,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
6120,GO:0016891,1,0.857245609665005,0,27,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
6121,GO:0016892,1,0.964656408398233,0,8,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
6122,GO:0016893,1,0.820482721092638,0,34,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6123,GO:0016894,1,0.868439703894141,0,28,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,
6124,GO:0016895,1,0.891667507998974,0,19,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6125,GO:0016896,1,0.804549486167407,0,32,exoribonuclease activity, producing 5'-phosphomonoesters,MF,
6126,GO:0016898,1,0.989250181174096,0,2,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
6127,GO:0016899,1,0.979235324403141,0,3,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
6128,GO:0016900,1,0.992424390047039,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
6129,GO:0016901,1,0.984903368380188,0,2,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
6130,GO:0016903,1,0.777149705162274,0,41,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,
6132,GO:0016909,1,0.981184082209509,0,3,SAP kinase activity,MF,
6134,GO:0016918,1,0.93889891289634,0,13,retinal binding,MF,
6135,GO:0016920,1,0.989781051568129,0,1,pyroglutamyl-peptidase activity,MF,
6136,GO:0016922,1,0.845514067378865,0,21,ligand-dependent nuclear receptor binding,MF,
6138,GO:0016926,1,0.950198894132451,0,7,protein desumoylation,BP,
6139,GO:0016929,1,0.954581525892477,0,6,SUMO-specific protease activity,MF,
6140,GO:0016933,1,0.971291328183301,0,5,extracellularly glycine-gated ion channel activity,MF,
6141,GO:0016934,1,0.971291328183301,0,5,extracellularly glycine-gated chloride channel activity,MF,
6142,GO:0016935,1,0.986980485601734,0,2,glycine-gated chloride channel complex,CC,
6143,GO:0016936,1,0.982951154846099,0,4,galactoside binding,MF,
6144,GO:0016938,1,0.993857475856426,0,1,kinesin I complex,CC,
6145,GO:0016939,1,0.975305611298981,0,3,kinesin II complex,CC,
6146,GO:0016941,1,0.980305160618225,0,3,natriuretic peptide receptor activity,MF,
6147,GO:0016942,1,0.966098864858599,0,5,insulin-like growth factor binding protein complex,CC,
6148,GO:0016964,1,0.983002221950436,0,1,alpha-2 macroglobulin receptor activity,MF,
6149,GO:0016971,1,0.980765835508714,0,3,flavin-linked sulfhydryl oxidase activity,MF,
6150,GO:0016972,1,0.972994530029986,0,4,thiol oxidase activity,MF,
6151,GO:0016973,1,0.930369239386898,0,12,poly(A)+ mRNA export from nucleus,BP,
6152,GO:0016979,1,0.995741800651002,0,1,lipoate-protein ligase activity,MF,
6153,GO:0016990,1,0.994652836670812,0,1,arginine deiminase activity,MF,
6154,GO:0016992,1,0.995411628283286,0,1,lipoate synthase activity,MF,
6155,GO:0016997,1,0.972910291912067,0,5,alpha-sialidase activity,MF,
6156,GO:0016998,1,0.982067331603382,0,4,cell wall macromolecule catabolic process,BP,
6157,GO:0016999,1,0.50058141958586,0,124,antibiotic metabolic process,BP,
6158,GO:0017000,1,0.905328705254057,0,15,antibiotic biosynthetic process,BP,
6159,GO:0017001,1,0.803202306863806,0,43,antibiotic catabolic process,BP,
6160,GO:0017002,1,0.934648443727226,0,7,activin-activated receptor activity,MF,
6161,GO:0017003,1,0.994637907871476,0,1,protein-heme linkage,BP,
6162,GO:0017004,1,0.826275439645942,0,34,cytochrome complex assembly,BP,
6163,GO:0017005,1,0.993156033822864,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
6164,GO:0017006,1,0.994637907871476,0,1,protein-tetrapyrrole linkage,BP,
6165,GO:0017014,1,0.911597301910037,0,13,protein nitrosylation,BP,
6166,GO:0017015,1,0.488964200394596,0,98,regulation of transforming growth factor beta receptor signaling pathway,BP,
6168,GO:0017017,1,0.937497387639978,0,11,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,
6169,GO:0017018,1,0.96482557818891,0,4,myosin phosphatase activity,MF,
6170,GO:0017020,1,0.993950748745565,0,1,myosin phosphatase regulator activity,MF,
6171,GO:0017022,1,0.670350388819734,0,58,myosin binding,MF,
6172,GO:0017024,1,0.996387680911386,0,1,myosin I binding,MF,
6173,GO:0017025,1,0.857613751632915,0,25,TBP-class protein binding,MF,
6174,GO:0017034,1,0.9576464441306,0,5,Rap guanyl-nucleotide exchange factor activity,MF,
6175,GO:0017038,1,0.309829199752356,0,179,protein import,BP,
6176,GO:0017040,1,0.972251167272598,0,5,N-acylsphingosine amidohydrolase activity,MF,
6177,GO:0017042,1,0.995400257842171,0,1,glycosylceramidase activity,MF,
6178,GO:0017045,1,0.99591309289349,0,1,corticotropin-releasing hormone activity,MF,
6179,GO:0017046,1,0.789458085706691,0,36,peptide hormone binding,MF,
6181,GO:0017049,1,0.875085560880743,0,20,GTP-Rho binding,MF,
6182,GO:0017050,1,0.989045960494139,0,2,D-erythro-sphingosine kinase activity,MF,
6183,GO:0017053,1,0.534978823129895,0,82,transcriptional repressor complex,CC,
6184,GO:0017055,1,0.987882251701889,0,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
6185,GO:0017056,1,0.84495193599484,0,23,structural constituent of nuclear pore,MF,
6186,GO:0017057,1,0.984150453867286,0,2,6-phosphogluconolactonase activity,MF,
6187,GO:0017059,1,0.952397797153031,0,8,serine C-palmitoyltransferase complex,CC,
6188,GO:0017060,1,0.983572665819377,0,3,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
6189,GO:0017061,1,0.991910741310349,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
6190,GO:0017062,1,0.948025607121719,0,9,respiratory chain complex III assembly,BP,
6191,GO:0017064,1,0.989872721077164,0,2,fatty acid amide hydrolase activity,MF,
6192,GO:0017065,1,0.995545917056036,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
6193,GO:0017069,1,0.806002145520276,0,38,snRNA binding,MF,
6194,GO:0017070,1,0.939714578676941,0,11,U6 snRNA binding,MF,
6195,GO:0017071,1,0.993144940283719,0,1,intracellular cyclic nucleotide activated cation channel complex,CC,
6198,GO:0017077,1,0.99005346528372,0,2,oxidative phosphorylation uncoupler activity,MF,
6200,GO:0017081,1,0.900583129340128,0,16,chloride channel regulator activity,MF,
6201,GO:0017082,1,0.994054740756748,0,1,mineralocorticoid receptor activity,MF,
6202,GO:0017084,1,0.993324266516756,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
6203,GO:0017085,1,0.904808760474132,0,16,response to insecticide,BP,
6204,GO:0017087,1,0.992886420826233,0,1,mitochondrial processing peptidase complex,CC,
6205,GO:0017089,1,0.989604752123979,0,2,glycolipid transporter activity,MF,
6206,GO:0017090,1,0.993873239431714,0,1,meprin A complex,CC,
6207,GO:0017091,1,0.859798937622982,0,24,AU-rich element binding,MF,
6208,GO:0017095,1,0.974505604337566,0,3,heparan sulfate 6-O-sulfotransferase activity,MF,
6209,GO:0017098,1,0.988881100261422,0,2,sulfonylurea receptor binding,MF,
6210,GO:0017099,1,0.978384243093799,0,4,very-long-chain-acyl-CoA dehydrogenase activity,MF,
6211,GO:0017101,1,0.931409951852206,0,12,aminoacyl-tRNA synthetase multienzyme complex,CC,
6212,GO:0017102,1,0.987987223145299,0,2,methionyl glutamyl tRNA synthetase complex,CC,
6213,GO:0017108,1,0.969625665567157,0,5,5'-flap endonuclease activity,MF,
6214,GO:0017109,1,0.986845598664973,0,2,glutamate-cysteine ligase complex,CC,
6215,GO:0017110,1,0.918983579781104,0,13,nucleoside-diphosphatase activity,MF,
6217,GO:0017112,1,0.694859813128022,0,51,Rab guanyl-nucleotide exchange factor activity,MF,
6218,GO:0017113,1,0.993673140428983,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
6219,GO:0017116,1,0.979941849372481,0,3,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
6220,GO:0017119,1,0.920380960597386,0,13,Golgi transport complex,CC,
6221,GO:0017121,1,0.937628973728402,0,10,phospholipid scrambling,BP,
6222,GO:0017124,1,0.414204030664645,0,121,SH3 domain binding,MF,
6223,GO:0017125,1,0.992082302421121,0,1,deoxycytidyl transferase activity,MF,
6224,GO:0017126,1,0.991498803696885,0,1,nucleologenesis,BP,
6225,GO:0017127,1,0.907314579978116,0,15,cholesterol transporter activity,MF,
6226,GO:0017128,1,0.948551489156374,0,8,phospholipid scramblase activity,MF,
6227,GO:0017129,1,0.988431318738982,0,2,triglyceride binding,MF,
6228,GO:0017130,1,0.990028927438995,0,1,poly(C) RNA binding,MF,
6229,GO:0017133,1,0.994556158930941,0,1,mitochondrial electron transfer flavoprotein complex,CC,
6230,GO:0017134,1,0.861296095695252,0,21,fibroblast growth factor binding,MF,
6231,GO:0017136,1,0.898621645618544,0,16,NAD-dependent histone deacetylase activity,MF,
6233,GO:0017143,1,0.988455983083352,0,2,insecticide metabolic process,BP,
6239,GO:0017150,1,0.979373710672435,0,4,tRNA dihydrouridine synthase activity,MF,
6240,GO:0017151,1,0.946707923814368,0,8,DEAD/H-box RNA helicase binding,MF,
6241,GO:0017153,1,0.938109256118217,0,9,sodium:dicarboxylate symporter activity,MF,
6242,GO:0017154,1,0.899977557036125,0,11,semaphorin receptor activity,MF,
6246,GO:0017159,1,0.983415233116959,0,3,pantetheine hydrolase activity,MF,
6247,GO:0017160,1,0.889459472362157,0,16,Ral GTPase binding,MF,
6248,GO:0017161,1,0.982942945491416,0,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,
6249,GO:0017162,1,0.936476752665822,0,9,aryl hydrocarbon receptor binding,MF,
6250,GO:0017166,1,0.914844773453322,0,10,vinculin binding,MF,
6251,GO:0017168,1,0.992783763344201,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
6252,GO:0017169,1,0.963610844491377,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
6254,GO:0017172,1,0.995491754334154,0,1,cysteine dioxygenase activity,MF,
6255,GO:0017174,1,0.996172004921414,0,1,glycine N-methyltransferase activity,MF,
6256,GO:0017176,1,0.967481909847262,0,7,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,
6257,GO:0017177,1,0.992905575990772,0,1,glucosidase II complex,CC,
6258,GO:0017178,1,0.994054740756748,0,1,diphthine-ammonia ligase activity,MF,
6259,GO:0017182,1,0.954089412208797,0,8,peptidyl-diphthamide metabolic process,BP,
6260,GO:0017183,1,0.954089412208797,0,8,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
6261,GO:0017185,1,0.950985174140272,0,8,peptidyl-lysine hydroxylation,BP,
6262,GO:0017186,1,0.990193066311805,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
6263,GO:0017187,1,0.96130559294655,0,8,peptidyl-glutamic acid carboxylation,BP,
6264,GO:0017188,1,0.990967064976562,0,1,aspartate N-acetyltransferase activity,MF,
6265,GO:0017196,1,0.960701453944621,0,6,N-terminal peptidyl-methionine acetylation,BP,
6266,GO:0017198,1,0.992032038177108,0,2,N-terminal peptidyl-serine acetylation,BP,
6267,GO:0018002,1,0.992032038177108,0,2,N-terminal peptidyl-glutamic acid acetylation,BP,
6268,GO:0018008,1,0.983830838874912,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
6269,GO:0018009,1,0.994828232067724,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
6270,GO:0018011,1,0.994054740756748,0,1,N-terminal peptidyl-alanine methylation,BP,
6271,GO:0018012,1,0.994054740756748,0,1,N-terminal peptidyl-alanine trimethylation,BP,
6272,GO:0018013,1,0.994054740756748,0,1,N-terminal peptidyl-glycine methylation,BP,
6273,GO:0018016,1,0.994054740756748,0,1,N-terminal peptidyl-proline dimethylation,BP,
6274,GO:0018022,1,0.462475729179843,0,104,peptidyl-lysine methylation,BP,
6275,GO:0018023,1,0.777977326873162,0,35,peptidyl-lysine trimethylation,BP,
6276,GO:0018024,1,0.73601343873201,0,41,histone-lysine N-methyltransferase activity,MF,
6277,GO:0018025,1,0.994054740756748,0,1,calmodulin-lysine N-methyltransferase activity,MF,
6278,GO:0018026,1,0.945578604202491,0,8,peptidyl-lysine monomethylation,BP,
6279,GO:0018027,1,0.899315395521088,0,15,peptidyl-lysine dimethylation,BP,
6280,GO:0018032,1,0.993074700335626,0,1,protein amidation,BP,
6281,GO:0018057,1,0.974099890293725,0,4,peptidyl-lysine oxidation,BP,
6282,GO:0018063,1,0.994637907871476,0,1,cytochrome c-heme linkage,BP,
6283,GO:0018065,1,0.951001267109648,0,12,protein-cofactor linkage,BP,
6284,GO:0018076,1,0.959702218230486,0,4,N-terminal peptidyl-lysine acetylation,BP,
6285,GO:0018094,1,0.988177871085991,0,2,protein polyglycylation,BP,
6286,GO:0018095,1,0.94384661931477,0,9,protein polyglutamylation,BP,
6287,GO:0018101,1,0.973913012962342,0,4,protein citrullination,BP,
6288,GO:0018103,1,0.963562883173934,0,5,protein C-linked glycosylation,BP,
6290,GO:0018106,1,0.996590334167902,0,1,peptidyl-histidine phosphorylation,BP,
6293,GO:0018114,1,0.994402058223341,0,1,threonine racemase activity,MF,
6294,GO:0018117,1,0.99544508758666,0,1,protein adenylylation,BP,
6295,GO:0018119,1,0.911597301910037,0,13,peptidyl-cysteine S-nitrosylation,BP,
6296,GO:0018125,1,0.984201659044184,0,3,peptidyl-cysteine methylation,BP,
6297,GO:0018126,1,0.866047537674976,0,22,protein hydroxylation,BP,
6299,GO:0018146,1,0.84183910834787,0,26,keratan sulfate biosynthetic process,BP,
6300,GO:0018149,1,0.838012733545031,0,28,peptide cross-linking,BP,
6301,GO:0018153,1,0.988775561600488,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
6302,GO:0018158,1,0.936054151276864,0,12,protein oxidation,BP,
6303,GO:0018160,1,0.995671590620381,0,1,peptidyl-pyrromethane cofactor linkage,BP,
6304,GO:0018166,1,0.99167221858092,0,1,C-terminal protein-tyrosinylation,BP,
6305,GO:0018171,1,0.979729030440059,0,4,peptidyl-cysteine oxidation,BP,
6306,GO:0018175,1,0.99544508758666,0,1,protein nucleotidylation,BP,
6307,GO:0018192,1,0.994433621392918,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
6309,GO:0018194,1,0.994054740756748,0,1,peptidyl-alanine modification,BP,
6310,GO:0018195,1,0.882584273356175,0,22,peptidyl-arginine modification,BP,
6311,GO:0018196,1,0.772617004051373,0,43,peptidyl-asparagine modification,BP,
6312,GO:0018197,1,0.976110996313379,0,3,peptidyl-aspartic acid modification,BP,
6314,GO:0018199,1,0.979077603422316,0,4,peptidyl-glutamine modification,BP,
6315,GO:0018200,1,0.851049118828442,0,28,peptidyl-glutamic acid modification,BP,
6316,GO:0018201,1,0.977980749560747,0,3,peptidyl-glycine modification,BP,
6317,GO:0018202,1,0.941268779652824,0,10,peptidyl-histidine modification,BP,
6319,GO:0018206,1,0.935822168801828,0,11,peptidyl-methionine modification,BP,
6320,GO:0018208,1,0.772495237060311,0,45,peptidyl-proline modification,BP,
6323,GO:0018211,1,0.963562883173934,0,5,peptidyl-tryptophan modification,BP,
6325,GO:0018214,1,0.96130559294655,0,8,protein carboxylation,BP,
6326,GO:0018216,1,0.917950796223104,0,15,peptidyl-arginine methylation,BP,
6327,GO:0018217,1,0.992810666932176,0,1,peptidyl-aspartic acid phosphorylation,BP,
6330,GO:0018242,1,0.876998667968357,0,20,protein O-linked glycosylation via serine,BP,
6331,GO:0018243,1,0.882250498964799,0,19,protein O-linked glycosylation via threonine,BP,
6332,GO:0018262,1,0.988775561600488,0,2,isopeptide cross-linking,BP,
6333,GO:0018271,1,0.990820609009119,0,1,biotin-protein ligase activity,MF,
6334,GO:0018272,1,0.99532436368798,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
6335,GO:0018277,1,0.994545061767327,0,1,protein deamination,BP,
6336,GO:0018279,1,0.780484723092312,0,42,protein N-linked glycosylation via asparagine,BP,
6337,GO:0018282,1,0.984281755371547,0,2,metal incorporation into metallo-sulfur cluster,BP,
6338,GO:0018283,1,0.984281755371547,0,2,iron incorporation into metallo-sulfur cluster,BP,
6339,GO:0018293,1,0.996000372959844,0,1,protein-FAD linkage,BP,
6340,GO:0018298,1,0.957193212584407,0,8,protein-chromophore linkage,BP,
6341,GO:0018307,1,0.99079319629983,0,2,enzyme active site formation,BP,
6342,GO:0018312,1,0.988003664144986,0,2,peptidyl-serine ADP-ribosylation,BP,
6343,GO:0018315,1,0.99255627241335,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
6344,GO:0018317,1,0.963562883173934,0,5,protein C-linked glycosylation via tryptophan,BP,
6345,GO:0018322,1,0.99167221858092,0,1,protein tyrosinylation,BP,
6346,GO:0018323,1,0.996339404102419,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
6347,GO:0018335,1,0.973634026611172,0,4,protein succinylation,BP,
6348,GO:0018342,1,0.939668225070308,0,9,protein prenylation,BP,
6349,GO:0018343,1,0.989528014042836,0,2,protein farnesylation,BP,
6350,GO:0018344,1,0.957756044346176,0,7,protein geranylgeranylation,BP,
6352,GO:0018350,1,0.994511848430069,0,1,protein esterification,BP,
6353,GO:0018352,1,0.989886091655268,0,2,protein-pyridoxal-5-phosphate linkage,BP,
6354,GO:0018364,1,0.992839243145867,0,2,peptidyl-glutamine methylation,BP,
6355,GO:0018377,1,0.96724636618023,0,4,protein myristoylation,BP,
6356,GO:0018393,1,0.382644532318477,0,140,internal peptidyl-lysine acetylation,BP,
6357,GO:0018394,1,0.36639384684663,0,147,peptidyl-lysine acetylation,BP,
6358,GO:0018395,1,0.993177281716257,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
6359,GO:0018400,1,0.990197901422744,0,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,
6360,GO:0018401,1,0.967402232182674,0,5,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
6361,GO:0018406,1,0.963562883173934,0,5,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
6362,GO:0018410,1,0.668914748466964,0,65,C-terminal protein amino acid modification,BP,
6363,GO:0018423,1,0.989818948358561,0,2,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
6364,GO:0018444,1,0.976972511629654,0,3,translation release factor complex,CC,
6365,GO:0018455,1,0.995909348799247,0,1,alcohol dehydrogenase [NAD(P)+] activity,MF,
6366,GO:0018467,1,0.99420511973291,0,1,formaldehyde dehydrogenase activity,MF,
6367,GO:0018478,1,0.994766612493681,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
6368,GO:0018479,1,0.990170680190928,0,2,benzaldehyde dehydrogenase (NAD+) activity,MF,
6369,GO:0018549,1,0.99536675762283,0,1,methanethiol oxidase activity,MF,
6370,GO:0018585,1,0.994794880073551,0,1,fluorene oxygenase activity,MF,
6371,GO:0018636,1,0.987448594978773,0,3,phenanthrene 9,10-monooxygenase activity,MF,
6372,GO:0018685,1,0.995338922498099,0,1,alkane 1-monooxygenase activity,MF,
6373,GO:0018733,1,0.996016565184452,0,1,3,4-dihydrocoumarin hydrolase activity,MF,
6374,GO:0018738,1,0.996012828977306,0,1,S-formylglutathione hydrolase activity,MF,
6375,GO:0018773,1,0.995405943503099,0,1,acetylpyruvate hydrolase activity,MF,
6376,GO:0018812,1,0.976428094882373,0,4,3-hydroxyacyl-CoA dehydratase activity,MF,
6377,GO:0018872,1,0.994414182379939,0,1,arsonoacetate metabolic process,BP,
6378,GO:0018874,1,0.994925447887085,0,1,benzoate metabolic process,BP,
6379,GO:0018879,1,0.989000155126686,0,2,biphenyl metabolic process,BP,
6380,GO:0018885,1,0.995417312185159,0,1,carbon tetrachloride metabolic process,BP,
6381,GO:0018894,1,0.988455983083352,0,2,dibenzo-p-dioxin metabolic process,BP,
6382,GO:0018904,1,0.916012296161016,0,16,ether metabolic process,BP,
6383,GO:0018910,1,0.995417312185159,0,1,benzene metabolic process,BP,
6384,GO:0018916,1,0.98057803486477,0,4,nitrobenzene metabolic process,BP,
6385,GO:0018917,1,0.994794880073551,0,1,fluorene metabolic process,BP,
6386,GO:0018931,1,0.995754326013234,0,1,naphthalene metabolic process,BP,
6387,GO:0018958,1,0.573260618637775,0,84,phenol-containing compound metabolic process,BP,
6388,GO:0018963,1,0.989322866623817,0,2,phthalate metabolic process,BP,
6389,GO:0018964,1,0.992546526863684,0,1,propylene metabolic process,BP,
6390,GO:0018969,1,0.993918137625205,0,1,thiocyanate metabolic process,BP,
6391,GO:0018992,1,0.984352719035787,0,2,germ-line sex determination,BP,
6392,GO:0018993,1,0.987700229045808,0,2,somatic sex determination,BP,
6395,GO:0019002,1,0.98698486950773,0,2,GMP binding,MF,
6396,GO:0019003,1,0.710007114565071,0,58,GDP binding,MF,
6397,GO:0019005,1,0.712606408606092,0,55,SCF ubiquitin ligase complex,CC,
6398,GO:0019008,1,0.98841639430526,0,2,molybdopterin synthase complex,CC,
6399,GO:0019034,1,0.984432825508352,0,2,viral replication complex,CC,
6401,GO:0019042,1,0.931662125739425,0,11,viral latency,BP,
6402,GO:0019043,1,0.951657973857038,0,9,establishment of viral latency,BP,
6403,GO:0019045,1,0.978998804923478,0,2,latent virus replication,BP,
6404,GO:0019046,1,0.978998804923478,0,2,release from viral latency,BP,
6405,GO:0019048,1,0.792589041243073,0,32,modulation by virus of host morphology or physiology,BP,
6406,GO:0019049,1,0.971722975422162,0,4,evasion or tolerance of host defenses by virus,BP,
6407,GO:0019050,1,0.984712076898247,0,3,suppression by virus of host apoptotic process,BP,
6408,GO:0019054,1,0.868011600316246,0,21,modulation by virus of host process,BP,
6409,GO:0019056,1,0.993943540738628,0,1,modulation by virus of host transcription,BP,
6411,GO:0019060,1,0.991833785922262,0,2,intracellular transport of viral protein in host cell,BP,
6412,GO:0019061,1,0.994654081587635,0,1,uncoating of virus,BP,
6413,GO:0019062,1,0.955531838784147,0,7,virion attachment to host cell,BP,
6414,GO:0019064,1,0.966467235312939,0,6,fusion of virus membrane with host plasma membrane,BP,
6415,GO:0019065,1,0.979932979416918,0,3,receptor-mediated endocytosis of virus by host cell,BP,
6416,GO:0019068,1,0.809752992572939,0,37,virion assembly,BP,
6417,GO:0019072,1,0.983467278229087,0,2,viral genome packaging,BP,
6418,GO:0019074,1,0.983467278229087,0,2,viral RNA genome packaging,BP,
6419,GO:0019075,1,0.988144472527205,0,2,virus maturation,BP,
6420,GO:0019076,1,0.807951066009497,0,33,viral release from host cell,BP,
6422,GO:0019080,1,0.375030828622502,0,184,viral gene expression,BP,
6423,GO:0019081,1,0.912393793123455,0,14,viral translation,BP,
6424,GO:0019082,1,0.992631143538398,0,1,viral protein processing,BP,
6425,GO:0019083,1,0.411202376351037,0,170,viral transcription,BP,
6426,GO:0019085,1,0.985818470256122,0,2,early viral transcription,BP,
6427,GO:0019086,1,0.976730625592939,0,4,late viral transcription,BP,
6428,GO:0019087,1,0.978340973920379,0,3,transformation of host cell by virus,BP,
6429,GO:0019088,1,0.995525772354966,0,1,immortalization of host cell by virus,BP,
6430,GO:0019089,1,0.990444323541363,0,1,transmission of virus,BP,
6431,GO:0019098,1,0.836376151840764,0,28,reproductive behavior,BP,
6432,GO:0019100,1,0.984352719035787,0,2,male germ-line sex determination,BP,
6433,GO:0019101,1,0.993901654896433,0,1,female somatic sex determination,BP,
6434,GO:0019102,1,0.993760908073491,0,1,male somatic sex determination,BP,
6435,GO:0019103,1,0.968369313639803,0,6,pyrimidine nucleotide binding,MF,
6436,GO:0019104,1,0.931451262961577,0,15,DNA N-glycosylase activity,MF,
6437,GO:0019107,1,0.983830838874912,0,2,myristoyltransferase activity,MF,
6438,GO:0019115,1,0.995024267850121,0,1,benzaldehyde dehydrogenase activity,MF,
6439,GO:0019118,1,0.99580314065602,0,1,phenanthrene-epoxide hydrolase activity,MF,
6440,GO:0019119,1,0.99580314065602,0,1,phenanthrene-9,10-epoxide hydrolase activity,MF,
6441,GO:0019135,1,0.99514422458029,0,1,deoxyhypusine monooxygenase activity,MF,
6442,GO:0019136,1,0.977963153635374,0,4,deoxynucleoside kinase activity,MF,
6443,GO:0019144,1,0.99160467420281,0,2,ADP-sugar diphosphatase activity,MF,
6444,GO:0019145,1,0.99437062895455,0,1,aminobutyraldehyde dehydrogenase activity,MF,
6445,GO:0019150,1,0.99492481536647,0,1,D-ribulokinase activity,MF,
6446,GO:0019153,1,0.995509397068136,0,1,protein-disulfide reductase (glutathione) activity,MF,
6447,GO:0019158,1,0.964375656274267,0,5,mannokinase activity,MF,
6448,GO:0019166,1,0.985282281463899,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
6449,GO:0019171,1,0.988453595791546,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
6450,GO:0019184,1,0.91414090754165,0,16,nonribosomal peptide biosynthetic process,BP,
6451,GO:0019185,1,0.986396718117318,0,2,snRNA-activating protein complex,CC,
6452,GO:0019187,1,0.992873008238407,0,1,beta-1,4-mannosyltransferase activity,MF,
6453,GO:0019198,1,0.868071684346517,0,16,transmembrane receptor protein phosphatase activity,MF,
6454,GO:0019199,1,0.525399264196695,0,80,transmembrane receptor protein kinase activity,MF,
6455,GO:0019200,1,0.870521085165647,0,22,carbohydrate kinase activity,MF,
6457,GO:0019202,1,0.987418297810363,0,2,amino acid kinase activity,MF,
6458,GO:0019203,1,0.952136001091186,0,8,carbohydrate phosphatase activity,MF,
6460,GO:0019206,1,0.925189670293095,0,14,nucleoside kinase activity,MF,
6461,GO:0019207,1,0.277289048632358,0,203,kinase regulator activity,MF,
6463,GO:0019209,1,0.613975087268122,0,75,kinase activator activity,MF,
6464,GO:0019210,1,0.559110840228178,0,93,kinase inhibitor activity,MF,
6465,GO:0019211,1,0.937950837199812,0,10,phosphatase activator activity,MF,
6467,GO:0019213,1,0.685264488583805,0,55,deacetylase activity,MF,
6468,GO:0019215,1,0.912289700255886,0,13,intermediate filament binding,MF,
6471,GO:0019218,1,0.538137143839023,0,97,regulation of steroid metabolic process,BP,
6476,GO:0019226,1,0.598768539452704,0,67,transmission of nerve impulse,BP,
6477,GO:0019227,1,0.957208399296885,0,6,neuronal action potential propagation,BP,
6478,GO:0019228,1,0.753020257127514,0,34,neuronal action potential,BP,
6480,GO:0019230,1,0.969061297652658,0,4,proprioception,BP,
6482,GO:0019236,1,0.981384784477439,0,4,response to pheromone,BP,
6483,GO:0019237,1,0.959258575776981,0,6,centromeric DNA binding,MF,
6484,GO:0019238,1,0.966170659271017,0,6,cyclohydrolase activity,MF,
6485,GO:0019239,1,0.841579510483626,0,30,deaminase activity,MF,
6486,GO:0019240,1,0.958398599131649,0,5,citrulline biosynthetic process,BP,
6487,GO:0019242,1,0.994888786457122,0,1,methylglyoxal biosynthetic process,BP,
6488,GO:0019243,1,0.989395786347222,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
6489,GO:0019244,1,0.995934303882709,0,1,lactate biosynthetic process from pyruvate,BP,
6490,GO:0019249,1,0.982844531618286,0,3,lactate biosynthetic process,BP,
6491,GO:0019254,1,0.982726571255891,0,3,carnitine metabolic process, CoA-linked,BP,
6492,GO:0019255,1,0.989843977859885,0,2,glucose 1-phosphate metabolic process,BP,
6493,GO:0019262,1,0.972026283548124,0,6,N-acetylneuraminate catabolic process,BP,
6494,GO:0019264,1,0.989153281269234,0,2,glycine biosynthetic process from serine,BP,
6495,GO:0019265,1,0.995503097025035,0,1,glycine biosynthetic process, by transamination of glyoxylate,BP,
6496,GO:0019276,1,0.986850495370808,0,2,UDP-N-acetylgalactosamine metabolic process,BP,
6497,GO:0019285,1,0.986436324888943,0,2,glycine betaine biosynthetic process from choline,BP,
6498,GO:0019287,1,0.986110665595158,0,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,
6499,GO:0019290,1,0.993888515932573,0,1,siderophore biosynthetic process,BP,
6500,GO:0019303,1,0.992022784662852,0,2,D-ribose catabolic process,BP,
6501,GO:0019317,1,0.939690020982231,0,8,fucose catabolic process,BP,
6502,GO:0019318,1,0.250533927225306,0,210,hexose metabolic process,BP,
6503,GO:0019319,1,0.660894267843355,0,70,hexose biosynthetic process,BP,
6504,GO:0019320,1,0.749617117724386,0,47,hexose catabolic process,BP,
6505,GO:0019321,1,0.93319180613127,0,14,pentose metabolic process,BP,
6506,GO:0019322,1,0.980597634188221,0,4,pentose biosynthetic process,BP,
6507,GO:0019323,1,0.976116229631991,0,5,pentose catabolic process,BP,
6508,GO:0019336,1,0.947824436579052,0,9,phenol-containing compound catabolic process,BP,
6509,GO:0019341,1,0.994247551829149,0,1,dibenzo-p-dioxin catabolic process,BP,
6510,GO:0019343,1,0.989606790326473,0,2,cysteine biosynthetic process via cystathionine,BP,
6511,GO:0019344,1,0.984204928949131,0,3,cysteine biosynthetic process,BP,
6512,GO:0019346,1,0.978736428914127,0,4,transsulfuration,BP,
6513,GO:0019348,1,0.97308719139397,0,5,dolichol metabolic process,BP,
6514,GO:0019353,1,0.994130505930031,0,1,protoporphyrinogen IX biosynthetic process from glutamate,BP,
6515,GO:0019355,1,0.979624255573908,0,3,nicotinamide nucleotide biosynthetic process from aspartate,BP,
6516,GO:0019357,1,0.994054740756748,0,1,nicotinate nucleotide biosynthetic process,BP,
6517,GO:0019358,1,0.994054740756748,0,1,nicotinate nucleotide salvage,BP,
6518,GO:0019359,1,0.449907618671693,0,119,nicotinamide nucleotide biosynthetic process,BP,
6519,GO:0019362,1,0.360867848296611,0,157,pyridine nucleotide metabolic process,BP,
6520,GO:0019363,1,0.449907618671693,0,119,pyridine nucleotide biosynthetic process,BP,
6521,GO:0019364,1,0.985835734522228,0,3,pyridine nucleotide catabolic process,BP,
6522,GO:0019365,1,0.994054740756748,0,1,pyridine nucleotide salvage,BP,
6523,GO:0019367,1,0.963017449392389,0,6,fatty acid elongation, saturated fatty acid,BP,
6524,GO:0019368,1,0.963017449392389,0,6,fatty acid elongation, unsaturated fatty acid,BP,
6525,GO:0019369,1,0.79203631827693,0,41,arachidonic acid metabolic process,BP,
6526,GO:0019370,1,0.946839518226736,0,11,leukotriene biosynthetic process,BP,
6527,GO:0019371,1,0.941590534930058,0,11,cyclooxygenase pathway,BP,
6528,GO:0019372,1,0.921192096672106,0,16,lipoxygenase pathway,BP,
6529,GO:0019373,1,0.942798693313691,0,11,epoxygenase P450 pathway,BP,
6530,GO:0019374,1,0.953930155905974,0,8,galactolipid metabolic process,BP,
6531,GO:0019375,1,0.972586594038321,0,5,galactolipid biosynthetic process,BP,
6532,GO:0019376,1,0.993903848785914,0,1,galactolipid catabolic process,BP,
6533,GO:0019377,1,0.928981914810605,0,13,glycolipid catabolic process,BP,
6534,GO:0019388,1,0.946998005005063,0,9,galactose catabolic process,BP,
6535,GO:0019389,1,0.994208643411358,0,1,glucuronoside metabolic process,BP,
6536,GO:0019391,1,0.994208643411358,0,1,glucuronoside catabolic process,BP,
6538,GO:0019400,1,0.912949230004174,0,15,alditol metabolic process,BP,
6539,GO:0019401,1,0.967276086372831,0,6,alditol biosynthetic process,BP,
6540,GO:0019402,1,0.995804391605079,0,1,galactitol metabolic process,BP,
6541,GO:0019405,1,0.961414034810633,0,5,alditol catabolic process,BP,
6542,GO:0019406,1,0.995754326013234,0,1,hexitol biosynthetic process,BP,
6543,GO:0019407,1,0.99434294248527,0,1,hexitol catabolic process,BP,
6544,GO:0019408,1,0.986260590275384,0,2,dolichol biosynthetic process,BP,
6545,GO:0019413,1,0.986209383521556,0,2,acetate biosynthetic process,BP,
6546,GO:0019417,1,0.986198953312715,0,2,sulfur oxidation,BP,
6547,GO:0019418,1,0.982901300168559,0,4,sulfide oxidation,BP,
6548,GO:0019427,1,0.986209383521556,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6549,GO:0019430,1,0.887854524640186,0,22,removal of superoxide radicals,BP,
6550,GO:0019432,1,0.832629697472833,0,28,triglyceride biosynthetic process,BP,
6553,GO:0019439,1,0.0203986283149203,0,633,aromatic compound catabolic process,BP,
6554,GO:0019441,1,0.968884666707515,0,6,tryptophan catabolic process to kynurenine,BP,
6555,GO:0019442,1,0.991050186164077,0,2,tryptophan catabolic process to acetyl-CoA,BP,
6556,GO:0019448,1,0.985321852774854,0,3,L-cysteine catabolic process,BP,
6557,GO:0019464,1,0.983603650358282,0,3,glycine decarboxylation via glycine cleavage system,BP,
6558,GO:0019470,1,0.976958799362847,0,4,4-hydroxyproline catabolic process,BP,
6559,GO:0019471,1,0.941656002931352,0,10,4-hydroxyproline metabolic process,BP,
6560,GO:0019474,1,0.974356773161737,0,4,L-lysine catabolic process to acetyl-CoA,BP,
6561,GO:0019477,1,0.974356773161737,0,4,L-lysine catabolic process,BP,
6562,GO:0019478,1,0.991008643827727,0,2,D-amino acid catabolic process,BP,
6563,GO:0019482,1,0.976853127830148,0,4,beta-alanine metabolic process,BP,
6564,GO:0019483,1,0.988615290120554,0,2,beta-alanine biosynthetic process,BP,
6565,GO:0019493,1,0.995022365211478,0,1,arginine catabolic process to proline,BP,
6566,GO:0019509,1,0.972238384522892,0,5,L-methionine salvage from methylthioadenosine,BP,
6567,GO:0019510,1,0.994632935851626,0,1,S-adenosylhomocysteine catabolic process,BP,
6568,GO:0019511,1,0.920808455161828,0,13,peptidyl-proline hydroxylation,BP,
6569,GO:0019516,1,0.990226256281217,0,2,lactate oxidation,BP,
6570,GO:0019518,1,0.995527031704895,0,1,L-threonine catabolic process to glycine,BP,
6571,GO:0019519,1,0.99434294248527,0,1,pentitol metabolic process,BP,
6572,GO:0019520,1,0.989154967310185,0,2,aldonic acid metabolic process,BP,
6573,GO:0019521,1,0.989154967310185,0,2,D-gluconate metabolic process,BP,
6574,GO:0019527,1,0.99434294248527,0,1,pentitol catabolic process,BP,
6575,GO:0019530,1,0.960356520261729,0,6,taurine metabolic process,BP,
6576,GO:0019531,1,0.937066249333581,0,9,oxalate transmembrane transporter activity,MF,
6577,GO:0019532,1,0.932849589161878,0,10,oxalate transport,BP,
6578,GO:0019534,1,0.961138488000298,0,5,toxin transmembrane transporter activity,MF,
6580,GO:0019541,1,0.975586018248719,0,4,propionate metabolic process,BP,
6581,GO:0019542,1,0.986209383521556,0,2,propionate biosynthetic process,BP,
6582,GO:0019543,1,0.989229586622609,0,2,propionate catabolic process,BP,
6583,GO:0019544,1,0.995022365211478,0,1,arginine catabolic process to glutamate,BP,
6584,GO:0019546,1,0.994652836670812,0,1,arginine deiminase pathway,BP,
6585,GO:0019547,1,0.990740895348684,0,2,arginine catabolic process to ornithine,BP,
6586,GO:0019550,1,0.989300290766131,0,2,glutamate catabolic process to aspartate,BP,
6587,GO:0019551,1,0.989300290766131,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
6588,GO:0019556,1,0.977214636179475,0,4,histidine catabolic process to glutamate and formamide,BP,
6589,GO:0019557,1,0.977214636179475,0,4,histidine catabolic process to glutamate and formate,BP,
6590,GO:0019563,1,0.966885617338843,0,4,glycerol catabolic process,BP,
6591,GO:0019566,1,0.988144472527205,0,2,arabinose metabolic process,BP,
6592,GO:0019585,1,0.956464557124527,0,8,glucuronate metabolic process,BP,
6593,GO:0019605,1,0.990050478073368,0,2,butyrate metabolic process,BP,
6594,GO:0019614,1,0.952708350095108,0,8,catechol-containing compound catabolic process,BP,
6595,GO:0019626,1,0.955951167386189,0,8,short-chain fatty acid catabolic process,BP,
6596,GO:0019627,1,0.927994185480579,0,13,urea metabolic process,BP,
6598,GO:0019640,1,0.975449316686297,0,5,glucuronate catabolic process to xylulose 5-phosphate,BP,
6599,GO:0019646,1,0.934471901036099,0,16,aerobic electron transport chain,BP,
6600,GO:0019673,1,0.969171994007848,0,7,GDP-mannose metabolic process,BP,
6601,GO:0019674,1,0.685954770849491,0,64,NAD metabolic process,BP,
6602,GO:0019676,1,0.987312119799548,0,2,ammonia assimilation cycle,BP,
6603,GO:0019677,1,0.989474119446994,0,2,NAD catabolic process,BP,
6604,GO:0019682,1,0.893334543330781,0,21,glyceraldehyde-3-phosphate metabolic process,BP,
6605,GO:0019692,1,0.855234025907652,0,31,deoxyribose phosphate metabolic process,BP,
6607,GO:0019694,1,0.960356520261729,0,6,alkanesulfonate metabolic process,BP,
6608,GO:0019695,1,0.943177100855894,0,9,choline metabolic process,BP,
6611,GO:0019720,1,0.964526815113495,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6613,GO:0019724,1,0.577503994877491,0,91,B cell mediated immunity,BP,
6616,GO:0019731,1,0.894508574018028,0,26,antibacterial humoral response,BP,
6617,GO:0019732,1,0.981938565850974,0,4,antifungal humoral response,BP,
6618,GO:0019740,1,0.96853040329347,0,5,nitrogen utilization,BP,
6619,GO:0019742,1,0.994491611210297,0,1,pentacyclic triterpenoid metabolic process,BP,
6620,GO:0019747,1,0.992375058554511,0,2,regulation of isoprenoid metabolic process,BP,
6621,GO:0019748,1,0.718568784868285,0,56,secondary metabolic process,BP,
6622,GO:0019751,1,0.51103851183174,0,101,polyol metabolic process,BP,
6625,GO:0019763,1,0.976601985117975,0,5,immunoglobulin receptor activity,MF,
6626,GO:0019767,1,0.996761707750108,0,1,IgE receptor activity,MF,
6627,GO:0019770,1,0.990822440697062,0,2,IgG receptor activity,MF,
6628,GO:0019772,1,0.995499946615139,0,1,low-affinity IgG receptor activity,MF,
6629,GO:0019773,1,0.97315541431683,0,7,proteasome core complex, alpha-subunit complex,CC,
6630,GO:0019774,1,0.966620111051466,0,9,proteasome core complex, beta-subunit complex,CC,
6631,GO:0019776,1,0.981987682133256,0,3,Atg8 ligase activity,MF,
6632,GO:0019777,1,0.990522332992833,0,2,Atg12 transferase activity,MF,
6633,GO:0019778,1,0.991856914529987,0,1,Atg12 activating enzyme activity,MF,
6634,GO:0019779,1,0.991856914529987,0,1,Atg8 activating enzyme activity,MF,
6635,GO:0019780,1,0.990371096176451,0,1,FAT10 activating enzyme activity,MF,
6636,GO:0019781,1,0.990105721596996,0,2,NEDD8 activating enzyme activity,MF,
6637,GO:0019782,1,0.993463980145089,0,1,ISG15 activating enzyme activity,MF,
6638,GO:0019783,1,0.477610225988376,0,98,ubiquitin-like protein-specific protease activity,MF,
6639,GO:0019784,1,0.965408185609554,0,7,NEDD8-specific protease activity,MF,
6640,GO:0019785,1,0.987729406228597,0,2,ISG15-specific protease activity,MF,
6642,GO:0019788,1,0.968557605482407,0,6,NEDD8 transferase activity,MF,
6643,GO:0019789,1,0.900111778142985,0,16,SUMO transferase activity,MF,
6644,GO:0019797,1,0.982268991460807,0,3,procollagen-proline 3-dioxygenase activity,MF,
6645,GO:0019798,1,0.960433315542339,0,7,procollagen-proline dioxygenase activity,MF,
6646,GO:0019799,1,0.994054740756748,0,1,tubulin N-acetyltransferase activity,MF,
6647,GO:0019800,1,0.965118974376928,0,6,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,
6648,GO:0019805,1,0.98344283105082,0,3,quinolinate biosynthetic process,BP,
6649,GO:0019807,1,0.995776862580052,0,1,aspartoacylase activity,MF,
6650,GO:0019808,1,0.972954930863376,0,5,polyamine binding,MF,
6651,GO:0019809,1,0.987272784417855,0,3,spermidine binding,MF,
6652,GO:0019810,1,0.993530949694249,0,1,putrescine binding,MF,
6653,GO:0019811,1,0.992288604496873,0,1,cocaine binding,MF,
6654,GO:0019814,1,0.974503173500862,0,5,immunoglobulin complex,CC,
6655,GO:0019815,1,0.98381836547155,0,3,B cell receptor complex,CC,
6656,GO:0019825,1,0.844727733773727,0,33,oxygen binding,MF,
6657,GO:0019826,1,0.977401326974769,0,3,oxygen sensor activity,MF,
6659,GO:0019828,1,0.983922455844911,0,3,aspartic-type endopeptidase inhibitor activity,MF,
6660,GO:0019829,1,0.699225407103487,0,52,cation-transporting ATPase activity,MF,
6661,GO:0019834,1,0.986745174980432,0,3,phospholipase A2 inhibitor activity,MF,
6662,GO:0019835,1,0.85922100570393,0,30,cytolysis,BP,
6663,GO:0019836,1,0.988854263786942,0,2,hemolysis by symbiont of host erythrocytes,BP,
6665,GO:0019840,1,0.871980752247702,0,24,isoprenoid binding,MF,
6666,GO:0019841,1,0.948221128889201,0,11,retinol binding,MF,
6667,GO:0019842,1,0.486933892330063,0,119,vitamin binding,MF,
6668,GO:0019843,1,0.763284035087431,0,55,rRNA binding,MF,
6669,GO:0019852,1,0.943640821721873,0,10,L-ascorbic acid metabolic process,BP,
6670,GO:0019853,1,0.990777915943805,0,2,L-ascorbic acid biosynthetic process,BP,
6671,GO:0019855,1,0.950285338357413,0,9,calcium channel inhibitor activity,MF,
6672,GO:0019856,1,0.952983722152518,0,6,pyrimidine nucleobase biosynthetic process,BP,
6673,GO:0019857,1,0.961773306294075,0,3,5-methylcytosine metabolic process,BP,
6674,GO:0019858,1,0.989431490452276,0,2,cytosine metabolic process,BP,
6675,GO:0019859,1,0.983370993824907,0,3,thymine metabolic process,BP,
6676,GO:0019860,1,0.984121544209135,0,3,uracil metabolic process,BP,
6677,GO:0019862,1,0.995547175754115,0,1,IgA binding,MF,
6678,GO:0019863,1,0.984137920270437,0,4,IgE binding,MF,
6679,GO:0019864,1,0.958884079159401,0,9,IgG binding,MF,
6680,GO:0019865,1,0.92110279542137,0,16,immunoglobulin binding,MF,
6681,GO:0019866,1,0.0743512628911149,0,486,organelle inner membrane,CC,
6683,GO:0019869,1,0.937228494400024,0,9,chloride channel inhibitor activity,MF,
6684,GO:0019870,1,0.953075691888537,0,6,potassium channel inhibitor activity,MF,
6685,GO:0019871,1,0.956687227367995,0,6,sodium channel inhibitor activity,MF,
6686,GO:0019878,1,0.98495825626829,0,2,lysine biosynthetic process via aminoadipic acid,BP,
6688,GO:0019883,1,0.933999905278207,0,11,antigen processing and presentation of endogenous antigen,BP,
6690,GO:0019885,1,0.954993744505223,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
6692,GO:0019887,1,0.318303723005941,0,183,protein kinase regulator activity,MF,
6694,GO:0019894,1,0.759154420572082,0,37,kinesin binding,MF,
6695,GO:0019896,1,0.923524034392153,0,11,axonal transport of mitochondrion,BP,
6701,GO:0019902,1,0.304628564410039,0,166,phosphatase binding,MF,
6702,GO:0019903,1,0.441032372487281,0,117,protein phosphatase binding,MF,
6705,GO:0019907,1,0.958074872363514,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6706,GO:0019908,1,0.899143724226647,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6707,GO:0019911,1,0.947102344368561,0,10,structural constituent of myelin sheath,MF,
6708,GO:0019912,1,0.989358640581766,0,2,cyclin-dependent protein kinase activating kinase activity,MF,
6709,GO:0019915,1,0.672945662576728,0,59,lipid storage,BP,
6710,GO:0019918,1,0.97725005414789,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
6711,GO:0019919,1,0.956730787911487,0,8,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6717,GO:0019948,1,0.988622512179371,0,2,SUMO activating enzyme activity,MF,
6719,GO:0019955,1,0.54345128461542,0,96,cytokine binding,MF,
6720,GO:0019956,1,0.856826005389556,0,25,chemokine binding,MF,
6721,GO:0019957,1,0.945421205250763,0,10,C-C chemokine binding,MF,
6722,GO:0019958,1,0.963660373387229,0,6,C-X-C chemokine binding,MF,
6723,GO:0019959,1,0.980738226357756,0,3,interleukin-8 binding,MF,
6724,GO:0019960,1,0.959889911606068,0,5,C-X3-C chemokine binding,MF,
6725,GO:0019961,1,0.984128101537066,0,2,interferon binding,MF,
6726,GO:0019962,1,0.99073971701134,0,1,type I interferon binding,MF,
6727,GO:0019964,1,0.993327211149906,0,1,interferon-gamma binding,MF,
6728,GO:0019966,1,0.955950143076507,0,7,interleukin-1 binding,MF,
6729,GO:0019969,1,0.99308238471263,0,1,interleukin-10 binding,MF,
6730,GO:0019970,1,0.993599757936655,0,1,interleukin-11 binding,MF,
6731,GO:0019972,1,0.995710471266797,0,1,interleukin-12 binding,MF,
6732,GO:0019975,1,0.995710471266797,0,1,interleukin-17 binding,MF,
6733,GO:0019976,1,0.982038178405354,0,3,interleukin-2 binding,MF,
6734,GO:0019981,1,0.986332943431376,0,2,interleukin-6 binding,MF,
6735,GO:0019985,1,0.787151148278955,0,38,translesion synthesis,BP,
6736,GO:0019988,1,0.994084438530368,0,1,charged-tRNA amino acid modification,BP,
6737,GO:0019992,1,0.909390432772489,0,12,diacylglycerol binding,MF,
6738,GO:0020003,1,0.985111417217983,0,3,symbiont-containing vacuole,CC,
6739,GO:0020005,1,0.991003728380444,0,2,symbiont-containing vacuole membrane,CC,
6740,GO:0020012,1,0.985801591534317,0,2,evasion or tolerance of host immune response,BP,
6741,GO:0020016,1,0.978957303122013,0,3,ciliary pocket,CC,
6742,GO:0020018,1,0.978957303122013,0,3,ciliary pocket membrane,CC,
6743,GO:0020021,1,0.995525772354966,0,1,immortalization of host cell,BP,
6744,GO:0020027,1,0.927505200816891,0,14,hemoglobin metabolic process,BP,
6745,GO:0020037,1,0.554597257576108,0,99,heme binding,MF,
6746,GO:0021501,1,0.994891313133287,0,1,prechordal plate formation,BP,
6747,GO:0021502,1,0.980505344220417,0,3,neural fold elevation formation,BP,
6748,GO:0021503,1,0.988491901170852,0,1,neural fold bending,BP,
6749,GO:0021508,1,0.990077745354199,0,1,floor plate formation,BP,
6750,GO:0021509,1,0.995011584938571,0,1,roof plate formation,BP,
6752,GO:0021511,1,0.844725845107989,0,25,spinal cord patterning,BP,
6753,GO:0021512,1,0.99256698679289,0,1,spinal cord anterior/posterior patterning,BP,
6754,GO:0021513,1,0.863436120848395,0,23,spinal cord dorsal/ventral patterning,BP,
6755,GO:0021514,1,0.892991512850272,0,17,ventral spinal cord interneuron differentiation,BP,
6756,GO:0021515,1,0.742494516622977,0,46,cell differentiation in spinal cord,BP,
6758,GO:0021517,1,0.764117789608293,0,41,ventral spinal cord development,BP,
6759,GO:0021519,1,0.995906852572358,0,1,spinal cord association neuron specification,BP,
6760,GO:0021520,1,0.925012425484334,0,12,spinal cord motor neuron cell fate specification,BP,
6761,GO:0021521,1,0.928648138917904,0,11,ventral spinal cord interneuron specification,BP,
6762,GO:0021522,1,0.827644168322898,0,29,spinal cord motor neuron differentiation,BP,
6763,GO:0021523,1,0.970377357120694,0,5,somatic motor neuron differentiation,BP,
6764,GO:0021524,1,0.984964516187135,0,3,visceral motor neuron differentiation,BP,
6765,GO:0021526,1,0.989709975521654,0,2,medial motor column neuron differentiation,BP,
6766,GO:0021527,1,0.935129781493486,0,11,spinal cord association neuron differentiation,BP,
6767,GO:0021528,1,0.994054740756748,0,1,commissural neuron differentiation in spinal cord,BP,
6768,GO:0021529,1,0.983800369705228,0,3,spinal cord oligodendrocyte cell differentiation,BP,
6769,GO:0021530,1,0.983800369705228,0,3,spinal cord oligodendrocyte cell fate specification,BP,
6770,GO:0021532,1,0.782667117951333,0,36,neural tube patterning,BP,
6771,GO:0021533,1,0.873588957945102,0,17,cell differentiation in hindbrain,BP,
6772,GO:0021534,1,0.928445617968165,0,11,cell proliferation in hindbrain,BP,
6773,GO:0021535,1,0.901664064357243,0,13,cell migration in hindbrain,BP,
6776,GO:0021538,1,0.976408626162913,0,3,epithalamus development,BP,
6777,GO:0021539,1,0.99025571538744,0,2,subthalamus development,BP,
6778,GO:0021540,1,0.964545403254213,0,5,corpus callosum morphogenesis,BP,
6779,GO:0021541,1,0.99259763513123,0,1,ammon gyrus development,BP,
6780,GO:0021542,1,0.902972248638388,0,15,dentate gyrus development,BP,
6782,GO:0021544,1,0.849566343723462,0,23,subpallium development,BP,
6783,GO:0021545,1,0.748725617432619,0,42,cranial nerve development,BP,
6784,GO:0021546,1,0.972245716290872,0,5,rhombomere development,BP,
6785,GO:0021547,1,0.994891313133287,0,1,midbrain-hindbrain boundary initiation,BP,
6786,GO:0021548,1,0.94348940973991,0,9,pons development,BP,
6788,GO:0021550,1,0.994409330361848,0,1,medulla oblongata development,BP,
6789,GO:0021551,1,0.985441175948677,0,1,central nervous system morphogenesis,BP,
6790,GO:0021553,1,0.972750035785924,0,3,olfactory nerve development,BP,
6791,GO:0021554,1,0.921436116150862,0,11,optic nerve development,BP,
6792,GO:0021555,1,0.98317671188809,0,3,midbrain-hindbrain boundary morphogenesis,BP,
6793,GO:0021557,1,0.984649743483941,0,3,oculomotor nerve development,BP,
6794,GO:0021558,1,0.991098314186714,0,2,trochlear nerve development,BP,
6795,GO:0021559,1,0.937155912892544,0,10,trigeminal nerve development,BP,
6796,GO:0021560,1,0.987926482389589,0,2,abducens nerve development,BP,
6797,GO:0021561,1,0.939484405464002,0,9,facial nerve development,BP,
6798,GO:0021562,1,0.958504941528958,0,6,vestibulocochlear nerve development,BP,
6799,GO:0021563,1,0.961654022241265,0,5,glossopharyngeal nerve development,BP,
6800,GO:0021564,1,0.975491705430586,0,3,vagus nerve development,BP,
6801,GO:0021566,1,0.991887820999033,0,1,hypoglossal nerve development,BP,
6802,GO:0021568,1,0.995843153769315,0,1,rhombomere 2 development,BP,
6803,GO:0021569,1,0.989497139137201,0,2,rhombomere 3 development,BP,
6804,GO:0021570,1,0.995510656952716,0,1,rhombomere 4 development,BP,
6805,GO:0021571,1,0.987439849502272,0,2,rhombomere 5 development,BP,
6806,GO:0021572,1,0.993440990616834,0,1,rhombomere 6 development,BP,
6807,GO:0021575,1,0.75475449077677,0,37,hindbrain morphogenesis,BP,
6808,GO:0021577,1,0.987154464785654,0,2,hindbrain structural organization,BP,
6809,GO:0021578,1,0.957918927826631,0,6,hindbrain maturation,BP,
6810,GO:0021586,1,0.980045743679662,0,3,pons maturation,BP,
6811,GO:0021587,1,0.768083004146244,0,34,cerebellum morphogenesis,BP,
6812,GO:0021589,1,0.987154464785654,0,2,cerebellum structural organization,BP,
6813,GO:0021590,1,0.977427211807713,0,3,cerebellum maturation,BP,
6815,GO:0021592,1,0.991552282300721,0,1,fourth ventricle development,BP,
6816,GO:0021593,1,0.993959637822564,0,1,rhombomere morphogenesis,BP,
6817,GO:0021594,1,0.993959637822564,0,1,rhombomere formation,BP,
6818,GO:0021598,1,0.987926482389589,0,2,abducens nerve morphogenesis,BP,
6819,GO:0021599,1,0.987926482389589,0,2,abducens nerve formation,BP,
6820,GO:0021602,1,0.842963559680918,0,25,cranial nerve morphogenesis,BP,
6821,GO:0021603,1,0.957189171688045,0,7,cranial nerve formation,BP,
6822,GO:0021604,1,0.940910925343663,0,9,cranial nerve structural organization,BP,
6823,GO:0021610,1,0.939484405464002,0,9,facial nerve morphogenesis,BP,
6824,GO:0021612,1,0.952738279790483,0,7,facial nerve structural organization,BP,
6825,GO:0021615,1,0.974975969131231,0,4,glossopharyngeal nerve morphogenesis,BP,
6826,GO:0021618,1,0.991887820999033,0,1,hypoglossal nerve morphogenesis,BP,
6827,GO:0021622,1,0.988909538994932,0,2,oculomotor nerve morphogenesis,BP,
6828,GO:0021623,1,0.988909538994932,0,2,oculomotor nerve formation,BP,
6829,GO:0021626,1,0.957918927826631,0,6,central nervous system maturation,BP,
6830,GO:0021631,1,0.95243173900544,0,6,optic nerve morphogenesis,BP,
6831,GO:0021633,1,0.987591966642749,0,2,optic nerve structural organization,BP,
6832,GO:0021634,1,0.992707630778446,0,1,optic nerve formation,BP,
6833,GO:0021636,1,0.962854858257065,0,5,trigeminal nerve morphogenesis,BP,
6834,GO:0021637,1,0.962854858257065,0,5,trigeminal nerve structural organization,BP,
6835,GO:0021639,1,0.99538572380177,0,1,trochlear nerve morphogenesis,BP,
6836,GO:0021642,1,0.99538572380177,0,1,trochlear nerve formation,BP,
6837,GO:0021644,1,0.989003388569549,0,2,vagus nerve morphogenesis,BP,
6838,GO:0021648,1,0.974267319783206,0,4,vestibulocochlear nerve morphogenesis,BP,
6839,GO:0021649,1,0.99439600355199,0,1,vestibulocochlear nerve structural organization,BP,
6840,GO:0021650,1,0.979759017165935,0,3,vestibulocochlear nerve formation,BP,
6841,GO:0021658,1,0.993959637822564,0,1,rhombomere 3 morphogenesis,BP,
6842,GO:0021660,1,0.993959637822564,0,1,rhombomere 3 formation,BP,
6843,GO:0021664,1,0.993959637822564,0,1,rhombomere 5 morphogenesis,BP,
6844,GO:0021666,1,0.993959637822564,0,1,rhombomere 5 formation,BP,
6845,GO:0021670,1,0.929924873853876,0,10,lateral ventricle development,BP,
6847,GO:0021678,1,0.984948608909482,0,3,third ventricle development,BP,
6848,GO:0021679,1,0.987266937380802,0,2,cerebellar molecular layer development,BP,
6849,GO:0021680,1,0.843194595353672,0,21,cerebellar Purkinje cell layer development,BP,
6850,GO:0021681,1,0.912931699850473,0,13,cerebellar granular layer development,BP,
6851,GO:0021682,1,0.991133999619016,0,1,nerve maturation,BP,
6852,GO:0021683,1,0.935993904802011,0,9,cerebellar granular layer morphogenesis,BP,
6853,GO:0021684,1,0.950932517039885,0,7,cerebellar granular layer formation,BP,
6854,GO:0021685,1,0.989572564292898,0,1,cerebellar granular layer structural organization,BP,
6855,GO:0021686,1,0.995452659100077,0,1,cerebellar granular layer maturation,BP,
6856,GO:0021687,1,0.987266937380802,0,2,cerebellar molecular layer morphogenesis,BP,
6857,GO:0021688,1,0.99348102780404,0,1,cerebellar molecular layer formation,BP,
6858,GO:0021691,1,0.981893036790536,0,2,cerebellar Purkinje cell layer maturation,BP,
6859,GO:0021692,1,0.903564460223846,0,11,cerebellar Purkinje cell layer morphogenesis,BP,
6860,GO:0021693,1,0.983120888281987,0,2,cerebellar Purkinje cell layer structural organization,BP,
6861,GO:0021694,1,0.929312645323451,0,8,cerebellar Purkinje cell layer formation,BP,
6863,GO:0021696,1,0.804224768791215,0,28,cerebellar cortex morphogenesis,BP,
6864,GO:0021697,1,0.861210907015595,0,19,cerebellar cortex formation,BP,
6865,GO:0021698,1,0.983120888281987,0,2,cerebellar cortex structural organization,BP,
6866,GO:0021699,1,0.977427211807713,0,3,cerebellar cortex maturation,BP,
6868,GO:0021702,1,0.929312645323451,0,8,cerebellar Purkinje cell differentiation,BP,
6869,GO:0021703,1,0.99538572380177,0,1,locus ceruleus development,BP,
6870,GO:0021707,1,0.950932517039885,0,7,cerebellar granule cell differentiation,BP,
6871,GO:0021718,1,0.987406288255042,0,2,superior olivary nucleus development,BP,
6872,GO:0021722,1,0.987406288255042,0,2,superior olivary nucleus maturation,BP,
6873,GO:0021730,1,0.9824652402415,0,2,trigeminal sensory nucleus development,BP,
6874,GO:0021740,1,0.9824652402415,0,2,principal sensory nucleus of trigeminal nerve development,BP,
6875,GO:0021747,1,0.976979968281337,0,3,cochlear nucleus development,BP,
6876,GO:0021750,1,0.994409330361848,0,1,vestibular nucleus development,BP,
6877,GO:0021756,1,0.880345779611617,0,17,striatum development,BP,
6878,GO:0021757,1,0.993156033822864,0,1,caudate nucleus development,BP,
6879,GO:0021758,1,0.993156033822864,0,1,putamen development,BP,
6881,GO:0021761,1,0.505182370403993,0,96,limbic system development,BP,
6882,GO:0021762,1,0.783621060040793,0,39,substantia nigra development,BP,
6883,GO:0021763,1,0.994703980650772,0,1,subthalamic nucleus development,BP,
6884,GO:0021764,1,0.963042382264135,0,4,amygdala development,BP,
6885,GO:0021766,1,0.595476166079965,0,72,hippocampus development,BP,
6886,GO:0021767,1,0.987832237786774,0,1,mammillary body development,BP,
6887,GO:0021768,1,0.993295856489262,0,1,nucleus accumbens development,BP,
6888,GO:0021769,1,0.973392197719426,0,4,orbitofrontal cortex development,BP,
6889,GO:0021771,1,0.99111707817235,0,1,lateral geniculate nucleus development,BP,
6890,GO:0021772,1,0.791202652907603,0,31,olfactory bulb development,BP,
6891,GO:0021773,1,0.973898561039667,0,3,striatal medium spiny neuron differentiation,BP,
6892,GO:0021775,1,0.970991431353208,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6893,GO:0021776,1,0.970991431353208,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
6894,GO:0021778,1,0.962270840643541,0,5,oligodendrocyte cell fate specification,BP,
6895,GO:0021779,1,0.962270840643541,0,5,oligodendrocyte cell fate commitment,BP,
6896,GO:0021780,1,0.962270840643541,0,5,glial cell fate specification,BP,
6897,GO:0021781,1,0.921279019986127,0,12,glial cell fate commitment,BP,
6898,GO:0021782,1,0.519986468907124,0,92,glial cell development,BP,
6899,GO:0021783,1,0.908376638661735,0,14,preganglionic parasympathetic fiber development,BP,
6900,GO:0021784,1,0.990064702854631,0,2,postganglionic parasympathetic fiber development,BP,
6901,GO:0021785,1,0.937715138537142,0,7,branchiomotor neuron axon guidance,BP,
6902,GO:0021793,1,0.993388323907162,0,1,chemorepulsion of branchiomotor axon,BP,
6903,GO:0021794,1,0.914178229994677,0,13,thalamus development,BP,
6904,GO:0021795,1,0.756753731141811,0,38,cerebral cortex cell migration,BP,
6905,GO:0021796,1,0.959769213848359,0,6,cerebral cortex regionalization,BP,
6906,GO:0021797,1,0.982812566048185,0,3,forebrain anterior/posterior pattern specification,BP,
6907,GO:0021798,1,0.952763889281485,0,7,forebrain dorsal/ventral pattern formation,BP,
6908,GO:0021799,1,0.834693697661803,0,24,cerebral cortex radially oriented cell migration,BP,
6909,GO:0021800,1,0.933082539816554,0,8,cerebral cortex tangential migration,BP,
6910,GO:0021801,1,0.876049878438172,0,17,cerebral cortex radial glia guided migration,BP,
6911,GO:0021812,1,0.985279123664055,0,2,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
6912,GO:0021813,1,0.994267698900796,0,1,cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration,BP,
6913,GO:0021814,1,0.958910561724131,0,5,cell motility involved in cerebral cortex radial glia guided migration,BP,
6914,GO:0021815,1,0.971342433798296,0,3,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
6915,GO:0021817,1,0.971342433798296,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
6916,GO:0021819,1,0.920526871558749,0,11,layer formation in cerebral cortex,BP,
6917,GO:0021822,1,0.994822564265031,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
6918,GO:0021823,1,0.981381586820559,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6919,GO:0021824,1,0.985613852814075,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6920,GO:0021825,1,0.967260629275796,0,4,substrate-dependent cerebral cortex tangential migration,BP,
6921,GO:0021826,1,0.946628273871546,0,8,substrate-independent telencephalic tangential migration,BP,
6922,GO:0021827,1,0.981381586820559,0,2,postnatal olfactory bulb interneuron migration,BP,
6923,GO:0021828,1,0.985613852814075,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6924,GO:0021830,1,0.946628273871546,0,8,interneuron migration from the subpallium to the cortex,BP,
6925,GO:0021831,1,0.993945757220618,0,1,embryonic olfactory bulb interneuron precursor migration,BP,
6926,GO:0021836,1,0.981381586820559,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
6927,GO:0021840,1,0.987670050349536,0,2,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6928,GO:0021842,1,0.987670050349536,0,2,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
6929,GO:0021843,1,0.946628273871546,0,8,substrate-independent telencephalic tangential interneuron migration,BP,
6931,GO:0021847,1,0.978624376877981,0,3,ventricular zone neuroblast division,BP,
6932,GO:0021849,1,0.986517596007403,0,2,neuroblast division in subventricular zone,BP,
6933,GO:0021853,1,0.964780284414121,0,5,cerebral cortex GABAergic interneuron migration,BP,
6934,GO:0021854,1,0.90121289507907,0,18,hypothalamus development,BP,
6935,GO:0021855,1,0.980393260488912,0,3,hypothalamus cell migration,BP,
6936,GO:0021856,1,0.985613852814075,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
6939,GO:0021861,1,0.959288605888752,0,7,forebrain radial glial cell differentiation,BP,
6940,GO:0021869,1,0.958720264362671,0,6,forebrain ventricular zone progenitor cell division,BP,
6941,GO:0021870,1,0.990747600996084,0,1,Cajal-Retzius cell differentiation,BP,
6942,GO:0021871,1,0.870526968603482,0,21,forebrain regionalization,BP,
6945,GO:0021877,1,0.931601937879291,0,10,forebrain neuron fate commitment,BP,
6947,GO:0021881,1,0.993395751736928,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
6948,GO:0021882,1,0.989301205266024,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
6950,GO:0021885,1,0.681756627058052,0,52,forebrain cell migration,BP,
6951,GO:0021886,1,0.981963873729878,0,3,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
6952,GO:0021888,1,0.981963873729878,0,3,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
6953,GO:0021889,1,0.911911583087103,0,12,olfactory bulb interneuron differentiation,BP,
6954,GO:0021891,1,0.945216358636421,0,7,olfactory bulb interneuron development,BP,
6955,GO:0021892,1,0.940457723302562,0,10,cerebral cortex GABAergic interneuron differentiation,BP,
6956,GO:0021893,1,0.989301205266024,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
6957,GO:0021894,1,0.961095359325576,0,6,cerebral cortex GABAergic interneuron development,BP,
6958,GO:0021895,1,0.858035078066209,0,22,cerebral cortex neuron differentiation,BP,
6959,GO:0021896,1,0.976633078788446,0,2,forebrain astrocyte differentiation,BP,
6960,GO:0021897,1,0.976633078788446,0,2,forebrain astrocyte development,BP,
6961,GO:0021898,1,0.982766906557146,0,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
6962,GO:0021902,1,0.953019015906462,0,6,commitment of neuronal cell to specific neuron type in forebrain,BP,
6963,GO:0021903,1,0.936358542818103,0,10,rostrocaudal neural tube patterning,BP,
6964,GO:0021904,1,0.860661154492415,0,22,dorsal/ventral neural tube patterning,BP,
6965,GO:0021905,1,0.989961852611242,0,1,forebrain-midbrain boundary formation,BP,
6966,GO:0021910,1,0.941236035913011,0,8,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6967,GO:0021912,1,0.982402362597872,0,3,regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification,BP,
6968,GO:0021913,1,0.977669235207444,0,4,regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification,BP,
6969,GO:0021914,1,0.969554155859639,0,5,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6971,GO:0021917,1,0.989961852611242,0,1,somatic motor neuron fate commitment,BP,
6972,GO:0021918,1,0.989961852611242,0,1,regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment,BP,
6973,GO:0021919,1,0.993256823035356,0,1,BMP signaling pathway involved in spinal cord dorsal/ventral patterning,BP,
6974,GO:0021920,1,0.995906852572358,0,1,regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification,BP,
6975,GO:0021924,1,0.933512578362183,0,10,cell proliferation in external granule layer,BP,
6976,GO:0021930,1,0.933512578362183,0,10,cerebellar granule cell precursor proliferation,BP,
6977,GO:0021932,1,0.935613198282986,0,9,hindbrain radial glia guided cell migration,BP,
6978,GO:0021933,1,0.995452659100077,0,1,radial glia guided migration of cerebellar granule cell,BP,
6979,GO:0021934,1,0.977145371080575,0,2,hindbrain tangential cell migration,BP,
6980,GO:0021935,1,0.977145371080575,0,2,cerebellar granule cell precursor tangential migration,BP,
6981,GO:0021936,1,0.942495015729066,0,9,regulation of cerebellar granule cell precursor proliferation,BP,
6982,GO:0021937,1,0.967310028780362,0,5,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
6983,GO:0021938,1,0.972276032966036,0,4,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
6984,GO:0021940,1,0.954164236165903,0,7,positive regulation of cerebellar granule cell precursor proliferation,BP,
6985,GO:0021941,1,0.987775977629177,0,2,negative regulation of cerebellar granule cell precursor proliferation,BP,
6986,GO:0021942,1,0.970415353242356,0,4,radial glia guided migration of Purkinje cell,BP,
6987,GO:0021943,1,0.968553280380597,0,4,formation of radial glial scaffolds,BP,
6988,GO:0021952,1,0.828000195244099,0,23,central nervous system projection neuron axonogenesis,BP,
6991,GO:0021955,1,0.801147398311873,0,28,central nervous system neuron axonogenesis,BP,
6992,GO:0021956,1,0.995002708888427,0,1,central nervous system interneuron axonogenesis,BP,
6993,GO:0021957,1,0.951317705634555,0,6,corticospinal tract morphogenesis,BP,
6994,GO:0021960,1,0.961514534083446,0,5,anterior commissure morphogenesis,BP,
6995,GO:0021965,1,0.969166318384921,0,3,spinal cord ventral commissure morphogenesis,BP,
6996,GO:0021966,1,0.987793279659675,0,2,corticospinal neuron axon guidance,BP,
6997,GO:0021972,1,0.991850930900194,0,1,corticospinal neuron axon guidance through spinal cord,BP,
6998,GO:0021978,1,0.930658527497855,0,12,telencephalon regionalization,BP,
6999,GO:0021979,1,0.962284457423108,0,6,hypothalamus cell differentiation,BP,
7000,GO:0021983,1,0.774787630363806,0,41,pituitary gland development,BP,
7001,GO:0021984,1,0.93615675006315,0,12,adenohypophysis development,BP,
7002,GO:0021985,1,0.986948515067548,0,2,neurohypophysis development,BP,
7003,GO:0021986,1,0.976408626162913,0,3,habenula development,BP,
7005,GO:0021988,1,0.786011199949054,0,32,olfactory lobe development,BP,
7006,GO:0021993,1,0.991552282300721,0,1,initiation of neural tube closure,BP,
7007,GO:0021997,1,0.979704826304509,0,2,neural plate axis specification,BP,
7008,GO:0021998,1,0.993177281716257,0,1,neural plate mediolateral regionalization,BP,
7009,GO:0021999,1,0.958885635878989,0,6,neural plate anterior/posterior regionalization,BP,
7010,GO:0022007,1,0.979283881362659,0,3,convergent extension involved in neural plate elongation,BP,
7012,GO:0022009,1,0.975520719798939,0,4,central nervous system vasculogenesis,BP,
7013,GO:0022010,1,0.898789383607286,0,17,central nervous system myelination,BP,
7014,GO:0022011,1,0.8058957155988,0,25,myelination in peripheral nervous system,BP,
7015,GO:0022012,1,0.988706395722025,0,1,subpallium cell proliferation in forebrain,BP,
7016,GO:0022013,1,0.988386783164001,0,1,pallium cell proliferation in forebrain,BP,
7017,GO:0022018,1,0.988706395722025,0,1,lateral ganglionic eminence cell proliferation,BP,
7018,GO:0022027,1,0.938486620153786,0,6,interkinetic nuclear migration,BP,
7019,GO:0022028,1,0.949104756251742,0,6,tangential migration from the subventricular zone to the olfactory bulb,BP,
7020,GO:0022029,1,0.696351410118966,0,49,telencephalon cell migration,BP,
7021,GO:0022030,1,0.876049878438172,0,17,telencephalon glial cell migration,BP,
7023,GO:0022038,1,0.902501472614965,0,15,corpus callosum development,BP,
7024,GO:0022400,1,0.883431288054497,0,20,regulation of rhodopsin mediated signaling pathway,BP,
7027,GO:0022404,1,0.559982304215864,0,83,molting cycle process,BP,
7028,GO:0022405,1,0.559982304215864,0,83,hair cycle process,BP,
7031,GO:0022408,1,0.426629692911847,0,135,negative regulation of cell-cell adhesion,BP,
7033,GO:0022410,1,0.884649994357582,0,22,circadian sleep/wake cycle process,BP,
7037,GO:0022417,1,0.968839195327114,0,7,protein maturation by protein folding,BP,
7042,GO:0022605,1,0.965453841081608,0,6,mammalian oogenesis stage,BP,
7045,GO:0022612,1,0.446604141245743,0,111,gland morphogenesis,BP,
7047,GO:0022614,1,0.964567564661211,0,5,membrane to membrane docking,BP,
7048,GO:0022615,1,0.980159453818912,0,4,protein to membrane docking,BP,
7049,GO:0022616,1,0.845468367846742,0,26,DNA strand elongation,BP,
7050,GO:0022617,1,0.56118392785877,0,81,extracellular matrix disassembly,BP,
7052,GO:0022622,1,0.996531076871997,0,1,root system development,BP,
7053,GO:0022624,1,0.891707399942216,0,24,proteasome accessory complex,CC,
7054,GO:0022625,1,0.777621170389921,0,62,cytosolic large ribosomal subunit,CC,
7055,GO:0022626,1,0.616701780259494,0,114,cytosolic ribosome,CC,
7056,GO:0022627,1,0.827008293910385,0,45,cytosolic small ribosomal subunit,CC,
7059,GO:0022821,1,0.903728957088446,0,14,potassium ion antiporter activity,MF,
7061,GO:0022829,1,0.907017945748447,0,17,wide pore channel activity,MF,
7072,GO:0022848,1,0.920420279746102,0,14,acetylcholine-gated cation-selective channel activity,MF,
7074,GO:0022850,1,0.979911885963093,0,4,serotonin-gated cation-selective channel activity,MF,
7076,GO:0022852,1,0.986702692516984,0,2,glycine-gated chloride ion channel activity,MF,
7077,GO:0022853,1,0.693860616602988,0,53,active ion transmembrane transporter activity,MF,
7079,GO:0022858,1,0.966902419896406,0,5,alanine transmembrane transporter activity,MF,
7080,GO:0022884,1,0.926356516248169,0,15,macromolecule transmembrane transporter activity,MF,
7081,GO:0022889,1,0.951936536034011,0,9,serine transmembrane transporter activity,MF,
7083,GO:0022894,1,0.99469523433253,0,1,Intermediate conductance calcium-activated potassium channel activity,MF,
7085,GO:0022900,1,0.463461930576556,0,158,electron transport chain,BP,
7086,GO:0022904,1,0.636777634975742,0,97,respiratory electron transport chain,BP,
7088,GO:0023016,1,0.975623714515651,0,3,signal transduction by trans-phosphorylation,BP,
7089,GO:0023019,1,0.895532623986997,0,18,signal transduction involved in regulation of gene expression,BP,
7090,GO:0023021,1,0.983216304745878,0,3,termination of signal transduction,BP,
7091,GO:0023023,1,0.903688406265468,0,20,MHC protein complex binding,MF,
7092,GO:0023024,1,0.985307827053622,0,3,MHC class I protein complex binding,MF,
7093,GO:0023025,1,0.988376869046576,0,2,MHC class Ib protein complex binding,MF,
7094,GO:0023026,1,0.922026681945189,0,16,MHC class II protein complex binding,MF,
7095,GO:0023029,1,0.969245630606773,0,5,MHC class Ib protein binding,MF,
7096,GO:0023030,1,0.988376869046576,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
7097,GO:0023035,1,0.953091755037422,0,8,CD40 signaling pathway,BP,
7098,GO:0023041,1,0.960576522895208,0,6,neuronal signal transduction,BP,
7106,GO:0030002,1,0.927645607923611,0,10,cellular anion homeostasis,BP,
7109,GO:0030007,1,0.90872937604408,0,14,cellular potassium ion homeostasis,BP,
7110,GO:0030008,1,0.926804513553953,0,14,TRAPP complex,CC,
7111,GO:0030010,1,0.407695573129413,0,119,establishment of cell polarity,BP,
7112,GO:0030011,1,0.880506403887339,0,17,maintenance of cell polarity,BP,
7113,GO:0030014,1,0.897668930542718,0,15,CCR4-NOT complex,CC,
7114,GO:0030015,1,0.967018145192506,0,5,CCR4-NOT core complex,CC,
7118,GO:0030020,1,0.952299733118811,0,6,extracellular matrix structural constituent conferring tensile strength,MF,
7119,GO:0030021,1,0.993721285237305,0,1,extracellular matrix structural constituent conferring compression resistance,MF,
7120,GO:0030023,1,0.948984941620836,0,5,extracellular matrix constituent conferring elasticity,MF,
7125,GO:0030032,1,0.683435854431633,0,53,lamellipodium assembly,BP,
7126,GO:0030033,1,0.887488337564578,0,16,microvillus assembly,BP,
7127,GO:0030035,1,0.969697273978461,0,4,microspike assembly,BP,
7129,GO:0030037,1,0.991857911748689,0,1,actin filament reorganization involved in cell cycle,BP,
7130,GO:0030038,1,0.540336738525656,0,86,contractile actin filament bundle assembly,BP,
7131,GO:0030041,1,0.345949547216427,0,161,actin filament polymerization,BP,
7132,GO:0030042,1,0.703290297754789,0,47,actin filament depolymerization,BP,
7133,GO:0030043,1,0.979058094001668,0,4,actin filament fragmentation,BP,
7134,GO:0030046,1,0.963245439609394,0,5,parallel actin filament bundle assembly,BP,
7135,GO:0030047,1,0.979075495207075,0,3,actin modification,BP,
7136,GO:0030048,1,0.382981647994734,0,121,actin filament-based movement,BP,
7137,GO:0030049,1,0.775044221585733,0,35,muscle filament sliding,BP,
7138,GO:0030050,1,0.935968563081591,0,8,vesicle transport along actin filament,BP,
7141,GO:0030056,1,0.938960671574302,0,5,hemidesmosome,CC,
7142,GO:0030057,1,0.837858435969425,0,22,desmosome,CC,
7143,GO:0030060,1,0.981472571523915,0,4,L-malate dehydrogenase activity,MF,
7144,GO:0030061,1,0.968265158086497,0,5,mitochondrial crista,CC,
7145,GO:0030062,1,0.961703389903717,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
7146,GO:0030070,1,0.970444945786328,0,4,insulin processing,BP,
7150,GO:0030091,1,0.966509768025011,0,7,protein repair,BP,
7152,GO:0030098,1,0.149838102557004,0,286,lymphocyte differentiation,BP,
7155,GO:0030101,1,0.748046405041795,0,49,natural killer cell activation,BP,
7156,GO:0030103,1,0.990423767520012,0,2,vasopressin secretion,BP,
7158,GO:0030107,1,0.993954635307716,0,1,HLA-A specific inhibitory MHC class I receptor activity,MF,
7159,GO:0030108,1,0.995664688661669,0,1,HLA-A specific activating MHC class I receptor activity,MF,
7160,GO:0030109,1,0.989105830840445,0,2,HLA-B specific inhibitory MHC class I receptor activity,MF,
7163,GO:0030118,1,0.711979074390005,0,48,clathrin coat,CC,
7164,GO:0030119,1,0.734884801433084,0,45,AP-type membrane coat adaptor complex,CC,
7165,GO:0030120,1,0.699518630539676,0,54,vesicle coat,CC,
7166,GO:0030121,1,0.961582201943554,0,6,AP-1 adaptor complex,CC,
7167,GO:0030122,1,0.904539819689601,0,14,AP-2 adaptor complex,CC,
7168,GO:0030123,1,0.932063250437104,0,10,AP-3 adaptor complex,CC,
7169,GO:0030124,1,0.97555226438155,0,4,AP-4 adaptor complex,CC,
7170,GO:0030125,1,0.833855646598828,0,26,clathrin vesicle coat,CC,
7171,GO:0030126,1,0.91547912750994,0,15,COPI vesicle coat,CC,
7172,GO:0030127,1,0.910067866524094,0,14,COPII vesicle coat,CC,
7173,GO:0030128,1,0.897443881366193,0,15,clathrin coat of endocytic vesicle,CC,
7174,GO:0030130,1,0.922119739310774,0,12,clathrin coat of trans-Golgi network vesicle,CC,
7175,GO:0030131,1,0.817775932016518,0,29,clathrin adaptor complex,CC,
7176,GO:0030132,1,0.872631562704025,0,19,clathrin coat of coated pit,CC,
7178,GO:0030134,1,0.593336907422091,0,83,COPII-coated ER to Golgi transport vesicle,CC,
7185,GO:0030144,1,0.981646330061715,0,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
7186,GO:0030145,1,0.72604539172821,0,48,manganese ion binding,MF,
7188,GO:0030149,1,0.880076113055558,0,22,sphingolipid catabolic process,BP,
7189,GO:0030150,1,0.916588103080234,0,17,protein import into mitochondrial matrix,BP,
7190,GO:0030151,1,0.976988841917651,0,4,molybdenum ion binding,MF,
7193,GO:0030156,1,0.996581695157228,0,1,benzodiazepine receptor binding,MF,
7194,GO:0030157,1,0.918546532682049,0,13,pancreatic juice secretion,BP,
7195,GO:0030158,1,0.975158252064999,0,3,protein xylosyltransferase activity,MF,
7196,GO:0030159,1,0.835209983942923,0,24,receptor signaling complex scaffold activity,MF,
7197,GO:0030160,1,0.962941197157152,0,4,GKAP/Homer scaffold activity,MF,
7202,GO:0030167,1,0.974573938821169,0,4,proteoglycan catabolic process,BP,
7203,GO:0030168,1,0.368389331418905,0,149,platelet activation,BP,
7204,GO:0030169,1,0.908482675935467,0,13,low-density lipoprotein particle binding,MF,
7205,GO:0030170,1,0.764508872685818,0,45,pyridoxal phosphate binding,MF,
7206,GO:0030171,1,0.995347148761435,0,1,voltage-gated proton channel activity,MF,
7207,GO:0030172,1,0.988592372042422,0,3,troponin C binding,MF,
7209,GO:0030174,1,0.965416479282681,0,6,regulation of DNA-dependent DNA replication initiation,BP,
7211,GO:0030176,1,0.44305664827943,0,137,integral component of endoplasmic reticulum membrane,CC,
7215,GO:0030183,1,0.515667110305636,0,96,B cell differentiation,BP,
7216,GO:0030184,1,0.994079856808501,0,1,nitric oxide transmembrane transporter activity,MF,
7217,GO:0030185,1,0.985743468984846,0,3,nitric oxide transport,BP,
7218,GO:0030186,1,0.995671590620381,0,1,melatonin metabolic process,BP,
7219,GO:0030187,1,0.995671590620381,0,1,melatonin biosynthetic process,BP,
7220,GO:0030193,1,0.654220447756037,0,70,regulation of blood coagulation,BP,
7221,GO:0030194,1,0.869764077298333,0,23,positive regulation of blood coagulation,BP,
7222,GO:0030195,1,0.771668782381594,0,44,negative regulation of blood coagulation,BP,
7223,GO:0030197,1,0.98650998650239,0,2,extracellular matrix constituent, lubricant activity,MF,
7226,GO:0030200,1,0.98257359422803,0,3,heparan sulfate proteoglycan catabolic process,BP,
7227,GO:0030201,1,0.795871289778504,0,31,heparan sulfate proteoglycan metabolic process,BP,
7228,GO:0030202,1,0.938095385235958,0,8,heparin metabolic process,BP,
7231,GO:0030205,1,0.907697607208129,0,13,dermatan sulfate metabolic process,BP,
7233,GO:0030207,1,0.907863107070529,0,14,chondroitin sulfate catabolic process,BP,
7234,GO:0030208,1,0.912487732381583,0,12,dermatan sulfate biosynthetic process,BP,
7235,GO:0030209,1,0.994755319278953,0,1,dermatan sulfate catabolic process,BP,
7236,GO:0030210,1,0.938095385235958,0,8,heparin biosynthetic process,BP,
7237,GO:0030212,1,0.805146225147197,0,34,hyaluronan metabolic process,BP,
7238,GO:0030213,1,0.918367113266454,0,13,hyaluronan biosynthetic process,BP,
7239,GO:0030214,1,0.917392448157991,0,14,hyaluronan catabolic process,BP,
7241,GO:0030216,1,0.418975178573775,0,133,keratinocyte differentiation,BP,
7242,GO:0030217,1,0.260258422634672,0,204,T cell differentiation,BP,
7243,GO:0030218,1,0.512550274915667,0,101,erythrocyte differentiation,BP,
7244,GO:0030219,1,0.631141698198625,0,70,megakaryocyte differentiation,BP,
7245,GO:0030220,1,0.880144870805131,0,18,platelet formation,BP,
7246,GO:0030221,1,0.987527365834006,0,2,basophil differentiation,BP,
7247,GO:0030222,1,0.982354702319959,0,3,eosinophil differentiation,BP,
7248,GO:0030223,1,0.96501925102087,0,6,neutrophil differentiation,BP,
7249,GO:0030224,1,0.817329646731812,0,30,monocyte differentiation,BP,
7250,GO:0030225,1,0.798910857558639,0,37,macrophage differentiation,BP,
7251,GO:0030226,1,0.960217005856723,0,3,apolipoprotein receptor activity,MF,
7252,GO:0030228,1,0.868030488860862,0,16,lipoprotein particle receptor activity,MF,
7253,GO:0030229,1,0.971703501155106,0,4,very-low-density lipoprotein particle receptor activity,MF,
7254,GO:0030233,1,0.995451397287598,0,1,deoxynucleotide transmembrane transporter activity,MF,
7256,GO:0030235,1,0.951966012146504,0,7,nitric-oxide synthase regulator activity,MF,
7257,GO:0030237,1,0.986852916534092,0,2,female sex determination,BP,
7258,GO:0030238,1,0.910268062369285,0,14,male sex determination,BP,
7259,GO:0030239,1,0.615545895818603,0,63,myofibril assembly,BP,
7260,GO:0030240,1,0.907508493511778,0,10,skeletal muscle thin filament assembly,BP,
7261,GO:0030241,1,0.920992254372373,0,7,skeletal muscle myosin thick filament assembly,BP,
7262,GO:0030242,1,0.963207142442894,0,5,autophagy of peroxisome,BP,
7264,GO:0030247,1,0.888468306522668,0,19,polysaccharide binding,MF,
7265,GO:0030249,1,0.981134689015136,0,4,guanylate cyclase regulator activity,MF,
7266,GO:0030250,1,0.981134689015136,0,4,guanylate cyclase activator activity,MF,
7267,GO:0030252,1,0.910372403235197,0,14,growth hormone secretion,BP,
7269,GO:0030259,1,0.961112820072451,0,7,lipid glycosylation,BP,
7270,GO:0030260,1,0.453498697372532,0,121,entry into host cell,BP,
7274,GO:0030264,1,0.994054740756748,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
7275,GO:0030267,1,0.983905459714775,0,3,glyoxylate reductase (NADP) activity,MF,
7276,GO:0030272,1,0.996402528339144,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
7277,GO:0030273,1,0.994476311331277,0,1,melanin-concentrating hormone receptor activity,MF,
7278,GO:0030274,1,0.958973878937984,0,6,LIM domain binding,MF,
7279,GO:0030275,1,0.904617552648028,0,15,LRR domain binding,MF,
7281,GO:0030277,1,0.913195322934046,0,14,maintenance of gastrointestinal epithelium,BP,
7283,GO:0030279,1,0.664633848892265,0,60,negative regulation of ossification,BP,
7284,GO:0030280,1,0.968347994398588,0,6,structural constituent of epidermis,MF,
7285,GO:0030282,1,0.537797502352839,0,93,bone mineralization,BP,
7286,GO:0030283,1,0.996317729861585,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
7287,GO:0030284,1,0.966249373220624,0,5,estrogen receptor activity,MF,
7289,GO:0030286,1,0.654140956500787,0,48,dynein complex,CC,
7290,GO:0030289,1,0.984459240078655,0,3,protein phosphatase 4 complex,CC,
7291,GO:0030290,1,0.993218919116147,0,1,sphingolipid activator protein activity,MF,
7292,GO:0030291,1,0.821145973448501,0,33,protein serine/threonine kinase inhibitor activity,MF,
7293,GO:0030292,1,0.981063084248828,0,3,protein tyrosine kinase inhibitor activity,MF,
7294,GO:0030294,1,0.994737142140827,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
7295,GO:0030295,1,0.640065460104995,0,69,protein kinase activator activity,MF,
7296,GO:0030296,1,0.896400809139601,0,15,protein tyrosine kinase activator activity,MF,
7297,GO:0030297,1,0.952035223632934,0,7,transmembrane receptor protein tyrosine kinase activator activity,MF,
7298,GO:0030299,1,0.953457763609682,0,8,intestinal cholesterol absorption,BP,
7299,GO:0030300,1,0.984011920771022,0,3,regulation of intestinal cholesterol absorption,BP,
7300,GO:0030301,1,0.636286862784905,0,67,cholesterol transport,BP,
7301,GO:0030302,1,0.995451397287598,0,1,deoxynucleotide transport,BP,
7302,GO:0030305,1,0.987889799352276,0,2,heparanase activity,MF,
7303,GO:0030306,1,0.937313864055758,0,8,ADP-ribosylation factor binding,MF,
7306,GO:0030309,1,0.954698332183053,0,8,poly-N-acetyllactosamine metabolic process,BP,
7307,GO:0030311,1,0.960968265620152,0,7,poly-N-acetyllactosamine biosynthetic process,BP,
7308,GO:0030312,1,0.994688990500014,0,1,external encapsulating structure,CC,
7309,GO:0030314,1,0.941491866139605,0,7,junctional membrane complex,CC,
7310,GO:0030315,1,0.685601995606081,0,44,T-tubule,CC,
7313,GO:0030318,1,0.838846955921755,0,22,melanocyte differentiation,BP,
7314,GO:0030320,1,0.927645607923611,0,10,cellular monovalent inorganic anion homeostasis,BP,
7315,GO:0030321,1,0.969375876619894,0,5,transepithelial chloride transport,BP,
7319,GO:0030325,1,0.880054375988194,0,19,adrenal gland development,BP,
7321,GO:0030327,1,0.979548992866055,0,3,prenylated protein catabolic process,BP,
7322,GO:0030328,1,0.985819774932378,0,2,prenylcysteine catabolic process,BP,
7323,GO:0030329,1,0.985819774932378,0,2,prenylcysteine metabolic process,BP,
7325,GO:0030331,1,0.7652186207947,0,37,estrogen receptor binding,MF,
7326,GO:0030332,1,0.822690188947196,0,30,cyclin binding,MF,
7330,GO:0030337,1,0.989915524921233,0,2,DNA polymerase processivity factor activity,MF,
7331,GO:0030342,1,0.993623927109821,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
7332,GO:0030343,1,0.995486712055545,0,1,vitamin D3 25-hydroxylase activity,MF,
7333,GO:0030345,1,0.993721285237305,0,1,structural constituent of tooth enamel,MF,
7334,GO:0030346,1,0.952090451939656,0,7,protein phosphatase 2B binding,MF,
7336,GO:0030350,1,0.983759268379967,0,2,iron-responsive element binding,MF,
7337,GO:0030351,1,0.993973566421534,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
7338,GO:0030366,1,0.991190483278225,0,2,molybdopterin synthase activity,MF,
7339,GO:0030368,1,0.94667288294669,0,8,interleukin-17 receptor activity,MF,
7340,GO:0030369,1,0.985640416590636,0,2,ICAM-3 receptor activity,MF,
7342,GO:0030372,1,0.992031153027586,0,1,high molecular weight B cell growth factor receptor binding,MF,
7344,GO:0030375,1,0.966022069391962,0,4,thyroid hormone receptor coactivator activity,MF,
7345,GO:0030377,1,0.995709217612478,0,1,urokinase plasminogen activator receptor activity,MF,
7346,GO:0030378,1,0.994402058223341,0,1,serine racemase activity,MF,
7347,GO:0030379,1,0.989830006563694,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
7348,GO:0030382,1,0.995326263001408,0,1,sperm mitochondrion organization,BP,
7349,GO:0030387,1,0.995715485513773,0,1,fructosamine-3-kinase activity,MF,
7350,GO:0030388,1,0.974943979997189,0,5,fructose 1,6-bisphosphate metabolic process,BP,
7351,GO:0030389,1,0.992379245066168,0,2,fructosamine metabolic process,BP,
7352,GO:0030393,1,0.995715485513773,0,1,fructoselysine metabolic process,BP,
7353,GO:0030395,1,0.992150870013824,0,2,lactose binding,MF,
7354,GO:0030397,1,0.724080075022049,0,46,membrane disassembly,BP,
7355,GO:0030407,1,0.995128351864053,0,1,formimidoyltransferase activity,MF,
7356,GO:0030409,1,0.995128351864053,0,1,glutamate formimidoyltransferase activity,MF,
7357,GO:0030412,1,0.995128351864053,0,1,formimidoyltetrahydrofolate cyclodeaminase activity,MF,
7359,GO:0030421,1,0.996385206025579,0,1,defecation,BP,
7360,GO:0030422,1,0.943055408751806,0,9,production of siRNA involved in RNA interference,BP,
7361,GO:0030423,1,0.97038388295159,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
7366,GO:0030429,1,0.995649625843794,0,1,kynureninase activity,MF,
7367,GO:0030430,1,0.966176334682691,0,6,host cell cytoplasm,CC,
7368,GO:0030431,1,0.829860611174529,0,30,sleep,BP,
7369,GO:0030432,1,0.957834684172237,0,8,peristalsis,BP,
7370,GO:0030433,1,0.643880800039401,0,70,ubiquitin-dependent ERAD pathway,BP,
7371,GO:0030449,1,0.797450423522532,0,37,regulation of complement activation,BP,
7372,GO:0030450,1,0.982455155645084,0,2,regulation of complement activation, classical pathway,BP,
7373,GO:0030451,1,0.987694060342987,0,1,regulation of complement activation, alternative pathway,BP,
7374,GO:0030473,1,0.956442128422777,0,5,nuclear migration along microtubule,BP,
7375,GO:0030474,1,0.994054740756748,0,1,spindle pole body duplication,BP,
7376,GO:0030478,1,0.972034926367142,0,4,actin cap,CC,
7377,GO:0030479,1,0.947805332483287,0,7,actin cortical patch,CC,
7378,GO:0030485,1,0.987816631629878,0,2,smooth muscle contractile fiber,CC,
7379,GO:0030488,1,0.831034457531446,0,31,tRNA methylation,BP,
7380,GO:0030490,1,0.747614433357178,0,51,maturation of SSU-rRNA,BP,
7381,GO:0030492,1,0.985452940730926,0,4,hemoglobin binding,MF,
7383,GO:0030497,1,0.936587704740305,0,11,fatty acid elongation,BP,
7384,GO:0030500,1,0.664537450389649,0,60,regulation of bone mineralization,BP,
7385,GO:0030501,1,0.784726164269552,0,34,positive regulation of bone mineralization,BP,
7386,GO:0030502,1,0.932572773711764,0,11,negative regulation of bone mineralization,BP,
7387,GO:0030504,1,0.988714762562097,0,1,inorganic diphosphate transmembrane transporter activity,MF,
7388,GO:0030505,1,0.978255184047255,0,2,inorganic diphosphate transport,BP,
7389,GO:0030506,1,0.842566623696406,0,17,ankyrin binding,MF,
7393,GO:0030511,1,0.838027900161884,0,25,positive regulation of transforming growth factor beta receptor signaling pathway,BP,
7394,GO:0030512,1,0.617232369339679,0,66,negative regulation of transforming growth factor beta receptor signaling pathway,BP,
7395,GO:0030513,1,0.791709250232307,0,31,positive regulation of BMP signaling pathway,BP,
7397,GO:0030515,1,0.848534876308898,0,29,snoRNA binding,MF,
7398,GO:0030516,1,0.533652210142396,0,82,regulation of axon extension,BP,
7399,GO:0030517,1,0.780772317573606,0,34,negative regulation of axon extension,BP,
7400,GO:0030518,1,0.411587975825612,0,128,intracellular steroid hormone receptor signaling pathway,BP,
7401,GO:0030520,1,0.692011278791027,0,54,intracellular estrogen receptor signaling pathway,BP,
7402,GO:0030521,1,0.648774323057041,0,61,androgen receptor signaling pathway,BP,
7403,GO:0030522,1,0.16552716761597,0,261,intracellular receptor signaling pathway,BP,
7404,GO:0030523,1,0.992473282198371,0,1,dihydrolipoamide S-acyltransferase activity,MF,
7405,GO:0030526,1,0.991979443321047,0,1,granulocyte macrophage colony-stimulating factor receptor complex,CC,
7406,GO:0030532,1,0.661504217601726,0,68,small nuclear ribonucleoprotein complex,CC,
7408,GO:0030538,1,0.98351052441162,0,3,embryonic genitalia morphogenesis,BP,
7409,GO:0030539,1,0.883038939629105,0,19,male genitalia development,BP,
7410,GO:0030540,1,0.884792759301736,0,16,female genitalia development,BP,
7411,GO:0030544,1,0.799226902273872,0,36,Hsp70 protein binding,MF,
7413,GO:0030546,1,0.922538961898905,0,11,receptor activator activity,MF,
7414,GO:0030547,1,0.897148745398163,0,19,receptor inhibitor activity,MF,
7415,GO:0030548,1,0.963858727997931,0,7,acetylcholine receptor regulator activity,MF,
7416,GO:0030549,1,0.996070709675589,0,1,acetylcholine receptor activator activity,MF,
7417,GO:0030550,1,0.976391970762383,0,4,acetylcholine receptor inhibitor activity,MF,
7418,GO:0030551,1,0.776694516922378,0,35,cyclic nucleotide binding,MF,
7419,GO:0030552,1,0.836134739425919,0,24,cAMP binding,MF,
7420,GO:0030553,1,0.91031443342914,0,13,cGMP binding,MF,
7422,GO:0030572,1,0.993005644329228,0,1,phosphatidyltransferase activity,MF,
7423,GO:0030573,1,0.989690895872851,0,2,bile acid catabolic process,BP,
7424,GO:0030574,1,0.629254562403736,0,61,collagen catabolic process,BP,
7425,GO:0030575,1,0.911973545514063,0,11,nuclear body organization,BP,
7426,GO:0030576,1,0.981947252560051,0,3,Cajal body organization,BP,
7427,GO:0030578,1,0.964521653499643,0,4,PML body organization,BP,
7428,GO:0030579,1,0.966532119615229,0,5,ubiquitin-dependent SMAD protein catabolic process,BP,
7429,GO:0030580,1,0.995925571083506,0,1,quinone cofactor methyltransferase activity,MF,
7430,GO:0030581,1,0.991833785922262,0,2,symbiont intracellular protein transport in host,BP,
7431,GO:0030586,1,0.993502154158033,0,1,[methionine synthase] reductase activity,MF,
7432,GO:0030593,1,0.690660327456506,0,69,neutrophil chemotaxis,BP,
7435,GO:0030611,1,0.996367879281004,0,1,arsenate reductase activity,MF,
7436,GO:0030613,1,0.988576082037509,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
7437,GO:0030614,1,0.988576082037509,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
7438,GO:0030616,1,0.988195392288915,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
7439,GO:0030617,1,0.987696144339425,0,2,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
7440,GO:0030618,1,0.953484190999208,0,5,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,
7441,GO:0030619,1,0.958368811850212,0,7,U1 snRNA binding,MF,
7442,GO:0030620,1,0.96889367362183,0,6,U2 snRNA binding,MF,
7443,GO:0030621,1,0.967185455530151,0,5,U4 snRNA binding,MF,
7444,GO:0030622,1,0.986208785105793,0,2,U4atac snRNA binding,MF,
7445,GO:0030623,1,0.98954397109162,0,1,U5 snRNA binding,MF,
7446,GO:0030624,1,0.992442931936121,0,1,U6atac snRNA binding,MF,
7447,GO:0030626,1,0.988148126430296,0,2,U12 snRNA binding,MF,
7448,GO:0030627,1,0.989980409194412,0,2,pre-mRNA 5'-splice site binding,MF,
7449,GO:0030628,1,0.969677167140914,0,6,pre-mRNA 3'-splice site binding,MF,
7450,GO:0030629,1,0.994054740756748,0,1,U6 snRNA 3'-end binding,MF,
7451,GO:0030638,1,0.964375809118986,0,8,polyketide metabolic process,BP,
7453,GO:0030643,1,0.952741326465458,0,6,cellular phosphate ion homeostasis,BP,
7454,GO:0030644,1,0.973672160960274,0,4,cellular chloride ion homeostasis,BP,
7455,GO:0030647,1,0.964375809118986,0,8,aminoglycoside antibiotic metabolic process,BP,
7456,GO:0030653,1,0.991755126917671,0,1,beta-lactam antibiotic metabolic process,BP,
7457,GO:0030656,1,0.939451970160175,0,11,regulation of vitamin metabolic process,BP,
7462,GO:0030663,1,0.902808639854233,0,18,COPI-coated vesicle membrane,CC,
7466,GO:0030669,1,0.765279494129198,0,41,clathrin-coated endocytic vesicle membrane,CC,
7467,GO:0030670,1,0.66064285681298,0,68,phagocytic vesicle membrane,CC,
7471,GO:0030676,1,0.881721185648431,0,16,Rac guanyl-nucleotide exchange factor activity,MF,
7472,GO:0030677,1,0.936284565572909,0,13,ribonuclease P complex,CC,
7473,GO:0030678,1,0.984694053196708,0,3,mitochondrial ribonuclease P complex,CC,
7474,GO:0030681,1,0.950845523627523,0,10,multimeric ribonuclease P complex,CC,
7475,GO:0030682,1,0.985801591534317,0,2,evasion or tolerance of host defense response,BP,
7476,GO:0030683,1,0.985801591534317,0,2,evasion or tolerance by virus of host immune response,BP,
7477,GO:0030684,1,0.642122165177196,0,72,preribosome,CC,
7478,GO:0030686,1,0.825291830695797,0,30,90S preribosome,CC,
7479,GO:0030687,1,0.863120105847478,0,24,preribosome, large subunit precursor,CC,
7480,GO:0030688,1,0.925697561212089,0,12,preribosome, small subunit precursor,CC,
7481,GO:0030689,1,0.983437091741947,0,3,Noc complex,CC,
7482,GO:0030690,1,0.994011699146293,0,1,Noc1p-Noc2p complex,CC,
7483,GO:0030691,1,0.994011699146293,0,1,Noc2p-Noc3p complex,CC,
7484,GO:0030692,1,0.989362329704694,0,2,Noc4p-Nop14p complex,CC,
7486,GO:0030696,1,0.993635280229503,0,1,tRNA (m5U54) methyltransferase activity,MF,
7487,GO:0030697,1,0.993635280229503,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
7488,GO:0030702,1,0.992783763344201,0,1,chromatin silencing at centromere,BP,
7490,GO:0030718,1,0.988564679829497,0,2,germ-line stem cell population maintenance,BP,
7491,GO:0030719,1,0.987599014291715,0,2,P granule organization,BP,
7492,GO:0030728,1,0.874317155691219,0,19,ovulation,BP,
7493,GO:0030729,1,0.993459975855565,0,1,acetoacetate-CoA ligase activity,MF,
7494,GO:0030730,1,0.907921008768443,0,15,sequestering of triglyceride,BP,
7495,GO:0030731,1,0.996248942126942,0,1,guanidinoacetate N-methyltransferase activity,MF,
7496,GO:0030742,1,0.863953779291731,0,23,GTP-dependent protein binding,MF,
7497,GO:0030748,1,0.994309390787771,0,1,amine N-methyltransferase activity,MF,
7498,GO:0030760,1,0.99553710503278,0,1,pyridine N-methyltransferase activity,MF,
7499,GO:0030791,1,0.994414182379939,0,1,arsenite methyltransferase activity,MF,
7500,GO:0030792,1,0.994414182379939,0,1,methylarsonite methyltransferase activity,MF,
7507,GO:0030805,1,0.974730343156418,0,3,regulation of cyclic nucleotide catabolic process,BP,
7508,GO:0030806,1,0.983749414719515,0,2,negative regulation of cyclic nucleotide catabolic process,BP,
7509,GO:0030807,1,0.990833449874668,0,1,positive regulation of cyclic nucleotide catabolic process,BP,
7513,GO:0030811,1,0.622027082403502,0,64,regulation of nucleotide catabolic process,BP,
7514,GO:0030812,1,0.914303531031963,0,12,negative regulation of nucleotide catabolic process,BP,
7515,GO:0030813,1,0.876370611298931,0,17,positive regulation of nucleotide catabolic process,BP,
7517,GO:0030815,1,0.847157706071087,0,26,negative regulation of cAMP metabolic process,BP,
7520,GO:0030818,1,0.869081875487558,0,22,negative regulation of cAMP biosynthetic process,BP,
7522,GO:0030820,1,0.974730343156418,0,3,regulation of cAMP catabolic process,BP,
7523,GO:0030821,1,0.983749414719515,0,2,negative regulation of cAMP catabolic process,BP,
7524,GO:0030822,1,0.990833449874668,0,1,positive regulation of cAMP catabolic process,BP,
7527,GO:0030825,1,0.907942491686605,0,17,positive regulation of cGMP metabolic process,BP,
7530,GO:0030828,1,0.920780566535055,0,15,positive regulation of cGMP biosynthetic process,BP,
7531,GO:0030832,1,0.322381928447457,0,167,regulation of actin filament length,BP,
7532,GO:0030833,1,0.379989498290606,0,147,regulation of actin filament polymerization,BP,
7533,GO:0030834,1,0.721250117193732,0,44,regulation of actin filament depolymerization,BP,
7534,GO:0030835,1,0.770904786307951,0,34,negative regulation of actin filament depolymerization,BP,
7535,GO:0030836,1,0.935573353903845,0,10,positive regulation of actin filament depolymerization,BP,
7536,GO:0030837,1,0.701632635839725,0,51,negative regulation of actin filament polymerization,BP,
7537,GO:0030838,1,0.579315607480858,0,88,positive regulation of actin filament polymerization,BP,
7538,GO:0030842,1,0.991278538166818,0,1,regulation of intermediate filament depolymerization,BP,
7539,GO:0030844,1,0.991278538166818,0,1,positive regulation of intermediate filament depolymerization,BP,
7540,GO:0030845,1,0.993964646557823,0,1,phospholipase C-inhibiting G-protein coupled receptor signaling pathway,BP,
7541,GO:0030846,1,0.986191593533253,0,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7542,GO:0030849,1,0.987060197928388,0,2,autosome,CC,
7543,GO:0030850,1,0.71162029062067,0,47,prostate gland development,BP,
7544,GO:0030851,1,0.85402454006965,0,26,granulocyte differentiation,BP,
7545,GO:0030852,1,0.92280228874652,0,13,regulation of granulocyte differentiation,BP,
7546,GO:0030853,1,0.954379513029003,0,7,negative regulation of granulocyte differentiation,BP,
7547,GO:0030854,1,0.96032470459606,0,7,positive regulation of granulocyte differentiation,BP,
7549,GO:0030856,1,0.436340639047011,0,120,regulation of epithelial cell differentiation,BP,
7550,GO:0030857,1,0.800311656898433,0,33,negative regulation of epithelial cell differentiation,BP,
7551,GO:0030858,1,0.714915733257874,0,50,positive regulation of epithelial cell differentiation,BP,
7552,GO:0030859,1,0.879295055479189,0,18,polarized epithelial cell differentiation,BP,
7553,GO:0030860,1,0.985711022268224,0,2,regulation of polarized epithelial cell differentiation,BP,
7554,GO:0030862,1,0.991281032996273,0,1,positive regulation of polarized epithelial cell differentiation,BP,
7556,GO:0030864,1,0.566972909852463,0,72,cortical actin cytoskeleton,CC,
7557,GO:0030865,1,0.707211776268397,0,49,cortical cytoskeleton organization,BP,
7558,GO:0030866,1,0.755108789612193,0,39,cortical actin cytoskeleton organization,BP,
7559,GO:0030867,1,0.857251276013726,0,28,rough endoplasmic reticulum membrane,CC,
7560,GO:0030868,1,0.971268411026153,0,5,smooth endoplasmic reticulum membrane,CC,
7561,GO:0030870,1,0.964702033994728,0,5,Mre11 complex,CC,
7562,GO:0030874,1,0.995357903332359,0,1,nucleolar chromatin,CC,
7563,GO:0030877,1,0.910149524509397,0,12,beta-catenin destruction complex,CC,
7564,GO:0030878,1,0.854057911047922,0,25,thyroid gland development,BP,
7566,GO:0030880,1,0.425396299399975,0,134,RNA polymerase complex,CC,
7567,GO:0030881,1,0.964075886074664,0,7,beta-2-microglobulin binding,MF,
7568,GO:0030882,1,0.982276072704271,0,3,lipid antigen binding,MF,
7569,GO:0030883,1,0.982276072704271,0,3,endogenous lipid antigen binding,MF,
7570,GO:0030884,1,0.982276072704271,0,3,exogenous lipid antigen binding,MF,
7571,GO:0030885,1,0.97784711431579,0,5,regulation of myeloid dendritic cell activation,BP,
7572,GO:0030886,1,0.985913518539514,0,3,negative regulation of myeloid dendritic cell activation,BP,
7573,GO:0030887,1,0.995594976503386,0,1,positive regulation of myeloid dendritic cell activation,BP,
7574,GO:0030888,1,0.705617661166426,0,55,regulation of B cell proliferation,BP,
7575,GO:0030889,1,0.898023133660087,0,16,negative regulation of B cell proliferation,BP,
7576,GO:0030890,1,0.802511744479607,0,36,positive regulation of B cell proliferation,BP,
7577,GO:0030891,1,0.977372595118218,0,4,VCB complex,CC,
7578,GO:0030893,1,0.955823115279426,0,6,meiotic cohesin complex,CC,
7579,GO:0030894,1,0.857740291619468,0,26,replisome,CC,
7580,GO:0030895,1,0.98934318907763,0,2,apolipoprotein B mRNA editing enzyme complex,CC,
7581,GO:0030896,1,0.971690677980491,0,5,checkpoint clamp complex,CC,
7582,GO:0030897,1,0.897319577219706,0,14,HOPS complex,CC,
7583,GO:0030898,1,0.894153671368169,0,12,actin-dependent ATPase activity,MF,
7584,GO:0030899,1,0.988388441879888,0,3,calcium-dependent ATPase activity,MF,
7588,GO:0030903,1,0.894214023542817,0,16,notochord development,BP,
7589,GO:0030904,1,0.866135964073422,0,21,retromer complex,CC,
7590,GO:0030905,1,0.972635797016147,0,4,retromer, tubulation complex,CC,
7591,GO:0030906,1,0.977188990182271,0,4,retromer, cargo-selective complex,CC,
7592,GO:0030908,1,0.995539622956947,0,1,protein splicing,BP,
7593,GO:0030910,1,0.972203599060235,0,4,olfactory placode formation,BP,
7594,GO:0030911,1,0.944153962456104,0,8,TPR domain binding,MF,
7595,GO:0030913,1,0.944906420897734,0,7,paranodal junction assembly,BP,
7596,GO:0030914,1,0.93089037978457,0,11,STAGA complex,CC,
7597,GO:0030915,1,0.966545546523794,0,6,Smc5-Smc6 complex,CC,
7598,GO:0030916,1,0.954428285260679,0,8,otic vesicle formation,BP,
7599,GO:0030917,1,0.95585632852988,0,7,midbrain-hindbrain boundary development,BP,
7600,GO:0030920,1,0.992032038177108,0,2,peptidyl-serine acetylation,BP,
7601,GO:0030934,1,0.965675250143441,0,3,anchoring collagen complex,CC,
7602,GO:0030935,1,0.994226885076045,0,1,sheet-forming collagen trimer,CC,
7603,GO:0030936,1,0.993742374400055,0,1,transmembrane collagen trimer,CC,
7604,GO:0030942,1,0.985211744999032,0,3,endoplasmic reticulum signal peptide binding,MF,
7605,GO:0030943,1,0.983087959905348,0,3,mitochondrion targeting sequence binding,MF,
7606,GO:0030947,1,0.829762004379518,0,28,regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7607,GO:0030948,1,0.940886833191609,0,9,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7608,GO:0030949,1,0.908317383199767,0,15,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7609,GO:0030950,1,0.915010304764601,0,14,establishment or maintenance of actin cytoskeleton polarity,BP,
7610,GO:0030951,1,0.97212507950683,0,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,
7611,GO:0030952,1,0.889481897109982,0,18,establishment or maintenance of cytoskeleton polarity,BP,
7612,GO:0030953,1,0.944692633571771,0,7,astral microtubule organization,BP,
7613,GO:0030955,1,0.901014217419867,0,14,potassium ion binding,MF,
7614,GO:0030956,1,0.983820772522336,0,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,
7615,GO:0030957,1,0.941460891520573,0,10,Tat protein binding,MF,
7616,GO:0030961,1,0.994054740756748,0,1,peptidyl-arginine hydroxylation,BP,
7617,GO:0030964,1,0.844036321761002,0,43,NADH dehydrogenase complex,CC,
7618,GO:0030968,1,0.451235780798351,0,124,endoplasmic reticulum unfolded protein response,BP,
7619,GO:0030969,1,0.981111627133794,0,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,
7620,GO:0030970,1,0.848806856943755,0,26,retrograde protein transport, ER to cytosol,BP,
7621,GO:0030971,1,0.677728481989459,0,55,receptor tyrosine kinase binding,MF,
7622,GO:0030974,1,0.989680273040968,0,2,thiamine pyrophosphate transmembrane transport,BP,
7623,GO:0030975,1,0.994548759404803,0,1,thiamine binding,MF,
7624,GO:0030976,1,0.967329488245345,0,5,thiamine pyrophosphate binding,MF,
7625,GO:0030977,1,0.995238798811842,0,1,taurine binding,MF,
7626,GO:0030981,1,0.973093321503815,0,3,cortical microtubule cytoskeleton,CC,
7627,GO:0030983,1,0.919248574922923,0,13,mismatched DNA binding,MF,
7628,GO:0030984,1,0.990130640061041,0,2,kininogen binding,MF,
7629,GO:0030990,1,0.817554504637135,0,31,intraciliary transport particle,CC,
7630,GO:0030991,1,0.941040874098177,0,8,intraciliary transport particle A,CC,
7631,GO:0030992,1,0.886234360898462,0,20,intraciliary transport particle B,CC,
7632,GO:0030997,1,0.97695327832371,0,3,regulation of centriole-centriole cohesion,BP,
7633,GO:0031000,1,0.853473785698306,0,18,response to caffeine,BP,
7634,GO:0031001,1,0.994054740756748,0,1,response to brefeldin A,BP,
7635,GO:0031005,1,0.924112121755729,0,11,filamin binding,MF,
7636,GO:0031010,1,0.916686985891274,0,11,ISWI-type complex,CC,
7637,GO:0031011,1,0.922255819377897,0,15,Ino80 complex,CC,
7639,GO:0031013,1,0.977948423068644,0,5,troponin I binding,MF,
7640,GO:0031014,1,0.985990777528035,0,4,troponin T binding,MF,
7641,GO:0031016,1,0.626697233648672,0,69,pancreas development,BP,
7642,GO:0031017,1,0.968854381742262,0,5,exocrine pancreas development,BP,
7643,GO:0031018,1,0.755309524805968,0,42,endocrine pancreas development,BP,
7644,GO:0031021,1,0.983814807804488,0,3,interphase microtubule organizing center,CC,
7645,GO:0031022,1,0.978117225364405,0,2,nuclear migration along microfilament,BP,
7646,GO:0031023,1,0.415309809300091,0,123,microtubule organizing center organization,BP,
7647,GO:0031032,1,0.259695695476528,0,179,actomyosin structure organization,BP,
7648,GO:0031033,1,0.874745835767347,0,15,myosin filament organization,BP,
7649,GO:0031034,1,0.879268022787486,0,14,myosin filament assembly,BP,
7650,GO:0031038,1,0.994863534742089,0,1,myosin II filament organization,BP,
7652,GO:0031047,1,0.383547682037668,0,140,gene silencing by RNA,BP,
7653,GO:0031048,1,0.986414205123864,0,2,chromatin silencing by small RNA,BP,
7654,GO:0031049,1,0.993994270098414,0,1,programmed DNA elimination,BP,
7655,GO:0031050,1,0.733259561865211,0,43,dsRNA fragmentation,BP,
7656,GO:0031052,1,0.993994270098414,0,1,chromosome breakage,BP,
7657,GO:0031053,1,0.928942415926424,0,10,primary miRNA processing,BP,
7658,GO:0031054,1,0.913146537570934,0,13,pre-miRNA processing,BP,
7659,GO:0031055,1,0.845525379150296,0,32,chromatin remodeling at centromere,BP,
7660,GO:0031056,1,0.391010646101872,0,132,regulation of histone modification,BP,
7661,GO:0031057,1,0.766583258835017,0,37,negative regulation of histone modification,BP,
7662,GO:0031058,1,0.572450856921867,0,81,positive regulation of histone modification,BP,
7663,GO:0031060,1,0.653561525896881,0,57,regulation of histone methylation,BP,
7664,GO:0031061,1,0.881086860142502,0,17,negative regulation of histone methylation,BP,
7665,GO:0031062,1,0.787589596623944,0,33,positive regulation of histone methylation,BP,
7666,GO:0031063,1,0.839747296960572,0,25,regulation of histone deacetylation,BP,
7667,GO:0031064,1,0.969074529394998,0,4,negative regulation of histone deacetylation,BP,
7668,GO:0031065,1,0.885104783313688,0,17,positive regulation of histone deacetylation,BP,
7669,GO:0031069,1,0.853235324382858,0,24,hair follicle morphogenesis,BP,
7670,GO:0031071,1,0.994525365392161,0,1,cysteine desulfurase activity,MF,
7671,GO:0031072,1,0.489494583965927,0,110,heat shock protein binding,MF,
7672,GO:0031074,1,0.980205555397644,0,3,nucleocytoplasmic transport complex,CC,
7674,GO:0031077,1,0.954644298211324,0,7,post-embryonic camera-type eye development,BP,
7675,GO:0031078,1,0.923454040502093,0,11,histone deacetylase activity (H3-K14 specific),MF,
7676,GO:0031080,1,0.933035556222025,0,10,nuclear pore outer ring,CC,
7677,GO:0031081,1,0.986730219147997,0,2,nuclear pore distribution,BP,
7680,GO:0031084,1,0.978814318209178,0,3,BLOC-2 complex,CC,
7681,GO:0031085,1,0.986726966570754,0,2,BLOC-3 complex,CC,
7682,GO:0031086,1,0.959076593918199,0,7,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,
7683,GO:0031087,1,0.965075802404491,0,6,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
7684,GO:0031088,1,0.958456710951397,0,6,platelet dense granule membrane,CC,
7685,GO:0031089,1,0.944426017223481,0,11,platelet dense granule lumen,CC,
7689,GO:0031093,1,0.68018914179295,0,63,platelet alpha granule lumen,CC,
7690,GO:0031094,1,0.903814214077359,0,11,platelet dense tubular network,CC,
7691,GO:0031095,1,0.915130188736477,0,9,platelet dense tubular network membrane,CC,
7695,GO:0031102,1,0.717078273919211,0,49,neuron projection regeneration,BP,
7696,GO:0031103,1,0.759827192747248,0,40,axon regeneration,BP,
7697,GO:0031104,1,0.992727421432256,0,1,dendrite regeneration,BP,
7698,GO:0031105,1,0.92489479007765,0,12,septin complex,CC,
7699,GO:0031106,1,0.90375982993226,0,15,septin ring organization,BP,
7707,GO:0031116,1,0.834133408239116,0,24,positive regulation of microtubule polymerization,BP,
7709,GO:0031118,1,0.965471279404727,0,8,rRNA pseudouridine synthesis,BP,
7710,GO:0031119,1,0.965433410624501,0,7,tRNA pseudouridine synthesis,BP,
7711,GO:0031120,1,0.983526810195957,0,4,snRNA pseudouridine synthesis,BP,
7712,GO:0031122,1,0.671381126132872,0,52,cytoplasmic microtubule organization,BP,
7713,GO:0031123,1,0.476057631372261,0,120,RNA 3'-end processing,BP,
7714,GO:0031124,1,0.57551766282867,0,88,mRNA 3'-end processing,BP,
7715,GO:0031125,1,0.947171239117235,0,12,rRNA 3'-end processing,BP,
7716,GO:0031126,1,0.969599682280764,0,7,snoRNA 3'-end processing,BP,
7717,GO:0031127,1,0.992580614502395,0,1,alpha-(1,2)-fucosyltransferase activity,MF,
7718,GO:0031128,1,0.831622924052569,0,28,developmental induction,BP,
7719,GO:0031129,1,0.99163724273666,0,1,inductive cell-cell signaling,BP,
7720,GO:0031133,1,0.970968863634985,0,4,regulation of axon diameter,BP,
7721,GO:0031134,1,0.981418270694664,0,3,sister chromatid biorientation,BP,
7722,GO:0031143,1,0.913205564111802,0,14,pseudopodium,CC,
7723,GO:0031145,1,0.682211557367974,0,77,anaphase-promoting complex-dependent catabolic process,BP,
7724,GO:0031146,1,0.690177798786916,0,70,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,
7725,GO:0031151,1,0.989424137282717,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7726,GO:0031161,1,0.993652358777711,0,1,phosphatidylinositol catabolic process,BP,
7727,GO:0031163,1,0.902673523195801,0,20,metallo-sulfur cluster assembly,BP,
7728,GO:0031166,1,0.97957074066771,0,3,integral component of vacuolar membrane,CC,
7729,GO:0031167,1,0.905535022141866,0,18,rRNA methylation,BP,
7731,GO:0031177,1,0.981907093033252,0,3,phosphopantetheine binding,MF,
7732,GO:0031179,1,0.993074700335626,0,1,peptide modification,BP,
7734,GO:0031204,1,0.979529749523076,0,3,posttranslational protein targeting to membrane, translocation,BP,
7735,GO:0031205,1,0.978871706818209,0,3,endoplasmic reticulum Sec complex,CC,
7736,GO:0031208,1,0.984412939714641,0,2,POZ domain binding,MF,
7737,GO:0031209,1,0.940738564620187,0,8,SCAR complex,CC,
7738,GO:0031210,1,0.898131747770297,0,17,phosphatidylcholine binding,MF,
7739,GO:0031211,1,0.952397797153031,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7740,GO:0031213,1,0.984688285658223,0,2,RSF complex,CC,
7741,GO:0031214,1,0.471952591269732,0,112,biomineral tissue development,BP,
7742,GO:0031223,1,0.906273710523819,0,11,auditory behavior,BP,
7744,GO:0031225,1,0.471533353911698,0,126,anchored component of membrane,CC,
7746,GO:0031227,1,0.43102579446985,0,141,intrinsic component of endoplasmic reticulum membrane,CC,
7748,GO:0031229,1,0.917734993965622,0,14,intrinsic component of nuclear inner membrane,CC,
7749,GO:0031231,1,0.910760844587706,0,17,intrinsic component of peroxisomal membrane,CC,
7750,GO:0031232,1,0.954293591832973,0,7,extrinsic component of external side of plasma membrane,CC,
7751,GO:0031233,1,0.898001286973808,0,18,intrinsic component of external side of plasma membrane,CC,
7753,GO:0031235,1,0.88502096063206,0,14,intrinsic component of the cytoplasmic side of the plasma membrane,CC,
7754,GO:0031247,1,0.989061478150743,0,2,actin rod assembly,BP,
7755,GO:0031248,1,0.569292846722326,0,85,protein acetyltransferase complex,CC,
7756,GO:0031249,1,0.994471421199389,0,1,denatured protein binding,MF,
7757,GO:0031251,1,0.982776114346172,0,2,PAN complex,CC,
7760,GO:0031254,1,0.919500219223605,0,13,cell trailing edge,CC,
7762,GO:0031257,1,0.994054740756748,0,1,cell trailing edge membrane,CC,
7763,GO:0031258,1,0.844683571116555,0,22,lamellipodium membrane,CC,
7764,GO:0031259,1,0.994054740756748,0,1,uropod membrane,CC,
7765,GO:0031261,1,0.971970991562966,0,5,DNA replication preinitiation complex,CC,
7766,GO:0031262,1,0.982486883639335,0,4,Ndc80 complex,CC,
7767,GO:0031264,1,0.947998642484243,0,9,death-inducing signaling complex,CC,
7768,GO:0031265,1,0.964435575522202,0,6,CD95 death-inducing signaling complex,CC,
7770,GO:0031268,1,0.922045472133262,0,13,pseudopodium organization,BP,
7771,GO:0031269,1,0.922045472133262,0,13,pseudopodium assembly,BP,
7772,GO:0031271,1,0.994054740756748,0,1,lateral pseudopodium assembly,BP,
7773,GO:0031272,1,0.922045472133262,0,13,regulation of pseudopodium assembly,BP,
7774,GO:0031274,1,0.927564261113389,0,12,positive regulation of pseudopodium assembly,BP,
7775,GO:0031275,1,0.994054740756748,0,1,regulation of lateral pseudopodium assembly,BP,
7781,GO:0031284,1,0.953822272001871,0,8,positive regulation of guanylate cyclase activity,BP,
7782,GO:0031289,1,0.993756134983809,0,1,actin phosphorylation,BP,
7783,GO:0031290,1,0.861191624510524,0,19,retinal ganglion cell axon guidance,BP,
7784,GO:0031291,1,0.982928831716808,0,3,Ran protein signal transduction,BP,
7785,GO:0031293,1,0.849536341811677,0,24,membrane protein intracellular domain proteolysis,BP,
7786,GO:0031294,1,0.68022157952603,0,68,lymphocyte costimulation,BP,
7787,GO:0031295,1,0.682947865087602,0,67,T cell costimulation,BP,
7788,GO:0031296,1,0.988447322638605,0,3,B cell costimulation,BP,
7789,GO:0031297,1,0.828251454559334,0,27,replication fork processing,BP,
7790,GO:0031298,1,0.945597260459678,0,9,replication fork protection complex,CC,
7793,GO:0031302,1,0.991703190862279,0,1,intrinsic component of endosome membrane,CC,
7794,GO:0031304,1,0.827794252984987,0,35,intrinsic component of mitochondrial inner membrane,CC,
7795,GO:0031305,1,0.827794252984987,0,35,integral component of mitochondrial inner membrane,CC,
7796,GO:0031306,1,0.872507812909109,0,23,intrinsic component of mitochondrial outer membrane,CC,
7797,GO:0031307,1,0.879363781911342,0,22,integral component of mitochondrial outer membrane,CC,
7798,GO:0031308,1,0.994054740756748,0,1,intrinsic component of nuclear outer membrane,CC,
7799,GO:0031309,1,0.994054740756748,0,1,integral component of nuclear outer membrane,CC,
7800,GO:0031310,1,0.97957074066771,0,3,intrinsic component of vacuolar membrane,CC,
7801,GO:0031312,1,0.814182142618206,0,32,extrinsic component of organelle membrane,CC,
7802,GO:0031313,1,0.948838154251818,0,8,extrinsic component of endosome membrane,CC,
7803,GO:0031314,1,0.967113569149366,0,5,extrinsic component of mitochondrial inner membrane,CC,
7804,GO:0031315,1,0.983876509537187,0,2,extrinsic component of mitochondrial outer membrane,CC,
7805,GO:0031320,1,0.99434294248527,0,1,hexitol dehydrogenase activity,MF,
7814,GO:0031331,1,0.108081257266149,0,314,positive regulation of cellular catabolic process,BP,
7815,GO:0031332,1,0.916585468634403,0,11,RNAi effector complex,CC,
7817,GO:0031334,1,0.2135863825746,0,232,positive regulation of protein complex assembly,BP,
7818,GO:0031335,1,0.989066114038946,0,2,regulation of sulfur amino acid metabolic process,BP,
7819,GO:0031337,1,0.994660930931217,0,1,positive regulation of sulfur amino acid metabolic process,BP,
7823,GO:0031341,1,0.716381792387616,0,60,regulation of cell killing,BP,
7824,GO:0031342,1,0.915605323236691,0,16,negative regulation of cell killing,BP,
7825,GO:0031343,1,0.808213964141601,0,38,positive regulation of cell killing,BP,
7830,GO:0031348,1,0.388825115391451,0,151,negative regulation of defense response,BP,
7832,GO:0031362,1,0.916965018096455,0,14,anchored component of external side of plasma membrane,CC,
7833,GO:0031365,1,0.828260951395348,0,28,N-terminal protein amino acid modification,BP,
7834,GO:0031369,1,0.837866621641449,0,29,translation initiation factor binding,MF,
7835,GO:0031370,1,0.992080813582689,0,1,eukaryotic initiation factor 4G binding,MF,
7836,GO:0031371,1,0.955814207395879,0,8,ubiquitin conjugating enzyme complex,CC,
7837,GO:0031372,1,0.989949958238835,0,2,UBC13-MMS2 complex,CC,
7838,GO:0031379,1,0.986358113722488,0,2,RNA-directed RNA polymerase complex,CC,
7839,GO:0031380,1,0.993502154158033,0,1,nuclear RNA-directed RNA polymerase complex,CC,
7840,GO:0031386,1,0.929056607028213,0,16,protein tag,MF,
7841,GO:0031389,1,0.993917036717789,0,1,Rad17 RFC-like complex,CC,
7842,GO:0031390,1,0.956981507568763,0,8,Ctf18 RFC-like complex,CC,
7843,GO:0031392,1,0.96780659050739,0,5,regulation of prostaglandin biosynthetic process,BP,
7844,GO:0031393,1,0.986684687385951,0,2,negative regulation of prostaglandin biosynthetic process,BP,
7845,GO:0031394,1,0.980869708495559,0,3,positive regulation of prostaglandin biosynthetic process,BP,
7846,GO:0031396,1,0.335182777392137,0,170,regulation of protein ubiquitination,BP,
7847,GO:0031397,1,0.675336366107824,0,61,negative regulation of protein ubiquitination,BP,
7848,GO:0031398,1,0.543642933184644,0,97,positive regulation of protein ubiquitination,BP,
7852,GO:0031402,1,0.910985392630183,0,12,sodium ion binding,MF,
7853,GO:0031403,1,0.982956523920978,0,2,lithium ion binding,MF,
7854,GO:0031404,1,0.947275544848074,0,9,chloride ion binding,MF,
7855,GO:0031405,1,0.986377574530637,0,1,lipoic acid binding,MF,
7857,GO:0031407,1,0.994541365559013,0,1,oxylipin metabolic process,BP,
7859,GO:0031414,1,0.932434259349592,0,10,N-terminal protein acetyltransferase complex,CC,
7860,GO:0031415,1,0.972024995892286,0,5,NatA complex,CC,
7861,GO:0031416,1,0.987207626836452,0,2,NatB complex,CC,
7862,GO:0031417,1,0.971715388802677,0,3,NatC complex,CC,
7863,GO:0031418,1,0.886687114613801,0,20,L-ascorbic acid binding,MF,
7864,GO:0031419,1,0.935495931007738,0,9,cobalamin binding,MF,
7865,GO:0031420,1,0.865885260027688,0,19,alkali metal ion binding,MF,
7866,GO:0031424,1,0.660993413856443,0,70,keratinization,BP,
7867,GO:0031427,1,0.97433780321755,0,4,response to methotrexate,BP,
7868,GO:0031428,1,0.981731348863149,0,4,box C/D snoRNP complex,CC,
7869,GO:0031429,1,0.979676281334196,0,5,box H/ACA snoRNP complex,CC,
7871,GO:0031431,1,0.986953395178435,0,2,Dbf4-dependent protein kinase complex,CC,
7872,GO:0031432,1,0.90599601250008,0,14,titin binding,MF,
7873,GO:0031433,1,0.939558424287684,0,6,telethonin binding,MF,
7874,GO:0031434,1,0.585062755622225,0,69,mitogen-activated protein kinase kinase binding,MF,
7875,GO:0031435,1,0.90148147911806,0,15,mitogen-activated protein kinase kinase kinase binding,MF,
7876,GO:0031436,1,0.984053978698579,0,2,BRCA1-BARD1 complex,CC,
7877,GO:0031437,1,0.980741063969268,0,3,regulation of mRNA cleavage,BP,
7878,GO:0031438,1,0.993727601796518,0,1,negative regulation of mRNA cleavage,BP,
7879,GO:0031439,1,0.98693231643158,0,2,positive regulation of mRNA cleavage,BP,
7880,GO:0031440,1,0.864668674224881,0,22,regulation of mRNA 3'-end processing,BP,
7881,GO:0031441,1,0.942390856127095,0,9,negative regulation of mRNA 3'-end processing,BP,
7882,GO:0031442,1,0.941487555409628,0,9,positive regulation of mRNA 3'-end processing,BP,
7883,GO:0031443,1,0.983304901774164,0,2,fast-twitch skeletal muscle fiber contraction,BP,
7884,GO:0031444,1,0.983173208254027,0,3,slow-twitch skeletal muscle fiber contraction,BP,
7885,GO:0031445,1,0.982832011950066,0,2,regulation of heterochromatin assembly,BP,
7886,GO:0031446,1,0.993265103642889,0,1,regulation of fast-twitch skeletal muscle fiber contraction,BP,
7887,GO:0031448,1,0.993265103642889,0,1,positive regulation of fast-twitch skeletal muscle fiber contraction,BP,
7888,GO:0031449,1,0.990773235766312,0,1,regulation of slow-twitch skeletal muscle fiber contraction,BP,
7889,GO:0031453,1,0.982832011950066,0,2,positive regulation of heterochromatin assembly,BP,
7890,GO:0031455,1,0.986436324888943,0,2,glycine betaine metabolic process,BP,
7891,GO:0031456,1,0.986436324888943,0,2,glycine betaine biosynthetic process,BP,
7892,GO:0031460,1,0.991938631515951,0,1,glycine betaine transport,BP,
7894,GO:0031462,1,0.911671197412645,0,14,Cul2-RING ubiquitin ligase complex,CC,
7896,GO:0031464,1,0.93037795562912,0,12,Cul4A-RING E3 ubiquitin ligase complex,CC,
7897,GO:0031465,1,0.968846655388545,0,5,Cul4B-RING E3 ubiquitin ligase complex,CC,
7898,GO:0031466,1,0.965913044122618,0,6,Cul5-RING ubiquitin ligase complex,CC,
7899,GO:0031467,1,0.970638775011089,0,5,Cul7-RING ubiquitin ligase complex,CC,
7900,GO:0031468,1,0.903067398598332,0,18,nuclear envelope reassembly,BP,
7901,GO:0031475,1,0.995607546107498,0,1,myosin V complex,CC,
7902,GO:0031477,1,0.989495416816709,0,1,myosin VII complex,CC,
7903,GO:0031489,1,0.908347417533231,0,16,myosin V binding,MF,
7904,GO:0031490,1,0.540538961244327,0,91,chromatin DNA binding,MF,
7905,GO:0031491,1,0.704081181458441,0,55,nucleosome binding,MF,
7906,GO:0031492,1,0.827398101694028,0,32,nucleosomal DNA binding,MF,
7907,GO:0031493,1,0.989450024305531,0,2,nucleosomal histone binding,MF,
7908,GO:0031497,1,0.537295652880678,0,108,chromatin assembly,BP,
7909,GO:0031498,1,0.874916682651217,0,19,chromatin disassembly,BP,
7910,GO:0031501,1,0.983357373580489,0,4,mannosyltransferase complex,CC,
7912,GO:0031506,1,0.995286990116764,0,1,cell wall glycoprotein biosynthetic process,BP,
7913,GO:0031507,1,0.938177680491723,0,9,heterochromatin assembly,BP,
7914,GO:0031508,1,0.98976319111096,0,2,pericentric heterochromatin assembly,BP,
7915,GO:0031509,1,0.995458967525347,0,1,telomeric heterochromatin assembly,BP,
7916,GO:0031510,1,0.9843651806279,0,3,SUMO activating enzyme complex,CC,
7917,GO:0031514,1,0.450927205334148,0,123,motile cilium,CC,
7918,GO:0031515,1,0.98344975610464,0,3,tRNA (m1A) methyltransferase complex,CC,
7919,GO:0031519,1,0.722884557474386,0,46,PcG protein complex,CC,
7921,GO:0031526,1,0.73772867864643,0,42,brush border membrane,CC,
7922,GO:0031527,1,0.868886130177479,0,17,filopodium membrane,CC,
7923,GO:0031528,1,0.867021117696064,0,21,microvillus membrane,CC,
7924,GO:0031529,1,0.762883129158876,0,44,ruffle organization,BP,
7925,GO:0031530,1,0.99237479803136,0,2,gonadotropin-releasing hormone receptor binding,MF,
7926,GO:0031531,1,0.995850652299223,0,1,thyrotropin-releasing hormone receptor binding,MF,
7927,GO:0031532,1,0.506144334510481,0,100,actin cytoskeleton reorganization,BP,
7928,GO:0031533,1,0.990629520793018,0,1,mRNA cap methyltransferase complex,CC,
7929,GO:0031536,1,0.981403853433114,0,4,positive regulation of exit from mitosis,BP,
7930,GO:0031543,1,0.929930376808021,0,12,peptidyl-proline dioxygenase activity,MF,
7931,GO:0031544,1,0.976155610933635,0,4,peptidyl-proline 3-dioxygenase activity,MF,
7932,GO:0031545,1,0.95265690132612,0,8,peptidyl-proline 4-dioxygenase activity,MF,
7933,GO:0031547,1,0.956900626583576,0,5,brain-derived neurotrophic factor receptor signaling pathway,BP,
7934,GO:0031548,1,0.984300495505966,0,2,regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7935,GO:0031549,1,0.991440334400826,0,1,negative regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7936,GO:0031550,1,0.99279914117432,0,1,positive regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7937,GO:0031554,1,0.986191593533253,0,1,regulation of DNA-templated transcription, termination,BP,
7938,GO:0031559,1,0.992565526096552,0,1,oxidosqualene cyclase activity,MF,
7940,GO:0031571,1,0.638416701240478,0,69,mitotic G1 DNA damage checkpoint,BP,
7941,GO:0031572,1,0.794309937495349,0,32,G2 DNA damage checkpoint,BP,
7942,GO:0031573,1,0.923164652985788,0,14,intra-S DNA damage checkpoint,BP,
7944,GO:0031579,1,0.878530768976855,0,22,membrane raft organization,BP,
7945,GO:0031580,1,0.950853027759013,0,9,membrane raft distribution,BP,
7946,GO:0031581,1,0.908496162508723,0,11,hemidesmosome assembly,BP,
7947,GO:0031583,1,0.994876788417062,0,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,
7949,GO:0031585,1,0.95475576143075,0,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7950,GO:0031587,1,0.9691103312721,0,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7951,GO:0031588,1,0.937069246995286,0,9,nucleotide-activated protein kinase complex,CC,
7953,GO:0031590,1,0.987992287717532,0,2,wybutosine metabolic process,BP,
7954,GO:0031591,1,0.987992287717532,0,2,wybutosine biosynthetic process,BP,
7955,GO:0031592,1,0.98896299656528,0,1,centrosomal corona,CC,
7957,GO:0031594,1,0.662044388167651,0,56,neuromuscular junction,CC,
7958,GO:0031595,1,0.962939460819755,0,8,nuclear proteasome complex,CC,
7959,GO:0031597,1,0.938589599460256,0,12,cytosolic proteasome complex,CC,
7960,GO:0031616,1,0.946078251640947,0,10,spindle pole centrosome,CC,
7961,GO:0031618,1,0.928463107534967,0,9,nuclear pericentric heterochromatin,CC,
7965,GO:0031624,1,0.779164785134883,0,33,ubiquitin conjugating enzyme binding,MF,
7966,GO:0031625,1,0.150122564456305,0,292,ubiquitin protein ligase binding,MF,
7967,GO:0031626,1,0.991630246832293,0,1,beta-endorphin binding,MF,
7968,GO:0031627,1,0.981065500220129,0,3,telomeric loop formation,BP,
7969,GO:0031628,1,0.952259492980487,0,8,opioid receptor binding,MF,
7971,GO:0031630,1,0.981888013285664,0,3,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
7972,GO:0031635,1,0.987085225010395,0,2,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7973,GO:0031638,1,0.783286742928855,0,41,zymogen activation,BP,
7974,GO:0031639,1,0.893359226200531,0,20,plasminogen activation,BP,
7976,GO:0031641,1,0.789934560063271,0,34,regulation of myelination,BP,
7977,GO:0031642,1,0.956954509387477,0,6,negative regulation of myelination,BP,
7978,GO:0031643,1,0.915312053294359,0,13,positive regulation of myelination,BP,
7979,GO:0031644,1,0.652936522973975,0,64,regulation of neurological system process,BP,
7980,GO:0031645,1,0.924834386754272,0,12,negative regulation of neurological system process,BP,
7981,GO:0031646,1,0.855380821607252,0,23,positive regulation of neurological system process,BP,
7983,GO:0031648,1,0.744355251390446,0,42,protein destabilization,BP,
7986,GO:0031651,1,0.992657323363829,0,1,negative regulation of heat generation,BP,
7988,GO:0031657,1,0.904911983501485,0,14,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7989,GO:0031658,1,0.953821569592342,0,7,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7990,GO:0031659,1,0.948746334574298,0,7,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7991,GO:0031663,1,0.741106186396376,0,49,lipopolysaccharide-mediated signaling pathway,BP,
7992,GO:0031664,1,0.877322201778982,0,21,regulation of lipopolysaccharide-mediated signaling pathway,BP,
7993,GO:0031665,1,0.942264768943428,0,10,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,
7994,GO:0031666,1,0.950548432648229,0,8,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,
7997,GO:0031669,1,0.272045576019542,0,196,cellular response to nutrient levels,BP,
7998,GO:0031670,1,0.677431889902069,0,59,cellular response to nutrient,BP,
8000,GO:0031673,1,0.980982376486145,0,1,H zone,CC,
8002,GO:0031681,1,0.948721508564376,0,9,G-protein beta-subunit binding,MF,
8003,GO:0031682,1,0.993765155092727,0,1,G-protein gamma-subunit binding,MF,
8004,GO:0031683,1,0.894277223384581,0,18,G-protein beta/gamma-subunit complex binding,MF,
8005,GO:0031685,1,0.982047446312529,0,3,adenosine receptor binding,MF,
8006,GO:0031686,1,0.993698197930378,0,1,A1 adenosine receptor binding,MF,
8007,GO:0031687,1,0.995491754334154,0,1,A2A adenosine receptor binding,MF,
8008,GO:0031690,1,0.888238321308677,0,18,adrenergic receptor binding,MF,
8009,GO:0031691,1,0.989890778185365,0,2,alpha-1A adrenergic receptor binding,MF,
8010,GO:0031692,1,0.982904322788032,0,3,alpha-1B adrenergic receptor binding,MF,
8011,GO:0031694,1,0.979703695006382,0,4,alpha-2A adrenergic receptor binding,MF,
8012,GO:0031695,1,0.994426933695245,0,1,alpha-2B adrenergic receptor binding,MF,
8013,GO:0031696,1,0.987408786294607,0,2,alpha-2C adrenergic receptor binding,MF,
8014,GO:0031697,1,0.96772328152152,0,4,beta-1 adrenergic receptor binding,MF,
8015,GO:0031698,1,0.969699516320858,0,4,beta-2 adrenergic receptor binding,MF,
8016,GO:0031699,1,0.986909230654608,0,2,beta-3 adrenergic receptor binding,MF,
8017,GO:0031700,1,0.995697933051767,0,1,adrenomedullin receptor binding,MF,
8020,GO:0031703,1,0.994283151526601,0,1,type 2 angiotensin receptor binding,MF,
8021,GO:0031704,1,0.993576212296719,0,1,apelin receptor binding,MF,
8022,GO:0031705,1,0.985169588232764,0,3,bombesin receptor binding,MF,
8023,GO:0031707,1,0.994876788417062,0,1,endothelin A receptor binding,MF,
8024,GO:0031708,1,0.985169588232764,0,3,endothelin B receptor binding,MF,
8025,GO:0031711,1,0.988057455881683,0,2,bradykinin receptor binding,MF,
8026,GO:0031714,1,0.991697196763401,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
8027,GO:0031715,1,0.991697196763401,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
8028,GO:0031717,1,0.995452659100077,0,1,cannabinoid receptor binding,MF,
8029,GO:0031718,1,0.995452659100077,0,1,type 1 cannabinoid receptor binding,MF,
8030,GO:0031720,1,0.990283173699533,0,3,haptoglobin binding,MF,
8031,GO:0031724,1,0.996006601352857,0,1,CXCR5 chemokine receptor binding,MF,
8032,GO:0031726,1,0.996501431598139,0,1,CCR1 chemokine receptor binding,MF,
8033,GO:0031727,1,0.987503925807867,0,3,CCR2 chemokine receptor binding,MF,
8034,GO:0031728,1,0.993750986286282,0,2,CCR3 chemokine receptor binding,MF,
8035,GO:0031730,1,0.973830040612515,0,4,CCR5 chemokine receptor binding,MF,
8036,GO:0031731,1,0.99338884603157,0,2,CCR6 chemokine receptor binding,MF,
8037,GO:0031732,1,0.993073868748878,0,2,CCR7 chemokine receptor binding,MF,
8038,GO:0031735,1,0.989089426974552,0,3,CCR10 chemokine receptor binding,MF,
8039,GO:0031737,1,0.99352639328701,0,1,CX3C chemokine receptor binding,MF,
8040,GO:0031739,1,0.994849658590611,0,1,cholecystokinin receptor binding,MF,
8041,GO:0031741,1,0.994849658590611,0,1,type B gastrin/cholecystokinin receptor binding,MF,
8042,GO:0031748,1,0.956678016692696,0,7,D1 dopamine receptor binding,MF,
8044,GO:0031750,1,0.989458488427721,0,2,D3 dopamine receptor binding,MF,
8045,GO:0031751,1,0.995417943675701,0,1,D4 dopamine receptor binding,MF,
8046,GO:0031752,1,0.978544874513471,0,3,D5 dopamine receptor binding,MF,
8047,GO:0031753,1,0.994035431181195,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
8048,GO:0031755,1,0.994035431181195,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
8049,GO:0031762,1,0.989890778185365,0,2,follicle-stimulating hormone receptor binding,MF,
8050,GO:0031763,1,0.996531076871997,0,1,galanin receptor binding,MF,
8051,GO:0031764,1,0.996531076871997,0,1,type 1 galanin receptor binding,MF,
8052,GO:0031765,1,0.996531076871997,0,1,type 2 galanin receptor binding,MF,
8053,GO:0031766,1,0.996531076871997,0,1,type 3 galanin receptor binding,MF,
8054,GO:0031768,1,0.996611310932968,0,1,ghrelin receptor binding,MF,
8055,GO:0031770,1,0.996935262058443,0,1,growth hormone-releasing hormone receptor binding,MF,
8056,GO:0031773,1,0.996613778448459,0,1,kisspeptin receptor binding,MF,
8057,GO:0031775,1,0.988685023314789,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
8063,GO:0031798,1,0.989239971308955,0,1,type 1 metabotropic glutamate receptor binding,MF,
8064,GO:0031802,1,0.968431472936954,0,5,type 5 metabotropic glutamate receptor binding,MF,
8065,GO:0031811,1,0.992913715434875,0,1,G-protein coupled nucleotide receptor binding,MF,
8066,GO:0031812,1,0.992913715434875,0,1,P2Y1 nucleotide receptor binding,MF,
8067,GO:0031821,1,0.957428415418376,0,7,G-protein coupled serotonin receptor binding,MF,
8068,GO:0031826,1,0.985494245305458,0,3,type 2A serotonin receptor binding,MF,
8069,GO:0031834,1,0.996085636213642,0,1,neurokinin receptor binding,MF,
8070,GO:0031835,1,0.996085636213642,0,1,substance P receptor binding,MF,
8071,GO:0031838,1,0.986149597842104,0,4,haptoglobin-hemoglobin complex,CC,
8072,GO:0031839,1,0.996486604643215,0,1,type 1 neuromedin U receptor binding,MF,
8073,GO:0031840,1,0.996486604643215,0,1,type 2 neuromedin U receptor binding,MF,
8074,GO:0031841,1,0.996801118490797,0,1,neuropeptide Y receptor binding,MF,
8075,GO:0031848,1,0.936461748614203,0,10,protection from non-homologous end joining at telomere,BP,
8076,GO:0031849,1,0.978258804707147,0,4,olfactory receptor binding,MF,
8077,GO:0031852,1,0.970395473703956,0,4,mu-type opioid receptor binding,MF,
8078,GO:0031858,1,0.993627020860235,0,1,pituitary adenylate cyclase-activating polypeptide receptor binding,MF,
8079,GO:0031859,1,0.995120733074394,0,1,platelet activating factor receptor binding,MF,
8080,GO:0031860,1,0.976519443979923,0,3,telomeric 3' overhang formation,BP,
8081,GO:0031862,1,0.983794419565305,0,2,prostanoid receptor binding,MF,
8082,GO:0031867,1,0.992970684494878,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
8083,GO:0031870,1,0.990759430181966,0,1,thromboxane A2 receptor binding,MF,
8084,GO:0031871,1,0.979917516214009,0,3,proteinase activated receptor binding,MF,
8085,GO:0031877,1,0.990189166709833,0,1,somatostatin receptor binding,MF,
8086,GO:0031883,1,0.994872369653937,0,1,taste receptor binding,MF,
8087,GO:0031893,1,0.98745271066958,0,2,vasopressin receptor binding,MF,
8088,GO:0031894,1,0.992669914326704,0,1,V1A vasopressin receptor binding,MF,
8089,GO:0031896,1,0.994744661048161,0,1,V2 vasopressin receptor binding,MF,
8090,GO:0031901,1,0.417165746729783,0,128,early endosome membrane,CC,
8092,GO:0031903,1,0.695506733767925,0,57,microbody membrane,CC,
8093,GO:0031904,1,0.836402638505679,0,27,endosome lumen,CC,
8094,GO:0031905,1,0.983512999807187,0,3,early endosome lumen,CC,
8095,GO:0031906,1,0.975242241171406,0,6,late endosome lumen,CC,
8096,GO:0031907,1,0.795767673284944,0,41,microbody lumen,CC,
8097,GO:0031914,1,0.970072731096639,0,4,negative regulation of synaptic plasticity,BP,
8099,GO:0031929,1,0.497397888338282,0,99,TOR signaling,BP,
8100,GO:0031930,1,0.995680373274803,0,1,mitochondria-nucleus signaling pathway,BP,
8101,GO:0031931,1,0.94775622327184,0,7,TORC1 complex,CC,
8102,GO:0031932,1,0.916646145246524,0,13,TORC2 complex,CC,
8103,GO:0031933,1,0.976448428546287,0,3,telomeric heterochromatin,CC,
8104,GO:0031935,1,0.864489326250344,0,19,regulation of chromatin silencing,BP,
8105,GO:0031936,1,0.935100068828708,0,8,negative regulation of chromatin silencing,BP,
8106,GO:0031937,1,0.942292704523102,0,8,positive regulation of chromatin silencing,BP,
8107,GO:0031938,1,0.990578881948923,0,2,regulation of chromatin silencing at telomere,BP,
8108,GO:0031940,1,0.995458967525347,0,1,positive regulation of chromatin silencing at telomere,BP,
8109,GO:0031941,1,0.779622211746858,0,36,filamentous actin,CC,
8110,GO:0031943,1,0.947097935161107,0,9,regulation of glucocorticoid metabolic process,BP,
8111,GO:0031944,1,0.969095665174133,0,5,negative regulation of glucocorticoid metabolic process,BP,
8112,GO:0031945,1,0.992908448818777,0,1,positive regulation of glucocorticoid metabolic process,BP,
8113,GO:0031946,1,0.954691648680847,0,7,regulation of glucocorticoid biosynthetic process,BP,
8114,GO:0031947,1,0.969095665174133,0,5,negative regulation of glucocorticoid biosynthetic process,BP,
8115,GO:0031948,1,0.992908448818777,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
8117,GO:0031953,1,0.935348247867618,0,10,negative regulation of protein autophosphorylation,BP,
8118,GO:0031954,1,0.836894671061056,0,25,positive regulation of protein autophosphorylation,BP,
8119,GO:0031956,1,0.953820047546115,0,7,medium-chain fatty acid-CoA ligase activity,MF,
8120,GO:0031957,1,0.94639209505129,0,9,very long-chain fatty acid-CoA ligase activity,MF,
8121,GO:0031958,1,0.880406848623825,0,17,corticosteroid receptor signaling pathway,BP,
8122,GO:0031959,1,0.985633887754612,0,2,mineralocorticoid receptor signaling pathway,BP,
8124,GO:0031962,1,0.990926929147752,0,1,mineralocorticoid receptor binding,MF,
8125,GO:0031965,1,0.145869989067359,0,278,nuclear membrane,CC,
8129,GO:0031970,1,0.662130626816943,0,77,organelle envelope lumen,CC,
8136,GO:0031985,1,0.517575073845885,0,99,Golgi cisterna,CC,
8137,GO:0031987,1,0.93887980332483,0,8,locomotion involved in locomotory behavior,BP,
8138,GO:0031989,1,0.995744306013715,0,1,bombesin receptor signaling pathway,BP,
8139,GO:0031990,1,0.981978378145403,0,2,mRNA export from nucleus in response to heat stress,BP,
8142,GO:0031996,1,0.934777440673683,0,11,thioesterase binding,MF,
8143,GO:0031997,1,0.983224968465849,0,3,N-terminal myristoylation domain binding,MF,
8146,GO:0032000,1,0.930070566354474,0,9,positive regulation of fatty acid beta-oxidation,BP,
8147,GO:0032002,1,0.989163800827153,0,2,interleukin-28 receptor complex,CC,
8148,GO:0032006,1,0.561513461278647,0,82,regulation of TOR signaling,BP,
8149,GO:0032007,1,0.764755848308132,0,38,negative regulation of TOR signaling,BP,
8150,GO:0032008,1,0.801297068379589,0,33,positive regulation of TOR signaling,BP,
8151,GO:0032009,1,0.942711440583609,0,8,early phagosome,CC,
8152,GO:0032010,1,0.974176263244113,0,5,phagolysosome,CC,
8155,GO:0032020,1,0.970717689426148,0,6,ISG15-protein conjugation,BP,
8156,GO:0032021,1,0.976428094882373,0,4,NELF complex,CC,
8157,GO:0032023,1,0.994649102699105,0,1,trypsinogen activation,BP,
8159,GO:0032025,1,0.94684553316956,0,9,response to cobalt ion,BP,
8161,GO:0032027,1,0.967481963318518,0,5,myosin light chain binding,MF,
8162,GO:0032028,1,0.99486479665574,0,1,myosin head/neck binding,MF,
8163,GO:0032029,1,0.985555599733346,0,1,myosin tail binding,MF,
8164,GO:0032036,1,0.946121214142472,0,9,myosin heavy chain binding,MF,
8165,GO:0032038,1,0.992756203243743,0,2,myosin II heavy chain binding,MF,
8166,GO:0032039,1,0.88950856453439,0,15,integrator complex,CC,
8167,GO:0032040,1,0.822829583820541,0,32,small-subunit processome,CC,
8168,GO:0032041,1,0.923454040502093,0,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,
8169,GO:0032042,1,0.898860120062652,0,16,mitochondrial DNA metabolic process,BP,
8170,GO:0032044,1,0.988751989827331,0,2,DSIF complex,CC,
8171,GO:0032045,1,0.907871306849101,0,13,guanyl-nucleotide exchange factor complex,CC,
8172,GO:0032048,1,0.917480511398284,0,14,cardiolipin metabolic process,BP,
8173,GO:0032049,1,0.954086789351827,0,8,cardiolipin biosynthetic process,BP,
8174,GO:0032050,1,0.944873000855819,0,7,clathrin heavy chain binding,MF,
8176,GO:0032052,1,0.954714215320555,0,10,bile acid binding,MF,
8177,GO:0032053,1,0.984275614260948,0,2,ciliary basal body organization,BP,
8178,GO:0032055,1,0.960873375869273,0,6,negative regulation of translation in response to stress,BP,
8179,GO:0032056,1,0.960487843437534,0,6,positive regulation of translation in response to stress,BP,
8180,GO:0032057,1,0.971769672704974,0,4,negative regulation of translational initiation in response to stress,BP,
8181,GO:0032058,1,0.970428391800288,0,4,positive regulation of translational initiation in response to stress,BP,
8182,GO:0032059,1,0.947124034526314,0,8,bleb,CC,
8183,GO:0032060,1,0.926209881002517,0,11,bleb assembly,BP,
8184,GO:0032069,1,0.837924150786618,0,30,regulation of nuclease activity,BP,
8185,GO:0032070,1,0.947081222261288,0,10,regulation of deoxyribonuclease activity,BP,
8186,GO:0032071,1,0.956666298645279,0,8,regulation of endodeoxyribonuclease activity,BP,
8187,GO:0032072,1,0.993371516535517,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
8188,GO:0032074,1,0.960458914754864,0,7,negative regulation of nuclease activity,BP,
8189,GO:0032075,1,0.911404361212496,0,16,positive regulation of nuclease activity,BP,
8190,GO:0032076,1,0.99053218311606,0,2,negative regulation of deoxyribonuclease activity,BP,
8191,GO:0032077,1,0.973430303081609,0,5,positive regulation of deoxyribonuclease activity,BP,
8192,GO:0032078,1,0.996386443479776,0,1,negative regulation of endodeoxyribonuclease activity,BP,
8193,GO:0032079,1,0.977501281304281,0,4,positive regulation of endodeoxyribonuclease activity,BP,
8194,GO:0032088,1,0.603699756750466,0,79,negative regulation of NF-kappaB transcription factor activity,BP,
8195,GO:0032089,1,0.985557363740163,0,2,NACHT domain binding,MF,
8196,GO:0032090,1,0.989677353691761,0,2,Pyrin domain binding,MF,
8197,GO:0032091,1,0.55719787858503,0,91,negative regulation of protein binding,BP,
8198,GO:0032092,1,0.551723573165232,0,84,positive regulation of protein binding,BP,
8199,GO:0032093,1,0.994054740756748,0,1,SAM domain binding,MF,
8200,GO:0032094,1,0.826774388335769,0,32,response to food,BP,
8201,GO:0032095,1,0.910578795593934,0,17,regulation of response to food,BP,
8202,GO:0032096,1,0.941063570337135,0,11,negative regulation of response to food,BP,
8203,GO:0032097,1,0.988626120294555,0,3,positive regulation of response to food,BP,
8204,GO:0032098,1,0.903767405926886,0,19,regulation of appetite,BP,
8205,GO:0032099,1,0.941063570337135,0,11,negative regulation of appetite,BP,
8206,GO:0032100,1,0.988626120294555,0,3,positive regulation of appetite,BP,
8210,GO:0032104,1,0.872471878277126,0,23,regulation of response to extracellular stimulus,BP,
8211,GO:0032105,1,0.928510276123559,0,13,negative regulation of response to extracellular stimulus,BP,
8212,GO:0032106,1,0.977997872862943,0,5,positive regulation of response to extracellular stimulus,BP,
8213,GO:0032107,1,0.872471878277126,0,23,regulation of response to nutrient levels,BP,
8214,GO:0032108,1,0.928510276123559,0,13,negative regulation of response to nutrient levels,BP,
8215,GO:0032109,1,0.977997872862943,0,5,positive regulation of response to nutrient levels,BP,
8216,GO:0032116,1,0.981088512286879,0,2,SMC loading complex,CC,
8219,GO:0032129,1,0.988456008678985,0,2,histone deacetylase activity (H3-K9 specific),MF,
8221,GO:0032135,1,0.961939915998568,0,6,DNA insertion or deletion binding,MF,
8222,GO:0032137,1,0.980681609988469,0,3,guanine/thymine mispair binding,MF,
8223,GO:0032138,1,0.972596226773654,0,4,single base insertion or deletion binding,MF,
8224,GO:0032139,1,0.981778403540856,0,3,dinucleotide insertion or deletion binding,MF,
8225,GO:0032142,1,0.978489400301138,0,3,single guanine insertion binding,MF,
8226,GO:0032143,1,0.98618986165478,0,2,single thymine insertion binding,MF,
8227,GO:0032144,1,0.991914726505661,0,1,4-aminobutyrate transaminase complex,CC,
8228,GO:0032145,1,0.991914726505661,0,1,succinate-semialdehyde dehydrogenase binding,MF,
8230,GO:0032148,1,0.81970438594629,0,29,activation of protein kinase B activity,BP,
8231,GO:0032153,1,0.586311508968708,0,77,cell division site,CC,
8232,GO:0032154,1,0.692830227348151,0,52,cleavage furrow,CC,
8233,GO:0032155,1,0.650145232851012,0,61,cell division site part,CC,
8234,GO:0032156,1,0.918043452301094,0,13,septin cytoskeleton,CC,
8235,GO:0032160,1,0.92489479007765,0,12,septin filament array,CC,
8236,GO:0032173,1,0.993805706117009,0,1,septin collar,CC,
8237,GO:0032181,1,0.985883938278276,0,2,dinucleotide repeat insertion binding,MF,
8239,GO:0032183,1,0.894448384672748,0,14,SUMO binding,MF,
8240,GO:0032184,1,0.960566619885626,0,5,SUMO polymer binding,MF,
8241,GO:0032185,1,0.898381264434233,0,16,septin cytoskeleton organization,BP,
8242,GO:0032190,1,0.986151290274165,0,3,acrosin binding,MF,
8243,GO:0032194,1,0.993151209466218,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
8244,GO:0032196,1,0.888311136380697,0,19,transposition,BP,
8245,GO:0032200,1,0.370377749427608,0,149,telomere organization,BP,
8246,GO:0032201,1,0.852275127031637,0,27,telomere maintenance via semi-conservative replication,BP,
8247,GO:0032202,1,0.977988103260204,0,4,telomere assembly,BP,
8248,GO:0032203,1,0.995181047312037,0,1,telomere formation via telomerase,BP,
8249,GO:0032204,1,0.584053880572177,0,76,regulation of telomere maintenance,BP,
8250,GO:0032205,1,0.769206552145143,0,34,negative regulation of telomere maintenance,BP,
8251,GO:0032206,1,0.722831553972466,0,49,positive regulation of telomere maintenance,BP,
8252,GO:0032207,1,0.993915936105817,0,1,regulation of telomere maintenance via recombination,BP,
8253,GO:0032208,1,0.993915936105817,0,1,negative regulation of telomere maintenance via recombination,BP,
8254,GO:0032210,1,0.698827470423211,0,52,regulation of telomere maintenance via telomerase,BP,
8255,GO:0032211,1,0.869899854147663,0,19,negative regulation of telomere maintenance via telomerase,BP,
8256,GO:0032212,1,0.803533358325775,0,34,positive regulation of telomere maintenance via telomerase,BP,
8257,GO:0032213,1,0.987829867704587,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
8258,GO:0032214,1,0.987829867704587,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
8259,GO:0032217,1,0.978363431791629,0,4,riboflavin transmembrane transporter activity,MF,
8260,GO:0032218,1,0.982268991460807,0,3,riboflavin transport,BP,
8261,GO:0032222,1,0.955043801255018,0,7,regulation of synaptic transmission, cholinergic,BP,
8262,GO:0032223,1,0.994282556467299,0,1,negative regulation of synaptic transmission, cholinergic,BP,
8263,GO:0032224,1,0.966170878476074,0,5,positive regulation of synaptic transmission, cholinergic,BP,
8264,GO:0032225,1,0.914035638735469,0,15,regulation of synaptic transmission, dopaminergic,BP,
8265,GO:0032226,1,0.96183074808133,0,7,positive regulation of synaptic transmission, dopaminergic,BP,
8266,GO:0032227,1,0.978404815341338,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
8268,GO:0032229,1,0.966215849037166,0,6,negative regulation of synaptic transmission, GABAergic,BP,
8269,GO:0032230,1,0.924052219754066,0,12,positive regulation of synaptic transmission, GABAergic,BP,
8270,GO:0032231,1,0.537180584832394,0,86,regulation of actin filament bundle assembly,BP,
8271,GO:0032232,1,0.845620546672125,0,22,negative regulation of actin filament bundle assembly,BP,
8272,GO:0032233,1,0.686374941311028,0,56,positive regulation of actin filament bundle assembly,BP,
8273,GO:0032237,1,0.971339116458232,0,4,activation of store-operated calcium channel activity,BP,
8274,GO:0032239,1,0.875439906726542,0,17,regulation of nucleobase-containing compound transport,BP,
8275,GO:0032240,1,0.978557425449712,0,2,negative regulation of nucleobase-containing compound transport,BP,
8276,GO:0032241,1,0.944018437234384,0,8,positive regulation of nucleobase-containing compound transport,BP,
8277,GO:0032242,1,0.993981387624088,0,1,regulation of nucleoside transport,BP,
8278,GO:0032244,1,0.993981387624088,0,1,positive regulation of nucleoside transport,BP,
8279,GO:0032252,1,0.963048814230422,0,4,secretory granule localization,BP,
8280,GO:0032253,1,0.994054740756748,0,1,dense core granule localization,BP,
8281,GO:0032258,1,0.988895887368587,0,2,protein localization by the Cvt pathway,BP,
8282,GO:0032259,1,0.134346679406728,0,306,methylation,BP,
8283,GO:0032261,1,0.964018764748227,0,7,purine nucleotide salvage,BP,
8284,GO:0032262,1,0.971539972509379,0,6,pyrimidine nucleotide salvage,BP,
8285,GO:0032263,1,0.990846505908206,0,2,GMP salvage,BP,
8286,GO:0032264,1,0.976570615297129,0,4,IMP salvage,BP,
8287,GO:0032266,1,0.787383943100628,0,33,phosphatidylinositol-3-phosphate binding,MF,
8293,GO:0032273,1,0.46966767580486,0,116,positive regulation of protein polymerization,BP,
8294,GO:0032274,1,0.911875071468131,0,14,gonadotropin secretion,BP,
8295,GO:0032275,1,0.933114861821804,0,10,luteinizing hormone secretion,BP,
8296,GO:0032276,1,0.940098315450781,0,10,regulation of gonadotropin secretion,BP,
8297,GO:0032277,1,0.966839172317539,0,6,negative regulation of gonadotropin secretion,BP,
8298,GO:0032278,1,0.956979825082273,0,7,positive regulation of gonadotropin secretion,BP,
8300,GO:0032280,1,0.940352710822408,0,8,symmetric synapse,CC,
8301,GO:0032281,1,0.84309394346521,0,27,AMPA glutamate receptor complex,CC,
8302,GO:0032286,1,0.974030511314113,0,4,central nervous system myelin maintenance,BP,
8303,GO:0032287,1,0.912442126832616,0,9,peripheral nervous system myelin maintenance,BP,
8304,GO:0032288,1,0.847463568654502,0,20,myelin assembly,BP,
8305,GO:0032289,1,0.982349558479965,0,3,central nervous system myelin formation,BP,
8306,GO:0032290,1,0.953889791997368,0,4,peripheral nervous system myelin formation,BP,
8307,GO:0032291,1,0.898789383607286,0,17,axon ensheathment in central nervous system,BP,
8308,GO:0032292,1,0.8058957155988,0,25,peripheral nervous system axon ensheathment,BP,
8309,GO:0032296,1,0.96895711260441,0,4,double-stranded RNA-specific ribonuclease activity,MF,
8310,GO:0032298,1,0.994694609815672,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
8311,GO:0032299,1,0.985728096279345,0,3,ribonuclease H2 complex,CC,
8312,GO:0032300,1,0.936292597615755,0,9,mismatch repair complex,CC,
8313,GO:0032301,1,0.98618986165478,0,2,MutSalpha complex,CC,
8314,GO:0032302,1,0.985883938278276,0,2,MutSbeta complex,CC,
8315,GO:0032303,1,0.936562059692849,0,11,regulation of icosanoid secretion,BP,
8316,GO:0032304,1,0.991792064916606,0,1,negative regulation of icosanoid secretion,BP,
8317,GO:0032305,1,0.94431124293355,0,10,positive regulation of icosanoid secretion,BP,
8318,GO:0032306,1,0.965281130615131,0,7,regulation of prostaglandin secretion,BP,
8319,GO:0032308,1,0.965281130615131,0,7,positive regulation of prostaglandin secretion,BP,
8320,GO:0032309,1,0.846838835355119,0,28,icosanoid secretion,BP,
8321,GO:0032310,1,0.944497288960311,0,10,prostaglandin secretion,BP,
8322,GO:0032311,1,0.99143369299433,0,2,angiogenin-PRI complex,CC,
8323,GO:0032324,1,0.960130051502271,0,7,molybdopterin cofactor biosynthetic process,BP,
8325,GO:0032329,1,0.946488356386164,0,10,serine transport,BP,
8326,GO:0032330,1,0.742320789234229,0,42,regulation of chondrocyte differentiation,BP,
8327,GO:0032331,1,0.895334887391926,0,17,negative regulation of chondrocyte differentiation,BP,
8328,GO:0032332,1,0.872172200999353,0,19,positive regulation of chondrocyte differentiation,BP,
8329,GO:0032341,1,0.952071500069949,0,7,aldosterone metabolic process,BP,
8330,GO:0032342,1,0.952071500069949,0,7,aldosterone biosynthetic process,BP,
8331,GO:0032344,1,0.962846963900429,0,6,regulation of aldosterone metabolic process,BP,
8332,GO:0032345,1,0.975881362004158,0,4,negative regulation of aldosterone metabolic process,BP,
8333,GO:0032346,1,0.986646731929135,0,2,positive regulation of aldosterone metabolic process,BP,
8334,GO:0032347,1,0.962846963900429,0,6,regulation of aldosterone biosynthetic process,BP,
8335,GO:0032348,1,0.975881362004158,0,4,negative regulation of aldosterone biosynthetic process,BP,
8336,GO:0032349,1,0.986646731929135,0,2,positive regulation of aldosterone biosynthetic process,BP,
8337,GO:0032350,1,0.822383198055219,0,31,regulation of hormone metabolic process,BP,
8338,GO:0032351,1,0.93691923197611,0,11,negative regulation of hormone metabolic process,BP,
8339,GO:0032352,1,0.925275813875571,0,12,positive regulation of hormone metabolic process,BP,
8340,GO:0032353,1,0.940707492964344,0,10,negative regulation of hormone biosynthetic process,BP,
8341,GO:0032354,1,0.897552129391771,0,14,response to follicle-stimulating hormone,BP,
8343,GO:0032356,1,0.938544295135192,0,10,oxidized DNA binding,MF,
8344,GO:0032357,1,0.943400029800118,0,9,oxidized purine DNA binding,MF,
8345,GO:0032358,1,0.996454469426125,0,1,oxidized pyrimidine DNA binding,MF,
8346,GO:0032361,1,0.994997637646617,0,1,pyridoxal phosphate catabolic process,BP,
8347,GO:0032364,1,0.96214453429598,0,6,oxygen homeostasis,BP,
8348,GO:0032365,1,0.811056352845884,0,29,intracellular lipid transport,BP,
8349,GO:0032366,1,0.880987379075156,0,18,intracellular sterol transport,BP,
8350,GO:0032367,1,0.880987379075156,0,18,intracellular cholesterol transport,BP,
8351,GO:0032368,1,0.578817227171232,0,82,regulation of lipid transport,BP,
8352,GO:0032369,1,0.875964384042954,0,19,negative regulation of lipid transport,BP,
8353,GO:0032370,1,0.737664075435159,0,47,positive regulation of lipid transport,BP,
8354,GO:0032371,1,0.792098362269965,0,35,regulation of sterol transport,BP,
8355,GO:0032372,1,0.954471796025716,0,8,negative regulation of sterol transport,BP,
8356,GO:0032373,1,0.875044965483897,0,18,positive regulation of sterol transport,BP,
8357,GO:0032374,1,0.792098362269965,0,35,regulation of cholesterol transport,BP,
8358,GO:0032375,1,0.954471796025716,0,8,negative regulation of cholesterol transport,BP,
8359,GO:0032376,1,0.875044965483897,0,18,positive regulation of cholesterol transport,BP,
8360,GO:0032377,1,0.955533232872346,0,7,regulation of intracellular lipid transport,BP,
8361,GO:0032378,1,0.993157964039784,0,1,negative regulation of intracellular lipid transport,BP,
8362,GO:0032379,1,0.985138189348,0,3,positive regulation of intracellular lipid transport,BP,
8363,GO:0032380,1,0.955533232872346,0,7,regulation of intracellular sterol transport,BP,
8364,GO:0032381,1,0.993157964039784,0,1,negative regulation of intracellular sterol transport,BP,
8365,GO:0032382,1,0.985138189348,0,3,positive regulation of intracellular sterol transport,BP,
8366,GO:0032383,1,0.955533232872346,0,7,regulation of intracellular cholesterol transport,BP,
8367,GO:0032384,1,0.993157964039784,0,1,negative regulation of intracellular cholesterol transport,BP,
8368,GO:0032385,1,0.985138189348,0,3,positive regulation of intracellular cholesterol transport,BP,
8372,GO:0032389,1,0.973108124313901,0,4,MutLalpha complex,CC,
8373,GO:0032391,1,0.79343285849552,0,32,photoreceptor connecting cilium,CC,
8375,GO:0032393,1,0.966547390666985,0,7,MHC class I receptor activity,MF,
8376,GO:0032394,1,0.995534586945707,0,1,MHC class Ib receptor activity,MF,
8377,GO:0032395,1,0.960391016464442,0,9,MHC class II receptor activity,MF,
8378,GO:0032396,1,0.983052156560881,0,3,inhibitory MHC class I receptor activity,MF,
8379,GO:0032397,1,0.995664688661669,0,1,activating MHC class I receptor activity,MF,
8380,GO:0032398,1,0.995407206863603,0,1,MHC class Ib protein complex,CC,
8381,GO:0032400,1,0.851248834808713,0,26,melanosome localization,BP,
8382,GO:0032401,1,0.861191848095233,0,24,establishment of melanosome localization,BP,
8383,GO:0032402,1,0.870403326592411,0,23,melanosome transport,BP,
8384,GO:0032404,1,0.950721496777581,0,8,mismatch repair complex binding,MF,
8385,GO:0032405,1,0.966499082154431,0,5,MutLalpha complex binding,MF,
8386,GO:0032407,1,0.968072015507164,0,5,MutSalpha complex binding,MF,
8388,GO:0032410,1,0.647973980094753,0,67,negative regulation of transporter activity,BP,
8391,GO:0032413,1,0.67920407874428,0,60,negative regulation of ion transmembrane transporter activity,BP,
8393,GO:0032415,1,0.974256429654368,0,5,regulation of sodium:proton antiporter activity,BP,
8394,GO:0032416,1,0.994995102249062,0,1,negative regulation of sodium:proton antiporter activity,BP,
8395,GO:0032417,1,0.979158057350084,0,4,positive regulation of sodium:proton antiporter activity,BP,
8397,GO:0032419,1,0.994706480646018,0,1,extrinsic component of lysosome membrane,CC,
8398,GO:0032420,1,0.753759479326636,0,39,stereocilium,CC,
8399,GO:0032421,1,0.731903579621578,0,44,stereocilium bundle,CC,
8400,GO:0032422,1,0.971869169630248,0,4,purine-rich negative regulatory element binding,MF,
8401,GO:0032423,1,0.979752987693293,0,3,regulation of mismatch repair,BP,
8402,GO:0032425,1,0.987070681353366,0,2,positive regulation of mismatch repair,BP,
8403,GO:0032426,1,0.904914151912184,0,15,stereocilium tip,CC,
8404,GO:0032427,1,0.987117339826337,0,2,GBD domain binding,MF,
8405,GO:0032428,1,0.993218919116147,0,1,beta-N-acetylgalactosaminidase activity,MF,
8406,GO:0032429,1,0.943863951236097,0,8,regulation of phospholipase A2 activity,BP,
8407,GO:0032430,1,0.972274738314594,0,5,positive regulation of phospholipase A2 activity,BP,
8408,GO:0032431,1,0.985576872648642,0,3,activation of phospholipase A2 activity,BP,
8410,GO:0032433,1,0.877646542322429,0,16,filopodium tip,CC,
8411,GO:0032434,1,0.481497292903604,0,113,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8412,GO:0032435,1,0.842012255219633,0,27,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8413,GO:0032436,1,0.602679570937602,0,78,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8414,GO:0032437,1,0.959060514292977,0,5,cuticular plate,CC,
8415,GO:0032438,1,0.843819334501075,0,26,melanosome organization,BP,
8416,GO:0032440,1,0.995943035099801,0,1,2-alkenal reductase [NAD(P)] activity,MF,
8417,GO:0032444,1,0.969954644481072,0,3,activin responsive factor complex,CC,
8418,GO:0032445,1,0.994596954618774,0,1,fructose import,BP,
8420,GO:0032447,1,0.994433621392918,0,1,protein urmylation,BP,
8421,GO:0032448,1,0.995530809509173,0,1,DNA hairpin binding,MF,
8422,GO:0032449,1,0.967296643040258,0,5,CBM complex,CC,
8423,GO:0032450,1,0.975933102010754,0,3,maltose alpha-glucosidase activity,MF,
8424,GO:0032451,1,0.764520546551714,0,34,demethylase activity,MF,
8425,GO:0032452,1,0.804813099148314,0,25,histone demethylase activity,MF,
8426,GO:0032453,1,0.946267355170415,0,6,histone demethylase activity (H3-K4 specific),MF,
8427,GO:0032454,1,0.906040012461445,0,12,histone demethylase activity (H3-K9 specific),MF,
8428,GO:0032455,1,0.975964217716038,0,4,nerve growth factor processing,BP,
8429,GO:0032456,1,0.784566034921708,0,34,endocytic recycling,BP,
8430,GO:0032458,1,0.992935258500989,0,1,slow endocytic recycling,BP,
8433,GO:0032461,1,0.885341554817655,0,21,positive regulation of protein oligomerization,BP,
8436,GO:0032464,1,0.960225019571601,0,7,positive regulation of protein homooligomerization,BP,
8437,GO:0032465,1,0.589023054962068,0,73,regulation of cytokinesis,BP,
8438,GO:0032466,1,0.957465197341804,0,7,negative regulation of cytokinesis,BP,
8439,GO:0032467,1,0.816623828793101,0,29,positive regulation of cytokinesis,BP,
8440,GO:0032468,1,0.993296834537137,0,1,Golgi calcium ion homeostasis,BP,
8441,GO:0032469,1,0.867140104653678,0,21,endoplasmic reticulum calcium ion homeostasis,BP,
8442,GO:0032470,1,0.982025570471237,0,2,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
8443,GO:0032471,1,0.955177186651743,0,8,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
8444,GO:0032472,1,0.988373024014109,0,2,Golgi calcium ion transport,BP,
8445,GO:0032473,1,0.987748176584163,0,1,cytoplasmic side of mitochondrial outer membrane,CC,
8446,GO:0032474,1,0.979355271738803,0,3,otolith morphogenesis,BP,
8447,GO:0032475,1,0.994202771880615,0,1,otolith formation,BP,
8448,GO:0032479,1,0.471622447795293,0,115,regulation of type I interferon production,BP,
8449,GO:0032480,1,0.745608754949906,0,45,negative regulation of type I interferon production,BP,
8450,GO:0032481,1,0.632763169308007,0,69,positive regulation of type I interferon production,BP,
8451,GO:0032482,1,0.674838794242195,0,68,Rab protein signal transduction,BP,
8452,GO:0032483,1,0.969460297276161,0,4,regulation of Rab protein signal transduction,BP,
8453,GO:0032484,1,0.975212975013996,0,3,Ral protein signal transduction,BP,
8454,GO:0032485,1,0.975212975013996,0,3,regulation of Ral protein signal transduction,BP,
8455,GO:0032486,1,0.904825004346339,0,13,Rap protein signal transduction,BP,
8456,GO:0032487,1,0.975256099622778,0,3,regulation of Rap protein signal transduction,BP,
8457,GO:0032488,1,0.912010611329245,0,14,Cdc42 protein signal transduction,BP,
8458,GO:0032489,1,0.961440415504236,0,6,regulation of Cdc42 protein signal transduction,BP,
8459,GO:0032490,1,0.919713048471685,0,12,detection of molecule of bacterial origin,BP,
8460,GO:0032493,1,0.946408954826345,0,8,response to bacterial lipoprotein,BP,
8461,GO:0032494,1,0.939593507392022,0,10,response to peptidoglycan,BP,
8462,GO:0032495,1,0.903513484191351,0,14,response to muramyl dipeptide,BP,
8464,GO:0032497,1,0.978467173880801,0,4,detection of lipopolysaccharide,BP,
8465,GO:0032498,1,0.992336875245075,0,1,detection of muramyl dipeptide,BP,
8466,GO:0032499,1,0.988558865181603,0,2,detection of peptidoglycan,BP,
8467,GO:0032500,1,0.992336875245075,0,1,muramyl dipeptide binding,MF,
8471,GO:0032506,1,0.852478049645722,0,23,cytokinetic process,BP,
8472,GO:0032507,1,0.594074334511658,0,72,maintenance of protein location in cell,BP,
8474,GO:0032509,1,0.875157120801632,0,21,endosome transport via multivesicular body sorting pathway,BP,
8475,GO:0032510,1,0.954756625338202,0,6,endosome to lysosome transport via multivesicular body sorting pathway,BP,
8476,GO:0032511,1,0.958250579530312,0,8,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
8478,GO:0032516,1,0.88276025429593,0,16,positive regulation of phosphoprotein phosphatase activity,BP,
8479,GO:0032525,1,0.944032611653296,0,9,somite rostral/caudal axis specification,BP,
8481,GO:0032527,1,0.769905789532179,0,39,protein exit from endoplasmic reticulum,BP,
8482,GO:0032528,1,0.845334372867582,0,23,microvillus organization,BP,
8483,GO:0032530,1,0.920106000985735,0,12,regulation of microvillus organization,BP,
8484,GO:0032532,1,0.963505319403391,0,6,regulation of microvillus length,BP,
8485,GO:0032534,1,0.954973368151549,0,6,regulation of microvillus assembly,BP,
8486,GO:0032535,1,0.0933032978865891,0,335,regulation of cellular component size,BP,
8487,GO:0032536,1,0.9288773811261,0,11,regulation of cell projection size,BP,
8488,GO:0032541,1,0.971257978004957,0,5,cortical endoplasmic reticulum,CC,
8489,GO:0032542,1,0.987651131940629,0,2,sulfiredoxin activity,MF,
8490,GO:0032543,1,0.542117951402915,0,127,mitochondrial translation,BP,
8491,GO:0032545,1,0.988659355699934,0,2,CURI complex,CC,
8494,GO:0032551,1,0.985583851178493,0,2,pyrimidine ribonucleoside binding,MF,
8495,GO:0032552,1,0.969702288606431,0,6,deoxyribonucleotide binding,MF,
8497,GO:0032554,1,0.97822218837118,0,4,purine deoxyribonucleotide binding,MF,
8499,GO:0032556,1,0.991292357064011,0,2,pyrimidine deoxyribonucleotide binding,MF,
8500,GO:0032557,1,0.98047596304424,0,3,pyrimidine ribonucleotide binding,MF,
8501,GO:0032558,1,0.984527422422119,0,3,adenyl deoxyribonucleotide binding,MF,
8503,GO:0032560,1,0.993596680715339,0,1,guanyl deoxyribonucleotide binding,MF,
8505,GO:0032564,1,0.984527422422119,0,3,dATP binding,MF,
8506,GO:0032567,1,0.993596680715339,0,1,dGTP binding,MF,
8507,GO:0032570,1,0.779708278625507,0,41,response to progesterone,BP,
8508,GO:0032571,1,0.978645651613348,0,4,response to vitamin K,BP,
8509,GO:0032574,1,0.992850004942848,0,1,5'-3' RNA helicase activity,MF,
8510,GO:0032575,1,0.992850004942848,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
8511,GO:0032580,1,0.596682314565004,0,78,Golgi cisterna membrane,CC,
8512,GO:0032581,1,0.995196282022219,0,1,ER-dependent peroxisome organization,BP,
8513,GO:0032584,1,0.963649545985907,0,6,growth cone membrane,CC,
8514,GO:0032585,1,0.950683823939617,0,9,multivesicular body membrane,CC,
8516,GO:0032588,1,0.605879787909699,0,79,trans-Golgi network membrane,CC,
8520,GO:0032592,1,0.694431693077376,0,65,integral component of mitochondrial membrane,CC,
8521,GO:0032593,1,0.950059464621698,0,7,insulin-responsive compartment,CC,
8523,GO:0032596,1,0.968882055810557,0,5,protein transport into membrane raft,BP,
8524,GO:0032601,1,0.995906852572358,0,1,connective tissue growth factor production,BP,
8525,GO:0032602,1,0.652045352221349,0,74,chemokine production,BP,
8526,GO:0032603,1,0.996365403665788,0,1,fractalkine production,BP,
8527,GO:0032604,1,0.931067310938023,0,12,granulocyte macrophage colony-stimulating factor production,BP,
8528,GO:0032605,1,0.993596680715339,0,1,hepatocyte growth factor production,BP,
8529,GO:0032606,1,0.469578640811759,0,116,type I interferon production,BP,
8530,GO:0032607,1,0.833157241707561,0,26,interferon-alpha production,BP,
8531,GO:0032608,1,0.734665742264991,0,47,interferon-beta production,BP,
8532,GO:0032609,1,0.590171631609742,0,91,interferon-gamma production,BP,
8533,GO:0032610,1,0.967387634424887,0,7,interleukin-1 alpha production,BP,
8534,GO:0032611,1,0.70061923920807,0,59,interleukin-1 beta production,BP,
8535,GO:0032612,1,0.654506050832688,0,72,interleukin-1 production,BP,
8536,GO:0032613,1,0.786892477702333,0,42,interleukin-10 production,BP,
8537,GO:0032615,1,0.741311837886608,0,49,interleukin-12 production,BP,
8538,GO:0032616,1,0.902411279057584,0,17,interleukin-13 production,BP,
8539,GO:0032618,1,0.990701747725731,0,2,interleukin-15 production,BP,
8540,GO:0032620,1,0.893985188502463,0,20,interleukin-17 production,BP,
8541,GO:0032621,1,0.947677386292906,0,8,interleukin-18 production,BP,
8542,GO:0032623,1,0.700194559131507,0,56,interleukin-2 production,BP,
8543,GO:0032625,1,0.993233966495427,0,1,interleukin-21 production,BP,
8544,GO:0032627,1,0.968373959329914,0,5,interleukin-23 production,BP,
8545,GO:0032632,1,0.979481482715529,0,3,interleukin-3 production,BP,
8546,GO:0032633,1,0.830233873886993,0,31,interleukin-4 production,BP,
8547,GO:0032634,1,0.908059937196937,0,15,interleukin-5 production,BP,
8548,GO:0032635,1,0.522067898492494,0,105,interleukin-6 production,BP,
8550,GO:0032639,1,0.989213416581716,0,2,TRAIL production,BP,
8551,GO:0032640,1,0.509574959133054,0,110,tumor necrosis factor production,BP,
8552,GO:0032641,1,0.98785889206834,0,2,lymphotoxin A production,BP,
8553,GO:0032642,1,0.674309434988651,0,67,regulation of chemokine production,BP,
8554,GO:0032643,1,0.995906852572358,0,1,regulation of connective tissue growth factor production,BP,
8555,GO:0032644,1,0.996365403665788,0,1,regulation of fractalkine production,BP,
8556,GO:0032645,1,0.935426791549494,0,11,regulation of granulocyte macrophage colony-stimulating factor production,BP,
8557,GO:0032646,1,0.993596680715339,0,1,regulation of hepatocyte growth factor production,BP,
8558,GO:0032647,1,0.836762478775511,0,25,regulation of interferon-alpha production,BP,
8559,GO:0032648,1,0.743088969400858,0,45,regulation of interferon-beta production,BP,
8560,GO:0032649,1,0.63326290566585,0,80,regulation of interferon-gamma production,BP,
8561,GO:0032650,1,0.970549448578465,0,6,regulation of interleukin-1 alpha production,BP,
8562,GO:0032651,1,0.741052640543695,0,51,regulation of interleukin-1 beta production,BP,
8563,GO:0032652,1,0.694575373227252,0,63,regulation of interleukin-1 production,BP,
8564,GO:0032653,1,0.796463195894696,0,40,regulation of interleukin-10 production,BP,
8566,GO:0032656,1,0.905970705533909,0,16,regulation of interleukin-13 production,BP,
8567,GO:0032658,1,0.995274312942595,0,1,regulation of interleukin-15 production,BP,
8568,GO:0032660,1,0.90796563101127,0,17,regulation of interleukin-17 production,BP,
8569,GO:0032661,1,0.961719301472285,0,6,regulation of interleukin-18 production,BP,
8570,GO:0032663,1,0.730483717111893,0,49,regulation of interleukin-2 production,BP,
8571,GO:0032667,1,0.968373959329914,0,5,regulation of interleukin-23 production,BP,
8572,GO:0032672,1,0.986438146720844,0,2,regulation of interleukin-3 production,BP,
8573,GO:0032673,1,0.865477080749448,0,25,regulation of interleukin-4 production,BP,
8574,GO:0032674,1,0.908059937196937,0,15,regulation of interleukin-5 production,BP,
8575,GO:0032675,1,0.551064365591038,0,97,regulation of interleukin-6 production,BP,
8576,GO:0032677,1,0.719397182683697,0,55,regulation of interleukin-8 production,BP,
8577,GO:0032679,1,0.989213416581716,0,2,regulation of TRAIL production,BP,
8578,GO:0032680,1,0.518716902266883,0,107,regulation of tumor necrosis factor production,BP,
8579,GO:0032681,1,0.994122989481126,0,1,regulation of lymphotoxin A production,BP,
8580,GO:0032682,1,0.919661512372613,0,16,negative regulation of chemokine production,BP,
8581,GO:0032685,1,0.99352943047969,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
8582,GO:0032686,1,0.993596680715339,0,1,negative regulation of hepatocyte growth factor production,BP,
8583,GO:0032687,1,0.962303096372562,0,6,negative regulation of interferon-alpha production,BP,
8584,GO:0032688,1,0.917925749557256,0,14,negative regulation of interferon-beta production,BP,
8585,GO:0032689,1,0.863417082213309,0,26,negative regulation of interferon-gamma production,BP,
8586,GO:0032690,1,0.995717992415467,0,1,negative regulation of interleukin-1 alpha production,BP,
8587,GO:0032691,1,0.921963867549268,0,15,negative regulation of interleukin-1 beta production,BP,
8588,GO:0032692,1,0.892148052662779,0,21,negative regulation of interleukin-1 production,BP,
8589,GO:0032693,1,0.927019189011141,0,14,negative regulation of interleukin-10 production,BP,
8590,GO:0032695,1,0.899926913231538,0,16,negative regulation of interleukin-12 production,BP,
8591,GO:0032696,1,0.98159665797204,0,3,negative regulation of interleukin-13 production,BP,
8592,GO:0032700,1,0.948172930096923,0,9,negative regulation of interleukin-17 production,BP,
8593,GO:0032701,1,0.989028765299963,0,2,negative regulation of interleukin-18 production,BP,
8594,GO:0032703,1,0.891525888261589,0,19,negative regulation of interleukin-2 production,BP,
8595,GO:0032707,1,0.985770898656753,0,2,negative regulation of interleukin-23 production,BP,
8596,GO:0032712,1,0.994595716009891,0,1,negative regulation of interleukin-3 production,BP,
8597,GO:0032713,1,0.969412236614624,0,5,negative regulation of interleukin-4 production,BP,
8598,GO:0032714,1,0.981157957862134,0,3,negative regulation of interleukin-5 production,BP,
8599,GO:0032715,1,0.814755443408424,0,33,negative regulation of interleukin-6 production,BP,
8600,GO:0032717,1,0.909879704198141,0,16,negative regulation of interleukin-8 production,BP,
8601,GO:0032720,1,0.783912544161216,0,43,negative regulation of tumor necrosis factor production,BP,
8602,GO:0032722,1,0.740055142047868,0,50,positive regulation of chemokine production,BP,
8603,GO:0032723,1,0.995906852572358,0,1,positive regulation of connective tissue growth factor production,BP,
8604,GO:0032724,1,0.996365403665788,0,1,positive regulation of fractalkine production,BP,
8605,GO:0032725,1,0.941522677313027,0,10,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,
8606,GO:0032727,1,0.869588686324932,0,19,positive regulation of interferon-alpha production,BP,
8607,GO:0032728,1,0.821739346388664,0,29,positive regulation of interferon-beta production,BP,
8608,GO:0032729,1,0.72491567029381,0,55,positive regulation of interferon-gamma production,BP,
8609,GO:0032730,1,0.974724305126584,0,5,positive regulation of interleukin-1 alpha production,BP,
8610,GO:0032731,1,0.820478536312709,0,32,positive regulation of interleukin-1 beta production,BP,
8611,GO:0032732,1,0.79305888034428,0,38,positive regulation of interleukin-1 production,BP,
8612,GO:0032733,1,0.852213966244671,0,28,positive regulation of interleukin-10 production,BP,
8613,GO:0032735,1,0.847685991155325,0,29,positive regulation of interleukin-12 production,BP,
8614,GO:0032736,1,0.922970075020487,0,13,positive regulation of interleukin-13 production,BP,
8615,GO:0032738,1,0.995274312942595,0,1,positive regulation of interleukin-15 production,BP,
8616,GO:0032740,1,0.952584294333979,0,9,positive regulation of interleukin-17 production,BP,
8617,GO:0032741,1,0.97869790253691,0,3,positive regulation of interleukin-18 production,BP,
8618,GO:0032743,1,0.823654481069582,0,29,positive regulation of interleukin-2 production,BP,
8619,GO:0032747,1,0.987543149390347,0,2,positive regulation of interleukin-23 production,BP,
8620,GO:0032752,1,0.991798552389647,0,1,positive regulation of interleukin-3 production,BP,
8621,GO:0032753,1,0.887972252750181,0,21,positive regulation of interleukin-4 production,BP,
8622,GO:0032754,1,0.930192134843648,0,11,positive regulation of interleukin-5 production,BP,
8623,GO:0032755,1,0.675563679075117,0,64,positive regulation of interleukin-6 production,BP,
8624,GO:0032757,1,0.787055466565718,0,40,positive regulation of interleukin-8 production,BP,
8625,GO:0032759,1,0.989213416581716,0,2,positive regulation of TRAIL production,BP,
8626,GO:0032760,1,0.667232619059194,0,64,positive regulation of tumor necrosis factor production,BP,
8627,GO:0032761,1,0.994122989481126,0,1,positive regulation of lymphotoxin A production,BP,
8629,GO:0032763,1,0.971144384348772,0,5,regulation of mast cell cytokine production,BP,
8630,GO:0032764,1,0.988863010339949,0,2,negative regulation of mast cell cytokine production,BP,
8631,GO:0032765,1,0.982083829534587,0,3,positive regulation of mast cell cytokine production,BP,
8632,GO:0032767,1,0.978530983440779,0,3,copper-dependent protein binding,MF,
8635,GO:0032770,1,0.872749027989238,0,23,positive regulation of monooxygenase activity,BP,
8636,GO:0032771,1,0.992537751672478,0,1,regulation of monophenol monooxygenase activity,BP,
8637,GO:0032773,1,0.992537751672478,0,1,positive regulation of monophenol monooxygenase activity,BP,
8639,GO:0032775,1,0.993125185721406,0,1,DNA methylation on adenine,BP,
8640,GO:0032776,1,0.976997054175694,0,3,DNA methylation on cytosine,BP,
8641,GO:0032777,1,0.977318401911596,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
8642,GO:0032780,1,0.931381303203183,0,13,negative regulation of ATPase activity,BP,
8643,GO:0032781,1,0.752728081097818,0,51,positive regulation of ATPase activity,BP,
8644,GO:0032782,1,0.977084994917032,0,4,bile acid secretion,BP,
8645,GO:0032783,1,0.938106135897427,0,6,ELL-EAF complex,CC,
8646,GO:0032784,1,0.772374311232124,0,41,regulation of DNA-templated transcription, elongation,BP,
8647,GO:0032785,1,0.920845814286964,0,13,negative regulation of DNA-templated transcription, elongation,BP,
8648,GO:0032786,1,0.86480101073918,0,23,positive regulation of DNA-templated transcription, elongation,BP,
8650,GO:0032788,1,0.995471581200991,0,1,saturated monocarboxylic acid metabolic process,BP,
8651,GO:0032789,1,0.995471581200991,0,1,unsaturated monocarboxylic acid metabolic process,BP,
8652,GO:0032790,1,0.949493210889977,0,8,ribosome disassembly,BP,
8653,GO:0032792,1,0.969467219873585,0,5,negative regulation of CREB transcription factor activity,BP,
8654,GO:0032793,1,0.901416594674844,0,14,positive regulation of CREB transcription factor activity,BP,
8655,GO:0032794,1,0.894806623634028,0,14,GTPase activating protein binding,MF,
8656,GO:0032795,1,0.983175491407797,0,3,heterotrimeric G-protein binding,MF,
8657,GO:0032796,1,0.984869458482184,0,2,uropod organization,BP,
8658,GO:0032797,1,0.932513389833489,0,12,SMN complex,CC,
8659,GO:0032798,1,0.988144472527205,0,2,Swi5-Sfr1 complex,CC,
8660,GO:0032799,1,0.871469150985396,0,21,low-density lipoprotein receptor particle metabolic process,BP,
8661,GO:0032800,1,0.85712272969883,0,23,receptor biosynthetic process,BP,
8662,GO:0032801,1,0.795432699413152,0,32,receptor catabolic process,BP,
8663,GO:0032802,1,0.91981620767474,0,13,low-density lipoprotein particle receptor catabolic process,BP,
8664,GO:0032803,1,0.97134126584426,0,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,
8665,GO:0032804,1,0.988123863165789,0,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,
8666,GO:0032805,1,0.989220060157091,0,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,
8667,GO:0032806,1,0.858737666392666,0,24,carboxy-terminal domain protein kinase complex,CC,
8668,GO:0032807,1,0.976672372876017,0,4,DNA ligase IV complex,CC,
8669,GO:0032808,1,0.950307110179158,0,7,lacrimal gland development,BP,
8671,GO:0032810,1,0.987457418620605,0,2,sterol response element binding,MF,
8672,GO:0032811,1,0.983999974064609,0,3,negative regulation of epinephrine secretion,BP,
8673,GO:0032812,1,0.996364165823634,0,1,positive regulation of epinephrine secretion,BP,
8674,GO:0032813,1,0.790344582874883,0,43,tumor necrosis factor receptor superfamily binding,MF,
8675,GO:0032814,1,0.878673758502949,0,22,regulation of natural killer cell activation,BP,
8676,GO:0032815,1,0.975945307588514,0,5,negative regulation of natural killer cell activation,BP,
8677,GO:0032816,1,0.923686074079161,0,13,positive regulation of natural killer cell activation,BP,
8678,GO:0032817,1,0.96699675390801,0,6,regulation of natural killer cell proliferation,BP,
8679,GO:0032819,1,0.979528070575767,0,4,positive regulation of natural killer cell proliferation,BP,
8680,GO:0032823,1,0.939792588040541,0,10,regulation of natural killer cell differentiation,BP,
8681,GO:0032824,1,0.996318349227192,0,1,negative regulation of natural killer cell differentiation,BP,
8682,GO:0032825,1,0.95531817793174,0,7,positive regulation of natural killer cell differentiation,BP,
8683,GO:0032826,1,0.991775635780122,0,2,regulation of natural killer cell differentiation involved in immune response,BP,
8684,GO:0032827,1,0.996318349227192,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
8685,GO:0032829,1,0.990020273122603,0,2,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8686,GO:0032831,1,0.990020273122603,0,2,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8687,GO:0032832,1,0.995416049171629,0,1,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8688,GO:0032834,1,0.995416049171629,0,1,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8689,GO:0032835,1,0.664358591512862,0,54,glomerulus development,BP,
8690,GO:0032836,1,0.918571710909141,0,10,glomerular basement membrane development,BP,
8693,GO:0032841,1,0.993182115711814,0,1,calcitonin binding,MF,
8694,GO:0032847,1,0.976728002305485,0,4,regulation of cellular pH reduction,BP,
8695,GO:0032848,1,0.99296254550758,0,1,negative regulation of cellular pH reduction,BP,
8696,GO:0032849,1,0.983651554268856,0,3,positive regulation of cellular pH reduction,BP,
8698,GO:0032869,1,0.271734729808185,0,187,cellular response to insulin stimulus,BP,
8702,GO:0032874,1,0.394445439307132,0,136,positive regulation of stress-activated MAPK cascade,BP,
8703,GO:0032875,1,0.942940911990788,0,7,regulation of DNA endoreduplication,BP,
8704,GO:0032876,1,0.964236325818251,0,4,negative regulation of DNA endoreduplication,BP,
8705,GO:0032877,1,0.984230142510202,0,2,positive regulation of DNA endoreduplication,BP,
8706,GO:0032878,1,0.846887521425825,0,21,regulation of establishment or maintenance of cell polarity,BP,
8709,GO:0032881,1,0.771793392091086,0,33,regulation of polysaccharide metabolic process,BP,
8710,GO:0032885,1,0.783392919121281,0,30,regulation of polysaccharide biosynthetic process,BP,
8712,GO:0032887,1,0.989666133385604,0,1,regulation of spindle elongation,BP,
8713,GO:0032888,1,0.989666133385604,0,1,regulation of mitotic spindle elongation,BP,
8714,GO:0032889,1,0.994346547415406,0,1,regulation of vacuole fusion, non-autophagic,BP,
8716,GO:0032891,1,0.902607622509597,0,15,negative regulation of organic acid transport,BP,
8718,GO:0032897,1,0.880261097075649,0,20,negative regulation of viral transcription,BP,
8719,GO:0032898,1,0.973295793931603,0,4,neurotrophin production,BP,
8720,GO:0032899,1,0.986946366798615,0,2,regulation of neurotrophin production,BP,
8721,GO:0032900,1,0.993981387624088,0,1,negative regulation of neurotrophin production,BP,
8722,GO:0032901,1,0.992922811730033,0,1,positive regulation of neurotrophin production,BP,
8723,GO:0032902,1,0.98617070312561,0,2,nerve growth factor production,BP,
8724,GO:0032905,1,0.937646961562164,0,10,transforming growth factor beta1 production,BP,
8725,GO:0032906,1,0.940905413189127,0,8,transforming growth factor beta2 production,BP,
8726,GO:0032907,1,0.978348505004663,0,2,transforming growth factor beta3 production,BP,
8727,GO:0032908,1,0.937646961562164,0,10,regulation of transforming growth factor beta1 production,BP,
8728,GO:0032909,1,0.940905413189127,0,8,regulation of transforming growth factor beta2 production,BP,
8729,GO:0032910,1,0.978348505004663,0,2,regulation of transforming growth factor beta3 production,BP,
8730,GO:0032911,1,0.972330290194539,0,4,negative regulation of transforming growth factor beta1 production,BP,
8731,GO:0032912,1,0.985887989892401,0,2,negative regulation of transforming growth factor beta2 production,BP,
8732,GO:0032914,1,0.96433961120639,0,6,positive regulation of transforming growth factor beta1 production,BP,
8733,GO:0032915,1,0.989969995537629,0,2,positive regulation of transforming growth factor beta2 production,BP,
8734,GO:0032916,1,0.978348505004663,0,2,positive regulation of transforming growth factor beta3 production,BP,
8735,GO:0032917,1,0.987272784417855,0,3,polyamine acetylation,BP,
8736,GO:0032918,1,0.987272784417855,0,3,spermidine acetylation,BP,
8737,GO:0032919,1,0.996301004705437,0,1,spermine acetylation,BP,
8738,GO:0032920,1,0.996301004705437,0,1,putrescine acetylation,BP,
8739,GO:0032922,1,0.679863513111447,0,50,circadian regulation of gene expression,BP,
8740,GO:0032924,1,0.776442338045186,0,37,activin receptor signaling pathway,BP,
8741,GO:0032925,1,0.859648944856987,0,23,regulation of activin receptor signaling pathway,BP,
8742,GO:0032926,1,0.94393552842292,0,9,negative regulation of activin receptor signaling pathway,BP,
8743,GO:0032927,1,0.937943150338929,0,8,positive regulation of activin receptor signaling pathway,BP,
8744,GO:0032928,1,0.914100943251086,0,16,regulation of superoxide anion generation,BP,
8745,GO:0032929,1,0.991563743503626,0,2,negative regulation of superoxide anion generation,BP,
8746,GO:0032930,1,0.929513538464431,0,13,positive regulation of superoxide anion generation,BP,
8747,GO:0032933,1,0.949304097032069,0,8,SREBP signaling pathway,BP,
8748,GO:0032934,1,0.759622187239297,0,41,sterol binding,MF,
8749,GO:0032937,1,0.981029663582076,0,3,SREBP-SCAP-Insig complex,CC,
8754,GO:0032945,1,0.671256729754902,0,64,negative regulation of mononuclear cell proliferation,BP,
8756,GO:0032947,1,0.542120220570895,0,80,protein-containing complex scaffold activity,MF,
8757,GO:0032954,1,0.984041829712786,0,2,regulation of cytokinetic process,BP,
8758,GO:0032956,1,0.11520310670959,0,306,regulation of actin cytoskeleton organization,BP,
8759,GO:0032957,1,0.943567229707728,0,8,inositol trisphosphate metabolic process,BP,
8760,GO:0032958,1,0.852619177419836,0,24,inositol phosphate biosynthetic process,BP,
8761,GO:0032959,1,0.958649375833769,0,6,inositol trisphosphate biosynthetic process,BP,
8762,GO:0032960,1,0.972966292460258,0,4,regulation of inositol trisphosphate biosynthetic process,BP,
8763,GO:0032962,1,0.980343658205428,0,3,positive regulation of inositol trisphosphate biosynthetic process,BP,
8764,GO:0032963,1,0.484547396290476,0,104,collagen metabolic process,BP,
8765,GO:0032964,1,0.798204764305551,0,35,collagen biosynthetic process,BP,
8766,GO:0032965,1,0.849015608907316,0,27,regulation of collagen biosynthetic process,BP,
8767,GO:0032966,1,0.961215609947618,0,7,negative regulation of collagen biosynthetic process,BP,
8768,GO:0032967,1,0.883316653677036,0,20,positive regulation of collagen biosynthetic process,BP,
8769,GO:0032968,1,0.912511090587875,0,14,positive regulation of transcription elongation from RNA polymerase II promoter,BP,
8770,GO:0032970,1,0.0818593548621242,0,347,regulation of actin filament-based process,BP,
8771,GO:0032971,1,0.979475472419953,0,4,regulation of muscle filament sliding,BP,
8772,GO:0032972,1,0.992731587718709,0,2,regulation of muscle filament sliding speed,BP,
8773,GO:0032976,1,0.996491547285932,0,1,release of matrix enzymes from mitochondria,BP,
8774,GO:0032977,1,0.992305361654249,0,1,membrane insertase activity,MF,
8775,GO:0032978,1,0.992305361654249,0,1,protein insertion into membrane from inner side,BP,
8776,GO:0032979,1,0.992305361654249,0,1,protein insertion into mitochondrial membrane from inner side,BP,
8777,GO:0032980,1,0.994478757464163,0,1,keratinocyte activation,BP,
8778,GO:0032981,1,0.791919179233702,0,55,mitochondrial respiratory chain complex I assembly,BP,
8779,GO:0032982,1,0.849939460451323,0,19,myosin filament,CC,
8780,GO:0032983,1,0.961140231681727,0,5,kainate selective glutamate receptor complex,CC,
8782,GO:0032986,1,0.879645784133868,0,19,protein-DNA complex disassembly,BP,
8783,GO:0032988,1,0.921265400212229,0,13,ribonucleoprotein complex disassembly,BP,
8787,GO:0032993,1,0.456207153274709,0,137,protein-DNA complex,CC,
8788,GO:0032994,1,0.813795507376845,0,34,protein-lipid complex,CC,
8789,GO:0032996,1,0.995168985328852,0,1,Bcl3-Bcl10 complex,CC,
8790,GO:0032997,1,0.992144578224643,0,2,Fc receptor complex,CC,
8791,GO:0032998,1,0.992144578224643,0,2,Fc-epsilon receptor I complex,CC,
8792,GO:0033002,1,0.324681500268015,0,167,muscle cell proliferation,BP,
8795,GO:0033005,1,0.916476418894764,0,15,positive regulation of mast cell activation,BP,
8796,GO:0033006,1,0.855483071019533,0,27,regulation of mast cell activation involved in immune response,BP,
8797,GO:0033007,1,0.964150545312572,0,7,negative regulation of mast cell activation involved in immune response,BP,
8798,GO:0033008,1,0.93497349879958,0,12,positive regulation of mast cell activation involved in immune response,BP,
8799,GO:0033010,1,0.945642058655228,0,7,paranodal junction,CC,
8800,GO:0033011,1,0.989710772190152,0,2,perinuclear theca,CC,
8801,GO:0033013,1,0.731771684813954,0,50,tetrapyrrole metabolic process,BP,
8802,GO:0033014,1,0.846201366717701,0,26,tetrapyrrole biosynthetic process,BP,
8803,GO:0033015,1,0.983590907831834,0,4,tetrapyrrole catabolic process,BP,
8804,GO:0033017,1,0.74839323085536,0,36,sarcoplasmic reticulum membrane,CC,
8805,GO:0033018,1,0.957893941235435,0,7,sarcoplasmic reticulum lumen,CC,
8806,GO:0033023,1,0.981540326677863,0,3,mast cell homeostasis,BP,
8807,GO:0033024,1,0.981540326677863,0,3,mast cell apoptotic process,BP,
8808,GO:0033025,1,0.981540326677863,0,3,regulation of mast cell apoptotic process,BP,
8809,GO:0033026,1,0.988227987643862,0,2,negative regulation of mast cell apoptotic process,BP,
8810,GO:0033028,1,0.842708067281791,0,28,myeloid cell apoptotic process,BP,
8811,GO:0033029,1,0.960180539854653,0,6,regulation of neutrophil apoptotic process,BP,
8812,GO:0033030,1,0.984797355998078,0,2,negative regulation of neutrophil apoptotic process,BP,
8813,GO:0033031,1,0.975006983532489,0,4,positive regulation of neutrophil apoptotic process,BP,
8814,GO:0033032,1,0.8611484042238,0,24,regulation of myeloid cell apoptotic process,BP,
8815,GO:0033033,1,0.925917672074396,0,13,negative regulation of myeloid cell apoptotic process,BP,
8816,GO:0033034,1,0.955206847485315,0,7,positive regulation of myeloid cell apoptotic process,BP,
8818,GO:0033037,1,0.991084745150877,0,1,polysaccharide localization,BP,
8819,GO:0033038,1,0.961241658782511,0,10,bitter taste receptor activity,MF,
8820,GO:0033040,1,0.993740261094865,0,1,sour taste receptor activity,MF,
8821,GO:0033041,1,0.994307000868295,0,1,sweet taste receptor activity,MF,
8828,GO:0033058,1,0.97027070919536,0,3,directional locomotion,BP,
8829,GO:0033059,1,0.710301973961679,0,52,cellular pigmentation,BP,
8830,GO:0033061,1,0.950978826314596,0,9,DNA recombinase mediator complex,CC,
8831,GO:0033063,1,0.962392897726939,0,7,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8832,GO:0033065,1,0.990607644592687,0,2,Rad51C-XRCC3 complex,CC,
8833,GO:0033076,1,0.985687478739472,0,3,isoquinoline alkaloid metabolic process,BP,
8834,GO:0033077,1,0.668549518630607,0,60,T cell differentiation in thymus,BP,
8835,GO:0033078,1,0.982818482378971,0,3,extrathymic T cell differentiation,BP,
8836,GO:0033079,1,0.960694610278674,0,7,immature T cell proliferation,BP,
8837,GO:0033080,1,0.970733190079703,0,5,immature T cell proliferation in thymus,BP,
8838,GO:0033081,1,0.883130296506305,0,20,regulation of T cell differentiation in thymus,BP,
8839,GO:0033082,1,0.987391393963994,0,2,regulation of extrathymic T cell differentiation,BP,
8840,GO:0033083,1,0.967558378580963,0,6,regulation of immature T cell proliferation,BP,
8841,GO:0033084,1,0.977667948844811,0,4,regulation of immature T cell proliferation in thymus,BP,
8842,GO:0033085,1,0.968079225835395,0,6,negative regulation of T cell differentiation in thymus,BP,
8843,GO:0033087,1,0.982825122478799,0,3,negative regulation of immature T cell proliferation,BP,
8844,GO:0033088,1,0.987401828744478,0,2,negative regulation of immature T cell proliferation in thymus,BP,
8845,GO:0033089,1,0.944915803311554,0,9,positive regulation of T cell differentiation in thymus,BP,
8846,GO:0033091,1,0.984469169462017,0,3,positive regulation of immature T cell proliferation,BP,
8847,GO:0033092,1,0.990143183791719,0,2,positive regulation of immature T cell proliferation in thymus,BP,
8848,GO:0033093,1,0.961696274307749,0,5,Weibel-Palade body,CC,
8849,GO:0033106,1,0.984327890748408,0,3,cis-Golgi network membrane,CC,
8850,GO:0033108,1,0.665968033944664,0,87,mitochondrial respiratory chain complex assembly,BP,
8851,GO:0033116,1,0.67650005970394,0,62,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,
8854,GO:0033121,1,0.974730343156418,0,3,regulation of purine nucleotide catabolic process,BP,
8855,GO:0033122,1,0.983749414719515,0,2,negative regulation of purine nucleotide catabolic process,BP,
8856,GO:0033123,1,0.990833449874668,0,1,positive regulation of purine nucleotide catabolic process,BP,
8857,GO:0033127,1,0.921792988810772,0,13,regulation of histone phosphorylation,BP,
8858,GO:0033128,1,0.984826892721672,0,3,negative regulation of histone phosphorylation,BP,
8859,GO:0033129,1,0.94724242401067,0,8,positive regulation of histone phosphorylation,BP,
8860,GO:0033130,1,0.932809180806611,0,10,acetylcholine receptor binding,MF,
8861,GO:0033131,1,0.944265652114738,0,9,regulation of glucokinase activity,BP,
8862,GO:0033132,1,0.978530945234167,0,4,negative regulation of glucokinase activity,BP,
8863,GO:0033133,1,0.964990466236944,0,5,positive regulation of glucokinase activity,BP,
8865,GO:0033137,1,0.862506466616149,0,23,negative regulation of peptidyl-serine phosphorylation,BP,
8867,GO:0033139,1,0.974039435912501,0,4,regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8868,GO:0033140,1,0.995174064163132,0,1,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8869,GO:0033141,1,0.978763910227851,0,3,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8870,GO:0033142,1,0.994759082777834,0,1,progesterone receptor binding,MF,
8871,GO:0033143,1,0.627160952683383,0,70,regulation of intracellular steroid hormone receptor signaling pathway,BP,
8872,GO:0033144,1,0.818764303035333,0,30,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,
8873,GO:0033145,1,0.908599592237272,0,15,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,
8874,GO:0033146,1,0.786738346188637,0,35,regulation of intracellular estrogen receptor signaling pathway,BP,
8875,GO:0033147,1,0.920092494324004,0,12,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8876,GO:0033148,1,0.940248403949331,0,9,positive regulation of intracellular estrogen receptor signaling pathway,BP,
8877,GO:0033149,1,0.983128545206085,0,2,FFAT motif binding,MF,
8878,GO:0033150,1,0.995080104224823,0,1,cytoskeletal calyx,CC,
8879,GO:0033151,1,0.904645224262859,0,12,V(D)J recombination,BP,
8880,GO:0033152,1,0.96576028753396,0,4,immunoglobulin V(D)J recombination,BP,
8881,GO:0033153,1,0.954166822631863,0,5,T cell receptor V(D)J recombination,BP,
8883,GO:0033158,1,0.868410188227607,0,18,regulation of protein import into nucleus, translocation,BP,
8884,GO:0033159,1,0.980388865415992,0,3,negative regulation of protein import into nucleus, translocation,BP,
8885,GO:0033160,1,0.904054561162031,0,11,positive regulation of protein import into nucleus, translocation,BP,
8886,GO:0033162,1,0.944949979295633,0,11,melanosome membrane,CC,
8887,GO:0033165,1,0.988415208145267,0,2,interphotoreceptor matrix,CC,
8888,GO:0033167,1,0.986855058494614,0,1,ARC complex,CC,
8889,GO:0033168,1,0.986855058494614,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8890,GO:0033169,1,0.900865974836118,0,13,histone H3-K9 demethylation,BP,
8891,GO:0033170,1,0.956063954651497,0,8,protein-DNA loading ATPase activity,MF,
8892,GO:0033173,1,0.838185830443063,0,24,calcineurin-NFAT signaling cascade,BP,
8893,GO:0033176,1,0.877988483617562,0,24,proton-transporting V-type ATPase complex,CC,
8894,GO:0033177,1,0.941253161786887,0,11,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8895,GO:0033178,1,0.941239491047735,0,11,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8896,GO:0033179,1,0.945258043089974,0,10,proton-transporting V-type ATPase, V0 domain,CC,
8897,GO:0033180,1,0.949903004413691,0,9,proton-transporting V-type ATPase, V1 domain,CC,
8898,GO:0033181,1,0.989972348919081,0,2,plasma membrane proton-transporting V-type ATPase complex,CC,
8899,GO:0033182,1,0.929941671353364,0,10,regulation of histone ubiquitination,BP,
8900,GO:0033183,1,0.972704693198883,0,3,negative regulation of histone ubiquitination,BP,
8901,GO:0033184,1,0.966510186163405,0,5,positive regulation of histone ubiquitination,BP,
8902,GO:0033185,1,0.98875156866348,0,3,dolichol-phosphate-mannose synthase complex,CC,
8903,GO:0033186,1,0.977211628628763,0,3,CAF-1 complex,CC,
8904,GO:0033188,1,0.979502851299741,0,3,sphingomyelin synthase activity,MF,
8905,GO:0033189,1,0.917943746464945,0,15,response to vitamin A,BP,
8906,GO:0033192,1,0.961687977964337,0,5,calmodulin-dependent protein phosphatase activity,MF,
8907,GO:0033193,1,0.991831979246863,0,1,Lsd1/2 complex,CC,
8908,GO:0033194,1,0.909503868724495,0,16,response to hydroperoxide,BP,
8909,GO:0033197,1,0.932099848475607,0,12,response to vitamin E,BP,
8911,GO:0033202,1,0.922255819377897,0,15,DNA helicase complex,CC,
8912,GO:0033204,1,0.994397819430939,0,1,ribonuclease P RNA binding,MF,
8913,GO:0033206,1,0.962925577319701,0,5,meiotic cytokinesis,BP,
8915,GO:0033210,1,0.946308487101771,0,9,leptin-mediated signaling pathway,BP,
8916,GO:0033211,1,0.970356134551209,0,5,adiponectin-activated signaling pathway,BP,
8917,GO:0033212,1,0.994533977466101,0,1,iron assimilation,BP,
8918,GO:0033214,1,0.994533977466101,0,1,iron assimilation by chelation and transport,BP,
8919,GO:0033216,1,0.959721932299289,0,6,ferric iron import,BP,
8921,GO:0033220,1,0.973461060831402,0,4,amide-transporting ATPase activity,MF,
8922,GO:0033227,1,0.96779245630473,0,5,dsRNA transport,BP,
8923,GO:0033229,1,0.993075180528113,0,1,cysteine transmembrane transporter activity,MF,
8924,GO:0033231,1,0.992825065831946,0,1,carbohydrate export,BP,
8925,GO:0033233,1,0.878855750927385,0,21,regulation of protein sumoylation,BP,
8926,GO:0033234,1,0.940870833079056,0,10,negative regulation of protein sumoylation,BP,
8927,GO:0033235,1,0.934349634021967,0,11,positive regulation of protein sumoylation,BP,
8928,GO:0033238,1,0.687742468664783,0,72,regulation of cellular amine metabolic process,BP,
8929,GO:0033239,1,0.960897897786944,0,5,negative regulation of cellular amine metabolic process,BP,
8930,GO:0033240,1,0.951518420214094,0,9,positive regulation of cellular amine metabolic process,BP,
8931,GO:0033241,1,0.988143720671723,0,1,regulation of cellular amine catabolic process,BP,
8932,GO:0033242,1,0.988143720671723,0,1,negative regulation of cellular amine catabolic process,BP,
8933,GO:0033256,1,0.961030924289482,0,7,I-kappaB/NF-kappaB complex,CC,
8934,GO:0033257,1,0.988934979734212,0,2,Bcl3/NF-kappaB2 complex,CC,
8935,GO:0033260,1,0.737823382290456,0,49,nuclear DNA replication,BP,
8936,GO:0033262,1,0.917612324127552,0,12,regulation of nuclear cell cycle DNA replication,BP,
8937,GO:0033263,1,0.970776889031351,0,4,CORVET complex,CC,
8938,GO:0033265,1,0.988625290853058,0,2,choline binding,MF,
8940,GO:0033268,1,0.876601119057744,0,15,node of Ranvier,CC,
8941,GO:0033269,1,0.974757571144867,0,4,internode region of axon,CC,
8942,GO:0033270,1,0.90317244646827,0,12,paranode region of axon,CC,
8943,GO:0033273,1,0.592846234985484,0,84,response to vitamin,BP,
8944,GO:0033274,1,0.989711097884374,0,1,response to vitamin B2,BP,
8945,GO:0033275,1,0.775044221585733,0,35,actin-myosin filament sliding,BP,
8946,GO:0033276,1,0.917746385250329,0,13,transcription factor TFTC complex,CC,
8947,GO:0033277,1,0.985274398291686,0,2,abortive mitotic cell cycle,BP,
8948,GO:0033278,1,0.965231323139391,0,5,cell proliferation in midbrain,BP,
8949,GO:0033280,1,0.803461232384144,0,33,response to vitamin D,BP,
8950,GO:0033283,1,0.985344617528228,0,2,organic acid-transporting ATPase activity,MF,
8951,GO:0033284,1,0.985344617528228,0,2,carboxylic acid-transporting ATPase activity,MF,
8952,GO:0033285,1,0.985344617528228,0,2,monocarboxylic acid-transporting ATPase activity,MF,
8953,GO:0033290,1,0.992654416442618,0,1,eukaryotic 48S preinitiation complex,CC,
8954,GO:0033291,1,0.997030560087482,0,1,eukaryotic 80S initiation complex,CC,
8955,GO:0033292,1,0.977609972939991,0,2,T-tubule organization,BP,
8956,GO:0033293,1,0.744454397543293,0,51,monocarboxylic acid binding,MF,
8957,GO:0033299,1,0.971171718498742,0,5,secretion of lysosomal enzymes,BP,
8958,GO:0033300,1,0.979489367889254,0,3,dehydroascorbic acid transmembrane transporter activity,MF,
8959,GO:0033301,1,0.9930828650798,0,1,cell cycle comprising mitosis without cytokinesis,BP,
8960,GO:0033306,1,0.988227903578437,0,2,phytol metabolic process,BP,
8961,GO:0033313,1,0.969277714753588,0,5,meiotic cell cycle checkpoint,BP,
8962,GO:0033314,1,0.952685485191732,0,8,mitotic DNA replication checkpoint,BP,
8963,GO:0033316,1,0.993772597113732,0,1,meiotic spindle assembly checkpoint,BP,
8964,GO:0033319,1,0.99488247093418,0,1,UDP-D-xylose metabolic process,BP,
8965,GO:0033320,1,0.99488247093418,0,1,UDP-D-xylose biosynthetic process,BP,
8966,GO:0033326,1,0.986038502761051,0,2,cerebrospinal fluid secretion,BP,
8967,GO:0033327,1,0.937669601388684,0,10,Leydig cell differentiation,BP,
8968,GO:0033328,1,0.993183566280531,0,1,peroxisome membrane targeting sequence binding,MF,
8969,GO:0033341,1,0.983422839907231,0,2,regulation of collagen binding,BP,
8970,GO:0033342,1,0.994347749486269,0,1,negative regulation of collagen binding,BP,
8971,GO:0033343,1,0.989013614120866,0,1,positive regulation of collagen binding,BP,
8972,GO:0033344,1,0.79642900070189,0,32,cholesterol efflux,BP,
8973,GO:0033345,1,0.994523520990386,0,1,asparagine catabolic process via L-aspartate,BP,
8974,GO:0033353,1,0.972962989733638,0,4,S-adenosylmethionine cycle,BP,
8976,GO:0033364,1,0.980140776721123,0,2,mast cell secretory granule organization,BP,
8977,GO:0033365,1,0.00626068604896238,0,780,protein localization to organelle,BP,
8978,GO:0033366,1,0.995945529443944,0,1,protein localization to secretory granule,BP,
8979,GO:0033367,1,0.995945529443944,0,1,protein localization to mast cell secretory granule,BP,
8980,GO:0033368,1,0.995945529443944,0,1,protease localization to mast cell secretory granule,BP,
8981,GO:0033370,1,0.995945529443944,0,1,maintenance of protein location in mast cell secretory granule,BP,
8982,GO:0033371,1,0.995945529443944,0,1,T cell secretory granule organization,BP,
8983,GO:0033373,1,0.995945529443944,0,1,maintenance of protease location in mast cell secretory granule,BP,
8984,GO:0033374,1,0.995945529443944,0,1,protein localization to T cell secretory granule,BP,
8985,GO:0033375,1,0.995945529443944,0,1,protease localization to T cell secretory granule,BP,
8986,GO:0033377,1,0.995945529443944,0,1,maintenance of protein location in T cell secretory granule,BP,
8987,GO:0033379,1,0.995945529443944,0,1,maintenance of protease location in T cell secretory granule,BP,
8988,GO:0033380,1,0.995945529443944,0,1,granzyme B localization to T cell secretory granule,BP,
8989,GO:0033382,1,0.995945529443944,0,1,maintenance of granzyme B location in T cell secretory granule,BP,
8990,GO:0033383,1,0.989688734730766,0,2,geranyl diphosphate metabolic process,BP,
8991,GO:0033384,1,0.989688734730766,0,2,geranyl diphosphate biosynthetic process,BP,
8992,GO:0033385,1,0.994013953503171,0,1,geranylgeranyl diphosphate metabolic process,BP,
8993,GO:0033386,1,0.994013953503171,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
8994,GO:0033387,1,0.981621819642333,0,3,putrescine biosynthetic process from ornithine,BP,
8995,GO:0033388,1,0.994750302710204,0,1,putrescine biosynthetic process from arginine,BP,
8996,GO:0033391,1,0.923761581781352,0,11,chromatoid body,CC,
8997,GO:0033396,1,0.99491027139586,0,1,beta-alanine biosynthetic process via 3-ureidopropionate,BP,
8998,GO:0033477,1,0.995007780707869,0,1,S-methylmethionine metabolic process,BP,
8999,GO:0033483,1,0.945571472029107,0,9,gas homeostasis,BP,
9000,GO:0033484,1,0.982781530204678,0,3,nitric oxide homeostasis,BP,
9001,GO:0033488,1,0.993726548433934,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
9002,GO:0033489,1,0.977041436276506,0,4,cholesterol biosynthetic process via desmosterol,BP,
9003,GO:0033490,1,0.977041436276506,0,4,cholesterol biosynthetic process via lathosterol,BP,
9004,GO:0033499,1,0.990255964998849,0,2,galactose catabolic process via UDP-galactose,BP,
9006,GO:0033503,1,0.975150476004771,0,4,HULC complex,CC,
9007,GO:0033504,1,0.962122842957221,0,5,floor plate development,BP,
9008,GO:0033505,1,0.985021742265954,0,2,floor plate morphogenesis,BP,
9009,GO:0033512,1,0.979765009995484,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
9010,GO:0033514,1,0.994481204304773,0,1,L-lysine catabolic process to acetyl-CoA via L-pipecolate,BP,
9011,GO:0033522,1,0.838992328341878,0,24,histone H2A ubiquitination,BP,
9012,GO:0033523,1,0.922039594345071,0,12,histone H2B ubiquitination,BP,
9013,GO:0033526,1,0.994130505930031,0,1,tetrapyrrole biosynthetic process from glutamate,BP,
9014,GO:0033539,1,0.919558474672864,0,14,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,
9015,GO:0033540,1,0.920343381520504,0,14,fatty acid beta-oxidation using acyl-CoA oxidase,BP,
9016,GO:0033549,1,0.930650024055899,0,12,MAP kinase phosphatase activity,MF,
9017,GO:0033552,1,0.99427126138325,0,1,response to vitamin B3,BP,
9018,GO:0033553,1,0.97082265296346,0,4,rDNA heterochromatin,CC,
9021,GO:0033557,1,0.988144472527205,0,2,Slx1-Slx4 complex,CC,
9022,GO:0033558,1,0.733487625984001,0,44,protein deacetylase activity,MF,
9023,GO:0033559,1,0.616635345535988,0,86,unsaturated fatty acid metabolic process,BP,
9024,GO:0033560,1,0.992894083586393,0,1,folate reductase activity,MF,
9025,GO:0033561,1,0.890213733097392,0,18,regulation of water loss via skin,BP,
9026,GO:0033563,1,0.972270981608027,0,3,dorsal/ventral axon guidance,BP,
9027,GO:0033564,1,0.951412123574908,0,6,anterior/posterior axon guidance,BP,
9028,GO:0033565,1,0.978990474413955,0,3,ESCRT-0 complex,CC,
9029,GO:0033566,1,0.988563561779619,0,2,gamma-tubulin complex localization,BP,
9030,GO:0033567,1,0.972620178983906,0,5,DNA replication, Okazaki fragment processing,BP,
9031,GO:0033570,1,0.985630668775277,0,2,transferrin transmembrane transporter activity,MF,
9032,GO:0033572,1,0.81022093446277,0,35,transferrin transport,BP,
9033,GO:0033574,1,0.780132495796428,0,41,response to testosterone,BP,
9034,GO:0033577,1,0.988278137116163,0,2,protein glycosylation in endoplasmic reticulum,BP,
9035,GO:0033578,1,0.967153889500203,0,5,protein glycosylation in Golgi,BP,
9036,GO:0033588,1,0.971904614540118,0,5,Elongator holoenzyme complex,CC,
9037,GO:0033590,1,0.98419122231234,0,3,response to cobalamin,BP,
9038,GO:0033591,1,0.967384462784064,0,5,response to L-ascorbic acid,BP,
9039,GO:0033592,1,0.965555308573529,0,5,RNA strand annealing activity,MF,
9040,GO:0033593,1,0.985873995580477,0,1,BRCA2-MAGE-D1 complex,CC,
9041,GO:0033594,1,0.979640908494585,0,4,response to hydroxyisoflavone,BP,
9042,GO:0033595,1,0.98838478872407,0,2,response to genistein,BP,
9043,GO:0033596,1,0.979665289726373,0,2,TSC1-TSC2 complex,CC,
9044,GO:0033597,1,0.99480620027945,0,1,mitotic checkpoint complex,CC,
9045,GO:0033598,1,0.829297876774889,0,26,mammary gland epithelial cell proliferation,BP,
9046,GO:0033599,1,0.882617414855081,0,17,regulation of mammary gland epithelial cell proliferation,BP,
9047,GO:0033600,1,0.965201060156705,0,4,negative regulation of mammary gland epithelial cell proliferation,BP,
9048,GO:0033601,1,0.936489376323539,0,8,positive regulation of mammary gland epithelial cell proliferation,BP,
9050,GO:0033603,1,0.962677242495688,0,6,positive regulation of dopamine secretion,BP,
9052,GO:0033605,1,0.940475018311963,0,10,positive regulation of catecholamine secretion,BP,
9053,GO:0033608,1,0.994054740756748,0,1,formyl-CoA transferase activity,MF,
9054,GO:0033609,1,0.994054740756748,0,1,oxalate metabolic process,BP,
9055,GO:0033612,1,0.888260573025831,0,19,receptor serine/threonine kinase binding,MF,
9056,GO:0033613,1,0.605123139149545,0,70,activating transcription factor binding,MF,
9057,GO:0033615,1,0.983118214871396,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
9058,GO:0033617,1,0.898769931113892,0,20,mitochondrial respiratory chain complex IV assembly,BP,
9060,GO:0033622,1,0.875048053132004,0,19,integrin activation,BP,
9061,GO:0033623,1,0.935236399861197,0,10,regulation of integrin activation,BP,
9062,GO:0033624,1,0.983024245027799,0,2,negative regulation of integrin activation,BP,
9063,GO:0033625,1,0.970234120982456,0,5,positive regulation of integrin activation,BP,
9064,GO:0033626,1,0.993091994234998,0,1,positive regulation of integrin activation by cell surface receptor linked signal transduction,BP,
9067,GO:0033629,1,0.945040877148829,0,8,negative regulation of cell adhesion mediated by integrin,BP,
9069,GO:0033631,1,0.928767808872155,0,11,cell-cell adhesion mediated by integrin,BP,
9070,GO:0033632,1,0.956541646629613,0,7,regulation of cell-cell adhesion mediated by integrin,BP,
9071,GO:0033633,1,0.99198043830004,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
9072,GO:0033634,1,0.981072404344296,0,3,positive regulation of cell-cell adhesion mediated by integrin,BP,
9073,GO:0033643,1,0.92640114618557,0,12,host cell part,CC,
9074,GO:0033644,1,0.992633084128786,0,1,host cell membrane,CC,
9075,GO:0033646,1,0.94601901640466,0,9,host intracellular part,CC,
9076,GO:0033647,1,0.968077195931406,0,5,host intracellular organelle,CC,
9077,GO:0033648,1,0.968077195931406,0,5,host intracellular membrane-bounded organelle,CC,
9078,GO:0033650,1,0.995313598987954,0,1,host cell mitochondrion,CC,
9079,GO:0033655,1,0.966176334682691,0,6,host cell cytoplasm part,CC,
9080,GO:0033668,1,0.977498653517009,0,4,negative regulation by symbiont of host apoptotic process,BP,
9083,GO:0033676,1,0.995749316303306,0,1,double-stranded DNA-dependent ATPase activity,MF,
9084,GO:0033677,1,0.980622388508981,0,3,DNA/RNA helicase activity,MF,
9085,GO:0033678,1,0.994182856446272,0,1,5'-3' DNA/RNA helicase activity,MF,
9086,GO:0033679,1,0.992204666131814,0,1,3'-5' DNA/RNA helicase activity,MF,
9087,GO:0033680,1,0.986432414318635,0,2,ATP-dependent DNA/RNA helicase activity,MF,
9088,GO:0033681,1,0.992204666131814,0,1,ATP-dependent 3'-5' DNA/RNA helicase activity,MF,
9089,GO:0033682,1,0.994182856446272,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
9090,GO:0033683,1,0.797370195903686,0,39,nucleotide-excision repair, DNA incision,BP,
9091,GO:0033684,1,0.955201342189271,0,7,regulation of luteinizing hormone secretion,BP,
9092,GO:0033685,1,0.982367364419471,0,3,negative regulation of luteinizing hormone secretion,BP,
9093,GO:0033686,1,0.972351271472704,0,4,positive regulation of luteinizing hormone secretion,BP,
9094,GO:0033687,1,0.841675709951959,0,26,osteoblast proliferation,BP,
9095,GO:0033688,1,0.855541193252673,0,23,regulation of osteoblast proliferation,BP,
9096,GO:0033689,1,0.934142705515767,0,9,negative regulation of osteoblast proliferation,BP,
9097,GO:0033690,1,0.93258551132051,0,11,positive regulation of osteoblast proliferation,BP,
9098,GO:0033691,1,0.939018712194056,0,8,sialic acid binding,MF,
9099,GO:0033692,1,0.64466403154333,0,61,cellular polysaccharide biosynthetic process,BP,
9101,GO:0033695,1,0.995092799545279,0,1,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
9102,GO:0033699,1,0.994973557798029,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
9103,GO:0033700,1,0.946031805490691,0,8,phospholipid efflux,BP,
9104,GO:0033735,1,0.996323303935876,0,1,aspartate dehydrogenase activity,MF,
9105,GO:0033737,1,0.99437062895455,0,1,1-pyrroline dehydrogenase activity,MF,
9106,GO:0033743,1,0.977858337275735,0,4,peptide-methionine (R)-S-oxide reductase activity,MF,
9107,GO:0033745,1,0.981944563683976,0,3,L-methionine-(R)-S-oxide reductase activity,MF,
9108,GO:0033746,1,0.993177281716257,0,1,histone demethylase activity (H3-R2 specific),MF,
9109,GO:0033749,1,0.993177281716257,0,1,histone demethylase activity (H4-R3 specific),MF,
9110,GO:0033750,1,0.934969601735993,0,13,ribosome localization,BP,
9111,GO:0033754,1,0.995542140718412,0,1,indoleamine 2,3-dioxygenase activity,MF,
9113,GO:0033764,1,0.903883693657526,0,22,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
9114,GO:0033765,1,0.988888480222838,0,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,
9115,GO:0033768,1,0.993863448192413,0,1,SUMO-targeted ubiquitin ligase complex,CC,
9116,GO:0033778,1,0.992868217048133,0,1,7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity,MF,
9117,GO:0033781,1,0.994891313133287,0,1,cholesterol 24-hydroxylase activity,MF,
9118,GO:0033787,1,0.993973566421534,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
9119,GO:0033791,1,0.994600671312194,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity,MF,
9120,GO:0033798,1,0.994876157112668,0,1,thyroxine 5-deiodinase activity,MF,
9121,GO:0033814,1,0.995731777742456,0,1,propanoyl-CoA C-acyltransferase activity,MF,
9122,GO:0033819,1,0.996310916442156,0,1,lipoyl(octanoyl) transferase activity,MF,
9123,GO:0033823,1,0.993816977564307,0,1,procollagen glucosyltransferase activity,MF,
9124,GO:0033829,1,0.984977842151556,0,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,
9125,GO:0033842,1,0.986715096580764,0,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,
9126,GO:0033857,1,0.98279493575385,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
9127,GO:0033858,1,0.993628052534786,0,1,N-acetylgalactosamine kinase activity,MF,
9128,GO:0033860,1,0.966902627541629,0,7,regulation of NAD(P)H oxidase activity,BP,
9129,GO:0033861,1,0.9904642037923,0,2,negative regulation of NAD(P)H oxidase activity,BP,
9130,GO:0033862,1,0.993820203377111,0,1,UMP kinase activity,MF,
9131,GO:0033864,1,0.976213861923088,0,5,positive regulation of NAD(P)H oxidase activity,BP,
9134,GO:0033867,1,0.99545013543259,0,1,Fas-activated serine/threonine kinase activity,MF,
9135,GO:0033869,1,0.996242741238324,0,1,nucleoside bisphosphate catabolic process,BP,
9136,GO:0033871,1,0.995067410461975,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
9137,GO:0033872,1,0.989340550891092,0,2,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
9139,GO:0033878,1,0.992997501099739,0,1,hormone-sensitive lipase activity,MF,
9140,GO:0033882,1,0.996060134155019,0,1,choloyl-CoA hydrolase activity,MF,
9141,GO:0033883,1,0.991121835922911,0,2,pyridoxal phosphatase activity,MF,
9142,GO:0033885,1,0.994737768570471,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
9143,GO:0033897,1,0.995945529443944,0,1,ribonuclease T2 activity,MF,
9144,GO:0033906,1,0.989837827178925,0,2,hyaluronoglucuronidase activity,MF,
9145,GO:0033919,1,0.992905575990772,0,1,glucan 1,3-alpha-glucosidase activity,MF,
9146,GO:0033925,1,0.992331953816647,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
9147,GO:0033961,1,0.995319298354662,0,1,cis-stilbene-oxide hydrolase activity,MF,
9148,GO:0033962,1,0.860536581553135,0,18,cytoplasmic mRNA processing body assembly,BP,
9149,GO:0033967,1,0.996047689627225,0,1,box C/D snoRNA metabolic process,BP,
9150,GO:0033979,1,0.994283746643721,0,1,box H/ACA snoRNA metabolic process,BP,
9151,GO:0033981,1,0.996697633327064,0,1,D-dopachrome decarboxylase activity,MF,
9152,GO:0033989,1,0.994151381045293,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9154,GO:0034014,1,0.99463604311237,0,1,response to triglyceride,BP,
9156,GO:0034031,1,0.996242741238324,0,1,ribonucleoside bisphosphate catabolic process,BP,
9159,GO:0034034,1,0.996242741238324,0,1,purine nucleoside bisphosphate catabolic process,BP,
9161,GO:0034036,1,0.960044438295858,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
9162,GO:0034038,1,0.996024036775176,0,1,deoxyhypusine synthase activity,MF,
9163,GO:0034039,1,0.990330738916625,0,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
9164,GO:0034040,1,0.955511910020883,0,6,lipid-transporting ATPase activity,MF,
9165,GO:0034041,1,0.981186299748999,0,3,sterol-transporting ATPase activity,MF,
9166,GO:0034045,1,0.889135787482734,0,16,phagophore assembly site membrane,CC,
9167,GO:0034046,1,0.945134202420793,0,7,poly(G) binding,MF,
9168,GO:0034056,1,0.971747552200075,0,4,estrogen response element binding,MF,
9169,GO:0034057,1,0.987177024352382,0,2,RNA strand-exchange activity,MF,
9170,GO:0034058,1,0.926096103754814,0,10,endosomal vesicle fusion,BP,
9171,GO:0034059,1,0.976673319024172,0,3,response to anoxia,BP,
9172,GO:0034061,1,0.783385154666844,0,35,DNA polymerase activity,MF,
9173,GO:0034062,1,0.785204174438119,0,43,5'-3' RNA polymerase activity,MF,
9174,GO:0034063,1,0.902291730560046,0,13,stress granule assembly,BP,
9175,GO:0034066,1,0.989962101948814,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
9176,GO:0034067,1,0.835836564895819,0,21,protein localization to Golgi apparatus,BP,
9177,GO:0034080,1,0.85428439778148,0,30,CENP-A containing nucleosome assembly,BP,
9178,GO:0034085,1,0.956490898867151,0,6,establishment of sister chromatid cohesion,BP,
9179,GO:0034086,1,0.922328563635415,0,10,maintenance of sister chromatid cohesion,BP,
9180,GO:0034087,1,0.980267315086225,0,2,establishment of mitotic sister chromatid cohesion,BP,
9181,GO:0034088,1,0.922328563635415,0,10,maintenance of mitotic sister chromatid cohesion,BP,
9182,GO:0034091,1,0.952758271984887,0,6,regulation of maintenance of sister chromatid cohesion,BP,
9183,GO:0034092,1,0.970188579046327,0,3,negative regulation of maintenance of sister chromatid cohesion,BP,
9184,GO:0034093,1,0.982039541100755,0,3,positive regulation of maintenance of sister chromatid cohesion,BP,
9186,GO:0034098,1,0.940340004997592,0,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,
9187,GO:0034101,1,0.492264582221561,0,109,erythrocyte homeostasis,BP,
9188,GO:0034103,1,0.673108124518802,0,59,regulation of tissue remodeling,BP,
9189,GO:0034104,1,0.902860618799736,0,16,negative regulation of tissue remodeling,BP,
9190,GO:0034105,1,0.863307986804225,0,22,positive regulation of tissue remodeling,BP,
9191,GO:0034109,1,0.62960776691122,0,67,homotypic cell-cell adhesion,BP,
9192,GO:0034110,1,0.853667701257561,0,23,regulation of homotypic cell-cell adhesion,BP,
9193,GO:0034111,1,0.912648153052843,0,14,negative regulation of homotypic cell-cell adhesion,BP,
9194,GO:0034112,1,0.972381019187539,0,4,positive regulation of homotypic cell-cell adhesion,BP,
9195,GO:0034113,1,0.736406232116676,0,46,heterotypic cell-cell adhesion,BP,
9196,GO:0034114,1,0.909137341089276,0,17,regulation of heterotypic cell-cell adhesion,BP,
9197,GO:0034115,1,0.958594761559589,0,8,negative regulation of heterotypic cell-cell adhesion,BP,
9198,GO:0034116,1,0.944129441019417,0,10,positive regulation of heterotypic cell-cell adhesion,BP,
9199,GO:0034117,1,0.996806043835904,0,1,erythrocyte aggregation,BP,
9200,GO:0034118,1,0.996806043835904,0,1,regulation of erythrocyte aggregation,BP,
9201,GO:0034120,1,0.996806043835904,0,1,positive regulation of erythrocyte aggregation,BP,
9202,GO:0034121,1,0.688200236561132,0,57,regulation of toll-like receptor signaling pathway,BP,
9203,GO:0034122,1,0.796569242939893,0,33,negative regulation of toll-like receptor signaling pathway,BP,
9204,GO:0034123,1,0.887974061997382,0,20,positive regulation of toll-like receptor signaling pathway,BP,
9205,GO:0034124,1,0.978880672046366,0,4,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9206,GO:0034125,1,0.990468365746777,0,2,negative regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9207,GO:0034127,1,0.951134589034736,0,8,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9208,GO:0034128,1,0.955888144463559,0,7,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9209,GO:0034130,1,0.993972450353285,0,1,toll-like receptor 1 signaling pathway,BP,
9210,GO:0034134,1,0.927599031326614,0,12,toll-like receptor 2 signaling pathway,BP,
9211,GO:0034135,1,0.957689308051054,0,7,regulation of toll-like receptor 2 signaling pathway,BP,
9212,GO:0034136,1,0.977263445000146,0,3,negative regulation of toll-like receptor 2 signaling pathway,BP,
9213,GO:0034137,1,0.979975067948399,0,4,positive regulation of toll-like receptor 2 signaling pathway,BP,
9214,GO:0034138,1,0.89073242479094,0,19,toll-like receptor 3 signaling pathway,BP,
9215,GO:0034139,1,0.944151932183993,0,9,regulation of toll-like receptor 3 signaling pathway,BP,
9216,GO:0034140,1,0.979167818935855,0,3,negative regulation of toll-like receptor 3 signaling pathway,BP,
9217,GO:0034141,1,0.9583992006161,0,7,positive regulation of toll-like receptor 3 signaling pathway,BP,
9218,GO:0034142,1,0.843649910717613,0,28,toll-like receptor 4 signaling pathway,BP,
9219,GO:0034143,1,0.913021732561417,0,15,regulation of toll-like receptor 4 signaling pathway,BP,
9220,GO:0034144,1,0.962525364728638,0,6,negative regulation of toll-like receptor 4 signaling pathway,BP,
9221,GO:0034145,1,0.948588341004783,0,9,positive regulation of toll-like receptor 4 signaling pathway,BP,
9222,GO:0034146,1,0.985008163889597,0,2,toll-like receptor 5 signaling pathway,BP,
9223,GO:0034147,1,0.99239585523513,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
9224,GO:0034148,1,0.99239585523513,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
9225,GO:0034150,1,0.990959133424442,0,1,toll-like receptor 6 signaling pathway,BP,
9226,GO:0034154,1,0.957396365377455,0,7,toll-like receptor 7 signaling pathway,BP,
9227,GO:0034155,1,0.983651490442323,0,3,regulation of toll-like receptor 7 signaling pathway,BP,
9228,GO:0034156,1,0.995368022343986,0,1,negative regulation of toll-like receptor 7 signaling pathway,BP,
9229,GO:0034157,1,0.988229494409598,0,2,positive regulation of toll-like receptor 7 signaling pathway,BP,
9230,GO:0034158,1,0.992611725974261,0,1,toll-like receptor 8 signaling pathway,BP,
9231,GO:0034162,1,0.875729377630835,0,20,toll-like receptor 9 signaling pathway,BP,
9232,GO:0034163,1,0.959625996311667,0,6,regulation of toll-like receptor 9 signaling pathway,BP,
9233,GO:0034164,1,0.985611837695588,0,2,negative regulation of toll-like receptor 9 signaling pathway,BP,
9234,GO:0034165,1,0.98669971456763,0,2,positive regulation of toll-like receptor 9 signaling pathway,BP,
9235,GO:0034166,1,0.993485046048761,0,1,toll-like receptor 10 signaling pathway,BP,
9236,GO:0034182,1,0.952758271984887,0,6,regulation of maintenance of mitotic sister chromatid cohesion,BP,
9237,GO:0034183,1,0.970188579046327,0,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
9238,GO:0034184,1,0.982039541100755,0,3,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
9239,GO:0034185,1,0.873501319771835,0,16,apolipoprotein binding,MF,
9240,GO:0034186,1,0.971551334452382,0,4,apolipoprotein A-I binding,MF,
9241,GO:0034188,1,0.976824742475403,0,2,apolipoprotein A-I receptor activity,MF,
9242,GO:0034189,1,0.986396348985744,0,2,very-low-density lipoprotein particle binding,MF,
9243,GO:0034190,1,0.967960668009522,0,5,apolipoprotein receptor binding,MF,
9244,GO:0034191,1,0.974630852175402,0,4,apolipoprotein A-I receptor binding,MF,
9245,GO:0034196,1,0.979135248779888,0,4,acylglycerol transport,BP,
9246,GO:0034197,1,0.979135248779888,0,4,triglyceride transport,BP,
9247,GO:0034198,1,0.770058358292777,0,42,cellular response to amino acid starvation,BP,
9249,GO:0034201,1,0.96849244140405,0,5,response to oleic acid,BP,
9250,GO:0034203,1,0.991729161933858,0,1,glycolipid translocation,BP,
9252,GO:0034205,1,0.84831301336246,0,23,amyloid-beta formation,BP,
9253,GO:0034211,1,0.987748176584163,0,1,GTP-dependent protein kinase activity,MF,
9254,GO:0034212,1,0.655086427986769,0,60,peptide N-acetyltransferase activity,MF,
9255,GO:0034213,1,0.99557234124322,0,1,quinolinate catabolic process,BP,
9256,GO:0034214,1,0.946953922915135,0,8,protein hexamerization,BP,
9257,GO:0034219,1,0.492568262583289,0,102,carbohydrate transmembrane transport,BP,
9259,GO:0034224,1,0.994687117932493,0,1,cellular response to zinc ion starvation,BP,
9260,GO:0034227,1,0.975534208129878,0,5,tRNA thio-modification,BP,
9261,GO:0034230,1,0.992082798687515,0,1,enkephalin processing,BP,
9262,GO:0034231,1,0.992082798687515,0,1,islet amyloid polypeptide processing,BP,
9263,GO:0034235,1,0.966686578558082,0,6,GPI anchor binding,MF,
9264,GO:0034236,1,0.903538329522724,0,14,protein kinase A catalytic subunit binding,MF,
9265,GO:0034237,1,0.857739597899757,0,18,protein kinase A regulatory subunit binding,MF,
9266,GO:0034238,1,0.992826985038539,0,1,macrophage fusion,BP,
9267,GO:0034239,1,0.992826985038539,0,1,regulation of macrophage fusion,BP,
9268,GO:0034241,1,0.992826985038539,0,1,positive regulation of macrophage fusion,BP,
9269,GO:0034242,1,0.982027106970813,0,3,negative regulation of syncytium formation by plasma membrane fusion,BP,
9270,GO:0034243,1,0.849230531049664,0,25,regulation of transcription elongation from RNA polymerase II promoter,BP,
9271,GO:0034244,1,0.933814082514573,0,11,negative regulation of transcription elongation from RNA polymerase II promoter,BP,
9272,GO:0034245,1,0.992991753728511,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
9273,GO:0034247,1,0.995894369461207,0,1,snoRNA splicing,BP,
9276,GO:0034250,1,0.437177572411077,0,131,positive regulation of cellular amide metabolic process,BP,
9277,GO:0034255,1,0.994811863082861,0,1,regulation of urea metabolic process,BP,
9278,GO:0034260,1,0.734293704531816,0,44,negative regulation of GTPase activity,BP,
9279,GO:0034271,1,0.980432105891319,0,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,
9280,GO:0034272,1,0.980432105891319,0,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,
9281,GO:0034274,1,0.978266025669233,0,3,Atg12-Atg5-Atg16 complex,CC,
9282,GO:0034275,1,0.995542140718412,0,1,kynurenic acid metabolic process,BP,
9283,GO:0034276,1,0.995542140718412,0,1,kynurenic acid biosynthetic process,BP,
9285,GO:0034285,1,0.972397945194991,0,4,response to disaccharide,BP,
9286,GO:0034287,1,0.979352430434235,0,4,detection of monosaccharide stimulus,BP,
9287,GO:0034308,1,0.748147242110261,0,51,primary alcohol metabolic process,BP,
9288,GO:0034309,1,0.996339404102419,0,1,primary alcohol biosynthetic process,BP,
9289,GO:0034310,1,0.939965756831176,0,13,primary alcohol catabolic process,BP,
9290,GO:0034311,1,0.902161568942403,0,19,diol metabolic process,BP,
9291,GO:0034312,1,0.915610759196574,0,16,diol biosynthetic process,BP,
9292,GO:0034314,1,0.828262037740984,0,31,Arp2/3 complex-mediated actin nucleation,BP,
9293,GO:0034315,1,0.910557434109753,0,15,regulation of Arp2/3 complex-mediated actin nucleation,BP,
9294,GO:0034316,1,0.971975079661697,0,5,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
9295,GO:0034329,1,0.197046232085781,0,216,cell junction assembly,BP,
9296,GO:0034330,1,0.143352952321714,0,257,cell junction organization,BP,
9297,GO:0034331,1,0.931598214324765,0,11,cell junction maintenance,BP,
9298,GO:0034332,1,0.398273001304513,0,121,adherens junction organization,BP,
9299,GO:0034333,1,0.532540256968873,0,81,adherens junction assembly,BP,
9300,GO:0034334,1,0.971056068545712,0,4,adherens junction maintenance,BP,
9301,GO:0034338,1,0.972892832431291,0,4,short-chain carboxylesterase activity,MF,
9302,GO:0034340,1,0.633252940865933,0,75,response to type I interferon,BP,
9304,GO:0034342,1,0.988925938040716,0,2,response to type III interferon,BP,
9305,GO:0034343,1,0.979334927209641,0,3,type III interferon production,BP,
9306,GO:0034344,1,0.979334927209641,0,3,regulation of type III interferon production,BP,
9307,GO:0034346,1,0.993764623994677,0,1,positive regulation of type III interferon production,BP,
9308,GO:0034349,1,0.909336121195499,0,14,glial cell apoptotic process,BP,
9309,GO:0034350,1,0.947720519045595,0,8,regulation of glial cell apoptotic process,BP,
9310,GO:0034351,1,0.947720519045595,0,8,negative regulation of glial cell apoptotic process,BP,
9311,GO:0034353,1,0.994054740756748,0,1,RNA pyrophosphohydrolase activity,MF,
9312,GO:0034354,1,0.995898114741313,0,1,'de novo' NAD biosynthetic process from tryptophan,BP,
9313,GO:0034355,1,0.994054740756748,0,1,NAD salvage,BP,
9314,GO:0034356,1,0.925884778292792,0,12,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,
9315,GO:0034358,1,0.823130574722309,0,32,plasma lipoprotein particle,CC,
9316,GO:0034359,1,0.983641317568993,0,1,mature chylomicron,CC,
9317,GO:0034360,1,0.983641317568993,0,1,chylomicron remnant,CC,
9318,GO:0034361,1,0.918630459218557,0,15,very-low-density lipoprotein particle,CC,
9319,GO:0034362,1,0.92318567362074,0,12,low-density lipoprotein particle,CC,
9320,GO:0034363,1,0.972882409457635,0,4,intermediate-density lipoprotein particle,CC,
9321,GO:0034364,1,0.904141045648315,0,21,high-density lipoprotein particle,CC,
9322,GO:0034365,1,0.989012525412862,0,3,discoidal high-density lipoprotein particle,CC,
9323,GO:0034366,1,0.975043249566754,0,6,spherical high-density lipoprotein particle,CC,
9324,GO:0034367,1,0.871393113310052,0,23,protein-containing complex remodeling,BP,
9325,GO:0034368,1,0.876861382119722,0,22,protein-lipid complex remodeling,BP,
9326,GO:0034369,1,0.876861382119722,0,22,plasma lipoprotein particle remodeling,BP,
9327,GO:0034370,1,0.953284830490045,0,8,triglyceride-rich lipoprotein particle remodeling,BP,
9328,GO:0034371,1,0.966122958684193,0,5,chylomicron remodeling,BP,
9329,GO:0034372,1,0.96914372107534,0,7,very-low-density lipoprotein particle remodeling,BP,
9330,GO:0034373,1,0.995498056244687,0,1,intermediate-density lipoprotein particle remodeling,BP,
9331,GO:0034374,1,0.93087381188238,0,11,low-density lipoprotein particle remodeling,BP,
9332,GO:0034375,1,0.930421940883806,0,14,high-density lipoprotein particle remodeling,BP,
9333,GO:0034377,1,0.865438952660098,0,22,plasma lipoprotein particle assembly,BP,
9334,GO:0034378,1,0.951792137319333,0,7,chylomicron assembly,BP,
9335,GO:0034379,1,0.939899644571208,0,9,very-low-density lipoprotein particle assembly,BP,
9336,GO:0034380,1,0.932193927151248,0,11,high-density lipoprotein particle assembly,BP,
9337,GO:0034381,1,0.746176189569702,0,47,plasma lipoprotein particle clearance,BP,
9338,GO:0034382,1,0.955309680470654,0,7,chylomicron remnant clearance,BP,
9339,GO:0034383,1,0.822151091298389,0,30,low-density lipoprotein particle clearance,BP,
9340,GO:0034384,1,0.939971925233656,0,10,high-density lipoprotein particle clearance,BP,
9341,GO:0034385,1,0.918630459218557,0,15,triglyceride-rich plasma lipoprotein particle,CC,
9342,GO:0034386,1,0.991914726505661,0,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,
9343,GO:0034388,1,0.961571126296807,0,6,Pwp2p-containing subcomplex of 90S preribosome,CC,
9344,GO:0034389,1,0.903615717903459,0,17,lipid particle organization,BP,
9345,GO:0034390,1,0.892573417671317,0,17,smooth muscle cell apoptotic process,BP,
9346,GO:0034391,1,0.892573417671317,0,17,regulation of smooth muscle cell apoptotic process,BP,
9347,GO:0034392,1,0.963138202749574,0,5,negative regulation of smooth muscle cell apoptotic process,BP,
9348,GO:0034393,1,0.938284406726151,0,10,positive regulation of smooth muscle cell apoptotic process,BP,
9349,GO:0034394,1,0.698497827805582,0,51,protein localization to cell surface,BP,
9350,GO:0034395,1,0.989037594923375,0,2,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
9351,GO:0034397,1,0.923844140682235,0,11,telomere localization,BP,
9352,GO:0034398,1,0.960361725938735,0,6,telomere tethering at nuclear periphery,BP,
9354,GO:0034402,1,0.985530082429294,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
9355,GO:0034404,1,0.283262824065377,0,198,nucleobase-containing small molecule biosynthetic process,BP,
9356,GO:0034405,1,0.794886787460221,0,33,response to fluid shear stress,BP,
9357,GO:0034414,1,0.987734584772594,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
9358,GO:0034416,1,0.993973566421534,0,1,bisphosphoglycerate phosphatase activity,MF,
9359,GO:0034417,1,0.993973566421534,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
9360,GO:0034418,1,0.989312618036077,0,2,urate biosynthetic process,BP,
9361,GO:0034421,1,0.980538900756531,0,3,post-translational protein acetylation,BP,
9362,GO:0034423,1,0.994218050969824,0,1,autophagosome lumen,CC,
9363,GO:0034427,1,0.953076293336358,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
9364,GO:0034431,1,0.977560788177497,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
9365,GO:0034432,1,0.977560788177497,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
9366,GO:0034433,1,0.951061597331064,0,10,steroid esterification,BP,
9367,GO:0034434,1,0.951061597331064,0,10,sterol esterification,BP,
9368,GO:0034435,1,0.951061597331064,0,10,cholesterol esterification,BP,
9369,GO:0034436,1,0.98337232158126,0,3,glycoprotein transport,BP,
9370,GO:0034437,1,0.987055727852356,0,2,glycoprotein transporter activity,MF,
9371,GO:0034439,1,0.989491119973403,0,2,lipoprotein lipid oxidation,BP,
9373,GO:0034441,1,0.991822921544183,0,2,plasma lipoprotein particle oxidation,BP,
9374,GO:0034442,1,0.989491119973403,0,2,regulation of lipoprotein oxidation,BP,
9375,GO:0034443,1,0.996094963172733,0,1,negative regulation of lipoprotein oxidation,BP,
9376,GO:0034444,1,0.996552068805292,0,1,regulation of plasma lipoprotein oxidation,BP,
9377,GO:0034445,1,0.996552068805292,0,1,negative regulation of plasma lipoprotein oxidation,BP,
9378,GO:0034446,1,0.576639357820278,0,79,substrate adhesion-dependent cell spreading,BP,
9379,GO:0034447,1,0.953619162536614,0,8,very-low-density lipoprotein particle clearance,BP,
9380,GO:0034448,1,0.973371414381708,0,5,EGO complex,CC,
9381,GO:0034450,1,0.912054632834168,0,13,ubiquitin-ubiquitin ligase activity,MF,
9382,GO:0034451,1,0.816333123498015,0,27,centriolar satellite,CC,
9383,GO:0034452,1,0.91290793403503,0,10,dynactin binding,MF,
9384,GO:0034453,1,0.830330385092828,0,22,microtubule anchoring,BP,
9385,GO:0034454,1,0.921787890429382,0,9,microtubule anchoring at centrosome,BP,
9386,GO:0034455,1,0.984497530842159,0,2,t-UTP complex,CC,
9387,GO:0034456,1,0.988659355699934,0,2,UTP-C complex,CC,
9388,GO:0034457,1,0.986604717929229,0,3,Mpp10 complex,CC,
9389,GO:0034458,1,0.986645117626309,0,2,3'-5' RNA helicase activity,MF,
9390,GO:0034459,1,0.992204666131814,0,1,ATP-dependent 3'-5' RNA helicase activity,MF,
9391,GO:0034462,1,0.994685245635728,0,1,small-subunit processome assembly,BP,
9392,GO:0034463,1,0.997030560087482,0,1,90S preribosome assembly,BP,
9393,GO:0034464,1,0.947747290047226,0,9,BBSome,CC,
9394,GO:0034465,1,0.975710444691266,0,4,response to carbon monoxide,BP,
9395,GO:0034466,1,0.994062716803448,0,1,chromaffin granule lumen,CC,
9396,GO:0034470,1,0.11494674863698,0,389,ncRNA processing,BP,
9397,GO:0034471,1,0.899883105849074,0,19,ncRNA 5'-end processing,BP,
9398,GO:0034472,1,0.915736893177247,0,15,snRNA 3'-end processing,BP,
9399,GO:0034473,1,0.987345950260992,0,3,U1 snRNA 3'-end processing,BP,
9400,GO:0034474,1,0.989845379114877,0,1,U2 snRNA 3'-end processing,BP,
9401,GO:0034475,1,0.966654232510369,0,8,U4 snRNA 3'-end processing,BP,
9402,GO:0034476,1,0.987345950260992,0,3,U5 snRNA 3'-end processing,BP,
9403,GO:0034477,1,0.994054740756748,0,1,U6 snRNA 3'-end processing,BP,
9405,GO:0034483,1,0.904522579694005,0,14,heparan sulfate sulfotransferase activity,MF,
9406,GO:0034485,1,0.97262820631308,0,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
9407,GO:0034497,1,0.913611660848709,0,13,protein localization to phagophore assembly site,BP,
9408,GO:0034498,1,0.946136731450789,0,8,early endosome to Golgi transport,BP,
9409,GO:0034499,1,0.982004865410361,0,2,late endosome to Golgi transport,BP,
9410,GO:0034501,1,0.912722121716629,0,16,protein localization to kinetochore,BP,
9411,GO:0034502,1,0.632227795121959,0,70,protein localization to chromosome,BP,
9412,GO:0034504,1,0.212263186134858,0,226,protein localization to nucleus,BP,
9413,GO:0034505,1,0.894184075930351,0,15,tooth mineralization,BP,
9414,GO:0034506,1,0.992788570226548,0,1,chromosome, centromeric core domain,CC,
9416,GO:0034511,1,0.967156672708519,0,5,U3 snoRNA binding,MF,
9417,GO:0034513,1,0.979676281334196,0,5,box H/ACA snoRNA binding,MF,
9418,GO:0034515,1,0.987461072862762,0,2,proteasome storage granule,CC,
9419,GO:0034516,1,0.995649625843794,0,1,response to vitamin B6,BP,
9420,GO:0034518,1,0.931401598701108,0,11,RNA cap binding complex,CC,
9421,GO:0034545,1,0.995405943503099,0,1,fumarylpyruvate hydrolase activity,MF,
9422,GO:0034551,1,0.948025607121719,0,9,mitochondrial respiratory chain complex III assembly,BP,
9423,GO:0034552,1,0.992113274131332,0,2,respiratory chain complex II assembly,BP,
9424,GO:0034553,1,0.992113274131332,0,2,mitochondrial respiratory chain complex II assembly,BP,
9425,GO:0034584,1,0.986602033988677,0,2,piRNA binding,MF,
9426,GO:0034587,1,0.914388199473853,0,14,piRNA metabolic process,BP,
9427,GO:0034589,1,0.992520677556813,0,1,hydroxyproline transport,BP,
9428,GO:0034590,1,0.992520677556813,0,1,L-hydroxyproline transmembrane transporter activity,MF,
9429,GO:0034593,1,0.823498737978393,0,25,phosphatidylinositol bisphosphate phosphatase activity,MF,
9430,GO:0034594,1,0.959528834953788,0,6,phosphatidylinositol trisphosphate phosphatase activity,MF,
9431,GO:0034595,1,0.906360085134145,0,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,
9432,GO:0034596,1,0.936623747115285,0,8,phosphatidylinositol phosphate 4-phosphatase activity,MF,
9433,GO:0034597,1,0.982942945491416,0,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
9435,GO:0034602,1,0.992518237196902,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
9436,GO:0034603,1,0.969249293980597,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
9437,GO:0034604,1,0.969249293980597,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
9442,GO:0034616,1,0.910699734974843,0,14,response to laminar fluid shear stress,BP,
9443,GO:0034617,1,0.972137924297832,0,4,tetrahydrobiopterin binding,MF,
9444,GO:0034618,1,0.961718879829631,0,6,arginine binding,MF,
9445,GO:0034620,1,0.406243223319138,0,141,cellular response to unfolded protein,BP,
9447,GO:0034625,1,0.963017449392389,0,6,fatty acid elongation, monounsaturated fatty acid,BP,
9448,GO:0034626,1,0.963017449392389,0,6,fatty acid elongation, polyunsaturated fatty acid,BP,
9449,GO:0034627,1,0.975605114029023,0,4,'de novo' NAD biosynthetic process,BP,
9450,GO:0034628,1,0.979624255573908,0,3,'de novo' NAD biosynthetic process from aspartate,BP,
9451,GO:0034629,1,0.865816730301962,0,23,cellular protein-containing complex localization,BP,
9452,GO:0034632,1,0.990338620047879,0,2,retinol transmembrane transporter activity,MF,
9453,GO:0034633,1,0.990338620047879,0,2,retinol transport,BP,
9454,GO:0034634,1,0.99043455124782,0,1,glutathione transmembrane transporter activity,MF,
9455,GO:0034635,1,0.985477047592991,0,2,glutathione transport,BP,
9456,GO:0034637,1,0.593576851877627,0,75,cellular carbohydrate biosynthetic process,BP,
9457,GO:0034638,1,0.956074961846789,0,8,phosphatidylcholine catabolic process,BP,
9458,GO:0034640,1,0.993569067122816,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
9460,GO:0034643,1,0.867600324504091,0,19,establishment of mitochondrion localization, microtubule-mediated,BP,
9461,GO:0034644,1,0.606541618554827,0,74,cellular response to UV,BP,
9463,GO:0034647,1,0.976871615154793,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
9464,GO:0034648,1,0.963858415893173,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
9465,GO:0034649,1,0.992922811730033,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
9466,GO:0034650,1,0.94589734285912,0,8,cortisol metabolic process,BP,
9467,GO:0034651,1,0.950618318250313,0,7,cortisol biosynthetic process,BP,
9468,GO:0034653,1,0.983692065189592,0,3,retinoic acid catabolic process,BP,
9470,GO:0034655,1,0.0283762471335461,0,578,nucleobase-containing compound catabolic process,BP,
9471,GO:0034656,1,0.785101400286052,0,43,nucleobase-containing small molecule catabolic process,BP,
9472,GO:0034657,1,0.974535480218252,0,4,GID complex,CC,
9473,GO:0034660,1,0.0434712829337253,0,546,ncRNA metabolic process,BP,
9474,GO:0034661,1,0.851808766900836,0,24,ncRNA catabolic process,BP,
9475,GO:0034663,1,0.948508918868024,0,9,endoplasmic reticulum chaperone complex,CC,
9476,GO:0034665,1,0.985108917781848,0,2,integrin alpha1-beta1 complex,CC,
9477,GO:0034666,1,0.975978353733625,0,3,integrin alpha2-beta1 complex,CC,
9478,GO:0034667,1,0.984954144313309,0,2,integrin alpha3-beta1 complex,CC,
9479,GO:0034668,1,0.992879715008209,0,1,integrin alpha4-beta1 complex,CC,
9480,GO:0034669,1,0.98484317818669,0,2,integrin alpha4-beta7 complex,CC,
9481,GO:0034670,1,0.987307564269414,0,1,chemotaxis to arachidonic acid,BP,
9482,GO:0034673,1,0.977888841069131,0,3,inhibin-betaglycan-ActRII complex,CC,
9483,GO:0034676,1,0.991068835869997,0,1,integrin alpha6-beta4 complex,CC,
9484,GO:0034677,1,0.993040631484393,0,1,integrin alpha7-beta1 complex,CC,
9485,GO:0034678,1,0.978937793986124,0,3,integrin alpha8-beta1 complex,CC,
9486,GO:0034679,1,0.992831782428248,0,1,integrin alpha9-beta1 complex,CC,
9487,GO:0034680,1,0.984737475928808,0,2,integrin alpha10-beta1 complex,CC,
9488,GO:0034681,1,0.984904113499681,0,2,integrin alpha11-beta1 complex,CC,
9489,GO:0034683,1,0.981923931275006,0,2,integrin alphav-beta3 complex,CC,
9490,GO:0034684,1,0.983393547378575,0,2,integrin alphav-beta5 complex,CC,
9491,GO:0034685,1,0.984459683937182,0,2,integrin alphav-beta6 complex,CC,
9492,GO:0034686,1,0.978221510812117,0,2,integrin alphav-beta8 complex,CC,
9493,GO:0034687,1,0.985640416590636,0,2,integrin alphaL-beta2 complex,CC,
9494,GO:0034688,1,0.985977615562056,0,2,integrin alphaM-beta2 complex,CC,
9495,GO:0034693,1,0.994422680895466,0,1,U11/U12 snRNP,CC,
9496,GO:0034694,1,0.8202509245343,0,29,response to prostaglandin,BP,
9497,GO:0034695,1,0.866852129616817,0,22,response to prostaglandin E,BP,
9498,GO:0034696,1,0.989173559724151,0,2,response to prostaglandin F,BP,
9499,GO:0034698,1,0.837849777635563,0,25,response to gonadotropin,BP,
9500,GO:0034699,1,0.978763692013958,0,3,response to luteinizing hormone,BP,
9503,GO:0034704,1,0.612496545551876,0,60,calcium channel complex,CC,
9505,GO:0034706,1,0.815526808237788,0,23,sodium channel complex,CC,
9507,GO:0034708,1,0.555655110775358,0,88,methyltransferase complex,CC,
9508,GO:0034709,1,0.950893119364672,0,12,methylosome,CC,
9509,GO:0034711,1,0.969992573950061,0,5,inhibin binding,MF,
9510,GO:0034713,1,0.939688927496744,0,9,type I transforming growth factor beta receptor binding,MF,
9511,GO:0034714,1,0.980123714646309,0,3,type III transforming growth factor beta receptor binding,MF,
9512,GO:0034715,1,0.975905778776138,0,6,pICln-Sm protein complex,CC,
9513,GO:0034718,1,0.991406359455606,0,1,SMN-Gemin2 complex,CC,
9514,GO:0034719,1,0.919811712448794,0,17,SMN-Sm protein complex,CC,
9515,GO:0034720,1,0.946267355170415,0,6,histone H3-K4 demethylation,BP,
9516,GO:0034721,1,0.976871615154793,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
9517,GO:0034722,1,0.995642720209646,0,1,gamma-glutamyl-peptidase activity,MF,
9518,GO:0034723,1,0.932545337920018,0,14,DNA replication-dependent nucleosome organization,BP,
9519,GO:0034724,1,0.788146717254543,0,41,DNA replication-independent nucleosome organization,BP,
9520,GO:0034727,1,0.991856914529987,0,1,piecemeal microautophagy of the nucleus,BP,
9521,GO:0034728,1,0.499273288313908,0,117,nucleosome organization,BP,
9522,GO:0034729,1,0.978084812660807,0,3,histone H3-K79 methylation,BP,
9523,GO:0034736,1,0.993392284425244,0,1,cholesterol O-acyltransferase activity,MF,
9524,GO:0034739,1,0.990447980672217,0,2,histone deacetylase activity (H4-K16 specific),MF,
9525,GO:0034750,1,0.985045792032253,0,2,Scrib-APC-beta-catenin complex,CC,
9526,GO:0034751,1,0.98099070797725,0,3,aryl hydrocarbon receptor complex,CC,
9527,GO:0034752,1,0.990587302290689,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
9528,GO:0034753,1,0.990587302290689,0,1,nuclear aryl hydrocarbon receptor complex,CC,
9529,GO:0034754,1,0.594024775740546,0,91,cellular hormone metabolic process,BP,
9530,GO:0034755,1,0.89933085692088,0,16,iron ion transmembrane transport,BP,
9531,GO:0034756,1,0.971095592907512,0,5,regulation of iron ion transport,BP,
9532,GO:0034757,1,0.985448736430853,0,2,negative regulation of iron ion transport,BP,
9533,GO:0034759,1,0.985448736430853,0,2,regulation of iron ion transmembrane transport,BP,
9534,GO:0034760,1,0.985448736430853,0,2,negative regulation of iron ion transmembrane transport,BP,
9536,GO:0034763,1,0.523876283268859,0,100,negative regulation of transmembrane transport,BP,
9539,GO:0034766,1,0.59082461030091,0,80,negative regulation of ion transmembrane transport,BP,
9541,GO:0034769,1,0.987652998298827,0,2,basement membrane disassembly,BP,
9542,GO:0034770,1,0.943403608472892,0,6,histone H4-K20 methylation,BP,
9543,GO:0034773,1,0.967836152120609,0,4,histone H4-K20 trimethylation,BP,
9545,GO:0034775,1,0.99043455124782,0,1,glutathione transmembrane transport,BP,
9547,GO:0034777,1,0.994703355724219,0,1,recycling endosome lumen,CC,
9548,GO:0034875,1,0.995092799545279,0,1,caffeine oxidase activity,MF,
9549,GO:0034899,1,0.994898262839766,0,1,trimethylamine monooxygenase activity,MF,
9550,GO:0034959,1,0.991703190862279,0,1,endothelin maturation,BP,
9551,GO:0034963,1,0.996047689627225,0,1,box C/D snoRNA processing,BP,
9552,GO:0034964,1,0.994283746643721,0,1,box H/ACA snoRNA processing,BP,
9553,GO:0034968,1,0.486065363887228,0,96,histone lysine methylation,BP,
9554,GO:0034969,1,0.933911936461731,0,12,histone arginine methylation,BP,
9555,GO:0034970,1,0.988079755002937,0,2,histone H3-R2 methylation,BP,
9556,GO:0034971,1,0.988673447970504,0,2,histone H3-R17 methylation,BP,
9557,GO:0034975,1,0.922772468027229,0,13,protein folding in endoplasmic reticulum,BP,
9558,GO:0034976,1,0.184885936695744,0,261,response to endoplasmic reticulum stress,BP,
9559,GO:0034979,1,0.892906714448722,0,17,NAD-dependent protein deacetylase activity,MF,
9560,GO:0034982,1,0.933362182455535,0,12,mitochondrial protein processing,BP,
9561,GO:0034983,1,0.952315399363502,0,7,peptidyl-lysine deacetylation,BP,
9562,GO:0034986,1,0.983785614601619,0,2,iron chaperone activity,MF,
9563,GO:0034987,1,0.96336877180094,0,6,immunoglobulin receptor binding,MF,
9564,GO:0034988,1,0.982916348855249,0,2,Fc-gamma receptor I complex binding,MF,
9565,GO:0034991,1,0.9753300588229,0,4,nuclear meiotic cohesin complex,CC,
9566,GO:0034992,1,0.936509659985754,0,7,microtubule organizing center attachment site,CC,
9567,GO:0034993,1,0.936509659985754,0,7,meiotic nuclear membrane microtubule tethering complex,CC,
9568,GO:0034998,1,0.994054740756748,0,1,oligosaccharyltransferase I complex,CC,
9569,GO:0035004,1,0.60036866674552,0,69,phosphatidylinositol 3-kinase activity,MF,
9570,GO:0035005,1,0.940879793431548,0,7,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
9571,GO:0035014,1,0.943241987352433,0,8,phosphatidylinositol 3-kinase regulator activity,MF,
9572,GO:0035019,1,0.639695199163597,0,67,somatic stem cell population maintenance,BP,
9573,GO:0035020,1,0.884065167792003,0,16,regulation of Rac protein signal transduction,BP,
9574,GO:0035021,1,0.965726718513569,0,4,negative regulation of Rac protein signal transduction,BP,
9575,GO:0035022,1,0.971213842615249,0,4,positive regulation of Rac protein signal transduction,BP,
9576,GO:0035023,1,0.376039906206015,0,125,regulation of Rho protein signal transduction,BP,
9577,GO:0035024,1,0.874673593944557,0,18,negative regulation of Rho protein signal transduction,BP,
9578,GO:0035025,1,0.861729596892075,0,23,positive regulation of Rho protein signal transduction,BP,
9579,GO:0035026,1,0.985750680217505,0,2,leading edge cell differentiation,BP,
9580,GO:0035032,1,0.963739228131871,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
9581,GO:0035033,1,0.983675348724194,0,3,histone deacetylase regulator activity,MF,
9582,GO:0035034,1,0.988542642072334,0,2,histone acetyltransferase regulator activity,MF,
9583,GO:0035035,1,0.810936077571959,0,29,histone acetyltransferase binding,MF,
9584,GO:0035036,1,0.821550386790375,0,37,sperm-egg recognition,BP,
9585,GO:0035037,1,0.992308317692818,0,1,sperm entry,BP,
9586,GO:0035038,1,0.988371785897523,0,2,female pronucleus assembly,BP,
9587,GO:0035039,1,0.994604389298739,0,1,male pronucleus assembly,BP,
9588,GO:0035050,1,0.614902129536565,0,69,embryonic heart tube development,BP,
9589,GO:0035051,1,0.413059733864483,0,119,cardiocyte differentiation,BP,
9590,GO:0035054,1,0.981918221991202,0,3,embryonic heart tube anterior/posterior pattern specification,BP,
9591,GO:0035061,1,0.967135786154942,0,4,interchromatin granule,CC,
9592,GO:0035063,1,0.977246430394661,0,2,nuclear speck organization,BP,
9593,GO:0035064,1,0.66578197530438,0,56,methylated histone binding,MF,
9594,GO:0035065,1,0.711744495382126,0,52,regulation of histone acetylation,BP,
9595,GO:0035066,1,0.835100580172888,0,28,positive regulation of histone acetylation,BP,
9596,GO:0035067,1,0.895684650782594,0,17,negative regulation of histone acetylation,BP,
9597,GO:0035068,1,0.93295385425827,0,9,micro-ribonucleoprotein complex,CC,
9599,GO:0035087,1,0.972193675716889,0,4,siRNA loading onto RISC involved in RNA interference,BP,
9600,GO:0035088,1,0.733292684211374,0,45,establishment or maintenance of apical/basal cell polarity,BP,
9601,GO:0035089,1,0.889595743679281,0,17,establishment of apical/basal cell polarity,BP,
9602,GO:0035090,1,0.925485817397224,0,12,maintenance of apical/basal cell polarity,BP,
9604,GO:0035092,1,0.953560915977387,0,6,sperm chromatin condensation,BP,
9605,GO:0035093,1,0.964951990070263,0,4,spermatogenesis, exchange of chromosomal proteins,BP,
9607,GO:0035095,1,0.948225227719376,0,7,behavioral response to nicotine,BP,
9608,GO:0035097,1,0.61102022674084,0,68,histone methyltransferase complex,CC,
9609,GO:0035098,1,0.893016568072637,0,16,ESC/E(Z) complex,CC,
9610,GO:0035101,1,0.980363328156884,0,3,FACT complex,CC,
9611,GO:0035102,1,0.926066845308158,0,11,PRC1 complex,CC,
9612,GO:0035106,1,0.981560639063711,0,3,operant conditioning,BP,
9615,GO:0035112,1,0.923040977152254,0,11,genitalia morphogenesis,BP,
9617,GO:0035115,1,0.810885759627331,0,32,embryonic forelimb morphogenesis,BP,
9618,GO:0035116,1,0.831300451987396,0,28,embryonic hindlimb morphogenesis,BP,
9619,GO:0035120,1,0.986090908152591,0,1,post-embryonic appendage morphogenesis,BP,
9620,GO:0035127,1,0.986090908152591,0,1,post-embryonic limb morphogenesis,BP,
9621,GO:0035128,1,0.986090908152591,0,1,post-embryonic forelimb morphogenesis,BP,
9622,GO:0035136,1,0.755822709916413,0,40,forelimb morphogenesis,BP,
9623,GO:0035137,1,0.778927186440855,0,36,hindlimb morphogenesis,BP,
9624,GO:0035145,1,0.888217425928078,0,19,exon-exon junction complex,CC,
9627,GO:0035162,1,0.863194327725693,0,20,embryonic hemopoiesis,BP,
9628,GO:0035166,1,0.979594696089006,0,3,post-embryonic hemopoiesis,BP,
9629,GO:0035173,1,0.896022168460195,0,16,histone kinase activity,MF,
9630,GO:0035174,1,0.956760086996967,0,7,histone serine kinase activity,MF,
9631,GO:0035175,1,0.995368022343986,0,1,histone kinase activity (H3-S10 specific),MF,
9632,GO:0035176,1,0.68411394871055,0,49,social behavior,BP,
9633,GO:0035184,1,0.96347580570342,0,5,histone threonine kinase activity,MF,
9634,GO:0035188,1,0.993544641356897,0,1,hatching,BP,
9635,GO:0035189,1,0.981056596702014,0,3,Rb-E2F complex,CC,
9636,GO:0035194,1,0.439470914516678,0,120,posttranscriptional gene silencing by RNA,BP,
9637,GO:0035195,1,0.456736739531227,0,114,gene silencing by miRNA,BP,
9638,GO:0035196,1,0.747865389074373,0,40,production of miRNAs involved in gene silencing by miRNA,BP,
9639,GO:0035197,1,0.926753401131121,0,10,siRNA binding,MF,
9640,GO:0035198,1,0.865562289161515,0,22,miRNA binding,MF,
9641,GO:0035226,1,0.993725495312843,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9642,GO:0035227,1,0.993725495312843,0,1,regulation of glutamate-cysteine ligase activity,BP,
9643,GO:0035229,1,0.993725495312843,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
9644,GO:0035234,1,0.947181040909412,0,7,ectopic germ cell programmed cell death,BP,
9646,GO:0035238,1,0.994054740756748,0,1,vitamin A biosynthetic process,BP,
9648,GO:0035240,1,0.956360749839993,0,8,dopamine binding,MF,
9649,GO:0035241,1,0.977521181208974,0,4,protein-arginine omega-N monomethyltransferase activity,MF,
9650,GO:0035242,1,0.956730787911487,0,8,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9651,GO:0035243,1,0.97725005414789,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
9652,GO:0035246,1,0.935162453736685,0,12,peptidyl-arginine N-methylation,BP,
9653,GO:0035247,1,0.945760511325683,0,10,peptidyl-arginine omega-N-methylation,BP,
9654,GO:0035248,1,0.993949084219626,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
9656,GO:0035250,1,0.852206019189328,0,27,UDP-galactosyltransferase activity,MF,
9657,GO:0035251,1,0.941004253145131,0,9,UDP-glucosyltransferase activity,MF,
9658,GO:0035252,1,0.954875325920923,0,6,UDP-xylosyltransferase activity,MF,
9659,GO:0035253,1,0.919956292616816,0,11,ciliary rootlet,CC,
9661,GO:0035255,1,0.812592051835448,0,27,ionotropic glutamate receptor binding,MF,
9662,GO:0035256,1,0.95232239633478,0,8,G-protein coupled glutamate receptor binding,MF,
9663,GO:0035257,1,0.366090092627605,0,144,nuclear hormone receptor binding,MF,
9664,GO:0035258,1,0.55343440381238,0,84,steroid hormone receptor binding,MF,
9665,GO:0035259,1,0.904434936351639,0,14,glucocorticoid receptor binding,MF,
9666,GO:0035261,1,0.974131566874676,0,2,external genitalia morphogenesis,BP,
9667,GO:0035262,1,0.982884910874208,0,2,gonad morphogenesis,BP,
9669,GO:0035265,1,0.358681381842335,0,142,organ growth,BP,
9670,GO:0035267,1,0.892629592448016,0,18,NuA4 histone acetyltransferase complex,CC,
9671,GO:0035268,1,0.893055699886635,0,17,protein mannosylation,BP,
9672,GO:0035269,1,0.931446943991617,0,12,protein O-linked mannosylation,BP,
9673,GO:0035270,1,0.459485694457282,0,119,endocrine system development,BP,
9674,GO:0035272,1,0.718380762034599,0,47,exocrine system development,BP,
9675,GO:0035276,1,0.986371588457333,0,2,ethanol binding,MF,
9676,GO:0035278,1,0.901546508524626,0,13,miRNA mediated inhibition of translation,BP,
9677,GO:0035279,1,0.98730055896615,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
9678,GO:0035280,1,0.95013406279505,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
9679,GO:0035281,1,0.987644069229719,0,2,pre-miRNA export from nucleus,BP,
9681,GO:0035283,1,0.987439849502272,0,2,central nervous system segmentation,BP,
9682,GO:0035284,1,0.987439849502272,0,2,brain segmentation,BP,
9683,GO:0035290,1,0.978978240959695,0,3,trunk segmentation,BP,
9686,GO:0035299,1,0.99241842510771,0,1,inositol pentakisphosphate 2-kinase activity,MF,
9691,GO:0035307,1,0.779506036504953,0,36,positive regulation of protein dephosphorylation,BP,
9693,GO:0035312,1,0.961802791773717,0,6,5'-3' exodeoxyribonuclease activity,MF,
9694,GO:0035313,1,0.888919612703943,0,14,wound healing, spreading of epidermal cells,BP,
9695,GO:0035315,1,0.773081419922345,0,36,hair cell differentiation,BP,
9696,GO:0035325,1,0.943342710658687,0,10,Toll-like receptor binding,MF,
9697,GO:0035326,1,0.506863300347096,0,100,enhancer binding,MF,
9698,GO:0035327,1,0.874436758312191,0,21,transcriptionally active chromatin,CC,
9700,GO:0035330,1,0.9078091780508,0,11,regulation of hippo signaling,BP,
9701,GO:0035331,1,0.932713262056857,0,8,negative regulation of hippo signaling,BP,
9702,GO:0035332,1,0.977756193274155,0,2,positive regulation of hippo signaling,BP,
9703,GO:0035333,1,0.913901666903959,0,13,Notch receptor processing, ligand-dependent,BP,
9705,GO:0035336,1,0.872715363989517,0,22,long-chain fatty-acyl-CoA metabolic process,BP,
9706,GO:0035337,1,0.805048979456943,0,35,fatty-acyl-CoA metabolic process,BP,
9707,GO:0035338,1,0.904593132400577,0,16,long-chain fatty-acyl-CoA biosynthetic process,BP,
9708,GO:0035339,1,0.980837536079668,0,4,SPOTS complex,CC,
9709,GO:0035349,1,0.982751723197433,0,3,coenzyme A transmembrane transport,BP,
9710,GO:0035350,1,0.988478899811264,0,2,FAD transmembrane transport,BP,
9711,GO:0035352,1,0.994666537808309,0,1,NAD transmembrane transport,BP,
9712,GO:0035354,1,0.987409087567867,0,2,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9713,GO:0035355,1,0.990959133424442,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9714,GO:0035356,1,0.961398432842003,0,7,cellular triglyceride homeostasis,BP,
9715,GO:0035357,1,0.871084790248084,0,20,peroxisome proliferator activated receptor signaling pathway,BP,
9716,GO:0035358,1,0.92447270062363,0,12,regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9717,GO:0035359,1,0.982737275497986,0,3,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9718,GO:0035360,1,0.952960854330255,0,7,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9719,GO:0035363,1,0.97659532210318,0,4,histone locus body,CC,
9720,GO:0035368,1,0.973689873511334,0,4,selenocysteine insertion sequence binding,MF,
9721,GO:0035370,1,0.988949996079122,0,2,UBC13-UEV1A complex,CC,
9722,GO:0035371,1,0.85255741011891,0,18,microtubule plus-end,CC,
9723,GO:0035372,1,0.906670823728016,0,13,protein localization to microtubule,BP,
9724,GO:0035373,1,0.970513919185569,0,3,chondroitin sulfate proteoglycan binding,MF,
9725,GO:0035374,1,0.956605952032206,0,6,chondroitin sulfate binding,MF,
9726,GO:0035375,1,0.989192315997504,0,1,zymogen binding,MF,
9727,GO:0035376,1,0.962216798733434,0,7,sterol import,BP,
9728,GO:0035377,1,0.984821964529918,0,2,transepithelial water transport,BP,
9729,GO:0035378,1,0.994079856808501,0,1,carbon dioxide transmembrane transport,BP,
9730,GO:0035379,1,0.994079856808501,0,1,carbon dioxide transmembrane transporter activity,MF,
9731,GO:0035381,1,0.954354036893857,0,8,ATP-gated ion channel activity,MF,
9732,GO:0035383,1,0.57242108918903,0,91,thioester metabolic process,BP,
9733,GO:0035384,1,0.736058585100938,0,46,thioester biosynthetic process,BP,
9735,GO:0035397,1,0.993691921123067,0,1,helper T cell enhancement of adaptive immune response,BP,
9736,GO:0035400,1,0.991529291220002,0,1,histone tyrosine kinase activity,MF,
9737,GO:0035401,1,0.991529291220002,0,1,histone kinase activity (H3-Y41 specific),MF,
9738,GO:0035402,1,0.987969085112421,0,2,histone kinase activity (H3-T11 specific),MF,
9739,GO:0035403,1,0.979750565764696,0,2,histone kinase activity (H3-T6 specific),MF,
9740,GO:0035404,1,0.928991086201548,0,12,histone-serine phosphorylation,BP,
9741,GO:0035405,1,0.96347580570342,0,5,histone-threonine phosphorylation,BP,
9742,GO:0035406,1,0.991529291220002,0,1,histone-tyrosine phosphorylation,BP,
9743,GO:0035407,1,0.987969085112421,0,2,histone H3-T11 phosphorylation,BP,
9744,GO:0035408,1,0.979750565764696,0,2,histone H3-T6 phosphorylation,BP,
9745,GO:0035409,1,0.991529291220002,0,1,histone H3-Y41 phosphorylation,BP,
9746,GO:0035410,1,0.995975451635579,0,1,dihydrotestosterone 17-beta-dehydrogenase activity,MF,
9748,GO:0035425,1,0.986580101607576,0,2,autocrine signaling,BP,
9749,GO:0035426,1,0.963738883300448,0,5,extracellular matrix-cell signaling,BP,
9750,GO:0035434,1,0.956599234184904,0,6,copper ion transmembrane transport,BP,
9751,GO:0035435,1,0.935272242931818,0,9,phosphate ion transmembrane transport,BP,
9752,GO:0035437,1,0.923694133697144,0,13,maintenance of protein localization in endoplasmic reticulum,BP,
9753,GO:0035438,1,0.995393307501462,0,1,cyclic-di-GMP binding,MF,
9754,GO:0035441,1,0.972991204170642,0,3,cell migration involved in vasculogenesis,BP,
9755,GO:0035442,1,0.989640228779888,0,2,dipeptide transmembrane transport,BP,
9756,GO:0035443,1,0.99043455124782,0,1,tripeptide transmembrane transport,BP,
9757,GO:0035445,1,0.993683564995919,0,1,borate transmembrane transport,BP,
9758,GO:0035455,1,0.88198560345366,0,20,response to interferon-alpha,BP,
9759,GO:0035456,1,0.899375364953111,0,20,response to interferon-beta,BP,
9760,GO:0035457,1,0.930184258678572,0,10,cellular response to interferon-alpha,BP,
9761,GO:0035458,1,0.926960461219302,0,13,cellular response to interferon-beta,BP,
9762,GO:0035459,1,0.871530034295874,0,20,cargo loading into vesicle,BP,
9763,GO:0035461,1,0.916880150592797,0,11,vitamin transmembrane transport,BP,
9764,GO:0035469,1,0.964346653836577,0,5,determination of pancreatic left/right asymmetry,BP,
9765,GO:0035470,1,0.99067962788187,0,2,positive regulation of vascular wound healing,BP,
9766,GO:0035473,1,0.966325349864245,0,4,lipase binding,MF,
9767,GO:0035480,1,0.996061378444575,0,1,regulation of Notch signaling pathway involved in heart induction,BP,
9768,GO:0035481,1,0.996061378444575,0,1,positive regulation of Notch signaling pathway involved in heart induction,BP,
9769,GO:0035482,1,0.985343579577434,0,4,gastric motility,BP,
9770,GO:0035483,1,0.989867801074654,0,3,gastric emptying,BP,
9771,GO:0035485,1,0.995198820943142,0,1,adenine/guanine mispair binding,MF,
9772,GO:0035490,1,0.993635796894997,0,1,regulation of leukotriene production involved in inflammatory response,BP,
9773,GO:0035491,1,0.993635796894997,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,
9774,GO:0035493,1,0.909550612860323,0,15,SNARE complex assembly,BP,
9775,GO:0035494,1,0.982267490489245,0,3,SNARE complex disassembly,BP,
9776,GO:0035497,1,0.916336969966568,0,13,cAMP response element binding,MF,
9777,GO:0035498,1,0.992855757159882,0,1,carnosine metabolic process,BP,
9778,GO:0035499,1,0.992855757159882,0,1,carnosine biosynthetic process,BP,
9779,GO:0035500,1,0.987074371570917,0,2,MH2 domain binding,MF,
9780,GO:0035501,1,0.993994270098414,0,1,MH1 domain binding,MF,
9781,GO:0035502,1,0.969756914179723,0,5,metanephric part of ureteric bud development,BP,
9782,GO:0035504,1,0.995632673571106,0,1,regulation of myosin light chain kinase activity,BP,
9783,GO:0035505,1,0.995632673571106,0,1,positive regulation of myosin light chain kinase activity,BP,
9784,GO:0035507,1,0.944399605153662,0,7,regulation of myosin-light-chain-phosphatase activity,BP,
9785,GO:0035508,1,0.991231651110979,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
9786,GO:0035509,1,0.962353919614386,0,5,negative regulation of myosin-light-chain-phosphatase activity,BP,
9787,GO:0035510,1,0.826094913181226,0,28,DNA dealkylation,BP,
9788,GO:0035511,1,0.972518553652471,0,5,oxidative DNA demethylation,BP,
9789,GO:0035513,1,0.975925713698489,0,4,oxidative RNA demethylation,BP,
9790,GO:0035514,1,0.984472835206246,0,3,DNA demethylase activity,MF,
9791,GO:0035515,1,0.975925713698489,0,4,oxidative RNA demethylase activity,MF,
9792,GO:0035516,1,0.992529948194665,0,1,oxidative DNA demethylase activity,MF,
9793,GO:0035517,1,0.965347082614752,0,4,PR-DUB complex,CC,
9794,GO:0035518,1,0.894912967900074,0,16,histone H2A monoubiquitination,BP,
9795,GO:0035519,1,0.978749715049199,0,4,protein K29-linked ubiquitination,BP,
9796,GO:0035520,1,0.932265404100066,0,9,monoubiquitinated protein deubiquitination,BP,
9797,GO:0035521,1,0.974292296999037,0,4,monoubiquitinated histone deubiquitination,BP,
9798,GO:0035522,1,0.974292296999037,0,4,monoubiquitinated histone H2A deubiquitination,BP,
9799,GO:0035523,1,0.97169572466663,0,3,protein K29-linked deubiquitination,BP,
9800,GO:0035524,1,0.963051953491023,0,5,proline transmembrane transport,BP,
9801,GO:0035525,1,0.994283746643721,0,1,NF-kappaB p50/p65 complex,CC,
9802,GO:0035526,1,0.984637701955769,0,2,retrograde transport, plasma membrane to Golgi,BP,
9803,GO:0035529,1,0.960375225798149,0,7,NADH pyrophosphatase activity,MF,
9804,GO:0035538,1,0.993537030697952,0,1,carbohydrate response element binding,MF,
9805,GO:0035539,1,0.991602992556259,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
9806,GO:0035542,1,0.941150719872203,0,9,regulation of SNARE complex assembly,BP,
9807,GO:0035544,1,0.978987337546645,0,3,negative regulation of SNARE complex assembly,BP,
9808,GO:0035545,1,0.992877798889938,0,1,determination of left/right asymmetry in nervous system,BP,
9809,GO:0035546,1,0.95786221830377,0,5,interferon-beta secretion,BP,
9810,GO:0035547,1,0.95786221830377,0,5,regulation of interferon-beta secretion,BP,
9811,GO:0035548,1,0.993954635307716,0,1,negative regulation of interferon-beta secretion,BP,
9812,GO:0035549,1,0.963690245916666,0,4,positive regulation of interferon-beta secretion,BP,
9813,GO:0035552,1,0.982444814028418,0,3,oxidative single-stranded DNA demethylation,BP,
9814,GO:0035553,1,0.981546291884304,0,3,oxidative single-stranded RNA demethylation,BP,
9816,GO:0035561,1,0.869285479044661,0,21,regulation of chromatin binding,BP,
9817,GO:0035562,1,0.948311382483733,0,7,negative regulation of chromatin binding,BP,
9818,GO:0035563,1,0.922833220158478,0,13,positive regulation of chromatin binding,BP,
9819,GO:0035564,1,0.980544260164133,0,2,regulation of kidney size,BP,
9820,GO:0035566,1,0.992707630778446,0,1,regulation of metanephros size,BP,
9822,GO:0035568,1,0.994054740756748,0,1,N-terminal peptidyl-proline methylation,BP,
9823,GO:0035570,1,0.994054740756748,0,1,N-terminal peptidyl-serine methylation,BP,
9824,GO:0035572,1,0.994054740756748,0,1,N-terminal peptidyl-serine dimethylation,BP,
9825,GO:0035573,1,0.994054740756748,0,1,N-terminal peptidyl-serine trimethylation,BP,
9826,GO:0035574,1,0.984872478887927,0,2,histone H4-K20 demethylation,BP,
9827,GO:0035575,1,0.984872478887927,0,2,histone demethylase activity (H4-K20 specific),MF,
9828,GO:0035577,1,0.697381833550212,0,56,azurophil granule membrane,CC,
9829,GO:0035578,1,0.621869964569028,0,85,azurophil granule lumen,CC,
9832,GO:0035581,1,0.937824265754961,0,8,sequestering of extracellular ligand from receptor,BP,
9833,GO:0035582,1,0.972142690673458,0,4,sequestering of BMP in extracellular matrix,BP,
9834,GO:0035583,1,0.964059706597532,0,3,sequestering of TGFbeta in extracellular matrix,BP,
9835,GO:0035584,1,0.888792050810982,0,18,calcium-mediated signaling using intracellular calcium source,BP,
9836,GO:0035585,1,0.978240848843712,0,2,calcium-mediated signaling using extracellular calcium source,BP,
9837,GO:0035586,1,0.884838548746374,0,23,purinergic receptor activity,MF,
9838,GO:0035587,1,0.845232702960787,0,30,purinergic receptor signaling pathway,BP,
9839,GO:0035588,1,0.884495999667663,0,22,G-protein coupled purinergic receptor signaling pathway,BP,
9840,GO:0035589,1,0.933950459525046,0,13,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
9841,GO:0035590,1,0.892514133159729,0,21,purinergic nucleotide receptor signaling pathway,BP,
9842,GO:0035591,1,0.571068641875482,0,80,signaling adaptor activity,MF,
9843,GO:0035594,1,0.977215265197094,0,4,ganglioside binding,MF,
9844,GO:0035596,1,0.988516061212568,0,2,methylthiotransferase activity,MF,
9845,GO:0035597,1,0.994968490295495,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
9846,GO:0035598,1,0.993515270897385,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
9847,GO:0035600,1,0.988516061212568,0,2,tRNA methylthiolation,BP,
9848,GO:0035601,1,0.478453360265462,0,105,protein deacylation,BP,
9849,GO:0035602,1,0.992721148971841,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,
9850,GO:0035603,1,0.992721148971841,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9851,GO:0035604,1,0.992721148971841,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
9852,GO:0035605,1,0.995865645684935,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
9853,GO:0035606,1,0.992661459338904,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
9854,GO:0035607,1,0.983976394385499,0,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,
9855,GO:0035608,1,0.956913155309442,0,7,protein deglutamylation,BP,
9856,GO:0035609,1,0.975698999622117,0,4,C-terminal protein deglutamylation,BP,
9857,GO:0035610,1,0.973120483876964,0,4,protein side chain deglutamylation,BP,
9858,GO:0035611,1,0.993977475111437,0,1,protein branching point deglutamylation,BP,
9859,GO:0035612,1,0.929268350984941,0,8,AP-2 adaptor complex binding,MF,
9860,GO:0035613,1,0.898713230689184,0,15,RNA stem-loop binding,MF,
9861,GO:0035614,1,0.985348504833071,0,3,snRNA stem-loop binding,MF,
9862,GO:0035615,1,0.926450199386856,0,11,clathrin adaptor activity,MF,
9863,GO:0035616,1,0.977387935416614,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
9864,GO:0035617,1,0.980138204820753,0,3,stress granule disassembly,BP,
9865,GO:0035620,1,0.97309467307221,0,4,ceramide transporter activity,MF,
9866,GO:0035621,1,0.986491586256929,0,2,ER to Golgi ceramide transport,BP,
9867,GO:0035622,1,0.992888336613997,0,1,intrahepatic bile duct development,BP,
9868,GO:0035623,1,0.993554805365188,0,1,renal glucose absorption,BP,
9869,GO:0035624,1,0.970465123504941,0,4,receptor transactivation,BP,
9870,GO:0035625,1,0.981352094996063,0,3,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
9871,GO:0035627,1,0.951183805139512,0,7,ceramide transport,BP,
9872,GO:0035630,1,0.951773180045122,0,7,bone mineralization involved in bone maturation,BP,
9873,GO:0035631,1,0.935392438142695,0,11,CD40 receptor complex,CC,
9874,GO:0035633,1,0.971942835864712,0,4,maintenance of permeability of blood-brain barrier,BP,
9875,GO:0035634,1,0.981587250298301,0,3,response to stilbenoid,BP,
9876,GO:0035635,1,0.877558736690039,0,18,entry of bacterium into host cell,BP,
9877,GO:0035637,1,0.236416350246445,0,190,multicellular organismal signaling,BP,
9878,GO:0035638,1,0.992085776148083,0,1,signal maturation,BP,
9882,GO:0035642,1,0.993829895337087,0,1,histone methyltransferase activity (H3-R17 specific),MF,
9883,GO:0035643,1,0.995381931359379,0,1,L-DOPA receptor activity,MF,
9884,GO:0035644,1,0.993798208022461,0,1,phosphoanandamide dephosphorylation,BP,
9885,GO:0035645,1,0.992539702056608,0,1,enteric smooth muscle cell differentiation,BP,
9886,GO:0035646,1,0.940845212896697,0,10,endosome to melanosome transport,BP,
9887,GO:0035650,1,0.978754473014311,0,4,AP-1 adaptor complex binding,MF,
9888,GO:0035651,1,0.984467044918888,0,3,AP-3 adaptor complex binding,MF,
9889,GO:0035655,1,0.956130278287184,0,8,interleukin-18-mediated signaling pathway,BP,
9890,GO:0035658,1,0.982655703026721,0,3,Mon1-Ccz1 complex,CC,
9891,GO:0035659,1,0.995364228047533,0,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,
9892,GO:0035662,1,0.989086230901971,0,3,Toll-like receptor 4 binding,MF,
9893,GO:0035663,1,0.980330088612479,0,3,Toll-like receptor 2 binding,MF,
9894,GO:0035664,1,0.995274312942595,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9895,GO:0035665,1,0.995274312942595,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
9896,GO:0035666,1,0.855387410180579,0,27,TRIF-dependent toll-like receptor signaling pathway,BP,
9897,GO:0035668,1,0.985178956190895,0,2,TRAM-dependent toll-like receptor signaling pathway,BP,
9898,GO:0035669,1,0.985178956190895,0,2,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
9899,GO:0035671,1,0.984908201352347,0,3,enone reductase activity,MF,
9900,GO:0035672,1,0.958464378373481,0,6,oligopeptide transmembrane transport,BP,
9901,GO:0035673,1,0.968501055573613,0,4,oligopeptide transmembrane transporter activity,MF,
9902,GO:0035674,1,0.989110448695877,0,2,tricarboxylic acid transmembrane transport,BP,
9903,GO:0035675,1,0.994202771880615,0,1,neuromast hair cell development,BP,
9904,GO:0035684,1,0.996574289575188,0,1,helper T cell extravasation,BP,
9905,GO:0035686,1,0.978858599860218,0,4,sperm fibrous sheath,CC,
9907,GO:0035691,1,0.988382661849176,0,2,macrophage migration inhibitory factor signaling pathway,BP,
9908,GO:0035692,1,0.9877442152692,0,2,macrophage migration inhibitory factor receptor complex,CC,
9909,GO:0035693,1,0.995866894913715,0,1,NOS2-CD74 complex,CC,
9910,GO:0035694,1,0.974504446291197,0,4,mitochondrial protein catabolic process,BP,
9911,GO:0035695,1,0.992518237196902,0,1,mitophagy by induced vacuole formation,BP,
9912,GO:0035696,1,0.977437763185481,0,3,monocyte extravasation,BP,
9913,GO:0035697,1,0.984741064379041,0,3,CD8-positive, alpha-beta T cell extravasation,BP,
9914,GO:0035698,1,0.990309259032093,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
9915,GO:0035700,1,0.989682266011565,0,2,astrocyte chemotaxis,BP,
9916,GO:0035701,1,0.956792704445686,0,6,hematopoietic stem cell migration,BP,
9917,GO:0035704,1,0.994377869669239,0,1,helper T cell chemotaxis,BP,
9918,GO:0035705,1,0.994377869669239,0,1,T-helper 17 cell chemotaxis,BP,
9919,GO:0035708,1,0.993306621233704,0,1,interleukin-4-dependent isotype switching to IgE isotypes,BP,
9920,GO:0035709,1,0.988084237233262,0,2,memory T cell activation,BP,
9921,GO:0035710,1,0.658098588392191,0,66,CD4-positive, alpha-beta T cell activation,BP,
9922,GO:0035711,1,0.989380804954496,0,2,T-helper 1 cell activation,BP,
9923,GO:0035712,1,0.986871889861632,0,2,T-helper 2 cell activation,BP,
9924,GO:0035713,1,0.993306621233704,0,1,response to nitrogen dioxide,BP,
9925,GO:0035715,1,0.994377869669239,0,1,chemokine (C-C motif) ligand 2 binding,MF,
9926,GO:0035716,1,0.994377869669239,0,1,chemokine (C-C motif) ligand 12 binding,MF,
9927,GO:0035717,1,0.988582647478581,0,2,chemokine (C-C motif) ligand 7 binding,MF,
9928,GO:0035718,1,0.991531193934998,0,2,macrophage migration inhibitory factor binding,MF,
9929,GO:0035720,1,0.979053622426095,0,3,intraciliary anterograde transport,BP,
9930,GO:0035721,1,0.912387727532322,0,12,intraciliary retrograde transport,BP,
9931,GO:0035722,1,0.781749088797404,0,44,interleukin-12-mediated signaling pathway,BP,
9932,GO:0035723,1,0.912760184660741,0,13,interleukin-15-mediated signaling pathway,BP,
9933,GO:0035724,1,0.990064688415245,0,1,CD24 biosynthetic process,BP,
9935,GO:0035726,1,0.956589596698646,0,7,common myeloid progenitor cell proliferation,BP,
9936,GO:0035727,1,0.971463811249793,0,5,lysophosphatidic acid binding,MF,
9937,GO:0035728,1,0.892840703833306,0,16,response to hepatocyte growth factor,BP,
9938,GO:0035729,1,0.907643094912717,0,14,cellular response to hepatocyte growth factor stimulus,BP,
9939,GO:0035730,1,0.996307199723185,0,1,S-nitrosoglutathione binding,MF,
9940,GO:0035731,1,0.996307199723185,0,1,dinitrosyl-iron complex binding,MF,
9941,GO:0035732,1,0.996307199723185,0,1,nitric oxide storage,BP,
9942,GO:0035733,1,0.954345709838706,0,7,hepatic stellate cell activation,BP,
9943,GO:0035735,1,0.757572813969839,0,40,intraciliary transport involved in cilium assembly,BP,
9944,GO:0035739,1,0.966078551412529,0,6,CD4-positive, alpha-beta T cell proliferation,BP,
9945,GO:0035740,1,0.984705212906503,0,3,CD8-positive, alpha-beta T cell proliferation,BP,
9946,GO:0035743,1,0.927673467930141,0,14,CD4-positive, alpha-beta T cell cytokine production,BP,
9947,GO:0035744,1,0.982061507941059,0,4,T-helper 1 cell cytokine production,BP,
9948,GO:0035745,1,0.946551159148751,0,10,T-helper 2 cell cytokine production,BP,
9949,GO:0035746,1,0.995982929342318,0,1,granzyme A production,BP,
9951,GO:0035748,1,0.95759755071376,0,6,myelin sheath abaxonal region,CC,
9952,GO:0035749,1,0.960721423151308,0,6,myelin sheath adaxonal region,CC,
9953,GO:0035750,1,0.99146731869827,0,1,protein localization to myelin sheath abaxonal region,BP,
9954,GO:0035751,1,0.936136039242782,0,12,regulation of lysosomal lumen pH,BP,
9955,GO:0035752,1,0.995121367967931,0,1,lysosomal lumen pH elevation,BP,
9956,GO:0035754,1,0.956147655692998,0,8,B cell chemotaxis,BP,
9957,GO:0035755,1,0.994291488409353,0,1,cardiolipin hydrolase activity,MF,
9958,GO:0035757,1,0.994786708960719,0,1,chemokine (C-C motif) ligand 19 binding,MF,
9959,GO:0035758,1,0.994786708960719,0,1,chemokine (C-C motif) ligand 21 binding,MF,
9960,GO:0035759,1,0.99055390496248,0,2,mesangial cell-matrix adhesion,BP,
9961,GO:0035766,1,0.966329832541836,0,5,cell chemotaxis to fibroblast growth factor,BP,
9962,GO:0035767,1,0.849553226385802,0,23,endothelial cell chemotaxis,BP,
9963,GO:0035768,1,0.966329832541836,0,5,endothelial cell chemotaxis to fibroblast growth factor,BP,
9964,GO:0035770,1,0.28286725532642,0,189,ribonucleoprotein granule,CC,
9965,GO:0035771,1,0.955027152976835,0,7,interleukin-4-mediated signaling pathway,BP,
9966,GO:0035772,1,0.995304731481997,0,1,interleukin-13-mediated signaling pathway,BP,
9969,GO:0035782,1,0.995982929342318,0,1,mature natural killer cell chemotaxis,BP,
9970,GO:0035783,1,0.993306621233704,0,1,CD4-positive, alpha-beta T cell costimulation,BP,
9971,GO:0035787,1,0.970901236892424,0,4,cell migration involved in kidney development,BP,
9972,GO:0035788,1,0.979240927656754,0,3,cell migration involved in metanephros development,BP,
9973,GO:0035789,1,0.979240927656754,0,3,metanephric mesenchymal cell migration,BP,
9974,GO:0035790,1,0.983289006810076,0,2,platelet-derived growth factor receptor-alpha signaling pathway,BP,
9975,GO:0035791,1,0.898648193258371,0,13,platelet-derived growth factor receptor-beta signaling pathway,BP,
9976,GO:0035793,1,0.979240927656754,0,3,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
9977,GO:0035794,1,0.715146839534686,0,59,positive regulation of mitochondrial membrane permeability,BP,
9978,GO:0035795,1,0.973125229105588,0,5,negative regulation of mitochondrial membrane permeability,BP,
9979,GO:0035799,1,0.972185479695957,0,4,ureter maturation,BP,
9980,GO:0035800,1,0.988750441605162,0,2,deubiquitinase activator activity,MF,
9981,GO:0035801,1,0.989099495855607,0,2,adrenal cortex development,BP,
9982,GO:0035802,1,0.989099495855607,0,2,adrenal cortex formation,BP,
9983,GO:0035803,1,0.991499035692071,0,2,egg coat formation,BP,
9984,GO:0035805,1,0.994688990500014,0,1,egg coat,CC,
9985,GO:0035809,1,0.898146301735462,0,18,regulation of urine volume,BP,
9986,GO:0035810,1,0.927497213738855,0,12,positive regulation of urine volume,BP,
9987,GO:0035811,1,0.982229872729231,0,3,negative regulation of urine volume,BP,
9988,GO:0035812,1,0.909803746778416,0,16,renal sodium excretion,BP,
9989,GO:0035813,1,0.909803746778416,0,16,regulation of renal sodium excretion,BP,
9990,GO:0035814,1,0.974487727161791,0,5,negative regulation of renal sodium excretion,BP,
9991,GO:0035815,1,0.946413391181383,0,9,positive regulation of renal sodium excretion,BP,
9993,GO:0035822,1,0.965574185977741,0,5,gene conversion,BP,
9995,GO:0035838,1,0.974936122701033,0,3,growing cell tip,CC,
9996,GO:0035841,1,0.982173016918656,0,2,new growing cell tip,CC,
9997,GO:0035844,1,0.974089876912516,0,4,cloaca development,BP,
9998,GO:0035845,1,0.935572750369146,0,9,photoreceptor cell outer segment organization,BP,
9999,GO:0035850,1,0.741676094867963,0,41,epithelial cell differentiation involved in kidney development,BP,
10000,GO:0035851,1,0.993837448695658,0,1,Krueppel-associated box domain binding,MF,
10001,GO:0035853,1,0.992343763619182,0,1,chromosome passenger complex localization to spindle midzone,BP,
10002,GO:0035854,1,0.989108636168157,0,2,eosinophil fate commitment,BP,
10003,GO:0035855,1,0.891508277408654,0,15,megakaryocyte development,BP,
10004,GO:0035859,1,0.924608087050378,0,13,Seh1-associated complex,CC,
10005,GO:0035860,1,0.959721946728519,0,5,glial cell-derived neurotrophic factor receptor signaling pathway,BP,
10006,GO:0035861,1,0.81071101048242,0,30,site of double-strand break,CC,
10007,GO:0035862,1,0.990809253553117,0,1,dITP metabolic process,BP,
10008,GO:0035863,1,0.990809253553117,0,1,dITP catabolic process,BP,
10009,GO:0035864,1,0.935009525716374,0,10,response to potassium ion,BP,
10010,GO:0035865,1,0.960333984708486,0,6,cellular response to potassium ion,BP,
10011,GO:0035866,1,0.970325193278699,0,3,alphav-beta3 integrin-PKCalpha complex,CC,
10012,GO:0035867,1,0.958115489051129,0,4,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,
10013,GO:0035868,1,0.975414070569443,0,3,alphav-beta3 integrin-HMGB1 complex,CC,
10014,GO:0035869,1,0.676693584206584,0,58,ciliary transition zone,CC,
10015,GO:0035870,1,0.986976083114308,0,2,dITP diphosphatase activity,MF,
10016,GO:0035871,1,0.932710281089377,0,8,protein K11-linked deubiquitination,BP,
10017,GO:0035872,1,0.793726133606645,0,35,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,
10018,GO:0035873,1,0.959795547634556,0,6,lactate transmembrane transport,BP,
10019,GO:0035877,1,0.976302338838254,0,4,death effector domain binding,MF,
10020,GO:0035878,1,0.949412067030357,0,8,nail development,BP,
10021,GO:0035879,1,0.980278435507842,0,3,plasma membrane lactate transport,BP,
10022,GO:0035880,1,0.982962484223143,0,3,embryonic nail plate morphogenesis,BP,
10023,GO:0035881,1,0.957442822241074,0,7,amacrine cell differentiation,BP,
10024,GO:0035883,1,0.843395240101819,0,25,enteroendocrine cell differentiation,BP,
10025,GO:0035886,1,0.884632994166222,0,19,vascular smooth muscle cell differentiation,BP,
10026,GO:0035887,1,0.99532436368798,0,1,aortic smooth muscle cell differentiation,BP,
10027,GO:0035890,1,0.807951066009497,0,33,exit from host,BP,
10028,GO:0035891,1,0.807951066009497,0,33,exit from host cell,BP,
10029,GO:0035897,1,0.966480593149989,0,6,proteolysis in other organism,BP,
10030,GO:0035898,1,0.980189782086719,0,3,parathyroid hormone secretion,BP,
10031,GO:0035900,1,0.965652727074813,0,6,response to isolation stress,BP,
10032,GO:0035902,1,0.886325720652764,0,19,response to immobilization stress,BP,
10033,GO:0035904,1,0.689668458866042,0,47,aorta development,BP,
10034,GO:0035905,1,0.973718764281033,0,4,ascending aorta development,BP,
10035,GO:0035907,1,0.943689662617233,0,9,dorsal aorta development,BP,
10036,GO:0035909,1,0.791979225699355,0,30,aorta morphogenesis,BP,
10037,GO:0035910,1,0.973718764281033,0,4,ascending aorta morphogenesis,BP,
10038,GO:0035912,1,0.949849490077967,0,8,dorsal aorta morphogenesis,BP,
10039,GO:0035914,1,0.656442783894184,0,61,skeletal muscle cell differentiation,BP,
10040,GO:0035915,1,0.988759100727046,0,3,pore formation in membrane of other organism,BP,
10041,GO:0035921,1,0.994878682434415,0,1,desmosome disassembly,BP,
10042,GO:0035922,1,0.995507507163806,0,1,foramen ovale closure,BP,
10043,GO:0035924,1,0.749111857751023,0,41,cellular response to vascular endothelial growth factor stimulus,BP,
10044,GO:0035925,1,0.920719494449915,0,12,mRNA 3'-UTR AU-rich region binding,MF,
10045,GO:0035926,1,0.969534680587344,0,5,chemokine (C-C motif) ligand 2 secretion,BP,
10046,GO:0035927,1,0.978201697821502,0,4,RNA import into mitochondrion,BP,
10047,GO:0035928,1,0.984689722598435,0,3,rRNA import into mitochondrion,BP,
10048,GO:0035929,1,0.904391499339326,0,18,steroid hormone secretion,BP,
10049,GO:0035930,1,0.932354230537505,0,13,corticosteroid hormone secretion,BP,
10050,GO:0035931,1,0.976893343881599,0,4,mineralocorticoid secretion,BP,
10051,GO:0035932,1,0.976893343881599,0,4,aldosterone secretion,BP,
10052,GO:0035933,1,0.95441792323873,0,9,glucocorticoid secretion,BP,
10053,GO:0035934,1,0.982339334279943,0,4,corticosterone secretion,BP,
10054,GO:0035935,1,0.993518302110512,0,1,androgen secretion,BP,
10055,GO:0035936,1,0.983507911337375,0,2,testosterone secretion,BP,
10056,GO:0035938,1,0.978480223212307,0,3,estradiol secretion,BP,
10057,GO:0035939,1,0.981618460696607,0,3,microsatellite binding,MF,
10058,GO:0035945,1,0.994397214088083,0,1,mitochondrial ncRNA surveillance,BP,
10059,GO:0035946,1,0.994397214088083,0,1,mitochondrial mRNA surveillance,BP,
10060,GO:0035947,1,0.965004692728467,0,5,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,
10061,GO:0035948,1,0.979490385731852,0,3,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,
10062,GO:0035962,1,0.982531017953274,0,3,response to interleukin-13,BP,
10063,GO:0035963,1,0.982531017953274,0,3,cellular response to interleukin-13,BP,
10064,GO:0035964,1,0.962427929899379,0,6,COPI-coated vesicle budding,BP,
10065,GO:0035965,1,0.969793768000081,0,5,cardiolipin acyl-chain remodeling,BP,
10066,GO:0035966,1,0.305234786481427,0,189,response to topologically incorrect protein,BP,
10067,GO:0035967,1,0.365609422086274,0,157,cellular response to topologically incorrect protein,BP,
10068,GO:0035970,1,0.902932441424053,0,16,peptidyl-threonine dephosphorylation,BP,
10069,GO:0035971,1,0.995982929342318,0,1,peptidyl-histidine dephosphorylation,BP,
10070,GO:0035973,1,0.94688451765866,0,7,aggrephagy,BP,
10071,GO:0035976,1,0.975304950900009,0,5,transcription factor AP-1 complex,CC,
10072,GO:0035977,1,0.970405141075512,0,4,protein deglycosylation involved in glycoprotein catabolic process,BP,
10073,GO:0035978,1,0.993994270098414,0,1,histone H2A-S139 phosphorylation,BP,
10074,GO:0035981,1,0.987920252630946,0,2,tongue muscle cell differentiation,BP,
10075,GO:0035983,1,0.973061182446281,0,4,response to trichostatin A,BP,
10076,GO:0035984,1,0.973061182446281,0,4,cellular response to trichostatin A,BP,
10077,GO:0035985,1,0.98044410346062,0,4,senescence-associated heterochromatin focus,CC,
10078,GO:0035986,1,0.985157852760119,0,3,senescence-associated heterochromatin focus assembly,BP,
10079,GO:0035987,1,0.718920493246052,0,45,endodermal cell differentiation,BP,
10080,GO:0035988,1,0.90981361176132,0,14,chondrocyte proliferation,BP,
10081,GO:0035989,1,0.964624809809851,0,5,tendon development,BP,
10082,GO:0035990,1,0.986173711908023,0,3,tendon cell differentiation,BP,
10083,GO:0035992,1,0.986173711908023,0,3,tendon formation,BP,
10084,GO:0035993,1,0.990004330171107,0,2,deltoid tuberosity development,BP,
10085,GO:0035994,1,0.860213630057692,0,18,response to muscle stretch,BP,
10086,GO:0035995,1,0.958381915080165,0,3,detection of muscle stretch,BP,
10087,GO:0035998,1,0.995059160510793,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
10088,GO:0035999,1,0.948153645584716,0,9,tetrahydrofolate interconversion,BP,
10090,GO:0036003,1,0.857138884697061,0,25,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,
10091,GO:0036004,1,0.995966726214887,0,1,GAF domain binding,MF,
10092,GO:0036005,1,0.951300977020725,0,8,response to macrophage colony-stimulating factor,BP,
10093,GO:0036006,1,0.951300977020725,0,8,cellular response to macrophage colony-stimulating factor stimulus,BP,
10094,GO:0036009,1,0.996047689627225,0,1,protein-glutamine N-methyltransferase activity,MF,
10095,GO:0036010,1,0.872786134095976,0,18,protein localization to endosome,BP,
10096,GO:0036015,1,0.973731203251593,0,4,response to interleukin-3,BP,
10097,GO:0036016,1,0.973731203251593,0,4,cellular response to interleukin-3,BP,
10098,GO:0036017,1,0.969540754146533,0,7,response to erythropoietin,BP,
10099,GO:0036018,1,0.972488520191537,0,6,cellular response to erythropoietin,BP,
10100,GO:0036019,1,0.876142030178171,0,19,endolysosome,CC,
10101,GO:0036020,1,0.902961325927731,0,14,endolysosome membrane,CC,
10102,GO:0036021,1,0.970328659861093,0,5,endolysosome lumen,CC,
10103,GO:0036022,1,0.983813958446877,0,3,limb joint morphogenesis,BP,
10104,GO:0036023,1,0.983813958446877,0,3,embryonic skeletal limb joint morphogenesis,BP,
10105,GO:0036024,1,0.99460686867035,0,1,protein C inhibitor-TMPRSS7 complex,CC,
10106,GO:0036025,1,0.99460686867035,0,1,protein C inhibitor-TMPRSS11E complex,CC,
10107,GO:0036026,1,0.99460686867035,0,1,protein C inhibitor-PLAT complex,CC,
10108,GO:0036027,1,0.99460686867035,0,1,protein C inhibitor-PLAU complex,CC,
10109,GO:0036028,1,0.99460686867035,0,1,protein C inhibitor-thrombin complex,CC,
10110,GO:0036029,1,0.99460686867035,0,1,protein C inhibitor-KLK3 complex,CC,
10111,GO:0036030,1,0.99460686867035,0,1,protein C inhibitor-plasma kallikrein complex,CC,
10112,GO:0036033,1,0.956443910517988,0,4,mediator complex binding,MF,
10113,GO:0036034,1,0.988762766555626,0,2,mediator complex assembly,BP,
10115,GO:0036037,1,0.926131185759335,0,13,CD8-positive, alpha-beta T cell activation,BP,
10116,GO:0036038,1,0.926429083904871,0,13,MKS complex,CC,
10117,GO:0036041,1,0.960393667076334,0,9,long-chain fatty acid binding,MF,
10118,GO:0036042,1,0.982043279985743,0,4,long-chain fatty acyl-CoA binding,MF,
10119,GO:0036046,1,0.99364717720168,0,1,protein demalonylation,BP,
10120,GO:0036047,1,0.99364717720168,0,1,peptidyl-lysine demalonylation,BP,
10121,GO:0036048,1,0.99364717720168,0,1,protein desuccinylation,BP,
10122,GO:0036049,1,0.99364717720168,0,1,peptidyl-lysine desuccinylation,BP,
10123,GO:0036053,1,0.994121834141147,0,1,glomerular endothelium fenestra,CC,
10124,GO:0036054,1,0.99364717720168,0,1,protein-malonyllysine demalonylase activity,MF,
10125,GO:0036055,1,0.99364717720168,0,1,protein-succinyllysine desuccinylase activity,MF,
10126,GO:0036056,1,0.942056208749362,0,7,filtration diaphragm,CC,
10127,GO:0036057,1,0.942056208749362,0,7,slit diaphragm,CC,
10128,GO:0036058,1,0.992786166938556,0,1,filtration diaphragm assembly,BP,
10129,GO:0036060,1,0.992786166938556,0,1,slit diaphragm assembly,BP,
10131,GO:0036065,1,0.838418694971719,0,25,fucosylation,BP,
10132,GO:0036066,1,0.906992501257883,0,14,protein O-linked fucosylation,BP,
10133,GO:0036071,1,0.99350517844687,0,1,N-glycan fucosylation,BP,
10134,GO:0036072,1,0.957851321903658,0,6,direct ossification,BP,
10135,GO:0036075,1,0.841813195440255,0,25,replacement ossification,BP,
10136,GO:0036080,1,0.983684860748946,0,2,purine nucleotide-sugar transmembrane transporter activity,MF,
10137,GO:0036085,1,0.993585413171457,0,1,GDP-fucose import into Golgi lumen,BP,
10138,GO:0036088,1,0.99550561716643,0,1,D-serine catabolic process,BP,
10139,GO:0036089,1,0.954708050942152,0,7,cleavage furrow formation,BP,
10140,GO:0036090,1,0.989982274238671,0,2,cleavage furrow ingression,BP,
10141,GO:0036091,1,0.96668118034042,0,5,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
10143,GO:0036093,1,0.971504548215394,0,6,germ cell proliferation,BP,
10145,GO:0036100,1,0.989179083471558,0,2,leukotriene catabolic process,BP,
10146,GO:0036101,1,0.989179083471558,0,2,leukotriene B4 catabolic process,BP,
10147,GO:0036102,1,0.989179083471558,0,2,leukotriene B4 metabolic process,BP,
10148,GO:0036105,1,0.993183566280531,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
10149,GO:0036109,1,0.927421416625188,0,12,alpha-linolenic acid metabolic process,BP,
10150,GO:0036111,1,0.994151381045293,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
10151,GO:0036112,1,0.983670019484985,0,3,medium-chain fatty-acyl-CoA metabolic process,BP,
10152,GO:0036114,1,0.995594347919703,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
10153,GO:0036115,1,0.995594347919703,0,1,fatty-acyl-CoA catabolic process,BP,
10154,GO:0036116,1,0.995594347919703,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
10155,GO:0036117,1,0.989202728384213,0,2,hyaluranon cable,CC,
10156,GO:0036118,1,0.982063627237644,0,3,hyaluranon cable assembly,BP,
10157,GO:0036119,1,0.853416896402771,0,21,response to platelet-derived growth factor,BP,
10158,GO:0036120,1,0.858711291840913,0,20,cellular response to platelet-derived growth factor stimulus,BP,
10159,GO:0036122,1,0.942725496450764,0,9,BMP binding,MF,
10160,GO:0036123,1,0.966094370565741,0,6,histone H3-K9 dimethylation,BP,
10161,GO:0036124,1,0.897868978121388,0,14,histone H3-K9 trimethylation,BP,
10162,GO:0036125,1,0.993751896488685,0,1,fatty acid beta-oxidation multienzyme complex,CC,
10163,GO:0036126,1,0.682463034057156,0,64,sperm flagellum,CC,
10164,GO:0036128,1,0.960184583273324,0,7,CatSper complex,CC,
10165,GO:0036130,1,0.995975451635579,0,1,prostaglandin H2 endoperoxidase reductase activity,MF,
10166,GO:0036131,1,0.995975451635579,0,1,prostaglandin D2 11-ketoreductase activity,MF,
10167,GO:0036132,1,0.981703419263698,0,3,13-prostaglandin reductase activity,MF,
10168,GO:0036134,1,0.994857857040155,0,1,12-hydroxyheptadecatrienoic acid synthase activity,MF,
10169,GO:0036135,1,0.983764592889291,0,2,Schwann cell migration,BP,
10170,GO:0036137,1,0.98918226350021,0,2,kynurenine aminotransferase activity,MF,
10171,GO:0036138,1,0.989944501514149,0,1,peptidyl-histidine hydroxylation,BP,
10172,GO:0036139,1,0.989944501514149,0,1,peptidyl-histidine dioxygenase activity,MF,
10173,GO:0036140,1,0.989944501514149,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
10174,GO:0036143,1,0.996443342395775,0,1,kringle domain binding,MF,
10175,GO:0036145,1,0.995278116487497,0,1,dendritic cell homeostasis,BP,
10176,GO:0036146,1,0.970086111793017,0,5,cellular response to mycotoxin,BP,
10177,GO:0036148,1,0.918825612580268,0,13,phosphatidylglycerol acyl-chain remodeling,BP,
10178,GO:0036149,1,0.945562465257396,0,10,phosphatidylinositol acyl-chain remodeling,BP,
10179,GO:0036150,1,0.912154955158067,0,15,phosphatidylserine acyl-chain remodeling,BP,
10180,GO:0036151,1,0.882608328221407,0,21,phosphatidylcholine acyl-chain remodeling,BP,
10181,GO:0036152,1,0.894373305925647,0,20,phosphatidylethanolamine acyl-chain remodeling,BP,
10182,GO:0036153,1,0.994016209096484,0,1,triglyceride acyl-chain remodeling,BP,
10183,GO:0036155,1,0.969243648027956,0,5,acylglycerol acyl-chain remodeling,BP,
10184,GO:0036156,1,0.943598089452489,0,4,inner dynein arm,CC,
10185,GO:0036157,1,0.928320002158347,0,9,outer dynein arm,CC,
10186,GO:0036158,1,0.891616387689376,0,16,outer dynein arm assembly,BP,
10187,GO:0036159,1,0.892186570863528,0,14,inner dynein arm assembly,BP,
10188,GO:0036164,1,0.996133497512217,0,1,cell-abiotic substrate adhesion,BP,
10189,GO:0036166,1,0.968778628137712,0,4,phenotypic switching,BP,
10190,GO:0036179,1,0.99407642355737,0,1,osteoclast maturation,BP,
10191,GO:0036194,1,0.986781628681919,0,3,muscle cell projection,CC,
10192,GO:0036195,1,0.986781628681919,0,3,muscle cell projection membrane,CC,
10194,GO:0036213,1,0.994771634288492,0,1,contractile ring contraction,BP,
10195,GO:0036215,1,0.985544061489326,0,2,response to stem cell factor,BP,
10196,GO:0036216,1,0.985544061489326,0,2,cellular response to stem cell factor stimulus,BP,
10197,GO:0036219,1,0.996611310932968,0,1,GTP diphosphatase activity,MF,
10198,GO:0036220,1,0.996131633573802,0,1,ITP diphosphatase activity,MF,
10199,GO:0036222,1,0.996131633573802,0,1,XTP diphosphatase activity,MF,
10200,GO:0036228,1,0.987106886657588,0,2,protein localization to nuclear inner membrane,BP,
10202,GO:0036245,1,0.987678399757582,0,2,cellular response to menadione,BP,
10203,GO:0036250,1,0.995091529952727,0,1,peroxisome transport along microtubule,BP,
10204,GO:0036255,1,0.992981218339583,0,1,response to methylamine,BP,
10205,GO:0036257,1,0.838440604858629,0,31,multivesicular body organization,BP,
10206,GO:0036258,1,0.843490338169964,0,30,multivesicular body assembly,BP,
10207,GO:0036260,1,0.833599278141395,0,32,RNA capping,BP,
10208,GO:0036261,1,0.99310497473633,0,1,7-methylguanosine cap hypermethylation,BP,
10209,GO:0036265,1,0.978776569096717,0,4,RNA (guanine-N7)-methylation,BP,
10210,GO:0036266,1,0.994317164197917,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
10211,GO:0036269,1,0.986180752956864,0,2,swimming behavior,BP,
10212,GO:0036270,1,0.853473785698306,0,18,response to diuretic,BP,
10213,GO:0036284,1,0.984915438258414,0,2,tubulobulbar complex,CC,
10214,GO:0036289,1,0.947641498237119,0,7,peptidyl-serine autophosphorylation,BP,
10215,GO:0036290,1,0.992794336896152,0,1,protein trans-autophosphorylation,BP,
10216,GO:0036292,1,0.988872771927892,0,2,DNA rewinding,BP,
10218,GO:0036294,1,0.296635417925378,0,190,cellular response to decreased oxygen levels,BP,
10219,GO:0036295,1,0.921567740131865,0,13,cellular response to increased oxygen levels,BP,
10220,GO:0036296,1,0.84555248173375,0,27,response to increased oxygen levels,BP,
10221,GO:0036297,1,0.752689666218485,0,44,interstrand cross-link repair,BP,
10222,GO:0036301,1,0.970786567887814,0,5,macrophage colony-stimulating factor production,BP,
10223,GO:0036302,1,0.94180897612557,0,7,atrioventricular canal development,BP,
10224,GO:0036303,1,0.865389342554779,0,18,lymph vessel morphogenesis,BP,
10225,GO:0036304,1,0.988831153107961,0,2,umbilical cord morphogenesis,BP,
10226,GO:0036306,1,0.995507507163806,0,1,embryonic heart tube elongation,BP,
10227,GO:0036309,1,0.967040586073929,0,2,protein localization to M-band,BP,
10228,GO:0036310,1,0.948693588441569,0,8,annealing helicase activity,MF,
10229,GO:0036312,1,0.929506632280447,0,8,phosphatidylinositol 3-kinase regulatory subunit binding,MF,
10230,GO:0036313,1,0.994459208442653,0,1,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
10231,GO:0036314,1,0.827550275670605,0,23,response to sterol,BP,
10232,GO:0036315,1,0.88287682897306,0,15,cellular response to sterol,BP,
10233,GO:0036316,1,0.994124723010534,0,1,SREBP-SCAP complex retention in endoplasmic reticulum,BP,
10234,GO:0036317,1,0.994054740756748,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
10235,GO:0036323,1,0.992089249552221,0,1,vascular endothelial growth factor receptor-1 signaling pathway,BP,
10236,GO:0036324,1,0.988460429024001,0,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,
10237,GO:0036326,1,0.992089249552221,0,1,VEGF-A-activated receptor activity,MF,
10238,GO:0036327,1,0.992089249552221,0,1,VEGF-B-activated receptor activity,MF,
10239,GO:0036328,1,0.991628747682515,0,1,VEGF-C-activated receptor activity,MF,
10240,GO:0036332,1,0.992089249552221,0,1,placental growth factor-activated receptor activity,MF,
10241,GO:0036333,1,0.994218639474739,0,1,hepatocyte homeostasis,BP,
10242,GO:0036335,1,0.991575273149653,0,1,intestinal stem cell homeostasis,BP,
10243,GO:0036336,1,0.852559767283269,0,26,dendritic cell migration,BP,
10244,GO:0036337,1,0.971505289234044,0,4,Fas signaling pathway,BP,
10246,GO:0036343,1,0.980495953423477,0,4,psychomotor behavior,BP,
10247,GO:0036344,1,0.875952838402406,0,19,platelet morphogenesis,BP,
10248,GO:0036345,1,0.989325964153903,0,2,platelet maturation,BP,
10249,GO:0036351,1,0.99460314982677,0,1,histone H2A-K13 ubiquitination,BP,
10250,GO:0036352,1,0.99460314982677,0,1,histone H2A-K15 ubiquitination,BP,
10251,GO:0036353,1,0.952313189984878,0,7,histone H2A-K119 monoubiquitination,BP,
10252,GO:0036361,1,0.994402058223341,0,1,racemase activity, acting on amino acids and derivatives,MF,
10253,GO:0036363,1,0.98661545653236,0,2,transforming growth factor beta activation,BP,
10254,GO:0036367,1,0.994298643242403,0,1,light adaption,BP,
10255,GO:0036369,1,0.978823110722883,0,2,transcription factor catabolic process,BP,
10256,GO:0036371,1,0.988799478361583,0,1,protein localization to T-tubule,BP,
10257,GO:0036372,1,0.996287373512551,0,1,opsin transport,BP,
10258,GO:0036374,1,0.983214094905455,0,3,glutathione hydrolase activity,MF,
10259,GO:0036376,1,0.910672733443012,0,15,sodium ion export across plasma membrane,BP,
10260,GO:0036378,1,0.989900526836917,0,2,calcitriol biosynthetic process from calciol,BP,
10261,GO:0036379,1,0.804073168290289,0,31,myofilament,CC,
10262,GO:0036387,1,0.984791274424711,0,3,pre-replicative complex,CC,
10263,GO:0036388,1,0.984791274424711,0,3,pre-replicative complex assembly,BP,
10264,GO:0036392,1,0.993089110889709,0,1,chemokine (C-C motif) ligand 20 production,BP,
10265,GO:0036393,1,0.993918137625205,0,1,thiocyanate peroxidase activity,MF,
10266,GO:0036396,1,0.985329976026844,0,3,RNA N6-methyladenosine methyltransferase complex,CC,
10267,GO:0036398,1,0.988002984041165,0,2,TCR signalosome,CC,
10268,GO:0036399,1,0.993514260851553,0,1,TCR signalosome assembly,BP,
10269,GO:0036402,1,0.974040053359016,0,6,proteasome-activating ATPase activity,MF,
10270,GO:0036403,1,0.994226295701403,0,1,arachidonate 8(S)-lipoxygenase activity,MF,
10271,GO:0036404,1,0.986855058494614,0,1,conversion of ds siRNA to ss siRNA,BP,
10272,GO:0036413,1,0.987146489190282,0,2,histone H3-R26 citrullination,BP,
10273,GO:0036414,1,0.973913012962342,0,4,histone citrullination,BP,
10274,GO:0036435,1,0.988862155514157,0,2,K48-linked polyubiquitin modification-dependent protein binding,MF,
10275,GO:0036438,1,0.974854556205702,0,4,maintenance of lens transparency,BP,
10276,GO:0036440,1,0.993825585102011,0,1,citrate synthase activity,MF,
10277,GO:0036442,1,0.851794948760004,0,27,proton-exporting ATPase activity,MF,
10278,GO:0036444,1,0.949056384466348,0,8,calcium import into the mitochondrion,BP,
10280,GO:0036446,1,0.977366534775235,0,3,myofibroblast differentiation,BP,
10282,GO:0036451,1,0.988144472527205,0,2,cap mRNA methylation,BP,
10283,GO:0036452,1,0.853243399183408,0,28,ESCRT complex,CC,
10284,GO:0036454,1,0.966098864858599,0,5,growth factor complex,CC,
10285,GO:0036455,1,0.996103045224219,0,1,iron-sulfur transferase activity,MF,
10286,GO:0036458,1,0.994755319278953,0,1,hepatocyte growth factor binding,MF,
10287,GO:0036459,1,0.509916835393786,0,88,thiol-dependent ubiquitinyl hydrolase activity,MF,
10288,GO:0036461,1,0.991773968504384,0,2,BLOC-2 complex binding,MF,
10289,GO:0036462,1,0.959200707753582,0,7,TRAIL-activated apoptotic signaling pathway,BP,
10290,GO:0036464,1,0.300878221499011,0,180,cytoplasmic ribonucleoprotein granule,CC,
10292,GO:0036466,1,0.984348094919642,0,2,synaptic vesicle recycling via endosome,BP,
10293,GO:0036468,1,0.994974191285603,0,1,L-dopa decarboxylase activity,MF,
10294,GO:0036470,1,0.996339404102419,0,1,tyrosine 3-monooxygenase activator activity,MF,
10295,GO:0036471,1,0.996339404102419,0,1,cellular response to glyoxal,BP,
10296,GO:0036473,1,0.628031361869938,0,73,cell death in response to oxidative stress,BP,
10297,GO:0036474,1,0.850666872934342,0,26,cell death in response to hydrogen peroxide,BP,
10298,GO:0036475,1,0.864727883068714,0,21,neuron death in response to oxidative stress,BP,
10299,GO:0036476,1,0.977698184002982,0,4,neuron death in response to hydrogen peroxide,BP,
10301,GO:0036478,1,0.996339404102419,0,1,L-dopa decarboxylase activator activity,MF,
10302,GO:0036479,1,0.987748176584163,0,1,peroxidase inhibitor activity,MF,
10303,GO:0036480,1,0.956687239787325,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
10304,GO:0036481,1,0.969364247617873,0,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10305,GO:0036482,1,0.990545670756894,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10306,GO:0036483,1,0.99226887678226,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
10307,GO:0036484,1,0.978978240959695,0,3,trunk neural crest cell migration,BP,
10308,GO:0036486,1,0.978978240959695,0,3,ventral trunk neural crest cell migration,BP,
10309,GO:0036487,1,0.988143720671723,0,1,nitric-oxide synthase inhibitor activity,MF,
10310,GO:0036488,1,0.991599706765715,0,2,CHOP-C/EBP complex,CC,
10311,GO:0036490,1,0.945174670128702,0,8,regulation of translation in response to endoplasmic reticulum stress,BP,
10312,GO:0036491,1,0.951545979489213,0,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10313,GO:0036492,1,0.956787550414637,0,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,
10314,GO:0036493,1,0.981094979334359,0,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,
10315,GO:0036494,1,0.991246611684519,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10316,GO:0036496,1,0.99021544526539,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
10317,GO:0036497,1,0.994524135749862,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
10318,GO:0036498,1,0.645955340657903,0,67,IRE1-mediated unfolded protein response,BP,
10319,GO:0036499,1,0.88829324026377,0,20,PERK-mediated unfolded protein response,BP,
10320,GO:0036500,1,0.941705277798445,0,10,ATF6-mediated unfolded protein response,BP,
10321,GO:0036501,1,0.992436072758355,0,1,UFD1-NPL4 complex,CC,
10322,GO:0036502,1,0.993664817058977,0,1,Derlin-1-VIMP complex,CC,
10323,GO:0036503,1,0.564615275604799,0,89,ERAD pathway,BP,
10324,GO:0036505,1,0.98832319678978,0,2,prosaposin receptor activity,MF,
10325,GO:0036506,1,0.978052121276861,0,3,maintenance of unfolded protein,BP,
10326,GO:0036507,1,0.845823127302161,0,24,protein demannosylation,BP,
10327,GO:0036508,1,0.845823127302161,0,24,protein alpha-1,2-demannosylation,BP,
10328,GO:0036509,1,0.989227491399861,0,2,trimming of terminal mannose on B branch,BP,
10329,GO:0036510,1,0.98000654908973,0,3,trimming of terminal mannose on C branch,BP,
10330,GO:0036511,1,0.989227491399861,0,2,trimming of first mannose on A branch,BP,
10331,GO:0036512,1,0.989227491399861,0,2,trimming of second mannose on A branch,BP,
10332,GO:0036513,1,0.931586764503453,0,11,Derlin-1 retrotranslocation complex,CC,
10333,GO:0036514,1,0.955421104314806,0,5,dopaminergic neuron axon guidance,BP,
10334,GO:0036515,1,0.961321074597868,0,4,serotonergic neuron axon guidance,BP,
10335,GO:0036517,1,0.990997815957518,0,1,chemoattraction of serotonergic neuron axon,BP,
10336,GO:0036518,1,0.984917568900898,0,2,chemorepulsion of dopaminergic neuron axon,BP,
10337,GO:0036524,1,0.996339404102419,0,1,protein deglycase activity,MF,
10338,GO:0036525,1,0.996339404102419,0,1,protein deglycation,BP,
10339,GO:0036526,1,0.996339404102419,0,1,peptidyl-cysteine deglycation,BP,
10340,GO:0036527,1,0.996339404102419,0,1,peptidyl-arginine deglycation,BP,
10341,GO:0036528,1,0.996339404102419,0,1,peptidyl-lysine deglycation,BP,
10342,GO:0036529,1,0.996339404102419,0,1,protein deglycation, glyoxal removal,BP,
10343,GO:0036530,1,0.996339404102419,0,1,protein deglycation, methylglyoxal removal,BP,
10344,GO:0036531,1,0.996339404102419,0,1,glutathione deglycation,BP,
10345,GO:0038001,1,0.972798696360453,0,3,paracrine signaling,BP,
10346,GO:0038002,1,0.99147381535401,0,1,endocrine signaling,BP,
10347,GO:0038003,1,0.946877494592585,0,10,opioid receptor signaling pathway,BP,
10348,GO:0038007,1,0.942120658721475,0,7,netrin-activated signaling pathway,BP,
10349,GO:0038016,1,0.987959644184989,0,2,insulin receptor internalization,BP,
10350,GO:0038018,1,0.982645993611059,0,2,Wnt receptor catabolic process,BP,
10351,GO:0038021,1,0.992561143333027,0,1,leptin receptor activity,MF,
10353,GO:0038024,1,0.563825806817295,0,81,cargo receptor activity,MF,
10354,GO:0038025,1,0.985839796643059,0,2,reelin receptor activity,MF,
10355,GO:0038026,1,0.9642878788625,0,4,reelin-mediated signaling pathway,BP,
10356,GO:0038027,1,0.954464418004533,0,5,apolipoprotein A-I-mediated signaling pathway,BP,
10357,GO:0038028,1,0.972949102590646,0,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
10358,GO:0038030,1,0.952379927424227,0,7,non-canonical Wnt signaling pathway via MAPK cascade,BP,
10359,GO:0038031,1,0.959184888226972,0,6,non-canonical Wnt signaling pathway via JNK cascade,BP,
10360,GO:0038033,1,0.967484918204652,0,5,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,
10361,GO:0038034,1,0.658787879490108,0,67,signal transduction in absence of ligand,BP,
10362,GO:0038036,1,0.955051859369571,0,8,sphingosine-1-phosphate receptor activity,MF,
10363,GO:0038037,1,0.948363791933373,0,8,G-protein coupled receptor dimeric complex,CC,
10364,GO:0038038,1,0.989957032003935,0,1,G-protein coupled receptor homodimeric complex,CC,
10365,GO:0038039,1,0.983561059619028,0,2,G-protein coupled receptor heterodimeric complex,CC,
10366,GO:0038042,1,0.960070669609744,0,7,dimeric G-protein coupled receptor signaling pathway,BP,
10367,GO:0038043,1,0.986991654429457,0,2,interleukin-5-mediated signaling pathway,BP,
10368,GO:0038044,1,0.95923807900141,0,5,transforming growth factor-beta secretion,BP,
10369,GO:0038046,1,0.995289525090722,0,1,enkephalin receptor activity,MF,
10370,GO:0038047,1,0.995171524763314,0,1,morphine receptor activity,MF,
10371,GO:0038048,1,0.991874862093252,0,1,dynorphin receptor activity,MF,
10372,GO:0038049,1,0.976205517928217,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
10373,GO:0038051,1,0.990231890163882,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
10374,GO:0038052,1,0.984979282647255,0,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,
10377,GO:0038062,1,0.986606196080764,0,2,protein tyrosine kinase collagen receptor activity,MF,
10378,GO:0038063,1,0.922218414380165,0,9,collagen-activated tyrosine kinase receptor signaling pathway,BP,
10379,GO:0038064,1,0.967769110637362,0,4,collagen receptor activity,MF,
10380,GO:0038065,1,0.90459880483732,0,11,collagen-activated signaling pathway,BP,
10381,GO:0038066,1,0.786847516257612,0,37,p38MAPK cascade,BP,
10382,GO:0038083,1,0.685621347198423,0,52,peptidyl-tyrosine autophosphorylation,BP,
10383,GO:0038084,1,0.828783017164072,0,25,vascular endothelial growth factor signaling pathway,BP,
10384,GO:0038085,1,0.962644598598045,0,5,vascular endothelial growth factor binding,MF,
10385,GO:0038086,1,0.974846427253658,0,3,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,
10386,GO:0038089,1,0.949283050424861,0,7,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,
10387,GO:0038091,1,0.974846427253658,0,3,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,
10388,GO:0038092,1,0.910167918490136,0,15,nodal signaling pathway,BP,
10389,GO:0038093,1,0.336106767118034,0,178,Fc receptor signaling pathway,BP,
10390,GO:0038094,1,0.620442534090319,0,74,Fc-gamma receptor signaling pathway,BP,
10391,GO:0038095,1,0.493597150799933,0,118,Fc-epsilon receptor signaling pathway,BP,
10392,GO:0038096,1,0.63182517299832,0,70,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
10393,GO:0038097,1,0.991522793779851,0,1,positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway,BP,
10394,GO:0038098,1,0.987634426241273,0,2,sequestering of BMP from receptor via BMP binding,BP,
10395,GO:0038100,1,0.979669583840602,0,3,nodal binding,MF,
10396,GO:0038101,1,0.995343985038049,0,1,sequestering of nodal from receptor via nodal binding,BP,
10397,GO:0038107,1,0.9592195858069,0,7,nodal signaling pathway involved in determination of left/right asymmetry,BP,
10398,GO:0038108,1,0.976215109347723,0,4,negative regulation of appetite by leptin-mediated signaling pathway,BP,
10399,GO:0038109,1,0.985544061489326,0,2,Kit signaling pathway,BP,
10400,GO:0038110,1,0.925071883082124,0,11,interleukin-2-mediated signaling pathway,BP,
10401,GO:0038111,1,0.882918601028433,0,18,interleukin-7-mediated signaling pathway,BP,
10402,GO:0038112,1,0.988501579974727,0,2,interleukin-8-mediated signaling pathway,BP,
10403,GO:0038113,1,0.978872329182894,0,3,interleukin-9-mediated signaling pathway,BP,
10404,GO:0038114,1,0.952383131571252,0,7,interleukin-21-mediated signaling pathway,BP,
10405,GO:0038115,1,0.994786708960719,0,1,chemokine (C-C motif) ligand 19 signaling pathway,BP,
10406,GO:0038116,1,0.994786708960719,0,1,chemokine (C-C motif) ligand 21 signaling pathway,BP,
10407,GO:0038117,1,0.994786708960719,0,1,C-C motif chemokine 19 receptor activity,MF,
10408,GO:0038118,1,0.996193110740806,0,1,C-C chemokine receptor CCR7 signaling pathway,BP,
10409,GO:0038121,1,0.994786708960719,0,1,C-C motif chemokine 21 receptor activity,MF,
10410,GO:0038123,1,0.98298565451865,0,3,toll-like receptor TLR1:TLR2 signaling pathway,BP,
10411,GO:0038124,1,0.975015095694401,0,4,toll-like receptor TLR6:TLR2 signaling pathway,BP,
10413,GO:0038128,1,0.769960764022059,0,38,ERBB2 signaling pathway,BP,
10414,GO:0038129,1,0.984003268071262,0,3,ERBB3 signaling pathway,BP,
10415,GO:0038131,1,0.988645928542013,0,2,neuregulin receptor activity,MF,
10416,GO:0038132,1,0.958215174034836,0,5,neuregulin binding,MF,
10417,GO:0038133,1,0.994948227730383,0,1,ERBB2-ERBB3 signaling pathway,BP,
10418,GO:0038145,1,0.970653170898949,0,5,macrophage colony-stimulating factor signaling pathway,BP,
10419,GO:0038154,1,0.993599757936655,0,1,interleukin-11-mediated signaling pathway,BP,
10420,GO:0038155,1,0.956325574424178,0,7,interleukin-23-mediated signaling pathway,BP,
10421,GO:0038156,1,0.991979443321047,0,1,interleukin-3-mediated signaling pathway,BP,
10422,GO:0038158,1,0.98879346366717,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
10423,GO:0038161,1,0.979688679699339,0,2,prolactin signaling pathway,BP,
10424,GO:0038162,1,0.982780390382292,0,3,erythropoietin-mediated signaling pathway,BP,
10425,GO:0038163,1,0.984755114850788,0,3,thrombopoietin-mediated signaling pathway,BP,
10426,GO:0038164,1,0.993150244795715,0,1,thrombopoietin receptor activity,MF,
10427,GO:0038165,1,0.969199081248904,0,4,oncostatin-M-mediated signaling pathway,BP,
10429,GO:0038167,1,0.991472815858942,0,1,epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity,BP,
10430,GO:0038168,1,0.991472815858942,0,1,epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade,BP,
10431,GO:0038169,1,0.977661680752294,0,4,somatostatin receptor signaling pathway,BP,
10432,GO:0038170,1,0.977661680752294,0,4,somatostatin signaling pathway,BP,
10434,GO:0038172,1,0.981950189583055,0,3,interleukin-33-mediated signaling pathway,BP,
10435,GO:0038178,1,0.988662582393187,0,2,complement component C5a signaling pathway,BP,
10436,GO:0038179,1,0.786258016565072,0,35,neurotrophin signaling pathway,BP,
10437,GO:0038180,1,0.91914330792671,0,12,nerve growth factor signaling pathway,BP,
10438,GO:0038181,1,0.982665357530147,0,3,bile acid receptor activity,MF,
10439,GO:0038182,1,0.995642720209646,0,1,G-protein coupled bile acid receptor activity,MF,
10440,GO:0038183,1,0.982665357530147,0,3,bile acid signaling pathway,BP,
10441,GO:0038184,1,0.995642720209646,0,1,cell surface bile acid receptor signaling pathway,BP,
10442,GO:0038185,1,0.994811863082861,0,1,intracellular bile acid receptor signaling pathway,BP,
10443,GO:0038186,1,0.992114050009461,0,1,lithocholic acid receptor activity,MF,
10444,GO:0038187,1,0.919837061866857,0,14,pattern recognition receptor activity,MF,
10445,GO:0038188,1,0.990276510765678,0,2,cholecystokinin signaling pathway,BP,
10446,GO:0038189,1,0.973909740405158,0,4,neuropilin signaling pathway,BP,
10447,GO:0038190,1,0.987710108482779,0,2,VEGF-activated neuropilin signaling pathway,BP,
10448,GO:0038191,1,0.857845203611941,0,19,neuropilin binding,MF,
10449,GO:0038192,1,0.99495835748087,0,1,gastric inhibitory peptide signaling pathway,BP,
10450,GO:0038193,1,0.994660930931217,0,1,thromboxane A2 signaling pathway,BP,
10451,GO:0038194,1,0.988917911303298,0,2,thyroid-stimulating hormone signaling pathway,BP,
10452,GO:0038195,1,0.995709217612478,0,1,urokinase plasminogen activator signaling pathway,BP,
10453,GO:0038201,1,0.894279293765849,0,16,TOR complex,CC,
10454,GO:0038202,1,0.80308787425719,0,32,TORC1 signaling,BP,
10455,GO:0038203,1,0.958514138133137,0,7,TORC2 signaling,BP,
10456,GO:0039003,1,0.985697693689836,0,2,pronephric field specification,BP,
10457,GO:0039007,1,0.991281032996273,0,1,pronephric nephron morphogenesis,BP,
10458,GO:0039008,1,0.991281032996273,0,1,pronephric nephron tubule morphogenesis,BP,
10459,GO:0039017,1,0.985697693689836,0,2,pattern specification involved in pronephros development,BP,
10460,GO:0039019,1,0.984499012102046,0,2,pronephric nephron development,BP,
10461,GO:0039020,1,0.991281032996273,0,1,pronephric nephron tubule development,BP,
10462,GO:0039022,1,0.991281032996273,0,1,pronephric duct development,BP,
10463,GO:0039023,1,0.991281032996273,0,1,pronephric duct morphogenesis,BP,
10464,GO:0039502,1,0.991621251797114,0,1,suppression by virus of host type I interferon-mediated signaling pathway,BP,
10465,GO:0039503,1,0.991621251797114,0,1,suppression by virus of host innate immune response,BP,
10466,GO:0039506,1,0.985741141132414,0,2,modulation by virus of host molecular function,BP,
10467,GO:0039507,1,0.985741141132414,0,2,suppression by virus of host molecular function,BP,
10468,GO:0039513,1,0.994070707289974,0,1,suppression by virus of host catalytic activity,BP,
10469,GO:0039514,1,0.991621251797114,0,1,suppression by virus of host JAK-STAT cascade,BP,
10470,GO:0039516,1,0.994070707289974,0,1,modulation by virus of host catalytic activity,BP,
10471,GO:0039519,1,0.983214671365924,0,2,modulation by virus of host autophagy,BP,
10472,GO:0039520,1,0.991287519922231,0,1,induction by virus of host autophagy,BP,
10473,GO:0039521,1,0.991856914529987,0,1,suppression by virus of host autophagy,BP,
10474,GO:0039526,1,0.984712076898247,0,3,modulation by virus of host apoptotic process,BP,
10475,GO:0039528,1,0.865921266719573,0,20,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,
10476,GO:0039529,1,0.891002099592474,0,15,RIG-I signaling pathway,BP,
10477,GO:0039530,1,0.946877495424105,0,8,MDA-5 signaling pathway,BP,
10478,GO:0039531,1,0.893308845433033,0,15,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10479,GO:0039532,1,0.942419268693088,0,9,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10480,GO:0039533,1,0.962314122591408,0,5,regulation of MDA-5 signaling pathway,BP,
10481,GO:0039534,1,0.983150024295956,0,3,negative regulation of MDA-5 signaling pathway,BP,
10482,GO:0039535,1,0.904423288629289,0,13,regulation of RIG-I signaling pathway,BP,
10483,GO:0039536,1,0.954138367194317,0,7,negative regulation of RIG-I signaling pathway,BP,
10484,GO:0039552,1,0.991332443033147,0,1,RIG-I binding,MF,
10485,GO:0039562,1,0.991621251797114,0,1,suppression by virus of host STAT activity,BP,
10486,GO:0039563,1,0.991621251797114,0,1,suppression by virus of host STAT1 activity,BP,
10487,GO:0039564,1,0.991621251797114,0,1,suppression by virus of host STAT2 activity,BP,
10488,GO:0039650,1,0.994070707289974,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
10489,GO:0039656,1,0.983030549827526,0,3,modulation by virus of host gene expression,BP,
10490,GO:0039663,1,0.966467235312939,0,6,membrane fusion involved in viral entry into host cell,BP,
10491,GO:0039689,1,0.981869925214241,0,3,negative stranded viral RNA replication,BP,
10494,GO:0039695,1,0.992204666131814,0,1,DNA-templated viral transcription,BP,
10495,GO:0039702,1,0.891322856478484,0,21,viral budding via host ESCRT complex,BP,
10496,GO:0039706,1,0.9319871354811,0,11,co-receptor binding,MF,
10497,GO:0039713,1,0.993355240892532,0,1,viral factory,CC,
10498,GO:0039714,1,0.993355240892532,0,1,cytoplasmic viral factory,CC,
10499,GO:0040001,1,0.840400698508715,0,24,establishment of mitotic spindle localization,BP,
10502,GO:0040009,1,0.956566102016645,0,5,regulation of growth rate,BP,
10503,GO:0040010,1,0.996611310932968,0,1,positive regulation of growth rate,BP,
10507,GO:0040014,1,0.652487697557252,0,61,regulation of multicellular organism growth,BP,
10508,GO:0040015,1,0.924667902869557,0,11,negative regulation of multicellular organism growth,BP,
10511,GO:0040018,1,0.816924029766853,0,29,positive regulation of multicellular organism growth,BP,
10512,GO:0040019,1,0.813593852556329,0,29,positive regulation of embryonic development,BP,
10513,GO:0040020,1,0.850510373904925,0,26,regulation of meiotic nuclear division,BP,
10514,GO:0040029,1,0.157908531120736,0,266,regulation of gene expression, epigenetic,BP,
10515,GO:0040030,1,0.989808901241221,0,2,regulation of molecular function, epigenetic,BP,
10516,GO:0040031,1,0.971898158708127,0,6,snRNA modification,BP,
10517,GO:0040032,1,0.995136605663745,0,1,post-embryonic body morphogenesis,BP,
10518,GO:0040033,1,0.901546508524626,0,13,negative regulation of translation, ncRNA-mediated,BP,
10519,GO:0040034,1,0.92345525401072,0,12,regulation of development, heterochronic,BP,
10522,GO:0040038,1,0.975568247108869,0,3,polar body extrusion after meiotic divisions,BP,
10523,GO:0040040,1,0.990766332318834,0,1,thermosensory behavior,BP,
10524,GO:0042000,1,0.994480592528411,0,1,translocation of peptides or proteins into host,BP,
10525,GO:0042007,1,0.995734283688682,0,1,interleukin-18 binding,MF,
10526,GO:0042008,1,0.993273391638312,0,1,interleukin-18 receptor activity,MF,
10527,GO:0042011,1,0.993691921123067,0,1,interleukin-16 binding,MF,
10528,GO:0042012,1,0.993691921123067,0,1,interleukin-16 receptor activity,MF,
10529,GO:0042015,1,0.982197532935981,0,3,interleukin-20 binding,MF,
10530,GO:0042019,1,0.995017291851267,0,1,interleukin-23 binding,MF,
10531,GO:0042020,1,0.995017291851267,0,1,interleukin-23 receptor activity,MF,
10532,GO:0042022,1,0.995017291851267,0,1,interleukin-12 receptor complex,CC,
10533,GO:0042023,1,0.937331567465645,0,8,DNA endoreduplication,BP,
10534,GO:0042025,1,0.979144194474601,0,3,host cell nucleus,CC,
10535,GO:0042026,1,0.857144875755532,0,26,protein refolding,BP,
10536,GO:0042030,1,0.976842736998806,0,3,ATPase inhibitor activity,MF,
10537,GO:0042033,1,0.94105708177278,0,12,chemokine biosynthetic process,BP,
10538,GO:0042035,1,0.582099768062411,0,88,regulation of cytokine biosynthetic process,BP,
10539,GO:0042036,1,0.853905828788455,0,28,negative regulation of cytokine biosynthetic process,BP,
10540,GO:0042040,1,0.99255627241335,0,1,metal incorporation into metallo-molybdopterin complex,BP,
10543,GO:0042045,1,0.947317150227531,0,7,epithelial fluid transport,BP,
10544,GO:0042048,1,0.93925139629918,0,7,olfactory behavior,BP,
10545,GO:0042053,1,0.896345548145943,0,18,regulation of dopamine metabolic process,BP,
10546,GO:0042054,1,0.688753873749689,0,53,histone methyltransferase activity,MF,
10547,GO:0042056,1,0.890553854862295,0,22,chemoattractant activity,MF,
10550,GO:0042060,1,0.0442594031509178,0,460,wound healing,BP,
10552,GO:0042069,1,0.896345548145943,0,18,regulation of catecholamine metabolic process,BP,
10553,GO:0042073,1,0.709986970336863,0,50,intraciliary transport,BP,
10554,GO:0042074,1,0.911751324064959,0,13,cell migration involved in gastrulation,BP,
10555,GO:0042078,1,0.983504220404566,0,3,germ-line stem cell division,BP,
10556,GO:0042083,1,0.995525772354966,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
10557,GO:0042084,1,0.986581230283702,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
10558,GO:0042088,1,0.810801264812492,0,36,T-helper 1 type immune response,BP,
10559,GO:0042089,1,0.559606126262028,0,95,cytokine biosynthetic process,BP,
10560,GO:0042090,1,0.954167021152477,0,7,interleukin-12 biosynthetic process,BP,
10561,GO:0042091,1,0.979997090670185,0,3,interleukin-10 biosynthetic process,BP,
10562,GO:0042092,1,0.830490641824764,0,33,type 2 immune response,BP,
10563,GO:0042093,1,0.73197777564232,0,48,T-helper cell differentiation,BP,
10564,GO:0042094,1,0.890235444220098,0,20,interleukin-2 biosynthetic process,BP,
10565,GO:0042095,1,0.918500779517262,0,15,interferon-gamma biosynthetic process,BP,
10566,GO:0042097,1,0.97933075772281,0,3,interleukin-4 biosynthetic process,BP,
10568,GO:0042100,1,0.654356448333826,0,68,B cell proliferation,BP,
10569,GO:0042101,1,0.899943635756573,0,19,T cell receptor complex,CC,
10572,GO:0042105,1,0.978404866477677,0,5,alpha-beta T cell receptor complex,CC,
10573,GO:0042107,1,0.556798898714907,0,96,cytokine metabolic process,BP,
10574,GO:0042108,1,0.724312470299894,0,52,positive regulation of cytokine biosynthetic process,BP,
10575,GO:0042109,1,0.98785889206834,0,2,lymphotoxin A biosynthetic process,BP,
10577,GO:0042113,1,0.272169107789107,0,197,B cell activation,BP,
10578,GO:0042116,1,0.666747025449906,0,60,macrophage activation,BP,
10579,GO:0042117,1,0.962121557762461,0,7,monocyte activation,BP,
10580,GO:0042118,1,0.93948058380375,0,9,endothelial cell activation,BP,
10582,GO:0042126,1,0.977251931615744,0,4,nitrate metabolic process,BP,
10584,GO:0042128,1,0.994580864111259,0,1,nitrate assimilation,BP,
10586,GO:0042130,1,0.73119445606512,0,51,negative regulation of T cell proliferation,BP,
10587,GO:0042131,1,0.994344744709564,0,1,thiamine phosphate phosphatase activity,MF,
10588,GO:0042132,1,0.995582402948917,0,1,fructose 1,6-bisphosphate 1-phosphatase activity,MF,
10589,GO:0042133,1,0.447569085494123,0,123,neurotransmitter metabolic process,BP,
10590,GO:0042134,1,0.991237450296653,0,2,rRNA primary transcript binding,MF,
10591,GO:0042135,1,0.87616076626945,0,21,neurotransmitter catabolic process,BP,
10592,GO:0042136,1,0.582027585873087,0,84,neurotransmitter biosynthetic process,BP,
10594,GO:0042138,1,0.982705246990218,0,3,meiotic DNA double-strand break formation,BP,
10595,GO:0042140,1,0.994054740756748,0,1,late meiotic recombination nodule assembly,BP,
10596,GO:0042144,1,0.986345147861062,0,2,vacuole fusion, non-autophagic,BP,
10597,GO:0042147,1,0.600104285557561,0,72,retrograde transport, endosome to Golgi,BP,
10598,GO:0042148,1,0.953785204376133,0,8,strand invasion,BP,
10599,GO:0042149,1,0.785739153153868,0,37,cellular response to glucose starvation,BP,
10602,GO:0042159,1,0.904862607844257,0,14,lipoprotein catabolic process,BP,
10603,GO:0042160,1,0.989491119973403,0,2,lipoprotein modification,BP,
10604,GO:0042161,1,0.989491119973403,0,2,lipoprotein oxidation,BP,
10605,GO:0042162,1,0.778996369791983,0,36,telomeric DNA binding,MF,
10606,GO:0042163,1,0.995710471266797,0,1,interleukin-12 beta subunit binding,MF,
10609,GO:0042167,1,0.983590907831834,0,4,heme catabolic process,BP,
10610,GO:0042168,1,0.866442934165339,0,25,heme metabolic process,BP,
10611,GO:0042169,1,0.792315780337594,0,32,SH2 domain binding,MF,
10612,GO:0042171,1,0.878311448991378,0,18,lysophosphatidic acid acyltransferase activity,MF,
10616,GO:0042178,1,0.951254901107129,0,10,xenobiotic catabolic process,BP,
10618,GO:0042181,1,0.827870027561082,0,33,ketone biosynthetic process,BP,
10619,GO:0042182,1,0.968391809064458,0,6,ketone catabolic process,BP,
10620,GO:0042197,1,0.995417312185159,0,1,halogenated hydrocarbon metabolic process,BP,
10621,GO:0042214,1,0.983228781564164,0,3,terpene metabolic process,BP,
10622,GO:0042219,1,0.887474198485216,0,20,cellular modified amino acid catabolic process,BP,
10625,GO:0042222,1,0.986544040555011,0,3,interleukin-1 biosynthetic process,BP,
10626,GO:0042223,1,0.991798552389647,0,1,interleukin-3 biosynthetic process,BP,
10627,GO:0042226,1,0.918568653951395,0,14,interleukin-6 biosynthetic process,BP,
10628,GO:0042228,1,0.938761693675165,0,10,interleukin-8 biosynthetic process,BP,
10629,GO:0042231,1,0.987624323386082,0,2,interleukin-13 biosynthetic process,BP,
10630,GO:0042241,1,0.993556840448378,0,1,interleukin-18 biosynthetic process,BP,
10631,GO:0042245,1,0.986847112391561,0,2,RNA repair,BP,
10632,GO:0042246,1,0.738869911839627,0,50,tissue regeneration,BP,
10633,GO:0042247,1,0.993870517351146,0,1,establishment of planar polarity of follicular epithelium,BP,
10635,GO:0042253,1,0.982051701340996,0,3,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
10636,GO:0042254,1,0.189215411385455,0,309,ribosome biogenesis,BP,
10637,GO:0042255,1,0.76995559951092,0,53,ribosome assembly,BP,
10638,GO:0042256,1,0.971830894266923,0,5,mature ribosome assembly,BP,
10639,GO:0042262,1,0.978505528381581,0,5,DNA protection,BP,
10640,GO:0042264,1,0.983180614720162,0,2,peptidyl-aspartic acid hydroxylation,BP,
10641,GO:0042265,1,0.989944501514149,0,1,peptidyl-asparagine hydroxylation,BP,
10642,GO:0042267,1,0.755293481498255,0,48,natural killer cell mediated cytotoxicity,BP,
10643,GO:0042268,1,0.951923864032273,0,10,regulation of cytolysis,BP,
10644,GO:0042269,1,0.834838154198659,0,31,regulation of natural killer cell mediated cytotoxicity,BP,
10645,GO:0042270,1,0.988116230093848,0,2,protection from natural killer cell mediated cytotoxicity,BP,
10646,GO:0042271,1,0.979951425304894,0,3,susceptibility to natural killer cell mediated cytotoxicity,BP,
10647,GO:0042272,1,0.973335979292894,0,3,nuclear RNA export factor complex,CC,
10648,GO:0042273,1,0.709429287464273,0,66,ribosomal large subunit biogenesis,BP,
10649,GO:0042274,1,0.699386153542441,0,67,ribosomal small subunit biogenesis,BP,
10650,GO:0042275,1,0.995606289324086,0,1,error-free postreplication DNA repair,BP,
10651,GO:0042276,1,0.892220839249386,0,19,error-prone translesion synthesis,BP,
10654,GO:0042281,1,0.988808292539762,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
10655,GO:0042282,1,0.992314228762417,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
10656,GO:0042284,1,0.990961315974492,0,2,sphingolipid delta-4 desaturase activity,MF,
10657,GO:0042285,1,0.954875325920923,0,6,xylosyltransferase activity,MF,
10658,GO:0042287,1,0.855886295318926,0,27,MHC protein binding,MF,
10659,GO:0042288,1,0.914580332159281,0,16,MHC class I protein binding,MF,
10660,GO:0042289,1,0.967414309245119,0,6,MHC class II protein binding,MF,
10661,GO:0042292,1,0.994433621392918,0,1,URM1 activating enzyme activity,MF,
10662,GO:0042296,1,0.980363070459419,0,4,ISG15 transferase activity,MF,
10663,GO:0042297,1,0.928465716134788,0,7,vocal learning,BP,
10665,GO:0042303,1,0.506862558188866,0,98,molting cycle,BP,
10666,GO:0042304,1,0.80635178329968,0,34,regulation of fatty acid biosynthetic process,BP,
10667,GO:0042306,1,0.720313019312054,0,47,regulation of protein import into nucleus,BP,
10668,GO:0042307,1,0.793224524500203,0,30,positive regulation of protein import into nucleus,BP,
10669,GO:0042308,1,0.942662186160794,0,10,negative regulation of protein import into nucleus,BP,
10670,GO:0042309,1,0.994062716803448,0,1,homoiothermy,BP,
10672,GO:0042311,1,0.844943019859506,0,28,vasodilation,BP,
10673,GO:0042313,1,0.994876788417062,0,1,protein kinase C deactivation,BP,
10674,GO:0042316,1,0.991755126917671,0,1,penicillin metabolic process,BP,
10675,GO:0042320,1,0.976832308369359,0,5,regulation of circadian sleep/wake cycle, REM sleep,BP,
10676,GO:0042321,1,0.976500972497108,0,5,negative regulation of circadian sleep/wake cycle, sleep,BP,
10677,GO:0042322,1,0.992538113071849,0,2,negative regulation of circadian sleep/wake cycle, REM sleep,BP,
10678,GO:0042323,1,0.989592610816747,0,2,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
10682,GO:0042328,1,0.966683654649489,0,4,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
10684,GO:0042335,1,0.97660071101955,0,3,cuticle development,BP,
10685,GO:0042339,1,0.816967802295825,0,31,keratan sulfate metabolic process,BP,
10686,GO:0042340,1,0.928717925316723,0,11,keratan sulfate catabolic process,BP,
10687,GO:0042350,1,0.98418106141937,0,3,GDP-L-fucose biosynthetic process,BP,
10688,GO:0042351,1,0.99123194450768,0,2,'de novo' GDP-L-fucose biosynthetic process,BP,
10689,GO:0042352,1,0.992887378728613,0,1,GDP-L-fucose salvage,BP,
10690,GO:0042354,1,0.939690020982231,0,8,L-fucose metabolic process,BP,
10691,GO:0042355,1,0.939690020982231,0,8,L-fucose catabolic process,BP,
10692,GO:0042356,1,0.99580314065602,0,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,
10693,GO:0042357,1,0.989834700127571,0,2,thiamine diphosphate metabolic process,BP,
10694,GO:0042359,1,0.881494814682568,0,19,vitamin D metabolic process,BP,
10695,GO:0042360,1,0.985042427079565,0,3,vitamin E metabolic process,BP,
10696,GO:0042361,1,0.99360540429135,0,1,menaquinone catabolic process,BP,
10697,GO:0042362,1,0.934796779156617,0,12,fat-soluble vitamin biosynthetic process,BP,
10698,GO:0042363,1,0.965716221670999,0,6,fat-soluble vitamin catabolic process,BP,
10699,GO:0042364,1,0.941646121549653,0,9,water-soluble vitamin biosynthetic process,BP,
10700,GO:0042365,1,0.983607385596947,0,3,water-soluble vitamin catabolic process,BP,
10701,GO:0042368,1,0.951248949164204,0,9,vitamin D biosynthetic process,BP,
10702,GO:0042369,1,0.988048090022512,0,2,vitamin D catabolic process,BP,
10703,GO:0042371,1,0.993151209466218,0,1,vitamin K biosynthetic process,BP,
10704,GO:0042373,1,0.975360430511549,0,5,vitamin K metabolic process,BP,
10705,GO:0042374,1,0.989752263764134,0,2,phylloquinone metabolic process,BP,
10706,GO:0042376,1,0.989752263764134,0,2,phylloquinone catabolic process,BP,
10707,GO:0042377,1,0.99360540429135,0,1,vitamin K catabolic process,BP,
10709,GO:0042382,1,0.960316771598607,0,6,paraspeckles,CC,
10710,GO:0042383,1,0.38315934873082,0,124,sarcolemma,CC,
10712,GO:0042392,1,0.989525886014588,0,2,sphingosine-1-phosphate phosphatase activity,MF,
10713,GO:0042393,1,0.296978608617201,0,170,histone binding,MF,
10714,GO:0042398,1,0.81506137448242,0,36,cellular modified amino acid biosynthetic process,BP,
10715,GO:0042401,1,0.902577421760467,0,20,cellular biogenic amine biosynthetic process,BP,
10716,GO:0042402,1,0.899585803959257,0,20,cellular biogenic amine catabolic process,BP,
10717,GO:0042403,1,0.886857349443815,0,17,thyroid hormone metabolic process,BP,
10718,GO:0042404,1,0.994876157112668,0,1,thyroid hormone catabolic process,BP,
10719,GO:0042405,1,0.902856383724364,0,11,nuclear inclusion body,CC,
10720,GO:0042406,1,0.978497295015694,0,4,extrinsic component of endoplasmic reticulum membrane,CC,
10721,GO:0042407,1,0.923037687777186,0,15,cristae formation,BP,
10722,GO:0042412,1,0.989651912603824,0,2,taurine biosynthetic process,BP,
10723,GO:0042413,1,0.994385117756413,0,1,carnitine catabolic process,BP,
10724,GO:0042414,1,0.97974736498317,0,3,epinephrine metabolic process,BP,
10725,GO:0042415,1,0.93652320991222,0,10,norepinephrine metabolic process,BP,
10726,GO:0042416,1,0.937571509843773,0,11,dopamine biosynthetic process,BP,
10727,GO:0042417,1,0.802383377668118,0,34,dopamine metabolic process,BP,
10728,GO:0042418,1,0.991202346901358,0,2,epinephrine biosynthetic process,BP,
10729,GO:0042420,1,0.958705044766982,0,7,dopamine catabolic process,BP,
10730,GO:0042421,1,0.965713583672372,0,6,norepinephrine biosynthetic process,BP,
10731,GO:0042423,1,0.895988443978909,0,19,catecholamine biosynthetic process,BP,
10732,GO:0042424,1,0.952708350095108,0,8,catecholamine catabolic process,BP,
10733,GO:0042426,1,0.960883206756526,0,6,choline catabolic process,BP,
10734,GO:0042427,1,0.984820756939437,0,3,serotonin biosynthetic process,BP,
10735,GO:0042428,1,0.925083300434545,0,10,serotonin metabolic process,BP,
10736,GO:0042430,1,0.884604556577265,0,19,indole-containing compound metabolic process,BP,
10737,GO:0042435,1,0.980557390787181,0,4,indole-containing compound biosynthetic process,BP,
10738,GO:0042436,1,0.96490914332102,0,7,indole-containing compound catabolic process,BP,
10739,GO:0042438,1,0.89773718396839,0,15,melanin biosynthetic process,BP,
10740,GO:0042439,1,0.963302910307091,0,6,ethanolamine-containing compound metabolic process,BP,
10741,GO:0042440,1,0.697910775592588,0,58,pigment metabolic process,BP,
10742,GO:0042441,1,0.981145968760821,0,3,eye pigment metabolic process,BP,
10745,GO:0042447,1,0.923017265609596,0,14,hormone catabolic process,BP,
10746,GO:0042448,1,0.928433970358161,0,13,progesterone metabolic process,BP,
10747,GO:0042450,1,0.990474128939402,0,2,arginine biosynthetic process via ornithine,BP,
10748,GO:0042451,1,0.902616432080956,0,21,purine nucleoside biosynthetic process,BP,
10749,GO:0042454,1,0.920189092815716,0,16,ribonucleoside catabolic process,BP,
10750,GO:0042455,1,0.829251850871483,0,36,ribonucleoside biosynthetic process,BP,
10751,GO:0042461,1,0.760177395272006,0,38,photoreceptor cell development,BP,
10752,GO:0042462,1,0.821641782987829,0,28,eye photoreceptor cell development,BP,
10753,GO:0042470,1,0.532612425446057,0,101,melanosome,CC,
10754,GO:0042471,1,0.481648415509434,0,108,ear morphogenesis,BP,
10755,GO:0042472,1,0.538985927172898,0,89,inner ear morphogenesis,BP,
10756,GO:0042473,1,0.945963302865121,0,9,outer ear morphogenesis,BP,
10757,GO:0042474,1,0.899250606376056,0,19,middle ear morphogenesis,BP,
10758,GO:0042475,1,0.601831108987888,0,71,odontogenesis of dentin-containing tooth,BP,
10759,GO:0042476,1,0.47985138123145,0,105,odontogenesis,BP,
10760,GO:0042481,1,0.889411354175478,0,20,regulation of odontogenesis,BP,
10761,GO:0042482,1,0.961382357750254,0,7,positive regulation of odontogenesis,BP,
10762,GO:0042483,1,0.973361814115301,0,4,negative regulation of odontogenesis,BP,
10763,GO:0042487,1,0.949538002383379,0,9,regulation of odontogenesis of dentin-containing tooth,BP,
10764,GO:0042488,1,0.994464091376545,0,1,positive regulation of odontogenesis of dentin-containing tooth,BP,
10765,GO:0042489,1,0.988250673142396,0,2,negative regulation of odontogenesis of dentin-containing tooth,BP,
10767,GO:0042491,1,0.813708462777364,0,29,inner ear auditory receptor cell differentiation,BP,
10768,GO:0042492,1,0.957274025353407,0,6,gamma-delta T cell differentiation,BP,
10770,GO:0042494,1,0.960075167184876,0,5,detection of bacterial lipoprotein,BP,
10771,GO:0042495,1,0.987409087567867,0,2,detection of triacyl bacterial lipopeptide,BP,
10772,GO:0042496,1,0.984415468692895,0,2,detection of diacyl bacterial lipopeptide,BP,
10773,GO:0042497,1,0.99339723826203,0,1,triacyl lipopeptide binding,MF,
10774,GO:0042500,1,0.962619667208823,0,6,aspartic endopeptidase activity, intramembrane cleaving,MF,
10775,GO:0042501,1,0.956878380744756,0,7,serine phosphorylation of STAT protein,BP,
10776,GO:0042509,1,0.71486192783652,0,56,regulation of tyrosine phosphorylation of STAT protein,BP,
10777,GO:0042531,1,0.749149079192416,0,48,positive regulation of tyrosine phosphorylation of STAT protein,BP,
10778,GO:0042532,1,0.937560297370341,0,10,negative regulation of tyrosine phosphorylation of STAT protein,BP,
10779,GO:0042533,1,0.896030908537281,0,18,tumor necrosis factor biosynthetic process,BP,
10780,GO:0042534,1,0.896030908537281,0,18,regulation of tumor necrosis factor biosynthetic process,BP,
10781,GO:0042535,1,0.930503727465019,0,11,positive regulation of tumor necrosis factor biosynthetic process,BP,
10782,GO:0042536,1,0.975123261797572,0,5,negative regulation of tumor necrosis factor biosynthetic process,BP,
10783,GO:0042537,1,0.91278901622361,0,18,benzene-containing compound metabolic process,BP,
10784,GO:0042538,1,0.959784451759608,0,7,hyperosmotic salinity response,BP,
10785,GO:0042539,1,0.983093454943495,0,2,hypotonic salinity response,BP,
10786,GO:0042541,1,0.951890558523185,0,9,hemoglobin biosynthetic process,BP,
10788,GO:0042543,1,0.996817125075419,0,1,protein N-linked glycosylation via arginine,BP,
10789,GO:0042546,1,0.995286990116764,0,1,cell wall biogenesis,BP,
10790,GO:0042551,1,0.749971800992148,0,39,neuron maturation,BP,
10791,GO:0042552,1,0.442545564160418,0,111,myelination,BP,
10792,GO:0042554,1,0.86507396565667,0,25,superoxide anion generation,BP,
10793,GO:0042555,1,0.933408876345318,0,11,MCM complex,CC,
10794,GO:0042558,1,0.815263159399365,0,34,pteridine-containing compound metabolic process,BP,
10795,GO:0042559,1,0.930222859030615,0,14,pteridine-containing compound biosynthetic process,BP,
10796,GO:0042560,1,0.971822078987877,0,4,pteridine-containing compound catabolic process,BP,
10798,GO:0042564,1,0.992469368457749,0,1,NLS-dependent protein nuclear import complex,CC,
10799,GO:0042565,1,0.987644069229719,0,2,RNA nuclear export complex,CC,
10800,GO:0042567,1,0.969688053612868,0,4,insulin-like growth factor ternary complex,CC,
10801,GO:0042568,1,0.996299765628725,0,1,insulin-like growth factor binary complex,CC,
10802,GO:0042571,1,0.990533149122554,0,2,immunoglobulin complex, circulating,CC,
10803,GO:0042572,1,0.856140209656949,0,27,retinol metabolic process,BP,
10804,GO:0042573,1,0.907545606265651,0,17,retinoic acid metabolic process,BP,
10805,GO:0042574,1,0.923230925685332,0,13,retinal metabolic process,BP,
10806,GO:0042575,1,0.898474612555541,0,16,DNA polymerase complex,CC,
10807,GO:0042577,1,0.988347444630295,0,2,lipid phosphatase activity,MF,
10809,GO:0042579,1,0.479135919331244,0,122,microbody,CC,
10811,GO:0042582,1,0.418070842427856,0,147,azurophil granule,CC,
10814,GO:0042585,1,0.994702730826671,0,1,germinal vesicle,CC,
10815,GO:0042586,1,0.996063866935014,0,1,peptide deformylase activity,MF,
10816,GO:0042587,1,0.964758086304985,0,5,glycogen granule,CC,
10817,GO:0042588,1,0.925174502924449,0,12,zymogen granule,CC,
10818,GO:0042589,1,0.937092147657364,0,10,zymogen granule membrane,CC,
10819,GO:0042590,1,0.701853762962037,0,72,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,
10822,GO:0042594,1,0.343900558125285,0,162,response to starvation,BP,
10823,GO:0042595,1,0.989353673654993,0,2,behavioral response to starvation,BP,
10826,GO:0042602,1,0.996434686844087,0,1,riboflavin reductase (NADPH) activity,MF,
10827,GO:0042605,1,0.894633027661576,0,21,peptide antigen binding,MF,
10828,GO:0042608,1,0.962436803985901,0,7,T cell receptor binding,MF,
10829,GO:0042609,1,0.958721911243142,0,7,CD4 receptor binding,MF,
10830,GO:0042610,1,0.989782725516909,0,2,CD8 receptor binding,MF,
10831,GO:0042611,1,0.9095682425567,0,22,MHC protein complex,CC,
10832,GO:0042612,1,0.966268020296934,0,8,MHC class I protein complex,CC,
10833,GO:0042613,1,0.941340652224457,0,14,MHC class II protein complex,CC,
10834,GO:0042622,1,0.914836722825246,0,13,photoreceptor outer segment membrane,CC,
10836,GO:0042624,1,0.996642149851149,0,1,ATPase activity, uncoupled,MF,
10837,GO:0042625,1,0.693860616602988,0,53,ATPase coupled ion transmembrane transporter activity,MF,
10838,GO:0042626,1,0.480461868270858,0,97,ATPase activity, coupled to transmembrane movement of substances,MF,
10839,GO:0042627,1,0.94855500441466,0,9,chylomicron,CC,
10840,GO:0042628,1,0.994670900476519,0,1,mating plug formation,BP,
10842,GO:0042631,1,0.98594141234073,0,2,cellular response to water deprivation,BP,
10843,GO:0042632,1,0.715676288595599,0,53,cholesterol homeostasis,BP,
10844,GO:0042633,1,0.506862558188866,0,98,hair cycle,BP,
10845,GO:0042634,1,0.840512486767971,0,25,regulation of hair cycle,BP,
10846,GO:0042635,1,0.931145063568637,0,12,positive regulation of hair cycle,BP,
10847,GO:0042636,1,0.970954063343804,0,4,negative regulation of hair cycle,BP,
10848,GO:0042637,1,0.975663106913955,0,4,catagen,BP,
10849,GO:0042640,1,0.964345870740131,0,5,anagen,BP,
10850,GO:0042641,1,0.605031656031322,0,64,actomyosin,CC,
10851,GO:0042643,1,0.987020199229063,0,2,actomyosin, actin portion,CC,
10852,GO:0042645,1,0.774091244453062,0,41,mitochondrial nucleoid,CC,
10853,GO:0042658,1,0.995866894913715,0,1,MHC class II protein binding, via antigen binding groove,MF,
10855,GO:0042660,1,0.990081615002755,0,1,positive regulation of cell fate specification,BP,
10858,GO:0042663,1,0.985641718049923,0,3,regulation of endodermal cell fate specification,BP,
10859,GO:0042664,1,0.996061378444575,0,1,negative regulation of endodermal cell fate specification,BP,
10860,GO:0042665,1,0.992962066760823,0,1,regulation of ectodermal cell fate specification,BP,
10861,GO:0042666,1,0.992962066760823,0,1,negative regulation of ectodermal cell fate specification,BP,
10862,GO:0042668,1,0.991589870797625,0,2,auditory receptor cell fate determination,BP,
10863,GO:0042670,1,0.950471225753795,0,8,retinal cone cell differentiation,BP,
10864,GO:0042692,1,0.109620263451231,0,308,muscle cell differentiation,BP,
10865,GO:0042693,1,0.93354783220452,0,12,muscle cell fate commitment,BP,
10866,GO:0042695,1,0.966620455879126,0,5,thelarche,BP,
10868,GO:0042699,1,0.989890778185365,0,2,follicle-stimulating hormone signaling pathway,BP,
10869,GO:0042700,1,0.992202688195683,0,1,luteinizing hormone signaling pathway,BP,
10870,GO:0042701,1,0.976359369427921,0,4,progesterone secretion,BP,
10871,GO:0042704,1,0.985300723733398,0,2,uterine wall breakdown,BP,
10872,GO:0042709,1,0.994553691795555,0,1,succinate-CoA ligase complex,CC,
10873,GO:0042710,1,0.994533977466101,0,1,biofilm formation,BP,
10874,GO:0042711,1,0.922228290890206,0,12,maternal behavior,BP,
10875,GO:0042713,1,0.963103995561837,0,5,sperm ejaculation,BP,
10876,GO:0042719,1,0.978414167162935,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10877,GO:0042720,1,0.992130339942131,0,2,mitochondrial inner membrane peptidase complex,CC,
10878,GO:0042721,1,0.976390999772803,0,5,mitochondrial inner membrane protein insertion complex,CC,
10879,GO:0042723,1,0.96068885411086,0,7,thiamine-containing compound metabolic process,BP,
10880,GO:0042726,1,0.95031525533506,0,8,flavin-containing compound metabolic process,BP,
10881,GO:0042727,1,0.989197861252226,0,2,flavin-containing compound biosynthetic process,BP,
10882,GO:0042728,1,0.992939088184012,0,1,flavin-containing compound catabolic process,BP,
10883,GO:0042730,1,0.888179250780352,0,21,fibrinolysis,BP,
10884,GO:0042731,1,0.973992885153707,0,4,PH domain binding,MF,
10885,GO:0042732,1,0.985788647069301,0,3,D-xylose metabolic process,BP,
10889,GO:0042738,1,0.91770821482493,0,15,exogenous drug catabolic process,BP,
10891,GO:0042743,1,0.806064322549851,0,40,hydrogen peroxide metabolic process,BP,
10892,GO:0042744,1,0.893359041837081,0,21,hydrogen peroxide catabolic process,BP,
10893,GO:0042745,1,0.875596234917842,0,24,circadian sleep/wake cycle,BP,
10894,GO:0042746,1,0.979266851050511,0,4,circadian sleep/wake cycle, wakefulness,BP,
10895,GO:0042747,1,0.962617665454429,0,8,circadian sleep/wake cycle, REM sleep,BP,
10896,GO:0042748,1,0.950459475535941,0,8,circadian sleep/wake cycle, non-REM sleep,BP,
10897,GO:0042749,1,0.908386391429199,0,18,regulation of circadian sleep/wake cycle,BP,
10899,GO:0042753,1,0.904427617753428,0,16,positive regulation of circadian rhythm,BP,
10900,GO:0042754,1,0.921677828176064,0,13,negative regulation of circadian rhythm,BP,
10901,GO:0042755,1,0.859197455408046,0,25,eating behavior,BP,
10902,GO:0042756,1,0.956626621078794,0,8,drinking behavior,BP,
10903,GO:0042758,1,0.956138090012428,0,8,long-chain fatty acid catabolic process,BP,
10904,GO:0042759,1,0.916470753456276,0,12,long-chain fatty acid biosynthetic process,BP,
10905,GO:0042760,1,0.957422194354158,0,7,very long-chain fatty acid catabolic process,BP,
10906,GO:0042761,1,0.93097543253926,0,12,very long-chain fatty acid biosynthetic process,BP,
10907,GO:0042762,1,0.88550259791844,0,17,regulation of sulfur metabolic process,BP,
10908,GO:0042765,1,0.971285418040061,0,5,GPI-anchor transamidase complex,CC,
10909,GO:0042766,1,0.988657630900164,0,1,nucleosome mobilization,BP,
10910,GO:0042769,1,0.809494082601031,0,37,DNA damage response, detection of DNA damage,BP,
10912,GO:0042771,1,0.76981791376304,0,42,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
10914,GO:0042773,1,0.701352626686042,0,81,ATP synthesis coupled electron transport,BP,
10915,GO:0042774,1,0.994054740756748,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10916,GO:0042775,1,0.705562161916592,0,80,mitochondrial ATP synthesis coupled electron transport,BP,
10917,GO:0042776,1,0.984628519382781,0,4,mitochondrial ATP synthesis coupled proton transport,BP,
10918,GO:0042779,1,0.987734584772594,0,2,tRNA 3'-trailer cleavage,BP,
10919,GO:0042780,1,0.962506941734003,0,7,tRNA 3'-end processing,BP,
10920,GO:0042781,1,0.987734584772594,0,2,3'-tRNA processing endoribonuclease activity,MF,
10921,GO:0042788,1,0.87063124666009,0,30,polysomal ribosome,CC,
10922,GO:0042789,1,0.880136740238926,0,19,mRNA transcription by RNA polymerase II,BP,
10923,GO:0042790,1,0.925919743745092,0,12,nucleolar large rRNA transcription by RNA polymerase I,BP,
10924,GO:0042791,1,0.960866872595198,0,6,5S class rRNA transcription by RNA polymerase III,BP,
10925,GO:0042795,1,0.670019985161694,0,66,snRNA transcription by RNA polymerase II,BP,
10926,GO:0042796,1,0.963307263584368,0,6,snRNA transcription by RNA polymerase III,BP,
10927,GO:0042797,1,0.960866872595198,0,6,tRNA transcription by RNA polymerase III,BP,
10928,GO:0042799,1,0.984872570999929,0,1,histone methyltransferase activity (H4-K20 specific),MF,
10929,GO:0042800,1,0.89499505122109,0,16,histone methyltransferase activity (H3-K4 specific),MF,
10932,GO:0042805,1,0.707483140867761,0,41,actinin binding,MF,
10933,GO:0042806,1,0.978634366990829,0,4,fucose binding,MF,
10934,GO:0042809,1,0.89346554298421,0,15,vitamin D receptor binding,MF,
10936,GO:0042816,1,0.96502426202469,0,5,vitamin B6 metabolic process,BP,
10937,GO:0042819,1,0.977827132252092,0,3,vitamin B6 biosynthetic process,BP,
10938,GO:0042820,1,0.994997637646617,0,1,vitamin B6 catabolic process,BP,
10939,GO:0042822,1,0.977974464277002,0,3,pyridoxal phosphate metabolic process,BP,
10940,GO:0042823,1,0.982892101728474,0,2,pyridoxal phosphate biosynthetic process,BP,
10941,GO:0042824,1,0.975270963695915,0,4,MHC class I peptide loading complex,CC,
10942,GO:0042825,1,0.980066387300632,0,3,TAP complex,CC,
10944,GO:0042827,1,0.898386658410929,0,18,platelet dense granule,CC,
10945,GO:0042832,1,0.899871115554176,0,19,defense response to protozoan,BP,
10946,GO:0042834,1,0.949369693045848,0,9,peptidoglycan binding,MF,
10948,GO:0042839,1,0.995664688661669,0,1,D-glucuronate metabolic process,BP,
10949,GO:0042840,1,0.995664688661669,0,1,D-glucuronate catabolic process,BP,
10950,GO:0042843,1,0.99615337561671,0,1,D-xylose catabolic process,BP,
10951,GO:0042851,1,0.983619217422701,0,3,L-alanine metabolic process,BP,
10952,GO:0042853,1,0.983619217422701,0,3,L-alanine catabolic process,BP,
10953,GO:0042866,1,0.519600238361625,0,96,pyruvate biosynthetic process,BP,
10954,GO:0042883,1,0.993075180528113,0,1,cysteine transport,BP,
10957,GO:0042891,1,0.950268855614157,0,8,antibiotic transport,BP,
10958,GO:0042895,1,0.964405469667657,0,6,antibiotic transmembrane transporter activity,MF,
10959,GO:0042903,1,0.987800072782351,0,2,tubulin deacetylase activity,MF,
10960,GO:0042904,1,0.977593278064803,0,4,9-cis-retinoic acid biosynthetic process,BP,
10961,GO:0042905,1,0.977593278064803,0,4,9-cis-retinoic acid metabolic process,BP,
10962,GO:0042908,1,0.930142382287083,0,9,xenobiotic transport,BP,
10963,GO:0042910,1,0.937160400898395,0,8,xenobiotic transmembrane transporter activity,MF,
10964,GO:0042921,1,0.893253959017689,0,15,glucocorticoid receptor signaling pathway,BP,
10965,GO:0042922,1,0.996486604643215,0,1,neuromedin U receptor binding,MF,
10966,GO:0042923,1,0.903330855126279,0,19,neuropeptide binding,MF,
10967,GO:0042924,1,0.988477320605621,0,2,neuromedin U binding,MF,
10968,GO:0042930,1,0.994054740756748,0,1,enterobactin transport,BP,
10969,GO:0042931,1,0.994054740756748,0,1,enterobactin transmembrane transporter activity,MF,
10970,GO:0042937,1,0.99043455124782,0,1,tripeptide transmembrane transporter activity,MF,
10971,GO:0042938,1,0.989640228779888,0,2,dipeptide transport,BP,
10972,GO:0042939,1,0.985477047592991,0,2,tripeptide transport,BP,
10973,GO:0042940,1,0.954467878981205,0,6,D-amino acid transport,BP,
10974,GO:0042941,1,0.995061064269811,0,1,D-alanine transport,BP,
10975,GO:0042942,1,0.989368614844325,0,2,D-serine transport,BP,
10976,GO:0042946,1,0.994054740756748,0,1,glucoside transport,BP,
10977,GO:0042947,1,0.994054740756748,0,1,glucoside transmembrane transporter activity,MF,
10978,GO:0042953,1,0.881074371885712,0,13,lipoprotein transport,BP,
10979,GO:0042954,1,0.942509657918493,0,6,lipoprotein transporter activity,MF,
10980,GO:0042974,1,0.843345127644642,0,24,retinoic acid receptor binding,MF,
10981,GO:0042975,1,0.916190955224532,0,11,peroxisome proliferator activated receptor binding,MF,
10982,GO:0042976,1,0.9389765998086,0,9,activation of Janus kinase activity,BP,
10983,GO:0042978,1,0.972381747329449,0,3,ornithine decarboxylase activator activity,MF,
10984,GO:0042979,1,0.960371878228055,0,6,ornithine decarboxylase regulator activity,MF,
10986,GO:0042982,1,0.737615886093434,0,46,amyloid precursor protein metabolic process,BP,
10987,GO:0042983,1,0.941650892075281,0,10,amyloid precursor protein biosynthetic process,BP,
10988,GO:0042984,1,0.941650892075281,0,10,regulation of amyloid precursor protein biosynthetic process,BP,
10989,GO:0042985,1,0.969808927730071,0,5,negative regulation of amyloid precursor protein biosynthetic process,BP,
10990,GO:0042986,1,0.988486916643579,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
10991,GO:0042987,1,0.800628040364196,0,32,amyloid precursor protein catabolic process,BP,
10992,GO:0042988,1,0.991643738734216,0,1,X11-like protein binding,MF,
10993,GO:0042989,1,0.956995168922625,0,10,sequestering of actin monomers,BP,
10994,GO:0042994,1,0.893948876525032,0,18,cytoplasmic sequestering of transcription factor,BP,
10996,GO:0042996,1,0.961345324781341,0,6,regulation of Golgi to plasma membrane protein transport,BP,
10997,GO:0042997,1,0.975515228792512,0,4,negative regulation of Golgi to plasma membrane protein transport,BP,
10998,GO:0042998,1,0.985478050413009,0,2,positive regulation of Golgi to plasma membrane protein transport,BP,
10999,GO:0042999,1,0.992237777128674,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
11000,GO:0043000,1,0.987971878976974,0,2,Golgi to plasma membrane CFTR protein transport,BP,
11001,GO:0043001,1,0.805323067409478,0,31,Golgi to plasma membrane protein transport,BP,
11002,GO:0043002,1,0.992237777128674,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
11003,GO:0043004,1,0.992237777128674,0,1,cytoplasmic sequestering of CFTR protein,BP,
11005,GO:0043006,1,0.989252451149472,0,2,activation of phospholipase A2 activity by calcium-mediated signaling,BP,
11006,GO:0043008,1,0.953950675268423,0,8,ATP-dependent protein binding,MF,
11009,GO:0043011,1,0.920390233461817,0,15,myeloid dendritic cell differentiation,BP,
11010,GO:0043012,1,0.994265325090249,0,1,regulation of fusion of sperm to egg plasma membrane,BP,
11011,GO:0043014,1,0.832879305518204,0,27,alpha-tubulin binding,MF,
11012,GO:0043015,1,0.839096362850636,0,26,gamma-tubulin binding,MF,
11013,GO:0043016,1,0.994122989481126,0,1,regulation of lymphotoxin A biosynthetic process,BP,
11014,GO:0043017,1,0.994122989481126,0,1,positive regulation of lymphotoxin A biosynthetic process,BP,
11015,GO:0043020,1,0.954890395839987,0,9,NADPH oxidase complex,CC,
11016,GO:0043021,1,0.492923157550445,0,109,ribonucleoprotein complex binding,MF,
11017,GO:0043022,1,0.734255805198768,0,47,ribosome binding,MF,
11018,GO:0043023,1,0.936223166538496,0,11,ribosomal large subunit binding,MF,
11021,GO:0043027,1,0.865325674725244,0,23,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,
11022,GO:0043028,1,0.785993834673472,0,38,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,
11023,GO:0043029,1,0.795860011266598,0,37,T cell homeostasis,BP,
11024,GO:0043030,1,0.781901579163599,0,36,regulation of macrophage activation,BP,
11025,GO:0043031,1,0.958016120887967,0,8,negative regulation of macrophage activation,BP,
11026,GO:0043032,1,0.872184225452606,0,21,positive regulation of macrophage activation,BP,
11027,GO:0043033,1,0.989660397416249,0,1,isoamylase complex,CC,
11028,GO:0043034,1,0.836818117182765,0,19,costamere,CC,
11029,GO:0043035,1,0.99301378904035,0,1,chromatin insulator sequence binding,MF,
11030,GO:0043038,1,0.736311272549888,0,53,amino acid activation,BP,
11031,GO:0043039,1,0.741345630333238,0,52,tRNA aminoacylation,BP,
11032,GO:0043041,1,0.993229595661597,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
11034,GO:0043044,1,0.674166117367831,0,62,ATP-dependent chromatin remodeling,BP,
11035,GO:0043045,1,0.955197574111741,0,6,DNA methylation involved in embryo development,BP,
11036,GO:0043046,1,0.897209098918674,0,17,DNA methylation involved in gamete generation,BP,
11037,GO:0043047,1,0.932710003501157,0,11,single-stranded telomeric DNA binding,MF,
11038,GO:0043048,1,0.994749048825574,0,1,dolichyl monophosphate biosynthetic process,BP,
11039,GO:0043049,1,0.993732872242499,0,1,otic placode formation,BP,
11040,GO:0043060,1,0.994415395872108,0,1,meiotic metaphase I plate congression,BP,
11042,GO:0043063,1,0.991938133605249,0,1,intercellular bridge organization,BP,
11048,GO:0043073,1,0.923701097303748,0,13,germ cell nucleus,CC,
11049,GO:0043083,1,0.931713691251498,0,9,synaptic cleft,CC,
11055,GO:0043094,1,0.831189590311704,0,34,cellular metabolic compound salvage,BP,
11056,GO:0043095,1,0.996613778448459,0,1,regulation of GTP cyclohydrolase I activity,BP,
11057,GO:0043096,1,0.977487041965734,0,5,purine nucleobase salvage,BP,
11058,GO:0043097,1,0.944742945323131,0,11,pyrimidine nucleoside salvage,BP,
11059,GO:0043101,1,0.927900069690425,0,14,purine-containing compound salvage,BP,
11060,GO:0043102,1,0.961940467912574,0,7,amino acid salvage,BP,
11061,GO:0043103,1,0.985683129086171,0,3,hypoxanthine salvage,BP,
11062,GO:0043105,1,0.996613778448459,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
11063,GO:0043111,1,0.987609344506459,0,2,replication fork arrest,BP,
11065,GO:0043113,1,0.695496748953549,0,49,receptor clustering,BP,
11066,GO:0043114,1,0.818308957959992,0,30,regulation of vascular permeability,BP,
11067,GO:0043116,1,0.929965299168598,0,11,negative regulation of vascular permeability,BP,
11068,GO:0043117,1,0.944144818007854,0,10,positive regulation of vascular permeability,BP,
11069,GO:0043120,1,0.973256062387083,0,5,tumor necrosis factor binding,MF,
11070,GO:0043121,1,0.927799752476306,0,10,neurotrophin binding,MF,
11071,GO:0043122,1,0.262486721845903,0,208,regulation of I-kappaB kinase/NF-kappaB signaling,BP,
11072,GO:0043123,1,0.369013489614811,0,160,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,
11073,GO:0043124,1,0.756468162167305,0,39,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,
11074,GO:0043125,1,0.973955325325354,0,4,ErbB-3 class receptor binding,MF,
11075,GO:0043126,1,0.995632673571106,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11076,GO:0043128,1,0.995632673571106,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11077,GO:0043129,1,0.949321373927508,0,8,surfactant homeostasis,BP,
11079,GO:0043131,1,0.991678213729253,0,1,erythrocyte enucleation,BP,
11080,GO:0043132,1,0.988355506434581,0,2,NAD transport,BP,
11081,GO:0043136,1,0.993665856694707,0,1,glycerol-3-phosphatase activity,MF,
11082,GO:0043137,1,0.978793773498936,0,4,DNA replication, removal of RNA primer,BP,
11083,GO:0043138,1,0.920698787996674,0,12,3'-5' DNA helicase activity,MF,
11084,GO:0043139,1,0.959285330599144,0,7,5'-3' DNA helicase activity,MF,
11085,GO:0043140,1,0.947247674827849,0,7,ATP-dependent 3'-5' DNA helicase activity,MF,
11086,GO:0043141,1,0.971697218017103,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
11087,GO:0043142,1,0.918685348261921,0,13,single-stranded DNA-dependent ATPase activity,MF,
11088,GO:0043144,1,0.965617621228461,0,8,snoRNA processing,BP,
11089,GO:0043149,1,0.540336738525656,0,86,stress fiber assembly,BP,
11090,GO:0043152,1,0.97711874011096,0,4,induction of bacterial agglutination,BP,
11091,GO:0043153,1,0.871588956864239,0,21,entrainment of circadian clock by photoperiod,BP,
11093,GO:0043159,1,0.989037259054739,0,2,acrosomal matrix,CC,
11094,GO:0043161,1,0.0828634326019405,0,387,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,
11095,GO:0043162,1,0.895074783533394,0,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11096,GO:0043163,1,0.988237334474678,0,2,cell envelope organization,BP,
11101,GO:0043171,1,0.848348622973628,0,25,peptide catabolic process,BP,
11102,GO:0043173,1,0.924374260420371,0,15,nucleotide salvage,BP,
11103,GO:0043174,1,0.920640856751316,0,16,nucleoside salvage,BP,
11104,GO:0043175,1,0.792794096387118,0,35,RNA polymerase core enzyme binding,MF,
11105,GO:0043176,1,0.93939845943042,0,11,amine binding,MF,
11108,GO:0043179,1,0.994876788417062,0,1,rhythmic excitation,BP,
11109,GO:0043181,1,0.993194693117792,0,1,vacuolar sequestering,BP,
11110,GO:0043183,1,0.989411345313614,0,2,vascular endothelial growth factor receptor 1 binding,MF,
11111,GO:0043184,1,0.955899784657326,0,7,vascular endothelial growth factor receptor 2 binding,MF,
11112,GO:0043185,1,0.994897630967621,0,1,vascular endothelial growth factor receptor 3 binding,MF,
11113,GO:0043186,1,0.913591000612689,0,14,P granule,CC,
11114,GO:0043189,1,0.892629592448016,0,18,H4/H2A histone acetyltransferase complex,CC,
11115,GO:0043190,1,0.94764789171895,0,7,ATP-binding cassette (ABC) transporter complex,CC,
11116,GO:0043194,1,0.896317102462681,0,12,axon initial segment,CC,
11120,GO:0043198,1,0.778178868920278,0,35,dendritic shaft,CC,
11121,GO:0043199,1,0.972591298543114,0,4,sulfate binding,MF,
11123,GO:0043201,1,0.905337957576572,0,12,response to leucine,BP,
11124,GO:0043202,1,0.562579513204642,0,87,lysosomal lumen,CC,
11125,GO:0043203,1,0.960803341045719,0,7,axon hillock,CC,
11130,GO:0043210,1,0.995238798811842,0,1,alkanesulfonate binding,MF,
11131,GO:0043215,1,0.992825065831946,0,1,daunorubicin transport,BP,
11132,GO:0043217,1,0.882652599303146,0,14,myelin maintenance,BP,
11133,GO:0043218,1,0.920627710493768,0,13,compact myelin,CC,
11134,GO:0043219,1,0.974356648531402,0,4,lateral loop,CC,
11135,GO:0043220,1,0.934056529571466,0,10,Schmidt-Lanterman incisure,CC,
11136,GO:0043221,1,0.992943875276567,0,1,SMC family protein binding,MF,
11137,GO:0043224,1,0.992380667540498,0,2,nuclear SCF ubiquitin ligase complex,CC,
11138,GO:0043225,1,0.908648823575891,0,12,ATPase-coupled anion transmembrane transporter activity,MF,
11148,GO:0043236,1,0.829966397187793,0,26,laminin binding,MF,
11149,GO:0043237,1,0.963195246072273,0,5,laminin-1 binding,MF,
11150,GO:0043240,1,0.944129908725206,0,9,Fanconi anaemia nuclear complex,CC,
11154,GO:0043247,1,0.914529877888772,0,13,telomere maintenance in response to DNA damage,BP,
11155,GO:0043248,1,0.947509216395395,0,12,proteasome assembly,BP,
11156,GO:0043249,1,0.926820572739334,0,13,erythrocyte maturation,BP,
11157,GO:0043250,1,0.995628905443747,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
11158,GO:0043251,1,0.995628905443747,0,1,sodium-dependent organic anion transport,BP,
11159,GO:0043252,1,0.841327735044899,0,27,sodium-independent organic anion transport,BP,
11161,GO:0043255,1,0.612473336198826,0,67,regulation of carbohydrate biosynthetic process,BP,
11162,GO:0043256,1,0.920472739578389,0,8,laminin complex,CC,
11163,GO:0043257,1,0.990960124774554,0,1,laminin-8 complex,CC,
11164,GO:0043259,1,0.966132628778254,0,3,laminin-10 complex,CC,
11165,GO:0043260,1,0.966172288433646,0,3,laminin-11 complex,CC,
11166,GO:0043262,1,0.982669077051502,0,3,adenosine-diphosphatase activity,MF,
11167,GO:0043265,1,0.993657545850382,0,1,ectoplasm,CC,
11169,GO:0043267,1,0.842537293382847,0,25,negative regulation of potassium ion transport,BP,
11174,GO:0043273,1,0.991427343197414,0,1,CTPase activity,MF,
11175,GO:0043274,1,0.913255590276324,0,13,phospholipase binding,MF,
11176,GO:0043276,1,0.814155810813326,0,29,anoikis,BP,
11177,GO:0043277,1,0.758002073745234,0,41,apoptotic cell clearance,BP,
11180,GO:0043280,1,0.478983009241021,0,122,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
11182,GO:0043291,1,0.97276644426269,0,2,RAVE complex,CC,
11184,GO:0043293,1,0.98513590483533,0,2,apoptosome,CC,
11185,GO:0043295,1,0.946626405697009,0,11,glutathione binding,MF,
11187,GO:0043297,1,0.673158373203464,0,57,apical junction assembly,BP,
11189,GO:0043300,1,0.778878931738413,0,41,regulation of leukocyte degranulation,BP,
11190,GO:0043301,1,0.936378687052115,0,11,negative regulation of leukocyte degranulation,BP,
11191,GO:0043302,1,0.886659458688736,0,20,positive regulation of leukocyte degranulation,BP,
11193,GO:0043304,1,0.855483071019533,0,27,regulation of mast cell degranulation,BP,
11194,GO:0043305,1,0.970124522376761,0,6,negative regulation of mast cell degranulation,BP,
11195,GO:0043306,1,0.93497349879958,0,12,positive regulation of mast cell degranulation,BP,
11196,GO:0043307,1,0.974295319362732,0,5,eosinophil activation,BP,
11197,GO:0043308,1,0.979053507927434,0,4,eosinophil degranulation,BP,
11198,GO:0043309,1,0.984167758840404,0,3,regulation of eosinophil degranulation,BP,
11199,GO:0043310,1,0.994377869669239,0,1,negative regulation of eosinophil degranulation,BP,
11200,GO:0043311,1,0.989732744488203,0,2,positive regulation of eosinophil degranulation,BP,
11202,GO:0043313,1,0.942744444206937,0,8,regulation of neutrophil degranulation,BP,
11203,GO:0043314,1,0.981628646003222,0,2,negative regulation of neutrophil degranulation,BP,
11204,GO:0043315,1,0.973413310354439,0,4,positive regulation of neutrophil degranulation,BP,
11205,GO:0043316,1,0.982942475512705,0,3,cytotoxic T cell degranulation,BP,
11206,GO:0043317,1,0.988852975234074,0,2,regulation of cytotoxic T cell degranulation,BP,
11207,GO:0043318,1,0.988852975234074,0,2,negative regulation of cytotoxic T cell degranulation,BP,
11208,GO:0043320,1,0.966671819605358,0,5,natural killer cell degranulation,BP,
11209,GO:0043321,1,0.984377728838257,0,2,regulation of natural killer cell degranulation,BP,
11210,GO:0043323,1,0.984377728838257,0,2,positive regulation of natural killer cell degranulation,BP,
11211,GO:0043324,1,0.981145968760821,0,3,pigment metabolic process involved in developmental pigmentation,BP,
11212,GO:0043325,1,0.869588330320299,0,20,phosphatidylinositol-3,4-bisphosphate binding,MF,
11213,GO:0043328,1,0.980898090915909,0,4,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11214,GO:0043330,1,0.837997683012613,0,28,response to exogenous dsRNA,BP,
11215,GO:0043331,1,0.58741668535813,0,78,response to dsRNA,BP,
11216,GO:0043335,1,0.988958240916077,0,2,protein unfolding,BP,
11217,GO:0043337,1,0.993005644329228,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
11218,GO:0043353,1,0.944137427359187,0,8,enucleate erythrocyte differentiation,BP,
11219,GO:0043354,1,0.991678213729253,0,1,enucleate erythrocyte maturation,BP,
11220,GO:0043363,1,0.994054740756748,0,1,nucleate erythrocyte differentiation,BP,
11221,GO:0043366,1,0.982077458868877,0,3,beta selection,BP,
11222,GO:0043367,1,0.688294345288937,0,58,CD4-positive, alpha-beta T cell differentiation,BP,
11223,GO:0043368,1,0.833131454567424,0,28,positive T cell selection,BP,
11224,GO:0043369,1,0.891627262079882,0,18,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,
11225,GO:0043370,1,0.820766824708832,0,32,regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11226,GO:0043371,1,0.908334864855859,0,14,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11227,GO:0043372,1,0.88903397783602,0,21,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11228,GO:0043373,1,0.918269458893975,0,14,CD4-positive, alpha-beta T cell lineage commitment,BP,
11229,GO:0043374,1,0.944508277265057,0,9,CD8-positive, alpha-beta T cell differentiation,BP,
11230,GO:0043375,1,0.99296254550758,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
11231,GO:0043376,1,0.986128002229844,0,2,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11232,GO:0043378,1,0.992894083586393,0,1,positive regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11233,GO:0043379,1,0.960322870157032,0,6,memory T cell differentiation,BP,
11234,GO:0043380,1,0.97166707366635,0,5,regulation of memory T cell differentiation,BP,
11235,GO:0043382,1,0.978258431819044,0,4,positive regulation of memory T cell differentiation,BP,
11236,GO:0043383,1,0.932734870264781,0,11,negative T cell selection,BP,
11237,GO:0043385,1,0.9940959129705,0,1,mycotoxin metabolic process,BP,
11238,GO:0043387,1,0.9940959129705,0,1,mycotoxin catabolic process,BP,
11239,GO:0043388,1,0.722815531550292,0,51,positive regulation of DNA binding,BP,
11240,GO:0043392,1,0.719020705815486,0,51,negative regulation of DNA binding,BP,
11241,GO:0043393,1,0.266567345263445,0,196,regulation of protein binding,BP,
11242,GO:0043394,1,0.763998331713216,0,35,proteoglycan binding,MF,
11243,GO:0043395,1,0.86257812180742,0,19,heparan sulfate proteoglycan binding,MF,
11244,GO:0043396,1,0.985706400898567,0,2,corticotropin-releasing hormone secretion,BP,
11245,GO:0043397,1,0.985706400898567,0,2,regulation of corticotropin-releasing hormone secretion,BP,
11246,GO:0043398,1,0.980857581948352,0,3,HLH domain binding,MF,
11247,GO:0043400,1,0.973912202306731,0,5,cortisol secretion,BP,
11248,GO:0043401,1,0.285067654967054,0,179,steroid hormone mediated signaling pathway,BP,
11249,GO:0043402,1,0.968880828804325,0,3,glucocorticoid mediated signaling pathway,BP,
11250,GO:0043403,1,0.847651484523907,0,27,skeletal muscle tissue regeneration,BP,
11259,GO:0043414,1,0.182779543937975,0,253,macromolecule methylation,BP,
11260,GO:0043415,1,0.970366223805109,0,5,positive regulation of skeletal muscle tissue regeneration,BP,
11261,GO:0043416,1,0.970366223805109,0,5,regulation of skeletal muscle tissue regeneration,BP,
11262,GO:0043418,1,0.982331957802316,0,3,homocysteine catabolic process,BP,
11263,GO:0043420,1,0.995649625843794,0,1,anthranilate metabolic process,BP,
11264,GO:0043422,1,0.922435417132384,0,12,protein kinase B binding,MF,
11265,GO:0043423,1,0.992476217027052,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
11266,GO:0043425,1,0.844118841163087,0,24,bHLH transcription factor binding,MF,
11267,GO:0043426,1,0.963071631116383,0,5,MRF binding,MF,
11268,GO:0043433,1,0.372912422122669,0,150,negative regulation of DNA binding transcription factor activity,BP,
11270,GO:0043435,1,0.969115440780266,0,5,response to corticotropin-releasing hormone,BP,
11272,GO:0043438,1,0.993939111405318,0,1,acetoacetic acid metabolic process,BP,
11273,GO:0043449,1,0.986836524202979,0,2,cellular alkene metabolic process,BP,
11274,GO:0043455,1,0.926174091573778,0,11,regulation of secondary metabolic process,BP,
11275,GO:0043456,1,0.982399267386844,0,4,regulation of pentose-phosphate shunt,BP,
11276,GO:0043457,1,0.871899086822339,0,21,regulation of cellular respiration,BP,
11277,GO:0043461,1,0.978755895614474,0,4,proton-transporting ATP synthase complex assembly,BP,
11278,GO:0043462,1,0.671575672711457,0,71,regulation of ATPase activity,BP,
11279,GO:0043467,1,0.458954670336358,0,108,regulation of generation of precursor metabolites and energy,BP,
11280,GO:0043470,1,0.609844867046703,0,69,regulation of carbohydrate catabolic process,BP,
11281,GO:0043471,1,0.951287649135838,0,9,regulation of cellular carbohydrate catabolic process,BP,
11282,GO:0043473,1,0.527545308282229,0,93,pigmentation,BP,
11283,GO:0043474,1,0.981145968760821,0,3,pigment metabolic process involved in pigmentation,BP,
11284,GO:0043476,1,0.918043008000902,0,12,pigment accumulation,BP,
11285,GO:0043482,1,0.918043008000902,0,12,cellular pigment accumulation,BP,
11287,GO:0043485,1,0.940845212896697,0,10,endosome to pigment granule transport,BP,
11288,GO:0043486,1,0.798151529068807,0,40,histone exchange,BP,
11289,GO:0043487,1,0.368717860959771,0,157,regulation of RNA stability,BP,
11290,GO:0043488,1,0.390317278943496,0,149,regulation of mRNA stability,BP,
11291,GO:0043489,1,0.779641926846303,0,36,RNA stabilization,BP,
11292,GO:0043490,1,0.986448023075871,0,2,malate-aspartate shuttle,BP,
11294,GO:0043492,1,0.425524140333156,0,110,ATPase activity, coupled to movement of substances,MF,
11295,GO:0043495,1,0.930829829158114,0,10,protein membrane anchor,MF,
11296,GO:0043496,1,0.875653294835835,0,21,regulation of protein homodimerization activity,BP,
11297,GO:0043497,1,0.941172752055711,0,10,regulation of protein heterodimerization activity,BP,
11298,GO:0043500,1,0.562772619993892,0,84,muscle adaptation,BP,
11299,GO:0043501,1,0.865518327659379,0,21,skeletal muscle adaptation,BP,
11300,GO:0043502,1,0.605375913632754,0,68,regulation of muscle adaptation,BP,
11301,GO:0043503,1,0.990913424391833,0,2,skeletal muscle fiber adaptation,BP,
11302,GO:0043504,1,0.979405948391721,0,3,mitochondrial DNA repair,BP,
11304,GO:0043507,1,0.624472350717774,0,64,positive regulation of JUN kinase activity,BP,
11306,GO:0043509,1,0.99478419556355,0,1,activin A complex,CC,
11307,GO:0043511,1,0.990539257715498,0,2,inhibin complex,CC,
11308,GO:0043512,1,0.990539257715498,0,2,inhibin A complex,CC,
11309,GO:0043513,1,0.995733030733855,0,1,inhibin B complex,CC,
11310,GO:0043514,1,0.995710471266797,0,1,interleukin-12 complex,CC,
11311,GO:0043515,1,0.961783968643452,0,5,kinetochore binding,MF,
11312,GO:0043516,1,0.830331932535333,0,29,regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11313,GO:0043517,1,0.907576167118191,0,14,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11314,GO:0043518,1,0.919209693472611,0,14,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11315,GO:0043519,1,0.994863534742089,0,1,regulation of myosin II filament organization,BP,
11316,GO:0043522,1,0.947891057448736,0,9,leucine zipper domain binding,MF,
11320,GO:0043527,1,0.974822609066575,0,5,tRNA methyltransferase complex,CC,
11321,GO:0043531,1,0.791052834735143,0,33,ADP binding,MF,
11322,GO:0043532,1,0.990117429323518,0,1,angiostatin binding,MF,
11323,GO:0043533,1,0.958698273976371,0,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,
11324,GO:0043534,1,0.505899377212732,0,98,blood vessel endothelial cell migration,BP,
11325,GO:0043535,1,0.581086554174566,0,78,regulation of blood vessel endothelial cell migration,BP,
11326,GO:0043536,1,0.718282258951268,0,48,positive regulation of blood vessel endothelial cell migration,BP,
11327,GO:0043537,1,0.816346833253588,0,29,negative regulation of blood vessel endothelial cell migration,BP,
11328,GO:0043538,1,0.993756134983809,0,1,regulation of actin phosphorylation,BP,
11329,GO:0043539,1,0.822891460037583,0,32,protein serine/threonine kinase activator activity,MF,
11330,GO:0043540,1,0.995327529153892,0,1,6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex,CC,
11331,GO:0043541,1,0.986882135901302,0,2,UDP-N-acetylglucosamine transferase complex,CC,
11332,GO:0043542,1,0.308599874461873,0,169,endothelial cell migration,BP,
11334,GO:0043544,1,0.993212130508638,0,1,lipoamide binding,MF,
11335,GO:0043545,1,0.960130051502271,0,7,molybdopterin cofactor metabolic process,BP,
11336,GO:0043546,1,0.958914012353588,0,6,molybdopterin cofactor binding,MF,
11338,GO:0043548,1,0.805597673563897,0,27,phosphatidylinositol 3-kinase binding,MF,
11341,GO:0043551,1,0.752960018538384,0,40,regulation of phosphatidylinositol 3-kinase activity,BP,
11342,GO:0043552,1,0.809040307795379,0,30,positive regulation of phosphatidylinositol 3-kinase activity,BP,
11343,GO:0043553,1,0.986844478727204,0,2,negative regulation of phosphatidylinositol 3-kinase activity,BP,
11344,GO:0043555,1,0.887458247126238,0,18,regulation of translation in response to stress,BP,
11345,GO:0043558,1,0.913192428111282,0,14,regulation of translational initiation in response to stress,BP,
11346,GO:0043559,1,0.951000749242362,0,5,insulin binding,MF,
11347,GO:0043560,1,0.912407998444585,0,11,insulin receptor substrate binding,MF,
11348,GO:0043562,1,0.946849894445564,0,11,cellular response to nitrogen levels,BP,
11349,GO:0043564,1,0.988207806651935,0,2,Ku70:Ku80 complex,CC,
11352,GO:0043568,1,0.935423931500513,0,9,positive regulation of insulin-like growth factor receptor signaling pathway,BP,
11353,GO:0043569,1,0.950392013775185,0,7,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
11354,GO:0043570,1,0.964269690035037,0,5,maintenance of DNA repeat elements,BP,
11355,GO:0043574,1,0.892605367208715,0,18,peroxisomal transport,BP,
11356,GO:0043576,1,0.856804854703048,0,22,regulation of respiratory gaseous exchange,BP,
11357,GO:0043578,1,0.966243336255513,0,3,nuclear matrix organization,BP,
11359,GO:0043584,1,0.887645910522195,0,16,nose development,BP,
11360,GO:0043585,1,0.974023859191418,0,3,nose morphogenesis,BP,
11361,GO:0043586,1,0.871340482672891,0,19,tongue development,BP,
11362,GO:0043587,1,0.946873949422651,0,8,tongue morphogenesis,BP,
11363,GO:0043588,1,0.187439597398277,0,241,skin development,BP,
11364,GO:0043589,1,0.936665614297744,0,8,skin morphogenesis,BP,
11365,GO:0043596,1,0.773543056419508,0,41,nuclear replication fork,CC,
11366,GO:0043601,1,0.865858027723465,0,24,nuclear replisome,CC,
11367,GO:0043602,1,0.994367011384535,0,1,nitrate catabolic process,BP,
11370,GO:0043605,1,0.985906054558262,0,3,cellular amide catabolic process,BP,
11371,GO:0043606,1,0.977214636179475,0,4,formamide metabolic process,BP,
11372,GO:0043610,1,0.988194477035737,0,1,regulation of carbohydrate utilization,BP,
11373,GO:0043614,1,0.984228437498546,0,2,multi-eIF complex,CC,
11374,GO:0043615,1,0.961176602658341,0,7,astrocyte cell migration,BP,
11375,GO:0043616,1,0.779063164697954,0,34,keratinocyte proliferation,BP,
11376,GO:0043618,1,0.53540408028399,0,108,regulation of transcription from RNA polymerase II promoter in response to stress,BP,
11377,GO:0043619,1,0.926737916025008,0,11,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
11378,GO:0043620,1,0.514870914776932,0,113,regulation of DNA-templated transcription in response to stress,BP,
11379,GO:0043621,1,0.679032478263538,0,52,protein self-association,MF,
11380,GO:0043622,1,0.970649272703914,0,4,cortical microtubule organization,BP,
11382,GO:0043625,1,0.97856350318119,0,4,delta DNA polymerase complex,CC,
11383,GO:0043626,1,0.995836279034428,0,1,PCNA complex,CC,
11385,GO:0043628,1,0.855249859450422,0,28,ncRNA 3'-end processing,BP,
11386,GO:0043629,1,0.988868993291414,0,1,ncRNA polyadenylation,BP,
11387,GO:0043630,1,0.988868993291414,0,1,ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process,BP,
11388,GO:0043631,1,0.750977171363847,0,42,RNA polyadenylation,BP,
11390,GO:0043633,1,0.954174295432883,0,8,polyadenylation-dependent RNA catabolic process,BP,
11391,GO:0043634,1,0.961650810171717,0,7,polyadenylation-dependent ncRNA catabolic process,BP,
11392,GO:0043647,1,0.649245168571857,0,62,inositol phosphate metabolic process,BP,
11393,GO:0043648,1,0.559757110019477,0,98,dicarboxylic acid metabolic process,BP,
11394,GO:0043649,1,0.899291068672309,0,18,dicarboxylic acid catabolic process,BP,
11395,GO:0043650,1,0.929242918058873,0,12,dicarboxylic acid biosynthetic process,BP,
11396,GO:0043651,1,0.91509605862373,0,15,linoleic acid metabolic process,BP,
11397,GO:0043652,1,0.93330751488947,0,11,engulfment of apoptotic cell,BP,
11398,GO:0043653,1,0.946141668443133,0,9,mitochondrial fragmentation involved in apoptotic process,BP,
11399,GO:0043654,1,0.961236384610115,0,6,recognition of apoptotic cell,BP,
11400,GO:0043656,1,0.94601901640466,0,9,intracellular region of host,CC,
11404,GO:0043682,1,0.97905071252116,0,2,copper-transporting ATPase activity,MF,
11405,GO:0043686,1,0.984540494052671,0,3,co-translational protein modification,BP,
11407,GO:0043691,1,0.92446407656114,0,13,reverse cholesterol transport,BP,
11408,GO:0043696,1,0.948358934660577,0,7,dedifferentiation,BP,
11409,GO:0043697,1,0.948358934660577,0,7,cell dedifferentiation,BP,
11410,GO:0043733,1,0.996149649013535,0,1,DNA-3-methylbase glycosylase activity,MF,
11411,GO:0043734,1,0.978835667474403,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
11412,GO:0043739,1,0.993547688572631,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
11413,GO:0043754,1,0.986377574530637,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
11414,GO:0043783,1,0.994556158930941,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
11415,GO:0043795,1,0.995754326013234,0,1,glyceraldehyde oxidoreductase activity,MF,
11416,GO:0043812,1,0.976706595178816,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
11417,GO:0043813,1,0.956816645259299,0,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
11418,GO:0043843,1,0.994307000868295,0,1,ADP-specific glucokinase activity,MF,
11419,GO:0043849,1,0.993894532786589,0,1,Ras palmitoyltransferase activity,MF,
11420,GO:0043855,1,0.939022581714592,0,9,cyclic nucleotide-gated ion channel activity,MF,
11421,GO:0043865,1,0.994049052484948,0,1,methionine transmembrane transporter activity,MF,
11422,GO:0043874,1,0.99498242760236,0,1,acireductone synthase activity,MF,
11423,GO:0043890,1,0.994535208412337,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
11424,GO:0043891,1,0.995865645684935,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
11426,GO:0043901,1,0.419212706082003,0,144,negative regulation of multi-organism process,BP,
11429,GO:0043914,1,0.992886420826233,0,1,NADPH:sulfur oxidoreductase activity,MF,
11430,GO:0043916,1,0.996149649013535,0,1,DNA-7-methylguanine glycosylase activity,MF,
11431,GO:0043921,1,0.849767117189439,0,24,modulation by host of viral transcription,BP,
11432,GO:0043922,1,0.945467808668122,0,9,negative regulation by host of viral transcription,BP,
11433,GO:0043923,1,0.886787140361835,0,17,positive regulation by host of viral transcription,BP,
11434,GO:0043924,1,0.981885587763481,0,1,suramin binding,MF,
11435,GO:0043928,1,0.831024689088696,0,32,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,
11436,GO:0043931,1,0.879685993552416,0,14,ossification involved in bone maturation,BP,
11437,GO:0043932,1,0.979033206032475,0,4,ossification involved in bone remodeling,BP,
11439,GO:0043946,1,0.995321831111845,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
11440,GO:0043947,1,0.995321831111845,0,1,positive regulation by host of symbiont catalytic activity,BP,
11445,GO:0043966,1,0.696013854373608,0,56,histone H3 acetylation,BP,
11446,GO:0043967,1,0.653820467575888,0,62,histone H4 acetylation,BP,
11447,GO:0043968,1,0.90734547469143,0,15,histone H2A acetylation,BP,
11448,GO:0043969,1,0.988186240910846,0,1,histone H2B acetylation,BP,
11449,GO:0043970,1,0.915062900942671,0,13,histone H3-K9 acetylation,BP,
11450,GO:0043972,1,0.992105619760906,0,1,histone H3-K23 acetylation,BP,
11451,GO:0043973,1,0.994742154322651,0,1,histone H3-K4 acetylation,BP,
11452,GO:0043974,1,0.977274562295244,0,3,histone H3-K27 acetylation,BP,
11453,GO:0043981,1,0.906846911043522,0,15,histone H4-K5 acetylation,BP,
11454,GO:0043982,1,0.906846911043522,0,15,histone H4-K8 acetylation,BP,
11455,GO:0043983,1,0.961069753302911,0,7,histone H4-K12 acetylation,BP,
11456,GO:0043984,1,0.880351403028289,0,18,histone H4-K16 acetylation,BP,
11457,GO:0043985,1,0.966053461339739,0,6,histone H4-R3 methylation,BP,
11458,GO:0043987,1,0.966920706740668,0,6,histone H3-S10 phosphorylation,BP,
11459,GO:0043988,1,0.983414292311661,0,3,histone H3-S28 phosphorylation,BP,
11460,GO:0043990,1,0.993705531490526,0,1,histone H2A-S1 phosphorylation,BP,
11461,GO:0043994,1,0.992105619760906,0,1,histone acetyltransferase activity (H3-K23 specific),MF,
11462,GO:0043995,1,0.932052104980251,0,10,histone acetyltransferase activity (H4-K5 specific),MF,
11463,GO:0043996,1,0.932052104980251,0,10,histone acetyltransferase activity (H4-K8 specific),MF,
11464,GO:0043997,1,0.993674181863851,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
11465,GO:0043998,1,0.993457974685994,0,1,H2A histone acetyltransferase activity,MF,
11466,GO:0044003,1,0.757185116319721,0,40,modification by symbiont of host morphology or physiology,BP,
11467,GO:0044004,1,0.973028979874562,0,5,disruption by symbiont of host cell,BP,
11468,GO:0044007,1,0.990444323541363,0,1,dissemination or transmission of symbiont from host,BP,
11469,GO:0044010,1,0.994533977466101,0,1,single-species biofilm formation,BP,
11470,GO:0044020,1,0.97905084727841,0,4,histone methyltransferase activity (H4-R3 specific),MF,
11471,GO:0044026,1,0.988797896358992,0,2,DNA hypermethylation,BP,
11472,GO:0044027,1,0.995749942548721,0,1,hypermethylation of CpG island,BP,
11473,GO:0044028,1,0.986076479235092,0,2,DNA hypomethylation,BP,
11474,GO:0044029,1,0.986076479235092,0,2,hypomethylation of CpG island,BP,
11475,GO:0044030,1,0.901000246437391,0,15,regulation of DNA methylation,BP,
11476,GO:0044033,1,0.962090872399626,0,7,multi-organism metabolic process,BP,
11477,GO:0044035,1,0.995459598309555,0,1,multi-organism catabolic process,BP,
11478,GO:0044036,1,0.97743799240339,0,5,cell wall macromolecule metabolic process,BP,
11479,GO:0044038,1,0.995286990116764,0,1,cell wall macromolecule biosynthetic process,BP,
11480,GO:0044042,1,0.607538169942331,0,69,glucan metabolic process,BP,
11481,GO:0044053,1,0.994480592528411,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
11483,GO:0044058,1,0.829892934118162,0,32,regulation of digestive system process,BP,
11484,GO:0044060,1,0.786773451592469,0,40,regulation of endocrine process,BP,
11485,GO:0044062,1,0.891451470355511,0,19,regulation of excretion,BP,
11486,GO:0044065,1,0.90508931313211,0,15,regulation of respiratory system process,BP,
11487,GO:0044068,1,0.843892740839886,0,25,modulation by symbiont of host cellular process,BP,
11491,GO:0044088,1,0.767767234003484,0,39,regulation of vacuole organization,BP,
11493,GO:0044090,1,0.921434743829189,0,11,positive regulation of vacuole organization,BP,
11494,GO:0044091,1,0.787935750506263,0,32,membrane biogenesis,BP,
11497,GO:0044094,1,0.979144194474601,0,3,host cell nuclear part,CC,
11498,GO:0044105,1,0.996465594746375,0,1,L-xylulose reductase (NAD+) activity,MF,
11499,GO:0044106,1,0.543271371104535,0,113,cellular amine metabolic process,BP,
11500,GO:0044107,1,0.979717671151109,0,4,cellular alcohol metabolic process,BP,
11501,GO:0044108,1,0.979717671151109,0,4,cellular alcohol biosynthetic process,BP,
11502,GO:0044110,1,0.93319737038483,0,14,growth involved in symbiotic interaction,BP,
11503,GO:0044111,1,0.985946873172517,0,2,development involved in symbiotic interaction,BP,
11504,GO:0044115,1,0.995459598309555,0,1,development of symbiont involved in interaction with host,BP,
11505,GO:0044116,1,0.93319737038483,0,14,growth of symbiont involved in interaction with host,BP,
11506,GO:0044117,1,0.936372557772318,0,13,growth of symbiont in host,BP,
11507,GO:0044126,1,0.93983487369655,0,12,regulation of growth of symbiont in host,BP,
11508,GO:0044128,1,0.991741146580531,0,1,positive regulation of growth of symbiont in host,BP,
11509,GO:0044130,1,0.947665740536822,0,11,negative regulation of growth of symbiont in host,BP,
11510,GO:0044133,1,0.996611310932968,0,1,growth of symbiont on or near host,BP,
11511,GO:0044139,1,0.996611310932968,0,1,modulation of growth of symbiont on or near host,BP,
11512,GO:0044140,1,0.996611310932968,0,1,negative regulation of growth of symbiont on or near host surface,BP,
11513,GO:0044144,1,0.936648065004987,0,13,modulation of growth of symbiont involved in interaction with host,BP,
11514,GO:0044145,1,0.995459598309555,0,1,modulation of development of symbiont involved in interaction with host,BP,
11515,GO:0044146,1,0.944452648226117,0,12,negative regulation of growth of symbiont involved in interaction with host,BP,
11516,GO:0044147,1,0.995459598309555,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
11517,GO:0044148,1,0.991741146580531,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
11518,GO:0044154,1,0.952628109369004,0,8,histone H3-K14 acetylation,BP,
11519,GO:0044179,1,0.988854263786942,0,2,hemolysis in other organism,BP,
11520,GO:0044183,1,0.800864328023567,0,38,protein binding involved in protein folding,MF,
11521,GO:0044190,1,0.995313598987954,0,1,host cell mitochondrial envelope,CC,
11522,GO:0044194,1,0.974767504093626,0,5,cytolytic granule,CC,
11523,GO:0044205,1,0.978965310430796,0,3,'de novo' UMP biosynthetic process,BP,
11524,GO:0044206,1,0.975945780343566,0,5,UMP salvage,BP,
11525,GO:0044207,1,0.992654416442618,0,1,translation initiation ternary complex,CC,
11526,GO:0044208,1,0.985065927175449,0,3,'de novo' AMP biosynthetic process,BP,
11527,GO:0044209,1,0.991528129831677,0,2,AMP salvage,BP,
11528,GO:0044210,1,0.986962074568497,0,2,'de novo' CTP biosynthetic process,BP,
11529,GO:0044211,1,0.986053945382758,0,3,CTP salvage,BP,
11531,GO:0044213,1,0.922171272892413,0,12,intronic transcription regulatory region DNA binding,MF,
11532,GO:0044214,1,0.957545270803739,0,5,spanning component of plasma membrane,CC,
11536,GO:0044218,1,0.970595894024403,0,5,other organism cell membrane,CC,
11537,GO:0044220,1,0.991992376379284,0,1,host cell perinuclear region of cytoplasm,CC,
11538,GO:0044221,1,0.992633084128786,0,1,host cell synapse,CC,
11539,GO:0044224,1,0.919606561503339,0,10,juxtaparanode region of axon,CC,
11540,GO:0044228,1,0.992094707101504,0,1,host cell surface,CC,
11541,GO:0044231,1,0.992633084128786,0,1,host cell presynaptic membrane,CC,
11542,GO:0044232,1,0.881018253318272,0,19,organelle membrane contact site,CC,
11543,GO:0044233,1,0.919833784036176,0,13,ER-mitochondrion membrane contact site,CC,
11546,GO:0044241,1,0.947682526427297,0,9,lipid digestion,BP,
11548,GO:0044245,1,0.980515398726483,0,3,polysaccharide digestion,BP,
11549,GO:0044247,1,0.833310949378595,0,25,cellular polysaccharide catabolic process,BP,
11554,GO:0044258,1,0.994511848430069,0,1,intestinal lipid catabolic process,BP,
11556,GO:0044262,1,0.209584354577234,0,227,cellular carbohydrate metabolic process,BP,
11557,GO:0044264,1,0.53536989609085,0,88,cellular polysaccharide metabolic process,BP,
11560,GO:0044270,1,0.0221916446339841,0,618,cellular nitrogen compound catabolic process,BP,
11563,GO:0044273,1,0.763977339213219,0,43,sulfur compound catabolic process,BP,
11564,GO:0044275,1,0.766362202343574,0,39,cellular carbohydrate catabolic process,BP,
11565,GO:0044278,1,0.996490311655787,0,1,cell wall disruption in other organism,BP,
11566,GO:0044279,1,0.970595894024403,0,5,other organism membrane,CC,
11570,GO:0044284,1,0.99638149352726,0,1,mitochondrial crista junction,CC,
11571,GO:0044291,1,0.624439873386931,0,62,cell-cell contact zone,CC,
11572,GO:0044292,1,0.93565672276591,0,10,dendrite terminus,CC,
11573,GO:0044294,1,0.955031923958043,0,6,dendritic growth cone,CC,
11574,GO:0044295,1,0.855003482278431,0,21,axonal growth cone,CC,
11577,GO:0044299,1,0.990325283244868,0,1,C-fiber,CC,
11579,GO:0044301,1,0.988014034132797,0,2,climbing fiber,CC,
11580,GO:0044302,1,0.964665832007253,0,4,dentate gyrus mossy fiber,CC,
11582,GO:0044305,1,0.960387646960215,0,4,calyx of Held,CC,
11584,GO:0044307,1,0.98496538047388,0,1,dendritic branch,CC,
11585,GO:0044308,1,0.972379471531251,0,3,axonal spine,CC,
11587,GO:0044313,1,0.972601244575686,0,3,protein K6-linked deubiquitination,BP,
11588,GO:0044314,1,0.981662238928385,0,4,protein K27-linked ubiquitination,BP,
11589,GO:0044316,1,0.987414398961963,0,2,cone cell pedicle,CC,
11590,GO:0044317,1,0.995793131798205,0,1,rod spherule,CC,
11591,GO:0044319,1,0.821839948719555,0,27,wound healing, spreading of cells,BP,
11592,GO:0044320,1,0.908002477343387,0,15,cellular response to leptin stimulus,BP,
11593,GO:0044321,1,0.88606963523634,0,19,response to leptin,BP,
11594,GO:0044322,1,0.826860514941135,0,28,endoplasmic reticulum quality control compartment,CC,
11595,GO:0044323,1,0.970613988708006,0,4,retinoic acid-responsive element binding,MF,
11596,GO:0044324,1,0.996370354804287,0,1,regulation of transcription involved in anterior/posterior axis specification,BP,
11598,GO:0044326,1,0.968052563900403,0,4,dendritic spine neck,CC,
11600,GO:0044331,1,0.808255968305295,0,33,cell-cell adhesion mediated by cadherin,BP,
11601,GO:0044332,1,0.938467695356602,0,7,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
11602,GO:0044333,1,0.995153748145458,0,1,Wnt signaling pathway involved in digestive tract morphogenesis,BP,
11603,GO:0044334,1,0.986247423099782,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
11604,GO:0044335,1,0.987006778235442,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
11605,GO:0044336,1,0.979723522076924,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
11606,GO:0044338,1,0.988151274696041,0,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,
11607,GO:0044339,1,0.972307683983207,0,4,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
11608,GO:0044340,1,0.962698282819775,0,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,
11611,GO:0044343,1,0.992363434097317,0,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
11613,GO:0044345,1,0.992363434097317,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
11614,GO:0044346,1,0.880601851312805,0,18,fibroblast apoptotic process,BP,
11615,GO:0044349,1,0.995346516039137,0,1,DNA excision,BP,
11616,GO:0044351,1,0.954813345294386,0,7,macropinocytosis,BP,
11617,GO:0044352,1,0.971883847902752,0,4,pinosome,CC,
11618,GO:0044354,1,0.971883847902752,0,4,macropinosome,CC,
11619,GO:0044355,1,0.995702948784143,0,1,clearance of foreign intracellular DNA,BP,
11620,GO:0044356,1,0.995702948784143,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
11621,GO:0044359,1,0.954900311329579,0,8,modulation of molecular function in other organism,BP,
11622,GO:0044362,1,0.964169734649576,0,7,negative regulation of molecular function in other organism,BP,
11624,GO:0044375,1,0.987787031040299,0,3,regulation of peroxisome size,BP,
11625,GO:0044378,1,0.986391713129371,0,2,non-sequence-specific DNA binding, bending,MF,
11626,GO:0044380,1,0.679975842012311,0,49,protein localization to cytoskeleton,BP,
11627,GO:0044381,1,0.855510503002183,0,21,glucose import in response to insulin stimulus,BP,
11628,GO:0044387,1,0.949091075896191,0,8,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,
11629,GO:0044388,1,0.97684390324101,0,5,small protein activating enzyme binding,MF,
11631,GO:0044390,1,0.756632140503106,0,39,ubiquitin-like protein conjugating enzyme binding,MF,
11632,GO:0044391,1,0.467870173851112,0,181,ribosomal subunit,CC,
11633,GO:0044393,1,0.980804072579195,0,3,microspike,CC,
11634,GO:0044396,1,0.965169299494034,0,5,actin cortical patch organization,BP,
11636,GO:0044406,1,0.934852158875312,0,11,adhesion of symbiont to host,BP,
11637,GO:0044407,1,0.994533977466101,0,1,single-species biofilm formation in or on host organism,BP,
11638,GO:0044409,1,0.453498697372532,0,121,entry into host,BP,
11639,GO:0044413,1,0.971722975422162,0,4,avoidance of host defenses,BP,
11640,GO:0044414,1,0.991621251797114,0,1,suppression of host defenses,BP,
11641,GO:0044415,1,0.971722975422162,0,4,evasion or tolerance of host defenses,BP,
11642,GO:0044416,1,0.994746541367731,0,1,induction by symbiont of host defense response,BP,
11643,GO:0044417,1,0.951250092335625,0,9,translocation of molecules into host,BP,
11658,GO:0044438,1,0.588686041230309,0,89,microbody part,CC,
11659,GO:0044439,1,0.588686041230309,0,89,peroxisomal part,CC,
11665,GO:0044447,1,0.758328765636431,0,29,axoneme part,CC,
11670,GO:0044452,1,0.343581570329146,0,170,nucleolar part,CC,
11671,GO:0044453,1,0.912274100417174,0,15,nuclear membrane part,CC,
11673,GO:0044455,1,0.422932728750675,0,171,mitochondrial membrane part,CC,
11675,GO:0044458,1,0.89238667844338,0,20,motile cilium assembly,BP,
11679,GO:0044467,1,0.988346684931961,0,2,glial cell-derived neurotrophic factor secretion,BP,
11680,GO:0044495,1,0.996486604643215,0,1,modulation of blood pressure in other organism,BP,
11681,GO:0044497,1,0.996486604643215,0,1,positive regulation of blood pressure in other organism,BP,
11682,GO:0044501,1,0.985191314104843,0,2,modulation of signal transduction in other organism,BP,
11683,GO:0044508,1,0.993668976946072,0,1,glucagon-like peptide 1 receptor activity,MF,
11684,GO:0044524,1,0.99532436368798,0,1,protein sulfhydration,BP,
11685,GO:0044528,1,0.976423825796556,0,4,regulation of mitochondrial mRNA stability,BP,
11686,GO:0044530,1,0.976859275100956,0,3,supraspliceosomal complex,CC,
11687,GO:0044531,1,0.965582636908406,0,6,modulation of programmed cell death in other organism,BP,
11688,GO:0044532,1,0.965582636908406,0,6,modulation of apoptotic process in other organism,BP,
11689,GO:0044533,1,0.983998142773872,0,3,positive regulation of apoptotic process in other organism,BP,
11690,GO:0044537,1,0.995275580827277,0,1,regulation of circulating fibrinogen levels,BP,
11691,GO:0044539,1,0.95975485392287,0,7,long-chain fatty acid import,BP,
11692,GO:0044540,1,0.99532436368798,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
11693,GO:0044545,1,0.971726561396859,0,5,NSL complex,CC,
11694,GO:0044546,1,0.919297012686739,0,12,NLRP3 inflammasome complex assembly,BP,
11695,GO:0044547,1,0.968370155046494,0,5,DNA topoisomerase binding,MF,
11696,GO:0044548,1,0.914178596377545,0,14,S100 protein binding,MF,
11697,GO:0044549,1,0.996613778448459,0,1,GTP cyclohydrolase binding,MF,
11698,GO:0044550,1,0.858258365657932,0,22,secondary metabolite biosynthetic process,BP,
11699,GO:0044557,1,0.957632994287968,0,7,relaxation of smooth muscle,BP,
11700,GO:0044558,1,0.991822002642289,0,1,uterine smooth muscle relaxation,BP,
11701,GO:0044565,1,0.9895339351314,0,2,dendritic cell proliferation,BP,
11702,GO:0044571,1,0.983067812664243,0,4,[2Fe-2S] cluster assembly,BP,
11703,GO:0044594,1,0.994151381045293,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
11704,GO:0044595,1,0.995925571083506,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
11705,GO:0044596,1,0.995925571083506,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
11706,GO:0044597,1,0.964375809118986,0,8,daunorubicin metabolic process,BP,
11707,GO:0044598,1,0.964375809118986,0,8,doxorubicin metabolic process,BP,
11708,GO:0044599,1,0.994054740756748,0,1,AP-5 adaptor complex,CC,
11709,GO:0044601,1,0.99544508758666,0,1,protein denucleotidylation,BP,
11710,GO:0044602,1,0.99544508758666,0,1,protein deadenylylation,BP,
11711,GO:0044603,1,0.99544508758666,0,1,protein adenylylhydrolase activity,MF,
11712,GO:0044609,1,0.988913411154002,0,2,DBIRD complex,CC,
11713,GO:0044610,1,0.994666537808309,0,1,FMN transmembrane transporter activity,MF,
11714,GO:0044611,1,0.97439046364658,0,3,nuclear pore inner ring,CC,
11715,GO:0044613,1,0.933722975978238,0,11,nuclear pore central transport channel,CC,
11716,GO:0044614,1,0.965411896562017,0,4,nuclear pore cytoplasmic filaments,CC,
11717,GO:0044615,1,0.928484954527281,0,8,nuclear pore nuclear basket,CC,
11718,GO:0044620,1,0.993377801209287,0,2,ACP phosphopantetheine attachment site binding,MF,
11719,GO:0044648,1,0.994054740756748,0,1,histone H3-K4 dimethylation,BP,
11720,GO:0044650,1,0.945518788804351,0,9,adhesion of symbiont to host cell,BP,
11721,GO:0044651,1,0.995903107985397,0,1,adhesion of symbiont to host epithelial cell,BP,
11722,GO:0044657,1,0.993782927964397,0,2,pore formation in membrane of other organism during symbiotic interaction,BP,
11723,GO:0044665,1,0.826420057232937,0,28,MLL1/2 complex,CC,
11724,GO:0044666,1,0.933797272185052,0,10,MLL3/4 complex,CC,
11725,GO:0044691,1,0.971346333107913,0,3,tooth eruption,BP,
11728,GO:0044713,1,0.996611310932968,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
11729,GO:0044714,1,0.996611310932968,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
11730,GO:0044715,1,0.995997881386698,0,1,8-oxo-dGDP phosphatase activity,MF,
11731,GO:0044721,1,0.995091529952727,0,1,protein import into peroxisome matrix, substrate release,BP,
11732,GO:0044722,1,0.992934301076455,0,1,renal phosphate excretion,BP,
11733,GO:0044725,1,0.986236261126443,0,1,chromatin reprogramming in the zygote,BP,
11734,GO:0044727,1,0.986236261126443,0,1,DNA demethylation of male pronucleus,BP,
11735,GO:0044728,1,0.596495922748981,0,74,DNA methylation or demethylation,BP,
11736,GO:0044729,1,0.987507209563897,0,2,hemi-methylated DNA-binding,MF,
11737,GO:0044730,1,0.995459598309555,0,1,bone sialoprotein binding,MF,
11738,GO:0044732,1,0.994054740756748,0,1,mitotic spindle pole body,CC,
11739,GO:0044736,1,0.982268991460807,0,3,acid-sensing ion channel activity,MF,
11740,GO:0044743,1,0.821402093187153,0,37,protein transmembrane import into intracellular organelle,BP,
11741,GO:0044752,1,0.981505582753199,0,3,response to human chorionic gonadotropin,BP,
11742,GO:0044753,1,0.981733562357516,0,2,amphisome,CC,
11743,GO:0044754,1,0.952152970623837,0,8,autolysosome,CC,
11744,GO:0044764,1,0.805518283160535,0,33,multi-organism cellular process,BP,
11745,GO:0044766,1,0.639533166471128,0,69,multi-organism transport,BP,
11746,GO:0044769,1,0.894098719975576,0,20,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,
11748,GO:0044771,1,0.987627692239989,0,2,meiotic cell cycle phase transition,BP,
11750,GO:0044773,1,0.521440520152032,0,100,mitotic DNA damage checkpoint,BP,
11752,GO:0044778,1,0.989192397316138,0,2,meiotic DNA integrity checkpoint,BP,
11753,GO:0044779,1,0.993772597113732,0,1,meiotic spindle checkpoint,BP,
11755,GO:0044783,1,0.634165807447612,0,70,G1 DNA damage checkpoint,BP,
11757,GO:0044785,1,0.993772597113732,0,1,metaphase/anaphase transition of meiotic cell cycle,BP,
11758,GO:0044786,1,0.691447519270992,0,57,cell cycle DNA replication,BP,
11759,GO:0044788,1,0.876785284348123,0,20,modulation by host of viral process,BP,
11760,GO:0044789,1,0.963130388930029,0,5,modulation by host of viral release from host cell,BP,
11761,GO:0044791,1,0.963130388930029,0,5,positive regulation by host of viral release from host cell,BP,
11762,GO:0044793,1,0.960271564262892,0,6,negative regulation by host of viral process,BP,
11763,GO:0044794,1,0.916359644060158,0,13,positive regulation by host of viral process,BP,
11764,GO:0044795,1,0.996062622704571,0,1,trans-Golgi network to recycling endosome transport,BP,
11765,GO:0044796,1,0.995836279034428,0,1,DNA polymerase processivity factor complex,CC,
11766,GO:0044798,1,0.307772227979259,0,176,nuclear transcription factor complex,CC,
11767,GO:0044800,1,0.966467235312939,0,6,multi-organism membrane fusion,BP,
11768,GO:0044803,1,0.958656181084955,0,7,multi-organism membrane organization,BP,
11769,GO:0044804,1,0.881504907400366,0,19,autophagy of nucleus,BP,
11770,GO:0044805,1,0.977327269363036,0,3,late nucleophagy,BP,
11771,GO:0044806,1,0.949238633439005,0,7,G-quadruplex DNA unwinding,BP,
11772,GO:0044815,1,0.765266001305501,0,54,DNA packaging complex,CC,
11773,GO:0044818,1,0.834557514213681,0,26,mitotic G2/M transition checkpoint,BP,
11774,GO:0044819,1,0.638416701240478,0,69,mitotic G1/S transition checkpoint,BP,
11775,GO:0044821,1,0.968506808955337,0,5,meiotic telomere tethering at nuclear periphery,BP,
11776,GO:0044827,1,0.918005812463175,0,12,modulation by host of viral genome replication,BP,
11777,GO:0044828,1,0.970324032004256,0,4,negative regulation by host of viral genome replication,BP,
11778,GO:0044829,1,0.949480395106546,0,7,positive regulation by host of viral genome replication,BP,
11779,GO:0044830,1,0.986406599095858,0,2,modulation by host of viral RNA genome replication,BP,
11780,GO:0044837,1,0.950819491882557,0,7,actomyosin contractile ring organization,BP,
11783,GO:0044848,1,0.940868186910675,0,9,biological phase,BP,
11784,GO:0044849,1,0.920668794800715,0,14,estrous cycle,BP,
11785,GO:0044851,1,0.940868186910675,0,9,hair cycle phase,BP,
11786,GO:0044853,1,0.506471283191614,0,93,plasma membrane raft,CC,
11787,GO:0044854,1,0.978013752733236,0,4,plasma membrane raft assembly,BP,
11788,GO:0044855,1,0.994099935774064,0,1,plasma membrane raft distribution,BP,
11789,GO:0044856,1,0.994099935774064,0,1,plasma membrane raft localization,BP,
11790,GO:0044857,1,0.978013752733236,0,4,plasma membrane raft organization,BP,
11791,GO:0044858,1,0.994099935774064,0,1,plasma membrane raft polarization,BP,
11792,GO:0044860,1,0.974764594842155,0,4,protein localization to plasma membrane raft,BP,
11793,GO:0044861,1,0.986184249154756,0,2,protein transport into plasma membrane raft,BP,
11794,GO:0044866,1,0.995082643175081,0,1,modulation by host of viral exo-alpha-sialidase activity,BP,
11795,GO:0044867,1,0.995082643175081,0,1,modulation by host of viral catalytic activity,BP,
11796,GO:0044868,1,0.985519059885076,0,2,modulation by host of viral molecular function,BP,
11797,GO:0044869,1,0.995082643175081,0,1,negative regulation by host of viral exo-alpha-sialidase activity,BP,
11798,GO:0044870,1,0.995082643175081,0,1,modulation by host of viral glycoprotein metabolic process,BP,
11799,GO:0044871,1,0.995082643175081,0,1,negative regulation by host of viral glycoprotein metabolic process,BP,
11800,GO:0044872,1,0.881074371885712,0,13,lipoprotein localization,BP,
11802,GO:0044878,1,0.980718489630383,0,4,mitotic cytokinesis checkpoint,BP,
11803,GO:0045002,1,0.965000807810756,0,6,double-strand break repair via single-strand annealing,BP,
11804,GO:0045003,1,0.945426273720465,0,10,double-strand break repair via synthesis-dependent strand annealing,BP,
11805,GO:0045004,1,0.982422761119413,0,2,DNA replication proofreading,BP,
11806,GO:0045005,1,0.795708100696516,0,33,DNA-dependent DNA replication maintenance of fidelity,BP,
11807,GO:0045006,1,0.944693481595872,0,12,DNA deamination,BP,
11808,GO:0045007,1,0.986517243284229,0,3,depurination,BP,
11809,GO:0045008,1,0.960382015222624,0,8,depyrimidination,BP,
11810,GO:0045009,1,0.944949979295633,0,11,chitosome,CC,
11811,GO:0045010,1,0.748566928363241,0,45,actin nucleation,BP,
11812,GO:0045016,1,0.993447978492698,0,1,mitochondrial magnesium ion transmembrane transport,BP,
11813,GO:0045017,1,0.190418000058991,0,246,glycerolipid biosynthetic process,BP,
11814,GO:0045019,1,0.926175174387052,0,12,negative regulation of nitric oxide biosynthetic process,BP,
11815,GO:0045022,1,0.771673466099214,0,37,early endosome to late endosome transport,BP,
11816,GO:0045023,1,0.738278093545709,0,42,G0 to G1 transition,BP,
11817,GO:0045025,1,0.986668711109556,0,2,mitochondrial degradosome,CC,
11819,GO:0045027,1,0.994872369653937,0,1,DNA end binding,MF,
11820,GO:0045028,1,0.933950459525046,0,13,G-protein coupled purinergic nucleotide receptor activity,MF,
11821,GO:0045029,1,0.989613975784053,0,2,UDP-activated nucleotide receptor activity,MF,
11822,GO:0045030,1,0.995462752071778,0,1,UTP-activated nucleotide receptor activity,MF,
11823,GO:0045031,1,0.988766113410056,0,2,ATP-activated adenosine receptor activity,MF,
11824,GO:0045032,1,0.993698197930378,0,1,ADP-activated adenosine receptor activity,MF,
11825,GO:0045039,1,0.974270350660818,0,6,protein import into mitochondrial inner membrane,BP,
11826,GO:0045040,1,0.971392802287125,0,6,protein import into mitochondrial outer membrane,BP,
11827,GO:0045041,1,0.990238537515025,0,2,protein import into mitochondrial intermembrane space,BP,
11828,GO:0045046,1,0.962824068655468,0,6,protein import into peroxisome membrane,BP,
11829,GO:0045047,1,0.667822827960917,0,100,protein targeting to ER,BP,
11830,GO:0045048,1,0.969342004341589,0,5,protein insertion into ER membrane,BP,
11831,GO:0045053,1,0.935656452692775,0,5,protein retention in Golgi apparatus,BP,
11832,GO:0045054,1,0.978255007046887,0,4,constitutive secretory pathway,BP,
11834,GO:0045056,1,0.898374631944326,0,15,transcytosis,BP,
11835,GO:0045058,1,0.759084601024923,0,42,T cell selection,BP,
11836,GO:0045059,1,0.947156068980664,0,9,positive thymic T cell selection,BP,
11837,GO:0045060,1,0.939367336833782,0,10,negative thymic T cell selection,BP,
11838,GO:0045061,1,0.890391770049097,0,18,thymic T cell selection,BP,
11839,GO:0045062,1,0.995369287020841,0,1,extrathymic T cell selection,BP,
11840,GO:0045063,1,0.899168321186345,0,17,T-helper 1 cell differentiation,BP,
11841,GO:0045064,1,0.923011724513844,0,14,T-helper 2 cell differentiation,BP,
11842,GO:0045065,1,0.982674681071271,0,3,cytotoxic T cell differentiation,BP,
11843,GO:0045066,1,0.849859332252858,0,26,regulatory T cell differentiation,BP,
11846,GO:0045071,1,0.745475032367158,0,49,negative regulation of viral genome replication,BP,
11847,GO:0045072,1,0.922123019981456,0,14,regulation of interferon-gamma biosynthetic process,BP,
11848,GO:0045073,1,0.944767363932514,0,11,regulation of chemokine biosynthetic process,BP,
11849,GO:0045074,1,0.979997090670185,0,3,regulation of interleukin-10 biosynthetic process,BP,
11850,GO:0045075,1,0.954167021152477,0,7,regulation of interleukin-12 biosynthetic process,BP,
11851,GO:0045076,1,0.904527000587887,0,17,regulation of interleukin-2 biosynthetic process,BP,
11852,GO:0045077,1,0.979213043839264,0,4,negative regulation of interferon-gamma biosynthetic process,BP,
11853,GO:0045078,1,0.941710072266184,0,10,positive regulation of interferon-gamma biosynthetic process,BP,
11854,GO:0045079,1,0.987844403961209,0,3,negative regulation of chemokine biosynthetic process,BP,
11855,GO:0045080,1,0.956398170264615,0,8,positive regulation of chemokine biosynthetic process,BP,
11856,GO:0045081,1,0.993181632227088,0,1,negative regulation of interleukin-10 biosynthetic process,BP,
11857,GO:0045082,1,0.986725855254001,0,2,positive regulation of interleukin-10 biosynthetic process,BP,
11858,GO:0045083,1,0.992717770480587,0,1,negative regulation of interleukin-12 biosynthetic process,BP,
11859,GO:0045084,1,0.969831243006032,0,5,positive regulation of interleukin-12 biosynthetic process,BP,
11860,GO:0045085,1,0.980955001313614,0,4,negative regulation of interleukin-2 biosynthetic process,BP,
11861,GO:0045086,1,0.926712034763413,0,12,positive regulation of interleukin-2 biosynthetic process,BP,
11863,GO:0045088,1,0.0958864492379063,0,364,regulation of innate immune response,BP,
11864,GO:0045089,1,0.137057138639916,0,309,positive regulation of innate immune response,BP,
11866,GO:0045092,1,0.993195661163544,0,1,interleukin-18 receptor complex,CC,
11867,GO:0045095,1,0.885587107252957,0,22,keratin filament,CC,
11868,GO:0045098,1,0.985190223219131,0,3,type III intermediate filament,CC,
11871,GO:0045105,1,0.991278538166818,0,1,intermediate filament polymerization or depolymerization,BP,
11872,GO:0045106,1,0.991278538166818,0,1,intermediate filament depolymerization,BP,
11873,GO:0045108,1,0.991278538166818,0,1,regulation of intermediate filament polymerization or depolymerization,BP,
11877,GO:0045112,1,0.966307514085688,0,5,integrin biosynthetic process,BP,
11878,GO:0045113,1,0.977599644700573,0,4,regulation of integrin biosynthetic process,BP,
11879,GO:0045116,1,0.924958331095112,0,14,protein neddylation,BP,
11880,GO:0045117,1,0.897431244569566,0,19,azole transport,BP,
11884,GO:0045124,1,0.806614779300606,0,31,regulation of bone resorption,BP,
11885,GO:0045125,1,0.922277972976782,0,15,bioactive lipid receptor activity,MF,
11886,GO:0045127,1,0.995535846009622,0,1,N-acetylglucosamine kinase activity,MF,
11887,GO:0045128,1,0.993642001084221,0,1,negative regulation of reciprocal meiotic recombination,BP,
11888,GO:0045130,1,0.994121256575164,0,1,keratan sulfotransferase activity,MF,
11889,GO:0045131,1,0.993824508218585,0,1,pre-mRNA branch point binding,MF,
11891,GO:0045134,1,0.976431768670878,0,4,uridine-diphosphatase activity,MF,
11892,GO:0045136,1,0.942564285972033,0,9,development of secondary sexual characteristics,BP,
11894,GO:0045141,1,0.931682585940938,0,10,meiotic telomere clustering,BP,
11895,GO:0045142,1,0.985128871793571,0,2,triplex DNA binding,MF,
11896,GO:0045143,1,0.743355733221353,0,46,homologous chromosome segregation,BP,
11897,GO:0045144,1,0.96169047370704,0,7,meiotic sister chromatid segregation,BP,
11898,GO:0045145,1,0.987688089295107,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
11899,GO:0045153,1,0.995994143794949,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
11900,GO:0045155,1,0.987357975251308,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
11901,GO:0045159,1,0.968391318245007,0,6,myosin II binding,MF,
11902,GO:0045161,1,0.904078551657026,0,12,neuronal ion channel clustering,BP,
11903,GO:0045162,1,0.940338122950452,0,7,clustering of voltage-gated sodium channels,BP,
11904,GO:0045163,1,0.971157824027331,0,3,clustering of voltage-gated potassium channels,BP,
11906,GO:0045167,1,0.995364228047533,0,1,asymmetric protein localization involved in cell fate determination,BP,
11907,GO:0045168,1,0.989201739777762,0,2,cell-cell signaling involved in cell fate commitment,BP,
11909,GO:0045174,1,0.992180086409795,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
11910,GO:0045176,1,0.909172966720333,0,11,apical protein localization,BP,
11912,GO:0045178,1,0.680630228631426,0,49,basal part of cell,CC,
11913,GO:0045179,1,0.957875802027276,0,7,apical cortex,CC,
11914,GO:0045180,1,0.953397138263206,0,5,basal cortex,CC,
11918,GO:0045185,1,0.479649241937629,0,102,maintenance of protein location,BP,
11919,GO:0045186,1,0.989380492027495,0,1,zonula adherens assembly,BP,
11920,GO:0045187,1,0.915799260976678,0,17,regulation of circadian sleep/wake cycle, sleep,BP,
11921,GO:0045188,1,0.961741073315037,0,7,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
11922,GO:0045190,1,0.775852756550749,0,39,isotype switching,BP,
11923,GO:0045191,1,0.837829839408697,0,27,regulation of isotype switching,BP,
11924,GO:0045196,1,0.977665683242894,0,3,establishment or maintenance of neuroblast polarity,BP,
11925,GO:0045197,1,0.747702109034524,0,42,establishment or maintenance of epithelial cell apical/basal polarity,BP,
11926,GO:0045198,1,0.915135198796125,0,13,establishment of epithelial cell apical/basal polarity,BP,
11927,GO:0045199,1,0.925485817397224,0,12,maintenance of epithelial cell apical/basal polarity,BP,
11928,GO:0045200,1,0.977665683242894,0,3,establishment of neuroblast polarity,BP,
11930,GO:0045204,1,0.977465482875264,0,3,MAPK export from nucleus,BP,
11931,GO:0045208,1,0.993230566797501,0,1,MAPK phosphatase export from nucleus,BP,
11932,GO:0045209,1,0.993230566797501,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
11933,GO:0045210,1,0.982386226567846,0,2,FasL biosynthetic process,BP,
11935,GO:0045212,1,0.994282556467299,0,1,neurotransmitter receptor biosynthetic process,BP,
11936,GO:0045213,1,0.984389257202951,0,3,neurotransmitter receptor metabolic process,BP,
11937,GO:0045214,1,0.712386760906456,0,43,sarcomere organization,BP,
11938,GO:0045216,1,0.186862266700786,0,225,cell-cell junction organization,BP,
11939,GO:0045217,1,0.939818214667449,0,10,cell-cell junction maintenance,BP,
11940,GO:0045218,1,0.979620624210733,0,3,zonula adherens maintenance,BP,
11941,GO:0045219,1,0.991382381639568,0,1,regulation of FasL biosynthetic process,BP,
11942,GO:0045221,1,0.991382381639568,0,1,negative regulation of FasL biosynthetic process,BP,
11943,GO:0045222,1,0.996060134155019,0,1,CD4 biosynthetic process,BP,
11944,GO:0045223,1,0.996060134155019,0,1,regulation of CD4 biosynthetic process,BP,
11945,GO:0045225,1,0.996060134155019,0,1,negative regulation of CD4 biosynthetic process,BP,
11946,GO:0045226,1,0.98266761979416,0,3,extracellular polysaccharide biosynthetic process,BP,
11947,GO:0045229,1,0.988237334474678,0,2,external encapsulating structure organization,BP,
11948,GO:0045234,1,0.995271777065748,0,1,protein palmitoleylation,BP,
11949,GO:0045236,1,0.926133826982708,0,16,CXCR chemokine receptor binding,MF,
11950,GO:0045239,1,0.91779545146983,0,13,tricarboxylic acid cycle enzyme complex,CC,
11951,GO:0045240,1,0.927220019043344,0,11,dihydrolipoyl dehydrogenase complex,CC,
11952,GO:0045244,1,0.994553691795555,0,1,succinate-CoA ligase complex (GDP-forming),CC,
11953,GO:0045251,1,0.994556158930941,0,1,electron transfer flavoprotein complex,CC,
11954,GO:0045252,1,0.954923782288717,0,7,oxoglutarate dehydrogenase complex,CC,
11955,GO:0045254,1,0.956568058495297,0,7,pyruvate dehydrogenase complex,CC,
11956,GO:0045257,1,0.980640989710721,0,4,succinate dehydrogenase complex (ubiquinone),CC,
11957,GO:0045259,1,0.990540401369592,0,2,proton-transporting ATP synthase complex,CC,
11958,GO:0045263,1,0.99576559574993,0,1,proton-transporting ATP synthase complex, coupling factor F(o),CC,
11959,GO:0045271,1,0.844036321761002,0,43,respiratory chain complex I,CC,
11960,GO:0045272,1,0.986284387398298,0,3,plasma membrane respiratory chain complex I,CC,
11961,GO:0045273,1,0.980640989710721,0,4,respiratory chain complex II,CC,
11962,GO:0045274,1,0.994503257274021,0,1,plasma membrane respiratory chain complex II,CC,
11963,GO:0045275,1,0.947731508902772,0,11,respiratory chain complex III,CC,
11964,GO:0045277,1,0.952556180606834,0,14,respiratory chain complex IV,CC,
11965,GO:0045281,1,0.980640989710721,0,4,succinate dehydrogenase complex,CC,
11966,GO:0045282,1,0.994503257274021,0,1,plasma membrane succinate dehydrogenase complex,CC,
11967,GO:0045283,1,0.980640989710721,0,4,fumarate reductase complex,CC,
11968,GO:0045292,1,0.903214862129186,0,17,mRNA cis splicing, via spliceosome,BP,
11969,GO:0045293,1,0.985329976026844,0,3,mRNA editing complex,CC,
11970,GO:0045294,1,0.919505423831339,0,11,alpha-catenin binding,MF,
11971,GO:0045295,1,0.899879786507593,0,11,gamma-catenin binding,MF,
11973,GO:0045297,1,0.994670900476519,0,1,post-mating behavior,BP,
11974,GO:0045298,1,0.964086320928409,0,5,tubulin complex,CC,
11977,GO:0045322,1,0.980960806521705,0,3,unmethylated CpG binding,MF,
11978,GO:0045323,1,0.981927130391564,0,3,interleukin-1 receptor complex,CC,
11979,GO:0045324,1,0.939173209774374,0,11,late endosome to vacuole transport,BP,
11980,GO:0045329,1,0.972446182585435,0,5,carnitine biosynthetic process,BP,
11981,GO:0045332,1,0.810290364439506,0,23,phospholipid translocation,BP,
11982,GO:0045333,1,0.428480295812986,0,162,cellular respiration,BP,
11983,GO:0045334,1,0.691796729882317,0,58,clathrin-coated endocytic vesicle,CC,
11984,GO:0045335,1,0.472520324772676,0,119,phagocytic vesicle,CC,
11985,GO:0045337,1,0.977652473057643,0,4,farnesyl diphosphate biosynthetic process,BP,
11986,GO:0045338,1,0.972629650111414,0,5,farnesyl diphosphate metabolic process,BP,
11987,GO:0045340,1,0.996339404102419,0,1,mercury ion binding,MF,
11988,GO:0045341,1,0.963258595491616,0,5,MHC class I biosynthetic process,BP,
11989,GO:0045342,1,0.934435427376482,0,11,MHC class II biosynthetic process,BP,
11990,GO:0045343,1,0.963258595491616,0,5,regulation of MHC class I biosynthetic process,BP,
11991,GO:0045345,1,0.963258595491616,0,5,positive regulation of MHC class I biosynthetic process,BP,
11992,GO:0045346,1,0.941075324461448,0,10,regulation of MHC class II biosynthetic process,BP,
11993,GO:0045347,1,0.971870748480112,0,5,negative regulation of MHC class II biosynthetic process,BP,
11994,GO:0045348,1,0.963934626156247,0,6,positive regulation of MHC class II biosynthetic process,BP,
11995,GO:0045349,1,0.962866610705746,0,6,interferon-alpha biosynthetic process,BP,
11996,GO:0045350,1,0.942922072769334,0,9,interferon-beta biosynthetic process,BP,
11997,GO:0045351,1,0.933979723206015,0,11,type I interferon biosynthetic process,BP,
11998,GO:0045352,1,0.995276848675697,0,1,interleukin-1 Type I receptor antagonist activity,MF,
11999,GO:0045353,1,0.995276848675697,0,1,interleukin-1 Type II receptor antagonist activity,MF,
12000,GO:0045354,1,0.962866610705746,0,6,regulation of interferon-alpha biosynthetic process,BP,
12001,GO:0045355,1,0.991145076815012,0,2,negative regulation of interferon-alpha biosynthetic process,BP,
12002,GO:0045356,1,0.971471422351437,0,4,positive regulation of interferon-alpha biosynthetic process,BP,
12003,GO:0045357,1,0.942922072769334,0,9,regulation of interferon-beta biosynthetic process,BP,
12004,GO:0045358,1,0.991161398341729,0,2,negative regulation of interferon-beta biosynthetic process,BP,
12005,GO:0045359,1,0.951334766109372,0,7,positive regulation of interferon-beta biosynthetic process,BP,
12006,GO:0045360,1,0.986544040555011,0,3,regulation of interleukin-1 biosynthetic process,BP,
12007,GO:0045362,1,0.986544040555011,0,3,positive regulation of interleukin-1 biosynthetic process,BP,
12008,GO:0045366,1,0.991516296381473,0,1,regulation of interleukin-13 biosynthetic process,BP,
12009,GO:0045368,1,0.991516296381473,0,1,positive regulation of interleukin-13 biosynthetic process,BP,
12010,GO:0045381,1,0.993556840448378,0,1,regulation of interleukin-18 biosynthetic process,BP,
12011,GO:0045399,1,0.991798552389647,0,1,regulation of interleukin-3 biosynthetic process,BP,
12012,GO:0045401,1,0.991798552389647,0,1,positive regulation of interleukin-3 biosynthetic process,BP,
12013,GO:0045402,1,0.97933075772281,0,3,regulation of interleukin-4 biosynthetic process,BP,
12014,GO:0045403,1,0.993550737487651,0,1,negative regulation of interleukin-4 biosynthetic process,BP,
12015,GO:0045404,1,0.985688644893664,0,2,positive regulation of interleukin-4 biosynthetic process,BP,
12016,GO:0045408,1,0.924397670701627,0,13,regulation of interleukin-6 biosynthetic process,BP,
12017,GO:0045409,1,0.976565933528725,0,4,negative regulation of interleukin-6 biosynthetic process,BP,
12018,GO:0045410,1,0.955901615643034,0,7,positive regulation of interleukin-6 biosynthetic process,BP,
12019,GO:0045414,1,0.946026440986997,0,9,regulation of interleukin-8 biosynthetic process,BP,
12020,GO:0045415,1,0.980093270076906,0,4,negative regulation of interleukin-8 biosynthetic process,BP,
12021,GO:0045416,1,0.961726682688702,0,6,positive regulation of interleukin-8 biosynthetic process,BP,
12022,GO:0045423,1,0.985921936231603,0,2,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12023,GO:0045425,1,0.985921936231603,0,2,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12024,GO:0045428,1,0.736708279780161,0,47,regulation of nitric oxide biosynthetic process,BP,
12025,GO:0045429,1,0.795571963421608,0,35,positive regulation of nitric oxide biosynthetic process,BP,
12029,GO:0045448,1,0.976448608068322,0,4,mitotic cell cycle, embryonic,BP,
12030,GO:0045453,1,0.723476626591938,0,49,bone resorption,BP,
12031,GO:0045454,1,0.70533105040002,0,63,cell redox homeostasis,BP,
12033,GO:0045472,1,0.932386780838438,0,10,response to ether,BP,
12034,GO:0045475,1,0.924322754059136,0,10,locomotor rhythm,BP,
12035,GO:0045485,1,0.992406652303097,0,1,omega-6 fatty acid desaturase activity,MF,
12036,GO:0045494,1,0.798327733513292,0,31,photoreceptor cell maintenance,BP,
12037,GO:0045495,1,0.913591000612689,0,14,pole plasm,CC,
12038,GO:0045499,1,0.853105384388878,0,21,chemorepellent activity,MF,
12039,GO:0045503,1,0.757654822533359,0,24,dynein light chain binding,MF,
12040,GO:0045504,1,0.915185000973337,0,14,dynein heavy chain binding,MF,
12041,GO:0045505,1,0.734029220890464,0,28,dynein intermediate chain binding,MF,
12042,GO:0045509,1,0.987170186001272,0,2,interleukin-27 receptor activity,MF,
12043,GO:0045513,1,0.995710471266797,0,1,interleukin-27 binding,MF,
12044,GO:0045519,1,0.99620676332082,0,1,interleukin-23 receptor binding,MF,
12045,GO:0045523,1,0.992312680828164,0,2,interleukin-27 receptor binding,MF,
12046,GO:0045540,1,0.751935539734842,0,41,regulation of cholesterol biosynthetic process,BP,
12047,GO:0045541,1,0.973943937903908,0,5,negative regulation of cholesterol biosynthetic process,BP,
12048,GO:0045542,1,0.965251285637944,0,5,positive regulation of cholesterol biosynthetic process,BP,
12049,GO:0045545,1,0.953111798672616,0,6,syndecan binding,MF,
12050,GO:0045550,1,0.991500229136624,0,2,geranylgeranyl reductase activity,MF,
12051,GO:0045553,1,0.993777920479341,0,1,TRAIL biosynthetic process,BP,
12052,GO:0045554,1,0.993777920479341,0,1,regulation of TRAIL biosynthetic process,BP,
12053,GO:0045556,1,0.993777920479341,0,1,positive regulation of TRAIL biosynthetic process,BP,
12054,GO:0045569,1,0.977289731535309,0,4,TRAIL binding,MF,
12055,GO:0045575,1,0.987530947336964,0,2,basophil activation,BP,
12057,GO:0045577,1,0.837323863264815,0,27,regulation of B cell differentiation,BP,
12058,GO:0045578,1,0.972238628607809,0,5,negative regulation of B cell differentiation,BP,
12059,GO:0045579,1,0.919461126674289,0,13,positive regulation of B cell differentiation,BP,
12060,GO:0045580,1,0.489659581418639,0,112,regulation of T cell differentiation,BP,
12061,GO:0045581,1,0.831622120599034,0,28,negative regulation of T cell differentiation,BP,
12062,GO:0045582,1,0.674590936694134,0,64,positive regulation of T cell differentiation,BP,
12063,GO:0045583,1,0.988643280528633,0,2,regulation of cytotoxic T cell differentiation,BP,
12064,GO:0045585,1,0.988643280528633,0,2,positive regulation of cytotoxic T cell differentiation,BP,
12065,GO:0045586,1,0.969508144878612,0,4,regulation of gamma-delta T cell differentiation,BP,
12066,GO:0045588,1,0.976601411934374,0,3,positive regulation of gamma-delta T cell differentiation,BP,
12067,GO:0045589,1,0.859542071886349,0,24,regulation of regulatory T cell differentiation,BP,
12068,GO:0045590,1,0.981756815807326,0,3,negative regulation of regulatory T cell differentiation,BP,
12069,GO:0045591,1,0.947796807847118,0,10,positive regulation of regulatory T cell differentiation,BP,
12074,GO:0045599,1,0.744060129084491,0,43,negative regulation of fat cell differentiation,BP,
12076,GO:0045601,1,0.805920033993423,0,30,regulation of endothelial cell differentiation,BP,
12077,GO:0045602,1,0.937327228673729,0,8,negative regulation of endothelial cell differentiation,BP,
12078,GO:0045603,1,0.902290555372101,0,15,positive regulation of endothelial cell differentiation,BP,
12079,GO:0045604,1,0.727002644718887,0,48,regulation of epidermal cell differentiation,BP,
12080,GO:0045605,1,0.944433816251324,0,9,negative regulation of epidermal cell differentiation,BP,
12081,GO:0045606,1,0.869774425426351,0,20,positive regulation of epidermal cell differentiation,BP,
12082,GO:0045607,1,0.956056622931929,0,7,regulation of inner ear auditory receptor cell differentiation,BP,
12083,GO:0045608,1,0.977031815264756,0,3,negative regulation of inner ear auditory receptor cell differentiation,BP,
12084,GO:0045616,1,0.803036651276057,0,31,regulation of keratinocyte differentiation,BP,
12085,GO:0045617,1,0.976188367849381,0,4,negative regulation of keratinocyte differentiation,BP,
12086,GO:0045618,1,0.902910636046256,0,14,positive regulation of keratinocyte differentiation,BP,
12087,GO:0045619,1,0.419740336610341,0,137,regulation of lymphocyte differentiation,BP,
12088,GO:0045620,1,0.801515999206961,0,35,negative regulation of lymphocyte differentiation,BP,
12089,GO:0045621,1,0.629111055700072,0,75,positive regulation of lymphocyte differentiation,BP,
12090,GO:0045622,1,0.851023823700692,0,26,regulation of T-helper cell differentiation,BP,
12091,GO:0045623,1,0.914401420728632,0,13,negative regulation of T-helper cell differentiation,BP,
12092,GO:0045624,1,0.91488690373942,0,16,positive regulation of T-helper cell differentiation,BP,
12093,GO:0045625,1,0.944576864920247,0,10,regulation of T-helper 1 cell differentiation,BP,
12094,GO:0045626,1,0.979342042849021,0,3,negative regulation of T-helper 1 cell differentiation,BP,
12095,GO:0045627,1,0.968186216179443,0,6,positive regulation of T-helper 1 cell differentiation,BP,
12096,GO:0045628,1,0.936776978619431,0,11,regulation of T-helper 2 cell differentiation,BP,
12097,GO:0045629,1,0.976242548257785,0,4,negative regulation of T-helper 2 cell differentiation,BP,
12098,GO:0045630,1,0.959583634489492,0,7,positive regulation of T-helper 2 cell differentiation,BP,
12099,GO:0045631,1,0.956056622931929,0,7,regulation of mechanoreceptor differentiation,BP,
12100,GO:0045632,1,0.973004899424357,0,4,negative regulation of mechanoreceptor differentiation,BP,
12101,GO:0045634,1,0.944469324962407,0,7,regulation of melanocyte differentiation,BP,
12102,GO:0045636,1,0.953699055176501,0,5,positive regulation of melanocyte differentiation,BP,
12105,GO:0045639,1,0.616027423188891,0,74,positive regulation of myeloid cell differentiation,BP,
12106,GO:0045643,1,0.99317244958927,0,1,regulation of eosinophil differentiation,BP,
12107,GO:0045645,1,0.99317244958927,0,1,positive regulation of eosinophil differentiation,BP,
12108,GO:0045646,1,0.754052699203451,0,42,regulation of erythrocyte differentiation,BP,
12109,GO:0045647,1,0.949991330387123,0,8,negative regulation of erythrocyte differentiation,BP,
12110,GO:0045648,1,0.831323775086969,0,27,positive regulation of erythrocyte differentiation,BP,
12111,GO:0045649,1,0.89225465482487,0,19,regulation of macrophage differentiation,BP,
12112,GO:0045650,1,0.968220606668304,0,6,negative regulation of macrophage differentiation,BP,
12113,GO:0045651,1,0.921565243755866,0,13,positive regulation of macrophage differentiation,BP,
12114,GO:0045652,1,0.710929090134949,0,54,regulation of megakaryocyte differentiation,BP,
12115,GO:0045653,1,0.969069225907692,0,8,negative regulation of megakaryocyte differentiation,BP,
12116,GO:0045654,1,0.969161253273636,0,6,positive regulation of megakaryocyte differentiation,BP,
12117,GO:0045655,1,0.899294897596841,0,16,regulation of monocyte differentiation,BP,
12118,GO:0045656,1,0.95448587068564,0,6,negative regulation of monocyte differentiation,BP,
12119,GO:0045657,1,0.953366659133805,0,8,positive regulation of monocyte differentiation,BP,
12120,GO:0045658,1,0.980290975159836,0,3,regulation of neutrophil differentiation,BP,
12121,GO:0045659,1,0.985207587436826,0,2,negative regulation of neutrophil differentiation,BP,
12122,GO:0045660,1,0.995010316827474,0,1,positive regulation of neutrophil differentiation,BP,
12125,GO:0045663,1,0.886043950174291,0,17,positive regulation of myoblast differentiation,BP,
12130,GO:0045668,1,0.767933826069345,0,38,negative regulation of osteoblast differentiation,BP,
12134,GO:0045672,1,0.894775300855361,0,17,positive regulation of osteoclast differentiation,BP,
12135,GO:0045682,1,0.639326430038788,0,68,regulation of epidermis development,BP,
12136,GO:0045683,1,0.923118250781723,0,12,negative regulation of epidermis development,BP,
12137,GO:0045684,1,0.814344663710353,0,32,positive regulation of epidermis development,BP,
12140,GO:0045687,1,0.79318309310659,0,37,positive regulation of glial cell differentiation,BP,
12141,GO:0045703,1,0.995975451635579,0,1,ketoreductase activity,MF,
12142,GO:0045713,1,0.94049588144973,0,9,low-density lipoprotein particle receptor biosynthetic process,BP,
12143,GO:0045714,1,0.945052641608282,0,8,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12144,GO:0045715,1,0.981923931275006,0,2,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12145,GO:0045716,1,0.978965284358662,0,4,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12146,GO:0045717,1,0.922215565928343,0,13,negative regulation of fatty acid biosynthetic process,BP,
12147,GO:0045719,1,0.960438427242378,0,5,negative regulation of glycogen biosynthetic process,BP,
12148,GO:0045720,1,0.989029113692279,0,2,negative regulation of integrin biosynthetic process,BP,
12149,GO:0045721,1,0.945418596110293,0,9,negative regulation of gluconeogenesis,BP,
12150,GO:0045722,1,0.931656614611542,0,9,positive regulation of gluconeogenesis,BP,
12151,GO:0045723,1,0.926749701339411,0,13,positive regulation of fatty acid biosynthetic process,BP,
12152,GO:0045724,1,0.87585678523467,0,18,positive regulation of cilium assembly,BP,
12153,GO:0045725,1,0.892205448331159,0,13,positive regulation of glycogen biosynthetic process,BP,
12154,GO:0045726,1,0.985448314114659,0,2,positive regulation of integrin biosynthetic process,BP,
12155,GO:0045727,1,0.494812391035975,0,112,positive regulation of translation,BP,
12156,GO:0045728,1,0.994799281509358,0,1,respiratory burst after phagocytosis,BP,
12157,GO:0045730,1,0.874541522575223,0,23,respiratory burst,BP,
12158,GO:0045732,1,0.260585624534511,0,198,positive regulation of protein catabolic process,BP,
12159,GO:0045736,1,0.81437800776316,0,30,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
12160,GO:0045737,1,0.823156547803961,0,32,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
12161,GO:0045738,1,0.853065887003092,0,22,negative regulation of DNA repair,BP,
12163,GO:0045740,1,0.714216679202843,0,51,positive regulation of DNA replication,BP,
12166,GO:0045743,1,0.965386117705072,0,5,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
12170,GO:0045747,1,0.727449660453919,0,44,positive regulation of Notch signaling pathway,BP,
12171,GO:0045751,1,0.993556840448378,0,1,negative regulation of Toll signaling pathway,BP,
12173,GO:0045760,1,0.927125292804874,0,10,positive regulation of action potential,BP,
12176,GO:0045763,1,0.980031143658286,0,2,negative regulation of cellular amino acid metabolic process,BP,
12177,GO:0045764,1,0.985877668015055,0,3,positive regulation of cellular amino acid metabolic process,BP,
12181,GO:0045773,1,0.739699244067111,0,37,positive regulation of axon extension,BP,
12185,GO:0045779,1,0.946269457931057,0,9,negative regulation of bone resorption,BP,
12186,GO:0045780,1,0.910097639266164,0,13,positive regulation of bone resorption,BP,
12189,GO:0045787,1,0.102751405159195,0,337,positive regulation of cell cycle,BP,
12190,GO:0045792,1,0.936761800590447,0,9,negative regulation of cell size,BP,
12191,GO:0045793,1,0.933884765780636,0,10,positive regulation of cell size,BP,
12192,GO:0045794,1,0.95943258258943,0,5,negative regulation of cell volume,BP,
12193,GO:0045795,1,0.989976318394343,0,1,positive regulation of cell volume,BP,
12194,GO:0045796,1,0.99417351035814,0,1,negative regulation of intestinal cholesterol absorption,BP,
12195,GO:0045799,1,0.974802823154821,0,3,positive regulation of chromatin assembly or disassembly,BP,
12198,GO:0045813,1,0.995250216689571,0,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,
12199,GO:0045814,1,0.557121129109799,0,90,negative regulation of gene expression, epigenetic,BP,
12200,GO:0045815,1,0.697176783402255,0,57,positive regulation of gene expression, epigenetic,BP,
12201,GO:0045819,1,0.992878756958936,0,1,positive regulation of glycogen catabolic process,BP,
12202,GO:0045820,1,0.929418189200658,0,10,negative regulation of glycolytic process,BP,
12203,GO:0045821,1,0.884488315685734,0,16,positive regulation of glycolytic process,BP,
12204,GO:0045822,1,0.878424766968355,0,19,negative regulation of heart contraction,BP,
12206,GO:0045824,1,0.776941916497861,0,39,negative regulation of innate immune response,BP,
12207,GO:0045827,1,0.995975451635579,0,1,negative regulation of isoprenoid metabolic process,BP,
12208,GO:0045829,1,0.976089619742083,0,4,negative regulation of isotype switching,BP,
12209,GO:0045830,1,0.882099328864437,0,19,positive regulation of isotype switching,BP,
12212,GO:0045835,1,0.945660248875012,0,9,negative regulation of meiotic nuclear division,BP,
12213,GO:0045836,1,0.9321692007853,0,11,positive regulation of meiotic nuclear division,BP,
12214,GO:0045837,1,0.952255142112634,0,9,negative regulation of membrane potential,BP,
12215,GO:0045838,1,0.932557593237956,0,11,positive regulation of membrane potential,BP,
12217,GO:0045840,1,0.726479516537635,0,45,positive regulation of mitotic nuclear division,BP,
12219,GO:0045842,1,0.94817939217413,0,8,positive regulation of mitotic metaphase/anaphase transition,BP,
12220,GO:0045843,1,0.757967685317415,0,42,negative regulation of striated muscle tissue development,BP,
12221,GO:0045844,1,0.646380798798326,0,60,positive regulation of striated muscle tissue development,BP,
12222,GO:0045848,1,0.994811863082861,0,1,positive regulation of nitrogen utilization,BP,
12223,GO:0045851,1,0.756027805089361,0,48,pH reduction,BP,
12224,GO:0045852,1,0.973229006489915,0,4,pH elevation,BP,
12229,GO:0045869,1,0.9524745604378,0,9,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12231,GO:0045872,1,0.995036953799931,0,1,positive regulation of rhodopsin gene expression,BP,
12232,GO:0045875,1,0.96067863408463,0,4,negative regulation of sister chromatid cohesion,BP,
12233,GO:0045876,1,0.94458154478358,0,8,positive regulation of sister chromatid cohesion,BP,
12234,GO:0045879,1,0.809447259337369,0,29,negative regulation of smoothened signaling pathway,BP,
12235,GO:0045880,1,0.808918255605396,0,30,positive regulation of smoothened signaling pathway,BP,
12236,GO:0045887,1,0.989526826501901,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
12239,GO:0045898,1,0.91489871140149,0,14,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
12240,GO:0045899,1,0.933452260107914,0,11,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
12241,GO:0045900,1,0.973389117437315,0,4,negative regulation of translational elongation,BP,
12242,GO:0045901,1,0.974213867724512,0,4,positive regulation of translational elongation,BP,
12243,GO:0045903,1,0.987596929894179,0,3,positive regulation of translational fidelity,BP,
12244,GO:0045905,1,0.980269786215912,0,3,positive regulation of translational termination,BP,
12245,GO:0045906,1,0.941331006573271,0,7,negative regulation of vasoconstriction,BP,
12246,GO:0045907,1,0.84830775901412,0,27,positive regulation of vasoconstriction,BP,
12247,GO:0045910,1,0.848513154632046,0,23,negative regulation of DNA recombination,BP,
12248,GO:0045911,1,0.857175592861006,0,23,positive regulation of DNA recombination,BP,
12249,GO:0045912,1,0.801454321964991,0,32,negative regulation of carbohydrate metabolic process,BP,
12250,GO:0045913,1,0.647125865715265,0,59,positive regulation of carbohydrate metabolic process,BP,
12251,GO:0045914,1,0.980480833963514,0,3,negative regulation of catecholamine metabolic process,BP,
12252,GO:0045915,1,0.96607972411923,0,6,positive regulation of catecholamine metabolic process,BP,
12253,GO:0045916,1,0.953744686684382,0,6,negative regulation of complement activation,BP,
12254,GO:0045917,1,0.980197985293318,0,3,positive regulation of complement activation,BP,
12255,GO:0045918,1,0.985814407925349,0,3,negative regulation of cytolysis,BP,
12256,GO:0045919,1,0.965626665890303,0,7,positive regulation of cytolysis,BP,
12260,GO:0045923,1,0.822175315644627,0,28,positive regulation of fatty acid metabolic process,BP,
12261,GO:0045924,1,0.966941310133438,0,5,regulation of female receptivity,BP,
12262,GO:0045925,1,0.994474477197674,0,1,positive regulation of female receptivity,BP,
12266,GO:0045931,1,0.402630420379529,0,130,positive regulation of mitotic cell cycle,BP,
12267,GO:0045932,1,0.87958817876469,0,19,negative regulation of muscle contraction,BP,
12273,GO:0045938,1,0.973170426133159,0,6,positive regulation of circadian sleep/wake cycle, sleep,BP,
12274,GO:0045939,1,0.881250623099951,0,22,negative regulation of steroid metabolic process,BP,
12275,GO:0045940,1,0.893615007715528,0,19,positive regulation of steroid metabolic process,BP,
12276,GO:0045943,1,0.859774959838273,0,21,positive regulation of transcription by RNA polymerase I,BP,
12278,GO:0045945,1,0.920110870531997,0,11,positive regulation of transcription by RNA polymerase III,BP,
12279,GO:0045947,1,0.881606248924122,0,19,negative regulation of translational initiation,BP,
12280,GO:0045948,1,0.841082082537722,0,26,positive regulation of translational initiation,BP,
12281,GO:0045950,1,0.983117600802293,0,3,negative regulation of mitotic recombination,BP,
12282,GO:0045953,1,0.94699809697728,0,10,negative regulation of natural killer cell mediated cytotoxicity,BP,
12283,GO:0045954,1,0.890968065299666,0,19,positive regulation of natural killer cell mediated cytotoxicity,BP,
12286,GO:0045957,1,0.987694060342987,0,1,negative regulation of complement activation, alternative pathway,BP,
12287,GO:0045959,1,0.982455155645084,0,2,negative regulation of complement activation, classical pathway,BP,
12288,GO:0045963,1,0.980480833963514,0,3,negative regulation of dopamine metabolic process,BP,
12289,GO:0045964,1,0.96607972411923,0,6,positive regulation of dopamine metabolic process,BP,
12290,GO:0045967,1,0.973707720465081,0,2,negative regulation of growth rate,BP,
12291,GO:0045974,1,0.901546508524626,0,13,regulation of translation, ncRNA-mediated,BP,
12292,GO:0045976,1,0.986315025694844,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
12293,GO:0045977,1,0.995692916722254,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
12296,GO:0045986,1,0.923107040679207,0,12,negative regulation of smooth muscle contraction,BP,
12298,GO:0045988,1,0.950725799128152,0,7,negative regulation of striated muscle contraction,BP,
12300,GO:0045990,1,0.968102038545097,0,5,carbon catabolite regulation of transcription,BP,
12301,GO:0045991,1,0.968102038545097,0,5,carbon catabolite activation of transcription,BP,
12303,GO:0045993,1,0.992357042927468,0,1,negative regulation of translational initiation by iron,BP,
12304,GO:0045994,1,0.986769496645796,0,2,positive regulation of translational initiation by iron,BP,
12306,GO:0046005,1,0.992998664241832,0,2,positive regulation of circadian sleep/wake cycle, REM sleep,BP,
12308,GO:0046007,1,0.931629278035667,0,11,negative regulation of activated T cell proliferation,BP,
12309,GO:0046010,1,0.985650199892538,0,3,positive regulation of circadian sleep/wake cycle, non-REM sleep,BP,
12310,GO:0046013,1,0.989520031731598,0,2,regulation of T cell homeostatic proliferation,BP,
12311,GO:0046015,1,0.973445907923589,0,5,regulation of transcription by glucose,BP,
12312,GO:0046016,1,0.977932181900263,0,4,positive regulation of transcription by glucose,BP,
12313,GO:0046030,1,0.9219608443429,0,11,inositol trisphosphate phosphatase activity,MF,
12314,GO:0046031,1,0.512639482537254,0,98,ADP metabolic process,BP,
12315,GO:0046032,1,0.995589318894315,0,1,ADP catabolic process,BP,
12316,GO:0046033,1,0.940068337663172,0,11,AMP metabolic process,BP,
12317,GO:0046034,1,0.245796308296897,0,236,ATP metabolic process,BP,
12318,GO:0046035,1,0.995950517747861,0,1,CMP metabolic process,BP,
12319,GO:0046036,1,0.941529620453249,0,13,CTP metabolic process,BP,
12321,GO:0046038,1,0.995736789488704,0,1,GMP catabolic process,BP,
12322,GO:0046039,1,0.839588751433179,0,30,GTP metabolic process,BP,
12323,GO:0046040,1,0.92194425340519,0,13,IMP metabolic process,BP,
12324,GO:0046041,1,0.990362454326775,0,2,ITP metabolic process,BP,
12325,GO:0046048,1,0.99387977965686,0,1,UDP metabolic process,BP,
12326,GO:0046049,1,0.944252868548572,0,10,UMP metabolic process,BP,
12327,GO:0046051,1,0.951975118665624,0,10,UTP metabolic process,BP,
12328,GO:0046054,1,0.996268780695775,0,1,dGMP metabolic process,BP,
12329,GO:0046056,1,0.987296706648802,0,2,dADP metabolic process,BP,
12331,GO:0046060,1,0.97719806691898,0,5,dATP metabolic process,BP,
12332,GO:0046061,1,0.985857093743812,0,3,dATP catabolic process,BP,
12333,GO:0046065,1,0.996112369163191,0,1,dCTP metabolic process,BP,
12334,GO:0046066,1,0.990345480967084,0,2,dGDP metabolic process,BP,
12336,GO:0046069,1,0.955554671093096,0,6,cGMP catabolic process,BP,
12337,GO:0046070,1,0.98155049559459,0,4,dGTP metabolic process,BP,
12338,GO:0046072,1,0.98993040397395,0,2,dTDP metabolic process,BP,
12339,GO:0046073,1,0.984989507375686,0,3,dTMP metabolic process,BP,
12340,GO:0046075,1,0.981419609288433,0,4,dTTP metabolic process,BP,
12341,GO:0046077,1,0.98993040397395,0,2,dUDP metabolic process,BP,
12342,GO:0046078,1,0.976874482499701,0,5,dUMP metabolic process,BP,
12343,GO:0046079,1,0.995524512964062,0,1,dUMP catabolic process,BP,
12344,GO:0046080,1,0.995161366844555,0,1,dUTP metabolic process,BP,
12345,GO:0046081,1,0.995161366844555,0,1,dUTP catabolic process,BP,
12346,GO:0046083,1,0.987457952127031,0,3,adenine metabolic process,BP,
12347,GO:0046084,1,0.987457952127031,0,3,adenine biosynthetic process,BP,
12348,GO:0046085,1,0.948661427995568,0,9,adenosine metabolic process,BP,
12349,GO:0046086,1,0.98772559596492,0,2,adenosine biosynthetic process,BP,
12350,GO:0046087,1,0.961723775594323,0,8,cytidine metabolic process,BP,
12351,GO:0046090,1,0.995584917977122,0,1,deoxyadenosine metabolic process,BP,
12352,GO:0046092,1,0.991780585840182,0,1,deoxycytidine metabolic process,BP,
12353,GO:0046098,1,0.976144836615179,0,4,guanine metabolic process,BP,
12354,GO:0046099,1,0.990846505908206,0,2,guanine biosynthetic process,BP,
12355,GO:0046100,1,0.975742115541441,0,5,hypoxanthine metabolic process,BP,
12356,GO:0046101,1,0.980558602420204,0,4,hypoxanthine biosynthetic process,BP,
12357,GO:0046102,1,0.984441305594303,0,3,inosine metabolic process,BP,
12358,GO:0046103,1,0.989903729787942,0,2,inosine biosynthetic process,BP,
12359,GO:0046104,1,0.981080285532142,0,3,thymidine metabolic process,BP,
12360,GO:0046108,1,0.989750321689555,0,2,uridine metabolic process,BP,
12361,GO:0046110,1,0.978688929233074,0,3,xanthine metabolic process,BP,
12362,GO:0046111,1,0.995584917977122,0,1,xanthine biosynthetic process,BP,
12363,GO:0046112,1,0.885916077906695,0,19,nucleobase biosynthetic process,BP,
12364,GO:0046113,1,0.958359465339353,0,6,nucleobase catabolic process,BP,
12365,GO:0046116,1,0.98591684796691,0,3,queuosine metabolic process,BP,
12366,GO:0046121,1,0.984681585087257,0,3,deoxyribonucleoside catabolic process,BP,
12367,GO:0046122,1,0.991844080332264,0,2,purine deoxyribonucleoside metabolic process,BP,
12368,GO:0046124,1,0.995584917977122,0,1,purine deoxyribonucleoside catabolic process,BP,
12369,GO:0046125,1,0.981080285532142,0,3,pyrimidine deoxyribonucleoside metabolic process,BP,
12370,GO:0046127,1,0.993673140428983,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
12372,GO:0046129,1,0.902616432080956,0,21,purine ribonucleoside biosynthetic process,BP,
12373,GO:0046130,1,0.967329231666264,0,6,purine ribonucleoside catabolic process,BP,
12374,GO:0046131,1,0.85674020137493,0,30,pyrimidine ribonucleoside metabolic process,BP,
12375,GO:0046132,1,0.901597771096098,0,20,pyrimidine ribonucleoside biosynthetic process,BP,
12376,GO:0046133,1,0.951283709959754,0,10,pyrimidine ribonucleoside catabolic process,BP,
12377,GO:0046134,1,0.877734353551033,0,25,pyrimidine nucleoside biosynthetic process,BP,
12378,GO:0046135,1,0.903035079278385,0,20,pyrimidine nucleoside catabolic process,BP,
12379,GO:0046136,1,0.99107608515702,0,2,positive regulation of vitamin metabolic process,BP,
12380,GO:0046137,1,0.967924731809704,0,6,negative regulation of vitamin metabolic process,BP,
12381,GO:0046144,1,0.99550561716643,0,1,D-alanine family amino acid metabolic process,BP,
12382,GO:0046146,1,0.966677844178117,0,7,tetrahydrobiopterin metabolic process,BP,
12383,GO:0046148,1,0.729269719508835,0,50,pigment biosynthetic process,BP,
12384,GO:0046149,1,0.983590907831834,0,4,pigment catabolic process,BP,
12385,GO:0046160,1,0.983661872908738,0,2,heme a metabolic process,BP,
12386,GO:0046164,1,0.781753209064716,0,41,alcohol catabolic process,BP,
12387,GO:0046165,1,0.446794994034098,0,126,alcohol biosynthetic process,BP,
12388,GO:0046166,1,0.99056585546257,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
12389,GO:0046167,1,0.979990403024461,0,2,glycerol-3-phosphate biosynthetic process,BP,
12390,GO:0046168,1,0.986881690127976,0,2,glycerol-3-phosphate catabolic process,BP,
12391,GO:0046173,1,0.727512652640503,0,52,polyol biosynthetic process,BP,
12392,GO:0046174,1,0.885371758565949,0,17,polyol catabolic process,BP,
12393,GO:0046176,1,0.994054740756748,0,1,aldonic acid catabolic process,BP,
12394,GO:0046177,1,0.994054740756748,0,1,D-gluconate catabolic process,BP,
12395,GO:0046184,1,0.914868518677398,0,13,aldehyde biosynthetic process,BP,
12396,GO:0046185,1,0.94985547222381,0,10,aldehyde catabolic process,BP,
12397,GO:0046189,1,0.796040888114542,0,36,phenol-containing compound biosynthetic process,BP,
12398,GO:0046203,1,0.991426662536788,0,2,spermidine catabolic process,BP,
12399,GO:0046204,1,0.996301004705437,0,1,nor-spermidine metabolic process,BP,
12400,GO:0046208,1,0.98134032020026,0,4,spermine catabolic process,BP,
12401,GO:0046209,1,0.665857733078304,0,61,nitric oxide metabolic process,BP,
12402,GO:0046210,1,0.994367011384535,0,1,nitric oxide catabolic process,BP,
12403,GO:0046218,1,0.96490914332102,0,7,indolalkylamine catabolic process,BP,
12404,GO:0046219,1,0.980557390787181,0,4,indolalkylamine biosynthetic process,BP,
12405,GO:0046222,1,0.9940959129705,0,1,aflatoxin metabolic process,BP,
12406,GO:0046223,1,0.9940959129705,0,1,aflatoxin catabolic process,BP,
12407,GO:0046226,1,0.991330976594837,0,2,coumarin catabolic process,BP,
12408,GO:0046247,1,0.993961306708447,0,1,terpene catabolic process,BP,
12409,GO:0046271,1,0.991330976594837,0,2,phenylpropanoid catabolic process,BP,
12410,GO:0046272,1,0.994737768570471,0,1,stilbene catabolic process,BP,
12411,GO:0046292,1,0.982374054515751,0,3,formaldehyde metabolic process,BP,
12412,GO:0046293,1,0.992056487690681,0,1,formaldehyde biosynthetic process,BP,
12413,GO:0046294,1,0.990240821117285,0,2,formaldehyde catabolic process,BP,
12414,GO:0046295,1,0.996339404102419,0,1,glycolate biosynthetic process,BP,
12415,GO:0046296,1,0.995318665137046,0,1,glycolate catabolic process,BP,
12416,GO:0046305,1,0.989651912603824,0,2,alkanesulfonate biosynthetic process,BP,
12417,GO:0046316,1,0.994054740756748,0,1,gluconokinase activity,MF,
12418,GO:0046317,1,0.991722170285736,0,1,regulation of glucosylceramide biosynthetic process,BP,
12419,GO:0046318,1,0.991722170285736,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
12421,GO:0046321,1,0.887241668985672,0,15,positive regulation of fatty acid oxidation,BP,
12423,GO:0046323,1,0.609816866861666,0,68,glucose import,BP,
12424,GO:0046324,1,0.666998812478396,0,56,regulation of glucose import,BP,
12425,GO:0046325,1,0.9288244757766,0,12,negative regulation of glucose import,BP,
12426,GO:0046326,1,0.760695448811237,0,36,positive regulation of glucose import,BP,
12427,GO:0046327,1,0.989229586622609,0,2,glycerol biosynthetic process from pyruvate,BP,
12430,GO:0046330,1,0.450489980237417,0,116,positive regulation of JNK cascade,BP,
12431,GO:0046331,1,0.989201739777762,0,2,lateral inhibition,BP,
12432,GO:0046332,1,0.562844529491922,0,74,SMAD binding,MF,
12433,GO:0046333,1,0.98785765934728,0,2,octopamine metabolic process,BP,
12434,GO:0046337,1,0.890297829994822,0,18,phosphatidylethanolamine metabolic process,BP,
12435,GO:0046338,1,0.98741546291064,0,2,phosphatidylethanolamine catabolic process,BP,
12436,GO:0046339,1,0.919443553273814,0,12,diacylglycerol metabolic process,BP,
12437,GO:0046340,1,0.978332872103594,0,3,diacylglycerol catabolic process,BP,
12438,GO:0046341,1,0.916435465137486,0,12,CDP-diacylglycerol metabolic process,BP,
12440,GO:0046349,1,0.921599511220951,0,13,amino sugar biosynthetic process,BP,
12441,GO:0046351,1,0.978102037623084,0,4,disaccharide biosynthetic process,BP,
12442,GO:0046355,1,0.993472999393672,0,1,mannan catabolic process,BP,
12443,GO:0046356,1,0.991086444319925,0,2,acetyl-CoA catabolic process,BP,
12444,GO:0046359,1,0.995100417345176,0,1,butyrate catabolic process,BP,
12445,GO:0046360,1,0.994854703412215,0,1,2-oxobutyrate biosynthetic process,BP,
12446,GO:0046361,1,0.994854703412215,0,1,2-oxobutyrate metabolic process,BP,
12447,GO:0046364,1,0.642015813177759,0,76,monosaccharide biosynthetic process,BP,
12448,GO:0046365,1,0.71861353659268,0,56,monosaccharide catabolic process,BP,
12449,GO:0046368,1,0.977787954140796,0,4,GDP-L-fucose metabolic process,BP,
12450,GO:0046370,1,0.990121044620983,0,2,fructose biosynthetic process,BP,
12451,GO:0046373,1,0.988144472527205,0,2,L-arabinose metabolic process,BP,
12452,GO:0046379,1,0.98266761979416,0,3,extracellular polysaccharide metabolic process,BP,
12453,GO:0046380,1,0.993012830756071,0,1,N-acetylneuraminate biosynthetic process,BP,
12454,GO:0046381,1,0.995957999246021,0,1,CMP-N-acetylneuraminate metabolic process,BP,
12455,GO:0046385,1,0.947031989578245,0,11,deoxyribose phosphate biosynthetic process,BP,
12456,GO:0046386,1,0.907538011141078,0,19,deoxyribose phosphate catabolic process,BP,
12458,GO:0046391,1,0.983244658699639,0,3,5-phosphoribose 1-diphosphate metabolic process,BP,
12461,GO:0046398,1,0.971947235554755,0,4,UDP-glucuronate metabolic process,BP,
12462,GO:0046403,1,0.995346516039137,0,1,polynucleotide 3'-phosphatase activity,MF,
12463,GO:0046404,1,0.98081249677662,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
12464,GO:0046415,1,0.954425001416305,0,8,urate metabolic process,BP,
12465,GO:0046416,1,0.985460529509106,0,3,D-amino acid metabolic process,BP,
12466,GO:0046425,1,0.499271792467736,0,110,regulation of JAK-STAT cascade,BP,
12467,GO:0046426,1,0.747354175363364,0,45,negative regulation of JAK-STAT cascade,BP,
12468,GO:0046427,1,0.693430185740837,0,59,positive regulation of JAK-STAT cascade,BP,
12469,GO:0046434,1,0.254094648794103,0,208,organophosphate catabolic process,BP,
12470,GO:0046436,1,0.99550561716643,0,1,D-alanine metabolic process,BP,
12471,GO:0046437,1,0.994402058223341,0,1,D-amino acid biosynthetic process,BP,
12472,GO:0046439,1,0.95867776723474,0,7,L-cysteine metabolic process,BP,
12473,GO:0046440,1,0.974356773161737,0,4,L-lysine metabolic process,BP,
12474,GO:0046443,1,0.995035050726997,0,1,FAD metabolic process,BP,
12475,GO:0046444,1,0.994133978983308,0,1,FMN metabolic process,BP,
12476,GO:0046448,1,0.994445795478841,0,1,tropane alkaloid metabolic process,BP,
12477,GO:0046449,1,0.968243748162234,0,4,creatinine metabolic process,BP,
12478,GO:0046452,1,0.984019590945917,0,3,dihydrofolate metabolic process,BP,
12479,GO:0046456,1,0.815504271200179,0,38,icosanoid biosynthetic process,BP,
12480,GO:0046457,1,0.888554936210298,0,22,prostanoid biosynthetic process,BP,
12481,GO:0046459,1,0.911848144067113,0,16,short-chain fatty acid metabolic process,BP,
12482,GO:0046460,1,0.820906968990555,0,30,neutral lipid biosynthetic process,BP,
12484,GO:0046462,1,0.989359387270577,0,2,monoacylglycerol metabolic process,BP,
12485,GO:0046463,1,0.820906968990555,0,30,acylglycerol biosynthetic process,BP,
12487,GO:0046465,1,0.960077110938945,0,7,dolichyl diphosphate metabolic process,BP,
12488,GO:0046466,1,0.86520873582001,0,25,membrane lipid catabolic process,BP,
12490,GO:0046469,1,0.963033114004592,0,6,platelet activating factor metabolic process,BP,
12491,GO:0046470,1,0.666733249869105,0,70,phosphatidylcholine metabolic process,BP,
12493,GO:0046473,1,0.78786631281481,0,34,phosphatidic acid metabolic process,BP,
12494,GO:0046474,1,0.220435579562981,0,223,glycerophospholipid biosynthetic process,BP,
12495,GO:0046475,1,0.88982905385238,0,19,glycerophospholipid catabolic process,BP,
12496,GO:0046476,1,0.960157948440103,0,7,glycosylceramide biosynthetic process,BP,
12497,GO:0046477,1,0.960497834022513,0,7,glycosylceramide catabolic process,BP,
12498,GO:0046478,1,0.992015248853713,0,1,lactosylceramide metabolic process,BP,
12499,GO:0046479,1,0.933793415426884,0,12,glycosphingolipid catabolic process,BP,
12501,GO:0046485,1,0.9462042060307,0,9,ether lipid metabolic process,BP,
12503,GO:0046487,1,0.96397712695848,0,7,glyoxylate metabolic process,BP,
12504,GO:0046488,1,0.245809956767278,0,201,phosphatidylinositol metabolic process,BP,
12505,GO:0046490,1,0.981012494891309,0,4,isopentenyl diphosphate metabolic process,BP,
12506,GO:0046491,1,0.996419846294915,0,1,L-methylmalonyl-CoA metabolic process,BP,
12507,GO:0046493,1,0.993377801209287,0,2,lipid A metabolic process,BP,
12508,GO:0046495,1,0.994482427989621,0,1,nicotinamide riboside metabolic process,BP,
12509,GO:0046496,1,0.360867848296611,0,157,nicotinamide nucleotide metabolic process,BP,
12510,GO:0046497,1,0.994054740756748,0,1,nicotinate nucleotide metabolic process,BP,
12511,GO:0046498,1,0.965690875984448,0,6,S-adenosylhomocysteine metabolic process,BP,
12512,GO:0046499,1,0.993530949694249,0,1,S-adenosylmethioninamine metabolic process,BP,
12513,GO:0046500,1,0.930640179835343,0,12,S-adenosylmethionine metabolic process,BP,
12514,GO:0046501,1,0.943282024496672,0,10,protoporphyrinogen IX metabolic process,BP,
12515,GO:0046502,1,0.990618975006062,0,2,uroporphyrinogen III metabolic process,BP,
12517,GO:0046504,1,0.966787810603996,0,5,glycerol ether biosynthetic process,BP,
12518,GO:0046511,1,0.984835545706263,0,2,sphinganine biosynthetic process,BP,
12519,GO:0046512,1,0.947190213007281,0,9,sphingosine biosynthetic process,BP,
12520,GO:0046513,1,0.71526871363996,0,54,ceramide biosynthetic process,BP,
12521,GO:0046514,1,0.925623465220324,0,14,ceramide catabolic process,BP,
12522,GO:0046519,1,0.918943185458196,0,14,sphingoid metabolic process,BP,
12523,GO:0046520,1,0.940515773295319,0,10,sphingoid biosynthetic process,BP,
12524,GO:0046521,1,0.995171524763314,0,1,sphingoid catabolic process,BP,
12525,GO:0046523,1,0.993693489541217,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
12526,GO:0046525,1,0.995347781472553,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
12527,GO:0046526,1,0.99434294248527,0,1,D-xylulose reductase activity,MF,
12528,GO:0046527,1,0.895500422080531,0,16,glucosyltransferase activity,MF,
12529,GO:0046530,1,0.68529067545901,0,52,photoreceptor cell differentiation,BP,
12530,GO:0046532,1,0.95943582857424,0,6,regulation of photoreceptor cell differentiation,BP,
12531,GO:0046533,1,0.95943582857424,0,6,negative regulation of photoreceptor cell differentiation,BP,
12532,GO:0046538,1,0.982399267386844,0,4,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
12533,GO:0046539,1,0.99637530557595,0,1,histamine N-methyltransferase activity,MF,
12534,GO:0046540,1,0.874546650977712,0,23,U4/U6 x U5 tri-snRNP complex,CC,
12536,GO:0046543,1,0.952918398077184,0,7,development of secondary female sexual characteristics,BP,
12537,GO:0046544,1,0.991726165566297,0,1,development of secondary male sexual characteristics,BP,
12540,GO:0046548,1,0.951494577479892,0,7,retinal rod cell development,BP,
12541,GO:0046549,1,0.950471225753795,0,8,retinal cone cell development,BP,
12542,GO:0046554,1,0.995874389579063,0,1,malate dehydrogenase (NADP+) activity,MF,
12543,GO:0046556,1,0.988144472527205,0,2,alpha-L-arabinofuranosidase activity,MF,
12544,GO:0046570,1,0.995933056437043,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
12545,GO:0046573,1,0.986843995321753,0,3,lactonohydrolase activity,MF,
12546,GO:0046577,1,0.993038233928979,0,1,long-chain-alcohol oxidase activity,MF,
12548,GO:0046579,1,0.728598985551858,0,46,positive regulation of Ras protein signal transduction,BP,
12550,GO:0046581,1,0.954607431227399,0,6,intercellular canaliculus,CC,
12551,GO:0046586,1,0.990190641361251,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
12552,GO:0046587,1,0.993795533248943,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
12553,GO:0046588,1,0.99637283023587,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
12554,GO:0046592,1,0.990314840067718,0,2,polyamine oxidase activity,MF,
12555,GO:0046596,1,0.863937577513476,0,26,regulation of viral entry into host cell,BP,
12556,GO:0046597,1,0.912714438309134,0,16,negative regulation of viral entry into host cell,BP,
12557,GO:0046598,1,0.953368082923057,0,9,positive regulation of viral entry into host cell,BP,
12558,GO:0046599,1,0.888279835798514,0,17,regulation of centriole replication,BP,
12559,GO:0046600,1,0.942349019824776,0,8,negative regulation of centriole replication,BP,
12560,GO:0046601,1,0.980007966631379,0,3,positive regulation of centriole replication,BP,
12561,GO:0046602,1,0.931822684318228,0,10,regulation of mitotic centrosome separation,BP,
12562,GO:0046603,1,0.995713605240531,0,1,negative regulation of mitotic centrosome separation,BP,
12563,GO:0046604,1,0.969975979074112,0,4,positive regulation of mitotic centrosome separation,BP,
12564,GO:0046605,1,0.685504777055125,0,54,regulation of centrosome cycle,BP,
12565,GO:0046606,1,0.911632215305731,0,14,negative regulation of centrosome cycle,BP,
12566,GO:0046607,1,0.929153442078176,0,10,positive regulation of centrosome cycle,BP,
12567,GO:0046618,1,0.969403488833685,0,5,drug export,BP,
12568,GO:0046619,1,0.983787202048172,0,2,optic placode formation involved in camera-type eye formation,BP,
12569,GO:0046620,1,0.557317754940848,0,82,regulation of organ growth,BP,
12570,GO:0046621,1,0.839116756343309,0,24,negative regulation of organ growth,BP,
12571,GO:0046622,1,0.726961100200343,0,44,positive regulation of organ growth,BP,
12572,GO:0046623,1,0.99043455124782,0,1,sphingolipid-translocating ATPase activity,MF,
12573,GO:0046624,1,0.942870313817499,0,9,sphingolipid transporter activity,MF,
12575,GO:0046626,1,0.720207433191689,0,48,regulation of insulin receptor signaling pathway,BP,
12576,GO:0046627,1,0.815655703999191,0,31,negative regulation of insulin receptor signaling pathway,BP,
12577,GO:0046628,1,0.916445945465726,0,11,positive regulation of insulin receptor signaling pathway,BP,
12578,GO:0046629,1,0.929722572337989,0,11,gamma-delta T cell activation,BP,
12579,GO:0046631,1,0.509179958234659,0,106,alpha-beta T cell activation,BP,
12580,GO:0046632,1,0.581879215758005,0,83,alpha-beta T cell differentiation,BP,
12581,GO:0046633,1,0.871281823186747,0,23,alpha-beta T cell proliferation,BP,
12582,GO:0046634,1,0.662919378478025,0,67,regulation of alpha-beta T cell activation,BP,
12583,GO:0046635,1,0.767951022716519,0,45,positive regulation of alpha-beta T cell activation,BP,
12584,GO:0046636,1,0.848884284212974,0,25,negative regulation of alpha-beta T cell activation,BP,
12585,GO:0046637,1,0.74326827164473,0,47,regulation of alpha-beta T cell differentiation,BP,
12586,GO:0046638,1,0.815456769862141,0,34,positive regulation of alpha-beta T cell differentiation,BP,
12587,GO:0046639,1,0.894056532134367,0,16,negative regulation of alpha-beta T cell differentiation,BP,
12588,GO:0046640,1,0.890093988327455,0,20,regulation of alpha-beta T cell proliferation,BP,
12589,GO:0046641,1,0.915712771442698,0,16,positive regulation of alpha-beta T cell proliferation,BP,
12590,GO:0046642,1,0.970264034187038,0,5,negative regulation of alpha-beta T cell proliferation,BP,
12591,GO:0046643,1,0.956258003496795,0,6,regulation of gamma-delta T cell activation,BP,
12592,GO:0046645,1,0.963255303285339,0,5,positive regulation of gamma-delta T cell activation,BP,
12595,GO:0046653,1,0.89679207187194,0,18,tetrahydrofolate metabolic process,BP,
12596,GO:0046654,1,0.959558243002479,0,7,tetrahydrofolate biosynthetic process,BP,
12597,GO:0046655,1,0.88071943305952,0,20,folic acid metabolic process,BP,
12598,GO:0046657,1,0.988553060601139,0,2,folic acid catabolic process,BP,
12599,GO:0046658,1,0.798032032497067,0,38,anchored component of plasma membrane,CC,
12602,GO:0046666,1,0.979927501687087,0,4,retinal cell programmed cell death,BP,
12603,GO:0046668,1,0.988138707548332,0,2,regulation of retinal cell programmed cell death,BP,
12604,GO:0046671,1,0.99296254550758,0,1,negative regulation of retinal cell programmed cell death,BP,
12607,GO:0046680,1,0.994884996941539,0,1,response to DDT,BP,
12609,GO:0046684,1,0.978090605028749,0,4,response to pyrethroid,BP,
12610,GO:0046685,1,0.84387218390541,0,29,response to arsenic-containing substance,BP,
12611,GO:0046686,1,0.742639809988798,0,56,response to cadmium ion,BP,
12612,GO:0046687,1,0.996139088949484,0,1,response to chromate,BP,
12614,GO:0046689,1,0.956342040342874,0,8,response to mercury ion,BP,
12615,GO:0046690,1,0.993311518882161,0,1,response to tellurium ion,BP,
12616,GO:0046691,1,0.993959081680909,0,1,intracellular canaliculus,CC,
12617,GO:0046695,1,0.985244451948378,0,3,SLIK (SAGA-like) complex,CC,
12618,GO:0046696,1,0.972078009083542,0,5,lipopolysaccharide receptor complex,CC,
12619,GO:0046697,1,0.880708315015872,0,19,decidualization,BP,
12620,GO:0046700,1,0.0224048796845364,0,616,heterocycle catabolic process,BP,
12621,GO:0046703,1,0.968504150516716,0,7,natural killer cell lectin-like receptor binding,MF,
12622,GO:0046707,1,0.986438703008076,0,2,IDP metabolic process,BP,
12623,GO:0046709,1,0.986438703008076,0,2,IDP catabolic process,BP,
12625,GO:0046711,1,0.996268780695775,0,1,GDP biosynthetic process,BP,
12626,GO:0046713,1,0.993683564995919,0,1,borate transport,BP,
12627,GO:0046715,1,0.993683564995919,0,1,active borate transmembrane transporter activity,MF,
12628,GO:0046716,1,0.907795221559318,0,15,muscle cell cellular homeostasis,BP,
12630,GO:0046718,1,0.508969933290505,0,105,viral entry into host cell,BP,
12631,GO:0046719,1,0.957972492837543,0,7,regulation by virus of viral protein levels in host cell,BP,
12632,GO:0046724,1,0.989721753432111,0,2,oxalic acid secretion,BP,
12633,GO:0046725,1,0.993226682799604,0,1,negative regulation by virus of viral protein levels in host cell,BP,
12634,GO:0046726,1,0.972451267803017,0,4,positive regulation by virus of viral protein levels in host cell,BP,
12635,GO:0046730,1,0.994746541367731,0,1,induction of host immune response by virus,BP,
12636,GO:0046732,1,0.994746541367731,0,1,active induction of host immune response by virus,BP,
12637,GO:0046745,1,0.994054740756748,0,1,viral capsid secondary envelopment,BP,
12638,GO:0046755,1,0.876076901301596,0,24,viral budding,BP,
12640,GO:0046778,1,0.989021182752696,0,2,modification by virus of host mRNA processing,BP,
12641,GO:0046782,1,0.687679826543547,0,60,regulation of viral transcription,BP,
12642,GO:0046784,1,0.956531948231523,0,8,viral mRNA export from host cell nucleus,BP,
12644,GO:0046786,1,0.991920703757226,0,1,viral replication complex formation and maintenance,BP,
12645,GO:0046789,1,0.993596680715339,0,1,host cell surface receptor binding,MF,
12646,GO:0046790,1,0.96130358432772,0,5,virion binding,MF,
12647,GO:0046794,1,0.686634081572394,0,56,transport of virus,BP,
12648,GO:0046811,1,0.987890546938951,0,2,histone deacetylase inhibitor activity,MF,
12649,GO:0046812,1,0.993596680715339,0,1,host cell surface binding,MF,
12650,GO:0046813,1,0.968156882365274,0,5,receptor-mediated virion attachment to host cell,BP,
12651,GO:0046822,1,0.503430151250413,0,97,regulation of nucleocytoplasmic transport,BP,
12652,GO:0046823,1,0.887471888747066,0,19,negative regulation of nucleocytoplasmic transport,BP,
12653,GO:0046824,1,0.661888265366261,0,55,positive regulation of nucleocytoplasmic transport,BP,
12654,GO:0046825,1,0.761634949020718,0,39,regulation of protein export from nucleus,BP,
12655,GO:0046826,1,0.962125004657083,0,7,negative regulation of protein export from nucleus,BP,
12656,GO:0046827,1,0.865968619262882,0,20,positive regulation of protein export from nucleus,BP,
12657,GO:0046831,1,0.887014853822828,0,15,regulation of RNA export from nucleus,BP,
12658,GO:0046832,1,0.978557425449712,0,2,negative regulation of RNA export from nucleus,BP,
12659,GO:0046833,1,0.949737507918184,0,7,positive regulation of RNA export from nucleus,BP,
12660,GO:0046834,1,0.469535227200632,0,103,lipid phosphorylation,BP,
12661,GO:0046835,1,0.846536306120351,0,26,carbohydrate phosphorylation,BP,
12662,GO:0046836,1,0.97198835662757,0,5,glycolipid transport,BP,
12663,GO:0046838,1,0.925748471078711,0,11,phosphorylated carbohydrate dephosphorylation,BP,
12666,GO:0046848,1,0.996833129419654,0,1,hydroxyapatite binding,MF,
12667,GO:0046849,1,0.612323560396978,0,73,bone remodeling,BP,
12668,GO:0046850,1,0.761429948377487,0,39,regulation of bone remodeling,BP,
12669,GO:0046851,1,0.93216978266537,0,11,negative regulation of bone remodeling,BP,
12670,GO:0046852,1,0.910097639266164,0,13,positive regulation of bone remodeling,BP,
12671,GO:0046854,1,0.514629905820755,0,91,phosphatidylinositol phosphorylation,BP,
12672,GO:0046855,1,0.931617669433979,0,10,inositol phosphate dephosphorylation,BP,
12673,GO:0046856,1,0.835111751382291,0,23,phosphatidylinositol dephosphorylation,BP,
12674,GO:0046864,1,0.990338620047879,0,2,isoprenoid transport,BP,
12675,GO:0046865,1,0.990338620047879,0,2,terpenoid transport,BP,
12676,GO:0046870,1,0.968660775104008,0,5,cadmium ion binding,MF,
12679,GO:0046874,1,0.979087747629548,0,4,quinolinate metabolic process,BP,
12680,GO:0046875,1,0.829390724323909,0,27,ephrin receptor binding,MF,
12681,GO:0046877,1,0.968630090706456,0,6,regulation of saliva secretion,BP,
12682,GO:0046878,1,0.983792760566562,0,3,positive regulation of saliva secretion,BP,
12684,GO:0046880,1,0.960232720156142,0,6,regulation of follicle-stimulating hormone secretion,BP,
12685,GO:0046881,1,0.960232720156142,0,6,positive regulation of follicle-stimulating hormone secretion,BP,
12686,GO:0046882,1,0.984195910814085,0,3,negative regulation of follicle-stimulating hormone secretion,BP,
12688,GO:0046884,1,0.952621064379783,0,7,follicle-stimulating hormone secretion,BP,
12689,GO:0046885,1,0.854743507795491,0,24,regulation of hormone biosynthetic process,BP,
12690,GO:0046886,1,0.942552240454133,0,9,positive regulation of hormone biosynthetic process,BP,
12693,GO:0046889,1,0.694924929672229,0,58,positive regulation of lipid biosynthetic process,BP,
12694,GO:0046890,1,0.379918902918779,0,151,regulation of lipid biosynthetic process,BP,
12695,GO:0046898,1,0.971050690872806,0,4,response to cycloheximide,BP,
12696,GO:0046899,1,0.988297469325015,0,2,nucleoside triphosphate adenylate kinase activity,MF,
12697,GO:0046900,1,0.990055668344331,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
12698,GO:0046901,1,0.994388744542027,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
12701,GO:0046906,1,0.518616873908253,0,108,tetrapyrrole binding,MF,
12703,GO:0046911,1,0.996035242113144,0,1,metal chelating activity,MF,
12704,GO:0046912,1,0.96563107527819,0,5,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
12708,GO:0046920,1,0.943083999382881,0,8,alpha-(1->3)-fucosyltransferase activity,MF,
12709,GO:0046921,1,0.99350517844687,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
12710,GO:0046922,1,0.987195172620738,0,2,peptide-O-fucosyltransferase activity,MF,
12711,GO:0046923,1,0.974327130725571,0,5,ER retention sequence binding,MF,
12714,GO:0046930,1,0.918038834767446,0,15,pore complex,CC,
12715,GO:0046931,1,0.895363064801321,0,16,pore complex assembly,BP,
12716,GO:0046933,1,0.987621639947811,0,3,proton-transporting ATP synthase activity, rotational mechanism,MF,
12717,GO:0046934,1,0.647066122357072,0,61,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,
12718,GO:0046935,1,0.963044160920986,0,5,1-phosphatidylinositol-3-kinase regulator activity,MF,
12719,GO:0046939,1,0.470153307038086,0,115,nucleotide phosphorylation,BP,
12720,GO:0046940,1,0.972516426748565,0,5,nucleoside monophosphate phosphorylation,BP,
12723,GO:0046946,1,0.980506545683797,0,3,hydroxylysine metabolic process,BP,
12724,GO:0046947,1,0.980506545683797,0,3,hydroxylysine biosynthetic process,BP,
12725,GO:0046949,1,0.844612233389462,0,27,fatty-acyl-CoA biosynthetic process,BP,
12726,GO:0046950,1,0.938566897193112,0,11,cellular ketone body metabolic process,BP,
12727,GO:0046951,1,0.949501136721016,0,9,ketone body biosynthetic process,BP,
12728,GO:0046952,1,0.976882494725973,0,4,ketone body catabolic process,BP,
12729,GO:0046958,1,0.955227287116627,0,6,nonassociative learning,BP,
12730,GO:0046959,1,0.966738648716977,0,4,habituation,BP,
12731,GO:0046960,1,0.98799681513844,0,2,sensitization,BP,
12732,GO:0046961,1,0.894098719975576,0,20,proton-transporting ATPase activity, rotational mechanism,MF,
12733,GO:0046963,1,0.989890247772364,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
12734,GO:0046964,1,0.989890247772364,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
12735,GO:0046965,1,0.899111076244,0,15,retinoid X receptor binding,MF,
12736,GO:0046966,1,0.81634607880083,0,27,thyroid hormone receptor binding,MF,
12737,GO:0046967,1,0.986685052754903,0,2,cytosol to ER transport,BP,
12738,GO:0046968,1,0.985440017308468,0,2,peptide antigen transport,BP,
12739,GO:0046969,1,0.988456008678985,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
12740,GO:0046970,1,0.995067410461975,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
12741,GO:0046972,1,0.932052104980251,0,10,histone acetyltransferase activity (H4-K16 specific),MF,
12742,GO:0046974,1,0.965048267335862,0,5,histone methyltransferase activity (H3-K9 specific),MF,
12743,GO:0046975,1,0.945129472328535,0,6,histone methyltransferase activity (H3-K36 specific),MF,
12744,GO:0046976,1,0.96754018639853,0,5,histone methyltransferase activity (H3-K27 specific),MF,
12745,GO:0046977,1,0.976049121141688,0,4,TAP binding,MF,
12746,GO:0046978,1,0.976049121141688,0,4,TAP1 binding,MF,
12747,GO:0046979,1,0.983140181017375,0,3,TAP2 binding,MF,
12748,GO:0046980,1,0.992788570226548,0,1,tapasin binding,MF,
12751,GO:0046984,1,0.976903877241878,0,4,regulation of hemoglobin biosynthetic process,BP,
12752,GO:0046985,1,0.98442901442449,0,3,positive regulation of hemoglobin biosynthetic process,BP,
12753,GO:0046986,1,0.992357042927468,0,1,negative regulation of hemoglobin biosynthetic process,BP,
12754,GO:0046996,1,0.994054740756748,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with NAD(P)H as one donor, and the other dehydrogenated,MF,
12755,GO:0046997,1,0.987231760243086,0,2,oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor,MF,
12756,GO:0047006,1,0.991515246885277,0,2,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
12757,GO:0047012,1,0.995506877175019,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
12758,GO:0047015,1,0.996317729861585,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
12759,GO:0047016,1,0.994764102188857,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
12760,GO:0047017,1,0.99005387837998,0,2,prostaglandin-F synthase activity,MF,
12761,GO:0047020,1,0.995975451635579,0,1,15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity,MF,
12762,GO:0047021,1,0.99595425864032,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
12763,GO:0047023,1,0.983510965420382,0,4,androsterone dehydrogenase activity,MF,
12764,GO:0047025,1,0.98963260934131,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
12765,GO:0047035,1,0.975128867613499,0,6,testosterone dehydrogenase (NAD+) activity,MF,
12766,GO:0047042,1,0.995780617547538,0,1,androsterone dehydrogenase (B-specific) activity,MF,
12767,GO:0047045,1,0.988062063177451,0,3,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
12768,GO:0047057,1,0.992424390047039,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
12769,GO:0047066,1,0.996330735281209,0,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
12770,GO:0047086,1,0.983510965420382,0,4,ketosteroid monooxygenase activity,MF,
12771,GO:0047105,1,0.99437062895455,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
12772,GO:0047115,1,0.983649765613672,0,4,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
12773,GO:0047117,1,0.988453595791546,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
12774,GO:0047127,1,0.995791254886287,0,1,thiomorpholine-carboxylate dehydrogenase activity,MF,
12775,GO:0047130,1,0.990947239315527,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
12776,GO:0047131,1,0.990947239315527,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
12777,GO:0047134,1,0.971272734100741,0,6,protein-disulfide reductase activity,MF,
12778,GO:0047144,1,0.938811262019676,0,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,
12779,GO:0047150,1,0.989411032439698,0,2,betaine-homocysteine S-methyltransferase activity,MF,
12780,GO:0047159,1,0.992860549928441,0,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
12781,GO:0047166,1,0.995106765795104,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
12782,GO:0047173,1,0.991946597430993,0,1,phosphatidylcholine-retinol O-acyltransferase activity,MF,
12783,GO:0047179,1,0.992195009552896,0,2,platelet-activating factor acetyltransferase activity,MF,
12784,GO:0047184,1,0.969563761081984,0,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,
12785,GO:0047186,1,0.992920896772471,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
12786,GO:0047191,1,0.992860549928441,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
12787,GO:0047192,1,0.979540945250582,0,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,
12788,GO:0047220,1,0.994042236420015,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
12789,GO:0047223,1,0.993967431886584,0,1,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
12790,GO:0047237,1,0.980020563534233,0,3,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12791,GO:0047238,1,0.965818634277316,0,5,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12792,GO:0047256,1,0.992700867474221,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
12793,GO:0047263,1,0.993912086286088,0,1,N-acylsphingosine galactosyltransferase activity,MF,
12794,GO:0047273,1,0.993479019695214,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
12795,GO:0047275,1,0.988080421531535,0,2,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
12796,GO:0047277,1,0.995064871925933,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
12797,GO:0047280,1,0.992245184906663,0,1,nicotinamide phosphoribosyltransferase activity,MF,
12798,GO:0047288,1,0.987732721155977,0,2,monosialoganglioside sialyltransferase activity,MF,
12799,GO:0047290,1,0.99544761159486,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
12800,GO:0047291,1,0.994610588791943,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
12801,GO:0047293,1,0.995455182597529,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
12802,GO:0047298,1,0.991914726505661,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
12803,GO:0047322,1,0.979492957831776,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
12804,GO:0047323,1,0.994833271518301,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
12805,GO:0047325,1,0.99353956641785,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
12806,GO:0047326,1,0.99526163217479,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
12807,GO:0047341,1,0.993370529098454,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
12808,GO:0047349,1,0.99137988419678,0,1,D-ribitol-5-phosphate cytidylyltransferase activity,MF,
12809,GO:0047369,1,0.994054740756748,0,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,
12810,GO:0047372,1,0.931650239916518,0,11,acylglycerol lipase activity,MF,
12811,GO:0047374,1,0.983968894221581,0,3,methylumbelliferyl-acetate deacetylase activity,MF,
12812,GO:0047389,1,0.985027127328432,0,2,glycerophosphocholine phosphodiesterase activity,MF,
12813,GO:0047390,1,0.992874924561546,0,1,glycerophosphocholine cholinephosphodiesterase activity,MF,
12814,GO:0047391,1,0.982620185485196,0,3,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,
12815,GO:0047394,1,0.994699606775209,0,1,glycerophosphoinositol inositolphosphodiesterase activity,MF,
12816,GO:0047395,1,0.993875418370528,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
12817,GO:0047408,1,0.988570267546972,0,2,alkenylglycerophosphocholine hydrolase activity,MF,
12818,GO:0047409,1,0.988570267546972,0,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,
12819,GO:0047429,1,0.946326408049709,0,9,nucleoside-triphosphate diphosphatase activity,MF,
12820,GO:0047444,1,0.995957999246021,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12821,GO:0047451,1,0.988453595791546,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
12822,GO:0047464,1,0.991790068667953,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12823,GO:0047484,1,0.943663242230276,0,9,regulation of response to osmotic stress,BP,
12824,GO:0047485,1,0.498838898867577,0,106,protein N-terminus binding,MF,
12825,GO:0047493,1,0.979502851299741,0,3,ceramide cholinephosphotransferase activity,MF,
12826,GO:0047496,1,0.757284077196718,0,38,vesicle transport along microtubule,BP,
12827,GO:0047497,1,0.867600324504091,0,19,mitochondrion transport along microtubule,BP,
12828,GO:0047498,1,0.959228413394806,0,7,calcium-dependent phospholipase A2 activity,MF,
12829,GO:0047499,1,0.966500455744601,0,6,calcium-independent phospholipase A2 activity,MF,
12830,GO:0047522,1,0.981703419263698,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
12831,GO:0047536,1,0.994717110730619,0,1,2-aminoadipate transaminase activity,MF,
12832,GO:0047545,1,0.99073971701134,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
12833,GO:0047555,1,0.911651771874247,0,12,3',5'-cyclic-GMP phosphodiesterase activity,MF,
12834,GO:0047560,1,0.991631246260237,0,1,3-dehydrosphinganine reductase activity,MF,
12835,GO:0047578,1,0.994436054706036,0,1,4-hydroxyglutamate transaminase activity,MF,
12836,GO:0047598,1,0.99419280488058,0,1,7-dehydrocholesterol reductase activity,MF,
12837,GO:0047617,1,0.924882933494231,0,15,acyl-CoA hydrolase activity,MF,
12838,GO:0047620,1,0.993875418370528,0,1,acylglycerol kinase activity,MF,
12839,GO:0047621,1,0.995405943503099,0,1,acylpyruvate hydrolase activity,MF,
12840,GO:0047623,1,0.985593557704322,0,2,adenosine-phosphate deaminase activity,MF,
12841,GO:0047631,1,0.978372462344825,0,5,ADP-ribose diphosphatase activity,MF,
12842,GO:0047635,1,0.988062979401258,0,2,alanine-oxo-acid transaminase activity,MF,
12843,GO:0047658,1,0.995384459698249,0,1,alpha-amino-acid esterase activity,MF,
12844,GO:0047661,1,0.994402058223341,0,1,amino-acid racemase activity,MF,
12845,GO:0047676,1,0.991642739363032,0,1,arachidonate-CoA ligase activity,MF,
12846,GO:0047685,1,0.995624508853938,0,1,amine sulfotransferase activity,MF,
12847,GO:0047693,1,0.996611310932968,0,1,ATP diphosphatase activity,MF,
12848,GO:0047696,1,0.988181409077666,0,2,beta-adrenergic receptor kinase activity,MF,
12849,GO:0047704,1,0.995015389472993,0,1,bile-salt sulfotransferase activity,MF,
12850,GO:0047708,1,0.990986713153932,0,2,biotinidase activity,MF,
12851,GO:0047710,1,0.988330908269821,0,2,bis(5'-adenosyl)-triphosphatase activity,MF,
12852,GO:0047718,1,0.987316349336996,0,3,indanol dehydrogenase activity,MF,
12853,GO:0047726,1,0.994367011384535,0,1,iron-cytochrome-c reductase activity,MF,
12854,GO:0047730,1,0.992855757159882,0,1,carnosine synthase activity,MF,
12855,GO:0047734,1,0.994054740756748,0,1,CDP-glycerol diphosphatase activity,MF,
12856,GO:0047743,1,0.996012828977306,0,1,chlordecone reductase activity,MF,
12857,GO:0047747,1,0.994536439520057,0,1,cholate-CoA ligase activity,MF,
12858,GO:0047750,1,0.992364471645852,0,2,cholestenol delta-isomerase activity,MF,
12859,GO:0047751,1,0.988888480222838,0,2,cholestenone 5-alpha-reductase activity,MF,
12861,GO:0047757,1,0.980621902455131,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
12862,GO:0047760,1,0.97218175374909,0,5,butyrate-CoA ligase activity,MF,
12863,GO:0047777,1,0.991061380407851,0,1,(3S)-citramalyl-CoA lyase activity,MF,
12864,GO:0047787,1,0.995975451635579,0,1,delta4-3-oxosteroid 5beta-reductase activity,MF,
12865,GO:0047800,1,0.993084786661257,0,1,cysteamine dioxygenase activity,MF,
12866,GO:0047801,1,0.99483579173195,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
12867,GO:0047837,1,0.99615337561671,0,1,D-xylose 1-dehydrogenase (NADP+) activity,MF,
12868,GO:0047840,1,0.996112369163191,0,1,dCTP diphosphatase activity,MF,
12869,GO:0047844,1,0.965642390291298,0,7,deoxycytidine deaminase activity,MF,
12870,GO:0047856,1,0.996016565184452,0,1,dihydrocoumarin hydrolase activity,MF,
12871,GO:0047860,1,0.99591808456089,0,1,diiodophenylpyruvate reductase activity,MF,
12872,GO:0047865,1,0.99370762890746,0,1,dimethylglycine dehydrogenase activity,MF,
12873,GO:0047874,1,0.994857226277089,0,1,dolichyldiphosphatase activity,MF,
12874,GO:0047888,1,0.995063602687153,0,1,fatty acid peroxidase activity,MF,
12875,GO:0047894,1,0.987290574340495,0,3,flavonol 3-sulfotransferase activity,MF,
12876,GO:0047915,1,0.99540341665156,0,1,ganglioside galactosyltransferase activity,MF,
12877,GO:0047933,1,0.988439761388255,0,1,glucose-1,6-bisphosphate synthase activity,MF,
12878,GO:0047936,1,0.987888400990943,0,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,
12879,GO:0047939,1,0.995664688661669,0,1,L-glucuronate reductase activity,MF,
12880,GO:0047946,1,0.994911535777861,0,1,glutamine N-acyltransferase activity,MF,
12881,GO:0047961,1,0.990719633152168,0,2,glycine N-acyltransferase activity,MF,
12882,GO:0047963,1,0.993370035430556,0,1,glycine N-choloyltransferase activity,MF,
12883,GO:0047969,1,0.995318665137046,0,1,glyoxylate oxidase activity,MF,
12884,GO:0047977,1,0.988730133905475,0,2,hepoxilin-epoxide hydrolase activity,MF,
12885,GO:0047982,1,0.99532436368798,0,1,homocysteine desulfhydrase activity,MF,
12886,GO:0047988,1,0.995124542452145,0,1,hydroxyacid-oxoacid transhydrogenase activity,MF,
12887,GO:0047992,1,0.994054740756748,0,1,hydroxylysine kinase activity,MF,
12889,GO:0048003,1,0.967412523105451,0,5,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
12890,GO:0048006,1,0.993023373203221,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
12891,GO:0048007,1,0.967412523105451,0,5,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
12892,GO:0048008,1,0.68886433397551,0,48,platelet-derived growth factor receptor signaling pathway,BP,
12894,GO:0048010,1,0.541320528415711,0,91,vascular endothelial growth factor receptor signaling pathway,BP,
12895,GO:0048011,1,0.852573573860818,0,24,neurotrophin TRK receptor signaling pathway,BP,
12896,GO:0048012,1,0.903814369400552,0,16,hepatocyte growth factor receptor signaling pathway,BP,
12898,GO:0048014,1,0.976295956335492,0,3,Tie signaling pathway,BP,
12899,GO:0048015,1,0.360053880416295,0,141,phosphatidylinositol-mediated signaling,BP,
12900,GO:0048016,1,0.760948861124597,0,36,inositol phosphate-mediated signaling,BP,
12901,GO:0048017,1,0.352562359373403,0,144,inositol lipid-mediated signaling,BP,
12903,GO:0048019,1,0.934554287163414,0,12,receptor antagonist activity,MF,
12904,GO:0048020,1,0.909325190385971,0,21,CCR chemokine receptor binding,MF,
12905,GO:0048021,1,0.953011626699327,0,6,regulation of melanin biosynthetic process,BP,
12906,GO:0048022,1,0.981105557124706,0,2,negative regulation of melanin biosynthetic process,BP,
12907,GO:0048023,1,0.971370457921689,0,4,positive regulation of melanin biosynthetic process,BP,
12911,GO:0048027,1,0.869665135508501,0,23,mRNA 5'-UTR binding,MF,
12912,GO:0048029,1,0.684006734914803,0,64,monosaccharide binding,MF,
12913,GO:0048030,1,0.987602536852778,0,3,disaccharide binding,MF,
12914,GO:0048033,1,0.993806242189318,0,1,heme o metabolic process,BP,
12915,GO:0048034,1,0.993806242189318,0,1,heme O biosynthetic process,BP,
12917,GO:0048038,1,0.933991605771715,0,14,quinone binding,MF,
12918,GO:0048039,1,0.97229765403998,0,6,ubiquinone binding,MF,
12919,GO:0048040,1,0.99488247093418,0,1,UDP-glucuronate decarboxylase activity,MF,
12920,GO:0048041,1,0.573444562506653,0,71,focal adhesion assembly,BP,
12921,GO:0048048,1,0.755903866182313,0,34,embryonic eye morphogenesis,BP,
12922,GO:0048050,1,0.963481466082112,0,6,post-embryonic eye morphogenesis,BP,
12923,GO:0048066,1,0.744475947625556,0,42,developmental pigmentation,BP,
12924,GO:0048069,1,0.95513335155804,0,7,eye pigmentation,BP,
12925,GO:0048070,1,0.895867848753867,0,15,regulation of developmental pigmentation,BP,
12926,GO:0048073,1,0.985039507628543,0,2,regulation of eye pigmentation,BP,
12927,GO:0048075,1,0.992514332001805,0,1,positive regulation of eye pigmentation,BP,
12928,GO:0048087,1,0.932044692286611,0,9,positive regulation of developmental pigmentation,BP,
12929,GO:0048096,1,0.937725256480393,0,9,chromatin-mediated maintenance of transcription,BP,
12930,GO:0048101,1,0.988233700669938,0,2,calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity,MF,
12931,GO:0048102,1,0.956844648680526,0,7,autophagic cell death,BP,
12933,GO:0048104,1,0.963042353078669,0,4,establishment of body hair or bristle planar orientation,BP,
12934,GO:0048105,1,0.963042353078669,0,4,establishment of body hair planar orientation,BP,
12935,GO:0048133,1,0.983504220404566,0,3,male germ-line stem cell asymmetric division,BP,
12936,GO:0048143,1,0.910876480037934,0,12,astrocyte activation,BP,
12937,GO:0048144,1,0.602537626914352,0,77,fibroblast proliferation,BP,
12938,GO:0048145,1,0.606867612896958,0,76,regulation of fibroblast proliferation,BP,
12939,GO:0048146,1,0.729338826659976,0,48,positive regulation of fibroblast proliferation,BP,
12940,GO:0048147,1,0.844288807616841,0,27,negative regulation of fibroblast proliferation,BP,
12941,GO:0048148,1,0.907960191354607,0,15,behavioral response to cocaine,BP,
12942,GO:0048149,1,0.936363045990353,0,10,behavioral response to ethanol,BP,
12943,GO:0048156,1,0.93719535050912,0,11,tau protein binding,MF,
12944,GO:0048160,1,0.992202688195683,0,1,primary follicle stage,BP,
12945,GO:0048162,1,0.985090657252406,0,3,multi-layer follicle stage,BP,
12946,GO:0048165,1,0.983544589258489,0,2,fused antrum stage,BP,
12953,GO:0048175,1,0.993596680715339,0,1,hepatocyte growth factor biosynthetic process,BP,
12954,GO:0048176,1,0.993596680715339,0,1,regulation of hepatocyte growth factor biosynthetic process,BP,
12955,GO:0048178,1,0.993596680715339,0,1,negative regulation of hepatocyte growth factor biosynthetic process,BP,
12956,GO:0048179,1,0.977540798605747,0,3,activin receptor complex,CC,
12957,GO:0048180,1,0.99478419556355,0,1,activin complex,CC,
12958,GO:0048185,1,0.917613945336542,0,12,activin binding,MF,
12959,GO:0048188,1,0.911940768590516,0,12,Set1C/COMPASS complex,CC,
12961,GO:0048194,1,0.58410276759044,0,78,Golgi vesicle budding,BP,
12962,GO:0048199,1,0.627950942750688,0,70,vesicle targeting, to, from or within Golgi,BP,
12963,GO:0048200,1,0.962427929899379,0,6,Golgi transport vesicle coating,BP,
12964,GO:0048203,1,0.989075072508356,0,2,vesicle targeting, trans-Golgi to endosome,BP,
12965,GO:0048205,1,0.962427929899379,0,6,COPI coating of Golgi vesicle,BP,
12966,GO:0048207,1,0.66105237665108,0,62,vesicle targeting, rough ER to cis-Golgi,BP,
12967,GO:0048208,1,0.66105237665108,0,62,COPII vesicle coating,BP,
12968,GO:0048209,1,0.986446483876697,0,2,regulation of vesicle targeting, to, from or within Golgi,BP,
12969,GO:0048210,1,0.978218417446868,0,4,Golgi vesicle fusion to target membrane,BP,
12970,GO:0048211,1,0.987041132315046,0,2,Golgi vesicle docking,BP,
12971,GO:0048213,1,0.989324071383022,0,2,Golgi vesicle prefusion complex stabilization,BP,
12972,GO:0048227,1,0.950822771853348,0,8,plasma membrane to endosome transport,BP,
12974,GO:0048237,1,0.985892207753019,0,3,rough endoplasmic reticulum lumen,CC,
12975,GO:0048239,1,0.988802882893642,0,2,negative regulation of DNA recombination at telomere,BP,
12976,GO:0048240,1,0.894125269469768,0,20,sperm capacitation,BP,
12977,GO:0048241,1,0.975701782973912,0,5,epinephrine transport,BP,
12978,GO:0048242,1,0.98042172970397,0,4,epinephrine secretion,BP,
12979,GO:0048243,1,0.926020936646778,0,13,norepinephrine secretion,BP,
12980,GO:0048244,1,0.995424889358917,0,1,phytanoyl-CoA dioxygenase activity,MF,
12981,GO:0048245,1,0.950122220579608,0,11,eosinophil chemotaxis,BP,
12982,GO:0048246,1,0.851906463600927,0,29,macrophage chemotaxis,BP,
12984,GO:0048248,1,0.97910975978015,0,5,CXCR3 chemokine receptor binding,MF,
12985,GO:0048250,1,0.990761309852731,0,2,iron import into the mitochondrion,BP,
12986,GO:0048251,1,0.933746293088457,0,9,elastic fiber assembly,BP,
12987,GO:0048254,1,0.977897168135886,0,4,snoRNA localization,BP,
12988,GO:0048255,1,0.798269728620474,0,32,mRNA stabilization,BP,
12989,GO:0048256,1,0.958102115781991,0,7,flap endonuclease activity,MF,
12990,GO:0048257,1,0.988575727464523,0,2,3'-flap endonuclease activity,MF,
12991,GO:0048259,1,0.61429132545186,0,72,regulation of receptor-mediated endocytosis,BP,
12992,GO:0048260,1,0.745515551520013,0,44,positive regulation of receptor-mediated endocytosis,BP,
12993,GO:0048261,1,0.901387015455132,0,17,negative regulation of receptor-mediated endocytosis,BP,
12994,GO:0048262,1,0.94998188904174,0,9,determination of dorsal/ventral asymmetry,BP,
12995,GO:0048263,1,0.955914500541343,0,8,determination of dorsal identity,BP,
12996,GO:0048264,1,0.993796602962107,0,1,determination of ventral identity,BP,
12997,GO:0048265,1,0.837792353048218,0,26,response to pain,BP,
12998,GO:0048266,1,0.919512254481783,0,12,behavioral response to pain,BP,
13000,GO:0048269,1,0.988924965505526,0,2,methionine adenosyltransferase complex,CC,
13001,GO:0048270,1,0.994891944843497,0,1,methionine adenosyltransferase regulator activity,MF,
13002,GO:0048273,1,0.959043445381092,0,6,mitogen-activated protein kinase p38 binding,MF,
13004,GO:0048280,1,0.954951251331469,0,8,vesicle fusion with Golgi apparatus,BP,
13007,GO:0048286,1,0.759781541271526,0,36,lung alveolus development,BP,
13008,GO:0048289,1,0.963006932898279,0,6,isotype switching to IgE isotypes,BP,
13009,GO:0048290,1,0.966276922158417,0,6,isotype switching to IgA isotypes,BP,
13010,GO:0048291,1,0.932571911841032,0,11,isotype switching to IgG isotypes,BP,
13011,GO:0048293,1,0.963006932898279,0,6,regulation of isotype switching to IgE isotypes,BP,
13012,GO:0048294,1,0.981162464834912,0,3,negative regulation of isotype switching to IgE isotypes,BP,
13013,GO:0048295,1,0.981499418205485,0,3,positive regulation of isotype switching to IgE isotypes,BP,
13014,GO:0048296,1,0.972648111743298,0,5,regulation of isotype switching to IgA isotypes,BP,
13015,GO:0048297,1,0.994830751629326,0,1,negative regulation of isotype switching to IgA isotypes,BP,
13016,GO:0048298,1,0.977703252352735,0,4,positive regulation of isotype switching to IgA isotypes,BP,
13017,GO:0048302,1,0.937635475544327,0,10,regulation of isotype switching to IgG isotypes,BP,
13018,GO:0048304,1,0.955389904188951,0,7,positive regulation of isotype switching to IgG isotypes,BP,
13019,GO:0048305,1,0.912568421569701,0,18,immunoglobulin secretion,BP,
13021,GO:0048308,1,0.912367046995078,0,15,organelle inheritance,BP,
13022,GO:0048311,1,0.880875815656278,0,16,mitochondrion distribution,BP,
13023,GO:0048312,1,0.937456323017455,0,8,intracellular distribution of mitochondria,BP,
13024,GO:0048313,1,0.917828491303485,0,14,Golgi inheritance,BP,
13025,GO:0048318,1,0.96025394613857,0,7,axial mesoderm development,BP,
13026,GO:0048319,1,0.978723532653629,0,3,axial mesoderm morphogenesis,BP,
13027,GO:0048320,1,0.988322975271176,0,2,axial mesoderm formation,BP,
13028,GO:0048321,1,0.994893840072259,0,1,axial mesodermal cell differentiation,BP,
13029,GO:0048322,1,0.994893840072259,0,1,axial mesodermal cell fate commitment,BP,
13030,GO:0048327,1,0.994893840072259,0,1,axial mesodermal cell fate specification,BP,
13033,GO:0048338,1,0.993177281716257,0,1,mesoderm structural organization,BP,
13034,GO:0048339,1,0.884714721567297,0,17,paraxial mesoderm development,BP,
13035,GO:0048340,1,0.934787072529843,0,9,paraxial mesoderm morphogenesis,BP,
13036,GO:0048341,1,0.962642450434103,0,6,paraxial mesoderm formation,BP,
13037,GO:0048342,1,0.995412259871258,0,1,paraxial mesodermal cell differentiation,BP,
13038,GO:0048343,1,0.995412259871258,0,1,paraxial mesodermal cell fate commitment,BP,
13039,GO:0048352,1,0.993177281716257,0,1,paraxial mesoderm structural organization,BP,
13040,GO:0048364,1,0.996531076871997,0,1,root development,BP,
13041,GO:0048365,1,0.638907450054591,0,60,Rac GTPase binding,MF,
13042,GO:0048368,1,0.911921406922034,0,15,lateral mesoderm development,BP,
13043,GO:0048369,1,0.974426177488358,0,4,lateral mesoderm morphogenesis,BP,
13044,GO:0048370,1,0.974426177488358,0,4,lateral mesoderm formation,BP,
13045,GO:0048371,1,0.978824489105703,0,3,lateral mesodermal cell differentiation,BP,
13046,GO:0048372,1,0.984428549369073,0,2,lateral mesodermal cell fate commitment,BP,
13047,GO:0048377,1,0.984428549369073,0,2,lateral mesodermal cell fate specification,BP,
13048,GO:0048378,1,0.984428549369073,0,2,regulation of lateral mesodermal cell fate specification,BP,
13049,GO:0048382,1,0.978233705122164,0,4,mesendoderm development,BP,
13050,GO:0048384,1,0.843347486234344,0,28,retinoic acid receptor signaling pathway,BP,
13051,GO:0048385,1,0.913996294987048,0,15,regulation of retinoic acid receptor signaling pathway,BP,
13052,GO:0048386,1,0.975102612912571,0,4,positive regulation of retinoic acid receptor signaling pathway,BP,
13053,GO:0048387,1,0.94954015068475,0,8,negative regulation of retinoic acid receptor signaling pathway,BP,
13054,GO:0048388,1,0.983770741417336,0,3,endosomal lumen acidification,BP,
13055,GO:0048389,1,0.990436827554303,0,2,intermediate mesoderm development,BP,
13056,GO:0048390,1,0.995275580827277,0,1,intermediate mesoderm morphogenesis,BP,
13057,GO:0048391,1,0.995275580827277,0,1,intermediate mesoderm formation,BP,
13058,GO:0048392,1,0.995275580827277,0,1,intermediate mesodermal cell differentiation,BP,
13059,GO:0048403,1,0.974328725050309,0,3,brain-derived neurotrophic factor binding,MF,
13060,GO:0048406,1,0.958062295640568,0,6,nerve growth factor binding,MF,
13061,GO:0048407,1,0.909854254317528,0,11,platelet-derived growth factor binding,MF,
13062,GO:0048408,1,0.984643771925314,0,3,epidermal growth factor binding,MF,
13064,GO:0048469,1,0.390923125453855,0,146,cell maturation,BP,
13067,GO:0048476,1,0.975529911658937,0,5,Holliday junction resolvase complex,CC,
13069,GO:0048478,1,0.950108270349321,0,7,replication fork protection,BP,
13070,GO:0048483,1,0.758361652957955,0,39,autonomic nervous system development,BP,
13071,GO:0048484,1,0.934489828814744,0,10,enteric nervous system development,BP,
13072,GO:0048485,1,0.865696787066574,0,20,sympathetic nervous system development,BP,
13073,GO:0048486,1,0.905334694394763,0,15,parasympathetic nervous system development,BP,
13074,GO:0048487,1,0.798356617048283,0,36,beta-tubulin binding,MF,
13077,GO:0048490,1,0.903660041813653,0,17,anterograde synaptic vesicle transport,BP,
13078,GO:0048495,1,0.957429904700459,0,5,Roundabout binding,MF,
13079,GO:0048496,1,0.963704395364402,0,4,maintenance of animal organ identity,BP,
13080,GO:0048499,1,0.977870774390367,0,4,synaptic vesicle membrane organization,BP,
13081,GO:0048500,1,0.954425429796557,0,9,signal recognition particle,CC,
13082,GO:0048505,1,0.927274473091356,0,11,regulation of timing of cell differentiation,BP,
13084,GO:0048512,1,0.787745836556904,0,39,circadian behavior,BP,
13090,GO:0048520,1,0.896280205171256,0,18,positive regulation of behavior,BP,
13091,GO:0048521,1,0.936476846483468,0,13,negative regulation of behavior,BP,
13095,GO:0048525,1,0.611787652756332,0,80,negative regulation of viral process,BP,
13096,GO:0048531,1,0.922262075811061,0,14,beta-1,3-galactosyltransferase activity,MF,
13097,GO:0048532,1,0.900986163922251,0,15,anatomical structure arrangement,BP,
13099,GO:0048535,1,0.914990778649093,0,15,lymph node development,BP,
13100,GO:0048536,1,0.805046941763696,0,33,spleen development,BP,
13101,GO:0048537,1,0.964450732739585,0,6,mucosal-associated lymphoid tissue development,BP,
13102,GO:0048538,1,0.736379596300357,0,43,thymus development,BP,
13103,GO:0048539,1,0.956284707469926,0,7,bone marrow development,BP,
13104,GO:0048541,1,0.964450732739585,0,6,Peyer's patch development,BP,
13107,GO:0048548,1,0.942819987014433,0,9,regulation of pinocytosis,BP,
13108,GO:0048549,1,0.971743023416398,0,4,positive regulation of pinocytosis,BP,
13109,GO:0048550,1,0.970244407723679,0,5,negative regulation of pinocytosis,BP,
13110,GO:0048557,1,0.896862097740654,0,16,embryonic digestive tract morphogenesis,BP,
13111,GO:0048560,1,0.989520444767314,0,2,establishment of anatomical structure orientation,BP,
13112,GO:0048561,1,0.994721490193593,0,1,establishment of animal organ orientation,BP,
13113,GO:0048562,1,0.156243109776817,0,268,embryonic organ morphogenesis,BP,
13114,GO:0048563,1,0.945643913233435,0,8,post-embryonic animal organ morphogenesis,BP,
13116,GO:0048566,1,0.812716903332997,0,32,embryonic digestive tract development,BP,
13117,GO:0048567,1,0.994308195715901,0,1,ectodermal digestive tract morphogenesis,BP,
13118,GO:0048568,1,0.0637007332687556,0,398,embryonic organ development,BP,
13119,GO:0048569,1,0.896689808604396,0,15,post-embryonic animal organ development,BP,
13120,GO:0048570,1,0.94384496772599,0,8,notochord morphogenesis,BP,
13126,GO:0048592,1,0.37643729301976,0,132,eye morphogenesis,BP,
13127,GO:0048593,1,0.488637188143122,0,98,camera-type eye morphogenesis,BP,
13128,GO:0048596,1,0.808257912028032,0,25,embryonic camera-type eye morphogenesis,BP,
13129,GO:0048597,1,0.987186294777622,0,3,post-embryonic camera-type eye morphogenesis,BP,
13131,GO:0048599,1,0.77906699781562,0,38,oocyte development,BP,
13134,GO:0048611,1,0.988186816464442,0,2,embryonic ectodermal digestive tract development,BP,
13135,GO:0048613,1,0.994308195715901,0,1,embryonic ectodermal digestive tract morphogenesis,BP,
13136,GO:0048617,1,0.927369069894901,0,9,embryonic foregut morphogenesis,BP,
13137,GO:0048619,1,0.981689323574462,0,3,embryonic hindgut morphogenesis,BP,
13138,GO:0048625,1,0.969177387451319,0,5,myoblast fate commitment,BP,
13139,GO:0048627,1,0.989344568916179,0,2,myoblast development,BP,
13140,GO:0048630,1,0.95365296636323,0,7,skeletal muscle tissue growth,BP,
13141,GO:0048631,1,0.962982495111026,0,5,regulation of skeletal muscle tissue growth,BP,
13142,GO:0048632,1,0.984151653026334,0,2,negative regulation of skeletal muscle tissue growth,BP,
13143,GO:0048633,1,0.978493373323049,0,3,positive regulation of skeletal muscle tissue growth,BP,
13145,GO:0048635,1,0.752776701619487,0,43,negative regulation of muscle organ development,BP,
13146,GO:0048636,1,0.646380798798326,0,60,positive regulation of muscle organ development,BP,
13150,GO:0048641,1,0.728122004301528,0,46,regulation of skeletal muscle tissue development,BP,
13151,GO:0048642,1,0.916823701813167,0,13,negative regulation of skeletal muscle tissue development,BP,
13152,GO:0048643,1,0.867386013812125,0,21,positive regulation of skeletal muscle tissue development,BP,
13153,GO:0048644,1,0.540817003927596,0,79,muscle organ morphogenesis,BP,
13154,GO:0048645,1,0.690755414542417,0,58,animal organ formation,BP,
13156,GO:0048659,1,0.460381996051818,0,117,smooth muscle cell proliferation,BP,
13157,GO:0048660,1,0.470212100084547,0,114,regulation of smooth muscle cell proliferation,BP,
13158,GO:0048661,1,0.612506593778805,0,72,positive regulation of smooth muscle cell proliferation,BP,
13159,GO:0048662,1,0.78965350225495,0,39,negative regulation of smooth muscle cell proliferation,BP,
13161,GO:0048664,1,0.970324559885562,0,6,neuron fate determination,BP,
13165,GO:0048668,1,0.836031180874598,0,25,collateral sprouting,BP,
13166,GO:0048669,1,0.980595678827952,0,3,collateral sprouting in absence of injury,BP,
13167,GO:0048670,1,0.878765603128833,0,19,regulation of collateral sprouting,BP,
13168,GO:0048671,1,0.935648675169499,0,8,negative regulation of collateral sprouting,BP,
13169,GO:0048672,1,0.939244233548414,0,11,positive regulation of collateral sprouting,BP,
13170,GO:0048673,1,0.995528291013897,0,1,collateral sprouting of intact axon in response to injury,BP,
13171,GO:0048674,1,0.994447013915942,0,1,collateral sprouting of injured axon,BP,
13172,GO:0048675,1,0.429956840696979,0,107,axon extension,BP,
13173,GO:0048677,1,0.976747923680177,0,3,axon extension involved in regeneration,BP,
13174,GO:0048678,1,0.675727713581207,0,62,response to axon injury,BP,
13175,GO:0048679,1,0.862885996684764,0,22,regulation of axon regeneration,BP,
13176,GO:0048680,1,0.962195384167888,0,7,positive regulation of axon regeneration,BP,
13177,GO:0048681,1,0.919563416523251,0,12,negative regulation of axon regeneration,BP,
13178,GO:0048682,1,0.971322770644357,0,4,sprouting of injured axon,BP,
13179,GO:0048683,1,0.995528291013897,0,1,regulation of collateral sprouting of intact axon in response to injury,BP,
13180,GO:0048685,1,0.995528291013897,0,1,negative regulation of collateral sprouting of intact axon in response to injury,BP,
13181,GO:0048686,1,0.980145075967619,0,3,regulation of sprouting of injured axon,BP,
13182,GO:0048687,1,0.988423848113322,0,2,positive regulation of sprouting of injured axon,BP,
13183,GO:0048688,1,0.986118302045269,0,2,negative regulation of sprouting of injured axon,BP,
13184,GO:0048689,1,0.994447013915942,0,1,formation of growth cone in injured axon,BP,
13185,GO:0048690,1,0.985619003327131,0,2,regulation of axon extension involved in regeneration,BP,
13186,GO:0048691,1,0.993943540738628,0,1,positive regulation of axon extension involved in regeneration,BP,
13187,GO:0048692,1,0.991625249630398,0,1,negative regulation of axon extension involved in regeneration,BP,
13188,GO:0048693,1,0.994447013915942,0,1,regulation of collateral sprouting of injured axon,BP,
13189,GO:0048694,1,0.994447013915942,0,1,positive regulation of collateral sprouting of injured axon,BP,
13190,GO:0048696,1,0.995637697199164,0,1,regulation of collateral sprouting in absence of injury,BP,
13191,GO:0048697,1,0.995637697199164,0,1,positive regulation of collateral sprouting in absence of injury,BP,
13193,GO:0048701,1,0.733517490378336,0,43,embryonic cranial skeleton morphogenesis,BP,
13194,GO:0048702,1,0.948740253289396,0,7,embryonic neurocranium morphogenesis,BP,
13195,GO:0048703,1,0.930424683728926,0,9,embryonic viscerocranium morphogenesis,BP,
13196,GO:0048704,1,0.551932316539373,0,88,embryonic skeletal system morphogenesis,BP,
13198,GO:0048706,1,0.457976968223404,0,115,embryonic skeletal system development,BP,
13199,GO:0048708,1,0.622954251051409,0,67,astrocyte differentiation,BP,
13201,GO:0048710,1,0.831571639934336,0,27,regulation of astrocyte differentiation,BP,
13202,GO:0048711,1,0.915256855014133,0,14,positive regulation of astrocyte differentiation,BP,
13203,GO:0048712,1,0.927368704376887,0,11,negative regulation of astrocyte differentiation,BP,
13205,GO:0048714,1,0.90092533008283,0,17,positive regulation of oligodendrocyte differentiation,BP,
13208,GO:0048730,1,0.839452036877319,0,27,epidermis morphogenesis,BP,
13211,GO:0048733,1,0.951833317366379,0,6,sebaceous gland development,BP,
13213,GO:0048738,1,0.244990385217696,0,186,cardiac muscle tissue development,BP,
13214,GO:0048739,1,0.883281485920616,0,13,cardiac muscle fiber development,BP,
13215,GO:0048741,1,0.828004706019708,0,28,skeletal muscle fiber development,BP,
13216,GO:0048742,1,0.939675401696154,0,9,regulation of skeletal muscle fiber development,BP,
13217,GO:0048743,1,0.963421347958797,0,6,positive regulation of skeletal muscle fiber development,BP,
13218,GO:0048745,1,0.86793381203864,0,19,smooth muscle tissue development,BP,
13219,GO:0048747,1,0.675950281885572,0,52,muscle fiber development,BP,
13220,GO:0048749,1,0.992790012054268,0,1,compound eye development,BP,
13221,GO:0048752,1,0.949754360890666,0,7,semicircular canal morphogenesis,BP,
13222,GO:0048753,1,0.837870838717943,0,27,pigment granule organization,BP,
13224,GO:0048755,1,0.931456310249809,0,9,branching morphogenesis of a nerve,BP,
13225,GO:0048757,1,0.940845212896697,0,10,pigment granule maturation,BP,
13227,GO:0048763,1,0.940096589343718,0,4,calcium-induced calcium release activity,MF,
13228,GO:0048764,1,0.996531076871997,0,1,trichoblast maturation,BP,
13229,GO:0048765,1,0.996531076871997,0,1,root hair cell differentiation,BP,
13230,GO:0048767,1,0.996531076871997,0,1,root hair elongation,BP,
13231,GO:0048769,1,0.945994466115728,0,4,sarcomerogenesis,BP,
13232,GO:0048770,1,0.532612425446057,0,101,pigment granule,CC,
13233,GO:0048771,1,0.395683888852647,0,136,tissue remodeling,BP,
13235,GO:0048787,1,0.964577755654518,0,5,presynaptic active zone membrane,CC,
13237,GO:0048789,1,0.991912733943847,0,1,cytoskeletal matrix organization at active zone,BP,
13238,GO:0048790,1,0.995631417567393,0,1,maintenance of presynaptic active zone structure,BP,
13240,GO:0048792,1,0.993361648201106,0,1,spontaneous exocytosis of neurotransmitter,BP,
13241,GO:0048793,1,0.954984338370651,0,6,pronephros development,BP,
13242,GO:0048799,1,0.848784206863366,0,19,animal organ maturation,BP,
13243,GO:0048806,1,0.739063453892896,0,40,genitalia development,BP,
13244,GO:0048807,1,0.985321863490765,0,3,female genitalia morphogenesis,BP,
13245,GO:0048808,1,0.981898122585459,0,3,male genitalia morphogenesis,BP,
13248,GO:0048814,1,0.547046618315846,0,78,regulation of dendrite morphogenesis,BP,
13249,GO:0048817,1,0.984272483992509,0,2,negative regulation of hair follicle maturation,BP,
13250,GO:0048818,1,0.968946061730813,0,5,positive regulation of hair follicle maturation,BP,
13251,GO:0048819,1,0.940868186910675,0,9,regulation of hair follicle maturation,BP,
13252,GO:0048820,1,0.883690773621134,0,16,hair follicle maturation,BP,
13253,GO:0048821,1,0.836739290583091,0,28,erythrocyte development,BP,
13254,GO:0048822,1,0.975472008512258,0,3,enucleate erythrocyte development,BP,
13255,GO:0048823,1,0.994054740756748,0,1,nucleate erythrocyte development,BP,
13257,GO:0048840,1,0.968107354430627,0,5,otolith development,BP,
13258,GO:0048841,1,0.790978334198529,0,27,regulation of axon extension involved in axon guidance,BP,
13259,GO:0048842,1,0.931565185774346,0,7,positive regulation of axon extension involved in axon guidance,BP,
13260,GO:0048843,1,0.860204487274241,0,19,negative regulation of axon extension involved in axon guidance,BP,
13261,GO:0048844,1,0.630177505189204,0,58,artery morphogenesis,BP,
13262,GO:0048845,1,0.927157984828101,0,10,venous blood vessel morphogenesis,BP,
13263,GO:0048846,1,0.756509181992903,0,32,axon extension involved in axon guidance,BP,
13264,GO:0048850,1,0.981551526764423,0,2,hypophysis morphogenesis,BP,
13265,GO:0048852,1,0.976438389257143,0,3,diencephalon morphogenesis,BP,
13266,GO:0048853,1,0.912185904078378,0,13,forebrain morphogenesis,BP,
13268,GO:0048855,1,0.990468765918622,0,1,adenohypophysis morphogenesis,BP,
13272,GO:0048859,1,0.971187248436696,0,5,formation of anatomical boundary,BP,
13273,GO:0048861,1,0.969192596281485,0,4,leukemia inhibitory factor signaling pathway,BP,
13274,GO:0048863,1,0.22830467722542,0,234,stem cell differentiation,BP,
13275,GO:0048864,1,0.612325993888178,0,72,stem cell development,BP,
13276,GO:0048865,1,0.957352344192025,0,8,stem cell fate commitment,BP,
13277,GO:0048866,1,0.979022939012107,0,4,stem cell fate specification,BP,
13278,GO:0048867,1,0.985395927587344,0,3,stem cell fate determination,BP,
13282,GO:0048872,1,0.230159567809334,0,225,homeostasis of number of cells,BP,
13283,GO:0048873,1,0.840919106810961,0,27,homeostasis of number of cells within a tissue,BP,
13284,GO:0048874,1,0.993514260851553,0,1,homeostasis of number of cells in a free-living population,BP,
13285,GO:0048875,1,0.937721783671684,0,10,chemical homeostasis within a tissue,BP,
13287,GO:0048880,1,0.972773735954533,0,4,sensory system development,BP,
13288,GO:0048882,1,0.994202771880615,0,1,lateral line development,BP,
13289,GO:0048884,1,0.994202771880615,0,1,neuromast development,BP,
13290,GO:0048886,1,0.994202771880615,0,1,neuromast hair cell differentiation,BP,
13291,GO:0048925,1,0.994202771880615,0,1,lateral line system development,BP,
13292,GO:0048934,1,0.905569387728911,0,13,peripheral nervous system neuron differentiation,BP,
13293,GO:0048935,1,0.905569387728911,0,13,peripheral nervous system neuron development,BP,
13294,GO:0048936,1,0.982385793218807,0,3,peripheral nervous system neuron axonogenesis,BP,
13296,GO:0050011,1,0.995518215394111,0,1,itaconyl-CoA hydratase activity,MF,
13297,GO:0050023,1,0.995175333849207,0,1,L-fuconate dehydratase activity,MF,
13298,GO:0050031,1,0.994481204304773,0,1,L-pipecolate oxidase activity,MF,
13299,GO:0050038,1,0.996465594746375,0,1,L-xylulose reductase (NADP+) activity,MF,
13300,GO:0050046,1,0.994054740756748,0,1,lathosterol oxidase activity,MF,
13301,GO:0050051,1,0.989179083471558,0,2,leukotriene-B4 20-monooxygenase activity,MF,
13302,GO:0050072,1,0.952825175645786,0,7,m7G(5')pppN diphosphatase activity,MF,
13303,GO:0050080,1,0.994756573677009,0,1,malonyl-CoA decarboxylase activity,MF,
13304,GO:0050104,1,0.995631417567393,0,1,L-gulonate 3-dehydrogenase activity,MF,
13305,GO:0050115,1,0.991946597430993,0,1,myosin-light-chain-phosphatase activity,MF,
13306,GO:0050119,1,0.981765819306494,0,2,N-acetylglucosamine deacetylase activity,MF,
13307,GO:0050121,1,0.995662806109828,0,1,N-acylglucosamine 2-epimerase activity,MF,
13308,GO:0050124,1,0.993012830756071,0,1,N-acylneuraminate-9-phosphatase activity,MF,
13309,GO:0050129,1,0.993595655382145,0,1,N-formylglutamate deformylase activity,MF,
13310,GO:0050135,1,0.991312984954525,0,2,NAD(P)+ nucleosidase activity,MF,
13311,GO:0050136,1,0.863704091858012,0,38,NADH dehydrogenase (quinone) activity,MF,
13312,GO:0050144,1,0.994054740756748,0,1,nucleoside deoxyribosyltransferase activity,MF,
13313,GO:0050145,1,0.972516426748565,0,5,nucleoside phosphate kinase activity,MF,
13314,GO:0050146,1,0.991507799868769,0,1,nucleoside phosphotransferase activity,MF,
13315,GO:0050152,1,0.995914340859385,0,1,omega-amidase activity,MF,
13316,GO:0050178,1,0.993509208685174,0,2,phenylpyruvate tautomerase activity,MF,
13317,GO:0050185,1,0.981945007832495,0,2,phosphatidylinositol deacylase activity,MF,
13318,GO:0050197,1,0.994604389298739,0,1,phytanate-CoA ligase activity,MF,
13319,GO:0050201,1,0.992887378728613,0,1,fucokinase activity,MF,
13320,GO:0050211,1,0.982034019024835,0,3,procollagen galactosyltransferase activity,MF,
13321,GO:0050220,1,0.982379477201277,0,4,prostaglandin-E synthase activity,MF,
13322,GO:0050221,1,0.99595425864032,0,1,prostaglandin-E2 9-reductase activity,MF,
13323,GO:0050252,1,0.987557217379541,0,2,retinol O-fatty-acyltransferase activity,MF,
13324,GO:0050253,1,0.985779879309499,0,2,retinyl-palmitate esterase activity,MF,
13325,GO:0050254,1,0.989614452307895,0,2,rhodopsin kinase activity,MF,
13326,GO:0050262,1,0.988144472527205,0,2,ribosylnicotinamide kinase activity,MF,
13327,GO:0050265,1,0.976325954411622,0,3,RNA uridylyltransferase activity,MF,
13328,GO:0050277,1,0.992968769384704,0,1,sedoheptulokinase activity,MF,
13329,GO:0050290,1,0.992083791200642,0,1,sphingomyelin phosphodiesterase D activity,MF,
13330,GO:0050291,1,0.960123861260111,0,7,sphingosine N-acyltransferase activity,MF,
13331,GO:0050294,1,0.982321366647004,0,4,steroid sulfotransferase activity,MF,
13332,GO:0050308,1,0.952136001091186,0,8,sugar-phosphatase activity,MF,
13333,GO:0050309,1,0.983042766196642,0,3,sugar-terminal-phosphatase activity,MF,
13334,GO:0050313,1,0.996301004705437,0,1,sulfur dioxygenase activity,MF,
13335,GO:0050321,1,0.913431815205444,0,13,tau-protein kinase activity,MF,
13336,GO:0050333,1,0.995260363913321,0,1,thiamin-triphosphatase activity,MF,
13337,GO:0050337,1,0.996771561789201,0,1,thiosulfate-thiol sulfurtransferase activity,MF,
13338,GO:0050346,1,0.994054740756748,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
13339,GO:0050347,1,0.988751334214559,0,2,trans-octaprenyltranstransferase activity,MF,
13340,GO:0050353,1,0.993961306708447,0,1,trimethyllysine dioxygenase activity,MF,
13341,GO:0050355,1,0.992354584338207,0,1,triphosphatase activity,MF,
13342,GO:0050379,1,0.991790068667953,0,1,UDP-glucuronate 5'-epimerase activity,MF,
13343,GO:0050405,1,0.979492957831776,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
13344,GO:0050421,1,0.994255839328277,0,1,nitrite reductase (NO-forming) activity,MF,
13346,GO:0050428,1,0.960044438295858,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
13347,GO:0050429,1,0.990381826829504,0,1,calcium-dependent phospholipase C activity,MF,
13348,GO:0050431,1,0.865181192754839,0,19,transforming growth factor beta binding,MF,
13351,GO:0050434,1,0.77432355945405,0,41,positive regulation of viral transcription,BP,
13352,GO:0050435,1,0.792207766083701,0,32,amyloid-beta metabolic process,BP,
13353,GO:0050436,1,0.984605693595004,0,2,microfibril binding,MF,
13354,GO:0050444,1,0.993502154158033,0,1,aquacobalamin reductase (NADPH) activity,MF,
13355,GO:0050459,1,0.994054740756748,0,1,ethanolamine-phosphate phospho-lyase activity,MF,
13356,GO:0050462,1,0.995957999246021,0,1,N-acetylneuraminate synthase activity,MF,
13357,GO:0050473,1,0.980836771804632,0,3,arachidonate 15-lipoxygenase activity,MF,
13358,GO:0050479,1,0.994054740756748,0,1,glyceryl-ether monooxygenase activity,MF,
13359,GO:0050480,1,0.994824453345047,0,1,imidazolonepropionase activity,MF,
13360,GO:0050482,1,0.89378773454949,0,19,arachidonic acid secretion,BP,
13361,GO:0050497,1,0.988516061212568,0,2,transferase activity, transferring alkylthio groups,MF,
13362,GO:0050501,1,0.97777041012072,0,4,hyaluronan synthase activity,MF,
13363,GO:0050508,1,0.979449394813339,0,3,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
13364,GO:0050509,1,0.986555356016462,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
13365,GO:0050510,1,0.97253743530169,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
13366,GO:0050512,1,0.994887523218437,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
13367,GO:0050528,1,0.994509392969713,0,1,acyloxyacyl hydrolase activity,MF,
13368,GO:0050542,1,0.974804489969879,0,6,icosanoid binding,MF,
13369,GO:0050543,1,0.97561628189963,0,6,icosatetraenoic acid binding,MF,
13370,GO:0050544,1,0.979400281601485,0,5,arachidonic acid binding,MF,
13371,GO:0050560,1,0.993435007118271,0,1,aspartate-tRNA(Asn) ligase activity,MF,
13372,GO:0050561,1,0.992893125796607,0,1,glutamate-tRNA(Gln) ligase activity,MF,
13373,GO:0050567,1,0.983820772522336,0,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
13374,GO:0050571,1,0.995494275223235,0,1,1,5-anhydro-D-fructose reductase activity,MF,
13375,GO:0050577,1,0.99580314065602,0,1,GDP-L-fucose synthase activity,MF,
13376,GO:0050610,1,0.992180086409795,0,2,methylarsonate reductase activity,MF,
13377,GO:0050613,1,0.988565682295752,0,2,delta14-sterol reductase activity,MF,
13378,GO:0050614,1,0.992534825731674,0,1,delta24-sterol reductase activity,MF,
13379,GO:0050632,1,0.995731777742456,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
13380,GO:0050646,1,0.995308532112099,0,1,5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13381,GO:0050647,1,0.995308532112099,0,1,5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13382,GO:0050648,1,0.995308532112099,0,1,5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13384,GO:0050651,1,0.89582304104163,0,15,dermatan sulfate proteoglycan biosynthetic process,BP,
13385,GO:0050652,1,0.993079983044061,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13386,GO:0050653,1,0.985987538916176,0,2,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13388,GO:0050655,1,0.891119523491153,0,16,dermatan sulfate proteoglycan metabolic process,BP,
13389,GO:0050656,1,0.959095160096265,0,6,3'-phosphoadenosine 5'-phosphosulfate binding,MF,
13392,GO:0050659,1,0.98330523711084,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
13393,GO:0050660,1,0.611059929320029,0,77,flavin adenine dinucleotide binding,MF,
13394,GO:0050661,1,0.763567899690046,0,44,NADP binding,MF,
13395,GO:0050662,1,0.209746293076658,0,258,coenzyme binding,MF,
13397,GO:0050664,1,0.919812522573614,0,13,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
13398,GO:0050665,1,0.931871427242813,0,11,hydrogen peroxide biosynthetic process,BP,
13399,GO:0050666,1,0.989066114038946,0,2,regulation of homocysteine metabolic process,BP,
13400,GO:0050667,1,0.916075649122458,0,14,homocysteine metabolic process,BP,
13401,GO:0050668,1,0.994660930931217,0,1,positive regulation of homocysteine metabolic process,BP,
13404,GO:0050672,1,0.671256729754902,0,64,negative regulation of lymphocyte proliferation,BP,
13406,GO:0050674,1,0.996719817594225,0,1,urothelial cell proliferation,BP,
13407,GO:0050675,1,0.996719817594225,0,1,regulation of urothelial cell proliferation,BP,
13408,GO:0050677,1,0.996719817594225,0,1,positive regulation of urothelial cell proliferation,BP,
13412,GO:0050681,1,0.750463269173929,0,41,androgen receptor binding,MF,
13413,GO:0050682,1,0.973054115414627,0,3,AF-2 domain binding,MF,
13414,GO:0050683,1,0.992706664763133,0,1,AF-1 domain binding,MF,
13418,GO:0050687,1,0.877320616634694,0,21,negative regulation of defense response to virus,BP,
13419,GO:0050688,1,0.683901654657551,0,58,regulation of defense response to virus,BP,
13420,GO:0050689,1,0.975443696734319,0,5,negative regulation of defense response to virus by host,BP,
13421,GO:0050690,1,0.836093296387258,0,29,regulation of defense response to virus by virus,BP,
13422,GO:0050691,1,0.819319776336465,0,32,regulation of defense response to virus by host,BP,
13423,GO:0050692,1,0.980345457556667,0,3,DBD domain binding,MF,
13424,GO:0050693,1,0.961229767421324,0,6,LBD domain binding,MF,
13425,GO:0050694,1,0.97894001257893,0,4,galactose 3-O-sulfotransferase activity,MF,
13426,GO:0050698,1,0.9878467496467,0,2,proteoglycan sulfotransferase activity,MF,
13427,GO:0050699,1,0.829033013705665,0,30,WW domain binding,MF,
13428,GO:0050700,1,0.924339018777543,0,12,CARD domain binding,MF,
13429,GO:0050701,1,0.768737686583138,0,44,interleukin-1 secretion,BP,
13430,GO:0050702,1,0.786792436964553,0,39,interleukin-1 beta secretion,BP,
13431,GO:0050703,1,0.976566887991826,0,5,interleukin-1 alpha secretion,BP,
13432,GO:0050704,1,0.80883780659635,0,37,regulation of interleukin-1 secretion,BP,
13433,GO:0050705,1,0.979758397431942,0,4,regulation of interleukin-1 alpha secretion,BP,
13434,GO:0050706,1,0.825123288132356,0,33,regulation of interleukin-1 beta secretion,BP,
13435,GO:0050707,1,0.40653587874551,0,146,regulation of cytokine secretion,BP,
13438,GO:0050710,1,0.743305875481201,0,49,negative regulation of cytokine secretion,BP,
13439,GO:0050711,1,0.941331403708413,0,11,negative regulation of interleukin-1 secretion,BP,
13440,GO:0050712,1,0.995717992415467,0,1,negative regulation of interleukin-1 alpha secretion,BP,
13441,GO:0050713,1,0.956905996713742,0,8,negative regulation of interleukin-1 beta secretion,BP,
13443,GO:0050715,1,0.53854433574546,0,100,positive regulation of cytokine secretion,BP,
13444,GO:0050716,1,0.854702787069288,0,26,positive regulation of interleukin-1 secretion,BP,
13445,GO:0050717,1,0.983972462699706,0,3,positive regulation of interleukin-1 alpha secretion,BP,
13446,GO:0050718,1,0.863268143953571,0,24,positive regulation of interleukin-1 beta secretion,BP,
13447,GO:0050719,1,0.996455087544158,0,1,interleukin-1 alpha biosynthetic process,BP,
13448,GO:0050720,1,0.99005405045692,0,2,interleukin-1 beta biosynthetic process,BP,
13449,GO:0050721,1,0.996455087544158,0,1,regulation of interleukin-1 alpha biosynthetic process,BP,
13450,GO:0050722,1,0.99005405045692,0,2,regulation of interleukin-1 beta biosynthetic process,BP,
13451,GO:0050725,1,0.99005405045692,0,2,positive regulation of interleukin-1 beta biosynthetic process,BP,
13452,GO:0050726,1,0.996455087544158,0,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,
13454,GO:0050728,1,0.543265982643346,0,100,negative regulation of inflammatory response,BP,
13459,GO:0050733,1,0.966840297919825,0,5,RS domain binding,MF,
13460,GO:0050746,1,0.924298811663678,0,12,regulation of lipoprotein metabolic process,BP,
13461,GO:0050747,1,0.968330186110048,0,5,positive regulation of lipoprotein metabolic process,BP,
13462,GO:0050748,1,0.973428375704592,0,4,negative regulation of lipoprotein metabolic process,BP,
13464,GO:0050751,1,0.996365403665788,0,1,fractalkine biosynthetic process,BP,
13465,GO:0050752,1,0.996365403665788,0,1,regulation of fractalkine biosynthetic process,BP,
13466,GO:0050754,1,0.996365403665788,0,1,positive regulation of fractalkine biosynthetic process,BP,
13467,GO:0050755,1,0.94105708177278,0,12,chemokine metabolic process,BP,
13468,GO:0050756,1,0.996365403665788,0,1,fractalkine metabolic process,BP,
13469,GO:0050757,1,0.990340047032558,0,2,thymidylate synthase biosynthetic process,BP,
13470,GO:0050758,1,0.990340047032558,0,2,regulation of thymidylate synthase biosynthetic process,BP,
13471,GO:0050760,1,0.994211581545942,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
13472,GO:0050764,1,0.654252965351266,0,68,regulation of phagocytosis,BP,
13473,GO:0050765,1,0.928639135675195,0,13,negative regulation of phagocytosis,BP,
13474,GO:0050766,1,0.73426154062583,0,49,positive regulation of phagocytosis,BP,
13478,GO:0050770,1,0.291485052453591,0,162,regulation of axonogenesis,BP,
13479,GO:0050771,1,0.641533565961134,0,60,negative regulation of axonogenesis,BP,
13480,GO:0050772,1,0.548028873695074,0,77,positive regulation of axonogenesis,BP,
13482,GO:0050774,1,0.897292263611856,0,15,negative regulation of dendrite morphogenesis,BP,
13483,GO:0050775,1,0.777769223000554,0,32,positive regulation of dendrite morphogenesis,BP,
13485,GO:0050777,1,0.480556009536833,0,118,negative regulation of immune response,BP,
13487,GO:0050779,1,0.830953328432717,0,24,RNA destabilization,BP,
13489,GO:0050783,1,0.994445795478841,0,1,cocaine metabolic process,BP,
13490,GO:0050785,1,0.995831903661952,0,1,advanced glycation end-product receptor activity,MF,
13491,GO:0050786,1,0.962761188401448,0,10,RAGE receptor binding,MF,
13492,GO:0050787,1,0.988124408610183,0,2,detoxification of mercury ion,BP,
13502,GO:0050802,1,0.891871100822605,0,21,circadian sleep/wake cycle, sleep,BP,
13509,GO:0050810,1,0.607041003664944,0,77,regulation of steroid biosynthetic process,BP,
13510,GO:0050811,1,0.907496645297891,0,14,GABA receptor binding,MF,
13511,GO:0050812,1,0.910406722447242,0,13,regulation of acyl-CoA biosynthetic process,BP,
13512,GO:0050815,1,0.962828800724419,0,6,phosphoserine residue binding,MF,
13513,GO:0050816,1,0.97989668751227,0,3,phosphothreonine residue binding,MF,
13514,GO:0050817,1,0.145068977464689,0,295,coagulation,BP,
13515,GO:0050818,1,0.638612939398651,0,74,regulation of coagulation,BP,
13516,GO:0050819,1,0.760344070803737,0,47,negative regulation of coagulation,BP,
13517,GO:0050820,1,0.861705384147614,0,24,positive regulation of coagulation,BP,
13519,GO:0050822,1,0.993292923015384,0,1,peptide stabilization,BP,
13520,GO:0050823,1,0.993292923015384,0,1,peptide antigen stabilization,BP,
13524,GO:0050833,1,0.976819943771779,0,4,pyruvate transmembrane transporter activity,MF,
13526,GO:0050840,1,0.708092141262,0,48,extracellular matrix binding,MF,
13527,GO:0050847,1,0.931521287802567,0,8,progesterone receptor signaling pathway,BP,
13529,GO:0050849,1,0.896136780678045,0,17,negative regulation of calcium-mediated signaling,BP,
13531,GO:0050851,1,0.271292927659299,0,221,antigen receptor-mediated signaling pathway,BP,
13532,GO:0050852,1,0.345814698040353,0,183,T cell receptor signaling pathway,BP,
13533,GO:0050853,1,0.717287745551981,0,52,B cell receptor signaling pathway,BP,
13534,GO:0050854,1,0.717992095939745,0,52,regulation of antigen receptor-mediated signaling pathway,BP,
13535,GO:0050855,1,0.877493026976173,0,20,regulation of B cell receptor signaling pathway,BP,
13536,GO:0050856,1,0.806203613647847,0,35,regulation of T cell receptor signaling pathway,BP,
13537,GO:0050857,1,0.880985705563353,0,20,positive regulation of antigen receptor-mediated signaling pathway,BP,
13538,GO:0050858,1,0.881684084536715,0,22,negative regulation of antigen receptor-mediated signaling pathway,BP,
13539,GO:0050859,1,0.971821465659526,0,5,negative regulation of B cell receptor signaling pathway,BP,
13540,GO:0050860,1,0.902439950498504,0,18,negative regulation of T cell receptor signaling pathway,BP,
13541,GO:0050861,1,0.952725373709301,0,7,positive regulation of B cell receptor signaling pathway,BP,
13542,GO:0050862,1,0.93239582664072,0,12,positive regulation of T cell receptor signaling pathway,BP,
13544,GO:0050864,1,0.510825195456728,0,106,regulation of B cell activation,BP,
13548,GO:0050868,1,0.580299850197024,0,87,negative regulation of T cell activation,BP,
13549,GO:0050869,1,0.822801451278287,0,31,negative regulation of B cell activation,BP,
13551,GO:0050871,1,0.655905278525528,0,68,positive regulation of B cell activation,BP,
13552,GO:0050872,1,0.923582168249701,0,12,white fat cell differentiation,BP,
13553,GO:0050873,1,0.812909413128757,0,33,brown fat cell differentiation,BP,
13556,GO:0050879,1,0.728283526253622,0,47,multicellular organismal movement,BP,
13558,GO:0050881,1,0.728283526253622,0,47,musculoskeletal movement,BP,
13559,GO:0050882,1,0.940255002286779,0,6,voluntary musculoskeletal movement,BP,
13560,GO:0050883,1,0.994409330361848,0,1,musculoskeletal movement, spinal reflex action,BP,
13561,GO:0050884,1,0.904573113656588,0,14,neuromuscular process controlling posture,BP,
13562,GO:0050885,1,0.716173949992597,0,44,neuromuscular process controlling balance,BP,
13563,GO:0050886,1,0.641441682791405,0,72,endocrine process,BP,
13567,GO:0050893,1,0.974374249457322,0,4,sensory processing,BP,
13568,GO:0050894,1,0.990189166709833,0,1,determination of affect,BP,
13570,GO:0050897,1,0.990809253553117,0,1,cobalt ion binding,MF,
13573,GO:0050902,1,0.987904395996808,0,2,leukocyte adhesive activation,BP,
13574,GO:0050904,1,0.984641066047748,0,2,diapedesis,BP,
13576,GO:0050906,1,0.609482536419292,0,87,detection of stimulus involved in sensory perception,BP,
13577,GO:0050907,1,0.820794115589806,0,43,detection of chemical stimulus involved in sensory perception,BP,
13578,GO:0050908,1,0.907897848685618,0,14,detection of light stimulus involved in visual perception,BP,
13579,GO:0050909,1,0.792911166363685,0,44,sensory perception of taste,BP,
13580,GO:0050910,1,0.931080840429486,0,11,detection of mechanical stimulus involved in sensory perception of sound,BP,
13581,GO:0050911,1,0.924653017071046,0,18,detection of chemical stimulus involved in sensory perception of smell,BP,
13582,GO:0050912,1,0.899667434569143,0,23,detection of chemical stimulus involved in sensory perception of taste,BP,
13583,GO:0050913,1,0.882294845181868,0,25,sensory perception of bitter taste,BP,
13584,GO:0050915,1,0.976119135937739,0,4,sensory perception of sour taste,BP,
13585,GO:0050916,1,0.971148881986675,0,4,sensory perception of sweet taste,BP,
13586,GO:0050917,1,0.965035391070098,0,5,sensory perception of umami taste,BP,
13587,GO:0050918,1,0.722453782948574,0,51,positive chemotaxis,BP,
13588,GO:0050919,1,0.748105180152729,0,36,negative chemotaxis,BP,
13591,GO:0050922,1,0.732362065192098,0,45,negative regulation of chemotaxis,BP,
13592,GO:0050923,1,0.966048126382353,0,4,regulation of negative chemotaxis,BP,
13593,GO:0050924,1,0.991850930900194,0,1,positive regulation of negative chemotaxis,BP,
13594,GO:0050925,1,0.980471161388521,0,2,negative regulation of negative chemotaxis,BP,
13595,GO:0050926,1,0.855553930714966,0,25,regulation of positive chemotaxis,BP,
13596,GO:0050927,1,0.862840827099752,0,24,positive regulation of positive chemotaxis,BP,
13597,GO:0050928,1,0.991567276395695,0,1,negative regulation of positive chemotaxis,BP,
13598,GO:0050929,1,0.991850930900194,0,1,induction of negative chemotaxis,BP,
13599,GO:0050930,1,0.934195496509033,0,13,induction of positive chemotaxis,BP,
13600,GO:0050931,1,0.789139663804805,0,32,pigment cell differentiation,BP,
13601,GO:0050932,1,0.933265720262778,0,9,regulation of pigment cell differentiation,BP,
13602,GO:0050942,1,0.942387070456496,0,7,positive regulation of pigment cell differentiation,BP,
13603,GO:0050951,1,0.879273923031108,0,19,sensory perception of temperature stimulus,BP,
13604,GO:0050953,1,0.32851028189179,0,167,sensory perception of light stimulus,BP,
13606,GO:0050955,1,0.983939547356858,0,2,thermoception,BP,
13607,GO:0050957,1,0.953408641658785,0,6,equilibrioception,BP,
13608,GO:0050960,1,0.992682979675518,0,1,detection of temperature stimulus involved in thermoception,BP,
13609,GO:0050961,1,0.917694631871903,0,14,detection of temperature stimulus involved in sensory perception,BP,
13610,GO:0050962,1,0.907897848685618,0,14,detection of light stimulus involved in sensory perception,BP,
13611,GO:0050965,1,0.917694631871903,0,14,detection of temperature stimulus involved in sensory perception of pain,BP,
13612,GO:0050966,1,0.940182637390588,0,8,detection of mechanical stimulus involved in sensory perception of pain,BP,
13613,GO:0050968,1,0.986780785567295,0,2,detection of chemical stimulus involved in sensory perception of pain,BP,
13614,GO:0050974,1,0.856237953399551,0,23,detection of mechanical stimulus involved in sensory perception,BP,
13615,GO:0050975,1,0.979925823040808,0,3,sensory perception of touch,BP,
13616,GO:0050976,1,0.984226185941977,0,2,detection of mechanical stimulus involved in sensory perception of touch,BP,
13617,GO:0050982,1,0.733901523212325,0,38,detection of mechanical stimulus,BP,
13618,GO:0050992,1,0.994830751629326,0,1,dimethylallyl diphosphate biosynthetic process,BP,
13619,GO:0050993,1,0.994830751629326,0,1,dimethylallyl diphosphate metabolic process,BP,
13622,GO:0050996,1,0.890545919742095,0,17,positive regulation of lipid catabolic process,BP,
13623,GO:0050997,1,0.898131747770297,0,17,quaternary ammonium group binding,MF,
13626,GO:0051000,1,0.898569829592648,0,17,positive regulation of nitric-oxide synthase activity,BP,
13628,GO:0051004,1,0.918450828198027,0,15,regulation of lipoprotein lipase activity,BP,
13629,GO:0051005,1,0.982040572763082,0,3,negative regulation of lipoprotein lipase activity,BP,
13630,GO:0051006,1,0.965686227708731,0,7,positive regulation of lipoprotein lipase activity,BP,
13631,GO:0051010,1,0.880490446981929,0,13,microtubule plus-end binding,MF,
13632,GO:0051011,1,0.921196829846034,0,9,microtubule minus-end binding,MF,
13633,GO:0051012,1,0.987071895904877,0,2,microtubule sliding,BP,
13634,GO:0051013,1,0.953745991296599,0,7,microtubule severing,BP,
13635,GO:0051014,1,0.950081463643827,0,8,actin filament severing,BP,
13636,GO:0051015,1,0.273758775074163,0,167,actin filament binding,MF,
13637,GO:0051016,1,0.916401884269718,0,14,barbed-end actin filament capping,BP,
13638,GO:0051017,1,0.378765635488628,0,139,actin filament bundle assembly,BP,
13639,GO:0051018,1,0.683413432963783,0,47,protein kinase A binding,MF,
13640,GO:0051019,1,0.832539880841162,0,26,mitogen-activated protein kinase binding,MF,
13642,GO:0051021,1,0.970907678842156,0,5,GDP-dissociation inhibitor binding,MF,
13643,GO:0051022,1,0.975168865859668,0,4,Rho GDP-dissociation inhibitor binding,MF,
13644,GO:0051023,1,0.928696617216367,0,15,regulation of immunoglobulin secretion,BP,
13645,GO:0051024,1,0.958154328972329,0,9,positive regulation of immunoglobulin secretion,BP,
13646,GO:0051025,1,0.98796753747143,0,2,negative regulation of immunoglobulin secretion,BP,
13647,GO:0051026,1,0.964746787006697,0,6,chiasma assembly,BP,
13648,GO:0051028,1,0.38546954238059,0,138,mRNA transport,BP,
13649,GO:0051029,1,0.965333550019828,0,6,rRNA transport,BP,
13650,GO:0051030,1,0.981874795733342,0,4,snRNA transport,BP,
13651,GO:0051031,1,0.793648745144505,0,32,tRNA transport,BP,
13652,GO:0051032,1,0.984742804182456,0,2,nucleic acid transmembrane transporter activity,MF,
13653,GO:0051033,1,0.984742804182456,0,2,RNA transmembrane transporter activity,MF,
13654,GO:0051036,1,0.972328135018485,0,5,regulation of endosome size,BP,
13655,GO:0051040,1,0.987217371773156,0,2,regulation of calcium-independent cell-cell adhesion,BP,
13656,GO:0051041,1,0.99352639328701,0,1,positive regulation of calcium-independent cell-cell adhesion,BP,
13657,GO:0051042,1,0.993650285489828,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
13659,GO:0051044,1,0.92276367028452,0,13,positive regulation of membrane protein ectodomain proteolysis,BP,
13668,GO:0051053,1,0.433345482609074,0,117,negative regulation of DNA metabolic process,BP,
13670,GO:0051055,1,0.767275015084328,0,44,negative regulation of lipid biosynthetic process,BP,
13672,GO:0051057,1,0.683358742828395,0,53,positive regulation of small GTPase mediated signal transduction,BP,
13674,GO:0051059,1,0.84442155063179,0,28,NF-kappaB binding,MF,
13675,GO:0051066,1,0.990524014604509,0,2,dihydrobiopterin metabolic process,BP,
13676,GO:0051068,1,0.993212130508638,0,1,dihydrolipoamide metabolic process,BP,
13677,GO:0051081,1,0.724080075022049,0,46,nuclear envelope disassembly,BP,
13679,GO:0051083,1,0.990081996775932,0,2,'de novo' cotranslational protein folding,BP,
13680,GO:0051084,1,0.821592126495684,0,32,'de novo' posttranslational protein folding,BP,
13681,GO:0051085,1,0.852093785585336,0,27,chaperone cofactor-dependent protein refolding,BP,
13682,GO:0051086,1,0.995044566688198,0,1,chaperone mediated protein folding independent of cofactor,BP,
13684,GO:0051088,1,0.979081429185297,0,3,PMA-inducible membrane protein ectodomain proteolysis,BP,
13685,GO:0051089,1,0.992874924561546,0,1,constitutive protein ectodomain proteolysis,BP,
13691,GO:0051095,1,0.945589171163423,0,9,regulation of helicase activity,BP,
13692,GO:0051096,1,0.962417280774129,0,6,positive regulation of helicase activity,BP,
13693,GO:0051097,1,0.982521454567462,0,3,negative regulation of helicase activity,BP,
13694,GO:0051098,1,0.109899874827951,0,333,regulation of binding,BP,
13695,GO:0051099,1,0.337261306597453,0,163,positive regulation of binding,BP,
13696,GO:0051100,1,0.389230071503629,0,147,negative regulation of binding,BP,
13697,GO:0051101,1,0.492295655099765,0,110,regulation of DNA binding,BP,
13698,GO:0051102,1,0.992762597767449,0,1,DNA ligation involved in DNA recombination,BP,
13699,GO:0051103,1,0.939347383192598,0,11,DNA ligation involved in DNA repair,BP,
13700,GO:0051105,1,0.964863741534627,0,6,regulation of DNA ligation,BP,
13701,GO:0051106,1,0.970770668970197,0,5,positive regulation of DNA ligation,BP,
13702,GO:0051107,1,0.993917036717789,0,1,negative regulation of DNA ligation,BP,
13704,GO:0051119,1,0.858388521827296,0,24,sugar transmembrane transporter activity,MF,
13705,GO:0051120,1,0.982272980670814,0,3,hepoxilin A3 synthase activity,MF,
13706,GO:0051121,1,0.971094579487715,0,5,hepoxilin metabolic process,BP,
13707,GO:0051122,1,0.971094579487715,0,5,hepoxilin biosynthetic process,BP,
13708,GO:0051123,1,0.824632633539738,0,31,RNA polymerase II transcriptional preinitiation complex assembly,BP,
13709,GO:0051124,1,0.915335393892592,0,10,synaptic growth at neuromuscular junction,BP,
13710,GO:0051125,1,0.834023312762056,0,27,regulation of actin nucleation,BP,
13711,GO:0051126,1,0.961821583061439,0,7,negative regulation of actin nucleation,BP,
13712,GO:0051127,1,0.892658171102066,0,15,positive regulation of actin nucleation,BP,
13716,GO:0051131,1,0.90342129749421,0,18,chaperone-mediated protein complex assembly,BP,
13717,GO:0051132,1,0.958556235920689,0,8,NK T cell activation,BP,
13718,GO:0051133,1,0.970120295527897,0,6,regulation of NK T cell activation,BP,
13719,GO:0051134,1,0.995141050033782,0,1,negative regulation of NK T cell activation,BP,
13720,GO:0051135,1,0.974858300971478,0,5,positive regulation of NK T cell activation,BP,
13721,GO:0051136,1,0.959607335221895,0,6,regulation of NK T cell differentiation,BP,
13722,GO:0051138,1,0.971864704128479,0,4,positive regulation of NK T cell differentiation,BP,
13723,GO:0051139,1,0.984373346491596,0,2,metal ion:proton antiporter activity,MF,
13724,GO:0051140,1,0.985838278777753,0,3,regulation of NK T cell proliferation,BP,
13725,GO:0051142,1,0.985838278777753,0,3,positive regulation of NK T cell proliferation,BP,
13726,GO:0051145,1,0.713818979447404,0,51,smooth muscle cell differentiation,BP,
13727,GO:0051146,1,0.189032554950418,0,233,striated muscle cell differentiation,BP,
13728,GO:0051147,1,0.423110723417263,0,127,regulation of muscle cell differentiation,BP,
13729,GO:0051148,1,0.760640742926688,0,40,negative regulation of muscle cell differentiation,BP,
13730,GO:0051149,1,0.621660926747346,0,73,positive regulation of muscle cell differentiation,BP,
13731,GO:0051150,1,0.842530543099678,0,26,regulation of smooth muscle cell differentiation,BP,
13732,GO:0051151,1,0.928482313995367,0,11,negative regulation of smooth muscle cell differentiation,BP,
13733,GO:0051152,1,0.935150724425787,0,11,positive regulation of smooth muscle cell differentiation,BP,
13734,GO:0051153,1,0.579253269032273,0,82,regulation of striated muscle cell differentiation,BP,
13735,GO:0051154,1,0.824678199864254,0,28,negative regulation of striated muscle cell differentiation,BP,
13736,GO:0051155,1,0.738874243847543,0,47,positive regulation of striated muscle cell differentiation,BP,
13737,GO:0051156,1,0.861880569128364,0,26,glucose 6-phosphate metabolic process,BP,
13738,GO:0051160,1,0.99434294248527,0,1,L-xylitol catabolic process,BP,
13739,GO:0051164,1,0.99434294248527,0,1,L-xylitol metabolic process,BP,
13740,GO:0051167,1,0.975449316686297,0,5,xylulose 5-phosphate metabolic process,BP,
13741,GO:0051168,1,0.277778778406748,0,191,nuclear export,BP,
13742,GO:0051169,1,0.111377467375649,0,327,nuclear transport,BP,
13743,GO:0051170,1,0.368670868577482,0,149,import into nucleus,BP,
13748,GO:0051176,1,0.978173615040714,0,3,positive regulation of sulfur metabolic process,BP,
13749,GO:0051177,1,0.96683554279799,0,6,meiotic sister chromatid cohesion,BP,
13751,GO:0051180,1,0.81849445039982,0,30,vitamin transport,BP,
13752,GO:0051181,1,0.772937747893656,0,41,cofactor transport,BP,
13753,GO:0051182,1,0.949716660371132,0,8,coenzyme transport,BP,
13754,GO:0051184,1,0.874056104943748,0,20,cofactor transmembrane transporter activity,MF,
13755,GO:0051185,1,0.962048238651431,0,6,coenzyme transmembrane transporter activity,MF,
13756,GO:0051186,1,0.0457011253969202,0,513,cofactor metabolic process,BP,
13757,GO:0051187,1,0.787484368133614,0,45,cofactor catabolic process,BP,
13758,GO:0051188,1,0.175839280412672,0,274,cofactor biosynthetic process,BP,
13759,GO:0051189,1,0.960130051502271,0,7,prosthetic group metabolic process,BP,
13760,GO:0051192,1,0.993377801209287,0,2,prosthetic group binding,MF,
13761,GO:0051193,1,0.521026404953552,0,94,regulation of cofactor metabolic process,BP,
13762,GO:0051194,1,0.869247933350384,0,19,positive regulation of cofactor metabolic process,BP,
13763,GO:0051195,1,0.899812714812042,0,16,negative regulation of cofactor metabolic process,BP,
13764,GO:0051196,1,0.562675510156251,0,80,regulation of coenzyme metabolic process,BP,
13765,GO:0051197,1,0.884488315685734,0,16,positive regulation of coenzyme metabolic process,BP,
13766,GO:0051198,1,0.929418189200658,0,10,negative regulation of coenzyme metabolic process,BP,
13767,GO:0051204,1,0.8239332115695,0,34,protein insertion into mitochondrial membrane,BP,
13768,GO:0051205,1,0.768130554195321,0,46,protein insertion into membrane,BP,
13769,GO:0051208,1,0.461398096698407,0,104,sequestering of calcium ion,BP,
13770,GO:0051209,1,0.474184095660389,0,100,release of sequestered calcium ion into cytosol,BP,
13771,GO:0051213,1,0.561885546068632,0,85,dioxygenase activity,MF,
13774,GO:0051220,1,0.850753290428935,0,24,cytoplasmic sequestering of protein,BP,
13779,GO:0051228,1,0.99165772939789,0,1,mitotic spindle disassembly,BP,
13780,GO:0051230,1,0.99165772939789,0,1,spindle disassembly,BP,
13782,GO:0051232,1,0.994530285599652,0,1,meiotic spindle elongation,BP,
13783,GO:0051233,1,0.805377548526017,0,31,spindle midzone,CC,
13795,GO:0051250,1,0.482087219534313,0,117,negative regulation of lymphocyte activation,BP,
13802,GO:0051257,1,0.994415395872108,0,1,meiotic spindle midzone assembly,BP,
13808,GO:0051264,1,0.994016209096484,0,1,mono-olein transacylation activity,MF,
13809,GO:0051265,1,0.994016209096484,0,1,diolein transacylation activity,MF,
13810,GO:0051267,1,0.993550737487651,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
13815,GO:0051279,1,0.607869763203809,0,69,regulation of release of sequestered calcium ion into cytosol,BP,
13816,GO:0051280,1,0.928994909124302,0,13,negative regulation of release of sequestered calcium ion into cytosol,BP,
13817,GO:0051281,1,0.793572574301834,0,36,positive regulation of release of sequestered calcium ion into cytosol,BP,
13818,GO:0051282,1,0.470997997560379,0,101,regulation of sequestering of calcium ion,BP,
13819,GO:0051283,1,0.474184095660389,0,100,negative regulation of sequestering of calcium ion,BP,
13820,GO:0051284,1,0.912154321690477,0,14,positive regulation of sequestering of calcium ion,BP,
13821,GO:0051286,1,0.948140193439481,0,7,cell tip,CC,
13822,GO:0051287,1,0.730289915201582,0,56,NAD binding,MF,
13823,GO:0051289,1,0.623561892847864,0,75,protein homotetramerization,BP,
13826,GO:0051292,1,0.925723882876549,0,10,nuclear pore complex assembly,BP,
13827,GO:0051293,1,0.770971134317145,0,34,establishment of spindle localization,BP,
13828,GO:0051294,1,0.831124372716875,0,26,establishment of spindle orientation,BP,
13829,GO:0051295,1,0.965172329120985,0,4,establishment of meiotic spindle localization,BP,
13830,GO:0051298,1,0.638618729301034,0,62,centrosome duplication,BP,
13831,GO:0051299,1,0.894862276441087,0,16,centrosome separation,BP,
13832,GO:0051300,1,0.994054740756748,0,1,spindle pole body organization,BP,
13837,GO:0051305,1,0.952998630963722,0,6,chromosome movement towards spindle pole,BP,
13840,GO:0051308,1,0.994054740756748,0,1,male meiosis chromosome separation,BP,
13842,GO:0051311,1,0.994415395872108,0,1,meiotic metaphase plate congression,BP,
13843,GO:0051315,1,0.920115433119075,0,13,attachment of mitotic spindle microtubules to kinetochore,BP,
13844,GO:0051316,1,0.988766304241583,0,2,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,
13849,GO:0051340,1,0.954893224942234,0,9,regulation of ligase activity,BP,
13851,GO:0051342,1,0.952635306594191,0,8,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13852,GO:0051343,1,0.9770962806738,0,4,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13853,GO:0051344,1,0.96889367642848,0,5,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13860,GO:0051351,1,0.965479826166276,0,7,positive regulation of ligase activity,BP,
13861,GO:0051352,1,0.989038755398943,0,2,negative regulation of ligase activity,BP,
13862,GO:0051353,1,0.774388993358602,0,41,positive regulation of oxidoreductase activity,BP,
13864,GO:0051355,1,0.99299845905591,0,1,proprioception involved in equilibrioception,BP,
13865,GO:0051365,1,0.982164986773897,0,3,cellular response to potassium ion starvation,BP,
13866,GO:0051371,1,0.847132217796113,0,18,muscle alpha-actinin binding,MF,
13867,GO:0051373,1,0.971902732964807,0,5,FATZ binding,MF,
13868,GO:0051377,1,0.979202799517885,0,3,mannose-ethanolamine phosphotransferase activity,MF,
13869,GO:0051378,1,0.93939845943042,0,11,serotonin binding,MF,
13870,GO:0051379,1,0.962183003233525,0,7,epinephrine binding,MF,
13871,GO:0051380,1,0.972188114393732,0,5,norepinephrine binding,MF,
13875,GO:0051385,1,0.845868607438169,0,28,response to mineralocorticoid,BP,
13876,GO:0051386,1,0.943481170650626,0,9,regulation of neurotrophin TRK receptor signaling pathway,BP,
13877,GO:0051387,1,0.983722867994444,0,3,negative regulation of neurotrophin TRK receptor signaling pathway,BP,
13878,GO:0051388,1,0.971351243562235,0,4,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
13879,GO:0051389,1,0.978069048194272,0,2,inactivation of MAPKK activity,BP,
13880,GO:0051391,1,0.992858153626207,0,1,tRNA acetylation,BP,
13881,GO:0051392,1,0.992858153626207,0,1,tRNA N-acetyltransferase activity,MF,
13882,GO:0051393,1,0.748680131240105,0,33,alpha-actinin binding,MF,
13883,GO:0051400,1,0.94801505311157,0,9,BH domain binding,MF,
13886,GO:0051409,1,0.938638245391011,0,10,response to nitrosative stress,BP,
13887,GO:0051410,1,0.973048744026904,0,5,detoxification of nitrogen compound,BP,
13888,GO:0051412,1,0.904814522657597,0,16,response to corticosterone,BP,
13889,GO:0051413,1,0.994364600709686,0,1,response to cortisone,BP,
13890,GO:0051414,1,0.961342999131026,0,5,response to cortisol,BP,
13891,GO:0051415,1,0.965540661555102,0,5,microtubule nucleation by interphase microtubule organizing center,BP,
13892,GO:0051417,1,0.994054740756748,0,1,microtubule nucleation by spindle pole body,BP,
13893,GO:0051418,1,0.945437096197628,0,7,microtubule nucleation by microtubule organizing center,BP,
13894,GO:0051424,1,0.995204533278585,0,1,corticotropin-releasing hormone binding,MF,
13895,GO:0051425,1,0.967115827087656,0,4,PTB domain binding,MF,
13896,GO:0051427,1,0.327756413269891,0,164,hormone receptor binding,MF,
13897,GO:0051428,1,0.915349055513668,0,17,peptide hormone receptor binding,MF,
13898,GO:0051429,1,0.975729053405709,0,5,corticotropin-releasing hormone receptor binding,MF,
13899,GO:0051430,1,0.979987700073587,0,4,corticotropin-releasing hormone receptor 1 binding,MF,
13900,GO:0051431,1,0.988348969441176,0,3,corticotropin-releasing hormone receptor 2 binding,MF,
13901,GO:0051433,1,0.992281701428379,0,1,BH2 domain binding,MF,
13902,GO:0051434,1,0.9725565582305,0,5,BH3 domain binding,MF,
13903,GO:0051438,1,0.727657982923289,0,51,regulation of ubiquitin-protein transferase activity,BP,
13904,GO:0051443,1,0.820077584083694,0,32,positive regulation of ubiquitin-protein transferase activity,BP,
13905,GO:0051444,1,0.922874186325333,0,14,negative regulation of ubiquitin-protein transferase activity,BP,
13907,GO:0051446,1,0.910447266933603,0,14,positive regulation of meiotic cell cycle,BP,
13908,GO:0051447,1,0.918997063829283,0,14,negative regulation of meiotic cell cycle,BP,
13909,GO:0051450,1,0.89272841122095,0,18,myoblast proliferation,BP,
13910,GO:0051451,1,0.928264726220882,0,11,myoblast migration,BP,
13911,GO:0051452,1,0.759938177118653,0,47,intracellular pH reduction,BP,
13913,GO:0051454,1,0.973229006489915,0,4,intracellular pH elevation,BP,
13914,GO:0051455,1,0.994054740756748,0,1,attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation,BP,
13915,GO:0051456,1,0.994680254176584,0,1,attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation,BP,
13916,GO:0051457,1,0.860881488168452,0,22,maintenance of protein location in nucleus,BP,
13917,GO:0051458,1,0.964827215346063,0,7,corticotropin secretion,BP,
13918,GO:0051459,1,0.970357774929248,0,6,regulation of corticotropin secretion,BP,
13919,GO:0051460,1,0.995204533278585,0,1,negative regulation of corticotropin secretion,BP,
13920,GO:0051461,1,0.97503471509448,0,5,positive regulation of corticotropin secretion,BP,
13921,GO:0051462,1,0.973912202306731,0,5,regulation of cortisol secretion,BP,
13922,GO:0051463,1,0.990548073540945,0,1,negative regulation of cortisol secretion,BP,
13923,GO:0051464,1,0.983206985791765,0,4,positive regulation of cortisol secretion,BP,
13924,GO:0051466,1,0.993576212296719,0,1,positive regulation of corticotropin-releasing hormone secretion,BP,
13926,GO:0051481,1,0.927621915493736,0,9,negative regulation of cytosolic calcium ion concentration,BP,
13927,GO:0051482,1,0.855862572944337,0,27,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,
13929,GO:0051490,1,0.989427466485957,0,2,negative regulation of filopodium assembly,BP,
13931,GO:0051492,1,0.583072833811608,0,75,regulation of stress fiber assembly,BP,
13935,GO:0051496,1,0.726854390076505,0,47,positive regulation of stress fiber assembly,BP,
13936,GO:0051497,1,0.8629088924083,0,20,negative regulation of stress fiber assembly,BP,
13937,GO:0051499,1,0.989880094311841,0,2,D-aminoacyl-tRNA deacylase activity,MF,
13938,GO:0051500,1,0.989880094311841,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
13939,GO:0051503,1,0.926558108726723,0,13,adenine nucleotide transport,BP,
13940,GO:0051525,1,0.963813931813871,0,5,NFAT protein binding,MF,
13941,GO:0051536,1,0.694061907313482,0,61,iron-sulfur cluster binding,MF,
13942,GO:0051537,1,0.893132356038461,0,20,2 iron, 2 sulfur cluster binding,MF,
13943,GO:0051538,1,0.983480084754437,0,3,3 iron, 4 sulfur cluster binding,MF,
13944,GO:0051539,1,0.784242782058662,0,40,4 iron, 4 sulfur cluster binding,MF,
13945,GO:0051540,1,0.694061907313482,0,61,metal cluster binding,MF,
13946,GO:0051541,1,0.972608751278439,0,4,elastin metabolic process,BP,
13947,GO:0051542,1,0.983057931425105,0,2,elastin biosynthetic process,BP,
13948,GO:0051543,1,0.994551225285948,0,1,regulation of elastin biosynthetic process,BP,
13949,GO:0051545,1,0.994551225285948,0,1,negative regulation of elastin biosynthetic process,BP,
13950,GO:0051546,1,0.910942052388335,0,14,keratinocyte migration,BP,
13951,GO:0051547,1,0.938396505579629,0,9,regulation of keratinocyte migration,BP,
13952,GO:0051548,1,0.991283527905061,0,1,negative regulation of keratinocyte migration,BP,
13953,GO:0051549,1,0.946652521942813,0,8,positive regulation of keratinocyte migration,BP,
13954,GO:0051552,1,0.990516721249158,0,1,flavone metabolic process,BP,
13955,GO:0051560,1,0.879526058633531,0,21,mitochondrial calcium ion homeostasis,BP,
13956,GO:0051561,1,0.945625774377808,0,10,positive regulation of mitochondrial calcium ion concentration,BP,
13957,GO:0051562,1,0.984158146281268,0,3,negative regulation of mitochondrial calcium ion concentration,BP,
13958,GO:0051563,1,0.984129127237415,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
13959,GO:0051567,1,0.79886928927275,0,29,histone H3-K9 methylation,BP,
13960,GO:0051568,1,0.704720763221021,0,48,histone H3-K4 methylation,BP,
13961,GO:0051569,1,0.845358966009421,0,24,regulation of histone H3-K4 methylation,BP,
13962,GO:0051570,1,0.856090289224839,0,20,regulation of histone H3-K9 methylation,BP,
13963,GO:0051571,1,0.895409646312742,0,15,positive regulation of histone H3-K4 methylation,BP,
13964,GO:0051572,1,0.975499200247252,0,3,negative regulation of histone H3-K4 methylation,BP,
13965,GO:0051573,1,0.930348694625872,0,10,negative regulation of histone H3-K9 methylation,BP,
13966,GO:0051574,1,0.93206627199082,0,9,positive regulation of histone H3-K9 methylation,BP,
13967,GO:0051575,1,0.96507811646198,0,5,5'-deoxyribose-5-phosphate lyase activity,MF,
13968,GO:0051580,1,0.912112153737069,0,15,regulation of neurotransmitter uptake,BP,
13969,GO:0051581,1,0.973792891103294,0,4,negative regulation of neurotransmitter uptake,BP,
13970,GO:0051582,1,0.980384200692921,0,4,positive regulation of neurotransmitter uptake,BP,
13971,GO:0051583,1,0.940715840381353,0,11,dopamine uptake involved in synaptic transmission,BP,
13972,GO:0051584,1,0.964687497694154,0,7,regulation of dopamine uptake involved in synaptic transmission,BP,
13973,GO:0051585,1,0.993629084422039,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
13974,GO:0051586,1,0.985641851479818,0,3,positive regulation of dopamine uptake involved in synaptic transmission,BP,
13977,GO:0051590,1,0.845644610867404,0,26,positive regulation of neurotransmitter transport,BP,
13980,GO:0051593,1,0.941091990728202,0,11,response to folic acid,BP,
13981,GO:0051594,1,0.979352430434235,0,4,detection of glucose,BP,
13982,GO:0051595,1,0.982342201124045,0,3,response to methylglyoxal,BP,
13983,GO:0051596,1,0.989395786347222,0,2,methylglyoxal catabolic process,BP,
13984,GO:0051597,1,0.951620720191716,0,7,response to methylmercury,BP,
13985,GO:0051598,1,0.992227897137593,0,1,meiotic recombination checkpoint,BP,
13986,GO:0051599,1,0.960879183460512,0,5,response to hydrostatic pressure,BP,
13987,GO:0051601,1,0.950722159025299,0,8,exocyst localization,BP,
13992,GO:0051607,1,0.308006618503394,0,188,defense response to virus,BP,
13993,GO:0051608,1,0.946632883629709,0,10,histamine transport,BP,
13994,GO:0051610,1,0.97129166102054,0,4,serotonin uptake,BP,
13995,GO:0051611,1,0.978841518157951,0,3,regulation of serotonin uptake,BP,
13996,GO:0051612,1,0.978841518157951,0,3,negative regulation of serotonin uptake,BP,
13997,GO:0051615,1,0.991204730740779,0,1,histamine uptake,BP,
13998,GO:0051620,1,0.993629084422039,0,1,norepinephrine uptake,BP,
13999,GO:0051621,1,0.993629084422039,0,1,regulation of norepinephrine uptake,BP,
14000,GO:0051622,1,0.993629084422039,0,1,negative regulation of norepinephrine uptake,BP,
14001,GO:0051639,1,0.944311535770253,0,8,actin filament network formation,BP,
14005,GO:0051643,1,0.955867522390336,0,5,endoplasmic reticulum localization,BP,
14006,GO:0051645,1,0.911448083380167,0,13,Golgi localization,BP,
14007,GO:0051646,1,0.752425035538936,0,39,mitochondrion localization,BP,
14008,GO:0051647,1,0.831693480015952,0,22,nucleus localization,BP,
14014,GO:0051654,1,0.867600324504091,0,19,establishment of mitochondrion localization,BP,
14017,GO:0051659,1,0.987979586609235,0,2,maintenance of mitochondrion location,BP,
14018,GO:0051660,1,0.969965849503952,0,4,establishment of centrosome localization,BP,
14020,GO:0051664,1,0.986730219147997,0,2,nuclear pore localization,BP,
14021,GO:0051665,1,0.945178718276691,0,10,membrane raft localization,BP,
14022,GO:0051666,1,0.965169299494034,0,5,actin cortical patch localization,BP,
14024,GO:0051673,1,0.972923685621621,0,7,membrane disruption in other organism,BP,
14026,GO:0051683,1,0.958751816754652,0,7,establishment of Golgi localization,BP,
14027,GO:0051684,1,0.975462975352279,0,3,maintenance of Golgi location,BP,
14028,GO:0051685,1,0.994054740756748,0,1,maintenance of ER location,BP,
14029,GO:0051686,1,0.985192534027647,0,1,establishment of ER localization,BP,
14030,GO:0051691,1,0.995400257842171,0,1,cellular oligosaccharide metabolic process,BP,
14031,GO:0051692,1,0.995400257842171,0,1,cellular oligosaccharide catabolic process,BP,
14032,GO:0051693,1,0.790613134582036,0,31,actin filament capping,BP,
14033,GO:0051694,1,0.958349634927239,0,6,pointed-end actin filament capping,BP,
14034,GO:0051695,1,0.992285646255758,0,1,actin filament uncapping,BP,
14035,GO:0051697,1,0.979249115102551,0,4,protein delipidation,BP,
14036,GO:0051701,1,0.290143349505314,0,190,interaction with host,BP,
14037,GO:0051702,1,0.680532831858129,0,64,interaction with symbiont,BP,
14038,GO:0051703,1,0.68411394871055,0,49,intraspecies interaction between organisms,BP,
14040,GO:0051705,1,0.625384183717191,0,63,multi-organism behavior,BP,
14042,GO:0051708,1,0.991833785922262,0,2,intracellular protein transport in other organism involved in symbiotic interaction,BP,
14043,GO:0051709,1,0.947231055651255,0,10,regulation of killing of cells of other organism,BP,
14044,GO:0051710,1,0.996318349227192,0,1,regulation of cytolysis in other organism,BP,
14045,GO:0051712,1,0.953282098538713,0,9,positive regulation of killing of cells of other organism,BP,
14046,GO:0051714,1,0.996318349227192,0,1,positive regulation of cytolysis in other organism,BP,
14047,GO:0051715,1,0.982183662486714,0,4,cytolysis in other organism,BP,
14049,GO:0051717,1,0.985309097193072,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
14050,GO:0051721,1,0.826137729136487,0,27,protein phosphatase 2A binding,MF,
14051,GO:0051722,1,0.994425110779127,0,1,protein C-terminal methylesterase activity,MF,
14052,GO:0051723,1,0.994425110779127,0,1,protein methylesterase activity,MF,
14053,GO:0051724,1,0.994666537808309,0,1,NAD transmembrane transporter activity,MF,
14054,GO:0051725,1,0.976930844762621,0,4,protein de-ADP-ribosylation,BP,
14056,GO:0051728,1,0.993816977564307,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
14057,GO:0051729,1,0.993816977564307,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
14058,GO:0051731,1,0.971134767410913,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
14059,GO:0051732,1,0.995321197939531,0,1,polyribonucleotide kinase activity,MF,
14060,GO:0051733,1,0.98081249677662,0,3,polydeoxyribonucleotide kinase activity,MF,
14061,GO:0051734,1,0.98081249677662,0,3,ATP-dependent polynucleotide kinase activity,MF,
14062,GO:0051736,1,0.995321197939531,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
14063,GO:0051747,1,0.99188286012228,0,2,cytosine C-5 DNA demethylase activity,MF,
14064,GO:0051748,1,0.994818157148879,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
14065,GO:0051750,1,0.995925571083506,0,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,
14066,GO:0051754,1,0.975141719528402,0,4,meiotic sister chromatid cohesion, centromeric,BP,
14067,GO:0051758,1,0.990408179344384,0,1,homologous chromosome movement towards spindle pole involved in homologous chromosome segregation,BP,
14068,GO:0051764,1,0.925664799726476,0,11,actin crosslink formation,BP,
14069,GO:0051765,1,0.98883150268113,0,2,inositol tetrakisphosphate kinase activity,MF,
14070,GO:0051766,1,0.961377541875532,0,6,inositol trisphosphate kinase activity,MF,
14071,GO:0051767,1,0.893078005314726,0,17,nitric-oxide synthase biosynthetic process,BP,
14072,GO:0051769,1,0.893078005314726,0,17,regulation of nitric-oxide synthase biosynthetic process,BP,
14073,GO:0051770,1,0.906359931750857,0,14,positive regulation of nitric-oxide synthase biosynthetic process,BP,
14074,GO:0051771,1,0.985360308700635,0,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,
14075,GO:0051775,1,0.929434572895334,0,11,response to redox state,BP,
14076,GO:0051780,1,0.992679109517626,0,1,behavioral response to nutrient,BP,
14077,GO:0051781,1,0.632083314737652,0,71,positive regulation of cell division,BP,
14081,GO:0051785,1,0.680653997972926,0,55,positive regulation of nuclear division,BP,
14082,GO:0051786,1,0.993479019695214,0,1,all-trans-retinol 13,14-reductase activity,MF,
14083,GO:0051787,1,0.851781803901279,0,26,misfolded protein binding,MF,
14085,GO:0051790,1,0.97712375717756,0,4,short-chain fatty acid biosynthetic process,BP,
14086,GO:0051791,1,0.944392221265514,0,10,medium-chain fatty acid metabolic process,BP,
14087,GO:0051792,1,0.970491571889291,0,5,medium-chain fatty acid biosynthetic process,BP,
14088,GO:0051793,1,0.969049769051694,0,5,medium-chain fatty acid catabolic process,BP,
14089,GO:0051794,1,0.975663106913955,0,4,regulation of timing of catagen,BP,
14090,GO:0051795,1,0.982999760998701,0,3,positive regulation of timing of catagen,BP,
14091,GO:0051796,1,0.992537751672478,0,1,negative regulation of timing of catagen,BP,
14092,GO:0051797,1,0.888554389396626,0,18,regulation of hair follicle development,BP,
14093,GO:0051798,1,0.937893143689954,0,11,positive regulation of hair follicle development,BP,
14094,GO:0051799,1,0.977443200618512,0,3,negative regulation of hair follicle development,BP,
14095,GO:0051800,1,0.986535733116953,0,2,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
14096,GO:0051801,1,0.988854263786942,0,2,cytolysis in other organism involved in symbiotic interaction,BP,
14097,GO:0051805,1,0.985801591534317,0,2,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
14098,GO:0051806,1,0.453498697372532,0,121,entry into cell of other organism involved in symbiotic interaction,BP,
14099,GO:0051807,1,0.985801591534317,0,2,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
14100,GO:0051808,1,0.994480592528411,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
14101,GO:0051817,1,0.551627805645834,0,93,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,
14102,GO:0051818,1,0.936095761324133,0,15,disruption of cells of other organism involved in symbiotic interaction,BP,
14103,GO:0051821,1,0.990444323541363,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,
14104,GO:0051823,1,0.931457721648704,0,9,regulation of synapse structural plasticity,BP,
14105,GO:0051828,1,0.453498697372532,0,121,entry into other organism involved in symbiotic interaction,BP,
14106,GO:0051832,1,0.971722975422162,0,4,avoidance of defenses of other organism involved in symbiotic interaction,BP,
14107,GO:0051833,1,0.991621251797114,0,1,suppression of defenses of other organism involved in symbiotic interaction,BP,
14108,GO:0051834,1,0.971722975422162,0,4,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,
14109,GO:0051835,1,0.968961730184588,0,4,positive regulation of synapse structural plasticity,BP,
14110,GO:0051836,1,0.951250092335625,0,9,translocation of molecules into other organism involved in symbiotic interaction,BP,
14111,GO:0051851,1,0.700135254064963,0,60,modification by host of symbiont morphology or physiology,BP,
14112,GO:0051852,1,0.958074325726202,0,11,disruption by host of symbiont cells,BP,
14114,GO:0051864,1,0.93796930649873,0,8,histone demethylase activity (H3-K36 specific),MF,
14115,GO:0051865,1,0.682036448527499,0,54,protein autoubiquitination,BP,
14116,GO:0051866,1,0.989216465751552,0,2,general adaptation syndrome,BP,
14117,GO:0051867,1,0.995923699562683,0,1,general adaptation syndrome, behavioral process,BP,
14118,GO:0051870,1,0.98526822798243,0,3,methotrexate binding,MF,
14119,GO:0051873,1,0.964070240118725,0,9,killing by host of symbiont cells,BP,
14120,GO:0051875,1,0.842292354708745,0,27,pigment granule localization,BP,
14121,GO:0051877,1,0.987927764040503,0,2,pigment granule aggregation in cell center,BP,
14122,GO:0051879,1,0.812047623137091,0,32,Hsp90 protein binding,MF,
14123,GO:0051880,1,0.942505321382893,0,7,G-quadruplex DNA binding,MF,
14124,GO:0051881,1,0.718770388045461,0,59,regulation of mitochondrial membrane potential,BP,
14125,GO:0051882,1,0.88467351129454,0,20,mitochondrial depolarization,BP,
14126,GO:0051883,1,0.941955510087254,0,13,killing of cells in other organism involved in symbiotic interaction,BP,
14127,GO:0051884,1,0.964345870740131,0,5,regulation of timing of anagen,BP,
14128,GO:0051885,1,0.985705711003237,0,2,positive regulation of timing of anagen,BP,
14129,GO:0051886,1,0.991673217788203,0,1,negative regulation of timing of anagen,BP,
14130,GO:0051890,1,0.959821291925007,0,6,regulation of cardioblast differentiation,BP,
14131,GO:0051891,1,0.967010103504536,0,5,positive regulation of cardioblast differentiation,BP,
14132,GO:0051892,1,0.992568447376529,0,1,negative regulation of cardioblast differentiation,BP,
14133,GO:0051893,1,0.663002403622099,0,53,regulation of focal adhesion assembly,BP,
14134,GO:0051894,1,0.835126584917529,0,23,positive regulation of focal adhesion assembly,BP,
14135,GO:0051895,1,0.89493535855063,0,15,negative regulation of focal adhesion assembly,BP,
14138,GO:0051898,1,0.761473737634253,0,39,negative regulation of protein kinase B signaling,BP,
14140,GO:0051900,1,0.895977134056597,0,18,regulation of mitochondrial depolarization,BP,
14141,GO:0051901,1,0.956131754567625,0,8,positive regulation of mitochondrial depolarization,BP,
14142,GO:0051902,1,0.966031208912736,0,6,negative regulation of mitochondrial depolarization,BP,
14143,GO:0051903,1,0.99420511973291,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
14144,GO:0051904,1,0.861247355061254,0,24,pigment granule transport,BP,
14145,GO:0051905,1,0.852131808106108,0,25,establishment of pigment granule localization,BP,
14146,GO:0051908,1,0.993595655382145,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
14147,GO:0051916,1,0.993841230388184,0,1,granulocyte colony-stimulating factor binding,MF,
14148,GO:0051917,1,0.943046934915434,0,10,regulation of fibrinolysis,BP,
14149,GO:0051918,1,0.958661614084926,0,7,negative regulation of fibrinolysis,BP,
14150,GO:0051919,1,0.984220068372744,0,3,positive regulation of fibrinolysis,BP,
14151,GO:0051920,1,0.967199309477581,0,8,peroxiredoxin activity,MF,
14152,GO:0051923,1,0.917700850417837,0,15,sulfation,BP,
14154,GO:0051926,1,0.736346573210233,0,50,negative regulation of calcium ion transport,BP,
14156,GO:0051930,1,0.813661727905435,0,31,regulation of sensory perception of pain,BP,
14157,GO:0051931,1,0.813661727905435,0,31,regulation of sensory perception,BP,
14159,GO:0051933,1,0.974452351069938,0,3,amino acid neurotransmitter reuptake,BP,
14160,GO:0051934,1,0.940715840381353,0,11,catecholamine uptake involved in synaptic transmission,BP,
14161,GO:0051935,1,0.974452351069938,0,3,glutamate reuptake,BP,
14164,GO:0051939,1,0.992325062204067,0,1,gamma-aminobutyric acid import,BP,
14165,GO:0051940,1,0.964687497694154,0,7,regulation of catecholamine uptake involved in synaptic transmission,BP,
14166,GO:0051941,1,0.98192524296565,0,2,regulation of amino acid uptake involved in synaptic transmission,BP,
14167,GO:0051944,1,0.985641851479818,0,3,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
14168,GO:0051945,1,0.993629084422039,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
14169,GO:0051946,1,0.98192524296565,0,2,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
14174,GO:0051956,1,0.941332012039301,0,10,negative regulation of amino acid transport,BP,
14176,GO:0051958,1,0.984397392804215,0,2,methotrexate transport,BP,
14177,GO:0051959,1,0.719647760489287,0,29,dynein light intermediate chain binding,MF,
14181,GO:0051963,1,0.553517793231445,0,78,regulation of synapse assembly,BP,
14182,GO:0051964,1,0.947973925282441,0,6,negative regulation of synapse assembly,BP,
14183,GO:0051965,1,0.646646013041757,0,59,positive regulation of synapse assembly,BP,
14185,GO:0051967,1,0.934493079471904,0,10,negative regulation of synaptic transmission, glutamatergic,BP,
14186,GO:0051968,1,0.80897717523941,0,28,positive regulation of synaptic transmission, glutamatergic,BP,
14187,GO:0051969,1,0.924037218972408,0,13,regulation of transmission of nerve impulse,BP,
14188,GO:0051970,1,0.983164891655542,0,3,negative regulation of transmission of nerve impulse,BP,
14189,GO:0051971,1,0.966377670946491,0,5,positive regulation of transmission of nerve impulse,BP,
14190,GO:0051972,1,0.756760101166644,0,45,regulation of telomerase activity,BP,
14191,GO:0051973,1,0.806592854946038,0,35,positive regulation of telomerase activity,BP,
14192,GO:0051974,1,0.948506771964303,0,9,negative regulation of telomerase activity,BP,
14193,GO:0051977,1,0.994760964868734,0,1,lysophospholipid transport,BP,
14194,GO:0051978,1,0.994760964868734,0,1,lysophospholipid transporter activity,MF,
14196,GO:0051984,1,0.841210939661865,0,24,positive regulation of chromosome segregation,BP,
14198,GO:0051987,1,0.967984999569835,0,5,positive regulation of attachment of spindle microtubules to kinetochore,BP,
14199,GO:0051988,1,0.919967640831913,0,12,regulation of attachment of spindle microtubules to kinetochore,BP,
14200,GO:0051990,1,0.988881725515079,0,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
14201,GO:0051996,1,0.994863534742089,0,1,squalene synthase activity,MF,
14202,GO:0051998,1,0.963285847750949,0,6,protein carboxyl O-methyltransferase activity,MF,
14203,GO:0052025,1,0.993782927964397,0,2,modification by symbiont of host cell membrane,BP,
14204,GO:0052026,1,0.993943540738628,0,1,modulation by symbiont of host transcription,BP,
14205,GO:0052027,1,0.985191314104843,0,2,modulation by symbiont of host signal transduction pathway,BP,
14206,GO:0052029,1,0.991621251797114,0,1,negative regulation by symbiont of host signal transduction pathway,BP,
14207,GO:0052031,1,0.986411368987859,0,2,modulation by symbiont of host defense response,BP,
14208,GO:0052037,1,0.991621251797114,0,1,negative regulation by symbiont of host defense response,BP,
14209,GO:0052040,1,0.965582636908406,0,6,modulation by symbiont of host programmed cell death,BP,
14210,GO:0052041,1,0.977498653517009,0,4,negative regulation by symbiont of host programmed cell death,BP,
14211,GO:0052042,1,0.983998142773872,0,3,positive regulation by symbiont of host programmed cell death,BP,
14212,GO:0052043,1,0.993782927964397,0,2,modification by symbiont of host cellular component,BP,
14213,GO:0052047,1,0.983138875288314,0,2,interaction with other organism via secreted substance involved in symbiotic interaction,BP,
14214,GO:0052053,1,0.994070707289974,0,1,negative regulation by symbiont of host catalytic activity,BP,
14215,GO:0052055,1,0.985741141132414,0,2,modulation by symbiont of host molecular function,BP,
14216,GO:0052056,1,0.985741141132414,0,2,negative regulation by symbiont of host molecular function,BP,
14217,GO:0052066,1,0.989913676237162,0,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,
14218,GO:0052097,1,0.993514260851553,0,1,interspecies quorum sensing,BP,
14219,GO:0052106,1,0.993514260851553,0,1,quorum sensing involved in interaction with host,BP,
14220,GO:0052111,1,0.993782927964397,0,2,modification by symbiont of host structure,BP,
14221,GO:0052126,1,0.807951066009497,0,33,movement in host environment,BP,
14222,GO:0052148,1,0.994070707289974,0,1,modulation by symbiont of host catalytic activity,BP,
14223,GO:0052150,1,0.969592526225867,0,5,modulation by symbiont of host apoptotic process,BP,
14224,GO:0052151,1,0.98808372562189,0,2,positive regulation by symbiont of host apoptotic process,BP,
14225,GO:0052167,1,0.991621251797114,0,1,modulation by symbiont of host innate immune response,BP,
14226,GO:0052170,1,0.991621251797114,0,1,negative regulation by symbiont of host innate immune response,BP,
14227,GO:0052173,1,0.967257533324889,0,5,response to defenses of other organism involved in symbiotic interaction,BP,
14228,GO:0052182,1,0.994532746681686,0,1,modification by host of symbiont morphology or physiology via secreted substance,BP,
14229,GO:0052185,1,0.993782927964397,0,2,modification of structure of other organism involved in symbiotic interaction,BP,
14230,GO:0052188,1,0.993782927964397,0,2,modification of cellular component in other organism involved in symbiotic interaction,BP,
14231,GO:0052190,1,0.989913676237162,0,1,modulation by symbiont of host phagocytosis,BP,
14232,GO:0052191,1,0.989913676237162,0,1,positive regulation by symbiont of host phagocytosis,BP,
14233,GO:0052192,1,0.807951066009497,0,33,movement in environment of other organism involved in symbiotic interaction,BP,
14234,GO:0052199,1,0.989182213638318,0,2,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14235,GO:0052200,1,0.967257533324889,0,5,response to host defenses,BP,
14236,GO:0052203,1,0.984554144052538,0,3,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14237,GO:0052204,1,0.964169734649576,0,7,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,
14238,GO:0052205,1,0.954900311329579,0,8,modulation of molecular function in other organism involved in symbiotic interaction,BP,
14239,GO:0052212,1,0.994532746681686,0,1,modification of morphology or physiology of other organism via secreted substance involved in symbiotic interaction,BP,
14240,GO:0052213,1,0.994532746681686,0,1,interaction with symbiont via secreted substance involved in symbiotic interaction,BP,
14241,GO:0052214,1,0.995459598309555,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
14242,GO:0052227,1,0.995459598309555,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
14243,GO:0052229,1,0.995459598309555,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
14244,GO:0052231,1,0.989913676237162,0,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,
14245,GO:0052248,1,0.965582636908406,0,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
14246,GO:0052250,1,0.985191314104843,0,2,modulation of signal transduction in other organism involved in symbiotic interaction,BP,
14247,GO:0052251,1,0.994746541367731,0,1,induction by organism of defense response of other organism involved in symbiotic interaction,BP,
14248,GO:0052255,1,0.986411368987859,0,2,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,
14249,GO:0052261,1,0.991621251797114,0,1,suppression of defense response of other organism involved in symbiotic interaction,BP,
14250,GO:0052306,1,0.991621251797114,0,1,modulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
14251,GO:0052309,1,0.991621251797114,0,1,negative regulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
14252,GO:0052312,1,0.844612092941661,0,25,modulation of transcription in other organism involved in symbiotic interaction,BP,
14253,GO:0052314,1,0.990117936220745,0,2,phytoalexin metabolic process,BP,
14254,GO:0052330,1,0.983998142773872,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14255,GO:0052331,1,0.988854263786942,0,2,hemolysis in other organism involved in symbiotic interaction,BP,
14256,GO:0052332,1,0.993782927964397,0,2,modification by organism of membrane in other organism involved in symbiotic interaction,BP,
14257,GO:0052360,1,0.995459598309555,0,1,catabolism by host of symbiont macromolecule,BP,
14258,GO:0052361,1,0.995459598309555,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
14259,GO:0052362,1,0.995459598309555,0,1,catabolism by host of symbiont protein,BP,
14260,GO:0052363,1,0.995459598309555,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14261,GO:0052364,1,0.995459598309555,0,1,catabolism by host of substance in symbiont,BP,
14262,GO:0052370,1,0.989913676237162,0,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,
14263,GO:0052381,1,0.994833271518301,0,1,tRNA dimethylallyltransferase activity,MF,
14264,GO:0052403,1,0.995082643175081,0,1,negative regulation by host of symbiont catalytic activity,BP,
14265,GO:0052405,1,0.978119703672552,0,5,negative regulation by host of symbiont molecular function,BP,
14266,GO:0052416,1,0.995459598309555,0,1,metabolism by host of symbiont macromolecule,BP,
14267,GO:0052417,1,0.995459598309555,0,1,metabolism by host of symbiont protein,BP,
14268,GO:0052418,1,0.995459598309555,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14269,GO:0052419,1,0.995459598309555,0,1,metabolism by host of substance in symbiont,BP,
14270,GO:0052422,1,0.990427246765674,0,2,modulation by host of symbiont catalytic activity,BP,
14271,GO:0052428,1,0.968717522772444,0,6,modulation by host of symbiont molecular function,BP,
14272,GO:0052433,1,0.965582636908406,0,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14273,GO:0052472,1,0.849767117189439,0,24,modulation by host of symbiont transcription,BP,
14274,GO:0052490,1,0.977498653517009,0,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14275,GO:0052493,1,0.991621251797114,0,1,negative regulation by organism of signal transduction in other organism involved in symbiotic interaction,BP,
14276,GO:0052501,1,0.983998142773872,0,3,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14277,GO:0052509,1,0.994746541367731,0,1,positive regulation by symbiont of host defense response,BP,
14278,GO:0052510,1,0.994746541367731,0,1,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,
14279,GO:0052522,1,0.989913676237162,0,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,
14282,GO:0052550,1,0.995405943503099,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
14283,GO:0052552,1,0.986411368987859,0,2,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,
14284,GO:0052553,1,0.986411368987859,0,2,modulation by symbiont of host immune response,BP,
14285,GO:0052561,1,0.991621251797114,0,1,negative regulation by organism of immune response of other organism involved in symbiotic interaction,BP,
14286,GO:0052562,1,0.991621251797114,0,1,negative regulation by symbiont of host immune response,BP,
14287,GO:0052564,1,0.976116054891891,0,4,response to immune response of other organism involved in symbiotic interaction,BP,
14288,GO:0052567,1,0.995405943503099,0,1,response to defense-related host reactive oxygen species production,BP,
14289,GO:0052572,1,0.976116054891891,0,4,response to host immune response,BP,
14290,GO:0052590,1,0.990908610133121,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
14291,GO:0052591,1,0.990908610133121,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
14292,GO:0052593,1,0.987068258683709,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
14293,GO:0052594,1,0.987068258683709,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
14294,GO:0052595,1,0.987068258683709,0,2,aliphatic-amine oxidase activity,MF,
14295,GO:0052596,1,0.987068258683709,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
14296,GO:0052629,1,0.904226455530884,0,12,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,
14297,GO:0052642,1,0.98960893666632,0,2,lysophosphatidic acid phosphatase activity,MF,
14298,GO:0052646,1,0.93347955157166,0,9,alditol phosphate metabolic process,BP,
14299,GO:0052650,1,0.960927978232573,0,8,NADP-retinol dehydrogenase activity,MF,
14300,GO:0052651,1,0.989359387270577,0,2,monoacylglycerol catabolic process,BP,
14305,GO:0052657,1,0.995736789488704,0,1,guanine phosphoribosyltransferase activity,MF,
14306,GO:0052658,1,0.956721217056434,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
14307,GO:0052659,1,0.935453861491179,0,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,
14308,GO:0052666,1,0.995052180476412,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
14309,GO:0052689,1,0.483337156136451,0,121,carboxylic ester hydrolase activity,MF,
14310,GO:0052692,1,0.995733030733855,0,1,raffinose alpha-galactosidase activity,MF,
14311,GO:0052695,1,0.980542263589057,0,3,cellular glucuronidation,BP,
14312,GO:0052717,1,0.990587302290689,0,1,tRNA-specific adenosine-34 deaminase activity,MF,
14313,GO:0052718,1,0.990587302290689,0,1,tRNA-specific adenosine-34 deaminase complex,CC,
14314,GO:0052723,1,0.965636118647957,0,5,inositol hexakisphosphate 1-kinase activity,MF,
14315,GO:0052724,1,0.965636118647957,0,5,inositol hexakisphosphate 3-kinase activity,MF,
14316,GO:0052725,1,0.99353956641785,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
14317,GO:0052726,1,0.99353956641785,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
14318,GO:0052731,1,0.994864165689797,0,1,phosphocholine phosphatase activity,MF,
14319,GO:0052732,1,0.994864165689797,0,1,phosphoethanolamine phosphatase activity,MF,
14320,GO:0052735,1,0.978052043370514,0,3,tRNA (cytosine-3-)-methyltransferase activity,MF,
14321,GO:0052739,1,0.986240157397807,0,3,phosphatidylserine 1-acylhydrolase activity,MF,
14322,GO:0052740,1,0.990889312608489,0,2,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
14323,GO:0052742,1,0.720258626278654,0,43,phosphatidylinositol kinase activity,MF,
14324,GO:0052743,1,0.921702010059882,0,11,inositol tetrakisphosphate phosphatase activity,MF,
14325,GO:0052744,1,0.884493511284262,0,15,phosphatidylinositol monophosphate phosphatase activity,MF,
14326,GO:0052745,1,0.870826827902008,0,19,inositol phosphate phosphatase activity,MF,
14327,GO:0052746,1,0.986006480743699,0,2,inositol phosphorylation,BP,
14328,GO:0052794,1,0.983651601763944,0,3,exo-alpha-(2->3)-sialidase activity,MF,
14329,GO:0052795,1,0.983651601763944,0,3,exo-alpha-(2->6)-sialidase activity,MF,
14330,GO:0052796,1,0.983651601763944,0,3,exo-alpha-(2->8)-sialidase activity,MF,
14331,GO:0052798,1,0.994876157112668,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
14332,GO:0052803,1,0.944994865869912,0,10,imidazole-containing compound metabolic process,BP,
14333,GO:0052805,1,0.961381507956749,0,7,imidazole-containing compound catabolic process,BP,
14334,GO:0052810,1,0.987291232259,0,2,1-phosphatidylinositol-5-kinase activity,MF,
14335,GO:0052811,1,0.972284440583394,0,4,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,
14336,GO:0052812,1,0.979167840299108,0,3,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
14337,GO:0052813,1,0.633527590785391,0,64,phosphatidylinositol bisphosphate kinase activity,MF,
14338,GO:0052815,1,0.989456027803319,0,2,medium-chain acyl-CoA hydrolase activity,MF,
14339,GO:0052816,1,0.993370035430556,0,1,long-chain acyl-CoA hydrolase activity,MF,
14340,GO:0052817,1,0.993370035430556,0,1,very long chain acyl-CoA hydrolase activity,MF,
14341,GO:0052821,1,0.996149649013535,0,1,DNA-7-methyladenine glycosylase activity,MF,
14342,GO:0052822,1,0.996149649013535,0,1,DNA-3-methylguanine glycosylase activity,MF,
14343,GO:0052825,1,0.99353956641785,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
14344,GO:0052826,1,0.993973566421534,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
14345,GO:0052827,1,0.987551675321423,0,2,inositol pentakisphosphate phosphatase activity,MF,
14346,GO:0052828,1,0.982942945491416,0,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,
14347,GO:0052829,1,0.994884365414324,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
14348,GO:0052830,1,0.99353956641785,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
14349,GO:0052831,1,0.99353956641785,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
14350,GO:0052832,1,0.972597476595278,0,4,inositol monophosphate 3-phosphatase activity,MF,
14351,GO:0052833,1,0.972597476595278,0,4,inositol monophosphate 4-phosphatase activity,MF,
14352,GO:0052834,1,0.972597476595278,0,4,inositol monophosphate phosphatase activity,MF,
14353,GO:0052835,1,0.99353956641785,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
14354,GO:0052836,1,0.982543828269759,0,3,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
14355,GO:0052839,1,0.982543828269759,0,3,inositol diphosphate tetrakisphosphate kinase activity,MF,
14356,GO:0052840,1,0.977560788177497,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
14357,GO:0052841,1,0.977560788177497,0,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,
14358,GO:0052842,1,0.977560788177497,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
14359,GO:0052843,1,0.977560788177497,0,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,
14360,GO:0052844,1,0.977560788177497,0,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,
14361,GO:0052845,1,0.977560788177497,0,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,
14362,GO:0052846,1,0.977560788177497,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,
14363,GO:0052847,1,0.977560788177497,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
14364,GO:0052848,1,0.977560788177497,0,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
14365,GO:0052851,1,0.965799071190292,0,5,ferric-chelate reductase (NADPH) activity,MF,
14366,GO:0052852,1,0.995318665137046,0,1,very-long-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14367,GO:0052853,1,0.995318665137046,0,1,long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity,MF,
14368,GO:0052854,1,0.995318665137046,0,1,medium-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14369,GO:0052856,1,0.996276218495569,0,1,NADHX epimerase activity,MF,
14370,GO:0052857,1,0.996276218495569,0,1,NADPHX epimerase activity,MF,
14371,GO:0052858,1,0.993222800245645,0,1,peptidyl-lysine acetyltransferase activity,MF,
14372,GO:0052866,1,0.805257030278122,0,28,phosphatidylinositol phosphate phosphatase activity,MF,
14373,GO:0052870,1,0.993811606553441,0,1,tocopherol omega-hydroxylase activity,MF,
14374,GO:0052871,1,0.993811606553441,0,1,alpha-tocopherol omega-hydroxylase activity,MF,
14375,GO:0052884,1,0.994238094890298,0,1,all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity,MF,
14376,GO:0052885,1,0.994238094890298,0,1,all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity,MF,
14377,GO:0052890,1,0.995100417345176,0,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
14378,GO:0052894,1,0.994907110706987,0,1,norspermine:oxygen oxidoreductase activity,MF,
14379,GO:0052895,1,0.994907110706987,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
14380,GO:0052899,1,0.995384459698249,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14381,GO:0052901,1,0.990314840067718,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
14382,GO:0052902,1,0.995384459698249,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
14383,GO:0052903,1,0.995384459698249,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14384,GO:0052904,1,0.995384459698249,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14385,GO:0052905,1,0.982268991460807,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
14386,GO:0052906,1,0.991554281522652,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
14387,GO:0052907,1,0.994054740756748,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
14388,GO:0052909,1,0.994054740756748,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
14389,GO:0052917,1,0.994529055302705,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
14390,GO:0052918,1,0.990545623160406,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14391,GO:0052925,1,0.995609431209037,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
14392,GO:0052926,1,0.990545623160406,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14393,GO:0052927,1,0.994652836670812,0,1,CTP:tRNA cytidylyltransferase activity,MF,
14394,GO:0052928,1,0.994652836670812,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
14395,GO:0052929,1,0.994652836670812,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
14396,GO:0055001,1,0.334601318031812,0,150,muscle cell development,BP,
14397,GO:0055002,1,0.375072601033692,0,135,striated muscle cell development,BP,
14398,GO:0055003,1,0.830439813985318,0,20,cardiac myofibril assembly,BP,
14399,GO:0055005,1,0.980323295525338,0,3,ventricular cardiac myofibril assembly,BP,
14400,GO:0055006,1,0.603875478879679,0,64,cardiac cell development,BP,
14401,GO:0055007,1,0.484413222553773,0,95,cardiac muscle cell differentiation,BP,
14402,GO:0055008,1,0.599203355196301,0,64,cardiac muscle tissue morphogenesis,BP,
14403,GO:0055009,1,0.962632083115525,0,6,atrial cardiac muscle tissue morphogenesis,BP,
14404,GO:0055010,1,0.703632342142345,0,45,ventricular cardiac muscle tissue morphogenesis,BP,
14405,GO:0055011,1,0.990504747345722,0,2,atrial cardiac muscle cell differentiation,BP,
14406,GO:0055012,1,0.905508166196538,0,15,ventricular cardiac muscle cell differentiation,BP,
14407,GO:0055013,1,0.630916854059318,0,59,cardiac muscle cell development,BP,
14408,GO:0055014,1,0.990504747345722,0,2,atrial cardiac muscle cell development,BP,
14409,GO:0055015,1,0.943349063841931,0,10,ventricular cardiac muscle cell development,BP,
14410,GO:0055017,1,0.620840268500577,0,67,cardiac muscle tissue growth,BP,
14411,GO:0055018,1,0.995275580827277,0,1,regulation of cardiac muscle fiber development,BP,
14412,GO:0055020,1,0.995275580827277,0,1,positive regulation of cardiac muscle fiber development,BP,
14413,GO:0055021,1,0.715754760918674,0,47,regulation of cardiac muscle tissue growth,BP,
14414,GO:0055022,1,0.902637755444263,0,16,negative regulation of cardiac muscle tissue growth,BP,
14415,GO:0055023,1,0.802239886263795,0,29,positive regulation of cardiac muscle tissue growth,BP,
14416,GO:0055024,1,0.62295681931625,0,66,regulation of cardiac muscle tissue development,BP,
14417,GO:0055025,1,0.751975162015968,0,38,positive regulation of cardiac muscle tissue development,BP,
14418,GO:0055026,1,0.844117775295356,0,25,negative regulation of cardiac muscle tissue development,BP,
14419,GO:0055028,1,0.989666133385604,0,1,cortical microtubule,CC,
14420,GO:0055029,1,0.434400333065412,0,131,nuclear DNA-directed RNA polymerase complex,CC,
14421,GO:0055037,1,0.348990998777182,0,152,recycling endosome,CC,
14422,GO:0055038,1,0.653393583390719,0,67,recycling endosome membrane,CC,
14423,GO:0055048,1,0.989666133385604,0,1,anastral spindle assembly,BP,
14424,GO:0055056,1,0.942358898409215,0,9,D-glucose transmembrane transporter activity,MF,
14426,GO:0055059,1,0.957210228543838,0,6,asymmetric neuroblast division,BP,
14427,GO:0055062,1,0.932546643570148,0,9,phosphate ion homeostasis,BP,
14428,GO:0055064,1,0.911879273719318,0,12,chloride ion homeostasis,BP,
14432,GO:0055070,1,0.905514684714938,0,16,copper ion homeostasis,BP,
14433,GO:0055072,1,0.609864058460571,0,78,iron ion homeostasis,BP,
14434,GO:0055073,1,0.989747651857653,0,2,cadmium ion homeostasis,BP,
14436,GO:0055075,1,0.82188411235178,0,27,potassium ion homeostasis,BP,
14438,GO:0055077,1,0.987889548522799,0,2,gap junction hemi-channel activity,MF,
14439,GO:0055078,1,0.764010484523692,0,41,sodium ion homeostasis,BP,
14441,GO:0055081,1,0.730486277836797,0,44,anion homeostasis,BP,
14443,GO:0055083,1,0.850314636433079,0,21,monovalent inorganic anion homeostasis,BP,
14446,GO:0055087,1,0.980409553884097,0,3,Ski complex,CC,
14447,GO:0055088,1,0.536910617627481,0,96,lipid homeostasis,BP,
14448,GO:0055089,1,0.921072653325992,0,12,fatty acid homeostasis,BP,
14449,GO:0055090,1,0.86488524150817,0,25,acylglycerol homeostasis,BP,
14450,GO:0055091,1,0.948319123172296,0,8,phospholipid homeostasis,BP,
14451,GO:0055092,1,0.715676288595599,0,53,sterol homeostasis,BP,
14452,GO:0055093,1,0.880672911959187,0,20,response to hyperoxia,BP,
14453,GO:0055094,1,0.857016862337457,0,23,response to lipoprotein particle,BP,
14454,GO:0055095,1,0.981057011935755,0,3,lipoprotein particle mediated signaling,BP,
14455,GO:0055096,1,0.981057011935755,0,3,low-density lipoprotein particle mediated signaling,BP,
14456,GO:0055100,1,0.980777256314486,0,3,adiponectin binding,MF,
14457,GO:0055102,1,0.95021200636431,0,11,lipase inhibitor activity,MF,
14458,GO:0055103,1,0.993550737487651,0,1,ligase regulator activity,MF,
14459,GO:0055105,1,0.976288592394614,0,6,ubiquitin-protein transferase inhibitor activity,MF,
14460,GO:0055106,1,0.921968443938751,0,16,ubiquitin-protein transferase regulator activity,MF,
14461,GO:0055108,1,0.995028073331356,0,1,Golgi to transport vesicle transport,BP,
14462,GO:0055111,1,0.991184797375481,0,1,ingression involved in gastrulation with mouth forming second,BP,
14463,GO:0055113,1,0.986221650898168,0,1,epiboly involved in gastrulation with mouth forming second,BP,
14466,GO:0055118,1,0.959014781896155,0,6,negative regulation of cardiac muscle contraction,BP,
14468,GO:0055120,1,0.996199316858008,0,1,striated muscle dense body,CC,
14470,GO:0055129,1,0.979038459233705,0,4,L-proline biosynthetic process,BP,
14471,GO:0055130,1,0.99550561716643,0,1,D-alanine catabolic process,BP,
14472,GO:0055131,1,0.967595533508487,0,6,C3HC4-type RING finger domain binding,MF,
14473,GO:0060001,1,0.988272365128704,0,1,minus-end directed microfilament motor activity,MF,
14474,GO:0060002,1,0.976972289252762,0,2,plus-end directed microfilament motor activity,MF,
14475,GO:0060003,1,0.97905071252116,0,2,copper ion export,BP,
14476,GO:0060004,1,0.880045701859102,0,18,reflex,BP,
14477,GO:0060005,1,0.971657627334324,0,4,vestibular reflex,BP,
14478,GO:0060007,1,0.992643753548125,0,1,linear vestibuloocular reflex,BP,
14479,GO:0060008,1,0.890779052981418,0,17,Sertoli cell differentiation,BP,
14480,GO:0060009,1,0.912025540093514,0,13,Sertoli cell development,BP,
14481,GO:0060010,1,0.993475507121384,0,1,Sertoli cell fate commitment,BP,
14482,GO:0060011,1,0.981422049307264,0,3,Sertoli cell proliferation,BP,
14483,GO:0060012,1,0.959205385873137,0,7,synaptic transmission, glycinergic,BP,
14484,GO:0060013,1,0.940826204934976,0,8,righting reflex,BP,
14485,GO:0060014,1,0.993901654896433,0,1,granulosa cell differentiation,BP,
14486,GO:0060017,1,0.959523083148214,0,6,parathyroid gland development,BP,
14487,GO:0060018,1,0.978629097435542,0,3,astrocyte fate commitment,BP,
14488,GO:0060019,1,0.932580662093546,0,12,radial glial cell differentiation,BP,
14489,GO:0060020,1,0.950157786073348,0,8,Bergmann glial cell differentiation,BP,
14490,GO:0060021,1,0.538569847955626,0,83,roof of mouth development,BP,
14491,GO:0060022,1,0.955011533421025,0,6,hard palate development,BP,
14492,GO:0060023,1,0.960357017665218,0,5,soft palate development,BP,
14493,GO:0060024,1,0.97082531936546,0,4,rhythmic synaptic transmission,BP,
14494,GO:0060025,1,0.977049153800763,0,3,regulation of synaptic activity,BP,
14496,GO:0060027,1,0.944664017027166,0,8,convergent extension involved in gastrulation,BP,
14498,GO:0060029,1,0.961764068481416,0,6,convergent extension involved in organogenesis,BP,
14499,GO:0060031,1,0.986135606159022,0,2,mediolateral intercalation,BP,
14500,GO:0060032,1,0.98345690568527,0,2,notochord regression,BP,
14501,GO:0060033,1,0.934335077213901,0,10,anatomical structure regression,BP,
14502,GO:0060037,1,0.843736109211765,0,24,pharyngeal system development,BP,
14503,GO:0060038,1,0.719417312310049,0,46,cardiac muscle cell proliferation,BP,
14504,GO:0060039,1,0.85036849745933,0,19,pericardium development,BP,
14505,GO:0060040,1,0.979180697036633,0,4,retinal bipolar neuron differentiation,BP,
14507,GO:0060042,1,0.735806420233772,0,41,retina morphogenesis in camera-type eye,BP,
14508,GO:0060043,1,0.773854654202547,0,36,regulation of cardiac muscle cell proliferation,BP,
14509,GO:0060044,1,0.924838926389482,0,12,negative regulation of cardiac muscle cell proliferation,BP,
14510,GO:0060045,1,0.846449294176316,0,22,positive regulation of cardiac muscle cell proliferation,BP,
14511,GO:0060046,1,0.934523185790418,0,12,regulation of acrosome reaction,BP,
14514,GO:0060049,1,0.913837718007014,0,13,regulation of protein glycosylation,BP,
14515,GO:0060050,1,0.936517416835539,0,9,positive regulation of protein glycosylation,BP,
14516,GO:0060051,1,0.989378900316549,0,2,negative regulation of protein glycosylation,BP,
14517,GO:0060052,1,0.962674712682333,0,6,neurofilament cytoskeleton organization,BP,
14518,GO:0060053,1,0.984542917593613,0,2,neurofilament cytoskeleton,CC,
14519,GO:0060054,1,0.977847329865251,0,4,positive regulation of epithelial cell proliferation involved in wound healing,BP,
14520,GO:0060055,1,0.884884786086279,0,19,angiogenesis involved in wound healing,BP,
14521,GO:0060056,1,0.950189678188652,0,8,mammary gland involution,BP,
14522,GO:0060057,1,0.981338416595721,0,3,apoptotic process involved in mammary gland involution,BP,
14523,GO:0060058,1,0.981338416595721,0,3,positive regulation of apoptotic process involved in mammary gland involution,BP,
14524,GO:0060059,1,0.932613987961798,0,7,embryonic retina morphogenesis in camera-type eye,BP,
14525,GO:0060060,1,0.989730249331766,0,1,post-embryonic retina morphogenesis in camera-type eye,BP,
14526,GO:0060061,1,0.985967923427051,0,2,Spemann organizer formation,BP,
14527,GO:0060064,1,0.995637697199164,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
14528,GO:0060065,1,0.861849233806384,0,19,uterus development,BP,
14529,GO:0060066,1,0.988764198059191,0,2,oviduct development,BP,
14530,GO:0060067,1,0.990997815957518,0,1,cervix development,BP,
14531,GO:0060068,1,0.931641229236012,0,9,vagina development,BP,
14534,GO:0060072,1,0.983675663691636,0,2,large conductance calcium-activated potassium channel activity,MF,
14535,GO:0060073,1,0.952277499578306,0,7,micturition,BP,
14537,GO:0060075,1,0.94790284667005,0,7,regulation of resting membrane potential,BP,
14542,GO:0060080,1,0.891818643156158,0,15,inhibitory postsynaptic potential,BP,
14543,GO:0060081,1,0.930006615916992,0,11,membrane hyperpolarization,BP,
14544,GO:0060083,1,0.976966758350356,0,3,smooth muscle contraction involved in micturition,BP,
14545,GO:0060084,1,0.979860495322577,0,3,synaptic transmission involved in micturition,BP,
14546,GO:0060086,1,0.987768806587705,0,2,circadian temperature homeostasis,BP,
14547,GO:0060087,1,0.974500229959818,0,5,relaxation of vascular smooth muscle,BP,
14548,GO:0060088,1,0.930985767157487,0,10,auditory receptor cell stereocilium organization,BP,
14551,GO:0060091,1,0.95791386077418,0,7,kinocilium,CC,
14552,GO:0060092,1,0.993576212296719,0,1,regulation of synaptic transmission, glycinergic,BP,
14553,GO:0060099,1,0.928685201493696,0,11,regulation of phagocytosis, engulfment,BP,
14554,GO:0060100,1,0.93871104633084,0,9,positive regulation of phagocytosis, engulfment,BP,
14555,GO:0060101,1,0.995141050033782,0,1,negative regulation of phagocytosis, engulfment,BP,
14556,GO:0060112,1,0.991833121126351,0,2,generation of ovulation cycle rhythm,BP,
14558,GO:0060117,1,0.881408639332445,0,17,auditory receptor cell development,BP,
14560,GO:0060120,1,0.966057040208345,0,5,inner ear receptor cell fate commitment,BP,
14561,GO:0060122,1,0.849769002160294,0,23,inner ear receptor cell stereocilium organization,BP,
14562,GO:0060123,1,0.929074204750826,0,11,regulation of growth hormone secretion,BP,
14563,GO:0060124,1,0.959560131042627,0,8,positive regulation of growth hormone secretion,BP,
14564,GO:0060125,1,0.981318845253632,0,2,negative regulation of growth hormone secretion,BP,
14565,GO:0060126,1,0.983495412090178,0,3,somatotropin secreting cell differentiation,BP,
14566,GO:0060127,1,0.994703980650772,0,1,prolactin secreting cell differentiation,BP,
14567,GO:0060128,1,0.989875342532352,0,2,corticotropin hormone secreting cell differentiation,BP,
14568,GO:0060129,1,0.982854871458116,0,3,thyroid-stimulating hormone-secreting cell differentiation,BP,
14569,GO:0060133,1,0.995794383028699,0,1,somatotropin secreting cell development,BP,
14572,GO:0060136,1,0.962669684476293,0,6,embryonic process involved in female pregnancy,BP,
14573,GO:0060137,1,0.950741595966842,0,8,maternal process involved in parturition,BP,
14574,GO:0060139,1,0.98808372562189,0,2,positive regulation of apoptotic process by virus,BP,
14575,GO:0060142,1,0.904034492385158,0,18,regulation of syncytium formation by plasma membrane fusion,BP,
14576,GO:0060143,1,0.912148257394275,0,16,positive regulation of syncytium formation by plasma membrane fusion,BP,
14577,GO:0060147,1,0.568804747583609,0,86,regulation of posttranscriptional gene silencing,BP,
14578,GO:0060148,1,0.86832212108484,0,21,positive regulation of posttranscriptional gene silencing,BP,
14579,GO:0060149,1,0.902193362787869,0,14,negative regulation of posttranscriptional gene silencing,BP,
14580,GO:0060151,1,0.98480105429358,0,2,peroxisome localization,BP,
14581,GO:0060152,1,0.98480105429358,0,2,microtubule-based peroxisome localization,BP,
14582,GO:0060154,1,0.982575203074233,0,3,cellular process regulating host cell cycle in response to virus,BP,
14583,GO:0060155,1,0.952305128118063,0,8,platelet dense granule organization,BP,
14584,GO:0060156,1,0.993673140428983,0,1,milk ejection reflex,BP,
14585,GO:0060157,1,0.966438068967319,0,5,urinary bladder development,BP,
14586,GO:0060158,1,0.951901569637579,0,9,phospholipase C-activating dopamine receptor signaling pathway,BP,
14587,GO:0060159,1,0.941763797442649,0,9,regulation of dopamine receptor signaling pathway,BP,
14588,GO:0060160,1,0.988238864247445,0,2,negative regulation of dopamine receptor signaling pathway,BP,
14589,GO:0060161,1,0.969627096696722,0,4,positive regulation of dopamine receptor signaling pathway,BP,
14590,GO:0060163,1,0.990428121877593,0,2,subpallium neuron fate commitment,BP,
14591,GO:0060164,1,0.983723779843981,0,3,regulation of timing of neuron differentiation,BP,
14592,GO:0060165,1,0.994409330361848,0,1,regulation of timing of subpallium neuron differentiation,BP,
14593,GO:0060166,1,0.983527100232923,0,3,olfactory pit development,BP,
14594,GO:0060167,1,0.97488503382802,0,4,regulation of adenosine receptor signaling pathway,BP,
14595,GO:0060168,1,0.97920923956586,0,3,positive regulation of adenosine receptor signaling pathway,BP,
14596,GO:0060169,1,0.995584917977122,0,1,negative regulation of adenosine receptor signaling pathway,BP,
14597,GO:0060170,1,0.602640306279211,0,72,ciliary membrane,CC,
14598,GO:0060171,1,0.977036189334471,0,2,stereocilium membrane,CC,
14600,GO:0060174,1,0.919851137832305,0,11,limb bud formation,BP,
14601,GO:0060175,1,0.989747494631519,0,1,brain-derived neurotrophic factor-activated receptor activity,MF,
14602,GO:0060177,1,0.993431519320577,0,1,regulation of angiotensin metabolic process,BP,
14603,GO:0060178,1,0.994675264672291,0,1,regulation of exocyst localization,BP,
14604,GO:0060179,1,0.973824685740917,0,4,male mating behavior,BP,
14605,GO:0060180,1,0.961190646547382,0,6,female mating behavior,BP,
14606,GO:0060183,1,0.993576212296719,0,1,apelin receptor signaling pathway,BP,
14607,GO:0060184,1,0.993816977564307,0,1,cell cycle switching,BP,
14608,GO:0060187,1,0.983703671269961,0,2,cell pole,CC,
14610,GO:0060192,1,0.9369021037319,0,11,negative regulation of lipase activity,BP,
14612,GO:0060197,1,0.982659156331138,0,3,cloacal septation,BP,
14619,GO:0060211,1,0.916246450275851,0,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14620,GO:0060212,1,0.995227378787111,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14621,GO:0060213,1,0.916246450275851,0,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14622,GO:0060214,1,0.979402711299126,0,4,endocardium formation,BP,
14623,GO:0060215,1,0.947749343259655,0,8,primitive hemopoiesis,BP,
14624,GO:0060216,1,0.860926682732827,0,21,definitive hemopoiesis,BP,
14625,GO:0060217,1,0.991831979246863,0,1,hemangioblast cell differentiation,BP,
14626,GO:0060218,1,0.624539478489112,0,89,hematopoietic stem cell differentiation,BP,
14627,GO:0060219,1,0.900638687407904,0,15,camera-type eye photoreceptor cell differentiation,BP,
14628,GO:0060221,1,0.982323891780665,0,3,retinal rod cell differentiation,BP,
14629,GO:0060228,1,0.989380639913771,0,3,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
14630,GO:0060229,1,0.943231319239714,0,10,lipase activator activity,MF,
14631,GO:0060230,1,0.99262145124604,0,2,lipoprotein lipase activator activity,MF,
14632,GO:0060231,1,0.886400422485977,0,20,mesenchymal to epithelial transition,BP,
14633,GO:0060232,1,0.982786613949337,0,3,delamination,BP,
14634,GO:0060235,1,0.962888927759806,0,4,lens induction in camera-type eye,BP,
14635,GO:0060236,1,0.764186270154283,0,36,regulation of mitotic spindle organization,BP,
14636,GO:0060242,1,0.948808534013225,0,8,contact inhibition,BP,
14637,GO:0060243,1,0.992586451911122,0,1,negative regulation of cell growth involved in contact inhibition,BP,
14638,GO:0060244,1,0.982692366701824,0,3,negative regulation of cell proliferation involved in contact inhibition,BP,
14639,GO:0060245,1,0.993062698868,0,1,detection of cell density,BP,
14640,GO:0060246,1,0.993062698868,0,1,detection of cell density by contact stimulus,BP,
14641,GO:0060248,1,0.993062698868,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
14643,GO:0060251,1,0.826818077025892,0,25,regulation of glial cell proliferation,BP,
14644,GO:0060252,1,0.92629172893698,0,11,positive regulation of glial cell proliferation,BP,
14645,GO:0060253,1,0.901059683987106,0,14,negative regulation of glial cell proliferation,BP,
14646,GO:0060254,1,0.995236261205466,0,1,regulation of N-terminal protein palmitoylation,BP,
14649,GO:0060260,1,0.841145715405226,0,27,regulation of transcription initiation from RNA polymerase II promoter,BP,
14650,GO:0060261,1,0.880672186025078,0,20,positive regulation of transcription initiation from RNA polymerase II promoter,BP,
14651,GO:0060262,1,0.995236261205466,0,1,negative regulation of N-terminal protein palmitoylation,BP,
14652,GO:0060263,1,0.942516824514021,0,10,regulation of respiratory burst,BP,
14653,GO:0060264,1,0.986412538835939,0,3,regulation of respiratory burst involved in inflammatory response,BP,
14654,GO:0060265,1,0.991673578966209,0,2,positive regulation of respiratory burst involved in inflammatory response,BP,
14655,GO:0060266,1,0.99115848355032,0,2,negative regulation of respiratory burst involved in inflammatory response,BP,
14656,GO:0060267,1,0.974831619754897,0,4,positive regulation of respiratory burst,BP,
14657,GO:0060268,1,0.981225886094373,0,3,negative regulation of respiratory burst,BP,
14659,GO:0060272,1,0.932130364464982,0,12,embryonic skeletal joint morphogenesis,BP,
14660,GO:0060278,1,0.983072866167441,0,3,regulation of ovulation,BP,
14661,GO:0060279,1,0.988413939089376,0,2,positive regulation of ovulation,BP,
14662,GO:0060280,1,0.994596954618774,0,1,negative regulation of ovulation,BP,
14663,GO:0060281,1,0.936568103328599,0,10,regulation of oocyte development,BP,
14664,GO:0060282,1,0.972749314999613,0,4,positive regulation of oocyte development,BP,
14665,GO:0060283,1,0.973960581508277,0,4,negative regulation of oocyte development,BP,
14667,GO:0060285,1,0.800181553290926,0,30,cilium-dependent cell motility,BP,
14668,GO:0060287,1,0.944668420618675,0,9,epithelial cilium movement involved in determination of left/right asymmetry,BP,
14669,GO:0060290,1,0.961905042725357,0,6,transdifferentiation,BP,
14671,GO:0060292,1,0.814766792828384,0,28,long term synaptic depression,BP,
14672,GO:0060293,1,0.913591000612689,0,14,germ plasm,CC,
14673,GO:0060294,1,0.920267951248271,0,16,cilium movement involved in cell motility,BP,
14674,GO:0060295,1,0.971078403947606,0,5,regulation of cilium movement involved in cell motility,BP,
14675,GO:0060296,1,0.971078403947606,0,5,regulation of cilium beat frequency involved in ciliary motility,BP,
14676,GO:0060297,1,0.953209899090243,0,5,regulation of sarcomere organization,BP,
14677,GO:0060298,1,0.977675808110883,0,3,positive regulation of sarcomere organization,BP,
14678,GO:0060300,1,0.977834777545364,0,4,regulation of cytokine activity,BP,
14679,GO:0060301,1,0.99439600355199,0,1,positive regulation of cytokine activity,BP,
14680,GO:0060302,1,0.990634421879524,0,2,negative regulation of cytokine activity,BP,
14681,GO:0060304,1,0.949549486558478,0,6,regulation of phosphatidylinositol dephosphorylation,BP,
14682,GO:0060305,1,0.993964646557823,0,1,regulation of cell diameter,BP,
14683,GO:0060306,1,0.801583456725025,0,29,regulation of membrane repolarization,BP,
14684,GO:0060307,1,0.875518750745379,0,18,regulation of ventricular cardiac muscle cell membrane repolarization,BP,
14685,GO:0060309,1,0.99653725154784,0,1,elastin catabolic process,BP,
14686,GO:0060310,1,0.99653725154784,0,1,regulation of elastin catabolic process,BP,
14687,GO:0060311,1,0.99653725154784,0,1,negative regulation of elastin catabolic process,BP,
14688,GO:0060312,1,0.945492422525917,0,8,regulation of blood vessel remodeling,BP,
14689,GO:0060313,1,0.978228876244879,0,3,negative regulation of blood vessel remodeling,BP,
14690,GO:0060314,1,0.846165514455856,0,25,regulation of ryanodine-sensitive calcium-release channel activity,BP,
14691,GO:0060315,1,0.940785672317115,0,11,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
14692,GO:0060316,1,0.948893998104821,0,8,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,
14693,GO:0060317,1,0.817483239610218,0,31,cardiac epithelial to mesenchymal transition,BP,
14694,GO:0060318,1,0.966228508514566,0,5,definitive erythrocyte differentiation,BP,
14695,GO:0060319,1,0.976120675441182,0,4,primitive erythrocyte differentiation,BP,
14697,GO:0060323,1,0.784401875451547,0,34,head morphogenesis,BP,
14698,GO:0060324,1,0.716068226443167,0,46,face development,BP,
14699,GO:0060325,1,0.806228655262619,0,29,face morphogenesis,BP,
14701,GO:0060327,1,0.994082147091451,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
14702,GO:0060330,1,0.868209830049552,0,23,regulation of response to interferon-gamma,BP,
14703,GO:0060331,1,0.966357439246086,0,6,negative regulation of response to interferon-gamma,BP,
14704,GO:0060332,1,0.957844493655117,0,6,positive regulation of response to interferon-gamma,BP,
14706,GO:0060334,1,0.868209830049552,0,23,regulation of interferon-gamma-mediated signaling pathway,BP,
14707,GO:0060335,1,0.957844493655117,0,6,positive regulation of interferon-gamma-mediated signaling pathway,BP,
14708,GO:0060336,1,0.966357439246086,0,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,
14709,GO:0060337,1,0.65184382878002,0,71,type I interferon signaling pathway,BP,
14710,GO:0060338,1,0.810309095130309,0,30,regulation of type I interferon-mediated signaling pathway,BP,
14711,GO:0060339,1,0.951423628254309,0,7,negative regulation of type I interferon-mediated signaling pathway,BP,
14712,GO:0060340,1,0.927693406267242,0,10,positive regulation of type I interferon-mediated signaling pathway,BP,
14714,GO:0060342,1,0.989243559537382,0,2,photoreceptor inner segment membrane,CC,
14715,GO:0060343,1,0.849941360679492,0,23,trabecula formation,BP,
14716,GO:0060345,1,0.993438995494363,0,1,spleen trabecula formation,BP,
14717,GO:0060346,1,0.923407951064185,0,10,bone trabecula formation,BP,
14718,GO:0060347,1,0.926585108035989,0,12,heart trabecula formation,BP,
14721,GO:0060350,1,0.717898968485484,0,48,endochondral bone morphogenesis,BP,
14722,GO:0060351,1,0.853253667479025,0,24,cartilage development involved in endochondral bone morphogenesis,BP,
14723,GO:0060352,1,0.961120381607191,0,7,cell adhesion molecule production,BP,
14724,GO:0060353,1,0.975303692472781,0,5,regulation of cell adhesion molecule production,BP,
14725,GO:0060354,1,0.996385206025579,0,1,negative regulation of cell adhesion molecule production,BP,
14726,GO:0060355,1,0.978842772755831,0,4,positive regulation of cell adhesion molecule production,BP,
14728,GO:0060363,1,0.951931682169125,0,8,cranial suture morphogenesis,BP,
14729,GO:0060364,1,0.972089339452934,0,4,frontal suture morphogenesis,BP,
14730,GO:0060366,1,0.988706395722025,0,1,lambdoid suture morphogenesis,BP,
14731,GO:0060367,1,0.988706395722025,0,1,sagittal suture morphogenesis,BP,
14732,GO:0060368,1,0.963497406765886,0,6,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14733,GO:0060369,1,0.974066952273059,0,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14734,GO:0060370,1,0.987302058705012,0,2,susceptibility to T cell mediated cytotoxicity,BP,
14735,GO:0060371,1,0.942594913929514,0,7,regulation of atrial cardiac muscle cell membrane depolarization,BP,
14736,GO:0060372,1,0.945403347028919,0,7,regulation of atrial cardiac muscle cell membrane repolarization,BP,
14737,GO:0060373,1,0.960334946979715,0,5,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
14738,GO:0060374,1,0.962730860754382,0,5,mast cell differentiation,BP,
14739,GO:0060375,1,0.985434866583666,0,2,regulation of mast cell differentiation,BP,
14740,GO:0060377,1,0.993550737487651,0,1,negative regulation of mast cell differentiation,BP,
14741,GO:0060378,1,0.984439677397069,0,2,regulation of brood size,BP,
14742,GO:0060379,1,0.927681302261731,0,10,cardiac muscle cell myoblast differentiation,BP,
14743,GO:0060380,1,0.994920388122017,0,1,regulation of single-stranded telomeric DNA binding,BP,
14744,GO:0060381,1,0.994920388122017,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
14745,GO:0060382,1,0.983182902443948,0,2,regulation of DNA strand elongation,BP,
14746,GO:0060383,1,0.992724044257892,0,1,positive regulation of DNA strand elongation,BP,
14749,GO:0060386,1,0.99110513719912,0,1,synapse assembly involved in innervation,BP,
14750,GO:0060389,1,0.68461014218603,0,59,pathway-restricted SMAD protein phosphorylation,BP,
14751,GO:0060390,1,0.890758448317038,0,17,regulation of SMAD protein signal transduction,BP,
14752,GO:0060391,1,0.911685795949849,0,13,positive regulation of SMAD protein signal transduction,BP,
14753,GO:0060392,1,0.985145986702147,0,3,negative regulation of SMAD protein signal transduction,BP,
14754,GO:0060393,1,0.702232885645739,0,56,regulation of pathway-restricted SMAD protein phosphorylation,BP,
14755,GO:0060394,1,0.942423161720883,0,10,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,
14756,GO:0060395,1,0.662131131531874,0,60,SMAD protein signal transduction,BP,
14757,GO:0060396,1,0.868137765253578,0,19,growth hormone receptor signaling pathway,BP,
14758,GO:0060397,1,0.912179927130201,0,12,JAK-STAT cascade involved in growth hormone signaling pathway,BP,
14759,GO:0060398,1,0.971440855743469,0,4,regulation of growth hormone receptor signaling pathway,BP,
14760,GO:0060399,1,0.979089336089273,0,3,positive regulation of growth hormone receptor signaling pathway,BP,
14761,GO:0060400,1,0.99218982850076,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
14764,GO:0060404,1,0.993144458152951,0,1,axonemal microtubule depolymerization,BP,
14766,GO:0060406,1,0.978856065558741,0,3,positive regulation of penile erection,BP,
14767,GO:0060407,1,0.995584917977122,0,1,negative regulation of penile erection,BP,
14768,GO:0060411,1,0.627358520125775,0,63,cardiac septum morphogenesis,BP,
14769,GO:0060412,1,0.77175569990513,0,35,ventricular septum morphogenesis,BP,
14770,GO:0060413,1,0.900124046307919,0,14,atrial septum morphogenesis,BP,
14771,GO:0060414,1,0.974552617472901,0,3,aorta smooth muscle tissue morphogenesis,BP,
14772,GO:0060415,1,0.561375148361745,0,73,muscle tissue morphogenesis,BP,
14773,GO:0060416,1,0.801897132335565,0,30,response to growth hormone,BP,
14774,GO:0060419,1,0.59131814215341,0,74,heart growth,BP,
14775,GO:0060420,1,0.68447317254872,0,53,regulation of heart growth,BP,
14776,GO:0060421,1,0.778792236277749,0,33,positive regulation of heart growth,BP,
14777,GO:0060422,1,0.994629208252484,0,1,peptidyl-dipeptidase inhibitor activity,MF,
14778,GO:0060423,1,0.982116062684583,0,3,foregut regionalization,BP,
14779,GO:0060424,1,0.982116062684583,0,3,lung field specification,BP,
14780,GO:0060425,1,0.717022115439929,0,50,lung morphogenesis,BP,
14781,GO:0060426,1,0.971310030354673,0,5,lung vasculature development,BP,
14782,GO:0060428,1,0.798058637167806,0,34,lung epithelium development,BP,
14784,GO:0060430,1,0.953362588001135,0,7,lung saccule development,BP,
14785,GO:0060431,1,0.970926355232361,0,5,primary lung bud formation,BP,
14786,GO:0060432,1,0.996719817594225,0,1,lung pattern specification process,BP,
14787,GO:0060433,1,0.941409613717049,0,10,bronchus development,BP,
14788,GO:0060434,1,0.986515055722757,0,2,bronchus morphogenesis,BP,
14789,GO:0060435,1,0.992580205954337,0,2,bronchiole development,BP,
14790,GO:0060436,1,0.996719817594225,0,1,bronchiole morphogenesis,BP,
14791,GO:0060437,1,0.969582584927322,0,5,lung growth,BP,
14792,GO:0060438,1,0.879448621833596,0,19,trachea development,BP,
14793,GO:0060439,1,0.930514476749881,0,11,trachea morphogenesis,BP,
14794,GO:0060440,1,0.963874861505512,0,6,trachea formation,BP,
14795,GO:0060441,1,0.824709426001422,0,29,epithelial tube branching involved in lung morphogenesis,BP,
14796,GO:0060442,1,0.919740283158871,0,12,branching involved in prostate gland morphogenesis,BP,
14797,GO:0060443,1,0.723282052416235,0,43,mammary gland morphogenesis,BP,
14798,GO:0060444,1,0.839830188468088,0,22,branching involved in mammary gland duct morphogenesis,BP,
14799,GO:0060445,1,0.851898077193802,0,22,branching involved in salivary gland morphogenesis,BP,
14800,GO:0060447,1,0.98162572663559,0,3,bud outgrowth involved in lung branching,BP,
14801,GO:0060448,1,0.973230518387245,0,3,dichotomous subdivision of terminal units involved in lung branching,BP,
14802,GO:0060449,1,0.959575008935988,0,7,bud elongation involved in lung branching,BP,
14804,GO:0060453,1,0.94542166672207,0,10,regulation of gastric acid secretion,BP,
14805,GO:0060454,1,0.986247229671152,0,2,positive regulation of gastric acid secretion,BP,
14806,GO:0060455,1,0.977744181901325,0,5,negative regulation of gastric acid secretion,BP,
14807,GO:0060456,1,0.948905756288352,0,10,positive regulation of digestive system process,BP,
14808,GO:0060457,1,0.924977006056067,0,13,negative regulation of digestive system process,BP,
14809,GO:0060458,1,0.98987295066868,0,2,right lung development,BP,
14810,GO:0060459,1,0.985210027112093,0,3,left lung development,BP,
14811,GO:0060460,1,0.989624590905543,0,2,left lung morphogenesis,BP,
14812,GO:0060461,1,0.994308195715901,0,1,right lung morphogenesis,BP,
14813,GO:0060462,1,0.960503459241073,0,6,lung lobe development,BP,
14814,GO:0060463,1,0.960503459241073,0,6,lung lobe morphogenesis,BP,
14815,GO:0060465,1,0.986808277008318,0,2,pharynx development,BP,
14816,GO:0060466,1,0.990064688415245,0,1,activation of meiosis involved in egg activation,BP,
14817,GO:0060467,1,0.990480584799719,0,2,negative regulation of fertilization,BP,
14818,GO:0060474,1,0.990394383291456,0,2,positive regulation of flagellated sperm motility involved in capacitation,BP,
14819,GO:0060478,1,0.977540441638096,0,4,acrosomal vesicle exocytosis,BP,
14820,GO:0060479,1,0.873394337822015,0,21,lung cell differentiation,BP,
14821,GO:0060480,1,0.986943660529964,0,3,lung goblet cell differentiation,BP,
14822,GO:0060481,1,0.979937155310989,0,4,lobar bronchus epithelium development,BP,
14823,GO:0060482,1,0.972978953404417,0,5,lobar bronchus development,BP,
14824,GO:0060484,1,0.949878487999812,0,8,lung-associated mesenchyme development,BP,
14826,GO:0060486,1,0.971586996400927,0,4,Clara cell differentiation,BP,
14827,GO:0060487,1,0.879231604185665,0,20,lung epithelial cell differentiation,BP,
14828,GO:0060488,1,0.977469124940737,0,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14829,GO:0060489,1,0.977469124940737,0,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14830,GO:0060490,1,0.977469124940737,0,2,lateral sprouting involved in lung morphogenesis,BP,
14832,GO:0060492,1,0.982116062684583,0,3,lung induction,BP,
14833,GO:0060495,1,0.996719817594225,0,1,cell-cell signaling involved in lung development,BP,
14834,GO:0060496,1,0.996719817594225,0,1,mesenchymal-epithelial cell signaling involved in lung development,BP,
14835,GO:0060501,1,0.962147758237239,0,6,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
14836,GO:0060502,1,0.934705985855977,0,10,epithelial cell proliferation involved in lung morphogenesis,BP,
14837,GO:0060503,1,0.995275580827277,0,1,bud dilation involved in lung branching,BP,
14838,GO:0060509,1,0.956163129943489,0,5,Type I pneumocyte differentiation,BP,
14839,GO:0060510,1,0.969797758400125,0,5,Type II pneumocyte differentiation,BP,
14840,GO:0060512,1,0.826427384318052,0,27,prostate gland morphogenesis,BP,
14841,GO:0060513,1,0.935578809824531,0,10,prostatic bud formation,BP,
14842,GO:0060514,1,0.993760908073491,0,1,prostate induction,BP,
14843,GO:0060515,1,0.993760908073491,0,1,prostate field specification,BP,
14844,GO:0060516,1,0.988459361365443,0,2,primary prostatic bud elongation,BP,
14845,GO:0060517,1,0.992888336613997,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
14846,GO:0060520,1,0.993760908073491,0,1,activation of prostate induction by androgen receptor signaling pathway,BP,
14847,GO:0060523,1,0.978901159119998,0,3,prostate epithelial cord elongation,BP,
14848,GO:0060525,1,0.916601916421177,0,11,prostate glandular acinus development,BP,
14849,GO:0060526,1,0.954799876687905,0,6,prostate glandular acinus morphogenesis,BP,
14850,GO:0060527,1,0.954799876687905,0,6,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
14851,GO:0060528,1,0.967569032065922,0,4,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
14852,GO:0060529,1,0.984969712769811,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
14853,GO:0060532,1,0.985447613088584,0,2,bronchus cartilage development,BP,
14854,GO:0060534,1,0.943664154837245,0,8,trachea cartilage development,BP,
14855,GO:0060535,1,0.96972863167177,0,4,trachea cartilage morphogenesis,BP,
14856,GO:0060536,1,0.928160539119526,0,11,cartilage morphogenesis,BP,
14859,GO:0060539,1,0.957512273491642,0,7,diaphragm development,BP,
14861,GO:0060542,1,0.991059392505537,0,1,regulation of strand invasion,BP,
14862,GO:0060544,1,0.891944251667626,0,20,regulation of necroptotic process,BP,
14863,GO:0060545,1,0.988072521444508,0,2,positive regulation of necroptotic process,BP,
14864,GO:0060546,1,0.939081092028579,0,10,negative regulation of necroptotic process,BP,
14865,GO:0060547,1,0.929056306551177,0,13,negative regulation of necrotic cell death,BP,
14867,GO:0060556,1,0.955563662637796,0,8,regulation of vitamin D biosynthetic process,BP,
14868,GO:0060557,1,0.99107608515702,0,2,positive regulation of vitamin D biosynthetic process,BP,
14869,GO:0060558,1,0.964928903049941,0,6,regulation of calcidiol 1-monooxygenase activity,BP,
14870,GO:0060559,1,0.99107608515702,0,2,positive regulation of calcidiol 1-monooxygenase activity,BP,
14874,GO:0060563,1,0.712986299829116,0,50,neuroepithelial cell differentiation,BP,
14875,GO:0060566,1,0.986191593533253,0,1,positive regulation of DNA-templated transcription, termination,BP,
14876,GO:0060571,1,0.850332208312599,0,26,morphogenesis of an epithelial fold,BP,
14877,GO:0060572,1,0.897384434260714,0,17,morphogenesis of an epithelial bud,BP,
14878,GO:0060573,1,0.928648138917904,0,11,cell fate specification involved in pattern specification,BP,
14879,GO:0060574,1,0.979089544847817,0,4,intestinal epithelial cell maturation,BP,
14880,GO:0060575,1,0.907898797718023,0,16,intestinal epithelial cell differentiation,BP,
14881,GO:0060576,1,0.946529561150817,0,10,intestinal epithelial cell development,BP,
14882,GO:0060577,1,0.99023504050783,0,2,pulmonary vein morphogenesis,BP,
14883,GO:0060578,1,0.994703980650772,0,1,superior vena cava morphogenesis,BP,
14884,GO:0060579,1,0.906689405406261,0,15,ventral spinal cord interneuron fate commitment,BP,
14885,GO:0060580,1,0.994907742814175,0,1,ventral spinal cord interneuron fate determination,BP,
14886,GO:0060581,1,0.906689405406261,0,15,cell fate commitment involved in pattern specification,BP,
14887,GO:0060582,1,0.994907742814175,0,1,cell fate determination involved in pattern specification,BP,
14888,GO:0060584,1,0.983261536787281,0,3,regulation of prostaglandin-endoperoxide synthase activity,BP,
14889,GO:0060585,1,0.983261536787281,0,3,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
14890,GO:0060586,1,0.948924891748447,0,8,multicellular organismal iron ion homeostasis,BP,
14891,GO:0060587,1,0.989491119973403,0,2,regulation of lipoprotein lipid oxidation,BP,
14892,GO:0060588,1,0.996094963172733,0,1,negative regulation of lipoprotein lipid oxidation,BP,
14894,GO:0060590,1,0.787581606794392,0,41,ATPase regulator activity,MF,
14895,GO:0060591,1,0.97298392142729,0,4,chondroblast differentiation,BP,
14896,GO:0060592,1,0.952971469429466,0,7,mammary gland formation,BP,
14897,GO:0060594,1,0.978288792338449,0,3,mammary gland specification,BP,
14898,GO:0060595,1,0.98946460199022,0,2,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
14899,GO:0060596,1,0.978751503195013,0,3,mammary placode formation,BP,
14900,GO:0060598,1,0.995962986275477,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
14901,GO:0060599,1,0.984814326920191,0,2,lateral sprouting involved in mammary gland duct morphogenesis,BP,
14902,GO:0060600,1,0.921462579409972,0,10,dichotomous subdivision of an epithelial terminal unit,BP,
14903,GO:0060601,1,0.907823008424046,0,13,lateral sprouting from an epithelium,BP,
14904,GO:0060602,1,0.877512068875188,0,19,branch elongation of an epithelium,BP,
14905,GO:0060603,1,0.789888897451552,0,30,mammary gland duct morphogenesis,BP,
14906,GO:0060605,1,0.967261995147704,0,5,tube lumen cavitation,BP,
14908,GO:0060611,1,0.994464091376545,0,1,mammary gland fat development,BP,
14909,GO:0060612,1,0.786411094689397,0,36,adipose tissue development,BP,
14910,GO:0060613,1,0.950398232922681,0,7,fat pad development,BP,
14911,GO:0060615,1,0.98946460199022,0,2,mammary gland bud formation,BP,
14912,GO:0060620,1,0.994054740756748,0,1,regulation of cholesterol import,BP,
14913,GO:0060623,1,0.988090096048388,0,2,regulation of chromosome condensation,BP,
14915,GO:0060628,1,0.922056557041862,0,12,regulation of ER to Golgi vesicle-mediated transport,BP,
14916,GO:0060629,1,0.993971334595742,0,1,regulation of homologous chromosome segregation,BP,
14917,GO:0060631,1,0.957171737108739,0,7,regulation of meiosis I,BP,
14918,GO:0060632,1,0.861608514013194,0,23,regulation of microtubule-based movement,BP,
14919,GO:0060633,1,0.96791784490457,0,5,negative regulation of transcription initiation from RNA polymerase II promoter,BP,
14920,GO:0060638,1,0.947784340336488,0,8,mesenchymal-epithelial cell signaling,BP,
14921,GO:0060644,1,0.890023702568698,0,16,mammary gland epithelial cell differentiation,BP,
14922,GO:0060648,1,0.984687742341732,0,3,mammary gland bud morphogenesis,BP,
14923,GO:0060661,1,0.991524707214325,0,2,submandibular salivary gland formation,BP,
14924,GO:0060662,1,0.967261995147704,0,5,salivary gland cavitation,BP,
14925,GO:0060664,1,0.974185262551929,0,5,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
14926,GO:0060665,1,0.975987474702129,0,4,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
14927,GO:0060666,1,0.955758352874498,0,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,
14928,GO:0060667,1,0.98946460199022,0,2,branch elongation involved in salivary gland morphogenesis,BP,
14929,GO:0060668,1,0.993181148761392,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
14930,GO:0060669,1,0.860950950674529,0,23,embryonic placenta morphogenesis,BP,
14931,GO:0060670,1,0.941533911160676,0,10,branching involved in labyrinthine layer morphogenesis,BP,
14932,GO:0060671,1,0.988871145071612,0,2,epithelial cell differentiation involved in embryonic placenta development,BP,
14933,GO:0060672,1,0.988871145071612,0,2,epithelial cell morphogenesis involved in placental branching,BP,
14934,GO:0060674,1,0.816546667945595,0,29,placenta blood vessel development,BP,
14935,GO:0060675,1,0.65473315790265,0,59,ureteric bud morphogenesis,BP,
14936,GO:0060676,1,0.963557377822836,0,6,ureteric bud formation,BP,
14937,GO:0060677,1,0.940845143104381,0,7,ureteric bud elongation,BP,
14938,GO:0060678,1,0.994670277144347,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
14939,GO:0060681,1,0.9733157360297,0,4,branch elongation involved in ureteric bud branching,BP,
14940,GO:0060683,1,0.994058157286956,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
14941,GO:0060684,1,0.962411972451543,0,7,epithelial-mesenchymal cell signaling,BP,
14942,GO:0060685,1,0.960202015979476,0,6,regulation of prostatic bud formation,BP,
14943,GO:0060686,1,0.970562896284194,0,4,negative regulation of prostatic bud formation,BP,
14944,GO:0060687,1,0.950601211977606,0,7,regulation of branching involved in prostate gland morphogenesis,BP,
14945,GO:0060688,1,0.718267284952803,0,51,regulation of morphogenesis of a branching structure,BP,
14946,GO:0060689,1,0.977771239144411,0,3,cell differentiation involved in salivary gland development,BP,
14947,GO:0060690,1,0.995245776674577,0,1,epithelial cell differentiation involved in salivary gland development,BP,
14948,GO:0060691,1,0.995245776674577,0,1,epithelial cell maturation involved in salivary gland development,BP,
14949,GO:0060693,1,0.945961783736244,0,9,regulation of branching involved in salivary gland morphogenesis,BP,
14950,GO:0060694,1,0.995181047312037,0,1,regulation of cholesterol transporter activity,BP,
14951,GO:0060696,1,0.968277620179781,0,6,regulation of phospholipid catabolic process,BP,
14952,GO:0060697,1,0.990661085668157,0,2,positive regulation of phospholipid catabolic process,BP,
14953,GO:0060698,1,0.986391479027021,0,2,endoribonuclease inhibitor activity,MF,
14954,GO:0060699,1,0.976817271960236,0,4,regulation of endoribonuclease activity,BP,
14955,GO:0060700,1,0.946397748615082,0,9,regulation of ribonuclease activity,BP,
14956,GO:0060701,1,0.986391479027021,0,2,negative regulation of ribonuclease activity,BP,
14957,GO:0060702,1,0.986391479027021,0,2,negative regulation of endoribonuclease activity,BP,
14958,GO:0060703,1,0.994124723010534,0,1,deoxyribonuclease inhibitor activity,MF,
14959,GO:0060706,1,0.869742959182688,0,22,cell differentiation involved in embryonic placenta development,BP,
14960,GO:0060707,1,0.931546463663796,0,11,trophoblast giant cell differentiation,BP,
14961,GO:0060708,1,0.983003442239633,0,3,spongiotrophoblast differentiation,BP,
14962,GO:0060709,1,0.993953524479694,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
14963,GO:0060710,1,0.957926714801457,0,7,chorio-allantoic fusion,BP,
14964,GO:0060711,1,0.75604355881141,0,43,labyrinthine layer development,BP,
14965,GO:0060712,1,0.907470089206067,0,14,spongiotrophoblast layer development,BP,
14966,GO:0060713,1,0.88916725182899,0,19,labyrinthine layer morphogenesis,BP,
14967,GO:0060715,1,0.979467730363675,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
14968,GO:0060716,1,0.887911661607072,0,19,labyrinthine layer blood vessel development,BP,
14969,GO:0060717,1,0.949847185520083,0,7,chorion development,BP,
14970,GO:0060718,1,0.961304964021114,0,5,chorionic trophoblast cell differentiation,BP,
14971,GO:0060720,1,0.985238092731363,0,2,spongiotrophoblast cell proliferation,BP,
14972,GO:0060721,1,0.985238092731363,0,2,regulation of spongiotrophoblast cell proliferation,BP,
14973,GO:0060722,1,0.985238092731363,0,2,cell proliferation involved in embryonic placenta development,BP,
14974,GO:0060723,1,0.985238092731363,0,2,regulation of cell proliferation involved in embryonic placenta development,BP,
14975,GO:0060729,1,0.967676322888071,0,5,intestinal epithelial structure maintenance,BP,
14976,GO:0060730,1,0.987778798475607,0,2,regulation of intestinal epithelial structure maintenance,BP,
14977,GO:0060731,1,0.993514260851553,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
14978,GO:0060732,1,0.941516182968019,0,10,positive regulation of inositol phosphate biosynthetic process,BP,
14979,GO:0060733,1,0.984391030247177,0,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,
14980,GO:0060734,1,0.992173003974695,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
14981,GO:0060735,1,0.995800638652605,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
14982,GO:0060736,1,0.914023437684655,0,11,prostate gland growth,BP,
14983,GO:0060737,1,0.971938050144804,0,4,prostate gland morphogenetic growth,BP,
14984,GO:0060738,1,0.989262520907702,0,2,epithelial-mesenchymal signaling involved in prostate gland development,BP,
14985,GO:0060739,1,0.98926973059957,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
14986,GO:0060740,1,0.829000465468262,0,26,prostate gland epithelium morphogenesis,BP,
14987,GO:0060741,1,0.985239071670596,0,3,prostate gland stromal morphogenesis,BP,
14988,GO:0060742,1,0.924011218118281,0,11,epithelial cell differentiation involved in prostate gland development,BP,
14989,GO:0060743,1,0.981889186110561,0,3,epithelial cell maturation involved in prostate gland development,BP,
14990,GO:0060744,1,0.966620455879126,0,5,mammary gland branching involved in thelarche,BP,
14991,GO:0060745,1,0.943884203471596,0,6,mammary gland branching involved in pregnancy,BP,
14992,GO:0060746,1,0.914692140675894,0,13,parental behavior,BP,
14993,GO:0060748,1,0.971437379430577,0,3,tertiary branching involved in mammary gland duct morphogenesis,BP,
14994,GO:0060749,1,0.88646589219345,0,17,mammary gland alveolus development,BP,
14995,GO:0060750,1,0.966632115585014,0,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,
14996,GO:0060751,1,0.961552217359794,0,5,branch elongation involved in mammary gland duct branching,BP,
14997,GO:0060752,1,0.99417351035814,0,1,intestinal phytosterol absorption,BP,
14998,GO:0060753,1,0.967711429206281,0,6,regulation of mast cell chemotaxis,BP,
14999,GO:0060754,1,0.971918279746686,0,5,positive regulation of mast cell chemotaxis,BP,
15000,GO:0060759,1,0.384335918075544,0,150,regulation of response to cytokine stimulus,BP,
15001,GO:0060760,1,0.739188743513208,0,47,positive regulation of response to cytokine stimulus,BP,
15002,GO:0060761,1,0.743860657458685,0,48,negative regulation of response to cytokine stimulus,BP,
15003,GO:0060762,1,0.974413273934833,0,4,regulation of branching involved in mammary gland duct morphogenesis,BP,
15004,GO:0060763,1,0.984955924533111,0,2,mammary duct terminal end bud growth,BP,
15005,GO:0060764,1,0.987572266084779,0,2,cell-cell signaling involved in mammary gland development,BP,
15006,GO:0060765,1,0.848693651338212,0,25,regulation of androgen receptor signaling pathway,BP,
15007,GO:0060766,1,0.931744480442057,0,11,negative regulation of androgen receptor signaling pathway,BP,
15008,GO:0060767,1,0.933144491322682,0,11,epithelial cell proliferation involved in prostate gland development,BP,
15009,GO:0060768,1,0.939832438257531,0,10,regulation of epithelial cell proliferation involved in prostate gland development,BP,
15010,GO:0060769,1,0.982767672275187,0,3,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
15011,GO:0060770,1,0.968233945564779,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
15012,GO:0060775,1,0.986135606159022,0,2,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
15013,GO:0060781,1,0.995539622956947,0,1,mesenchymal cell proliferation involved in prostate gland development,BP,
15014,GO:0060782,1,0.995539622956947,0,1,regulation of mesenchymal cell proliferation involved in prostate gland development,BP,
15015,GO:0060783,1,0.995539622956947,0,1,mesenchymal smoothened signaling pathway involved in prostate gland development,BP,
15016,GO:0060784,1,0.992888336613997,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
15017,GO:0060788,1,0.908929585804103,0,14,ectodermal placode formation,BP,
15018,GO:0060789,1,0.964901527311502,0,6,hair follicle placode formation,BP,
15020,GO:0060796,1,0.990235939300059,0,2,regulation of transcription involved in primary germ layer cell fate commitment,BP,
15021,GO:0060800,1,0.980022067658351,0,3,regulation of cell differentiation involved in embryonic placenta development,BP,
15022,GO:0060802,1,0.994893840072259,0,1,epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification,BP,
15023,GO:0060803,1,0.995646487063245,0,1,BMP signaling pathway involved in mesodermal cell fate specification,BP,
15024,GO:0060804,1,0.993650285489828,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
15025,GO:0060806,1,0.995395835051012,0,1,negative regulation of cell differentiation involved in embryonic placenta development,BP,
15026,GO:0060807,1,0.994566033676475,0,1,regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification,BP,
15027,GO:0060809,1,0.985150902857071,0,2,mesodermal to mesenchymal transition involved in gastrulation,BP,
15028,GO:0060816,1,0.980089466794737,0,2,random inactivation of X chromosome,BP,
15029,GO:0060819,1,0.980990646120521,0,2,inactivation of X chromosome by genetic imprinting,BP,
15030,GO:0060821,1,0.98825218807586,0,1,inactivation of X chromosome by DNA methylation,BP,
15031,GO:0060823,1,0.986188443767999,0,2,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15032,GO:0060825,1,0.990591722928662,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15033,GO:0060827,1,0.992745260332433,0,1,regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15035,GO:0060829,1,0.992745260332433,0,1,negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15036,GO:0060830,1,0.981582447132595,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
15037,GO:0060831,1,0.905608106236889,0,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
15038,GO:0060836,1,0.936983692632195,0,8,lymphatic endothelial cell differentiation,BP,
15039,GO:0060837,1,0.941996738199784,0,9,blood vessel endothelial cell differentiation,BP,
15040,GO:0060838,1,0.980872605225362,0,3,lymphatic endothelial cell fate commitment,BP,
15041,GO:0060839,1,0.957802162066464,0,7,endothelial cell fate commitment,BP,
15042,GO:0060840,1,0.544507337931843,0,76,artery development,BP,
15043,GO:0060841,1,0.877135188926016,0,16,venous blood vessel development,BP,
15044,GO:0060842,1,0.960181629377846,0,6,arterial endothelial cell differentiation,BP,
15045,GO:0060843,1,0.987698566533785,0,1,venous endothelial cell differentiation,BP,
15046,GO:0060844,1,0.988066804115751,0,2,arterial endothelial cell fate commitment,BP,
15047,GO:0060846,1,0.982529011201577,0,3,blood vessel endothelial cell fate commitment,BP,
15048,GO:0060847,1,0.982529011201577,0,3,endothelial cell fate specification,BP,
15049,GO:0060849,1,0.986677229437147,0,2,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
15050,GO:0060850,1,0.902027281148306,0,16,regulation of transcription involved in cell fate commitment,BP,
15051,GO:0060853,1,0.99348102780404,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
15052,GO:0060856,1,0.940776080252519,0,10,establishment of blood-brain barrier,BP,
15053,GO:0060857,1,0.994651591883558,0,1,establishment of glial blood-brain barrier,BP,
15054,GO:0060872,1,0.932840052122534,0,9,semicircular canal development,BP,
15055,GO:0060873,1,0.988706395722025,0,1,anterior semicircular canal development,BP,
15056,GO:0060875,1,0.988706395722025,0,1,lateral semicircular canal development,BP,
15057,GO:0060876,1,0.991187292014416,0,2,semicircular canal formation,BP,
15058,GO:0060879,1,0.996719817594225,0,1,semicircular canal fusion,BP,
15059,GO:0060896,1,0.933003320023129,0,9,neural plate pattern specification,BP,
15060,GO:0060897,1,0.952340665051903,0,7,neural plate regionalization,BP,
15061,GO:0060900,1,0.908942206917772,0,12,embryonic camera-type eye formation,BP,
15062,GO:0060901,1,0.992537751672478,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
15063,GO:0060903,1,0.975255746563821,0,4,positive regulation of meiosis I,BP,
15064,GO:0060904,1,0.992846169558835,0,1,regulation of protein folding in endoplasmic reticulum,BP,
15065,GO:0060907,1,0.95644099900166,0,7,positive regulation of macrophage cytokine production,BP,
15066,GO:0060911,1,0.944837549358651,0,10,cardiac cell fate commitment,BP,
15067,GO:0060912,1,0.988652756029456,0,2,cardiac cell fate specification,BP,
15068,GO:0060913,1,0.984830003184258,0,3,cardiac cell fate determination,BP,
15069,GO:0060914,1,0.871879083044168,0,22,heart formation,BP,
15070,GO:0060915,1,0.98946460199022,0,2,mesenchymal cell differentiation involved in lung development,BP,
15071,GO:0060916,1,0.963872745426468,0,5,mesenchymal cell proliferation involved in lung development,BP,
15072,GO:0060920,1,0.966164987125126,0,5,cardiac pacemaker cell differentiation,BP,
15073,GO:0060921,1,0.979631209525107,0,3,sinoatrial node cell differentiation,BP,
15074,GO:0060922,1,0.986256620128967,0,2,atrioventricular node cell differentiation,BP,
15075,GO:0060923,1,0.965137709990324,0,6,cardiac muscle cell fate commitment,BP,
15076,GO:0060926,1,0.969986572703693,0,4,cardiac pacemaker cell development,BP,
15077,GO:0060927,1,0.995100417345176,0,1,cardiac pacemaker cell fate commitment,BP,
15078,GO:0060928,1,0.986256620128967,0,2,atrioventricular node cell development,BP,
15079,GO:0060929,1,0.995100417345176,0,1,atrioventricular node cell fate commitment,BP,
15080,GO:0060931,1,0.983505515913695,0,2,sinoatrial node cell development,BP,
15081,GO:0060932,1,0.987215196865704,0,2,His-Purkinje system cell differentiation,BP,
15082,GO:0060935,1,0.978234842362292,0,3,cardiac fibroblast cell differentiation,BP,
15083,GO:0060936,1,0.978234842362292,0,3,cardiac fibroblast cell development,BP,
15084,GO:0060938,1,0.978234842362292,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
15085,GO:0060939,1,0.978234842362292,0,3,epicardium-derived cardiac fibroblast cell development,BP,
15086,GO:0060940,1,0.987702165086763,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
15087,GO:0060947,1,0.942571990147767,0,8,cardiac vascular smooth muscle cell differentiation,BP,
15088,GO:0060948,1,0.975341177076568,0,3,cardiac vascular smooth muscle cell development,BP,
15089,GO:0060956,1,0.9550397583489,0,6,endocardial cell differentiation,BP,
15090,GO:0060957,1,0.993848803865067,0,1,endocardial cell fate commitment,BP,
15091,GO:0060964,1,0.583609967069743,0,83,regulation of gene silencing by miRNA,BP,
15092,GO:0060965,1,0.917639856266832,0,12,negative regulation of gene silencing by miRNA,BP,
15093,GO:0060966,1,0.568804747583609,0,86,regulation of gene silencing by RNA,BP,
15094,GO:0060967,1,0.902193362787869,0,14,negative regulation of gene silencing by RNA,BP,
15095,GO:0060968,1,0.488691134849392,0,106,regulation of gene silencing,BP,
15096,GO:0060969,1,0.843582240372378,0,22,negative regulation of gene silencing,BP,
15097,GO:0060971,1,0.969771806586073,0,4,embryonic heart tube left/right pattern formation,BP,
15098,GO:0060972,1,0.859356842581215,0,21,left/right pattern formation,BP,
15099,GO:0060973,1,0.887549302099843,0,17,cell migration involved in heart development,BP,
15100,GO:0060974,1,0.992275513507494,0,2,cell migration involved in heart formation,BP,
15101,GO:0060975,1,0.996061378444575,0,1,cardioblast migration to the midline involved in heart field formation,BP,
15102,GO:0060976,1,0.724369631683382,0,41,coronary vasculature development,BP,
15103,GO:0060977,1,0.873912663140224,0,15,coronary vasculature morphogenesis,BP,
15104,GO:0060978,1,0.97616714173801,0,3,angiogenesis involved in coronary vascular morphogenesis,BP,
15105,GO:0060979,1,0.961439246456659,0,4,vasculogenesis involved in coronary vascular morphogenesis,BP,
15106,GO:0060980,1,0.993151209466218,0,1,cell migration involved in coronary vasculogenesis,BP,
15107,GO:0060981,1,0.991103147331732,0,1,cell migration involved in coronary angiogenesis,BP,
15108,GO:0060982,1,0.921796277955781,0,9,coronary artery morphogenesis,BP,
15109,GO:0060986,1,0.764822249655268,0,43,endocrine hormone secretion,BP,
15110,GO:0060987,1,0.994596954618774,0,1,lipid tube,CC,
15111,GO:0060988,1,0.98724626652606,0,2,lipid tube assembly,BP,
15112,GO:0060992,1,0.922623416732144,0,11,response to fungicide,BP,
15113,GO:0060993,1,0.530492507953684,0,86,kidney morphogenesis,BP,
15114,GO:0060994,1,0.988405145859408,0,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
15115,GO:0060995,1,0.985361984288866,0,2,cell-cell signaling involved in kidney development,BP,
15117,GO:0060997,1,0.677963360208217,0,48,dendritic spine morphogenesis,BP,
15120,GO:0061000,1,0.91479548716245,0,11,negative regulation of dendritic spine development,BP,
15121,GO:0061001,1,0.75677268807829,0,34,regulation of dendritic spine morphogenesis,BP,
15122,GO:0061002,1,0.955542798987556,0,6,negative regulation of dendritic spine morphogenesis,BP,
15123,GO:0061003,1,0.867340593820897,0,17,positive regulation of dendritic spine morphogenesis,BP,
15124,GO:0061004,1,0.951631857126802,0,9,pattern specification involved in kidney development,BP,
15125,GO:0061005,1,0.695564754972588,0,50,cell differentiation involved in kidney development,BP,
15127,GO:0061009,1,0.973235867873077,0,5,common bile duct development,BP,
15128,GO:0061010,1,0.97698847095165,0,3,gall bladder development,BP,
15129,GO:0061011,1,0.99530979889918,0,1,hepatic duct development,BP,
15130,GO:0061013,1,0.332039875510589,0,170,regulation of mRNA catabolic process,BP,
15131,GO:0061014,1,0.741349484060919,0,39,positive regulation of mRNA catabolic process,BP,
15132,GO:0061015,1,0.991566468038539,0,2,snRNA import into nucleus,BP,
15133,GO:0061017,1,0.99530979889918,0,1,hepatoblast differentiation,BP,
15136,GO:0061026,1,0.985441175948677,0,1,cardiac muscle tissue regeneration,BP,
15137,GO:0061027,1,0.988831153107961,0,2,umbilical cord development,BP,
15139,GO:0061029,1,0.912879677591524,0,13,eyelid development in camera-type eye,BP,
15140,GO:0061030,1,0.983020802535097,0,3,epithelial cell differentiation involved in mammary gland alveolus development,BP,
15141,GO:0061031,1,0.985151055805141,0,3,endodermal digestive tract morphogenesis,BP,
15142,GO:0061032,1,0.988378570957409,0,2,visceral serous pericardium development,BP,
15143,GO:0061033,1,0.989621698169684,0,2,secretion by lung epithelial cell involved in lung growth,BP,
15144,GO:0061034,1,0.984217421822524,0,2,olfactory bulb mitral cell layer development,BP,
15145,GO:0061035,1,0.674570961367871,0,56,regulation of cartilage development,BP,
15146,GO:0061036,1,0.820797609548719,0,27,positive regulation of cartilage development,BP,
15147,GO:0061037,1,0.870545613323496,0,22,negative regulation of cartilage development,BP,
15148,GO:0061038,1,0.949017471469584,0,6,uterus morphogenesis,BP,
15149,GO:0061040,1,0.988195392288915,0,1,female gonad morphogenesis,BP,
15150,GO:0061041,1,0.491017542477441,0,109,regulation of wound healing,BP,
15151,GO:0061042,1,0.947704210002863,0,9,vascular wound healing,BP,
15152,GO:0061043,1,0.976887636202607,0,4,regulation of vascular wound healing,BP,
15153,GO:0061044,1,0.993635796894997,0,1,negative regulation of vascular wound healing,BP,
15154,GO:0061045,1,0.672848073877051,0,61,negative regulation of wound healing,BP,
15155,GO:0061046,1,0.966079406631378,0,6,regulation of branching involved in lung morphogenesis,BP,
15156,GO:0061047,1,0.977475289753853,0,4,positive regulation of branching involved in lung morphogenesis,BP,
15157,GO:0061048,1,0.995423626604521,0,1,negative regulation of branching involved in lung morphogenesis,BP,
15158,GO:0061049,1,0.888849035603356,0,17,cell growth involved in cardiac muscle cell development,BP,
15159,GO:0061050,1,0.925108110308378,0,11,regulation of cell growth involved in cardiac muscle cell development,BP,
15160,GO:0061051,1,0.947856233934641,0,7,positive regulation of cell growth involved in cardiac muscle cell development,BP,
15161,GO:0061052,1,0.976013268329362,0,4,negative regulation of cell growth involved in cardiac muscle cell development,BP,
15164,GO:0061055,1,0.972048411846904,0,4,myotome development,BP,
15167,GO:0061072,1,0.931951623299314,0,9,iris morphogenesis,BP,
15168,GO:0061073,1,0.980120078685814,0,3,ciliary body morphogenesis,BP,
15169,GO:0061074,1,0.971033021933175,0,5,regulation of neural retina development,BP,
15170,GO:0061075,1,0.989301205266024,0,2,positive regulation of neural retina development,BP,
15171,GO:0061076,1,0.993661699491691,0,1,negative regulation of neural retina development,BP,
15172,GO:0061077,1,0.663587823937192,0,71,chaperone-mediated protein folding,BP,
15173,GO:0061078,1,0.996801118490797,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
15174,GO:0061081,1,0.936290989694558,0,11,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
15176,GO:0061083,1,0.975004222612314,0,4,regulation of protein refolding,BP,
15177,GO:0061084,1,0.975004222612314,0,4,negative regulation of protein refolding,BP,
15178,GO:0061085,1,0.941470112888897,0,9,regulation of histone H3-K27 methylation,BP,
15179,GO:0061086,1,0.973718625512237,0,4,negative regulation of histone H3-K27 methylation,BP,
15180,GO:0061087,1,0.96079809801998,0,6,positive regulation of histone H3-K27 methylation,BP,
15182,GO:0061090,1,0.994497125833657,0,1,positive regulation of sequestering of zinc ion,BP,
15183,GO:0061091,1,0.973506785375254,0,3,regulation of phospholipid translocation,BP,
15184,GO:0061092,1,0.973506785375254,0,3,positive regulation of phospholipid translocation,BP,
15187,GO:0061099,1,0.856782457768585,0,24,negative regulation of protein tyrosine kinase activity,BP,
15188,GO:0061100,1,0.994409330361848,0,1,lung neuroendocrine cell differentiation,BP,
15189,GO:0061101,1,0.958422255522315,0,8,neuroendocrine cell differentiation,BP,
15190,GO:0061102,1,0.990126084050942,0,2,stomach neuroendocrine cell differentiation,BP,
15191,GO:0061103,1,0.994409330361848,0,1,carotid body glomus cell differentiation,BP,
15192,GO:0061104,1,0.988444098501161,0,2,adrenal chromaffin cell differentiation,BP,
15193,GO:0061105,1,0.995692916722254,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
15194,GO:0061106,1,0.995692916722254,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
15195,GO:0061107,1,0.983935892239688,0,3,seminal vesicle development,BP,
15196,GO:0061108,1,0.994670900476519,0,1,seminal vesicle epithelium development,BP,
15198,GO:0061113,1,0.978802122524226,0,3,pancreas morphogenesis,BP,
15199,GO:0061114,1,0.993732872242499,0,1,branching involved in pancreas morphogenesis,BP,
15200,GO:0061115,1,0.996719817594225,0,1,lung proximal/distal axis specification,BP,
15201,GO:0061117,1,0.902637755444263,0,16,negative regulation of heart growth,BP,
15205,GO:0061136,1,0.343387508919823,0,165,regulation of proteasomal protein catabolic process,BP,
15207,GO:0061140,1,0.951778473509115,0,9,lung secretory cell differentiation,BP,
15208,GO:0061141,1,0.979017832814538,0,3,lung ciliated cell differentiation,BP,
15209,GO:0061143,1,0.993972450353285,0,1,alveolar primary septum development,BP,
15210,GO:0061144,1,0.99369505848113,0,1,alveolar secondary septum development,BP,
15211,GO:0061145,1,0.985447613088584,0,2,lung smooth muscle development,BP,
15212,GO:0061146,1,0.980925717646599,0,3,Peyer's patch morphogenesis,BP,
15213,GO:0061149,1,0.995275580827277,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
15214,GO:0061150,1,0.995275580827277,0,1,renal system segmentation,BP,
15215,GO:0061151,1,0.995275580827277,0,1,BMP signaling pathway involved in renal system segmentation,BP,
15216,GO:0061152,1,0.989348661325139,0,2,trachea submucosa development,BP,
15217,GO:0061153,1,0.989348661325139,0,2,trachea gland development,BP,
15218,GO:0061154,1,0.912531220986763,0,15,endothelial tube morphogenesis,BP,
15219,GO:0061155,1,0.995275580827277,0,1,pulmonary artery endothelial tube morphogenesis,BP,
15220,GO:0061156,1,0.949854663649577,0,6,pulmonary artery morphogenesis,BP,
15221,GO:0061157,1,0.841730538819468,0,22,mRNA destabilization,BP,
15222,GO:0061158,1,0.906266848761385,0,12,3'-UTR-mediated mRNA destabilization,BP,
15223,GO:0061162,1,0.868187808184995,0,19,establishment of monopolar cell polarity,BP,
15225,GO:0061179,1,0.951127118896991,0,9,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15226,GO:0061180,1,0.620326273220035,0,64,mammary gland epithelium development,BP,
15227,GO:0061181,1,0.992587424634168,0,1,regulation of chondrocyte development,BP,
15229,GO:0061184,1,0.992908448818777,0,1,positive regulation of dermatome development,BP,
15231,GO:0061187,1,0.982310698977994,0,2,regulation of chromatin silencing at rDNA,BP,
15232,GO:0061188,1,0.982310698977994,0,2,negative regulation of chromatin silencing at rDNA,BP,
15233,GO:0061189,1,0.995539622956947,0,1,positive regulation of sclerotome development,BP,
15234,GO:0061190,1,0.995539622956947,0,1,regulation of sclerotome development,BP,
15235,GO:0061193,1,0.996263821660609,0,1,taste bud development,BP,
15236,GO:0061196,1,0.958602296521824,0,6,fungiform papilla development,BP,
15237,GO:0061197,1,0.96375034135922,0,5,fungiform papilla morphogenesis,BP,
15238,GO:0061198,1,0.978587528891202,0,3,fungiform papilla formation,BP,
15241,GO:0061205,1,0.98692321494671,0,2,paramesonephric duct development,BP,
15242,GO:0061209,1,0.977479406867541,0,4,cell proliferation involved in mesonephros development,BP,
15243,GO:0061213,1,0.882877305564553,0,20,positive regulation of mesonephros development,BP,
15244,GO:0061216,1,0.995275580827277,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
15245,GO:0061217,1,0.869685484668304,0,23,regulation of mesonephros development,BP,
15246,GO:0061218,1,0.971110797780316,0,5,negative regulation of mesonephros development,BP,
15247,GO:0061227,1,0.990436827554303,0,2,pattern specification involved in mesonephros development,BP,
15248,GO:0061245,1,0.733292684211374,0,45,establishment or maintenance of bipolar cell polarity,BP,
15249,GO:0061289,1,0.985361984288866,0,2,Wnt signaling pathway involved in kidney development,BP,
15250,GO:0061290,1,0.985361984288866,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
15251,GO:0061298,1,0.873846702187483,0,16,retina vasculature development in camera-type eye,BP,
15252,GO:0061299,1,0.934643069638928,0,9,retina vasculature morphogenesis in camera-type eye,BP,
15253,GO:0061300,1,0.985152430269662,0,2,cerebellum vasculature development,BP,
15254,GO:0061301,1,0.989499222530994,0,1,cerebellum vasculature morphogenesis,BP,
15255,GO:0061302,1,0.972757503520941,0,5,smooth muscle cell-matrix adhesion,BP,
15256,GO:0061303,1,0.949179152240147,0,8,cornea development in camera-type eye,BP,
15257,GO:0061304,1,0.963642025427821,0,4,retinal blood vessel morphogenesis,BP,
15258,GO:0061307,1,0.937186719961971,0,11,cardiac neural crest cell differentiation involved in heart development,BP,
15259,GO:0061308,1,0.937186719961971,0,11,cardiac neural crest cell development involved in heart development,BP,
15260,GO:0061309,1,0.948304661687786,0,9,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,
15261,GO:0061311,1,0.853727498572243,0,24,cell surface receptor signaling pathway involved in heart development,BP,
15262,GO:0061312,1,0.967710128534279,0,6,BMP signaling pathway involved in heart development,BP,
15263,GO:0061314,1,0.932660906908326,0,9,Notch signaling involved in heart development,BP,
15264,GO:0061316,1,0.98326276927547,0,3,canonical Wnt signaling pathway involved in heart development,BP,
15265,GO:0061317,1,0.989826448321314,0,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
15266,GO:0061318,1,0.895449295153486,0,15,renal filtration cell differentiation,BP,
15267,GO:0061323,1,0.903966576421738,0,15,cell proliferation involved in heart morphogenesis,BP,
15268,GO:0061324,1,0.993369541796353,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
15269,GO:0061325,1,0.978071554437133,0,4,cell proliferation involved in outflow tract morphogenesis,BP,
15270,GO:0061326,1,0.529988343143782,0,87,renal tubule development,BP,
15271,GO:0061333,1,0.591341210479275,0,72,renal tubule morphogenesis,BP,
15272,GO:0061337,1,0.361708177078438,0,137,cardiac conduction,BP,
15273,GO:0061339,1,0.868187808184995,0,19,establishment or maintenance of monopolar cell polarity,BP,
15274,GO:0061341,1,0.982559010329697,0,2,non-canonical Wnt signaling pathway involved in heart development,BP,
15275,GO:0061343,1,0.967733029239403,0,4,cell adhesion involved in heart morphogenesis,BP,
15276,GO:0061346,1,0.982559010329697,0,2,planar cell polarity pathway involved in heart morphogenesis,BP,
15277,GO:0061347,1,0.990997815957518,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
15278,GO:0061348,1,0.990997815957518,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
15279,GO:0061349,1,0.990997815957518,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
15280,GO:0061350,1,0.990997815957518,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
15282,GO:0061354,1,0.990997815957518,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
15283,GO:0061355,1,0.974927106372736,0,4,Wnt protein secretion,BP,
15284,GO:0061356,1,0.974927106372736,0,4,regulation of Wnt protein secretion,BP,
15285,GO:0061357,1,0.979658342921426,0,3,positive regulation of Wnt protein secretion,BP,
15286,GO:0061358,1,0.995171524763314,0,1,negative regulation of Wnt protein secretion,BP,
15287,GO:0061360,1,0.992707630778446,0,1,optic chiasma development,BP,
15288,GO:0061364,1,0.974423916922957,0,3,apoptotic process involved in luteolysis,BP,
15289,GO:0061365,1,0.965686227708731,0,7,positive regulation of triglyceride lipase activity,BP,
15290,GO:0061366,1,0.980815477775744,0,3,behavioral response to chemical pain,BP,
15291,GO:0061368,1,0.980815477775744,0,3,behavioral response to formalin induced pain,BP,
15292,GO:0061369,1,0.992908448818777,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
15293,GO:0061370,1,0.968145985935459,0,6,testosterone biosynthetic process,BP,
15294,GO:0061371,1,0.671012896418487,0,58,determination of heart left/right asymmetry,BP,
15295,GO:0061373,1,0.987832237786774,0,1,mammillary axonal complex development,BP,
15296,GO:0061377,1,0.88646589219345,0,17,mammary gland lobule development,BP,
15297,GO:0061383,1,0.706533751146187,0,46,trabecula morphogenesis,BP,
15298,GO:0061384,1,0.794734930202695,0,31,heart trabecula morphogenesis,BP,
15299,GO:0061386,1,0.978990693894001,0,2,closure of optic fissure,BP,
15300,GO:0061387,1,0.484408297089614,0,96,regulation of extent of cell growth,BP,
15301,GO:0061394,1,0.990324934614916,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15302,GO:0061395,1,0.99535853585389,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15303,GO:0061400,1,0.994054740756748,0,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,
15304,GO:0061402,1,0.988614450462913,0,2,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH,BP,
15305,GO:0061408,1,0.983353616614599,0,3,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
15306,GO:0061418,1,0.659846686661465,0,74,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15307,GO:0061419,1,0.962972535261882,0,5,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15308,GO:0061428,1,0.974447025276116,0,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15309,GO:0061430,1,0.89954987415666,0,13,bone trabecula morphogenesis,BP,
15310,GO:0061433,1,0.995067410461975,0,1,cellular response to caloric restriction,BP,
15311,GO:0061436,1,0.901912802618664,0,16,establishment of skin barrier,BP,
15312,GO:0061437,1,0.853255705932396,0,23,renal system vasculature development,BP,
15313,GO:0061438,1,0.952562581266902,0,6,renal system vasculature morphogenesis,BP,
15314,GO:0061439,1,0.952562581266902,0,6,kidney vasculature morphogenesis,BP,
15315,GO:0061440,1,0.853255705932396,0,23,kidney vasculature development,BP,
15316,GO:0061441,1,0.986209779258297,0,2,renal artery morphogenesis,BP,
15317,GO:0061443,1,0.984733164990258,0,2,endocardial cushion cell differentiation,BP,
15318,GO:0061444,1,0.990828510544773,0,1,endocardial cushion cell development,BP,
15319,GO:0061445,1,0.993848803865067,0,1,endocardial cushion cell fate commitment,BP,
15321,GO:0061450,1,0.943891206377624,0,10,trophoblast cell migration,BP,
15323,GO:0061459,1,0.989317967241379,0,1,L-arginine transmembrane transporter activity,MF,
15324,GO:0061462,1,0.791162029262254,0,35,protein localization to lysosome,BP,
15326,GO:0061470,1,0.968103919563768,0,4,T follicular helper cell differentiation,BP,
15327,GO:0061474,1,0.994324946976544,0,1,phagolysosome membrane,CC,
15328,GO:0061476,1,0.96496963541748,0,5,response to anticoagulant,BP,
15330,GO:0061481,1,0.996454469426125,0,1,response to TNF agonist,BP,
15331,GO:0061484,1,0.972133020996184,0,4,hematopoietic stem cell homeostasis,BP,
15332,GO:0061485,1,0.989389026960135,0,1,memory T cell proliferation,BP,
15333,GO:0061495,1,0.994054740756748,0,1,gamma-tubulin small complex, mitotic spindle pole body,CC,
15334,GO:0061502,1,0.963145509654152,0,4,early endosome to recycling endosome transport,BP,
15336,GO:0061507,1,0.995393307501462,0,1,cyclic-GMP-AMP binding,MF,
15337,GO:0061508,1,0.994054740756748,0,1,CDP phosphorylation,BP,
15338,GO:0061511,1,0.972252832957898,0,4,centriole elongation,BP,
15339,GO:0061512,1,0.797083647253386,0,34,protein localization to cilium,BP,
15340,GO:0061513,1,0.981312692773125,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
15342,GO:0061517,1,0.988213200675666,0,2,macrophage proliferation,BP,
15343,GO:0061518,1,0.988213200675666,0,2,microglial cell proliferation,BP,
15344,GO:0061519,1,0.993205346099724,0,1,macrophage homeostasis,BP,
15345,GO:0061523,1,0.993144458152951,0,1,cilium disassembly,BP,
15346,GO:0061525,1,0.939935016861174,0,8,hindgut development,BP,
15347,GO:0061526,1,0.977349699912448,0,4,acetylcholine secretion,BP,
15348,GO:0061528,1,0.991914726505661,0,1,aspartate secretion,BP,
15349,GO:0061534,1,0.985032922026261,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
15350,GO:0061535,1,0.970096089473397,0,3,glutamate secretion, neurotransmission,BP,
15351,GO:0061536,1,0.993576212296719,0,1,glycine secretion,BP,
15352,GO:0061537,1,0.993576212296719,0,1,glycine secretion, neurotransmission,BP,
15353,GO:0061542,1,0.995925571083506,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
15354,GO:0061547,1,0.987050103141114,0,2,glycogen synthase activity, transferring glucose-1-phosphate,MF,
15355,GO:0061548,1,0.920716520960085,0,12,ganglion development,BP,
15356,GO:0061549,1,0.946256089747671,0,8,sympathetic ganglion development,BP,
15357,GO:0061550,1,0.964233281255364,0,5,cranial ganglion development,BP,
15358,GO:0061551,1,0.970671204128385,0,4,trigeminal ganglion development,BP,
15359,GO:0061552,1,0.99439600355199,0,1,ganglion morphogenesis,BP,
15361,GO:0061565,1,0.994054740756748,0,1,dAMP phosphorylation,BP,
15362,GO:0061566,1,0.994054740756748,0,1,CMP phosphorylation,BP,
15363,GO:0061567,1,0.994054740756748,0,1,dCMP phosphorylation,BP,
15364,GO:0061568,1,0.994054740756748,0,1,GDP phosphorylation,BP,
15365,GO:0061569,1,0.994054740756748,0,1,UDP phosphorylation,BP,
15366,GO:0061570,1,0.994054740756748,0,1,dCDP phosphorylation,BP,
15367,GO:0061571,1,0.994054740756748,0,1,TDP phosphorylation,BP,
15368,GO:0061572,1,0.378765635488628,0,139,actin filament bundle organization,BP,
15369,GO:0061574,1,0.981764156887379,0,3,ASAP complex,CC,
15370,GO:0061575,1,0.98393200772121,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
15371,GO:0061577,1,0.914851942688443,0,11,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
15372,GO:0061578,1,0.926909344993262,0,10,Lys63-specific deubiquitinase activity,MF,
15373,GO:0061580,1,0.992697001478449,0,1,colon epithelial cell migration,BP,
15374,GO:0061582,1,0.983313411954932,0,2,intestinal epithelial cell migration,BP,
15375,GO:0061588,1,0.964389637622874,0,5,calcium activated phospholipid scrambling,BP,
15376,GO:0061589,1,0.973269318034436,0,4,calcium activated phosphatidylserine scrambling,BP,
15377,GO:0061590,1,0.964389637622874,0,5,calcium activated phosphatidylcholine scrambling,BP,
15378,GO:0061591,1,0.964389637622874,0,5,calcium activated galactosylceramide scrambling,BP,
15379,GO:0061598,1,0.99255627241335,0,1,molybdopterin adenylyltransferase activity,MF,
15380,GO:0061599,1,0.99255627241335,0,1,molybdopterin molybdotransferase activity,MF,
15381,GO:0061604,1,0.994433621392918,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
15382,GO:0061605,1,0.994433621392918,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
15383,GO:0061608,1,0.942921770110025,0,9,nuclear import signal receptor activity,MF,
15384,GO:0061609,1,0.994462870370802,0,1,fructose-1-phosphate aldolase activity,MF,
15385,GO:0061611,1,0.995286990116764,0,1,mannose to fructose-6-phosphate metabolic process,BP,
15386,GO:0061614,1,0.759531721230269,0,38,pri-miRNA transcription by RNA polymerase II,BP,
15387,GO:0061615,1,0.86640288358924,0,25,glycolytic process through fructose-6-phosphate,BP,
15388,GO:0061617,1,0.960139796010749,0,8,MICOS complex,CC,
15389,GO:0061618,1,0.985819274844075,0,1,sublamina densa,CC,
15390,GO:0061620,1,0.86640288358924,0,25,glycolytic process through glucose-6-phosphate,BP,
15391,GO:0061621,1,0.870058443718303,0,24,canonical glycolysis,BP,
15392,GO:0061622,1,0.989414409474924,0,2,glycolytic process through glucose-1-phosphate,BP,
15393,GO:0061623,1,0.995804391605079,0,1,glycolytic process from galactose,BP,
15394,GO:0061624,1,0.977557097652614,0,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
15395,GO:0061626,1,0.953341621624499,0,7,pharyngeal arch artery morphogenesis,BP,
15396,GO:0061627,1,0.995007780707869,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
15397,GO:0061628,1,0.971472022022477,0,3,H3K27me3 modified histone binding,MF,
15398,GO:0061629,1,0.969733054343084,0,5,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,
15400,GO:0061631,1,0.846822783623176,0,27,ubiquitin conjugating enzyme activity,MF,
15401,GO:0061635,1,0.957581713675268,0,8,regulation of protein complex stability,BP,
15403,GO:0061641,1,0.85428439778148,0,30,CENP-A containing chromatin organization,BP,
15404,GO:0061642,1,0.990997815957518,0,1,chemoattraction of axon,BP,
15405,GO:0061643,1,0.978404617127415,0,3,chemorepulsion of axon,BP,
15406,GO:0061645,1,0.947805332483287,0,7,endocytic patch,CC,
15407,GO:0061646,1,0.991887820999033,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
15408,GO:0061647,1,0.741536884773388,0,40,histone H3-K9 modification,BP,
15409,GO:0061649,1,0.977786088144025,0,3,ubiquitin modification-dependent histone binding,MF,
15410,GO:0061650,1,0.843435398324741,0,28,ubiquitin-like protein conjugating enzyme activity,MF,
15411,GO:0061656,1,0.996006601352857,0,1,SUMO conjugating enzyme activity,MF,
15413,GO:0061663,1,0.989508738651349,0,1,NEDD8 ligase activity,MF,
15414,GO:0061665,1,0.970711260305851,0,5,SUMO ligase activity,MF,
15415,GO:0061668,1,0.961441186519712,0,6,mitochondrial ribosome assembly,BP,
15416,GO:0061669,1,0.970973049186111,0,3,spontaneous neurotransmitter secretion,BP,
15417,GO:0061670,1,0.995631417567393,0,1,evoked neurotransmitter secretion,BP,
15418,GO:0061673,1,0.966384942834822,0,5,mitotic spindle astral microtubule,CC,
15419,GO:0061676,1,0.960141875059251,0,6,importin-alpha family protein binding,MF,
15420,GO:0061682,1,0.994572210378613,0,1,seminal vesicle morphogenesis,BP,
15422,GO:0061685,1,0.994054740756748,0,1,diphthine methylesterase activity,MF,
15423,GO:0061687,1,0.945425133303025,0,13,detoxification of inorganic compound,BP,
15424,GO:0061689,1,0.972885041050234,0,4,tricellular tight junction,CC,
15425,GO:0061690,1,0.996046445010638,0,1,lipoamidase activity,MF,
15426,GO:0061695,1,0.183570834307587,0,251,transferase complex, transferring phosphorus-containing groups,CC,
15427,GO:0061697,1,0.99364717720168,0,1,protein-glutaryllysine deglutarylase activity,MF,
15428,GO:0061698,1,0.99364717720168,0,1,protein deglutarylation,BP,
15429,GO:0061699,1,0.99364717720168,0,1,peptidyl-lysine deglutarylation,BP,
15430,GO:0061700,1,0.947724764525471,0,9,GATOR2 complex,CC,
15431,GO:0061702,1,0.932910109549816,0,12,inflammasome complex,CC,
15432,GO:0061709,1,0.990170248862729,0,1,reticulophagy,BP,
15433,GO:0061711,1,0.990189206181433,0,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,
15434,GO:0061712,1,0.993515270897385,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
15435,GO:0061713,1,0.996199316858008,0,1,anterior neural tube closure,BP,
15436,GO:0061714,1,0.992320119977397,0,2,folic acid receptor activity,MF,
15437,GO:0061718,1,0.870058443718303,0,24,glucose catabolic process to pyruvate,BP,
15438,GO:0061723,1,0.984664063737723,0,2,glycophagy,BP,
15439,GO:0061724,1,0.952774681523114,0,6,lipophagy,BP,
15440,GO:0061726,1,0.592071635243045,0,80,mitochondrion disassembly,BP,
15441,GO:0061727,1,0.989395786347222,0,2,methylglyoxal catabolic process to lactate,BP,
15442,GO:0061731,1,0.979091393063358,0,3,ribonucleoside-diphosphate reductase activity,MF,
15443,GO:0061732,1,0.965020768161859,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
15444,GO:0061733,1,0.68740711755328,0,52,peptide-lysine-N-acetyltransferase activity,MF,
15445,GO:0061734,1,0.955200856229105,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
15446,GO:0061736,1,0.991122552116754,0,1,engulfment of target by autophagosome,BP,
15447,GO:0061737,1,0.974872010215083,0,5,leukotriene signaling pathway,BP,
15448,GO:0061738,1,0.983234748313227,0,3,late endosomal microautophagy,BP,
15449,GO:0061739,1,0.975016400040481,0,4,protein lipidation involved in autophagosome assembly,BP,
15450,GO:0061740,1,0.98178257782382,0,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
15451,GO:0061741,1,0.988961853465544,0,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
15452,GO:0061743,1,0.978250537384746,0,4,motor learning,BP,
15453,GO:0061744,1,0.972540418030643,0,5,motor behavior,BP,
15454,GO:0061749,1,0.98341429723533,0,2,forked DNA-dependent helicase activity,MF,
15455,GO:0061750,1,0.994590763027963,0,1,acid sphingomyelin phosphodiesterase activity,MF,
15456,GO:0061752,1,0.988934839128869,0,2,telomeric repeat-containing RNA binding,MF,
15457,GO:0061753,1,0.991122552116754,0,1,substrate localization to autophagosome,BP,
15459,GO:0061757,1,0.98933221896101,0,2,leukocyte adhesion to arterial endothelial cell,BP,
15460,GO:0061760,1,0.990481628647951,0,2,antifungal innate immune response,BP,
15461,GO:0061762,1,0.966707318730919,0,4,CAMKK-AMPK signaling cascade,BP,
15462,GO:0061763,1,0.988313846088614,0,2,multivesicular body-lysosome fusion,BP,
15463,GO:0061767,1,0.990926929147752,0,1,negative regulation of lung blood pressure,BP,
15464,GO:0061768,1,0.991972477878271,0,1,magnesium:sodium antiporter activity,MF,
15465,GO:0061769,1,0.988144472527205,0,2,ribosylnicotinate kinase activity,MF,
15466,GO:0061770,1,0.994799281509358,0,1,translation elongation factor binding,MF,
15467,GO:0061771,1,0.98275448633244,0,3,response to caloric restriction,BP,
15468,GO:0061772,1,0.993377444008772,0,1,drug transport across blood-nerve barrier,BP,
15469,GO:0061778,1,0.882919297045129,0,18,intracellular chloride channel activity,MF,
15470,GO:0061780,1,0.986957002349607,0,1,mitotic cohesin loading,BP,
15472,GO:0061783,1,0.984880343304098,0,4,peptidoglycan muralytic activity,MF,
15473,GO:0061789,1,0.966774153587135,0,3,dense core granule priming,BP,
15475,GO:0061798,1,0.992657323363829,0,1,GTP 3',8'-cyclase activity,MF,
15476,GO:0061799,1,0.992657323363829,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
15477,GO:0061809,1,0.991312984954525,0,2,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
15478,GO:0061811,1,0.995654019734025,0,1,ADP-ribosyl cyclase activity,MF,
15479,GO:0061812,1,0.995654019734025,0,1,cyclic ADP-ribose hydrolase,MF,
15480,GO:0061817,1,0.976042885653783,0,3,endoplasmic reticulum-plasma membrane tethering,BP,
15481,GO:0061819,1,0.978570783584199,0,3,telomeric DNA-containing double minutes formation,BP,
15482,GO:0061820,1,0.946239263058207,0,8,telomeric D-loop disassembly,BP,
15483,GO:0061821,1,0.969398407911277,0,4,telomeric D-loop binding,MF,
15484,GO:0061825,1,0.992883547014093,0,1,podosome core,CC,
15485,GO:0061827,1,0.972831921670079,0,5,sperm head,CC,
15486,GO:0061828,1,0.989239971308955,0,1,apical tubulobulbar complex,CC,
15487,GO:0061829,1,0.989239971308955,0,1,basal tubulobulbar complex,CC,
15488,GO:0061832,1,0.989070884403905,0,1,basal ectoplasmic specialization,CC,
15489,GO:0061833,1,0.987244267484847,0,2,protein localization to tricellular tight junction,BP,
15491,GO:0061844,1,0.875532303793752,0,34,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,
15492,GO:0061845,1,0.99353956641785,0,1,neuron projection branch point,CC,
15493,GO:0061846,1,0.99353956641785,0,1,dendritic spine cytoplasm,CC,
15494,GO:0061847,1,0.994613069578521,0,1,response to cholecystokinin,BP,
15495,GO:0061849,1,0.98341429723533,0,2,telomeric G-quadruplex DNA binding,MF,
15496,GO:0061850,1,0.996398816784159,0,1,growth cone leading edge,CC,
15497,GO:0061851,1,0.994117792638113,0,1,leading edge of lamellipodium,CC,
15498,GO:0061853,1,0.991822002642289,0,1,regulation of neuroblast migration,BP,
15499,GO:0061855,1,0.991822002642289,0,1,negative regulation of neuroblast migration,BP,
15500,GO:0061857,1,0.987035386624632,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
15501,GO:0061880,1,0.995378138521008,0,1,regulation of anterograde axonal transport of mitochondrion,BP,
15502,GO:0061881,1,0.995378138521008,0,1,positive regulation of anterograde axonal transport of mitochondrion,BP,
15503,GO:0061884,1,0.99495329221185,0,1,regulation of mini excitatory postsynaptic potential,BP,
15504,GO:0061885,1,0.99495329221185,0,1,positive regulation of mini excitatory postsynaptic potential,BP,
15505,GO:0061888,1,0.970752753129426,0,4,regulation of astrocyte activation,BP,
15506,GO:0061889,1,0.991558279959692,0,1,negative regulation of astrocyte activation,BP,
15507,GO:0061890,1,0.979019119465475,0,3,positive regulation of astrocyte activation,BP,
15508,GO:0061896,1,0.9921432921955,0,1,all-trans retinol 3,4-desaturase activity,MF,
15509,GO:0061897,1,0.9921432921955,0,1,all-trans retinal 3,4-desaturase activity,MF,
15510,GO:0061898,1,0.9921432921955,0,1,all-trans retinoic acid 3,4-desaturase activity,MF,
15511,GO:0061899,1,0.9921432921955,0,1,11-cis-retinal 3,4-desaturase activity,MF,
15512,GO:0061900,1,0.799931443158309,0,31,glial cell activation,BP,
15513,GO:0061901,1,0.99505471859325,0,1,regulation of 1-phosphatidylinositol-3-kinase activity,BP,
15514,GO:0061903,1,0.99505471859325,0,1,positive regulation of 1-phosphatidylinositol-3-kinase activity,BP,
15515,GO:0061912,1,0.753197158352747,0,40,selective autophagy,BP,
15517,GO:0061920,1,0.988186240910846,0,1,protein propionyltransferase activity,MF,
15518,GO:0061921,1,0.988186240910846,0,1,peptidyl-lysine propionylation,BP,
15519,GO:0061930,1,0.991678213729253,0,1,regulation of erythrocyte enucleation,BP,
15520,GO:0061931,1,0.991678213729253,0,1,positive regulation of erythrocyte enucleation,BP,
15521,GO:0061944,1,0.992488929862041,0,1,negative regulation of protein K48-linked ubiquitination,BP,
15522,GO:0061945,1,0.981322308929233,0,3,regulation of protein K48-linked ubiquitination,BP,
15523,GO:0061951,1,0.768199012673523,0,39,establishment of protein localization to plasma membrane,BP,
15524,GO:0061953,1,0.982908660161923,0,3,mRNA (adenine-N1-)-methyltransferase activity,MF,
15525,GO:0061971,1,0.717898968485484,0,48,replacement bone morphogenesis,BP,
15526,GO:0061980,1,0.813031012897536,0,30,regulatory RNA binding,MF,
15527,GO:0061981,1,0.995649625843794,0,1,3-hydroxykynureninase activity,MF,
15529,GO:0061983,1,0.955120041329727,0,8,meiosis II cell cycle process,BP,
15530,GO:0061986,1,0.994483651850392,0,1,negative regulation of transcription by glucose,BP,
15531,GO:0061987,1,0.994483651850392,0,1,negative regulation of transcription from RNA polymerase II promoter by glucose,BP,
15532,GO:0062009,1,0.926590512789812,0,10,secondary palate development,BP,
15536,GO:0065001,1,0.972461187794592,0,4,specification of axis polarity,BP,
15537,GO:0065002,1,0.762009272879174,0,49,intracellular protein transmembrane transport,BP,
15540,GO:0065005,1,0.854385354467659,0,24,protein-lipid complex assembly,BP,
15541,GO:0065006,1,0.99204501794397,0,2,protein-carbohydrate complex assembly,BP,
15545,GO:0065010,1,0.974442674030995,0,5,extracellular membrane-bounded organelle,CC,
15546,GO:0070001,1,0.900432092946527,0,18,aspartic-type peptidase activity,MF,
15547,GO:0070003,1,0.931622773983415,0,18,threonine-type peptidase activity,MF,
15548,GO:0070004,1,0.994054740756748,0,1,cysteine-type exopeptidase activity,MF,
15549,GO:0070006,1,0.878049491160794,0,19,metalloaminopeptidase activity,MF,
15550,GO:0070008,1,0.923237099884643,0,12,serine-type exopeptidase activity,MF,
15552,GO:0070012,1,0.988509625743532,0,2,oligopeptidase activity,MF,
15554,GO:0070016,1,0.928323704028841,0,10,armadillo repeat domain binding,MF,
15555,GO:0070022,1,0.968896448269952,0,4,transforming growth factor beta receptor complex,CC,
15556,GO:0070025,1,0.994255839328277,0,1,carbon monoxide binding,MF,
15557,GO:0070026,1,0.990584037260738,0,2,nitric oxide binding,MF,
15559,GO:0070033,1,0.981906701696268,0,3,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,
15560,GO:0070034,1,0.854838497406064,0,22,telomerase RNA binding,MF,
15561,GO:0070035,1,0.534302305111101,0,91,purine NTP-dependent helicase activity,MF,
15562,GO:0070037,1,0.996194352017623,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
15563,GO:0070039,1,0.991679212898038,0,1,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
15564,GO:0070042,1,0.993767811530995,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
15565,GO:0070044,1,0.977977328660901,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,
15567,GO:0070051,1,0.978888371063209,0,3,fibrinogen binding,MF,
15568,GO:0070052,1,0.984714771768216,0,2,collagen V binding,MF,
15569,GO:0070053,1,0.980790519308187,0,3,thrombospondin receptor activity,MF,
15570,GO:0070054,1,0.981111627133794,0,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
15571,GO:0070055,1,0.981111627133794,0,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
15572,GO:0070059,1,0.715203486459734,0,54,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
15573,GO:0070060,1,0.987870273121607,0,1,'de novo' actin filament nucleation,BP,
15574,GO:0070061,1,0.972162948013154,0,5,fructose binding,MF,
15576,GO:0070063,1,0.693112331442654,0,54,RNA polymerase binding,MF,
15577,GO:0070064,1,0.870145696583158,0,18,proline-rich region binding,MF,
15578,GO:0070069,1,0.895686636767349,0,25,cytochrome complex,CC,
15579,GO:0070070,1,0.921439237690908,0,10,proton-transporting V-type ATPase complex assembly,BP,
15580,GO:0070071,1,0.901848074613981,0,14,proton-transporting two-sector ATPase complex assembly,BP,
15581,GO:0070072,1,0.921439237690908,0,10,vacuolar proton-transporting V-type ATPase complex assembly,BP,
15582,GO:0070075,1,0.996719817594225,0,1,tear secretion,BP,
15583,GO:0070076,1,0.809677632160274,0,25,histone lysine demethylation,BP,
15584,GO:0070077,1,0.993177281716257,0,1,histone arginine demethylation,BP,
15585,GO:0070078,1,0.993177281716257,0,1,histone H3-R2 demethylation,BP,
15586,GO:0070079,1,0.993177281716257,0,1,histone H4-R3 demethylation,BP,
15587,GO:0070080,1,0.988621046916064,0,2,titin Z domain binding,MF,
15591,GO:0070086,1,0.97613660093718,0,4,ubiquitin-dependent endocytosis,BP,
15592,GO:0070087,1,0.946769277306952,0,6,chromo shadow domain binding,MF,
15593,GO:0070091,1,0.961183967309311,0,7,glucagon secretion,BP,
15594,GO:0070092,1,0.965016207052569,0,6,regulation of glucagon secretion,BP,
15595,GO:0070093,1,0.985713083665086,0,3,negative regulation of glucagon secretion,BP,
15596,GO:0070094,1,0.994277203542687,0,1,positive regulation of glucagon secretion,BP,
15597,GO:0070095,1,0.98378501673123,0,3,fructose-6-phosphate binding,MF,
15598,GO:0070096,1,0.993412121398656,0,1,mitochondrial outer membrane translocase complex assembly,BP,
15599,GO:0070097,1,0.9500273972084,0,6,delta-catenin binding,MF,
15600,GO:0070098,1,0.71991635993434,0,63,chemokine-mediated signaling pathway,BP,
15601,GO:0070099,1,0.950127967766393,0,7,regulation of chemokine-mediated signaling pathway,BP,
15602,GO:0070100,1,0.965618740969278,0,4,negative regulation of chemokine-mediated signaling pathway,BP,
15603,GO:0070101,1,0.983963292967443,0,3,positive regulation of chemokine-mediated signaling pathway,BP,
15604,GO:0070102,1,0.879004820369319,0,17,interleukin-6-mediated signaling pathway,BP,
15605,GO:0070103,1,0.985329424608174,0,3,regulation of interleukin-6-mediated signaling pathway,BP,
15606,GO:0070104,1,0.995375609741751,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
15607,GO:0070105,1,0.989907612667542,0,2,positive regulation of interleukin-6-mediated signaling pathway,BP,
15608,GO:0070106,1,0.929819154231455,0,11,interleukin-27-mediated signaling pathway,BP,
15609,GO:0070110,1,0.981417026721421,0,3,ciliary neurotrophic factor receptor complex,CC,
15610,GO:0070119,1,0.992686848939122,0,1,ciliary neurotrophic factor binding,MF,
15611,GO:0070120,1,0.963878477050061,0,5,ciliary neurotrophic factor-mediated signaling pathway,BP,
15612,GO:0070121,1,0.991281032996273,0,1,Kupffer's vesicle development,BP,
15613,GO:0070122,1,0.967923123210074,0,5,isopeptidase activity,MF,
15614,GO:0070123,1,0.990415991220026,0,1,transforming growth factor beta receptor activity, type III,MF,
15615,GO:0070124,1,0.990298515973527,0,2,mitochondrial translational initiation,BP,
15616,GO:0070125,1,0.693370080063014,0,84,mitochondrial translational elongation,BP,
15617,GO:0070126,1,0.685783385744381,0,86,mitochondrial translational termination,BP,
15618,GO:0070127,1,0.95228250090879,0,8,tRNA aminoacylation for mitochondrial protein translation,BP,
15619,GO:0070129,1,0.902591758957029,0,18,regulation of mitochondrial translation,BP,
15620,GO:0070130,1,0.994054740756748,0,1,negative regulation of mitochondrial translation,BP,
15621,GO:0070131,1,0.940725585104418,0,11,positive regulation of mitochondrial translation,BP,
15622,GO:0070137,1,0.966831336004512,0,4,ubiquitin-like protein-specific endopeptidase activity,MF,
15623,GO:0070138,1,0.978740315420569,0,3,ubiquitin-like protein-specific isopeptidase activity,MF,
15624,GO:0070139,1,0.966831336004512,0,4,SUMO-specific endopeptidase activity,MF,
15625,GO:0070140,1,0.978740315420569,0,3,SUMO-specific isopeptidase activity,MF,
15626,GO:0070141,1,0.961826336796373,0,6,response to UV-A,BP,
15628,GO:0070143,1,0.992033140627037,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
15629,GO:0070145,1,0.993435007118271,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
15630,GO:0070150,1,0.989612495296607,0,2,mitochondrial glycyl-tRNA aminoacylation,BP,
15631,GO:0070159,1,0.994519218829091,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
15634,GO:0070162,1,0.959034878730757,0,6,adiponectin secretion,BP,
15635,GO:0070163,1,0.959034878730757,0,6,regulation of adiponectin secretion,BP,
15636,GO:0070164,1,0.971439613913988,0,4,negative regulation of adiponectin secretion,BP,
15637,GO:0070165,1,0.987234276617254,0,2,positive regulation of adiponectin secretion,BP,
15638,GO:0070166,1,0.931873554563832,0,9,enamel mineralization,BP,
15639,GO:0070167,1,0.654025747414776,0,63,regulation of biomineral tissue development,BP,
15640,GO:0070168,1,0.922133258858125,0,13,negative regulation of biomineral tissue development,BP,
15641,GO:0070169,1,0.781093372735266,0,35,positive regulation of biomineral tissue development,BP,
15642,GO:0070170,1,0.974007140947926,0,4,regulation of tooth mineralization,BP,
15643,GO:0070171,1,0.984935911713809,0,2,negative regulation of tooth mineralization,BP,
15644,GO:0070172,1,0.988905770979325,0,2,positive regulation of tooth mineralization,BP,
15645,GO:0070176,1,0.995255290548518,0,1,DRM complex,CC,
15646,GO:0070178,1,0.989932581370377,0,2,D-serine metabolic process,BP,
15647,GO:0070179,1,0.994402058223341,0,1,D-serine biosynthetic process,BP,
15648,GO:0070180,1,0.996778951719443,0,1,large ribosomal subunit rRNA binding,MF,
15649,GO:0070181,1,0.962085040616387,0,8,small ribosomal subunit rRNA binding,MF,
15650,GO:0070182,1,0.900587310299491,0,16,DNA polymerase binding,MF,
15651,GO:0070183,1,0.99400438105788,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
15652,GO:0070184,1,0.994799281509358,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
15653,GO:0070187,1,0.965767525153422,0,6,shelterin complex,CC,
15654,GO:0070189,1,0.963492126700064,0,7,kynurenine metabolic process,BP,
15655,GO:0070191,1,0.989160645906606,0,2,methionine-R-sulfoxide reductase activity,MF,
15656,GO:0070192,1,0.693214672956552,0,55,chromosome organization involved in meiotic cell cycle,BP,
15657,GO:0070193,1,0.886866004805132,0,19,synaptonemal complex organization,BP,
15658,GO:0070194,1,0.988879498010429,0,2,synaptonemal complex disassembly,BP,
15659,GO:0070195,1,0.992462517672236,0,1,growth hormone receptor complex,CC,
15660,GO:0070197,1,0.968506808955337,0,5,meiotic attachment of telomere to nuclear envelope,BP,
15661,GO:0070198,1,0.82771292366141,0,27,protein localization to chromosome, telomeric region,BP,
15662,GO:0070199,1,0.868415693411827,0,23,establishment of protein localization to chromosome,BP,
15663,GO:0070200,1,0.909746981946691,0,15,establishment of protein localization to telomere,BP,
15665,GO:0070202,1,0.941081250513089,0,11,regulation of establishment of protein localization to chromosome,BP,
15666,GO:0070203,1,0.946712810905359,0,10,regulation of establishment of protein localization to telomere,BP,
15667,GO:0070206,1,0.736281075414274,0,48,protein trimerization,BP,
15668,GO:0070207,1,0.837432530129873,0,28,protein homotrimerization,BP,
15669,GO:0070208,1,0.928186398007932,0,11,protein heterotrimerization,BP,
15670,GO:0070209,1,0.99345197504884,0,1,ASTRA complex,CC,
15671,GO:0070212,1,0.968468054294293,0,4,protein poly-ADP-ribosylation,BP,
15672,GO:0070213,1,0.966012612161579,0,4,protein auto-ADP-ribosylation,BP,
15673,GO:0070221,1,0.982901300168559,0,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
15674,GO:0070227,1,0.68670265304887,0,63,lymphocyte apoptotic process,BP,
15675,GO:0070228,1,0.752415675603325,0,48,regulation of lymphocyte apoptotic process,BP,
15676,GO:0070229,1,0.847101861001344,0,27,negative regulation of lymphocyte apoptotic process,BP,
15677,GO:0070230,1,0.925570111741603,0,14,positive regulation of lymphocyte apoptotic process,BP,
15678,GO:0070231,1,0.777560394438919,0,43,T cell apoptotic process,BP,
15679,GO:0070232,1,0.844138629711706,0,29,regulation of T cell apoptotic process,BP,
15681,GO:0070234,1,0.948259841590299,0,10,positive regulation of T cell apoptotic process,BP,
15682,GO:0070235,1,0.970675953083733,0,5,regulation of activation-induced cell death of T cells,BP,
15683,GO:0070236,1,0.975461460231758,0,4,negative regulation of activation-induced cell death of T cells,BP,
15684,GO:0070238,1,0.995416049171629,0,1,activated T cell autonomous cell death,BP,
15685,GO:0070239,1,0.995416049171629,0,1,regulation of activated T cell autonomous cell death,BP,
15686,GO:0070241,1,0.995416049171629,0,1,positive regulation of activated T cell autonomous cell death,BP,
15687,GO:0070242,1,0.897852566998482,0,17,thymocyte apoptotic process,BP,
15688,GO:0070243,1,0.929063640487005,0,12,regulation of thymocyte apoptotic process,BP,
15689,GO:0070244,1,0.957836732057506,0,7,negative regulation of thymocyte apoptotic process,BP,
15690,GO:0070245,1,0.969973213911672,0,5,positive regulation of thymocyte apoptotic process,BP,
15691,GO:0070246,1,0.995888126664531,0,1,natural killer cell apoptotic process,BP,
15692,GO:0070247,1,0.995888126664531,0,1,regulation of natural killer cell apoptotic process,BP,
15693,GO:0070251,1,0.994604389298739,0,1,pristanate-CoA ligase activity,MF,
15694,GO:0070252,1,0.470677254068992,0,98,actin-mediated cell contraction,BP,
15695,GO:0070253,1,0.983707842389206,0,4,somatostatin secretion,BP,
15696,GO:0070254,1,0.944601806200549,0,10,mucus secretion,BP,
15697,GO:0070255,1,0.947845929233874,0,9,regulation of mucus secretion,BP,
15698,GO:0070256,1,0.989592610816747,0,2,negative regulation of mucus secretion,BP,
15699,GO:0070257,1,0.963444361912498,0,6,positive regulation of mucus secretion,BP,
15700,GO:0070259,1,0.987251055327492,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
15701,GO:0070260,1,0.994054740756748,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
15702,GO:0070262,1,0.910089540830214,0,16,peptidyl-serine dephosphorylation,BP,
15703,GO:0070265,1,0.762690290220053,0,48,necrotic cell death,BP,
15704,GO:0070266,1,0.804867954988651,0,36,necroptotic process,BP,
15705,GO:0070267,1,0.993211161052748,0,1,oncosis,BP,
15706,GO:0070268,1,0.700322690825622,0,59,cornification,BP,
15707,GO:0070269,1,0.953720536311069,0,9,pyroptosis,BP,
15708,GO:0070273,1,0.86134440373995,0,22,phosphatidylinositol-4-phosphate binding,MF,
15709,GO:0070274,1,0.990609356822153,0,2,RES complex,CC,
15710,GO:0070278,1,0.971078002153985,0,5,extracellular matrix constituent secretion,BP,
15711,GO:0070279,1,0.764508872685818,0,45,vitamin B6 binding,MF,
15712,GO:0070280,1,0.992981218339583,0,1,pyridoxal binding,MF,
15713,GO:0070283,1,0.995411628283286,0,1,radical SAM enzyme activity,MF,
15714,GO:0070286,1,0.791814720491781,0,30,axonemal dynein complex assembly,BP,
15715,GO:0070287,1,0.993170517253164,0,1,ferritin receptor activity,MF,
15716,GO:0070288,1,0.992408328884874,0,2,ferritin complex,CC,
15717,GO:0070290,1,0.966356783048081,0,5,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,
15718,GO:0070291,1,0.980888410685612,0,3,N-acylethanolamine metabolic process,BP,
15719,GO:0070292,1,0.98538945304824,0,2,N-acylphosphatidylethanolamine metabolic process,BP,
15720,GO:0070293,1,0.917320991211885,0,15,renal absorption,BP,
15721,GO:0070294,1,0.972194484302746,0,4,renal sodium ion absorption,BP,
15722,GO:0070295,1,0.983574925741732,0,3,renal water absorption,BP,
15723,GO:0070296,1,0.781400851483379,0,31,sarcoplasmic reticulum calcium ion transport,BP,
15725,GO:0070301,1,0.594220536337424,0,82,cellular response to hydrogen peroxide,BP,
15728,GO:0070304,1,0.391952027768723,0,137,positive regulation of stress-activated protein kinase signaling cascade,BP,
15729,GO:0070305,1,0.951626558207224,0,6,response to cGMP,BP,
15730,GO:0070306,1,0.833657022497127,0,26,lens fiber cell differentiation,BP,
15731,GO:0070307,1,0.932513815565329,0,11,lens fiber cell development,BP,
15732,GO:0070309,1,0.974484725652941,0,4,lens fiber cell morphogenesis,BP,
15733,GO:0070314,1,0.961256926552403,0,6,G1 to G0 transition,BP,
15734,GO:0070315,1,0.987212812634357,0,2,G1 to G0 transition involved in cell differentiation,BP,
15735,GO:0070316,1,0.751349425884952,0,40,regulation of G0 to G1 transition,BP,
15736,GO:0070317,1,0.77192453265159,0,36,negative regulation of G0 to G1 transition,BP,
15737,GO:0070318,1,0.973414348493739,0,4,positive regulation of G0 to G1 transition,BP,
15738,GO:0070320,1,0.994174093998246,0,1,inward rectifier potassium channel inhibitor activity,MF,
15739,GO:0070324,1,0.959732975584836,0,7,thyroid hormone binding,MF,
15741,GO:0070326,1,0.970713638898176,0,4,very-low-density lipoprotein particle receptor binding,MF,
15742,GO:0070327,1,0.958562508171757,0,7,thyroid hormone transport,BP,
15743,GO:0070328,1,0.86488524150817,0,25,triglyceride homeostasis,BP,
15744,GO:0070329,1,0.988957602047516,0,2,tRNA seleno-modification,BP,
15745,GO:0070330,1,0.913045013026642,0,16,aromatase activity,MF,
15746,GO:0070335,1,0.989721629878409,0,1,aspartate binding,MF,
15747,GO:0070336,1,0.985166754899979,0,2,flap-structured DNA binding,MF,
15748,GO:0070337,1,0.991059392505537,0,1,3'-flap-structured DNA binding,MF,
15749,GO:0070339,1,0.964555360434781,0,6,response to bacterial lipopeptide,BP,
15750,GO:0070340,1,0.978480917276005,0,3,detection of bacterial lipopeptide,BP,
15751,GO:0070341,1,0.944847644672404,0,9,fat cell proliferation,BP,
15752,GO:0070343,1,0.985219396612893,0,3,white fat cell proliferation,BP,
15753,GO:0070344,1,0.944847644672404,0,9,regulation of fat cell proliferation,BP,
15754,GO:0070345,1,0.964698540284377,0,5,negative regulation of fat cell proliferation,BP,
15755,GO:0070346,1,0.986802543209534,0,3,positive regulation of fat cell proliferation,BP,
15756,GO:0070350,1,0.985219396612893,0,3,regulation of white fat cell proliferation,BP,
15757,GO:0070352,1,0.992634984032942,0,2,positive regulation of white fat cell proliferation,BP,
15758,GO:0070358,1,0.960361493769074,0,6,actin polymerization-dependent cell motility,BP,
15759,GO:0070365,1,0.922897871659591,0,13,hepatocyte differentiation,BP,
15760,GO:0070366,1,0.991035608589732,0,2,regulation of hepatocyte differentiation,BP,
15761,GO:0070367,1,0.994954558456113,0,1,negative regulation of hepatocyte differentiation,BP,
15762,GO:0070368,1,0.996061378444575,0,1,positive regulation of hepatocyte differentiation,BP,
15763,GO:0070369,1,0.974998660468367,0,3,beta-catenin-TCF7L2 complex,CC,
15764,GO:0070370,1,0.97574255651168,0,5,cellular heat acclimation,BP,
15769,GO:0070375,1,0.979958058369755,0,3,ERK5 cascade,BP,
15770,GO:0070376,1,0.993919238828364,0,1,regulation of ERK5 cascade,BP,
15771,GO:0070377,1,0.993919238828364,0,1,negative regulation of ERK5 cascade,BP,
15772,GO:0070381,1,0.986444126258808,0,2,endosome to plasma membrane transport vesicle,CC,
15774,GO:0070383,1,0.959852509049064,0,8,DNA cytosine deamination,BP,
15775,GO:0070384,1,0.97708522930135,0,4,Harderian gland development,BP,
15776,GO:0070390,1,0.995364228047533,0,1,transcription export complex 2,CC,
15777,GO:0070391,1,0.940833044340517,0,11,response to lipoteichoic acid,BP,
15778,GO:0070392,1,0.996193110740806,0,1,detection of lipoteichoic acid,BP,
15779,GO:0070401,1,0.990151472553026,0,2,NADP+ binding,MF,
15780,GO:0070402,1,0.924736751493091,0,13,NADPH binding,MF,
15781,GO:0070403,1,0.926059635235847,0,14,NAD+ binding,MF,
15782,GO:0070404,1,0.986392754685542,0,3,NADH binding,MF,
15784,GO:0070407,1,0.993676265412654,0,1,oxidation-dependent protein catabolic process,BP,
15785,GO:0070408,1,0.991080270082418,0,1,carbamoyl phosphate metabolic process,BP,
15786,GO:0070409,1,0.991080270082418,0,1,carbamoyl phosphate biosynthetic process,BP,
15787,GO:0070410,1,0.900904344096784,0,12,co-SMAD binding,MF,
15788,GO:0070411,1,0.915924645801874,0,11,I-SMAD binding,MF,
15789,GO:0070412,1,0.830733170978553,0,23,R-SMAD binding,MF,
15790,GO:0070413,1,0.993852595675553,0,1,trehalose metabolism in response to stress,BP,
15791,GO:0070417,1,0.949652816948981,0,7,cellular response to cold,BP,
15792,GO:0070418,1,0.991658229045136,0,1,DNA-dependent protein kinase complex,CC,
15793,GO:0070419,1,0.949487384049485,0,7,nonhomologous end joining complex,CC,
15794,GO:0070423,1,0.797767998025715,0,34,nucleotide-binding oligomerization domain containing signaling pathway,BP,
15795,GO:0070424,1,0.942153877425073,0,8,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15796,GO:0070425,1,0.986240749680452,0,2,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15797,GO:0070426,1,0.980143667846769,0,3,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15798,GO:0070427,1,0.973657159724076,0,4,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15799,GO:0070428,1,0.983648992059903,0,2,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15800,GO:0070429,1,0.99239585523513,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15801,GO:0070430,1,0.991186790406003,0,1,positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15802,GO:0070431,1,0.934168764460194,0,11,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15803,GO:0070432,1,0.966654913113098,0,5,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15804,GO:0070433,1,0.986240749680452,0,2,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15805,GO:0070434,1,0.980143667846769,0,3,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15806,GO:0070435,1,0.987805252700762,0,2,Shc-EGFR complex,CC,
15807,GO:0070436,1,0.986069774076123,0,2,Grb2-EGFR complex,CC,
15808,GO:0070442,1,0.995781869132212,0,1,integrin alphaIIb-beta3 complex,CC,
15809,GO:0070444,1,0.937172686529793,0,8,oligodendrocyte progenitor proliferation,BP,
15810,GO:0070445,1,0.937172686529793,0,8,regulation of oligodendrocyte progenitor proliferation,BP,
15811,GO:0070446,1,0.995067410461975,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
15812,GO:0070447,1,0.971041957601944,0,3,positive regulation of oligodendrocyte progenitor proliferation,BP,
15813,GO:0070458,1,0.984724984594678,0,3,cellular detoxification of nitrogen compound,BP,
15814,GO:0070459,1,0.962627487044627,0,7,prolactin secretion,BP,
15815,GO:0070460,1,0.992939088184012,0,1,thyroid-stimulating hormone secretion,BP,
15816,GO:0070461,1,0.856163768304131,0,23,SAGA-type complex,CC,
15817,GO:0070462,1,0.993144458152951,0,1,plus-end specific microtubule depolymerization,BP,
15818,GO:0070463,1,0.993321322969469,0,1,tubulin-dependent ATPase activity,MF,
15819,GO:0070469,1,0.708144104873218,0,81,respiratory chain,CC,
15820,GO:0070470,1,0.980862280278409,0,4,plasma membrane respiratory chain,CC,
15821,GO:0070471,1,0.952136041920088,0,8,uterine smooth muscle contraction,BP,
15822,GO:0070472,1,0.957612960035766,0,7,regulation of uterine smooth muscle contraction,BP,
15823,GO:0070473,1,0.995061064269811,0,1,negative regulation of uterine smooth muscle contraction,BP,
15824,GO:0070474,1,0.962367872283478,0,6,positive regulation of uterine smooth muscle contraction,BP,
15825,GO:0070475,1,0.964066539509577,0,7,rRNA base methylation,BP,
15826,GO:0070476,1,0.996778951719443,0,1,rRNA (guanine-N7)-methylation,BP,
15827,GO:0070478,1,0.992629202734837,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
15828,GO:0070481,1,0.99389727060909,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
15830,GO:0070483,1,0.99361208529434,0,1,detection of hypoxia,BP,
15831,GO:0070486,1,0.928192758748977,0,12,leukocyte aggregation,BP,
15832,GO:0070487,1,0.965772758767902,0,5,monocyte aggregation,BP,
15833,GO:0070488,1,0.993782834052263,0,2,neutrophil aggregation,BP,
15834,GO:0070489,1,0.987944964464393,0,2,T cell aggregation,BP,
15835,GO:0070491,1,0.662454914650545,0,62,repressing transcription factor binding,MF,
15837,GO:0070493,1,0.922247241810613,0,12,thrombin-activated receptor signaling pathway,BP,
15838,GO:0070494,1,0.979433506422933,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
15839,GO:0070495,1,0.979433506422933,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
15840,GO:0070498,1,0.580455014891635,0,96,interleukin-1-mediated signaling pathway,BP,
15841,GO:0070506,1,0.988380664949839,0,2,high-density lipoprotein particle receptor activity,MF,
15843,GO:0070508,1,0.962216798733434,0,7,cholesterol import,BP,
15844,GO:0070509,1,0.613178740852737,0,65,calcium ion import,BP,
15845,GO:0070510,1,0.989737433837329,0,1,regulation of histone H4-K20 methylation,BP,
15846,GO:0070512,1,0.989737433837329,0,1,positive regulation of histone H4-K20 methylation,BP,
15847,GO:0070513,1,0.94944809787784,0,10,death domain binding,MF,
15848,GO:0070522,1,0.972751657361099,0,4,ERCC4-ERCC1 complex,CC,
15849,GO:0070524,1,0.995744932331678,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
15850,GO:0070525,1,0.932179152946474,0,13,tRNA threonylcarbamoyladenosine metabolic process,BP,
15851,GO:0070527,1,0.709742284686654,0,52,platelet aggregation,BP,
15852,GO:0070528,1,0.839990227650564,0,27,protein kinase C signaling,BP,
15853,GO:0070530,1,0.887737029540219,0,17,K63-linked polyubiquitin modification-dependent protein binding,MF,
15854,GO:0070531,1,0.966667897495548,0,5,BRCA1-A complex,CC,
15855,GO:0070534,1,0.755238221177019,0,42,protein K63-linked ubiquitination,BP,
15856,GO:0070535,1,0.959037421894017,0,5,histone H2A K63-linked ubiquitination,BP,
15857,GO:0070536,1,0.837347721006782,0,24,protein K63-linked deubiquitination,BP,
15858,GO:0070537,1,0.982106420224667,0,3,histone H2A K63-linked deubiquitination,BP,
15859,GO:0070538,1,0.991885323653874,0,2,oleic acid binding,MF,
15860,GO:0070539,1,0.993281199020643,0,1,linoleic acid binding,MF,
15861,GO:0070541,1,0.979153081854303,0,3,response to platinum ion,BP,
15862,GO:0070542,1,0.615826093991651,0,75,response to fatty acid,BP,
15863,GO:0070543,1,0.994909007074522,0,1,response to linoleic acid,BP,
15864,GO:0070544,1,0.93796930649873,0,8,histone H3-K36 demethylation,BP,
15865,GO:0070545,1,0.981615780838755,0,3,PeBoW complex,CC,
15866,GO:0070547,1,0.994067281034976,0,1,L-tyrosine aminotransferase activity,MF,
15867,GO:0070548,1,0.982157859059995,0,2,L-glutamine aminotransferase activity,MF,
15868,GO:0070550,1,0.986957002349607,0,1,rDNA condensation,BP,
15869,GO:0070551,1,0.994054740756748,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
15870,GO:0070552,1,0.982784481149584,0,3,BRISC complex,CC,
15871,GO:0070553,1,0.994054740756748,0,1,nicotinic acid receptor activity,MF,
15872,GO:0070554,1,0.986996925579538,0,2,synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex,CC,
15874,GO:0070557,1,0.990602601329706,0,2,PCNA-p21 complex,CC,
15875,GO:0070560,1,0.988054908615079,0,2,protein secretion by platelet,BP,
15876,GO:0070561,1,0.939019568551911,0,9,vitamin D receptor signaling pathway,BP,
15877,GO:0070562,1,0.958189640407947,0,6,regulation of vitamin D receptor signaling pathway,BP,
15878,GO:0070563,1,0.986668655767153,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
15879,GO:0070564,1,0.989250716266301,0,2,positive regulation of vitamin D receptor signaling pathway,BP,
15880,GO:0070566,1,0.834871342475691,0,27,adenylyltransferase activity,MF,
15881,GO:0070567,1,0.946472560352123,0,9,cytidylyltransferase activity,MF,
15882,GO:0070568,1,0.970161974771401,0,5,guanylyltransferase activity,MF,
15883,GO:0070569,1,0.955654497498986,0,7,uridylyltransferase activity,MF,
15884,GO:0070570,1,0.838920967866783,0,26,regulation of neuron projection regeneration,BP,
15885,GO:0070571,1,0.905086456756481,0,14,negative regulation of neuron projection regeneration,BP,
15886,GO:0070572,1,0.95737172116609,0,8,positive regulation of neuron projection regeneration,BP,
15887,GO:0070573,1,0.982966380850199,0,3,metallodipeptidase activity,MF,
15888,GO:0070574,1,0.97438548912721,0,4,cadmium ion transmembrane transport,BP,
15889,GO:0070576,1,0.987907788579739,0,2,vitamin D 24-hydroxylase activity,MF,
15890,GO:0070577,1,0.863147100508862,0,17,lysine-acetylated histone binding,MF,
15891,GO:0070578,1,0.942976267808147,0,9,RISC-loading complex,CC,
15892,GO:0070579,1,0.9562648273126,0,4,methylcytosine dioxygenase activity,MF,
15893,GO:0070584,1,0.881476286057986,0,21,mitochondrion morphogenesis,BP,
15894,GO:0070585,1,0.353671083258425,0,177,protein localization to mitochondrion,BP,
15895,GO:0070586,1,0.952973671444705,0,9,cell-cell adhesion involved in gastrulation,BP,
15896,GO:0070587,1,0.958594761559589,0,8,regulation of cell-cell adhesion involved in gastrulation,BP,
15898,GO:0070589,1,0.995286990116764,0,1,cellular component macromolecule biosynthetic process,BP,
15899,GO:0070593,1,0.981624534750549,0,2,dendrite self-avoidance,BP,
15900,GO:0070601,1,0.940353670943256,0,10,centromeric sister chromatid cohesion,BP,
15901,GO:0070602,1,0.975589473596771,0,4,regulation of centromeric sister chromatid cohesion,BP,
15902,GO:0070603,1,0.589888688018549,0,73,SWI/SNF superfamily-type complex,CC,
15903,GO:0070611,1,0.994214521253028,0,1,histone methyltransferase activity (H3-R2 specific),MF,
15904,GO:0070612,1,0.994214521253028,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
15906,GO:0070615,1,0.992733209216204,0,1,nucleosome-dependent ATPase activity,MF,
15907,GO:0070618,1,0.994154868753435,0,1,Grb2-Sos complex,CC,
15908,GO:0070625,1,0.994897630967621,0,1,zymogen granule exocytosis,BP,
15909,GO:0070626,1,0.995657785552636,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
15910,GO:0070627,1,0.992648601131098,0,1,ferrous iron import,BP,
15911,GO:0070628,1,0.880014737724723,0,21,proteasome binding,MF,
15912,GO:0070631,1,0.994054740756748,0,1,spindle pole body localization,BP,
15913,GO:0070632,1,0.994054740756748,0,1,establishment of spindle pole body localization,BP,
15914,GO:0070633,1,0.899862041946689,0,15,transepithelial transport,BP,
15915,GO:0070634,1,0.985097702863955,0,2,transepithelial ammonium transport,BP,
15916,GO:0070637,1,0.994482427989621,0,1,pyridine nucleoside metabolic process,BP,
15917,GO:0070638,1,0.994482427989621,0,1,pyridine nucleoside catabolic process,BP,
15918,GO:0070640,1,0.981180368459724,0,3,vitamin D3 metabolic process,BP,
15919,GO:0070643,1,0.995486712055545,0,1,vitamin D 25-hydroxylase activity,MF,
15920,GO:0070644,1,0.976161088593658,0,3,vitamin D response element binding,MF,
15921,GO:0070646,1,0.165368411091154,0,264,protein modification by small protein removal,BP,
15923,GO:0070649,1,0.975568247108869,0,3,formin-nucleated actin cable assembly,BP,
15924,GO:0070651,1,0.99389727060909,0,1,nonfunctional rRNA decay,BP,
15925,GO:0070652,1,0.950606360702382,0,8,HAUS complex,CC,
15926,GO:0070653,1,0.996385206025579,0,1,high-density lipoprotein particle receptor binding,MF,
15928,GO:0070662,1,0.977000882034504,0,3,mast cell proliferation,BP,
15930,GO:0070664,1,0.656110939633753,0,68,negative regulation of leukocyte proliferation,BP,
15932,GO:0070666,1,0.985229532304257,0,2,regulation of mast cell proliferation,BP,
15933,GO:0070667,1,0.993737620843766,0,1,negative regulation of mast cell proliferation,BP,
15934,GO:0070668,1,0.985229532304257,0,2,positive regulation of mast cell proliferation,BP,
15935,GO:0070669,1,0.915979590201661,0,13,response to interleukin-2,BP,
15936,GO:0070670,1,0.833544165067804,0,30,response to interleukin-4,BP,
15937,GO:0070671,1,0.772443920025777,0,46,response to interleukin-12,BP,
15938,GO:0070672,1,0.905125009593923,0,14,response to interleukin-15,BP,
15939,GO:0070673,1,0.938879190364451,0,11,response to interleukin-18,BP,
15940,GO:0070676,1,0.985778819525068,0,3,intralumenal vesicle formation,BP,
15941,GO:0070678,1,0.994163016098735,0,1,preprotein binding,MF,
15943,GO:0070681,1,0.983820772522336,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
15944,GO:0070682,1,0.983687788672085,0,3,proteasome regulatory particle assembly,BP,
15945,GO:0070684,1,0.996088745381014,0,1,seminal clot liquefaction,BP,
15946,GO:0070685,1,0.994859118622196,0,1,macropinocytic cup,CC,
15947,GO:0070694,1,0.994054740756748,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
15948,GO:0070695,1,0.957338178870864,0,5,FHF complex,CC,
15949,GO:0070696,1,0.892558194770007,0,18,transmembrane receptor protein serine/threonine kinase binding,MF,
15950,GO:0070697,1,0.965362058680914,0,6,activin receptor binding,MF,
15951,GO:0070698,1,0.988866892925798,0,2,type I activin receptor binding,MF,
15952,GO:0070699,1,0.984797880562297,0,2,type II activin receptor binding,MF,
15953,GO:0070700,1,0.924609703725586,0,12,BMP receptor binding,MF,
15954,GO:0070704,1,0.986506084658379,0,2,sterol desaturase activity,MF,
15955,GO:0070715,1,0.993514260851553,0,1,sodium-dependent organic cation transport,BP,
15956,GO:0070717,1,0.84934710148116,0,23,poly-purine tract binding,MF,
15957,GO:0070722,1,0.993298790969629,0,1,Tle3-Aes complex,CC,
15958,GO:0070723,1,0.849349040543402,0,20,response to cholesterol,BP,
15959,GO:0070724,1,0.993650285489828,0,1,BMP receptor complex,CC,
15961,GO:0070728,1,0.951928159152358,0,7,leucine binding,MF,
15962,GO:0070733,1,0.99544508758666,0,1,protein adenylyltransferase activity,MF,
15963,GO:0070734,1,0.879080644452178,0,19,histone H3-K27 methylation,BP,
15964,GO:0070735,1,0.988177871085991,0,2,protein-glycine ligase activity,MF,
15965,GO:0070736,1,0.993386344491873,0,1,protein-glycine ligase activity, initiating,MF,
15966,GO:0070739,1,0.955175950828135,0,7,protein-glutamic acid ligase activity,MF,
15967,GO:0070740,1,0.955175950828135,0,7,tubulin-glutamic acid ligase activity,MF,
15969,GO:0070742,1,0.90490525568473,0,14,C2H2 zinc finger domain binding,MF,
15970,GO:0070743,1,0.99620676332082,0,1,interleukin-23 complex,CC,
15971,GO:0070757,1,0.928436905513368,0,11,interleukin-35-mediated signaling pathway,BP,
15972,GO:0070761,1,0.970285755060063,0,5,pre-snoRNP complex,CC,
15973,GO:0070762,1,0.994054740756748,0,1,nuclear pore transmembrane ring,CC,
15974,GO:0070765,1,0.962214988570033,0,6,gamma-secretase complex,CC,
15975,GO:0070772,1,0.993691921123067,0,1,PAS complex,CC,
15976,GO:0070773,1,0.995821901222997,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
15977,GO:0070774,1,0.992434112600359,0,1,phytoceramidase activity,MF,
15978,GO:0070775,1,0.95074237591555,0,7,H3 histone acetyltransferase complex,CC,
15979,GO:0070776,1,0.95074237591555,0,7,MOZ/MORF histone acetyltransferase complex,CC,
15980,GO:0070777,1,0.964727973795814,0,4,D-aspartate transport,BP,
15981,GO:0070778,1,0.962612474823358,0,6,L-aspartate transmembrane transport,BP,
15982,GO:0070779,1,0.964727973795814,0,4,D-aspartate import across plasma membrane,BP,
15983,GO:0070780,1,0.989525886014588,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
15984,GO:0070781,1,0.986304587088455,0,2,response to biotin,BP,
15985,GO:0070782,1,0.994803055049089,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
15986,GO:0070813,1,0.971132060545612,0,5,hydrogen sulfide metabolic process,BP,
15987,GO:0070814,1,0.974738546229837,0,4,hydrogen sulfide biosynthetic process,BP,
15988,GO:0070815,1,0.973815500256527,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
15989,GO:0070816,1,0.908532991767653,0,15,phosphorylation of RNA polymerase II C-terminal domain,BP,
15990,GO:0070818,1,0.99532309742253,0,1,protoporphyrinogen oxidase activity,MF,
15993,GO:0070822,1,0.897435501609978,0,15,Sin3-type complex,CC,
15994,GO:0070826,1,0.992648601131098,0,1,paraferritin complex,CC,
15995,GO:0070827,1,0.96755163135207,0,4,chromatin maintenance,BP,
15996,GO:0070828,1,0.89484775687448,0,15,heterochromatin organization,BP,
15997,GO:0070829,1,0.98191479865202,0,2,heterochromatin maintenance,BP,
15998,GO:0070830,1,0.718081395606627,0,48,bicellular tight junction assembly,BP,
15999,GO:0070831,1,0.93581019801937,0,8,basement membrane assembly,BP,
16000,GO:0070836,1,0.982723456293613,0,3,caveola assembly,BP,
16001,GO:0070837,1,0.979489367889254,0,3,dehydroascorbic acid transport,BP,
16003,GO:0070839,1,0.986433457763776,0,2,divalent metal ion export,BP,
16005,GO:0070841,1,0.869321318973465,0,20,inclusion body assembly,BP,
16006,GO:0070842,1,0.974876758836769,0,4,aggresome assembly,BP,
16007,GO:0070843,1,0.992697001478449,0,1,misfolded protein transport,BP,
16008,GO:0070844,1,0.992697001478449,0,1,polyubiquitinated protein transport,BP,
16009,GO:0070845,1,0.992697001478449,0,1,polyubiquitinated misfolded protein transport,BP,
16010,GO:0070846,1,0.992697001478449,0,1,Hsp90 deacetylation,BP,
16011,GO:0070847,1,0.957648065585201,0,8,core mediator complex,CC,
16013,GO:0070849,1,0.731557186482529,0,43,response to epidermal growth factor,BP,
16014,GO:0070851,1,0.496237849188836,0,108,growth factor receptor binding,MF,
16015,GO:0070852,1,0.952573611419915,0,6,cell body fiber,CC,
16016,GO:0070853,1,0.978897751188056,0,2,myosin VI binding,MF,
16017,GO:0070856,1,0.990753515107686,0,1,myosin VI light chain binding,MF,
16018,GO:0070857,1,0.953211572396367,0,8,regulation of bile acid biosynthetic process,BP,
16019,GO:0070858,1,0.982698896636672,0,3,negative regulation of bile acid biosynthetic process,BP,
16020,GO:0070859,1,0.982999546645708,0,3,positive regulation of bile acid biosynthetic process,BP,
16021,GO:0070860,1,0.994614310182455,0,1,RNA polymerase I core factor complex,CC,
16022,GO:0070861,1,0.848305560259461,0,23,regulation of protein exit from endoplasmic reticulum,BP,
16023,GO:0070862,1,0.940225744707068,0,10,negative regulation of protein exit from endoplasmic reticulum,BP,
16024,GO:0070863,1,0.917670535261626,0,11,positive regulation of protein exit from endoplasmic reticulum,BP,
16025,GO:0070873,1,0.81281957574588,0,26,regulation of glycogen metabolic process,BP,
16026,GO:0070874,1,0.960438427242378,0,5,negative regulation of glycogen metabolic process,BP,
16027,GO:0070875,1,0.885844546777025,0,14,positive regulation of glycogen metabolic process,BP,
16028,GO:0070876,1,0.974723943913541,0,4,SOSS complex,CC,
16029,GO:0070877,1,0.986479729842114,0,2,microprocessor complex,CC,
16030,GO:0070878,1,0.939307102908093,0,8,primary miRNA binding,MF,
16031,GO:0070883,1,0.965822883897564,0,5,pre-miRNA binding,MF,
16032,GO:0070884,1,0.885900783290313,0,16,regulation of calcineurin-NFAT signaling cascade,BP,
16033,GO:0070885,1,0.976476842197614,0,3,negative regulation of calcineurin-NFAT signaling cascade,BP,
16034,GO:0070886,1,0.937914636911997,0,9,positive regulation of calcineurin-NFAT signaling cascade,BP,
16037,GO:0070889,1,0.988796928610875,0,2,platelet alpha granule organization,BP,
16038,GO:0070890,1,0.989895386513853,0,1,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
16039,GO:0070891,1,0.980566968567297,0,4,lipoteichoic acid binding,MF,
16040,GO:0070892,1,0.994909007074522,0,1,lipoteichoic acid receptor activity,MF,
16041,GO:0070893,1,0.985524191604885,0,2,transposon integration,BP,
16042,GO:0070894,1,0.985524191604885,0,2,regulation of transposon integration,BP,
16043,GO:0070895,1,0.985524191604885,0,2,negative regulation of transposon integration,BP,
16044,GO:0070897,1,0.759363535837425,0,42,DNA-templated transcriptional preinitiation complex assembly,BP,
16045,GO:0070898,1,0.986128999932431,0,1,RNA polymerase III transcriptional preinitiation complex assembly,BP,
16046,GO:0070899,1,0.993800884433856,0,1,mitochondrial tRNA wobble uridine modification,BP,
16047,GO:0070900,1,0.952219029607559,0,9,mitochondrial tRNA modification,BP,
16048,GO:0070901,1,0.977313604423246,0,4,mitochondrial tRNA methylation,BP,
16049,GO:0070902,1,0.995422363806997,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
16050,GO:0070903,1,0.995039491324869,0,1,mitochondrial tRNA thio-modification,BP,
16051,GO:0070904,1,0.989895386513853,0,1,transepithelial L-ascorbic acid transport,BP,
16052,GO:0070905,1,0.982012549609605,0,3,serine binding,MF,
16053,GO:0070911,1,0.826731754940348,0,32,global genome nucleotide-excision repair,BP,
16054,GO:0070914,1,0.932090121734532,0,11,UV-damage excision repair,BP,
16055,GO:0070915,1,0.973183305591801,0,5,lysophosphatidic acid receptor activity,MF,
16056,GO:0070918,1,0.733259561865211,0,43,production of small RNA involved in gene silencing by RNA,BP,
16057,GO:0070920,1,0.901275563074027,0,15,regulation of production of small RNA involved in gene silencing by RNA,BP,
16058,GO:0070922,1,0.938310199358803,0,9,small RNA loading onto RISC,BP,
16060,GO:0070926,1,0.992942917857439,0,1,regulation of ATP:ADP antiporter activity,BP,
16061,GO:0070931,1,0.991101654987127,0,1,Golgi-associated vesicle lumen,CC,
16062,GO:0070932,1,0.870037721467272,0,20,histone H3 deacetylation,BP,
16063,GO:0070933,1,0.934202590928165,0,9,histone H4 deacetylation,BP,
16064,GO:0070934,1,0.957003302798995,0,5,CRD-mediated mRNA stabilization,BP,
16065,GO:0070935,1,0.904552810846557,0,15,3'-UTR-mediated mRNA stabilization,BP,
16066,GO:0070936,1,0.719458327624326,0,49,protein K48-linked ubiquitination,BP,
16067,GO:0070937,1,0.950004741446712,0,6,CRD-mediated mRNA stability complex,CC,
16068,GO:0070938,1,0.914836878263356,0,11,contractile ring,CC,
16069,GO:0070939,1,0.977454279603757,0,3,Dsl1/NZR complex,CC,
16070,GO:0070940,1,0.968576588112658,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
16071,GO:0070942,1,0.964050281462906,0,8,neutrophil mediated cytotoxicity,BP,
16072,GO:0070943,1,0.97438232994596,0,6,neutrophil mediated killing of symbiont cell,BP,
16073,GO:0070944,1,0.978595690099617,0,5,neutrophil mediated killing of bacterium,BP,
16074,GO:0070945,1,0.985762913358749,0,3,neutrophil mediated killing of gram-negative bacterium,BP,
16075,GO:0070946,1,0.99635178612943,0,1,neutrophil mediated killing of gram-positive bacterium,BP,
16076,GO:0070947,1,0.992063989280848,0,2,neutrophil mediated killing of fungus,BP,
16077,GO:0070948,1,0.979166865721951,0,4,regulation of neutrophil mediated cytotoxicity,BP,
16078,GO:0070949,1,0.989659261430993,0,2,regulation of neutrophil mediated killing of symbiont cell,BP,
16079,GO:0070950,1,0.993938004826597,0,1,regulation of neutrophil mediated killing of bacterium,BP,
16080,GO:0070951,1,0.993938004826597,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16081,GO:0070953,1,0.995695424961761,0,1,regulation of neutrophil mediated killing of fungus,BP,
16082,GO:0070960,1,0.989659261430993,0,2,positive regulation of neutrophil mediated cytotoxicity,BP,
16083,GO:0070961,1,0.989659261430993,0,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,
16084,GO:0070962,1,0.993938004826597,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
16085,GO:0070963,1,0.993938004826597,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16086,GO:0070965,1,0.995695424961761,0,1,positive regulation of neutrophil mediated killing of fungus,BP,
16087,GO:0070966,1,0.977412358748193,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
16088,GO:0070970,1,0.927967534418393,0,10,interleukin-2 secretion,BP,
16089,GO:0070971,1,0.880435970052925,0,17,endoplasmic reticulum exit site,CC,
16090,GO:0070972,1,0.538794083768461,0,129,protein localization to endoplasmic reticulum,BP,
16091,GO:0070973,1,0.953205595203242,0,6,protein localization to endoplasmic reticulum exit site,BP,
16092,GO:0070974,1,0.993760908073491,0,1,POU domain binding,MF,
16093,GO:0070975,1,0.989501125545391,0,1,FHA domain binding,MF,
16094,GO:0070976,1,0.994128191935161,0,1,TIR domain binding,MF,
16095,GO:0070977,1,0.873101925588428,0,15,bone maturation,BP,
16096,GO:0070979,1,0.86356083306623,0,27,protein K11-linked ubiquitination,BP,
16097,GO:0070981,1,0.994588287413867,0,1,L-asparagine biosynthetic process,BP,
16098,GO:0070982,1,0.994588287413867,0,1,L-asparagine metabolic process,BP,
16099,GO:0070984,1,0.992651509031266,0,1,SET domain binding,MF,
16100,GO:0070985,1,0.991404001538453,0,2,TFIIK complex,CC,
16101,GO:0070986,1,0.905519087734988,0,13,left/right axis specification,BP,
16102,GO:0070987,1,0.898882653837331,0,18,error-free translesion synthesis,BP,
16103,GO:0070988,1,0.643421771382739,0,59,demethylation,BP,
16104,GO:0070989,1,0.91614825679763,0,12,oxidative demethylation,BP,
16105,GO:0070990,1,0.972911431040984,0,6,snRNP binding,MF,
16106,GO:0070991,1,0.981854274642335,0,3,medium-chain-acyl-CoA dehydrogenase activity,MF,
16107,GO:0070992,1,0.990788168330994,0,2,translation initiation complex,CC,
16108,GO:0070993,1,0.98504506384538,0,2,translation preinitiation complex,CC,
16109,GO:0070995,1,0.98025043678067,0,3,NADPH oxidation,BP,
16112,GO:0071000,1,0.989765236969294,0,2,response to magnetism,BP,
16113,GO:0071001,1,0.983125069602287,0,3,U4/U6 snRNP,CC,
16114,GO:0071004,1,0.899705772117116,0,17,U2-type prespliceosome,CC,
16115,GO:0071005,1,0.994757828176757,0,1,U2-type precatalytic spliceosome,CC,
16116,GO:0071006,1,0.982721197595853,0,3,U2-type catalytic step 1 spliceosome,CC,
16117,GO:0071007,1,0.850006430992241,0,29,U2-type catalytic step 2 spliceosome,CC,
16118,GO:0071008,1,0.977943806812739,0,4,U2-type post-mRNA release spliceosomal complex,CC,
16119,GO:0071010,1,0.876428519539363,0,22,prespliceosome,CC,
16120,GO:0071011,1,0.833820937158869,0,31,precatalytic spliceosome,CC,
16121,GO:0071012,1,0.965025497925164,0,6,catalytic step 1 spliceosome,CC,
16122,GO:0071013,1,0.54913746732033,0,97,catalytic step 2 spliceosome,CC,
16123,GO:0071014,1,0.950935526547172,0,9,post-mRNA release spliceosomal complex,CC,
16124,GO:0071020,1,0.990690496939022,0,2,post-spliceosomal complex,CC,
16125,GO:0071021,1,0.995369287020841,0,1,U2-type post-spliceosomal complex,CC,
16126,GO:0071025,1,0.923123382819792,0,15,RNA surveillance,BP,
16127,GO:0071026,1,0.994397214088083,0,1,cytoplasmic RNA surveillance,BP,
16128,GO:0071027,1,0.934032580900883,0,13,nuclear RNA surveillance,BP,
16129,GO:0071028,1,0.934032580900883,0,13,nuclear mRNA surveillance,BP,
16130,GO:0071029,1,0.972478509420434,0,6,nuclear ncRNA surveillance,BP,
16131,GO:0071030,1,0.989437704769919,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
16132,GO:0071031,1,0.990848857010501,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
16133,GO:0071033,1,0.975836512215644,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
16134,GO:0071034,1,0.974381066883236,0,4,CUT catabolic process,BP,
16135,GO:0071035,1,0.972478509420434,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
16136,GO:0071038,1,0.978309445946885,0,5,nuclear polyadenylation-dependent tRNA catabolic process,BP,
16137,GO:0071042,1,0.979671699479712,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
16138,GO:0071043,1,0.974381066883236,0,4,CUT metabolic process,BP,
16139,GO:0071044,1,0.912075430028762,0,11,histone mRNA catabolic process,BP,
16140,GO:0071045,1,0.995451397287598,0,1,nuclear histone mRNA catabolic process,BP,
16141,GO:0071046,1,0.972478509420434,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
16142,GO:0071047,1,0.979671699479712,0,4,polyadenylation-dependent mRNA catabolic process,BP,
16143,GO:0071048,1,0.989437704769919,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
16144,GO:0071049,1,0.990848857010501,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
16145,GO:0071051,1,0.9790457685471,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
16146,GO:0071062,1,0.980019321698444,0,3,alphav-beta3 integrin-vitronectin complex,CC,
16147,GO:0071065,1,0.987530318790067,0,2,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,
16148,GO:0071071,1,0.925979126104344,0,13,regulation of phospholipid biosynthetic process,BP,
16149,GO:0071072,1,0.974348911034191,0,4,negative regulation of phospholipid biosynthetic process,BP,
16150,GO:0071073,1,0.955548963238602,0,8,positive regulation of phospholipid biosynthetic process,BP,
16151,GO:0071074,1,0.995111844710202,0,1,eukaryotic initiation factor eIF2 binding,MF,
16152,GO:0071077,1,0.982751723197433,0,3,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
16154,GO:0071104,1,0.975309513781595,0,4,response to interleukin-9,BP,
16155,GO:0071105,1,0.98843825607342,0,2,response to interleukin-11,BP,
16156,GO:0071106,1,0.982751723197433,0,3,adenosine 3',5'-bisphosphate transmembrane transport,BP,
16157,GO:0071107,1,0.942275987065517,0,8,response to parathyroid hormone,BP,
16158,GO:0071108,1,0.814610013212847,0,24,protein K48-linked deubiquitination,BP,
16159,GO:0071109,1,0.977067572277511,0,2,superior temporal gyrus development,BP,
16160,GO:0071110,1,0.990820609009119,0,1,histone biotinylation,BP,
16161,GO:0071133,1,0.993648213078983,0,1,alpha9-beta1 integrin-ADAM8 complex,CC,
16162,GO:0071139,1,0.984840788996329,0,2,resolution of recombination intermediates,BP,
16163,GO:0071140,1,0.984840788996329,0,2,resolution of mitotic recombination intermediates,BP,
16164,GO:0071141,1,0.930037216449466,0,8,SMAD protein complex,CC,
16165,GO:0071144,1,0.977746985136505,0,2,heteromeric SMAD protein complex,CC,
16166,GO:0071148,1,0.979236305150218,0,2,TEAD-1-YAP complex,CC,
16167,GO:0071149,1,0.986371412259992,0,2,TEAD-2-YAP complex,CC,
16169,GO:0071157,1,0.883458113097085,0,21,negative regulation of cell cycle arrest,BP,
16170,GO:0071158,1,0.59038578709016,0,84,positive regulation of cell cycle arrest,BP,
16171,GO:0071159,1,0.990758278849328,0,2,NF-kappaB complex,CC,
16172,GO:0071163,1,0.985323216883775,0,3,DNA replication preinitiation complex assembly,BP,
16173,GO:0071164,1,0.99310497473633,0,1,RNA trimethylguanosine synthase activity,MF,
16174,GO:0071166,1,0.450142406195242,0,123,ribonucleoprotein complex localization,BP,
16175,GO:0071168,1,0.878560187671324,0,20,protein localization to chromatin,BP,
16176,GO:0071169,1,0.960322478022338,0,7,establishment of protein localization to chromatin,BP,
16179,GO:0071203,1,0.962082660986774,0,5,WASH complex,CC,
16180,GO:0071204,1,0.964192923700094,0,6,histone pre-mRNA 3'end processing complex,CC,
16181,GO:0071205,1,0.948269508925434,0,5,protein localization to juxtaparanode region of axon,BP,
16182,GO:0071206,1,0.989239499148074,0,1,establishment of protein localization to juxtaparanode region of axon,BP,
16183,GO:0071207,1,0.987594695646873,0,2,histone pre-mRNA stem-loop binding,MF,
16184,GO:0071208,1,0.9838215420443,0,4,histone pre-mRNA DCP binding,MF,
16185,GO:0071209,1,0.986588338858628,0,3,U7 snRNA binding,MF,
16186,GO:0071211,1,0.973065243746066,0,4,protein targeting to vacuole involved in autophagy,BP,
16188,GO:0071215,1,0.992471325418713,0,1,cellular response to abscisic acid stimulus,BP,
16189,GO:0071216,1,0.317912664284556,0,184,cellular response to biotic stimulus,BP,
16190,GO:0071217,1,0.992825065831946,0,1,cellular response to external biotic stimulus,BP,
16191,GO:0071218,1,0.865570710525751,0,21,cellular response to misfolded protein,BP,
16192,GO:0071219,1,0.364342441973764,0,165,cellular response to molecule of bacterial origin,BP,
16193,GO:0071220,1,0.964555360434781,0,6,cellular response to bacterial lipoprotein,BP,
16194,GO:0071221,1,0.964555360434781,0,6,cellular response to bacterial lipopeptide,BP,
16195,GO:0071222,1,0.38344012744519,0,157,cellular response to lipopolysaccharide,BP,
16196,GO:0071223,1,0.940833044340517,0,11,cellular response to lipoteichoic acid,BP,
16197,GO:0071224,1,0.969980039931677,0,5,cellular response to peptidoglycan,BP,
16198,GO:0071225,1,0.965826969052678,0,5,cellular response to muramyl dipeptide,BP,
16199,GO:0071226,1,0.986074064725305,0,2,cellular response to molecule of fungal origin,BP,
16200,GO:0071228,1,0.996142195059216,0,1,cellular response to tumor cell,BP,
16203,GO:0071231,1,0.992320119977397,0,2,cellular response to folic acid,BP,
16204,GO:0071233,1,0.927682955463697,0,9,cellular response to leucine,BP,
16208,GO:0071243,1,0.918469565627708,0,16,cellular response to arsenic-containing substance,BP,
16209,GO:0071245,1,0.993158446636833,0,1,cellular response to carbon monoxide,BP,
16210,GO:0071247,1,0.996139088949484,0,1,cellular response to chromate,BP,
16212,GO:0071250,1,0.990516721249158,0,1,cellular response to nitrite,BP,
16213,GO:0071253,1,0.974018611376465,0,4,connexin binding,MF,
16214,GO:0071256,1,0.983861248422546,0,4,translocon complex,CC,
16216,GO:0071258,1,0.992679109517626,0,1,cellular response to gravity,BP,
16217,GO:0071259,1,0.989765236969294,0,2,cellular response to magnetism,BP,
16218,GO:0071260,1,0.616422230245602,0,76,cellular response to mechanical stimulus,BP,
16219,GO:0071262,1,0.984391030247177,0,2,regulation of translational initiation in response to starvation,BP,
16220,GO:0071264,1,0.984391030247177,0,2,positive regulation of translational initiation in response to starvation,BP,
16221,GO:0071265,1,0.957441022124679,0,8,L-methionine biosynthetic process,BP,
16222,GO:0071266,1,0.99532436368798,0,1,'de novo' L-methionine biosynthetic process,BP,
16223,GO:0071267,1,0.961940467912574,0,7,L-methionine salvage,BP,
16224,GO:0071268,1,0.994632935851626,0,1,homocysteine biosynthetic process,BP,
16225,GO:0071275,1,0.994810604528976,0,1,cellular response to aluminum ion,BP,
16226,GO:0071276,1,0.852497223024473,0,32,cellular response to cadmium ion,BP,
16228,GO:0071279,1,0.979730587713444,0,3,cellular response to cobalt ion,BP,
16229,GO:0071280,1,0.920342938513221,0,18,cellular response to copper ion,BP,
16230,GO:0071281,1,0.940430148122996,0,10,cellular response to iron ion,BP,
16231,GO:0071283,1,0.991178837159918,0,2,cellular response to iron(III) ion,BP,
16232,GO:0071284,1,0.968137153660363,0,4,cellular response to lead ion,BP,
16233,GO:0071285,1,0.935251005017668,0,12,cellular response to lithium ion,BP,
16234,GO:0071286,1,0.941455615989435,0,6,cellular response to magnesium ion,BP,
16235,GO:0071287,1,0.938334776112865,0,9,cellular response to manganese ion,BP,
16236,GO:0071288,1,0.994079856808501,0,1,cellular response to mercury ion,BP,
16237,GO:0071294,1,0.921866873292346,0,17,cellular response to zinc ion,BP,
16238,GO:0071295,1,0.828673719311814,0,28,cellular response to vitamin,BP,
16239,GO:0071298,1,0.993370529098454,0,1,cellular response to L-ascorbic acid,BP,
16240,GO:0071300,1,0.652295840247967,0,64,cellular response to retinoic acid,BP,
16241,GO:0071301,1,0.989508738651349,0,1,cellular response to vitamin B1,BP,
16242,GO:0071305,1,0.878934054842996,0,19,cellular response to vitamin D,BP,
16243,GO:0071306,1,0.986089703899437,0,2,cellular response to vitamin E,BP,
16244,GO:0071307,1,0.987974336161023,0,2,cellular response to vitamin K,BP,
16246,GO:0071312,1,0.795137359298704,0,31,cellular response to alkaloid,BP,
16247,GO:0071313,1,0.912314868586459,0,8,cellular response to caffeine,BP,
16248,GO:0071314,1,0.985215814014323,0,3,cellular response to cocaine,BP,
16249,GO:0071315,1,0.976694778286921,0,4,cellular response to morphine,BP,
16250,GO:0071316,1,0.957494878561625,0,8,cellular response to nicotine,BP,
16251,GO:0071317,1,0.976694778286921,0,4,cellular response to isoquinoline alkaloid,BP,
16252,GO:0071318,1,0.913940589805218,0,13,cellular response to ATP,BP,
16253,GO:0071320,1,0.696318343937826,0,48,cellular response to cAMP,BP,
16254,GO:0071321,1,0.951626558207224,0,6,cellular response to cGMP,BP,
16256,GO:0071324,1,0.991828986410219,0,1,cellular response to disaccharide stimulus,BP,
16258,GO:0071329,1,0.991828986410219,0,1,cellular response to sucrose stimulus,BP,
16260,GO:0071332,1,0.969090359049978,0,5,cellular response to fructose stimulus,BP,
16262,GO:0071335,1,0.991524707214325,0,2,hair follicle cell proliferation,BP,
16263,GO:0071336,1,0.991524707214325,0,2,regulation of hair follicle cell proliferation,BP,
16264,GO:0071338,1,0.991524707214325,0,2,positive regulation of hair follicle cell proliferation,BP,
16265,GO:0071339,1,0.826420057232937,0,28,MLL1 complex,CC,
16266,GO:0071340,1,0.934719667027303,0,11,skeletal muscle acetylcholine-gated channel clustering,BP,
16267,GO:0071344,1,0.991409665040504,0,2,diphosphate metabolic process,BP,
16271,GO:0071348,1,0.99204854126773,0,1,cellular response to interleukin-11,BP,
16272,GO:0071349,1,0.781749088797404,0,44,cellular response to interleukin-12,BP,
16273,GO:0071350,1,0.912760184660741,0,13,cellular response to interleukin-15,BP,
16274,GO:0071351,1,0.956130278287184,0,8,cellular response to interleukin-18,BP,
16275,GO:0071352,1,0.919327803078689,0,12,cellular response to interleukin-2,BP,
16276,GO:0071353,1,0.843585600124928,0,28,cellular response to interleukin-4,BP,
16277,GO:0071354,1,0.804621311657122,0,31,cellular response to interleukin-6,BP,
16278,GO:0071355,1,0.978872329182894,0,3,cellular response to interleukin-9,BP,
16280,GO:0071357,1,0.65184382878002,0,71,cellular response to type I interferon,BP,
16281,GO:0071359,1,0.649279862556793,0,62,cellular response to dsRNA,BP,
16282,GO:0071360,1,0.919096855790064,0,13,cellular response to exogenous dsRNA,BP,
16283,GO:0071361,1,0.907127726896405,0,13,cellular response to ethanol,BP,
16284,GO:0071362,1,0.962671534957209,0,5,cellular response to ether,BP,
16286,GO:0071364,1,0.754022949817809,0,39,cellular response to epidermal growth factor stimulus,BP,
16287,GO:0071371,1,0.893493644655536,0,16,cellular response to gonadotropin stimulus,BP,
16288,GO:0071372,1,0.928864260579904,0,10,cellular response to follicle-stimulating hormone stimulus,BP,
16289,GO:0071373,1,0.988236081186671,0,2,cellular response to luteinizing hormone stimulus,BP,
16290,GO:0071374,1,0.956229556052757,0,6,cellular response to parathyroid hormone stimulus,BP,
16292,GO:0071376,1,0.969115440780266,0,5,cellular response to corticotropin-releasing hormone stimulus,BP,
16294,GO:0071378,1,0.863073883905807,0,20,cellular response to growth hormone stimulus,BP,
16295,GO:0071379,1,0.855220480813077,0,21,cellular response to prostaglandin stimulus,BP,
16296,GO:0071380,1,0.893992618680455,0,16,cellular response to prostaglandin E stimulus,BP,
16297,GO:0071383,1,0.19013364034118,0,243,cellular response to steroid hormone stimulus,BP,
16298,GO:0071384,1,0.679067759088585,0,61,cellular response to corticosteroid stimulus,BP,
16299,GO:0071385,1,0.692223018188671,0,57,cellular response to glucocorticoid stimulus,BP,
16300,GO:0071386,1,0.973261982711692,0,3,cellular response to corticosterone stimulus,BP,
16301,GO:0071387,1,0.991630246832293,0,1,cellular response to cortisol stimulus,BP,
16302,GO:0071389,1,0.953775058489969,0,7,cellular response to mineralocorticoid stimulus,BP,
16303,GO:0071391,1,0.919809181056391,0,12,cellular response to estrogen stimulus,BP,
16304,GO:0071392,1,0.810082901485218,0,33,cellular response to estradiol stimulus,BP,
16305,GO:0071393,1,0.986763378826452,0,2,cellular response to progesterone stimulus,BP,
16306,GO:0071394,1,0.944992379798543,0,9,cellular response to testosterone stimulus,BP,
16307,GO:0071395,1,0.983510965420382,0,4,cellular response to jasmonic acid stimulus,BP,
16309,GO:0071397,1,0.906117597229247,0,12,cellular response to cholesterol,BP,
16310,GO:0071398,1,0.709246940835388,0,49,cellular response to fatty acid,BP,
16311,GO:0071400,1,0.985561838734799,0,2,cellular response to oleic acid,BP,
16312,GO:0071401,1,0.99463604311237,0,1,cellular response to triglyceride,BP,
16313,GO:0071402,1,0.845941367723956,0,25,cellular response to lipoprotein particle stimulus,BP,
16314,GO:0071403,1,0.987096683205594,0,2,cellular response to high density lipoprotein particle stimulus,BP,
16315,GO:0071404,1,0.886405268754341,0,18,cellular response to low-density lipoprotein particle stimulus,BP,
16317,GO:0071409,1,0.976495254554725,0,3,cellular response to cycloheximide,BP,
16318,GO:0071412,1,0.994645369902597,0,1,cellular response to genistein,BP,
16319,GO:0071413,1,0.994645369902597,0,1,cellular response to hydroxyisoflavone,BP,
16320,GO:0071415,1,0.904034721888269,0,9,cellular response to purine-containing compound,BP,
16322,GO:0071418,1,0.995810645825072,0,1,cellular response to amine stimulus,BP,
16324,GO:0071421,1,0.972771995981831,0,4,manganese ion transmembrane transport,BP,
16325,GO:0071422,1,0.981584079329087,0,3,succinate transmembrane transport,BP,
16326,GO:0071423,1,0.995139780213873,0,1,malate transmembrane transport,BP,
16327,GO:0071424,1,0.994054740756748,0,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,
16329,GO:0071426,1,0.452533703925641,0,122,ribonucleoprotein complex export from nucleus,BP,
16330,GO:0071427,1,0.501085138618102,0,104,mRNA-containing ribonucleoprotein complex export from nucleus,BP,
16331,GO:0071428,1,0.920449790131548,0,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
16332,GO:0071431,1,0.798923862136045,0,31,tRNA-containing ribonucleoprotein complex export from nucleus,BP,
16333,GO:0071435,1,0.930317335549886,0,12,potassium ion export,BP,
16334,GO:0071437,1,0.907173408861935,0,14,invadopodium,CC,
16335,GO:0071438,1,0.96793759159903,0,5,invadopodium membrane,CC,
16336,GO:0071439,1,0.937436847482842,0,9,clathrin complex,CC,
16337,GO:0071440,1,0.963698093527888,0,6,regulation of histone H3-K14 acetylation,BP,
16338,GO:0071441,1,0.992965418025289,0,1,negative regulation of histone H3-K14 acetylation,BP,
16339,GO:0071442,1,0.97633336000946,0,4,positive regulation of histone H3-K14 acetylation,BP,
16340,GO:0071444,1,0.997231453566511,0,1,cellular response to pheromone,BP,
16341,GO:0071447,1,0.950600568589374,0,8,cellular response to hydroperoxide,BP,
16342,GO:0071449,1,0.996361690070134,0,1,cellular response to lipid hydroperoxide,BP,
16343,GO:0071450,1,0.880544482471326,0,24,cellular response to oxygen radical,BP,
16344,GO:0071451,1,0.880544482471326,0,24,cellular response to superoxide,BP,
16345,GO:0071453,1,0.270037260725527,0,205,cellular response to oxygen levels,BP,
16346,GO:0071454,1,0.989456432416391,0,1,cellular response to anoxia,BP,
16347,GO:0071455,1,0.959811541045959,0,6,cellular response to hyperoxia,BP,
16348,GO:0071456,1,0.316976274523124,0,183,cellular response to hypoxia,BP,
16349,GO:0071458,1,0.968827954513857,0,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,
16350,GO:0071459,1,0.891022279909851,0,20,protein localization to chromosome, centromeric region,BP,
16351,GO:0071460,1,0.991927671942015,0,2,cellular response to cell-matrix adhesion,BP,
16352,GO:0071461,1,0.990033397191113,0,2,cellular response to redox state,BP,
16353,GO:0071462,1,0.977824093106447,0,3,cellular response to water stimulus,BP,
16354,GO:0071464,1,0.991768106860702,0,1,cellular response to hydrostatic pressure,BP,
16355,GO:0071466,1,0.409107586964671,0,146,cellular response to xenobiotic stimulus,BP,
16356,GO:0071467,1,0.893083034094506,0,19,cellular response to pH,BP,
16357,GO:0071468,1,0.943753501637879,0,9,cellular response to acidic pH,BP,
16358,GO:0071469,1,0.987932954729272,0,2,cellular response to alkaline pH,BP,
16359,GO:0071470,1,0.809833476140362,0,32,cellular response to osmotic stress,BP,
16360,GO:0071471,1,0.992331953816647,0,1,cellular response to non-ionic osmotic stress,BP,
16361,GO:0071472,1,0.942683480687572,0,9,cellular response to salt stress,BP,
16362,GO:0071474,1,0.935897995104304,0,11,cellular hyperosmotic response,BP,
16363,GO:0071475,1,0.976950330999313,0,4,cellular hyperosmotic salinity response,BP,
16364,GO:0071476,1,0.948802052813714,0,7,cellular hypotonic response,BP,
16365,GO:0071477,1,0.983093454943495,0,2,cellular hypotonic salinity response,BP,
16370,GO:0071482,1,0.497314281663158,0,106,cellular response to light stimulus,BP,
16371,GO:0071483,1,0.986257402171809,0,2,cellular response to blue light,BP,
16372,GO:0071484,1,0.985118710303071,0,2,cellular response to light intensity,BP,
16373,GO:0071485,1,0.993502154158033,0,1,cellular response to absence of light,BP,
16374,GO:0071486,1,0.991562278385074,0,1,cellular response to high light intensity,BP,
16375,GO:0071492,1,0.980544362510723,0,3,cellular response to UV-A,BP,
16376,GO:0071493,1,0.957196837965987,0,8,cellular response to UV-B,BP,
16377,GO:0071494,1,0.968040572600809,0,4,cellular response to UV-C,BP,
16380,GO:0071498,1,0.889818298589315,0,18,cellular response to fluid shear stress,BP,
16381,GO:0071499,1,0.960299882654656,0,7,cellular response to laminar fluid shear stress,BP,
16382,GO:0071500,1,0.96222592840838,0,6,cellular response to nitrosative stress,BP,
16383,GO:0071501,1,0.941528100098938,0,9,cellular response to sterol depletion,BP,
16384,GO:0071502,1,0.969968372237414,0,5,cellular response to temperature stimulus,BP,
16385,GO:0071503,1,0.971083385603516,0,4,response to heparin,BP,
16386,GO:0071504,1,0.971083385603516,0,4,cellular response to heparin,BP,
16387,GO:0071505,1,0.987642423303705,0,2,response to mycophenolic acid,BP,
16388,GO:0071506,1,0.987642423303705,0,2,cellular response to mycophenolic acid,BP,
16389,GO:0071514,1,0.857908694736982,0,22,genetic imprinting,BP,
16390,GO:0071526,1,0.768865762593356,0,32,semaphorin-plexin signaling pathway,BP,
16391,GO:0071527,1,0.994542597469096,0,1,semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
16392,GO:0071528,1,0.992925684123928,0,1,tRNA re-export from nucleus,BP,
16393,GO:0071529,1,0.994278392674853,0,1,cementum mineralization,BP,
16394,GO:0071532,1,0.959945581714245,0,5,ankyrin repeat binding,MF,
16395,GO:0071535,1,0.97613897437139,0,4,RING-like zinc finger domain binding,MF,
16396,GO:0071538,1,0.994613069578521,0,1,SH2 domain-mediated complex assembly,BP,
16397,GO:0071539,1,0.803253877867243,0,27,protein localization to centrosome,BP,
16398,GO:0071540,1,0.991512298009007,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
16399,GO:0071541,1,0.964340740137986,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
16401,GO:0071543,1,0.977560788177497,0,4,diphosphoinositol polyphosphate metabolic process,BP,
16402,GO:0071544,1,0.995821901222997,0,1,diphosphoinositol polyphosphate catabolic process,BP,
16403,GO:0071545,1,0.920935941067316,0,12,inositol phosphate catabolic process,BP,
16404,GO:0071546,1,0.960402559532071,0,6,pi-body,CC,
16405,GO:0071547,1,0.969612924164312,0,5,piP-body,CC,
16406,GO:0071548,1,0.774835915975008,0,41,response to dexamethasone,BP,
16407,GO:0071549,1,0.821754979395351,0,32,cellular response to dexamethasone stimulus,BP,
16408,GO:0071550,1,0.953491590376681,0,9,death-inducing signaling complex assembly,BP,
16409,GO:0071553,1,0.985123378396994,0,3,G-protein coupled pyrimidinergic nucleotide receptor activity,MF,
16410,GO:0071554,1,0.97743799240339,0,5,cell wall organization or biogenesis,BP,
16411,GO:0071556,1,0.883537870032755,0,25,integral component of lumenal side of endoplasmic reticulum membrane,CC,
16412,GO:0071557,1,0.958575589226701,0,5,histone H3-K27 demethylation,BP,
16413,GO:0071558,1,0.958575589226701,0,5,histone demethylase activity (H3-K27 specific),MF,
16414,GO:0071559,1,0.219910794969136,0,212,response to transforming growth factor beta,BP,
16415,GO:0071560,1,0.229400616913414,0,208,cellular response to transforming growth factor beta stimulus,BP,
16416,GO:0071561,1,0.991780086714867,0,1,nucleus-vacuole junction,CC,
16417,GO:0071564,1,0.919421867027232,0,12,npBAF complex,CC,
16418,GO:0071565,1,0.902869718740999,0,14,nBAF complex,CC,
16419,GO:0071566,1,0.993862361683502,0,1,UFM1 activating enzyme activity,MF,
16420,GO:0071567,1,0.990821108152397,0,2,UFM1 hydrolase activity,MF,
16421,GO:0071568,1,0.990182574918968,0,2,UFM1 transferase activity,MF,
16422,GO:0071569,1,0.96974166075489,0,6,protein ufmylation,BP,
16423,GO:0071573,1,0.993877053319629,0,1,shelterin complex assembly,BP,
16425,GO:0071578,1,0.955965613970017,0,7,zinc ion import across plasma membrane,BP,
16426,GO:0071579,1,0.988979118800704,0,2,regulation of zinc ion transport,BP,
16427,GO:0071580,1,0.994981160360306,0,1,regulation of zinc ion transmembrane transport,BP,
16428,GO:0071581,1,0.994981160360306,0,1,regulation of zinc ion transmembrane import,BP,
16429,GO:0071582,1,0.994981160360306,0,1,negative regulation of zinc ion transport,BP,
16430,GO:0071583,1,0.994981160360306,0,1,negative regulation of zinc ion transmembrane transport,BP,
16431,GO:0071584,1,0.994981160360306,0,1,negative regulation of zinc ion transmembrane import,BP,
16432,GO:0071585,1,0.994981160360306,0,1,detoxification of cadmium ion,BP,
16433,GO:0071586,1,0.98933503387879,0,2,CAAX-box protein processing,BP,
16434,GO:0071593,1,0.974621955814243,0,4,lymphocyte aggregation,BP,
16435,GO:0071595,1,0.988144472527205,0,2,Nem1-Spo7 phosphatase complex,CC,
16436,GO:0071596,1,0.969873118062648,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
16437,GO:0071598,1,0.970855495669989,0,5,neuronal ribonucleoprotein granule,CC,
16438,GO:0071599,1,0.908131163016253,0,15,otic vesicle development,BP,
16439,GO:0071600,1,0.941649078012276,0,10,otic vesicle morphogenesis,BP,
16440,GO:0071602,1,0.992434112600359,0,1,phytosphingosine biosynthetic process,BP,
16441,GO:0071603,1,0.973195345073865,0,4,endothelial cell-cell adhesion,BP,
16442,GO:0071604,1,0.827257103053584,0,28,transforming growth factor beta production,BP,
16443,GO:0071605,1,0.938105128233927,0,12,monocyte chemotactic protein-1 production,BP,
16444,GO:0071606,1,0.995024267850121,0,1,chemokine (C-C motif) ligand 4 production,BP,
16445,GO:0071608,1,0.975925826264015,0,4,macrophage inflammatory protein-1 alpha production,BP,
16446,GO:0071609,1,0.934152686953734,0,10,chemokine (C-C motif) ligand 5 production,BP,
16447,GO:0071610,1,0.994364600709686,0,1,chemokine (C-C motif) ligand 1 production,BP,
16448,GO:0071611,1,0.972848137531879,0,5,granulocyte colony-stimulating factor production,BP,
16449,GO:0071612,1,0.985575765234179,0,1,IP-10 production,BP,
16450,GO:0071613,1,0.990367539500184,0,2,granzyme B production,BP,
16451,GO:0071614,1,0.995177873192027,0,1,linoleic acid epoxygenase activity,MF,
16452,GO:0071616,1,0.736058585100938,0,46,acyl-CoA biosynthetic process,BP,
16453,GO:0071617,1,0.878311448991378,0,18,lysophospholipid acyltransferase activity,MF,
16454,GO:0071619,1,0.994655949205073,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
16455,GO:0071621,1,0.634853979701123,0,83,granulocyte chemotaxis,BP,
16456,GO:0071622,1,0.800531747254268,0,43,regulation of granulocyte chemotaxis,BP,
16457,GO:0071623,1,0.985953634246584,0,2,negative regulation of granulocyte chemotaxis,BP,
16458,GO:0071624,1,0.868110675590029,0,30,positive regulation of granulocyte chemotaxis,BP,
16459,GO:0071625,1,0.861665082112403,0,17,vocalization behavior,BP,
16460,GO:0071626,1,0.995923075706157,0,1,mastication,BP,
16461,GO:0071629,1,0.995451397287598,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
16462,GO:0071630,1,0.975146483399218,0,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,
16463,GO:0071633,1,0.993966874666324,0,1,dihydroceramidase activity,MF,
16464,GO:0071634,1,0.833731897585089,0,27,regulation of transforming growth factor beta production,BP,
16465,GO:0071635,1,0.955663127060115,0,7,negative regulation of transforming growth factor beta production,BP,
16466,GO:0071636,1,0.896812235824504,0,17,positive regulation of transforming growth factor beta production,BP,
16467,GO:0071637,1,0.938105128233927,0,12,regulation of monocyte chemotactic protein-1 production,BP,
16468,GO:0071638,1,0.97300669605869,0,5,negative regulation of monocyte chemotactic protein-1 production,BP,
16469,GO:0071639,1,0.964139934833548,0,7,positive regulation of monocyte chemotactic protein-1 production,BP,
16470,GO:0071640,1,0.975925826264015,0,4,regulation of macrophage inflammatory protein 1 alpha production,BP,
16471,GO:0071641,1,0.98835022808911,0,2,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
16472,GO:0071642,1,0.987430629704235,0,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
16473,GO:0071643,1,0.995024267850121,0,1,regulation of chemokine (C-C motif) ligand 4 production,BP,
16474,GO:0071644,1,0.995024267850121,0,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,
16475,GO:0071649,1,0.938466819433574,0,9,regulation of chemokine (C-C motif) ligand 5 production,BP,
16476,GO:0071650,1,0.985001572188689,0,3,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
16477,GO:0071651,1,0.952763712688328,0,6,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
16478,GO:0071652,1,0.994364600709686,0,1,regulation of chemokine (C-C motif) ligand 1 production,BP,
16479,GO:0071654,1,0.994364600709686,0,1,positive regulation of chemokine (C-C motif) ligand 1 production,BP,
16480,GO:0071655,1,0.977401219540464,0,4,regulation of granulocyte colony-stimulating factor production,BP,
16481,GO:0071656,1,0.994595716009891,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
16482,GO:0071657,1,0.982713013625535,0,3,positive regulation of granulocyte colony-stimulating factor production,BP,
16483,GO:0071658,1,0.985575765234179,0,1,regulation of IP-10 production,BP,
16484,GO:0071660,1,0.985575765234179,0,1,positive regulation of IP-10 production,BP,
16485,GO:0071661,1,0.990367539500184,0,2,regulation of granzyme B production,BP,
16486,GO:0071663,1,0.990367539500184,0,2,positive regulation of granzyme B production,BP,
16487,GO:0071664,1,0.968587427799034,0,4,catenin-TCF7L2 complex,CC,
16488,GO:0071665,1,0.993426042293638,0,1,gamma-catenin-TCF7L2 complex,CC,
16489,GO:0071670,1,0.952266766881341,0,8,smooth muscle cell chemotaxis,BP,
16490,GO:0071671,1,0.96692603803323,0,6,regulation of smooth muscle cell chemotaxis,BP,
16491,GO:0071672,1,0.980113779503126,0,4,negative regulation of smooth muscle cell chemotaxis,BP,
16492,GO:0071673,1,0.983295089732618,0,3,positive regulation of smooth muscle cell chemotaxis,BP,
16493,GO:0071674,1,0.742423266657082,0,55,mononuclear cell migration,BP,
16494,GO:0071675,1,0.819042927788362,0,34,regulation of mononuclear cell migration,BP,
16495,GO:0071676,1,0.959292947814079,0,6,negative regulation of mononuclear cell migration,BP,
16496,GO:0071677,1,0.913215980243961,0,17,positive regulation of mononuclear cell migration,BP,
16497,GO:0071678,1,0.989190430027763,0,1,olfactory bulb axon guidance,BP,
16498,GO:0071679,1,0.937123711158533,0,8,commissural neuron axon guidance,BP,
16499,GO:0071680,1,0.962148001933064,0,5,response to indole-3-methanol,BP,
16500,GO:0071681,1,0.962148001933064,0,5,cellular response to indole-3-methanol,BP,
16501,GO:0071682,1,0.904306357940362,0,19,endocytic vesicle lumen,CC,
16502,GO:0071684,1,0.993544641356897,0,1,organism emergence from protective structure,BP,
16503,GO:0071688,1,0.885376354443202,0,13,striated muscle myosin thick filament assembly,BP,
16504,GO:0071691,1,0.989919453918078,0,1,cardiac muscle thin filament assembly,BP,
16505,GO:0071692,1,0.950912111027263,0,6,protein localization to extracellular region,BP,
16506,GO:0071694,1,0.950912111027263,0,6,maintenance of protein location in extracellular region,BP,
16507,GO:0071695,1,0.370502698808589,0,138,anatomical structure maturation,BP,
16508,GO:0071696,1,0.903831044805402,0,15,ectodermal placode development,BP,
16509,GO:0071697,1,0.908929585804103,0,14,ectodermal placode morphogenesis,BP,
16510,GO:0071698,1,0.972203599060235,0,4,olfactory placode development,BP,
16511,GO:0071699,1,0.972203599060235,0,4,olfactory placode morphogenesis,BP,
16512,GO:0071701,1,0.991977453299639,0,1,regulation of MAPK export from nucleus,BP,
16516,GO:0071706,1,0.497901930260981,0,114,tumor necrosis factor superfamily cytokine production,BP,
16517,GO:0071707,1,0.995923075706157,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
16518,GO:0071709,1,0.810088258751942,0,27,membrane assembly,BP,
16519,GO:0071711,1,0.862806616657519,0,19,basement membrane organization,BP,
16520,GO:0071712,1,0.924420686958848,0,12,ER-associated misfolded protein catabolic process,BP,
16521,GO:0071713,1,0.992122478254213,0,1,para-aminobenzoyl-glutamate hydrolase activity,MF,
16522,GO:0071714,1,0.992593259897461,0,1,icosanoid transmembrane transporter activity,MF,
16523,GO:0071715,1,0.827625548247547,0,31,icosanoid transport,BP,
16524,GO:0071723,1,0.952244527593617,0,8,lipopeptide binding,MF,
16525,GO:0071724,1,0.975015095694401,0,4,response to diacyl bacterial lipopeptide,BP,
16526,GO:0071725,1,0.98298565451865,0,3,response to triacyl bacterial lipopeptide,BP,
16527,GO:0071726,1,0.975015095694401,0,4,cellular response to diacyl bacterial lipopeptide,BP,
16528,GO:0071727,1,0.98298565451865,0,3,cellular response to triacyl bacterial lipopeptide,BP,
16531,GO:0071733,1,0.972072151947683,0,4,transcriptional activation by promoter-enhancer looping,BP,
16532,GO:0071763,1,0.96261830263973,0,6,nuclear membrane organization,BP,
16533,GO:0071765,1,0.992605896606313,0,1,nuclear inner membrane organization,BP,
16537,GO:0071782,1,0.893904027429113,0,18,endoplasmic reticulum tubular network,CC,
16538,GO:0071786,1,0.906163701788005,0,15,endoplasmic reticulum tubular network organization,BP,
16539,GO:0071787,1,0.977510068758233,0,4,endoplasmic reticulum tubular network formation,BP,
16540,GO:0071789,1,0.994054740756748,0,1,spindle pole body localization to nuclear envelope,BP,
16541,GO:0071790,1,0.994054740756748,0,1,establishment of spindle pole body localization to nuclear envelope,BP,
16542,GO:0071791,1,0.987474363753544,0,2,chemokine (C-C motif) ligand 5 binding,MF,
16543,GO:0071796,1,0.995894369461207,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
16544,GO:0071797,1,0.976860964119342,0,4,LUBAC complex,CC,
16545,GO:0071798,1,0.966632548812818,0,5,response to prostaglandin D,BP,
16546,GO:0071799,1,0.966632548812818,0,5,cellular response to prostaglandin D stimulus,BP,
16547,GO:0071800,1,0.870504252516869,0,20,podosome assembly,BP,
16548,GO:0071801,1,0.916115837735668,0,13,regulation of podosome assembly,BP,
16549,GO:0071802,1,0.99262629113065,0,1,negative regulation of podosome assembly,BP,
16550,GO:0071803,1,0.939448106645031,0,9,positive regulation of podosome assembly,BP,
16553,GO:0071806,1,0.742883848672586,0,54,protein transmembrane transport,BP,
16554,GO:0071812,1,0.993670017478937,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
16555,GO:0071813,1,0.867322348293379,0,21,lipoprotein particle binding,MF,
16556,GO:0071814,1,0.867322348293379,0,21,protein-lipid complex binding,MF,
16557,GO:0071816,1,0.979330211540971,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
16558,GO:0071817,1,0.973320084780398,0,5,MMXD complex,CC,
16559,GO:0071818,1,0.983647849737809,0,3,BAT3 complex,CC,
16560,GO:0071819,1,0.990002011994401,0,2,DUBm complex,CC,
16561,GO:0071820,1,0.995692916722254,0,1,N-box binding,MF,
16562,GO:0071821,1,0.986102912278535,0,2,FANCM-MHF complex,CC,
16563,GO:0071823,1,0.99204501794397,0,2,protein-carbohydrate complex subunit organization,BP,
16565,GO:0071825,1,0.778282222794352,0,39,protein-lipid complex subunit organization,BP,
16567,GO:0071827,1,0.788360792320385,0,37,plasma lipoprotein particle organization,BP,
16568,GO:0071830,1,0.955309680470654,0,7,triglyceride-rich lipoprotein particle clearance,BP,
16570,GO:0071838,1,0.960172060106598,0,6,cell proliferation in bone marrow,BP,
16571,GO:0071839,1,0.978140437698862,0,4,apoptotic process in bone marrow,BP,
16573,GO:0071846,1,0.996679142521548,0,1,actin filament debranching,BP,
16575,GO:0071848,1,0.993670017478937,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
16576,GO:0071850,1,0.91685264042312,0,14,mitotic cell cycle arrest,BP,
16578,GO:0071863,1,0.959485237179801,0,6,regulation of cell proliferation in bone marrow,BP,
16579,GO:0071864,1,0.959485237179801,0,6,positive regulation of cell proliferation in bone marrow,BP,
16580,GO:0071865,1,0.976463504603462,0,4,regulation of apoptotic process in bone marrow,BP,
16581,GO:0071866,1,0.976463504603462,0,4,negative regulation of apoptotic process in bone marrow,BP,
16583,GO:0071868,1,0.785500330777502,0,32,cellular response to monoamine stimulus,BP,
16585,GO:0071870,1,0.785500330777502,0,32,cellular response to catecholamine stimulus,BP,
16586,GO:0071871,1,0.889881937822552,0,15,response to epinephrine,BP,
16587,GO:0071872,1,0.906972474568211,0,12,cellular response to epinephrine stimulus,BP,
16588,GO:0071873,1,0.978415539272639,0,3,response to norepinephrine,BP,
16589,GO:0071874,1,0.987784128040168,0,2,cellular response to norepinephrine stimulus,BP,
16591,GO:0071877,1,0.995821901222997,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16592,GO:0071878,1,0.981169473510188,0,2,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16593,GO:0071879,1,0.97730740925336,0,3,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16595,GO:0071881,1,0.988794007688927,0,2,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16596,GO:0071882,1,0.992942917857439,0,1,phospholipase C-activating adrenergic receptor signaling pathway,BP,
16597,GO:0071885,1,0.990410764385042,0,2,N-terminal protein N-methyltransferase activity,MF,
16598,GO:0071886,1,0.985734344971615,0,2,1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding,MF,
16599,GO:0071887,1,0.569409526016629,0,93,leukocyte apoptotic process,BP,
16600,GO:0071888,1,0.945557459633559,0,9,macrophage apoptotic process,BP,
16601,GO:0071889,1,0.83403496656762,0,25,14-3-3 protein binding,MF,
16602,GO:0071890,1,0.991613255952324,0,1,bicarbonate binding,MF,
16603,GO:0071893,1,0.995275580827277,0,1,BMP signaling pathway involved in nephric duct formation,BP,
16604,GO:0071894,1,0.988237439781656,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
16605,GO:0071895,1,0.963540188369066,0,6,odontoblast differentiation,BP,
16606,GO:0071896,1,0.961306423324783,0,4,protein localization to adherens junction,BP,
16608,GO:0071898,1,0.982547218285896,0,3,regulation of estrogen receptor binding,BP,
16609,GO:0071899,1,0.982547218285896,0,3,negative regulation of estrogen receptor binding,BP,
16613,GO:0071907,1,0.947193182129524,0,7,determination of digestive tract left/right asymmetry,BP,
16614,GO:0071908,1,0.991441333760389,0,1,determination of intestine left/right asymmetry,BP,
16615,GO:0071909,1,0.991441333760389,0,1,determination of stomach left/right asymmetry,BP,
16616,GO:0071910,1,0.956405358651634,0,6,determination of liver left/right asymmetry,BP,
16617,GO:0071914,1,0.98590185224606,0,2,prominosome,CC,
16619,GO:0071920,1,0.989111214665836,0,2,cleavage body,CC,
16620,GO:0071921,1,0.963019952057501,0,5,cohesin loading,BP,
16621,GO:0071922,1,0.96878144827401,0,4,regulation of cohesin loading,BP,
16622,GO:0071926,1,0.972395183925963,0,4,endocannabinoid signaling pathway,BP,
16623,GO:0071929,1,0.987766153574864,0,2,alpha-tubulin acetylation,BP,
16624,GO:0071930,1,0.977433838254869,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16625,GO:0071931,1,0.983736739347288,0,3,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16626,GO:0071933,1,0.944756169187059,0,8,Arp2/3 complex binding,MF,
16627,GO:0071934,1,0.981764806812992,0,3,thiamine transmembrane transport,BP,
16628,GO:0071936,1,0.936618936917181,0,8,coreceptor activity involved in Wnt signaling pathway,MF,
16629,GO:0071938,1,0.993972450353285,0,1,vitamin A transport,BP,
16630,GO:0071939,1,0.993972450353285,0,1,vitamin A import,BP,
16631,GO:0071941,1,0.922961468098614,0,14,nitrogen cycle metabolic process,BP,
16632,GO:0071942,1,0.982130969703641,0,3,XPC complex,CC,
16634,GO:0071947,1,0.978197653067276,0,3,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
16635,GO:0071949,1,0.850931478197157,0,25,FAD binding,MF,
16636,GO:0071951,1,0.994084438530368,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
16637,GO:0071953,1,0.977278998033518,0,4,elastic fiber,CC,
16638,GO:0071954,1,0.993306621233704,0,1,chemokine (C-C motif) ligand 11 production,BP,
16639,GO:0071955,1,0.981927043424868,0,2,recycling endosome to Golgi transport,BP,
16640,GO:0071960,1,0.996398816784159,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
16641,GO:0071962,1,0.984905746664192,0,3,mitotic sister chromatid cohesion, centromeric,BP,
16642,GO:0071963,1,0.995322464272846,0,1,establishment or maintenance of cell polarity regulating cell shape,BP,
16643,GO:0071971,1,0.958097314296795,0,7,extracellular exosome assembly,BP,
16644,GO:0071976,1,0.993499131445205,0,1,cell gliding,BP,
16646,GO:0071986,1,0.965111596632749,0,6,Ragulator complex,CC,
16647,GO:0071987,1,0.969952050404896,0,4,WD40-repeat domain binding,MF,
16648,GO:0071988,1,0.989666133385604,0,1,protein localization to spindle pole body,BP,
16649,GO:0071997,1,0.99043455124782,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
16651,GO:0072003,1,0.981437991803262,0,3,kidney rudiment formation,BP,
16652,GO:0072004,1,0.985697693689836,0,2,kidney field specification,BP,
16653,GO:0072006,1,0.389452014851948,0,127,nephron development,BP,
16654,GO:0072007,1,0.956407621452788,0,7,mesangial cell differentiation,BP,
16655,GO:0072008,1,0.961081781499053,0,6,glomerular mesangial cell differentiation,BP,
16656,GO:0072009,1,0.486244147246665,0,99,nephron epithelium development,BP,
16657,GO:0072010,1,0.87913454235103,0,18,glomerular epithelium development,BP,
16658,GO:0072011,1,0.989560790113397,0,2,glomerular endothelium development,BP,
16659,GO:0072012,1,0.865204400103202,0,21,glomerulus vasculature development,BP,
16660,GO:0072014,1,0.960906225403925,0,5,proximal tubule development,BP,
16661,GO:0072015,1,0.927933503178729,0,9,glomerular visceral epithelial cell development,BP,
16662,GO:0072016,1,0.994215697574978,0,1,glomerular parietal epithelial cell development,BP,
16663,GO:0072017,1,0.907318228974285,0,11,distal tubule development,BP,
16664,GO:0072019,1,0.994824453345047,0,1,proximal convoluted tubule development,BP,
16665,GO:0072021,1,0.971257717249669,0,3,ascending thin limb development,BP,
16666,GO:0072023,1,0.995635185462448,0,1,thick ascending limb development,BP,
16667,GO:0072024,1,0.995635185462448,0,1,macula densa development,BP,
16668,GO:0072025,1,0.975832396869367,0,4,distal convoluted tubule development,BP,
16669,GO:0072027,1,0.994333338801902,0,1,connecting tubule development,BP,
16670,GO:0072028,1,0.593416804889909,0,72,nephron morphogenesis,BP,
16671,GO:0072033,1,0.934197535055109,0,8,renal vesicle formation,BP,
16672,GO:0072034,1,0.979691380849859,0,3,renal vesicle induction,BP,
16673,GO:0072036,1,0.993062698868,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
16674,GO:0072038,1,0.969296732963819,0,5,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
16675,GO:0072039,1,0.978583635212061,0,3,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16676,GO:0072040,1,0.978583635212061,0,3,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16677,GO:0072044,1,0.909125352228165,0,12,collecting duct development,BP,
16678,GO:0072046,1,0.995679118723186,0,1,establishment of planar polarity involved in nephron morphogenesis,BP,
16679,GO:0072047,1,0.975228060947847,0,5,proximal/distal pattern formation involved in nephron development,BP,
16680,GO:0072048,1,0.951631857126802,0,9,renal system pattern specification,BP,
16681,GO:0072049,1,0.971215293318592,0,5,comma-shaped body morphogenesis,BP,
16682,GO:0072050,1,0.957246198619599,0,7,S-shaped body morphogenesis,BP,
16683,GO:0072051,1,0.995635185462448,0,1,juxtaglomerular apparatus development,BP,
16684,GO:0072053,1,0.986316928518609,0,2,renal inner medulla development,BP,
16685,GO:0072054,1,0.986316928518609,0,2,renal outer medulla development,BP,
16686,GO:0072055,1,0.991768106860702,0,1,renal cortex development,BP,
16687,GO:0072059,1,0.991768106860702,0,1,cortical collecting duct development,BP,
16688,GO:0072060,1,0.99290078771553,0,1,outer medullary collecting duct development,BP,
16689,GO:0072061,1,0.982625744159945,0,3,inner medullary collecting duct development,BP,
16690,GO:0072069,1,0.981394680637013,0,3,DCT cell differentiation,BP,
16691,GO:0072070,1,0.930278970340162,0,10,loop of Henle development,BP,
16692,GO:0072071,1,0.990852154883257,0,2,kidney interstitial fibroblast differentiation,BP,
16693,GO:0072073,1,0.387580886547368,0,130,kidney epithelium development,BP,
16694,GO:0072074,1,0.887001626844627,0,18,kidney mesenchyme development,BP,
16695,GO:0072075,1,0.906068776993138,0,14,metanephric mesenchyme development,BP,
16696,GO:0072076,1,0.97583368643548,0,3,nephrogenic mesenchyme development,BP,
16697,GO:0072077,1,0.882447537470778,0,18,renal vesicle morphogenesis,BP,
16698,GO:0072078,1,0.611647398336182,0,68,nephron tubule morphogenesis,BP,
16699,GO:0072079,1,0.899723253011702,0,18,nephron tubule formation,BP,
16700,GO:0072080,1,0.538520504698994,0,85,nephron tubule development,BP,
16701,GO:0072081,1,0.975228060947847,0,5,specification of nephron tubule identity,BP,
16702,GO:0072086,1,0.979993260087653,0,4,specification of loop of Henle identity,BP,
16703,GO:0072087,1,0.87815211447229,0,19,renal vesicle development,BP,
16704,GO:0072088,1,0.603146132453974,0,70,nephron epithelium morphogenesis,BP,
16707,GO:0072092,1,0.966648145599476,0,3,ureteric bud invasion,BP,
16708,GO:0072093,1,0.959939929893378,0,4,metanephric renal vesicle formation,BP,
16709,GO:0072095,1,0.980187926234617,0,3,regulation of branch elongation involved in ureteric bud branching,BP,
16710,GO:0072096,1,0.995275580827277,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
16711,GO:0072097,1,0.995275580827277,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
16712,GO:0072098,1,0.990436827554303,0,2,anterior/posterior pattern specification involved in kidney development,BP,
16713,GO:0072099,1,0.995275580827277,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
16714,GO:0072100,1,0.995275580827277,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
16715,GO:0072101,1,0.995275580827277,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
16716,GO:0072102,1,0.94286900184463,0,7,glomerulus morphogenesis,BP,
16717,GO:0072103,1,0.965887009918873,0,4,glomerulus vasculature morphogenesis,BP,
16718,GO:0072104,1,0.965887009918873,0,4,glomerular capillary formation,BP,
16719,GO:0072106,1,0.975395057931865,0,4,regulation of ureteric bud formation,BP,
16720,GO:0072107,1,0.975395057931865,0,4,positive regulation of ureteric bud formation,BP,
16721,GO:0072108,1,0.975418388722418,0,4,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
16722,GO:0072109,1,0.913457537575226,0,14,glomerular mesangium development,BP,
16723,GO:0072110,1,0.944702472566546,0,9,glomerular mesangial cell proliferation,BP,
16724,GO:0072111,1,0.892731357545914,0,18,cell proliferation involved in kidney development,BP,
16725,GO:0072112,1,0.895449295153486,0,15,glomerular visceral epithelial cell differentiation,BP,
16726,GO:0072114,1,0.991281032996273,0,1,pronephros morphogenesis,BP,
16727,GO:0072124,1,0.95318692315749,0,8,regulation of glomerular mesangial cell proliferation,BP,
16728,GO:0072125,1,0.981968639409069,0,3,negative regulation of glomerular mesangial cell proliferation,BP,
16729,GO:0072126,1,0.970695090544908,0,5,positive regulation of glomerular mesangial cell proliferation,BP,
16730,GO:0072127,1,0.994670277144347,0,1,renal capsule development,BP,
16731,GO:0072128,1,0.994670277144347,0,1,renal capsule morphogenesis,BP,
16732,GO:0072129,1,0.994670277144347,0,1,renal capsule formation,BP,
16733,GO:0072130,1,0.994670277144347,0,1,renal capsule specification,BP,
16734,GO:0072131,1,0.970967438363262,0,4,kidney mesenchyme morphogenesis,BP,
16735,GO:0072132,1,0.736167089612241,0,45,mesenchyme morphogenesis,BP,
16736,GO:0072133,1,0.970967438363262,0,4,metanephric mesenchyme morphogenesis,BP,
16737,GO:0072134,1,0.981063489689118,0,2,nephrogenic mesenchyme morphogenesis,BP,
16738,GO:0072135,1,0.9816600167409,0,3,kidney mesenchymal cell proliferation,BP,
16739,GO:0072136,1,0.9816600167409,0,3,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
16740,GO:0072137,1,0.95583469585858,0,4,condensed mesenchymal cell proliferation,BP,
16741,GO:0072138,1,0.983643494024788,0,3,mesenchymal cell proliferation involved in ureteric bud development,BP,
16742,GO:0072139,1,0.987139995167445,0,2,glomerular parietal epithelial cell differentiation,BP,
16743,GO:0072141,1,0.990852154883257,0,2,renal interstitial fibroblast development,BP,
16744,GO:0072143,1,0.962065002776465,0,6,mesangial cell development,BP,
16745,GO:0072144,1,0.96676653047726,0,5,glomerular mesangial cell development,BP,
16746,GO:0072148,1,0.908713445486714,0,15,epithelial cell fate commitment,BP,
16747,GO:0072156,1,0.966642649380968,0,3,distal tubule morphogenesis,BP,
16748,GO:0072160,1,0.899592730104449,0,13,nephron tubule epithelial cell differentiation,BP,
16749,GO:0072161,1,0.958855644722238,0,7,mesenchymal cell differentiation involved in kidney development,BP,
16750,GO:0072162,1,0.974229699412417,0,4,metanephric mesenchymal cell differentiation,BP,
16751,GO:0072163,1,0.513892201927521,0,93,mesonephric epithelium development,BP,
16752,GO:0072164,1,0.513892201927521,0,93,mesonephric tubule development,BP,
16753,GO:0072165,1,0.995138510393713,0,1,anterior mesonephric tubule development,BP,
16754,GO:0072166,1,0.988970827591762,0,2,posterior mesonephric tubule development,BP,
16755,GO:0072167,1,0.995138510393713,0,1,specification of mesonephric tubule identity,BP,
16756,GO:0072168,1,0.995138510393713,0,1,specification of anterior mesonephric tubule identity,BP,
16757,GO:0072169,1,0.995138510393713,0,1,specification of posterior mesonephric tubule identity,BP,
16758,GO:0072170,1,0.849636183046086,0,22,metanephric tubule development,BP,
16759,GO:0072171,1,0.651536557448173,0,60,mesonephric tubule morphogenesis,BP,
16760,GO:0072172,1,0.954726372768114,0,8,mesonephric tubule formation,BP,
16761,GO:0072173,1,0.924358111630502,0,11,metanephric tubule morphogenesis,BP,
16762,GO:0072174,1,0.961502607499012,0,6,metanephric tubule formation,BP,
16764,GO:0072176,1,0.906315928652252,0,13,nephric duct development,BP,
16765,GO:0072177,1,0.956665812472998,0,6,mesonephric duct development,BP,
16766,GO:0072178,1,0.933663164367219,0,10,nephric duct morphogenesis,BP,
16767,GO:0072179,1,0.977582958891592,0,4,nephric duct formation,BP,
16768,GO:0072180,1,0.985516342119399,0,3,mesonephric duct morphogenesis,BP,
16769,GO:0072181,1,0.995679118723186,0,1,mesonephric duct formation,BP,
16770,GO:0072182,1,0.915691601027108,0,11,regulation of nephron tubule epithelial cell differentiation,BP,
16771,GO:0072183,1,0.988397790644071,0,2,negative regulation of nephron tubule epithelial cell differentiation,BP,
16772,GO:0072184,1,0.995138510393713,0,1,renal vesicle progenitor cell differentiation,BP,
16773,GO:0072185,1,0.989711050833734,0,2,metanephric cap development,BP,
16774,GO:0072186,1,0.989711050833734,0,2,metanephric cap morphogenesis,BP,
16775,GO:0072189,1,0.915491476368894,0,13,ureter development,BP,
16776,GO:0072190,1,0.983392492442612,0,3,ureter urothelium development,BP,
16777,GO:0072191,1,0.978043319946145,0,4,ureter smooth muscle development,BP,
16778,GO:0072192,1,0.995275580827277,0,1,ureter epithelial cell differentiation,BP,
16779,GO:0072193,1,0.978043319946145,0,4,ureter smooth muscle cell differentiation,BP,
16780,GO:0072194,1,0.982543498696235,0,3,kidney smooth muscle tissue development,BP,
16781,GO:0072195,1,0.995539622956947,0,1,kidney smooth muscle cell differentiation,BP,
16782,GO:0072197,1,0.982027318362584,0,3,ureter morphogenesis,BP,
16783,GO:0072198,1,0.985049724787873,0,3,mesenchymal cell proliferation involved in ureter development,BP,
16784,GO:0072199,1,0.985049724787873,0,3,regulation of mesenchymal cell proliferation involved in ureter development,BP,
16785,GO:0072200,1,0.995275580827277,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
16786,GO:0072201,1,0.947377454554775,0,8,negative regulation of mesenchymal cell proliferation,BP,
16787,GO:0072202,1,0.852429294566509,0,23,cell differentiation involved in metanephros development,BP,
16788,GO:0072203,1,0.935424024233639,0,10,cell proliferation involved in metanephros development,BP,
16789,GO:0072204,1,0.985361984288866,0,2,cell-cell signaling involved in metanephros development,BP,
16790,GO:0072205,1,0.942556382556191,0,7,metanephric collecting duct development,BP,
16791,GO:0072206,1,0.995635185462448,0,1,metanephric juxtaglomerular apparatus development,BP,
16792,GO:0072207,1,0.836750403021699,0,24,metanephric epithelium development,BP,
16793,GO:0072208,1,0.986946234792919,0,2,metanephric smooth muscle tissue development,BP,
16794,GO:0072209,1,0.988095664451186,0,2,metanephric mesangial cell differentiation,BP,
16795,GO:0072210,1,0.773147982449159,0,36,metanephric nephron development,BP,
16796,GO:0072213,1,0.994670277144347,0,1,metanephric capsule development,BP,
16797,GO:0072214,1,0.991768106860702,0,1,metanephric cortex development,BP,
16798,GO:0072215,1,0.871317675309148,0,20,regulation of metanephros development,BP,
16799,GO:0072216,1,0.92610331397366,0,12,positive regulation of metanephros development,BP,
16800,GO:0072217,1,0.958429119920881,0,7,negative regulation of metanephros development,BP,
16801,GO:0072218,1,0.971257717249669,0,3,metanephric ascending thin limb development,BP,
16802,GO:0072219,1,0.991768106860702,0,1,metanephric cortical collecting duct development,BP,
16803,GO:0072221,1,0.975832396869367,0,4,metanephric distal convoluted tubule development,BP,
16804,GO:0072223,1,0.967066861224218,0,5,metanephric glomerular mesangium development,BP,
16805,GO:0072224,1,0.922104103374033,0,11,metanephric glomerulus development,BP,
16806,GO:0072227,1,0.995635185462448,0,1,metanephric macula densa development,BP,
16807,GO:0072229,1,0.994824453345047,0,1,metanephric proximal convoluted tubule development,BP,
16808,GO:0072233,1,0.995635185462448,0,1,metanephric thick ascending limb development,BP,
16809,GO:0072234,1,0.864569504312283,0,19,metanephric nephron tubule development,BP,
16810,GO:0072235,1,0.95193500506291,0,6,metanephric distal tubule development,BP,
16811,GO:0072236,1,0.964360531048592,0,4,metanephric loop of Henle development,BP,
16812,GO:0072237,1,0.978523495069613,0,2,metanephric proximal tubule development,BP,
16813,GO:0072239,1,0.952984117810459,0,7,metanephric glomerulus vasculature development,BP,
16814,GO:0072240,1,0.981394680637013,0,3,metanephric DCT cell differentiation,BP,
16815,GO:0072243,1,0.856777687066251,0,20,metanephric nephron epithelium development,BP,
16816,GO:0072244,1,0.991000793221,0,1,metanephric glomerular epithelium development,BP,
16817,GO:0072248,1,0.991000793221,0,1,metanephric glomerular visceral epithelial cell differentiation,BP,
16818,GO:0072249,1,0.991000793221,0,1,metanephric glomerular visceral epithelial cell development,BP,
16819,GO:0072254,1,0.988095664451186,0,2,metanephric glomerular mesangial cell differentiation,BP,
16820,GO:0072255,1,0.993938558078282,0,1,metanephric glomerular mesangial cell development,BP,
16821,GO:0072257,1,0.93884548046283,0,7,metanephric nephron tubule epithelial cell differentiation,BP,
16822,GO:0072258,1,0.995138510393713,0,1,metanephric interstitial fibroblast differentiation,BP,
16823,GO:0072259,1,0.995138510393713,0,1,metanephric interstitial fibroblast development,BP,
16824,GO:0072262,1,0.978720393551663,0,3,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
16825,GO:0072265,1,0.994670277144347,0,1,metanephric capsule morphogenesis,BP,
16826,GO:0072266,1,0.994670277144347,0,1,metanephric capsule formation,BP,
16827,GO:0072267,1,0.994670277144347,0,1,metanephric capsule specification,BP,
16828,GO:0072268,1,0.979319197219025,0,4,pattern specification involved in metanephros development,BP,
16829,GO:0072272,1,0.989377861104968,0,2,proximal/distal pattern formation involved in metanephric nephron development,BP,
16830,GO:0072273,1,0.833612018826023,0,25,metanephric nephron morphogenesis,BP,
16831,GO:0072274,1,0.991000793221,0,1,metanephric glomerular basement membrane development,BP,
16832,GO:0072275,1,0.9814461221687,0,2,metanephric glomerulus morphogenesis,BP,
16833,GO:0072276,1,0.9814461221687,0,2,metanephric glomerulus vasculature morphogenesis,BP,
16834,GO:0072277,1,0.9814461221687,0,2,metanephric glomerular capillary formation,BP,
16835,GO:0072278,1,0.979454353662132,0,3,metanephric comma-shaped body morphogenesis,BP,
16836,GO:0072282,1,0.940590811920474,0,8,metanephric nephron tubule morphogenesis,BP,
16837,GO:0072283,1,0.900759844279484,0,15,metanephric renal vesicle morphogenesis,BP,
16838,GO:0072284,1,0.965367950591085,0,5,metanephric S-shaped body morphogenesis,BP,
16839,GO:0072285,1,0.993062698868,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
16840,GO:0072286,1,0.994333338801902,0,1,metanephric connecting tubule development,BP,
16841,GO:0072287,1,0.983615087237089,0,1,metanephric distal tubule morphogenesis,BP,
16842,GO:0072289,1,0.972575652289157,0,4,metanephric nephron tubule formation,BP,
16843,GO:0072298,1,0.972394504015376,0,4,regulation of metanephric glomerulus development,BP,
16844,GO:0072299,1,0.993802491068859,0,1,negative regulation of metanephric glomerulus development,BP,
16845,GO:0072300,1,0.978459847138848,0,3,positive regulation of metanephric glomerulus development,BP,
16846,GO:0072301,1,0.987507209563897,0,2,regulation of metanephric glomerular mesangial cell proliferation,BP,
16847,GO:0072302,1,0.993802491068859,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
16848,GO:0072303,1,0.993665856694707,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
16849,GO:0072304,1,0.985697693689836,0,2,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16850,GO:0072305,1,0.985697693689836,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16851,GO:0072307,1,0.93884548046283,0,7,regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16852,GO:0072308,1,0.993226682799604,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16853,GO:0072309,1,0.985697693689836,0,2,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
16854,GO:0072310,1,0.922562011751249,0,10,glomerular epithelial cell development,BP,
16855,GO:0072311,1,0.890263981957,0,16,glomerular epithelial cell differentiation,BP,
16856,GO:0072312,1,0.991000793221,0,1,metanephric glomerular epithelial cell differentiation,BP,
16857,GO:0072313,1,0.991000793221,0,1,metanephric glomerular epithelial cell development,BP,
16858,GO:0072318,1,0.957382511993794,0,6,clathrin coat disassembly,BP,
16859,GO:0072319,1,0.952374768558756,0,7,vesicle uncoating,BP,
16860,GO:0072320,1,0.973493896908657,0,4,volume-sensitive chloride channel activity,MF,
16861,GO:0072321,1,0.95191421925966,0,10,chaperone-mediated protein transport,BP,
16863,GO:0072330,1,0.178966718223068,0,269,monocarboxylic acid biosynthetic process,BP,
16866,GO:0072334,1,0.991388930989588,0,2,UDP-galactose transmembrane transport,BP,
16867,GO:0072337,1,0.88565784489467,0,17,modified amino acid transport,BP,
16868,GO:0072338,1,0.955824190122778,0,6,cellular lactam metabolic process,BP,
16869,GO:0072340,1,0.995384459698249,0,1,cellular lactam catabolic process,BP,
16871,GO:0072343,1,0.991107425652781,0,2,pancreatic stellate cell proliferation,BP,
16872,GO:0072344,1,0.977376519472077,0,4,rescue of stalled ribosome,BP,
16873,GO:0072345,1,0.960809214963815,0,6,NAADP-sensitive calcium-release channel activity,MF,
16875,GO:0072348,1,0.820591336524247,0,30,sulfur compound transport,BP,
16876,GO:0072349,1,0.911113993972457,0,13,modified amino acid transmembrane transporter activity,MF,
16877,GO:0072350,1,0.811021423342434,0,36,tricarboxylic acid metabolic process,BP,
16878,GO:0072354,1,0.995368022343986,0,1,histone kinase activity (H3-T3 specific),MF,
16879,GO:0072355,1,0.995368022343986,0,1,histone H3-T3 phosphorylation,BP,
16880,GO:0072356,1,0.992788570226548,0,1,chromosome passenger complex localization to kinetochore,BP,
16881,GO:0072357,1,0.951397025824345,0,7,PTW/PP1 phosphatase complex,CC,
16884,GO:0072361,1,0.976181632178192,0,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,
16885,GO:0072362,1,0.988955504111825,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
16886,GO:0072363,1,0.987084906890167,0,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,
16887,GO:0072364,1,0.975538490249555,0,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
16888,GO:0072365,1,0.988304031439794,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
16889,GO:0072366,1,0.987084906890167,0,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,
16890,GO:0072367,1,0.962911063780288,0,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,
16891,GO:0072368,1,0.981544924434109,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
16892,GO:0072369,1,0.981019314894981,0,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,
16893,GO:0072376,1,0.675827109319799,0,67,protein activation cascade,BP,
16894,GO:0072378,1,0.885490195782106,0,21,blood coagulation, fibrin clot formation,BP,
16895,GO:0072379,1,0.983647849737809,0,3,ER membrane insertion complex,CC,
16896,GO:0072382,1,0.98343143532959,0,1,minus-end-directed vesicle transport along microtubule,BP,
16897,GO:0072383,1,0.940303794259087,0,7,plus-end-directed vesicle transport along microtubule,BP,
16898,GO:0072384,1,0.601122278066288,0,69,organelle transport along microtubule,BP,
16899,GO:0072385,1,0.962002955851237,0,4,minus-end-directed organelle transport along microtubule,BP,
16900,GO:0072386,1,0.931898725390219,0,8,plus-end-directed organelle transport along microtubule,BP,
16901,GO:0072387,1,0.988008843766711,0,2,flavin adenine dinucleotide metabolic process,BP,
16902,GO:0072388,1,0.995035050726997,0,1,flavin adenine dinucleotide biosynthetic process,BP,
16903,GO:0072389,1,0.992939088184012,0,1,flavin adenine dinucleotide catabolic process,BP,
16904,GO:0072393,1,0.907694142107356,0,11,microtubule anchoring at microtubule organizing center,BP,
16905,GO:0072395,1,0.615640302679064,0,74,signal transduction involved in cell cycle checkpoint,BP,
16906,GO:0072396,1,0.960829849542173,0,5,response to cell cycle checkpoint signaling,BP,
16907,GO:0072401,1,0.622993928154872,0,73,signal transduction involved in DNA integrity checkpoint,BP,
16908,GO:0072402,1,0.960829849542173,0,5,response to DNA integrity checkpoint signaling,BP,
16909,GO:0072413,1,0.670988527675068,0,62,signal transduction involved in mitotic cell cycle checkpoint,BP,
16910,GO:0072414,1,0.989788726253076,0,1,response to mitotic cell cycle checkpoint signaling,BP,
16911,GO:0072422,1,0.622993928154872,0,73,signal transduction involved in DNA damage checkpoint,BP,
16912,GO:0072423,1,0.960829849542173,0,5,response to DNA damage checkpoint signaling,BP,
16913,GO:0072425,1,0.920895004965688,0,11,signal transduction involved in G2 DNA damage checkpoint,BP,
16914,GO:0072428,1,0.995167715599473,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
16915,GO:0072429,1,0.983212379530177,0,3,response to intra-S DNA damage checkpoint signaling,BP,
16916,GO:0072431,1,0.675176791186064,0,61,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,
16917,GO:0072432,1,0.989788726253076,0,1,response to G1 DNA damage checkpoint signaling,BP,
16918,GO:0072434,1,0.980036831090539,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
16919,GO:0072487,1,0.974415467413481,0,4,MSL complex,CC,
16920,GO:0072488,1,0.933660605271172,0,12,ammonium transmembrane transport,BP,
16921,GO:0072492,1,0.995313598987954,0,1,host cell mitochondrial intermembrane space,CC,
16922,GO:0072497,1,0.938858764461915,0,8,mesenchymal stem cell differentiation,BP,
16923,GO:0072498,1,0.922253602133433,0,14,embryonic skeletal joint development,BP,
16924,GO:0072501,1,0.952741326465458,0,6,cellular divalent inorganic anion homeostasis,BP,
16925,GO:0072502,1,0.952741326465458,0,6,cellular trivalent inorganic anion homeostasis,BP,
16927,GO:0072505,1,0.932546643570148,0,9,divalent inorganic anion homeostasis,BP,
16928,GO:0072506,1,0.932546643570148,0,9,trivalent inorganic anion homeostasis,BP,
16931,GO:0072510,1,0.979739793152995,0,3,trivalent inorganic cation transmembrane transporter activity,MF,
16933,GO:0072512,1,0.793128849538654,0,38,trivalent inorganic cation transport,BP,
16934,GO:0072513,1,0.976890361085014,0,4,positive regulation of secondary heart field cardioblast proliferation,BP,
16935,GO:0072517,1,0.993355240892532,0,1,host cell viral assembly compartment,CC,
16936,GO:0072518,1,0.990415014642476,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
16937,GO:0072520,1,0.924046231437583,0,11,seminiferous tubule development,BP,
16940,GO:0072523,1,0.721837841613327,0,49,purine-containing compound catabolic process,BP,
16941,GO:0072524,1,0.34811797003918,0,162,pyridine-containing compound metabolic process,BP,
16942,GO:0072525,1,0.439852016800652,0,122,pyridine-containing compound biosynthetic process,BP,
16943,GO:0072526,1,0.9711700370967,0,6,pyridine-containing compound catabolic process,BP,
16944,GO:0072527,1,0.645598472462478,0,77,pyrimidine-containing compound metabolic process,BP,
16945,GO:0072528,1,0.80965114379089,0,39,pyrimidine-containing compound biosynthetic process,BP,
16946,GO:0072529,1,0.822413926063646,0,34,pyrimidine-containing compound catabolic process,BP,
16947,GO:0072530,1,0.956795608860053,0,8,purine-containing compound transmembrane transport,BP,
16948,GO:0072531,1,0.948363424972574,0,9,pyrimidine-containing compound transmembrane transport,BP,
16949,GO:0072534,1,0.98046217595958,0,2,perineuronal net,CC,
16950,GO:0072535,1,0.988216560721023,0,2,tumor necrosis factor (ligand) superfamily member 11 production,BP,
16951,GO:0072536,1,0.995017291851267,0,1,interleukin-23 receptor complex,CC,
16952,GO:0072537,1,0.942382319821035,0,9,fibroblast activation,BP,
16953,GO:0072538,1,0.896972411582723,0,17,T-helper 17 type immune response,BP,
16954,GO:0072539,1,0.902826632036336,0,16,T-helper 17 cell differentiation,BP,
16955,GO:0072540,1,0.945481931518089,0,10,T-helper 17 cell lineage commitment,BP,
16956,GO:0072542,1,0.95895668265539,0,7,protein phosphatase activator activity,MF,
16957,GO:0072544,1,0.995381931359379,0,1,L-DOPA binding,MF,
16958,GO:0072545,1,0.990204988258624,0,2,tyrosine binding,MF,
16959,GO:0072546,1,0.941243762198877,0,10,ER membrane protein complex,CC,
16960,GO:0072553,1,0.957763691577855,0,6,terminal button organization,BP,
16961,GO:0072554,1,0.987992344413516,0,2,blood vessel lumenization,BP,
16962,GO:0072556,1,0.992633084128786,0,1,other organism presynaptic membrane,CC,
16963,GO:0072557,1,0.981542752984608,0,4,IPAF inflammasome complex,CC,
16964,GO:0072558,1,0.980018135799158,0,4,NLRP1 inflammasome complex,CC,
16965,GO:0072559,1,0.95701931493172,0,8,NLRP3 inflammasome complex,CC,
16966,GO:0072560,1,0.989811291721259,0,2,type B pancreatic cell maturation,BP,
16967,GO:0072562,1,0.595567973759425,0,93,blood microparticle,CC,
16968,GO:0072563,1,0.989189772831693,0,2,endothelial microparticle,CC,
16969,GO:0072564,1,0.990355697273027,0,2,blood microparticle formation,BP,
16970,GO:0072566,1,0.988944513256728,0,2,chemokine (C-X-C motif) ligand 1 production,BP,
16971,GO:0072567,1,0.937655219135445,0,12,chemokine (C-X-C motif) ligand 2 production,BP,
16972,GO:0072570,1,0.993554296713824,0,1,ADP-D-ribose binding,MF,
16973,GO:0072572,1,0.99482319393742,0,1,poly-ADP-D-ribose binding,MF,
16974,GO:0072573,1,0.99239585523513,0,1,tolerance induction to lipopolysaccharide,BP,
16975,GO:0072574,1,0.915111161104136,0,14,hepatocyte proliferation,BP,
16976,GO:0072575,1,0.915111161104136,0,14,epithelial cell proliferation involved in liver morphogenesis,BP,
16977,GO:0072576,1,0.906006274274229,0,15,liver morphogenesis,BP,
16978,GO:0072577,1,0.721616508130236,0,47,endothelial cell apoptotic process,BP,
16979,GO:0072578,1,0.9202805719258,0,10,neurotransmitter-gated ion channel clustering,BP,
16980,GO:0072579,1,0.99255627241335,0,1,glycine receptor clustering,BP,
16982,GO:0072584,1,0.941705590771134,0,9,caveolin-mediated endocytosis,BP,
16983,GO:0072586,1,0.992321123300634,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
16984,GO:0072587,1,0.992321123300634,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
16985,GO:0072588,1,0.979676281334196,0,5,box H/ACA RNP complex,CC,
16986,GO:0072589,1,0.98380462201869,0,4,box H/ACA scaRNP complex,CC,
16987,GO:0072590,1,0.977717329202785,0,2,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
16988,GO:0072591,1,0.991002778194846,0,1,citrate-L-glutamate ligase activity,MF,
16989,GO:0072592,1,0.974619657902615,0,5,oxygen metabolic process,BP,
16991,GO:0072594,1,0.0512559358077201,0,493,establishment of protein localization to organelle,BP,
16992,GO:0072595,1,0.769470866299988,0,40,maintenance of protein localization in organelle,BP,
16993,GO:0072599,1,0.638978204597618,0,104,establishment of protein localization to endoplasmic reticulum,BP,
16994,GO:0072602,1,0.96058022044588,0,6,interleukin-4 secretion,BP,
16995,GO:0072603,1,0.964947642059666,0,6,interleukin-5 secretion,BP,
16996,GO:0072604,1,0.835518227642484,0,28,interleukin-6 secretion,BP,
16998,GO:0072608,1,0.959173065935237,0,8,interleukin-10 secretion,BP,
16999,GO:0072610,1,0.949942964327389,0,9,interleukin-12 secretion,BP,
17000,GO:0072611,1,0.961160214899499,0,7,interleukin-13 secretion,BP,
17001,GO:0072615,1,0.989861685848293,0,2,interleukin-17 secretion,BP,
17002,GO:0072616,1,0.992814027468536,0,1,interleukin-18 secretion,BP,
17003,GO:0072619,1,0.993233966495427,0,1,interleukin-21 secretion,BP,
17004,GO:0072641,1,0.944920738760266,0,7,type I interferon secretion,BP,
17005,GO:0072642,1,0.950670817480126,0,6,interferon-alpha secretion,BP,
17006,GO:0072643,1,0.910953952970069,0,15,interferon-gamma secretion,BP,
17007,GO:0072655,1,0.361141870814265,0,174,establishment of protein localization to mitochondrion,BP,
17008,GO:0072656,1,0.967844885460675,0,5,maintenance of protein location in mitochondrion,BP,
17010,GO:0072658,1,0.987140201115925,0,1,maintenance of protein location in membrane,BP,
17012,GO:0072660,1,0.987140201115925,0,1,maintenance of protein location in plasma membrane,BP,
17013,GO:0072662,1,0.898784047237699,0,17,protein localization to peroxisome,BP,
17014,GO:0072663,1,0.898784047237699,0,17,establishment of protein localization to peroxisome,BP,
17015,GO:0072665,1,0.682317911237147,0,54,protein localization to vacuole,BP,
17016,GO:0072666,1,0.737383935174829,0,42,establishment of protein localization to vacuole,BP,
17017,GO:0072669,1,0.967477184023133,0,7,tRNA-splicing ligase complex,CC,
17018,GO:0072671,1,0.994317164197917,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
17019,GO:0072672,1,0.954020354144728,0,7,neutrophil extravasation,BP,
17020,GO:0072673,1,0.885347110670039,0,17,lamellipodium morphogenesis,BP,
17021,GO:0072674,1,0.961025717396832,0,4,multinuclear osteoclast differentiation,BP,
17022,GO:0072675,1,0.961025717396832,0,4,osteoclast fusion,BP,
17024,GO:0072677,1,0.933274018869102,0,14,eosinophil migration,BP,
17025,GO:0072678,1,0.781546079785923,0,44,T cell migration,BP,
17026,GO:0072679,1,0.97464784898448,0,5,thymocyte migration,BP,
17027,GO:0072680,1,0.993648213078983,0,1,extracellular matrix-dependent thymocyte migration,BP,
17028,GO:0072681,1,0.993648213078983,0,1,fibronectin-dependent thymocyte migration,BP,
17029,GO:0072682,1,0.993383376416789,0,1,eosinophil extravasation,BP,
17030,GO:0072683,1,0.981367101697095,0,4,T cell extravasation,BP,
17031,GO:0072684,1,0.992988880264395,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
17034,GO:0072695,1,0.988802882893642,0,2,regulation of DNA recombination at telomere,BP,
17035,GO:0072697,1,0.924592361468969,0,11,protein localization to cell cortex,BP,
17036,GO:0072698,1,0.712103485371715,0,43,protein localization to microtubule cytoskeleton,BP,
17037,GO:0072702,1,0.991202238703682,0,1,response to methyl methanesulfonate,BP,
17038,GO:0072703,1,0.991202238703682,0,1,cellular response to methyl methanesulfonate,BP,
17039,GO:0072706,1,0.99429446859228,0,1,response to sodium dodecyl sulfate,BP,
17040,GO:0072707,1,0.99429446859228,0,1,cellular response to sodium dodecyl sulfate,BP,
17041,GO:0072708,1,0.971896015522284,0,5,response to sorbitol,BP,
17042,GO:0072709,1,0.983449126487942,0,3,cellular response to sorbitol,BP,
17043,GO:0072710,1,0.939782622854733,0,8,response to hydroxyurea,BP,
17044,GO:0072711,1,0.945406487060922,0,7,cellular response to hydroxyurea,BP,
17045,GO:0072714,1,0.995330061323471,0,1,response to selenite ion,BP,
17046,GO:0072715,1,0.995330061323471,0,1,cellular response to selenite ion,BP,
17047,GO:0072716,1,0.974838499770379,0,4,response to actinomycin D,BP,
17048,GO:0072717,1,0.980669983520218,0,3,cellular response to actinomycin D,BP,
17049,GO:0072718,1,0.940325434958978,0,9,response to cisplatin,BP,
17050,GO:0072719,1,0.961536074078166,0,6,cellular response to cisplatin,BP,
17051,GO:0072720,1,0.988144472527205,0,2,response to dithiothreitol,BP,
17052,GO:0072721,1,0.994054740756748,0,1,cellular response to dithiothreitol,BP,
17053,GO:0072733,1,0.984177187641365,0,3,response to staurosporine,BP,
17054,GO:0072734,1,0.984177187641365,0,3,cellular response to staurosporine,BP,
17055,GO:0072737,1,0.989108906332639,0,2,response to diamide,BP,
17056,GO:0072738,1,0.989108906332639,0,2,cellular response to diamide,BP,
17057,GO:0072739,1,0.989218076189426,0,2,response to anisomycin,BP,
17058,GO:0072740,1,0.995134700935133,0,1,cellular response to anisomycin,BP,
17059,GO:0072741,1,0.977166594023451,0,3,protein localization to cell division site,BP,
17060,GO:0072749,1,0.995242605021767,0,1,cellular response to cytochalasin B,BP,
17061,GO:0072750,1,0.995901859723872,0,1,cellular response to leptomycin B,BP,
17062,GO:0072752,1,0.990245494756206,0,1,cellular response to rapamycin,BP,
17063,GO:0072755,1,0.993043508811968,0,1,cellular response to benomyl,BP,
17064,GO:0072757,1,0.974388959716902,0,4,cellular response to camptothecin,BP,
17065,GO:0075044,1,0.963280526957546,0,5,autophagy of host cells involved in interaction with symbiont,BP,
17066,GO:0075071,1,0.963280526957546,0,5,autophagy involved in symbiotic interaction,BP,
17067,GO:0075109,1,0.991621251797114,0,1,modulation by symbiont of host receptor-mediated signal transduction,BP,
17068,GO:0075111,1,0.991621251797114,0,1,negative regulation by symbiont of host receptor-mediated signal transduction,BP,
17069,GO:0075112,1,0.991621251797114,0,1,modulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
17070,GO:0075114,1,0.991621251797114,0,1,negative regulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
17071,GO:0075136,1,0.967257533324889,0,5,response to host,BP,
17072,GO:0075341,1,0.994628587104681,0,1,host cell PML body,CC,
17073,GO:0075509,1,0.979932979416918,0,3,endocytosis involved in viral entry into host cell,BP,
17074,GO:0075519,1,0.99663351604631,0,1,microtubule-dependent intracellular transport of viral material,BP,
17075,GO:0075521,1,0.99663351604631,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
17076,GO:0075522,1,0.93592849105969,0,10,IRES-dependent viral translational initiation,BP,
17077,GO:0075525,1,0.971775999373878,0,5,viral translational termination-reinitiation,BP,
17078,GO:0075528,1,0.986411368987859,0,2,modulation by virus of host immune response,BP,
17079,GO:0075606,1,0.99663351604631,0,1,transport of viral material towards nucleus,BP,
17080,GO:0075713,1,0.956414119586209,0,8,establishment of integrated proviral latency,BP,
17081,GO:0075732,1,0.983540037197739,0,2,viral penetration into host nucleus,BP,
17082,GO:0075733,1,0.700746044977767,0,53,intracellular transport of virus,BP,
17083,GO:0080008,1,0.798493192692073,0,34,Cul4-RING E3 ubiquitin ligase complex,CC,
17084,GO:0080009,1,0.946171273409224,0,10,mRNA methylation,BP,
17085,GO:0080019,1,0.986468528664904,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
17086,GO:0080023,1,0.988144472527205,0,2,3R-hydroxyacyl-CoA dehydratase activity,MF,
17087,GO:0080025,1,0.854645521172865,0,22,phosphatidylinositol-3,5-bisphosphate binding,MF,
17088,GO:0080033,1,0.990516721249158,0,1,response to nitrite,BP,
17089,GO:0080048,1,0.994054740756748,0,1,GDP-D-glucose phosphorylase activity,MF,
17090,GO:0080058,1,0.995808144242034,0,1,protein deglutathionylation,BP,
17091,GO:0080084,1,0.958544699585962,0,5,5S rDNA binding,MF,
17093,GO:0080101,1,0.996265061457174,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
17094,GO:0080111,1,0.855098426981977,0,22,DNA demethylation,BP,
17095,GO:0080120,1,0.98933503387879,0,2,CAAX-box protein maturation,BP,
17096,GO:0080121,1,0.988363769857886,0,2,AMP transport,BP,
17097,GO:0080122,1,0.982751723197433,0,3,AMP transmembrane transporter activity,MF,
17098,GO:0080129,1,0.996142195059216,0,1,proteasome core complex assembly,BP,
17099,GO:0080132,1,0.99446653393058,0,1,fatty acid alpha-hydroxylase activity,MF,
17102,GO:0080144,1,0.987713044758035,0,2,amino acid homeostasis,BP,
17103,GO:0080146,1,0.99532436368798,0,1,L-cysteine desulfhydrase activity,MF,
17104,GO:0080147,1,0.996531076871997,0,1,root hair cell development,BP,
17105,GO:0080154,1,0.913594986040609,0,16,regulation of fertilization,BP,
17106,GO:0080163,1,0.994507551816696,0,1,regulation of protein serine/threonine phosphatase activity,BP,
17107,GO:0080171,1,0.679824365732065,0,58,lytic vacuole organization,BP,
17108,GO:0080182,1,0.889610885060068,0,16,histone H3-K4 trimethylation,BP,
17109,GO:0080184,1,0.974363771554703,0,5,response to phenylpropanoid,BP,
17110,GO:0085018,1,0.994079856808501,0,1,maintenance of symbiont-containing vacuole by host,BP,
17111,GO:0085020,1,0.960075716681452,0,7,protein K6-linked ubiquitination,BP,
17112,GO:0085029,1,0.80360741474172,0,30,extracellular matrix assembly,BP,
17113,GO:0085032,1,0.993516281122288,0,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,
17114,GO:0086001,1,0.599475828971342,0,63,cardiac muscle cell action potential,BP,
17115,GO:0086002,1,0.689114910589575,0,46,cardiac muscle cell action potential involved in contraction,BP,
17116,GO:0086003,1,0.642180312597809,0,56,cardiac muscle cell contraction,BP,
17117,GO:0086004,1,0.751700629432248,0,33,regulation of cardiac muscle cell contraction,BP,
17118,GO:0086005,1,0.790385284973814,0,29,ventricular cardiac muscle cell action potential,BP,
17119,GO:0086006,1,0.960258013730558,0,5,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
17120,GO:0086007,1,0.949161686702103,0,5,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
17121,GO:0086008,1,0.930125365868108,0,12,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
17122,GO:0086009,1,0.750301290299762,0,40,membrane repolarization,BP,
17124,GO:0086011,1,0.857285014284927,0,24,membrane repolarization during action potential,BP,
17125,GO:0086012,1,0.836038825808769,0,20,membrane depolarization during cardiac muscle cell action potential,BP,
17126,GO:0086013,1,0.873575918064653,0,21,membrane repolarization during cardiac muscle cell action potential,BP,
17127,GO:0086014,1,0.852019377332985,0,18,atrial cardiac muscle cell action potential,BP,
17128,GO:0086015,1,0.915397287105873,0,8,SA node cell action potential,BP,
17129,GO:0086016,1,0.910519087806622,0,9,AV node cell action potential,BP,
17130,GO:0086017,1,0.977265114541188,0,3,Purkinje myocyte action potential,BP,
17131,GO:0086018,1,0.915397287105873,0,8,SA node cell to atrial cardiac muscle cell signaling,BP,
17132,GO:0086019,1,0.784355712354972,0,29,cell-cell signaling involved in cardiac conduction,BP,
17133,GO:0086020,1,0.989252722119176,0,1,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
17134,GO:0086021,1,0.989252722119176,0,1,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
17136,GO:0086024,1,0.988792022222766,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
17137,GO:0086026,1,0.852019377332985,0,18,atrial cardiac muscle cell to AV node cell signaling,BP,
17138,GO:0086027,1,0.910519087806622,0,9,AV node cell to bundle of His cell signaling,BP,
17139,GO:0086028,1,0.956309667898542,0,6,bundle of His cell to Purkinje myocyte signaling,BP,
17140,GO:0086029,1,0.953929561473416,0,5,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
17142,GO:0086036,1,0.946892632763062,0,8,regulation of cardiac muscle cell membrane potential,BP,
17143,GO:0086037,1,0.993231538024867,0,1,sodium:potassium-exchanging ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
17144,GO:0086038,1,0.994054740756748,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
17145,GO:0086039,1,0.988685023314789,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
17146,GO:0086040,1,0.992252097099493,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
17147,GO:0086041,1,0.989641284350118,0,1,voltage-gated potassium channel activity involved in SA node cell action potential depolarization,MF,
17148,GO:0086042,1,0.946023826357875,0,7,cardiac muscle cell-cardiac muscle cell adhesion,BP,
17149,GO:0086043,1,0.956309667898542,0,6,bundle of His cell action potential,BP,
17150,GO:0086045,1,0.948294324860928,0,5,membrane depolarization during AV node cell action potential,BP,
17151,GO:0086046,1,0.946521535259675,0,5,membrane depolarization during SA node cell action potential,BP,
17152,GO:0086047,1,0.977265114541188,0,3,membrane depolarization during Purkinje myocyte cell action potential,BP,
17153,GO:0086048,1,0.97436400153273,0,3,membrane depolarization during bundle of His cell action potential,BP,
17154,GO:0086050,1,0.993959081680909,0,1,membrane repolarization during bundle of His cell action potential,BP,
17155,GO:0086052,1,0.993959081680909,0,1,membrane repolarization during SA node cell action potential,BP,
17156,GO:0086053,1,0.989252722119176,0,1,AV node cell to bundle of His cell communication by electrical coupling,BP,
17157,GO:0086056,1,0.966391391266403,0,3,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
17158,GO:0086057,1,0.992953449568544,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
17159,GO:0086059,1,0.978574202696463,0,2,voltage-gated calcium channel activity involved SA node cell action potential,MF,
17160,GO:0086060,1,0.98845175086968,0,1,voltage-gated sodium channel activity involved in AV node cell action potential,MF,
17161,GO:0086061,1,0.98845175086968,0,1,voltage-gated sodium channel activity involved in bundle of His cell action potential,MF,
17162,GO:0086062,1,0.984407865889493,0,2,voltage-gated sodium channel activity involved in Purkinje myocyte action potential,MF,
17163,GO:0086063,1,0.98845175086968,0,1,voltage-gated sodium channel activity involved in SA node cell action potential,MF,
17164,GO:0086064,1,0.842533625392141,0,22,cell communication by electrical coupling involved in cardiac conduction,BP,
17165,GO:0086065,1,0.667489235061783,0,52,cell communication involved in cardiac conduction,BP,
17166,GO:0086066,1,0.852019377332985,0,18,atrial cardiac muscle cell to AV node cell communication,BP,
17167,GO:0086067,1,0.900724288714427,0,10,AV node cell to bundle of His cell communication,BP,
17168,GO:0086068,1,0.953929561473416,0,5,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
17169,GO:0086069,1,0.9039681382395,0,13,bundle of His cell to Purkinje myocyte communication,BP,
17170,GO:0086070,1,0.905550539653908,0,9,SA node cell to atrial cardiac muscle cell communication,BP,
17171,GO:0086072,1,0.994411755980108,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
17172,GO:0086073,1,0.951342833377601,0,6,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
17173,GO:0086075,1,0.982993178903082,0,2,gap junction channel activity involved in cardiac conduction electrical coupling,MF,
17174,GO:0086077,1,0.989252722119176,0,1,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
17175,GO:0086080,1,0.919030120862006,0,10,protein binding involved in heterotypic cell-cell adhesion,MF,
17176,GO:0086082,1,0.994411755980108,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
17177,GO:0086083,1,0.957500211637196,0,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
17178,GO:0086087,1,0.993959081680909,0,1,voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization,MF,
17179,GO:0086089,1,0.975689103322477,0,4,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
17180,GO:0086090,1,0.993959081680909,0,1,voltage-gated potassium channel activity involved in SA node cell action potential repolarization,MF,
17181,GO:0086091,1,0.756399936699664,0,35,regulation of heart rate by cardiac conduction,BP,
17182,GO:0086092,1,0.987655647043847,0,2,regulation of the force of heart contraction by cardiac conduction,BP,
17183,GO:0086096,1,0.995821901222997,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17184,GO:0086097,1,0.98691771927969,0,2,phospholipase C-activating angiotensin-activated signaling pathway,BP,
17185,GO:0086098,1,0.986977954509485,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
17186,GO:0086100,1,0.98557560976996,0,2,endothelin receptor signaling pathway,BP,
17188,GO:0089700,1,0.971154288269228,0,4,protein kinase D signaling,BP,
17189,GO:0089701,1,0.976289588992616,0,5,U2AF,CC,
17190,GO:0089709,1,0.983106858156491,0,3,L-histidine transmembrane transport,BP,
17191,GO:0089717,1,0.91958362630576,0,10,spanning component of membrane,CC,
17192,GO:0089718,1,0.871112605939332,0,19,amino acid import across plasma membrane,BP,
17193,GO:0089720,1,0.957844144080935,0,9,caspase binding,MF,
17194,GO:0090009,1,0.940720404906658,0,9,primitive streak formation,BP,
17195,GO:0090010,1,0.994893840072259,0,1,transforming growth factor beta receptor signaling pathway involved in primitive streak formation,BP,
17196,GO:0090022,1,0.845254052163342,0,34,regulation of neutrophil chemotaxis,BP,
17197,GO:0090023,1,0.87141969878708,0,29,positive regulation of neutrophil chemotaxis,BP,
17198,GO:0090024,1,0.985953634246584,0,2,negative regulation of neutrophil chemotaxis,BP,
17199,GO:0090025,1,0.902934529823415,0,18,regulation of monocyte chemotaxis,BP,
17200,GO:0090026,1,0.932899727275275,0,13,positive regulation of monocyte chemotaxis,BP,
17201,GO:0090027,1,0.974002880533365,0,4,negative regulation of monocyte chemotaxis,BP,
17202,GO:0090030,1,0.943321886402045,0,9,regulation of steroid hormone biosynthetic process,BP,
17203,GO:0090031,1,0.98108820928446,0,3,positive regulation of steroid hormone biosynthetic process,BP,
17204,GO:0090032,1,0.969095665174133,0,5,negative regulation of steroid hormone biosynthetic process,BP,
17205,GO:0090034,1,0.988232609286186,0,2,regulation of chaperone-mediated protein complex assembly,BP,
17206,GO:0090035,1,0.988232609286186,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,
17207,GO:0090036,1,0.897831671938505,0,15,regulation of protein kinase C signaling,BP,
17208,GO:0090037,1,0.949759338160776,0,8,positive regulation of protein kinase C signaling,BP,
17209,GO:0090038,1,0.986634100605102,0,2,negative regulation of protein kinase C signaling,BP,
17210,GO:0090042,1,0.935797164943821,0,9,tubulin deacetylation,BP,
17211,GO:0090043,1,0.947361176169254,0,7,regulation of tubulin deacetylation,BP,
17212,GO:0090044,1,0.995503097025035,0,1,positive regulation of tubulin deacetylation,BP,
17213,GO:0090045,1,0.944544975073293,0,8,positive regulation of deacetylase activity,BP,
17214,GO:0090049,1,0.790504350722748,0,34,regulation of cell migration involved in sprouting angiogenesis,BP,
17215,GO:0090050,1,0.885554599814081,0,18,positive regulation of cell migration involved in sprouting angiogenesis,BP,
17216,GO:0090051,1,0.898606428500728,0,15,negative regulation of cell migration involved in sprouting angiogenesis,BP,
17217,GO:0090063,1,0.972493733320994,0,4,positive regulation of microtubule nucleation,BP,
17218,GO:0090065,1,0.992809706686633,0,1,regulation of production of siRNA involved in RNA interference,BP,
17220,GO:0090067,1,0.992288604496873,0,1,regulation of thalamus size,BP,
17221,GO:0090068,1,0.190306014000123,0,244,positive regulation of cell cycle process,BP,
17222,GO:0090069,1,0.915122109833137,0,13,regulation of ribosome biogenesis,BP,
17223,GO:0090070,1,0.951018455194418,0,8,positive regulation of ribosome biogenesis,BP,
17224,GO:0090071,1,0.970441102860584,0,4,negative regulation of ribosome biogenesis,BP,
17225,GO:0090073,1,0.943763017003269,0,9,positive regulation of protein homodimerization activity,BP,
17226,GO:0090074,1,0.963040392697014,0,5,negative regulation of protein homodimerization activity,BP,
17228,GO:0090076,1,0.984774421835384,0,2,relaxation of skeletal muscle,BP,
17229,GO:0090077,1,0.812900026627431,0,29,foam cell differentiation,BP,
17231,GO:0090080,1,0.979552555406711,0,3,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,
17232,GO:0090081,1,0.99133011400556,0,2,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
17233,GO:0090082,1,0.99133011400556,0,2,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
17234,GO:0090083,1,0.8997971463426,0,15,regulation of inclusion body assembly,BP,
17235,GO:0090084,1,0.92662260638735,0,10,negative regulation of inclusion body assembly,BP,
17236,GO:0090085,1,0.931630545664478,0,11,regulation of protein deubiquitination,BP,
17237,GO:0090086,1,0.98737406546731,0,3,negative regulation of protein deubiquitination,BP,
17239,GO:0090088,1,0.989640228779888,0,2,regulation of oligopeptide transport,BP,
17240,GO:0090089,1,0.989640228779888,0,2,regulation of dipeptide transport,BP,
17242,GO:0090091,1,0.960913746675501,0,5,positive regulation of extracellular matrix disassembly,BP,
17244,GO:0090094,1,0.989711050833734,0,2,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
17245,GO:0090095,1,0.994546294154807,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
17246,GO:0090096,1,0.994546294154807,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
17247,GO:0090100,1,0.5150917135086,0,96,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
17250,GO:0090103,1,0.864212858268189,0,22,cochlea morphogenesis,BP,
17251,GO:0090107,1,0.977562142996362,0,3,regulation of high-density lipoprotein particle assembly,BP,
17252,GO:0090108,1,0.99491027139586,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
17253,GO:0090109,1,0.663002403622099,0,53,regulation of cell-substrate junction assembly,BP,
17254,GO:0090110,1,0.908588255321645,0,13,cargo loading into COPII-coated vesicle,BP,
17255,GO:0090113,1,0.994787965799874,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
17256,GO:0090114,1,0.625600588061672,0,69,COPII-coated vesicle budding,BP,
17257,GO:0090116,1,0.976997054175694,0,3,C-5 methylation of cytosine,BP,
17258,GO:0090118,1,0.961632719827934,0,5,receptor-mediated endocytosis involved in cholesterol transport,BP,
17259,GO:0090119,1,0.987314668843972,0,2,vesicle-mediated cholesterol transport,BP,
17260,GO:0090122,1,0.994979893160071,0,1,cholesterol ester hydrolysis involved in cholesterol transport,BP,
17263,GO:0090130,1,0.176075850137356,0,245,tissue migration,BP,
17264,GO:0090131,1,0.974684590175178,0,5,mesenchyme migration,BP,
17265,GO:0090132,1,0.180729862663308,0,240,epithelium migration,BP,
17266,GO:0090133,1,0.996201178563294,0,1,mesendoderm migration,BP,
17267,GO:0090134,1,0.996201178563294,0,1,cell migration involved in mesendoderm migration,BP,
17268,GO:0090135,1,0.981207847215324,0,3,actin filament branching,BP,
17269,GO:0090136,1,0.899046479461288,0,15,epithelial cell-cell adhesion,BP,
17270,GO:0090138,1,0.993132891757971,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
17271,GO:0090140,1,0.853571316073234,0,21,regulation of mitochondrial fission,BP,
17272,GO:0090141,1,0.909776573263538,0,14,positive regulation of mitochondrial fission,BP,
17274,GO:0090149,1,0.986912567156731,0,2,mitochondrial membrane fission,BP,
17276,GO:0090151,1,0.946391953464961,0,12,establishment of protein localization to mitochondrial membrane,BP,
17277,GO:0090153,1,0.928042558029242,0,13,regulation of sphingolipid biosynthetic process,BP,
17278,GO:0090154,1,0.953629174341886,0,8,positive regulation of sphingolipid biosynthetic process,BP,
17279,GO:0090155,1,0.977455455196495,0,4,negative regulation of sphingolipid biosynthetic process,BP,
17280,GO:0090156,1,0.985615401258742,0,3,cellular sphingolipid homeostasis,BP,
17281,GO:0090158,1,0.964864037258021,0,6,endoplasmic reticulum membrane organization,BP,
17282,GO:0090160,1,0.946449638350755,0,8,Golgi to lysosome transport,BP,
17283,GO:0090161,1,0.918909439474654,0,11,Golgi ribbon formation,BP,
17284,GO:0090162,1,0.812734286589329,0,28,establishment of epithelial cell polarity,BP,
17285,GO:0090164,1,0.983524231931049,0,2,asymmetric Golgi ribbon formation,BP,
17286,GO:0090166,1,0.963998325339815,0,6,Golgi disassembly,BP,
17287,GO:0090168,1,0.973506701958516,0,4,Golgi reassembly,BP,
17288,GO:0090169,1,0.827993571374696,0,25,regulation of spindle assembly,BP,
17289,GO:0090170,1,0.978040465503674,0,4,regulation of Golgi inheritance,BP,
17290,GO:0090171,1,0.992977387693188,0,1,chondrocyte morphogenesis,BP,
17293,GO:0090176,1,0.99121469990588,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
17297,GO:0090181,1,0.708304277041367,0,51,regulation of cholesterol metabolic process,BP,
17298,GO:0090182,1,0.990489899873836,0,2,regulation of secretion of lysosomal enzymes,BP,
17299,GO:0090183,1,0.731317632505873,0,48,regulation of kidney development,BP,
17300,GO:0090184,1,0.80342365889075,0,35,positive regulation of kidney development,BP,
17301,GO:0090185,1,0.91434380456549,0,15,negative regulation of kidney development,BP,
17302,GO:0090186,1,0.950515906551833,0,7,regulation of pancreatic juice secretion,BP,
17303,GO:0090187,1,0.99178385031356,0,2,positive regulation of pancreatic juice secretion,BP,
17304,GO:0090188,1,0.958393581983261,0,5,negative regulation of pancreatic juice secretion,BP,
17305,GO:0090189,1,0.884829924848084,0,20,regulation of branching involved in ureteric bud morphogenesis,BP,
17306,GO:0090190,1,0.898249103459921,0,17,positive regulation of branching involved in ureteric bud morphogenesis,BP,
17307,GO:0090191,1,0.977235129437459,0,4,negative regulation of branching involved in ureteric bud morphogenesis,BP,
17308,GO:0090192,1,0.934031973411772,0,11,regulation of glomerulus development,BP,
17309,GO:0090193,1,0.951191852233039,0,8,positive regulation of glomerulus development,BP,
17310,GO:0090194,1,0.981968639409069,0,3,negative regulation of glomerulus development,BP,
17311,GO:0090195,1,0.923161634143598,0,13,chemokine secretion,BP,
17312,GO:0090196,1,0.935303795039533,0,11,regulation of chemokine secretion,BP,
17313,GO:0090197,1,0.941011698412269,0,10,positive regulation of chemokine secretion,BP,
17314,GO:0090198,1,0.993938004826597,0,1,negative regulation of chemokine secretion,BP,
17315,GO:0090199,1,0.790617099617798,0,42,regulation of release of cytochrome c from mitochondria,BP,
17316,GO:0090200,1,0.860661262009516,0,28,positive regulation of release of cytochrome c from mitochondria,BP,
17317,GO:0090201,1,0.91390923858858,0,15,negative regulation of release of cytochrome c from mitochondria,BP,
17318,GO:0090202,1,0.972072151947683,0,4,gene looping,BP,
17319,GO:0090204,1,0.981824389102057,0,3,protein localization to nuclear pore,BP,
17320,GO:0090205,1,0.959336367700155,0,6,positive regulation of cholesterol metabolic process,BP,
17321,GO:0090206,1,0.973943937903908,0,5,negative regulation of cholesterol metabolic process,BP,
17322,GO:0090207,1,0.861106376209648,0,25,regulation of triglyceride metabolic process,BP,
17323,GO:0090208,1,0.91414434700315,0,16,positive regulation of triglyceride metabolic process,BP,
17324,GO:0090209,1,0.962350032204554,0,6,negative regulation of triglyceride metabolic process,BP,
17325,GO:0090210,1,0.986945250088114,0,2,regulation of establishment of blood-brain barrier,BP,
17326,GO:0090212,1,0.986945250088114,0,2,negative regulation of establishment of blood-brain barrier,BP,
17327,GO:0090214,1,0.985238092731363,0,2,spongiotrophoblast layer developmental growth,BP,
17329,GO:0090219,1,0.98059077890457,0,3,negative regulation of lipid kinase activity,BP,
17330,GO:0090220,1,0.931682585940938,0,10,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,
17331,GO:0090222,1,0.979186241442997,0,2,centrosome-templated microtubule nucleation,BP,
17332,GO:0090224,1,0.746729204081125,0,39,regulation of spindle organization,BP,
17333,GO:0090226,1,0.996469302809806,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
17334,GO:0090230,1,0.970483309014722,0,4,regulation of centromere complex assembly,BP,
17335,GO:0090231,1,0.908026395072372,0,15,regulation of spindle checkpoint,BP,
17336,GO:0090232,1,0.94706992170458,0,8,positive regulation of spindle checkpoint,BP,
17337,GO:0090233,1,0.994165346306363,0,1,negative regulation of spindle checkpoint,BP,
17338,GO:0090234,1,0.978271979067059,0,3,regulation of kinetochore assembly,BP,
17339,GO:0090235,1,0.938348305090314,0,7,regulation of metaphase plate congression,BP,
17340,GO:0090237,1,0.967153746205822,0,5,regulation of arachidonic acid secretion,BP,
17341,GO:0090238,1,0.97515343929375,0,4,positive regulation of arachidonic acid secretion,BP,
17342,GO:0090239,1,0.929917114223721,0,12,regulation of histone H4 acetylation,BP,
17343,GO:0090240,1,0.957788053942689,0,7,positive regulation of histone H4 acetylation,BP,
17344,GO:0090241,1,0.973013155950201,0,5,negative regulation of histone H4 acetylation,BP,
17346,GO:0090245,1,0.963970510357748,0,4,axis elongation involved in somitogenesis,BP,
17347,GO:0090246,1,0.992363434097317,0,1,convergent extension involved in somitogenesis,BP,
17348,GO:0090247,1,0.994268886159727,0,1,cell motility involved in somitogenic axis elongation,BP,
17349,GO:0090249,1,0.994268886159727,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17350,GO:0090251,1,0.985864656130846,0,1,protein localization involved in establishment of planar polarity,BP,
17352,GO:0090258,1,0.975958170866722,0,3,negative regulation of mitochondrial fission,BP,
17353,GO:0090259,1,0.966425320809546,0,5,regulation of retinal ganglion cell axon guidance,BP,
17354,GO:0090260,1,0.984695295204838,0,2,negative regulation of retinal ganglion cell axon guidance,BP,
17355,GO:0090261,1,0.980469650517707,0,4,positive regulation of inclusion body assembly,BP,
17357,GO:0090264,1,0.98990286145183,0,2,regulation of immune complex clearance by monocytes and macrophages,BP,
17358,GO:0090265,1,0.994377869669239,0,1,positive regulation of immune complex clearance by monocytes and macrophages,BP,
17359,GO:0090266,1,0.913968295933147,0,14,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17360,GO:0090267,1,0.953264670007697,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17361,GO:0090269,1,0.955393008808496,0,6,fibroblast growth factor production,BP,
17362,GO:0090270,1,0.955393008808496,0,6,regulation of fibroblast growth factor production,BP,
17363,GO:0090271,1,0.974434658490526,0,3,positive regulation of fibroblast growth factor production,BP,
17364,GO:0090272,1,0.980463829040577,0,3,negative regulation of fibroblast growth factor production,BP,
17365,GO:0090273,1,0.990504591636518,0,2,regulation of somatostatin secretion,BP,
17366,GO:0090274,1,0.990504591636518,0,2,positive regulation of somatostatin secretion,BP,
17370,GO:0090279,1,0.83896192759071,0,28,regulation of calcium ion import,BP,
17371,GO:0090280,1,0.90971412199501,0,15,positive regulation of calcium ion import,BP,
17372,GO:0090281,1,0.977930380881047,0,5,negative regulation of calcium ion import,BP,
17373,GO:0090282,1,0.993786984924752,0,1,positive regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
17374,GO:0090283,1,0.979113984318995,0,3,regulation of protein glycosylation in Golgi,BP,
17375,GO:0090284,1,0.989626001462961,0,1,positive regulation of protein glycosylation in Golgi,BP,
17376,GO:0090285,1,0.989378900316549,0,2,negative regulation of protein glycosylation in Golgi,BP,
17377,GO:0090286,1,0.9421141344196,0,6,cytoskeletal anchoring at nuclear membrane,BP,
17380,GO:0090289,1,0.981403944902272,0,3,regulation of osteoclast proliferation,BP,
17381,GO:0090290,1,0.996208004305224,0,1,positive regulation of osteoclast proliferation,BP,
17382,GO:0090291,1,0.985140157006032,0,2,negative regulation of osteoclast proliferation,BP,
17383,GO:0090292,1,0.966243336255513,0,3,nuclear matrix anchoring at nuclear membrane,BP,
17384,GO:0090293,1,0.994811863082861,0,1,nitrogen catabolite regulation of transcription,BP,
17385,GO:0090294,1,0.994811863082861,0,1,nitrogen catabolite activation of transcription,BP,
17386,GO:0090296,1,0.975514979960393,0,4,regulation of mitochondrial DNA replication,BP,
17387,GO:0090297,1,0.995910596863438,0,1,positive regulation of mitochondrial DNA replication,BP,
17388,GO:0090298,1,0.979521475024954,0,3,negative regulation of mitochondrial DNA replication,BP,
17389,GO:0090299,1,0.995427414738478,0,1,regulation of neural crest formation,BP,
17390,GO:0090301,1,0.995427414738478,0,1,negative regulation of neural crest formation,BP,
17391,GO:0090303,1,0.763511181464643,0,42,positive regulation of wound healing,BP,
17393,GO:0090305,1,0.190501682666963,0,265,nucleic acid phosphodiester bond hydrolysis,BP,
17396,GO:0090308,1,0.945972864132072,0,7,regulation of methylation-dependent chromatin silencing,BP,
17397,GO:0090309,1,0.970374187490082,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
17398,GO:0090310,1,0.981566072108075,0,2,negative regulation of methylation-dependent chromatin silencing,BP,
17399,GO:0090311,1,0.771106170043205,0,36,regulation of protein deacetylation,BP,
17400,GO:0090312,1,0.870010755848321,0,20,positive regulation of protein deacetylation,BP,
17403,GO:0090315,1,0.971104657950249,0,5,negative regulation of protein targeting to membrane,BP,
17405,GO:0090317,1,0.80449900583195,0,36,negative regulation of intracellular protein transport,BP,
17406,GO:0090322,1,0.861109874597378,0,27,regulation of superoxide metabolic process,BP,
17407,GO:0090323,1,0.996801118490797,0,1,prostaglandin secretion involved in immune response,BP,
17408,GO:0090324,1,0.970203149813656,0,5,negative regulation of oxidative phosphorylation,BP,
17409,GO:0090325,1,0.980475092490903,0,3,regulation of locomotion involved in locomotory behavior,BP,
17410,GO:0090326,1,0.993500138841552,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
17411,GO:0090327,1,0.992657323363829,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
17412,GO:0090329,1,0.738136081391845,0,45,regulation of DNA-dependent DNA replication,BP,
17413,GO:0090330,1,0.884146354412555,0,18,regulation of platelet aggregation,BP,
17414,GO:0090331,1,0.930065962808299,0,11,negative regulation of platelet aggregation,BP,
17415,GO:0090335,1,0.917569358630735,0,12,regulation of brown fat cell differentiation,BP,
17416,GO:0090336,1,0.959621277728352,0,6,positive regulation of brown fat cell differentiation,BP,
17417,GO:0090340,1,0.99491027139586,0,1,positive regulation of secretion of lysosomal enzymes,BP,
17418,GO:0090341,1,0.995557243882537,0,1,negative regulation of secretion of lysosomal enzymes,BP,
17420,GO:0090343,1,0.946933912500006,0,10,positive regulation of cell aging,BP,
17422,GO:0090345,1,0.989917733259709,0,2,cellular organohalogen metabolic process,BP,
17423,GO:0090346,1,0.989917733259709,0,2,cellular organofluorine metabolic process,BP,
17424,GO:0090347,1,0.995525772354966,0,1,regulation of cellular organohalogen metabolic process,BP,
17425,GO:0090348,1,0.995525772354966,0,1,regulation of cellular organofluorine metabolic process,BP,
17426,GO:0090349,1,0.995525772354966,0,1,negative regulation of cellular organohalogen metabolic process,BP,
17427,GO:0090350,1,0.995525772354966,0,1,negative regulation of cellular organofluorine metabolic process,BP,
17428,GO:0090360,1,0.982217184903656,0,3,platelet-derived growth factor production,BP,
17429,GO:0090361,1,0.982217184903656,0,3,regulation of platelet-derived growth factor production,BP,
17430,GO:0090362,1,0.98723635832455,0,2,positive regulation of platelet-derived growth factor production,BP,
17431,GO:0090365,1,0.994770378692479,0,1,regulation of mRNA modification,BP,
17432,GO:0090367,1,0.994770378692479,0,1,negative regulation of mRNA modification,BP,
17433,GO:0090370,1,0.980112979320217,0,3,negative regulation of cholesterol efflux,BP,
17434,GO:0090381,1,0.99133011400556,0,2,regulation of heart induction,BP,
17435,GO:0090382,1,0.786541349942801,0,40,phagosome maturation,BP,
17436,GO:0090383,1,0.86784419496632,0,26,phagosome acidification,BP,
17437,GO:0090385,1,0.957787159923672,0,7,phagosome-lysosome fusion,BP,
17438,GO:0090386,1,0.981782751007624,0,2,phagosome maturation involved in apoptotic cell clearance,BP,
17439,GO:0090387,1,0.981782751007624,0,2,phagolysosome assembly involved in apoptotic cell clearance,BP,
17440,GO:0090389,1,0.989240915650297,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
17442,GO:0090398,1,0.684625054037366,0,58,cellular senescence,BP,
17443,GO:0090399,1,0.910298515954438,0,13,replicative senescence,BP,
17444,GO:0090400,1,0.95015542358824,0,8,stress-induced premature senescence,BP,
17445,GO:0090402,1,0.989053794699175,0,2,oncogene-induced cell senescence,BP,
17446,GO:0090403,1,0.974144444597648,0,4,oxidative stress-induced premature senescence,BP,
17448,GO:0090409,1,0.994636664665273,0,1,malonyl-CoA synthetase activity,MF,
17449,GO:0090410,1,0.994636664665273,0,1,malonate catabolic process,BP,
17450,GO:0090416,1,0.994299836510832,0,1,nicotinate transmembrane transporter activity,MF,
17451,GO:0090420,1,0.995754326013234,0,1,naphthalene-containing compound metabolic process,BP,
17452,GO:0090422,1,0.989680273040968,0,2,thiamine pyrophosphate transmembrane transporter activity,MF,
17453,GO:0090425,1,0.993732872242499,0,1,acinar cell differentiation,BP,
17454,GO:0090427,1,0.980019280659471,0,3,activation of meiosis,BP,
17455,GO:0090435,1,0.958337940212841,0,7,protein localization to nuclear envelope,BP,
17456,GO:0090461,1,0.992534825731674,0,1,glutamate homeostasis,BP,
17457,GO:0090472,1,0.992631143538398,0,1,dibasic protein processing,BP,
17458,GO:0090480,1,0.977835630739237,0,3,purine nucleotide-sugar transmembrane transport,BP,
17459,GO:0090481,1,0.936450647032724,0,11,pyrimidine nucleotide-sugar transmembrane transport,BP,
17460,GO:0090482,1,0.870837270709773,0,22,vitamin transmembrane transporter activity,MF,
17461,GO:0090493,1,0.940715840381353,0,11,catecholamine uptake,BP,
17462,GO:0090494,1,0.940715840381353,0,11,dopamine uptake,BP,
17463,GO:0090498,1,0.979192541561334,0,3,extrinsic component of Golgi membrane,CC,
17464,GO:0090500,1,0.970898836629838,0,5,endocardial cushion to mesenchymal transition,BP,
17465,GO:0090501,1,0.4568522574488,0,129,RNA phosphodiester bond hydrolysis,BP,
17466,GO:0090502,1,0.696414196862727,0,62,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,
17467,GO:0090503,1,0.792930711178672,0,35,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,
17468,GO:0090504,1,0.810494086988954,0,28,epiboly,BP,
17469,GO:0090505,1,0.821839948719555,0,27,epiboly involved in wound healing,BP,
17470,GO:0090520,1,0.932488981012022,0,12,sphingolipid mediated signaling pathway,BP,
17471,GO:0090521,1,0.971587206211106,0,4,glomerular visceral epithelial cell migration,BP,
17472,GO:0090527,1,0.915951426018425,0,11,actin filament reorganization,BP,
17473,GO:0090529,1,0.995191838765683,0,1,cell septum assembly,BP,
17474,GO:0090533,1,0.914871902471211,0,15,cation-transporting ATPase complex,CC,
17475,GO:0090534,1,0.995368022343986,0,1,calcium ion-transporting ATPase complex,CC,
17476,GO:0090537,1,0.983981423737362,0,2,CERF complex,CC,
17477,GO:0090541,1,0.986543124689834,0,2,MIT domain binding,MF,
17478,GO:0090543,1,0.837328547875516,0,26,Flemming body,CC,
17479,GO:0090545,1,0.870218280959724,0,17,CHD-type complex,CC,
17480,GO:0090554,1,0.961992067531257,0,4,phosphatidylcholine-translocating ATPase activity,MF,
17481,GO:0090555,1,0.981530072447182,0,2,phosphatidylethanolamine-translocating ATPase activity,MF,
17482,GO:0090556,1,0.976824742475403,0,2,phosphatidylserine-translocating ATPase activity,MF,
17484,GO:0090558,1,0.996531076871997,0,1,plant epidermis development,BP,
17486,GO:0090560,1,0.994802426069782,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
17487,GO:0090568,1,0.798596571304284,0,29,nuclear transcriptional repressor complex,CC,
17488,GO:0090571,1,0.97740005656962,0,4,RNA polymerase II transcription repressor complex,CC,
17489,GO:0090575,1,0.378556533835117,0,147,RNA polymerase II transcription factor complex,CC,
17490,GO:0090576,1,0.941062810033926,0,8,RNA polymerase III transcription factor complex,CC,
17491,GO:0090579,1,0.972072151947683,0,4,dsDNA loop formation,BP,
17492,GO:0090594,1,0.96036205748159,0,7,inflammatory response to wounding,BP,
17493,GO:0090596,1,0.197582502438102,0,229,sensory organ morphogenesis,BP,
17494,GO:0090598,1,0.981898122585459,0,3,male anatomical structure morphogenesis,BP,
17495,GO:0090599,1,0.958985403190518,0,5,alpha-glucosidase activity,MF,
17496,GO:0090600,1,0.992905575990772,0,1,alpha-1,3-glucosidase activity,MF,
17497,GO:0090601,1,0.991678213729253,0,1,enucleation,BP,
17498,GO:0090611,1,0.970392298538556,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
17499,GO:0090615,1,0.987367763745615,0,2,mitochondrial mRNA processing,BP,
17500,GO:0090616,1,0.992228391216673,0,1,mitochondrial mRNA 3'-end processing,BP,
17501,GO:0090624,1,0.994054740756748,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
17502,GO:0090625,1,0.994054740756748,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
17503,GO:0090627,1,0.996531076871997,0,1,plant epidermal cell differentiation,BP,
17504,GO:0090630,1,0.560509163847711,0,79,activation of GTPase activity,BP,
17505,GO:0090634,1,0.995612572848999,0,1,microglial cell mediated cytotoxicity,BP,
17506,GO:0090646,1,0.935065164261416,0,12,mitochondrial tRNA processing,BP,
17507,GO:0090647,1,0.952253916854593,0,7,modulation of age-related behavioral decline,BP,
17508,GO:0090648,1,0.990597116145004,0,1,response to environmental enrichment,BP,
17509,GO:0090649,1,0.957299582767865,0,5,response to oxygen-glucose deprivation,BP,
17510,GO:0090650,1,0.957299582767865,0,5,cellular response to oxygen-glucose deprivation,BP,
17511,GO:0090651,1,0.9900970978305,0,1,apical cytoplasm,CC,
17512,GO:0090656,1,0.908471383177724,0,14,t-circle formation,BP,
17513,GO:0090657,1,0.93350226315801,0,10,telomeric loop disassembly,BP,
17514,GO:0090659,1,0.811664603524826,0,27,walking behavior,BP,
17515,GO:0090661,1,0.98380462201869,0,4,box H/ACA telomerase RNP complex,CC,
17516,GO:0090662,1,0.844170299822541,0,29,ATP hydrolysis coupled transmembrane transport,BP,
17517,GO:0090663,1,0.99197049794039,0,2,galanin-activated signaling pathway,BP,
17518,GO:0090665,1,0.863671431686147,0,20,glycoprotein complex,CC,
17519,GO:0090666,1,0.979435884557965,0,4,scaRNA localization to Cajal body,BP,
17520,GO:0090667,1,0.98903566580212,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
17521,GO:0090668,1,0.98903566580212,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
17522,GO:0090669,1,0.976717207734041,0,4,telomerase RNA stabilization,BP,
17523,GO:0090670,1,0.900663845901129,0,19,RNA localization to Cajal body,BP,
17524,GO:0090671,1,0.900663845901129,0,19,telomerase RNA localization to Cajal body,BP,
17525,GO:0090672,1,0.900663845901129,0,19,telomerase RNA localization,BP,
17526,GO:0090673,1,0.989531588035677,0,1,endothelial cell-matrix adhesion,BP,
17527,GO:0090675,1,0.992586451911122,0,1,intermicrovillar adhesion,BP,
17528,GO:0090677,1,0.989144104263098,0,2,reversible differentiation,BP,
17529,GO:0090678,1,0.989144104263098,0,2,cell dedifferentiation involved in phenotypic switching,BP,
17530,GO:0090685,1,0.900663845901129,0,19,RNA localization to nucleus,BP,
17531,GO:0090694,1,0.981088512286879,0,2,Scc2-Scc4 cohesin loading complex,CC,
17532,GO:0090713,1,0.960322870157032,0,6,immunological memory process,BP,
17533,GO:0090715,1,0.960322870157032,0,6,immunological memory formation process,BP,
17534,GO:0090722,1,0.973686395437144,0,4,receptor-receptor interaction,MF,
17535,GO:0090723,1,0.911221802800116,0,14,growth cone part,CC,
17536,GO:0090724,1,0.981044978111056,0,3,central region of growth cone,CC,
17537,GO:0090725,1,0.996398816784159,0,1,peripheral region of growth cone,CC,
17538,GO:0090731,1,0.996035242113144,0,1,cellular response to very-low-density lipoprotein particle stimulus,BP,
17539,GO:0090734,1,0.794503631893645,0,33,site of DNA damage,CC,
17540,GO:0090735,1,0.945426273720465,0,10,DNA repair complex assembly,BP,
17541,GO:0090737,1,0.908471383177724,0,14,telomere maintenance via telomere trimming,BP,
17542,GO:0090741,1,0.944949979295633,0,11,pigment granule membrane,CC,
17543,GO:0093001,1,0.99358336713993,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
17545,GO:0097001,1,0.944360673077154,0,10,ceramide binding,MF,
17546,GO:0097003,1,0.987716360197207,0,2,adipokinetic hormone receptor activity,MF,
17547,GO:0097006,1,0.622029934112941,0,74,regulation of plasma lipoprotein particle levels,BP,
17549,GO:0097010,1,0.97888293370685,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
17550,GO:0097011,1,0.952389340813304,0,8,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,
17551,GO:0097012,1,0.952389340813304,0,8,response to granulocyte macrophage colony-stimulating factor,BP,
17552,GO:0097013,1,0.987327507664584,0,3,phagocytic vesicle lumen,CC,
17554,GO:0097016,1,0.976524951262886,0,4,L27 domain binding,MF,
17555,GO:0097017,1,0.988502245557055,0,2,renal protein absorption,BP,
17556,GO:0097018,1,0.994369422890623,0,1,renal albumin absorption,BP,
17557,GO:0097020,1,0.993429029189707,0,1,COPII adaptor activity,MF,
17558,GO:0097021,1,0.98208549394105,0,3,lymphocyte migration into lymphoid organs,BP,
17559,GO:0097022,1,0.994786708960719,0,1,lymphocyte migration into lymph node,BP,
17560,GO:0097025,1,0.968333130239605,0,5,MPP7-DLG1-LIN7 complex,CC,
17561,GO:0097026,1,0.976832776551214,0,4,dendritic cell dendrite assembly,BP,
17562,GO:0097027,1,0.962755117030245,0,7,ubiquitin-protein transferase activator activity,MF,
17563,GO:0097028,1,0.816950950388167,0,37,dendritic cell differentiation,BP,
17564,GO:0097029,1,0.981753166495157,0,4,mature conventional dendritic cell differentiation,BP,
17565,GO:0097035,1,0.74442860143904,0,37,regulation of membrane lipid distribution,BP,
17566,GO:0097036,1,0.995710471266797,0,1,regulation of plasma membrane sterol distribution,BP,
17567,GO:0097037,1,0.993359676130477,0,1,heme export,BP,
17568,GO:0097038,1,0.924716743525097,0,11,perinuclear endoplasmic reticulum,CC,
17569,GO:0097039,1,0.962812609050479,0,5,protein linear polyubiquitination,BP,
17570,GO:0097045,1,0.992046057687384,0,1,phosphatidylserine exposure on blood platelet,BP,
17571,GO:0097048,1,0.943961487177451,0,10,dendritic cell apoptotic process,BP,
17572,GO:0097049,1,0.956721733477732,0,7,motor neuron apoptotic process,BP,
17573,GO:0097050,1,0.918696165835899,0,12,type B pancreatic cell apoptotic process,BP,
17574,GO:0097051,1,0.974639599413487,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
17575,GO:0097052,1,0.984878477791498,0,3,L-kynurenine metabolic process,BP,
17576,GO:0097053,1,0.995649625843794,0,1,L-kynurenine catabolic process,BP,
17577,GO:0097055,1,0.988835940478427,0,2,agmatine biosynthetic process,BP,
17578,GO:0097056,1,0.976787927239643,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
17579,GO:0097057,1,0.990972143787236,0,2,TRAF2-GSTP1 complex,CC,
17580,GO:0097058,1,0.985713801666062,0,3,CRLF-CLCF1 complex,CC,
17581,GO:0097059,1,0.990297247807216,0,2,CNTFR-CLCF1 complex,CC,
17585,GO:0097064,1,0.775513329093726,0,36,ncRNA export from nucleus,BP,
17586,GO:0097065,1,0.960057293995405,0,6,anterior head development,BP,
17587,GO:0097066,1,0.854483578994428,0,24,response to thyroid hormone,BP,
17588,GO:0097067,1,0.895286910660468,0,16,cellular response to thyroid hormone stimulus,BP,
17589,GO:0097068,1,0.966784740993605,0,5,response to thyroxine,BP,
17590,GO:0097069,1,0.986845598664973,0,2,cellular response to thyroxine stimulus,BP,
17591,GO:0097070,1,0.963975337351528,0,5,ductus arteriosus closure,BP,
17592,GO:0097084,1,0.950348891438509,0,8,vascular smooth muscle cell development,BP,
17593,GO:0097086,1,0.993140601683347,0,1,amniotic stem cell differentiation,BP,
17594,GO:0097089,1,0.99005371560194,0,2,methyl-branched fatty acid metabolic process,BP,
17595,GO:0097090,1,0.906698234196207,0,12,presynaptic membrane organization,BP,
17596,GO:0097091,1,0.929517010041579,0,9,synaptic vesicle clustering,BP,
17597,GO:0097094,1,0.896811685934886,0,15,craniofacial suture morphogenesis,BP,
17598,GO:0097100,1,0.97227480378553,0,5,supercoiled DNA binding,MF,
17599,GO:0097101,1,0.982529011201577,0,3,blood vessel endothelial cell fate specification,BP,
17600,GO:0097102,1,0.987913196719049,0,2,endothelial tip cell fate specification,BP,
17601,GO:0097104,1,0.907714074744488,0,11,postsynaptic membrane assembly,BP,
17602,GO:0097105,1,0.920221118998045,0,10,presynaptic membrane assembly,BP,
17603,GO:0097106,1,0.874177568149713,0,15,postsynaptic density organization,BP,
17604,GO:0097107,1,0.930962746399361,0,7,postsynaptic density assembly,BP,
17605,GO:0097108,1,0.975292277429967,0,3,hedgehog family protein binding,MF,
17606,GO:0097109,1,0.958834521954819,0,5,neuroligin family protein binding,MF,
17607,GO:0097110,1,0.647895379160035,0,59,scaffold protein binding,MF,
17608,GO:0097111,1,0.980476161982244,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
17609,GO:0097112,1,0.986359471352602,0,2,gamma-aminobutyric acid receptor clustering,BP,
17610,GO:0097113,1,0.946569215962177,0,7,AMPA glutamate receptor clustering,BP,
17611,GO:0097114,1,0.963811895912566,0,4,NMDA glutamate receptor clustering,BP,
17612,GO:0097115,1,0.991912733943847,0,1,neurexin clustering involved in presynaptic membrane assembly,BP,
17613,GO:0097116,1,0.970571444600774,0,3,gephyrin clustering involved in postsynaptic density assembly,BP,
17614,GO:0097117,1,0.989705354501657,0,1,guanylate kinase-associated protein clustering,BP,
17615,GO:0097118,1,0.961079538364777,0,4,neuroligin clustering involved in postsynaptic membrane assembly,BP,
17616,GO:0097119,1,0.923464230565344,0,9,postsynaptic density protein 95 clustering,BP,
17618,GO:0097123,1,0.989839705609578,0,2,cyclin A1-CDK2 complex,CC,
17619,GO:0097124,1,0.988752358114375,0,2,cyclin A2-CDK2 complex,CC,
17620,GO:0097125,1,0.990229885935788,0,2,cyclin B1-CDK1 complex,CC,
17621,GO:0097129,1,0.982048072656965,0,3,cyclin D2-CDK4 complex,CC,
17622,GO:0097134,1,0.989884546797427,0,2,cyclin E1-CDK2 complex,CC,
17623,GO:0097135,1,0.988831828347345,0,2,cyclin E2-CDK2 complex,CC,
17624,GO:0097136,1,0.964295556336043,0,6,Bcl-2 family protein complex,CC,
17625,GO:0097144,1,0.996491547285932,0,1,BAX complex,CC,
17626,GO:0097145,1,0.994756573677009,0,1,BAK complex,CC,
17627,GO:0097149,1,0.97980732127423,0,3,centralspindlin complex,CC,
17629,GO:0097151,1,0.941262036073436,0,7,positive regulation of inhibitory postsynaptic potential,BP,
17630,GO:0097152,1,0.928511675750283,0,12,mesenchymal cell apoptotic process,BP,
17631,GO:0097153,1,0.935429197916039,0,13,cysteine-type endopeptidase activity involved in apoptotic process,MF,
17632,GO:0097154,1,0.929389464276186,0,12,GABAergic neuron differentiation,BP,
17633,GO:0097155,1,0.969576651707391,0,3,fasciculation of sensory neuron axon,BP,
17634,GO:0097156,1,0.983124795521684,0,2,fasciculation of motor neuron axon,BP,
17635,GO:0097157,1,0.943691219066182,0,8,pre-mRNA intronic binding,MF,
17636,GO:0097158,1,0.995452659100077,0,1,pre-mRNA intronic pyrimidine-rich binding,MF,
17638,GO:0097161,1,0.990483439331061,0,1,DH domain binding,MF,
17639,GO:0097162,1,0.993518302110512,0,1,MADS box domain binding,MF,
17640,GO:0097164,1,0.343522894534725,0,180,ammonium ion metabolic process,BP,
17641,GO:0097165,1,0.967910064012742,0,5,nuclear stress granule,CC,
17642,GO:0097166,1,0.983340593512267,0,2,lens epithelial cell proliferation,BP,
17643,GO:0097167,1,0.973106929485392,0,4,circadian regulation of translation,BP,
17644,GO:0097168,1,0.987098575638041,0,2,mesenchymal stem cell proliferation,BP,
17645,GO:0097169,1,0.98018572186427,0,5,AIM2 inflammasome complex,CC,
17646,GO:0097176,1,0.980011800592637,0,4,epoxide metabolic process,BP,
17647,GO:0097177,1,0.985515108032059,0,3,mitochondrial ribosome binding,MF,
17648,GO:0097178,1,0.812823406404867,0,34,ruffle assembly,BP,
17649,GO:0097179,1,0.982927411949603,0,4,protease inhibitor complex,CC,
17650,GO:0097180,1,0.990078784661304,0,2,serine protease inhibitor complex,CC,
17651,GO:0097181,1,0.99460686867035,0,1,protein C inhibitor-coagulation factor V complex,CC,
17652,GO:0097182,1,0.99460686867035,0,1,protein C inhibitor-coagulation factor Xa complex,CC,
17653,GO:0097183,1,0.99460686867035,0,1,protein C inhibitor-coagulation factor XI complex,CC,
17654,GO:0097186,1,0.887558713920869,0,16,amelogenesis,BP,
17655,GO:0097187,1,0.982655433153333,0,3,dentinogenesis,BP,
17658,GO:0097192,1,0.658787879490108,0,67,extrinsic apoptotic signaling pathway in absence of ligand,BP,
17661,GO:0097195,1,0.982012595663465,0,3,pilomotor reflex,BP,
17662,GO:0097196,1,0.989159383966655,0,2,Shu complex,CC,
17663,GO:0097197,1,0.958396398673307,0,7,tetraspanin-enriched microdomain,CC,
17664,GO:0097198,1,0.982365146394013,0,2,histone H3-K36 trimethylation,BP,
17665,GO:0097199,1,0.968571373275503,0,6,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
17666,GO:0097200,1,0.941917709017995,0,11,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,
17667,GO:0097201,1,0.929987792103273,0,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,
17668,GO:0097202,1,0.917225586900817,0,13,activation of cysteine-type endopeptidase activity,BP,
17669,GO:0097205,1,0.897624109415447,0,16,renal filtration,BP,
17670,GO:0097208,1,0.964630110112996,0,6,alveolar lamellar body,CC,
17671,GO:0097209,1,0.972542481853845,0,4,epidermal lamellar body,CC,
17672,GO:0097210,1,0.968833072776848,0,5,response to gonadotropin-releasing hormone,BP,
17673,GO:0097211,1,0.968833072776848,0,5,cellular response to gonadotropin-releasing hormone,BP,
17674,GO:0097212,1,0.98656233299268,0,3,lysosomal membrane organization,BP,
17675,GO:0097213,1,0.991492385889784,0,2,regulation of lysosomal membrane permeability,BP,
17676,GO:0097214,1,0.996776488465986,0,1,positive regulation of lysosomal membrane permeability,BP,
17677,GO:0097222,1,0.992228391216673,0,1,mitochondrial mRNA polyadenylation,BP,
17679,GO:0097224,1,0.990499920112151,0,2,sperm connecting piece,CC,
17680,GO:0097225,1,0.91856240897183,0,16,sperm midpiece,CC,
17681,GO:0097226,1,0.994641638290359,0,1,sperm mitochondrial sheath,CC,
17682,GO:0097227,1,0.967841477565541,0,5,sperm annulus,CC,
17683,GO:0097228,1,0.891268588534305,0,18,sperm principal piece,CC,
17684,GO:0097229,1,0.995845653415935,0,1,sperm end piece,CC,
17685,GO:0097231,1,0.995360433351761,0,1,cell motility in response to calcium ion,BP,
17686,GO:0097232,1,0.983716362746261,0,2,lamellar body membrane,CC,
17687,GO:0097233,1,0.983716362746261,0,2,alveolar lamellar body membrane,CC,
17689,GO:0097238,1,0.992109114822259,0,2,cellular response to methylglyoxal,BP,
17690,GO:0097240,1,0.968506808955337,0,5,chromosome attachment to the nuclear envelope,BP,
17691,GO:0097241,1,0.989035364453918,0,2,hematopoietic stem cell migration to bone marrow,BP,
17692,GO:0097242,1,0.850193002478522,0,19,amyloid-beta clearance,BP,
17693,GO:0097252,1,0.981915898565582,0,3,oligodendrocyte apoptotic process,BP,
17694,GO:0097254,1,0.994855334100235,0,1,renal tubular secretion,BP,
17695,GO:0097255,1,0.971144861198598,0,6,R2TP complex,CC,
17696,GO:0097258,1,0.993811606553441,0,1,20-hydroxy-leukotriene B4 omega oxidase activity,MF,
17697,GO:0097259,1,0.993811606553441,0,1,20-aldehyde-leukotriene B4 20-monooxygenase activity,MF,
17698,GO:0097260,1,0.994157195232083,0,1,eoxin A4 synthase activity,MF,
17700,GO:0097267,1,0.973367724676696,0,4,omega-hydroxylase P450 pathway,BP,
17701,GO:0097272,1,0.986546251150848,0,2,ammonia homeostasis,BP,
17702,GO:0097273,1,0.991063368403532,0,1,creatinine homeostasis,BP,
17703,GO:0097274,1,0.984453507874119,0,2,urea homeostasis,BP,
17704,GO:0097275,1,0.991063368403532,0,1,cellular ammonia homeostasis,BP,
17705,GO:0097276,1,0.991063368403532,0,1,cellular creatinine homeostasis,BP,
17706,GO:0097277,1,0.991063368403532,0,1,cellular urea homeostasis,BP,
17707,GO:0097278,1,0.984334813951387,0,3,complement-dependent cytotoxicity,BP,
17708,GO:0097283,1,0.972676760886773,0,5,keratinocyte apoptotic process,BP,
17709,GO:0097284,1,0.925629683066555,0,12,hepatocyte apoptotic process,BP,
17710,GO:0097286,1,0.919320506277837,0,13,iron ion import,BP,
17711,GO:0097291,1,0.994995102249062,0,1,renal phosphate ion absorption,BP,
17712,GO:0097296,1,0.926832702426328,0,13,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
17713,GO:0097298,1,0.992883547014093,0,1,regulation of nucleus size,BP,
17714,GO:0097300,1,0.785592336708634,0,41,programmed necrotic cell death,BP,
17716,GO:0097306,1,0.672086396317313,0,53,cellular response to alcohol,BP,
17717,GO:0097309,1,0.988144472527205,0,2,cap1 mRNA methylation,BP,
17718,GO:0097310,1,0.994054740756748,0,1,cap2 mRNA methylation,BP,
17720,GO:0097322,1,0.953937115435479,0,7,7SK snRNA binding,MF,
17721,GO:0097323,1,0.989335118203454,0,2,B cell adhesion,BP,
17722,GO:0097324,1,0.979582069458771,0,2,melanocyte migration,BP,
17723,GO:0097325,1,0.985077427351796,0,2,melanocyte proliferation,BP,
17724,GO:0097326,1,0.991649235187485,0,1,melanocyte adhesion,BP,
17725,GO:0097327,1,0.574560218590617,0,84,response to antineoplastic agent,BP,
17726,GO:0097329,1,0.91565080504863,0,12,response to antimetabolite,BP,
17727,GO:0097332,1,0.981885807805993,0,3,response to antipsychotic drug,BP,
17728,GO:0097338,1,0.985530596321732,0,2,response to clozapine,BP,
17731,GO:0097342,1,0.963022669736722,0,6,ripoptosome,CC,
17732,GO:0097343,1,0.974569973338794,0,3,ripoptosome assembly,BP,
17733,GO:0097344,1,0.989319007419211,0,2,Rix1 complex,CC,
17734,GO:0097345,1,0.740065411575167,0,53,mitochondrial outer membrane permeabilization,BP,
17735,GO:0097346,1,0.867227762707621,0,23,INO80-type complex,CC,
17736,GO:0097350,1,0.969134804623027,0,5,neutrophil clearance,BP,
17738,GO:0097354,1,0.939668225070308,0,9,prenylation,BP,
17739,GO:0097359,1,0.978299582133783,0,2,UDP-glucosylation,BP,
17740,GO:0097360,1,0.968075988850938,0,4,chorionic trophoblast cell proliferation,BP,
17741,GO:0097361,1,0.977487704231677,0,4,CIA complex,CC,
17742,GO:0097362,1,0.987551587807278,0,2,MCM8-MCM9 complex,CC,
17743,GO:0097363,1,0.985455074871663,0,2,protein O-GlcNAc transferase activity,MF,
17746,GO:0097368,1,0.971985954710066,0,4,establishment of Sertoli cell barrier,BP,
17747,GO:0097371,1,0.949310891255448,0,7,MDM2/MDM4 family protein binding,MF,
17748,GO:0097372,1,0.995357903332359,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
17749,GO:0097374,1,0.99439600355199,0,1,sensory neuron axon guidance,BP,
17750,GO:0097376,1,0.990382451218108,0,2,interneuron axon guidance,BP,
17751,GO:0097377,1,0.994626723865598,0,1,spinal cord interneuron axon guidance,BP,
17752,GO:0097378,1,0.994626723865598,0,1,dorsal spinal cord interneuron axon guidance,BP,
17753,GO:0097380,1,0.994626723865598,0,1,dorsal spinal cord interneuron anterior axon guidance,BP,
17754,GO:0097381,1,0.906119746019752,0,15,photoreceptor disc membrane,CC,
17755,GO:0097382,1,0.990809253553117,0,1,deoxynucleoside-diphosphatase activity,MF,
17756,GO:0097383,1,0.990809253553117,0,1,dIDP diphosphatase activity,MF,
17757,GO:0097384,1,0.956840347728762,0,7,cellular lipid biosynthetic process,BP,
17759,GO:0097393,1,0.986090908152591,0,1,telomeric repeat-containing RNA transcription,BP,
17760,GO:0097394,1,0.986090908152591,0,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,
17761,GO:0097396,1,0.970330346932629,0,5,response to interleukin-17,BP,
17762,GO:0097398,1,0.970330346932629,0,5,cellular response to interleukin-17,BP,
17763,GO:0097400,1,0.970330346932629,0,5,interleukin-17-mediated signaling pathway,BP,
17765,GO:0097402,1,0.986222671099524,0,2,neuroblast migration,BP,
17766,GO:0097403,1,0.993785917552307,0,1,cellular response to raffinose,BP,
17767,GO:0097409,1,0.995052814997107,0,1,glial cytoplasmic inclusion,CC,
17768,GO:0097411,1,0.963698427695126,0,5,hypoxia-inducible factor-1alpha signaling pathway,BP,
17769,GO:0097413,1,0.961700436122368,0,7,Lewy body,CC,
17770,GO:0097414,1,0.995052814997107,0,1,classical Lewy body,CC,
17773,GO:0097422,1,0.969084161367102,0,5,tubular endosome,CC,
17774,GO:0097425,1,0.971268411026153,0,5,smooth endoplasmic reticulum part,CC,
17775,GO:0097427,1,0.957781402768328,0,6,microtubule bundle,CC,
17776,GO:0097428,1,0.957381153686152,0,10,protein maturation by iron-sulfur cluster transfer,BP,
17778,GO:0097433,1,0.970981713891018,0,5,dense body,CC,
17783,GO:0097443,1,0.955834681726751,0,6,sorting endosome,CC,
17784,GO:0097444,1,0.991696697242895,0,1,spine apparatus,CC,
17787,GO:0097450,1,0.976959135129962,0,4,astrocyte end-foot,CC,
17788,GO:0097451,1,0.985604452581002,0,2,glial limiting end-foot,CC,
17789,GO:0097452,1,0.974067359570437,0,4,GAIT complex,CC,
17790,GO:0097453,1,0.994488549045981,0,1,mesaxon,CC,
17791,GO:0097454,1,0.976622857040938,0,3,Schwann cell microvillus,CC,
17792,GO:0097457,1,0.970738055260235,0,3,hippocampal mossy fiber,CC,
17794,GO:0097462,1,0.995052814997107,0,1,Lewy neurite,CC,
17795,GO:0097466,1,0.970405141075512,0,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,
17796,GO:0097468,1,0.929848394789735,0,12,programmed cell death in response to reactive oxygen species,BP,
17797,GO:0097470,1,0.958826187001268,0,5,ribbon synapse,CC,
17798,GO:0097472,1,0.802048488651692,0,35,cyclin-dependent protein kinase activity,MF,
17799,GO:0097473,1,0.991562278385074,0,1,retinal rod cell apoptotic process,BP,
17800,GO:0097475,1,0.957942400609992,0,5,motor neuron migration,BP,
17801,GO:0097476,1,0.980038790213187,0,2,spinal cord motor neuron migration,BP,
17802,GO:0097477,1,0.980038790213187,0,2,lateral motor column neuron migration,BP,
17806,GO:0097485,1,0.155247682263357,0,238,neuron projection guidance,BP,
17807,GO:0097486,1,0.979444478914025,0,5,multivesicular body lumen,CC,
17808,GO:0097487,1,0.973236061868895,0,4,multivesicular body, internal vesicle,CC,
17809,GO:0097489,1,0.994303417674368,0,1,multivesicular body, internal vesicle lumen,CC,
17810,GO:0097490,1,0.970610425945532,0,4,sympathetic neuron projection extension,BP,
17811,GO:0097491,1,0.970610425945532,0,4,sympathetic neuron projection guidance,BP,
17812,GO:0097493,1,0.840905188979803,0,17,structural molecule activity conferring elasticity,MF,
17813,GO:0097494,1,0.972239085421323,0,4,regulation of vesicle size,BP,
17814,GO:0097497,1,0.993640449307716,0,1,blood vessel endothelial cell delamination,BP,
17815,GO:0097498,1,0.986110852491414,0,2,endothelial tube lumen extension,BP,
17816,GO:0097499,1,0.94429052273355,0,9,protein localization to non-motile cilium,BP,
17817,GO:0097500,1,0.974028218654523,0,4,receptor localization to non-motile cilium,BP,
17818,GO:0097501,1,0.946465710100565,0,13,stress response to metal ion,BP,
17819,GO:0097502,1,0.835255293958113,0,29,mannosylation,BP,
17821,GO:0097504,1,0.930135099701005,0,12,Gemini of coiled bodies,CC,
17822,GO:0097505,1,0.991089220669085,0,1,Rad6-Rad18 complex,CC,
17823,GO:0097506,1,0.975632465650335,0,5,deaminated base DNA N-glycosylase activity,MF,
17824,GO:0097510,1,0.994934937371526,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
17826,GO:0097513,1,0.968916363271289,0,3,myosin II filament,CC,
17827,GO:0097517,1,0.674570442916729,0,52,contractile actin filament bundle,CC,
17828,GO:0097524,1,0.976000102594502,0,3,sperm plasma membrane,CC,
17829,GO:0097525,1,0.697741019286755,0,61,spliceosomal snRNP complex,CC,
17830,GO:0097526,1,0.858028155953742,0,28,spliceosomal tri-snRNP complex,CC,
17831,GO:0097527,1,0.96723374635249,0,6,necroptotic signaling pathway,BP,
17833,GO:0097530,1,0.594262977894441,0,94,granulocyte migration,BP,
17835,GO:0097532,1,0.988757223982355,0,2,stress response to acid chemical,BP,
17836,GO:0097533,1,0.988757223982355,0,2,cellular stress response to acid chemical,BP,
17837,GO:0097534,1,0.989190430027763,0,1,lymphoid lineage cell migration,BP,
17838,GO:0097535,1,0.989190430027763,0,1,lymphoid lineage cell migration into thymus,BP,
17839,GO:0097536,1,0.994855334100235,0,1,thymus epithelium morphogenesis,BP,
17841,GO:0097541,1,0.994054740756748,0,1,axonemal basal plate,CC,
17842,GO:0097542,1,0.741835311319523,0,43,ciliary tip,CC,
17843,GO:0097543,1,0.985444988278386,0,2,ciliary inversin compartment,CC,
17844,GO:0097546,1,0.834501048218398,0,27,ciliary base,CC,
17845,GO:0097550,1,0.966729877436663,0,6,transcriptional preinitiation complex,CC,
17847,GO:0097573,1,0.995808144242034,0,1,glutathione oxidoreductase activity,MF,
17848,GO:0097574,1,0.983491395464076,0,2,lateral part of cell,CC,
17849,GO:0097575,1,0.983491395464076,0,2,lateral cell cortex,CC,
17850,GO:0097576,1,0.986345147861062,0,2,vacuole fusion,BP,
17851,GO:0097577,1,0.987441044120523,0,3,sequestering of iron ion,BP,
17852,GO:0097581,1,0.602640073423373,0,71,lamellipodium organization,BP,
17853,GO:0097598,1,0.985536513474326,0,2,sperm cytoplasmic droplet,CC,
17854,GO:0097602,1,0.898898804906547,0,17,cullin family protein binding,MF,
17855,GO:0097603,1,0.987957525838854,0,2,temperature-gated ion channel activity,MF,
17856,GO:0097604,1,0.995240067575435,0,1,temperature-gated cation channel activity,MF,
17857,GO:0097617,1,0.915999047338727,0,13,annealing activity,MF,
17858,GO:0097621,1,0.994624240025219,0,1,monoamine oxidase activity,MF,
17859,GO:0097623,1,0.958650023679583,0,7,potassium ion export across plasma membrane,BP,
17860,GO:0097625,1,0.989317967241379,0,1,low-affinity basic amino acid transmembrane transporter activity,MF,
17861,GO:0097626,1,0.989317967241379,0,1,low-affinity L-arginine transmembrane transporter activity,MF,
17862,GO:0097627,1,0.989317967241379,0,1,high-affinity L-ornithine transmembrane transporter activity,MF,
17863,GO:0097629,1,0.968605674744095,0,5,extrinsic component of omegasome membrane,CC,
17864,GO:0097630,1,0.994054740756748,0,1,intrinsic component of omegasome membrane,CC,
17865,GO:0097631,1,0.994054740756748,0,1,integral component of omegasome membrane,CC,
17866,GO:0097632,1,0.985693510727544,0,2,extrinsic component of phagophore assembly site membrane,CC,
17867,GO:0097635,1,0.983828424926967,0,2,extrinsic component of autophagosome membrane,CC,
17868,GO:0097636,1,0.986665163187071,0,2,intrinsic component of autophagosome membrane,CC,
17869,GO:0097637,1,0.986665163187071,0,2,integral component of autophagosome membrane,CC,
17870,GO:0097638,1,0.968194191126997,0,4,L-arginine import across plasma membrane,BP,
17871,GO:0097639,1,0.983661575055724,0,2,L-lysine import across plasma membrane,BP,
17872,GO:0097640,1,0.989317967241379,0,1,L-ornithine import across plasma membrane,BP,
17873,GO:0097642,1,0.968296548647673,0,6,calcitonin family receptor activity,MF,
17874,GO:0097643,1,0.98203047333883,0,4,amylin receptor activity,MF,
17875,GO:0097644,1,0.978083707120946,0,4,calcitonin family binding,MF,
17876,GO:0097646,1,0.969813475206303,0,6,calcitonin family receptor signaling pathway,BP,
17877,GO:0097647,1,0.977804938075599,0,5,amylin receptor signaling pathway,BP,
17878,GO:0097648,1,0.948363791933373,0,8,G-protein coupled receptor complex,CC,
17879,GO:0097651,1,0.968293444819802,0,4,phosphatidylinositol 3-kinase complex, class I,CC,
17880,GO:0097655,1,0.994054740756748,0,1,serpin family protein binding,MF,
17882,GO:0097676,1,0.969146458716752,0,3,histone H3-K36 dimethylation,BP,
17883,GO:0097677,1,0.963506301398354,0,5,STAT family protein binding,MF,
17884,GO:0097679,1,0.991327358653524,0,2,other organism cytoplasm,CC,
17885,GO:0097680,1,0.979382086713483,0,3,double-strand break repair via classical nonhomologous end joining,BP,
17886,GO:0097681,1,0.972473786442341,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
17887,GO:0097682,1,0.994866058642159,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
17888,GO:0097688,1,0.946569215962177,0,7,glutamate receptor clustering,BP,
17889,GO:0097689,1,0.993438995494363,0,1,iron channel activity,MF,
17890,GO:0097692,1,0.990588283556084,0,1,histone H3-K4 monomethylation,BP,
17891,GO:0097694,1,0.968957117144736,0,3,establishment of RNA localization to telomere,BP,
17892,GO:0097695,1,0.968957117144736,0,3,establishment of protein-containing complex localization to telomere,BP,
17893,GO:0097696,1,0.442956275217373,0,127,STAT cascade,BP,
17894,GO:0097698,1,0.995643975865978,0,1,telomere maintenance via base-excision repair,BP,
17895,GO:0097699,1,0.992366383299041,0,1,vascular endothelial cell response to fluid shear stress,BP,
17896,GO:0097707,1,0.996330735281209,0,1,ferroptosis,BP,
17898,GO:0097709,1,0.963022846038844,0,6,connective tissue replacement,BP,
17899,GO:0097711,1,0.508690598267473,0,96,ciliary basal body-plasma membrane docking,BP,
17900,GO:0097712,1,0.994054740756748,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
17901,GO:0097718,1,0.797758571767202,0,30,disordered domain specific binding,MF,
17902,GO:0097720,1,0.82770436823581,0,26,calcineurin-mediated signaling,BP,
17904,GO:0097724,1,0.995216591458026,0,1,sperm flagellum movement,BP,
17905,GO:0097726,1,0.996106774992739,0,1,LEM domain binding,MF,
17906,GO:0097729,1,0.682463034057156,0,64,9+2 motile cilium,CC,
17907,GO:0097730,1,0.460481433913146,0,111,non-motile cilium,CC,
17908,GO:0097731,1,0.540593184278574,0,87,9+0 non-motile cilium,CC,
17909,GO:0097732,1,0.95791386077418,0,7,9+2 non-motile cilium,CC,
17910,GO:0097733,1,0.540593184278574,0,87,photoreceptor cell cilium,CC,
17911,GO:0097734,1,0.900017211117182,0,18,extracellular exosome biogenesis,BP,
17912,GO:0097742,1,0.971992011175677,0,4,de novo centriole assembly,BP,
17913,GO:0097745,1,0.984694053196708,0,3,mitochondrial tRNA 5'-end processing,BP,
17915,GO:0097747,1,0.785204174438119,0,43,RNA polymerase activity,MF,
17916,GO:0097749,1,0.984624808743938,0,2,membrane tubulation,BP,
17917,GO:0097752,1,0.982247669134615,0,3,regulation of DNA stability,BP,
17918,GO:0097753,1,0.987154146628555,0,2,membrane bending,BP,
17919,GO:0097755,1,0.726768060971284,0,51,positive regulation of blood vessel diameter,BP,
17921,GO:0098501,1,0.97496965213111,0,5,polynucleotide dephosphorylation,BP,
17922,GO:0098502,1,0.98696991424923,0,3,DNA dephosphorylation,BP,
17923,GO:0098503,1,0.995346516039137,0,1,DNA 3' dephosphorylation,BP,
17924,GO:0098504,1,0.995346516039137,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
17925,GO:0098505,1,0.941200640502428,0,10,G-rich strand telomeric DNA binding,MF,
17926,GO:0098506,1,0.995346516039137,0,1,polynucleotide 3' dephosphorylation,BP,
17927,GO:0098507,1,0.987842912652185,0,2,polynucleotide 5' dephosphorylation,BP,
17928,GO:0098508,1,0.989077397806934,0,2,endothelial to hematopoietic transition,BP,
17929,GO:0098518,1,0.983245434072253,0,3,polynucleotide phosphatase activity,MF,
17930,GO:0098519,1,0.969353677519921,0,5,nucleotide phosphatase activity, acting on free nucleotides,MF,
17931,GO:0098528,1,0.966935992373195,0,5,skeletal muscle fiber differentiation,BP,
17932,GO:0098530,1,0.991059392505537,0,1,positive regulation of strand invasion,BP,
17933,GO:0098531,1,0.721463993801797,0,46,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,
17934,GO:0098532,1,0.954717203291545,0,7,histone H3-K27 trimethylation,BP,
17935,GO:0098533,1,0.866934515191009,0,22,ATPase dependent transmembrane transport complex,CC,
17936,GO:0098534,1,0.802406129018407,0,32,centriole assembly,BP,
17937,GO:0098535,1,0.971992011175677,0,4,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
17938,GO:0098536,1,0.973352777224617,0,4,deuterosome,CC,
17940,GO:0098543,1,0.92099506605574,0,11,detection of other organism,BP,
17941,GO:0098547,1,0.994685245635728,0,1,lumenal side of Golgi membrane,CC,
17943,GO:0098553,1,0.883537870032755,0,25,lumenal side of endoplasmic reticulum membrane,CC,
17944,GO:0098554,1,0.933008224735297,0,13,cytoplasmic side of endoplasmic reticulum membrane,CC,
17945,GO:0098556,1,0.982922996261401,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
17946,GO:0098559,1,0.982987623306782,0,3,cytoplasmic side of early endosome membrane,CC,
17947,GO:0098560,1,0.988408921126589,0,2,cytoplasmic side of late endosome membrane,CC,
17950,GO:0098573,1,0.689004672099544,0,66,intrinsic component of mitochondrial membrane,CC,
17952,GO:0098575,1,0.989671352806476,0,2,lumenal side of lysosomal membrane,CC,
17953,GO:0098576,1,0.977913010062457,0,4,lumenal side of membrane,CC,
17954,GO:0098577,1,0.990028927438995,0,1,inactive sex chromosome,CC,
17955,GO:0098581,1,0.896995229633791,0,16,detection of external biotic stimulus,BP,
17956,GO:0098582,1,0.984106582412345,0,2,innate vocalization behavior,BP,
17957,GO:0098583,1,0.995923075706157,0,1,learned vocalization behavior,BP,
17958,GO:0098586,1,0.764909891033871,0,40,cellular response to virus,BP,
17962,GO:0098592,1,0.98058355235378,0,3,cytoplasmic side of apical plasma membrane,CC,
17963,GO:0098594,1,0.996579226703613,0,1,mucin granule,CC,
17964,GO:0098595,1,0.994688990500014,0,1,perivitelline space,CC,
17965,GO:0098596,1,0.928465716134788,0,7,imitative learning,BP,
17966,GO:0098597,1,0.914558984555815,0,8,observational learning,BP,
17967,GO:0098598,1,0.924677596966493,0,8,learned vocalization behavior or vocal learning,BP,
17968,GO:0098599,1,0.945123030648136,0,10,palmitoyl hydrolase activity,MF,
17969,GO:0098601,1,0.993388323907162,0,1,selenomethionine adenosyltransferase activity,MF,
17971,GO:0098619,1,0.995125812252772,0,1,selenocysteine-tRNA ligase activity,MF,
17972,GO:0098621,1,0.991183800886234,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
17973,GO:0098625,1,0.993005165276533,0,1,methylselenol reductase activity,MF,
17974,GO:0098626,1,0.993005165276533,0,1,methylseleninic acid reductase activity,MF,
17975,GO:0098629,1,0.994054740756748,0,1,trans-Golgi network membrane organization,BP,
17976,GO:0098631,1,0.765097447067252,0,40,cell adhesion mediator activity,MF,
17977,GO:0098632,1,0.815412206807094,0,31,cell-cell adhesion mediator activity,MF,
17978,GO:0098633,1,0.994338138916662,0,1,collagen fibril binding,MF,
17979,GO:0098634,1,0.94734891661379,0,7,cell-matrix adhesion mediator activity,MF,
17980,GO:0098636,1,0.767444279095178,0,35,protein complex involved in cell adhesion,CC,
17981,GO:0098637,1,0.992879715008209,0,1,protein complex involved in cell-matrix adhesion,CC,
17982,GO:0098639,1,0.958218350890278,0,5,collagen binding involved in cell-matrix adhesion,MF,
17983,GO:0098640,1,0.988661480281564,0,2,integrin binding involved in cell-matrix adhesion,MF,
17984,GO:0098641,1,0.902369960950089,0,19,cadherin binding involved in cell-cell adhesion,MF,
17985,GO:0098642,1,0.93337192524731,0,7,network-forming collagen trimer,CC,
17986,GO:0098643,1,0.89917113851273,0,12,banded collagen fibril,CC,
17987,GO:0098644,1,0.828888635544762,0,20,complex of collagen trimers,CC,
17988,GO:0098645,1,0.93337192524731,0,7,collagen network,CC,
17989,GO:0098646,1,0.994226885076045,0,1,collagen sheet,CC,
17990,GO:0098647,1,0.976555328178329,0,3,collagen beaded filament,CC,
17991,GO:0098648,1,0.987735541272552,0,1,collagen anchoring fibril,CC,
17992,GO:0098651,1,0.925454526641771,0,8,basement membrane collagen trimer,CC,
17993,GO:0098652,1,0.987735541272552,0,1,collagen type VII anchoring fibril,CC,
17997,GO:0098659,1,0.714676808187843,0,48,inorganic cation import across plasma membrane,BP,
18001,GO:0098664,1,0.932089838489807,0,13,G-protein coupled serotonin receptor signaling pathway,BP,
18002,GO:0098679,1,0.976181632178192,0,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,
18003,GO:0098680,1,0.992809706686633,0,1,template-free RNA nucleotidyltransferase,MF,
18006,GO:0098698,1,0.930962746399361,0,7,postsynaptic specialization assembly,BP,
18008,GO:0098703,1,0.91207878973888,0,13,calcium ion import across plasma membrane,BP,
18009,GO:0098704,1,0.994596954618774,0,1,carbohydrate import across plasma membrane,BP,
18010,GO:0098705,1,0.992054997857129,0,1,copper ion import across plasma membrane,BP,
18011,GO:0098706,1,0.969212383338098,0,4,ferric iron import across plasma membrane,BP,
18012,GO:0098711,1,0.95768473238102,0,6,iron ion import across plasma membrane,BP,
18013,GO:0098712,1,0.919736640852784,0,11,L-glutamate import across plasma membrane,BP,
18014,GO:0098713,1,0.994667784128221,0,1,leucine import across plasma membrane,BP,
18015,GO:0098719,1,0.899619698289229,0,14,sodium ion import across plasma membrane,BP,
18016,GO:0098722,1,0.941413379594487,0,9,asymmetric stem cell division,BP,
18017,GO:0098725,1,0.994054740756748,0,1,symmetric cell division,BP,
18019,GO:0098728,1,0.983504220404566,0,3,germline stem cell asymmetric division,BP,
18020,GO:0098732,1,0.476191348715193,0,106,macromolecule deacylation,BP,
18021,GO:0098734,1,0.945123030648136,0,10,macromolecule depalmitoylation,BP,
18022,GO:0098735,1,0.955381320402555,0,4,positive regulation of the force of heart contraction,BP,
18023,GO:0098736,1,0.988143720671723,0,1,negative regulation of the force of heart contraction,BP,
18024,GO:0098739,1,0.607312180406683,0,69,import across plasma membrane,BP,
18026,GO:0098743,1,0.887213876955801,0,18,cell aggregation,BP,
18027,GO:0098745,1,0.995327529153892,0,1,Dcp1-Dcp2 complex,CC,
18029,GO:0098748,1,0.926450199386856,0,11,endocytic adaptor activity,MF,
18030,GO:0098749,1,0.992207632794609,0,1,cerebellar neuron development,BP,
18032,GO:0098754,1,0.594854084280863,0,100,detoxification,BP,
18033,GO:0098756,1,0.952383131571252,0,7,response to interleukin-21,BP,
18034,GO:0098757,1,0.952383131571252,0,7,cellular response to interleukin-21,BP,
18035,GO:0098758,1,0.98223953986463,0,3,response to interleukin-8,BP,
18036,GO:0098759,1,0.98223953986463,0,3,cellular response to interleukin-8,BP,
18037,GO:0098760,1,0.877816576335191,0,19,response to interleukin-7,BP,
18038,GO:0098761,1,0.877816576335191,0,19,cellular response to interleukin-7,BP,
18039,GO:0098770,1,0.978819253190672,0,2,FBXO family protein binding,MF,
18042,GO:0098773,1,0.56488294156578,0,82,skin epidermis development,BP,
18043,GO:0098779,1,0.942068257020956,0,8,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
18044,GO:0098780,1,0.888593790762595,0,17,response to mitochondrial depolarisation,BP,
18045,GO:0098781,1,0.560704765901805,0,94,ncRNA transcription,BP,
18046,GO:0098782,1,0.995240067575435,0,1,mechanosensitived potassium channel activity,MF,
18047,GO:0098787,1,0.910709325970243,0,14,mRNA cleavage involved in mRNA processing,BP,
18048,GO:0098789,1,0.928255628231431,0,11,pre-mRNA cleavage required for polyadenylation,BP,
18050,GO:0098792,1,0.937498167452664,0,10,xenophagy,BP,
18053,GO:0098795,1,0.98730055896615,0,2,mRNA cleavage involved in gene silencing,BP,
18056,GO:0098798,1,0.366336452154697,0,217,mitochondrial protein complex,CC,
18057,GO:0098799,1,0.94045718818974,0,12,outer mitochondrial membrane protein complex,CC,
18058,GO:0098800,1,0.64112842822188,0,100,inner mitochondrial membrane protein complex,CC,
18059,GO:0098801,1,0.848501160065146,0,27,regulation of renal system process,BP,
18061,GO:0098803,1,0.75619306154362,0,69,respiratory chain complex,CC,
18063,GO:0098808,1,0.989137303011466,0,2,mRNA cap binding,MF,
18064,GO:0098809,1,0.994255839328277,0,1,nitrite reductase activity,MF,
18065,GO:0098810,1,0.903014884809894,0,16,neurotransmitter reuptake,BP,
18067,GO:0098814,1,0.960463825425692,0,5,spontaneous synaptic transmission,BP,
18069,GO:0098816,1,0.99495329221185,0,1,mini excitatory postsynaptic potential,BP,
18070,GO:0098821,1,0.958540144033052,0,5,BMP receptor activity,MF,
18071,GO:0098822,1,0.994433621392918,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
18072,GO:0098826,1,0.97742361651869,0,4,endoplasmic reticulum tubular network membrane,CC,
18074,GO:0098828,1,0.941262036073436,0,7,modulation of inhibitory postsynaptic potential,BP,
18075,GO:0098829,1,0.990357443633155,0,1,intestinal folate absorption,BP,
18076,GO:0098830,1,0.992005305754115,0,1,presynaptic endosome,CC,
18078,GO:0098833,1,0.991881840309996,0,1,presynaptic endocytic zone,CC,
18079,GO:0098835,1,0.991881840309996,0,1,presynaptic endocytic zone membrane,CC,
18080,GO:0098837,1,0.983440580510916,0,3,postsynaptic recycling endosome,CC,
18081,GO:0098838,1,0.99398250618881,0,1,reduced folate transmembrane transport,BP,
18083,GO:0098840,1,0.968817923506222,0,4,protein transport along microtubule,BP,
18084,GO:0098842,1,0.989227596928735,0,2,postsynaptic early endosome,CC,
18087,GO:0098845,1,0.965670265144647,0,6,postsynaptic endosome,CC,
18088,GO:0098847,1,0.923514825630013,0,13,sequence-specific single stranded DNA binding,MF,
18089,GO:0098850,1,0.995067410461975,0,1,extrinsic component of synaptic vesicle membrane,CC,
18091,GO:0098855,1,0.9747006623585,0,3,HCN channel complex,CC,
18092,GO:0098856,1,0.953457763609682,0,8,intestinal lipid absorption,BP,
18095,GO:0098862,1,0.419503756389044,0,120,cluster of actin-based cell projections,CC,
18096,GO:0098868,1,0.851784946695148,0,24,bone growth,BP,
18097,GO:0098869,1,0.644203655022492,0,82,cellular oxidant detoxification,BP,
18098,GO:0098870,1,0.957208399296885,0,6,action potential propagation,BP,
18099,GO:0098871,1,0.995388251877053,0,1,postsynaptic actin cytoskeleton,CC,
18100,GO:0098875,1,0.992090738054654,0,1,epididymosome,CC,
18105,GO:0098883,1,0.995250216689571,0,1,synapse disassembly,BP,
18107,GO:0098885,1,0.989648928315445,0,1,modification of postsynaptic actin cytoskeleton,BP,
18108,GO:0098886,1,0.985800308416008,0,2,modification of dendritic spine,BP,
18109,GO:0098887,1,0.974079742289103,0,4,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
18110,GO:0098888,1,0.989607861766737,0,1,extrinsic component of presynaptic membrane,CC,
18111,GO:0098889,1,0.974691939599726,0,4,intrinsic component of presynaptic membrane,CC,
18112,GO:0098890,1,0.989607861766737,0,1,extrinsic component of postsynaptic membrane,CC,
18113,GO:0098895,1,0.992627261718495,0,1,postsynaptic endosome membrane,CC,
18115,GO:0098901,1,0.795205486147187,0,25,regulation of cardiac muscle cell action potential,BP,
18117,GO:0098903,1,0.94192287753077,0,8,regulation of membrane repolarization during action potential,BP,
18118,GO:0098904,1,0.976397562651512,0,2,regulation of AV node cell action potential,BP,
18119,GO:0098905,1,0.996469302809806,0,1,regulation of bundle of His cell action potential,BP,
18120,GO:0098907,1,0.970885944286453,0,2,regulation of SA node cell action potential,BP,
18121,GO:0098908,1,0.975833805042691,0,4,regulation of neuronal action potential,BP,
18122,GO:0098909,1,0.942722852915908,0,7,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
18123,GO:0098910,1,0.945841038646941,0,5,regulation of atrial cardiac muscle cell action potential,BP,
18124,GO:0098911,1,0.880956398197861,0,14,regulation of ventricular cardiac muscle cell action potential,BP,
18125,GO:0098912,1,0.965551516458134,0,3,membrane depolarization during atrial cardiac muscle cell action potential,BP,
18126,GO:0098914,1,0.959572092843381,0,6,membrane repolarization during atrial cardiac muscle cell action potential,BP,
18127,GO:0098915,1,0.927133834837488,0,12,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
18130,GO:0098918,1,0.995242605021767,0,1,structural constituent of synapse,MF,
18131,GO:0098920,1,0.985232997567743,0,2,retrograde trans-synaptic signaling by lipid,BP,
18132,GO:0098921,1,0.985232997567743,0,2,retrograde trans-synaptic signaling by endocannabinoid,BP,
18133,GO:0098923,1,0.989717799694166,0,1,retrograde trans-synaptic signaling by soluble gas,BP,
18134,GO:0098924,1,0.989717799694166,0,1,retrograde trans-synaptic signaling by nitric oxide,BP,
18135,GO:0098926,1,0.989900198675586,0,1,postsynaptic signal transduction,BP,
18136,GO:0098927,1,0.751227695142388,0,40,vesicle-mediated transport between endosomal compartments,BP,
18137,GO:0098928,1,0.96290342819875,0,2,presynaptic signal transduction,BP,
18139,GO:0098935,1,0.957778178354324,0,5,dendritic transport,BP,
18140,GO:0098936,1,0.920089818324557,0,10,intrinsic component of postsynaptic membrane,CC,
18141,GO:0098937,1,0.957778178354324,0,5,anterograde dendritic transport,BP,
18142,GO:0098939,1,0.990309700742166,0,1,dendritic transport of mitochondrion,BP,
18143,GO:0098942,1,0.991912733943847,0,1,retrograde trans-synaptic signaling by trans-synaptic protein complex,BP,
18144,GO:0098943,1,0.963415639763997,0,7,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,
18145,GO:0098945,1,0.992448809519178,0,1,intrinsic component of presynaptic active zone membrane,CC,
18146,GO:0098948,1,0.958768244224229,0,4,intrinsic component of postsynaptic specialization membrane,CC,
18147,GO:0098953,1,0.957117529236536,0,8,receptor diffusion trapping,BP,
18148,GO:0098957,1,0.970883129915569,0,4,anterograde axonal transport of mitochondrion,BP,
18150,GO:0098961,1,0.989907899506145,0,1,dendritic transport of ribonucleoprotein complex,BP,
18151,GO:0098963,1,0.989907899506145,0,1,dendritic transport of messenger ribonucleoprotein complex,BP,
18152,GO:0098964,1,0.989907899506145,0,1,anterograde dendritic transport of messenger ribonucleoprotein complex,BP,
18154,GO:0098968,1,0.991621251797114,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
18156,GO:0098970,1,0.957117529236536,0,8,postsynaptic neurotransmitter receptor diffusion trapping,BP,
18157,GO:0098971,1,0.967153324780329,0,4,anterograde dendritic transport of neurotransmitter receptor complex,BP,
18158,GO:0098972,1,0.990309700742166,0,1,anterograde dendritic transport of mitochondrion,BP,
18159,GO:0098973,1,0.995242605021767,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
18160,GO:0098974,1,0.995242605021767,0,1,postsynaptic actin cytoskeleton organization,BP,
18162,GO:0098978,1,0.948978357068847,0,6,glutamatergic synapse,CC,
18163,GO:0098982,1,0.962158639448775,0,5,GABA-ergic synapse,CC,
18164,GO:0098983,1,0.968204919530883,0,4,symmetric, GABA-ergic, inhibitory synapse,CC,
18166,GO:0098985,1,0.948978357068847,0,6,asymmetric, glutamatergic, excitatory synapse,CC,
18167,GO:0098988,1,0.952005106903324,0,6,G-protein coupled glutamate receptor activity,MF,
18168,GO:0098989,1,0.985318273938724,0,2,NMDA selective glutamate receptor signaling pathway,BP,
18169,GO:0098992,1,0.994412969082495,0,1,neuronal dense core vesicle,CC,
18170,GO:0098993,1,0.954218991439821,0,9,anchored component of synaptic vesicle membrane,CC,
18171,GO:0098999,1,0.992627261718495,0,1,extrinsic component of postsynaptic endosome membrane,CC,
18173,GO:0099004,1,0.963622212986903,0,5,calmodulin dependent kinase signaling pathway,BP,
18174,GO:0099010,1,0.975594754425895,0,3,modification of postsynaptic structure,BP,
18175,GO:0099011,1,0.951686527366089,0,5,neuronal dense core vesicle exocytosis,BP,
18176,GO:0099022,1,0.989485526020406,0,2,vesicle tethering,BP,
18177,GO:0099023,1,0.625538446272704,0,69,tethering complex,CC,
18178,GO:0099024,1,0.713612862639009,0,53,plasma membrane invagination,BP,
18179,GO:0099038,1,0.99193663984444,0,1,ceramide-translocating ATPase activity,MF,
18180,GO:0099039,1,0.982447549793924,0,2,sphingolipid translocation,BP,
18181,GO:0099040,1,0.99193663984444,0,1,ceramide translocation,BP,
18182,GO:0099044,1,0.989485526020406,0,2,vesicle tethering to endoplasmic reticulum,BP,
18183,GO:0099046,1,0.995702948784143,0,1,clearance of foreign intracellular nucleic acids,BP,
18184,GO:0099050,1,0.994106264340881,0,1,vesicle scission,BP,
18185,GO:0099053,1,0.980401413046013,0,3,activating signal cointegrator 1 complex,CC,
18186,GO:0099054,1,0.866677041109486,0,18,presynapse assembly,BP,
18187,GO:0099055,1,0.920089818324557,0,10,integral component of postsynaptic membrane,CC,
18188,GO:0099056,1,0.974691939599726,0,4,integral component of presynaptic membrane,CC,
18189,GO:0099059,1,0.992448809519178,0,1,integral component of presynaptic active zone membrane,CC,
18190,GO:0099060,1,0.958768244224229,0,4,integral component of postsynaptic specialization membrane,CC,
18191,GO:0099061,1,0.966065720502337,0,3,integral component of postsynaptic density membrane,CC,
18192,GO:0099068,1,0.858791758153232,0,17,postsynapse assembly,BP,
18194,GO:0099073,1,0.985831505267558,0,2,mitochondrion-derived vesicle,CC,
18195,GO:0099074,1,0.987722750297661,0,2,mitochondrion to lysosome transport,BP,
18196,GO:0099075,1,0.987722750297661,0,2,mitochondrion-derived vesicle mediated transport,BP,
18197,GO:0099077,1,0.991066847619513,0,1,histone-dependent DNA binding,MF,
18198,GO:0099078,1,0.982185555127044,0,4,BORC complex,CC,
18202,GO:0099083,1,0.989089595736548,0,2,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
18203,GO:0099084,1,0.874177568149713,0,15,postsynaptic specialization organization,BP,
18204,GO:0099086,1,0.822514941708992,0,31,synaptonemal structure,CC,
18205,GO:0099089,1,0.985192534027647,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
18206,GO:0099093,1,0.985469968272099,0,2,calcium export from the mitochondrion,BP,
18209,GO:0099098,1,0.993569067122816,0,1,microtubule polymerization based movement,BP,
18210,GO:0099103,1,0.977788851964953,0,4,channel activator activity,MF,
18211,GO:0099104,1,0.977788851964953,0,4,potassium channel activator activity,MF,
18214,GO:0099116,1,0.921401887247129,0,16,tRNA 5'-end processing,BP,
18215,GO:0099118,1,0.968817923506222,0,4,microtubule-based protein transport,BP,
18216,GO:0099122,1,0.976810994475107,0,3,RNA polymerase II C-terminal domain binding,MF,
18217,GO:0099130,1,0.994717736284321,0,1,estrogen binding,MF,
18218,GO:0099131,1,0.846904901644309,0,28,ATP hydrolysis coupled ion transmembrane transport,BP,
18219,GO:0099132,1,0.724775512183552,0,45,ATP hydrolysis coupled cation transmembrane transport,BP,
18220,GO:0099133,1,0.908648823575891,0,12,ATP hydrolysis coupled anion transmembrane transport,BP,
18221,GO:0099142,1,0.990687528820758,0,1,intracellularly ATP-gated ion channel activity,MF,
18222,GO:0099146,1,0.966065720502337,0,3,intrinsic component of postsynaptic density membrane,CC,
18223,GO:0099159,1,0.989648928315445,0,1,regulation of modification of postsynaptic structure,BP,
18224,GO:0099163,1,0.989717799694166,0,1,synaptic signaling by nitric oxide,BP,
18225,GO:0099170,1,0.98044855001255,0,3,postsynaptic modulation of chemical synaptic transmission,BP,
18226,GO:0099172,1,0.855018494951586,0,20,presynapse organization,BP,
18228,GO:0099174,1,0.964049948340938,0,5,regulation of presynapse organization,BP,
18231,GO:0099186,1,0.995242605021767,0,1,structural constituent of postsynapse,MF,
18232,GO:0099188,1,0.995242605021767,0,1,postsynaptic cytoskeleton organization,BP,
18233,GO:0099240,1,0.920089818324557,0,10,intrinsic component of synaptic membrane,CC,
18234,GO:0099243,1,0.989607861766737,0,1,extrinsic component of synaptic membrane,CC,
18235,GO:0099400,1,0.987748176584163,0,1,caveola neck,CC,
18236,GO:0099402,1,0.996531076871997,0,1,plant organ development,BP,
18237,GO:0099403,1,0.973695979994239,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
18238,GO:0099404,1,0.973695979994239,0,2,mitotic sister chromatid cohesion, telomeric,BP,
18243,GO:0099509,1,0.985784478341339,0,3,regulation of presynaptic cytosolic calcium ion concentration,BP,
18246,GO:0099514,1,0.903660041813653,0,17,synaptic vesicle cytoskeletal transport,BP,
18247,GO:0099515,1,0.915473456384276,0,10,actin filament-based transport,BP,
18249,GO:0099517,1,0.903660041813653,0,17,synaptic vesicle transport along microtubule,BP,
18250,GO:0099518,1,0.708662302797076,0,46,vesicle cytoskeletal trafficking,BP,
18251,GO:0099519,1,0.994054740756748,0,1,dense core granule cytoskeletal transport,BP,
18252,GO:0099522,1,0.994957091090962,0,1,region of cytosol,CC,
18253,GO:0099523,1,0.994957091090962,0,1,presynaptic cytosol,CC,
18254,GO:0099524,1,0.994957091090962,0,1,postsynaptic cytosol,CC,
18255,GO:0099525,1,0.951686527366089,0,5,presynaptic dense core vesicle exocytosis,BP,
18256,GO:0099526,1,0.96290342819875,0,2,presynapse to nucleus signaling pathway,BP,
18257,GO:0099527,1,0.989900198675586,0,1,postsynapse to nucleus signaling pathway,BP,
18260,GO:0099530,1,0.979078953173498,0,2,G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential,MF,
18262,GO:0099532,1,0.980982328562655,0,2,synaptic vesicle endosomal processing,BP,
18269,GO:0099543,1,0.989717799694166,0,1,trans-synaptic signaling by soluble gas,BP,
18270,GO:0099545,1,0.983932204286593,0,2,trans-synaptic signaling by trans-synaptic complex,BP,
18271,GO:0099547,1,0.98044855001255,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
18272,GO:0099548,1,0.989717799694166,0,1,trans-synaptic signaling by nitric oxide,BP,
18274,GO:0099551,1,0.978947832054083,0,3,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
18277,GO:0099557,1,0.991955059843106,0,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,
18278,GO:0099558,1,0.991287979621205,0,2,maintenance of synapse structure,BP,
18279,GO:0099560,1,0.973516961406751,0,3,synaptic membrane adhesion,BP,
18280,GO:0099563,1,0.923675127380326,0,11,modification of synaptic structure,BP,
18282,GO:0099566,1,0.970357615782799,0,3,regulation of postsynaptic cytosolic calcium ion concentration,BP,
18285,GO:0099571,1,0.995388251877053,0,1,postsynaptic cytoskeleton,CC,
18287,GO:0099578,1,0.98044855001255,0,3,regulation of translation at postsynapse, modulating synaptic transmission,BP,
18288,GO:0099580,1,0.982453374157468,0,2,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
18289,GO:0099583,1,0.970357615782799,0,3,neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
18290,GO:0099587,1,0.714676808187843,0,48,inorganic ion import across plasma membrane,BP,
18291,GO:0099589,1,0.932089838489807,0,13,serotonin receptor activity,MF,
18293,GO:0099601,1,0.731080334678015,0,44,regulation of neurotransmitter receptor activity,BP,
18294,GO:0099602,1,0.963858727997931,0,7,neurotransmitter receptor regulator activity,MF,
18296,GO:0099606,1,0.988305408929369,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
18297,GO:0099607,1,0.988305408929369,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
18298,GO:0099609,1,0.982074508851219,0,2,microtubule lateral binding,MF,
18299,GO:0099612,1,0.936506287658614,0,7,protein localization to axon,BP,
18300,GO:0099617,1,0.993400212279601,0,1,matrix side of mitochondrial inner membrane,CC,
18301,GO:0099622,1,0.798859958707977,0,32,cardiac muscle cell membrane repolarization,BP,
18302,GO:0099623,1,0.847744140637341,0,22,regulation of cardiac muscle cell membrane repolarization,BP,
18303,GO:0099624,1,0.929285911337513,0,10,atrial cardiac muscle cell membrane repolarization,BP,
18304,GO:0099625,1,0.855142492930207,0,22,ventricular cardiac muscle cell membrane repolarization,BP,
18305,GO:0099628,1,0.957117529236536,0,8,neurotransmitter receptor diffusion trapping,BP,
18306,GO:0099631,1,0.992136253779448,0,2,postsynaptic endocytic zone cytoplasmic component,CC,
18310,GO:0099638,1,0.967746685081533,0,5,endosome to plasma membrane protein transport,BP,
18311,GO:0099639,1,0.967746685081533,0,5,neurotransmitter receptor transport, endosome to plasma membrane,BP,
18312,GO:0099640,1,0.986331670102979,0,2,axo-dendritic protein transport,BP,
18313,GO:0099641,1,0.996387680911386,0,1,anterograde axonal protein transport,BP,
18315,GO:0099699,1,0.920089818324557,0,10,integral component of synaptic membrane,CC,
18317,GO:0100001,1,0.991452327030306,0,1,regulation of skeletal muscle contraction by action potential,BP,
18318,GO:0100002,1,0.993953524479694,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
18319,GO:0100012,1,0.99133011400556,0,2,regulation of heart induction by canonical Wnt signaling pathway,BP,
18320,GO:0100057,1,0.989266422732595,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
18321,GO:0101002,1,0.339358011160668,0,179,ficolin-1-rich granule,CC,
18322,GO:0101003,1,0.684607335398548,0,56,ficolin-1-rich granule membrane,CC,
18323,GO:0101005,1,0.509916835393786,0,88,ubiquitinyl hydrolase activity,MF,
18324,GO:0101006,1,0.9854825962463,0,3,protein histidine phosphatase activity,MF,
18325,GO:0101020,1,0.984780063483711,0,3,estrogen 16-alpha-hydroxylase activity,MF,
18326,GO:0101023,1,0.901229997767964,0,14,vascular endothelial cell proliferation,BP,
18327,GO:0101030,1,0.99583565400703,0,1,tRNA-guanine transglycosylation,BP,
18328,GO:0101031,1,0.931751962440549,0,12,chaperone complex,CC,
18329,GO:0102005,1,0.995620111787861,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
18330,GO:0102007,1,0.986843995321753,0,3,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
18331,GO:0102008,1,0.991819009395278,0,1,cytosolic dipeptidase activity,MF,
18332,GO:0102009,1,0.995133431117364,0,1,proline dipeptidase activity,MF,
18333,GO:0102076,1,0.993961306708447,0,1,beta,beta-carotene-9',10'-cleaving oxygenase activity,MF,
18334,GO:0102077,1,0.989872721077164,0,2,oleamide hydrolase activity,MF,
18335,GO:0102084,1,0.988441639088164,0,2,L-dopa O-methyltransferase activity,MF,
18336,GO:0102092,1,0.98279493575385,0,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,
18337,GO:0102102,1,0.992855757159882,0,1,homocarnosine synthase activity,MF,
18338,GO:0102113,1,0.989944501514149,0,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,
18339,GO:0102121,1,0.982896645427135,0,3,ceramidase activity,MF,
18340,GO:0102131,1,0.988453595791546,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
18341,GO:0102132,1,0.988453595791546,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
18342,GO:0102148,1,0.984355584841592,0,3,N-acetyl-beta-D-galactosaminidase activity,MF,
18343,GO:0102158,1,0.976428094882373,0,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,
18344,GO:0102166,1,0.991700193847049,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18345,GO:0102167,1,0.991700193847049,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18346,GO:0102200,1,0.991620252329227,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity,MF,
18347,GO:0102250,1,0.980123632208085,0,3,linear malto-oligosaccharide phosphorylase activity,MF,
18348,GO:0102279,1,0.991946597430993,0,1,lecithin:11-cis retinol acyltransferase activity,MF,
18349,GO:0102336,1,0.963017449392389,0,6,3-oxo-arachidoyl-CoA synthase activity,MF,
18350,GO:0102337,1,0.963017449392389,0,6,3-oxo-cerotoyl-CoA synthase activity,MF,
18351,GO:0102338,1,0.963017449392389,0,6,3-oxo-lignoceronyl-CoA synthase activity,MF,
18352,GO:0102339,1,0.994327343548176,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
18353,GO:0102340,1,0.994327343548176,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
18354,GO:0102341,1,0.994327343548176,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
18355,GO:0102342,1,0.994327343548176,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
18356,GO:0102343,1,0.976428094882373,0,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,
18357,GO:0102344,1,0.976428094882373,0,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,
18358,GO:0102345,1,0.976428094882373,0,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,
18359,GO:0102389,1,0.994187535736652,0,1,polyprenol reductase activity,MF,
18360,GO:0102390,1,0.994208643411358,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
18361,GO:0102391,1,0.953820047546115,0,7,decanoate-CoA ligase activity,MF,
18362,GO:0102420,1,0.984493335654276,0,2,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
18363,GO:0102483,1,0.995400257842171,0,1,scopolin beta-glucosidase activity,MF,
18364,GO:0102485,1,0.97389753023544,0,3,dATP phosphohydrolase activity,MF,
18365,GO:0102486,1,0.97389753023544,0,3,dCTP phosphohydrolase activity,MF,
18366,GO:0102487,1,0.97389753023544,0,3,dUTP phosphohydrolase activity,MF,
18367,GO:0102488,1,0.97389753023544,0,3,dTTP phosphohydrolase activity,MF,
18368,GO:0102489,1,0.97389753023544,0,3,GTP phosphohydrolase activity,MF,
18369,GO:0102490,1,0.97389753023544,0,3,8-oxo-dGTP phosphohydrolase activity,MF,
18370,GO:0102491,1,0.97389753023544,0,3,dGTP phosphohydrolase activity,MF,
18371,GO:0102499,1,0.980123632208085,0,3,SHG alpha-glucan phosphorylase activity,MF,
18372,GO:0102500,1,0.989660397416249,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
18373,GO:0102521,1,0.993455974163309,0,1,tRNA-4-demethylwyosine synthase activity,MF,
18374,GO:0102522,1,0.994731505481574,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
18375,GO:0102524,1,0.994054740756748,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
18376,GO:0102555,1,0.996310916442156,0,1,octanoyl transferase activity (acting on glycine-cleavage complex H protein),MF,
18377,GO:0102567,1,0.915298011244278,0,15,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,
18378,GO:0102568,1,0.915298011244278,0,15,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,
18379,GO:0102571,1,0.991700193847049,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18380,GO:0102704,1,0.993908240068689,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
18381,GO:0102707,1,0.994309390787771,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
18382,GO:0102751,1,0.98871601361843,0,2,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
18383,GO:0102752,1,0.993689830708738,0,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,
18384,GO:0102756,1,0.963017449392389,0,6,very-long-chain 3-ketoacyl-CoA synthase activity,MF,
18385,GO:0102758,1,0.996045200364164,0,1,very-long-chain enoyl-CoA reductase activity,MF,
18386,GO:0102769,1,0.995465274891211,0,1,dihydroceramide glucosyltransferase activity,MF,
18387,GO:0102773,1,0.992376211355555,0,1,dihydroceramide kinase activity,MF,
18388,GO:0102797,1,0.991871871186814,0,1,geranial:oxygen oxidoreductase activity,MF,
18389,GO:0102798,1,0.991871871186814,0,1,heptaldehyde:oxygen oxidoreductase activity,MF,
18390,GO:0102867,1,0.994099360874657,0,1,molybdenum cofactor sulfurtransferase activity,MF,
18391,GO:0102938,1,0.988441639088164,0,2,orcinol O-methyltransferase activity,MF,
18392,GO:0102953,1,0.983214094905455,0,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,
18393,GO:0102965,1,0.986468528664904,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
18394,GO:0102991,1,0.970349023620851,0,6,myristoyl-CoA hydrolase activity,MF,
18395,GO:0103025,1,0.990260394305553,0,2,alpha-amylase activity (releasing maltohexaose),MF,
18396,GO:0103045,1,0.994907742814175,0,1,methione N-acyltransferase activity,MF,
18397,GO:0103046,1,0.991819009395278,0,1,alanylglutamate dipeptidase activity,MF,
18398,GO:0103053,1,0.990622662153841,0,2,1-ethyladenine demethylase activity,MF,
18399,GO:0103066,1,0.995506877175019,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
18400,GO:0103067,1,0.995506877175019,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
18401,GO:0103068,1,0.983214094905455,0,3,leukotriene C4 gamma-glutamyl transferase activity,MF,
18402,GO:0103073,1,0.989872721077164,0,2,anandamide amidohydrolase activity,MF,
18404,GO:0104005,1,0.652548864209107,0,64,hijacked molecular function,MF,
18405,GO:0106001,1,0.961303914646434,0,6,intestinal hexose absorption,BP,
18406,GO:0106003,1,0.918588875679155,0,11,amyloid-beta complex,CC,
18407,GO:0106004,1,0.991229143766722,0,2,tRNA (guanine-N7)-methylation,BP,
18408,GO:0106005,1,0.990629520793018,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
18409,GO:0106014,1,0.989696931514695,0,2,regulation of inflammatory response to wounding,BP,
18410,GO:0106015,1,0.989696931514695,0,2,negative regulation of inflammatory response to wounding,BP,
18411,GO:0106017,1,0.96970605688682,0,4,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,
18412,GO:0106018,1,0.882850025463156,0,15,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,
18413,GO:0106019,1,0.925324053951457,0,10,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,
18414,GO:0106020,1,0.987606329058421,0,2,regulation of vesicle docking,BP,
18415,GO:0106022,1,0.992893604693382,0,1,positive regulation of vesicle docking,BP,
18417,GO:0106028,1,0.991955059843106,0,1,neuron projection retraction,BP,
18419,GO:0106044,1,0.996339404102419,0,1,guanine deglycation,BP,
18420,GO:0106045,1,0.996339404102419,0,1,guanine deglycation, methylglyoxal removal,BP,
18421,GO:0106046,1,0.996339404102419,0,1,guanine deglycation, glyoxal removal,BP,
18422,GO:0106049,1,0.9641618667917,0,6,regulation of cellular response to osmotic stress,BP,
18423,GO:0106050,1,0.995052180476412,0,1,tRNA 2'-O-methyltransferase activity,MF,
18424,GO:0106056,1,0.885900783290313,0,16,regulation of calcineurin-mediated signaling,BP,
18425,GO:0106057,1,0.976476842197614,0,3,negative regulation of calcineurin-mediated signaling,BP,
18426,GO:0106058,1,0.937914636911997,0,9,positive regulation of calcineurin-mediated signaling,BP,
18427,GO:0106064,1,0.991061380407851,0,1,regulation of cobalamin metabolic process,BP,
18428,GO:0106068,1,0.966545546523794,0,6,SUMO ligase complex,CC,
18432,GO:0106073,1,0.980788931388818,0,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,
18433,GO:0106074,1,0.930993052980634,0,11,aminoacyl-tRNA metabolism involved in translational fidelity,BP,
18434,GO:0106075,1,0.993674181863851,0,1,peptide N-succinyltransferase activity,MF,
18435,GO:0106077,1,0.973634026611172,0,4,histone succinylation,BP,
18436,GO:0106078,1,0.993674181863851,0,1,histone succinyltransferase activity,MF,
18437,GO:0106083,1,0.936509659985754,0,7,nuclear membrane protein complex,CC,
18438,GO:0106088,1,0.989984035908545,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
18439,GO:0106089,1,0.989984035908545,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
18440,GO:0106094,1,0.936509659985754,0,7,nuclear membrane microtubule tethering complex,CC,
18441,GO:0106101,1,0.995196282022219,0,1,ER-dependent peroxisome localization,BP,
18442,GO:0106104,1,0.974970441627373,0,3,regulation of glutamate receptor clustering,BP,
18443,GO:0110008,1,0.993750308080392,0,1,ncRNA deadenylation,BP,
18444,GO:0110009,1,0.975568247108869,0,3,formin-nucleated actin cable organization,BP,
18445,GO:0110011,1,0.952787322398241,0,5,regulation of basement membrane organization,BP,
18446,GO:0110017,1,0.991903394914749,0,2,cap-independent translational initiation of linear mRNA,BP,
18447,GO:0110020,1,0.549047541638346,0,81,regulation of actomyosin structure organization,BP,
18448,GO:0110021,1,0.981466802273618,0,3,cardiac muscle myoblast proliferation,BP,
18449,GO:0110022,1,0.981466802273618,0,3,regulation of cardiac muscle myoblast proliferation,BP,
18450,GO:0110024,1,0.981466802273618,0,3,positive regulation of cardiac muscle myoblast proliferation,BP,
18451,GO:0110025,1,0.993745546204059,0,1,DNA strand resection involved in replication fork processing,BP,
18452,GO:0110026,1,0.993745546204059,0,1,regulation of DNA strand resection involved in replication fork processing,BP,
18453,GO:0110028,1,0.989666133385604,0,1,positive regulation of mitotic spindle organization,BP,
18454,GO:0110029,1,0.993642001084221,0,1,negative regulation of meiosis I,BP,
18455,GO:0110053,1,0.195622206761961,0,236,regulation of actin filament organization,BP,
18456,GO:0110057,1,0.991346423531907,0,1,regulation of blood vessel endothelial cell differentiation,BP,
18457,GO:0110059,1,0.991346423531907,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
18458,GO:0110075,1,0.996330735281209,0,1,regulation of ferroptosis,BP,
18459,GO:0110076,1,0.996330735281209,0,1,negative regulation of ferroptosis,BP,
18460,GO:0110095,1,0.98661558998663,0,3,cellular detoxification of aldehyde,BP,
18461,GO:0110096,1,0.977251799081174,0,5,cellular response to aldehyde,BP,
18462,GO:0120009,1,0.9696470260463,0,5,intermembrane lipid transfer,BP,
18463,GO:0120012,1,0.99142634391198,0,1,intermembrane sphingolipid transfer,BP,
18464,GO:0120013,1,0.9696470260463,0,5,intermembrane lipid transfer activity,MF,
18465,GO:0120016,1,0.99142634391198,0,1,intermembrane sphingolipid transfer activity,MF,
18466,GO:0120017,1,0.99142634391198,0,1,intermembrane ceramide transfer activity,MF,
18470,GO:0120033,1,0.884259570032339,0,20,negative regulation of plasma membrane bounded cell projection assembly,BP,
18476,GO:0120043,1,0.992084783687516,0,1,stereocilium shaft,CC,
18477,GO:0120044,1,0.992084783687516,0,1,stereocilium base,CC,
18478,GO:0120048,1,0.994054740756748,0,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,
18479,GO:0120049,1,0.994054740756748,0,1,snRNA (adenine-N6)-methylation,BP,
18480,GO:0120054,1,0.996611310932968,0,1,intestinal motility,BP,
18481,GO:0120055,1,0.996611310932968,0,1,small intestinal transit,BP,
18482,GO:0120057,1,0.996611310932968,0,1,regulation of small intestinal transit,BP,
18483,GO:0120058,1,0.996611310932968,0,1,positive regulation of small intestinal transit,BP,
18484,GO:0120060,1,0.996486604643215,0,1,regulation of gastric emptying,BP,
18485,GO:0120061,1,0.996486604643215,0,1,negative regulation of gastric emptying,BP,
18486,GO:0120063,1,0.988164884210309,0,2,stomach smooth muscle contraction,BP,
18487,GO:0120064,1,0.991649235187485,0,1,stomach pylorus smooth muscle contraction,BP,
18488,GO:0120065,1,0.991649235187485,0,1,pyloric antrum smooth muscle contraction,BP,
18489,GO:0120068,1,0.996486604643215,0,1,regulation of stomach fundus smooth muscle contraction,BP,
18490,GO:0120069,1,0.996486604643215,0,1,positive regulation of stomach fundus smooth muscle contraction,BP,
18491,GO:0120071,1,0.991649235187485,0,1,regulation of pyloric antrum smooth muscle contraction,BP,
18492,GO:0120072,1,0.991649235187485,0,1,positive regulation of pyloric antrum smooth muscle contraction,BP,
18493,GO:0120077,1,0.989984035908545,0,1,angiogenic sprout fusion,BP,
18494,GO:0120078,1,0.989984035908545,0,1,cell adhesion involved in sprouting angiogenesis,BP,
18495,GO:0120092,1,0.993430025127122,0,1,crotonyl-CoA hydratase activity,MF,
18496,GO:0120093,1,0.993430025127122,0,1,regulation of peptidyl-lysine crotonylation,BP,
18497,GO:0120094,1,0.993430025127122,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
18498,GO:0120103,1,0.935669311842067,0,9,centriolar subdistal appendage,CC,
18499,GO:0120108,1,0.994973557798029,0,1,DNA-3'-diphospho-5'-guanosine diphosphatase,MF,
18501,GO:0120114,1,0.624558821840292,0,79,Sm-like protein family complex,CC,
18502,GO:0140007,1,0.978418249514593,0,4,KICSTOR complex,CC,
18503,GO:0140009,1,0.986268551435647,0,2,L-aspartate import across plasma membrane,BP,
18507,GO:0140030,1,0.438675198619754,0,113,modification-dependent protein binding,MF,
18508,GO:0140031,1,0.988447135365698,0,2,phosphorylation-dependent protein binding,MF,
18509,GO:0140033,1,0.863147100508862,0,17,acetylation-dependent protein binding,MF,
18510,GO:0140034,1,0.66578197530438,0,56,methylation-dependent protein binding,MF,
18511,GO:0140035,1,0.963834094872862,0,5,ubiquitination-like modification-dependent protein binding,MF,
18512,GO:0140036,1,0.963834094872862,0,5,ubiquitin-dependent protein binding,MF,
18513,GO:0140041,1,0.996339404102419,0,1,cellular detoxification of methylglyoxal,BP,
18514,GO:0140049,1,0.995429939945863,0,1,regulation of endocardial cushion to mesenchymal transition,BP,
18515,GO:0140051,1,0.995429939945863,0,1,positive regulation of endocardial cushion to mesenchymal transition,BP,
18516,GO:0140052,1,0.965791481979854,0,5,cellular response to oxidised low-density lipoprotein particle stimulus,BP,
18517,GO:0140053,1,0.465316326475138,0,151,mitochondrial gene expression,BP,
18519,GO:0140058,1,0.87128535572302,0,16,neuron projection arborization,BP,
18520,GO:0140059,1,0.966606668885988,0,5,dendrite arborization,BP,
18521,GO:0140064,1,0.988186240910846,0,1,peptide crotonyltransferase activity,MF,
18522,GO:0140065,1,0.988186240910846,0,1,peptide butyryltransferase activity,MF,
18523,GO:0140066,1,0.98169310648484,0,2,peptidyl-lysine crotonylation,BP,
18524,GO:0140067,1,0.988186240910846,0,1,peptidyl-lysine butyrylation,BP,
18525,GO:0140068,1,0.988186240910846,0,1,histone crotonyltransferase activity,MF,
18526,GO:0140069,1,0.988186240910846,0,1,histone butyryltransferase activity,MF,
18527,GO:0140074,1,0.991647236494745,0,1,cardiac endothelial to mesenchymal transition,BP,
18528,GO:0140078,1,0.951188666285503,0,10,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
18529,GO:0140080,1,0.951188666285503,0,10,class III/IV DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
18532,GO:0140098,1,0.127366625571702,0,338,catalytic activity, acting on RNA,MF,
18533,GO:0140101,1,0.515015686594605,0,115,catalytic activity, acting on a tRNA,MF,
18534,GO:0140102,1,0.919921536306581,0,15,catalytic activity, acting on a rRNA,MF,
18535,GO:0140103,1,0.882412037851213,0,20,catalytic activity, acting on a glycoprotein,MF,
18536,GO:0140104,1,0.79381377568326,0,40,molecular carrier activity,MF,
18538,GO:0140112,1,0.889465265798287,0,20,extracellular vesicle biogenesis,BP,
18539,GO:0140115,1,0.867246084232219,0,23,export across plasma membrane,BP,
18541,GO:0140135,1,0.974871063151046,0,4,mechanosensitive cation channel activity,MF,
18542,GO:0140142,1,0.878662058411475,0,18,nucleocytoplasmic carrier activity,MF,
18543,GO:0140161,1,0.957886874384786,0,8,monocarboxylate:sodium symporter activity,MF,
18544,GO:0140192,1,0.977982214362188,0,2,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18545,GO:0140193,1,0.995821901222997,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
18546,GO:0140194,1,0.995821901222997,0,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
18547,GO:0140196,1,0.989717799694166,0,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18548,GO:0140199,1,0.988143720671723,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18549,GO:0140200,1,0.988792022222766,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,
18550,GO:0150003,1,0.968786555207482,0,4,regulation of spontaneous synaptic transmission,BP,
18551,GO:0150005,1,0.936406236688496,0,11,enzyme activator complex,CC,
18552,GO:0150011,1,0.945875670236462,0,7,regulation of neuron projection arborization,BP,
18553,GO:0150012,1,0.945875670236462,0,7,positive regulation of neuron projection arborization,BP,
18554,GO:0150018,1,0.977779560220797,0,3,basal dendrite development,BP,
18555,GO:0150019,1,0.977779560220797,0,3,basal dendrite morphogenesis,BP,
18556,GO:0150020,1,0.977779560220797,0,3,basal dendrite arborization,BP,
18557,GO:0150024,1,0.994909007074522,0,1,oxidised low-density lipoprotein particle clearance,BP,
18558,GO:0150025,1,0.994909007074522,0,1,oxidised low-density lipoprotein particle receptor activity,MF,
18559,GO:0150031,1,0.990415014642476,0,1,regulation of protein localization to lysosome,BP,
18560,GO:0150033,1,0.990415014642476,0,1,negative regulation of protein localization to lysosome,BP,
18563,GO:1900003,1,0.968793835958647,0,6,regulation of serine-type endopeptidase activity,BP,
18564,GO:1900004,1,0.968793835958647,0,6,negative regulation of serine-type endopeptidase activity,BP,
18565,GO:1900005,1,0.987694060342987,0,1,positive regulation of serine-type endopeptidase activity,BP,
18567,GO:1900010,1,0.995204533278585,0,1,regulation of corticotropin-releasing hormone receptor activity,BP,
18568,GO:1900011,1,0.995204533278585,0,1,negative regulation of corticotropin-releasing hormone receptor activity,BP,
18569,GO:1900015,1,0.842273321833732,0,27,regulation of cytokine production involved in inflammatory response,BP,
18570,GO:1900016,1,0.947287239693767,0,9,negative regulation of cytokine production involved in inflammatory response,BP,
18571,GO:1900017,1,0.922147369346193,0,13,positive regulation of cytokine production involved in inflammatory response,BP,
18572,GO:1900019,1,0.97236472491391,0,4,regulation of protein kinase C activity,BP,
18573,GO:1900020,1,0.97236472491391,0,4,positive regulation of protein kinase C activity,BP,
18574,GO:1900024,1,0.747821500002217,0,44,regulation of substrate adhesion-dependent cell spreading,BP,
18575,GO:1900025,1,0.924299172010686,0,12,negative regulation of substrate adhesion-dependent cell spreading,BP,
18576,GO:1900026,1,0.815400097985279,0,31,positive regulation of substrate adhesion-dependent cell spreading,BP,
18577,GO:1900027,1,0.864840263407083,0,24,regulation of ruffle assembly,BP,
18578,GO:1900028,1,0.972760530808717,0,5,negative regulation of ruffle assembly,BP,
18579,GO:1900029,1,0.933874522783177,0,11,positive regulation of ruffle assembly,BP,
18581,GO:1900035,1,0.994121834141147,0,1,negative regulation of cellular response to heat,BP,
18582,GO:1900036,1,0.994578390865901,0,1,positive regulation of cellular response to heat,BP,
18583,GO:1900037,1,0.932651523519851,0,12,regulation of cellular response to hypoxia,BP,
18584,GO:1900038,1,0.958860547298084,0,7,negative regulation of cellular response to hypoxia,BP,
18585,GO:1900039,1,0.989459881506097,0,2,positive regulation of cellular response to hypoxia,BP,
18586,GO:1900040,1,0.949302648155082,0,7,regulation of interleukin-2 secretion,BP,
18587,GO:1900041,1,0.975589321749205,0,4,negative regulation of interleukin-2 secretion,BP,
18588,GO:1900042,1,0.9730622245907,0,3,positive regulation of interleukin-2 secretion,BP,
18589,GO:1900044,1,0.928330585636219,0,9,regulation of protein K63-linked ubiquitination,BP,
18590,GO:1900045,1,0.958304058430045,0,5,negative regulation of protein K63-linked ubiquitination,BP,
18591,GO:1900046,1,0.654220447756037,0,70,regulation of hemostasis,BP,
18592,GO:1900047,1,0.771668782381594,0,44,negative regulation of hemostasis,BP,
18593,GO:1900048,1,0.869764077298333,0,23,positive regulation of hemostasis,BP,
18594,GO:1900052,1,0.995975451635579,0,1,regulation of retinoic acid biosynthetic process,BP,
18595,GO:1900053,1,0.995975451635579,0,1,negative regulation of retinoic acid biosynthetic process,BP,
18596,GO:1900060,1,0.977455455196495,0,4,negative regulation of ceramide biosynthetic process,BP,
18597,GO:1900062,1,0.993087669375988,0,1,regulation of replicative cell aging,BP,
18598,GO:1900063,1,0.973058323208334,0,3,regulation of peroxisome organization,BP,
18599,GO:1900073,1,0.995535216482764,0,1,regulation of neuromuscular synaptic transmission,BP,
18600,GO:1900075,1,0.995535216482764,0,1,positive regulation of neuromuscular synaptic transmission,BP,
18601,GO:1900076,1,0.634737006058268,0,66,regulation of cellular response to insulin stimulus,BP,
18602,GO:1900077,1,0.804070657072637,0,33,negative regulation of cellular response to insulin stimulus,BP,
18603,GO:1900078,1,0.822037014256422,0,26,positive regulation of cellular response to insulin stimulus,BP,
18604,GO:1900081,1,0.988143720671723,0,1,regulation of arginine catabolic process,BP,
18605,GO:1900082,1,0.988143720671723,0,1,negative regulation of arginine catabolic process,BP,
18606,GO:1900084,1,0.955820022133465,0,6,regulation of peptidyl-tyrosine autophosphorylation,BP,
18607,GO:1900085,1,0.994174093998246,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
18608,GO:1900086,1,0.96142340365641,0,5,positive regulation of peptidyl-tyrosine autophosphorylation,BP,
18609,GO:1900087,1,0.83416233832992,0,27,positive regulation of G1/S transition of mitotic cell cycle,BP,
18610,GO:1900094,1,0.9592195858069,0,7,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
18611,GO:1900095,1,0.986572101447893,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
18612,GO:1900098,1,0.995245776674577,0,1,regulation of plasma cell differentiation,BP,
18613,GO:1900100,1,0.995245776674577,0,1,positive regulation of plasma cell differentiation,BP,
18614,GO:1900101,1,0.85577591778656,0,25,regulation of endoplasmic reticulum unfolded protein response,BP,
18615,GO:1900102,1,0.933626463710062,0,11,negative regulation of endoplasmic reticulum unfolded protein response,BP,
18616,GO:1900103,1,0.918859194690596,0,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,
18617,GO:1900104,1,0.982063627237644,0,3,regulation of hyaluranon cable assembly,BP,
18618,GO:1900106,1,0.982063627237644,0,3,positive regulation of hyaluranon cable assembly,BP,
18619,GO:1900107,1,0.957824303954774,0,7,regulation of nodal signaling pathway,BP,
18620,GO:1900108,1,0.985294733161338,0,3,negative regulation of nodal signaling pathway,BP,
18621,GO:1900109,1,0.985789751368238,0,3,regulation of histone H3-K9 dimethylation,BP,
18622,GO:1900110,1,0.991354179218141,0,2,negative regulation of histone H3-K9 dimethylation,BP,
18623,GO:1900111,1,0.994387535411269,0,1,positive regulation of histone H3-K9 dimethylation,BP,
18624,GO:1900112,1,0.93459275185836,0,9,regulation of histone H3-K9 trimethylation,BP,
18625,GO:1900113,1,0.969563703095435,0,5,negative regulation of histone H3-K9 trimethylation,BP,
18626,GO:1900114,1,0.983354548779815,0,2,positive regulation of histone H3-K9 trimethylation,BP,
18627,GO:1900115,1,0.904344922604302,0,15,extracellular regulation of signal transduction,BP,
18628,GO:1900116,1,0.904344922604302,0,15,extracellular negative regulation of signal transduction,BP,
18629,GO:1900117,1,0.877784291461396,0,21,regulation of execution phase of apoptosis,BP,
18630,GO:1900118,1,0.956647087676761,0,7,negative regulation of execution phase of apoptosis,BP,
18631,GO:1900119,1,0.931983784916091,0,12,positive regulation of execution phase of apoptosis,BP,
18632,GO:1900120,1,0.886119891939657,0,20,regulation of receptor binding,BP,
18633,GO:1900121,1,0.936409444383914,0,11,negative regulation of receptor binding,BP,
18634,GO:1900122,1,0.952566001276826,0,8,positive regulation of receptor binding,BP,
18635,GO:1900125,1,0.949628854898614,0,7,regulation of hyaluronan biosynthetic process,BP,
18636,GO:1900126,1,0.976587566845091,0,3,negative regulation of hyaluronan biosynthetic process,BP,
18637,GO:1900127,1,0.97240149594764,0,4,positive regulation of hyaluronan biosynthetic process,BP,
18638,GO:1900130,1,0.993183566280531,0,1,regulation of lipid binding,BP,
18639,GO:1900131,1,0.993183566280531,0,1,negative regulation of lipid binding,BP,
18640,GO:1900133,1,0.981104844641679,0,3,regulation of renin secretion into blood stream,BP,
18641,GO:1900134,1,0.993001333035015,0,1,negative regulation of renin secretion into blood stream,BP,
18642,GO:1900135,1,0.988020509983863,0,2,positive regulation of renin secretion into blood stream,BP,
18643,GO:1900138,1,0.98757592000427,0,2,negative regulation of phospholipase A2 activity,BP,
18644,GO:1900139,1,0.991792064916606,0,1,negative regulation of arachidonic acid secretion,BP,
18645,GO:1900141,1,0.994369422890623,0,1,regulation of oligodendrocyte apoptotic process,BP,
18646,GO:1900142,1,0.994369422890623,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
18647,GO:1900145,1,0.968846592667387,0,5,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18648,GO:1900146,1,0.991370231978456,0,2,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18649,GO:1900147,1,0.983764592889291,0,2,regulation of Schwann cell migration,BP,
18650,GO:1900148,1,0.994054740756748,0,1,negative regulation of Schwann cell migration,BP,
18651,GO:1900149,1,0.989648928315445,0,1,positive regulation of Schwann cell migration,BP,
18652,GO:1900150,1,0.989605631631384,0,2,regulation of defense response to fungus,BP,
18653,GO:1900151,1,0.889946304788421,0,16,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18654,GO:1900152,1,0.995227378787111,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18655,GO:1900153,1,0.889946304788421,0,16,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18656,GO:1900154,1,0.988112149912013,0,2,regulation of bone trabecula formation,BP,
18657,GO:1900155,1,0.988112149912013,0,2,negative regulation of bone trabecula formation,BP,
18658,GO:1900157,1,0.987262803732735,0,2,regulation of bone mineralization involved in bone maturation,BP,
18659,GO:1900158,1,0.992689266773365,0,1,negative regulation of bone mineralization involved in bone maturation,BP,
18660,GO:1900159,1,0.994533977466101,0,1,positive regulation of bone mineralization involved in bone maturation,BP,
18661,GO:1900161,1,0.994037131471992,0,1,regulation of phospholipid scramblase activity,BP,
18662,GO:1900163,1,0.994037131471992,0,1,positive regulation of phospholipid scramblase activity,BP,
18663,GO:1900164,1,0.9592195858069,0,7,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18664,GO:1900165,1,0.955503604295318,0,7,negative regulation of interleukin-6 secretion,BP,
18665,GO:1900166,1,0.988346684931961,0,2,regulation of glial cell-derived neurotrophic factor secretion,BP,
18666,GO:1900168,1,0.988346684931961,0,2,positive regulation of glial cell-derived neurotrophic factor secretion,BP,
18667,GO:1900169,1,0.978440431529791,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
18668,GO:1900170,1,0.994054740756748,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
18669,GO:1900175,1,0.968846592667387,0,5,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18670,GO:1900176,1,0.991370231978456,0,2,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18671,GO:1900180,1,0.534453511834645,0,93,regulation of protein localization to nucleus,BP,
18672,GO:1900181,1,0.86632066964807,0,21,negative regulation of protein localization to nucleus,BP,
18673,GO:1900182,1,0.653335219399875,0,62,positive regulation of protein localization to nucleus,BP,
18674,GO:1900186,1,0.980699172212795,0,3,negative regulation of clathrin-dependent endocytosis,BP,
18675,GO:1900190,1,0.994533977466101,0,1,regulation of single-species biofilm formation,BP,
18676,GO:1900191,1,0.994533977466101,0,1,negative regulation of single-species biofilm formation,BP,
18677,GO:1900193,1,0.962995233458549,0,7,regulation of oocyte maturation,BP,
18678,GO:1900194,1,0.984186735027985,0,3,negative regulation of oocyte maturation,BP,
18679,GO:1900195,1,0.989796007533546,0,2,positive regulation of oocyte maturation,BP,
18680,GO:1900200,1,0.985697693689836,0,2,mesenchymal cell apoptotic process involved in metanephros development,BP,
18681,GO:1900204,1,0.985697693689836,0,2,apoptotic process involved in metanephric collecting duct development,BP,
18682,GO:1900205,1,0.985697693689836,0,2,apoptotic process involved in metanephric nephron tubule development,BP,
18683,GO:1900208,1,0.991102932647795,0,2,regulation of cardiolipin metabolic process,BP,
18684,GO:1900210,1,0.991102932647795,0,2,positive regulation of cardiolipin metabolic process,BP,
18685,GO:1900211,1,0.985697693689836,0,2,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18686,GO:1900212,1,0.985697693689836,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18687,GO:1900214,1,0.985697693689836,0,2,regulation of apoptotic process involved in metanephric collecting duct development,BP,
18688,GO:1900215,1,0.985697693689836,0,2,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
18689,GO:1900217,1,0.985697693689836,0,2,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18690,GO:1900218,1,0.985697693689836,0,2,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18691,GO:1900220,1,0.981993209018659,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
18692,GO:1900221,1,0.918870095299515,0,10,regulation of amyloid-beta clearance,BP,
18693,GO:1900222,1,0.978239005978033,0,3,negative regulation of amyloid-beta clearance,BP,
18694,GO:1900223,1,0.944551481603022,0,6,positive regulation of amyloid-beta clearance,BP,
18695,GO:1900224,1,0.981661661604662,0,2,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18696,GO:1900225,1,0.92621398111185,0,11,regulation of NLRP3 inflammasome complex assembly,BP,
18697,GO:1900226,1,0.973113386210241,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
18698,GO:1900227,1,0.957438761784831,0,6,positive regulation of NLRP3 inflammasome complex assembly,BP,
18699,GO:1900228,1,0.994533977466101,0,1,regulation of single-species biofilm formation in or on host organism,BP,
18700,GO:1900229,1,0.994533977466101,0,1,negative regulation of single-species biofilm formation in or on host organism,BP,
18701,GO:1900238,1,0.979240927656754,0,3,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
18702,GO:1900239,1,0.968778628137712,0,4,regulation of phenotypic switching,BP,
18703,GO:1900241,1,0.993938558078282,0,1,positive regulation of phenotypic switching,BP,
18704,GO:1900242,1,0.933276868842447,0,8,regulation of synaptic vesicle endocytosis,BP,
18705,GO:1900243,1,0.991585268949594,0,1,negative regulation of synaptic vesicle endocytosis,BP,
18706,GO:1900244,1,0.967203995063097,0,4,positive regulation of synaptic vesicle endocytosis,BP,
18707,GO:1900245,1,0.973159165774177,0,3,positive regulation of MDA-5 signaling pathway,BP,
18708,GO:1900246,1,0.955856788041143,0,5,positive regulation of RIG-I signaling pathway,BP,
18709,GO:1900247,1,0.937207522414745,0,10,regulation of cytoplasmic translational elongation,BP,
18710,GO:1900248,1,0.982314076011268,0,2,negative regulation of cytoplasmic translational elongation,BP,
18711,GO:1900259,1,0.995134700935133,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18712,GO:1900260,1,0.995134700935133,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18713,GO:1900262,1,0.969746146097019,0,6,regulation of DNA-directed DNA polymerase activity,BP,
18714,GO:1900264,1,0.969746146097019,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
18716,GO:1900272,1,0.94302162884949,0,8,negative regulation of long-term synaptic potentiation,BP,
18718,GO:1900274,1,0.792829226622538,0,33,regulation of phospholipase C activity,BP,
18719,GO:1900275,1,0.984609412084372,0,2,negative regulation of phospholipase C activity,BP,
18720,GO:1900276,1,0.993355240892532,0,1,regulation of proteinase activated receptor activity,BP,
18721,GO:1900279,1,0.993306621233704,0,1,regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18722,GO:1900281,1,0.993306621233704,0,1,positive regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18723,GO:1900363,1,0.923139552141858,0,12,regulation of mRNA polyadenylation,BP,
18724,GO:1900364,1,0.947836070535099,0,8,negative regulation of mRNA polyadenylation,BP,
18725,GO:1900365,1,0.978361257318283,0,3,positive regulation of mRNA polyadenylation,BP,
18726,GO:1900368,1,0.974767428639906,0,3,regulation of RNA interference,BP,
18727,GO:1900369,1,0.983181619924412,0,2,negative regulation of RNA interference,BP,
18728,GO:1900370,1,0.991443332494232,0,1,positive regulation of RNA interference,BP,
18732,GO:1900376,1,0.94277746475196,0,7,regulation of secondary metabolite biosynthetic process,BP,
18733,GO:1900377,1,0.981105557124706,0,2,negative regulation of secondary metabolite biosynthetic process,BP,
18734,GO:1900378,1,0.960941139831481,0,5,positive regulation of secondary metabolite biosynthetic process,BP,
18735,GO:1900383,1,0.993531456190943,0,1,regulation of synaptic plasticity by receptor localization to synapse,BP,
18736,GO:1900387,1,0.994878682434415,0,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,
18737,GO:1900390,1,0.985437058097268,0,3,regulation of iron ion import,BP,
18738,GO:1900402,1,0.933957683557708,0,8,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
18739,GO:1900407,1,0.659687937619612,0,66,regulation of cellular response to oxidative stress,BP,
18740,GO:1900408,1,0.781948325005299,0,39,negative regulation of cellular response to oxidative stress,BP,
18741,GO:1900409,1,0.91047620207074,0,15,positive regulation of cellular response to oxidative stress,BP,
18742,GO:1900424,1,0.926622815440402,0,12,regulation of defense response to bacterium,BP,
18743,GO:1900425,1,0.967836658772124,0,5,negative regulation of defense response to bacterium,BP,
18744,GO:1900426,1,0.966882246830311,0,6,positive regulation of defense response to bacterium,BP,
18745,GO:1900449,1,0.734013655451506,0,42,regulation of glutamate receptor signaling pathway,BP,
18746,GO:1900450,1,0.991955059843106,0,1,negative regulation of glutamate receptor signaling pathway,BP,
18747,GO:1900451,1,0.92826623853891,0,9,positive regulation of glutamate receptor signaling pathway,BP,
18748,GO:1900452,1,0.912203070289791,0,12,regulation of long term synaptic depression,BP,
18749,GO:1900453,1,0.982365808732202,0,3,negative regulation of long term synaptic depression,BP,
18750,GO:1900454,1,0.962948740245987,0,5,positive regulation of long term synaptic depression,BP,
18751,GO:1900477,1,0.99490142243916,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
18752,GO:1900533,1,0.995594347919703,0,1,palmitic acid metabolic process,BP,
18753,GO:1900535,1,0.995594347919703,0,1,palmitic acid biosynthetic process,BP,
18757,GO:1900558,1,0.995036319435478,0,1,austinol metabolic process,BP,
18758,GO:1900560,1,0.995036319435478,0,1,austinol biosynthetic process,BP,
18759,GO:1900561,1,0.995036319435478,0,1,dehydroaustinol metabolic process,BP,
18760,GO:1900563,1,0.995036319435478,0,1,dehydroaustinol biosynthetic process,BP,
18761,GO:1900619,1,0.982377859125742,0,3,acetate ester metabolic process,BP,
18762,GO:1900620,1,0.994202771880615,0,1,acetate ester biosynthetic process,BP,
18763,GO:1900623,1,0.977062774014892,0,3,regulation of monocyte aggregation,BP,
18764,GO:1900625,1,0.977062774014892,0,3,positive regulation of monocyte aggregation,BP,
18765,GO:1900673,1,0.981642868340018,0,3,olefin metabolic process,BP,
18766,GO:1900719,1,0.991822002642289,0,1,regulation of uterine smooth muscle relaxation,BP,
18767,GO:1900721,1,0.991822002642289,0,1,positive regulation of uterine smooth muscle relaxation,BP,
18769,GO:1900737,1,0.993355240892532,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18771,GO:1900739,1,0.841442701540872,0,30,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18772,GO:1900740,1,0.841442701540872,0,30,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18773,GO:1900744,1,0.814810229563968,0,31,regulation of p38MAPK cascade,BP,
18774,GO:1900745,1,0.874749897872679,0,21,positive regulation of p38MAPK cascade,BP,
18775,GO:1900746,1,0.930022372765697,0,10,regulation of vascular endothelial growth factor signaling pathway,BP,
18776,GO:1900747,1,0.979207896794825,0,3,negative regulation of vascular endothelial growth factor signaling pathway,BP,
18777,GO:1900748,1,0.963589795428068,0,4,positive regulation of vascular endothelial growth factor signaling pathway,BP,
18778,GO:1900750,1,0.941186945107998,0,12,oligopeptide binding,MF,
18779,GO:1900753,1,0.992468389909409,0,1,doxorubicin transport,BP,
18780,GO:1900756,1,0.983508537262953,0,2,protein processing in phagocytic vesicle,BP,
18781,GO:1900825,1,0.976169498821424,0,3,regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18782,GO:1900827,1,0.987140201115925,0,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18783,GO:1900864,1,0.952219029607559,0,9,mitochondrial RNA modification,BP,
18784,GO:1901004,1,0.995916836693064,0,1,ubiquinone-6 metabolic process,BP,
18785,GO:1901006,1,0.995916836693064,0,1,ubiquinone-6 biosynthetic process,BP,
18787,GO:1901017,1,0.899284961666126,0,15,negative regulation of potassium ion transmembrane transporter activity,BP,
18790,GO:1901020,1,0.83582146385438,0,31,negative regulation of calcium ion transmembrane transporter activity,BP,
18791,GO:1901021,1,0.802025759112229,0,31,positive regulation of calcium ion transmembrane transporter activity,BP,
18792,GO:1901026,1,0.974569973338794,0,3,ripoptosome assembly involved in necroptotic process,BP,
18793,GO:1901028,1,0.769984140622691,0,46,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18794,GO:1901029,1,0.959877062491993,0,8,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18795,GO:1901030,1,0.806112439548212,0,37,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18796,GO:1901031,1,0.805820118565611,0,35,regulation of response to reactive oxygen species,BP,
18797,GO:1901032,1,0.898661850051383,0,17,negative regulation of response to reactive oxygen species,BP,
18798,GO:1901033,1,0.95410797082259,0,8,positive regulation of response to reactive oxygen species,BP,
18799,GO:1901052,1,0.993483538889398,0,1,sarcosine metabolic process,BP,
18800,GO:1901053,1,0.993483538889398,0,1,sarcosine catabolic process,BP,
18802,GO:1901069,1,0.995736789488704,0,1,guanosine-containing compound catabolic process,BP,
18803,GO:1901070,1,0.939986076382342,0,14,guanosine-containing compound biosynthetic process,BP,
18806,GO:1901073,1,0.984603693700211,0,2,glucosamine-containing compound biosynthetic process,BP,
18807,GO:1901074,1,0.98421355765093,0,2,regulation of engulfment of apoptotic cell,BP,
18808,GO:1901076,1,0.989998510804613,0,1,positive regulation of engulfment of apoptotic cell,BP,
18810,GO:1901078,1,0.977424595504708,0,3,negative regulation of relaxation of muscle,BP,
18812,GO:1901080,1,0.991822002642289,0,1,regulation of relaxation of smooth muscle,BP,
18813,GO:1901082,1,0.991822002642289,0,1,positive regulation of relaxation of smooth muscle,BP,
18814,GO:1901086,1,0.991755126917671,0,1,benzylpenicillin metabolic process,BP,
18815,GO:1901090,1,0.988738750641244,0,2,regulation of protein tetramerization,BP,
18816,GO:1901091,1,0.988738750641244,0,2,negative regulation of protein tetramerization,BP,
18817,GO:1901093,1,0.988738750641244,0,2,regulation of protein homotetramerization,BP,
18818,GO:1901094,1,0.988738750641244,0,2,negative regulation of protein homotetramerization,BP,
18819,GO:1901096,1,0.926310867131451,0,10,regulation of autophagosome maturation,BP,
18820,GO:1901097,1,0.978341114294466,0,3,negative regulation of autophagosome maturation,BP,
18821,GO:1901098,1,0.943926045037,0,7,positive regulation of autophagosome maturation,BP,
18822,GO:1901099,1,0.831379095738178,0,32,negative regulation of signal transduction in absence of ligand,BP,
18826,GO:1901142,1,0.949001527780102,0,7,insulin metabolic process,BP,
18827,GO:1901143,1,0.985008854740164,0,2,insulin catabolic process,BP,
18828,GO:1901145,1,0.978583635212061,0,3,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
18829,GO:1901147,1,0.985697693689836,0,2,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
18830,GO:1901159,1,0.975449316686297,0,5,xylulose 5-phosphate biosynthetic process,BP,
18831,GO:1901160,1,0.909388999464321,0,13,primary amino compound metabolic process,BP,
18832,GO:1901162,1,0.97382446788974,0,5,primary amino compound biosynthetic process,BP,
18833,GO:1901163,1,0.943891206377624,0,10,regulation of trophoblast cell migration,BP,
18834,GO:1901164,1,0.970931464265874,0,5,negative regulation of trophoblast cell migration,BP,
18835,GO:1901165,1,0.97215837638794,0,5,positive regulation of trophoblast cell migration,BP,
18836,GO:1901166,1,0.978978240959695,0,3,neural crest cell migration involved in autonomic nervous system development,BP,
18840,GO:1901187,1,0.985076630599985,0,2,regulation of ephrin receptor signaling pathway,BP,
18841,GO:1901189,1,0.994550608756633,0,1,positive regulation of ephrin receptor signaling pathway,BP,
18842,GO:1901193,1,0.996098693501358,0,1,regulation of formation of translation preinitiation complex,BP,
18843,GO:1901194,1,0.996098693501358,0,1,negative regulation of formation of translation preinitiation complex,BP,
18844,GO:1901201,1,0.899465215611105,0,13,regulation of extracellular matrix assembly,BP,
18845,GO:1901202,1,0.994558626689401,0,1,negative regulation of extracellular matrix assembly,BP,
18846,GO:1901203,1,0.92694442971248,0,9,positive regulation of extracellular matrix assembly,BP,
18847,GO:1901207,1,0.986300284187805,0,2,regulation of heart looping,BP,
18848,GO:1901208,1,0.993415101981676,0,1,negative regulation of heart looping,BP,
18849,GO:1901210,1,0.993415101981676,0,1,regulation of cardiac chamber formation,BP,
18850,GO:1901211,1,0.993415101981676,0,1,negative regulation of cardiac chamber formation,BP,
18851,GO:1901213,1,0.921119034370511,0,12,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
18855,GO:1901219,1,0.993415101981676,0,1,regulation of cardiac chamber morphogenesis,BP,
18856,GO:1901220,1,0.993415101981676,0,1,negative regulation of cardiac chamber morphogenesis,BP,
18858,GO:1901223,1,0.945037250734016,0,9,negative regulation of NIK/NF-kappaB signaling,BP,
18860,GO:1901228,1,0.975436456601043,0,3,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
18861,GO:1901229,1,0.994268886159727,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18862,GO:1901231,1,0.994268886159727,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18863,GO:1901232,1,0.994268886159727,0,1,regulation of convergent extension involved in axis elongation,BP,
18864,GO:1901233,1,0.994268886159727,0,1,negative regulation of convergent extension involved in axis elongation,BP,
18865,GO:1901246,1,0.990145987668646,0,2,regulation of lung ciliated cell differentiation,BP,
18866,GO:1901247,1,0.995906852572358,0,1,negative regulation of lung ciliated cell differentiation,BP,
18867,GO:1901248,1,0.994215697574978,0,1,positive regulation of lung ciliated cell differentiation,BP,
18868,GO:1901249,1,0.995906852572358,0,1,regulation of lung goblet cell differentiation,BP,
18869,GO:1901251,1,0.995906852572358,0,1,positive regulation of lung goblet cell differentiation,BP,
18870,GO:1901252,1,0.988812359222727,0,2,regulation of intracellular transport of viral material,BP,
18871,GO:1901253,1,0.996333212205767,0,1,negative regulation of intracellular transport of viral material,BP,
18872,GO:1901254,1,0.992451747714538,0,1,positive regulation of intracellular transport of viral material,BP,
18873,GO:1901255,1,0.98565613554279,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
18874,GO:1901256,1,0.970786567887814,0,5,regulation of macrophage colony-stimulating factor production,BP,
18875,GO:1901257,1,0.994595716009891,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
18876,GO:1901258,1,0.982713013625535,0,3,positive regulation of macrophage colony-stimulating factor production,BP,
18877,GO:1901264,1,0.68617648932063,0,65,carbohydrate derivative transport,BP,
18879,GO:1901269,1,0.993377801209287,0,2,lipooligosaccharide metabolic process,BP,
18880,GO:1901271,1,0.993377801209287,0,2,lipooligosaccharide biosynthetic process,BP,
18881,GO:1901291,1,0.99510867037347,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
18882,GO:1901292,1,0.342468806354715,0,162,nucleoside phosphate catabolic process,BP,
18884,GO:1901295,1,0.989826448321314,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18885,GO:1901296,1,0.995250216689571,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18886,GO:1901297,1,0.994550608756633,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18887,GO:1901298,1,0.938552160336014,0,10,regulation of hydrogen peroxide-mediated programmed cell death,BP,
18888,GO:1901299,1,0.963973272483584,0,6,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
18889,GO:1901300,1,0.973638464033095,0,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,
18890,GO:1901301,1,0.986389473663993,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
18891,GO:1901303,1,0.994124723010534,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
18892,GO:1901304,1,0.995384459698249,0,1,regulation of spermidine biosynthetic process,BP,
18893,GO:1901307,1,0.995384459698249,0,1,positive regulation of spermidine biosynthetic process,BP,
18894,GO:1901314,1,0.972704693198883,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
18895,GO:1901315,1,0.972704693198883,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
18896,GO:1901317,1,0.958406223060778,0,9,regulation of flagellated sperm motility,BP,
18897,GO:1901318,1,0.995092164747453,0,1,negative regulation of flagellated sperm motility,BP,
18898,GO:1901321,1,0.99133011400556,0,2,positive regulation of heart induction,BP,
18899,GO:1901328,1,0.995242605021767,0,1,response to cytochalasin B,BP,
18900,GO:1901329,1,0.981457474967725,0,3,regulation of odontoblast differentiation,BP,
18901,GO:1901331,1,0.993635796894997,0,1,positive regulation of odontoblast differentiation,BP,
18902,GO:1901337,1,0.994187535736652,0,1,thioester transport,BP,
18903,GO:1901338,1,0.924053481545803,0,14,catecholamine binding,MF,
18904,GO:1901339,1,0.953359712482576,0,7,regulation of store-operated calcium channel activity,BP,
18905,GO:1901340,1,0.992689750298082,0,1,negative regulation of store-operated calcium channel activity,BP,
18906,GO:1901341,1,0.966527997655535,0,5,positive regulation of store-operated calcium channel activity,BP,
18908,GO:1901343,1,0.515051305054124,0,94,negative regulation of vasculature development,BP,
18909,GO:1901344,1,0.995901859723872,0,1,response to leptomycin B,BP,
18910,GO:1901350,1,0.989799761565302,0,1,cell-cell signaling involved in cell-cell junction organization,BP,
18911,GO:1901355,1,0.985096243872328,0,2,response to rapamycin,BP,
18913,GO:1901361,1,0.017732625998183,0,657,organic cyclic compound catabolic process,BP,
18916,GO:1901373,1,0.995731777742456,0,1,lipid hydroperoxide transport,BP,
18917,GO:1901374,1,0.961817594143112,0,7,acetate ester transport,BP,
18918,GO:1901375,1,0.984111586093965,0,3,acetate ester transmembrane transporter activity,MF,
18919,GO:1901376,1,0.9940959129705,0,1,organic heteropentacyclic compound metabolic process,BP,
18920,GO:1901377,1,0.9940959129705,0,1,organic heteropentacyclic compound catabolic process,BP,
18922,GO:1901380,1,0.88314597502749,0,18,negative regulation of potassium ion transmembrane transport,BP,
18924,GO:1901382,1,0.968075988850938,0,4,regulation of chorionic trophoblast cell proliferation,BP,
18925,GO:1901383,1,0.983217274925977,0,2,negative regulation of chorionic trophoblast cell proliferation,BP,
18927,GO:1901386,1,0.936420269429661,0,12,negative regulation of voltage-gated calcium channel activity,BP,
18928,GO:1901387,1,0.955842636289925,0,8,positive regulation of voltage-gated calcium channel activity,BP,
18929,GO:1901388,1,0.994323749019896,0,1,regulation of transforming growth factor beta activation,BP,
18930,GO:1901389,1,0.994323749019896,0,1,negative regulation of transforming growth factor beta activation,BP,
18931,GO:1901401,1,0.991061380407851,0,1,regulation of tetrapyrrole metabolic process,BP,
18932,GO:1901407,1,0.948300988437781,0,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
18933,GO:1901409,1,0.96142025046253,0,7,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
18934,GO:1901419,1,0.992471325418713,0,1,regulation of response to alcohol,BP,
18935,GO:1901421,1,0.992471325418713,0,1,positive regulation of response to alcohol,BP,
18936,GO:1901474,1,0.959092170904279,0,7,azole transmembrane transporter activity,MF,
18937,GO:1901475,1,0.976819943771779,0,4,pyruvate transmembrane transport,BP,
18938,GO:1901490,1,0.969965103397034,0,4,regulation of lymphangiogenesis,BP,
18939,GO:1901491,1,0.984218099671723,0,2,negative regulation of lymphangiogenesis,BP,
18940,GO:1901492,1,0.985520765160361,0,2,positive regulation of lymphangiogenesis,BP,
18941,GO:1901503,1,0.966787810603996,0,5,ether biosynthetic process,BP,
18942,GO:1901505,1,0.818129881723509,0,34,carbohydrate derivative transmembrane transporter activity,MF,
18943,GO:1901509,1,0.974369734273085,0,4,regulation of endothelial tube morphogenesis,BP,
18944,GO:1901522,1,0.845212464427696,0,23,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,
18945,GO:1901523,1,0.983297512441997,0,3,icosanoid catabolic process,BP,
18946,GO:1901524,1,0.907013319137455,0,13,regulation of mitophagy,BP,
18947,GO:1901525,1,0.962811371644654,0,5,negative regulation of mitophagy,BP,
18948,GO:1901526,1,0.942068257020956,0,8,positive regulation of mitophagy,BP,
18949,GO:1901529,1,0.969701950925893,0,4,positive regulation of anion channel activity,BP,
18950,GO:1901532,1,0.62433816193603,0,88,regulation of hematopoietic progenitor cell differentiation,BP,
18951,GO:1901533,1,0.958852838895208,0,7,negative regulation of hematopoietic progenitor cell differentiation,BP,
18952,GO:1901534,1,0.986239354932143,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
18953,GO:1901535,1,0.954596339716005,0,5,regulation of DNA demethylation,BP,
18954,GO:1901536,1,0.987610127318571,0,2,negative regulation of DNA demethylation,BP,
18955,GO:1901537,1,0.966576177887895,0,3,positive regulation of DNA demethylation,BP,
18956,GO:1901538,1,0.955197574111741,0,6,changes to DNA methylation involved in embryo development,BP,
18957,GO:1901545,1,0.993785917552307,0,1,response to raffinose,BP,
18958,GO:1901550,1,0.92362677451947,0,12,regulation of endothelial cell development,BP,
18959,GO:1901551,1,0.992620466491251,0,1,negative regulation of endothelial cell development,BP,
18960,GO:1901552,1,0.969353133140905,0,5,positive regulation of endothelial cell development,BP,
18961,GO:1901555,1,0.989911750554616,0,1,response to paclitaxel,BP,
18962,GO:1901557,1,0.992825065831946,0,1,response to fenofibrate,BP,
18963,GO:1901558,1,0.985743009698065,0,2,response to metformin,BP,
18964,GO:1901561,1,0.993043508811968,0,1,response to benomyl,BP,
18965,GO:1901563,1,0.96632103006907,0,5,response to camptothecin,BP,
18969,GO:1901567,1,0.883860490627555,0,24,fatty acid derivative binding,MF,
18970,GO:1901568,1,0.4656174688011,0,132,fatty acid derivative metabolic process,BP,
18971,GO:1901569,1,0.95632867809147,0,8,fatty acid derivative catabolic process,BP,
18972,GO:1901570,1,0.648132433159397,0,75,fatty acid derivative biosynthetic process,BP,
18973,GO:1901571,1,0.827625548247547,0,31,fatty acid derivative transport,BP,
18976,GO:1901580,1,0.986090908152591,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18977,GO:1901581,1,0.986090908152591,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18978,GO:1901582,1,0.986090908152591,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18979,GO:1901585,1,0.993999322404328,0,1,regulation of acid-sensing ion channel activity,BP,
18980,GO:1901588,1,0.992149236693131,0,1,dendritic microtubule,CC,
18981,GO:1901594,1,0.992682979675518,0,1,response to capsazepine,BP,
18983,GO:1901606,1,0.580577394611201,0,96,alpha-amino acid catabolic process,BP,
18985,GO:1901608,1,0.995844403609718,0,1,regulation of vesicle transport along microtubule,BP,
18986,GO:1901609,1,0.995844403609718,0,1,negative regulation of vesicle transport along microtubule,BP,
18987,GO:1901611,1,0.941901674115619,0,10,phosphatidylglycerol binding,MF,
18988,GO:1901612,1,0.957625012122202,0,7,cardiolipin binding,MF,
18989,GO:1901615,1,0.0578770497835814,0,436,organic hydroxy compound metabolic process,BP,
18990,GO:1901616,1,0.72358141199631,0,54,organic hydroxy compound catabolic process,BP,
18991,GO:1901617,1,0.255750750273014,0,215,organic hydroxy compound biosynthetic process,BP,
18992,GO:1901618,1,0.773890997713546,0,40,organic hydroxy compound transmembrane transporter activity,MF,
18993,GO:1901620,1,0.955123190533369,0,7,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18994,GO:1901621,1,0.965943180567713,0,5,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18995,GO:1901622,1,0.994278392674853,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18997,GO:1901624,1,0.984636563306996,0,3,negative regulation of lymphocyte chemotaxis,BP,
18998,GO:1901626,1,0.927630687266399,0,11,regulation of postsynaptic membrane organization,BP,
18999,GO:1901627,1,0.994577154467648,0,1,negative regulation of postsynaptic membrane organization,BP,
19000,GO:1901628,1,0.975172817703668,0,4,positive regulation of postsynaptic membrane organization,BP,
19001,GO:1901629,1,0.984980969426807,0,2,regulation of presynaptic membrane organization,BP,
19002,GO:1901630,1,0.996035242113144,0,1,negative regulation of presynaptic membrane organization,BP,
19003,GO:1901631,1,0.988902168483734,0,1,positive regulation of presynaptic membrane organization,BP,
19004,GO:1901639,1,0.990809253553117,0,1,XDP catabolic process,BP,
19005,GO:1901640,1,0.990809253553117,0,1,XTP binding,MF,
19006,GO:1901641,1,0.990809253553117,0,1,ITP binding,MF,
19007,GO:1901642,1,0.96768133986971,0,6,nucleoside transmembrane transport,BP,
19012,GO:1901656,1,0.979487939241569,0,3,glycoside transport,BP,
19014,GO:1901658,1,0.831692276344928,0,35,glycosyl compound catabolic process,BP,
19015,GO:1901659,1,0.79757042503924,0,43,glycosyl compound biosynthetic process,BP,
19016,GO:1901660,1,0.93651286451187,0,8,calcium ion export,BP,
19017,GO:1901661,1,0.87564761046444,0,27,quinone metabolic process,BP,
19018,GO:1901662,1,0.989752263764134,0,2,quinone catabolic process,BP,
19019,GO:1901663,1,0.933508473535124,0,14,quinone biosynthetic process,BP,
19020,GO:1901664,1,0.981804303389564,0,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,
19021,GO:1901666,1,0.981804303389564,0,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
19022,GO:1901668,1,0.981043491028318,0,4,regulation of superoxide dismutase activity,BP,
19023,GO:1901671,1,0.986911716918206,0,3,positive regulation of superoxide dismutase activity,BP,
19024,GO:1901673,1,0.876109739716898,0,19,regulation of mitotic spindle assembly,BP,
19025,GO:1901674,1,0.977274562295244,0,3,regulation of histone H3-K27 acetylation,BP,
19026,GO:1901675,1,0.990156188276912,0,1,negative regulation of histone H3-K27 acetylation,BP,
19027,GO:1901676,1,0.992895041361311,0,1,positive regulation of histone H3-K27 acetylation,BP,
19028,GO:1901678,1,0.934146087629563,0,11,iron coordination entity transport,BP,
19029,GO:1901679,1,0.955043707010629,0,8,nucleotide transmembrane transport,BP,
19030,GO:1901680,1,0.987400732769895,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
19032,GO:1901682,1,0.830119038315887,0,27,sulfur compound transmembrane transporter activity,MF,
19033,GO:1901685,1,0.92773347217935,0,18,glutathione derivative metabolic process,BP,
19034,GO:1901687,1,0.92773347217935,0,18,glutathione derivative biosynthetic process,BP,
19039,GO:1901702,1,0.974570988490225,0,5,salt transmembrane transporter activity,MF,
19040,GO:1901706,1,0.99427126138325,0,1,mesenchymal cell differentiation involved in bone development,BP,
19041,GO:1901707,1,0.995901859723872,0,1,leptomycin B binding,MF,
19042,GO:1901722,1,0.936500711375941,0,11,regulation of cell proliferation involved in kidney development,BP,
19043,GO:1901723,1,0.970075834401017,0,5,negative regulation of cell proliferation involved in kidney development,BP,
19044,GO:1901724,1,0.965399617424198,0,6,positive regulation of cell proliferation involved in kidney development,BP,
19045,GO:1901725,1,0.932939163180918,0,8,regulation of histone deacetylase activity,BP,
19046,GO:1901726,1,0.986302526475961,0,1,negative regulation of histone deacetylase activity,BP,
19047,GO:1901727,1,0.952881259540554,0,6,positive regulation of histone deacetylase activity,BP,
19048,GO:1901731,1,0.988207153290859,0,2,positive regulation of platelet aggregation,BP,
19049,GO:1901739,1,0.923023938973174,0,15,regulation of myoblast fusion,BP,
19050,GO:1901740,1,0.991113009888781,0,2,negative regulation of myoblast fusion,BP,
19051,GO:1901741,1,0.931306386442416,0,13,positive regulation of myoblast fusion,BP,
19052,GO:1901748,1,0.983214094905455,0,3,leukotriene D4 metabolic process,BP,
19053,GO:1901750,1,0.983214094905455,0,3,leukotriene D4 biosynthetic process,BP,
19054,GO:1901751,1,0.994541365559013,0,1,leukotriene A4 metabolic process,BP,
19055,GO:1901796,1,0.334188471669803,0,167,regulation of signal transduction by p53 class mediator,BP,
19056,GO:1901797,1,0.85889398308788,0,26,negative regulation of signal transduction by p53 class mediator,BP,
19057,GO:1901798,1,0.875528887252719,0,20,positive regulation of signal transduction by p53 class mediator,BP,
19058,GO:1901799,1,0.752057603365833,0,44,negative regulation of proteasomal protein catabolic process,BP,
19059,GO:1901800,1,0.527664448831142,0,99,positive regulation of proteasomal protein catabolic process,BP,
19060,GO:1901804,1,0.994494674458398,0,1,beta-glucoside metabolic process,BP,
19061,GO:1901805,1,0.994494674458398,0,1,beta-glucoside catabolic process,BP,
19062,GO:1901810,1,0.994054740756748,0,1,beta-carotene metabolic process,BP,
19063,GO:1901825,1,0.994238094890298,0,1,zeaxanthin metabolic process,BP,
19064,GO:1901827,1,0.994238094890298,0,1,zeaxanthin biosynthetic process,BP,
19065,GO:1901834,1,0.995327529153892,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
19066,GO:1901835,1,0.995327529153892,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
19067,GO:1901836,1,0.930937100017266,0,11,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19068,GO:1901837,1,0.989894897966017,0,2,negative regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19069,GO:1901838,1,0.9404462755423,0,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19070,GO:1901841,1,0.938851875375261,0,11,regulation of high voltage-gated calcium channel activity,BP,
19071,GO:1901842,1,0.981260700253181,0,4,negative regulation of high voltage-gated calcium channel activity,BP,
19072,GO:1901843,1,0.979769931168107,0,3,positive regulation of high voltage-gated calcium channel activity,BP,
19073,GO:1901844,1,0.942125507229578,0,9,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
19074,GO:1901846,1,0.992318168724959,0,1,positive regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
19075,GO:1901856,1,0.988276128831492,0,2,negative regulation of cellular respiration,BP,
19076,GO:1901857,1,0.967695701798377,0,6,positive regulation of cellular respiration,BP,
19077,GO:1901858,1,0.960162214385257,0,6,regulation of mitochondrial DNA metabolic process,BP,
19078,GO:1901859,1,0.979521475024954,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
19079,GO:1901860,1,0.986465709683089,0,2,positive regulation of mitochondrial DNA metabolic process,BP,
19081,GO:1901862,1,0.747466555076049,0,44,negative regulation of muscle tissue development,BP,
19082,GO:1901863,1,0.64022407752066,0,61,positive regulation of muscle tissue development,BP,
19083,GO:1901873,1,0.984310334653903,0,2,regulation of post-translational protein modification,BP,
19084,GO:1901874,1,0.984310334653903,0,2,negative regulation of post-translational protein modification,BP,
19085,GO:1901876,1,0.991987502032673,0,2,regulation of calcium ion binding,BP,
19086,GO:1901877,1,0.991987502032673,0,2,negative regulation of calcium ion binding,BP,
19090,GO:1901888,1,0.553962326139199,0,80,regulation of cell junction assembly,BP,
19091,GO:1901889,1,0.861674326904788,0,20,negative regulation of cell junction assembly,BP,
19092,GO:1901890,1,0.799228681869885,0,30,positive regulation of cell junction assembly,BP,
19093,GO:1901894,1,0.943593424112774,0,8,regulation of calcium-transporting ATPase activity,BP,
19094,GO:1901895,1,0.97904208548409,0,3,negative regulation of calcium-transporting ATPase activity,BP,
19095,GO:1901896,1,0.967085527094747,0,4,positive regulation of calcium-transporting ATPase activity,BP,
19097,GO:1901898,1,0.981426554129274,0,2,negative regulation of relaxation of cardiac muscle,BP,
19099,GO:1901906,1,0.977560788177497,0,4,diadenosine pentaphosphate metabolic process,BP,
19100,GO:1901907,1,0.977560788177497,0,4,diadenosine pentaphosphate catabolic process,BP,
19101,GO:1901908,1,0.977560788177497,0,4,diadenosine hexaphosphate metabolic process,BP,
19102,GO:1901909,1,0.977560788177497,0,4,diadenosine hexaphosphate catabolic process,BP,
19103,GO:1901910,1,0.977560788177497,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
19104,GO:1901911,1,0.977560788177497,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
19105,GO:1901917,1,0.994084438530368,0,1,regulation of exoribonuclease activity,BP,
19106,GO:1901919,1,0.994084438530368,0,1,positive regulation of exoribonuclease activity,BP,
19107,GO:1901950,1,0.994054740756748,0,1,dense core granule transport,BP,
19108,GO:1901962,1,0.994712732642883,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
19109,GO:1901963,1,0.988676132739988,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19110,GO:1901964,1,0.995275580827277,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19111,GO:1901970,1,0.94817939217413,0,8,positive regulation of mitotic sister chromatid separation,BP,
19112,GO:1901976,1,0.819369242048283,0,32,regulation of cell cycle checkpoint,BP,
19113,GO:1901977,1,0.965315755075601,0,6,negative regulation of cell cycle checkpoint,BP,
19114,GO:1901978,1,0.935532573142102,0,10,positive regulation of cell cycle checkpoint,BP,
19115,GO:1901979,1,0.977849061286975,0,3,regulation of inward rectifier potassium channel activity,BP,
19116,GO:1901980,1,0.987031475627511,0,1,positive regulation of inward rectifier potassium channel activity,BP,
19118,GO:1901983,1,0.6586947828328,0,65,regulation of protein acetylation,BP,
19119,GO:1901984,1,0.867304838565577,0,23,negative regulation of protein acetylation,BP,
19120,GO:1901985,1,0.798275562687441,0,35,positive regulation of protein acetylation,BP,
19124,GO:1901989,1,0.629017099273513,0,72,positive regulation of cell cycle phase transition,BP,
19127,GO:1901992,1,0.673902142680603,0,61,positive regulation of mitotic cell cycle phase transition,BP,
19128,GO:1901993,1,0.987627692239989,0,2,regulation of meiotic cell cycle phase transition,BP,
19129,GO:1901994,1,0.987627692239989,0,2,negative regulation of meiotic cell cycle phase transition,BP,
19131,GO:1902001,1,0.897416230508854,0,14,fatty acid transmembrane transport,BP,
19132,GO:1902003,1,0.876151771542289,0,18,regulation of amyloid-beta formation,BP,
19133,GO:1902004,1,0.933671328423728,0,10,positive regulation of amyloid-beta formation,BP,
19134,GO:1902010,1,0.993307600531823,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
19135,GO:1902017,1,0.76137480649476,0,39,regulation of cilium assembly,BP,
19136,GO:1902018,1,0.944766458787354,0,9,negative regulation of cilium assembly,BP,
19137,GO:1902019,1,0.971078403947606,0,5,regulation of cilium-dependent cell motility,BP,
19138,GO:1902022,1,0.968372187261388,0,5,L-lysine transport,BP,
19139,GO:1902023,1,0.958759775713036,0,6,L-arginine transport,BP,
19140,GO:1902031,1,0.968412189421463,0,6,regulation of NADP metabolic process,BP,
19141,GO:1902033,1,0.957274812749507,0,7,regulation of hematopoietic stem cell proliferation,BP,
19142,GO:1902035,1,0.969296553016894,0,5,positive regulation of hematopoietic stem cell proliferation,BP,
19143,GO:1902036,1,0.665206813783927,0,79,regulation of hematopoietic stem cell differentiation,BP,
19144,GO:1902037,1,0.982341801778664,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
19145,GO:1902038,1,0.993352778012759,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
19148,GO:1902043,1,0.885555656965484,0,17,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
19149,GO:1902044,1,0.986843143516645,0,2,regulation of Fas signaling pathway,BP,
19150,GO:1902045,1,0.994553691795555,0,1,negative regulation of Fas signaling pathway,BP,
19151,GO:1902047,1,0.967450005487689,0,6,polyamine transmembrane transport,BP,
19153,GO:1902071,1,0.996037731856149,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19154,GO:1902073,1,0.996037731856149,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19157,GO:1902076,1,0.98568988060007,0,1,regulation of lateral motor column neuron migration,BP,
19158,GO:1902078,1,0.98568988060007,0,1,positive regulation of lateral motor column neuron migration,BP,
19159,GO:1902080,1,0.995368022343986,0,1,regulation of calcium ion import into sarcoplasmic reticulum,BP,
19160,GO:1902081,1,0.995368022343986,0,1,negative regulation of calcium ion import into sarcoplasmic reticulum,BP,
19161,GO:1902083,1,0.956659847282646,0,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,
19162,GO:1902093,1,0.963134923773045,0,8,positive regulation of flagellated sperm motility,BP,
19163,GO:1902098,1,0.992114050009461,0,1,calcitriol binding,MF,
19166,GO:1902101,1,0.94817939217413,0,8,positive regulation of metaphase/anaphase transition of cell cycle,BP,
19167,GO:1902102,1,0.993772597113732,0,1,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19168,GO:1902103,1,0.993772597113732,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19171,GO:1902107,1,0.47509895611669,0,118,positive regulation of leukocyte differentiation,BP,
19173,GO:1902109,1,0.98650976392574,0,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
19174,GO:1902110,1,0.731852483163813,0,55,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
19175,GO:1902115,1,0.339079609364184,0,149,regulation of organelle assembly,BP,
19176,GO:1902116,1,0.809774220217036,0,31,negative regulation of organelle assembly,BP,
19177,GO:1902117,1,0.643812505620221,0,58,positive regulation of organelle assembly,BP,
19178,GO:1902121,1,0.992114050009461,0,1,lithocholic acid binding,MF,
19179,GO:1902122,1,0.994811863082861,0,1,chenodeoxycholic acid binding,MF,
19180,GO:1902159,1,0.987223661300271,0,2,regulation of cyclic nucleotide-gated ion channel activity,BP,
19181,GO:1902161,1,0.990687528820758,0,1,positive regulation of cyclic nucleotide-gated ion channel activity,BP,
19182,GO:1902162,1,0.986399513693574,0,3,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19183,GO:1902164,1,0.986399513693574,0,3,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19184,GO:1902165,1,0.931262932562874,0,14,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19185,GO:1902166,1,0.940058428931625,0,12,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19186,GO:1902167,1,0.996774025155976,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19188,GO:1902172,1,0.972676760886773,0,5,regulation of keratinocyte apoptotic process,BP,
19189,GO:1902174,1,0.983355652339057,0,3,positive regulation of keratinocyte apoptotic process,BP,
19190,GO:1902175,1,0.861004828208375,0,26,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19191,GO:1902176,1,0.904302452026619,0,18,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19192,GO:1902177,1,0.972666256985392,0,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19193,GO:1902178,1,0.992525069451645,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,
19194,GO:1902186,1,0.825493506104006,0,29,regulation of viral release from host cell,BP,
19195,GO:1902187,1,0.906229379314819,0,14,negative regulation of viral release from host cell,BP,
19196,GO:1902188,1,0.911991820198203,0,15,positive regulation of viral release from host cell,BP,
19197,GO:1902202,1,0.975912991554529,0,4,regulation of hepatocyte growth factor receptor signaling pathway,BP,
19198,GO:1902203,1,0.991859906140274,0,1,negative regulation of hepatocyte growth factor receptor signaling pathway,BP,
19199,GO:1902204,1,0.994986863274027,0,1,positive regulation of hepatocyte growth factor receptor signaling pathway,BP,
19200,GO:1902205,1,0.995375609741751,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
19201,GO:1902206,1,0.995375609741751,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
19202,GO:1902211,1,0.994054740756748,0,1,regulation of prolactin signaling pathway,BP,
19203,GO:1902213,1,0.994054740756748,0,1,positive regulation of prolactin signaling pathway,BP,
19204,GO:1902214,1,0.979978691987368,0,3,regulation of interleukin-4-mediated signaling pathway,BP,
19205,GO:1902215,1,0.995375609741751,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
19206,GO:1902216,1,0.984532269188214,0,2,positive regulation of interleukin-4-mediated signaling pathway,BP,
19207,GO:1902217,1,0.995848152925827,0,1,erythrocyte apoptotic process,BP,
19208,GO:1902218,1,0.9641618667917,0,6,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19209,GO:1902219,1,0.967900074760092,0,5,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19210,GO:1902220,1,0.996139088949484,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19211,GO:1902221,1,0.952438632545791,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
19212,GO:1902222,1,0.952438632545791,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
19213,GO:1902224,1,0.93287471266698,0,12,ketone body metabolic process,BP,
19214,GO:1902226,1,0.985521635903851,0,3,regulation of macrophage colony-stimulating factor signaling pathway,BP,
19215,GO:1902227,1,0.991008267199802,0,2,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
19216,GO:1902228,1,0.994464091376545,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
19219,GO:1902231,1,0.972047513740564,0,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19220,GO:1902232,1,0.995375609741751,0,1,regulation of positive thymic T cell selection,BP,
19221,GO:1902233,1,0.995375609741751,0,1,negative regulation of positive thymic T cell selection,BP,
19222,GO:1902235,1,0.840775306067581,0,29,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19223,GO:1902236,1,0.899992090799835,0,17,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19224,GO:1902237,1,0.945659079694349,0,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19225,GO:1902238,1,0.992627261718495,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19226,GO:1902239,1,0.992627261718495,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19227,GO:1902250,1,0.995848152925827,0,1,regulation of erythrocyte apoptotic process,BP,
19228,GO:1902251,1,0.995848152925827,0,1,negative regulation of erythrocyte apoptotic process,BP,
19229,GO:1902253,1,0.881147480630784,0,23,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19230,GO:1902254,1,0.904111333203111,0,17,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19231,GO:1902255,1,0.984834603791996,0,4,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19232,GO:1902256,1,0.980523752991712,0,3,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19233,GO:1902257,1,0.988795226946846,0,2,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19235,GO:1902260,1,0.955945084321934,0,7,negative regulation of delayed rectifier potassium channel activity,BP,
19236,GO:1902261,1,0.96873262995506,0,4,positive regulation of delayed rectifier potassium channel activity,BP,
19237,GO:1902262,1,0.972285035840995,0,5,apoptotic process involved in blood vessel morphogenesis,BP,
19238,GO:1902263,1,0.976272796582156,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
19239,GO:1902267,1,0.974457530646525,0,5,regulation of polyamine transmembrane transport,BP,
19240,GO:1902268,1,0.987652493026954,0,3,negative regulation of polyamine transmembrane transport,BP,
19241,GO:1902269,1,0.986641743896037,0,2,positive regulation of polyamine transmembrane transport,BP,
19242,GO:1902271,1,0.992114050009461,0,1,D3 vitamins binding,MF,
19244,GO:1902282,1,0.954776579366048,0,8,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
19245,GO:1902283,1,0.992794336896152,0,1,negative regulation of primary amine oxidase activity,BP,
19246,GO:1902284,1,0.756509181992903,0,32,neuron projection extension involved in neuron projection guidance,BP,
19247,GO:1902285,1,0.886009783070715,0,13,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,
19248,GO:1902287,1,0.893655295757068,0,12,semaphorin-plexin signaling pathway involved in axon guidance,BP,
19249,GO:1902292,1,0.996033997196469,0,1,cell cycle DNA replication initiation,BP,
19250,GO:1902296,1,0.993504170174971,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
19251,GO:1902298,1,0.980645263774375,0,2,cell cycle DNA replication maintenance of fidelity,BP,
19252,GO:1902299,1,0.984791274424711,0,3,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
19253,GO:1902302,1,0.968045492039862,0,5,regulation of potassium ion export,BP,
19254,GO:1902303,1,0.987379564164369,0,2,negative regulation of potassium ion export,BP,
19255,GO:1902304,1,0.988516178166344,0,2,positive regulation of potassium ion export,BP,
19257,GO:1902306,1,0.911380621126442,0,12,negative regulation of sodium ion transmembrane transport,BP,
19258,GO:1902307,1,0.879647773148662,0,18,positive regulation of sodium ion transmembrane transport,BP,
19259,GO:1902308,1,0.968203917157097,0,5,regulation of peptidyl-serine dephosphorylation,BP,
19260,GO:1902309,1,0.977984538679414,0,3,negative regulation of peptidyl-serine dephosphorylation,BP,
19261,GO:1902310,1,0.990001444747304,0,2,positive regulation of peptidyl-serine dephosphorylation,BP,
19262,GO:1902311,1,0.995289525090722,0,1,regulation of copper ion transmembrane transport,BP,
19263,GO:1902315,1,0.996033997196469,0,1,nuclear cell cycle DNA replication initiation,BP,
19264,GO:1902319,1,0.993504170174971,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
19265,GO:1902336,1,0.987710108482779,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
19266,GO:1902337,1,0.941606798414441,0,9,regulation of apoptotic process involved in morphogenesis,BP,
19267,GO:1902338,1,0.967616442830411,0,5,negative regulation of apoptotic process involved in morphogenesis,BP,
19268,GO:1902339,1,0.981338416595721,0,3,positive regulation of apoptotic process involved in morphogenesis,BP,
19269,GO:1902356,1,0.995139780213873,0,1,oxaloacetate(2-) transmembrane transport,BP,
19270,GO:1902358,1,0.926831478308772,0,11,sulfate transmembrane transport,BP,
19271,GO:1902359,1,0.989058289539419,0,2,Notch signaling pathway involved in somitogenesis,BP,
19272,GO:1902362,1,0.994026374495186,0,1,melanocyte apoptotic process,BP,
19273,GO:1902363,1,0.989666133385604,0,1,regulation of protein localization to spindle pole body,BP,
19274,GO:1902365,1,0.989666133385604,0,1,positive regulation of protein localization to spindle pole body,BP,
19275,GO:1902366,1,0.989058289539419,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
19276,GO:1902367,1,0.989058289539419,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
19277,GO:1902369,1,0.728536990025223,0,45,negative regulation of RNA catabolic process,BP,
19278,GO:1902373,1,0.757879748666065,0,39,negative regulation of mRNA catabolic process,BP,
19279,GO:1902378,1,0.99439600355199,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
19280,GO:1902379,1,0.990997815957518,0,1,chemoattractant activity involved in axon guidance,MF,
19281,GO:1902380,1,0.994471421199389,0,1,positive regulation of endoribonuclease activity,BP,
19282,GO:1902387,1,0.994054740756748,0,1,ceramide 1-phosphate binding,MF,
19283,GO:1902388,1,0.994054740756748,0,1,ceramide 1-phosphate transporter activity,MF,
19284,GO:1902389,1,0.994054740756748,0,1,ceramide 1-phosphate transport,BP,
19285,GO:1902396,1,0.992902703061741,0,1,protein localization to bicellular tight junction,BP,
19286,GO:1902400,1,0.675176791186064,0,61,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,
19287,GO:1902402,1,0.670988527675068,0,62,signal transduction involved in mitotic DNA damage checkpoint,BP,
19288,GO:1902403,1,0.670988527675068,0,62,signal transduction involved in mitotic DNA integrity checkpoint,BP,
19289,GO:1902410,1,0.962929097648179,0,6,mitotic cytokinetic process,BP,
19290,GO:1902412,1,0.968805192267996,0,4,regulation of mitotic cytokinesis,BP,
19291,GO:1902414,1,0.937572938711852,0,8,protein localization to cell junction,BP,
19292,GO:1902415,1,0.949055026497167,0,9,regulation of mRNA binding,BP,
19293,GO:1902416,1,0.959432267183467,0,7,positive regulation of mRNA binding,BP,
19294,GO:1902423,1,0.98489075728318,0,2,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19295,GO:1902425,1,0.98489075728318,0,2,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19296,GO:1902426,1,0.994165346306363,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19297,GO:1902430,1,0.934772133655481,0,9,negative regulation of amyloid-beta formation,BP,
19298,GO:1902442,1,0.993064618682302,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
19299,GO:1902443,1,0.993064618682302,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
19300,GO:1902444,1,0.996024659358314,0,1,riboflavin binding,MF,
19301,GO:1902445,1,0.987417202337169,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
19302,GO:1902455,1,0.961803701937326,0,6,negative regulation of stem cell population maintenance,BP,
19303,GO:1902459,1,0.947123428281322,0,7,positive regulation of stem cell population maintenance,BP,
19304,GO:1902460,1,0.992248147480969,0,1,regulation of mesenchymal stem cell proliferation,BP,
19305,GO:1902462,1,0.992248147480969,0,1,positive regulation of mesenchymal stem cell proliferation,BP,
19306,GO:1902463,1,0.991192255007482,0,2,protein localization to cell leading edge,BP,
19307,GO:1902464,1,0.992415482479783,0,1,regulation of histone H3-K27 trimethylation,BP,
19308,GO:1902466,1,0.992415482479783,0,1,positive regulation of histone H3-K27 trimethylation,BP,
19309,GO:1902473,1,0.943680450658455,0,8,regulation of protein localization to synapse,BP,
19310,GO:1902474,1,0.949327404219047,0,7,positive regulation of protein localization to synapse,BP,
19313,GO:1902480,1,0.994467755478193,0,1,protein localization to mitotic spindle,BP,
19314,GO:1902488,1,0.988194477035737,0,1,cholangiocyte apoptotic process,BP,
19315,GO:1902490,1,0.995024267850121,0,1,regulation of sperm capacitation,BP,
19316,GO:1902493,1,0.569292846722326,0,85,acetyltransferase complex,CC,
19319,GO:1902498,1,0.960673040270192,0,4,regulation of protein autoubiquitination,BP,
19320,GO:1902499,1,0.981794839742737,0,2,positive regulation of protein autoubiquitination,BP,
19321,GO:1902504,1,0.993821279184255,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
19322,GO:1902510,1,0.962665061714742,0,7,regulation of apoptotic DNA fragmentation,BP,
19323,GO:1902511,1,0.994124723010534,0,1,negative regulation of apoptotic DNA fragmentation,BP,
19324,GO:1902512,1,0.987422656044531,0,3,positive regulation of apoptotic DNA fragmentation,BP,
19325,GO:1902513,1,0.957582783274089,0,7,regulation of organelle transport along microtubule,BP,
19326,GO:1902514,1,0.93514043853369,0,9,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19327,GO:1902523,1,0.97934162513806,0,3,positive regulation of protein K63-linked ubiquitination,BP,
19328,GO:1902524,1,0.98874972301237,0,2,positive regulation of protein K48-linked ubiquitination,BP,
19329,GO:1902525,1,0.974304259029241,0,5,regulation of protein monoubiquitination,BP,
19330,GO:1902527,1,0.981074815498085,0,4,positive regulation of protein monoubiquitination,BP,
19331,GO:1902528,1,0.988528401733288,0,1,regulation of protein linear polyubiquitination,BP,
19332,GO:1902530,1,0.988528401733288,0,1,positive regulation of protein linear polyubiquitination,BP,
19336,GO:1902544,1,0.990024804356068,0,2,regulation of DNA N-glycosylase activity,BP,
19337,GO:1902546,1,0.996454469426125,0,1,positive regulation of DNA N-glycosylase activity,BP,
19338,GO:1902547,1,0.922446382013669,0,11,regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19339,GO:1902548,1,0.971235369182941,0,4,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19340,GO:1902554,1,0.588839216954181,0,80,serine/threonine protein kinase complex,CC,
19341,GO:1902555,1,0.847338007206084,0,29,endoribonuclease complex,CC,
19342,GO:1902559,1,0.989890247772364,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
19343,GO:1902560,1,0.990782325803101,0,2,GMP reductase complex,CC,
19344,GO:1902562,1,0.778112886182843,0,39,H4 histone acetyltransferase complex,CC,
19345,GO:1902563,1,0.93393647806033,0,10,regulation of neutrophil activation,BP,
19346,GO:1902564,1,0.972461118540097,0,4,negative regulation of neutrophil activation,BP,
19347,GO:1902565,1,0.973413310354439,0,4,positive regulation of neutrophil activation,BP,
19348,GO:1902566,1,0.979384966611514,0,4,regulation of eosinophil activation,BP,
19349,GO:1902567,1,0.989545962459302,0,2,negative regulation of eosinophil activation,BP,
19350,GO:1902568,1,0.989732744488203,0,2,positive regulation of eosinophil activation,BP,
19351,GO:1902569,1,0.995141050033782,0,1,negative regulation of activation of Janus kinase activity,BP,
19352,GO:1902570,1,0.94140676282206,0,10,protein localization to nucleolus,BP,
19353,GO:1902571,1,0.968793835958647,0,6,regulation of serine-type peptidase activity,BP,
19354,GO:1902572,1,0.968793835958647,0,6,negative regulation of serine-type peptidase activity,BP,
19355,GO:1902573,1,0.987694060342987,0,1,positive regulation of serine-type peptidase activity,BP,
19356,GO:1902576,1,0.976432447479862,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
19357,GO:1902579,1,0.639533166471128,0,69,multi-organism localization,BP,
19358,GO:1902581,1,0.970341740292431,0,5,multi-organism cellular localization,BP,
19359,GO:1902583,1,0.970341740292431,0,5,multi-organism intracellular transport,BP,
19360,GO:1902594,1,0.983540037197739,0,2,multi-organism nuclear import,BP,
19361,GO:1902595,1,0.989923645504515,0,2,regulation of DNA replication origin binding,BP,
19363,GO:1902603,1,0.978637339999505,0,4,carnitine transmembrane transport,BP,
19364,GO:1902605,1,0.994092467631051,0,1,heterotrimeric G-protein complex assembly,BP,
19365,GO:1902606,1,0.992434567475908,0,2,regulation of large conductance calcium-activated potassium channel activity,BP,
19366,GO:1902608,1,0.992434567475908,0,2,positive regulation of large conductance calcium-activated potassium channel activity,BP,
19367,GO:1902612,1,0.994086731122564,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
19368,GO:1902613,1,0.994086731122564,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
19369,GO:1902616,1,0.995163906366786,0,1,acyl carnitine transmembrane transport,BP,
19370,GO:1902617,1,0.966165151568197,0,5,response to fluoride,BP,
19371,GO:1902618,1,0.990865077439089,0,1,cellular response to fluoride,BP,
19372,GO:1902622,1,0.827973253811803,0,37,regulation of neutrophil migration,BP,
19373,GO:1902623,1,0.985953634246584,0,2,negative regulation of neutrophil migration,BP,
19374,GO:1902624,1,0.853609386067136,0,32,positive regulation of neutrophil migration,BP,
19375,GO:1902626,1,0.988664800458059,0,3,assembly of large subunit precursor of preribosome,BP,
19376,GO:1902629,1,0.995800638652605,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
19377,GO:1902630,1,0.980963450079053,0,2,regulation of membrane hyperpolarization,BP,
19378,GO:1902631,1,0.989884321044431,0,1,negative regulation of membrane hyperpolarization,BP,
19379,GO:1902636,1,0.990567866105169,0,2,kinociliary basal body,CC,
19380,GO:1902652,1,0.44366856335654,0,123,secondary alcohol metabolic process,BP,
19381,GO:1902653,1,0.657474207504654,0,63,secondary alcohol biosynthetic process,BP,
19382,GO:1902656,1,0.91207878973888,0,13,calcium ion import into cytosol,BP,
19383,GO:1902659,1,0.98291137670615,0,3,regulation of glucose mediated signaling pathway,BP,
19384,GO:1902661,1,0.98291137670615,0,3,positive regulation of glucose mediated signaling pathway,BP,
19385,GO:1902667,1,0.741440599819961,0,36,regulation of axon guidance,BP,
19386,GO:1902668,1,0.847019446863119,0,21,negative regulation of axon guidance,BP,
19387,GO:1902669,1,0.926884107241115,0,8,positive regulation of axon guidance,BP,
19390,GO:1902683,1,0.983138001713508,0,3,regulation of receptor localization to synapse,BP,
19391,GO:1902684,1,0.995844403609718,0,1,negative regulation of receptor localization to synapse,BP,
19392,GO:1902685,1,0.992549451045981,0,1,positive regulation of receptor localization to synapse,BP,
19393,GO:1902686,1,0.723721556876247,0,57,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,
19394,GO:1902691,1,0.99369505848113,0,1,respiratory basal cell differentiation,BP,
19398,GO:1902713,1,0.952165676684432,0,8,regulation of interferon-gamma secretion,BP,
19399,GO:1902714,1,0.988965611499525,0,2,negative regulation of interferon-gamma secretion,BP,
19400,GO:1902715,1,0.962793564366593,0,6,positive regulation of interferon-gamma secretion,BP,
19401,GO:1902722,1,0.982798121783237,0,3,positive regulation of prolactin secretion,BP,
19402,GO:1902723,1,0.979758380115896,0,3,negative regulation of skeletal muscle satellite cell proliferation,BP,
19403,GO:1902724,1,0.983463392611222,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
19404,GO:1902725,1,0.976956771598038,0,3,negative regulation of satellite cell differentiation,BP,
19405,GO:1902728,1,0.983463392611222,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
19406,GO:1902730,1,0.980383108678533,0,3,positive regulation of proteoglycan biosynthetic process,BP,
19407,GO:1902731,1,0.971102245842595,0,3,negative regulation of chondrocyte proliferation,BP,
19408,GO:1902732,1,0.984879403869128,0,3,positive regulation of chondrocyte proliferation,BP,
19409,GO:1902737,1,0.992451747714538,0,1,dendritic filopodium,CC,
19410,GO:1902739,1,0.950670817480126,0,6,regulation of interferon-alpha secretion,BP,
19411,GO:1902741,1,0.950670817480126,0,6,positive regulation of interferon-alpha secretion,BP,
19413,GO:1902743,1,0.762451961128027,0,38,regulation of lamellipodium organization,BP,
19414,GO:1902744,1,0.968469329804628,0,4,negative regulation of lamellipodium organization,BP,
19415,GO:1902745,1,0.851196105161709,0,22,positive regulation of lamellipodium organization,BP,
19416,GO:1902746,1,0.977502031782985,0,3,regulation of lens fiber cell differentiation,BP,
19417,GO:1902747,1,0.995030610466277,0,1,negative regulation of lens fiber cell differentiation,BP,
19418,GO:1902748,1,0.987832237786774,0,1,positive regulation of lens fiber cell differentiation,BP,
19420,GO:1902750,1,0.58387483463506,0,96,negative regulation of cell cycle G2/M phase transition,BP,
19421,GO:1902751,1,0.853255023093616,0,25,positive regulation of cell cycle G2/M phase transition,BP,
19422,GO:1902766,1,0.990971236401939,0,2,skeletal muscle satellite cell migration,BP,
19423,GO:1902767,1,0.987839602814174,0,2,isoprenoid biosynthetic process via mevalonate,BP,
19424,GO:1902769,1,0.986250878508321,0,1,regulation of choline O-acetyltransferase activity,BP,
19425,GO:1902771,1,0.986250878508321,0,1,positive regulation of choline O-acetyltransferase activity,BP,
19426,GO:1902773,1,0.993765155092727,0,1,GTPase activator complex,CC,
19427,GO:1902774,1,0.951745827624906,0,7,late endosome to lysosome transport,BP,
19428,GO:1902775,1,0.977071357180343,0,3,mitochondrial large ribosomal subunit assembly,BP,
19430,GO:1902804,1,0.977511572743596,0,4,negative regulation of synaptic vesicle transport,BP,
19431,GO:1902805,1,0.974845650049346,0,3,positive regulation of synaptic vesicle transport,BP,
19432,GO:1902806,1,0.357779866988635,0,156,regulation of cell cycle G1/S phase transition,BP,
19433,GO:1902807,1,0.523193326596117,0,99,negative regulation of cell cycle G1/S phase transition,BP,
19434,GO:1902808,1,0.79800625566834,0,34,positive regulation of cell cycle G1/S phase transition,BP,
19435,GO:1902809,1,0.981926381158079,0,3,regulation of skeletal muscle fiber differentiation,BP,
19436,GO:1902811,1,0.987920252630946,0,2,positive regulation of skeletal muscle fiber differentiation,BP,
19437,GO:1902816,1,0.973622241951988,0,4,regulation of protein localization to microtubule,BP,
19438,GO:1902817,1,0.973622241951988,0,4,negative regulation of protein localization to microtubule,BP,
19439,GO:1902822,1,0.97275083873128,0,4,regulation of late endosome to lysosome transport,BP,
19440,GO:1902823,1,0.981327154915557,0,2,negative regulation of late endosome to lysosome transport,BP,
19441,GO:1902824,1,0.991262149672519,0,2,positive regulation of late endosome to lysosome transport,BP,
19442,GO:1902838,1,0.991678213729253,0,1,regulation of nuclear migration along microtubule,BP,
19443,GO:1902846,1,0.989666133385604,0,1,positive regulation of mitotic spindle elongation,BP,
19444,GO:1902847,1,0.993974682800764,0,1,regulation of neuronal signal transduction,BP,
19446,GO:1902855,1,0.93504972238881,0,10,regulation of non-motile cilium assembly,BP,
19447,GO:1902856,1,0.984888061983303,0,2,negative regulation of non-motile cilium assembly,BP,
19448,GO:1902857,1,0.95477722237463,0,7,positive regulation of non-motile cilium assembly,BP,
19449,GO:1902858,1,0.994824453345047,0,1,propionyl-CoA metabolic process,BP,
19450,GO:1902860,1,0.994824453345047,0,1,propionyl-CoA biosynthetic process,BP,
19452,GO:1902867,1,0.993661699491691,0,1,negative regulation of retina development in camera-type eye,BP,
19453,GO:1902868,1,0.989301205266024,0,2,positive regulation of retina development in camera-type eye,BP,
19454,GO:1902869,1,0.983030037322264,0,3,regulation of amacrine cell differentiation,BP,
19455,GO:1902870,1,0.993661699491691,0,1,negative regulation of amacrine cell differentiation,BP,
19456,GO:1902871,1,0.989301205266024,0,2,positive regulation of amacrine cell differentiation,BP,
19457,GO:1902882,1,0.62918389917126,0,74,regulation of response to oxidative stress,BP,
19458,GO:1902883,1,0.771968434201017,0,41,negative regulation of response to oxidative stress,BP,
19459,GO:1902884,1,0.905555591908656,0,16,positive regulation of response to oxidative stress,BP,
19460,GO:1902889,1,0.990028927438995,0,1,protein localization to spindle microtubule,BP,
19461,GO:1902890,1,0.996531076871997,0,1,regulation of root hair elongation,BP,
19462,GO:1902891,1,0.996531076871997,0,1,negative regulation of root hair elongation,BP,
19463,GO:1902893,1,0.792804512854577,0,32,regulation of pri-miRNA transcription by RNA polymerase II,BP,
19464,GO:1902894,1,0.913529181830019,0,11,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,
19465,GO:1902895,1,0.856217581385096,0,23,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,
19466,GO:1902896,1,0.980936415305615,0,3,terminal web assembly,BP,
19467,GO:1902897,1,0.979931347122643,0,3,regulation of postsynaptic density protein 95 clustering,BP,
19468,GO:1902902,1,0.932021092400844,0,11,negative regulation of autophagosome assembly,BP,
19472,GO:1902908,1,0.987953797937414,0,2,regulation of melanosome transport,BP,
19473,GO:1902910,1,0.992537751672478,0,1,positive regulation of melanosome transport,BP,
19474,GO:1902911,1,0.52946417078158,0,93,protein kinase complex,CC,
19475,GO:1902912,1,0.994054740756748,0,1,pyruvate kinase complex,CC,
19476,GO:1902913,1,0.993635796894997,0,1,positive regulation of neuroepithelial cell differentiation,BP,
19477,GO:1902914,1,0.886885804227778,0,16,regulation of protein polyubiquitination,BP,
19478,GO:1902915,1,0.951103087656914,0,6,negative regulation of protein polyubiquitination,BP,
19479,GO:1902916,1,0.942727646891444,0,9,positive regulation of protein polyubiquitination,BP,
19480,GO:1902930,1,0.673661978113352,0,59,regulation of alcohol biosynthetic process,BP,
19481,GO:1902931,1,0.950013851959062,0,9,negative regulation of alcohol biosynthetic process,BP,
19482,GO:1902932,1,0.900662441753109,0,17,positive regulation of alcohol biosynthetic process,BP,
19484,GO:1902937,1,0.980883047088265,0,3,inward rectifier potassium channel complex,CC,
19485,GO:1902938,1,0.97720564542971,0,3,regulation of intracellular calcium activated chloride channel activity,BP,
19486,GO:1902939,1,0.993922544215373,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
19487,GO:1902941,1,0.983434131912463,0,2,regulation of voltage-gated chloride channel activity,BP,
19488,GO:1902943,1,0.983434131912463,0,2,positive regulation of voltage-gated chloride channel activity,BP,
19489,GO:1902946,1,0.934496627279865,0,8,protein localization to early endosome,BP,
19490,GO:1902947,1,0.958942024767111,0,6,regulation of tau-protein kinase activity,BP,
19491,GO:1902948,1,0.986250878508321,0,1,negative regulation of tau-protein kinase activity,BP,
19492,GO:1902949,1,0.977212433318616,0,4,positive regulation of tau-protein kinase activity,BP,
19495,GO:1902952,1,0.980550951440467,0,3,positive regulation of dendritic spine maintenance,BP,
19496,GO:1902953,1,0.96879024301013,0,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,
19497,GO:1902954,1,0.975689055371213,0,2,regulation of early endosome to recycling endosome transport,BP,
19498,GO:1902955,1,0.986250878508321,0,1,positive regulation of early endosome to recycling endosome transport,BP,
19499,GO:1902956,1,0.984234383604455,0,3,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19500,GO:1902957,1,0.993629084422039,0,1,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19501,GO:1902958,1,0.990545670756894,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19502,GO:1902959,1,0.940907292238062,0,8,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19503,GO:1902960,1,0.980921377843806,0,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19504,GO:1902961,1,0.959215416420987,0,6,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19505,GO:1902962,1,0.979353147223493,0,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19506,GO:1902963,1,0.979353147223493,0,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19507,GO:1902965,1,0.947711287839077,0,6,regulation of protein localization to early endosome,BP,
19508,GO:1902966,1,0.947711287839077,0,6,positive regulation of protein localization to early endosome,BP,
19509,GO:1902969,1,0.940125521363401,0,9,mitotic DNA replication,BP,
19510,GO:1902975,1,0.996033997196469,0,1,mitotic DNA replication initiation,BP,
19511,GO:1902977,1,0.99509787803419,0,1,mitotic DNA replication preinitiation complex assembly,BP,
19512,GO:1902983,1,0.993504170174971,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
19513,GO:1902988,1,0.971548591704864,0,3,neurofibrillary tangle assembly,BP,
19514,GO:1902990,1,0.980606080911835,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
19515,GO:1902991,1,0.84702110930228,0,23,regulation of amyloid precursor protein catabolic process,BP,
19516,GO:1902992,1,0.922856622255463,0,11,negative regulation of amyloid precursor protein catabolic process,BP,
19517,GO:1902993,1,0.923444151144923,0,12,positive regulation of amyloid precursor protein catabolic process,BP,
19518,GO:1902994,1,0.986073008321631,0,2,regulation of phospholipid efflux,BP,
19519,GO:1902995,1,0.986073008321631,0,2,positive regulation of phospholipid efflux,BP,
19520,GO:1902996,1,0.98030757678995,0,2,regulation of neurofibrillary tangle assembly,BP,
19521,GO:1902997,1,0.986250878508321,0,1,negative regulation of neurofibrillary tangle assembly,BP,
19522,GO:1902998,1,0.993974682800764,0,1,positive regulation of neurofibrillary tangle assembly,BP,
19523,GO:1903000,1,0.996035242113144,0,1,regulation of lipid transport across blood brain barrier,BP,
19524,GO:1903002,1,0.996035242113144,0,1,positive regulation of lipid transport across blood brain barrier,BP,
19525,GO:1903003,1,0.962494202590628,0,6,positive regulation of protein deubiquitination,BP,
19526,GO:1903004,1,0.992939088184012,0,1,regulation of protein K63-linked deubiquitination,BP,
19527,GO:1903006,1,0.992939088184012,0,1,positive regulation of protein K63-linked deubiquitination,BP,
19528,GO:1903007,1,0.992939088184012,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
19529,GO:1903008,1,0.519290034775398,0,100,organelle disassembly,BP,
19532,GO:1903012,1,0.961114845816972,0,7,positive regulation of bone development,BP,
19533,GO:1903015,1,0.990505291703229,0,2,regulation of exo-alpha-sialidase activity,BP,
19534,GO:1903016,1,0.995082643175081,0,1,negative regulation of exo-alpha-sialidase activity,BP,
19535,GO:1903017,1,0.995400257842171,0,1,positive regulation of exo-alpha-sialidase activity,BP,
19536,GO:1903018,1,0.77771384201618,0,40,regulation of glycoprotein metabolic process,BP,
19537,GO:1903019,1,0.934432607499219,0,12,negative regulation of glycoprotein metabolic process,BP,
19538,GO:1903020,1,0.869112203355232,0,21,positive regulation of glycoprotein metabolic process,BP,
19539,GO:1903025,1,0.943280081375106,0,9,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19540,GO:1903026,1,0.97534291088612,0,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19541,GO:1903027,1,0.984045124306607,0,2,regulation of opsonization,BP,
19542,GO:1903028,1,0.989292421732962,0,1,positive regulation of opsonization,BP,
19543,GO:1903031,1,0.989421363543927,0,2,regulation of microtubule plus-end binding,BP,
19544,GO:1903033,1,0.989421363543927,0,2,positive regulation of microtubule plus-end binding,BP,
19545,GO:1903034,1,0.417480036753496,0,133,regulation of response to wounding,BP,
19546,GO:1903035,1,0.620120894813924,0,73,negative regulation of response to wounding,BP,
19547,GO:1903036,1,0.726054900274579,0,50,positive regulation of response to wounding,BP,
19549,GO:1903038,1,0.557655471571485,0,94,negative regulation of leukocyte cell-cell adhesion,BP,
19551,GO:1903044,1,0.953069972145038,0,8,protein localization to membrane raft,BP,
19552,GO:1903045,1,0.991168855662925,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
19555,GO:1903050,1,0.286879012461985,0,190,regulation of proteolysis involved in cellular protein catabolic process,BP,
19556,GO:1903051,1,0.689442603659185,0,56,negative regulation of proteolysis involved in cellular protein catabolic process,BP,
19557,GO:1903052,1,0.479266584337651,0,112,positive regulation of proteolysis involved in cellular protein catabolic process,BP,
19558,GO:1903053,1,0.811173902468209,0,28,regulation of extracellular matrix organization,BP,
19559,GO:1903054,1,0.967539928830313,0,6,negative regulation of extracellular matrix organization,BP,
19560,GO:1903055,1,0.895076052184641,0,15,positive regulation of extracellular matrix organization,BP,
19561,GO:1903056,1,0.983269798007839,0,2,regulation of melanosome organization,BP,
19562,GO:1903059,1,0.967329946850223,0,5,regulation of protein lipidation,BP,
19563,GO:1903060,1,0.995236261205466,0,1,negative regulation of protein lipidation,BP,
19564,GO:1903061,1,0.971961445435102,0,4,positive regulation of protein lipidation,BP,
19565,GO:1903069,1,0.948969515470082,0,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19566,GO:1903070,1,0.983168992645111,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19567,GO:1903071,1,0.960002730932357,0,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19568,GO:1903072,1,0.996339404102419,0,1,regulation of death-inducing signaling complex assembly,BP,
19569,GO:1903073,1,0.996339404102419,0,1,negative regulation of death-inducing signaling complex assembly,BP,
19572,GO:1903078,1,0.716287992213036,0,47,positive regulation of protein localization to plasma membrane,BP,
19573,GO:1903080,1,0.996193110740806,0,1,regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19574,GO:1903082,1,0.996193110740806,0,1,positive regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19575,GO:1903093,1,0.98211192700508,0,3,regulation of protein K48-linked deubiquitination,BP,
19576,GO:1903094,1,0.992248650770929,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19577,GO:1903095,1,0.986479729842114,0,2,ribonuclease III complex,CC,
19578,GO:1903096,1,0.993772597113732,0,1,protein localization to meiotic spindle midzone,BP,
19579,GO:1903108,1,0.991722170285736,0,1,regulation of mitochondrial transcription,BP,
19580,GO:1903109,1,0.991722170285736,0,1,positive regulation of mitochondrial transcription,BP,
19581,GO:1903115,1,0.731884227878708,0,38,regulation of actin filament-based movement,BP,
19582,GO:1903116,1,0.978103351835164,0,3,positive regulation of actin filament-based movement,BP,
19583,GO:1903119,1,0.977166594023451,0,3,protein localization to actin cytoskeleton,BP,
19584,GO:1903121,1,0.974156434748351,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
19585,GO:1903122,1,0.996339404102419,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
19586,GO:1903123,1,0.987748176584163,0,1,regulation of thioredoxin peroxidase activity,BP,
19587,GO:1903124,1,0.987748176584163,0,1,negative regulation of thioredoxin peroxidase activity,BP,
19588,GO:1903125,1,0.987748176584163,0,1,negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation,BP,
19589,GO:1903126,1,0.994832011533058,0,1,negative regulation of centriole-centriole cohesion,BP,
19590,GO:1903131,1,0.817329646731812,0,30,mononuclear cell differentiation,BP,
19591,GO:1903135,1,0.983344402248666,0,3,cupric ion binding,MF,
19592,GO:1903136,1,0.96575207362082,0,6,cuprous ion binding,MF,
19593,GO:1903140,1,0.92362677451947,0,12,regulation of establishment of endothelial barrier,BP,
19594,GO:1903141,1,0.992620466491251,0,1,negative regulation of establishment of endothelial barrier,BP,
19595,GO:1903142,1,0.969353133140905,0,5,positive regulation of establishment of endothelial barrier,BP,
19596,GO:1903143,1,0.984261824032797,0,3,adrenomedullin receptor complex,CC,
19597,GO:1903146,1,0.740070784657829,0,44,regulation of autophagy of mitochondrion,BP,
19598,GO:1903147,1,0.953912366133327,0,7,negative regulation of autophagy of mitochondrion,BP,
19599,GO:1903165,1,0.994147315111515,0,1,response to polycyclic arene,BP,
19600,GO:1903167,1,0.996339404102419,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
19601,GO:1903168,1,0.996339404102419,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
19603,GO:1903170,1,0.814328229675694,0,34,negative regulation of calcium ion transmembrane transport,BP,
19604,GO:1903173,1,0.988227903578437,0,2,fatty alcohol metabolic process,BP,
19605,GO:1903176,1,0.996339404102419,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
19606,GO:1903178,1,0.996339404102419,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
19607,GO:1903179,1,0.989863096631972,0,2,regulation of dopamine biosynthetic process,BP,
19608,GO:1903181,1,0.989863096631972,0,2,positive regulation of dopamine biosynthetic process,BP,
19609,GO:1903182,1,0.996006601352857,0,1,regulation of SUMO transferase activity,BP,
19610,GO:1903184,1,0.996339404102419,0,1,L-dopa metabolic process,BP,
19611,GO:1903185,1,0.996339404102419,0,1,L-dopa biosynthetic process,BP,
19612,GO:1903189,1,0.996339404102419,0,1,glyoxal metabolic process,BP,
19613,GO:1903195,1,0.996339404102419,0,1,regulation of L-dopa biosynthetic process,BP,
19614,GO:1903197,1,0.996339404102419,0,1,positive regulation of L-dopa biosynthetic process,BP,
19615,GO:1903198,1,0.996339404102419,0,1,regulation of L-dopa decarboxylase activity,BP,
19616,GO:1903200,1,0.996339404102419,0,1,positive regulation of L-dopa decarboxylase activity,BP,
19617,GO:1903201,1,0.695194339727412,0,57,regulation of oxidative stress-induced cell death,BP,
19618,GO:1903202,1,0.781948325005299,0,39,negative regulation of oxidative stress-induced cell death,BP,
19619,GO:1903203,1,0.868135804354537,0,20,regulation of oxidative stress-induced neuron death,BP,
19620,GO:1903204,1,0.902877120583452,0,15,negative regulation of oxidative stress-induced neuron death,BP,
19621,GO:1903205,1,0.858636670103882,0,24,regulation of hydrogen peroxide-induced cell death,BP,
19622,GO:1903206,1,0.898661850051383,0,17,negative regulation of hydrogen peroxide-induced cell death,BP,
19623,GO:1903207,1,0.977698184002982,0,4,regulation of hydrogen peroxide-induced neuron death,BP,
19624,GO:1903208,1,0.977698184002982,0,4,negative regulation of hydrogen peroxide-induced neuron death,BP,
19625,GO:1903209,1,0.919180847697599,0,13,positive regulation of oxidative stress-induced cell death,BP,
19626,GO:1903210,1,0.990516721249158,0,1,glomerular visceral epithelial cell apoptotic process,BP,
19627,GO:1903214,1,0.600805560124259,0,82,regulation of protein targeting to mitochondrion,BP,
19628,GO:1903215,1,0.971673940358418,0,4,negative regulation of protein targeting to mitochondrion,BP,
19629,GO:1903216,1,0.983842574302332,0,2,regulation of protein processing involved in protein targeting to mitochondrion,BP,
19630,GO:1903217,1,0.983842574302332,0,2,negative regulation of protein processing involved in protein targeting to mitochondrion,BP,
19631,GO:1903223,1,0.968522922801219,0,4,positive regulation of oxidative stress-induced neuron death,BP,
19632,GO:1903224,1,0.964398365228233,0,5,regulation of endodermal cell differentiation,BP,
19633,GO:1903225,1,0.974595706968267,0,3,negative regulation of endodermal cell differentiation,BP,
19634,GO:1903232,1,0.975193011581897,0,5,melanosome assembly,BP,
19635,GO:1903233,1,0.980663717084047,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
19636,GO:1903236,1,0.959253411496805,0,8,regulation of leukocyte tethering or rolling,BP,
19637,GO:1903237,1,0.984470315131107,0,4,negative regulation of leukocyte tethering or rolling,BP,
19638,GO:1903238,1,0.974389313640652,0,4,positive regulation of leukocyte tethering or rolling,BP,
19639,GO:1903242,1,0.938757470842071,0,8,regulation of cardiac muscle hypertrophy in response to stress,BP,
19640,GO:1903243,1,0.952500388025713,0,6,negative regulation of cardiac muscle hypertrophy in response to stress,BP,
19641,GO:1903244,1,0.985578778832116,0,2,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
19642,GO:1903248,1,0.988143720671723,0,1,regulation of citrulline biosynthetic process,BP,
19643,GO:1903249,1,0.988143720671723,0,1,negative regulation of citrulline biosynthetic process,BP,
19644,GO:1903251,1,0.957138951096345,0,7,multi-ciliated epithelial cell differentiation,BP,
19645,GO:1903265,1,0.957504473963764,0,8,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
19646,GO:1903276,1,0.980768684930686,0,4,regulation of sodium ion export across plasma membrane,BP,
19647,GO:1903278,1,0.980768684930686,0,4,positive regulation of sodium ion export across plasma membrane,BP,
19648,GO:1903279,1,0.978910201490316,0,3,regulation of calcium:sodium antiporter activity,BP,
19649,GO:1903280,1,0.991360405897632,0,1,negative regulation of calcium:sodium antiporter activity,BP,
19650,GO:1903281,1,0.987442386427863,0,2,positive regulation of calcium:sodium antiporter activity,BP,
19651,GO:1903282,1,0.993629084422039,0,1,regulation of glutathione peroxidase activity,BP,
19652,GO:1903284,1,0.993629084422039,0,1,positive regulation of glutathione peroxidase activity,BP,
19653,GO:1903285,1,0.993629084422039,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
19654,GO:1903286,1,0.975826485705971,0,4,regulation of potassium ion import,BP,
19655,GO:1903288,1,0.983883818814194,0,3,positive regulation of potassium ion import,BP,
19656,GO:1903292,1,0.987149696196444,0,2,protein localization to Golgi membrane,BP,
19657,GO:1903293,1,0.747446229394057,0,44,phosphatase complex,CC,
19658,GO:1903294,1,0.984838496704714,0,2,regulation of glutamate secretion, neurotransmission,BP,
19659,GO:1903296,1,0.984838496704714,0,2,positive regulation of glutamate secretion, neurotransmission,BP,
19660,GO:1903297,1,0.971516546517274,0,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19661,GO:1903298,1,0.971516546517274,0,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19662,GO:1903299,1,0.944265652114738,0,9,regulation of hexokinase activity,BP,
19663,GO:1903300,1,0.978530945234167,0,4,negative regulation of hexokinase activity,BP,
19664,GO:1903301,1,0.964990466236944,0,5,positive regulation of hexokinase activity,BP,
19671,GO:1903314,1,0.994811863082861,0,1,regulation of nitrogen cycle metabolic process,BP,
19674,GO:1903319,1,0.87616198129745,0,20,positive regulation of protein maturation,BP,
19675,GO:1903320,1,0.284864019117676,0,195,regulation of protein modification by small protein conjugation or removal,BP,
19676,GO:1903321,1,0.640874036593267,0,70,negative regulation of protein modification by small protein conjugation or removal,BP,
19677,GO:1903322,1,0.48856797715931,0,114,positive regulation of protein modification by small protein conjugation or removal,BP,
19678,GO:1903332,1,0.959440255224256,0,7,regulation of protein folding,BP,
19679,GO:1903333,1,0.971884500771562,0,5,negative regulation of protein folding,BP,
19680,GO:1903335,1,0.97275083873128,0,4,regulation of vacuolar transport,BP,
19681,GO:1903336,1,0.981327154915557,0,2,negative regulation of vacuolar transport,BP,
19682,GO:1903337,1,0.991262149672519,0,2,positive regulation of vacuolar transport,BP,
19683,GO:1903347,1,0.969243446578504,0,4,negative regulation of bicellular tight junction assembly,BP,
19684,GO:1903348,1,0.979489546474912,0,3,positive regulation of bicellular tight junction assembly,BP,
19685,GO:1903349,1,0.962845212209655,0,6,omegasome membrane,CC,
19686,GO:1903350,1,0.909882210501429,0,13,response to dopamine,BP,
19687,GO:1903351,1,0.909882210501429,0,13,cellular response to dopamine,BP,
19688,GO:1903352,1,0.957369438494666,0,6,L-ornithine transmembrane transport,BP,
19689,GO:1903358,1,0.902851123644037,0,15,regulation of Golgi organization,BP,
19690,GO:1903361,1,0.96338819633579,0,7,protein localization to basolateral plasma membrane,BP,
19691,GO:1903362,1,0.231697764875533,0,220,regulation of cellular protein catabolic process,BP,
19692,GO:1903363,1,0.645220251580992,0,67,negative regulation of cellular protein catabolic process,BP,
19693,GO:1903364,1,0.414171121753076,0,131,positive regulation of cellular protein catabolic process,BP,
19694,GO:1903365,1,0.95977606766616,0,7,regulation of fear response,BP,
19695,GO:1903367,1,0.973065812364366,0,5,positive regulation of fear response,BP,
19696,GO:1903371,1,0.965687419476473,0,4,regulation of endoplasmic reticulum tubular network organization,BP,
19697,GO:1903373,1,0.976255756106745,0,3,positive regulation of endoplasmic reticulum tubular network organization,BP,
19698,GO:1903375,1,0.985613852814075,0,2,facioacoustic ganglion development,BP,
19699,GO:1903376,1,0.956687239787325,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19700,GO:1903377,1,0.977247950237737,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19701,GO:1903378,1,0.98605266146075,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19702,GO:1903381,1,0.99226887678226,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19703,GO:1903382,1,0.99226887678226,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19704,GO:1903383,1,0.990545670756894,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19705,GO:1903384,1,0.990545670756894,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19706,GO:1903385,1,0.984929419567734,0,2,regulation of homophilic cell adhesion,BP,
19707,GO:1903387,1,0.991550283077046,0,1,positive regulation of homophilic cell adhesion,BP,
19708,GO:1903391,1,0.647600014540696,0,56,regulation of adherens junction organization,BP,
19709,GO:1903392,1,0.888065290787038,0,16,negative regulation of adherens junction organization,BP,
19710,GO:1903393,1,0.822086360661904,0,25,positive regulation of adherens junction organization,BP,
19711,GO:1903394,1,0.994558626689401,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
19712,GO:1903400,1,0.962906259100592,0,5,L-arginine transmembrane transport,BP,
19713,GO:1903401,1,0.968372187261388,0,5,L-lysine transmembrane transport,BP,
19714,GO:1903402,1,0.992934301076455,0,1,regulation of renal phosphate excretion,BP,
19715,GO:1903403,1,0.992934301076455,0,1,negative regulation of renal phosphate excretion,BP,
19716,GO:1903405,1,0.953111019125029,0,9,protein localization to nuclear body,BP,
19717,GO:1903406,1,0.993158446636833,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
19718,GO:1903408,1,0.993158446636833,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
19719,GO:1903409,1,0.577303675015954,0,83,reactive oxygen species biosynthetic process,BP,
19720,GO:1903412,1,0.985473092000365,0,3,response to bile acid,BP,
19721,GO:1903413,1,0.985473092000365,0,3,cellular response to bile acid,BP,
19722,GO:1903414,1,0.993438995494363,0,1,iron cation export,BP,
19723,GO:1903416,1,0.960969130394404,0,6,response to glycoside,BP,
19724,GO:1903420,1,0.990432597108412,0,1,protein localization to endoplasmic reticulum tubular network,BP,
19726,GO:1903422,1,0.983930289769719,0,2,negative regulation of synaptic vesicle recycling,BP,
19728,GO:1903426,1,0.659024617658911,0,65,regulation of reactive oxygen species biosynthetic process,BP,
19729,GO:1903427,1,0.880210195994909,0,21,negative regulation of reactive oxygen species biosynthetic process,BP,
19730,GO:1903428,1,0.758091424572011,0,42,positive regulation of reactive oxygen species biosynthetic process,BP,
19731,GO:1903429,1,0.871720672481758,0,20,regulation of cell maturation,BP,
19732,GO:1903430,1,0.961904829395706,0,7,negative regulation of cell maturation,BP,
19733,GO:1903431,1,0.946251111452,0,7,positive regulation of cell maturation,BP,
19734,GO:1903432,1,0.848302764151381,0,25,regulation of TORC1 signaling,BP,
19735,GO:1903433,1,0.987015833290438,0,2,regulation of constitutive secretory pathway,BP,
19736,GO:1903434,1,0.992950577253236,0,1,negative regulation of constitutive secretory pathway,BP,
19737,GO:1903435,1,0.994023548281361,0,1,positive regulation of constitutive secretory pathway,BP,
19738,GO:1903436,1,0.984041829712786,0,2,regulation of mitotic cytokinetic process,BP,
19739,GO:1903438,1,0.984041829712786,0,2,positive regulation of mitotic cytokinetic process,BP,
19740,GO:1903439,1,0.974004824215524,0,5,calcitonin family receptor complex,CC,
19741,GO:1903440,1,0.98203047333883,0,4,amylin receptor complex,CC,
19742,GO:1903441,1,0.950835156472228,0,8,protein localization to ciliary membrane,BP,
19743,GO:1903442,1,0.992981218339583,0,1,response to lipoic acid,BP,
19744,GO:1903444,1,0.993640449307716,0,1,negative regulation of brown fat cell differentiation,BP,
19745,GO:1903445,1,0.985799878813338,0,3,protein transport from ciliary membrane to plasma membrane,BP,
19746,GO:1903450,1,0.988324699852866,0,1,regulation of G1 to G0 transition,BP,
19747,GO:1903452,1,0.988324699852866,0,1,positive regulation of G1 to G0 transition,BP,
19748,GO:1903461,1,0.993694012463166,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
19749,GO:1903463,1,0.979755955376205,0,3,regulation of mitotic cell cycle DNA replication,BP,
19750,GO:1903464,1,0.988463582224172,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
19751,GO:1903465,1,0.991191773283465,0,1,positive regulation of mitotic cell cycle DNA replication,BP,
19752,GO:1903487,1,0.984595066239563,0,3,regulation of lactation,BP,
19753,GO:1903489,1,0.991282948169484,0,2,positive regulation of lactation,BP,
19754,GO:1903490,1,0.984041829712786,0,2,positive regulation of mitotic cytokinesis,BP,
19755,GO:1903494,1,0.996283655396962,0,1,response to dehydroepiandrosterone,BP,
19756,GO:1903496,1,0.996283655396962,0,1,response to 11-deoxycorticosterone,BP,
19757,GO:1903504,1,0.913968295933147,0,14,regulation of mitotic spindle checkpoint,BP,
19763,GO:1903513,1,0.848806856943755,0,26,endoplasmic reticulum to cytosol transport,BP,
19764,GO:1903514,1,0.792466880114767,0,29,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,
19765,GO:1903515,1,0.988685023314789,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
19766,GO:1903516,1,0.981696092405515,0,3,regulation of single strand break repair,BP,
19767,GO:1903517,1,0.993915936105817,0,1,negative regulation of single strand break repair,BP,
19768,GO:1903518,1,0.987706108316329,0,2,positive regulation of single strand break repair,BP,
19769,GO:1903519,1,0.981338416595721,0,3,regulation of mammary gland involution,BP,
19770,GO:1903521,1,0.981338416595721,0,3,positive regulation of mammary gland involution,BP,
19772,GO:1903523,1,0.821025278063757,0,27,negative regulation of blood circulation,BP,
19774,GO:1903525,1,0.960127686183643,0,5,regulation of membrane tubulation,BP,
19775,GO:1903526,1,0.985613604399961,0,2,negative regulation of membrane tubulation,BP,
19776,GO:1903527,1,0.9741458107362,0,3,positive regulation of membrane tubulation,BP,
19781,GO:1903537,1,0.988559866013296,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
19782,GO:1903538,1,0.988559866013296,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
19785,GO:1903541,1,0.919833532396059,0,14,regulation of exosomal secretion,BP,
19786,GO:1903542,1,0.988154112907672,0,2,negative regulation of exosomal secretion,BP,
19787,GO:1903543,1,0.919833532396059,0,14,positive regulation of exosomal secretion,BP,
19788,GO:1903544,1,0.993377444008772,0,1,response to butyrate,BP,
19789,GO:1903545,1,0.993377444008772,0,1,cellular response to butyrate,BP,
19790,GO:1903546,1,0.959666399386318,0,6,protein localization to photoreceptor outer segment,BP,
19791,GO:1903547,1,0.992173740851422,0,2,regulation of growth hormone activity,BP,
19792,GO:1903551,1,0.963764589510999,0,6,regulation of extracellular exosome assembly,BP,
19793,GO:1903553,1,0.974047155923343,0,4,positive regulation of extracellular exosome assembly,BP,
19794,GO:1903555,1,0.510072270868453,0,110,regulation of tumor necrosis factor superfamily cytokine production,BP,
19795,GO:1903556,1,0.776164426282825,0,45,negative regulation of tumor necrosis factor superfamily cytokine production,BP,
19796,GO:1903557,1,0.659064705194175,0,66,positive regulation of tumor necrosis factor superfamily cytokine production,BP,
19798,GO:1903564,1,0.965791545057916,0,4,regulation of protein localization to cilium,BP,
19799,GO:1903565,1,0.993392284425244,0,1,negative regulation of protein localization to cilium,BP,
19800,GO:1903566,1,0.972217502351203,0,3,positive regulation of protein localization to cilium,BP,
19801,GO:1903567,1,0.987965686176714,0,2,regulation of protein localization to ciliary membrane,BP,
19802,GO:1903568,1,0.993392284425244,0,1,negative regulation of protein localization to ciliary membrane,BP,
19803,GO:1903569,1,0.994537670788916,0,1,positive regulation of protein localization to ciliary membrane,BP,
19804,GO:1903570,1,0.993276806533302,0,1,regulation of protein kinase D signaling,BP,
19805,GO:1903572,1,0.993276806533302,0,1,positive regulation of protein kinase D signaling,BP,
19806,GO:1903573,1,0.77865755370501,0,40,negative regulation of response to endoplasmic reticulum stress,BP,
19807,GO:1903575,1,0.989104574548513,0,2,cornified envelope assembly,BP,
19808,GO:1903576,1,0.994912800220172,0,1,response to L-arginine,BP,
19809,GO:1903578,1,0.559069591637812,0,83,regulation of ATP metabolic process,BP,
19810,GO:1903579,1,0.881662056757897,0,19,negative regulation of ATP metabolic process,BP,
19811,GO:1903580,1,0.818478909487754,0,29,positive regulation of ATP metabolic process,BP,
19812,GO:1903584,1,0.992442931936121,0,1,regulation of histone deubiquitination,BP,
19813,GO:1903586,1,0.992442931936121,0,1,positive regulation of histone deubiquitination,BP,
19814,GO:1903587,1,0.943179342720067,0,9,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19815,GO:1903588,1,0.973972360924202,0,4,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19816,GO:1903589,1,0.96839238135712,0,5,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19817,GO:1903593,1,0.987411758354944,0,3,regulation of histamine secretion by mast cell,BP,
19818,GO:1903595,1,0.987411758354944,0,3,positive regulation of histamine secretion by mast cell,BP,
19819,GO:1903596,1,0.975392740865956,0,4,regulation of gap junction assembly,BP,
19820,GO:1903597,1,0.993431519320577,0,1,negative regulation of gap junction assembly,BP,
19821,GO:1903598,1,0.981843148582841,0,3,positive regulation of gap junction assembly,BP,
19822,GO:1903599,1,0.881580607013814,0,17,positive regulation of autophagy of mitochondrion,BP,
19823,GO:1903608,1,0.961572635645705,0,6,protein localization to cytoplasmic stress granule,BP,
19824,GO:1903609,1,0.994174093998246,0,1,negative regulation of inward rectifier potassium channel activity,BP,
19825,GO:1903610,1,0.995092164747453,0,1,regulation of calcium-dependent ATPase activity,BP,
19826,GO:1903611,1,0.995092164747453,0,1,negative regulation of calcium-dependent ATPase activity,BP,
19827,GO:1903613,1,0.991482810955034,0,1,regulation of protein tyrosine phosphatase activity,BP,
19828,GO:1903615,1,0.991482810955034,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
19829,GO:1903618,1,0.992809706686633,0,1,regulation of transdifferentiation,BP,
19830,GO:1903620,1,0.992809706686633,0,1,positive regulation of transdifferentiation,BP,
19831,GO:1903621,1,0.995069314413876,0,1,protein localization to photoreceptor connecting cilium,BP,
19832,GO:1903624,1,0.944646997773636,0,9,regulation of DNA catabolic process,BP,
19833,GO:1903625,1,0.989245432588639,0,2,negative regulation of DNA catabolic process,BP,
19834,GO:1903626,1,0.973726069128489,0,4,positive regulation of DNA catabolic process,BP,
19835,GO:1903627,1,0.995092164747453,0,1,regulation of dUTP diphosphatase activity,BP,
19836,GO:1903629,1,0.995092164747453,0,1,positive regulation of dUTP diphosphatase activity,BP,
19837,GO:1903630,1,0.991098330656867,0,2,regulation of aminoacyl-tRNA ligase activity,BP,
19838,GO:1903631,1,0.995092164747453,0,1,negative regulation of aminoacyl-tRNA ligase activity,BP,
19839,GO:1903632,1,0.995986667773477,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
19840,GO:1903633,1,0.995092164747453,0,1,regulation of leucine-tRNA ligase activity,BP,
19841,GO:1903634,1,0.995092164747453,0,1,negative regulation of leucine-tRNA ligase activity,BP,
19842,GO:1903636,1,0.996801118490797,0,1,regulation of protein import into mitochondrial outer membrane,BP,
19843,GO:1903638,1,0.996801118490797,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
19844,GO:1903639,1,0.996857747248315,0,1,regulation of gastrin-induced gastric acid secretion,BP,
19845,GO:1903640,1,0.996857747248315,0,1,negative regulation of gastrin-induced gastric acid secretion,BP,
19846,GO:1903644,1,0.991132104350064,0,2,regulation of chaperone-mediated protein folding,BP,
19847,GO:1903645,1,0.996801118490797,0,1,negative regulation of chaperone-mediated protein folding,BP,
19848,GO:1903649,1,0.866125762390233,0,20,regulation of cytoplasmic transport,BP,
19849,GO:1903650,1,0.992455184421824,0,2,negative regulation of cytoplasmic transport,BP,
19850,GO:1903651,1,0.930911672486993,0,9,positive regulation of cytoplasmic transport,BP,
19851,GO:1903659,1,0.99025360126977,0,2,regulation of complement-dependent cytotoxicity,BP,
19852,GO:1903660,1,0.99025360126977,0,2,negative regulation of complement-dependent cytotoxicity,BP,
19853,GO:1903670,1,0.681128350014616,0,55,regulation of sprouting angiogenesis,BP,
19854,GO:1903671,1,0.842896078048739,0,23,negative regulation of sprouting angiogenesis,BP,
19855,GO:1903672,1,0.814107518911174,0,31,positive regulation of sprouting angiogenesis,BP,
19856,GO:1903673,1,0.995102956696936,0,1,mitotic cleavage furrow formation,BP,
19857,GO:1903674,1,0.995111844710202,0,1,regulation of cap-dependent translational initiation,BP,
19858,GO:1903676,1,0.995111844710202,0,1,positive regulation of cap-dependent translational initiation,BP,
19859,GO:1903677,1,0.984242098013994,0,3,regulation of cap-independent translational initiation,BP,
19860,GO:1903679,1,0.984242098013994,0,3,positive regulation of cap-independent translational initiation,BP,
19861,GO:1903689,1,0.938875939019935,0,6,regulation of wound healing, spreading of epidermal cells,BP,
19862,GO:1903690,1,0.961255602570623,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
19863,GO:1903691,1,0.976727460536246,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
19864,GO:1903697,1,0.993441988412737,0,1,negative regulation of microvillus assembly,BP,
19865,GO:1903699,1,0.985546361916191,0,1,tarsal gland development,BP,
19866,GO:1903701,1,0.991635743632507,0,1,substantia propria of cornea development,BP,
19867,GO:1903704,1,0.992809706686633,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
19870,GO:1903708,1,0.382219342985913,0,151,positive regulation of hemopoiesis,BP,
19871,GO:1903709,1,0.985546361916191,0,1,uterine gland development,BP,
19872,GO:1903712,1,0.993075180528113,0,1,cysteine transmembrane transport,BP,
19873,GO:1903715,1,0.960184931602069,0,6,regulation of aerobic respiration,BP,
19874,GO:1903717,1,0.991080270082418,0,1,response to ammonia,BP,
19875,GO:1903718,1,0.991080270082418,0,1,cellular response to ammonia,BP,
19876,GO:1903719,1,0.98461964118296,0,3,regulation of I-kappaB phosphorylation,BP,
19877,GO:1903721,1,0.98461964118296,0,3,positive regulation of I-kappaB phosphorylation,BP,
19878,GO:1903722,1,0.989812055299262,0,2,regulation of centriole elongation,BP,
19879,GO:1903723,1,0.99637530557595,0,1,negative regulation of centriole elongation,BP,
19880,GO:1903724,1,0.993413114778193,0,1,positive regulation of centriole elongation,BP,
19881,GO:1903725,1,0.639523781222087,0,66,regulation of phospholipid metabolic process,BP,
19882,GO:1903726,1,0.958567668440875,0,7,negative regulation of phospholipid metabolic process,BP,
19883,GO:1903727,1,0.759375174579588,0,42,positive regulation of phospholipid metabolic process,BP,
19884,GO:1903729,1,0.927502681861563,0,11,regulation of plasma membrane organization,BP,
19885,GO:1903742,1,0.995844403609718,0,1,regulation of anterograde synaptic vesicle transport,BP,
19886,GO:1903743,1,0.995844403609718,0,1,negative regulation of anterograde synaptic vesicle transport,BP,
19887,GO:1903747,1,0.494871149629944,0,115,regulation of establishment of protein localization to mitochondrion,BP,
19888,GO:1903748,1,0.952138342664794,0,7,negative regulation of establishment of protein localization to mitochondrion,BP,
19889,GO:1903749,1,0.532065754972398,0,104,positive regulation of establishment of protein localization to mitochondrion,BP,
19890,GO:1903750,1,0.978434062976278,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
19891,GO:1903751,1,0.978434062976278,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
19892,GO:1903753,1,0.967512762454445,0,5,negative regulation of p38MAPK cascade,BP,
19893,GO:1903755,1,0.996006601352857,0,1,positive regulation of SUMO transferase activity,BP,
19894,GO:1903756,1,0.986799165882215,0,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,
19895,GO:1903758,1,0.986799165882215,0,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,
19896,GO:1903759,1,0.993640449307716,0,1,signal transduction involved in regulation of aerobic respiration,BP,
19897,GO:1903760,1,0.977183742944549,0,3,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19898,GO:1903762,1,0.985252167877355,0,2,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19899,GO:1903763,1,0.977782642438538,0,3,gap junction channel activity involved in cell communication by electrical coupling,MF,
19900,GO:1903764,1,0.982091666974482,0,3,regulation of potassium ion export across plasma membrane,BP,
19901,GO:1903765,1,0.993736037427491,0,1,negative regulation of potassium ion export across plasma membrane,BP,
19902,GO:1903766,1,0.996442105952666,0,1,positive regulation of potassium ion export across plasma membrane,BP,
19903,GO:1903767,1,0.994307000868295,0,1,sweet taste receptor complex,CC,
19904,GO:1903768,1,0.994307000868295,0,1,taste receptor complex,CC,
19905,GO:1903770,1,0.993915936105817,0,1,negative regulation of beta-galactosidase activity,BP,
19906,GO:1903772,1,0.974747979441067,0,5,regulation of viral budding via host ESCRT complex,BP,
19907,GO:1903774,1,0.98452710463494,0,3,positive regulation of viral budding via host ESCRT complex,BP,
19908,GO:1903775,1,0.988286736895017,0,2,regulation of DNA double-strand break processing,BP,
19909,GO:1903778,1,0.990466809916231,0,1,protein localization to vacuolar membrane,BP,
19910,GO:1903779,1,0.595033190469949,0,69,regulation of cardiac conduction,BP,
19911,GO:1903781,1,0.978062607137215,0,3,positive regulation of cardiac conduction,BP,
19912,GO:1903786,1,0.9940959129705,0,1,regulation of glutathione biosynthetic process,BP,
19913,GO:1903788,1,0.9940959129705,0,1,positive regulation of glutathione biosynthetic process,BP,
19914,GO:1903789,1,0.948792672166741,0,8,regulation of amino acid transmembrane transport,BP,
19915,GO:1903792,1,0.85779775739241,0,22,negative regulation of anion transport,BP,
19917,GO:1903795,1,0.949663859905356,0,6,regulation of inorganic anion transmembrane transport,BP,
19918,GO:1903796,1,0.982188051429379,0,2,negative regulation of inorganic anion transmembrane transport,BP,
19919,GO:1903797,1,0.983434131912463,0,2,positive regulation of inorganic anion transmembrane transport,BP,
19920,GO:1903798,1,0.907809332178856,0,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19921,GO:1903799,1,0.938864469447124,0,8,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19922,GO:1903800,1,0.961861861478366,0,7,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19923,GO:1903801,1,0.994667784128221,0,1,L-leucine import across plasma membrane,BP,
19924,GO:1903803,1,0.995092799545279,0,1,L-glutamine import across plasma membrane,BP,
19925,GO:1903804,1,0.993945757220618,0,1,glycine import across plasma membrane,BP,
19926,GO:1903814,1,0.996442105952666,0,1,regulation of collecting lymphatic vessel constriction,BP,
19927,GO:1903815,1,0.996442105952666,0,1,negative regulation of collecting lymphatic vessel constriction,BP,
19928,GO:1903817,1,0.950373309589569,0,8,negative regulation of voltage-gated potassium channel activity,BP,
19930,GO:1903823,1,0.993915936105817,0,1,telomere single strand break repair,BP,
19931,GO:1903824,1,0.993915936105817,0,1,negative regulation of telomere single strand break repair,BP,
19933,GO:1903826,1,0.958226985622751,0,6,arginine transmembrane transport,BP,
19937,GO:1903830,1,0.896235932725894,0,16,magnesium ion transmembrane transport,BP,
19939,GO:1903837,1,0.994409330361848,0,1,regulation of mRNA 3'-UTR binding,BP,
19940,GO:1903839,1,0.994409330361848,0,1,positive regulation of mRNA 3'-UTR binding,BP,
19941,GO:1903844,1,0.483905346927139,0,100,regulation of cellular response to transforming growth factor beta stimulus,BP,
19942,GO:1903845,1,0.61086138343994,0,68,negative regulation of cellular response to transforming growth factor beta stimulus,BP,
19943,GO:1903846,1,0.838027900161884,0,25,positive regulation of cellular response to transforming growth factor beta stimulus,BP,
19944,GO:1903847,1,0.980298275941658,0,2,regulation of aorta morphogenesis,BP,
19945,GO:1903849,1,0.980298275941658,0,2,positive regulation of aorta morphogenesis,BP,
19946,GO:1903850,1,0.994185195573167,0,1,regulation of cristae formation,BP,
19947,GO:1903852,1,0.994185195573167,0,1,positive regulation of cristae formation,BP,
19949,GO:1903860,1,0.984379807286746,0,3,negative regulation of dendrite extension,BP,
19951,GO:1903862,1,0.969390385271056,0,6,positive regulation of oxidative phosphorylation,BP,
19952,GO:1903867,1,0.938069142916035,0,9,extraembryonic membrane development,BP,
19953,GO:1903874,1,0.978380616866413,0,3,ferrous iron transmembrane transport,BP,
19954,GO:1903881,1,0.993089110889709,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
19955,GO:1903883,1,0.993089110889709,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
19956,GO:1903884,1,0.993089110889709,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
19957,GO:1903886,1,0.993089110889709,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
19958,GO:1903888,1,0.996531076871997,0,1,regulation of plant epidermal cell differentiation,BP,
19959,GO:1903889,1,0.996531076871997,0,1,negative regulation of plant epidermal cell differentiation,BP,
19960,GO:1903891,1,0.974856217867137,0,4,regulation of ATF6-mediated unfolded protein response,BP,
19961,GO:1903892,1,0.987431517001397,0,2,negative regulation of ATF6-mediated unfolded protein response,BP,
19962,GO:1903893,1,0.994380284882707,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
19963,GO:1903894,1,0.921534294979543,0,13,regulation of IRE1-mediated unfolded protein response,BP,
19964,GO:1903895,1,0.975104898573591,0,4,negative regulation of IRE1-mediated unfolded protein response,BP,
19965,GO:1903896,1,0.953555321846048,0,7,positive regulation of IRE1-mediated unfolded protein response,BP,
19966,GO:1903897,1,0.94245146446392,0,9,regulation of PERK-mediated unfolded protein response,BP,
19967,GO:1903898,1,0.969664170421974,0,5,negative regulation of PERK-mediated unfolded protein response,BP,
19968,GO:1903899,1,0.978949290999113,0,3,positive regulation of PERK-mediated unfolded protein response,BP,
19970,GO:1903901,1,0.655071576887557,0,69,negative regulation of viral life cycle,BP,
19972,GO:1903903,1,0.977859678226917,0,3,regulation of establishment of T cell polarity,BP,
19973,GO:1903905,1,0.983664323291273,0,2,positive regulation of establishment of T cell polarity,BP,
19974,GO:1903906,1,0.994099935774064,0,1,regulation of plasma membrane raft polarization,BP,
19975,GO:1903909,1,0.944049726329602,0,8,regulation of receptor clustering,BP,
19976,GO:1903910,1,0.994577154467648,0,1,negative regulation of receptor clustering,BP,
19977,GO:1903911,1,0.973910840698994,0,4,positive regulation of receptor clustering,BP,
19978,GO:1903912,1,0.972816165706972,0,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
19979,GO:1903916,1,0.994524135749862,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
19980,GO:1903917,1,0.994524135749862,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
19981,GO:1903918,1,0.989346373481308,0,1,regulation of actin filament severing,BP,
19982,GO:1903919,1,0.989346373481308,0,1,negative regulation of actin filament severing,BP,
19983,GO:1903921,1,0.983508537262953,0,2,regulation of protein processing in phagocytic vesicle,BP,
19984,GO:1903923,1,0.983508537262953,0,2,positive regulation of protein processing in phagocytic vesicle,BP,
19985,GO:1903924,1,0.994717736284321,0,1,estradiol binding,MF,
19986,GO:1903925,1,0.995167715599473,0,1,response to bisphenol A,BP,
19987,GO:1903926,1,0.995167715599473,0,1,cellular response to bisphenol A,BP,
19988,GO:1903929,1,0.988209181420339,0,2,primary palate development,BP,
19989,GO:1903935,1,0.973803257088874,0,5,response to sodium arsenite,BP,
19990,GO:1903936,1,0.973803257088874,0,5,cellular response to sodium arsenite,BP,
19991,GO:1903937,1,0.991874862093252,0,1,response to acrylamide,BP,
19992,GO:1903939,1,0.99345197504884,0,1,regulation of TORC2 signaling,BP,
19993,GO:1903943,1,0.995050911452303,0,1,regulation of hepatocyte apoptotic process,BP,
19994,GO:1903944,1,0.995050911452303,0,1,negative regulation of hepatocyte apoptotic process,BP,
19995,GO:1903946,1,0.993736037427491,0,1,negative regulation of ventricular cardiac muscle cell action potential,BP,
19996,GO:1903947,1,0.985252167877355,0,2,positive regulation of ventricular cardiac muscle cell action potential,BP,
19997,GO:1903949,1,0.985635191829306,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
19998,GO:1903952,1,0.992838497329052,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19999,GO:1903954,1,0.992838497329052,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
20000,GO:1903955,1,0.632832170519368,0,74,positive regulation of protein targeting to mitochondrion,BP,
20001,GO:1903959,1,0.841168719530701,0,23,regulation of anion transmembrane transport,BP,
20002,GO:1903960,1,0.921228995603253,0,11,negative regulation of anion transmembrane transport,BP,
20003,GO:1903961,1,0.959012409402023,0,6,positive regulation of anion transmembrane transport,BP,
20004,GO:1903963,1,0.89378773454949,0,19,arachidonate transport,BP,
20005,GO:1903964,1,0.981530451000193,0,3,monounsaturated fatty acid metabolic process,BP,
20006,GO:1903965,1,0.99578687511576,0,1,monounsaturated fatty acid catabolic process,BP,
20007,GO:1903966,1,0.985683864636842,0,2,monounsaturated fatty acid biosynthetic process,BP,
20008,GO:1903969,1,0.985521635903851,0,3,regulation of response to macrophage colony-stimulating factor,BP,
20009,GO:1903970,1,0.991008267199802,0,2,negative regulation of response to macrophage colony-stimulating factor,BP,
20010,GO:1903971,1,0.994464091376545,0,1,positive regulation of response to macrophage colony-stimulating factor,BP,
20011,GO:1903972,1,0.985521635903851,0,3,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
20012,GO:1903973,1,0.991008267199802,0,2,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
20013,GO:1903974,1,0.994464091376545,0,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
20014,GO:1903975,1,0.950351878585401,0,9,regulation of glial cell migration,BP,
20015,GO:1903976,1,0.979976163401084,0,4,negative regulation of glial cell migration,BP,
20016,GO:1903977,1,0.978635728606363,0,3,positive regulation of glial cell migration,BP,
20017,GO:1903978,1,0.930315260150129,0,9,regulation of microglial cell activation,BP,
20018,GO:1903979,1,0.9877265536795,0,2,negative regulation of microglial cell activation,BP,
20019,GO:1903980,1,0.951443113415293,0,7,positive regulation of microglial cell activation,BP,
20020,GO:1903984,1,0.97773634654183,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
20021,GO:1903988,1,0.993438995494363,0,1,ferrous iron export across plasma membrane,BP,
20022,GO:1903995,1,0.990405039936352,0,2,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
20023,GO:1903997,1,0.990405039936352,0,2,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
20024,GO:1903998,1,0.973159396753881,0,4,regulation of eating behavior,BP,
20025,GO:1903999,1,0.988136002162661,0,2,negative regulation of eating behavior,BP,
20026,GO:1904000,1,0.984845391628886,0,2,positive regulation of eating behavior,BP,
20030,GO:1904016,1,0.968475340980645,0,4,response to Thyroglobulin triiodothyronine,BP,
20031,GO:1904017,1,0.980707093726299,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
20033,GO:1904019,1,0.545758671924218,0,87,epithelial cell apoptotic process,BP,
20034,GO:1904020,1,0.982550454102089,0,3,regulation of G-protein coupled receptor internalization,BP,
20035,GO:1904021,1,0.988903675442561,0,2,negative regulation of G-protein coupled receptor internalization,BP,
20036,GO:1904022,1,0.993576212296719,0,1,positive regulation of G-protein coupled receptor internalization,BP,
20037,GO:1904026,1,0.988426202632812,0,2,regulation of collagen fibril organization,BP,
20038,GO:1904027,1,0.994338138916662,0,1,negative regulation of collagen fibril organization,BP,
20039,GO:1904028,1,0.994054740756748,0,1,positive regulation of collagen fibril organization,BP,
20040,GO:1904029,1,0.579047338159033,0,88,regulation of cyclin-dependent protein kinase activity,BP,
20041,GO:1904030,1,0.806131538847113,0,32,negative regulation of cyclin-dependent protein kinase activity,BP,
20042,GO:1904031,1,0.800901321933069,0,36,positive regulation of cyclin-dependent protein kinase activity,BP,
20043,GO:1904035,1,0.65518624779372,0,64,regulation of epithelial cell apoptotic process,BP,
20044,GO:1904036,1,0.790960665954247,0,35,negative regulation of epithelial cell apoptotic process,BP,
20045,GO:1904037,1,0.842670776816553,0,26,positive regulation of epithelial cell apoptotic process,BP,
20046,GO:1904041,1,0.993502154158033,0,1,regulation of cystathionine beta-synthase activity,BP,
20047,GO:1904042,1,0.993502154158033,0,1,negative regulation of cystathionine beta-synthase activity,BP,
20048,GO:1904044,1,0.976884934219857,0,4,response to aldosterone,BP,
20049,GO:1904045,1,0.994734010394284,0,1,cellular response to aldosterone,BP,
20050,GO:1904046,1,0.991542004717462,0,2,negative regulation of vascular endothelial growth factor production,BP,
20051,GO:1904047,1,0.983127678005375,0,3,S-adenosyl-L-methionine binding,MF,
20052,GO:1904048,1,0.979385916256072,0,2,regulation of spontaneous neurotransmitter secretion,BP,
20053,GO:1904049,1,0.98700589654982,0,1,negative regulation of spontaneous neurotransmitter secretion,BP,
20054,GO:1904050,1,0.992280715131527,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
20055,GO:1904054,1,0.988194477035737,0,1,regulation of cholangiocyte proliferation,BP,
20056,GO:1904056,1,0.988194477035737,0,1,positive regulation of cholangiocyte proliferation,BP,
20057,GO:1904057,1,0.989753096221107,0,2,negative regulation of sensory perception of pain,BP,
20058,GO:1904058,1,0.967107461608164,0,5,positive regulation of sensory perception of pain,BP,
20059,GO:1904059,1,0.977048503710828,0,2,regulation of locomotor rhythm,BP,
20061,GO:1904063,1,0.641315981664051,0,69,negative regulation of cation transmembrane transport,BP,
20063,GO:1904071,1,0.980907467548424,0,2,presynaptic active zone assembly,BP,
20064,GO:1904073,1,0.989611202577478,0,1,regulation of trophectodermal cell proliferation,BP,
20065,GO:1904075,1,0.989611202577478,0,1,positive regulation of trophectodermal cell proliferation,BP,
20066,GO:1904090,1,0.982927411949603,0,4,peptidase inhibitor complex,CC,
20067,GO:1904098,1,0.981134240796841,0,3,regulation of protein O-linked glycosylation,BP,
20068,GO:1904100,1,0.981134240796841,0,3,positive regulation of protein O-linked glycosylation,BP,
20069,GO:1904106,1,0.994072421404705,0,1,protein localization to microvillus,BP,
20071,GO:1904116,1,0.978272870314195,0,3,response to vasopressin,BP,
20072,GO:1904117,1,0.978272870314195,0,3,cellular response to vasopressin,BP,
20073,GO:1904118,1,0.993689830708738,0,1,regulation of otic vesicle morphogenesis,BP,
20074,GO:1904120,1,0.993689830708738,0,1,positive regulation of otic vesicle morphogenesis,BP,
20075,GO:1904121,1,0.977023120929014,0,3,phosphatidylethanolamine transporter activity,MF,
20076,GO:1904124,1,0.985794209663455,0,3,microglial cell migration,BP,
20077,GO:1904139,1,0.985794209663455,0,3,regulation of microglial cell migration,BP,
20078,GO:1904140,1,0.995612572848999,0,1,negative regulation of microglial cell migration,BP,
20079,GO:1904141,1,0.994464091376545,0,1,positive regulation of microglial cell migration,BP,
20080,GO:1904149,1,0.995612572848999,0,1,regulation of microglial cell mediated cytotoxicity,BP,
20081,GO:1904151,1,0.995612572848999,0,1,positive regulation of microglial cell mediated cytotoxicity,BP,
20082,GO:1904152,1,0.922022470435454,0,13,regulation of retrograde protein transport, ER to cytosol,BP,
20083,GO:1904153,1,0.945785618715238,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
20084,GO:1904154,1,0.981483339304978,0,3,positive regulation of retrograde protein transport, ER to cytosol,BP,
20085,GO:1904155,1,0.993451475339819,0,1,DN2 thymocyte differentiation,BP,
20086,GO:1904156,1,0.993451475339819,0,1,DN3 thymocyte differentiation,BP,
20087,GO:1904158,1,0.972438515519761,0,3,axonemal central apparatus assembly,BP,
20088,GO:1904167,1,0.986664821333736,0,1,regulation of thyroid hormone receptor activity,BP,
20089,GO:1904168,1,0.986664821333736,0,1,negative regulation of thyroid hormone receptor activity,BP,
20090,GO:1904170,1,0.985750499015925,0,2,regulation of bleb assembly,BP,
20091,GO:1904172,1,0.985750499015925,0,2,positive regulation of bleb assembly,BP,
20092,GO:1904177,1,0.96277205818837,0,6,regulation of adipose tissue development,BP,
20093,GO:1904179,1,0.966683746037508,0,5,positive regulation of adipose tissue development,BP,
20094,GO:1904180,1,0.966031208912736,0,6,negative regulation of membrane depolarization,BP,
20095,GO:1904181,1,0.936979333259455,0,10,positive regulation of membrane depolarization,BP,
20096,GO:1904182,1,0.996046445010638,0,1,regulation of pyruvate dehydrogenase activity,BP,
20097,GO:1904192,1,0.988194477035737,0,1,regulation of cholangiocyte apoptotic process,BP,
20098,GO:1904193,1,0.988194477035737,0,1,negative regulation of cholangiocyte apoptotic process,BP,
20099,GO:1904195,1,0.988194477035737,0,1,regulation of granulosa cell proliferation,BP,
20100,GO:1904197,1,0.988194477035737,0,1,positive regulation of granulosa cell proliferation,BP,
20101,GO:1904199,1,0.992745260332433,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
20102,GO:1904200,1,0.988194477035737,0,1,iodide transmembrane transport,BP,
20103,GO:1904201,1,0.988194477035737,0,1,regulation of iodide transport,BP,
20104,GO:1904202,1,0.988194477035737,0,1,negative regulation of iodide transport,BP,
20105,GO:1904204,1,0.97890731315283,0,2,regulation of skeletal muscle hypertrophy,BP,
20106,GO:1904205,1,0.990603005738011,0,1,negative regulation of skeletal muscle hypertrophy,BP,
20107,GO:1904206,1,0.988194477035737,0,1,positive regulation of skeletal muscle hypertrophy,BP,
20108,GO:1904207,1,0.988272036319858,0,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,
20109,GO:1904209,1,0.988272036319858,0,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,
20110,GO:1904210,1,0.995775610852966,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20111,GO:1904211,1,0.987146852435233,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
20112,GO:1904212,1,0.988194477035737,0,1,regulation of iodide transmembrane transport,BP,
20113,GO:1904213,1,0.988194477035737,0,1,negative regulation of iodide transmembrane transport,BP,
20114,GO:1904217,1,0.983825005359277,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
20115,GO:1904219,1,0.983825005359277,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
20116,GO:1904220,1,0.97797494919163,0,4,regulation of serine C-palmitoyltransferase activity,BP,
20117,GO:1904222,1,0.983825005359277,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
20118,GO:1904226,1,0.994766612493681,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
20119,GO:1904227,1,0.994766612493681,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
20120,GO:1904229,1,0.989700569072569,0,1,regulation of succinate dehydrogenase activity,BP,
20121,GO:1904231,1,0.989700569072569,0,1,positive regulation of succinate dehydrogenase activity,BP,
20122,GO:1904232,1,0.989700569072569,0,1,regulation of aconitate hydratase activity,BP,
20123,GO:1904234,1,0.989700569072569,0,1,positive regulation of aconitate hydratase activity,BP,
20124,GO:1904235,1,0.988544123218506,0,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20125,GO:1904237,1,0.988544123218506,0,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20126,GO:1904238,1,0.956407621452788,0,7,pericyte cell differentiation,BP,
20127,GO:1904239,1,0.995775610852966,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20128,GO:1904240,1,0.995775610852966,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20129,GO:1904245,1,0.989080999009937,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
20130,GO:1904246,1,0.995327529153892,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
20131,GO:1904247,1,0.993724442432942,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
20132,GO:1904251,1,0.94080218370647,0,10,regulation of bile acid metabolic process,BP,
20133,GO:1904252,1,0.982698896636672,0,3,negative regulation of bile acid metabolic process,BP,
20134,GO:1904253,1,0.982999546645708,0,3,positive regulation of bile acid metabolic process,BP,
20135,GO:1904259,1,0.952787322398241,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20136,GO:1904261,1,0.952787322398241,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20137,GO:1904262,1,0.92966401674082,0,11,negative regulation of TORC1 signaling,BP,
20138,GO:1904263,1,0.944653187218713,0,9,positive regulation of TORC1 signaling,BP,
20139,GO:1904265,1,0.990578472102234,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
20140,GO:1904266,1,0.989648928315445,0,1,regulation of Schwann cell chemotaxis,BP,
20141,GO:1904268,1,0.989648928315445,0,1,positive regulation of Schwann cell chemotaxis,BP,
20142,GO:1904271,1,0.994415395872108,0,1,L-proline import across plasma membrane,BP,
20143,GO:1904274,1,0.994718987475769,0,1,tricellular tight junction assembly,BP,
20144,GO:1904282,1,0.995068679758576,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20145,GO:1904283,1,0.995068679758576,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20146,GO:1904288,1,0.970026081139645,0,4,BAT3 complex binding,MF,
20147,GO:1904289,1,0.986164891282005,0,2,regulation of mitotic DNA damage checkpoint,BP,
20148,GO:1904290,1,0.99229649153923,0,1,negative regulation of mitotic DNA damage checkpoint,BP,
20149,GO:1904292,1,0.837036280940244,0,27,regulation of ERAD pathway,BP,
20150,GO:1904293,1,0.922380614666792,0,13,negative regulation of ERAD pathway,BP,
20151,GO:1904294,1,0.915707344599197,0,13,positive regulation of ERAD pathway,BP,
20152,GO:1904298,1,0.992679109517626,0,1,regulation of transcytosis,BP,
20153,GO:1904300,1,0.992679109517626,0,1,positive regulation of transcytosis,BP,
20154,GO:1904301,1,0.992679109517626,0,1,regulation of maternal process involved in parturition,BP,
20155,GO:1904303,1,0.992679109517626,0,1,positive regulation of maternal process involved in parturition,BP,
20156,GO:1904304,1,0.971791615017473,0,5,regulation of gastro-intestinal system smooth muscle contraction,BP,
20157,GO:1904306,1,0.971791615017473,0,5,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
20158,GO:1904313,1,0.992846169558835,0,1,response to methamphetamine hydrochloride,BP,
20160,GO:1904316,1,0.992679109517626,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20161,GO:1904317,1,0.992679109517626,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20164,GO:1904323,1,0.993910437466855,0,1,regulation of inhibitory G-protein coupled receptor phosphorylation,BP,
20165,GO:1904325,1,0.993910437466855,0,1,positive regulation of inhibitory G-protein coupled receptor phosphorylation,BP,
20166,GO:1904327,1,0.984248633109185,0,2,protein localization to cytosolic proteasome complex,BP,
20167,GO:1904328,1,0.994117792638113,0,1,regulation of myofibroblast contraction,BP,
20169,GO:1904339,1,0.985347657588519,0,2,negative regulation of dopaminergic neuron differentiation,BP,
20170,GO:1904340,1,0.98072360639279,0,4,positive regulation of dopaminergic neuron differentiation,BP,
20171,GO:1904341,1,0.991649235187485,0,1,regulation of colon smooth muscle contraction,BP,
20172,GO:1904343,1,0.991649235187485,0,1,positive regulation of colon smooth muscle contraction,BP,
20173,GO:1904344,1,0.996611310932968,0,1,regulation of gastric mucosal blood circulation,BP,
20174,GO:1904346,1,0.996611310932968,0,1,positive regulation of gastric mucosal blood circulation,BP,
20175,GO:1904347,1,0.988288559505802,0,2,regulation of small intestine smooth muscle contraction,BP,
20176,GO:1904349,1,0.988288559505802,0,2,positive regulation of small intestine smooth muscle contraction,BP,
20177,GO:1904350,1,0.924660961800082,0,9,regulation of protein catabolic process in the vacuole,BP,
20178,GO:1904351,1,0.981127646336694,0,3,negative regulation of protein catabolic process in the vacuole,BP,
20179,GO:1904352,1,0.947677998364817,0,5,positive regulation of protein catabolic process in the vacuole,BP,
20180,GO:1904353,1,0.829057069170454,0,26,regulation of telomere capping,BP,
20181,GO:1904354,1,0.934254289629331,0,8,negative regulation of telomere capping,BP,
20182,GO:1904355,1,0.895183879798973,0,17,positive regulation of telomere capping,BP,
20183,GO:1904356,1,0.668774178276839,0,58,regulation of telomere maintenance via telomere lengthening,BP,
20184,GO:1904357,1,0.826373755169262,0,25,negative regulation of telomere maintenance via telomere lengthening,BP,
20185,GO:1904358,1,0.791790181334321,0,36,positive regulation of telomere maintenance via telomere lengthening,BP,
20186,GO:1904373,1,0.995576114681991,0,1,response to kainic acid,BP,
20189,GO:1904377,1,0.685083585300151,0,53,positive regulation of protein localization to cell periphery,BP,
20190,GO:1904378,1,0.978052121276861,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
20191,GO:1904379,1,0.984248633109185,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
20192,GO:1904380,1,0.873553238743285,0,20,endoplasmic reticulum mannose trimming,BP,
20193,GO:1904381,1,0.977879328201229,0,3,Golgi apparatus mannose trimming,BP,
20194,GO:1904382,1,0.970405141075512,0,4,mannose trimming involved in glycoprotein ERAD pathway,BP,
20195,GO:1904383,1,0.988773049866582,0,2,response to sodium phosphate,BP,
20197,GO:1904386,1,0.966784740993605,0,5,response to L-phenylalanine derivative,BP,
20198,GO:1904387,1,0.986845598664973,0,2,cellular response to L-phenylalanine derivative,BP,
20199,GO:1904389,1,0.995576114681991,0,1,rod bipolar cell differentiation,BP,
20200,GO:1904391,1,0.995576114681991,0,1,response to ciliary neurotrophic factor,BP,
20201,GO:1904393,1,0.979187110579465,0,3,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20202,GO:1904394,1,0.994577154467648,0,1,negative regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20203,GO:1904395,1,0.984526886574324,0,2,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20204,GO:1904396,1,0.94296914086815,0,8,regulation of neuromuscular junction development,BP,
20205,GO:1904397,1,0.99017701758096,0,2,negative regulation of neuromuscular junction development,BP,
20206,GO:1904398,1,0.97421415275363,0,3,positive regulation of neuromuscular junction development,BP,
20207,GO:1904399,1,0.995576114681991,0,1,heparan sulfate binding,MF,
20208,GO:1904400,1,0.99370605575639,0,1,response to Thyroid stimulating hormone,BP,
20209,GO:1904404,1,0.989508738651349,0,1,response to formaldehyde,BP,
20210,GO:1904406,1,0.926175174387052,0,12,negative regulation of nitric oxide metabolic process,BP,
20211,GO:1904407,1,0.795571963421608,0,35,positive regulation of nitric oxide metabolic process,BP,
20212,GO:1904408,1,0.996081283074209,0,1,melatonin binding,MF,
20213,GO:1904412,1,0.993177281716257,0,1,regulation of cardiac ventricle development,BP,
20214,GO:1904414,1,0.993177281716257,0,1,positive regulation of cardiac ventricle development,BP,
20215,GO:1904415,1,0.963025570345565,0,6,regulation of xenophagy,BP,
20216,GO:1904417,1,0.963025570345565,0,6,positive regulation of xenophagy,BP,
20217,GO:1904424,1,0.928220128632558,0,10,regulation of GTP binding,BP,
20218,GO:1904425,1,0.993033918811683,0,1,negative regulation of GTP binding,BP,
20219,GO:1904426,1,0.984568333879464,0,2,positive regulation of GTP binding,BP,
20220,GO:1904427,1,0.680415328542252,0,59,positive regulation of calcium ion transmembrane transport,BP,
20221,GO:1904428,1,0.973681056991286,0,3,negative regulation of tubulin deacetylation,BP,
20222,GO:1904429,1,0.961727302009333,0,6,regulation of t-circle formation,BP,
20223,GO:1904430,1,0.979656736385608,0,3,negative regulation of t-circle formation,BP,
20224,GO:1904431,1,0.981702012501789,0,3,positive regulation of t-circle formation,BP,
20225,GO:1904432,1,0.991361842612445,0,2,regulation of ferrous iron binding,BP,
20226,GO:1904434,1,0.991361842612445,0,2,positive regulation of ferrous iron binding,BP,
20227,GO:1904435,1,0.991361842612445,0,2,regulation of transferrin receptor binding,BP,
20228,GO:1904437,1,0.991361842612445,0,2,positive regulation of transferrin receptor binding,BP,
20229,GO:1904447,1,0.97289576147814,0,2,folic acid import across plasma membrane,BP,
20230,GO:1904448,1,0.991914726505661,0,1,regulation of aspartate secretion,BP,
20231,GO:1904450,1,0.991914726505661,0,1,positive regulation of aspartate secretion,BP,
20232,GO:1904454,1,0.98896299656528,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
20233,GO:1904455,1,0.982500471976516,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
20234,GO:1904456,1,0.995163906366786,0,1,negative regulation of neuronal action potential,BP,
20235,GO:1904457,1,0.994494674458398,0,1,positive regulation of neuronal action potential,BP,
20236,GO:1904464,1,0.995336390958826,0,1,regulation of matrix metallopeptidase secretion,BP,
20237,GO:1904465,1,0.995336390958826,0,1,negative regulation of matrix metallopeptidase secretion,BP,
20238,GO:1904467,1,0.889152784513111,0,17,regulation of tumor necrosis factor secretion,BP,
20239,GO:1904468,1,0.972455049315441,0,5,negative regulation of tumor necrosis factor secretion,BP,
20240,GO:1904469,1,0.914361294707492,0,12,positive regulation of tumor necrosis factor secretion,BP,
20241,GO:1904475,1,0.980741976684299,0,2,regulation of Ras GTPase binding,BP,
20242,GO:1904477,1,0.990483439331061,0,1,positive regulation of Ras GTPase binding,BP,
20243,GO:1904478,1,0.973989401122983,0,5,regulation of intestinal absorption,BP,
20244,GO:1904479,1,0.991160687207352,0,2,negative regulation of intestinal absorption,BP,
20245,GO:1904481,1,0.994427541429606,0,1,response to tetrahydrofolate,BP,
20246,GO:1904482,1,0.994427541429606,0,1,cellular response to tetrahydrofolate,BP,
20247,GO:1904491,1,0.98093174171277,0,4,protein localization to ciliary transition zone,BP,
20248,GO:1904492,1,0.994257024215483,0,1,Ac-Asp-Glu binding,MF,
20249,GO:1904493,1,0.994257024215483,0,1,tetrahydrofolyl-poly(glutamate) polymer binding,MF,
20250,GO:1904498,1,0.977166594023451,0,3,protein localization to mitotic actomyosin contractile ring,BP,
20251,GO:1904499,1,0.993369541796353,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
20252,GO:1904501,1,0.993369541796353,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
20253,GO:1904502,1,0.957847264604947,0,5,regulation of lipophagy,BP,
20254,GO:1904504,1,0.957847264604947,0,5,positive regulation of lipophagy,BP,
20255,GO:1904505,1,0.970986777705319,0,4,regulation of telomere maintenance in response to DNA damage,BP,
20256,GO:1904506,1,0.970986777705319,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
20257,GO:1904515,1,0.99345197504884,0,1,positive regulation of TORC2 signaling,BP,
20258,GO:1904526,1,0.944582191333389,0,9,regulation of microtubule binding,BP,
20259,GO:1904527,1,0.979251172114071,0,3,negative regulation of microtubule binding,BP,
20260,GO:1904528,1,0.965249458123383,0,6,positive regulation of microtubule binding,BP,
20261,GO:1904529,1,0.984951974858118,0,2,regulation of actin filament binding,BP,
20262,GO:1904530,1,0.993700815741448,0,1,negative regulation of actin filament binding,BP,
20263,GO:1904531,1,0.991196258237097,0,1,positive regulation of actin filament binding,BP,
20264,GO:1904533,1,0.98017482742266,0,3,regulation of telomeric loop disassembly,BP,
20265,GO:1904534,1,0.987829867704587,0,2,negative regulation of telomeric loop disassembly,BP,
20266,GO:1904535,1,0.992251603427303,0,1,positive regulation of telomeric loop disassembly,BP,
20267,GO:1904542,1,0.994185195573167,0,1,regulation of free ubiquitin chain polymerization,BP,
20268,GO:1904544,1,0.994185195573167,0,1,positive regulation of free ubiquitin chain polymerization,BP,
20269,GO:1904550,1,0.994914064722476,0,1,response to arachidonic acid,BP,
20270,GO:1904555,1,0.994415395872108,0,1,L-proline transmembrane transport,BP,
20271,GO:1904556,1,0.994415395872108,0,1,L-tryptophan transmembrane transport,BP,
20272,GO:1904562,1,0.979018886970553,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
20273,GO:1904565,1,0.993672619796311,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20274,GO:1904566,1,0.993672619796311,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20275,GO:1904567,1,0.993795533248943,0,1,response to wortmannin,BP,
20276,GO:1904568,1,0.993795533248943,0,1,cellular response to wortmannin,BP,
20277,GO:1904569,1,0.995330061323471,0,1,regulation of selenocysteine incorporation,BP,
20278,GO:1904570,1,0.995330061323471,0,1,negative regulation of selenocysteine incorporation,BP,
20279,GO:1904572,1,0.995330061323471,0,1,negative regulation of mRNA binding,BP,
20280,GO:1904573,1,0.995330061323471,0,1,regulation of selenocysteine insertion sequence binding,BP,
20281,GO:1904574,1,0.995330061323471,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
20282,GO:1904576,1,0.989441920596174,0,2,response to tunicamycin,BP,
20283,GO:1904577,1,0.989441920596174,0,2,cellular response to tunicamycin,BP,
20284,GO:1904578,1,0.982930470574981,0,3,response to thapsigargin,BP,
20285,GO:1904579,1,0.982930470574981,0,3,cellular response to thapsigargin,BP,
20286,GO:1904580,1,0.989142189759532,0,2,regulation of intracellular mRNA localization,BP,
20287,GO:1904582,1,0.989142189759532,0,2,positive regulation of intracellular mRNA localization,BP,
20288,GO:1904585,1,0.994800539266136,0,1,response to putrescine,BP,
20289,GO:1904586,1,0.994800539266136,0,1,cellular response to putrescine,BP,
20290,GO:1904587,1,0.960389286629039,0,6,response to glycoprotein,BP,
20291,GO:1904588,1,0.995950517747861,0,1,cellular response to glycoprotein,BP,
20292,GO:1904589,1,0.703715257484492,0,51,regulation of protein import,BP,
20293,GO:1904590,1,0.942662186160794,0,10,negative regulation of protein import,BP,
20294,GO:1904591,1,0.778902143609026,0,33,positive regulation of protein import,BP,
20295,GO:1904594,1,0.986191593533253,0,1,regulation of termination of RNA polymerase II transcription,BP,
20296,GO:1904595,1,0.986191593533253,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
20297,GO:1904596,1,0.995831903661952,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20298,GO:1904597,1,0.995831903661952,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20299,GO:1904599,1,0.995831903661952,0,1,advanced glycation end-product binding,MF,
20300,GO:1904602,1,0.989952668206528,0,2,serotonin-activated cation-selective channel complex,CC,
20301,GO:1904603,1,0.995831903661952,0,1,regulation of advanced glycation end-product receptor activity,BP,
20302,GO:1904604,1,0.995831903661952,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
20303,GO:1904606,1,0.993370529098454,0,1,fat cell apoptotic process,BP,
20304,GO:1904612,1,0.977083929426302,0,3,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20305,GO:1904613,1,0.983273649431422,0,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20306,GO:1904616,1,0.984951974858118,0,2,regulation of actin binding,BP,
20307,GO:1904617,1,0.993700815741448,0,1,negative regulation of actin binding,BP,
20308,GO:1904618,1,0.991196258237097,0,1,positive regulation of actin binding,BP,
20309,GO:1904627,1,0.989804000466809,0,2,response to phorbol 13-acetate 12-myristate,BP,
20310,GO:1904628,1,0.989804000466809,0,2,cellular response to phorbol 13-acetate 12-myristate,BP,
20311,GO:1904631,1,0.994697108060162,0,1,response to glucoside,BP,
20312,GO:1904633,1,0.990516721249158,0,1,regulation of glomerular visceral epithelial cell apoptotic process,BP,
20313,GO:1904635,1,0.990516721249158,0,1,positive regulation of glomerular visceral epithelial cell apoptotic process,BP,
20314,GO:1904636,1,0.972157135176402,0,4,response to ionomycin,BP,
20315,GO:1904637,1,0.972157135176402,0,4,cellular response to ionomycin,BP,
20316,GO:1904638,1,0.990516721249158,0,1,response to resveratrol,BP,
20317,GO:1904639,1,0.990516721249158,0,1,cellular response to resveratrol,BP,
20318,GO:1904640,1,0.98118676479568,0,3,response to methionine,BP,
20319,GO:1904645,1,0.810848355169068,0,27,response to amyloid-beta,BP,
20320,GO:1904646,1,0.819281748284323,0,25,cellular response to amyloid-beta,BP,
20321,GO:1904647,1,0.987855325306768,0,1,response to rotenone,BP,
20322,GO:1904649,1,0.993370529098454,0,1,regulation of fat cell apoptotic process,BP,
20323,GO:1904651,1,0.993370529098454,0,1,positive regulation of fat cell apoptotic process,BP,
20324,GO:1904659,1,0.519205113836604,0,94,glucose transmembrane transport,BP,
20325,GO:1904666,1,0.906419187480501,0,19,regulation of ubiquitin protein ligase activity,BP,
20326,GO:1904667,1,0.971861011713915,0,7,negative regulation of ubiquitin protein ligase activity,BP,
20327,GO:1904668,1,0.932682180591458,0,12,positive regulation of ubiquitin protein ligase activity,BP,
20328,GO:1904672,1,0.964993110626504,0,5,regulation of somatic stem cell population maintenance,BP,
20329,GO:1904673,1,0.978583635212061,0,3,negative regulation of somatic stem cell population maintenance,BP,
20330,GO:1904674,1,0.986115059718505,0,2,positive regulation of somatic stem cell population maintenance,BP,
20331,GO:1904675,1,0.993875418370528,0,1,regulation of somatic stem cell division,BP,
20332,GO:1904677,1,0.993875418370528,0,1,positive regulation of somatic stem cell division,BP,
20333,GO:1904680,1,0.883077520303844,0,22,peptide transmembrane transporter activity,MF,
20334,GO:1904681,1,0.994147315111515,0,1,response to 3-methylcholanthrene,BP,
20335,GO:1904683,1,0.950561254302456,0,6,regulation of metalloendopeptidase activity,BP,
20336,GO:1904684,1,0.963498295980237,0,4,negative regulation of metalloendopeptidase activity,BP,
20337,GO:1904685,1,0.986577847156491,0,2,positive regulation of metalloendopeptidase activity,BP,
20338,GO:1904688,1,0.968825197712419,0,5,regulation of cytoplasmic translational initiation,BP,
20339,GO:1904689,1,0.996098693501358,0,1,negative regulation of cytoplasmic translational initiation,BP,
20340,GO:1904690,1,0.97262075338024,0,4,positive regulation of cytoplasmic translational initiation,BP,
20341,GO:1904691,1,0.9948370519597,0,1,negative regulation of type B pancreatic cell proliferation,BP,
20343,GO:1904693,1,0.974746160868888,0,3,midbrain morphogenesis,BP,
20344,GO:1904694,1,0.972152402016716,0,3,negative regulation of vascular smooth muscle contraction,BP,
20345,GO:1904695,1,0.995102956696936,0,1,positive regulation of vascular smooth muscle contraction,BP,
20346,GO:1904700,1,0.9942593947056,0,1,granulosa cell apoptotic process,BP,
20347,GO:1904701,1,0.995250216689571,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
20348,GO:1904705,1,0.78277438868008,0,36,regulation of vascular smooth muscle cell proliferation,BP,
20349,GO:1904706,1,0.918958038218618,0,14,negative regulation of vascular smooth muscle cell proliferation,BP,
20350,GO:1904707,1,0.848057938521552,0,23,positive regulation of vascular smooth muscle cell proliferation,BP,
20351,GO:1904708,1,0.9942593947056,0,1,regulation of granulosa cell apoptotic process,BP,
20352,GO:1904711,1,0.995250216689571,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20353,GO:1904713,1,0.98187502942294,0,2,beta-catenin destruction complex binding,MF,
20355,GO:1904715,1,0.983499723750996,0,3,negative regulation of chaperone-mediated autophagy,BP,
20356,GO:1904716,1,0.994540133808727,0,1,positive regulation of chaperone-mediated autophagy,BP,
20357,GO:1904717,1,0.974970441627373,0,3,regulation of AMPA glutamate receptor clustering,BP,
20358,GO:1904719,1,0.994443359162968,0,1,positive regulation of AMPA glutamate receptor clustering,BP,
20359,GO:1904720,1,0.988233352024349,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20360,GO:1904721,1,0.993727601796518,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20361,GO:1904722,1,0.994471421199389,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20362,GO:1904723,1,0.995250216689571,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20363,GO:1904724,1,0.773116663016191,0,52,tertiary granule lumen,CC,
20364,GO:1904729,1,0.984011920771022,0,3,regulation of intestinal lipid absorption,BP,
20365,GO:1904730,1,0.99417351035814,0,1,negative regulation of intestinal lipid absorption,BP,
20366,GO:1904732,1,0.985449952107639,0,2,regulation of electron transfer activity,BP,
20367,GO:1904734,1,0.996970928815275,0,1,positive regulation of electron transfer activity,BP,
20368,GO:1904738,1,0.874811281066489,0,16,vascular associated smooth muscle cell migration,BP,
20369,GO:1904742,1,0.968973147476735,0,4,regulation of telomeric DNA binding,BP,
20370,GO:1904743,1,0.977641804214293,0,2,negative regulation of telomeric DNA binding,BP,
20371,GO:1904744,1,0.99113511138178,0,2,positive regulation of telomeric DNA binding,BP,
20372,GO:1904746,1,0.967616442830411,0,5,negative regulation of apoptotic process involved in development,BP,
20373,GO:1904747,1,0.981338416595721,0,3,positive regulation of apoptotic process involved in development,BP,
20374,GO:1904748,1,0.941606798414441,0,9,regulation of apoptotic process involved in development,BP,
20375,GO:1904749,1,0.968854179089828,0,5,regulation of protein localization to nucleolus,BP,
20376,GO:1904750,1,0.99018625561594,0,1,negative regulation of protein localization to nucleolus,BP,
20377,GO:1904751,1,0.978458622878665,0,4,positive regulation of protein localization to nucleolus,BP,
20378,GO:1904752,1,0.874811281066489,0,16,regulation of vascular associated smooth muscle cell migration,BP,
20379,GO:1904753,1,0.963461676556233,0,5,negative regulation of vascular associated smooth muscle cell migration,BP,
20380,GO:1904754,1,0.908020546859095,0,11,positive regulation of vascular associated smooth muscle cell migration,BP,
20381,GO:1904760,1,0.977366534775235,0,3,regulation of myofibroblast differentiation,BP,
20382,GO:1904761,1,0.984442298223242,0,2,negative regulation of myofibroblast differentiation,BP,
20383,GO:1904762,1,0.992813547422387,0,1,positive regulation of myofibroblast differentiation,BP,
20384,GO:1904764,1,0.994957091090962,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
20385,GO:1904766,1,0.989951248146519,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
20386,GO:1904768,1,0.988555384985492,0,2,all-trans-retinol binding,MF,
20387,GO:1904772,1,0.994218639474739,0,1,response to tetrachloromethane,BP,
20388,GO:1904776,1,0.956114548674695,0,6,regulation of protein localization to cell cortex,BP,
20389,GO:1904777,1,0.994054740756748,0,1,negative regulation of protein localization to cell cortex,BP,
20390,GO:1904778,1,0.961835148671665,0,5,positive regulation of protein localization to cell cortex,BP,
20391,GO:1904779,1,0.943319095336912,0,7,regulation of protein localization to centrosome,BP,
20392,GO:1904781,1,0.94856144035953,0,6,positive regulation of protein localization to centrosome,BP,
20393,GO:1904782,1,0.991955059843106,0,1,negative regulation of NMDA glutamate receptor activity,BP,
20394,GO:1904783,1,0.986186566054339,0,2,positive regulation of NMDA glutamate receptor activity,BP,
20395,GO:1904784,1,0.991342428907376,0,1,NLRP1 inflammasome complex assembly,BP,
20396,GO:1904790,1,0.993877053319629,0,1,regulation of shelterin complex assembly,BP,
20397,GO:1904792,1,0.993877053319629,0,1,positive regulation of shelterin complex assembly,BP,
20398,GO:1904793,1,0.993369541796353,0,1,regulation of euchromatin binding,BP,
20399,GO:1904796,1,0.967227751527257,0,5,regulation of core promoter binding,BP,
20400,GO:1904797,1,0.990747600996084,0,1,negative regulation of core promoter binding,BP,
20401,GO:1904798,1,0.976262704008693,0,4,positive regulation of core promoter binding,BP,
20402,GO:1904799,1,0.992856715766406,0,1,regulation of neuron remodeling,BP,
20403,GO:1904800,1,0.992856715766406,0,1,negative regulation of neuron remodeling,BP,
20404,GO:1904803,1,0.996774025155976,0,1,regulation of translation involved in cellular response to UV,BP,
20405,GO:1904806,1,0.988144472527205,0,2,regulation of protein oxidation,BP,
20406,GO:1904808,1,0.988144472527205,0,2,positive regulation of protein oxidation,BP,
20407,GO:1904812,1,0.992858153626207,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
20408,GO:1904813,1,0.497033041700443,0,123,ficolin-1-rich granule lumen,CC,
20409,GO:1904814,1,0.927936357905101,0,13,regulation of protein localization to chromosome, telomeric region,BP,
20410,GO:1904815,1,0.989005906879748,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
20411,GO:1904816,1,0.938258268360545,0,11,positive regulation of protein localization to chromosome, telomeric region,BP,
20412,GO:1904823,1,0.983537899913126,0,3,purine nucleobase transmembrane transport,BP,
20413,GO:1904826,1,0.989266422732595,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
20414,GO:1904828,1,0.989266422732595,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
20415,GO:1904829,1,0.99532436368798,0,1,regulation of aortic smooth muscle cell differentiation,BP,
20416,GO:1904831,1,0.99532436368798,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
20417,GO:1904833,1,0.986911716918206,0,3,positive regulation of removal of superoxide radicals,BP,
20418,GO:1904835,1,0.99439600355199,0,1,dorsal root ganglion morphogenesis,BP,
20419,GO:1904837,1,0.791035279901249,0,34,beta-catenin-TCF complex assembly,BP,
20420,GO:1904842,1,0.994799281509358,0,1,response to nitroglycerin,BP,
20421,GO:1904843,1,0.994799281509358,0,1,cellular response to nitroglycerin,BP,
20422,GO:1904844,1,0.984021818790663,0,3,response to L-glutamine,BP,
20423,GO:1904845,1,0.984021818790663,0,3,cellular response to L-glutamine,BP,
20424,GO:1904847,1,0.966329832541836,0,5,regulation of cell chemotaxis to fibroblast growth factor,BP,
20425,GO:1904848,1,0.996006601352857,0,1,negative regulation of cell chemotaxis to fibroblast growth factor,BP,
20426,GO:1904849,1,0.977055883944884,0,3,positive regulation of cell chemotaxis to fibroblast growth factor,BP,
20427,GO:1904850,1,0.993877053319629,0,1,negative regulation of establishment of protein localization to telomere,BP,
20428,GO:1904851,1,0.952548070048149,0,9,positive regulation of establishment of protein localization to telomere,BP,
20429,GO:1904854,1,0.988175315277568,0,2,proteasome core complex binding,MF,
20430,GO:1904861,1,0.894738288282727,0,13,excitatory synapse assembly,BP,
20431,GO:1904862,1,0.976852306303463,0,3,inhibitory synapse assembly,BP,
20432,GO:1904863,1,0.993004686228937,0,1,regulation of beta-catenin-TCF complex assembly,BP,
20433,GO:1904864,1,0.993004686228937,0,1,negative regulation of beta-catenin-TCF complex assembly,BP,
20434,GO:1904867,1,0.953111019125029,0,9,protein localization to Cajal body,BP,
20435,GO:1904868,1,0.974928074158499,0,2,telomerase catalytic core complex assembly,BP,
20436,GO:1904869,1,0.957728278775833,0,8,regulation of protein localization to Cajal body,BP,
20437,GO:1904871,1,0.957728278775833,0,8,positive regulation of protein localization to Cajal body,BP,
20438,GO:1904872,1,0.905029534775292,0,18,regulation of telomerase RNA localization to Cajal body,BP,
20439,GO:1904874,1,0.927294733713204,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
20440,GO:1904875,1,0.9888039779006,0,2,regulation of DNA ligase activity,BP,
20441,GO:1904876,1,0.993917036717789,0,1,negative regulation of DNA ligase activity,BP,
20442,GO:1904877,1,0.994855964807089,0,1,positive regulation of DNA ligase activity,BP,
20443,GO:1904878,1,0.98669099067645,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20444,GO:1904879,1,0.987238736057456,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20445,GO:1904880,1,0.979472503466451,0,3,response to hydrogen sulfide,BP,
20446,GO:1904881,1,0.984996839287099,0,2,cellular response to hydrogen sulfide,BP,
20447,GO:1904882,1,0.974928074158499,0,2,regulation of telomerase catalytic core complex assembly,BP,
20448,GO:1904884,1,0.974928074158499,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
20449,GO:1904885,1,0.95794919219025,0,5,beta-catenin destruction complex assembly,BP,
20450,GO:1904886,1,0.8734315679376,0,18,beta-catenin destruction complex disassembly,BP,
20451,GO:1904887,1,0.987748176584163,0,1,Wnt signalosome assembly,BP,
20452,GO:1904888,1,0.646814328251797,0,59,cranial skeletal system development,BP,
20453,GO:1904889,1,0.989446252341677,0,2,regulation of excitatory synapse assembly,BP,
20454,GO:1904891,1,0.989446252341677,0,2,positive regulation of excitatory synapse assembly,BP,
20455,GO:1904892,1,0.496882407520428,0,111,regulation of STAT cascade,BP,
20456,GO:1904893,1,0.747354175363364,0,45,negative regulation of STAT cascade,BP,
20457,GO:1904894,1,0.69012258855044,0,60,positive regulation of STAT cascade,BP,
20458,GO:1904895,1,0.995423626604521,0,1,ESCRT complex assembly,BP,
20459,GO:1904896,1,0.945081943589011,0,10,ESCRT complex disassembly,BP,
20460,GO:1904897,1,0.99347450390528,0,1,regulation of hepatic stellate cell proliferation,BP,
20461,GO:1904899,1,0.99347450390528,0,1,positive regulation of hepatic stellate cell proliferation,BP,
20462,GO:1904902,1,0.995423626604521,0,1,ESCRT III complex assembly,BP,
20463,GO:1904903,1,0.945081943589011,0,10,ESCRT III complex disassembly,BP,
20464,GO:1904907,1,0.973695979994239,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20465,GO:1904908,1,0.973695979994239,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20466,GO:1904910,1,0.993877053319629,0,1,regulation of establishment of RNA localization to telomere,BP,
20467,GO:1904911,1,0.993877053319629,0,1,negative regulation of establishment of RNA localization to telomere,BP,
20468,GO:1904913,1,0.993877053319629,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
20469,GO:1904914,1,0.993877053319629,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
20470,GO:1904923,1,0.917034865537089,0,12,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
20471,GO:1904924,1,0.994491611210297,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
20472,GO:1904925,1,0.922118402947535,0,11,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
20473,GO:1904928,1,0.978804862244839,0,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,
20474,GO:1904929,1,0.956909684746938,0,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,
20475,GO:1904933,1,0.990997815957518,0,1,regulation of cell proliferation in midbrain,BP,
20476,GO:1904934,1,0.990997815957518,0,1,negative regulation of cell proliferation in midbrain,BP,
20477,GO:1904936,1,0.964780284414121,0,5,interneuron migration,BP,
20478,GO:1904938,1,0.955421104314806,0,5,planar cell polarity pathway involved in axon guidance,BP,
20479,GO:1904947,1,0.993779518736603,0,1,folic acid import into mitochondrion,BP,
20481,GO:1904949,1,0.507371913636177,0,96,ATPase complex,CC,
20484,GO:1904953,1,0.934069397225377,0,10,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20485,GO:1904954,1,0.983047343513802,0,3,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20486,GO:1904955,1,0.990997815957518,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
20488,GO:1904958,1,0.984426602423391,0,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,
20489,GO:1904959,1,0.985449952107639,0,2,regulation of cytochrome-c oxidase activity,BP,
20490,GO:1904960,1,0.996970928815275,0,1,positive regulation of cytochrome-c oxidase activity,BP,
20491,GO:1904970,1,0.976929846541452,0,3,brush border assembly,BP,
20492,GO:1904971,1,0.992204666131814,0,1,regulation of viral translation,BP,
20493,GO:1904973,1,0.992204666131814,0,1,positive regulation of viral translation,BP,
20494,GO:1904975,1,0.984599191097409,0,2,response to bleomycin,BP,
20495,GO:1904976,1,0.984599191097409,0,2,cellular response to bleomycin,BP,
20496,GO:1904977,1,0.993938004826597,0,1,lymphatic endothelial cell migration,BP,
20497,GO:1904978,1,0.976729723684297,0,3,regulation of endosome organization,BP,
20498,GO:1904979,1,0.994706480646018,0,1,negative regulation of endosome organization,BP,
20499,GO:1904980,1,0.989771460581554,0,1,positive regulation of endosome organization,BP,
20500,GO:1904983,1,0.994840833122559,0,1,glycine import into mitochondrion,BP,
20501,GO:1904990,1,0.994451279905621,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20502,GO:1904992,1,0.994451279905621,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20503,GO:1904994,1,0.935044877647717,0,12,regulation of leukocyte adhesion to vascular endothelial cell,BP,
20504,GO:1904995,1,0.978445262360744,0,5,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
20505,GO:1904996,1,0.955653081337045,0,7,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,
20506,GO:1904997,1,0.98933221896101,0,2,regulation of leukocyte adhesion to arterial endothelial cell,BP,
20507,GO:1904998,1,0.993880870690363,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
20508,GO:1904999,1,0.995423626604521,0,1,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,
20509,GO:1905000,1,0.988411649298833,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
20510,GO:1905005,1,0.957687484555908,0,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20511,GO:1905006,1,0.986818286544439,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20512,GO:1905007,1,0.962364150118966,0,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20513,GO:1905008,1,0.994283151526601,0,1,regulation of L-lysine import across plasma membrane,BP,
20514,GO:1905010,1,0.994283151526601,0,1,positive regulation of L-lysine import across plasma membrane,BP,
20515,GO:1905024,1,0.97106127845098,0,4,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20516,GO:1905025,1,0.993736037427491,0,1,negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20517,GO:1905026,1,0.985252167877355,0,2,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20518,GO:1905030,1,0.991499303479958,0,1,voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20519,GO:1905031,1,0.959804966713212,0,5,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20520,GO:1905032,1,0.993736037427491,0,1,negative regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20521,GO:1905033,1,0.985252167877355,0,2,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20522,GO:1905034,1,0.993884145504371,0,1,regulation of antifungal innate immune response,BP,
20523,GO:1905035,1,0.993884145504371,0,1,negative regulation of antifungal innate immune response,BP,
20524,GO:1905037,1,0.538643920783844,0,91,autophagosome organization,BP,
20525,GO:1905038,1,0.928042558029242,0,13,regulation of membrane lipid metabolic process,BP,
20527,GO:1905040,1,0.99439600355199,0,1,otic placode development,BP,
20528,GO:1905041,1,0.99469523433253,0,1,regulation of epithelium regeneration,BP,
20529,GO:1905042,1,0.99469523433253,0,1,negative regulation of epithelium regeneration,BP,
20530,GO:1905044,1,0.994054740756748,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
20531,GO:1905045,1,0.994054740756748,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
20532,GO:1905048,1,0.915484771441874,0,13,regulation of metallopeptidase activity,BP,
20533,GO:1905049,1,0.953411881556315,0,6,negative regulation of metallopeptidase activity,BP,
20534,GO:1905050,1,0.960238373619924,0,7,positive regulation of metallopeptidase activity,BP,
20535,GO:1905051,1,0.991763052942948,0,2,regulation of base-excision repair,BP,
20536,GO:1905053,1,0.991763052942948,0,2,positive regulation of base-excision repair,BP,
20537,GO:1905062,1,0.994131663339992,0,1,positive regulation of cardioblast proliferation,BP,
20538,GO:1905063,1,0.947261486856955,0,8,regulation of vascular smooth muscle cell differentiation,BP,
20539,GO:1905064,1,0.981408868822945,0,3,negative regulation of vascular smooth muscle cell differentiation,BP,
20540,GO:1905065,1,0.965212232098889,0,5,positive regulation of vascular smooth muscle cell differentiation,BP,
20541,GO:1905066,1,0.989826448321314,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
20542,GO:1905067,1,0.995250216689571,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
20543,GO:1905068,1,0.994550608756633,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
20544,GO:1905069,1,0.987606467086301,0,2,allantois development,BP,
20545,GO:1905071,1,0.976105028374935,0,3,occluding junction disassembly,BP,
20546,GO:1905073,1,0.976105028374935,0,3,regulation of occluding junction disassembly,BP,
20547,GO:1905075,1,0.976105028374935,0,3,positive regulation of occluding junction disassembly,BP,
20548,GO:1905076,1,0.995024267850121,0,1,regulation of interleukin-17 secretion,BP,
20549,GO:1905077,1,0.995024267850121,0,1,negative regulation of interleukin-17 secretion,BP,
20550,GO:1905089,1,0.985139919576016,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20551,GO:1905090,1,0.985139919576016,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20552,GO:1905097,1,0.954501240390758,0,6,regulation of guanyl-nucleotide exchange factor activity,BP,
20553,GO:1905098,1,0.973249174206876,0,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,
20554,GO:1905099,1,0.990483439331061,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
20555,GO:1905103,1,0.992810666932176,0,1,integral component of lysosomal membrane,CC,
20557,GO:1905123,1,0.984943901694053,0,2,regulation of glucosylceramidase activity,BP,
20558,GO:1905132,1,0.993772597113732,0,1,regulation of meiotic chromosome separation,BP,
20559,GO:1905133,1,0.993772597113732,0,1,negative regulation of meiotic chromosome separation,BP,
20560,GO:1905143,1,0.995564793285439,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
20563,GO:1905146,1,0.919276410510786,0,10,lysosomal protein catabolic process,BP,
20564,GO:1905150,1,0.977000178404085,0,3,regulation of voltage-gated sodium channel activity,BP,
20565,GO:1905152,1,0.990927424383623,0,1,positive regulation of voltage-gated sodium channel activity,BP,
20566,GO:1905153,1,0.920864752783849,0,12,regulation of membrane invagination,BP,
20567,GO:1905154,1,0.986766795365964,0,2,negative regulation of membrane invagination,BP,
20568,GO:1905155,1,0.93871104633084,0,9,positive regulation of membrane invagination,BP,
20569,GO:1905161,1,0.991585268949594,0,1,protein localization to phagocytic vesicle,BP,
20570,GO:1905162,1,0.991585268949594,0,1,regulation of phagosome maturation,BP,
20571,GO:1905165,1,0.934260636342934,0,7,regulation of lysosomal protein catabolic process,BP,
20572,GO:1905166,1,0.981127646336694,0,3,negative regulation of lysosomal protein catabolic process,BP,
20573,GO:1905167,1,0.957514173994049,0,3,positive regulation of lysosomal protein catabolic process,BP,
20574,GO:1905168,1,0.993093436068615,0,1,positive regulation of double-strand break repair via homologous recombination,BP,
20575,GO:1905169,1,0.991585268949594,0,1,regulation of protein localization to phagocytic vesicle,BP,
20576,GO:1905171,1,0.991585268949594,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
20577,GO:1905172,1,0.992204666131814,0,1,RISC complex binding,MF,
20578,GO:1905174,1,0.989144104263098,0,2,regulation of vascular smooth muscle cell dedifferentiation,BP,
20579,GO:1905176,1,0.993938558078282,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
20580,GO:1905202,1,0.987479442583646,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
20581,GO:1905203,1,0.988041146554981,0,2,regulation of connective tissue replacement,BP,
20582,GO:1905204,1,0.995831903661952,0,1,negative regulation of connective tissue replacement,BP,
20583,GO:1905205,1,0.992176963491661,0,1,positive regulation of connective tissue replacement,BP,
20584,GO:1905206,1,0.96676557030707,0,5,positive regulation of hydrogen peroxide-induced cell death,BP,
20585,GO:1905207,1,0.75827243471411,0,39,regulation of cardiocyte differentiation,BP,
20586,GO:1905208,1,0.902993129220021,0,14,negative regulation of cardiocyte differentiation,BP,
20587,GO:1905209,1,0.844480083566335,0,24,positive regulation of cardiocyte differentiation,BP,
20588,GO:1905214,1,0.931876154544618,0,11,regulation of RNA binding,BP,
20589,GO:1905215,1,0.995330061323471,0,1,negative regulation of RNA binding,BP,
20590,GO:1905216,1,0.951213550550893,0,8,positive regulation of RNA binding,BP,
20591,GO:1905217,1,0.99370605575639,0,1,response to astaxanthin,BP,
20592,GO:1905222,1,0.993662218946887,0,1,atrioventricular canal morphogenesis,BP,
20593,GO:1905223,1,0.990482460917187,0,1,epicardium morphogenesis,BP,
20594,GO:1905224,1,0.983926377094316,0,2,clathrin-coated pit assembly,BP,
20595,GO:1905225,1,0.989681804113225,0,2,response to thyrotropin-releasing hormone,BP,
20596,GO:1905226,1,0.995903107985397,0,1,regulation of adhesion of symbiont to host epithelial cell,BP,
20597,GO:1905229,1,0.995950517747861,0,1,cellular response to thyrotropin-releasing hormone,BP,
20598,GO:1905230,1,0.992825065831946,0,1,response to borneol,BP,
20599,GO:1905231,1,0.992825065831946,0,1,cellular response to borneol,BP,
20600,GO:1905232,1,0.965075077603452,0,5,cellular response to L-glutamate,BP,
20601,GO:1905233,1,0.992825065831946,0,1,response to codeine,BP,
20602,GO:1905235,1,0.992825065831946,0,1,response to quercetin,BP,
20603,GO:1905237,1,0.992825065831946,0,1,response to cyclosporin A,BP,
20604,GO:1905239,1,0.991811026818773,0,1,regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20605,GO:1905240,1,0.991811026818773,0,1,negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20606,GO:1905242,1,0.987610890781329,0,2,response to 3,3',5-triiodo-L-thyronine,BP,
20607,GO:1905243,1,0.994160686953175,0,1,cellular response to 3,3',5-triiodo-L-thyronine,BP,
20608,GO:1905244,1,0.941900942674911,0,8,regulation of modification of synaptic structure,BP,
20609,GO:1905245,1,0.940907292238062,0,8,regulation of aspartic-type peptidase activity,BP,
20610,GO:1905246,1,0.980921377843806,0,2,negative regulation of aspartic-type peptidase activity,BP,
20611,GO:1905247,1,0.959215416420987,0,6,positive regulation of aspartic-type peptidase activity,BP,
20612,GO:1905255,1,0.990389632961235,0,1,regulation of RNA binding transcription factor activity,BP,
20613,GO:1905258,1,0.991935308713319,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20614,GO:1905259,1,0.991935308713319,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20615,GO:1905267,1,0.987734584772594,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
20616,GO:1905268,1,0.716702844896188,0,45,negative regulation of chromatin organization,BP,
20617,GO:1905269,1,0.540495863607575,0,88,positive regulation of chromatin organization,BP,
20618,GO:1905271,1,0.99671858526701,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20619,GO:1905273,1,0.99671858526701,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20620,GO:1905274,1,0.989648928315445,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
20622,GO:1905277,1,0.993734454560747,0,1,negative regulation of epithelial tube formation,BP,
20623,GO:1905278,1,0.975395057931865,0,4,positive regulation of epithelial tube formation,BP,
20624,GO:1905279,1,0.98187502942294,0,2,regulation of retrograde transport, endosome to Golgi,BP,
20625,GO:1905285,1,0.993177281716257,0,1,fibrous ring of heart morphogenesis,BP,
20626,GO:1905286,1,0.98285400714575,0,3,serine-type peptidase complex,CC,
20627,GO:1905288,1,0.953427541494303,0,6,vascular associated smooth muscle cell apoptotic process,BP,
20628,GO:1905289,1,0.987748176584163,0,1,regulation of CAMKK-AMPK signaling cascade,BP,
20629,GO:1905292,1,0.979838792187224,0,3,regulation of neural crest cell differentiation,BP,
20630,GO:1905294,1,0.979838792187224,0,3,positive regulation of neural crest cell differentiation,BP,
20631,GO:1905301,1,0.992280715131527,0,1,regulation of macropinocytosis,BP,
20632,GO:1905302,1,0.992280715131527,0,1,negative regulation of macropinocytosis,BP,
20633,GO:1905304,1,0.988195392288915,0,1,regulation of cardiac myofibril assembly,BP,
20634,GO:1905305,1,0.988195392288915,0,1,negative regulation of cardiac myofibril assembly,BP,
20635,GO:1905309,1,0.986957002349607,0,1,positive regulation of cohesin loading,BP,
20636,GO:1905310,1,0.979838792187224,0,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
20637,GO:1905312,1,0.979838792187224,0,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
20638,GO:1905313,1,0.994746541367731,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
20639,GO:1905314,1,0.891984628589147,0,15,semi-lunar valve development,BP,
20640,GO:1905317,1,0.992165083474084,0,1,inferior endocardial cushion morphogenesis,BP,
20641,GO:1905319,1,0.994054740756748,0,1,mesenchymal stem cell migration,BP,
20642,GO:1905320,1,0.994054740756748,0,1,regulation of mesenchymal stem cell migration,BP,
20643,GO:1905322,1,0.994054740756748,0,1,positive regulation of mesenchymal stem cell migration,BP,
20644,GO:1905323,1,0.953542198440847,0,6,telomerase holoenzyme complex assembly,BP,
20645,GO:1905327,1,0.995539622956947,0,1,tracheoesophageal septum formation,BP,
20647,GO:1905331,1,0.879788407274663,0,18,negative regulation of morphogenesis of an epithelium,BP,
20648,GO:1905332,1,0.81567872675945,0,30,positive regulation of morphogenesis of an epithelium,BP,
20649,GO:1905333,1,0.988570812396675,0,3,regulation of gastric motility,BP,
20650,GO:1905335,1,0.984121977764427,0,1,regulation of aggrephagy,BP,
20651,GO:1905337,1,0.984121977764427,0,1,positive regulation of aggrephagy,BP,
20652,GO:1905340,1,0.978502596859787,0,4,regulation of protein localization to kinetochore,BP,
20653,GO:1905341,1,0.994165346306363,0,1,negative regulation of protein localization to kinetochore,BP,
20654,GO:1905342,1,0.978502596859787,0,4,positive regulation of protein localization to kinetochore,BP,
20655,GO:1905344,1,0.994054740756748,0,1,prostaglandin catabolic process,BP,
20656,GO:1905348,1,0.847338007206084,0,29,endonuclease complex,CC,
20657,GO:1905349,1,0.991519292755955,0,2,ciliary transition zone assembly,BP,
20658,GO:1905354,1,0.880877709764668,0,22,exoribonuclease complex,CC,
20659,GO:1905355,1,0.991696697242895,0,1,spine apparatus assembly,BP,
20660,GO:1905359,1,0.993772597113732,0,1,protein localization to meiotic spindle,BP,
20662,GO:1905365,1,0.994706480646018,0,1,regulation of intralumenal vesicle formation,BP,
20663,GO:1905366,1,0.994706480646018,0,1,negative regulation of intralumenal vesicle formation,BP,
20664,GO:1905368,1,0.649938249056137,0,83,peptidase complex,CC,
20665,GO:1905369,1,0.725660097576859,0,63,endopeptidase complex,CC,
20666,GO:1905370,1,0.994491611210297,0,1,serine-type endopeptidase complex,CC,
20667,GO:1905371,1,0.986361630303741,0,2,ceramide phosphoethanolamine metabolic process,BP,
20668,GO:1905373,1,0.986361630303741,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
20669,GO:1905383,1,0.985697056051553,0,3,protein localization to presynapse,BP,
20670,GO:1905384,1,0.989271008470272,0,2,regulation of protein localization to presynapse,BP,
20671,GO:1905386,1,0.989271008470272,0,2,positive regulation of protein localization to presynapse,BP,
20672,GO:1905392,1,0.996531076871997,0,1,plant organ morphogenesis,BP,
20673,GO:1905394,1,0.979490287542974,0,3,retromer complex binding,MF,
20674,GO:1905395,1,0.981793499290883,0,3,response to flavonoid,BP,
20675,GO:1905397,1,0.990628430074065,0,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20676,GO:1905402,1,0.990628430074065,0,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20677,GO:1905403,1,0.995024267850121,0,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20678,GO:1905404,1,0.995582402948917,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20679,GO:1905405,1,0.986957002349607,0,1,regulation of mitotic cohesin loading,BP,
20680,GO:1905406,1,0.986957002349607,0,1,positive regulation of mitotic cohesin loading,BP,
20681,GO:1905407,1,0.988678961342316,0,2,regulation of creatine transmembrane transporter activity,BP,
20682,GO:1905408,1,0.988678961342316,0,2,negative regulation of creatine transmembrane transporter activity,BP,
20683,GO:1905419,1,0.995216591458026,0,1,sperm flagellum movement involved in flagellated sperm motility,BP,
20684,GO:1905421,1,0.996531076871997,0,1,regulation of plant organ morphogenesis,BP,
20685,GO:1905422,1,0.996531076871997,0,1,negative regulation of plant organ morphogenesis,BP,
20686,GO:1905424,1,0.989125251582391,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20687,GO:1905426,1,0.989125251582391,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20688,GO:1905429,1,0.987486824434087,0,2,response to glycine,BP,
20689,GO:1905430,1,0.99490268638949,0,1,cellular response to glycine,BP,
20692,GO:1905435,1,0.994054740756748,0,1,regulation of histone H3-K4 trimethylation,BP,
20693,GO:1905437,1,0.994054740756748,0,1,positive regulation of histone H3-K4 trimethylation,BP,
20694,GO:1905438,1,0.986715441510812,0,2,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20695,GO:1905443,1,0.992329000498027,0,1,regulation of clathrin coat assembly,BP,
20696,GO:1905445,1,0.992329000498027,0,1,positive regulation of clathrin coat assembly,BP,
20697,GO:1905446,1,0.974616762740691,0,5,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20698,GO:1905447,1,0.993629084422039,0,1,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20699,GO:1905448,1,0.980867000520614,0,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20700,GO:1905449,1,0.985911398181489,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20701,GO:1905451,1,0.985911398181489,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20702,GO:1905456,1,0.946327251448798,0,7,regulation of lymphoid progenitor cell differentiation,BP,
20703,GO:1905457,1,0.979390859577766,0,3,negative regulation of lymphoid progenitor cell differentiation,BP,
20704,GO:1905458,1,0.99283945646826,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
20705,GO:1905459,1,0.953427541494303,0,6,regulation of vascular associated smooth muscle cell apoptotic process,BP,
20706,GO:1905460,1,0.989611202577478,0,1,negative regulation of vascular associated smooth muscle cell apoptotic process,BP,
20707,GO:1905461,1,0.96344026775934,0,5,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,
20710,GO:1905464,1,0.992724044257892,0,1,positive regulation of DNA duplex unwinding,BP,
20711,GO:1905468,1,0.991585268949594,0,1,regulation of clathrin-coated pit assembly,BP,
20712,GO:1905469,1,0.991585268949594,0,1,negative regulation of clathrin-coated pit assembly,BP,
20713,GO:1905474,1,0.995637697199164,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
20717,GO:1905483,1,0.98568988060007,0,1,regulation of motor neuron migration,BP,
20718,GO:1905485,1,0.98568988060007,0,1,positive regulation of motor neuron migration,BP,
20719,GO:1905502,1,0.996019055836529,0,1,acetyl-CoA binding,MF,
20720,GO:1905508,1,0.79493489885736,0,28,protein localization to microtubule organizing center,BP,
20721,GO:1905512,1,0.994299836510832,0,1,regulation of short-term synaptic potentiation,BP,
20722,GO:1905513,1,0.994299836510832,0,1,negative regulation of short-term synaptic potentiation,BP,
20723,GO:1905515,1,0.727977135323541,0,48,non-motile cilium assembly,BP,
20724,GO:1905516,1,0.94542365959427,0,8,positive regulation of fertilization,BP,
20725,GO:1905517,1,0.831089488197405,0,33,macrophage migration,BP,
20726,GO:1905518,1,0.991912733943847,0,1,regulation of presynaptic active zone assembly,BP,
20727,GO:1905520,1,0.991912733943847,0,1,positive regulation of presynaptic active zone assembly,BP,
20728,GO:1905521,1,0.887332282943777,0,20,regulation of macrophage migration,BP,
20729,GO:1905522,1,0.973089712908699,0,5,negative regulation of macrophage migration,BP,
20730,GO:1905523,1,0.934602209954642,0,11,positive regulation of macrophage migration,BP,
20731,GO:1905524,1,0.989202219049928,0,1,negative regulation of protein autoubiquitination,BP,
20732,GO:1905535,1,0.991599262716787,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20733,GO:1905537,1,0.991599262716787,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20734,GO:1905538,1,0.992204666131814,0,1,polysome binding,MF,
20735,GO:1905541,1,0.994283151526601,0,1,regulation of L-arginine import across plasma membrane,BP,
20736,GO:1905546,1,0.994645369902597,0,1,cellular response to phenylpropanoid,BP,
20737,GO:1905547,1,0.995458967525347,0,1,regulation of telomeric heterochromatin assembly,BP,
20738,GO:1905549,1,0.995458967525347,0,1,positive regulation of telomeric heterochromatin assembly,BP,
20739,GO:1905550,1,0.990412350291632,0,2,regulation of protein localization to endoplasmic reticulum,BP,
20740,GO:1905552,1,0.990412350291632,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
20741,GO:1905553,1,0.982585308298425,0,3,regulation of blood vessel branching,BP,
20742,GO:1905555,1,0.986694802525633,0,2,positive regulation blood vessel branching,BP,
20743,GO:1905562,1,0.901229997767964,0,14,regulation of vascular endothelial cell proliferation,BP,
20744,GO:1905563,1,0.977967617153812,0,3,negative regulation of vascular endothelial cell proliferation,BP,
20745,GO:1905564,1,0.921550515065045,0,11,positive regulation of vascular endothelial cell proliferation,BP,
20746,GO:1905572,1,0.993985863764801,0,1,ganglioside GM1 transport to membrane,BP,
20747,GO:1905573,1,0.989124286464212,0,2,ganglioside GM1 binding,MF,
20748,GO:1905574,1,0.993985863764801,0,1,ganglioside GM2 binding,MF,
20749,GO:1905575,1,0.993985863764801,0,1,ganglioside GM3 binding,MF,
20750,GO:1905576,1,0.983672175300375,0,3,ganglioside GT1b binding,MF,
20751,GO:1905577,1,0.993985863764801,0,1,ganglioside GP1c binding,MF,
20752,GO:1905578,1,0.994447013915942,0,1,regulation of ERBB3 signaling pathway,BP,
20753,GO:1905580,1,0.994447013915942,0,1,positive regulation of ERBB3 signaling pathway,BP,
20754,GO:1905581,1,0.995459598309555,0,1,positive regulation of low-density lipoprotein particle clearance,BP,
20755,GO:1905589,1,0.994283151526601,0,1,positive regulation of L-arginine import across plasma membrane,BP,
20756,GO:1905590,1,0.993668976946072,0,1,fibronectin fibril organization,BP,
20757,GO:1905594,1,0.996081283074209,0,1,resveratrol binding,MF,
20758,GO:1905595,1,0.988648315581891,0,2,regulation of low-density lipoprotein particle receptor binding,BP,
20759,GO:1905596,1,0.993157964039784,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
20760,GO:1905597,1,0.995459598309555,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
20761,GO:1905598,1,0.993157964039784,0,1,negative regulation of low-density lipoprotein receptor activity,BP,
20762,GO:1905599,1,0.995459598309555,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
20763,GO:1905600,1,0.982591484362057,0,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20764,GO:1905601,1,0.993157964039784,0,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20765,GO:1905602,1,0.989361460225431,0,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20766,GO:1905603,1,0.991822002642289,0,1,regulation of maintenance of permeability of blood-brain barrier,BP,
20767,GO:1905604,1,0.991822002642289,0,1,negative regulation of maintenance of permeability of blood-brain barrier,BP,
20768,GO:1905606,1,0.970958052681315,0,4,regulation of presynapse assembly,BP,
20769,GO:1905608,1,0.991912733943847,0,1,positive regulation of presynapse assembly,BP,
20770,GO:1905610,1,0.991599262716787,0,1,regulation of mRNA cap binding,BP,
20771,GO:1905612,1,0.991599262716787,0,1,positive regulation of mRNA cap binding,BP,
20772,GO:1905616,1,0.985703447394925,0,2,regulation of miRNA mediated inhibition of translation,BP,
20773,GO:1905618,1,0.985703447394925,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
20774,GO:1905634,1,0.95763488902979,0,5,regulation of protein localization to chromatin,BP,
20775,GO:1905636,1,0.995943035099801,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
20776,GO:1905642,1,0.994054740756748,0,1,negative regulation of DNA methylation,BP,
20777,GO:1905643,1,0.990870516188888,0,1,positive regulation of DNA methylation,BP,
20778,GO:1905647,1,0.994415395872108,0,1,proline import across plasma membrane,BP,
20779,GO:1905651,1,0.974606075730071,0,3,regulation of artery morphogenesis,BP,
20780,GO:1905653,1,0.974606075730071,0,3,positive regulation of artery morphogenesis,BP,
20781,GO:1905661,1,0.987949139908187,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
20782,GO:1905663,1,0.987949139908187,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
20783,GO:1905664,1,0.9781973916374,0,4,regulation of calcium ion import across plasma membrane,BP,
20784,GO:1905665,1,0.989040909319817,0,2,positive regulation of calcium ion import across plasma membrane,BP,
20785,GO:1905666,1,0.930898379279433,0,9,regulation of protein localization to endosome,BP,
20786,GO:1905668,1,0.930898379279433,0,9,positive regulation of protein localization to endosome,BP,
20787,GO:1905671,1,0.981695733523416,0,3,regulation of lysosome organization,BP,
20788,GO:1905672,1,0.994810604528976,0,1,negative regulation of lysosome organization,BP,
20789,GO:1905687,1,0.991066847619513,0,1,regulation of diacylglycerol kinase activity,BP,
20790,GO:1905689,1,0.991066847619513,0,1,positive regulation of diacylglycerol kinase activity,BP,
20791,GO:1905693,1,0.994811863082861,0,1,regulation of phosphatidic acid biosynthetic process,BP,
20792,GO:1905695,1,0.994811863082861,0,1,positive regulation of phosphatidic acid biosynthetic process,BP,
20793,GO:1905696,1,0.983868760105235,0,2,regulation of polysome binding,BP,
20794,GO:1905698,1,0.992204666131814,0,1,positive regulation of polysome binding,BP,
20795,GO:1905705,1,0.989911750554616,0,1,cellular response to paclitaxel,BP,
20796,GO:1905709,1,0.973125229105588,0,5,negative regulation of membrane permeability,BP,
20797,GO:1905710,1,0.712833720270568,0,60,positive regulation of membrane permeability,BP,
20798,GO:1905711,1,0.993005644329228,0,1,response to phosphatidylethanolamine,BP,
20799,GO:1905719,1,0.987995327372205,0,2,protein localization to perinuclear region of cytoplasm,BP,
20800,GO:1905720,1,0.989666133385604,0,1,cytoplasmic microtubule bundle,CC,
20801,GO:1905747,1,0.995923075706157,0,1,negative regulation of saliva secretion,BP,
20802,GO:1905748,1,0.995923075706157,0,1,hard palate morphogenesis,BP,
20803,GO:1905764,1,0.978570783584199,0,3,regulation of protection from non-homologous end joining at telomere,BP,
20804,GO:1905765,1,0.978570783584199,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
20805,GO:1905767,1,0.990086452658766,0,1,regulation of double-stranded telomeric DNA binding,BP,
20806,GO:1905768,1,0.990086452658766,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
20809,GO:1905773,1,0.976257815166166,0,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,
20810,GO:1905774,1,0.992724044257892,0,1,regulation of DNA helicase activity,BP,
20811,GO:1905776,1,0.992724044257892,0,1,positive regulation of DNA helicase activity,BP,
20812,GO:1905777,1,0.981985578432949,0,3,regulation of exonuclease activity,BP,
20813,GO:1905778,1,0.987829867704587,0,2,negative regulation of exonuclease activity,BP,
20814,GO:1905779,1,0.994084438530368,0,1,positive regulation of exonuclease activity,BP,
20815,GO:1905793,1,0.978079504243163,0,2,protein localization to pericentriolar material,BP,
20816,GO:1905794,1,0.986999725453428,0,1,response to puromycin,BP,
20817,GO:1905795,1,0.986999725453428,0,1,cellular response to puromycin,BP,
20818,GO:1905799,1,0.996660648059643,0,1,regulation of intraciliary retrograde transport,BP,
20819,GO:1905802,1,0.993967989184179,0,1,regulation of cellular response to manganese ion,BP,
20823,GO:1905820,1,0.938375798905429,0,9,positive regulation of chromosome separation,BP,
20824,GO:1905832,1,0.960404700573163,0,4,positive regulation of spindle assembly,BP,
20825,GO:1905838,1,0.987829867704587,0,2,regulation of telomeric D-loop disassembly,BP,
20826,GO:1905839,1,0.987829867704587,0,2,negative regulation of telomeric D-loop disassembly,BP,
20827,GO:1905843,1,0.986130713070966,0,1,regulation of cellular response to gamma radiation,BP,
20828,GO:1905853,1,0.996035242113144,0,1,regulation of heparan sulfate binding,BP,
20829,GO:1905855,1,0.996035242113144,0,1,positive regulation of heparan sulfate binding,BP,
20830,GO:1905858,1,0.996035242113144,0,1,regulation of heparan sulfate proteoglycan binding,BP,
20831,GO:1905860,1,0.996035242113144,0,1,positive regulation of heparan sulfate proteoglycan binding,BP,
20832,GO:1905863,1,0.981472287565181,0,2,invadopodium organization,BP,
20833,GO:1905867,1,0.979798573715934,0,4,epididymis development,BP,
20834,GO:1905874,1,0.973933261523064,0,4,regulation of postsynaptic density organization,BP,
20835,GO:1905875,1,0.993880325137963,0,1,negative regulation of postsynaptic density organization,BP,
20836,GO:1905878,1,0.987280423538017,0,1,invadopodium disassembly,BP,
20837,GO:1905879,1,0.936568103328599,0,10,regulation of oogenesis,BP,
20838,GO:1905880,1,0.973960581508277,0,4,negative regulation of oogenesis,BP,
20839,GO:1905881,1,0.972749314999613,0,4,positive regulation of oogenesis,BP,
20840,GO:1905890,1,0.996035242113144,0,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,
20841,GO:1905891,1,0.993974682800764,0,1,regulation of cellular response to thapsigargin,BP,
20842,GO:1905892,1,0.993974682800764,0,1,negative regulation of cellular response to thapsigargin,BP,
20843,GO:1905894,1,0.993974682800764,0,1,regulation of cellular response to tunicamycin,BP,
20844,GO:1905895,1,0.993974682800764,0,1,negative regulation of cellular response to tunicamycin,BP,
20845,GO:1905897,1,0.629386526184368,0,73,regulation of response to endoplasmic reticulum stress,BP,
20846,GO:1905898,1,0.802360129901826,0,35,positive regulation of response to endoplasmic reticulum stress,BP,
20847,GO:1905899,1,0.995539622956947,0,1,regulation of smooth muscle tissue development,BP,
20848,GO:1905900,1,0.995539622956947,0,1,negative regulation of smooth muscle tissue development,BP,
20849,GO:1905901,1,0.995539622956947,0,1,positive regulation of smooth muscle tissue development,BP,
20854,GO:1905908,1,0.974319298687768,0,4,positive regulation of amyloid fibril formation,BP,
20855,GO:1905912,1,0.995199455663535,0,1,regulation of calcium ion export across plasma membrane,BP,
20856,GO:1905913,1,0.995199455663535,0,1,negative regulation of calcium ion export across plasma membrane,BP,
20857,GO:1905918,1,0.994798023842829,0,1,regulation of CoA-transferase activity,BP,
20858,GO:1905920,1,0.994798023842829,0,1,positive regulation of CoA-transferase activity,BP,
20859,GO:1905927,1,0.987280423538017,0,1,regulation of invadopodium disassembly,BP,
20860,GO:1905929,1,0.987280423538017,0,1,positive regulation of invadopodium disassembly,BP,
20861,GO:1905936,1,0.982294015511945,0,4,regulation of germ cell proliferation,BP,
20862,GO:1905937,1,0.985958702041883,0,3,negative regulation of germ cell proliferation,BP,
20863,GO:1905938,1,0.996283655396962,0,1,positive regulation of germ cell proliferation,BP,
20864,GO:1905939,1,0.896714408614996,0,18,regulation of gonad development,BP,
20865,GO:1905940,1,0.969483689162598,0,5,negative regulation of gonad development,BP,
20866,GO:1905941,1,0.943480209713426,0,10,positive regulation of gonad development,BP,
20867,GO:1905942,1,0.994447013915942,0,1,regulation of formation of growth cone in injured axon,BP,
20868,GO:1905943,1,0.994447013915942,0,1,negative regulation of formation of growth cone in injured axon,BP,
20869,GO:1905952,1,0.485940234528139,0,109,regulation of lipid localization,BP,
20870,GO:1905953,1,0.803805326971082,0,31,negative regulation of lipid localization,BP,
20871,GO:1905954,1,0.649081033302076,0,66,positive regulation of lipid localization,BP,
20872,GO:1905957,1,0.992471325418713,0,1,regulation of cellular response to alcohol,BP,
20873,GO:1905959,1,0.992471325418713,0,1,positive regulation of cellular response to alcohol,BP,
20874,GO:1905961,1,0.952397797153031,0,8,protein-cysteine S-palmitoyltransferase complex,CC,
20877,GO:1990003,1,0.990809253553117,0,1,IDP phosphatase activity,MF,
20878,GO:1990005,1,0.989447509707039,0,2,granular vesicle,CC,
20879,GO:1990008,1,0.995365492857349,0,1,neurosecretory vesicle,CC,
20880,GO:1990009,1,0.984726756571038,0,2,retinal cell apoptotic process,BP,
20881,GO:1990015,1,0.994488549045981,0,1,ensheathing process,CC,
20882,GO:1990023,1,0.908256578024763,0,12,mitotic spindle midzone,CC,
20883,GO:1990026,1,0.985130729855387,0,2,hippocampal mossy fiber expansion,CC,
20884,GO:1990030,1,0.992898393460792,0,1,pericellular basket,CC,
20885,GO:1990031,1,0.993637347214129,0,1,pinceau fiber,CC,
20886,GO:1990032,1,0.992343271655656,0,1,parallel fiber,CC,
20887,GO:1990034,1,0.961735272943169,0,5,calcium ion export across plasma membrane,BP,
20888,GO:1990036,1,0.984104931259715,0,2,calcium ion import into sarcoplasmic reticulum,BP,
20889,GO:1990037,1,0.985261447716355,0,3,Lewy body core,CC,
20890,GO:1990038,1,0.995052814997107,0,1,Lewy body corona,CC,
20891,GO:1990046,1,0.995910596863438,0,1,stress-induced mitochondrial fusion,BP,
20892,GO:1990047,1,0.994647858302576,0,1,spindle matrix,CC,
20893,GO:1990048,1,0.994054740756748,0,1,anterograde neuronal dense core vesicle transport,BP,
20894,GO:1990050,1,0.982399738146866,0,4,phosphatidic acid transporter activity,MF,
20895,GO:1990051,1,0.98462456703609,0,2,activation of protein kinase C activity,BP,
20896,GO:1990070,1,0.996544660521493,0,1,TRAPPI protein complex,CC,
20897,GO:1990071,1,0.986455434841194,0,2,TRAPPII protein complex,CC,
20898,GO:1990072,1,0.990619737026906,0,2,TRAPPIII protein complex,CC,
20899,GO:1990074,1,0.993280222725594,0,1,polyuridylation-dependent mRNA catabolic process,BP,
20900,GO:1990075,1,0.9650802737442,0,4,periciliary membrane compartment,CC,
20901,GO:1990079,1,0.996260102119505,0,1,cartilage homeostasis,BP,
20902,GO:1990086,1,0.972579881268968,0,4,lens fiber cell apoptotic process,BP,
20905,GO:1990108,1,0.982476489164223,0,2,protein linear deubiquitination,BP,
20906,GO:1990111,1,0.978213747962859,0,4,spermatoproteasome complex,CC,
20907,GO:1990112,1,0.988144472527205,0,2,RQC complex,CC,
20908,GO:1990116,1,0.988144472527205,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
20909,GO:1990117,1,0.996491547285932,0,1,B cell receptor apoptotic signaling pathway,BP,
20910,GO:1990124,1,0.940814400765253,0,8,messenger ribonucleoprotein complex,CC,
20911,GO:1990126,1,0.898070496593665,0,16,retrograde transport, endosome to plasma membrane,BP,
20912,GO:1990127,1,0.992627261718495,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
20913,GO:1990130,1,0.969819541946172,0,5,GATOR1 complex,CC,
20914,GO:1990131,1,0.978036534547224,0,4,Gtr1-Gtr2 GTPase complex,CC,
20915,GO:1990134,1,0.991793562071462,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
20916,GO:1990136,1,0.994363395684829,0,1,linoleate 9S-lipoxygenase activity,MF,
20918,GO:1990144,1,0.967229635501042,0,6,intrinsic apoptotic signaling pathway in response to hypoxia,BP,
20919,GO:1990145,1,0.987041142345652,0,2,maintenance of translational fidelity,BP,
20920,GO:1990164,1,0.987737224853982,0,2,histone H2A phosphorylation,BP,
20921,GO:1990165,1,0.994973557798029,0,1,single-strand break-containing DNA binding,MF,
20922,GO:1990166,1,0.99454691040799,0,1,protein localization to site of double-strand break,BP,
20923,GO:1990167,1,0.981005578157726,0,2,protein K27-linked deubiquitination,BP,
20924,GO:1990168,1,0.982541958218072,0,2,protein K33-linked deubiquitination,BP,
20925,GO:1990169,1,0.958099292183819,0,11,stress response to copper ion,BP,
20926,GO:1990170,1,0.994981160360306,0,1,stress response to cadmium ion,BP,
20927,GO:1990172,1,0.990959133424442,0,1,G-protein coupled receptor catabolic process,BP,
20928,GO:1990173,1,0.94523180231784,0,10,protein localization to nucleoplasm,BP,
20929,GO:1990174,1,0.992953449568544,0,1,phosphodiesterase decapping endonuclease activity,MF,
20930,GO:1990175,1,0.992881631048789,0,1,EH domain binding,MF,
20931,GO:1990179,1,0.977166594023451,0,3,protein localization to actomyosin contractile ring,BP,
20932,GO:1990180,1,0.985097826958956,0,3,mitochondrial tRNA 3'-end processing,BP,
20933,GO:1990182,1,0.905344310674947,0,17,exosomal secretion,BP,
20934,GO:1990183,1,0.996442105952666,0,1,lymphatic vascular process in circulatory system,BP,
20935,GO:1990186,1,0.996442105952666,0,1,regulation of lymphatic vessel size,BP,
20936,GO:1990188,1,0.994228064010722,0,1,euchromatin binding,MF,
20937,GO:1990189,1,0.985541615772647,0,3,peptide-serine-N-acetyltransferase activity,MF,
20938,GO:1990190,1,0.992032038177108,0,2,peptide-glutamate-N-acetyltransferase activity,MF,
20939,GO:1990192,1,0.996442105952666,0,1,collecting lymphatic vessel constriction,BP,
20940,GO:1990204,1,0.617614737131575,0,96,oxidoreductase complex,CC,
20941,GO:1990226,1,0.966573943876976,0,6,histone methyltransferase binding,MF,
20943,GO:1990239,1,0.958615677947434,0,6,steroid hormone binding,MF,
20944,GO:1990246,1,0.976428094882373,0,4,uniplex complex,CC,
20945,GO:1990247,1,0.948197345404083,0,7,N6-methyladenosine-containing RNA binding,MF,
20946,GO:1990253,1,0.935455352538623,0,9,cellular response to leucine starvation,BP,
20947,GO:1990254,1,0.968905253068882,0,5,keratin filament binding,MF,
20948,GO:1990256,1,0.985521182892708,0,1,signal clustering,BP,
20949,GO:1990258,1,0.996047689627225,0,1,histone glutamine methylation,BP,
20950,GO:1990259,1,0.996047689627225,0,1,histone-glutamine methyltransferase activity,MF,
20951,GO:1990261,1,0.994054740756748,0,1,pre-mRNA catabolic process,BP,
20952,GO:1990262,1,0.994086731122564,0,1,anti-Mullerian hormone signaling pathway,BP,
20953,GO:1990264,1,0.988205503639614,0,2,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
20954,GO:1990266,1,0.654054419369664,0,78,neutrophil migration,BP,
20955,GO:1990267,1,0.993574169836367,0,1,response to transition metal nanoparticle,BP,
20956,GO:1990268,1,0.993574169836367,0,1,response to gold nanoparticle,BP,
20957,GO:1990269,1,0.98665028334142,0,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,
20958,GO:1990275,1,0.993930819393885,0,1,preribosome binding,MF,
20959,GO:1990280,1,0.990028927438995,0,1,RNA localization to chromatin,BP,
20960,GO:1990298,1,0.99480620027945,0,1,bub1-bub3 complex,CC,
20961,GO:1990314,1,0.938198355182478,0,8,cellular response to insulin-like growth factor stimulus,BP,
20962,GO:1990316,1,0.938288325719438,0,8,Atg1/ULK1 kinase complex,CC,
20963,GO:1990332,1,0.992794336896152,0,1,Ire1 complex,CC,
20964,GO:1990349,1,0.994997637646617,0,1,gap junction-mediated intercellular transport,BP,
20966,GO:1990356,1,0.996006601352857,0,1,sumoylated E2 ligase complex,CC,
20967,GO:1990357,1,0.983896482641973,0,3,terminal web,CC,
20968,GO:1990379,1,0.990816769082883,0,2,lipid transport across blood brain barrier,BP,
20969,GO:1990380,1,0.933837817384625,0,7,Lys48-specific deubiquitinase activity,MF,
20970,GO:1990381,1,0.912481342368275,0,13,ubiquitin-specific protease binding,MF,
20971,GO:1990384,1,0.995909348799247,0,1,hyaloid vascular plexus regression,BP,
20972,GO:1990386,1,0.995028073331356,0,1,mitotic cleavage furrow ingression,BP,
20973,GO:1990390,1,0.993327211149906,0,1,protein K33-linked ubiquitination,BP,
20974,GO:1990391,1,0.786941223697083,0,33,DNA repair complex,CC,
20975,GO:1990393,1,0.963352463786926,0,5,3M complex,CC,
20976,GO:1990399,1,0.99469523433253,0,1,epithelium regeneration,BP,
20977,GO:1990401,1,0.994058157286956,0,1,embryonic lung development,BP,
20978,GO:1990402,1,0.994746541367731,0,1,embryonic liver development,BP,
20979,GO:1990403,1,0.934174983926085,0,10,embryonic brain development,BP,
20980,GO:1990404,1,0.988003664144986,0,2,protein ADP-ribosylase activity,MF,
20981,GO:1990405,1,0.95531823785838,0,6,protein antigen binding,MF,
20982,GO:1990406,1,0.98823238383906,0,2,CGRP receptor complex,CC,
20983,GO:1990407,1,0.996374067917336,0,1,calcitonin gene-related peptide binding,MF,
20984,GO:1990408,1,0.98823238383906,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,
20985,GO:1990409,1,0.988383222554109,0,2,adrenomedullin binding,MF,
20986,GO:1990410,1,0.980026785179801,0,4,adrenomedullin receptor signaling pathway,BP,
20987,GO:1990414,1,0.969935855841624,0,4,replication-born double-strand break repair via sister chromatid exchange,BP,
20988,GO:1990415,1,0.981681781541331,0,3,Pex17p-Pex14p docking complex,CC,
20989,GO:1990416,1,0.941631647774864,0,8,cellular response to brain-derived neurotrophic factor stimulus,BP,
20990,GO:1990418,1,0.983233695010604,0,3,response to insulin-like growth factor stimulus,BP,
20991,GO:1990421,1,0.986090908152591,0,1,subtelomeric heterochromatin,CC,
20992,GO:1990423,1,0.977484820726246,0,3,RZZ complex,CC,
20993,GO:1990425,1,0.968548190281637,0,3,ryanodine receptor complex,CC,
20994,GO:1990426,1,0.980645263774375,0,2,mitotic recombination-dependent replication fork processing,BP,
20995,GO:1990427,1,0.989495416816709,0,1,stereocilia tip-link density,CC,
20996,GO:1990428,1,0.985331653194328,0,2,miRNA transport,BP,
20997,GO:1990429,1,0.981681781541331,0,3,peroxisomal importomer complex,CC,
20998,GO:1990430,1,0.968202024921268,0,4,extracellular matrix protein binding,MF,
20999,GO:1990435,1,0.989495416816709,0,1,upper tip-link density,CC,
21000,GO:1990439,1,0.993862904902913,0,1,MAP kinase serine/threonine phosphatase activity,MF,
21001,GO:1990440,1,0.940030412668509,0,11,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
21002,GO:1990441,1,0.977134054146867,0,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
21003,GO:1990442,1,0.988334640275628,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
21004,GO:1990446,1,0.982001038921196,0,4,U1 snRNP binding,MF,
21005,GO:1990448,1,0.990228975570435,0,1,exon-exon junction complex binding,MF,
21006,GO:1990452,1,0.986679865856259,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
21007,GO:1990454,1,0.937629308368775,0,7,L-type voltage-gated calcium channel complex,CC,
21008,GO:1990456,1,0.992971642063943,0,1,mitochondrion-endoplasmic reticulum membrane tethering,BP,
21009,GO:1990459,1,0.957259380580867,0,7,transferrin receptor binding,MF,
21010,GO:1990460,1,0.978225349232877,0,3,leptin receptor binding,MF,
21011,GO:1990462,1,0.956481533386248,0,7,omegasome,CC,
21012,GO:1990478,1,0.995088990805623,0,1,response to ultrasound,BP,
21013,GO:1990481,1,0.978460080436599,0,4,mRNA pseudouridine synthesis,BP,
21014,GO:1990498,1,0.978498919962344,0,2,mitotic spindle microtubule,CC,
21016,GO:1990504,1,0.942888031059729,0,6,dense core granule exocytosis,BP,
21017,GO:1990505,1,0.980645263774375,0,2,mitotic DNA replication maintenance of fidelity,BP,
21018,GO:1990511,1,0.97317273889574,0,4,piRNA biosynthetic process,BP,
21019,GO:1990518,1,0.992204666131814,0,1,single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,MF,
21020,GO:1990519,1,0.98788339701756,0,2,pyrimidine nucleotide import into mitochondrion,BP,
21021,GO:1990523,1,0.976056621615704,0,4,bone regeneration,BP,
21022,GO:1990535,1,0.95998031117682,0,5,neuron projection maintenance,BP,
21023,GO:1990539,1,0.994596954618774,0,1,fructose import across plasma membrane,BP,
21024,GO:1990542,1,0.682019710080654,0,67,mitochondrial transmembrane transport,BP,
21025,GO:1990546,1,0.995503097025035,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
21026,GO:1990564,1,0.974481566813411,0,5,protein polyufmylation,BP,
21027,GO:1990565,1,0.995413523014708,0,1,HSP90-CDC37 chaperone complex,CC,
21028,GO:1990569,1,0.984895473958835,0,2,UDP-N-acetylglucosamine transmembrane transport,BP,
21029,GO:1990570,1,0.994054740756748,0,1,GDP-mannose transmembrane transport,BP,
21030,GO:1990572,1,0.992809706686633,0,1,TERT-RMRP complex,CC,
21031,GO:1990573,1,0.943196034807499,0,9,potassium ion import across plasma membrane,BP,
21032,GO:1990575,1,0.987373417692934,0,2,mitochondrial L-ornithine transmembrane transport,BP,
21033,GO:1990578,1,0.99102461973732,0,1,perinuclear endoplasmic reticulum membrane,CC,
21034,GO:1990579,1,0.992794336896152,0,1,peptidyl-serine trans-autophosphorylation,BP,
21035,GO:1990583,1,0.995028073331356,0,1,phospholipase D activator activity,MF,
21036,GO:1990584,1,0.989209112602055,0,3,cardiac Troponin complex,CC,
21037,GO:1990589,1,0.982724421887979,0,2,ATF4-CREB1 transcription factor complex,CC,
21038,GO:1990590,1,0.989834703918924,0,2,ATF1-ATF4 transcription factor complex,CC,
21039,GO:1990592,1,0.974481566813411,0,5,protein K69-linked ufmylation,BP,
21040,GO:1990597,1,0.979916094681783,0,3,AIP1-IRE1 complex,CC,
21041,GO:1990599,1,0.978570783584199,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
21042,GO:1990603,1,0.993502154158033,0,1,dark adaptation,BP,
21043,GO:1990604,1,0.979196116662185,0,3,IRE1-TRAF2-ASK1 complex,CC,
21044,GO:1990613,1,0.993273391638312,0,1,mitochondrial membrane fusion,BP,
21045,GO:1990617,1,0.991745567444031,0,2,CHOP-ATF4 complex,CC,
21046,GO:1990619,1,0.988456008678985,0,2,histone H3-K9 deacetylation,BP,
21047,GO:1990622,1,0.991331688183896,0,2,CHOP-ATF3 complex,CC,
21048,GO:1990630,1,0.992794336896152,0,1,IRE1-RACK1-PP2A complex,CC,
21049,GO:1990635,1,0.971935284251049,0,4,proximal dendrite,CC,
21050,GO:1990637,1,0.978758766873182,0,3,response to prolactin,BP,
21051,GO:1990641,1,0.984470341780981,0,3,response to iron ion starvation,BP,
21052,GO:1990646,1,0.993795533248943,0,1,cellular response to prolactin,BP,
21053,GO:1990654,1,0.991914228371951,0,1,sebum secreting cell proliferation,BP,
21054,GO:1990666,1,0.984773424121067,0,2,PCSK9-LDLR complex,CC,
21055,GO:1990667,1,0.988648315581891,0,2,PCSK9-AnxA2 complex,CC,
21056,GO:1990668,1,0.971143891946892,0,5,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,
21057,GO:1990682,1,0.987314158267655,0,2,CSF1-CSF1R complex,CC,
21058,GO:1990696,1,0.979889071239122,0,2,USH2 complex,CC,
21059,GO:1990697,1,0.99472023877896,0,1,protein depalmitoleylation,BP,
21060,GO:1990698,1,0.988162405505185,0,2,palmitoleoyltransferase activity,MF,
21061,GO:1990699,1,0.99472023877896,0,1,palmitoleyl hydrolase activity,MF,
21062,GO:1990700,1,0.992869175331111,0,1,nucleolar chromatin organization,BP,
21063,GO:1990705,1,0.988194477035737,0,1,cholangiocyte proliferation,BP,
21064,GO:1990707,1,0.986090908152591,0,1,nuclear subtelomeric heterochromatin,CC,
21065,GO:1990708,1,0.991874862093252,0,1,conditioned place preference,BP,
21066,GO:1990709,1,0.976621459408517,0,3,presynaptic active zone organization,BP,
21067,GO:1990712,1,0.956226200882059,0,7,HFE-transferrin receptor complex,CC,
21068,GO:1990715,1,0.99275778371461,0,1,mRNA CDS binding,MF,
21069,GO:1990716,1,0.972638047163207,0,3,axonemal central apparatus,CC,
21070,GO:1990718,1,0.987344085532843,0,1,axonemal central pair projection,CC,
21071,GO:1990723,1,0.979460378851303,0,2,cytoplasmic periphery of the nuclear pore complex,CC,
21072,GO:1990726,1,0.981002750378437,0,5,Lsm1-7-Pat1 complex,CC,
21073,GO:1990729,1,0.995050911452303,0,1,primary miRNA modification,BP,
21074,GO:1990730,1,0.98623241619279,0,2,VCP-NSFL1C complex,CC,
21075,GO:1990736,1,0.992745260332433,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
21076,GO:1990737,1,0.980312330915126,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
21077,GO:1990739,1,0.988194477035737,0,1,granulosa cell proliferation,BP,
21079,GO:1990743,1,0.969844332016275,0,4,protein sialylation,BP,
21080,GO:1990744,1,0.995050911452303,0,1,primary miRNA methylation,BP,
21081,GO:1990745,1,0.978392116528212,0,3,EARP complex,CC,
21082,GO:1990748,1,0.630743084204113,0,86,cellular detoxification,BP,
21083,GO:1990751,1,0.989648928315445,0,1,Schwann cell chemotaxis,BP,
21085,GO:1990755,1,0.994054740756748,0,1,mitotic spindle microtubule depolymerization,BP,
21086,GO:1990756,1,0.983006768954481,0,3,protein binding, bridging involved in substrate recognition for ubiquitination,MF,
21087,GO:1990758,1,0.995210879903036,0,1,mitotic sister chromatid biorientation,BP,
21088,GO:1990761,1,0.974736002253798,0,3,growth cone lamellipodium,CC,
21089,GO:1990763,1,0.958212658914551,0,6,arrestin family protein binding,MF,
21090,GO:1990764,1,0.994117792638113,0,1,myofibroblast contraction,BP,
21091,GO:1990765,1,0.991649235187485,0,1,colon smooth muscle contraction,BP,
21092,GO:1990768,1,0.996611310932968,0,1,gastric mucosal blood circulation,BP,
21093,GO:1990769,1,0.98365708324337,0,3,proximal neuron projection,CC,
21094,GO:1990770,1,0.988288559505802,0,2,small intestine smooth muscle contraction,BP,
21095,GO:1990771,1,0.990740702415856,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
21096,GO:1990773,1,0.995336390958826,0,1,matrix metallopeptidase secretion,BP,
21097,GO:1990774,1,0.883252077053274,0,18,tumor necrosis factor secretion,BP,
21099,GO:1990777,1,0.823130574722309,0,32,lipoprotein particle,CC,
21101,GO:1990782,1,0.621888118708826,0,67,protein tyrosine kinase binding,MF,
21102,GO:1990784,1,0.992777993439408,0,1,response to dsDNA,BP,
21103,GO:1990785,1,0.972831844744516,0,3,response to water-immersion restraint stress,BP,
21104,GO:1990786,1,0.992777993439408,0,1,cellular response to dsDNA,BP,
21105,GO:1990791,1,0.981540567356639,0,3,dorsal root ganglion development,BP,
21106,GO:1990796,1,0.993865622052031,0,1,photoreceptor cell terminal bouton,CC,
21107,GO:1990809,1,0.97742239158999,0,4,endoplasmic reticulum tubular network membrane organization,BP,
21108,GO:1990812,1,0.980114833062094,0,3,growth cone filopodium,CC,
21109,GO:1990817,1,0.994652836670812,0,1,RNA adenylyltransferase activity,MF,
21110,GO:1990822,1,0.947967792315314,0,8,basic amino acid transmembrane transport,BP,
21112,GO:1990825,1,0.946905525327846,0,9,sequence-specific mRNA binding,MF,
21113,GO:1990828,1,0.994800539266136,0,1,hepatocyte dedifferentiation,BP,
21114,GO:1990829,1,0.995054084055567,0,1,C-rich single-stranded DNA binding,MF,
21116,GO:1990832,1,0.994957091090962,0,1,slow axonal transport,BP,
21117,GO:1990833,1,0.994957091090962,0,1,clathrin-uncoating ATPase activity,MF,
21118,GO:1990834,1,0.976739994830266,0,4,response to odorant,BP,
21120,GO:1990839,1,0.987192556333022,0,2,response to endothelin,BP,
21121,GO:1990841,1,0.75949609167674,0,38,promoter-specific chromatin binding,MF,
21122,GO:1990843,1,0.990516721249158,0,1,subsarcolemmal mitochondrion,CC,
21123,GO:1990844,1,0.990516721249158,0,1,interfibrillar mitochondrion,CC,
21124,GO:1990845,1,0.9204105139431,0,13,adaptive thermogenesis,BP,
21125,GO:1990851,1,0.972554014855144,0,3,Wnt-Frizzled-LRP5/6 complex,CC,
21126,GO:1990859,1,0.994613069578521,0,1,cellular response to endothelin,BP,
21127,GO:1990868,1,0.963832708572012,0,5,response to chemokine,BP,
21128,GO:1990869,1,0.963832708572012,0,5,cellular response to chemokine,BP,
21129,GO:1990874,1,0.78277438868008,0,36,vascular smooth muscle cell proliferation,BP,
21130,GO:1990876,1,0.990218290769763,0,1,cytoplasmic side of nuclear pore,CC,
21131,GO:1990879,1,0.988144472527205,0,2,CST complex,CC,
21132,GO:1990882,1,0.992858153626207,0,1,rRNA acetylation,BP,
21133,GO:1990883,1,0.992858153626207,0,1,rRNA cytidine N-acetyltransferase activity,MF,
21134,GO:1990884,1,0.992858153626207,0,1,RNA acetylation,BP,
21135,GO:1990889,1,0.995174064163132,0,1,H4K20me3 modified histone binding,MF,
21136,GO:1990904,1,0.0144348774757702,0,719,ribonucleoprotein complex,CC,
21137,GO:1990907,1,0.91654172687941,0,11,beta-catenin-TCF complex,CC,
21138,GO:1990909,1,0.915211290690504,0,10,Wnt signalosome,CC,
21139,GO:1990910,1,0.983745998861174,0,3,response to hypobaric hypoxia,BP,
21140,GO:1990911,1,0.977272674266487,0,4,response to psychosocial stress,BP,
21141,GO:1990913,1,0.994323749019896,0,1,sperm head plasma membrane,CC,
21142,GO:1990917,1,0.994323749019896,0,1,ooplasm,CC,
21143,GO:1990918,1,0.986352439169014,0,2,double-strand break repair involved in meiotic recombination,BP,
21144,GO:1990922,1,0.99347450390528,0,1,hepatic stellate cell proliferation,BP,
21145,GO:1990923,1,0.9824262997964,0,3,PET complex,CC,
21147,GO:1990927,1,0.983945934743073,0,2,calcium ion regulated lysosome exocytosis,BP,
21148,GO:1990928,1,0.98323759865095,0,2,response to amino acid starvation,BP,
21149,GO:1990930,1,0.995539622956947,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
21150,GO:1990931,1,0.992529948194665,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
21151,GO:1990936,1,0.989144104263098,0,2,vascular smooth muscle cell dedifferentiation,BP,
21152,GO:1990938,1,0.992810666932176,0,1,peptidyl-aspartic acid autophosphorylation,BP,
21154,GO:1990948,1,0.98125032119228,0,5,ubiquitin ligase inhibitor activity,MF,
21155,GO:1990955,1,0.992724044257892,0,1,G-rich single-stranded DNA binding,MF,
21156,GO:1990962,1,0.992825065831946,0,1,drug transport across blood-brain barrier,BP,
21157,GO:1990963,1,0.992825065831946,0,1,establishment of blood-retinal barrier,BP,
21158,GO:1990966,1,0.974636367368104,0,4,ATP generation from poly-ADP-D-ribose,BP,
21159,GO:1990967,1,0.989388365427458,0,2,multi-organism toxin transport,BP,
21160,GO:1990968,1,0.990389632961235,0,1,modulation by host of RNA binding by virus,BP,
21161,GO:1990969,1,0.990389632961235,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
21162,GO:1990971,1,0.992879715008209,0,1,EMILIN complex,CC,
21163,GO:1990983,1,0.994274825977625,0,1,tRNA demethylation,BP,
21164,GO:1990984,1,0.994274825977625,0,1,tRNA demethylase activity,MF,
21165,GO:2000001,1,0.908150193777444,0,16,regulation of DNA damage checkpoint,BP,
21166,GO:2000002,1,0.97098278480085,0,5,negative regulation of DNA damage checkpoint,BP,
21167,GO:2000003,1,0.994054740756748,0,1,positive regulation of DNA damage checkpoint,BP,
21168,GO:2000004,1,0.995275580827277,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
21169,GO:2000005,1,0.995275580827277,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
21170,GO:2000006,1,0.995275580827277,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
21171,GO:2000007,1,0.995275580827277,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
21172,GO:2000008,1,0.798895433402907,0,33,regulation of protein localization to cell surface,BP,
21173,GO:2000009,1,0.92272214816966,0,12,negative regulation of protein localization to cell surface,BP,
21174,GO:2000010,1,0.913718914052065,0,13,positive regulation of protein localization to cell surface,BP,
21175,GO:2000011,1,0.994742780964552,0,1,regulation of adaxial/abaxial pattern formation,BP,
21176,GO:2000015,1,0.978925668631116,0,4,regulation of determination of dorsal identity,BP,
21177,GO:2000016,1,0.991560493472778,0,2,negative regulation of determination of dorsal identity,BP,
21178,GO:2000017,1,0.98725872154657,0,2,positive regulation of determination of dorsal identity,BP,
21179,GO:2000018,1,0.950576973198603,0,8,regulation of male gonad development,BP,
21180,GO:2000019,1,0.992908448818777,0,1,negative regulation of male gonad development,BP,
21181,GO:2000020,1,0.957369182906054,0,7,positive regulation of male gonad development,BP,
21185,GO:2000036,1,0.841008020392812,0,24,regulation of stem cell population maintenance,BP,
21188,GO:2000042,1,0.929055099880675,0,9,negative regulation of double-strand break repair via homologous recombination,BP,
21189,GO:2000043,1,0.994566033676475,0,1,regulation of cardiac cell fate specification,BP,
21190,GO:2000045,1,0.386788165885043,0,145,regulation of G1/S transition of mitotic cell cycle,BP,
21191,GO:2000047,1,0.944542490207361,0,10,regulation of cell-cell adhesion mediated by cadherin,BP,
21192,GO:2000048,1,0.980173672934714,0,4,negative regulation of cell-cell adhesion mediated by cadherin,BP,
21193,GO:2000049,1,0.963655318213806,0,6,positive regulation of cell-cell adhesion mediated by cadherin,BP,
21196,GO:2000052,1,0.922674616492293,0,12,positive regulation of non-canonical Wnt signaling pathway,BP,
21197,GO:2000053,1,0.974204392270187,0,3,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21198,GO:2000054,1,0.987030779502647,0,2,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21199,GO:2000055,1,0.987006778235442,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21200,GO:2000056,1,0.995153748145458,0,1,regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
21201,GO:2000057,1,0.995153748145458,0,1,negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
21202,GO:2000058,1,0.411224792410817,0,135,regulation of ubiquitin-dependent protein catabolic process,BP,
21203,GO:2000059,1,0.782877929396299,0,37,negative regulation of ubiquitin-dependent protein catabolic process,BP,
21204,GO:2000060,1,0.551482280540652,0,90,positive regulation of ubiquitin-dependent protein catabolic process,BP,
21205,GO:2000061,1,0.995539622956947,0,1,regulation of ureter smooth muscle cell differentiation,BP,
21206,GO:2000062,1,0.995539622956947,0,1,negative regulation of ureter smooth muscle cell differentiation,BP,
21207,GO:2000063,1,0.995539622956947,0,1,positive regulation of ureter smooth muscle cell differentiation,BP,
21208,GO:2000064,1,0.961377501269969,0,6,regulation of cortisol biosynthetic process,BP,
21209,GO:2000065,1,0.975881362004158,0,4,negative regulation of cortisol biosynthetic process,BP,
21210,GO:2000066,1,0.992908448818777,0,1,positive regulation of cortisol biosynthetic process,BP,
21211,GO:2000067,1,0.996531076871997,0,1,regulation of root morphogenesis,BP,
21212,GO:2000074,1,0.95142530354099,0,8,regulation of type B pancreatic cell development,BP,
21213,GO:2000077,1,0.984582481765685,0,2,negative regulation of type B pancreatic cell development,BP,
21214,GO:2000078,1,0.985989322655168,0,3,positive regulation of type B pancreatic cell development,BP,
21215,GO:2000079,1,0.992363434097317,0,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
21216,GO:2000080,1,0.992363434097317,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
21218,GO:2000096,1,0.948552437446387,0,8,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
21219,GO:2000097,1,0.984162816411107,0,3,regulation of smooth muscle cell-matrix adhesion,BP,
21220,GO:2000098,1,0.989755362253067,0,2,negative regulation of smooth muscle cell-matrix adhesion,BP,
21221,GO:2000101,1,0.993875418370528,0,1,regulation of mammary stem cell proliferation,BP,
21222,GO:2000103,1,0.993875418370528,0,1,positive regulation of mammary stem cell proliferation,BP,
21223,GO:2000104,1,0.872644931572428,0,19,negative regulation of DNA-dependent DNA replication,BP,
21224,GO:2000105,1,0.905160589947993,0,14,positive regulation of DNA-dependent DNA replication,BP,
21225,GO:2000106,1,0.633140494321121,0,75,regulation of leukocyte apoptotic process,BP,
21226,GO:2000107,1,0.769967395703703,0,43,negative regulation of leukocyte apoptotic process,BP,
21227,GO:2000108,1,0.862372192943266,0,24,positive regulation of leukocyte apoptotic process,BP,
21228,GO:2000109,1,0.955530095297783,0,7,regulation of macrophage apoptotic process,BP,
21229,GO:2000110,1,0.980751089008177,0,3,negative regulation of macrophage apoptotic process,BP,
21230,GO:2000111,1,0.979697451501402,0,3,positive regulation of macrophage apoptotic process,BP,
21233,GO:2000114,1,0.865901314991253,0,18,regulation of establishment of cell polarity,BP,
21236,GO:2000118,1,0.986560038948072,0,2,regulation of sodium-dependent phosphate transport,BP,
21237,GO:2000119,1,0.993835289231854,0,1,negative regulation of sodium-dependent phosphate transport,BP,
21238,GO:2000121,1,0.94619482737087,0,10,regulation of removal of superoxide radicals,BP,
21239,GO:2000124,1,0.986971713175215,0,2,regulation of endocannabinoid signaling pathway,BP,
21240,GO:2000134,1,0.531934620295235,0,96,negative regulation of G1/S transition of mitotic cell cycle,BP,
21241,GO:2000136,1,0.897594087797772,0,15,regulation of cell proliferation involved in heart morphogenesis,BP,
21242,GO:2000137,1,0.980655660804656,0,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,
21243,GO:2000138,1,0.965506687997497,0,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,
21244,GO:2000142,1,0.785465212943223,0,36,regulation of DNA-templated transcription, initiation,BP,
21245,GO:2000143,1,0.961158187045559,0,6,negative regulation of DNA-templated transcription, initiation,BP,
21246,GO:2000144,1,0.834002580920535,0,27,positive regulation of DNA-templated transcription, initiation,BP,
21250,GO:2000152,1,0.981085416980757,0,4,regulation of ubiquitin-specific protease activity,BP,
21251,GO:2000156,1,0.986925397057182,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
21252,GO:2000157,1,0.992248650770929,0,2,negative regulation of ubiquitin-specific protease activity,BP,
21253,GO:2000158,1,0.988750441605162,0,2,positive regulation of ubiquitin-specific protease activity,BP,
21254,GO:2000167,1,0.991441333760389,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
21255,GO:2000169,1,0.943108203592922,0,7,regulation of peptidyl-cysteine S-nitrosylation,BP,
21256,GO:2000170,1,0.985840704000368,0,2,positive regulation of peptidyl-cysteine S-nitrosylation,BP,
21257,GO:2000171,1,0.816126321774012,0,26,negative regulation of dendrite development,BP,
21258,GO:2000172,1,0.969048592133584,0,4,regulation of branching morphogenesis of a nerve,BP,
21259,GO:2000173,1,0.992856715766406,0,1,negative regulation of branching morphogenesis of a nerve,BP,
21260,GO:2000174,1,0.99283945646826,0,1,regulation of pro-T cell differentiation,BP,
21261,GO:2000176,1,0.99283945646826,0,1,positive regulation of pro-T cell differentiation,BP,
21263,GO:2000178,1,0.871388250156658,0,20,negative regulation of neural precursor cell proliferation,BP,
21265,GO:2000181,1,0.534572083514266,0,88,negative regulation of blood vessel morphogenesis,BP,
21266,GO:2000182,1,0.976542028745656,0,3,regulation of progesterone biosynthetic process,BP,
21267,GO:2000184,1,0.990516721249158,0,1,positive regulation of progesterone biosynthetic process,BP,
21268,GO:2000191,1,0.895460990248085,0,16,regulation of fatty acid transport,BP,
21269,GO:2000192,1,0.958886717742697,0,5,negative regulation of fatty acid transport,BP,
21270,GO:2000193,1,0.94431124293355,0,10,positive regulation of fatty acid transport,BP,
21271,GO:2000194,1,0.930336405214139,0,12,regulation of female gonad development,BP,
21272,GO:2000195,1,0.976409611807641,0,4,negative regulation of female gonad development,BP,
21273,GO:2000196,1,0.985498906527232,0,3,positive regulation of female gonad development,BP,
21274,GO:2000197,1,0.956082564292561,0,6,regulation of ribonucleoprotein complex localization,BP,
21275,GO:2000199,1,0.993701339479024,0,1,positive regulation of ribonucleoprotein complex localization,BP,
21276,GO:2000200,1,0.993701339479024,0,1,regulation of ribosomal subunit export from nucleus,BP,
21277,GO:2000202,1,0.993701339479024,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
21278,GO:2000206,1,0.993701339479024,0,1,regulation of ribosomal small subunit export from nucleus,BP,
21279,GO:2000208,1,0.993701339479024,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
21280,GO:2000209,1,0.863433109298621,0,21,regulation of anoikis,BP,
21281,GO:2000210,1,0.967859510377963,0,6,positive regulation of anoikis,BP,
21282,GO:2000211,1,0.986645091603365,0,2,regulation of glutamate metabolic process,BP,
21283,GO:2000212,1,0.991791066798282,0,1,negative regulation of glutamate metabolic process,BP,
21284,GO:2000213,1,0.994811863082861,0,1,positive regulation of glutamate metabolic process,BP,
21285,GO:2000224,1,0.985174052487919,0,3,regulation of testosterone biosynthetic process,BP,
21286,GO:2000225,1,0.989155394873127,0,2,negative regulation of testosterone biosynthetic process,BP,
21287,GO:2000226,1,0.995692916722254,0,1,regulation of pancreatic A cell differentiation,BP,
21288,GO:2000227,1,0.995692916722254,0,1,negative regulation of pancreatic A cell differentiation,BP,
21289,GO:2000229,1,0.991107425652781,0,2,regulation of pancreatic stellate cell proliferation,BP,
21290,GO:2000230,1,0.995181047312037,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
21291,GO:2000231,1,0.995906852572358,0,1,positive regulation of pancreatic stellate cell proliferation,BP,
21292,GO:2000232,1,0.928700890562461,0,11,regulation of rRNA processing,BP,
21293,GO:2000233,1,0.984832126092952,0,2,negative regulation of rRNA processing,BP,
21294,GO:2000234,1,0.951018455194418,0,8,positive regulation of rRNA processing,BP,
21296,GO:2000242,1,0.769275745498833,0,44,negative regulation of reproductive process,BP,
21297,GO:2000243,1,0.739801756381185,0,47,positive regulation of reproductive process,BP,
21298,GO:2000249,1,0.802286967189384,0,35,regulation of actin cytoskeleton reorganization,BP,
21299,GO:2000251,1,0.905079725693464,0,18,positive regulation of actin cytoskeleton reorganization,BP,
21300,GO:2000252,1,0.966118731409686,0,7,negative regulation of feeding behavior,BP,
21301,GO:2000253,1,0.963035707710668,0,5,positive regulation of feeding behavior,BP,
21302,GO:2000254,1,0.982294015511945,0,4,regulation of male germ cell proliferation,BP,
21303,GO:2000255,1,0.985958702041883,0,3,negative regulation of male germ cell proliferation,BP,
21304,GO:2000256,1,0.996283655396962,0,1,positive regulation of male germ cell proliferation,BP,
21305,GO:2000257,1,0.797450423522532,0,37,regulation of protein activation cascade,BP,
21306,GO:2000258,1,0.953744686684382,0,6,negative regulation of protein activation cascade,BP,
21307,GO:2000259,1,0.980197985293318,0,3,positive regulation of protein activation cascade,BP,
21308,GO:2000269,1,0.899056121815758,0,15,regulation of fibroblast apoptotic process,BP,
21309,GO:2000270,1,0.950297902827609,0,7,negative regulation of fibroblast apoptotic process,BP,
21310,GO:2000271,1,0.948915718835591,0,7,positive regulation of fibroblast apoptotic process,BP,
21311,GO:2000272,1,0.825497537270691,0,28,negative regulation of signaling receptor activity,BP,
21313,GO:2000275,1,0.981410085912484,0,4,regulation of oxidative phosphorylation uncoupler activity,BP,
21314,GO:2000276,1,0.990206489192541,0,2,negative regulation of oxidative phosphorylation uncoupler activity,BP,
21315,GO:2000277,1,0.996339404102419,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
21316,GO:2000278,1,0.53071563814872,0,96,regulation of DNA biosynthetic process,BP,
21317,GO:2000279,1,0.79898169277966,0,32,negative regulation of DNA biosynthetic process,BP,
21318,GO:2000280,1,0.996531076871997,0,1,regulation of root development,BP,
21319,GO:2000282,1,0.984526090413091,0,2,regulation of cellular amino acid biosynthetic process,BP,
21320,GO:2000283,1,0.988143720671723,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
21321,GO:2000284,1,0.996339404102419,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
21322,GO:2000286,1,0.981624179652597,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
21323,GO:2000287,1,0.994692736442737,0,1,positive regulation of myotome development,BP,
21324,GO:2000288,1,0.948972349685673,0,9,positive regulation of myoblast proliferation,BP,
21325,GO:2000290,1,0.994692736442737,0,1,regulation of myotome development,BP,
21326,GO:2000291,1,0.91840692390033,0,14,regulation of myoblast proliferation,BP,
21327,GO:2000295,1,0.98629173772364,0,3,regulation of hydrogen peroxide catabolic process,BP,
21328,GO:2000296,1,0.992616084021476,0,2,negative regulation of hydrogen peroxide catabolic process,BP,
21330,GO:2000298,1,0.98797444339384,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21331,GO:2000299,1,0.993433013859775,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21333,GO:2000301,1,0.98159143600139,0,3,negative regulation of synaptic vesicle exocytosis,BP,
21334,GO:2000302,1,0.974845650049346,0,3,positive regulation of synaptic vesicle exocytosis,BP,
21335,GO:2000303,1,0.928042558029242,0,13,regulation of ceramide biosynthetic process,BP,
21336,GO:2000304,1,0.953629174341886,0,8,positive regulation of ceramide biosynthetic process,BP,
21337,GO:2000307,1,0.988216560721023,0,2,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21338,GO:2000308,1,0.994533977466101,0,1,negative regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21339,GO:2000309,1,0.993648213078983,0,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21340,GO:2000310,1,0.875082574793682,0,18,regulation of NMDA receptor activity,BP,
21341,GO:2000311,1,0.835925731257444,0,24,regulation of AMPA receptor activity,BP,
21342,GO:2000312,1,0.977435578247611,0,3,regulation of kainate selective glutamate receptor activity,BP,
21343,GO:2000313,1,0.990591722928662,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21344,GO:2000314,1,0.995427414738478,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21345,GO:2000316,1,0.947952562818562,0,9,regulation of T-helper 17 type immune response,BP,
21346,GO:2000317,1,0.969807908594092,0,5,negative regulation of T-helper 17 type immune response,BP,
21347,GO:2000318,1,0.977471155694949,0,4,positive regulation of T-helper 17 type immune response,BP,
21348,GO:2000319,1,0.954136048768646,0,8,regulation of T-helper 17 cell differentiation,BP,
21349,GO:2000320,1,0.969807908594092,0,5,negative regulation of T-helper 17 cell differentiation,BP,
21350,GO:2000321,1,0.983845210005687,0,3,positive regulation of T-helper 17 cell differentiation,BP,
21351,GO:2000322,1,0.947901546340413,0,8,regulation of glucocorticoid receptor signaling pathway,BP,
21352,GO:2000323,1,0.959264084018539,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
21353,GO:2000324,1,0.988159888721203,0,2,positive regulation of glucocorticoid receptor signaling pathway,BP,
21354,GO:2000325,1,0.990657038438086,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
21355,GO:2000327,1,0.990657038438086,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
21356,GO:2000328,1,0.97934190132395,0,4,regulation of T-helper 17 cell lineage commitment,BP,
21357,GO:2000329,1,0.987995058844791,0,2,negative regulation of T-helper 17 cell lineage commitment,BP,
21358,GO:2000330,1,0.991242765097668,0,2,positive regulation of T-helper 17 cell lineage commitment,BP,
21359,GO:2000331,1,0.986433284967475,0,2,regulation of terminal button organization,BP,
21360,GO:2000332,1,0.990355697273027,0,2,regulation of blood microparticle formation,BP,
21361,GO:2000334,1,0.990355697273027,0,2,positive regulation of blood microparticle formation,BP,
21362,GO:2000338,1,0.988944513256728,0,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21363,GO:2000340,1,0.988944513256728,0,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21364,GO:2000341,1,0.949807089648897,0,10,regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21365,GO:2000342,1,0.988457139384124,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21366,GO:2000343,1,0.960903109188556,0,8,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21367,GO:2000344,1,0.953253572582283,0,7,positive regulation of acrosome reaction,BP,
21368,GO:2000345,1,0.931261650442302,0,11,regulation of hepatocyte proliferation,BP,
21369,GO:2000346,1,0.981347599041567,0,3,negative regulation of hepatocyte proliferation,BP,
21370,GO:2000347,1,0.962507412574726,0,6,positive regulation of hepatocyte proliferation,BP,
21371,GO:2000348,1,0.964211062035832,0,6,regulation of CD40 signaling pathway,BP,
21372,GO:2000349,1,0.987431149600658,0,2,negative regulation of CD40 signaling pathway,BP,
21373,GO:2000350,1,0.996193110740806,0,1,positive regulation of CD40 signaling pathway,BP,
21374,GO:2000351,1,0.767227159032044,0,40,regulation of endothelial cell apoptotic process,BP,
21375,GO:2000352,1,0.840300895748371,0,26,negative regulation of endothelial cell apoptotic process,BP,
21376,GO:2000353,1,0.913184521433236,0,14,positive regulation of endothelial cell apoptotic process,BP,
21377,GO:2000354,1,0.966170382380581,0,6,regulation of ovarian follicle development,BP,
21378,GO:2000355,1,0.990076872696888,0,2,negative regulation of ovarian follicle development,BP,
21379,GO:2000356,1,0.995539622956947,0,1,regulation of kidney smooth muscle cell differentiation,BP,
21380,GO:2000357,1,0.995539622956947,0,1,negative regulation of kidney smooth muscle cell differentiation,BP,
21381,GO:2000358,1,0.995539622956947,0,1,positive regulation of kidney smooth muscle cell differentiation,BP,
21382,GO:2000359,1,0.990480584799719,0,2,regulation of binding of sperm to zona pellucida,BP,
21383,GO:2000360,1,0.990480584799719,0,2,negative regulation of binding of sperm to zona pellucida,BP,
21384,GO:2000361,1,0.984462495657174,0,2,regulation of prostaglandin-E synthase activity,BP,
21385,GO:2000363,1,0.984462495657174,0,2,positive regulation of prostaglandin-E synthase activity,BP,
21386,GO:2000367,1,0.990865003983876,0,2,regulation of acrosomal vesicle exocytosis,BP,
21387,GO:2000368,1,0.990865003983876,0,2,positive regulation of acrosomal vesicle exocytosis,BP,
21388,GO:2000369,1,0.877539604120511,0,16,regulation of clathrin-dependent endocytosis,BP,
21389,GO:2000370,1,0.970945479038635,0,4,positive regulation of clathrin-dependent endocytosis,BP,
21390,GO:2000371,1,0.964590431679138,0,5,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21391,GO:2000373,1,0.964590431679138,0,5,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21392,GO:2000374,1,0.988078770922718,0,3,regulation of oxygen metabolic process,BP,
21393,GO:2000376,1,0.993099176354599,0,2,positive regulation of oxygen metabolic process,BP,
21396,GO:2000379,1,0.609568731628205,0,78,positive regulation of reactive oxygen species metabolic process,BP,
21399,GO:2000382,1,0.974096068067559,0,4,positive regulation of mesoderm development,BP,
21400,GO:2000383,1,0.992962066760823,0,1,regulation of ectoderm development,BP,
21401,GO:2000384,1,0.992962066760823,0,1,negative regulation of ectoderm development,BP,
21402,GO:2000386,1,0.988561781122819,0,2,positive regulation of ovarian follicle development,BP,
21403,GO:2000387,1,0.99576935168197,0,1,regulation of antral ovarian follicle growth,BP,
21404,GO:2000388,1,0.99576935168197,0,1,positive regulation of antral ovarian follicle growth,BP,
21405,GO:2000389,1,0.979589858210447,0,3,regulation of neutrophil extravasation,BP,
21406,GO:2000391,1,0.979589858210447,0,3,positive regulation of neutrophil extravasation,BP,
21407,GO:2000392,1,0.922859915541837,0,11,regulation of lamellipodium morphogenesis,BP,
21408,GO:2000393,1,0.985778457139728,0,2,negative regulation of lamellipodium morphogenesis,BP,
21409,GO:2000394,1,0.949473443617707,0,7,positive regulation of lamellipodium morphogenesis,BP,
21410,GO:2000395,1,0.991849654831814,0,2,regulation of ubiquitin-dependent endocytosis,BP,
21411,GO:2000397,1,0.991849654831814,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
21413,GO:2000402,1,0.959174242143477,0,7,negative regulation of lymphocyte migration,BP,
21415,GO:2000404,1,0.851285602491041,0,28,regulation of T cell migration,BP,
21416,GO:2000405,1,0.987473844815866,0,2,negative regulation of T cell migration,BP,
21417,GO:2000406,1,0.880955794385257,0,22,positive regulation of T cell migration,BP,
21418,GO:2000407,1,0.984741064379041,0,3,regulation of T cell extravasation,BP,
21419,GO:2000409,1,0.989595206036885,0,2,positive regulation of T cell extravasation,BP,
21420,GO:2000410,1,0.984564415377779,0,3,regulation of thymocyte migration,BP,
21421,GO:2000412,1,0.989656401106525,0,2,positive regulation of thymocyte migration,BP,
21422,GO:2000413,1,0.993648213078983,0,1,regulation of fibronectin-dependent thymocyte migration,BP,
21423,GO:2000415,1,0.993648213078983,0,1,positive regulation of fibronectin-dependent thymocyte migration,BP,
21424,GO:2000416,1,0.976595930564226,0,4,regulation of eosinophil migration,BP,
21425,GO:2000417,1,0.988556253109192,0,2,negative regulation of eosinophil migration,BP,
21426,GO:2000418,1,0.987902620893182,0,2,positive regulation of eosinophil migration,BP,
21427,GO:2000419,1,0.993383376416789,0,1,regulation of eosinophil extravasation,BP,
21428,GO:2000420,1,0.993383376416789,0,1,negative regulation of eosinophil extravasation,BP,
21429,GO:2000422,1,0.994218050969824,0,1,regulation of eosinophil chemotaxis,BP,
21430,GO:2000424,1,0.994218050969824,0,1,positive regulation of eosinophil chemotaxis,BP,
21431,GO:2000425,1,0.939689479593405,0,9,regulation of apoptotic cell clearance,BP,
21432,GO:2000426,1,0.988707057602808,0,2,negative regulation of apoptotic cell clearance,BP,
21433,GO:2000427,1,0.951525649707728,0,7,positive regulation of apoptotic cell clearance,BP,
21434,GO:2000434,1,0.992968424418537,0,2,regulation of protein neddylation,BP,
21435,GO:2000435,1,0.992968424418537,0,2,negative regulation of protein neddylation,BP,
21436,GO:2000437,1,0.977437763185481,0,3,regulation of monocyte extravasation,BP,
21437,GO:2000438,1,0.990064688415245,0,1,negative regulation of monocyte extravasation,BP,
21438,GO:2000439,1,0.987247640050841,0,2,positive regulation of monocyte extravasation,BP,
21439,GO:2000446,1,0.992485019047148,0,1,regulation of macrophage migration inhibitory factor signaling pathway,BP,
21440,GO:2000449,1,0.984741064379041,0,3,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21441,GO:2000451,1,0.989595206036885,0,2,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21442,GO:2000452,1,0.990309259032093,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21443,GO:2000454,1,0.995190569231579,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21444,GO:2000458,1,0.989682266011565,0,2,regulation of astrocyte chemotaxis,BP,
21445,GO:2000463,1,0.820623379086153,0,25,positive regulation of excitatory postsynaptic potential,BP,
21446,GO:2000464,1,0.994377869669239,0,1,positive regulation of astrocyte chemotaxis,BP,
21447,GO:2000465,1,0.954004220515388,0,6,regulation of glycogen (starch) synthase activity,BP,
21448,GO:2000466,1,0.978256743943628,0,3,negative regulation of glycogen (starch) synthase activity,BP,
21449,GO:2000467,1,0.976092764095745,0,3,positive regulation of glycogen (starch) synthase activity,BP,
21450,GO:2000468,1,0.981454536362687,0,2,regulation of peroxidase activity,BP,
21451,GO:2000469,1,0.987748176584163,0,1,negative regulation of peroxidase activity,BP,
21452,GO:2000470,1,0.993629084422039,0,1,positive regulation of peroxidase activity,BP,
21453,GO:2000471,1,0.986214129018304,0,2,regulation of hematopoietic stem cell migration,BP,
21454,GO:2000473,1,0.986214129018304,0,2,positive regulation of hematopoietic stem cell migration,BP,
21455,GO:2000474,1,0.987261953624001,0,2,regulation of opioid receptor signaling pathway,BP,
21456,GO:2000479,1,0.913530491866707,0,14,regulation of cAMP-dependent protein kinase activity,BP,
21457,GO:2000480,1,0.954895505954114,0,8,negative regulation of cAMP-dependent protein kinase activity,BP,
21458,GO:2000481,1,0.966492572745316,0,4,positive regulation of cAMP-dependent protein kinase activity,BP,
21459,GO:2000482,1,0.879252802155419,0,22,regulation of interleukin-8 secretion,BP,
21460,GO:2000483,1,0.954445871000873,0,7,negative regulation of interleukin-8 secretion,BP,
21461,GO:2000484,1,0.926767813039623,0,14,positive regulation of interleukin-8 secretion,BP,
21462,GO:2000485,1,0.987829813319656,0,2,regulation of glutamine transport,BP,
21463,GO:2000486,1,0.993370529098454,0,1,negative regulation of glutamine transport,BP,
21464,GO:2000487,1,0.994422680895466,0,1,positive regulation of glutamine transport,BP,
21465,GO:2000489,1,0.960374034821137,0,6,regulation of hepatic stellate cell activation,BP,
21466,GO:2000490,1,0.988174534870727,0,2,negative regulation of hepatic stellate cell activation,BP,
21467,GO:2000491,1,0.971870144430687,0,4,positive regulation of hepatic stellate cell activation,BP,
21468,GO:2000492,1,0.993821279184255,0,1,regulation of interleukin-18-mediated signaling pathway,BP,
21469,GO:2000494,1,0.993821279184255,0,1,positive regulation of interleukin-18-mediated signaling pathway,BP,
21471,GO:2000502,1,0.992124019189,0,2,negative regulation of natural killer cell chemotaxis,BP,
21473,GO:2000504,1,0.986439631767769,0,2,positive regulation of blood vessel remodeling,BP,
21474,GO:2000508,1,0.961945258725649,0,8,regulation of dendritic cell chemotaxis,BP,
21475,GO:2000510,1,0.961945258725649,0,8,positive regulation of dendritic cell chemotaxis,BP,
21476,GO:2000511,1,0.995982929342318,0,1,regulation of granzyme A production,BP,
21477,GO:2000513,1,0.995982929342318,0,1,positive regulation of granzyme A production,BP,
21478,GO:2000514,1,0.788052447502792,0,39,regulation of CD4-positive, alpha-beta T cell activation,BP,
21479,GO:2000515,1,0.889811523458187,0,18,negative regulation of CD4-positive, alpha-beta T cell activation,BP,
21480,GO:2000516,1,0.867535927507406,0,25,positive regulation of CD4-positive, alpha-beta T cell activation,BP,
21481,GO:2000517,1,0.995982929342318,0,1,regulation of T-helper 1 cell activation,BP,
21482,GO:2000518,1,0.995982929342318,0,1,negative regulation of T-helper 1 cell activation,BP,
21483,GO:2000520,1,0.985205432332593,0,3,regulation of immunological synapse formation,BP,
21484,GO:2000521,1,0.990369018566501,0,2,negative regulation of immunological synapse formation,BP,
21485,GO:2000522,1,0.994786708960719,0,1,positive regulation of immunological synapse formation,BP,
21486,GO:2000523,1,0.988127874137623,0,2,regulation of T cell costimulation,BP,
21487,GO:2000525,1,0.988127874137623,0,2,positive regulation of T cell costimulation,BP,
21488,GO:2000526,1,0.994786708960719,0,1,positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation,BP,
21489,GO:2000527,1,0.996411187857165,0,1,regulation of myeloid dendritic cell chemotaxis,BP,
21490,GO:2000529,1,0.996411187857165,0,1,positive regulation of myeloid dendritic cell chemotaxis,BP,
21491,GO:2000532,1,0.994369422890623,0,1,regulation of renal albumin absorption,BP,
21492,GO:2000533,1,0.994369422890623,0,1,negative regulation of renal albumin absorption,BP,
21493,GO:2000535,1,0.958131010861145,0,6,regulation of entry of bacterium into host cell,BP,
21494,GO:2000536,1,0.989913676237162,0,1,negative regulation of entry of bacterium into host cell,BP,
21495,GO:2000537,1,0.98848906597393,0,2,regulation of B cell chemotaxis,BP,
21496,GO:2000538,1,0.98848906597393,0,2,positive regulation of B cell chemotaxis,BP,
21497,GO:2000539,1,0.994373041702465,0,1,regulation of protein geranylgeranylation,BP,
21498,GO:2000541,1,0.994373041702465,0,1,positive regulation of protein geranylgeranylation,BP,
21500,GO:2000543,1,0.978683791535223,0,4,positive regulation of gastrulation,BP,
21501,GO:2000544,1,0.966329832541836,0,5,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21502,GO:2000545,1,0.996006601352857,0,1,negative regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21503,GO:2000546,1,0.977055883944884,0,3,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21504,GO:2000547,1,0.987896321891223,0,3,regulation of dendritic cell dendrite assembly,BP,
21505,GO:2000548,1,0.996411187857165,0,1,negative regulation of dendritic cell dendrite assembly,BP,
21506,GO:2000549,1,0.996650782820428,0,1,positive regulation of dendritic cell dendrite assembly,BP,
21507,GO:2000551,1,0.957209887242809,0,8,regulation of T-helper 2 cell cytokine production,BP,
21508,GO:2000552,1,0.990010052044717,0,2,negative regulation of T-helper 2 cell cytokine production,BP,
21509,GO:2000553,1,0.966872165282917,0,6,positive regulation of T-helper 2 cell cytokine production,BP,
21510,GO:2000554,1,0.995982929342318,0,1,regulation of T-helper 1 cell cytokine production,BP,
21511,GO:2000556,1,0.995982929342318,0,1,positive regulation of T-helper 1 cell cytokine production,BP,
21512,GO:2000557,1,0.995982929342318,0,1,regulation of immunoglobulin production in mucosal tissue,BP,
21513,GO:2000558,1,0.995982929342318,0,1,positive regulation of immunoglobulin production in mucosal tissue,BP,
21514,GO:2000559,1,0.990064688415245,0,1,regulation of CD24 biosynthetic process,BP,
21515,GO:2000560,1,0.990064688415245,0,1,positive regulation of CD24 biosynthetic process,BP,
21516,GO:2000561,1,0.966078551412529,0,6,regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21517,GO:2000562,1,0.979626969248801,0,4,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21518,GO:2000563,1,0.977707373240995,0,4,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21519,GO:2000564,1,0.984705212906503,0,3,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21520,GO:2000566,1,0.991408399640292,0,2,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21521,GO:2000567,1,0.994742780964552,0,1,regulation of memory T cell activation,BP,
21522,GO:2000568,1,0.994742780964552,0,1,positive regulation of memory T cell activation,BP,
21523,GO:2000569,1,0.993522346249169,0,1,regulation of T-helper 2 cell activation,BP,
21524,GO:2000570,1,0.993522346249169,0,1,positive regulation of T-helper 2 cell activation,BP,
21525,GO:2000571,1,0.993306621233704,0,1,regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21526,GO:2000572,1,0.993306621233704,0,1,positive regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21527,GO:2000573,1,0.673553072932338,0,63,positive regulation of DNA biosynthetic process,BP,
21528,GO:2000574,1,0.950015411806729,0,9,regulation of microtubule motor activity,BP,
21529,GO:2000576,1,0.970307943568225,0,6,positive regulation of microtubule motor activity,BP,
21530,GO:2000580,1,0.97611260104196,0,5,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
21531,GO:2000582,1,0.97611260104196,0,5,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
21532,GO:2000583,1,0.992963981758228,0,1,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21533,GO:2000584,1,0.992963981758228,0,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21534,GO:2000586,1,0.916607211221459,0,10,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21535,GO:2000587,1,0.933405339246788,0,8,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21536,GO:2000588,1,0.982015783727984,0,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21537,GO:2000589,1,0.979240927656754,0,3,regulation of metanephric mesenchymal cell migration,BP,
21538,GO:2000591,1,0.979240927656754,0,3,positive regulation of metanephric mesenchymal cell migration,BP,
21539,GO:2000592,1,0.985697693689836,0,2,regulation of metanephric DCT cell differentiation,BP,
21540,GO:2000594,1,0.985697693689836,0,2,positive regulation of metanephric DCT cell differentiation,BP,
21541,GO:2000595,1,0.992707630778446,0,1,regulation of optic nerve formation,BP,
21542,GO:2000597,1,0.992707630778446,0,1,positive regulation of optic nerve formation,BP,
21543,GO:2000601,1,0.958625615686748,0,6,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
21544,GO:2000606,1,0.993734454560747,0,1,regulation of cell proliferation involved in mesonephros development,BP,
21545,GO:2000607,1,0.993734454560747,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
21546,GO:2000609,1,0.976918091055724,0,4,regulation of thyroid hormone generation,BP,
21547,GO:2000611,1,0.981681441069286,0,3,positive regulation of thyroid hormone generation,BP,
21548,GO:2000612,1,0.992939088184012,0,1,regulation of thyroid-stimulating hormone secretion,BP,
21549,GO:2000615,1,0.927773239703394,0,11,regulation of histone H3-K9 acetylation,BP,
21550,GO:2000616,1,0.986845368675226,0,2,negative regulation of histone H3-K9 acetylation,BP,
21551,GO:2000617,1,0.951334380194529,0,7,positive regulation of histone H3-K9 acetylation,BP,
21552,GO:2000618,1,0.963612281050761,0,5,regulation of histone H4-K16 acetylation,BP,
21553,GO:2000619,1,0.982560539019385,0,3,negative regulation of histone H4-K16 acetylation,BP,
21554,GO:2000620,1,0.980718820669076,0,2,positive regulation of histone H4-K16 acetylation,BP,
21555,GO:2000622,1,0.969598756674327,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21556,GO:2000623,1,0.969598756674327,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21557,GO:2000625,1,0.986397169755635,0,2,regulation of miRNA catabolic process,BP,
21558,GO:2000627,1,0.986397169755635,0,2,positive regulation of miRNA catabolic process,BP,
21559,GO:2000628,1,0.957781399380102,0,7,regulation of miRNA metabolic process,BP,
21560,GO:2000630,1,0.969785931007822,0,5,positive regulation of miRNA metabolic process,BP,
21561,GO:2000631,1,0.993550737487651,0,1,regulation of pre-miRNA processing,BP,
21562,GO:2000632,1,0.993550737487651,0,1,negative regulation of pre-miRNA processing,BP,
21563,GO:2000637,1,0.875826266779979,0,20,positive regulation of gene silencing by miRNA,BP,
21564,GO:2000638,1,0.987229679994078,0,2,regulation of SREBP signaling pathway,BP,
21565,GO:2000639,1,0.987229679994078,0,2,negative regulation of SREBP signaling pathway,BP,
21566,GO:2000641,1,0.894446076544017,0,17,regulation of early endosome to late endosome transport,BP,
21567,GO:2000642,1,0.992455184421824,0,2,negative regulation of early endosome to late endosome transport,BP,
21568,GO:2000643,1,0.943896929813386,0,8,positive regulation of early endosome to late endosome transport,BP,
21569,GO:2000644,1,0.93974594634541,0,9,regulation of receptor catabolic process,BP,
21570,GO:2000645,1,0.980311515938793,0,3,negative regulation of receptor catabolic process,BP,
21571,GO:2000646,1,0.964677833599281,0,5,positive regulation of receptor catabolic process,BP,
21572,GO:2000647,1,0.932429130532114,0,10,negative regulation of stem cell proliferation,BP,
21575,GO:2000650,1,0.914478919018151,0,11,negative regulation of sodium ion transmembrane transporter activity,BP,
21576,GO:2000651,1,0.90635679634237,0,13,positive regulation of sodium ion transmembrane transporter activity,BP,
21577,GO:2000653,1,0.97955324839069,0,3,regulation of genetic imprinting,BP,
21578,GO:2000654,1,0.992965418025289,0,1,regulation of cellular response to testosterone stimulus,BP,
21579,GO:2000655,1,0.992965418025289,0,1,negative regulation of cellular response to testosterone stimulus,BP,
21580,GO:2000656,1,0.995153748145458,0,1,regulation of apolipoprotein binding,BP,
21581,GO:2000657,1,0.995153748145458,0,1,negative regulation of apolipoprotein binding,BP,
21582,GO:2000659,1,0.959218180826257,0,7,regulation of interleukin-1-mediated signaling pathway,BP,
21583,GO:2000660,1,0.971854817499743,0,5,negative regulation of interleukin-1-mediated signaling pathway,BP,
21584,GO:2000661,1,0.991920703757226,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
21585,GO:2000662,1,0.964947642059666,0,6,regulation of interleukin-5 secretion,BP,
21586,GO:2000663,1,0.993166653449893,0,1,negative regulation of interleukin-5 secretion,BP,
21587,GO:2000664,1,0.971588771757933,0,5,positive regulation of interleukin-5 secretion,BP,
21588,GO:2000665,1,0.961160214899499,0,7,regulation of interleukin-13 secretion,BP,
21589,GO:2000666,1,0.988224580533476,0,2,negative regulation of interleukin-13 secretion,BP,
21590,GO:2000667,1,0.972616376821882,0,5,positive regulation of interleukin-13 secretion,BP,
21591,GO:2000668,1,0.943961487177451,0,10,regulation of dendritic cell apoptotic process,BP,
21592,GO:2000669,1,0.963914357097477,0,7,negative regulation of dendritic cell apoptotic process,BP,
21593,GO:2000670,1,0.979307770424896,0,3,positive regulation of dendritic cell apoptotic process,BP,
21594,GO:2000671,1,0.969211998226463,0,5,regulation of motor neuron apoptotic process,BP,
21595,GO:2000672,1,0.975994729076091,0,4,negative regulation of motor neuron apoptotic process,BP,
21596,GO:2000674,1,0.935656295647185,0,11,regulation of type B pancreatic cell apoptotic process,BP,
21597,GO:2000675,1,0.961636628390436,0,6,negative regulation of type B pancreatic cell apoptotic process,BP,
21598,GO:2000676,1,0.972993746473359,0,5,positive regulation of type B pancreatic cell apoptotic process,BP,
21599,GO:2000677,1,0.74504661698076,0,44,regulation of transcription regulatory region DNA binding,BP,
21600,GO:2000678,1,0.883263568514,0,19,negative regulation of transcription regulatory region DNA binding,BP,
21601,GO:2000679,1,0.878161573734216,0,21,positive regulation of transcription regulatory region DNA binding,BP,
21602,GO:2000683,1,0.987765975953319,0,2,regulation of cellular response to X-ray,BP,
21603,GO:2000685,1,0.993994270098414,0,1,positive regulation of cellular response to X-ray,BP,
21604,GO:2000690,1,0.992568447376529,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
21605,GO:2000691,1,0.992568447376529,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
21606,GO:2000696,1,0.896985196704104,0,15,regulation of epithelial cell differentiation involved in kidney development,BP,
21607,GO:2000697,1,0.978269969769893,0,4,negative regulation of epithelial cell differentiation involved in kidney development,BP,
21608,GO:2000698,1,0.968475130863714,0,5,positive regulation of epithelial cell differentiation involved in kidney development,BP,
21609,GO:2000699,1,0.993734454560747,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21610,GO:2000701,1,0.993734454560747,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21611,GO:2000702,1,0.993734454560747,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21612,GO:2000703,1,0.993734454560747,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21614,GO:2000706,1,0.993140601683347,0,1,negative regulation of dense core granule biogenesis,BP,
21616,GO:2000718,1,0.996398816784159,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
21617,GO:2000719,1,0.996398816784159,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
21618,GO:2000721,1,0.975980341886538,0,3,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21619,GO:2000722,1,0.978420423145098,0,3,regulation of cardiac vascular smooth muscle cell differentiation,BP,
21620,GO:2000723,1,0.99417467770393,0,1,negative regulation of cardiac vascular smooth muscle cell differentiation,BP,
21621,GO:2000724,1,0.984154361548667,0,2,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
21622,GO:2000725,1,0.821251109772404,0,27,regulation of cardiac muscle cell differentiation,BP,
21623,GO:2000726,1,0.92034318476489,0,11,negative regulation of cardiac muscle cell differentiation,BP,
21624,GO:2000727,1,0.892416568204005,0,16,positive regulation of cardiac muscle cell differentiation,BP,
21625,GO:2000729,1,0.98972609326937,0,2,positive regulation of mesenchymal cell proliferation involved in ureter development,BP,
21626,GO:2000733,1,0.993734454560747,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21627,GO:2000734,1,0.993734454560747,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21628,GO:2000736,1,0.513118018700637,0,115,regulation of stem cell differentiation,BP,
21629,GO:2000737,1,0.87258222467788,0,18,negative regulation of stem cell differentiation,BP,
21630,GO:2000738,1,0.890215737575982,0,17,positive regulation of stem cell differentiation,BP,
21631,GO:2000739,1,0.95012228458421,0,6,regulation of mesenchymal stem cell differentiation,BP,
21632,GO:2000740,1,0.993140601683347,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
21633,GO:2000741,1,0.966103355327102,0,4,positive regulation of mesenchymal stem cell differentiation,BP,
21634,GO:2000742,1,0.994891313133287,0,1,regulation of anterior head development,BP,
21635,GO:2000744,1,0.994891313133287,0,1,positive regulation of anterior head development,BP,
21636,GO:2000752,1,0.994037131471992,0,1,regulation of glucosylceramide catabolic process,BP,
21637,GO:2000753,1,0.994037131471992,0,1,positive regulation of glucosylceramide catabolic process,BP,
21638,GO:2000754,1,0.994037131471992,0,1,regulation of sphingomyelin catabolic process,BP,
21639,GO:2000755,1,0.994037131471992,0,1,positive regulation of sphingomyelin catabolic process,BP,
21640,GO:2000756,1,0.689219222229047,0,57,regulation of peptidyl-lysine acetylation,BP,
21641,GO:2000757,1,0.874442280257426,0,21,negative regulation of peptidyl-lysine acetylation,BP,
21642,GO:2000758,1,0.828374643398322,0,29,positive regulation of peptidyl-lysine acetylation,BP,
21643,GO:2000759,1,0.991960534754264,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
21644,GO:2000761,1,0.991960534754264,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
21645,GO:2000763,1,0.994542597469096,0,1,positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process,BP,
21646,GO:2000764,1,0.994542597469096,0,1,positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
21647,GO:2000765,1,0.86245482625975,0,22,regulation of cytoplasmic translation,BP,
21648,GO:2000766,1,0.947522631918157,0,7,negative regulation of cytoplasmic translation,BP,
21649,GO:2000767,1,0.95318461000742,0,7,positive regulation of cytoplasmic translation,BP,
21650,GO:2000768,1,0.992883547014093,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
21651,GO:2000772,1,0.797646607177397,0,33,regulation of cellular senescence,BP,
21652,GO:2000773,1,0.886781124251034,0,16,negative regulation of cellular senescence,BP,
21653,GO:2000774,1,0.952981084995387,0,9,positive regulation of cellular senescence,BP,
21654,GO:2000775,1,0.994884996941539,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
21655,GO:2000777,1,0.989634204519752,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
21656,GO:2000778,1,0.886899008456788,0,19,positive regulation of interleukin-6 secretion,BP,
21658,GO:2000780,1,0.861354421355181,0,20,negative regulation of double-strand break repair,BP,
21660,GO:2000785,1,0.786062206043075,0,35,regulation of autophagosome assembly,BP,
21661,GO:2000786,1,0.925640801462137,0,10,positive regulation of autophagosome assembly,BP,
21662,GO:2000790,1,0.981804475138065,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
21663,GO:2000791,1,0.981804475138065,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
21664,GO:2000793,1,0.969227476522755,0,3,cell proliferation involved in heart valve development,BP,
21665,GO:2000794,1,0.944562218797276,0,8,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21666,GO:2000795,1,0.988762214242541,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21667,GO:2000797,1,0.993140601683347,0,1,regulation of amniotic stem cell differentiation,BP,
21668,GO:2000798,1,0.993140601683347,0,1,negative regulation of amniotic stem cell differentiation,BP,
21669,GO:2000800,1,0.995429939945863,0,1,regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21670,GO:2000802,1,0.995429939945863,0,1,positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21671,GO:2000804,1,0.986191593533253,0,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21672,GO:2000806,1,0.986191593533253,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21673,GO:2000807,1,0.941108025404907,0,7,regulation of synaptic vesicle clustering,BP,
21674,GO:2000808,1,0.991283527905061,0,1,negative regulation of synaptic vesicle clustering,BP,
21675,GO:2000809,1,0.960042810492745,0,5,positive regulation of synaptic vesicle clustering,BP,
21676,GO:2000810,1,0.869973831495945,0,20,regulation of bicellular tight junction assembly,BP,
21677,GO:2000811,1,0.896961369620827,0,15,negative regulation of anoikis,BP,
21678,GO:2000812,1,0.992929513915958,0,1,regulation of barbed-end actin filament capping,BP,
21680,GO:2000818,1,0.989286709499186,0,2,negative regulation of myoblast proliferation,BP,
21681,GO:2000819,1,0.987240251302085,0,2,regulation of nucleotide-excision repair,BP,
21682,GO:2000820,1,0.979802616027596,0,3,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21683,GO:2000821,1,0.965451976601185,0,5,regulation of grooming behavior,BP,
21684,GO:2000822,1,0.95977606766616,0,7,regulation of behavioral fear response,BP,
21685,GO:2000823,1,0.9657331993036,0,6,regulation of androgen receptor activity,BP,
21686,GO:2000824,1,0.987518541725106,0,2,negative regulation of androgen receptor activity,BP,
21687,GO:2000825,1,0.977942077286165,0,4,positive regulation of androgen receptor activity,BP,
21688,GO:2000826,1,0.803519863495336,0,32,regulation of heart morphogenesis,BP,
21689,GO:2000827,1,0.994397214088083,0,1,mitochondrial RNA surveillance,BP,
21690,GO:2000828,1,0.986370787002795,0,2,regulation of parathyroid hormone secretion,BP,
21691,GO:2000830,1,0.991191773283465,0,1,positive regulation of parathyroid hormone secretion,BP,
21692,GO:2000831,1,0.918794206318039,0,16,regulation of steroid hormone secretion,BP,
21693,GO:2000832,1,0.984139054415111,0,2,negative regulation of steroid hormone secretion,BP,
21694,GO:2000833,1,0.958209512085367,0,9,positive regulation of steroid hormone secretion,BP,
21695,GO:2000834,1,0.993518302110512,0,1,regulation of androgen secretion,BP,
21696,GO:2000836,1,0.993518302110512,0,1,positive regulation of androgen secretion,BP,
21697,GO:2000843,1,0.983507911337375,0,2,regulation of testosterone secretion,BP,
21698,GO:2000845,1,0.983507911337375,0,2,positive regulation of testosterone secretion,BP,
21699,GO:2000846,1,0.932354230537505,0,13,regulation of corticosteroid hormone secretion,BP,
21700,GO:2000847,1,0.984139054415111,0,2,negative regulation of corticosteroid hormone secretion,BP,
21701,GO:2000848,1,0.967461305852282,0,7,positive regulation of corticosteroid hormone secretion,BP,
21702,GO:2000849,1,0.95441792323873,0,9,regulation of glucocorticoid secretion,BP,
21703,GO:2000850,1,0.984139054415111,0,2,negative regulation of glucocorticoid secretion,BP,
21704,GO:2000851,1,0.979357696443094,0,5,positive regulation of glucocorticoid secretion,BP,
21705,GO:2000852,1,0.982339334279943,0,4,regulation of corticosterone secretion,BP,
21706,GO:2000854,1,0.992014565188053,0,2,positive regulation of corticosterone secretion,BP,
21707,GO:2000855,1,0.976893343881599,0,4,regulation of mineralocorticoid secretion,BP,
21708,GO:2000857,1,0.987855412802887,0,2,positive regulation of mineralocorticoid secretion,BP,
21709,GO:2000858,1,0.976893343881599,0,4,regulation of aldosterone secretion,BP,
21710,GO:2000860,1,0.987855412802887,0,2,positive regulation of aldosterone secretion,BP,
21711,GO:2000864,1,0.978480223212307,0,3,regulation of estradiol secretion,BP,
21712,GO:2000866,1,0.987926509215883,0,2,positive regulation of estradiol secretion,BP,
21713,GO:2000870,1,0.991896071833431,0,2,regulation of progesterone secretion,BP,
21714,GO:2000872,1,0.99690204701045,0,1,positive regulation of progesterone secretion,BP,
21715,GO:2000878,1,0.989640228779888,0,2,positive regulation of oligopeptide transport,BP,
21716,GO:2000880,1,0.989640228779888,0,2,positive regulation of dipeptide transport,BP,
21717,GO:2000896,1,0.993644070878608,0,1,amylopectin metabolic process,BP,
21718,GO:2000909,1,0.994054740756748,0,1,regulation of sterol import,BP,
21719,GO:2000969,1,0.957801119573857,0,5,positive regulation of AMPA receptor activity,BP,
21720,GO:2000970,1,0.994483651850392,0,1,regulation of detection of glucose,BP,
21721,GO:2000971,1,0.994483651850392,0,1,negative regulation of detection of glucose,BP,
21722,GO:2000973,1,0.953155657412805,0,6,regulation of pro-B cell differentiation,BP,
21723,GO:2000974,1,0.979390859577766,0,3,negative regulation of pro-B cell differentiation,BP,
21724,GO:2000977,1,0.97889026288136,0,4,regulation of forebrain neuron differentiation,BP,
21725,GO:2000978,1,0.991589870797625,0,2,negative regulation of forebrain neuron differentiation,BP,
21726,GO:2000979,1,0.993732872242499,0,1,positive regulation of forebrain neuron differentiation,BP,
21727,GO:2000980,1,0.956056622931929,0,7,regulation of inner ear receptor cell differentiation,BP,
21728,GO:2000981,1,0.973004899424357,0,4,negative regulation of inner ear receptor cell differentiation,BP,
21729,GO:2000983,1,0.992648258469151,0,2,regulation of ATP citrate synthase activity,BP,
21730,GO:2000984,1,0.992648258469151,0,2,negative regulation of ATP citrate synthase activity,BP,
21731,GO:2000987,1,0.973065812364366,0,5,positive regulation of behavioral fear response,BP,
21732,GO:2001012,1,0.958855644722238,0,7,mesenchymal cell differentiation involved in renal system development,BP,
21733,GO:2001013,1,0.968237426073967,0,4,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
21734,GO:2001014,1,0.882502329064986,0,18,regulation of skeletal muscle cell differentiation,BP,
21735,GO:2001015,1,0.957227231680719,0,6,negative regulation of skeletal muscle cell differentiation,BP,
21736,GO:2001016,1,0.96601798516698,0,5,positive regulation of skeletal muscle cell differentiation,BP,
21742,GO:2001025,1,0.867694016982262,0,25,positive regulation of response to drug,BP,
21743,GO:2001026,1,0.885552671858736,0,16,regulation of endothelial cell chemotaxis,BP,
21744,GO:2001027,1,0.97492669207836,0,3,negative regulation of endothelial cell chemotaxis,BP,
21745,GO:2001028,1,0.914767809104876,0,12,positive regulation of endothelial cell chemotaxis,BP,
21746,GO:2001029,1,0.99130448816716,0,1,regulation of cellular glucuronidation,BP,
21747,GO:2001031,1,0.99130448816716,0,1,positive regulation of cellular glucuronidation,BP,
21748,GO:2001032,1,0.923621057233539,0,12,regulation of double-strand break repair via nonhomologous end joining,BP,
21749,GO:2001033,1,0.972927105441769,0,5,negative regulation of double-strand break repair via nonhomologous end joining,BP,
21750,GO:2001034,1,0.96235960841419,0,5,positive regulation of double-strand break repair via nonhomologous end joining,BP,
21751,GO:2001035,1,0.987920252630946,0,2,regulation of tongue muscle cell differentiation,BP,
21752,GO:2001037,1,0.987920252630946,0,2,positive regulation of tongue muscle cell differentiation,BP,
21753,GO:2001038,1,0.839849628364561,0,27,regulation of cellular response to drug,BP,
21754,GO:2001039,1,0.898661850051383,0,17,negative regulation of cellular response to drug,BP,
21755,GO:2001040,1,0.961015941399297,0,6,positive regulation of cellular response to drug,BP,
21756,GO:2001044,1,0.920414368571711,0,13,regulation of integrin-mediated signaling pathway,BP,
21757,GO:2001045,1,0.983727112009891,0,2,negative regulation of integrin-mediated signaling pathway,BP,
21758,GO:2001046,1,0.959542925784772,0,6,positive regulation of integrin-mediated signaling pathway,BP,
21759,GO:2001049,1,0.995011584938571,0,1,regulation of tendon cell differentiation,BP,
21760,GO:2001051,1,0.995011584938571,0,1,positive regulation of tendon cell differentiation,BP,
21761,GO:2001053,1,0.937084881411209,0,11,regulation of mesenchymal cell apoptotic process,BP,
21762,GO:2001054,1,0.946694577349971,0,9,negative regulation of mesenchymal cell apoptotic process,BP,
21763,GO:2001055,1,0.989854804242711,0,2,positive regulation of mesenchymal cell apoptotic process,BP,
21765,GO:2001057,1,0.654350837564131,0,64,reactive nitrogen species metabolic process,BP,
21766,GO:2001065,1,0.995829403259578,0,1,mannan binding,MF,
21767,GO:2001069,1,0.988344503973381,0,2,glycogen binding,MF,
21768,GO:2001070,1,0.985847669018512,0,2,starch binding,MF,
21769,GO:2001074,1,0.989103276594264,0,2,regulation of metanephric ureteric bud development,BP,
21770,GO:2001076,1,0.989103276594264,0,2,positive regulation of metanephric ureteric bud development,BP,
21771,GO:2001106,1,0.980741976684299,0,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
21772,GO:2001108,1,0.990483439331061,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
21773,GO:2001109,1,0.983340593512267,0,2,regulation of lens epithelial cell proliferation,BP,
21774,GO:2001111,1,0.983340593512267,0,2,positive regulation of lens epithelial cell proliferation,BP,
21775,GO:2001112,1,0.991859906140274,0,1,regulation of cellular response to hepatocyte growth factor stimulus,BP,
21776,GO:2001113,1,0.991859906140274,0,1,negative regulation of cellular response to hepatocyte growth factor stimulus,BP,
21777,GO:2001135,1,0.934366103550117,0,9,regulation of endocytic recycling,BP,
21778,GO:2001136,1,0.993444982742771,0,1,negative regulation of endocytic recycling,BP,
21779,GO:2001137,1,0.965523706402055,0,4,positive regulation of endocytic recycling,BP,
21780,GO:2001138,1,0.946649315805245,0,8,regulation of phospholipid transport,BP,
21781,GO:2001140,1,0.946649315805245,0,8,positive regulation of phospholipid transport,BP,
21783,GO:2001142,1,0.994299836510832,0,1,nicotinate transport,BP,
21784,GO:2001144,1,0.994770378692479,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
21785,GO:2001145,1,0.994770378692479,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
21786,GO:2001148,1,0.989640228779888,0,2,regulation of dipeptide transmembrane transport,BP,
21787,GO:2001150,1,0.989640228779888,0,2,positive regulation of dipeptide transmembrane transport,BP,
21788,GO:2001151,1,0.993576212296719,0,1,regulation of renal water transport,BP,
21789,GO:2001153,1,0.993576212296719,0,1,positive regulation of renal water transport,BP,
21790,GO:2001160,1,0.988540693017869,0,2,regulation of histone H3-K79 methylation,BP,
21791,GO:2001162,1,0.988540693017869,0,2,positive regulation of histone H3-K79 methylation,BP,
21792,GO:2001163,1,0.994655949205073,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
21793,GO:2001165,1,0.994655949205073,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
21794,GO:2001166,1,0.967596943299223,0,5,regulation of histone H2B ubiquitination,BP,
21795,GO:2001168,1,0.972624863958534,0,4,positive regulation of histone H2B ubiquitination,BP,
21796,GO:2001169,1,0.610119212477349,0,69,regulation of ATP biosynthetic process,BP,
21797,GO:2001170,1,0.911909970381932,0,13,negative regulation of ATP biosynthetic process,BP,
21798,GO:2001171,1,0.841784377753454,0,24,positive regulation of ATP biosynthetic process,BP,
21799,GO:2001173,1,0.994832011533058,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
21800,GO:2001176,1,0.988762766555626,0,2,regulation of mediator complex assembly,BP,
21801,GO:2001178,1,0.988762766555626,0,2,positive regulation of mediator complex assembly,BP,
21802,GO:2001179,1,0.965025143508803,0,7,regulation of interleukin-10 secretion,BP,
21803,GO:2001180,1,0.982368748450347,0,3,negative regulation of interleukin-10 secretion,BP,
21804,GO:2001181,1,0.982348266628624,0,4,positive regulation of interleukin-10 secretion,BP,
21805,GO:2001182,1,0.958133962405258,0,7,regulation of interleukin-12 secretion,BP,
21806,GO:2001183,1,0.981819793818876,0,3,negative regulation of interleukin-12 secretion,BP,
21807,GO:2001184,1,0.982529003685279,0,3,positive regulation of interleukin-12 secretion,BP,
21808,GO:2001185,1,0.960409951403315,0,7,regulation of CD8-positive, alpha-beta T cell activation,BP,
21809,GO:2001186,1,0.989052826873153,0,2,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
21810,GO:2001187,1,0.984362921799521,0,3,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
21811,GO:2001188,1,0.97576236095108,0,5,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21812,GO:2001189,1,0.984381292429683,0,3,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21813,GO:2001190,1,0.991245705094764,0,2,positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21814,GO:2001191,1,0.993954635307716,0,1,regulation of gamma-delta T cell activation involved in immune response,BP,
21815,GO:2001193,1,0.993954635307716,0,1,positive regulation of gamma-delta T cell activation involved in immune response,BP,
21816,GO:2001197,1,0.952787322398241,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
21817,GO:2001198,1,0.949209574865266,0,10,regulation of dendritic cell differentiation,BP,
21818,GO:2001199,1,0.969905207589667,0,6,negative regulation of dendritic cell differentiation,BP,
21819,GO:2001200,1,0.977260839398978,0,4,positive regulation of dendritic cell differentiation,BP,
21820,GO:2001201,1,0.974384251574954,0,3,regulation of transforming growth factor-beta secretion,BP,
21821,GO:2001202,1,0.982567320854638,0,2,negative regulation of transforming growth factor-beta secretion,BP,
21822,GO:2001203,1,0.991673217788203,0,1,positive regulation of transforming growth factor-beta secretion,BP,
21825,GO:2001206,1,0.983034055202188,0,3,positive regulation of osteoclast development,BP,
21826,GO:2001207,1,0.99299845905591,0,1,regulation of transcription elongation from RNA polymerase I promoter,BP,
21827,GO:2001208,1,0.99299845905591,0,1,negative regulation of transcription elongation by RNA polymerase I,BP,
21828,GO:2001212,1,0.91166412879198,0,14,regulation of vasculogenesis,BP,
21829,GO:2001213,1,0.99108623694053,0,1,negative regulation of vasculogenesis,BP,
21830,GO:2001214,1,0.938103251777344,0,10,positive regulation of vasculogenesis,BP,
21831,GO:2001222,1,0.77341120250387,0,29,regulation of neuron migration,BP,
21832,GO:2001223,1,0.937708729831375,0,8,negative regulation of neuron migration,BP,
21833,GO:2001224,1,0.882108063528616,0,13,positive regulation of neuron migration,BP,
21834,GO:2001225,1,0.932441516353807,0,10,regulation of chloride transport,BP,
21835,GO:2001226,1,0.981138134346376,0,3,negative regulation of chloride transport,BP,
21836,GO:2001228,1,0.970466790278053,0,2,regulation of response to gamma radiation,BP,
21837,GO:2001229,1,0.984117989289267,0,1,negative regulation of response to gamma radiation,BP,
21840,GO:2001235,1,0.377695605526467,0,164,positive regulation of apoptotic signaling pathway,BP,
21843,GO:2001238,1,0.738755330292922,0,49,positive regulation of extrinsic apoptotic signaling pathway,BP,
21844,GO:2001239,1,0.769965093727692,0,44,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21845,GO:2001240,1,0.831379095738178,0,32,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21846,GO:2001241,1,0.927984277368154,0,12,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21849,GO:2001244,1,0.772804376273155,0,48,positive regulation of intrinsic apoptotic signaling pathway,BP,
21850,GO:2001245,1,0.981613978405466,0,3,regulation of phosphatidylcholine biosynthetic process,BP,
21851,GO:2001246,1,0.992860549928441,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
21852,GO:2001247,1,0.992507496084931,0,1,positive regulation of phosphatidylcholine biosynthetic process,BP,
21853,GO:2001248,1,0.994811863082861,0,1,regulation of ammonia assimilation cycle,BP,
21854,GO:2001250,1,0.994811863082861,0,1,positive regulation of ammonia assimilation cycle,BP,
21856,GO:2001252,1,0.35171360899283,0,152,positive regulation of chromosome organization,BP,
21857,GO:2001253,1,0.993796602962107,0,1,regulation of histone H3-K36 trimethylation,BP,
21858,GO:2001256,1,0.930030807414816,0,12,regulation of store-operated calcium entry,BP,
21860,GO:2001258,1,0.811124773692411,0,36,negative regulation of cation channel activity,BP,
21862,GO:2001260,1,0.994542597469096,0,1,regulation of semaphorin-plexin signaling pathway,BP,
21863,GO:2001262,1,0.994542597469096,0,1,positive regulation of semaphorin-plexin signaling pathway,BP,
21864,GO:2001267,1,0.877998924767116,0,23,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21865,GO:2001268,1,0.976975469815908,0,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21866,GO:2001269,1,0.898713488470181,0,18,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21867,GO:2001270,1,0.975010768523463,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21868,GO:2001271,1,0.978480764708153,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21869,GO:2001272,1,0.996454469426125,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21870,GO:2001273,1,0.860991151510803,0,20,regulation of glucose import in response to insulin stimulus,BP,
21871,GO:2001274,1,0.980032800088127,0,3,negative regulation of glucose import in response to insulin stimulus,BP,
21872,GO:2001275,1,0.88440819383314,0,16,positive regulation of glucose import in response to insulin stimulus,BP,
21873,GO:2001279,1,0.96780659050739,0,5,regulation of unsaturated fatty acid biosynthetic process,BP,
21874,GO:2001280,1,0.980869708495559,0,3,positive regulation of unsaturated fatty acid biosynthetic process,BP,
21875,GO:2001286,1,0.970193395213466,0,4,regulation of caveolin-mediated endocytosis,BP,
21876,GO:2001287,1,0.988610633167366,0,2,negative regulation of caveolin-mediated endocytosis,BP,
21877,GO:2001288,1,0.988528401733288,0,1,positive regulation of caveolin-mediated endocytosis,BP,
21878,GO:2001293,1,0.982545009241289,0,2,malonyl-CoA metabolic process,BP,
21879,GO:2001294,1,0.994756573677009,0,1,malonyl-CoA catabolic process,BP,
21880,GO:2001295,1,0.98772471497335,0,1,malonyl-CoA biosynthetic process,BP,
21881,GO:2001300,1,0.970522940795835,0,6,lipoxin metabolic process,BP,
21882,GO:2001301,1,0.970522940795835,0,6,lipoxin biosynthetic process,BP,
21883,GO:2001302,1,0.988730133905475,0,2,lipoxin A4 metabolic process,BP,
21884,GO:2001303,1,0.988730133905475,0,2,lipoxin A4 biosynthetic process,BP,
21885,GO:2001304,1,0.994541365559013,0,1,lipoxin B4 metabolic process,BP,
21886,GO:2001306,1,0.994541365559013,0,1,lipoxin B4 biosynthetic process,BP,
21887,GO:2001311,1,0.995237530021739,0,1,lysobisphosphatidic acid metabolic process,BP,
973,GO:0002287,1,0.724299676158152,0,50,alpha-beta T cell activation involved in immune response,BP,
977,GO:0002293,1,0.724299676158152,0,50,alpha-beta T cell differentiation involved in immune response,BP,
10142,GO:0036092,1,0.706296866322437,0,44,phosphatidylinositol-3-phosphate biosynthetic process,BP,
12664,GO:0046839,1,0.830709214434628,0,24,phospholipid dephosphorylation,BP,
7673,GO:0031076,1,0.74687323390331,0,37,embryonic camera-type eye development,BP,
412,GO:0001091,1,0.893579852194635,0,16,RNA polymerase II basal transcription factor binding,MF,
9690,GO:0035306,1.00000000000001,0.708925851436343,0,48,positive regulation of dephosphorylation,BP,
1119,GO:0002534,1.00000000000001,0.827216476505237,0,30,cytokine production involved in inflammatory response,BP,
12492,GO:0046471,1.00000000000001,0.842542204869707,0,27,phosphatidylglycerol metabolic process,BP,
16582,GO:0071867,1.00000000000001,0.770677449394114,0,35,response to monoamine,BP,
16584,GO:0071869,1.00000000000001,0.770677449394114,0,35,response to catecholamine,BP,
9734,GO:0035385,1.00000000000001,0.941730928154492,0,7,Roundabout signaling pathway,BP,
